PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Garrett, S; Rosenthal, JJC				Garrett, Sandra; Rosenthal, Joshua J. C.			RNA Editing Underlies Temperature Adaptation in K+ Channels from Polar Octopuses	SCIENCE			English	Article							SQUID GIANT-AXON; POTASSIUM CHANNELS; CRYSTAL-STRUCTURE; T1 DOMAIN; INACTIVATION; CONDUCTANCE; ACTIVATION; INTERFACE; SODIUM	To operate in the extreme cold, ion channels from psychrophiles must have evolved structural changes to compensate for their thermal environment. A reasonable assumption would be that the underlying adaptations lie within the encoding genes. Here, we show that delayed rectifier K+ channel genes from an Antarctic and a tropical octopus encode channels that differ at only four positions and display very similar behavior when expressed in Xenopus oocytes. However, the transcribed messenger RNAs are extensively edited, creating functional diversity. One editing site, which recodes an isoleucine to a valine in the channel's pore, greatly accelerates gating kinetics by destabilizing the open state. This site is extensively edited in both Antarctic and Arctic species, but mostly unedited in tropical species. Thus adenosine-to-inosine RNA editing can respond to the physical environment.	[Garrett, Sandra; Rosenthal, Joshua J. C.] Univ Puerto Rico, Inst Neurobiol, San Juan, PR 00901 USA; [Rosenthal, Joshua J. C.] Univ Puerto Rico, Dept Biochem, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico	Rosenthal, JJC (corresponding author), Univ Puerto Rico, Inst Neurobiol, Med Sci Campus, San Juan, PR 00901 USA.	rosenthal.joshua@gmail.com			National Institutes of Health (NIH) Ruth L. Kirschstein National Research Service [FNS064774A, NIH 2 U54 NS039405-06, NIH R01 NS064259NIH]; National Science Foundation (NSF) [IBN-0344070]; Research Centers in Minority Institutions [G12 RR 03051]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS039405, R01NS064259] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); Research Centers in Minority Institutions(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to T. de Lange Wenneck and the Norwegian Institute of Marine Research for the invitation to collect Arctic cephalopods aboard the RV Jan Mayen. We thank C. DeVries for samples of Pareledone. This work was supported by the National Institutes of Health (NIH) Ruth L. Kirschstein National Research Service Predoctoral Fellow Award FNS064774A, NIH 2 U54 NS039405-06, NIH R01 NS064259NIH, and the National Science Foundation (NSF) IBN-0344070. Part of the work was conducted in the Molecular Biology Core Facility at the Institute of Neurobiology that is supported by Research Centers in Minority Institutions grant G12 RR 03051. K<INF>v</INF>1 sequences have been submitted to GenBank. The accession nos. are as follows: JQ246406, Pareledone sp.; JQ246407, Octopus vulgaris; JQ246408, Octopus digueti; JQ246409, Octopus defilippi; JQ246410, Octopus bimaculata; JQ246411, Bathypolypus arcticus; JQ246412, Benthoctopus piscatorum; JQ246413, Octopus rubescens. S. C. G. performed all experiments, participated in designing experiments, collected Arctic samples, and wrote the manuscript. J.J.C.R. participated in designing experiments; collected Antarctic, temperate, and tropical samples; and edited the manuscript.	ARMSTRONG CM, 1973, J GEN PHYSIOL, V62, P375, DOI 10.1085/jgp.62.4.375; BASILIO C, 1962, P NATL ACAD SCI USA, V48, P613, DOI 10.1073/pnas.48.4.613; BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; Bhalla T, 2004, NAT STRUCT MOL BIOL, V11, P950, DOI 10.1038/nsmb825; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; CONTI F, 1980, NATURE, V285, P140, DOI 10.1038/285140a0; Cushman SJ, 2000, NAT STRUCT BIOL, V7, P403; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; HODGKIN AL, 1949, J PHYSIOL-LONDON, V109, P240, DOI 10.1113/jphysiol.1949.sp004388; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P449, DOI 10.1113/jphysiol.1952.sp004717; Katz ME, 2011, SCIENCE, V332, P1076, DOI 10.1126/science.1202122; Kobertz WR, 2000, BIOCHEMISTRY-US, V39, P10347, DOI 10.1021/bi001292j; Kreusch A, 1998, NATURE, V392, P945, DOI 10.1038/31978; KUKITA F, 1982, J MEMBRANE BIOL, V68, P151, DOI 10.1007/BF01872261; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; LLANO I, 1988, J GEN PHYSIOL, V92, P179, DOI 10.1085/jgp.92.2.179; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; MELCHER T, 1995, J BIOL CHEM, V270, P8566, DOI 10.1074/jbc.270.15.8566; Minor DL, 2000, CELL, V102, P657, DOI 10.1016/S0092-8674(00)00088-X; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; Patton DE, 1997, NEURON, V19, P711, DOI 10.1016/S0896-6273(00)80383-9; Qin F, 2004, BIOPHYS J, V87, P1657, DOI 10.1529/biophysj.103.037531; Reenan RA, 2005, NATURE, V434, P409, DOI 10.1038/nature03364; Rodriguez BM, 1998, J GEN PHYSIOL, V112, P223, DOI 10.1085/jgp.112.2.223; Rosenthal JC, 1996, J GEN PHYSIOL, V108, P207, DOI 10.1085/jgp.108.3.207; Rosenthal JJC, 2002, NEURON, V34, P743, DOI 10.1016/S0896-6273(02)00701-8; Soler-Llavina GJ, 2006, NEURON, V52, P623, DOI 10.1016/j.neuron.2006.10.005	30	146	149	2	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2012	335	6070					848	851		10.1126/science.1212795	http://dx.doi.org/10.1126/science.1212795			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893LC	22223739	Green Accepted			2022-12-28	WOS:000300356400042
J	Hanney, M; Prasher, V; Williams, N; Jones, EL; Aarsland, D; Corbett, A; Lawrence, D; Yu, LM; Tyrer, S; Francis, PT; Johnson, T; Bullock, R; Ballard, C				Hanney, Marisa; Prasher, Vee; Williams, Nicola; Jones, Emma L.; Aarsland, Dag; Corbett, Anne; Lawrence, Dale; Yu, Ly-Mee; Tyrer, Stephen; Francis, Paul T.; Johnson, Tony; Bullock, Roger; Ballard, Clive		MEADOWS Trial Researchers	Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							TS65DN MOUSE MODEL; COGNITIVE DECLINE; ONSET; FEATURES; AGE	Background Prevalence of Alzheimer's disease in people with Down's syndrome is very high, and many such individuals who are older than 40 years have pathological changes characteristic of Alzheimer's disease. Evidence to support treatment with Alzheimer's drugs is inadequate, although memantine is beneficial in transgenic mice. We aimed to assess safety and efficacy of memantine on cognition and function in individuals with Down's syndrome. Methods In our prospective randomised double-blind trial, we enrolled adults (>40 years) with karyotypic or clinically diagnosed Down's syndrome, with and without dementia, at four learning disability centres in the UK and Norway. We randomly allocated participants (1: 1) to receive memantine or placebo for 52 weeks by use of a computer-generated sequence and a minimisation algorithm to ensure balanced allocation for five prognostic factors (sex, dementia, age group, total Down's syndrome attention, memory, and executive function scales [DAMES] score, and centre). The primary outcome was change in cognition and function, measured with DAMES scores and the adaptive behaviour scale (ABS) parts I and II. We analysed differences in DAMES and ABS scores between groups with analyses of covariance or quantile regression in all patients who completed the 52 week assessment and had available follow-up data. This study is registered, number ISRCTN47562898. Findings We randomly allocated 88 patients to receive memantine (72 [82%] had DAMES data and 75 [85%] had ABS data at 52 weeks) and 85 to receive placebo (74 [87%] and 73 [86%]). Both groups declined in cognition and function but rates did not differ between groups for any outcomes. After adjustment for baseline score, there were nonsignificant differences between groups of -4.1 (95% CI -13.1 to 4.8) in DAMES scores, -8.5 (-20.1 to 3.1) in ABS I scores, and 2.0 (-7.2 to 11.3) in ABS II scores, all in favour of controls. 10 (11%) of 88 participants in the memantine group and six (7%) of 85 controls had serious adverse events (p=0.33). Five participants in the memantine group and four controls died from serious adverse events (p=0.77). Interpretation There is a striking absence of evidence about pharmacological treatment of cognitive impairment and dementia in people older than 40 years with Down's syndrome. Despite promising indications, memantine is not an effective treatment. Therapies that are effective for Alzheimer's disease are not necessarily effective in this group of patients.	[Hanney, Marisa; Jones, Emma L.; Francis, Paul T.; Ballard, Clive] Kings Coll London, Wolfson Ctr Age Related Dis, London SE1 1UL, England; [Prasher, Vee; Lawrence, Dale] Birmingham Community Healthcare Natl Hlth Serv Tr, Birmingham, W Midlands, England; [Williams, Nicola; Yu, Ly-Mee] Ctr Stat Med, Oxford, England; [Aarsland, Dag] Univ Hosp Stavanger, Stavanger, Norway; [Corbett, Anne] Alzheimers Soc, London, England; [Tyrer, Stephen] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Johnson, Tony] MRC, Biostat Unit, Cambridge CB2 2BW, England; [Bullock, Roger] Kingshill Res Ctr, Swindon, Wilts, England	University of London; King's College London; University of Oxford; Stavanger University Hospital; Newcastle University - UK; MRC Biostatistics Unit	Ballard, C (corresponding author), Kings Coll London, Wolfson Ctr Age Related Dis, Hodgkin Bldg,Guys Campus, London SE1 1UL, England.	clive.ballard@kcl.ac.uk	Francis, Paul Thomas T/A-9199-2008; Yu, LM/J-4284-2012; Corbett, Anne/B-3223-2014	Francis, Paul Thomas T/0000-0001-8159-4469; Corbett, Anne/0000-0003-2015-0316; Aarsland, Dag/0000-0001-6314-216X; Williams, Nicola/0000-0002-7476-9715; Ballard, Clive/0000-0003-0022-5632; Yu, Ly-Mee/0000-0003-0331-7364	Lundbeck; Roche; Janssen; Novartis; Acadia; Alzheimer's Society; Henry Smith Trust; Lundbeck (Valby, Denmark); King's College London	Lundbeck(Lundbeck Corporation); Roche(Roche Holding); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Novartis(Novartis); Acadia; Alzheimer's Society; Henry Smith Trust; Lundbeck (Valby, Denmark); King's College London	MH received grant funding from Lundbeck and consultancy fees from Roche. CB received consultancy and speaking fees from Lundbeck, Janssen, Novartis, and Acadia, and grants from Lundbeck and Acadia. ELJ received grant funding from Lundbeck. DA received grants and speaking fees from Lundbeck, and consultancy fees from Novartis and Lundbeck. AC received consultancy fees from Acadia and speaking fees from Lundbeck and Novartis. PTF is on the advisory board and has received honoraria and grants from Lundbeck, honoraria from Novartis, and paid expert testimony from Novartis and Eisai. EJ was supported by funding from the Alzheimer's Society and the Henry Smith Trust. All other authors declare that they have no conflicts of interest.; The study was funded by Lundbeck (Valby, Denmark) as an investigator-led trial. The funder contributed to the design of the study and supplied the study drugs but did not have any role in the writing of the final manuscript. The study sponsor was King's College London.	Begni B, 2003, NEUROSCI LETT, V343, P73, DOI 10.1016/S0304-3940(03)00260-X; Behar TN, 2003, FREE RADICAL BIO MED, V35, P566, DOI 10.1016/S0891-5849(03)00329-0; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V54, P1301; Costa ACS, 2008, NEUROPSYCHOPHARMACOL, V33, P1624, DOI 10.1038/sj.npp.1301535; Danysz W, 2000, NEUROTOX RES, V2, P85, DOI 10.1007/BF03033787; Epstein CJ, 2006, NATURE, V441, P582, DOI 10.1038/441582a; Holland AJ, 2000, J INTELL DISABIL RES, V44, P138, DOI 10.1046/j.1365-2788.2000.00263.x; Jones EL, 2008, DEMENT GERIATR COGN, V26, P199, DOI 10.1159/000152044; Koenker R, 2001, J ECON PERSPECT, V15, P143, DOI 10.1038/s41592-019-0406-y; Kuhn DE, 2010, J BIOL CHEM, V285, P1529, DOI 10.1074/jbc.M109.033407; Lockrow J, 2011, BEHAV BRAIN RES, V221, P610, DOI 10.1016/j.bbr.2010.03.036; Margallo-Lana ML, 2007, J INTELL DISABIL RES, V51, P463, DOI 10.1111/j.1365-2788.2006.00902.x; Margallo-Lana ML, 2003, ARCH NEUROL-CHICAGO, V60, P1024, DOI 10.1001/archneur.60.7.1024-a; McShane R, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003154.pub5; Mehta PD, 2003, NEUROSCI LETT, V342, P155, DOI 10.1016/S0304-3940(03)00275-1; Mohan M, 2009, COCHRANE DB SYST REV, V1; Mohan M, 2009, COCHRANE DB SYST REV, V1; Mohan M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007178.pub2; Morris JK, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3794; Park J, 2007, MOL CELL NEUROSCI, V36, P270, DOI 10.1016/j.mcn.2007.07.007; Rachidi M, 2010, AJIDD-AM J INTELLECT, V115, P83, DOI 10.1352/1944-7558-115.2.83; Risser D, 1997, LIFE SCI, V60, P1231, DOI 10.1016/S0024-3205(97)00067-2; Rueda N, 2010, J ALZHEIMERS DIS, V21, P277, DOI 10.3233/JAD-2010-100240; Salarbaks A M, 2009, Tijdschr Gerontol Geriatr, V40, P79; Schupf N, 2010, NEUROLOGY, V75, P1639, DOI 10.1212/WNL.0b013e3181fb448b; Wegiel J, 2008, ACTA NEUROPATHOL, V116, P391, DOI 10.1007/s00401-008-0419-6	26	98	101	0	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 11	2012	379	9815					528	536		10.1016/S0140-6736(11)61676-0	http://dx.doi.org/10.1016/S0140-6736(11)61676-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	891AO	22236802				2022-12-28	WOS:000300188800029
J	Adrain, C; Zettl, M; Christova, Y; Taylor, N; Freeman, M				Adrain, Colin; Zettl, Markus; Christova, Yonka; Taylor, Neil; Freeman, Matthew			Tumor Necrosis Factor Signaling Requires iRhom2 to Promote Trafficking and Activation of TACE	SCIENCE			English	Article							FACTOR-ALPHA; TNF-ALPHA; MACROPHAGES; DISINTEGRIN; MACHINERY; MEMBRANE; ENZYME	The cytokine tumor necrosis factor (TNF) is the primary trigger of inflammation. Like many extracellular signaling proteins, TNF is synthesized as a transmembrane protein; the active signal is its ectodomain, which is shed from cells after cleavage by an ADAM family metalloprotease, ADAM17 (TNF alpha-converting enzyme, TACE). We report that iRhom2 (RHBDF2), a proteolytically inactive member of the rhomboid family, is required for TNF release in mice. iRhom2 binds TACE and promotes its exit from the endoplasmic reticulum. The failure of TACE to exit the endoplasmic reticulum in the absence of iRhom2 prevents the furin-mediated maturation and trafficking of TACE to the cell surface, the site of TNF cleavage. Given the role of TNF in autoimmune and inflammatory diseases, iRhom2 may represent an attractive therapeutic target.	[Adrain, Colin; Zettl, Markus; Christova, Yonka; Freeman, Matthew] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Taylor, Neil] Canc Res UK, Li Ka Shing Ctr, Cambridge Res Inst, Cambridge CB2 0RE, England	MRC Laboratory Molecular Biology; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Freeman, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	MF1@mrc-lmb.cam.ac.uk	Adrain, Colin/I-6259-2013	Adrain, Colin/0000-0001-7597-4393; Freeman, Matthew/0000-0003-0410-5451	The International Human Frontier Science Program Organization; EMBO; Austrian Science Fund (FWF); Austrian Academy of Science; Medical Research Council [U105178780]; MRC [MC_U105178780] Funding Source: UKRI; Medical Research Council [MC_U105178780] Funding Source: researchfish	The International Human Frontier Science Program Organization(Human Frontier Science Program); EMBO(European Molecular Biology Organization (EMBO)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Academy of Science; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank C. Blobel, R. Hegde, G. Murphy, S. Munro, V. Lastun, C. Luginsland, and K. Strisovsky for their advice and generously sharing unpublished reagents. We are grateful to R. Pannell for help with the mouse knockout and to members of the animal facility for their assistance. The data presented in this paper are reported in the main paper and in the Supporting Online Material. C. A. was supported by a long-term fellowship from The International Human Frontier Science Program Organization and was the recipient of an EMBO Long-Term Fellowship. M. Z. was supported by Erwin-Schrodinger fellowship from the Austrian Science Fund (FWF), and an APART fellowship from the Austrian Academy of Science. This work was supported by the Medical Research Council programme number U105178780.	Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Gooz M, 2010, CRIT REV BIOCHEM MOL, V45, P146, DOI 10.3109/10409231003628015; Greenblatt EJ, 2011, NAT STRUCT MOL BIOL, V18, P1147, DOI 10.1038/nsmb.2111; Ha SD, 2008, J IMMUNOL, V181, P690, DOI 10.4049/jimmunol.181.1.690; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Le Gall SM, 2010, J CELL SCI, V123, P3913, DOI 10.1242/jcs.069997; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; Lieu ZZ, 2008, P NATL ACAD SCI USA, V105, P3351, DOI 10.1073/pnas.0800137105; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; Murphy G, 2009, SEMIN CELL DEV BIOL, V20, P138, DOI 10.1016/j.semcdb.2008.09.004; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Rousseau S, 2008, J CELL SCI, V121, P149, DOI 10.1242/jcs.018671; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; Xu PL, 2010, MOL CELL, V37, P551, DOI 10.1016/j.molcel.2010.01.034; Zettl M, 2011, CELL, V145, P79, DOI 10.1016/j.cell.2011.02.047	21	274	281	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 13	2012	335	6065					225	228		10.1126/science.1214400	http://dx.doi.org/10.1126/science.1214400			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875LZ	22246777	Green Accepted			2022-12-28	WOS:000299033100055
J	Cooper, AL; Trivedi, AN				Cooper, Alicia L.; Trivedi, Amal N.			Fitness Memberships and Favorable Selection in Medicare Advantage Plans	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHYSICAL-ACTIVITY; RISK SELECTION; HEALTH-STATUS; MORTALITY; PREDICTION; BENEFITS; CHOICE	BACKGROUND Because Medicare Advantage plans must pay for covered services, they may design insurance benefits to appeal to healthier beneficiaries. METHODS We identified 11 Medicare Advantage plans that offered new fitness-membership benefits in 2004 or 2005 and matched these plans to 11 Medicare Advantage control plans that did not offer coverage for fitness memberships. Using a difference-in-differences approach, we compared the self-reported health status of persons who enrolled after the fitness benefit was added to the plan with the self-reported health status of persons entering the same plan before the fitness benefit was offered. RESULTS The proportion of enrollees reporting excellent or very good health was 6.1 percentage points higher (95% confidence interval [CI], 2.6 to 9.7) among the 755 new enrollees in plans that added fitness benefits than among the 4097 earlier enrollees. The proportion of new enrollees reporting activity limitation was 10.4 percentage points lower (95% CI, 6.6 to 14.3) and the proportion reporting difficulty walking was 8.1 percentage points lower (95% CI, 4.4 to 11.7), as compared with earlier enrollees. Within control plans, the differences between the 1154 new enrollees and the 3910 earlier enrollees were 1.5 percentage points or less for each measure. The adjusted differences between the fitness-benefit plans and the control plans were 4.7 percentage points higher for general health (95% CI, 0.2 to 9.2), 9.2 percentage points lower for activity limitation (95% CI, 5.1 to 13.3), and 7.4 percentage points lower for difficulty walking (95% CI, 4.5 to 10.4). These differences persisted at 2 years for activity limitation and difficulty walking. CONCLUSIONS Medicare Advantage plans offering coverage for fitness memberships may attract and retain a healthier subgroup of the Medicare population. (Funded by the National Institute on Aging.)	[Cooper, Alicia L.; Trivedi, Amal N.] Brown Univ, Dept Hlth Serv Policy & Practice, Alpert Med Sch, Providence, RI 02912 USA; [Trivedi, Amal N.] Providence Vet Affairs Med Ctr, Res Enhancement Award Program, Providence, RI USA	Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center	Trivedi, AN (corresponding author), Brown Univ, Dept Hlth Serv Policy & Practice, Alpert Med Sch, Providence, RI 02912 USA.	amal_trivedi@brown.edu			National Institute on Aging [5RC1AG036158, 5T32AG023482-07]; NATIONAL INSTITUTE ON AGING [T32AG023482, RC1AG036158] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants (5RC1AG036158 and 5T32AG023482-07) from the National Institute on Aging.	[Anonymous], 2008, MED HLTH OUTC SURV 2; Atherly A, 2004, HEALTH SERV RES, V39, P847, DOI 10.1111/j.1475-6773.2004.00261.x; Barengo NC, 2004, EUR HEART J, V25, P2204, DOI 10.1016/j.ehj.2004.10.009; Benzo RP, 2010, RESPIRATION, V80, P10, DOI 10.1159/000296504; Berenson RA, 2004, HLTH AFF MILLWOOD S, VW4-572-W4-585; Brown J, 2010, CAN RISK ADJUSTMENT; Chandra A, 2007, PATIENT COST SHARING; Chard SE, 2010, J APPL GERONTOL 1025; Cutler DM, 1998, NBER FR HLTH POL RES, V1, P1; DeSalvo KB, 2009, MED CARE, V47, P440, DOI 10.1097/MLR.0b013e318190b716; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Feldman R, 2003, HEALTH CARE FINANC R, V25, P23; Fried TR, 2001, ARCH INTERN MED, V161, P2602, DOI 10.1001/archinte.161.21.2602; Iezzoni LI, 1998, NEW ENGL J MED, V339, P1933, DOI 10.1056/NEJM199812243392613; Kazis L., 2009, VETERANS RAND 12 ITE; Kazis LE, 2006, J AMBUL CARE MANAG, V29, P310, DOI 10.1097/00004479-200610000-00007; Kazis Lewis E, 2004, J Ambul Care Manage, V27, P70; LUFT HS, 1988, HEALTH AFFAIR, V7, P97, DOI 10.1377/hlthaff.7.3.97; Medicare Advantage, 2009, MED ADV CMS ASS BEN; Medicare Payment Advisory Commission, 2005, REP C ISS MOD MED PR; Miilunpalo S, 1997, J CLIN EPIDEMIOL, V50, P517, DOI 10.1016/S0895-4356(97)00045-0; Newhouse JP, 1999, RISK ADJUSTMENT MEDI; Ng JH, 2007, MED CARE, V45, P513, DOI 10.1097/MLR.0b013e31802f91a5; Nguyen Huong Q, 2008, Prev Chronic Dis, V5, pA14; Nguyen HQ, 2008, DIABETES CARE, V31, P1562, DOI 10.2337/dc08-0624; O'Brien E, 2008, MEDICARE ADVANTAGE O; Pizer SD, 2008, HEALTH ECON, V17, P453, DOI 10.1002/hec.1252; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; Pope GC, 1998, HEALTH CARE FINANC R, V20, P109	29	34	34	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 12	2012	366	2					150	157		10.1056/NEJMsa1104273	http://dx.doi.org/10.1056/NEJMsa1104273			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	874VA	22236225	Green Accepted			2022-12-28	WOS:000298985000009
J	Schmitz, J; West, KP; Khatry, SK; Wu, L; LeClerq, SC; Karna, SL; Katz, J; Sommer, A; Pillion, J				Schmitz, Jane; West, Keith P., Jr.; Khatry, Subarna K.; Wu, Lee; LeClerq, Steven C.; Karna, Sureswor L.; Katz, Joanne; Sommer, Alfred; Pillion, Joseph			Vitamin A supplementation in preschool children and risk of hearing loss as adolescents and young adults in rural Nepal: randomised trial cohort follow-up study	BRITISH MEDICAL JOURNAL			English	Article							ACUTE OTITIS-MEDIA; NUTRITIONAL FACTORS; ACUTE SINUSITIS; IMMUNE FUNCTION; MIDDLE-EAR; DEFICIENCY; IMPAIRMENT; MORBIDITY; EFFICACY; XEROPHTHALMIA	Objective To determine whether vitamin A supplementation administered in the preschool years can lower the risk of hearing loss in adolescence and adulthood. Design Follow-up study of adolescents and young adults who, as preschool aged children in 1989, were enrolled into a cluster randomised, double blinded, placebo controlled trial of vitamin A supplementation. Setting South central, rural Nepal. Participants 2378 adolescents and young adults aged 14 to 23, representing 51% of those who finished the original trial and 71% of those living in the study area in 2006. Interventions Every four months for 16 months preschool children were visited at home, given an oral 200 000 IU dose of vitamin A (half dose at age 1-11 months, quarter dose at <1 month) or placebo and the parents were queried about any childhood illnesses in the previous week, including purulent discharge from the ears. Main outcome measures Prevalence of mild or worse hearing loss (>= 30 dB) in the most affected ear and tympanometric measures of middle ear function (peak height, ear canal volume, and gradient). Results During the original trial, the prevalence of middle ear infection during the preschool years did not differ between the supplement groups. By adolescence and early adulthood, a non-significant 17% reduction in hearing loss occurred among those who had periodically received vitamin A compared with placebo as preschool aged children (odds ratio 0.83, 95% confidence interval 0.62 to 1.12). Among participants with any ear discharge in early childhood, vitamin A supplementation was associated with a reduced risk of hearing loss, by 42% (0.58, 0.37 to 0.92) compared with controls, after adjusting the confidence interval for the design effect of the original trial. Abnormal tympanometric peak height of the middle ear system was less likely among participants supplemented with vitamin A in childhood. Conclusion In undernourished settings, periodic, high dose vitamin A supplementation may reduce the risk of hearing loss associated with purulent ear infections in early childhood.	[West, Keith P., Jr.; Wu, Lee; LeClerq, Steven C.; Katz, Joanne; Sommer, Alfred] Johns Hopkins Univ, Dept Int Hlth, Ctr Human Nutr, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Schmitz, Jane] Univ So Calif, Inst Global Hlth, Los Angeles, CA USA; [Schmitz, Jane] Univ So Calif, Dept Prevent Med, Los Angeles, CA USA; [West, Keith P., Jr.; Khatry, Subarna K.; LeClerq, Steven C.; Katz, Joanne] Natl Soc Prevent Blindness, Nepal Nutr Intervent Project Sarlahi, Kathmandu, Nepal; [Karna, Sureswor L.] Tribhuvan Univ, Teaching Hosp, Dept Ear Nose & Throat, Kathmandu, Nepal; [Pillion, Joseph] Johns Hopkins Univ, Sch Med, Kennedy Krieger Inst, Dept Audiol, Baltimore, MD USA; [Pillion, Joseph] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Southern California; University of Southern California; Tribhuvan University; Institute of Medicine (IoM) - Nepal; Johns Hopkins University; Kennedy Krieger Institute; Johns Hopkins University	West, KP (corresponding author), Johns Hopkins Univ, Dept Int Hlth, Ctr Human Nutr, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	kwest@jhsph.edu		Katz, Joanne/0000-0002-5997-7823	Bill and Melinda Gates Foundation, Seattle [GH614]; Center for Human Nutrition, Department of International Health of the Johns Hopkins Bloomberg School of Public Health, Baltimore [GH614]	Bill and Melinda Gates Foundation, Seattle(Bill & Melinda Gates Foundation); Center for Human Nutrition, Department of International Health of the Johns Hopkins Bloomberg School of Public Health, Baltimore	This follow-up study was supported by grant No GH614 (Control of Global Micronutrient Deficiency) between the Bill and Melinda Gates Foundation, Seattle, and the Center for Human Nutrition, Department of International Health of the Johns Hopkins Bloomberg School of Public Health, Baltimore, and was undertaken in collaboration with the National Society for the Prevention of Blindness (Nepal Netra Jyoti Sangh), Kathmandu, Nepal. The original vitamin A supplementation trial was carried out under Cooperative Agreement No DAN 0045-A-5094 between the Office of Nutrition, US Agency for International Development, Washington, and the Johns Hopkins University, as a joint undertaking of the Dana Center for Preventive Ophthalmology and the National Society for the Prevention of Blindness, Kathmandu, Nepal, with in-kind (provision of supplements) and technical (nutrient potency analyses) assistance from Task Force Sight and Life (formerly of Roche, Basel, Switzerland, now Sight and Life, DSM, Basel, Switzerland). The funding agencies had no role in the study design, data collection, data analysis, data interpretation, or the writing of the report.	Aladag I, 2007, INT J PEDIATR OTORHI, V71, P623, DOI 10.1016/j.ijporl.2006.12.019; ARTHUR P, 1992, LANCET, V339, P361, DOI 10.1016/0140-6736(92)91677-Z; BARRETO ML, 1994, LANCET, V344, P228, DOI 10.1016/S0140-6736(94)92998-X; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Brooks WA, 2005, LANCET, V366, P999, DOI 10.1016/S0140-6736(05)67109-7; Cemek M, 2005, INT J PEDIATR OTORHI, V69, P823, DOI 10.1016/j.ijporl.2005.01.016; Cemek M, 2004, INT J PEDIATR OTORHI, V68, P1381, DOI 10.1016/j.ijporl.2004.05.003; CHOLE RA, 1979, OTOLARYNG HEAD NECK, V87, P837, DOI 10.1177/019459987908700618; Clausen S W, 1934, Bull N Y Acad Med, V10, P471; da Costa SS, 2009, EUR ARCH OTO-RHINO-L, V266, P221, DOI 10.1007/s00405-008-0739-0; Elemraid MA, 2011, EUR J CLIN NUTR, V65, P895, DOI 10.1038/ejcn.2011.58; Elemraid MA, 2009, ANN TROP PAEDIATR, V29, P85, DOI 10.1179/146532809X440707; Gibson RS, 2005, ASSESSMENT NUTR STAT, P879; Gorstein J, 2003, ASIA PAC J CLIN NUTR, V12, P96; Guven M, 2007, ACTA OTO-LARYNGOL, V127, P855, DOI 10.1080/00016480601053107; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jarvelin MR, 1997, BRIT J AUDIOL, V31, P165, DOI 10.3109/03005364000000019; Joglekar S, 2010, ACTA OTO-LARYNGOL, V130, P472, DOI 10.3109/00016480903311252; Katz J, 1998, J TROP PEDIATRICS, V44, P225, DOI 10.1093/tropej/44.4.225; KATZ J, 1995, INVEST OPHTH VIS SCI, V36, P2577; KHATRY SK, 1995, ARCH OPHTHALMOL-CHIC, V113, P425, DOI 10.1001/archopht.1995.01100040039024; Lasisi AO, 2009, EUR ARCH OTO-RHINO-L, V266, P647, DOI 10.1007/s00405-008-0794-6; LIANG KY, 1993, ANNU REV PUBL HEALTH, V14, P43, DOI 10.1146/annurev.pu.14.050193.000355; LITTLE P, 1993, J LARYNGOL OTOL, V107, P395, DOI 10.1017/S0022215100123278; LLOYDPURYEAR M, 1989, NUTR RES, V9, P1007, DOI 10.1016/S0271-5317(89)80061-2; MANNING SC, 1992, OTOLARYNG HEAD NECK, V107, P701, DOI 10.1177/019459989210700512; Mellanby E, 1938, J PHYSIOL-LONDON, V94, P380, DOI 10.1113/jphysiol.1938.sp003688; OGARO FO, 1993, TROP GEOGR MED, V45, P283; Olusanya BO, 2007, LANCET, V369, P1314, DOI 10.1016/S0140-6736(07)60602-3; Olusanya BO, 2006, JAMA-J AM MED ASSOC, V296, P441, DOI 10.1001/jama.296.4.441; Pino-Lagos K, 2008, ANN NY ACAD SCI, V1143, P170, DOI 10.1196/annals.1443.017; Ross CA, 1996, VITAMIN A DEFICIENCY, P251; Sade J, 1997, OTOLARYNG HEAD NECK, V116, P499, DOI 10.1016/S0194-5998(97)70302-4; Schmitz J, 2008, PRESCHOOL VITAMIN A; Schmitz J, 2010, INT J AUDIOL, V49, P388, DOI 10.3109/14992020903555708; Semba RD, 1998, NUTR REV, V56, pS38, DOI 10.1111/j.1753-4887.1998.tb01643.x; Sindhusake D, 2001, INT J EPIDEMIOL, V30, P1371, DOI 10.1093/ije/30.6.1371; Sommer A, 2002, J NUTR, V132, p2845S, DOI 10.1093/jn/132.9.2845S; Stephensen CB, 2001, ANNU REV NUTR, V21, P167, DOI 10.1146/annurev.nutr.21.1.167; Torre P, 2006, INT J AUDIOL, V45, P559, DOI 10.1080/14992020600860935; Ukoumunne OC, 2008, STAT MED, V27, P5143, DOI 10.1002/sim.3359; Unal M, 2002, INT J PEDIATR OTORHI, V65, P219, DOI 10.1016/S0165-5876(02)00175-1; West KP, 2008, LANCET, V371, P452, DOI 10.1016/S0140-6736(08)60214-7; WEST KP, 1991, LANCET, V338, P67, DOI 10.1016/0140-6736(91)90070-6; West KP, 2002, J NUTR, V132, p2857S, DOI 10.1093/jn/132.9.2857S; WHO, 2007, WHO CHILD GROWTH STA, P57; *WHO, 2006, DEAFN HEAR IMP FACT; Wiley T L, 2000, J Am Acad Audiol, V11, P67; World Health Organization, 2004, CHRON SUPP OT MED BU; Yilmaz S, 2006, J LARYNGOL OTOL, V120, P103, DOI 10.1017/S0022215105004871	50	25	25	0	9	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 10	2012	344								d7962	10.1136/bmj.d7962	http://dx.doi.org/10.1136/bmj.d7962			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877SD	22234907	hybrid, Green Published			2022-12-28	WOS:000299202000024
J	Brook, RH				Brook, Robert H.			Two Years and Counting How Will the Effects of the Affordable Care Act Be Monitored?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Brook, Robert H.] RAND Corp, Santa Monica, CA 90401 USA; [Brook, Robert H.] David Geffen UCLA Sch Med, Santa Monica, CA USA	RAND Corporation; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Brook, RH (corresponding author), RAND Corp, 1776 Main St, Santa Monica, CA 90401 USA.	brook@rand.org						Davison JD, 2008, 136 ANN M AM PUBL HL; DUBOIS RW, 1988, ANN INTERN MED, V109, P582, DOI 10.7326/0003-4819-109-7-582; Marmot Michael, 2009, Glob Health Promot, VSuppl 1, P23, DOI 10.1177/1757975909103742; Nolte E, 2008, HEALTH AFFAIR, V27, P58, DOI 10.1377/hlthaff.27.1.58; Organisation for Economic Co-operation and Development, 2011, HLTH GLANC 2011 OECD; West CP, 2011, JAMA-J AM MED ASSOC, V306, P952, DOI 10.1001/jama.2011.1247	6	4	4	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 4	2012	307	1					41	42		10.1001/jama.2011.1948	http://dx.doi.org/10.1001/jama.2011.1948			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	872ET	22215162				2022-12-28	WOS:000298792300018
J	Charpinet, S; Fontaine, G; Brassard, P; Green, EM; Van Grootel, V; Randall, SK; Silvotti, R; Baran, AS; Ostensen, RH; Kawaler, SD; Telting, JH				Charpinet, S.; Fontaine, G.; Brassard, P.; Green, E. M.; Van Grootel, V.; Randall, S. K.; Silvotti, R.; Baran, A. S.; Ostensen, R. H.; Kawaler, S. D.; Telting, J. H.			A compact system of small planets around a former red-giant star	NATURE			English	Article							HORIZONTAL-BRANCH STARS; SUBDWARF-B-STARS; BROWN DWARF; EXOPLANETS; PULSATORS; ORIGIN; ENGULFMENT; EVOLUTION; BINARY	Planets that orbit their parent star at less than about one astronomical unit (1 AU is the Earth-Sun distance) are expected to be engulfed when the star becomes a red giant(1). Previous observations have revealed the existence of post-red-giant host stars with giant planets(2-4) orbiting as close as 0.116 AU or with brown dwarf companions(5,6) in tight orbits, showing that these bodies can survive engulfment. What has remained unclear is whether planets can be dragged deeper into the red-giant envelope without being disrupted and whether the evolution of the parent star itself could be affected(7-9). Here we report the presence of two nearly Earth-sized bodies orbiting the post-red-giant, hot B subdwarf star KIC 05807616 at distances of 0.0060 and 0.0076 AU, with orbital periods of 5.7625 and 8.2293 hours, respectively. These bodies probably survived deep immersion in the former red-giant envelope. They may be the dense cores of evaporated giant planets that were transported closer to the star during the engulfment and triggered the mass loss necessary for the formation of the hot B subdwarf, which might also explain how some stars of this type did not form in binary systems.	[Charpinet, S.] Univ Toulouse, UPS OMP, IRAP, F-31400 Toulouse, France; [Charpinet, S.] CNRS, IRAP, F-31400 Toulouse, France; [Fontaine, G.; Brassard, P.] Univ Montreal, Dept Phys, Montreal, PQ H3C 3J7, Canada; [Green, E. M.] Univ Arizona, Steward Observ, Tucson, AZ 85721 USA; [Van Grootel, V.] Univ Liege, Inst Astrophys & Geophys, B-4000 Liege, Belgium; [Van Grootel, V.] FNRS, B-1000 Brussels, Belgium; [Randall, S. K.] ESO, D-85748 Garching, Germany; [Silvotti, R.] Osserv Astron Torino, INAF, I-10025 Pino Torinese, Italy; [Baran, A. S.] Cracow Pedag Univ, Mt Suhora Observ, PL-30084 Krakow, Poland; [Baran, A. S.; Kawaler, S. D.] Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA; [Ostensen, R. H.] Katholieke Univ Leuven, Inst Sterrenkunde, B-3001 Louvain, Belgium; [Telting, J. H.] Nord Opt Telescope, Santa Cruz De La Palma 38700, Spain	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Montreal; University of Arizona; University of Liege; Fonds de la Recherche Scientifique - FNRS; Istituto Nazionale Astrofisica (INAF); University of Turin; Pedagogical University of Cracow; Iowa State University; KU Leuven	Charpinet, S (corresponding author), Univ Toulouse, UPS OMP, IRAP, F-31400 Toulouse, France.	stephane.charpinet@ast.obs-mip.fr	Silvotti, Roberto/ABB-7598-2021; Charpinet, Stephane/C-2196-2012; Baran, Andrzej/V-1285-2018	Silvotti, Roberto/0000-0002-1295-8174; Baran, Andrzej/0000-0001-6446-6617; Kawaler, Steven/0000-0002-6536-6367; Charpinet, Stephane/0000-0002-6018-6180	CNRS/INSU, France; NSERC of Canada; Polish Ministry of Science and Higher Education; NASA's Science Mission Directorate	CNRS/INSU, France(Centre National de la Recherche Scientifique (CNRS)); NSERC of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); NASA's Science Mission Directorate	S.C. thanks the Programme National de Physique Stellaire (PNPS, CNRS/INSU, France) for support. G. F. acknowledges the support of the NSERC of Canada and the contribution of the Canada Research Chair Program. MMT spectra for KIC 05807616 were obtained at the MMT Observatory, a joint facility of the University of Arizona and the Smithsonian Institution. A. S. B. acknowledges funding from the Polish Ministry of Science and Higher Education. S. C. thanks R. Gilliland for help in managing Kepler's procedures. We acknowledge the Kepler team and all who have contributed to making this mission possible. Funding for the Kepler mission is provided by NASA's Science Mission Directorate.	Batalha NM, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/27; Bear E, 2011, MON NOT R ASTRON SOC, V411, P1792, DOI 10.1111/j.1365-2966.2010.17808.x; Charpinet S, 2009, AIP CONF PROC, V1170, P585, DOI 10.1063/1.3246567; DCruz NL, 1996, ASTROPHYS J, V466, P359, DOI 10.1086/177515; Geier S, 2011, ASTROPHYS J LETT, V731, DOI 10.1088/2041-8205/731/2/L22; Gilliland RL, 2010, PUBL ASTRON SOC PAC, V122, P131, DOI 10.1086/650399; Green EM, 2003, ASTROPHYS J, V583, pL31, DOI 10.1086/367929; Han Z, 2002, MON NOT R ASTRON SOC, V336, P449, DOI 10.1046/j.1365-8711.2002.05752.x; Heber U, 2009, ANNU REV ASTRON ASTR, V47, P211, DOI 10.1146/annurev-astro-082708-101836; Hebrard G, 2004, ASTR SOC P, V321, P203; Knutson HA, 2007, NATURE, V447, P183, DOI 10.1038/nature05782; Lee JW, 2009, ASTRON J, V137, P3181, DOI 10.1088/0004-6256/137/2/3181; Leger A, 2009, ASTRON ASTROPHYS, V506, P287, DOI 10.1051/0004-6361/200911933; Leigh C, 2003, MON NOT R ASTRON SOC, V344, P1271, DOI 10.1046/j.1365-8711.2003.06901.x; Mallama A, 2009, ICARUS, V204, P11, DOI 10.1016/j.icarus.2009.07.010; Maxted PFL, 2006, NATURE, V442, P543, DOI 10.1038/nature04987; Maxted PFL, 2001, MON NOT R ASTRON SOC, V326, P1391, DOI 10.1111/j.1365-2966.2001.04714.x; Nordhaus J, 2010, MON NOT R ASTRON SOC, V408, P631, DOI 10.1111/j.1365-2966.2010.17155.x; Ostensen RH, 2010, MON NOT R ASTRON SOC, V409, P1470, DOI 10.1111/j.1365-2966.2010.17366.x; Reed MD, 2010, MON NOT R ASTRON SOC, V409, P1496, DOI 10.1111/j.1365-2966.2010.17423.x; Rowe JF, 2008, ASTROPHYS J, V689, P1345, DOI 10.1086/591835; Setiawan J, 2010, SCIENCE, V330, P1642, DOI 10.1126/science.1193342; Silvotti R, 2007, NATURE, V449, P189, DOI 10.1038/nature06143; Silvotti R, 2008, ASTR SOC P, V392, P215; Snellen IAG, 2009, NATURE, V459, P543, DOI 10.1038/nature08045; Soker N, 1998, ASTRON J, V116, P1308, DOI 10.1086/300503; Van Grootel V, 2010, ASTROPHYS J LETT, V718, pL97, DOI 10.1088/2041-8205/718/2/L97; Villaver E, 2009, ASTROPHYS J LETT, V705, pL81, DOI 10.1088/0004-637X/705/1/L81; WOLSZCZAN A, 1992, NATURE, V355, P145, DOI 10.1038/355145a0	30	125	126	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2011	480	7378					496	499		10.1038/nature10631	http://dx.doi.org/10.1038/nature10631			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865NQ	22193103				2022-12-28	WOS:000298318000054
J	Brewster, LM; Berentzen, CA; van Montfrans, GA				Brewster, L. M.; Berentzen, C. A.; van Montfrans, G. A.			CHRISTMAS 2011: ORAL TRADITIONS High salt meals in staff canteens of salt policy makers: observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DIETARY SALT; METAANALYSIS; DISEASE; SODIUM	Objective To assess the salt content of hot meals served at the institutions of salt policy makers in the Netherlands. Design Observational study. Setting 18 canteens at the Department of Health, the Health Council, the Food and Consumer Product Safety Authority, university hospitals, and affiliated non-university hospitals. Intervention A standard hot meal collected from the institutional staff canteens on three random days. Main outcome measure Salt content of the meals measured with an ion selective electrode assay. Results The mean salt content of the meals (7.1 g, SE 0.2 g) exceeded the total daily recommended salt intake of 6 g and was high at all locations: 6.9 g (0.4 g) at the Department of Health and National Health Council; 6.0 g (0.9 g) at the Food and Consumer Product Safety Authority; 7.4 g (0.5 g) at university hospital staff canteens; and 7.0 g (0.3 g) at non-university hospital staff canteens. With data from a national food consumption survey, the estimated total mean daily salt intake in people who ate these meals was 15.4 g. This translates into a 23-36% increase in premature cardiovascular mortality compared with people who adhere to the recommended levels of salt intake. Conclusion If salt policy makers eat at their institutional canteens they might consume too much salt, which could put their health at risk.	[Brewster, L. M.; Berentzen, C. A.; van Montfrans, G. A.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands; [Brewster, L. M.; van Montfrans, G. A.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Brewster, L. M.] Univ Amsterdam, Acad Med Ctr, Dept Social Med, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Brewster, LM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	l.m.brewster@amc.uva.nl	Brewster, Lizzy M/K-7675-2019	Brewster, Lizzy M/0000-0002-7434-0038				Appel LJ, 2011, CIRCULATION, V123, P1138, DOI 10.1161/CIR.0b013e31820d0793; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; European Commission Directorate General Health Consumers Directorate C, 2010, EV EUR PLATF ACT DIE; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Food and Drug administration, 2008, GUID IND LAB GUID RE; He FJ, 2011, LANCET, V378, P380, DOI 10.1016/S0140-6736(11)61174-4; He FJ, 2003, HYPERTENSION, V42, P1093, DOI 10.1161/01.HYP.0000102864.05174.E8; Health Council of the Netherlands, 2006, GUID HLTH DIET; MATTES RD, 1991, J AM COLL NUTR, V10, P383; Mitchell RK, 1997, ACAD MANAGE REV, V22, P853, DOI 10.2307/259247; National Institute for Health and Clinical Excellence, 2010, PREV CARD DIS POP LE; Ocke MC, 2003, RESULTATEN VOEDSELCO; Pathman DE, 1996, MED CARE, V34, P873, DOI 10.1097/00005650-199609000-00002; SHORTT C, 1988, EUR J CLIN NUTR, V42, P605; Taylor RS, 2011, AM J HYPERTENS, V24, P843, DOI 10.1038/ajh.2011.115; WHO Expert Committee on Problems Related to Alcohol Consumption, 2007, World Health Organ Tech Rep Ser, P1	17	6	6	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 20	2011	343								d7352	10.1136/bmj.d7352	http://dx.doi.org/10.1136/bmj.d7352			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	868QK	22187322	Green Published, hybrid			2022-12-28	WOS:000298538200001
J	Zulman, DM; Nazi, KM; Turvey, CL; Wagner, TH; Woods, SS; An, LC				Zulman, Donna M.; Nazi, Kim M.; Turvey, Carolyn L.; Wagner, Todd H.; Woods, Susan S.; An, Larry C.			Patient Interest in Sharing Personal Health Record Information A Web-Based Survey	ANNALS OF INTERNAL MEDICINE			English	Article							SHARED MEDICAL-RECORD; SATISFACTION; EXCHANGE	Background: Electronic personal health record (PHR) systems are proliferating but largely have not realized their potential for enhancing communication among patients and their network of care providers. Objective: To explore preferences about sharing electronic health information among users of the U.S. Department of Veterans Affairs (VA) PHR system, My HealtheVet. Design: Web-based survey of a convenience sample. Setting: My HealtheVet Web site from 7 July through 4 October 2010. Participants: 18 471 users of My HealtheVet. Measurements: Interest in shared PHR access and preferences about who would receive access, the information that would be shared, and the activities that users would delegate. Results: Survey respondents were predominantly men (92%) and aged 50 to 64 years (51%) or 65 years or older (39%); approximately 39% reported poor or fair health status. Almost 4 of 5 respondents (79%) were interested in sharing access to their PHR with someone outside of their health system (62% with a spouse or partner, 23% with a child, 15% with another family member, and 25% with a non-VA health care provider). Among those who selected a family member other than a spouse or partner, 47% lived apart from the specified person. Preferences about degree of access varied on the basis of the type of information being shared, the type of activity being performed, and the respondent's relationship with the selected person. Limitations: The survey completion rate was 40.8%. Results might not be generalizable to all My HealtheVet users. Conclusion: In a large survey of PHR users in the VA system, most respondents were interested in sharing access to their electronic health information with caregivers and non-VA providers. Existing and evolving PHR systems should explore secure mechanisms for shared PHR access to improve information exchange among patients and the multiple persons involved in their health care.	[Zulman, Donna M.] Stanford Univ, Ctr Hlth Care Evaluat, VA Palo Alto Hlth Care Syst, Menlo Pk, CA 94025 USA; Vet Rural Hlth Resource Ctr Cent Reg, Iowa City, IA USA; Vet Affairs Hlth Care Syst, Ctr Comprehens Access & Delivery Res & Evaluat, Iowa City, IA USA; US Dept Vet Affairs, Washington, DC USA; Vet Affairs Hlth Serv Res & Dev Serv, Portland, OR USA; Univ Michigan, Ctr Hlth Commun Res, Ann Arbor, MI 48109 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; University of Michigan System; University of Michigan	Zulman, DM (corresponding author), Stanford Univ, Ctr Hlth Care Evaluat, VA Palo Alto Hlth Care Syst, 795 Willow Rd,152-MPD, Menlo Pk, CA 94025 USA.	dzulman@stanford.edu		Turvey, Carolyn/0000-0002-8219-8676; Wagner, Todd/0000-0001-7625-3504	Veterans Health Administration; Robert Wood Johnson Foundation	Veterans Health Administration(US Department of Veterans Affairs); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	Grant Support: By the Veterans Health Administration and The Robert Wood Johnson Foundation Clinical Scholars Program.	California HealthCare Foundation, 2010, CONS HLTH INF TECHN; Cleveland Clinic, 2010, MYCHART CAR; Cushman R, 2010, J BIOMED INFORM, V43, pS51, DOI 10.1016/j.jbi.2010.05.003; Deloitte Center for Health Solutions, 2009, SURV HLTH CAR CONS K; Detmer D, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-45; Fricton J. R., 2008, ADV PATIENT SAFETY N, V4; GroupHealth Cooperative, 2011, MY GROUPHEALTH MEMB; Kaelber DC, 2008, J AM MED INFORM ASSN, V15, P729, DOI 10.1197/jamia.M2547; Kaelber DC, 2007, J BIOMED INFORM, V40, pS40, DOI 10.1016/j.jbi.2007.08.011; Kaiser Permanente, 2011, MY HLTH MAN; Krist AH, 2011, JAMA-J AM MED ASSOC, V305, P300, DOI 10.1001/jama.2010.2011; Markle Foundation, 2006, SURV FINDS AM WANT E; Markle Foundation, 2008, AM OV BEL EL PERS HL; National Alliance for Caregiving and American Association of Retired Persons, 2009, CAR US; National Center for Veterans Affairs Analysis and Statistics, 2011, VET POP; Nazi KM, 2010, J AM MED INFORM ASSN, V17, P203, DOI 10.1136/jamia.2009.000240; Nazi KM, 2010, J GEN INTERN MED, V25, P62, DOI 10.1007/s11606-009-1114-6; Pagliari C, 2007, BMJ-BRIT MED J, V335, P330, DOI 10.1136/bmj.39279.482963.AD; Patel VN, 2011, AM J MANAG CARE, V17, pE104; Piette JD, 2010, CHRONIC ILLN, V6, P34, DOI 10.1177/1742395309347804; Ralston JD, 2007, J AM MED INFORM ASSN, V14, P798, DOI 10.1197/jamia.M2302; Stock R, 2008, ADV PATIENT SAFETY N, V4; Tang PC, 2006, J AM MED INFORM ASSN, V13, P121, DOI 10.1197/jamia.M2025; The Markle Foundation, 2011, MARKL SURV HLTH NETW; Turvey CL, TELEMEDICIN IN PRESS; U.S. Department of Health and Human Services, 2010, PERS HLTH REC PHRS H; U.S. Department of Health and Human Services, 2011, PERS HLTH REC PHR MO; *US DEP VET AFF, 2001, NAT SURV VET; Wen KY, 2010, J MED INTERNET RES, V12, P122, DOI 10.2196/jmir.1668; Weppner WG, 2010, DIABETES CARE, V33, P2314, DOI 10.2337/dc10-1124; Wood FB, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.944	31	96	96	0	24	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2011	155	12					805	U46		10.7326/0003-4819-155-12-201112200-00002	http://dx.doi.org/10.7326/0003-4819-155-12-201112200-00002			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	864ZU	22184687				2022-12-28	WOS:000298280500014
J	Ascaso, FJ; van Velze, JL				Ascaso, Francisco J.; van Velze, Jan L.			CHRISTMAS 2011: DIAGNOSIS Was James Joyce myopic or hyperopic?	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ascaso, Francisco J.] Lozano Blesa Univ Clin Hosp, Dept Ophthalmol, ES-50009 Zaragoza, Spain; [Ascaso, Francisco J.] Aragon Hlth Sci Inst, Zaragoza, Spain; [van Velze, Jan L.] Univ Utrecht, Dept Literary Studies, NL-3508 TC Utrecht, Netherlands	Lozano Blesa University Clinical Hospital; Utrecht University	Ascaso, FJ (corresponding author), Lozano Blesa Univ Clin Hosp, Dept Ophthalmol, San Juan Bosco 15, ES-50009 Zaragoza, Spain.	jascaso@gmail.com	PUYUELO, FCO. JAVIER ASCASO/I-8426-2019					Ascaso FJ, 2010, J MED BIOGR, V18, P57, DOI 10.1258/jmb.2009.009064; Ellmann R., 1982, J JOYCE, p[26, 64, 333, 568]; GROSVENOR T, 1971, AMER J OPT ARCH AM A, V48, P376; Joyce J., 1966, LETT J JOYCE, V2, P81; Kenner Hugh, 1977, J JOYCES ULYSSES CRI, P353; Lyons JB., 1988, THRUST SYPHILIS HELL, P26; Lyons JB., 1973, J JOYCE MED, P200; Pound E., 1967, POUNDJOYCE LETT E PO, P101	8	2	2	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 15	2011	343								d7464	10.1136/bmj.d7464	http://dx.doi.org/10.1136/bmj.d7464			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	888WF	22174321				2022-12-28	WOS:000300034600004
J	Steger, CM; Antretter, H; Moser, PL				Steger, Christina M.; Antretter, Herwig; Moser, Patrizia L.			Endocardial fibroelastosis of the heart	LANCET			English	Editorial Material									[Steger, Christina M.; Moser, Patrizia L.] Innsbruck Med Univ, Dept Pathol, A-6020 Innsbruck, Austria; [Antretter, Herwig] Innsbruck Med Univ, Dept Cardiac Surg, A-6020 Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck	Steger, CM (corresponding author), Innsbruck Med Univ, Dept Pathol, Mullerstr 44, A-6020 Innsbruck, Austria.	christina.m.steger@i-med.ac.at							0	5	6	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 10	2012	379	9819					932	932		10.1016/S0140-6736(11)61418-9	http://dx.doi.org/10.1016/S0140-6736(11)61418-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906NY	22217671				2022-12-28	WOS:000301353700033
J	Van de Perre, P; Nagot, N				Van de Perre, Philippe; Nagot, Nicolas			Herpes simplex virus: a new era?	LANCET			English	Editorial Material							GENITAL HERPES; INFECTION; HIV-1; TRANSMISSION; ACYCLOVIR; VACCINE; HSV-2		[Van de Perre, Philippe; Nagot, Nicolas] INSERM, U1058, Montpellier, France; [Van de Perre, Philippe; Nagot, Nicolas] Univ Montpellier 1, Montpellier, France; [Van de Perre, Philippe; Nagot, Nicolas] CHU Montpellier, Dept Baceriol Virol, F-34295 Montpellier 5, France; [Van de Perre, Philippe; Nagot, Nicolas] CHU Montpellier, Dept Med Informat, F-34295 Montpellier 5, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier	Van de Perre, P (corresponding author), INSERM, U1058, Montpellier, France.	p-van_de_perre@chu-montpellier.fr	Van de Perre, Philippe/B-9692-2008; Nagot, Nicolas/I-9467-2014	Van de Perre, Philippe/0000-0002-3912-0427; Nagot, Nicolas/0000-0002-3493-2821				Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Chono K, 2010, J ANTIMICROB CHEMOTH, V65, P1733, DOI 10.1093/jac/dkq198; Corey L, 2004, NEW ENGL J MED, V350, P11, DOI 10.1056/NEJMoa035144; Dasgupta G, 2011, VACCINE, V29, P5824, DOI 10.1016/j.vaccine.2011.06.083; Dasgupta G, 2010, FUTURE MICROBIOL, V5, P1, DOI 10.2217/FMB.09.101; FIDDIAN AP, 1982, AM J MED, V73, P335, DOI 10.1016/0002-9343(82)90118-8; Johnston C, 2012, LANCET, V379, P641, DOI 10.1016/S0140-6736(11)61750-9; Nagot N, 2007, NEW ENGL J MED, V356, P790, DOI 10.1056/NEJMoa062607; Rubbo PA, 2011, JAIDS-J ACQ IMM DEF, V58, P9, DOI 10.1097/QAI.0b013e318224d0ad; Schiffer J, 2011, SEX TRANSM INFECT, V87, pA84, DOI 10.1136/sextrans-2011-050109.142; Schiffer Joshua T, 2010, Proc Natl Acad Sci U S A, V107, P18973, DOI 10.1073/pnas.1006614107; Smith JS, 2002, J INFECT DIS, V186, pS3, DOI 10.1086/343739; Tronstein E, 2011, JAMA-J AM MED ASSOC, V305, P1441, DOI 10.1001/jama.2011.420; Van de Perre P, 2008, LANCET INFECT DIS, V8, P490, DOI 10.1016/S1473-3099(08)70181-6	14	1	1	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 18	2012	379	9816					598	599		10.1016/S0140-6736(11)61614-0	http://dx.doi.org/10.1016/S0140-6736(11)61614-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	897ES	22226046				2022-12-28	WOS:000300629000009
J	Bostrom, P; Wu, J; Jedrychowski, MP; Korde, A; Ye, L; Lo, JC; Rasbach, KA; Bostrom, EA; Choi, JH; Long, JZ; Kajimura, S; Zingaretti, MC; Vind, BF; Tu, H; Cinti, S; Hojlund, K; Gygi, SP; Spiegelman, BM				Bostroem, Pontus; Wu, Jun; Jedrychowski, Mark P.; Korde, Anisha; Ye, Li; Lo, James C.; Rasbach, Kyle A.; Bostroem, Elisabeth Almer; Choi, Jang Hyun; Long, Jonathan Z.; Kajimura, Shingo; Zingaretti, Maria Cristina; Vind, Birgitte F.; Tu, Hua; Cinti, Saverio; Hojlund, Kurt; Gygi, Steven P.; Spiegelman, Bruce M.			A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis	NATURE			English	Article							SKELETAL-MUSCLE; EXERCISE; PGC-1-ALPHA; PROTECTS; PHOSPHORYLATION; COACTIVATOR; EXPRESSION; MYOBLAST; SWITCH; ROLES	Exercise benefits a variety of organ systems in mammals, and some of the best-recognized effects of exercise on muscle are mediated by the transcriptional co-activator PPAR-gamma co-activator-1 alpha (PGC1-alpha). Here we show in mouse that PGC1-alpha expression in muscle stimulates an increase in expression of FNDC5, a membrane protein that is cleaved and secreted as a newly identified hormone, irisin. Irisin acts on white adipose cells in culture and in vivo to stimulate UCP1 expression and a broad program of brown-fat-like development. Irisin is induced with exercise in mice and humans, and mildly increased irisin levels in the blood cause an increase in energy expenditure in mice with no changes in movement or food intake. This results in improvements in obesity and glucose homeostasis. Irisin could be therapeutic for human metabolic disease and other disorders that are improved with exercise.	[Bostroem, Pontus; Wu, Jun; Korde, Anisha; Ye, Li; Lo, James C.; Rasbach, Kyle A.; Choi, Jang Hyun; Long, Jonathan Z.; Spiegelman, Bruce M.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Jedrychowski, Mark P.; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Bostroem, Elisabeth Almer] Harvard Univ, Sch Med, Div Renal, Brigham & Womens Hosp, Boston, MA 02115 USA; [Kajimura, Shingo] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Kajimura, Shingo] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Zingaretti, Maria Cristina; Cinti, Saverio] Univ Politecn Marche, Dept Expt & Clin Med, Azienda Osped Riuniti, Electron Microscopy Unit, I-60020 Ancona, Italy; [Vind, Birgitte F.; Hojlund, Kurt] Odense Univ Hosp, Diabet Res Ctr, Dept Endocrinol, DK-5000 Odense, Denmark; [Tu, Hua] LakePharma Inc, Belmont, CA 94002 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Marche Polytechnic University; University of Southern Denmark; Odense University Hospital	Spiegelman, BM (corresponding author), Dana Farber Canc Inst, 3 Blackfan Circle,CLS Bldg,Floor 11, Boston, MA 02115 USA.	bruce_spiegelman@dfci.harvard.edu	Choi, Jang Hyun/B-3055-2012; Korde, Anisha/M-7275-2018; Lo, James/GYR-1149-2022; Kajimura, Shingo/AAC-5090-2019	Lo, James/0000-0003-0244-1670; Kajimura, Shingo/0000-0003-0672-5910; Long, Jonathan/0000-0003-2631-7463; Korde, Anisha/0000-0002-2233-4322; CINTI, Saverio/0000-0003-0362-5017; Hojlund, Kurt/0000-0002-0891-4224	National Institutes of Health [DK54477, DK31405, DK61562]; Wenner-Gren Foundation; Swedish Heart and Lung Foundation; Svenska Sallskapet for Medicinsk Forskning; American Heart Association [09POST2010078]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK087853, R01DK031405, R01DK061562, R56DK054477, R37DK031405, R01DK054477] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wenner-Gren Foundation; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Svenska Sallskapet for Medicinsk Forskning; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health grants DK54477, DK31405, DK61562 to B. M. S. P. B. and E. A. B. were supported by the Wenner-Gren Foundation, Swedish Heart and Lung Foundation and the 'Svenska Sallskapet for Medicinsk Forskning'. J.W. was supported by a postdoctoral fellowship from the American Heart Association (Founders Affiliate #09POST2010078). The animal procedures were in accordance with Institutional Animal Use and Care Committee protocols 110-2008 and 056-2009. The authors thank S. Loffredo and M. Kirschner for discussions and suggestions on the manuscript.	Bell JB, 2010, MOL THER, V18, P1796, DOI 10.1038/mt.2010.152; Bostrom P, 2010, CELL, V143, P1072, DOI 10.1016/j.cell.2010.11.036; Bostrom P, 2010, DIABETES, V59, P1870, DOI 10.2337/db09-1503; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; Cinti S, 2000, METH MOL B, V155, P21; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Enerback S, 2010, CELL METAB, V11, P248, DOI 10.1016/j.cmet.2010.03.008; Ferrer-Martinez A, 2002, DEV DYNAM, V224, P154, DOI 10.1002/dvdy.10099; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Komatsu M, 2010, GENES CELLS, V15, P91, DOI 10.1111/j.1365-2443.2009.01368.x; Nielsen AR, 2007, APPL PHYSIOL NUTR ME, V32, P833, DOI 10.1139/H07-054; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rasbach KA, 2010, P NATL ACAD SCI USA, V107, P21866, DOI 10.1073/pnas.1016089107; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Speakman JR, 2003, P NUTR SOC, V62, P621, DOI 10.1079/PNS2003282; Teufel A, 2002, GENE, V297, P79, DOI 10.1016/S0378-1119(02)00828-4; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; Vind BF, 2011, DIABETOLOGIA, V54, P157, DOI 10.1007/s00125-010-1924-4; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Wu J, 2011, CELL METAB, V13, P160, DOI 10.1016/j.cmet.2011.01.003; Xu XH, 2011, AM J PHYSIOL-REG I, V300, pR1115, DOI 10.1152/ajpregu.00806.2010	26	2880	3132	34	582	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2012	481	7382					463	U72		10.1038/nature10777	http://dx.doi.org/10.1038/nature10777			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881GY	22237023	Green Submitted, Green Accepted			2022-12-28	WOS:000299471800031
J	Kroshinsky, D; Hoang, MP; Hasserjian, RP				Kroshinsky, Daniela; Hoang, Mai P.; Hasserjian, Robert P.			Case 1-2012: An 82-Year-Old Man with Persistent Ulcers on the Hands	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PYODERMA-GANGRENOSUM; INFLIXIMAB		[Kroshinsky, Daniela] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; [Hoang, Mai P.; Hasserjian, Robert P.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Kroshinsky, Daniela] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Hoang, Mai P.; Hasserjian, Robert P.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Kroshinsky, D (corresponding author), Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA.		Kroshinsky, Daniela/AAM-4608-2020	Kroshinsky, Daniela/0000-0002-4781-9676	Harvard Medical School Department of Continuing Education and Department of Pathology; Massachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham and Women's Hospital	Harvard Medical School Department of Continuing Education and Department of Pathology; Massachusetts General Hospital(General Electric); Beth Israel Deaconess Medical Center; Brigham and Women's Hospital	This case was presented at the postgraduate course Dermatopathology Update, sponsored by the Harvard Medical School Department of Continuing Education and Department of Pathology, Massachusetts General Hospital, Beth Israel Deaconess Medical Center, and Brigham and Women's Hospital.	Brooklyn TN, 2006, GUT, V55, P505, DOI 10.1136/gut.2005.074815; Brunning RD, 2008, WHO CLASSIFICATION T; Callen JP, 2007, RHEUM DIS CLIN N AM, V33, P787, DOI 10.1016/j.rdc.2007.07.016; Fernandez A, 2008, AM J GASTROENTEROL, V103, P2951, DOI 10.1111/j.1572-0241.2008.02094_14.x; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Powell FC, 1996, J AM ACAD DERMATOL, V34, P395, DOI 10.1016/S0190-9622(96)90428-4; Regueiro M, 2003, AM J GASTROENTEROL, V98, P1821, DOI 10.1016/S0002-9270(03)00430-1; Su WPD, 2004, INT J DERMATOL, V43, P790, DOI 10.1111/j.1365-4632.2004.02128.x; Walling HW, 2006, ARCH DERMATOL, V142, P57, DOI 10.1001/archderm.142.1.57	9	5	6	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 12	2012	366	2					166	174		10.1056/NEJMcpc1104568	http://dx.doi.org/10.1056/NEJMcpc1104568			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874VA	22236228				2022-12-28	WOS:000298985000013
J	Emanuel, EJ				Emanuel, Ezekiel J.			Where Are the Health Care Cost Savings?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Emanuel, Ezekiel J.] Univ Penn, Sch Med, Off Provost, Philadelphia, PA 19104 USA; [Emanuel, Ezekiel J.] Univ Penn, Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Emanuel, EJ (corresponding author), Univ Penn, Sch Med, Off Provost, 122 Coll Hall, Philadelphia, PA 19104 USA.	zemanuel@upenn.edu						Agency for Healthcare Research and Quality, 2006, RES ACTION, P19; [Anonymous], LONG TERM OUTL HLTH; Congressional Budget Office, EFF US GEN DRUGS MED; Congressional Budget Office, SEL CBO PUBL REL HLT; de Brantes F, 2009, NEW ENGL J MED, V361, P1033, DOI 10.1056/NEJMp0906121; Health Care for America Now (HCAN), HCAN AN SHOWS HLTH I; Martin A, 2011, HEALTH AFFAIR, V30, P11, DOI 10.1377/hlthaff.2010.1032; Mello MM, EVALUATION OPTIONS M; US Department of Health and Human Services, 2010, ASPE ISS BRIEF EXP U	9	59	59	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 4	2012	307	1					39	40		10.1001/jama.2011.1927	http://dx.doi.org/10.1001/jama.2011.1927			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	872ET	22215161				2022-12-28	WOS:000298792300017
J	Hart, B; Lundh, A; Bero, L				Hart, Beth; Lundh, Andreas; Bero, Lisa			Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EMPIRICAL-EVIDENCE; RANDOMIZED-TRIALS; SEARCH STRATEGIES; PUBLICATION; INDUSTRY	Objective To investigate the effect of including unpublished trial outcome data obtained from the Food and Drug Administration (FDA) on the results of meta-analyses of drug trials. Design Reanalysis of meta-analyses. Data sources Drug trials with unpublished outcome data for new molecular entities that were approved by the FDA between 2001 and 2002 were identified. For each drug, eligible systematic reviews containing at least one meta-analysis were identified by searches of Medline, Embase, and the Cochrane Library in November 2010. Selection criteria Eligible systematic reviews were done after FDA approval of the drug, were published in English, and had outcomes and comparators that were the same as those of the trials with unpublished FDA trial outcomes, and the characteristics of participants in the systematic reviews were consistent with the FDA approved indication for the drug. Clinical guidelines, conference proceedings, duplicate systematic reviews, and systematic reviews in which included trials were not referenced or that combined trials across multiple drug classes were excluded. Systematic reviews using non-standard meta-analytic techniques (such as Bayesian or network meta-analyses) and those that used inappropriate or invalid methods for calculation of summary statistics (such as unweighted pooled analyses) were also excluded. Data extraction Two authors independently extracted data from both the published systematic reviews and the FDA's medical and statistical reviews of the trials submitted to FDA. Main outcome measure Summary statistics (risk ratios, odds ratios, or weighted mean differences) for relevant outcomes with and without unpublished FDA trial data. Results 42 meta-analyses (41 efficacy outcomes, one harm outcome) for nine drugs across six drug classes were reanalysed. Overall, addition of unpublished FDA trial data caused 46% (19/41) of the summary estimates from the meta-analyses to show lower efficacy of the drug, 7% (3/41) to show identical efficacy, and 46% (19/41) to show greater efficacy. The summary estimate of the single harm outcome showed more harm from the drug after inclusion of unpublished FDA trial data. Conclusion The effect of including unpublished FDA trial outcome data varies by drug and outcome. Unpublished FDA trial outcome data should be available and included in meta-analysis. Making these data easily accessible is particularly important because the effects of including unpublished data vary.	[Hart, Beth; Bero, Lisa] Univ Calif San Francisco, Inst Hlth Policy Studies, Dept Clin Pharm, San Francisco, CA 94118 USA; [Lundh, Andreas] Rigshosp, Nord Cochrane Ctr, DK-2100 Copenhagen, Denmark; [Lundh, Andreas] Univ Copenhagen, Copenhagen, Denmark	University of California System; University of California San Francisco; Rigshospitalet; University of Copenhagen; University of Copenhagen	Bero, L (corresponding author), Univ Calif San Francisco, Inst Hlth Policy Studies, Dept Clin Pharm, 3333 Calif St,Suite 420, San Francisco, CA 94118 USA.	berol@pharmacy.ucsf.edu		Lundh, Andreas/0000-0002-4982-8680; Bero, Lisa/0000-0003-1893-6651	Doris Duke Charitable Foundation	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF))	This work was supported by a grant from the Doris Duke Charitable Foundation to the University of California, San Francisco, to fund clinical research fellow BH. The sponsor had no role in the design, conduct, or publication of the research. The authors retain full control of all the data.	Boulton G, 2011, LANCET, V377, P1633, DOI 10.1016/S0140-6736(11)60647-8; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Cook D, 2004, JAMA-J AM MED ASSOC, V291, P2457; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Eyding D, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4737; Gotzsche PC, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2686; Hopewell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000006.pub3; Hrynaszkiewicz I, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c181; JISC, 2011, DRYAD UK REP INF DIS; Kirkham JJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c365; McGauran N, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-37; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; Montori VM, 2005, BMJ-BRIT MED J, V330, P68, DOI 10.1136/bmj.38336.804167.47; Oxman AD, 2006, HLTH RES POLICY SYST, V4; Pharmaceutical Research and Manufacturers of America, 2011, PHARM RES MAN AM; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Schunemann HJ, 2006, HLTH RES POLICY SYST, V4; Science, 2011, GEN INF AUTH; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Vedula SS, 2009, NEW ENGL J MED, V361, P1963, DOI 10.1056/NEJMsa0906126; Wilczynski NL, 2007, J CLIN EPIDEMIOL, V60, P29, DOI 10.1016/j.jclinepi.2006.04.001	22	146	147	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 3	2012	344								d7202	10.1136/bmj.d7202	http://dx.doi.org/10.1136/bmj.d7202			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874UE	22214754	hybrid			2022-12-28	WOS:000298982800004
J	Levine, MT; Malik, HS				Levine, Mia T.; Malik, Harmit S.			Learning to Protect Your Genome on the Fly	CELL			English	Editorial Material							DROSOPHILA-MELANOGASTER; STERILITY	Piwi-interacting RNAs (piRNAs) help defend host genomes against germline transposons. In this issue of Cell, Khurana et al. show how alterations in the piRNA-encoding loci within a single generation allow a naive fly genome to overcome the initially insurmountable challenge imposed by a newly encountered mobile element.	[Levine, Mia T.; Malik, Harmit S.] Fred Hutchinson Canc Res Ctr, Basic Sci Div, Seattle, WA 98109 USA; [Malik, Harmit S.] Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Malik, HS (corresponding author), Fred Hutchinson Canc Res Ctr, Basic Sci Div, Seattle, WA 98109 USA.	hsmalik@fhcrc.org	Malik, Harmit S/E-8519-2012	Levine, Mia/0000-0003-4311-7535; Malik, Harmit/0000-0001-6005-0016	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM097897, R01GM074108] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [F32 GM097897, R01GM074108, F32GM097897, R01 GM074108] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; BUCHETON A, 1979, GENETICS, V93, P131; DANIELS SB, 1990, GENETICS, V124, P339; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Khurana JS, 2011, CELL, V147, P1551, DOI 10.1016/j.cell.2011.11.042; KIDWELL MG, 1977, GENETICS, V86, P813; Klattenhoff C, 2009, CELL, V138, P1137, DOI 10.1016/j.cell.2009.07.014; Nagaoka SI, 2011, CURR BIOL, V21, P651, DOI 10.1016/j.cub.2011.03.003; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089	10	3	3	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 23	2011	147	7					1440	1441		10.1016/j.cell.2011.12.001	http://dx.doi.org/10.1016/j.cell.2011.12.001			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	866SP	22196722	Green Accepted, Bronze			2022-12-28	WOS:000298403400009
J	Rauniyar, V; Lackner, AD; Hamilton, GL; Toste, FD				Rauniyar, Vivek; Lackner, Aaron D.; Hamilton, Gregory L.; Toste, F. Dean			Asymmetric Electrophilic Fluorination Using an Anionic Chiral Phase-Transfer Catalyst	SCIENCE			English	Article							ENANTIOSELECTIVE FLUORINATION; PALLADIUM COMPLEXES; ALPHA-FLUORINATION; AMMONIUM-SALTS; ALDEHYDES; ACID	The discovery of distinct modes of asymmetric catalysis has the potential to rapidly advance chemists' ability to build enantioenriched molecules. As an example, the use of chiral cation salts as phase-transfer catalysts for anionic reagents has enabled a vast set of enantioselective transformations. Here, we present evidence that a largely overlooked analogous mechanism wherein a chiral anionic catalyst brings a cationic species into solution is itself a powerful method. The concept is applied to the enantioselective fluorocyclization of olefins with a cationic fluorinating agent and a chiral phosphate catalyst. The reactions proceed in high yield and stereoselectivity, especially considering the scarcity of alternative approaches. This technology can in principle be applied to the large portion of reaction space that uses positively charged reagents and reaction intermediates.	[Rauniyar, Vivek; Lackner, Aaron D.; Hamilton, Gregory L.; Toste, F. Dean] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Toste, FD (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	fdtoste@berkeley.edu	Toste, F. Dean/Y-2556-2019	Toste, F. Dean/0000-0001-8018-2198	University of California, Berkeley; Amgen; Natural Sciences and Engineering Research Council of Canada (NSERC)	University of California, Berkeley(University of California System); Amgen(Amgen); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	We gratefully acknowledge the University of California, Berkeley, and Amgen for financial support. V. R. thanks the Natural Sciences and Engineering Research Council of Canada (NSERC) for a postdoctoral fellowship. A. D. L. thanks J. Lee for initial investigations. Structural parameters for compound 4c are available free of charge from the Cambridge Crystallographic Data Center under reference number CCDC-847686.	Baudoux J., 2007, ORG REACTIONS, P347; Beeson TD, 2005, J AM CHEM SOC, V127, P8826, DOI 10.1021/ja051805f; Bloom S, 2011, ORG LETT, V13, P5068, DOI 10.1021/ol2019295; Bobbio C, 2006, ORG BIOMOL CHEM, V4, P2065, DOI 10.1039/b603163c; Cahard D, 2000, ORG LETT, V2, P3699, DOI 10.1021/ol006610l; Carter C, 2003, TETRAHEDRON-ASYMMETR, V14, P1995, DOI 10.1016/S0957-4166(03)00367-7; Furuya T, 2011, NATURE, V473, P470, DOI 10.1038/nature10108; Hamashima Y, 2005, TETRAHEDRON LETT, V46, P1447, DOI 10.1016/j.tetlet.2005.01.018; Hamilton GL, 2008, J AM CHEM SOC, V130, P14984, DOI 10.1021/ja806431d; Hamilton GL, 2007, SCIENCE, V317, P496, DOI 10.1126/science.1145229; Hintermann L, 2000, ANGEW CHEM INT EDIT, V39, P4359, DOI 10.1002/1521-3773(20001201)39:23<4359::AID-ANIE4359>3.0.CO;2-P; Ishimaru T, 2008, ANGEW CHEM INT EDIT, V47, P4157, DOI 10.1002/anie.200800717; Katcher MH, 2011, J AM CHEM SOC, V133, P15902, DOI 10.1021/ja206960k; Kim HR, 2005, TETRAHEDRON LETT, V46, P3115, DOI 10.1016/j.tetlet.2005.02.164; Kwiatkowski P, 2011, J AM CHEM SOC, V133, P1738, DOI 10.1021/ja111163u; Lacour J, 2009, CHEM COMMUN, P7073, DOI 10.1039/b912530b; Lectard S, 2010, ADV SYNTH CATAL, V352, P2708, DOI 10.1002/adsc.201000624; Lozano O, 2011, ANGEW CHEM INT EDIT, V50, P8105, DOI 10.1002/anie.201103151; Lygo B, 2004, ACCOUNTS CHEM RES, V37, P518, DOI 10.1021/ar030058t; Ma JA, 2008, CHEM REV, V108, pPR1, DOI 10.1021/cr800221v; Marigo M, 2005, ANGEW CHEM INT EDIT, V44, P3703, DOI 10.1002/anie.200500395; Maruoka K., 2008, ASYMMETRIC PHASE TRA; Mayer S, 2006, ANGEW CHEM INT EDIT, V45, P4193, DOI 10.1002/anie.200600512; Nyffeler PT, 2005, ANGEW CHEM INT EDIT, V44, P192, DOI 10.1002/anie.200400648; O'Donnell M. J., 2000, CATALYTIC ASYMMETRIC; Ojima I., 2009, FLUORINE MED CHEM CH; Ooi T, 2007, ANGEW CHEM INT EDIT, V46, P4222, DOI 10.1002/anie.200601737; Purser S, 2008, CHEM SOC REV, V37, P320, DOI 10.1039/b610213c; Satyanarayana T, 2009, ANGEW CHEM INT EDIT, V48, P456, DOI 10.1002/anie.200705241; Shibata N, 2000, J AM CHEM SOC, V122, P10728, DOI 10.1021/ja002732x; Stavber S, 2011, MOLECULES, V16, P6432, DOI 10.3390/molecules16086432; Steiner DD, 2005, ANGEW CHEM INT EDIT, V44, P3706, DOI 10.1002/anie.200500571; Suzuki T, 2007, J ORG CHEM, V72, P246, DOI 10.1021/jo062048m; Terada M, 2008, CHEM COMMUN, P4097, DOI 10.1039/b807577h; VINEYARD BD, 1977, J AM CHEM SOC, V99, P5946, DOI 10.1021/ja00460a018; Wang XS, 2010, CHEM COMMUN, V46, P321, DOI 10.1039/b920099a; Wilkinson SC, 2009, FUTURE MED CHEM, V1, P847, DOI [10.4155/fmc.09.47, 10.4155/FMC.09.47]	37	373	374	7	202	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1681	1684		10.1126/science.1213918	http://dx.doi.org/10.1126/science.1213918			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22194571				2022-12-28	WOS:000298344000060
J	Sodeoka, M				Sodeoka, Mikiko			Efficient Fluorination of Organic Molecules with Chiral Anions	SCIENCE			English	Editorial Material							CATALYTIC ENANTIOSELECTIVE FLUORINATION; ASYMMETRIC ALPHA-FLUORINATION; BETA-KETOESTERS		[Sodeoka, Mikiko] RIKEN, Wako, Saitama 3510198, Japan; [Sodeoka, Mikiko] JST, ERATO, Wako, Saitama 3510198, Japan	RIKEN; Japan Science & Technology Agency (JST)	Sodeoka, M (corresponding author), RIKEN, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	sodeoka@riken.jp	Sodeoka, Mikiko/A-9952-2008	Sodeoka, Mikiko/0000-0002-1344-364X				Benson T. D., 2005, J AM CHEM SOC, V127, P8826; Hamashima Y, 2002, J AM CHEM SOC, V124, P14530, DOI 10.1021/ja028464f; Hintermann L, 2000, ANGEW CHEM INT EDIT, V39, P4359, DOI 10.1002/1521-3773(20001201)39:23<4359::AID-ANIE4359>3.0.CO;2-P; Ishimaru T, 2008, ANGEW CHEM INT EDIT, V47, P4157, DOI 10.1002/anie.200800717; Kim DY, 2002, ORG LETT, V4, P545, DOI 10.1021/ol010281v; Lacour J, 2009, CHEM COMMUN, P7073, DOI 10.1039/b912530b; Lectard S, 2010, ADV SYNTH CATAL, V352, P2708, DOI 10.1002/adsc.201000624; Lozano O, 2011, ANGEW CHEM INT EDIT, V50, P8105, DOI 10.1002/anie.201103151; Ma JA, 2008, CHEM REV, V108, pPR1, DOI 10.1021/cr800221v; Marigo M, 2005, ANGEW CHEM INT EDIT, V44, P3703, DOI 10.1002/anie.200500395; Ojima I., 2009, FLUORINE MED CHEM CH; Paull DH, 2008, J AM CHEM SOC, V130, P17260, DOI 10.1021/ja807792c; Rauniyar V, 2011, SCIENCE, V334, P1681, DOI 10.1126/science.1213918; Steiner DD, 2005, ANGEW CHEM INT EDIT, V44, P3706, DOI 10.1002/anie.200500571; Wang XS, 2010, CHEM COMMUN, V46, P321, DOI 10.1039/b920099a	15	7	7	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1651	1652		10.1126/science.1215220	http://dx.doi.org/10.1126/science.1215220			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22194563				2022-12-28	WOS:000298344000051
J	Andrianov, A; Nissenbaum, MA				Andrianov, Alexandre; Nissenbaum, Michael A.			Pneumopericardium Associated with a Peptic Ulcer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Andrianov, Alexandre; Nissenbaum, Michael A.] No Maine Med Ctr, Ft Kent, ME USA		Andrianov, A (corresponding author), No Maine Med Ctr, Ft Kent, ME USA.	alexmd2@gmail.com							0	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2011	365	25					2412	2412		10.1056/NEJMicm1107529	http://dx.doi.org/10.1056/NEJMicm1107529			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	865OM	22187988				2022-12-28	WOS:000298320200007
J	Giri, G; Verploegen, E; Mannsfeld, SCB; Atahan-Evrenk, S; Kim, DH; Lee, SY; Becerril, HA; Aspuru-Guzik, A; Toney, MF; Bao, ZA				Giri, Gaurav; Verploegen, Eric; Mannsfeld, Stefan C. B.; Atahan-Evrenk, Sule; Kim, Do Hwan; Lee, Sang Yoon; Becerril, Hector A.; Aspuru-Guzik, Alan; Toney, Michael F.; Bao, Zhenan			Tuning charge transport in solution-sheared organic semiconductors using lattice strain	NATURE			English	Article							FIELD-EFFECT TRANSISTORS; THIN-FILM TRANSISTORS; PENTACENE DERIVATIVES; HIGH-PERFORMANCE; ELECTRONICS; MOBILITY	Circuits based on organic semiconductors are being actively explored for flexible, transparent and low-cost electronic applications(1-5). But to realize such applications, the charge carrier mobilities of solution-processed organic semiconductors must be improved. For inorganic semiconductors, a general method of increasing charge carrier mobility is to introduce strain within the crystal lattice(6). Here we describe a solution-processing technique for organic semiconductors in which lattice strain is used to increase charge carrier mobilities by introducing greater electron orbital overlap between the component molecules. For organic semiconductors, the spacing between cofacially stacked, conjugated backbones (the pi-pi stacking distance) greatly influences electron orbital overlap and therefore mobility(7). Using our method to incrementally introduce lattice strain, we alter the pi-pi stacking distance of 6,13-bis(triisopropylsilylethynyl) pentacene (TIPS-pentacene) from 3.33 angstrom to 3.08 angstrom. We believe that 3.08 angstrom is the shortest pi-pi stacking distance that has been achieved in an organic semiconductor crystal lattice (although a pi-pi distance of 3.04 angstrom has been achieved through intramolecular bonding(8-10)). The positive charge carrier (hole) mobility in TIPS-pentacene transistors increased from 0.8 cm(2) V-1 s(-1) for unstrained films to a high mobility of 4.6 cm(2) V-1 s(-1) for a strained film. Using solution processing to modify molecular packing through lattice strain should aid the development of high-performance, low-cost organic semiconducting devices.	[Giri, Gaurav; Verploegen, Eric; Kim, Do Hwan; Bao, Zhenan] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Verploegen, Eric; Mannsfeld, Stefan C. B.; Toney, Michael F.] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [Atahan-Evrenk, Sule; Aspuru-Guzik, Alan] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Lee, Sang Yoon] Samsung Adv Inst Technol, Display Device Lab, Yongin 449712, Kyunggi Do, South Korea; [Becerril, Hector A.] Brigham Young Univ Idaho, Dept Chem, Rexburg, ID 83460 USA	Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Harvard University; Samsung; Brigham Young University	Bao, ZA (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.	zbao@stanford.edu	Mannsfeld, Stefan/Q-1924-2019; Bao, Zhenan/AAC-5044-2019; Atahan-Evrenk, Sule/D-4736-2012; Aspuru-Guzik, Alan/A-4984-2008; Kim, Do Hwan/B-4990-2012; Toney, Michael/ABD-5429-2021	Bao, Zhenan/0000-0002-0972-1715; Atahan-Evrenk, Sule/0000-0002-4905-3491; Aspuru-Guzik, Alan/0000-0002-8277-4434; Toney, Michael/0000-0002-7513-1166; Lee, Sangyoon/0000-0002-7037-736X	National Science Foundation DMR-Solid State Chemistry [DMR-0705687-002]; Samsung Advanced Institute of Technology; Stanford University [SPO 25591130-45282-A]; Air Force Office of Scientific Research [FA9550-09-1-0256]; Eastman Kodak Corporation	National Science Foundation DMR-Solid State Chemistry(National Science Foundation (NSF)); Samsung Advanced Institute of Technology(Samsung); Stanford University(Stanford University); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Eastman Kodak Corporation	We thank A. Salleo, J. E. Anthony, H. Li, A. Sokolov and J. Rivnay for discussions. We thank J. E. Anthony and M. M. Nelson of 3M Corp. for providing high-purity TIPS-pentacene. This publication was partially supported by the National Science Foundation DMR-Solid State Chemistry (DMR-0705687-002), the Samsung Advanced Institute of Technology, the Global Climate and Energy Project at Stanford University (SPO 25591130-45282-A) and the Air Force Office of Scientific Research (award number FA9550-09-1-0256). E. V. thanks the Eastman Kodak Corporation Kodak Fellows Program for support. Z.B. acknowledges support from the David Filo and Jerry Yang Faculty Fellowship from Stanford University. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a national user facility operated by Stanford University on behalf of the US Department of Energy, Office of Basic Energy Sciences. Any opinions, findings, and conclusions or recommendations expressed in this publication are those of the authors and do not necessarily reflect the views of Stanford University, the Sponsors of the Global Climate and Energy Project, or others involved with the Global Climate and Energy Project.	Anthony JE, 2002, ORG LETT, V4, P15, DOI 10.1021/ol0167356; Becerril HA, 2008, ADV MATER, V20, P2588, DOI 10.1002/adma.200703120; Bredas JL, 2002, P NATL ACAD SCI USA, V99, P5804, DOI 10.1073/pnas.092143399; Che CM, 2011, CHEM SCI, V2, P216, DOI 10.1039/c0sc00479k; Chen J., 2008, J APPL PHYS, V103; Chen JH, 2006, J PHYS CHEM B, V110, P16397, DOI 10.1021/jp0627877; Chui SSY, 2010, CHEM-ASIAN J, V5, P2062, DOI 10.1002/asia.201000233; Dimitrakopoulos CD, 2002, ADV MATER, V14, P99, DOI 10.1002/1521-4095(20020116)14:2<99::AID-ADMA99>3.0.CO;2-9; Feng XL, 2009, NAT MATER, V8, P421, DOI [10.1038/NMAT2427, 10.1038/nmat2427]; Gao P, 2009, ADV MATER, V21, P213, DOI 10.1002/adma.200802031; Gsanger M., 2010, ANGEW CHEM, V122, P752, DOI DOI 10.1002/ANGE.200904215; Ito Y, 2009, J AM CHEM SOC, V131, P9396, DOI 10.1021/ja9029957; Lee ML, 2005, J APPL PHYS, V97, DOI 10.1063/1.1819976; Lee SS, 2009, ADV MATER, V21, P3605, DOI 10.1002/adma.200900705; Lee WH, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2717087; LOVINGER AJ, 1979, POLYMER, V20, P725, DOI 10.1016/0032-3861(79)90247-7; Mannsfeld SCB, 2011, ADV MATER, V23, P127, DOI 10.1002/adma.201003135; Ni ZH, 2008, ACS NANO, V2, P2301, DOI 10.1021/nn800459e; Okamoto T, 2007, ADV MATER, V19, P3381, DOI 10.1002/adma.200700298; Park SK, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2768934; Rivnay J, 2009, NAT MATER, V8, P952, DOI [10.1038/NMAT2570, 10.1038/nmat2570]; Rogers JA, 2001, P NATL ACAD SCI USA, V98, P4835, DOI 10.1073/pnas.091588098; Rogowski RZ, 2010, LANGMUIR, V26, P11485, DOI 10.1021/la101002x; Sakanoue T, 2010, NAT MATER, V9, P736, DOI [10.1038/NMAT2825, 10.1038/nmat2825]; Sele CW, 2009, ADV MATER, V21, P4926, DOI 10.1002/adma.200901548; Sokolov A. N., 2007, THESIS U IOWA; Tang ML, 2009, J AM CHEM SOC, V131, P3733, DOI 10.1021/ja809045s; Wasielewski M. R., 2004, ANGEW CHEM, V116, P6523, DOI DOI 10.1002/ANGE.200461324); Yuan Q, 2008, J AM CHEM SOC, V130, P3502, DOI 10.1021/ja0773002; Zhang M, 2007, J AM CHEM SOC, V129, P3472, DOI 10.1021/ja0683537	30	876	888	25	891	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2011	480	7378					504	U124		10.1038/nature10683	http://dx.doi.org/10.1038/nature10683			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865NQ	22193105	Green Submitted			2022-12-28	WOS:000298318000056
J	Xu, ZG				Xu, Zhiguo			MODERNIZATION One step at a time	NATURE			English	Editorial Material																		Zhang BG, 2010, PLANTA MED, V76, P1948, DOI 10.1055/s-0030-1250527; Zhang X, 2011, ANAL BIOANAL CHEM	2	69	73	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2011	480	7378					S90	S92		10.1038/480S90a	http://dx.doi.org/10.1038/480S90a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	865NQ	22190089	Bronze			2022-12-28	WOS:000298318000005
J	Staud, R				Staud, Roland			Patients with rheumatoid arthritis and those with diabetes mellitus had a similar increased risk for myocardial infarction	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CARDIOVASCULAR-DISEASE; ATHEROSCLEROSIS; MORTALITY		Univ Florida, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Staud, R (corresponding author), Univ Florida, Gainesville, FL 32611 USA.		Staud, Roland/A-8442-2008					Chung CP, 2005, ARTHRITIS RHEUM-US, V52, P3045, DOI 10.1002/art.21288; Ford ES, 2005, DIABETES CARE, V28, P1769, DOI 10.2337/diacare.28.7.1769; Kremers HM, 2008, ARTHRITIS RHEUM-US, V58, P2268, DOI 10.1002/art.23650; Park YB, 2002, ARTHRITIS RHEUM, V46, P1714, DOI 10.1002/art.10359; Peters MJL, 2009, ARTHRIT RHEUM-ARTHR, V61, P1571, DOI 10.1002/art.24836; PINCUS T, 1986, J RHEUMATOL, V13, P841	6	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2011	155	12							JC6-11	10.7326/0003-4819-155-12-201112200-02011	http://dx.doi.org/10.7326/0003-4819-155-12-201112200-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	864ZU	22184712				2022-12-28	WOS:000298280500010
J	Sagar, S; Liu, PP; Cooper, LT				Sagar, Sandeep; Liu, Peter P.; Cooper, Leslie T., Jr.			Myocarditis	LANCET			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; GIANT-CELL MYOCARDITIS; VENTRICULAR ENDOMYOCARDIAL BIOPSY; COXSACKIE-ADENOVIRUS RECEPTOR; ASSOCIATION TASK-FORCE; COLLEGE-OF-CARDIOLOGY; DILATED CARDIOMYOPATHY; VIRAL MYOCARDITIS; IMMUNOSUPPRESSIVE THERAPY; HEART-ASSOCIATION	Myocarditis is an underdiagnosed cause of acute heart failure, sudden death, and chronic dilated cardiomyopathy. In developed countries, viral infections commonly cause myocarditis; however, in the developing world, rheumatic carditis, Trypanosoma cruzi, and bacterial infections such as diphtheria still contribute to the global burden of the disease. The short-term prognosis of acute myocarditis is usually good, but varies widely by cause. Those patients who initially recover might develop recurrent dilated cardiomyopathy and heart failure, sometimes years later. Because myocarditis presents with non-specific symptoms including chest pain, dyspnoea, and palpitations, it often mimics more common disorders such as coronary artery disease. In some patients, cardiac MRI and endomyocardial biopsy can help identify myocarditis, predict risk of cardiovascular events, and guide treatment. Finding effective therapies has been challenging because the pathogenesis of chronic dilated cardiomyopathy after viral myocarditis is complex and determined by host and viral genetics as well as environmental factors. Findings from recent clinical trials suggest that some patients with chronic inflammatory cardiomyopathy have a progressive clinical course despite standard medical care and might improve with a short course of immunosuppression.	[Sagar, Sandeep; Cooper, Leslie T., Jr.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA; [Liu, Peter P.] Univ Toronto, Toronto Gen Hosp, Univ Hlth Network, Toronto, ON M5G 1L7, Canada	Mayo Clinic; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Cooper, LT (corresponding author), Mayo Clin, Div Cardiovasc Dis, 200 1st St SW, Rochester, MN 55905 USA.	cooper.leslie@mayo.edu	Franzeck, Fabian C/B-5055-2011	Cooper, Leslie/0000-0003-1002-3313	Sanofi Pasteur; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056267, R56HL056267] Funding Source: NIH RePORTER	Sanofi Pasteur; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	PPL ans SS declare that they have no conflicts of interest. LTC has received consultancy fees from Sanofi Pasteur.	de Noya BA, 2010, J INFECT DIS, V201, P1308, DOI 10.1086/651608; Alvarez JA, 2011, CIRCULATION, V124, P814, DOI 10.1161/CIRCULATIONAHA.110.973826; Assomull RG, 2006, J AM COLL CARDIOL, V48, P1977, DOI 10.1016/j.jacc.2006.07.049; Baccouche H, 2009, EUR HEART J, V30, P2869, DOI 10.1093/eurheartj/ehp328; Barton M, 2008, PEDIATR INFECT DIS J, V27, P831, DOI 10.1097/INF.0b013e31816ff7b2; Ben m'rad M, 2009, MEDICINE, V88, P131, DOI 10.1097/MD.0b013e3181a4d1a1; Caforio ALP, 2008, AUTOIMMUNITY, V41, P35, DOI 10.1080/08916930701619235; COBB S, 1953, NEW ENGL J MED, V249, P553, DOI 10.1056/NEJM195310012491402; Cooper LT, 2007, CIRCULATION, V116, P2216, DOI 10.1161/CIRCULATIONAHA.107.186093; Cooper Leslie T Jr, 2005, Heart Fail Clin, V1, P431, DOI 10.1016/j.hfc.2005.06.004; Cooper LT, 2009, NEW ENGL J MED, V360, P1526, DOI 10.1056/NEJMra0800028; Cooper LT, 2008, AM J CARDIOL, V102, P1535, DOI 10.1016/j.amjcard.2008.07.041; Cooper LT, 1997, NEW ENGL J MED, V336, P1860, DOI 10.1056/NEJM199706263362603; COSTANZONORDIN MR, 1985, J AM COLL CARDIOL, V6, P1078, DOI 10.1016/S0735-1097(85)80312-0; Costello JM, 2009, PEDIATRICS, V123, pE835, DOI 10.1542/peds.2008-3058; Coyne CB, 2006, CELL, V124, P119, DOI 10.1016/j.cell.2005.10.035; Daniels PR, 2000, CARDIOVASC PATHOL, V9, P287, DOI 10.1016/S1054-8807(00)00049-1; de Leeuw N, 1999, CLIN INFECT DIS, V29, P522, DOI 10.1086/598625; DEC GW, 1992, J AM COLL CARDIOL, V20, P85, DOI 10.1016/0735-1097(92)90141-9; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; DRUCKER NA, 1994, CIRCULATION, V89, P252, DOI 10.1161/01.CIR.89.1.252; Duncan BW, 2001, J THORAC CARDIOV SUR, V122, P440, DOI 10.1067/mtc.2001.115243; Engler RJM, 2009, J ALLERGY CLIN IMMUN, V123, pS264, DOI 10.1016/j.jaci.2008.12.1022; Enko K, 2009, CIRC J, V73, P1344, DOI 10.1253/circj.CJ-08-0334; Friedrich MG, 2009, J AM COLL CARDIOL, V53, P1475, DOI 10.1016/j.jacc.2009.02.007; Frustaci A, 2003, CIRCULATION, V107, P857, DOI 10.1161/01.CIR.0000048147.15962.31; Frustaci A, 2009, EUR HEART J, V30, P1995, DOI 10.1093/eurheartj/ehp249; Fuse K, 2000, CIRCULATION, V102, P2829; Fuse K, 2005, CIRCULATION, V112, P2276, DOI 10.1161/CIRCULATIONAHA.105.536433; Galazka A, 2000, J INFECT DIS, V181, pS2, DOI 10.1086/315533; Grupi C J, 1995, Sao Paulo Med J, V113, P835; Heidecker B, 2011, CIRCULATION, V123, P1174, DOI 10.1161/CIRCULATIONAHA.110.002857; Hia CPP, 2004, ARCH DIS CHILD, V89, P580, DOI 10.1136/adc.2003.034686; Hill KD, 2009, J HEART LUNG TRANSPL, V28, P1261, DOI 10.1016/j.healun.2009.06.019; Holzmann M, 2008, CIRCULATION, V118, P1722, DOI 10.1161/CIRCULATIONAHA.107.743427; Hundley WG, 2010, CIRCULATION, V121, P2462, DOI 10.1161/CIR.0b013e3181d44a8f; Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013; Imazio M, 2010, J CARDIOVASC MED, V11, P712, DOI 10.2459/JCM.0b013e3283340b97; Kaji M, 2001, INTERNAL MED, V40, P594, DOI 10.2169/internalmedicine.40.594; Kandolin R, 2011, CIRC-ARRHYTHMIA ELEC, V4, P303, DOI 10.1161/CIRCEP.110.959254; KASPER EK, 1994, J AM COLL CARDIOL, V23, P586, DOI 10.1016/0735-1097(94)90740-4; Kindermann I, 2008, CIRCULATION, V118, P639, DOI 10.1161/CIRCULATIONAHA.108.769489; Kishimoto C, 1999, CIRCULATION, V99, P975, DOI 10.1161/01.CIR.99.7.975; Kuhl U, 2008, J MED VIROL, V80, P1243, DOI 10.1002/jmv.21187; Kuhl U, 2005, CIRCULATION, V112, P1965, DOI 10.1161/CIRCULATIONAHA.105.548156; Kuhl U, 2005, CIRCULATION, V111, P887, DOI 10.1161/01.CIR.0000155616.07901.35; Kuhl U, 2003, CIRCULATION, V108, P945, DOI 10.1161/01.CIR.0000085168.02782.2C; Kuhl U, 2003, CIRCULATION, V107, P2793, DOI 10.1161/01.CIR.0000072766.67150.51; Lee JK, 1998, NAT MED, V4, P1383, DOI 10.1038/3973; Levin MD, 1999, LANCET, V354, P128, DOI 10.1016/S0140-6736(99)02251-5; Lindenfeld J, 2010, J CARD FAIL, V16, P475, DOI 10.1016/j.cardfail.2010.04.005; Liu PP, 2000, CIRC RES, V86, P253, DOI 10.1161/01.RES.86.3.253; Liu QN, 2001, AIDS RES HUM RETROV, V17, P1423, DOI 10.1089/088922201753197097; Maekawa Y, 2007, CIRCULATION, V115, P5, DOI 10.1161/CIRCULATIONAHA.106.670554; Magnani JW, 2006, AM HEART J, V151, P463, DOI 10.1016/j.ahj.2005.03.037; Mahrholdt H, 2006, CIRCULATION, V114, P1581, DOI 10.1161/CIRCULATIONAHA.105.606509; Marin JA, 2007, CIRCULATION, V115, P1109, DOI 10.1161/CIRCULATIONAHA.106.624296; Maron BJ, 2005, J AM COLL CARDIOL, V45, P1340, DOI 10.1016/j.jacc.2005.02.011; Marques Divina Seila de Oliveira, 2006, Arq. Bras. Cardiol., V87, P336, DOI 10.1590/S0066-782X2006001600017; MASON JW, 1995, NEW ENGL J MED, V333, P269, DOI 10.1056/NEJM199508033330501; MATSUMORI A, 1995, CIRCULATION, V92, P2519, DOI 10.1161/01.CIR.92.9.2519; Mavrouli MD, 2007, VIRAL IMMUNOL, V20, P11, DOI 10.1089/vim.2006.0085; McCarthy RE, 2000, NEW ENGL J MED, V342, P690, DOI 10.1056/NEJM200003093421003; McNamara DM, 2011, J AM COLL CARDIOL, V58, P1112, DOI 10.1016/j.jacc.2011.05.033; McNamara DM, 2001, CIRCULATION, V103, P2254; MENDES LA, 1994, AM HEART J, V128, P301, DOI 10.1016/0002-8703(94)90483-9; Moloney ED, 2005, J HEART LUNG TRANSPL, V24, P1103, DOI 10.1016/j.healun.2004.06.015; Morgan J, 2008, CLIN INFECT DIS, V46, pS242, DOI 10.1086/524747; Nakashima H, 1998, JPN HEART J, V39, P763; Nishii M, 2004, J AM COLL CARDIOL, V44, P1292, DOI 10.1016/j.jacc.2004.01.055; Noutsias M, 2001, CIRCULATION, V104, P275; Ntsekhe M, 2009, NAT CLIN PRACT CARD, V6, P120, DOI 10.1038/ncpcardio1437; Okura Y, 2003, J AM COLL CARDIOL, V41, P322, DOI 10.1016/S0735-1097(02)02715-8; Pages ON, 2009, J THORAC CARDIOV SUR, V137, P194, DOI 10.1016/j.jtcvs.2008.09.051; Park JP, 2009, J AM COLL CARDIOL, V53, pA144; Patel RAG, 2005, J CARDIOVASC MAGN R, V7, P685, DOI 10.1081/JCMR-200065627; Peltomaa R, 2002, ANN RHEUM DIS, V61, P889, DOI 10.1136/ard.61.10.889; Pieroni M, 2009, J AM COLL CARDIOL, V53, P681, DOI 10.1016/j.jacc.2008.11.017; PRIOR P, 1984, BRIT J RHEUMATOL, V23, P92; Pugliese A, 2000, J INFECTION, V40, P282, DOI 10.1053/jinf.2000.0672; Punukollu G, 2007, INT J CARDIOL, V115, P279, DOI 10.1016/j.ijcard.2006.03.004; Reinhartz O, 2005, ASAIO J, V51, P501, DOI 10.1097/01.mat.0000178214.95010.c0; Rezkalla SH, 1996, AM J CARDIOL, V77, P634, DOI 10.1016/S0002-9149(97)89320-4; Saegusa S, 2007, CARDIOVASC DRUG THER, V21, P155, DOI 10.1007/s10557-007-6024-4; Sarda L, 2001, J AM COLL CARDIOL, V37, P786, DOI 10.1016/S0735-1097(00)01201-8; Sendagire H, 2009, AIDS REV, V11, P59; Shi Y, 2010, CIRCULATION, V121, P2624, DOI 10.1161/CIRCULATIONAHA.109.893248; Skouri HN, 2006, J AM COLL CARDIOL, V48, P2085, DOI 10.1016/j.jacc.2006.08.017; Smith SC, 1997, CIRCULATION, V95, P163, DOI 10.1161/01.CIR.95.1.163; Tedeschi A, 2002, J INTERN MED, V251, P169, DOI 10.1046/j.1365-2796.2002.00929.x; Topkara VK, 2006, J THORAC CARDIOV SUR, V131, P1190, DOI 10.1016/j.jtcvs.2005.08.073; Uemura A, 2001, JPN HEART J, V42, P691, DOI 10.1536/jhj.42.691; Ukena C, 2011, EUR J HEART FAIL, V13, P398, DOI 10.1093/eurjhf/hfq229; Wojnicz R, 2001, CIRCULATION, V104, P39, DOI 10.1161/01.CIR.104.1.39; Wu LA, 2003, MYOCARDITIS: FROM BENCH TO BEDSIDE, P437; Xiong DD, 2007, CIRCULATION, V115, P94, DOI 10.1161/CIRCULATIONAHA.106.631093; Yilmaz A, 2008, HEART, V94, P1456, DOI 10.1136/hrt.2007.131383; Yilmaz A, 2010, CIRCULATION, V122, P900, DOI 10.1161/CIRCULATIONAHA.109.924167; Zipes DP, 2006, CIRCULATION, V114, pE385, DOI 10.1161/CIRCULATIONAHA.106.178233	99	390	411	7	76	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 25	2012	379	9817					738	747		10.1016/S0140-6736(11)60648-X	http://dx.doi.org/10.1016/S0140-6736(11)60648-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	899CU	22185868	Green Accepted			2022-12-28	WOS:000300792600030
J	Krishnamurthy, H; Gouaux, E				Krishnamurthy, Harini; Gouaux, Eric			X-ray structures of LeuT in substrate-free outward-open and apo inward-open states	NATURE			English	Article							AMINOBUTYRIC-ACID TRANSPORTER; SEROTONIN TRANSPORTER; DOPAMINE TRANSPORTER; BACTERIAL HOMOLOG; MEMBRANE-TRANSPORT; PERMEATION PATHWAY; ALTERNATING ACCESS; PROTEIN-STRUCTURE; CRYSTAL-STRUCTURE; SODIUM SYMPORTER	Neurotransmitter sodium symporters are integral membrane proteins that remove chemical transmitters from the synapse and terminate neurotransmission mediated by serotonin, dopamine, noradrenaline, glycine and GABA (gamma-aminobutyric acid). Crystal structures of the bacterial homologue, LeuT, in substrate-bound outward-occluded and competitive inhibitor-bound outward-facing states have advanced our mechanistic understanding of neurotransmitter sodium symporters but have left fundamental questions unanswered. Here we report crystal structures of LeuT mutants in complexes with conformation-specific antibody fragments in the outward-open and inward-open states. In the absence of substrate but in the presence of sodium the transporter is outward-open, illustrating how the binding of substrate closes the extracellular gate through local conformational changes: hinge-bending movements of the extracellular halves of transmembrane domains 1, 2 and 6, together with translation of extracellular loop 4. The inward-open conformation, by contrast, involves large-scale conformational changes, including a reorientation of transmembrane domains 1, 2, 5, 6 and 7, a marked hinge bending of transmembrane domain 1a and occlusion of the extracellular vestibule by extracellular loop 4. These changes close the extracellular gate, open an intracellular vestibule, and largely disrupt the two sodium sites, thus providing a mechanism by which ions and substrate are released to the cytoplasm. The new structures establish a structural framework for the mechanism of neurotransmitter sodium symporters and their modulation by therapeutic and illicit substances.	[Krishnamurthy, Harini; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019	Gouaux, Eric/0000-0002-8549-2360	National Institutes of Health; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH070039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank D. Cawley for monoclonal antibody production, L. Vaskalis for help with illustrations and the staff at the Advanced Photon Source beamline 24-ID-E and at the Advanced Light Source beamline 5.0.2 for their assistance with X-ray data collection and processing. We are grateful to E. Haddadian, T. Sosnick and K. Freed for assistance in refining the backbone torsional and side-chain angles using their unpublished TOP algorithm. We thank all Gouaux laboratory members, especially C. Piscitelli and S. K. Singh, for discussions and helpful suggestions throughout the project. This work was supported by the National Institutes of Health. E. G. is an investigator with the Howard Hughes Medical Institute.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Amara SG, 1998, DRUG ALCOHOL DEPEN, V51, P87, DOI 10.1016/S0376-8716(98)00068-4; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ben-Yona A, 2009, J BIOL CHEM, V284, P9727, DOI 10.1074/jbc.M809423200; Bennett ER, 2000, J BIOL CHEM, V275, P34106, DOI 10.1074/jbc.M004229200; Boudker O, 2010, TRENDS PHARMACOL SCI, V31, P418, DOI 10.1016/j.tips.2010.06.004; Celik L, 2008, BIOPHYS J, V94, P1600, DOI 10.1529/biophysj.107.117580; Chen NH, 2004, J BIOL CHEM, V279, P5508, DOI 10.1074/jbc.M306294200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Claxton DP, 2010, NAT STRUCT MOL BIOL, V17, P822, DOI 10.1038/nsmb.1854; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Hahn M. K., 2002, Pharmacogenomics Journal, V2, P217, DOI 10.1038/sj.tpj.6500106; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; Henry LK, 2003, J BIOL CHEM, V278, P37052, DOI 10.1074/jbc.M305514200; HERTTING G, 1961, NATURE, V192, P172, DOI 10.1038/192172a0; Hirayama BA, 2001, BRIT J PHARMACOL, V134, P484, DOI 10.1038/sj.bjp.0704274; Jacobs MT, 2007, J BIOL CHEM, V282, P29441, DOI 10.1074/jbc.M704456200; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Klimek V, 1997, J NEUROSCI, V17, P8451; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Kopp J, 2006, NUCLEIC ACIDS RES, V34, pD315, DOI 10.1093/nar/gkj056; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Loland CJ, 2004, J BIOL CHEM, V279, P3228, DOI 10.1074/jbc.M304755200; Loland CJ, 2002, P NATL ACAD SCI USA, V99, P1683, DOI 10.1073/pnas.032386299; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MITCHELL P, 1957, NATURE, V180, P134, DOI 10.1038/180134a0; Mitchell SM, 2004, J BIOL CHEM, V279, P24089, DOI 10.1074/jbc.M311173200; Nelson N, 1998, J NEUROCHEM, V71, P1785; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; PANTANOWITZ S, 1993, J BIOL CHEM, V268, P3222; Piscitelli CL, 2010, NATURE, V468, P1129, DOI 10.1038/nature09581; Quick M, 2006, J BIOL CHEM, V281, P26444, DOI 10.1074/jbc.M602438200; Richerson GB, 2004, ADV EXP MED BIOL, V548, P76; Rosenberg A, 2008, J BIOL CHEM, V283, P14376, DOI 10.1074/jbc.M801093200; Rudnick G, 2011, BIOCHEMISTRY-US, V50, P7462, DOI 10.1021/bi200926b; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Shaikh SA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000905; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Shi L, 2010, BIOPHYS J, V99, pL103, DOI 10.1016/j.bpj.2010.10.003; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Smicun Y, 1999, J BIOL CHEM, V274, P36058, DOI 10.1074/jbc.274.51.36058; Tao Z, 2009, J BIOL CHEM, V284, P33807, DOI 10.1074/jbc.M109.071977; Terwilliger TC, 2004, ACTA CRYSTALLOGR D, V60, P2144, DOI 10.1107/S0907444904019535; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zhao YF, 2011, NATURE, V474, P109, DOI 10.1038/nature09971; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602; Zomot E, 2003, J BIOL CHEM, V278, P42950, DOI 10.1074/jbc.M209307200	61	376	378	1	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2012	481	7382					469	U80		10.1038/nature10737	http://dx.doi.org/10.1038/nature10737			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881GY	22230955	Green Accepted			2022-12-28	WOS:000299471800032
J	Steinhauser, ML; Bailey, AP; Senyo, SE; Guillermier, C; Perlstein, TS; Gould, AP; Lee, RT; Lechene, CP				Steinhauser, Matthew L.; Bailey, Andrew P.; Senyo, Samuel E.; Guillermier, Christelle; Perlstein, Todd S.; Gould, Alex P.; Lee, Richard T.; Lechene, Claude P.			Multi-isotope imaging mass spectrometry quantifies stem cell division and metabolism	NATURE			English	Article							SMALL-INTESTINE; SEGREGATION; TELOMERASE; DNA; PROTECT; STRANDS; GENOME; CRYPT	Mass spectrometry with stable isotope labels has been seminal in discovering the dynamic state of living matter(1,2), but is limited to bulk tissues or cells. We developed multi-isotope imaging mass spectrometry (MIMS) that allowed us to view and measure stable isotope incorporation with submicrometre resolution(3,4). Here we apply MIMS to diverse organisms, including Drosophila, mice and humans. We test the 'immortal strand hypothesis', which predicts that during asymmetric stem cell division chromosomes containing older template DNA are segregated to the daughter destined to remain a stem cell, thus insuring lifetime genetic stability. After labelling mice with N-15-thymidine from gestation until post-natal week 8, we find no N-15 label retention by dividing small intestinal crypt cells after a four-week chase. In adult mice administered N-15-thymidine pulse-chase, we find that proliferating crypt cells dilute the N-15 label, consistent with random strand segregation. We demonstrate the broad utility of MIMS with proof-of-principle studies of lipid turnover in Drosophila and translation to the human haematopoietic system. These studies show that MIMS provides high-resolution quantification of stable isotope labels that cannot be obtained using other techniques and that is broadly applicable to biological and medical research.	[Steinhauser, Matthew L.; Senyo, Samuel E.; Guillermier, Christelle; Perlstein, Todd S.; Lee, Richard T.; Lechene, Claude P.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Steinhauser, Matthew L.; Senyo, Samuel E.; Perlstein, Todd S.; Lee, Richard T.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, Boston, MA 02115 USA; [Bailey, Andrew P.; Gould, Alex P.] Natl Inst Med Res, Div Physiol & Metab, MRC, London NW7 1AA, England; [Guillermier, Christelle; Lechene, Claude P.] Natl Resource Imaging Mass Spect, Cambridge, MA 02139 USA; [Guillermier, Christelle; Lechene, Claude P.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Lee, Richard T.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; MRC National Institute for Medical Research; Harvard University; Brigham & Women's Hospital; Harvard University	Lechene, CP (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	cpl@harvard.edu	Gould, Alex/M-5353-2019; Steinhauser, Matthew L./GVT-6393-2022; Gould, Alex/A-7479-2010	Gould, Alex/0000-0002-6875-6985; Steinhauser, Matthew L./0000-0001-5287-9246; Gould, Alex/0000-0002-6875-6985; Lee, Richard/0000-0003-4687-1381; Senyo, Samuel/0000-0002-9206-6845; Bailey, Andrew/0000-0003-2143-1689	American Heart Association; Future Leaders in Cardiovascular Medicine; Medical Research Council [U117584237]; National Institutes of Health [AG032977, EB001974, AG034641]; Harvard Stem Cell Institute; Ellison Medical Foundation; Human Frontier Science Program; MRC [MC_U117584237] Funding Source: UKRI; Medical Research Council [MC_U117584237] Funding Source: researchfish; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001974, P20EB001974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK090147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032977, R21AG034641, R01AG040019] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Future Leaders in Cardiovascular Medicine; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; Ellison Medical Foundation(Lawrence Ellison Foundation); Human Frontier Science Program(Human Frontier Science Program); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank A. Mudge, M. Raff and A. Aperia for critical reading of the manuscript; M. Raff for numerous enlightening discussions; T. Bloom for her strong support at the origin of MIMS development; M. Wang for MIMS analysis; J. Poczatek and Z. Kaufman for MIMS analysis software development; L. Trakimas, C. MacGillivray, S. Clark and E. Hurst for histology; W. Wang for statistics advice. We thank Cambridge Isotope Laboratories for their generous gift of thymidine (<SUP>15</SUP>N<INF>2</INF>, 96-98%). M. L. S. is funded by the American Heart Association and Future Leaders in Cardiovascular Medicine. A. P. G. is funded by the Medical Research Council (U117584237). R. T. L. is funded by the National Institutes of Health (AG032977) and a grant from the Harvard Stem Cell Institute. C. P. L. is funded by the National Institutes of Health (EB001974, AG034641), the Ellison Medical Foundation and the Human Frontier Science Program.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bjerknes M, 1999, GASTROENTEROLOGY, V116, P7, DOI 10.1016/S0016-5085(99)70222-2; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Conboy MJ, 2007, PLOS BIOL, V5, P1120, DOI 10.1371/journal.pbio.0050102; Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Lansdorp PM, 2007, CELL, V129, P1244, DOI 10.1016/j.cell.2007.06.017; LARK KG, 1966, SCIENCE, V154, P1202, DOI 10.1126/science.154.3753.1202; Lechene Claude, 2006, J Biol, V5, P20, DOI 10.1186/jbiol42; Lechene CP, 2007, SCIENCE, V317, P1563, DOI 10.1126/science.1145557; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Pech MF, 2011, EMBO J, V30, P986, DOI 10.1038/emboj.2011.51; Potten CS, 2002, J CELL SCI, V115, P2381; POTTEN CS, 1978, CELL, V15, P899, DOI 10.1016/0092-8674(78)90274-X; Quyn AJ, 2010, CELL STEM CELL, V6, P175, DOI 10.1016/j.stem.2009.12.007; Rando TA, 2007, CELL, V129, P1239, DOI 10.1016/j.cell.2007.06.019; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Schepers AG, 2011, EMBO J, V30, P1104, DOI 10.1038/emboj.2011.26; SCHICK P, 1978, J CELL SCI, V33, P351; Schoenheimer R, 1938, SCIENCE, V87, P221, DOI 10.1126/science.87.2254.221; Schoenheimer R, 1938, SCIENCE, V88, P599, DOI 10.1126/science.88.2295.599; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Sotiropoulou PA, 2008, STEM CELLS, V26, P2964, DOI 10.1634/stemcells.2008-0634; Sturup S, 2008, ANAL BIOANAL CHEM, V390, P541, DOI 10.1007/s00216-007-1638-8; TOTAFURNO J, 1987, BIOPHYS J, V52, P279, DOI 10.1016/S0006-3495(87)83215-0	28	210	215	1	178	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2012	481	7382					516	U131		10.1038/nature10734	http://dx.doi.org/10.1038/nature10734			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881GY	22246326	Green Accepted			2022-12-28	WOS:000299471800042
J	Spence, D				Spence, Des			FROM THE FRONTLINE Out of hours care: a call for continuity	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 11	2012	344								e279	10.1136/bmj.e279	http://dx.doi.org/10.1136/bmj.e279			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	877SI	22236600				2022-12-28	WOS:000299202500007
J	Rajakumar, R; San Mauro, D; Dijkstra, MB; Huang, MH; Wheeler, DE; Hiou-Tim, F; Khila, A; Cournoyea, M; Abouheif, E				Rajakumar, Rajendhran; San Mauro, Diego; Dijkstra, Michiel B.; Huang, Ming H.; Wheeler, Diana E.; Hiou-Tim, Francois; Khila, Abderrahman; Cournoyea, Michael; Abouheif, Ehab			Ancestral Developmental Potential Facilitates Parallel Evolution in Ants	SCIENCE			English	Article							SOLDIER DETERMINATION; WING POLYPHENISM; HYMENOPTERA; CASTE; DEFENSE	Complex worker caste systems have contributed to the evolutionary success of advanced ant societies; however, little is known about the developmental processes underlying their origin and evolution. We combined hormonal manipulation, gene expression, and phylogenetic analyses with field observations to understand how novel worker subcastes evolve. We uncovered an ancestral developmental potential to produce a "supersoldier" subcaste that has been actualized at least two times independently in the hyperdiverse ant genus Pheidole. This potential has been retained and can be environmentally induced throughout the genus. Therefore, the retention and induction of this potential have facilitated the parallel evolution of supersoldiers through a process known as genetic accommodation. The recurrent induction of ancestral developmental potential may facilitate the adaptive and parallel evolution of phenotypes.	[Rajakumar, Rajendhran; San Mauro, Diego; Dijkstra, Michiel B.; Hiou-Tim, Francois; Khila, Abderrahman; Cournoyea, Michael; Abouheif, Ehab] McGill Univ, Dept Biol, 1205 Ave Dr Penfield, Montreal, PQ H3A 1B1, Canada; [Huang, Ming H.; Wheeler, Diana E.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA	McGill University; University of Arizona	Abouheif, E (corresponding author), McGill Univ, Dept Biol, 1205 Ave Dr Penfield, Montreal, PQ H3A 1B1, Canada.	ehab.abouheif@mcgill.ca	San Mauro, Diego/E-7996-2012	San Mauro, Diego/0000-0002-2214-1125; rajakumar, rajendhran/0000-0001-7054-8619; Dijkstra, Michiel/0000-0003-1519-4656; Khila, Abderrahman/0000-0003-0908-483X; Abouheif, Ehab/0000-0001-7651-1737	Natural Sciences and Engineering Research Council; KLI; NSF [0344946]; Arizona Agricultural Experiment Station [ARZT 136321-H3106]	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); KLI; NSF(National Science Foundation (NSF)); Arizona Agricultural Experiment Station	We thank R. Sanwald, R. Johnson, S. Cover, M. Seid, W. Tschinkel, and J. King for help with ant collection or identification; Wellmark for methoprene; and T. Flatt, G. Wray, C. Metzl, S. Jolie, Abouheif lab members, and Konrad Lorenz Institute (KLI) fellows for comments. This work was supported by a Natural Sciences and Engineering Research Council grant and a KLI fellowship to E. A., as well as grants from NSF (0344946) and the Arizona Agricultural Experiment Station (ARZT 136321-H3106) to D. E. W. DNA sequences were deposited in GenBank (accession nos. JN205075 to JN205109).	Abouheif E, 2002, SCIENCE, V297, P249, DOI 10.1126/science.1071468; Armbruster WS, 2009, P NATL ACAD SCI USA, V106, P18085, DOI 10.1073/pnas.0907051106; Bely AE, 2010, P NATL ACAD SCI USA, V107, P1464, DOI 10.1073/pnas.0907931107; Darwin C., 1959, WHATS NEW, V67, P2; DROUAL R, 1983, BEHAV ECOL SOCIOBIOL, V12, P203, DOI 10.1007/BF00290772; GOETSCH W., 1939, ZOOL ANZ, V128, P209; Goetsch W, 1937, NATURWISSENSCHAFTEN, V25, P803, DOI 10.1007/BF01733918; Gregg RE, 1942, ECOLOGY, V23, P295, DOI 10.2307/1930669; Harris MP, 2006, CURR BIOL, V16, P371, DOI 10.1016/j.cub.2005.12.047; Holldobler B., 1990, pi; Holldobler B., 2009, SUPERORGANISM, P522; Huang MH, 2011, INSECT SOC, V58, P539, DOI 10.1007/s00040-011-0176-8; Huang MH, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.0101; Ledon-Rettig CC, 2008, EVOL DEV, V10, P316, DOI 10.1111/j.1525-142X.2008.00240.x; Meyer A., 1999, HOMOLOGY, V22, P141; Moreau CS, 2008, MOL PHYLOGENET EVOL, V48, P224, DOI 10.1016/j.ympev.2008.02.020; PASSERA L, 1979, INSECT SOC, V26, P343, DOI 10.1007/BF02223553; Sameshima SY, 2004, EVOL DEV, V6, P336, DOI 10.1111/j.1525-142X.2004.04041.x; Shbailat SJ, 2010, EVOL DEV, V12, P580, DOI 10.1111/j.1525-142X.2010.00443.x; Stearns S. C., 1994, ACTA PALAEONTOL POL, V38, P215; Stiassny M. L. J., 2003, KEYWORDS CONCEPTS EV, P10; Suzuki Y, 2006, SCIENCE, V311, P650, DOI 10.1126/science.1118888; West-Eberhard Mary Jane, 2003, pi; WHEELER DE, 1983, J INSECT PHYSIOL, V29, P847, DOI 10.1016/0022-1910(83)90151-8; WHEELER DE, 1986, AM NAT, V128, P13, DOI 10.1086/284536; WHEELER DE, 1981, INT J INSECT MORPHOL, V10, P131, DOI 10.1016/S0020-7322(81)80018-9; WHEELER DE, 1981, SCIENCE, V213, P361, DOI 10.1126/science.213.4505.361; Wheeler WM, 1902, SCIENCE, V15, P766, DOI 10.1126/science.15.385.766; WILSON EO, 1953, Q REV BIOL, V28, P136, DOI 10.1086/399512; WILSON EO, 2003, PHEIDOLE NEW WORLD	30	131	134	4	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2012	335	6064					79	82		10.1126/science.1211451	http://dx.doi.org/10.1126/science.1211451			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872YA	22223805				2022-12-28	WOS:000298846200054
J	Skinner, JS; Weinstein, JN; Fisher, ES				Skinner, Jonathan S.; Weinstein, James N.; Fisher, Elliott S.			Withholds to Slow Medicare Spending A Better Deal Than Cuts	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LESSONS		[Skinner, Jonathan S.; Weinstein, James N.; Fisher, Elliott S.] Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH 03766 USA; [Skinner, Jonathan S.] Dartmouth Coll, Dept Econ, Hanover, NH 03755 USA; [Weinstein, James N.] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA; [Fisher, Elliott S.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Med, Hanover, NH 03756 USA	Dartmouth College; Dartmouth College; Dartmouth College; Dartmouth College	Fisher, ES (corresponding author), Dartmouth Inst Hlth Policy & Clin Practice, 35 Centerra Dr, Lebanon, NH 03766 USA.	elliott.s.fisher@dartmouth.edu						Bodenheimer T, 2010, NEW ENGL J MED, V363, P1391, DOI 10.1056/NEJMp1008450; GAWANDE A, 2009, NY TIMES        0813, pA27; HENKE KD, 1994, HEALTH AFFAIR, V13, P7, DOI 10.1377/hlthaff.13.4.7; Lucas FL, 2011, HEALTH AFFAIR, V30, P1569, DOI 10.1377/hlthaff.2010.0210; Ostrom E, 2010, AM ECON REV, V100, P641, DOI 10.1257/aer.100.3.641	5	6	6	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 4	2012	307	1					43	44		10.1001/jama.2011.1946	http://dx.doi.org/10.1001/jama.2011.1946			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	872ET	22215163				2022-12-28	WOS:000298792300019
J	Spence, D				Spence, Des			FROM THE FRONTLINE Lessons from America	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 4	2012	344								d8352	10.1136/bmj.d8352	http://dx.doi.org/10.1136/bmj.d8352			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	874UF	22218101				2022-12-28	WOS:000298982900031
J	Young, C				Young, C.			Plantar Fasciitis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							SHOCK-WAVE THERAPY; BOTULINUM-TOXIN-A; HEEL PAIN; FOOT ORTHOSES; DOUBLE-BLIND; STEROID INJECTION; OVERUSE INJURIES; RISK-FACTORS; SHORT-TERM; DIAGNOSIS											Acevedo JI, 1998, FOOT ANKLE INT, V19, P91, DOI 10.1177/107110079801900207; Aldridge T, 2004, AM FAM PHYSICIAN, V70, P332; Babcock MS, 2005, AM J PHYS MED REHAB, V84, P649, DOI 10.1097/01.phm.0000176339.73591.d7; Baldassin V, 2009, ARCH PHYS MED REHAB, V90, P701, DOI 10.1016/j.apmr.2008.11.002; Barry Lance D, 2002, J Foot Ankle Surg, V41, P221; Bazaz R, 2007, FOOT ANKLE INT, V28, P549, DOI 10.3113/FAI.2007.0549; Berlet GC, 2002, ORTHOPEDICS, V25, P1273; CAVANAGH PR, 1980, J BIOMECH, V13, P397, DOI 10.1016/0021-9290(80)90033-0; Chia JKK, 2009, ANN ACAD MED SINGAP, V38, P869; Cole C, 2005, AM FAM PHYSICIAN, V72, P2237; CRAWFORD F, 2003, CD000416; De Garceau D, 2003, FOOT ANKLE INT, V24, P251, DOI 10.1177/107110070302400309; DiGiovanni BF, 2003, J BONE JOINT SURG AM, V85A, P1270, DOI 10.2106/00004623-200307000-00013; Donley BG, 2007, FOOT ANKLE INT, V28, P20, DOI 10.3113/FAI.2007.0004; Fadale, 1994, J Am Acad Orthop Surg, V2, P133; Flanigan RM, 2007, FOOT ANKLE INT, V28, P815, DOI 10.3113/FAI.2007.0815; Frater C, 2006, J NUCL MED, V47, P1577; Gerdesmeyer L, 2008, AM J SPORT MED, V36, P2100, DOI 10.1177/0363546508324176; Goff JD, 2011, AM FAM PHYSICIAN, V84, P676; Graves R H 3rd, 1994, J Foot Ankle Surg, V33, P475; Gudeman SD, 1997, AM J SPORT MED, V25, P312, DOI 10.1177/036354659702500307; HAAKE M, 2003, BMJ-BRIT MED J, P327; Hogan KA, 2004, FOOT ANKLE INT, V25, P875, DOI 10.1177/107110070402501206; Kane D, 2001, RHEUMATOLOGY, V40, P1002, DOI 10.1093/rheumatology/40.9.1002; Kinoshita M, 2001, J BONE JOINT SURG AM, V83A, P1835, DOI 10.2106/00004623-200112000-00011; Kiter E, 2006, J AM PODIAT MED ASSN, V96, P293, DOI 10.7547/0960293; Knobloch K, 2008, FOOT ANKLE INT, V29, P671, DOI 10.3113/FAI.2008.0671; Kogler GF, 1999, J BONE JOINT SURG AM, V81A, P1403, DOI 10.2106/00004623-199910000-00005; KOGLER GF, 1995, CLIN BIOMECH, V10, P245, DOI 10.1016/0268-0033(95)99802-9; Kogler GF, 1996, CLIN BIOMECH, V11, P243, DOI 10.1016/0268-0033(96)00019-8; Krivickas LS, 1997, SPORTS MED, V24, P132, DOI 10.2165/00007256-199724020-00005; Landorf KB, 2006, ARCH INTERN MED, V166, P1305, DOI 10.1001/archinte.166.12.1305; Landorf KB, 2005, J AM PODIAT MED ASSN, V95, P525, DOI 10.7547/0950525; Lee SY, 2009, PHYS THER SPORT, V10, P12, DOI 10.1016/j.ptsp.2008.09.002; Lee TG, 2007, FOOT ANKLE INT, V28, P984, DOI 10.3113/FAI.2007.0984; Levy JC, 2006, FOOT ANKLE INT, V27, P427, DOI 10.1177/107110070602700607; Maffulli N, 2003, CLIN SPORT MED, V22, P675, DOI 10.1016/S0278-5919(03)00004-8; MAHOWALD S, 2011, AM PODIATR MED ASS, V101, P385; MARTIN RP, 2005, CLIN J SPORT MED, V15, P387; MOSELEY JB, 1995, FOOT ANKLE SPORT, V321; Osborne HR, 2006, J SCI MED SPORT, V9, P231, DOI 10.1016/j.jsams.2006.03.028; Placzek R, 2005, ANN RHEUM DIS, V64, P1659, DOI 10.1136/ard.2005.035840; Pohl MB, 2009, CLIN J SPORT MED, V19, P372, DOI 10.1097/JSM.0b013e3181b8c270; Powell M, 1998, FOOT ANKLE INT, V19, P10, DOI 10.1177/107110079801900103; QUILLEN WS, 1996, ATHLETIC INJURIES RE, P3; Reid DC, 1992, SPORTS INJURY ASSESS, P1131; Riddle D, 2003, J BONE JOINT SURG AM, V85A, P872, DOI 10.2106/00004623-200305000-00015; Riddle DL, 2004, FOOT ANKLE INT, V25, P303, DOI 10.1177/107110070402500505; Rompe JD, 2007, BRIT MED BULL, V81-82, P183, DOI 10.1093/bmb/ldm005; Roos E, 2006, FOOT ANKLE INT, V27, P606, DOI 10.1177/107110070602700807; Sabir N, 2005, J ULTRAS MED, V24, P1041, DOI 10.7863/jum.2005.24.8.1041; Saxena A, 2004, FOOT ANKLE INT, V25, P882, DOI 10.1177/107110070402501207; Seligman DA, 2003, ARCH PHYS MED REHAB, V84, P1564, DOI 10.1016/S0003-9993(03)00363-0; SELLMAN JR, 1994, FOOT ANKLE INT, V15, P376, DOI 10.1177/107110079401500706; Speed CA, 2003, J ORTHOPAED RES, V21, P937, DOI 10.1016/S0736-0266(03)00048-2; Stanley KL, 1998, CLIN SPORT MED, V17, P375, DOI 10.1016/S0278-5919(05)70087-9; Tenforde AS, 2011, PM&R, V3, P125, DOI 10.1016/j.pmrj.2010.09.009; Tomczak R L, 1995, J Foot Ankle Surg, V34, P305; Tong Kuo Bianchini, 2010, Am J Orthop (Belle Mead NJ), V39, P227; Tsai WC, 2006, J CLIN ULTRASOUND, V34, P12, DOI 10.1002/jcu.20177; Wang CJ, 2006, AM J SPORT MED, V34, P592, DOI 10.1177/0363546505281811; Wearing SC, 2006, SPORTS MED, V36, P585, DOI 10.2165/00007256-200636070-00004; Werner RA, 2010, PM&R, V2, P110, DOI 10.1016/j.pmrj.2009.11.012; WOLGIN M, 1994, FOOT ANKLE INT, V15, P97, DOI 10.1177/107110079401500303; YOUNG C, 2011, PLANTAR FASCIITIS; Young CC, 2001, AM FAM PHYSICIAN, V63, P467; Yuan J, 2003, CLIN SPORT MED, V22, P693, DOI 10.1016/S0278-5919(03)00049-8; Yucel I, 2009, ARCH ORTHOP TRAUM SU, V129, P695, DOI 10.1007/s00402-008-0760-1	68	16	16	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 3	2012	156	1	1						ITC1	10.7326/0003-4819-156-1-201201030-01001	http://dx.doi.org/10.7326/0003-4819-156-1-201201030-01001			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	872VK	22213510				2022-12-28	WOS:000298837600026
J	Xi, QR; Wang, ZX; Zaromytidou, AI; Zhang, XHF; Chow-Tsang, LF; Liu, JX; Kim, H; Barlas, A; Manova-Todorova, K; Kaartinen, V; Studer, L; Mark, W; Patel, DJ; Massague, J				Xi, Qiaoran; Wang, Zhanxin; Zaromytidou, Alexia-Ileana; Zhang, Xiang H. -F.; Chow-Tsang, Lai-Fong; Liu, Jing X.; Kim, Hyesoo; Barlas, Afsar; Manova-Todorova, Katia; Kaartinen, Vesa; Studer, Lorenz; Mark, Willie; Patel, Dinshaw J.; Massague, Joan			A Poised Chromatin Platform for TGF-beta Access to Master Regulators	CELL			English	Article							EMBRYONIC STEM-CELLS; PHD FINGER; UBIQUITIN LIGASE; BINDING MODULES; HISTONE H3K4ME3; SMAD4; TRANSCRIPTION; TIF1-GAMMA; CANCER; DIFFERENTIATION	Specific chromatin marks keep master regulators of differentiation silent yet poised for activation by extracellular signals. We report that nodal TGF-beta signals use the poised histone mark H3K9me3 to trigger differentiation of mammalian embryonic stem cells. Nodal receptors induce the formation of companion Smad4-Smad2/3 and TRIM33-Smad2/3 complexes. The PHD-Bromo cassette of TRIM33 facilitates binding of TRIM33-Smad2/3 to H3K9me3 and H3K18ac on the promoters of mesendoderm regulators Gsc and Mixl1. The crystal structure of this cassette, bound to histone H3 peptides, illustrates that PHD recognizes K9me3, and Bromo binds an adjacent K18ac. The interaction between TRIM33Smad2/3 and H3K9me3 displaces the chromatin-compacting factor HP1g, making nodal response elements accessible to Smad4-Smad2/3 for Pol II recruitment. In turn, Smad4 increases K18 acetylation to augment TRIM33-Smad2/3 binding. Thus, nodal effectors use the H3K9me3 mark as a platform to switch master regulators of stem cell differentiation from the poised to the active state.	[Xi, Qiaoran; Zaromytidou, Alexia-Ileana; Zhang, Xiang H. -F.; Chow-Tsang, Lai-Fong; Massague, Joan] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Wang, Zhanxin; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Kim, Hyesoo; Studer, Lorenz] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA; [Kaartinen, Vesa] Univ Michigan, Sch Dent, Ann Arbor, MI 48109 USA; [Massague, Joan] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Michigan System; University of Michigan; Howard Hughes Medical Institute	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA.	massaguj@mskcc.org	Kaartinen, Vesa/AAU-5396-2021; Studer, Lorenz/ABH-1491-2021	Studer, Lorenz/0000-0003-0741-7987; Zhang, Xiang/0000-0002-5674-8670; Kaartinen, Vesa/0000-0002-9432-510X; Massague, Joan/0000-0001-9324-8408	National Cancer Institute; NIH [NS052671, CA34610]; Starr Foundation; NYSTEM; Abby Rockefeller Mauze Trust; Maloris Foundation; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [P30CA008748, R37CA034610, K99CA151293, R01CA034610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052671] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Foundation; NYSTEM; Abby Rockefeller Mauze Trust; Maloris Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank E.J. Robertson, D. Rifkin, and Y. Kang for reagents; W. He, E. P. Papapetrou, S. Acharyya, and C.J. David for helpful discussions; A. Viale for valuable help with microarray analysis; P. Y. Chen, S. Francis, and N. Fan for technical help; and the staff at beamline 24ID-C of the Advanced Photon Source at the Argonne National Laboratory and beamline X25 of the National Synchrotron Light Source at the Brookhaven National Laboratory, for assistance with data collection. Support for the MSKCC Transgenic Mouse Core, Genomics Core, and Molecular Cytology Core was provided by the National Cancer Institute. L. S. is supported by NIH Grant NS052671 as well as funds from the Starr Foundation and from NYSTEM. D.J.P. is supported by funds from the Abby Rockefeller Mauze Trust and the Maloris Foundation, as well as funds from the Leukemia and Lymphoma Society and the Starr Foundation. J.M. is supported by NIH Grant CA34610, and is a Howard Hughes Medical Institute Investigator.	Agricola E, 2011, MOL CELL, V43, P85, DOI 10.1016/j.molcel.2011.05.020; Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Aragon E, 2011, GENE DEV, V25, P1275, DOI 10.1101/gad.2060811; Bai XY, 2010, CELL, V142, P133, DOI 10.1016/j.cell.2010.05.028; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; BLUM M, 1992, CELL, V69, P1097, DOI 10.1016/0092-8674(92)90632-M; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Chu GC, 2004, DEVELOPMENT, V131, P3501, DOI 10.1242/dev.01248; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Dunn NR, 2005, GENE DEV, V19, P152, DOI 10.1101/gad.1243205; Dupont S, 2005, CELL, V121, P87, DOI 10.1016/j.cell.2005.01.033; Flavell RA, 2010, NAT REV IMMUNOL, V10, P554, DOI 10.1038/nri2808; Gomis RR, 2006, P NATL ACAD SCI USA, V103, P12747, DOI 10.1073/pnas.0605333103; Hart AH, 2002, DEVELOPMENT, V129, P3597; Hart AH, 2005, BIOCHEM BIOPH RES CO, V333, P1361, DOI 10.1016/j.bbrc.2005.06.044; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Kwon SH, 2008, MOL CELLS, V26, P217; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Morsut L, 2010, DEVELOPMENT, V137, P2571, DOI 10.1242/dev.053801; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Reissmann E, 2001, GENE DEV, V15, P2010, DOI 10.1101/gad.201801; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Tsai WW, 2010, NATURE, V468, P927, DOI 10.1038/nature09542; Vincent DF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000575; Wang GG, 2009, NATURE, V459, P847, DOI 10.1038/nature08036; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Yeo CY, 2001, MOL CELL, V7, P949, DOI 10.1016/S1097-2765(01)00249-0; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	44	206	212	0	35	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 23	2011	147	7					1511	1524		10.1016/j.cell.2011.11.032	http://dx.doi.org/10.1016/j.cell.2011.11.032			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	866SP	22196728	Green Accepted, Bronze			2022-12-28	WOS:000298403400016
J	Webster, JR				Webster, James R.			Fix It!	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Webster, JR (corresponding author), Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.	j-webster@northwestern.edu							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 21	2011	306	23					2544	2545		10.1001/jama.2011.1825	http://dx.doi.org/10.1001/jama.2011.1825			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	864YQ	22187265				2022-12-28	WOS:000298276800001
J	Grant, RW; Ashburner, JM; Hong, CC; Chang, YC; Barry, MJ; Atlas, SJ				Grant, Richard W.; Ashburner, Jeffrey M.; Hong, Clemens C.; Chang, Yuchiao; Barry, Michael J.; Atlas, Steve J.			Defining Patient Complexity From the Primary Care Physician's Perspective A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-CARE; SATISFACTION; VALIDATION; DISEASE; HEALTH	Background: Patients with complex health needs are increasingly the focus of health system redesign. Objective: To characterize complex patients, as defined by their primary care physicians (PCPs), and to compare this definition with other commonly used algorithms. Design: Cohort study. Setting: 1 hospital-based practice, 4 community health centers, and 7 private practices in a primary care network in the United States. Participants: 40 physicians who reviewed a random sample of 120 of their own patients. Measurements: After excluding patients for whom they were not directly responsible, PCPs indicated which of their patients they considered complex. These patients were characterized, independent predictors of complexity were identified, and PCP-defined complexity was compared with 3 comorbidity-based methods (Charlson score, Higashi score, and a proprietary Centers for Medicare & Medicaid Services algorithm). Results: Physicians identified 1126 of their 4302 eligible patients (26.2%) as complex and assigned a mean of 2.2 domains of complexity per patient (median, 2.0 [interquartile range, 1 to 3]). Mental health and substance use were identified as major issues in younger complex patients, whereas medical decision making and care coordination predominated in older patients (P < 0.001 for trends by decade). Major independent predictors of PCP-defined complexity (P < 0.001) included age (probability of complexity increased from 14.8% to 19.8% with age increasing from 55 to 65 years), poorly controlled diabetes (from 12.7% to 47.6% if hemoglobin A(1c) level >= 9%), use of antipsychotics (from 12.7% to 31.8%), alcohol-related diagnoses (from 12.9% to 27.4%), and inadequate insurance (from 12.5% to 19.2%). Classification agreement for complex patients ranged from 26.2% to 56.0% when PCP assignment was compared with each of the other methods. Limitation: Results may not be generalizable to other primary care settings. Conclusion: Primary care physicians identified approximately one quarter of their patients as complex. Medical, social, and behavioral factors all contributed to PCP-defined complexity. Physician-defined complexity had only modest agreement with 3 comorbidity-based algorithms.	Harvard Univ, Sch Med, Boston, MA USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; [Grant, Richard W.] Kaiser Permanente, Div Res, Oakland, CA 94612 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Kaiser Permanente	Grant, RW (corresponding author), Kaiser Permanente, Div Res, 2101 Webster St,20th Floor, Oakland, CA 94612 USA.	Richard.W.Grant@KP.org; satlas@partners.org		Grant, Richard/0000-0002-6164-8025	Partners Community Healthcare, Inc.	Partners Community Healthcare, Inc.	Grant Support: By the Systems Improvement Grant Program of Partners Community Healthcare, Inc.	Anderson G, 2001, HEALTH AFFAIR, V20, P146, DOI 10.1377/hlthaff.20.6.146; Ash A S, 2001, Health Serv Res, V36, P194; Atlas SJ, 2006, J GEN INTERN MED, V21, P973, DOI 10.1007/BF02743147; Bitton A, 2010, J GEN INTERN MED, V25, P584, DOI 10.1007/s11606-010-1262-8; Bodenheimer T, 2003, JAMA-J AM MED ASSOC, V290, P259, DOI 10.1001/jama.290.2.259; Bodenheimer T, 2010, HEALTH AFFAIR, V29, P799, DOI 10.1377/hlthaff.2010.0026; Bodenheimer T, 2009, HEALTH AFFAIR, V28, P64, DOI 10.1377/hlthaff.28.1.64; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; de Jonge P, 2006, MED CLIN N AM, V90, P679, DOI 10.1016/j.mcna.2006.04.005; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Haas JS, 2000, J GEN INTERN MED, V15, P122, DOI 10.1046/j.1525-1497.2000.02219.x; Higashi T, 2007, NEW ENGL J MED, V356, P2496, DOI 10.1056/NEJMsa066253; Jeffe DB, 2010, ACAD MED, V85, P947, DOI 10.1097/ACM.0b013e3181dbe77d; Katerndahl D, 2009, J AM BOARD FAM MED, V22, P24, DOI 10.3122/jabfm.2009.01.080027; Kerr EA, 2007, J GEN INTERN MED, V22, P1635, DOI 10.1007/s11606-007-0313-2; Ku L, 2011, NEW ENGL J MED, V364, P493, DOI 10.1056/NEJMp1011623; Margolius D, 2010, HEALTH AFFAIR, V29, P779, DOI 10.1377/hlthaff.2010.0045; Peek CJ, 2009, FAM SYST HEALTH, V27, P287, DOI 10.1037/a0018048; Rosen Amy K, 2003, Ann Fam Med, V1, P44, DOI 10.1370/afm.6; Valderas JM, 2009, ANN FAM MED, V7, P357, DOI 10.1370/afm.983; Warshaw G, 2006, GENERATIONS, V30, P5; Weiss KB, 2007, J GEN INTERN MED, V22, P374, DOI 10.1007/s11606-007-0379-x; Werner RM, 2007, J GEN INTERN MED, V22, P1206, DOI 10.1007/s11606-007-0230-4; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269	24	146	146	1	30	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2011	155	12					797	U39		10.7326/0003-4819-155-12-201112200-00001	http://dx.doi.org/10.7326/0003-4819-155-12-201112200-00001			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	864ZU	22184686				2022-12-28	WOS:000298280500013
J	Ruder, TD; Thali, Y; Bucher, M; Cottier, A; Thali, MJ; Hatch, GM				Ruder, Thomas D.; Thali, Yannick; Bucher, Matthias; Cottier, Annie; Thali, Michael J.; Hatch, Gary M.			CHRISTMAS 2011: DIAGNOSIS The writing's on the wall for Sherlock	BRITISH MEDICAL JOURNAL			English	Editorial Material							STATURE; LENGTH		[Ruder, Thomas D.; Bucher, Matthias; Thali, Michael J.] Univ Zurich, Inst Forens Med, CH-8057 Zurich, Switzerland; [Ruder, Thomas D.; Thali, Yannick] Univ Bern, Inst Forens Med, Bern, Switzerland; [Cottier, Annie] Univ Bern, Dept English, Bern, Switzerland; [Hatch, Gary M.] Univ New Mexico, Off Med Investigator, Albuquerque, NM 87131 USA	University of Zurich; University of Bern; University of Bern; University of New Mexico	Ruder, TD (corresponding author), Univ Zurich, Inst Forens Med, Winterthurerstr 190-52, CH-8057 Zurich, Switzerland.	thomas_ruder@hotmail.com		Ruder, Thomas/0000-0002-3110-9143				Conan Doyle A., 2018, STUDY SCARLET AMAZON; Doyle, 1888, STUDY SCARLET; Doyle Arthur Conan, 2001, STUDY SCARLET; Jasuja OP, 1997, FORENSIC SCI INT, V86, P181, DOI 10.1016/S0379-0738(97)00038-8; JASUJA OP, 1993, FORENSIC SCI INT, V61, P1, DOI 10.1016/0379-0738(93)90244-5; Klinger Leslie S., 2005, NEW ANNOTATED SHERLO; WAGNER JE, 2006, SCI SHERLOCK HOLMES	7	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2011	343								d7406	10.1136/bmj.d7406	http://dx.doi.org/10.1136/bmj.d7406			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	868QK	22187185	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000298538200002
J	Scott, G; Vijayan, R; Male, P				Scott, Gregory; Vijayan, Roshan; Male, Pandora			CHRISTMAS 2011: PROFESSIONAL MATTERS Relevance of the expression "obs stable" in nursing observations: retrospective study	BRITISH MEDICAL JOURNAL			English	Editorial Material								Objective To ascertain whether use of the term "obs stable" with respect to the nursing observations is so liberal as to render it meaningless. Design Retrospective study. Setting Three teaching hospitals in London, United Kingdom. Methods We searched progress notes for the current admission of 46 inpatients for entries containing the phrases "obs stable" and "observations stable," and reviewed the nursing observations recorded during the 24 hour period preceding each entry containing at least one phrase. We calculated the frequency of abnormalities and of persistent abnormalities (defined as occurring in every observation) observed during these 24 hour periods, and the range of observation values over a 24 hour period if at least two observations had been recorded. Results We found at least one entry in 36 (78%) progress notes (95% confidence interval 66% to 90%). Observations in the 24 hours preceding an entry included at least one abnormality for 113 (71%) of 159 cases and at least one persistent abnormality for 31 (19%). The most frequently occurring abnormalities were tachypnoea (respiratory rate >= 20 breaths/min) and hypotension (systolic blood pressure <100 mm Hg). An abnormality occurred in the observations immediately preceding an entry in 42% of cases. Mean ranges of observations over 24 hours were within the limits of normal diurnal variation, although we found that some instances of greater than normal variability were described as "stable." Conclusions The expression "obs stable" does not reliably indicate normal observations or variations in observations within physiological limits. Doctors should avoid using the expression altogether or clarify it with further information.	[Scott, Gregory] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, London W12 0HS, England; [Vijayan, Roshan] Imperial Coll Healthcare NHS Trust, St Marys Hosp, London W12 0HS, England; [Male, Pandora] Univ London Imperial Coll Sci Technol & Med, Sch Med, London SW7 2AZ, England	Imperial College London; Imperial College London; Imperial College London	Scott, G (corresponding author), Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, London W12 0HS, England.	gregory.scott99@imperial.ac.uk		Scott, Gregory/0000-0001-8063-5871				ARONSON J, 2006, BMJ-BRIT MED J, V333, P445; Chatterjee MT, 2005, POSTGRAD MED J, V81, P663, DOI 10.1136/pgmj.2004.031872; Heckmann C, 1990, BIOL RHYTHM RES, V21, P198; Horswill M. S., 2010, HUMAN FACTORS RES RE; Jansen JO, 2010, CURR OPIN CRIT CARE, V16, P184, DOI 10.1097/MCC.0b013e328338844e; Javier Rodriguez-Vera F, 2002, J ROY SOC MED, V95, P545; Krauchi K, 2002, CLIN AUTON RES, V12, P147, DOI 10.1007/s10286-002-0043-9; Mann R, 2003, CLIN MED, V3, P329, DOI 10.7861/clinmedicine.3-4-329; MOORMAN PW, 1995, LANCET, V345, P865, DOI 10.1016/S0140-6736(95)93004-3; Nygren E, 1998, LANCET, V352, P1462, DOI 10.1016/S0140-6736(97)08307-4; Parvaiz Muhammad Asad, 2008, Commun Med, V5, P25; Pullen I, 2006, ADV PSYCHIAT TREATME, V12, P280, DOI [DOI 10.1192/APT.12.4.280, 10.1192/apt.12.4.280]; Sheppard JE, 2008, ARCH DIS CHILD, V93, P204, DOI 10.1136/adc.2007.128132; Smolensky MH, 1999, CHRONOBIOL INT, V16, P539, DOI 10.3109/07420529908998728; WHITE KB, 1986, NEW ENGL J MED, V314, P390	15	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2011	343								d7504	10.1136/bmj.d7504	http://dx.doi.org/10.1136/bmj.d7504			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	868QK	22187323	hybrid, Green Published			2022-12-28	WOS:000298538200003
J	Douglas, P; Hill, P				Douglas, Pamela; Hill, Peter			Managing infants who cry excessively in the first few months of life	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PREVALENCE; CHILDHOOD; OUTCOMES		[Douglas, Pamela] UQ Healthcare, Clin Unsettled Babies, Possums, Annerley, Qld 4103, Australia; [Douglas, Pamela] Univ Queensland, Royal Brisbane & Womens Hosp, Discipline Gen Practice, Brisbane, Qld 4029, Australia; [Hill, Peter] Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia	University of Queensland; Royal Brisbane & Women's Hospital; University of Queensland; University of Queensland	Douglas, P (corresponding author), UQ Healthcare, Clin Unsettled Babies, Possums, Annerley, Qld 4103, Australia.	pameladouglas@uq.edu.au	Hill, Peter Stewart/AAL-8053-2020; Hill, Peter/F-2768-2010; Douglas, Pamela/B-3264-2013	Hill, Peter Stewart/0000-0001-7091-5108; Hill, Peter/0000-0001-7091-5108; 	Australian Primary Health Care Research and Development programme; Discipline of General Practice, the University of Queensland; Royal Australian College of General Practitioners Foundation; Bayer Australia	Australian Primary Health Care Research and Development programme; Discipline of General Practice, the University of Queensland(University of Queensland); Royal Australian College of General Practitioners Foundation; Bayer Australia	Both authors have completed the ICMJE uniform disclosure form and declare that PD received funding for this work from the Australian Primary Health Care Research and Development programme; the Discipline of General Practice, the University of Queensland; and the Royal Australian College of General Practitioners Foundation; in 2010, PD received a school based scholarship administered by the Children's Nutrition Research Centre, the University of Queensland, and funded by Bayer Australia, to develop training materials for health professionals dealing with crying babies; no other relationships or activities that could appear to have influenced the submitted work.	Ammaniti M, 2010, INT J EAT DISORDER, V43, P233, DOI 10.1002/eat.20688; Barr RG, 2005, J DEV BEHAV PEDIATR, V26, P14; BARR RG, 1993, J DEV BEHAV PEDIATR, V14, P264; Bernaix LW, 2010, JOGNN-J OBST GYN NEO, V39, P658, DOI 10.1111/j.1552-6909.2010.01184.x; Davies WH, 2006, J FAM PSYCHOL, V20, P409, DOI 10.1037/0893-3200.20.3.409; Douglas PS, 2010, MED J AUSTRALIA, V193, P533, DOI 10.5694/j.1326-5377.2010.tb04039.x; Douglas PS, 2011, ARCH DIS CHILD, V96, P793, DOI 10.1136/adc.2010.199190; EVANS K, 1995, ACTA PAEDIATR, V84, P849, DOI 10.1111/j.1651-2227.1995.tb13777.x; Feldman-Winter L, 2010, PEDIATRICS, V126, P289, DOI 10.1542/peds.2009-3250; Freedman SB, 2009, PEDIATRICS, V123, P841, DOI [10.1542/peds.2008-0113, 10.1542/peds.2008-1570]; Garrison MM, 2000, PEDIATRICS, V106, P184; Hemmi MH, 2011, ARCH DIS CHILD, V96, P622, DOI 10.1136/adc.2010.191312; Hill DJ, 2005, PEDIATRICS, V116, pE709, DOI 10.1542/peds.2005-0147; Howard CR, 2006, BREASTFEED MED, V1, P146, DOI 10.1089/bfm.2006.1.146; Huhtala V, 2003, J PEDIATR GASTR NUTR, V37, P42, DOI 10.1097/00005176-200307000-00007; Jonathan Spergel A M, 2008, J PEDIAT GASTROENTER, V48, P30; Katz Y, 2011, J ALLERGY CLIN IMMUN, V127, P647, DOI 10.1016/j.jaci.2010.12.1105; Lucassen PLBJ, 2000, PEDIATRICS, V106, P1349, DOI 10.1542/peds.106.6.1349; McCallum SM, 2011, J PAEDIATR CHILD H, V47, P818, DOI 10.1111/j.1440-1754.2011.02032.x; Merwat SN, 2009, AM J GASTROENTEROL, V104, P1897, DOI 10.1038/ajg.2009.87; Miller-Loncar C, 2004, ARCH DIS CHILD, V89, P908, DOI 10.1136/adc.2003.033233; Orenstein SR, 2009, J PEDIATR-US, V154, P514, DOI 10.1016/j.jpeds.2008.09.054; Reijneveld SA, 2004, LANCET, V364, P1340, DOI 10.1016/S0140-6736(04)17191-2; Reyna BA, 2009, JOGNN-J OBST GYN NEO, V38, P470, DOI 10.1111/j.1552-6909.2009.01044.x; Savino F, 2010, PEDIATRICS, V126, pE526, DOI 10.1542/peds.2010-0433; Schmid G, 2011, CHILD CARE HLTH DEV, V37, P493, DOI 10.1111/j.1365-2214.2010.01201.x; Schmid G, 2010, ACTA PAEDIATR, V99, P286, DOI 10.1111/j.1651-2227.2009.01572.x; Sherman PM, 2009, AM J GASTROENTEROL, V104, P1278, DOI 10.1038/ajg.2009.129; Smillie CM, 2005, NEWBORN INFANT NURS, V5, P49, DOI 10.1053/j.nainr.2005.02.007; St James-Roberts I, 2006, PEDIATRICS, V117, pE1146, DOI 10.1542/peds.2005-2387; St James-Roberts I, 2011, ARCH DIS CHILD, V96, P340, DOI 10.1136/adc.2010.200204; Urinary tract infection in children, 2007, UR TRACT INF CHILDR; Vik T, 2009, ACTA PAEDIATR, V98, P1344, DOI 10.1111/j.1651-2227.2009.01317.x; Wake M, 2006, PEDIATRICS, V117, P836, DOI 10.1542/peds.2005-0775; Wolke D, 2011, 2011 P 11 INT INF CR	35	39	43	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 15	2011	343								d7772	10.1136/bmj.d7772	http://dx.doi.org/10.1136/bmj.d7772			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	865NR	22174332				2022-12-28	WOS:000298318100002
J	Stepney, R				Stepney, Rob			CHRISTMAS 2011: DEATH'S DOMINION A series of unfortunate events? Morbidity and mortality in a Borsetshire village	BRITISH MEDICAL JOURNAL			English	Editorial Material											Stepney, R (corresponding author), 2 Walcot Farm, Charlbury OX7 3HJ, England.	walcot2@freenetname.co.uk						[Anonymous], 2008, OBSERVER        1116; Crayford T, 1997, BRIT MED J, V315, P1649, DOI 10.1136/bmj.315.7123.1649; Dover S., 1989, BRIT MED J, V299, P1625; Office for National Statistics, 2010, DEATH REG SUMM TABL; Stepney R., 1992, MED MONITOR     0221	5	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 15	2011	343								d7518	10.1136/bmj.d7518	http://dx.doi.org/10.1136/bmj.d7518			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	888WF	22174323				2022-12-28	WOS:000300034600005
J	Kupfer, DJ; Frank, E; Phillips, ML				Kupfer, David J.; Frank, Ellen; Phillips, Mary L.			Major depressive disorder: new clinical, neurobiological, and treatment perspectives	LANCET			English	Article							DEEP BRAIN-STIMULATION; STAR-ASTERISK-D; TRANSCRANIAL MAGNETIC STIMULATION; SEROTONIN REUPTAKE INHIBITORS; SEQUENCED TREATMENT ALTERNATIVES; RANDOMIZED CONTROLLED-TRIAL; GENE PROMOTER POLYMORPHISM; MOOD-REGULATING CIRCUIT; S-ADENOSYL METHIONINE; ANTIDEPRESSANT TREATMENT	In this Seminar we discuss developments from the past 5 years in the diagnosis, neurobiology, and treatment of major depressive disorder. For diagnosis, psychiatric and medical comorbidity have been emphasised as important factors in improving the appropriate assessment and management of depression. Advances in neurobiology have also increased, and we aim to indicate genetic, molecular, and neuroimaging studies that are relevant for assessment and treatment selection of this disorder. Further studies of depression-specific psychotherapies, the continued application of antidepressants, the development of new treatment compounds, and the status of new somatic treatments are also discussed. We address two treatment-related issues: suicide risk with selective serotonin reuptake inhibitors, and the safety of antidepressants in pregnancy. Although clear advances have been made, no fully satisfactory treatments for major depression are available.	[Kupfer, David J.; Frank, Ellen; Phillips, Mary L.] Univ Pittsburgh, Med Ctr, Western Psychiat Inst & Clin, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC	Kupfer, DJ (corresponding author), Univ Pittsburgh, Med Ctr, Western Psychiat Inst & Clin, 3811 OHara St, Pittsburgh, PA 15213 USA.	Kupferdj@upmc.edu	Franzeck, Fabian C/B-5055-2011		National Institute of Mental Health [MH081003, MH065376, MH076971]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081003, R01MH065376, R01MH076971] Funding Source: NIH RePORTER; Medical Research Council [G0801418B] Funding Source: researchfish	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	DK and EF were supported by a grant from the National Institute of Mental Health (MH081003). EF was supported by a grant from the National Institute of Mental Health (MH065376). MP was supported by a grant from the National Institute of Mental Health (MH076971). We thank Tanya Fabian, Jessica Levenson, and Meredith Lotz for their assistance with the literature search for the section about advances in treatment.	Aan het Rot M, 2010, BIOL PSYCHIAT, V67, P139, DOI DOI 10.1016/J.BIOPSYCH.2009.08.038; Akiskal HS., 2000, BIPOLAR DISORDERS 10, P37; Almeida JRC, 2010, BIOL PSYCHIAT, V67, P414, DOI 10.1016/j.biopsych.2009.09.027; American Psychiatric Association, 2010, PRACT GUID TREATM PA; Anand A, 2005, NEUROPSYCHOPHARMACOL, V30, P1334, DOI 10.1038/sj.npp.1300725; Anand A, 2007, J NEUROPSYCH CLIN N, V19, P274, DOI 10.1176/appi.neuropsych.19.3.274; Bauer M, 2010, NEUROPSYCHOBIOLOGY, V62, P36, DOI 10.1159/000314308; Baune BT, 2008, NEUROPSYCHOPHARMACOL, V33, P924, DOI 10.1038/sj.npp.1301462; Baune BT, 2010, BIOL PSYCHIAT, V67, P543, DOI 10.1016/j.biopsych.2009.11.004; Beesdo K, 2007, ARCH GEN PSYCHIAT, V64, P903, DOI 10.1001/archpsyc.64.8.903; Bell AC, 2009, CLIN PSYCHOL REV, V29, P348, DOI 10.1016/j.cpr.2009.02.003; Benazzi F, 2007, LANCET, V369, P935, DOI 10.1016/S0140-6736(07)60453-X; Bertolino A, 2005, BIOL PSYCHIAT, V57, P1517, DOI 10.1016/j.biopsych.2005.02.031; Bewernick BH, 2010, BIOL PSYCHIAT, V67, P110, DOI 10.1016/j.biopsych.2009.09.013; Binder EB, 2009, PSYCHONEUROENDOCRINO, V34, P99, DOI 10.1016/j.psyneuen.2009.05.021; Binder EB, 2004, NAT GENET, V36, P1319, DOI 10.1038/ng1479; Binder EB, 2010, ARCH GEN PSYCHIAT, V67, P369, DOI 10.1001/archgenpsychiatry.2010.18; Blumberg HP, 2008, BIOL PSYCHIAT, V64, P901, DOI 10.1016/j.biopsych.2008.07.003; Bortolotti B, 2008, GEN HOSP PSYCHIAT, V30, P293, DOI 10.1016/j.genhosppsych.2008.04.001; Brunoni AR, 2008, INT J NEUROPSYCHOPH, V11, P1169, DOI 10.1017/S1461145708009309; Brustolim D, 2006, INT IMMUNOPHARMACOL, V6, P903, DOI 10.1016/j.intimp.2005.12.007; Bschor T, 2010, ACTA PSYCHIAT SCAND, V121, P174, DOI 10.1111/j.1600-0447.2009.01458.x; Campayo A, 2010, AM J PSYCHIAT, V167, P580, DOI 10.1176/appi.ajp.2009.09010038; de Almeida JRC, 2009, BIOL PSYCHIAT, V66, P451, DOI 10.1016/j.biopsych.2009.03.024; Cassano GB, 2004, AM J PSYCHIAT, V161, P1264, DOI 10.1176/appi.ajp.161.7.1264; Connolly KR, 2011, DRUGS, V71, P43, DOI 10.2165/11587620-000000000-00000; Craddock RC, 2009, MAGN RESON MED, V62, P1619, DOI 10.1002/mrm.22159; Cuijpers P, 2009, J CLIN PSYCHIAT, V70, P1219, DOI 10.4088/JCP.09r05021; Cuijpers P, 2008, J CLIN PSYCHIAT, V69, P1675, DOI 10.4088/JCP.v69n1102; Dannlowski U, 2007, J PSYCHIATR NEUROSCI, V32, P423; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Das-Munshi J, 2008, BRIT J PSYCHIAT, V192, P171, DOI 10.1192/bjp.bp.107.036707; Dell'Osso B, 2009, WORLD J BIOL PSYCHIA, V10, P673, DOI 10.1080/15622970701806192; Dillon DG, 2010, HUM BRAIN MAPP, V31, P210, DOI 10.1002/hbm.20858; Dotson VM, 2009, J PSYCHIATR NEUROSCI, V34, P367; Ebmeier KP, 2006, LANCET, V367, P153, DOI 10.1016/S0140-6736(06)67964-6; Epstein J, 2006, AM J PSYCHIAT, V163, P1784, DOI 10.1176/appi.ajp.163.10.1784; Erickson KI, 2010, J NEUROSCI, V30, P5368, DOI 10.1523/JNEUROSCI.6251-09.2010; Fales CL, 2008, BIOL PSYCHIAT, V63, P377, DOI 10.1016/j.biopsych.2007.06.012; Fan M, 2010, PSYCHIAT GENET, V20, P1, DOI 10.1097/YPG.0b013e3283351112; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P683, DOI 10.1002/hbm.20426; Forbes EE, 2009, AM J PSYCHIAT, V166, P64, DOI 10.1176/appi.ajp.2008.07081336; Frank E, 2007, AM J PSYCHIAT, V164, P761, DOI 10.1176/appi.ajp.164.5.761; Frasure-Smith N, 2008, ARCH GEN PSYCHIAT, V65, P62, DOI 10.1001/archgenpsychiatry.2007.4; Fu CHY, 2008, BIOL PSYCHIAT, V63, P656, DOI 10.1016/j.biopsych.2007.08.020; Gaiteri C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009970; Gaynes BN, 2009, PSYCHIAT SERV, V60, P1439, DOI 10.1176/ps.2009.60.11.1439; Ghosh A, 2007, EXPERT OPIN INV DRUG, V16, P1999, DOI 10.1517/13543784.16.12.1999; Giacobbe Peter, 2006, Curr Psychiatry Rep, V8, P437, DOI 10.1007/s11920-006-0048-5; Gibbons RD, 2005, ARCH GEN PSYCHIAT, V62, P165, DOI 10.1001/archpsyc.62.2.165; Gibbons RD, 2007, AM J PSYCHIAT, V164, P1044, DOI 10.1176/appi.ajp.164.7.1044; Glassman AH, 2009, ARCH GEN PSYCHIAT, V66, P1022, DOI 10.1001/archgenpsychiatry.2009.121; Goldberg D, 2010, WORLD PSYCHIATRY, V9, P16; Goodwin GM, 2009, J CLIN PSYCHIAT, V70, P1128, DOI 10.4088/JCP.08m04548; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hariri AR, 2005, ARCH GEN PSYCHIAT, V62, P146, DOI 10.1001/archpsyc.62.2.146; Harrison NA, 2009, BIOL PSYCHIAT, V66, P407, DOI 10.1016/j.biopsych.2009.03.015; Heinz A, 2007, BIOL PSYCHIAT, V61, P1011, DOI 10.1016/j.biopsych.2006.08.019; Hollon SD, 2005, ARCH GEN PSYCHIAT, V62, P417, DOI 10.1001/archpsyc.62.4.417; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Horstmann S, 2010, NEUROPSYCHOPHARMACOL, V35, P727, DOI 10.1038/npp.2009.180; Huezo-Diaz P, 2009, BRIT J PSYCHIAT, V195, P30, DOI 10.1192/bjp.bp.108.062521; Ising M, 2007, BIOL PSYCHIAT, V62, P47, DOI 10.1016/j.biopsych.2006.07.039; Joffe RT, 2009, HUM BRAIN MAPP, V30, P1246, DOI 10.1002/hbm.20592; Kato M, 2010, MOL PSYCHIATR, V15, P473, DOI 10.1038/mp.2008.116; Keedwell PA, 2005, BIOL PSYCHIAT, V58, P495, DOI 10.1016/j.biopsych.2005.04.035; Kendler KS, 2009, ARCH GEN PSYCHIAT, V66, P857, DOI 10.1001/archgenpsychiatry.2009.94; Kessler D, 2009, LANCET, V374, P628, DOI 10.1016/S0140-6736(09)61257-5; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kessler RC, 2007, WORLD PSYCHIATRY, V6, P168; Kim DR, 2009, CURR PSYCHIAT REP, V11, P447, DOI 10.1007/s11920-009-0068-z; Kopell BH, 2004, J CLIN NEUROPHYSIOL, V21, P51, DOI 10.1097/00004691-200401000-00007; Kronenberg G, 2009, J PSYCHIATR RES, V43, P1112, DOI 10.1016/j.jpsychires.2009.03.007; Krystal JH, 2010, ARCH GEN PSYCHIAT, V67, P1110, DOI 10.1001/archgenpsychiatry.2010.138; Kuhn J, 2010, DTSCH ARZTEBL INT, V107, P105, DOI 10.3238/arztebl.2010.0105; Laje G, 2007, AM J PSYCHIAT, V164, P1530, DOI 10.1176/appi.ajp.2007.06122018; Lekman M, 2008, BIOL PSYCHIAT, V63, P1103, DOI 10.1016/j.biopsych.2007.10.026; Li LJ, 2007, BRAIN RES, V1168, P124, DOI 10.1016/j.brainres.2007.06.094; Licinio J, 2009, ARCH GEN PSYCHIAT, V66, P488, DOI 10.1001/archgenpsychiatry.2009.38; Lisanby SH, 2009, NEUROPSYCHOPHARMACOL, V34, P522, DOI 10.1038/npp.2008.118; Liu ZC, 2007, NEUROSCI LETT, V414, P155, DOI 10.1016/j.neulet.2006.12.013; Lozano AM, 2008, BIOL PSYCHIAT, V64, P461, DOI 10.1016/j.biopsych.2008.05.034; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Luty SE, 2007, BRIT J PSYCHIAT, V190, P496, DOI 10.1192/bjp.bp.106.024729; Lyketsos CG, 2010, AM J PSYCHIAT, V167, P496, DOI 10.1176/appi.ajp.2010.10020243; Malone DA, 2009, BIOL PSYCHIAT, V65, P267, DOI 10.1016/j.biopsych.2008.08.029; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; McMahon FJ, 2006, AM J HUM GENET, V78, P804, DOI 10.1086/503820; Medicine and Healthcare Products Regulatory Agency, MHRA UPD RISKS BIRTH; Meyers BS, 2009, ARCH GEN PSYCHIAT, V66, P838, DOI 10.1001/archgenpsychiatry.2009.79; Michels R, 2010, AM J PSYCHIAT, V167, P487, DOI 10.1176/appi.ajp.2010.10020172; Mitchell AJ, 2009, LANCET, V374, P609, DOI 10.1016/S0140-6736(09)60879-5; Mitka M, 2008, JAMA-J AM MED ASSOC, V300, P2356, DOI 10.1001/jama.2008.622; Moffitt TE, 2007, ARCH GEN PSYCHIAT, V64, P651, DOI 10.1001/archpsyc.64.6.651; Moses-Kolko EL, 2005, JAMA-J AM MED ASSOC, V293, P2372, DOI 10.1001/jama.293.19.2372; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Murphy GM, 2004, ARCH GEN PSYCHIAT, V61, P1163, DOI 10.1001/archpsyc.61.11.1163; Nelson JC, 2010, AM J PSYCHIAT, V167, P889, DOI 10.1176/appi.ajp.2010.10040627; Olfson M, 2008, J CLIN PSYCHIAT, V69, P425, DOI 10.4088/JCP.v69n0313; Olfson M, 2006, ARCH GEN PSYCHIAT, V63, P865, DOI 10.1001/archpsyc.63.8.865; Olfson M, 2009, ARCH GEN PSYCHIAT, V66, P848, DOI 10.1001/archgenpsychiatry.2009.81; Olie JP, 2007, INT J NEUROPSYCHOPH, V10, P661, DOI 10.1017/S1461145707007766; Paddock S, 2007, AM J PSYCHIAT, V164, P1181, DOI 10.1176/appi.ajp.2007.06111790; Papakostas GI, 2007, J CLIN PSYCHIAT, V68, P826, DOI 10.4088/JCP.v68n0602; Papakostas GI, 2010, AM J PSYCHIAT, V167, P942, DOI 10.1176/appi.ajp.2009.09081198; Perlis RH, 2008, NEUROPSYCHOPHARMACOL, V33, P2810, DOI 10.1038/npp.2008.6; Perlis RH, 2009, NEUROPSYCHOPHARMACOL, V34, P1819, DOI 10.1038/npp.2009.4; Perlis RH, 2009, BIOL PSYCHIAT, V65, P785, DOI 10.1016/j.biopsych.2008.10.002; Pezawas L, 2008, MOL PSYCHIATR, V13, P709, DOI 10.1038/mp.2008.32; Phillips M, 2008, MOL PSYCHIATR, V13, P833, DOI 10.1038/mp.2008.65; Pizzagalli DA, 2011, NEUROPSYCHOPHARMACOL, V36, P183, DOI 10.1038/npp.2010.166; Pizzagalli DA, 2009, AM J PSYCHIAT, V166, P702, DOI 10.1176/appi.ajp.2008.08081201; Raison CL, 2009, BIOL PSYCHIAT, V65, P296, DOI 10.1016/j.biopsych.2008.08.010; Rajkowska G, 2007, NEUROPSYCHOPHARMACOL, V32, P471, DOI 10.1038/sj.npp.1301234; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Rush AJ, 2010, AM J PSYCHIAT, V167, P241, DOI 10.1176/appi.ajp.2009.09121768; Rush AJ, 2004, CONTROL CLIN TRIALS, V25, P119, DOI 10.1016/S0197-2456(03)00112-0; Salvadore G, 2010, NEUROPSYCHOPHARMACOL, V35, P1415, DOI 10.1038/npp.2010.24; Schlaepfer TE, 2008, NEUROPSYCHOPHARMACOL, V33, P368, DOI 10.1038/sj.npp.1301408; Schneck CD, 2009, AM J PSYCHIAT, V166, P127, DOI 10.1176/appi.ajp.2008.08111669; Schramm E, 2007, AM J PSYCHIAT, V164, P768, DOI 10.1176/appi.ajp.164.5.768; Schreuders B, 2007, BRIT J GEN PRACT, V57, P886, DOI 10.3399/096016407782317829; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; Sen S, 2008, BIOL PSYCHIAT, V64, P527, DOI 10.1016/j.biopsych.2008.05.005; Serretti A, 2007, MOL PSYCHIATR, V12, P247, DOI 10.1038/sj.mp.4001926; Shyn SI, 2010, PSYCHIAT CLIN N AM, V33, P125, DOI 10.1016/j.psc.2009.10.004; Siegle GJ, 2006, AM J PSYCHIAT, V163, P735, DOI 10.1176/appi.ajp.163.4.735; Simon GE, 2009, ARCH GEN PSYCHIAT, V66, P1081, DOI 10.1001/archgenpsychiatry.2009.123; Slotema CW, 2010, J CLIN PSYCHIAT, V71, P873, DOI 10.4088/JCP.08m04872gre; Soliman F, 2010, SCIENCE, V327, P863, DOI 10.1126/science.1181886; Stahl SM, 2010, J CLIN PSYCHIAT, V71, P616, DOI 10.4088/JCP.09m05471blu; Surguladze S, 2005, BIOL PSYCHIAT, V57, P201, DOI 10.1016/j.biopsych.2004.10.028; Thase ME, 2007, AM J PSYCHIAT, V164, P739, DOI 10.1176/appi.ajp.164.5.739; Thombs BD, 2008, JAMA-J AM MED ASSOC, V300, P2161, DOI 10.1001/jama.2008.667; Tomba E, J CONT PSYCHO, V39, P101; Tsunoka T, 2009, PROG NEURO-PSYCHOPH, V33, P875, DOI 10.1016/j.pnpbp.2009.04.007; Tuccori M, 2009, CLIN THER, V31, P1426, DOI 10.1016/j.clinthera.2009.07.009; Tyrer P, 2009, LANCET, V374, P589, DOI 10.1016/S0140-6736(09)61156-9; Uher R, 2009, MOL PSYCHIATR, V14, P1072, DOI 10.1038/mp.2009.85; Uher R, 2010, AM J PSYCHIAT, V167, P555, DOI 10.1176/appi.ajp.2009.09070932; US Food and Drug Administration, PUBL HLTH ADV PAR; van Rossum EFC, 2006, BIOL PSYCHIAT, V59, P681, DOI 10.1016/j.biopsych.2006.02.007; Versace A, 2010, BIOL PSYCHIAT, V68, P560, DOI 10.1016/j.biopsych.2010.04.036; Vittengl JR, 2009, J CONSULT CLIN PSYCH, V77, P367, DOI 10.1037/a0015238; Ward HE, 2010, NEUROBIOL DIS, V38, P346, DOI 10.1016/j.nbd.2010.01.011; Wijkstra J, 2010, ACTA PSYCHIAT SCAND, V121, P190, DOI 10.1111/j.1600-0447.2009.01464.x; Wilkie MJV, 2009, PHARMACOGENOMICS J, V9, P61, DOI 10.1038/sj.tpj.6500491; Wisner KL, 2009, AM J PSYCHIAT, V166, P557, DOI 10.1176/appi.ajp.2008.08081170; Wolf NJ, 2008, CLIN PSYCHOL REV, V28, P131, DOI 10.1016/j.cpr.2007.04.004; Yoon HK, 2010, PROG NEURO-PSYCHOPH, V34, P331, DOI 10.1016/j.pnpbp.2009.12.009; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856; Zobel A, 2008, AM J MED GENET B, V147B, P836, DOI 10.1002/ajmg.b.30709	153	530	575	15	193	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 17	2012	379	9820					1045	1055		10.1016/S0140-6736(11)60602-8	http://dx.doi.org/10.1016/S0140-6736(11)60602-8			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	911JE	22189047	Green Accepted			2022-12-28	WOS:000301712300033
J	Rosenbaum, S; Jost, TS				Rosenbaum, Sara; Jost, Timothy Stoltzfus			All Heat, No Light - The States' Medicaid Claims before the Supreme Court	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rosenbaum, Sara] George Washington Univ, Dept Hlth Policy, Sch Publ Hlth & Hlth Serv, Washington, DC 20052 USA; [Jost, Timothy Stoltzfus] Washington & Lee Univ, Sch Law, Lexington, VA 24450 USA	George Washington University; Washington & Lee University	Rosenbaum, S (corresponding author), George Washington Univ, Dept Hlth Policy, Sch Publ Hlth & Hlth Serv, Washington, DC 20052 USA.							Cohen IG, 2012, NEW ENGL J MED, V366, P103, DOI 10.1056/NEJMp1113416	1	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 9	2012	366	6					487	489		10.1056/NEJMp1114480	http://dx.doi.org/10.1056/NEJMp1114480			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	888GH	22236195				2022-12-28	WOS:000299991300003
J	Steinbrook, R				Steinbrook, Robert			Science, Politics, and Over-the-Counter Emergency Contraception	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FDA		Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA	Yale University	Steinbrook, R (corresponding author), Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St,I-456 SHM,POB 208008, New Haven, CT 06520 USA.	rsteinbrook@attglobal.net						Abma Joyce C, 2010, Vital Health Stat 23, P1; [Anonymous], 2011, STATEMENT FDA COMMIS; [Anonymous], 2011, KATHLEEN SEBELIUS MA; [Anonymous], 2011, NEW GOVT DATA FINDS; Eaton Danice K., 2010, Morbidity and Mortality Weekly Report, V59, P1; Hamburg MA, 2009, NEW ENGL J MED, V360, P2493, DOI 10.1056/NEJMp0903764; Hamilton B. E., 2011, BIRTHS PRELIMINARY D; Raymond EG, 2009, CONTRACEPTION, V79, P199, DOI 10.1016/j.contraception.2008.09.004; Steinbrook R, 2004, NEW ENGL J MED, V350, P2327, DOI 10.1056/NEJMp048135; Steinbrook R, 2004, NEW ENGL J MED, V350, P1454, DOI 10.1056/NEJMhpr033416	10	7	7	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 25	2012	307	4					365	366		10.1001/jama.2011.1957	http://dx.doi.org/10.1001/jama.2011.1957			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	881EP	22182592				2022-12-28	WOS:000299464000019
J	Hawkes, N				Hawkes, Nigel			BODY POLITIC Faith, hype, and charity	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						2011, BRIT MED J, V343, DOI DOI 10.1136/BMJ.D7802	1	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 11	2012	344								e317	10.1136/bmj.e317	http://dx.doi.org/10.1136/bmj.e317			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	877SI	22236601				2022-12-28	WOS:000299202500010
J	Kirby, T				Kirby, Tony			Profile Louisa Degenhardt: hooked on addiction research	LANCET			English	Biographical-Item																		DEGENHARDT L, PUBLICATION LIST	1	1	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 7	2012	379	9810					21	21		10.1016/S0140-6736(12)60010-5	http://dx.doi.org/10.1016/S0140-6736(12)60010-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	873WC	22225658				2022-12-28	WOS:000298913000019
J	Bodurtha, J; Strauss, JF				Bodurtha, Joann; Strauss, Jerome F., III			Genomics and Perinatal Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PREIMPLANTATION GENETIC DIAGNOSIS; NONINVASIVE PRENATAL DETECTION; FREE FETAL DNA; HEALTH-CARE; ANEUPLOIDY; PRECONCEPTION; RNA		[Strauss, Jerome F., III] Virginia Commonwealth Univ, Dept Obstet & Gynecol, Richmond, VA 23298 USA; [Bodurtha, Joann] Johns Hopkins Med Inst, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA	Virginia Commonwealth University; Johns Hopkins University; Johns Hopkins Medicine	Strauss, JF (corresponding author), Virginia Commonwealth Univ, Dept Obstet & Gynecol, 1101 E Marshall St, Richmond, VA 23298 USA.	jfstrauss@vcu.edu			NCI NIH HHS [P30 CA006973] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ACOG Committee on Obstetrics, 2007, Obstet Gynecol, V109, P229; ACOG Committee on Practice Bulletins, 2007, Obstet Gynecol, V109, P217; Alfarawati S, 2011, HUM REPROD, V26, P1560, DOI 10.1093/humrep/der068; Amer Soc Reprod Med, 2008, FERTIL STERIL, V90, pS45, DOI 10.1016/j.fertnstert.2008.08.099; American College of Medicine Genetics Board of Directors, 2004, Genet Med, V6, P60; American College of Obstetricians and Gynecologists Committee on Genetics, 2006, Obstet Gynecol, V107, P1483; Anderson Richard A, 2008, Hum Fertil (Camb), V11, P71, DOI 10.1080/14647270802041607; Anderson SA, 2011, PM&R, V3, P168, DOI 10.1016/j.pmrj.2010.12.017; [Anonymous], 2011, Obstet Gynecol, V117, P1028, DOI 10.1097/AOG.0b013e31821922c2; [Anonymous], 2009, Obstet Gynecol, V113, P1194, DOI 10.1097/AOG.0b013e3181a6d03a; [Anonymous], 2011, Obstet Gynecol, V117, P747, DOI 10.1097/AOG.0b013e318214780e; [Anonymous], 2009, Obstet Gynecol, V114, P950, DOI 10.1097/AOG.0b013e3181bd12f4; [Anonymous], 2009, Obstet Gynecol, V114, P1161, DOI 10.1097/AOG.0b013e3181c33cad; [Anonymous], 2011, REC UN SCREEN PAN; [Anonymous], 2011, SUMM MOL CLIN GEN PA; [Anonymous], 2010, FAM HIST PREN CAR WO; [Anonymous], 2008, GEN SERV POL PROJ FI; Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Bombard Y, 2010, EUR J HUM GENET, V18, P751, DOI 10.1038/ejhg.2010.13; Borry P, 2011, HUM REPROD, V26, P972, DOI 10.1093/humrep/der042; Bredenoord A, 2009, EUR J HUM GENET, V17, P1550, DOI 10.1038/ejhg.2009.88; Broussard DL, 2011, MATERN CHILD HLTH J, V15, P158, DOI 10.1007/s10995-010-0575-x; Chiu RWK, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7401; Committee on Genetics American College of Obstetricians and Gynecologists, 2008, Obstet Gynecol, V111, P1493, DOI 10.1097/AOG.0b013e31817d250e; Cooper AR, 2010, CLIN LAB MED, V30, P519, DOI 10.1016/j.cll.2010.04.008; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; de Jong A, 2011, NAT REV GENET, V12, P657, DOI 10.1038/nrg3036; Devaney SA, 2011, JAMA-J AM MED ASSOC, V306, P627, DOI 10.1001/jama.2011.1114; Driscoll DA, 2009, GENET MED, V11, P818, DOI 10.1097/GIM.0b013e3181bb267b; Ehrich M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.060; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Feero WG, 2011, JAMA-J AM MED ASSOC, V306, P989, DOI 10.1001/jama.2011.1245; Foster MW, 2009, GENET MED, V11, P570, DOI 10.1097/GIM.0b013e3181a2743e; Geraedts JPM, 2009, CLIN GENET, V76, P315, DOI 10.1111/j.1399-0004.2009.01273.x; Go ATJI, 2011, HUM REPROD UPDATE, V17, P372, DOI 10.1093/humupd/dmq054; Green NS, 2007, GENET MED, V9, P792, DOI 10.1097/GIM.0b013e318159a38e; Grody Wayne W., 2001, Genetics in Medicine, V3, P149, DOI 10.1097/00125817-200103000-00010; Harton G, 2011, HUM REPROD, V26, P14, DOI 10.1093/humrep/deq229; Hudson KL, 2011, NEW ENGL J MED, V365, P1033, DOI 10.1056/NEJMra1010517; Jostins L, 2011, HUM MOL GENET, V20, pR182, DOI 10.1093/hmg/ddr378; Kaback MM, 1993, GENEREVIEWS; KIDO S, 1993, GENOMICS, V17, P256, DOI 10.1006/geno.1993.1317; Kuliev A, 2011, MOL HUM REPROD  0214; Lazaros L, 2006, FETAL DIAGN THER, V21, P506, DOI 10.1159/000095662; Levy PA, 2010, J DEV BEHAV PEDIATR, V31, P622, DOI 10.1097/DBP.0b013e3181eedf01; Lipstein EA, 2010, PEDIATRICS, V125, pE1226, DOI 10.1542/peds.2009-1567; Manning M, 2010, GENET MED, V12, P742, DOI 10.1097/GIM.0b013e3181f8baad; Mastenbroek S, 2011, HUM REPROD UPDATE, V17, P454, DOI 10.1093/humupd/dmr003; Munne S, 2009, CURR OPIN OBSTET GYN, V21, P442, DOI 10.1097/GCO.0b013e32832fad73; Murray ABV, 2010, TRENDS GENET, V26, P459, DOI 10.1016/j.tig.2010.08.001; Peters D, 2011, NEW ENGL J MED, V365, P1847, DOI 10.1056/NEJMc1106975; Pletcher BA, 2008, GENET MED, V10, P33, DOI [10.1097/GIM.0b013e31815f6eac, 10.1097/GIM.0b013e31815f247c]; Prior TW, 2008, GENET MED, V10, P340, DOI 10.1097/GIM.0b013e318188d069; Sharp Richard R, 2011, Genet Med, V13, P750, DOI 10.1097/GIM.0b013e318228821f; Sherman S, 2005, GENET MED, V7, P584, DOI 10.1097/01.GIM.0000182468.22666.dd; Spits C, 2009, PRENATAL DIAG, V29, P50, DOI 10.1002/pd.2161; Treff NR, 2010, MOL HUM REPROD, V16, P583, DOI 10.1093/molehr/gaq039; Tsui NBY, 2010, CLIN CHEM, V56, P73, DOI 10.1373/clinchem.2009.132662; Watson MS, 2006, GENET MED, V8, p1S, DOI 10.1097/01.gim.0000223891.82390.ad; Watson Michael S, 2004, Genet Med, V6, P387, DOI 10.1097/01.GIM.0000139506.11694.7C; Watson MS, 2004, GENET MED, V6, P548; Watson MS, 2005, GENET MED, V7, P286; Wright CF, 2009, HUM REPROD UPDATE, V15, P139, DOI 10.1093/humupd/dmn047	64	29	40	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 5	2012	366	1					64	73		10.1056/NEJMra1105043	http://dx.doi.org/10.1056/NEJMra1105043			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	887XY	22216843	Green Accepted			2022-12-28	WOS:000299968800008
J	Hippisley-Cox, J; Coupland, C				Hippisley-Cox, Julia; Coupland, Carol			Identifying women with suspected ovarian cancer in primary care: derivation and validation of algorithm	BMJ-BRITISH MEDICAL JOURNAL			English	Article							WALES PROSPECTIVE DERIVATION; EXTERNAL VALIDATION; CARDIOVASCULAR RISK; EARLY-DIAGNOSIS; ALARM SYMPTOMS; MISSING DATA; ENGLAND; IMPUTATION; SURVIVAL; DISEASE	Objective To derive and validate an algorithm to estimate the absolute risk of having ovarian cancer in women with and without symptoms. Design Cohort study with data from 375 UK QResearch general practices for development and 189 for validation. Participants Women aged 30-84 without a diagnosis of ovarian cancer at baseline and without appetite loss, weight loss, abdominal pain, abdominal distension, rectal bleeding, or postmenopausal bleeding recorded in previous 12 months. Main outcome The primary outcome was incident diagnosis of ovarian cancer recorded in the next two years. Methods Risk factors examined included age, family history of ovarian cancer, previous cancers other than ovarian, body mass index (BMI), smoking, alcohol, deprivation, loss of appetite, weight loss, abdominal pain, abdominal distension, rectal bleeding, postmenopausal bleeding, urinary frequency, diarrhoea, constipation, tiredness, and anaemia. Cox proportional hazards models were used to develop the risk equation. Measures of calibration and discrimination assessed performance in the validation cohort. Results In the derivation cohort there were 976 incident cases of ovarian cancer from 2.03 million person years. Independent predictors were age, family history of ovarian cancer (9.8-fold higher risk), anaemia (2.3-fold higher), abdominal pain (sevenfold higher), abdominal distension (23-fold higher), rectal bleeding (twofold higher), postmenopausal bleeding (6.6-fold higher), appetite loss (5.2-fold higher), and weight loss (twofold higher). On validation, the algorithm explained 57.6% of the variation. The receiver operating characteristics curve (ROC) statistic was 0.84, and the D statistic was 2.38. The 10% of women with the highest predicted risks contained 63% of all ovarian cancers diagnosed over the next two years. Conclusion The algorithm has good discrimination and calibration and, after independent validation in an external cohort, could potentially be used to identify those at highest risk of ovarian cancer to facilitate early referral and investigation. Further research is needed to assess how best to implement the algorithm, its cost effectiveness, and whether, on implementation, it has any impact on health outcomes.	[Hippisley-Cox, Julia; Coupland, Carol] Univ Nottingham, Div Primary Care, Nottingham NG2 7RD, England	University of Nottingham	Hippisley-Cox, J (corresponding author), Univ Nottingham, Div Primary Care, Nottingham NG2 7RD, England.	julia.hippisley-cox@nottingham.ac.uk	Hippisley-Cox, Julia/AAY-2788-2020	Hippisley-Cox, Julia/0000-0002-2479-7283; Coupland, Carol/0000-0002-2327-3306				Abdel-Rahman M, 2009, BRIT J CANCER, V101, pS115, DOI 10.1038/sj.bjc.6605401; Bankhead CR, 2005, BJOG-INT J OBSTET GY, V112, P857, DOI 10.1111/j.1471-0528.2005.00572.x; Collins GS, 2011, DIABETIC MED, V28, P599, DOI 10.1111/j.1464-5491.2011.03237.x; Collins GS, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2442; Collins GS, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2584; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Goff BA, 2004, JAMA-J AM MED ASSOC, V291, P2705, DOI 10.1001/jama.291.22.2705; Hamilton W, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2998; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Hippisley-Cox J, 2011, BR J GEN PR IN PRESS; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Hippisley-Cox J, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X606627; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b880; Hippisley-Cox J, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-49; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4229; HOFFENBERG R, 1989, BRIT MED J, V298, P573; HOSMER DW, 1989, APPL LOGISTIC REGRES; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Jones R, 2007, BMJ-BRIT MED J, V334, P1040, DOI 10.1136/bmj.39171.637106.AE; Jones R, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3094; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; National Institute for Health and Clinical Excellence: Guidance, 2011, OV CANC REC IN MAN O; Richards MA, 2009, BRIT J CANCER, V101, pS1, DOI 10.1038/sj.bjc.6605382; Royston P, 2004, STAT MED, V23, P723, DOI 10.1002/sim.1621; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Royston P, 2006, STATA J, V6, P83, DOI 10.1177/1536867X0600600105; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Rufford BD, 2007, BJOG-INT J OBSTET GY, V114, P59, DOI 10.1111/j.1471-0528.2006.01153.x; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Steyerberg EW, 2007, J CLIN EPIDEMIOL, V60, P979, DOI 10.1016/j.jclinepi.2007.03.003; UK Cancer Research, 2011, STAT OUTL OV CANC	32	35	35	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 4	2012	344								d8009	10.1136/bmj.d8009	http://dx.doi.org/10.1136/bmj.d8009			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874UF	22217630	Green Published, hybrid			2022-12-28	WOS:000298982900010
J	Perren, TJ; Swart, AM; Pfisterer, J; Ledermann, JA; Pujade-Lauraine, E; Kristensen, G; Carey, MS; Beale, P; Cervantes, A; Kurzeder, C; du Bois, A; Sehouli, J; Kimmig, R; Stahle, A; Collinson, F; Essapen, S; Gourley, C; Lortholary, A; Selle, F; Mirza, MR; Leminen, A; Plante, M; Stark, D; Qian, WD; Parmar, MKB; Oza, AM				Perren, Timothy J.; Swart, Ann Marie; Pfisterer, Jacobus; Ledermann, Jonathan A.; Pujade-Lauraine, Eric; Kristensen, Gunnar; Carey, Mark S.; Beale, Philip; Cervantes, Andres; Kurzeder, Christian; du Bois, Andreas; Sehouli, Jalid; Kimmig, Rainer; Staehle, Anne; Collinson, Fiona; Essapen, Sharadah; Gourley, Charlie; Lortholary, Alain; Selle, Frederic; Mirza, Mansoor R.; Leminen, Arto; Plante, Marie; Stark, Dan; Qian, Wendi; Parmar, Mahesh K. B.; Oza, Amit M.		ICON7 Investigators	A Phase 3 Trial of Bevacizumab in Ovarian Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTRAPERITONEAL CISPLATIN; III TRIAL; CARBOPLATIN-PACLITAXEL; 1ST-LINE TREATMENT; INTERGROUP TRIAL; ANGIOGENESIS; CYCLOPHOSPHAMIDE; EXPRESSION; GUIDELINES; TOPOTECAN	BACKGROUND Angiogenesis plays a role in the biology of ovarian cancer. We examined the effect of bevacizumab, the vascular endothelial growth factor inhibitor, on survival in women with this disease. METHODS We randomly assigned women with ovarian cancer to carboplatin (area under the curve, 5 or 6) and paclitaxel (175 mg per square meter of body-surface area), given every 3 weeks for 6 cycles, or to this regimen plus bevacizumab (7.5 mg per kilogram of body weight), given concurrently every 3 weeks for 5 or 6 cycles and continued for 12 additional cycles or until progression of disease. Outcome measures included progression-free survival, first analyzed per protocol and then updated, and interim overall survival. RESULTS A total of 1528 women from 11 countries were randomly assigned to one of the two treatment regimens. Their median age was 57 years; 90% had epithelial ovarian cancer, 69% had a serous histologic type, 9% had high-risk early-stage disease, 30% were at high risk for progression, and 70% had stage IIIC or IV ovarian cancer. Progression-free survival (restricted mean) at 36 months was 20.3 months with standard therapy, as compared with 21.8 months with standard therapy plus bevacizumab (hazard ratio for progression or death with bevacizumab added, 0.81; 95% confidence interval, 0.70 to 0.94; P=0.004 by the log-rank test). Nonproportional hazards were detected (i.e., the treatment effect was not consistent over time on the hazard function scale) (P<0.001), with a maximum effect at 12 months, coinciding with the end of planned bevacizumab treatment and diminishing by 24 months. Bevacizumab was associated with more toxic effects (most often hypertension of grade 2 or higher) (18%, vs. 2% with chemotherapy alone). In the updated analyses, progression-free survival (restricted mean) at 42 months was 22.4 months without bevacizumab versus 24.1 months with bevacizumab (P=0.04 by log-rank test); in patients at high risk for progression, the benefit was greater with bevacizumab than without it, with progression-free survival (restricted mean) at 42 months of 14.5 months with standard therapy alone and 18.1 months with bevacizumab added, with respective median overall survival of 28.8 and 36.6 months. CONCLUSIONS Bevacizumab improved progression-free survival in women with ovarian cancer. The benefits with respect to both progression-free and overall survival were greater among those at high risk for disease progression. (Funded by Roche and others; ICON7 Controlled-Trials.com number, ISRCTN91273375.)	[Perren, Timothy J.; Collinson, Fiona] St James Univ Hosp, St Jamess Inst Oncol, Leeds, W Yorkshire, England; [Stark, Dan] Leeds Inst Mol Med, Leeds, W Yorkshire, England; [Essapen, Sharadah] Royal Surrey Cty Natl Hlth Serv NHS Fdn Trust, St Lukes Canc Ctr, Guildford, Surrey, England; [Qian, Wendi] Cambridge Univ Hosp NHS Fdn Trust, Cambridge Canc Trials Ctr, Cambridge, England; [Swart, Ann Marie; Qian, Wendi; Parmar, Mahesh K. B.] MRC CTU, London WL2B 6NH, England; [Ledermann, Jonathan A.] UCL, Biomed Res Ctr, Univ Coll London Hosp, London WC1E 6BT, England; [Pfisterer, Jacobus] Klin Gynakol & Geburtshilfe, Stadt Klinikum Solingen, Solingen, Germany; [Kurzeder, Christian] Univ Ulm Klinikum, Ulm, Germany; [du Bois, Andreas] Dr Horst Schmidt Klin, Wiesbaden, Germany; [Kimmig, Rainer] Univ Klinikum Essen, Essen, Germany; [Staehle, Anne] St Vincentius Kliniken, Karlsruhe, Germany; [Pujade-Lauraine, Eric] Univ Paris 05, Hop Univ Paris Ctr, AP HP, Paris, France; [Kristensen, Gunnar] Oslo Univ Hosp, Dept Gynecol Oncol, Oslo, Norway; [Kristensen, Gunnar] Oslo Univ Hosp, Inst Med Informat, Oslo, Norway; [Carey, Mark S.] Univ British Columbia, Dept Obstet & Gynecol, Vancouver, BC V5Z 1M9, Canada; [Plante, Marie] Univ Laval, Dept Obstet & Gynecol, Quebec City, PQ, Canada; [Beale, Philip] Australia New Zealand Gynaecol Oncol Grp, Camperdown, NSW, Australia; [Cervantes, Andres] Univ Valencia, Dept Hematol & Med Oncol, Inst Hlth Res Hosp Clin, Valencia, Spain; [Sehouli, Jalid] Charite Campus Virchow Klinikum, Berlin, Germany; [Gourley, Charlie] Univ Edinburgh, Canc Res Ctr, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Lortholary, Alain] Ctr Catherine Sienne, Nantes, France; [Selle, Frederic] Hop Tenon, AP HP, Med Oncol Serv, F-75970 Paris, France; [Mirza, Mansoor R.] Rigshosp, Dept Oncol, DK-2100 Copenhagen, Denmark; [Leminen, Arto] Univ Helsinki, Cent Hosp, Womens Clin, Helsinki, Finland; [Oza, Amit M.] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada	Saint James's University Hospital; University of Leeds; University of Cambridge; Medical Research Council Clinical Trials Unit; University College London Hospitals NHS Foundation Trust; University of London; University College London; Ulm University; University of Duisburg Essen; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; University of Oslo; University of Oslo; University of British Columbia; Laval University; University of Valencia; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Edinburgh; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Rigshospitalet; University of Copenhagen; University of Helsinki; Helsinki University Central Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Parmar, MKB (corresponding author), MRC CTU, Aviat House,125 Kingsway, London WL2B 6NH, England.	mp@ctu.mrc.ac.uk	friedlander, michael l/G-3490-2013; GLADIEFF, Laurence/O-5129-2014; Mahner, Sven/F-3560-2014; Solomayer, Erich/A-9580-2015; Perren, Timothy J/D-5387-2013; Jayson, Gordon C/O-8224-2015; Gascon, Pere/F-7905-2015; Kimmig, Rainer/F-1176-2014; Menon, Usha/C-4716-2008; Cervantes, Andres/J-8713-2013	friedlander, michael l/0000-0002-6488-0604; GLADIEFF, Laurence/0000-0002-6980-9719; Solomayer, Erich/0000-0002-2622-5676; Perren, Timothy J/0000-0001-8472-8856; Jayson, Gordon C/0000-0002-8515-8944; Menon, Usha/0000-0003-3708-1732; Breitbach, Georg-Peter/0000-0002-8257-917X; Sorbe, Bengt/0000-0002-5063-631X; Oza, Amit/0000-0002-9510-8641; Durando, Xavier/0000-0001-6035-3172; joly, florence/0000-0001-6168-4942; Sculpher, Mark/0000-0003-3746-9913; McNeish, Iain/0000-0002-9387-7586; Beale, Philip/0000-0003-3628-4597; Earl, Helena/0000-0003-1549-8094; Cervantes, Andres/0000-0003-3806-3691; Ellard, Susan/0000-0001-5757-9787	Roche; National Institute for Health Research, through the National Cancer Research Network; MRC [MC_U122861379] Funding Source: UKRI; Medical Research Council [MC_U122861379] Funding Source: researchfish; Chief Scientist Office [SCD/11] Funding Source: researchfish	Roche(Roche Holding); National Institute for Health Research, through the National Cancer Research Network(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	Supported by Roche and the National Institute for Health Research, through the National Cancer Research Network.	Alberts DS, 1996, NEW ENGL J MED, V335, P1950, DOI 10.1056/NEJM199612263352603; Armstrong DK, 2006, NEW ENGL J MED, V354, P34, DOI 10.1056/NEJMoa052985; Bookman MA, 2009, J CLIN ONCOL, V27, P1419, DOI 10.1200/JCO.2008.19.1684; Burger RA, 2007, J CLIN ONCOL, V25, P5165, DOI 10.1200/JCO.2007.11.5345; Burger RA, 2011, NEW ENGL J MED, V365, P2473, DOI 10.1056/NEJMoa1104390; Cannistra SA, 2008, J CLIN ONCOL, V26, P3665, DOI 10.1200/JCO.2008.17.2676; Cannistra SA, 2007, J CLIN ONCOL, V25, P5180, DOI 10.1200/JCO.2007.12.0782; du Bois A, 2006, J CLIN ONCOL, V24, P1127, DOI 10.1200/JCO.2005.03.2938; Eskens FALM, 2008, EUR J CANCER, V44, P2350, DOI 10.1016/j.ejca.2008.07.042; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; FOLKMAN J, 1972, ANN SURG, V175, P409, DOI 10.1097/00000658-197203000-00014; Garcia AA, 2008, J CLIN ONCOL, V26, P76, DOI 10.1200/JCO.2007.12.1939; Hoskins P, 2010, J NATL CANCER I, V102, P1547, DOI 10.1093/jnci/djq362; Huang S, 2000, CANCER RES, V60, P5334; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Katsumata N, 2009, LANCET, V374, P1331, DOI 10.1016/S0140-6736(09)61157-0; Markman M, 2001, J CLIN ONCOL, V19, P1001, DOI 10.1200/JCO.2001.19.4.1001; Pfisterer J, 2006, JNCI-J NATL CANCER I, V98, P1036, DOI 10.1093/jnci/djj296; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Rustin GJS, 2004, JNCI-J NATL CANCER I, V96, P487, DOI 10.1093/jnci/djh081; SANDLER AB, 2005, 41 ANN M AM SOC CLIN; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Yoneda J, 1998, JNCI-J NATL CANCER I, V90, P447, DOI 10.1093/jnci/90.6.447	23	1452	1502	4	115	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2011	365	26					2484	2496		10.1056/NEJMoa1103799	http://dx.doi.org/10.1056/NEJMoa1103799			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	868SD	22204725	Green Published			2022-12-28	WOS:000298544600009
J	Engelhardt, B				Engelhardt, Britta			Blood-Brain Barrier Differentiation	SCIENCE			English	Editorial Material									Univ Bern, Theodor Kocher Inst, CH-3012 Bern, Switzerland	University of Bern	Engelhardt, B (corresponding author), Univ Bern, Theodor Kocher Inst, CH-3012 Bern, Switzerland.	bengel@tki.unibe.ch	Engelhardt, Britta/K-7267-2014	Engelhardt, Britta/0000-0003-3059-9846				Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Altaba ARI, 2002, NAT REV NEUROSCI, V3, P24; Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Lassmann H, 2008, J NEUROL SCI, V274, P45, DOI 10.1016/j.jns.2008.04.003; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Pfeiffer F, 2011, ACTA NEUROPATHOL, V122, P601, DOI 10.1007/s00401-011-0883-2	8	9	10	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1652	1653		10.1126/science.1216853	http://dx.doi.org/10.1126/science.1216853			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22194564				2022-12-28	WOS:000298344000052
J	Nauman, J; Janszky, I; Vatten, LJ; Wisloff, U				Nauman, Javaid; Janszky, Imre; Vatten, Lars J.; Wisloff, Ulrik			Temporal Changes in Resting Heart Rate and Deaths From Ischemic Heart Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-ARTERY-DISEASE; SYSTOLIC DYSFUNCTION BEAUTIFUL; PLACEBO-CONTROLLED TRIAL; NORD-TRONDELAG HEALTH; MIDDLE-AGED MEN; HYPERTENSIVE PATIENTS; PHYSICAL-ACTIVITY; RISK-FACTOR; BLOOD-PRESSURE; ALL-CAUSE	Context Resting heart rate (RHR) has long been recognized as an independent predictor of cardiovascular risk. However, whether temporal changes in RHR influence the risk of death from ischemic heart disease (IHD) in the general population is not known. Objective To assess the association of long-term longitudinal changes in RHR with the risk of dying from IHD. Design, Settings, and Participants A prospective cohort study of 13 499 men and 15 826 women without known cardiovascular disease in Norway. Resting heart rate was measured on 2 occasions around 10 years apart in the Nord-Trondelag County Health Study. The second RHR measurement was obtained between August 1995 and June 1997, with subsequent mortality follow-up until December 31, 2008. A total of 60 participants were lost to follow-up, all due to emigration from Norway. Using Cox regression analyses, adjusted hazard ratios (AHRs) were estimated of death from IHD related to changes in RHR over time. In a corresponding analysis, death from all causes also was assessed. Results During a mean (SD) of 12 (2) years of follow-up, 3038 people died, and 388 deaths were caused by IHD. An increase in RHR was associated with increased risk of death from IHD. Compared with participants with a RHR of less than 70 beats/min at both measurements (8.2 deaths/10 000 person-years), the AHR was 1.9 (95% CI, 1.0-3.6) for participants with a RHR of less than 70 beats/min at the first measurement but greater than 85 beats/min at the second measurement (17.2 deaths/10 000 person-years). For participants with RHRs between 70 and 85 beats/min at the first measurement and greater than 85 beats/min at the second measurement (17.4 deaths/10 000 person-years), the AHR was 1.8 (95% CI, 1.2-2.8). The association of change in RHR with IHD mortality was not linear (P=.003 for quadratic trend), suggesting that a decrease in RHR showed no general mortality benefit. Excluding the first 3 years of follow-up did not substantially alter the findings. The associations for total mortality were similar but generally weaker than those observed for IHD mortality. Conclusion Among men and women without known cardiovascular disease, an increase in RHR over a 10-year period was associated with increased risk of death from IHD and also for all-cause mortality. JAMA. 2011;306(23):2579-2587	[Wisloff, Ulrik] Norwegian Univ Sci & Technol, Fac Med, KG Jebsen Ctr Exercise Med, Medisinsk Tekn Forskningssenter, N-7491 Trondheim, Norway; [Nauman, Javaid; Wisloff, Ulrik] Norwegian Univ Sci & Technol, Fac Med, Dept Circulat & Med Imaging, N-7491 Trondheim, Norway; [Janszky, Imre; Vatten, Lars J.] Norwegian Univ Sci & Technol, Fac Med, Dept Publ Hlth, N-7491 Trondheim, Norway; [Janszky, Imre] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Karolinska Institutet	Wisloff, U (corresponding author), Norwegian Univ Sci & Technol, Fac Med, KG Jebsen Ctr Exercise Med, Medisinsk Tekn Forskningssenter, POB 8905, N-7491 Trondheim, Norway.	ulrik.wisloff@ntnu.no	Vatten, Lars/AAF-9380-2022; Nauman, Javaid/AAF-2284-2019; Wisloff, Ulrik/K-2899-2012; Vatten, Lars/AFK-2073-2022	Nauman, Javaid/0000-0003-1347-2448; Wisloff, Ulrik/0000-0002-7211-3587	K. G. Jebsen Foundation; Norwegian Council of Cardiovascular Disease; Norwegian Research Council; St Olav's University Hospital, Trondheim; Torstein Erbo's Foundation, Trondheim; Liaison Committee; Central Norway Regional Health Authority; Norwegian University of Science and Technology; Swedish Council of Working Life and Social Research	K. G. Jebsen Foundation; Norwegian Council of Cardiovascular Disease; Norwegian Research Council(Research Council of NorwayEuropean Commission); St Olav's University Hospital, Trondheim; Torstein Erbo's Foundation, Trondheim; Liaison Committee; Central Norway Regional Health Authority; Norwegian University of Science and Technology; Swedish Council of Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	The present study was supported by grants from K. G. Jebsen Foundation, the Norwegian Council of Cardiovascular Disease, the Norwegian Research Council (Funding for Outstanding Young Investigators awarded to Dr Wisloff), Funds for Cardiovascular and Medical Research at St Olav's University Hospital, Trondheim, the Torstein Erbo's Foundation, Trondheim, the Liaison Committee between the Central Norway Regional Health Authority and the Norwegian University of Science and Technology (Dr Janszky), and by the Swedish Council of Working Life and Social Research (Dr Janszky).	Black A, 2006, HEART, V92, P468, DOI 10.1136/hrt.2005.067777; Bohm M, 2010, LANCET, V376, P886, DOI 10.1016/S0140-6736(10)61259-7; Cook S, 2006, EUR HEART J, V27, P2387, DOI 10.1093/eurheartj/ehl259; Diaz A, 2005, EUR HEART J, V26, P967, DOI 10.1093/eurheartj/ehi190; Dietrich DF, 2007, INT J EPIDEMIOL, V36, P834, DOI [10.1093/ije/dymo31, 10.1093/ije/dym031]; DYER AR, 1980, AM J EPIDEMIOL, V112, P736, DOI 10.1093/oxfordjournals.aje.a113046; Eijgelsheim M, 2010, HUM MOL GENET, V19, P3885, DOI 10.1093/hmg/ddq303; ERIKSSEN J, 1979, EUR J APPL PHYSIOL O, V42, P61, DOI 10.1007/BF00421105; Fox K, 2008, LANCET, V372, P807, DOI 10.1016/S0140-6736(08)61170-8; Fox K, 2008, LANCET, V372, P817, DOI 10.1016/S0140-6736(08)61171-X; Fox K, 2007, J AM COLL CARDIOL, V50, P823, DOI 10.1016/j.jacc.2007.04.079; Hjalmarson A, 2000, JAMA-J AM MED ASSOC, V283, P1295, DOI 10.1001/jama.283.10.1295; Jouven X, 2005, NEW ENGL J MED, V352, P1951, DOI 10.1056/NEJMoa043012; Jouven X, 2009, AM J CARDIOL, V103, P279, DOI 10.1016/j.amjcard.2008.08.071; Kolloch R, 2008, EUR HEART J, V29, P1327, DOI 10.1093/eurheartj/ehn123; Kurtze N, 2007, EUR J EPIDEMIOL, V22, P379, DOI 10.1007/s10654-007-9110-9; Lightwood JM, 1997, CIRCULATION, V96, P1089, DOI 10.1161/01.CIR.96.4.1089; Midthjell K, 1999, DIABETES CARE, V22, P1813, DOI 10.2337/diacare.22.11.1813; Mozaffarian D, 2005, CIRCULATION, V112, P1945, DOI 10.1161/CIRCULATIONAHA.105.556886; Mozaffarian D, 2006, J AM COLL CARDIOL, V48, P478, DOI 10.1016/j.jacc.2006.03.048; Okin PM, 2010, EUR HEART J, V31, P2271, DOI 10.1093/eurheartj/ehq225; Palatini P, 1999, HYPERTENSION, V33, P622, DOI 10.1161/01.HYP.33.2.622; Palatini P, 2002, ARCH INTERN MED, V162, P2313, DOI 10.1001/archinte.162.20.2313; Paul L, 2010, HYPERTENSION, V55, P567, DOI 10.1161/HYPERTENSIONAHA.109.144808; RUNCIE CJ, 1990, INTENS CARE MED, V16, P317, DOI 10.1007/BF01706357; Sandercock GRH, 2008, J SPORT SCI, V26, P1171, DOI 10.1080/02640410802004930; Shishehbor MH, 2006, JAMA-J AM MED ASSOC, V295, P784, DOI 10.1001/jama.295.7.784; Stensvold D, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-109	28	135	141	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 21	2011	306	23					2579	2587		10.1001/jama.2011.1826	http://dx.doi.org/10.1001/jama.2011.1826			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	864YQ	22187277				2022-12-28	WOS:000298276800019
J	Rajaratnam, SMW; Barger, LK; Lockley, SW; Shea, SA; Wang, W; Landrigan, CP; O'Brien, CS; Qadri, S; Sullivan, JP; Cade, BE; Epstein, LJ; White, DP; Czeisler, CA				Rajaratnam, Shantha M. W.; Barger, Laura K.; Lockley, Steven W.; Shea, Steven A.; Wang, Wei; Landrigan, Christopher P.; O'Brien, Conor S.; Qadri, Salim; Sullivan, Jason P.; Cade, Brian E.; Epstein, Lawrence J.; White, David P.; Czeisler, Charles A.		Harvard Work Hours Hlth Safety Grp	Sleep Disorders, Health, and Safety in Police Officers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSITIVE AIRWAY PRESSURE; MOTOR-VEHICLE CRASHES; WORK HOURS; APNEA-HYPOPNEA; RISK-FACTORS; PREVALENCE; CONSEQUENCES; INSOMNIA; IMPACT; QUESTIONNAIRE	Context Sleep disorders often remain undiagnosed. Untreated sleep disorders among police officers may adversely affect their health and safety and pose a risk to the public. Objective To quantify associations between sleep disorder risk and self-reported health, safety, and performance outcomes in police officers. Design, Setting, and Participants Cross-sectional and prospective cohort study of North American police officers participating in either an online or an on-site screening (n=4957) and monthly follow-up surveys (n=3545 officers representing 15 735 person-months) between July 2005 and December 2007. A total of 3693 officers in the United States and Canada participated in the online screening survey, and 1264 officers from a municipal police department and a state police department participated in the on-site survey. Main Outcome Measures Comorbid health conditions (cross-sectional); performance and safety outcomes (prospective). Results Of the 4957 participants, 40.4% screened positive for at least 1 sleep disorder, most of whom had not been diagnosed previously. Of the total cohort, 1666 (33.6%) screened positive for obstructive sleep apnea, 281 (6.5%) for moderate to severe insomnia, 269 (5.4%) for shift work disorder (14.5% of those who worked the night shift). Of the 4608 participants who completed the sleepiness scale, 1312 (28.5%) reported excessive sleepiness. Of the total cohort, 1294 (26.1%) reported falling asleep while driving at least 1 time a month. Respondents who screened positive for obstructive sleep apnea or any sleep disorder had an increased prevalence of reported physical and mental health conditions, including diabetes, depression, and cardiovascular disease. An analysis of up to 2 years of monthly follow-up surveys showed that those respondents who screened positive for a sleep disorder vs those who did not had a higher rate of reporting that they had made a serious administrative error (17.9% vs 12.7%; adjusted odds ratio [OR], 1.43 [95% CI, 1.23-1.67]); of falling asleep while driving (14.4% vs 9.2%; adjusted OR, 1.51 [95% CI, 1.20-1.90]); of making an error or safety violation attributed to fatigue (23.7% vs 15.5%; adjusted OR, 1.63 [95% CI, 1.43-1.85]); and of exhibiting other adverse work-related outcomes including uncontrolled anger toward suspects (34.1% vs 28.5%; adjusted OR, 1.25 [95% CI, 1.09-1.43]), absenteeism (26.0% vs 20.9%; adjusted OR, 1.23 [95% CI, 1.08-1.40]), and falling asleep during meetings (14.1% vs 7.0%; adjusted OR, 1.95 [95% CI, 1.52-2.52]). Conclusion Among a group of North American police officers, sleep disorders were common and were significantly associated with increased risk of self-reported adverse health, performance, and safety outcomes. JAMA. 2011;306(23):2567-2578	[Rajaratnam, Shantha M. W.; Barger, Laura K.; Lockley, Steven W.; Shea, Steven A.; Wang, Wei; Landrigan, Christopher P.; O'Brien, Conor S.; Qadri, Salim; Sullivan, Jason P.; Cade, Brian E.; Epstein, Lawrence J.; White, David P.; Czeisler, Charles A.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Sleep Med, Boston, MA 02115 USA; [Wang, Wei] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Channing Lab, Boston, MA 02115 USA; [Landrigan, Christopher P.] Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Med,Div Gen Pediat, Boston, MA 02115 USA; [Rajaratnam, Shantha M. W.; Barger, Laura K.; Lockley, Steven W.; Shea, Steven A.; Wang, Wei; Landrigan, Christopher P.; Epstein, Lawrence J.; White, David P.; Czeisler, Charles A.] Harvard Univ, Sch Med, Div Sleep Med, Boston, MA 02115 USA; [Shea, Steven A.; Epstein, Lawrence J.; White, David P.] Sleep HealthCtr, Boston, MA USA; [Rajaratnam, Shantha M. W.] Monash Univ, Sch Psychol & Psychiat, Clayton, Vic, Australia	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Monash University	Czeisler, CA (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Sleep Med, 221 Longwood Ave, Boston, MA 02115 USA.	czeisler@hms.harvard.edu	Cade, Brian/J-6770-2019; Rajaratnam, Shantha/D-8144-2012	Cade, Brian/0000-0003-1424-0673; Rajaratnam, Shantha/0000-0001-7527-8558; Lockley, Steven/0000-0001-5209-2881; Shea, Steven/0000-0003-1949-0954; Landrigan, Christopher/0000-0001-8386-4100	Vanda Pharmaceuticals; Takeda Pharmaceuticals North America; Philips Lighting; Philips Respironics; Cephalon; ResMed Foundation; Optalert; Compumedics; Tyco Healthcare; Apollo Lighting; Naturebright; Sound Oasis; Wyle Integrated Science and Engineering; Brigham and Women's Hospital; Thomas Jefferson University; Warwick Medical School; I Slept Great/Euforma, LLC; Emergency Social Services Association Conference, UK; Swinburne University of Technology, Australia; Optalert, Pty Ltd, Melbourne, Australia; Respironics Inc; Alcon Inc; Sleep HealthCenters; American Academy of Sleep Medicine; Tufts University School of Dental Medicine; Cephalon Inc; World Sleep Federation; Actelion Ltd; Bombardier Inc; Boston Celtics; Celedon Trucking; Delta Airlines; Eli Lilly and Co; Garda Siochana Inspectorate; Gerson Lehrman Group; Global Ground Support; Johnson Johnson; Koninklijke Philips Electronics, NV; Minnesota Timberwolves; Norfolk Southern; Novartis; Portland Trail Blazers; Philips; sanofi-aventis Group; Sepracor Inc; Sleep Multimedia Inc; Somnus Therapeutics Inc; Zeo Inc; Accreditation Council of Graduate Medical Education; Alliance for Epilepsy Research; Duke University School of Medicine; Harvard School of Public Health; Hokkaido University Graduate School of Medicine; Japan Aerospace Exploration Agency (JAXA); LOTTE Health Products; Mount Sinai School of Medicine; National Academy of Sciences; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK/NIH); National Sleep Foundation; New England College of Occupational and Environmental Medicine (NECOEM); North East Sleep Society; Office of Rare Diseases Resarch (NIH); Rockpointe; sanofi-aventis Inc; Sleep Research Society; Society for Obstetric Anesthesia and Perinatology (SOAP); St Lukes Roosevelt Hospital; University of Chicago; University of Colorado; University of Pittsburgh; University of Virginia Medical School; University of Washington Medical Center; University of Wisconsin Medical School; World Federation of Sleep Research Society; World Federation of Sleep Medicine Society; Koninklijke Philips Electronics NV; ResMed; Committee for Interns and Residents; Boehringer Ingelheim Pharmaceuticals Inc; George H. KidderEsq; Gerald McGinnis; GlaxoSmithKline; Herbert Lee; Hypnion; Jazz Pharmaceuticals; Jordan's Furniture; Merck Co Inc; Pfizer; Sealy Inc; Simmons; Sleep Health Centers LLC; Spring Aire; Tempur-Pedic; National Institute of Justice, Office of Justice Programs, US Department of Justice [2004-FS-BX-0001, 2010C-10002]; Centers for Disease Control and Prevention [R01 OH008496, R01 OH009403]; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [R01OH008496, R01OH009403] Funding Source: NIH RePORTER	Vanda Pharmaceuticals; Takeda Pharmaceuticals North America(Takeda Pharmaceutical Company Ltd); Philips Lighting; Philips Respironics; Cephalon; ResMed Foundation; Optalert; Compumedics; Tyco Healthcare; Apollo Lighting; Naturebright; Sound Oasis; Wyle Integrated Science and Engineering; Brigham and Women's Hospital; Thomas Jefferson University; Warwick Medical School; I Slept Great/Euforma, LLC; Emergency Social Services Association Conference, UK; Swinburne University of Technology, Australia; Optalert, Pty Ltd, Melbourne, Australia; Respironics Inc; Alcon Inc(Novartis); Sleep HealthCenters; American Academy of Sleep Medicine; Tufts University School of Dental Medicine; Cephalon Inc(Teva Pharmaceutical Industries); World Sleep Federation; Actelion Ltd; Bombardier Inc; Boston Celtics; Celedon Trucking; Delta Airlines; Eli Lilly and Co(Eli Lilly); Garda Siochana Inspectorate; Gerson Lehrman Group; Global Ground Support; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Koninklijke Philips Electronics, NV; Minnesota Timberwolves; Norfolk Southern; Novartis(Novartis); Portland Trail Blazers; Philips; sanofi-aventis Group(Sanofi-Aventis); Sepracor Inc; Sleep Multimedia Inc; Somnus Therapeutics Inc; Zeo Inc; Accreditation Council of Graduate Medical Education; Alliance for Epilepsy Research; Duke University School of Medicine; Harvard School of Public Health; Hokkaido University Graduate School of Medicine; Japan Aerospace Exploration Agency (JAXA); LOTTE Health Products; Mount Sinai School of Medicine; National Academy of Sciences; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK/NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Sleep Foundation; New England College of Occupational and Environmental Medicine (NECOEM); North East Sleep Society; Office of Rare Diseases Resarch (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockpointe; sanofi-aventis Inc(Sanofi-Aventis); Sleep Research Society; Society for Obstetric Anesthesia and Perinatology (SOAP); St Lukes Roosevelt Hospital; University of Chicago(University of Chicago); University of Colorado; University of Pittsburgh(University of Pittsburgh); University of Virginia Medical School; University of Washington Medical Center(University of Washington); University of Wisconsin Medical School; World Federation of Sleep Research Society; World Federation of Sleep Medicine Society; Koninklijke Philips Electronics NV; ResMed; Committee for Interns and Residents; Boehringer Ingelheim Pharmaceuticals Inc(Boehringer Ingelheim); George H. KidderEsq; Gerald McGinnis; GlaxoSmithKline(GlaxoSmithKline); Herbert Lee; Hypnion; Jazz Pharmaceuticals(Jazz Pharmaceuticals); Jordan's Furniture; Merck Co Inc(Merck & Company); Pfizer(Pfizer); Sealy Inc; Simmons; Sleep Health Centers LLC; Spring Aire; Tempur-Pedic; National Institute of Justice, Office of Justice Programs, US Department of Justice; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Rajaratnam reported that he has served as a consultant through his institution to Vanda Pharmaceuticals, Philips Respironics, EdanSafe, the Australian Workers' Union, and National Transport Commission, and has through his institution received research grants and unrestricted educational grants from Vanda Pharmaceuticals, Takeda Pharmaceuticals North America, Philips Lighting, Philips Respironics, Cephalon, and ResMed Foundation, and reimbursements for conference travel expenses from Vanda Pharmaceuticals. His institution has received equipment donations or other support from Optalert, Compumedics, and Tyco Healthcare. He has also served as an expert witness and consultant to shift work organizations. Dr Barger reported receiving a research grant through her institution from Cephalon, receiving payment for lectures from Vital Issues in Medicine and National Sleep Foundation, and serving as a consultant for Alertness Solutions. Dr Lockley reported that he received 2 investigator-initiated research grants from the ResMed Foundation and an unrestricted equipment gift from ResMed Inc, in support of the studies described in this article; receiving consulting fees from Apollo Lighting, Naturebright, Sound Oasis, and Wyle Integrated Science and Engineering, and federally funded projects at Brigham and Women's Hospital, Thomas Jefferson University, and Warwick Medical School; lecture fees from Takeda Pharmaceuticals North America, I Slept Great/Euforma, LLC, and Emergency Social Services Association Conference, UK; unrestricted equipment gifts from Philips Lighting and Bionetics Corporation; an unrestricted monetary gift to support research from Swinburne University of Technology, Australia; a fellowship gift from Optalert, Pty Ltd, Melbourne, Australia; advance author payment and royalties from Oxford University Press, and honoraria from Servier Inc for writing an article for Dialogues in Clinical Neuroscience and from AMO Inc, for writing an educational monograph, neither of which refer to the companies' products; honoraria or travel and accommodation support for invited seminars, conference presentations or teaching from the Second International Symposium on the Design of Artificial Environments, Eighth International Conference on Managing Fatigue, American Academy of Sleep Medicine, American Society for Photobiology, Apollo Lighting, Bar Harbor Chamber of Commerce, Bassett Research Institute, Canadian Sleep Society, Committee of Interns and Residents, Coney Island Hospital, FASEB, Harvard University, Illinois Coalition for Responsible Outdoor Lighting, International Graduate School of Neuroscience, Japan National Institute of Occupational Safety and Health, Lightfair, National Research Council Canada, New York Academy of Sciences, North East Sleep Society, Ontario Association of Fire Chiefs, Philips Lighting, Thomas Jefferson University, University of Montreal, University of Tsukuba, University of Vermont College of Medicine, Utica College, Vanda Pharmaceuticals, Velux, Warwick Medical School, Woolcock Institute of Medical Research, and Wyle Integrated Science and Engineering (NASA); investigator-initiated research grants from Respironics Inc, Philips Lighting, Apollo Lighting, and Alcon Inc; and a service agreement and sponsor-initiated research contract from Vanda Pharmaceuticals.; Dr Lockley also holds a process patent for the use of short-wavelength light for resetting the human circadian pacemaker and improving alertness and peformance which is assigned to the Brigham and Women's Hospital per Hospital policy and has received revenue from a patent on the use of short-wavelength light, which is assigned to the University of Surrey. Dr Lockley has also served as a paid expert witness on behalf of 2 public bodies on arbitration panels related to sleep, circadian rhythms, and work hours. Dr Shea reported receiving fees for interpretation of polysomnographic sleep studies of participants in this study from Sleep HealthCenters, a sleep medicine specialty practice group; receiving fees for attendance at directors meeting of the American Academy of Sleep Medicine; and lecture fees from Tufts University School of Dental Medicine. Dr Landrigan reported serving as a consultant for Vital Issues in Medicine, developing an educational course for physicians on Shift Work Disorder (supported by an unrestricted educational grant from Cephalon Inc to Vital Issues in Medicine); and AXDev, to assist in the development of a study of Shift Work Disorder (supported by an unrestricted research grant from Cephalon Inc to AXDev). Dr Landrigan also reported receiving monetary awards, honoraria, and travel reimbursement from multiple academic and professional organizations for delivering lectures on sleep deprivation and safety. Mr O'Brien reported receiving support for travel to meetings for the study or other purposes from National Institute of Justice and Centers for Disease Control and Prevention. Dr Cade reported receiving a monetary award from the World Sleep Federation. Dr Epstein reported being employed by Sleep HealthCenters, a sleep medicine specialty practice group. Dr White reported being employed as the chief medical officer for Philips Respironics, for which he owns stock. Dr Czeisler reported that he has received consulting fees from or served as a paid member of scientific advisory boards for: Actelion Ltd; Bombardier Inc; Boston Celtics, Celedon Trucking, Cephalon, Inc, Delta Airlines, Eli Lilly and Co, Garda Siochana Inspectorate, Gerson Lehrman Group, Global Ground Support, Johnson & Johnson, Koninklijke Philips Electronics, NV, Minnesota Timberwolves, Norfolk Southern, Novartis, Portland Trail Blazers, Philips, Respironics Inc, sanofi-aventis Group, Sepracor Inc, Sleep Multimedia Inc, Somnus Therapeutics Inc, Vanda Pharmaceuticals, Inc, and Zeo Inc. Dr Czeisler reported that he owns an equity interest in Lifetrac Inc, Somnus Therapeutics Inc, Vanda Pharmaceuticals Inc, and Zeo Inc; that he has received royalties from the Massachusetts Medical Society/New England Journal of Medicine, McGraw Hill, the New York Times, Penguin Press, and Philips Respironics Inc.; Dr Czeisler reported receiving lecture fees from the Accreditation Council of Graduate Medical Education, Alliance for Epilepsy Research, American Academy of Sleep Medicine, Cephalon Inc, Duke University School of Medicine, Harvard School of Public Health, Hokkaido University Graduate School of Medicine, Japan Aerospace Exploration Agency (JAXA), LOTTE Health Products, Mount Sinai School of Medicine, National Academy of Sciences, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK/NIH), National Sleep Foundation, New England College of Occupational and Environmental Medicine (NECOEM), North East Sleep Society, Office of Rare Diseases Resarch (NIH), Rockpointe, sanofi-aventis Inc, Sleep Research Society, Society for Obstetric Anesthesia and Periatology (SOAP), St Lukes Roosevelt Hospital, University of Chicago, University of Colorado, University of Pittsburgh, University of Virginia Medical School, University of Washington Medical Center, University of Wisconsin Medical School, and the World Federation of Sleep Research and Sleep Medicine Societies. Dr Czeisler reported that he has received research prizes with monetary awards from the American Academy of Sleep Medicine and Sleep Research Society, a clinical trial research contract from Cephalon Inc, and an investigator-initiated research grant from Cephalon Inc and that his research laboratory at the Brigham and Women's Hospital has received unrestricted research and education funds and support for research expenses from Cephalon Inc, Koninklijke Philips Electronics NV, ResMed, and the Committee for Interns and Residents and the Brigham and Women's Hospital. The Harvard Medical School Division of Sleep Medicine (HMS/DSM), which Dr Czeisler directs, has received unrestricted research and educational gifts and endowment funds from Boehringer Ingelheim Pharmaceuticals Inc, Cephalon Inc, George H. KidderEsq, Gerald McGinnis, GlaxoSmithKline, Herbert Lee, Hypnion, Jazz Pharmaceuticals, Jordan's Furniture, Merck & Co Inc, Peter C. Farrell, PhD, Pfizer, ResMed, Respironics Inc, sanofi-aventis Inc, Sealy Inc, Sepracor Inc, Simmons, Sleep Health Centers LLC, Spring Aire, Takeda Pharmaceuticals, and Tempur-Pedic. The HMS/DSM has received gifts from many outside organizations and individuals including: Brigham and Women's Hospital (Development Office), Catalyst Group, Cephalon Inc, Committee for Interns and Residents, Eisai Inc, Farrell Family Foundation, Fisher & Paykel Healthcare Corp, Jordan's Furniture, Lilly USA, LLC, Neurocare Center for Sleep, Philips-Respironics Inc, Praxair US Homecare, sanofi-aventis Inc, Select Comfort Corp, Sepracor Inc, Sleep HealthCenters LLC, Somaxon Pharmaceuticals, Synchrony Healthcare Communications, Vanda Pharmaceuticals Inc, Wake Up Narcolepsy Inc, Watermark Medical, and Zeo Inc. The HMS/DSM Sleep and Health Education Program has received Educational Grant funding from Cephalon Inc, Takeda Pharmaceuticals, sanofi-aventis Inc, and Sepracor Inc. Dr Czeisler is the incumbent of an endowed professorship provided to Harvard University by Cephalon Inc and holds a number of process patents in the field of sleep and circadian rhythms (eg, photic resetting of the human circadian pacemaker). Since 1985, Dr Czeisler has also served as an expert witness on various legal cases related to sleep, circadian rhythms, or both.; This study was supported by grant 2004-FS-BX-0001 and grant 2010C-10002 from the National Institute of Justice, Office of Justice Programs, US Department of Justice; grants R01 OH008496 and R01 OH009403 from the Centers for Disease Control and Prevention; and grants from the ResMed Foundation.	AAA Foundation for Traffic Safety, 2004, SURV US CAN POL OFF; Allen RP, 2005, ARCH INTERN MED, V165, P1286, DOI 10.1001/archinte.165.11.1286; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; American Association for Public Opinion Research (AAPOR), 2016, STAND DEF FIN DISP C; Anderson AB, 1983, HDB SURVEY RES, P415; Anic-Labat S, 1999, SLEEP, V22, P77; Ayas NT, 2006, JAMA-J AM MED ASSOC, V296, P1055, DOI 10.1001/jama.296.9.1055; Barger LK, 2006, PLOS MED, V3, P2440, DOI 10.1371/journal.pmed.0030487; Barger LK, 2005, NEW ENGL J MED, V352, P125, DOI 10.1056/NEJMoa041401; Botros N, 2009, AM J MED, V122, P1122, DOI 10.1016/j.amjmed.2009.04.026; Budhiraja R, 2010, RESP CARE, V55, P1322; Bureau of Labor Statistics, 2007, CURR POP SURV CPS AN; Buysse DJ, 2008, SLEEP, V31, P473, DOI 10.1093/sleep/31.4.473; Czeisler Charles A, 2009, Trans Am Clin Climatol Assoc, V120, P249; Drake C, 2010, SLEEP, V33, P745, DOI 10.1093/sleep/33.6.745; Drake CL, 2004, SLEEP, V27, P1453, DOI 10.1093/sleep/27.8.1453; Faccenda JF, 2001, AM J RESP CRIT CARE, V163, P344, DOI 10.1164/ajrccm.163.2.2005037; Fahrenkopf AM, 2008, BRIT MED J, V336, P488, DOI 10.1136/bmj.39469.763218.BE; Franke WD, 2010, J OCCUP ENVIRON MED, V52, P561, DOI 10.1097/JOM.0b013e3181dd086b; Gangwisch JE, 2010, AM J HYPERTENS, V23, P62, DOI 10.1038/ajh.2009.202; Garbarino S, 2002, SLEEP, V25, P648; Hampton SM, 1996, J ENDOCRINOL, V151, P259, DOI 10.1677/joe.0.1510259; Howard ME, 2004, AM J RESP CRIT CARE, V170, P1014, DOI 10.1164/rccm.200312-1782oc; Johns MW, 2000, J SLEEP RES, V9, P5, DOI 10.1046/j.1365-2869.2000.00177.x; Joseph PN, 2010, J OCCUP ENVIRON MED, V52, P1004, DOI 10.1097/JOM.0b013e3181f4385c; Kapsimalis F, 2009, J WOMENS HEALTH, V18, P1211, DOI 10.1089/jwh.2008.1054; Kapur VK, 2002, SLEEP, V25, P289; Kessler RC, 2011, SLEEP, V34, P1161, DOI 10.5665/SLEEP.1230; Knutsson A, 1999, OCCUP ENVIRON MED, V56, P46, DOI 10.1136/oem.56.1.46; Komada Y, 2008, SLEEP MED, V9, P851, DOI 10.1016/j.sleep.2007.08.018; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lockley SW, 2004, NEW ENGL J MED, V351, P1829, DOI 10.1056/NEJMoa041404; National Center on Sleep Disorders, 2011, RES NIH SLEEP DIS RE, p[11, November]; National Law Enforcement, 2011, RES B LAW ENF OFF DE; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Neylan TC, 2002, PSYCHOSOM MED, V64, P345, DOI 10.1097/00006842-200203000-00019; Ohayon MM, 2002, J PSYCHOSOM RES, V53, P577, DOI 10.1016/S0022-3999(02)00438-5; Punjabi NM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000132; Raj R, 2003, SLEEP MED, V4, P29, DOI 10.1016/S1389-9457(02)00150-8; Redline S, 2000, AM J RESP CRIT CARE, V161, P369, DOI 10.1164/ajrccm.161.2.9904031; Redline S, 2010, AM J RESP CRIT CARE, V182, P269, DOI 10.1164/rccm.200911-1746OC; Rosen IM, 2006, ACAD MED, V81, P82, DOI 10.1097/00001888-200601000-00020; Schaufeli W.B., 1996, MASLACH BURNOUT INVE, V3rd, P22; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Schroeder S., 2006, PERFORMANCE MEASUREM; Sherry B., 2010, Morbidity and Mortality Weekly Report, V59, P951; Soldatos CR, 2000, J PSYCHOSOM RES, V48, P555, DOI 10.1016/S0022-3999(00)00095-7; Toshihiro M, 2008, DIABETIC MED, V25, P1211, DOI 10.1111/j.1464-5491.2008.02566.x; Tregear S, 2009, J CLIN SLEEP MED, V5, P573; Vila B, 2006, AM J IND MED, V49, P972, DOI 10.1002/ajim.20333; Violanti JM, 1998, AM J IND MED, V33, P366, DOI 10.1002/(SICI)1097-0274(199804)33:4<366::AID-AJIM6>3.0.CO;2-S; Violanti JM, 2009, ARCH ENVIRON OCCUP H, V64, P194, DOI 10.1080/19338240903241259; Yaffe K, 2011, JAMA-J AM MED ASSOC, V306, P613, DOI 10.1001/jama.2011.1115; Yoo SS, 2007, CURR BIOL, V17, pR877, DOI 10.1016/j.cub.2007.08.007; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	55	222	230	2	57	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 21	2011	306	23					2567	2578		10.1001/jama.2011.1851	http://dx.doi.org/10.1001/jama.2011.1851			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	864YQ	22187276	Bronze			2022-12-28	WOS:000298276800018
J	Spence, JD; Stampfer, MJ				Spence, J. David; Stampfer, Meir J.			Understanding the Complexity of Homocysteine Lowering With Vitamins The Potential Role of Subgroup Analyses	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; STROKE PREVENTION; RECURRENT STROKE; RISK; INTERVENTION; THERAPY		[Spence, J. David] Univ Western Ontario, Robarts Res Inst, Stroke Prevent & Atherosclerosis Res Ctr, London, ON N6G 2V2, Canada; [Stampfer, Meir J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Stampfer, Meir J.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Stampfer, Meir J.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Stampfer, Meir J.] Harvard Univ, Sch Med, Boston, MA USA	Western University (University of Western Ontario); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Spence, JD (corresponding author), Univ Western Ontario, Robarts Res Inst, Stroke Prevent & Atherosclerosis Res Ctr, 1400 Western Rd, London, ON N6G 2V2, Canada.	dspence@robarts.ca	Spence, J. David/K-6396-2013	Spence, J. David/0000-0001-7478-1098				House AA, 2010, JAMA-J AM MED ASSOC, V303, P1603, DOI 10.1001/jama.2010.490; Hsu FC, 2011, NEUROLOGY, V77, P1543, DOI 10.1212/WNL.0b013e318233b1f9; Rimm EB, 2011, LANCET, V378, P544, DOI 10.1016/S0140-6736(11)61057-X; Spence D, 2009, LANCET, V373, P1006, DOI 10.1016/S0140-6736(09)60604-8; Spence JD, 2007, LANCET NEUROL, V6, P830, DOI 10.1016/S1474-4422(07)70219-3; Spence JD, 2005, STROKE, V36, P2404, DOI 10.1161/01.STR.0000185929.38534.f3; Toole JF, 2004, JAMA-J AM MED ASSOC, V291, P565, DOI 10.1001/jama.291.5.565; Veeranna V, 2011, J AM COLL CARDIOL, V58, P1025, DOI 10.1016/j.jacc.2011.05.028; Vogiatzoglou A, 2009, CLIN CHEM, V55, P2198, DOI 10.1373/clinchem.2009.128678; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	10	60	62	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 21	2011	306	23					2610	2611		10.1001/jama.2011.1834	http://dx.doi.org/10.1001/jama.2011.1834			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	864YQ	22187282				2022-12-28	WOS:000298276800024
J	Havranek, EP				Havranek, Edward P.			Review: A Mediterranean diet reduces cardiovascular risk factors in overweight patients compared with a low-fat diet	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							METAANALYSIS		Denver Hlth Med Ctr, Denver, CO USA	Denver Health Medical Center	Havranek, EP (corresponding author), Denver Hlth Med Ctr, Denver, CO USA.							Kastorini CM, 2011, J AM COLL CARDIOL, V57, P1299, DOI 10.1016/j.jacc.2010.09.073; Sofi F, 2010, AM J CLIN NUTR, V92, P1189, DOI 10.3945/ajcn.2010.29673	2	2	2	1	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2011	155	12							JC6-3	10.7326/0003-4819-155-12-201112200-02003	http://dx.doi.org/10.7326/0003-4819-155-12-201112200-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	864ZU	22184704				2022-12-28	WOS:000298280500002
J	McGreevy, C; Williams, D				McGreevy, Cora; Williams, David			New Insights About Vitamin D and Cardiovascular Disease A Narrative Review	ANNALS OF INTERNAL MEDICINE			English	Review							PARATHYROID-HORMONE LEVELS; D DEFICIENCY; D INSUFFICIENCY; POSTMENOPAUSAL WOMEN; BLOOD-PRESSURE; 25-HYDROXYVITAMIN-D LEVELS; CALCIUM SUPPLEMENTATION; MYOCARDIAL-INFARCTION; ENDOTHELIAL FUNCTION; AUGMENTATION INDEX	The worsening worldwide trend toward nutritional insufficiency and the emerging knowledge of the nonhormonal actions of vitamin D and its metabolites have increased interest in the synthesis, metabolism, and action of vitamin D. Vitamin D deficiency has been linked with hypertension, myocardial infarction, and stroke, as well as other cardiovascular-related diseases, such as diabetes, congestive heart failure, peripheral vascular disease, atherosclerosis, and endothelial dysfunction. This review discusses the physiology and definition of vitamin D deficiency, evaluates the worldwide prevalence of vitamin D deficiency, and discusses recent evidence for the association between hypovitaminosis D and cardiovascular disease. Few randomized, controlled trials have evaluated the effect of vitamin D replacement on cardiovascular outcomes, and the results have been inconclusive or contradictory. Carefully designed randomized, controlled trials are essential to evaluate the role of vitamin D supplementation in reducing cardiovascular disease.	[McGreevy, Cora; Williams, David] Beaumont Hosp, Royal Coll Surg Ireland, Dublin 9, Ireland	Royal College of Surgeons - Ireland	McGreevy, C (corresponding author), Beaumont Hosp, Royal Coll Surg Ireland, Dublin 9, Ireland.	coramcgreevy@rcsi.ie		Williams, David/0000-0002-1923-462X				Aggarwal N, 2010, CURR CARDIOVASC RISK, V4, P68, DOI 10.1007/s12170-009-0072-1; Andrade J, 2008, CLIN J AM SOC NEPHRO, V3, P1800, DOI 10.2215/CJN.00900208; AUWERX J, 1992, ARTERIOSCLER THROMB, V12, P671, DOI 10.1161/01.ATV.12.6.671; Bostick RM, 1999, AM J EPIDEMIOL, V149, P151, DOI 10.1093/oxfordjournals.aje.a009781; Braam LAJLM, 2004, THROMB HAEMOSTASIS, V91, P373, DOI 10.1160/TH03-07-0423; Brazier M, 2005, CLIN THER, V27, P1885, DOI 10.1016/j.clinthera.2005.12.010; Brock K, 2004, J STEROID BIOCHEM, V89-90, P581, DOI 10.1016/j.jsbmb.2004.03.073; Burgaz A, 2011, J INTERN MED, V269, P211, DOI 10.1111/j.1365-2796.2010.02309.x; Carrelli AL, 2011, STROKE, V42, P2240, DOI 10.1161/STROKEAHA.110.608539; Chapuy MC, 1997, OSTEOPOROSIS INT, V7, P439, DOI 10.1007/s001980050030; Cigolini M, 2006, DIABETES CARE, V29, P722, DOI 10.2337/diacare.29.03.06.dc05-2148; Dawson-Hughes B, 2010, OSTEOPOROSIS INT, V21, P1151, DOI 10.1007/s00198-010-1285-3; de Boer IH, 2009, J AM SOC NEPHROL, V20, P1805, DOI 10.1681/ASN.2008111157; DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S; DeLuca HF, 1998, NUTR REV, V56, pS4; Dong YB, 2010, J CLIN ENDOCR METAB, V95, P4584, DOI 10.1210/jc.2010-0606; Douglas AS, 1995, J EPIDEMIOL COMMUN H, V49, P575, DOI 10.1136/jech.49.6.575; Elamin MB, 2011, J CLIN ENDOCR METAB, V96, P1931, DOI 10.1210/jc.2011-0398; Endemann DH, 2004, J AM SOC NEPHROL, V15, P1983, DOI 10.1097/01.ASN.0000132474.50966.DA; Fitzpatrick Lorraine A, 2008, Curr Osteoporos Rep, V6, P77, DOI 10.1007/s11914-008-0014-8; Forman JP, 2007, HYPERTENSION, V49, P1063, DOI 10.1161/HYPERTENSIONAHA.107.087288; Ginde AA, 2009, ARCH INTERN MED, V169, P626, DOI 10.1001/archinternmed.2008.604; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Grey A, 2010, ARCH INTERN MED, V170, P1099, DOI 10.1001/archinternmed.2010.174; Grimes DS, 1996, QJM-INT J MED, V89, P579; Heaney RP, 2003, AM J CLIN NUTR, V77, P204, DOI 10.1093/ajcn/77.1.204; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; HULTER H N, 1986, Journal of Clinical Hypertension, V2, P360; Hypponen E, 2007, AM J CLIN NUTR, V85, P860, DOI 10.1093/ajcn/85.3.860; Institute of Medicine, 2010, DIET REF INT CALC VI; Kai HK, 1998, J AM COLL CARDIOL, V32, P368, DOI 10.1016/S0735-1097(98)00250-2; LaCroix AZ, 2009, J GERONTOL A-BIOL, V64, P559, DOI 10.1093/gerona/glp006; Lim SK, 2008, CURR MED RES OPIN, V24, P99, DOI 10.1185/030079908X253429; Lips P, 2006, J INTERN MED, V260, P245, DOI 10.1111/j.1365-2796.2006.01685.x; Lips P, 2001, ENDOCR REV, V22, P477, DOI 10.1210/er.22.4.477; Llewellyn DJ, 2010, ARCH INTERN MED, V170, P1135, DOI 10.1001/archinternmed.2010.173; MACLAUGHLIN J, 1985, J CLIN INVEST, V76, P1536, DOI 10.1172/JCI112134; Major GC, 2007, AM J CLIN NUTR, V85, P54; Martins D, 2007, ARCH INTERN MED, V167, P1159, DOI 10.1001/archinte.167.11.1159; MATSUOKA LY, 1987, J CLIN ENDOCR METAB, V64, P1165, DOI 10.1210/jcem-64-6-1165; McEniery CM, 2006, HYPERTENSION, V48, P602, DOI 10.1161/01.HYP.0000239206.64270.5f; Melamed ML, 2008, ARTERIOSCL THROM VAS, V28, P1179, DOI 10.1161/ATVBAHA.108.165886; Mithal A, 2009, OSTEOPOROSIS INT, V20, P1807, DOI 10.1007/s00198-009-0954-6; Momiyama Y, 2010, ATHEROSCLEROSIS, V209, P206, DOI 10.1016/j.atherosclerosis.2009.07.037; Moore CE, 2005, J NUTR, V135, P2478, DOI 10.1093/jn/135.10.2478; Nowson CA, 2002, MED J AUSTRALIA, V177, P149, DOI 10.5694/j.1326-5377.2002.tb04702.x; Ovesen L, 2003, P NUTR SOC, V62, P813, DOI 10.1079/PNS2003297; Pan W H, 1993, Chin J Physiol, V36, P85; Pfeifer M, 2001, J CLIN ENDOCR METAB, V86, P1633, DOI 10.1210/jc.86.4.1633; Pilz S, 2009, NAT REV CARDIOL, V6, P621, DOI 10.1038/nrcardio.2009.135; Pittas AG, 2010, ANN INTERN MED, V152, P307, DOI 10.7326/0003-4819-152-5-201003020-00009; Poole KES, 2006, STROKE, V37, P243, DOI 10.1161/01.STR.0000195184.24297.c1; Prince RL, 2008, ARCH INTERN MED, V168, P103, DOI 10.1001/archinternmed.2007.31; Robinson PD, 2006, ARCH DIS CHILD, V91, P564, DOI 10.1136/adc.2004.069575; Rostand SG, 1997, HYPERTENSION, V30, P150, DOI 10.1161/01.HYP.30.2.150; Sachan A, 2005, AM J CLIN NUTR, V81, P1060; Sambrook PN, 2002, MED J AUSTRALIA, V176, P560, DOI 10.5694/j.1326-5377.2002.tb04557.x; SCRAGG R, 1990, INT J EPIDEMIOL, V19, P559, DOI 10.1093/ije/19.3.559; Secchiero P, 2006, AM J PATHOL, V169, P2236, DOI 10.2353/ajpath.2006.060398; Snijder MB, 2007, J INTERN MED, V261, P558, DOI 10.1111/j.1365-2796.2007.01778.x; Snijder MB, 2005, J CLIN ENDOCR METAB, V90, P4119, DOI 10.1210/jc.2005-0216; Sugden JA, 2008, DIABETIC MED, V25, P320, DOI 10.1111/j.1464-5491.2007.02360.x; Targher G, 2006, CLIN ENDOCRINOL, V65, P593, DOI 10.1111/j.1365-2265.2006.02633.x; Timms PM, 2002, QJM-INT J MED, V95, P787, DOI 10.1093/qjmed/95.12.787; Tishkoff DX, 2008, ENDOCRINOLOGY, V149, P558, DOI 10.1210/en.2007-0805; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469; Van Campenhout A, 2009, ATHEROSCLEROSIS, V204, P321, DOI 10.1016/j.atherosclerosis.2008.09.033; Van Den Bout-Van Den Beukel CJP, 2008, AIDS RES HUM RETROV, V24, P1375, DOI 10.1089/aid.2008.0058; VANDERWIELEN RPJ, 1995, LANCET, V346, P207, DOI 10.1016/S0140-6736(95)91266-5; Wang L, 2010, ANN INTERN MED, V152, P315, DOI 10.7326/0003-4819-152-5-201003020-00010; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Xiang W, 2005, AM J PHYSIOL-ENDOC M, V288, pE125, DOI 10.1152/ajpendo.00224.2004; Young KA, 2011, DIABETES CARE, V34, P454, DOI 10.2337/dc10-0757; Zauli G, 2007, BLOOD, V110, P536, DOI 10.1182/blood-2007-01-068395; Zhou CC, 2006, J CLIN INVEST, V116, P1703, DOI 10.1172/JCI27793; Zhou CL, 2008, KIDNEY INT, V74, P170, DOI 10.1038/ki.2008.101; Zittermann A, 2005, BRIT J NUTR, V94, P483, DOI 10.1079/BJN20051544; Zittermann A, 2003, J AM COLL CARDIOL, V41, P105, DOI 10.1016/S0735-1097(02)02624-4; Zittermann A, 1998, EUR J CLIN NUTR, V52, P501, DOI 10.1038/sj.ejcn.1600591	80	123	128	1	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2011	155	12					820	U65		10.7326/0003-4819-155-12-201112200-00004	http://dx.doi.org/10.7326/0003-4819-155-12-201112200-00004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	864ZU	22184689				2022-12-28	WOS:000298280500016
J	Molony, DA				Molony, Donald A.			Young adults with persistent, asymptomatic, isolated microscopic hematuria were at increased risk for ESRD	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DISEASE		Univ Texas Houston Med Sch, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston	Molony, DA (corresponding author), Univ Texas Houston Med Sch, Houston, TX USA.							Iseki K, 1996, KIDNEY INT, V49, P800, DOI 10.1038/ki.1996.111; Jafar TH, 2003, ANN INTERN MED, V139, P244, DOI 10.7326/0003-4819-139-4-200308190-00006; Young A, 2008, AM J TRANSPLANT, V8, P1878, DOI 10.1111/j.1600-6143.2008.02339.x	3	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2011	155	12							JC6-12	10.7326/0003-4819-155-12-201112200-02012	http://dx.doi.org/10.7326/0003-4819-155-12-201112200-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	864ZU	22184713				2022-12-28	WOS:000298280500011
J	Kuzdzal-Fick, JJ; Fox, SA; Strassmann, JE; Queller, DC				Kuzdzal-Fick, Jennie J.; Fox, Sara A.; Strassmann, Joan E.; Queller, David C.			High Relatedness Is Necessary and Sufficient to Maintain Multicellularity in Dictyostelium	SCIENCE			English	Article							SOCIAL AMEBA; COOPERATION; EVOLUTION; CONFLICT; INDIVIDUALITY; SELECTION	Most complex multicellular organisms develop clonally from a single cell. This should limit conflicts between cell lineages that could threaten the extensive cooperation of cells within multicellular bodies. Cellular composition can be manipulated in the social amoeba Dictyostelium discoideum, which allows us to test and confirm the two key predictions of this theory. Experimental evolution at low relatedness favored cheating mutants that could destroy multicellular development. However, under high relatedness, the forces of mutation and within-individual selection are too small for these destructive cheaters to spread, as shown by a mutation accumulation experiment. Thus, we conclude that the single-cell bottleneck is a powerful stabilizer of cellular cooperation in multicellular organisms.	[Kuzdzal-Fick, Jennie J.; Fox, Sara A.; Strassmann, Joan E.; Queller, David C.] Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77005 USA; [Kuzdzal-Fick, Jennie J.] Univ Texas Austin, Coll Nat Sci, Sect Integrat Biol, Austin, TX 78712 USA; [Strassmann, Joan E.; Queller, David C.] Washington Univ, Dept Biol CB1137, St Louis, MO 63130 USA	Rice University; University of Texas System; University of Texas Austin; Washington University (WUSTL)	Queller, DC (corresponding author), Rice Univ, Dept Ecol & Evolutionary Biol, 6100 Main St, Houston, TX 77005 USA.	queller@wustl.edu		Strassmann, Joan/0000-0003-0638-8440	NSF [DEB-0918931, DEB-0816690]; Wray-Todd Graduate Fellowships	NSF(National Science Foundation (NSF)); Wray-Todd Graduate Fellowships	Supported by the NSF grants DEB-0918931 and DEB-0816690. J.J.K. and S. A. F. were supported partly by Wray-Todd Graduate Fellowships. We thank J. Potter and A. Smith for laboratory work, G. Saxer for advice, and C. Kuzdzal Fick for advice and for comments on the manuscript. Data are available in the supporting online material.	BONNER JT, 1953, BIOL BULL, V104, P297, DOI 10.2307/1538484; BONNER JT, 1967, CELLULAR SLIME MOLDS; Bourke AFG, 2011, OX ECOL EV, P28; Brockhurst MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000634; Buss LW, 1987, EVOLUTION INDIVIDUAL, DOI DOI 10.1515/9781400858712; Chen GK, 2005, EUKARYOT CELL, V4, P1755, DOI 10.1128/EC.4.10.1755-1764.2005; Ennis HL, 2000, P NATL ACAD SCI USA, V97, P3292, DOI 10.1073/pnas.050005097; Gilbert OM, 2007, P NATL ACAD SCI USA, V104, P8913, DOI 10.1073/pnas.0702723104; GRAFEN, 1985, OXFORD SURV EVOL BIO, V2, P28; Grosberg RK, 2007, ANNU REV ECOL EVOL S, V38, P621, DOI 10.1146/annurev.ecolsys.36.102403.114735; Hirose S, 2011, SCIENCE, V333, P467, DOI 10.1126/science.1203903; Hughes WOH, 2008, SCIENCE, V320, P1213, DOI 10.1126/science.1156108; Keller L, 1999, LEVELS SELECTION EVO; Kessin R.H., 2001, DICTYOSTELIUM EVOLUT; Le Gac M, 2010, EVOLUTION, V64, P522, DOI 10.1111/j.1558-5646.2009.00814.x; Lynch M, 1999, EVOLUTION, V53, P645, DOI 10.1111/j.1558-5646.1999.tb05361.x; Maynard Smith J, 1989, EVOLUTIONARY PROGR, P219; Michod RE, 1997, AM NAT, V149, P607, DOI 10.1086/286012; Michod RE, 1997, P ROY SOC B-BIOL SCI, V264, P853, DOI 10.1098/rspb.1997.0119; Michod RE, 1996, P ROY SOC B-BIOL SCI, V263, P813, DOI 10.1098/rspb.1996.0121; Ostrowski EA, 2008, PLOS BIOL, V6, P2376, DOI 10.1371/journal.pbio.0060287; Queller DC, 2000, PHILOS T R SOC B, V355, P1647, DOI 10.1098/rstb.2000.0727; Ratnieks FLW, 2006, ANNU REV ENTOMOL, V51, P581, DOI 10.1146/annurev.ento.51.110104.151003; Santorelli LA, 2008, NATURE, V451, P1107, DOI 10.1038/nature06558; Strassmann JE, 2000, NATURE, V408, P965, DOI 10.1038/35050087; Szathmary E, 1995, MAJOR TRANSITIONS EV	28	68	68	0	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2011	334	6062					1548	1551		10.1126/science.1213272	http://dx.doi.org/10.1126/science.1213272			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	862LE	22174251				2022-12-28	WOS:000298091400051
J	Laland, KN; Sterelny, K; Odling-Smee, J; Hoppitt, W; Uller, T				Laland, Kevin N.; Sterelny, Kim; Odling-Smee, John; Hoppitt, William; Uller, Tobias			Cause and Effect in Biology Revisited: Is Mayr's Proximate-Ultimate Dichotomy Still Useful?	SCIENCE			English	Review							GENE-CULTURE COEVOLUTION; NICHE CONSTRUCTION; EVO-DEVO; EVOLUTION; DISTINCTION; LANGUAGE; ALTRUISM; ECOLOGY	Fifty years ago, Ernst Mayr published a hugely influential paper on the nature of causation in biology, in which he distinguished between proximate and ultimate causes. Mayr equated proximate causation with immediate factors (for example, physiology) and ultimate causation with evolutionary explanations (for example, natural selection). He argued that proximate and ultimate causes addressed different questions and were not alternatives. Mayr's account of causation remains widely accepted today, with both positive and negative ramifications. Several current debates in biology (for example, over evolution and development, niche construction, cooperation, and the evolution of language) are linked by a common axis of acceptance/rejection of Mayr's model of causation. We argue that Mayr's formulation has acted to stabilize the dominant evolutionary paradigm against change but may now hamper progress in the biological sciences.	[Laland, Kevin N.; Hoppitt, William] Univ St Andrews, Sch Biol, St Andrews KY16 9TS, Fife, Scotland; [Sterelny, Kim] Australian Natl Univ, Sch Philosophy, Canberra, ACT 0200, Australia; [Sterelny, Kim] Victoria Univ Wellington, Sch Hist Philosophy Polit Sci & Int Relat, Wellington 6140, New Zealand; [Odling-Smee, John] Univ Oxford, Mansfield Coll, Oxford OX1 3TF, England; [Uller, Tobias] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England	University of St Andrews; Australian National University; Victoria University Wellington; University of Oxford; University of Oxford	Laland, KN (corresponding author), Univ St Andrews, Sch Biol, St Andrews KY16 9TS, Fife, Scotland.	knl1@st-andrews.ac.uk	Hoppitt, William/A-8216-2008; Laland, Kevin N/C-9482-2011	Hoppitt, William/0000-0003-0815-5720; Sterelny, Kim/0000-0003-3159-6698; Laland, Kevin/0000-0002-2457-0900	European Research Council [232823]; Biology and Biotechnology Sciences Research Center [BB/D015812/1]; BBSRC [BB/D015812/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D015812/1] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Biology and Biotechnology Sciences Research Center; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Research supported in part by a European Research Council advanced grant (EVOCULTURE, reference no. 232823) to K.N.L. and Biology and Biotechnology Sciences Research Center grant (BB/D015812/1) to K.N.L. and W. H. We are grateful to C. Efferson, E. Fehr, D. Ferrier, S. Gilbert, J. Hogan, G. Muller, P. Richerson, and the Laland lab members for helpful comments on earlier drafts.	Amundson R, 2005, CAMB STUD PHIL BIOL, P1, DOI 10.1017/CBO9781139164856; [Anonymous], 2001, CYCLES CONTINGENCY D; [Anonymous], 1983, EVOLUTION MOL MEN; [Anonymous], 2000, CAUSALITY; Ariew A, 2003, BIOL PHILOS, V18, P553, DOI 10.1023/A:1025565119032; Arthur W, 2004, BIASED EMBRYO EVOLUT; Baker J. R., 1938, P161; BEATTY J, 1994, BIOL PHILOS, V9, P333, DOI 10.1007/BF00857940; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Boyd R., 1985, CULTURE EVOLUTIONARY; Brakefield PM, 2006, TRENDS ECOL EVOL, V21, P362, DOI 10.1016/j.tree.2006.05.001; CAVALLI-SFORZA L.L, 1981, CULTURAL TRANSMISSIO; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Chomsky Noam., 1965, ASPECTS THEORY SYNTA; Cornwallis CK, 2010, TRENDS ECOL EVOL, V25, P145, DOI 10.1016/j.tree.2009.09.008; Danchin E, 2011, NAT REV GENET, V12, P475, DOI 10.1038/nrg3028; Dawkins Richard, 1976, SELFISH GENE; Dewsbury DA, 1999, BEHAV PROCESS, V46, P189, DOI 10.1016/S0376-6357(99)00035-2; Dunn M, 2011, NATURE, V473, P79, DOI 10.1038/nature09923; Durham WH., 1991, COEVOLUTION GENES CU; Efferson C, 2008, SCIENCE, V321, P1844, DOI 10.1126/science.1155805; Erwin DH, 2008, TRENDS ECOL EVOL, V23, P304, DOI 10.1016/j.tree.2008.01.013; Evans N, 2009, BEHAV BRAIN SCI, V32, P429, DOI 10.1017/S0140525X0999094X; Ewald PW, 1994, EVOLUTION INFECT DIS; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Galis F, 2010, EVOLUTION, V64, P2466, DOI 10.1111/j.1558-5646.2010.01041.x; Gilbert S.F., 2003, DEV BIOL, V7th Edn; Gintis H, 2003, J THEOR BIOL, V220, P407, DOI 10.1006/jtbi.2003.3104; Gluckman, 2011, PLASTICITY ROBUSTNES; Grafen A, 2009, PHILOS T R SOC B, V364, P3135, DOI 10.1098/rstb.2009.0056; Henrich J, 2004, J ECON BEHAV ORGAN, V53, P3, DOI 10.1016/S0167-2681(03)00094-5; Hogan J., 1994, CAUSAL MECH BEHAV DE, P3, DOI 10.1017/CBO9780511565120.003; Jablonka E., 2005, EVOLUTION 4 DIMENSIO; Kirby S, 2008, P NATL ACAD SCI USA, V105, P10681, DOI 10.1073/pnas.0707835105; Kirby S, 2007, P NATL ACAD SCI USA, V104, P5241, DOI 10.1073/pnas.0608222104; Laland KN, 2008, J EXP ZOOL PART B, V310B, P549, DOI 10.1002/jez.b.21232; Laland KN, 2006, EVOLUTION, V60, P1751; Laland KN, 2010, NAT REV GENET, V11, P137, DOI 10.1038/nrg2734; Laland KN, 1999, P NATL ACAD SCI USA, V96, P10242, DOI 10.1073/pnas.96.18.10242; Laland KN, 2011, SENSE NONSENSE EVOLU; Lehmann L, 2008, EVOLUTION, V62, P549, DOI 10.1111/j.1558-5646.2007.00291.x; MacDougall-Shackleton SA, 2011, PHILOS T R SOC B, V366, P2076, DOI 10.1098/rstb.2010.0363; MAYR E, 1961, SCIENCE, V134, P1501, DOI 10.1126/science.134.3489.1501; MAYR E, 1984, TLS-TIMES LIT SUPPL, P1261; Mayr E., 1992, Oxford Surveys in Evolutionary Biology, V8, P1; Mesoudi A, 2011, CULTURAL EVOLUTION; Moczek AP, 2011, P ROY SOC B-BIOL SCI, V278, P2705, DOI 10.1098/rspb.2011.0971; Muller GB, 2007, NAT REV GENET, V8, P943, DOI 10.1038/nrg2219; Nowak MA, 2010, NATURE, V466, P1057, DOI 10.1038/nature09205; Odling-Smee F. J., 2003, MONOGR POPUL BIOL, V37, P1; PINKER S, 1990, BEHAV BRAIN SCI, V13, P707, DOI 10.1017/S0140525X00081061; Plotkin H ., 2010, EVOLUTIONARY WORLDS; Post DM, 2009, PHILOS T R SOC B, V364, P1629, DOI 10.1098/rstb.2009.0012; Richerson PJ, 2010, P NATL ACAD SCI USA, V107, P8985, DOI 10.1073/pnas.0914631107; Scott-Phillips TC, 2011, PERSPECT PSYCHOL SCI, V6, P38, DOI 10.1177/1745691610393528; SHERMAN PW, 1988, ANIM BEHAV, V36, P616, DOI 10.1016/S0003-3472(88)80039-3; Shipley B., 2000, CAUSE CORRELATIONS B; ten Cate C, 2000, TRENDS ECOL EVOL, V15, P179, DOI 10.1016/S0169-5347(00)01852-8; Tinbergen N., 1963, Zeitschrift fuer Tierpsychologie, V20, P410; Tooby J., 1992, ADAPTED MIND EVOLUTI, P137; Turner JS, 2002, EXTENDED ORGANISM PH; West SA, 2007, J EVOLUTION BIOL, V20, P415, DOI 10.1111/j.1420-9101.2006.01258.x; West SA, 2011, EVOL HUM BEHAV, V32, P231, DOI 10.1016/j.evolhumbehav.2010.08.001; West-Eberhard Mary Jane, 2003, pi	64	319	339	7	217	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2011	334	6062					1512	1516		10.1126/science.1210879	http://dx.doi.org/10.1126/science.1210879			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	862LE	22174243				2022-12-28	WOS:000298091400042
J	Michaud, M; Martins, I; Sukkurwala, AQ; Adjemian, S; Ma, YT; Pellegatti, P; Shen, SS; Kepp, O; Scoazec, M; Mignot, G; Rello-Varona, S; Tailler, M; Menger, L; Vacchelli, E; Galluzzi, L; Ghiringhelli, F; di Virgilio, F; Zitvogel, L; Kroemer, G				Michaud, Mickael; Martins, Isabelle; Sukkurwala, Abdul Qader; Adjemian, Sandy; Ma, Yuting; Pellegatti, Patrizia; Shen, Shensi; Kepp, Oliver; Scoazec, Marie; Mignot, Gregoire; Rello-Varona, Santiago; Tailler, Maximilien; Menger, Laurie; Vacchelli, Erika; Galluzzi, Lorenzo; Ghiringhelli, Francois; di Virgilio, Francesco; Zitvogel, Laurence; Kroemer, Guido			Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice	SCIENCE			English	Article							CALRETICULIN EXPOSURE; CELLS; CANCER; IMMUNOGENICITY; HMGB1	Antineoplastic chemotherapies are particularly efficient when they elicit immunogenic cell death, thus provoking an anticancer immune response. Here we demonstrate that autophagy, which is often disabled in cancer, is dispensable for chemotherapy-induced cell death but required for its immunogenicity. In response to chemotherapy, autophagy-competent, but not autophagy-deficient, cancers attracted dendritic cells and T lymphocytes into the tumor bed. Suppression of autophagy inhibited the release of adenosine triphosphate (ATP) from dying tumor cells. Conversely, inhibition of extracellular ATP-degrading enzymes increased pericellular ATP in autophagy-deficient tumors, reestablished the recruitment of immune cells, and restored chemotherapeutic responses but only in immunocompetent hosts. Thus, autophagy is essential for the immunogenic release of ATP from dying cells, and increased extracellular ATP concentrations improve the efficacy of antineoplastic chemotherapies when autophagy is disabled.	[Michaud, Mickael; Martins, Isabelle; Sukkurwala, Abdul Qader; Adjemian, Sandy; Ma, Yuting; Shen, Shensi; Kepp, Oliver; Scoazec, Marie; Rello-Varona, Santiago; Tailler, Maximilien; Menger, Laurie; Vacchelli, Erika; Galluzzi, Lorenzo; Zitvogel, Laurence; Kroemer, Guido] Inst Gustave Roussy, Villejuif, France; [Michaud, Mickael; Martins, Isabelle; Sukkurwala, Abdul Qader; Adjemian, Sandy; Shen, Shensi; Kepp, Oliver; Rello-Varona, Santiago; Tailler, Maximilien; Menger, Laurie; Vacchelli, Erika; Galluzzi, Lorenzo; Kroemer, Guido] INSERM, U848, Villejuif, France; [Michaud, Mickael; Martins, Isabelle; Sukkurwala, Abdul Qader; Adjemian, Sandy; Ma, Yuting; Shen, Shensi; Kepp, Oliver; Rello-Varona, Santiago; Tailler, Maximilien; Menger, Laurie; Vacchelli, Erika; Galluzzi, Lorenzo; Zitvogel, Laurence] Univ Paris Sud, Fac Med Paris 11, F-94275 Le Kremlin Bicetre, France; [Ma, Yuting; Zitvogel, Laurence] INSERM, U1015, Villejuif, France; [Ma, Yuting; Zitvogel, Laurence] Ctr Clin Invest Biotherapies Canc CICBT 507, Villejuif, France; [Pellegatti, Patrizia; di Virgilio, Francesco] Univ Ferrara, Dept Expt & Diagnost Med, Sect Gen Pathol, Interdisciplinary Ctr Study Inflammat, I-44100 Ferrara, Italy; [Mignot, Gregoire; Ghiringhelli, Francois] Georges Francois Leclerc Ctr, Dept Med Oncol, Dijon, France; [Mignot, Gregoire; Ghiringhelli, Francois] CRI 866 Univ Burgundy, INSERM Avenir Team INSERM, Dijon, France; [Kroemer, Guido] Ctr Rech Cordeliers, Paris, France; [Kroemer, Guido] Hop Europeen Georges Pompidou, AP HP, Paris, France; [Kroemer, Guido] Univ Paris 05, Paris, France	UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Ferrara; UNICANCER; Centre Georges-Francois Leclerc; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Zitvogel, L (corresponding author), Inst Gustave Roussy, Villejuif, France.	zitvogel@igr.fr; kroemer@orange.fr	Kepp, Oliver/N-2763-2017; KROEMER, Guido/B-4263-2013; Mignot, Grégoire/R-4976-2017; Galluzzi, Lorenzo/AAG-6432-2019; Kroemer, Guido/AAY-9859-2020; Galluzzi, Lorenzo/K-2709-2012; Galluzzi, Lorenzo/AAG-6294-2019; Vacchelli, Erika/E-5212-2018; Rello-Varona, Santi/A-4882-2009; Kepp, Oliver/GPX-8627-2022; ADJEMIAN, Sandy/K-7632-2012; SHEN, Shensi/AAW-2735-2020; Di Virgilio, Francesco/J-3754-2018; DI VIRGILIO, Francesco/O-4634-2019; Galluzzi, Lorenzo/AAH-3286-2021	Kepp, Oliver/0000-0002-6081-9558; KROEMER, Guido/0000-0002-9334-4405; Mignot, Grégoire/0000-0002-0682-0152; Galluzzi, Lorenzo/0000-0003-2257-8500; Vacchelli, Erika/0000-0001-8010-0594; Rello-Varona, Santi/0000-0002-7500-5522; ADJEMIAN, Sandy/0000-0001-5594-5499; SHEN, Shensi/0000-0002-5087-8220; Di Virgilio, Francesco/0000-0003-3566-1362; DI VIRGILIO, Francesco/0000-0003-3566-1362; Menger, Laurie/0000-0003-0949-6607; ghiringhelli, francois/0000-0002-5465-8305; ZITVOGEL, laurence/0000-0003-1596-0998	Ligue Nationale contre le Cancer (Equipes labelisees); Agence Nationale pour la Recherche (ANR); European Commission; Fondation pour la Recherche Medicale (FRM); Fondation Bettencourt-Schueller Institut National du Cancer (INCa); Canceropole Ile-de-France; LabEx OncoImmunology; Association pour la Recherche sur le Cancer; Italian Association for Cancer Research (AIRC); La Ligue Nationale contre le Cancer; China Scholarship Council; Higher Education Commission of Pakistan; Fondation de France	Ligue Nationale contre le Cancer (Equipes labelisees)(Institut National du Cancer (INCA) France); Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Fondation Bettencourt-Schueller Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Canceropole Ile-de-France(Region Ile-de-France); LabEx OncoImmunology; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); La Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); China Scholarship Council(China Scholarship Council); Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); Fondation de France(Fondation de France)	G.K. and L.Z. are supported by the Ligue Nationale contre le Cancer (Equipes labelisees), Agence Nationale pour la Recherche (ANR), European Commission (Active p53, Apo-Sys, ChemoRes, ApopTrain INFLACare), Fondation pour la Recherche Medicale (FRM), Fondation Bettencourt-Schueller Institut National du Cancer (INCa), and Canceropole Ile-de-France and the LabEx OncoImmunology. G. M. is supported by Association pour la Recherche sur le Cancer. F.d.V. and P. P. are supported by Italian Association for Cancer Research (AIRC). M. M. is supported by FRM. I. M., S. A., M. T. are supported by La Ligue Nationale contre le Cancer and Y.M. by China Scholarship Council. A. Q. S. is supported by Higher Education Commission of Pakistan. S.R.-V. is supported by Fondation de France. L.Z. has served as a paid consultant for Innate Pharma S. A., a biopharmaceutical company developing immunotherapy drugs for cancer.	Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Apetoh L, 2007, IMMUNOL REV, V220, P47, DOI 10.1111/j.1600-065X.2007.00573.x; Bianchi ME, 2009, J LEUKOCYTE BIOL, V86, P573, DOI 10.1189/jlb.1008585; Casares N, 2005, J EXP MED, V202, P1691, DOI 10.1084/jem.20050915; Chao MP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001375; Elgendy M, 2011, MOL CELL, V42, P23, DOI 10.1016/j.molcel.2011.02.009; Ferguson TA, 2011, IMMUNOL REV, V241, P77, DOI 10.1111/j.1600-065X.2011.01006.x; Finn OJ, 2008, NEW ENGL J MED, V358, P2704, DOI 10.1056/NEJMra072739; Fleming A, 2011, NAT CHEM BIOL, V7, P9, DOI 10.1038/NCHEMBIO.500; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Ma YT, 2011, J EXP MED, V208, P491, DOI 10.1084/jem.20100269; Maiuri MC, 2009, CELL DEATH DIFFER, V16, P87, DOI 10.1038/cdd.2008.131; Mandapathil M, 2010, J BIOL CHEM, V285, P7176, DOI 10.1074/jbc.M109.047423; Mathew R, 2011, CURR OPIN GENET DEV, V21, P113, DOI 10.1016/j.gde.2010.12.008; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Mutini C, 1999, J IMMUNOL, V163, P1958; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Panaretakis T, 2009, EMBO J, V28, P578, DOI 10.1038/emboj.2009.1; Pellegatti P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002599; Ray-Coquard I, 2009, CANCER RES, V69, P5383, DOI 10.1158/0008-5472.CAN-08-3845; Tesniere A, 2010, ONCOGENE, V29, P482, DOI 10.1038/onc.2009.356; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Zappasodi R, 2010, CANCER RES, V70, P9062, DOI 10.1158/0008-5472.CAN-10-1825; Zitvogel L, 2011, NAT REV CLIN ONCOL, V8, P151, DOI 10.1038/nrclinonc.2010.223	29	931	966	11	257	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2011	334	6062					1573	1577		10.1126/science.1208347	http://dx.doi.org/10.1126/science.1208347			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	862LE	22174255				2022-12-28	WOS:000298091400058
J	Reshef, DN; Reshef, YA; Finucane, HK; Grossman, SR; McVean, G; Turnbaugh, PJ; Lander, ES; Mitzenmacher, M; Sabeti, PC				Reshef, David N.; Reshef, Yakir A.; Finucane, Hilary K.; Grossman, Sharon R.; McVean, Gilean; Turnbaugh, Peter J.; Lander, Eric S.; Mitzenmacher, Michael; Sabeti, Pardis C.			Detecting Novel Associations in Large Data Sets	SCIENCE			English	Article							PRINCIPAL CURVES; REGRESSION; INFORMATION; MICROBIOME; HEALTH; CYCLE	Identifying interesting relationships between pairs of variables in large data sets is increasingly important. Here, we present a measure of dependence for two-variable relationships: the maximal information coefficient (MIC). MIC captures a wide range of associations both functional and not, and for functional relationships provides a score that roughly equals the coefficient of determination (R-2) of the data relative to the regression function. MIC belongs to a larger class of maximal information-based nonparametric exploration (MINE) statistics for identifying and classifying relationships. We apply MIC and MINE to data sets in global health, gene expression, major-league baseball, and the human gut microbiota and identify known and novel relationships.	[Reshef, David N.] MIT, Dept Comp Sci, Cambridge, MA 02139 USA; [Reshef, David N.; Reshef, Yakir A.; Grossman, Sharon R.; Lander, Eric S.; Sabeti, Pardis C.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Reshef, David N.; McVean, Gilean] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Reshef, Yakir A.] Harvard Univ, Dept Math, Cambridge, MA 02138 USA; [Finucane, Hilary K.] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Grossman, Sharon R.; Turnbaugh, Peter J.; Sabeti, Pardis C.] Harvard Univ, Dept Organism & Evolutionary Biol, Ctr Syst Biol, Cambridge, MA 02138 USA; [McVean, Gilean] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Mitzenmacher, Michael] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Oxford; Harvard University; Weizmann Institute of Science; Harvard University; University of Oxford; Wellcome Centre for Human Genetics; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University	Reshef, DN (corresponding author), MIT, Dept Comp Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	dnreshef@mit.edu; yreshef@post.harvard.edu	Sabeti, Pardis/GQH-8610-2022	Grossman, Sharon/0000-0001-6422-1134; McVean, Gil/0000-0002-5012-4162; Turnbaugh, Peter/0000-0002-0888-2875	Packard Foundation; NIH MIDAS [U54GM088558]; Marshall Scholarship; NSF [0915922]; ERC [239985]; Medical Scientist Training Program; NIH [P50 GM068763]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558, P50GM068763, T32GM007753] Funding Source: NIH RePORTER	Packard Foundation(The David & Lucile Packard Foundation); NIH MIDAS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marshall Scholarship; NSF(National Science Foundation (NSF)); ERC(European Research Council (ERC)European Commission); Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Blattler, B. Eidelson, M. D. Finucane, M. M. Finucane, M. Fujihara, T. Gingrich, E. Goldstein, R. Gupta, R. Hahne, T. Jaakkola, N. Laird, M. Lipsitch, S. Manber, G. Nicholls, A. Papageorge, N. Patterson, E. Phelan, J. Rinn, B. Ripley, I. Shylakhter, and R. Tibshirani for invaluable support and critical discussions throughout; and O. Derby, M. Fitzgerald, S. Hart, M. Huang, E. Karlsson, S. Schaffner, C. Edwards, and D. Yamins for assistance. P. C. S. and this work are supported by the Packard Foundation. For data set analysis, P. C. S. was also supported by NIH MIDAS award U54GM088558, D. N. R. by a Marshall Scholarship, M. M. by NSF grant 0915922, H. K. F. by ERC grant 239985, S. R. G. by the Medical Scientist Training Program, and P. J. T. by NIH P50 GM068763. Data and software are available online at http://exploredata.net.	Ahdesmaki M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-117; Algeo TJ, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2004PA001112; Baseball Prospectus Statistics Reports, 2009, BAS PROSP STAT REP; BREIMAN L, 1985, J AM STAT ASSOC, V80, P580, DOI 10.2307/2288473; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Central Intelligence Agency, 2009, WORLD FACTB 2009; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Clayton RN, 1996, GEOCHIM COSMOCHIM AC, V60, P1999, DOI 10.1016/0016-7037(96)00074-9; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Darbellay GA, 1999, IEEE T INFORM THEORY, V45, P1315, DOI 10.1109/18.761290; Delicado P, 2009, STAT COMPUT, V19, P255, DOI 10.1007/s11222-008-9090-y; Desai S, 1998, DEMOGRAPHY, V35, P71, DOI 10.2307/3004028; Fisher RA, 1929, P R SOC LOND A-CONTA, V125, P54, DOI 10.1098/rspa.1929.0151; Gill T., 2002, NOUMEA; Gupta S, 2001, J POLICY MODEL, V23, P433, DOI 10.1016/S0161-8938(00)00036-3; HASTIE T, 1989, J AM STAT ASSOC, V84, P502, DOI 10.2307/2289936; Hastie T., 2009, UNSUPERVISED LEARNIN; Kegl B, 1999, ADV NEUR IN, V11, P501; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Lahman S., 2009, BASEBALL ARCH; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; MOON YI, 1995, PHYS REV E, V52, P2318, DOI 10.1103/PhysRevE.52.2318; Renyi A, 1959, ACTA MATH ACAD SCI H, V10, P441, DOI DOI 10.1007/BF02024507; Rosling H., 2008, INDICATORS GAPMINDER; Science Staff, 2011, SCIENCE, V331, P692, DOI DOI 10.1126/SCIENCE.331.6018.692; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; STONE CJ, 1977, ANN STAT, V5, P595, DOI 10.1214/aos/1176343886; Szekely GJ, 2009, ANN APPL STAT, V3, P1236, DOI 10.1214/09-AOAS312; Tibshirani R., 1992, Statistics and Computing, V2, P183, DOI 10.1007/BF01889678; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; World Health Organization, 2009, WHO STAT INF SYST	33	1599	1757	64	699	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2011	334	6062					1518	1524		10.1126/science.1205438	http://dx.doi.org/10.1126/science.1205438			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	862LE	22174245	Green Submitted, Green Accepted			2022-12-28	WOS:000298091400044
J	Ahmed, U; Spyridis, N; Wong, ICK; Sharland, M; Long, PF				Ahmed, Umar; Spyridis, Nikos; Wong, Ian C. K.; Sharland, Mike; Long, Paul F.		Improving Children's Antibiotic Pr	CHRISTMAS 2011: ORAL TRADITIONS Dosing of oral penicillins in children: is big child=half an adult, small child=half a big child, baby=half a small child still the best we can do?	BRITISH MEDICAL JOURNAL			English	Editorial Material							OTITIS-MEDIA; PRIMARY-CARE; RESISTANCE; COHORT		[Ahmed, Umar; Wong, Ian C. K.; Long, Paul F.] Univ London, Sch Pharm, Ctr Paediat Pharm Res, London WC1H 9JP, England; [Ahmed, Umar] Boots Chemist, London, England; [Spyridis, Nikos; Sharland, Mike] St George Hosp, Paediat Infect Dis Unit, London, England; [Spyridis, Nikos] Univ Athens, P & A Kyriakou Childrens Hosp, Athens, Greece; [Wong, Ian C. K.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Long, Paul F.] Kings Coll London, Inst Pharmaceut Sci, London WC2R 2LS, England; [Long, Paul F.] Kings Coll London, Dept Chem, London WC2R 2LS, England	University of London; University College London; University of London School of Pharmacy; St Georges University London; National & Kapodistrian University of Athens; University of Hong Kong; University of London; King's College London; University of London; King's College London	Long, PF (corresponding author), Univ London, Sch Pharm, Ctr Paediat Pharm Res, London WC1H 9JP, England.	paul.long@kcl.ac.uk						[Anonymous], 1963, BMJ-BRIT MED J, V2, P1577; [Anonymous], 2009, HIV MED, V10, P591; Buchnan JL., 1946, LANCET, V248, P560; Chung A, 2007, BMJ-BRIT MED J, V335, P429, DOI 10.1136/bmj.39274.647465.BE; Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096; Electronic Medicines Compendium, 2011, SUMM PROD CHAR AM PA; EMERY JL, 1949, BRIT MED J, V1, P1110, DOI 10.1136/bmj.1.4616.1110; HAUSMANN E, 1953, Wien Med Wochenschr, V103, P725; Henderson JL, 1946, LANCET, V247, P922; HOFFMAN WS, 1948, J PEDIATR-US, V32, P1, DOI 10.1016/S0022-3476(48)80123-X; Keith T, 2010, CURR OPIN INFECT DIS, V23, P242, DOI 10.1097/QCO.0b013e328338c46d; KNUDSEN LF, 1945, J BACTERIOL, V50, P187, DOI 10.1128/JB.50.2.187-200.1945; Lieberthal AS, 2004, PEDIATRICS, V113, P1451, DOI 10.1542/peds.113.5.1451; Menson EN, 2006, BMJ-BRIT MED J, V332, P1183, DOI 10.1136/bmj.332.7551.1183; MOSELEY JH, 1948, ARCH DIS CHILD, V23, P93, DOI 10.1136/adc.23.114.93; NMH Information Centre, HLTH SURV ENGL 2009; SPITZY K H, 1955, Wien Klin Wochenschr, V67, P212; SUCHETTKAYE AI, 1947, BMJ-BRIT MED J, V2, P953, DOI 10.1136/bmj.2.4536.953; Thompson PL, 2009, ARCH DIS CHILD, V94, P337, DOI 10.1136/adc.2008.147579; Vergison A, 2010, LANCET INFECT DIS, V10, P195, DOI 10.1016/S1473-3099(10)70012-8; WHEATLEY D, 1958, BRIT MED J, V2, P907, DOI 10.1136/bmj.2.5101.907; Young BA., 1947, BRIT MED J, Vviii, P290	22	5	6	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 15	2011	343								d7803	10.1136/bmj.d7803	http://dx.doi.org/10.1136/bmj.d7803			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	888WF	22174326	Green Submitted			2022-12-28	WOS:000300034600007
J	Shennan, AH; Redman, C; Cooper, C; Milne, F				Shennan, Andrew H.; Redman, Christopher; Cooper, Carol; Milne, Fiona			Are most maternal deaths from pre-eclampsia avoidable?	LANCET			English	Editorial Material							ECLAMPSIA		[Shennan, Andrew H.] Kings Coll London, Maternal & Fetal Res Unit, St Thomas Hosp, London SE1 7EH, England; [Redman, Christopher] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England; [Cooper, Carol] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Social Med, Sch Med, London, England; [Milne, Fiona] Act Preeclampsia, Leicester, Leics, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Oxford; Imperial College London	Shennan, AH (corresponding author), Kings Coll London, Maternal & Fetal Res Unit, St Thomas Hosp, London SE1 7EH, England.	andrew.shennan@kcl.ac.uk		Shennan, Andrew/0000-0001-5273-3132				[Anonymous], 2011, NEV EV LIST 2011 12; ANSARI MZ, 1995, EUR J EPIDEMIOL, V11, P447, DOI 10.1007/BF01721231; Chappell LC, 2010, BJOG-INT J OBSTET GY, V117, P695, DOI 10.1111/j.1471-0528.2010.02507.x; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Henderson J, 2000, J Health Serv Res Policy, V5, P69; Martin JN, 2005, OBSTET GYNECOL, V105, P246, DOI 10.1097/01.AOG.0000151116.84113.56; Milne F, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3129; Oates M, 2011, BJOG-INT J OBSTET GY, V118, P132, DOI 10.1111/j.1471-0528.2010.02847.x; Schutte JM, 2010, BJOG-INT J OBSTET GY, V117, P399, DOI 10.1111/j.1471-0528.2009.02382.x; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Visintin C, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c2207; Wallis AB, 2008, AM J HYPERTENS, V21, P521, DOI 10.1038/ajh.2008.20; Waterstone M, 2001, BMJ-BRIT MED J, V322, P1089, DOI 10.1136/bmj.322.7294.1089	13	42	47	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 5	2012	379	9827					1686	1687		10.1016/S0140-6736(11)60785-X	http://dx.doi.org/10.1016/S0140-6736(11)60785-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	937KX	22177535				2022-12-28	WOS:000303658500009
J	Pomahac, B; Pribaz, J; Eriksson, E; Bueno, EM; Diaz-Siso, JR; Rybicki, FJ; Annino, DJ; Orgill, D; Caterson, EJ; Caterson, SA; Carty, MJ; Chun, YS; Sampson, CE; Janis, JE; Alam, DS; Saavedra, A; Molnar, JA; Edrich, T; Marty, FM; Tullius, SG				Pomahac, Bohdan; Pribaz, Julian; Eriksson, Elof; Bueno, Ericka M.; Diaz-Siso, J. Rodrigo; Rybicki, Frank J.; Annino, Donald J.; Orgill, Dennis; Caterson, Edward J.; Caterson, Stephanie A.; Carty, Matthew J.; Chun, Yoon S.; Sampson, Christian E.; Janis, Jeffrey E.; Alam, Daniel S.; Saavedra, Arturo; Molnar, Joseph A.; Edrich, Thomas; Marty, Francisco M.; Tullius, Stefan G.			Three Patients with Full Facial Transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMPOSITE TISSUE ALLOTRANSPLANTATION; FACE TRANSPLANTATION; ALLOGRAFT; OUTCOMES	Unlike conventional reconstruction, facial transplantation seeks to correct severe deformities in a single operation. We report on three patients who received full-face transplants at our institution in 2011 in operations that aimed for functional restoration by coaptation of all main available motor and sensory nerves. We enumerate the technical challenges and postoperative complications and their management, including single episodes of acute rejection in two patients. At 6 months of follow-up, all facial allografts were surviving, facial appearance and function were improved, and glucocorticoids were successfully withdrawn in all patients.	[Pomahac, Bohdan; Pribaz, Julian; Eriksson, Elof; Bueno, Ericka M.; Diaz-Siso, J. Rodrigo; Orgill, Dennis; Caterson, Edward J.; Caterson, Stephanie A.; Carty, Matthew J.; Chun, Yoon S.; Sampson, Christian E.] Brigham & Womens Hosp, Dept Surg, Div Plast Surg, Boston, MA 02115 USA; [Rybicki, Frank J.] Brigham & Womens Hosp, Appl Imaging Sci Lab, Dept Radiol, Boston, MA 02115 USA; [Annino, Donald J.] Brigham & Womens Hosp, Dept Surg, Div Otolaryngol, Boston, MA 02115 USA; [Saavedra, Arturo] Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Edrich, Thomas] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Marty, Francisco M.] Brigham & Womens Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA; [Tullius, Stefan G.] Brigham & Womens Hosp, Dept Surg, Div Transplant Surg, Boston, MA 02115 USA; [Janis, Jeffrey E.] Univ Texas SW Med Ctr Dallas, Dept Plast Surg, Dallas, TX 75390 USA; [Alam, Daniel S.] Cleveland Clin, Head & Neck Inst, Sect Facial Plast & Reconstruct Surg, Cleveland, OH USA; [Molnar, Joseph A.] Wake Forest Univ, Bowman Gray Sch Med, Dept Plast & Reconstruct Surg, Winston Salem, NC 27103 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas; Cleveland Clinic Foundation; Wake Forest University; Wake Forest Baptist Medical Center	Pomahac, B (corresponding author), Brigham & Womens Hosp, Dept Surg, Div Plast Surg, 75 Francis St, Boston, MA 02115 USA.	bpomahac@partners.org	Guntinas-Lichius, Orlando/L-1871-2016; Pomahac, Bohdan/AAH-1792-2019; Marty, Francisco M./H-7088-2019; Orgill, Dennis P./H-7596-2019; Janis, Jeffrey/W-6760-2019; Sampson, Christian E./K-2895-2019	Guntinas-Lichius, Orlando/0000-0001-9671-0784; Pomahac, Bohdan/0000-0003-3703-8240; Marty, Francisco M./0000-0002-3708-8734; Orgill, Dennis P./0000-0002-8279-7310; Janis, Jeffrey/0000-0001-6103-4798; 	Department of Defense under the Biomedical Translational Initiative [W911QY-09-C-0216]; Brigham and Women's Hospital under the Biomedical Translational Initiative [W911QY-09-C-0216]	Department of Defense under the Biomedical Translational Initiative; Brigham and Women's Hospital under the Biomedical Translational Initiative	Supported by a research contract (W911QY-09-C-0216) between the Department of Defense and Brigham and Women's Hospital under the Biomedical Translational Initiative.	Alam DS, 2009, ARCH FACIAL PLAST S, V11, P369, DOI 10.1001/archfacial.2009.80; Barret JP, 2011, ANN SURG, V254, P252, DOI 10.1097/SLA.0b013e318226a607; Bueno EM, 2011, J PLAST RECONSTR AES, V64, P1572, DOI 10.1016/j.bjps.2011.07.008; Cendales LC, 2008, AM J TRANSPLANT, V8, P1396, DOI 10.1111/j.1600-6143.2008.02243.x; Dubernard JM, 2007, NEW ENGL J MED, V357, P2451, DOI 10.1056/NEJMoa072828; Guo SZ, 2008, LANCET, V372, P631, DOI 10.1016/S0140-6736(08)61276-3; Lantieri L, 2011, AM J TRANSPLANT, V11, P367, DOI 10.1111/j.1600-6143.2010.03406.x; Lantieri L, 2008, LANCET, V372, P639, DOI 10.1016/S0140-6736(08)61277-5; Lengele BG, 2009, CLIN PLAST SURG, V36, P507, DOI 10.1016/j.cps.2009.02.006; Meningaud JP, 2011, PLAST RECONSTR SURG, V127, P1892, DOI 10.1097/PRS.0b013e31820e915a; Meningaud JP, 2008, PLAST RECONSTR SURG, V122, P1383, DOI 10.1097/PRS.0b013e3181882146; Meningaud JP, 2010, PLAST RECONSTR  0615; Pomahac B, 2011, J PLAST RECONSTR AES, V64, P1410, DOI 10.1016/j.bjps.2011.06.024; Pomahac B, 2011, AM J TRANSPLANT, V11, P386, DOI 10.1111/j.1600-6143.2010.03368.x; Pomahac Bohdan, 2011, Curr Probl Surg, V48, P293, DOI 10.1067/j.cpsurg.2011.01.003; Saavedra AP, 2011, AM J TRANSPLANT, V11, P1340, DOI 10.1111/j.1600-6143.2011.03596.x; Soga S, 2011, PLAST RECONSTR SURG, V128, P883, DOI 10.1097/PRS.0b013e3182268b43; Soga S, 2010, J COMPUT ASSIST TOMO, V34, P766, DOI 10.1097/RCT.0b013e3181e9c133; Wang HY, 2007, J PLAST RECONSTR AES, V60, P1175, DOI 10.1016/j.bjps.2007.06.027	19	189	194	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 23	2012	366	8					715	722		10.1056/NEJMoa1111432	http://dx.doi.org/10.1056/NEJMoa1111432			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	896FS	22204672	Green Published			2022-12-28	WOS:000300551500009
J	Watson, PJ; Fairall, L; Santos, GM; Schwabe, JWR				Watson, Peter J.; Fairall, Louise; Santos, Guilherme M.; Schwabe, John W. R.			Structure of HDAC3 bound to co-repressor and inositol tetraphosphate	NATURE			English	Article							NUCLEAR RECEPTOR COREPRESSOR; HISTONE DEACETYLASE; N-COR; PROTEIN COMPLEXES; SMRT; KINASE; ACETYLATION; ALPHA; 1,4,5-TRISPHOSPHATE; TRANSCRIPTION	Histone deacetylase enzymes (HDACs) are emerging cancer drug targets. They regulate gene expression by removing acetyl groups from lysine residues in histone tails, resulting in chromatin condensation. The enzymatic activity of most class I HDACs requires recruitment into multi-subunit co-repressor complexes, which are in turn recruited to chromatin by repressive transcription factors. Here we report the structure of a complex between an HDAC and a co-repressor, namely, human HDAC3 with the deacetylase activation domain (DAD) from the human SMRT co-repressor (also known as NCOR2). The structure reveals two remarkable features. First, the SMRT-DAD undergoes a large structural rearrangement on forming the complex. Second, there is an essential inositol tetraphosphate molecule-D-myo-inositol-(1,4,5,6)-tetrakisphosphate (Ins(1,4,5,6)P-4)-acting as an 'intermolecular glue' between the two proteins. Assembly of the complex is clearly dependent on the Ins(1,4,5,6)P-4, which may act as a regulator-potentially explaining why inositol phosphates and their kinases have been found to act as transcriptional regulators. This mechanism for the activation of HDAC3 appears to be conserved in class I HDACs from yeast to humans, and opens the way to novel therapeutic opportunities.	[Watson, Peter J.; Fairall, Louise; Santos, Guilherme M.; Schwabe, John W. R.] Univ Leicester, Dept Biochem, Henry Wellcome Labs Struct Biol, Leicester LE1 9HN, Leics, England	University of Leicester	Schwabe, JWR (corresponding author), Univ Leicester, Dept Biochem, Henry Wellcome Labs Struct Biol, Leicester LE1 9HN, Leics, England.	john.schwabe@le.ac.uk	Schwabe, John WR/A-9132-2008; Fairall, Louise/G-6763-2013	Schwabe, John WR/0000-0003-2865-4383; Fairall, Lara/0000-0002-7460-4670; Fairall, Louise/0000-0001-9456-3047; Santos, Guilherme/0000-0003-1489-2161	Wellcome Trust [WT085408]	Wellcome Trust(Wellcome TrustEuropean Commission)	We thank R. Owen and the other beamline staff at DIAMOND I24 for help with data collection; J. Goodchild for help with biochemical experiments; and S. Cowley, M. Lazar, P. Moody, L. Nagy, P. Tontonoz and S. Shears for literature and discussions. This work was supported by the Wellcome Trust (grant WT085408).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Billin AN, 2000, MOL CELL BIOL, V20, P6882, DOI 10.1128/MCB.20.18.6882-6890.2000; Bressi JC, 2010, BIOORG MED CHEM LETT, V20, P3142, DOI 10.1016/j.bmcl.2010.03.091; Caffrey JJ, 2001, FEBS LETT, V499, P6, DOI 10.1016/S0014-5793(01)02500-5; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Codina A, 2005, P NATL ACAD SCI USA, V102, P6009, DOI 10.1073/pnas.0500299102; Craxton A, 1997, BIOCHEM J, V328, P75, DOI 10.1042/bj3280075; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Dowling DP, 2008, BIOCHEMISTRY-US, V47, P13554, DOI 10.1021/bi801610c; El Alami M, 2003, MOL MICROBIOL, V49, P457, DOI 10.1046/j.1365-2958.2003.03562.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Guan HP, 2005, GENE DEV, V19, P453, DOI 10.1101/gad.1263305; Guenther MG, 2000, GENE DEV, V14, P1048; Guenther MG, 2002, GENE DEV, V16, P3130, DOI 10.1101/gad.1037502; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; Hildmann C, 2007, APPL MICROBIOL BIOT, V75, P487, DOI 10.1007/s00253-007-0911-2; Hoberg JE, 2004, MOL CELL, V16, P245, DOI 10.1016/j.molcel.2004.10.010; Hu E, 2000, J BIOL CHEM, V275, P15254, DOI 10.1074/jbc.M908988199; Humphrey GW, 2001, J BIOL CHEM, V276, P6817, DOI 10.1074/jbc.M007372200; Ishizuka T, 2005, MOL ENDOCRINOL, V19, P1443, DOI 10.1210/me.2005-0009; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Lechner T, 2000, J BIOL CHEM, V275, P40961, DOI 10.1074/jbc.M005730200; Lee H, 2004, MOL CELL BIOL, V24, P765, DOI 10.1128/MCB.24.2.765-773.2004; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; MATTINGLY RR, 1991, J BIOL CHEM, V266, P15144; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Nalaskowski MM, 2002, BIOCHEM J, V366, P549, DOI 10.1042/BJ20020327; Oberoi J, 2011, NAT STRUCT MOL BIOL, V18, P177, DOI 10.1038/nsmb.1983; Odom AR, 2000, SCIENCE, V287, P2026, DOI 10.1126/science.287.5460.2026; POGO BGT, 1966, P NATL ACAD SCI USA, V55, P805, DOI 10.1073/pnas.55.4.805; Saiardi A, 2001, P NATL ACAD SCI USA, V98, P2306, DOI 10.1073/pnas.041614598; Shen XT, 2003, SCIENCE, V299, P112, DOI 10.1126/science.1078068; Somoza JR, 2004, STRUCTURE, V12, P1325, DOI 10.1016/j.str.2004.04.012; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Wagner JM, 2010, CLIN EPIGENETICS, V1, DOI 10.1007/s13148-010-0012-4; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Yang WM, 2002, J BIOL CHEM, V277, P9447, DOI 10.1074/jbc.M105993200; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; You SH, 2010, MOL ENDOCRINOL, V24, P1359, DOI 10.1210/me.2009-0501; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	50	323	330	0	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 19	2012	481	7381					335	U114		10.1038/nature10728	http://dx.doi.org/10.1038/nature10728			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877VK	22230954	Green Accepted			2022-12-28	WOS:000299210600036
J	Zhang, WY; Du, J; Evans, SL; Yu, YK; Yu, XF				Zhang, Wenyan; Du, Juan; Evans, Sean L.; Yu, Yunkai; Yu, Xiao-Fang			T-cell differentiation factor CBF-beta regulates HIV-1 Vif-mediated evasion of host restriction	NATURE			English	Article							VIRUS TYPE-1 VIF; E3 UBIQUITIN LIGASE; ANTIVIRAL ACTIVITY; ENZYME APOBEC3G; RUNT DOMAIN; SOCS-BOX; DEGRADATION; COMPLEX; BINDING; PROTEIN	The human APOBEC3 cytidine deaminases are potent inhibitors of diverse retroviruses, including human immunodeficiency virus-1 (HIV-1)(1-6). HIV-1 Vif forms an E3 ubiquitin ligase complex with cullin 5 (CUL5), elongin B and elongin C (7-9), which promotes the polyubiquitination and degradation of APOBEC3 substrates(7,10-14). Here we demonstrate in human T cells that core binding factor beta (CBF-beta) is a key regulator of the evasion of HIV-1 from the host defence mediated by APOBEC3. CBF-beta, the non-DNA-binding subunit of a heterodimeric transcription factor, regulates the folding and DNA-binding activity of partner RUNX family proteins, which have important roles in the development and differentiation of diverse cell types, including T lymphocytes(15,16). In our study, knockdown of endogenous CBF-beta blocked Vif-induced APOBEC3G polyubiquitination and degradation. CBF-beta was not required for the interaction between Vif and APOBEC3G, yet was essential for the assembly of the Vif-CUL5 E3-ubiquitin-ligase complex. CBF-beta proved to be a unique regulator of primate lentiviral Vif and not a general component of the CUL5 E3 ubiquitin ligase. We show that Vif and CBF-beta physically interact, and that the amino-terminal region of Vif is required for this interaction. Furthermore, interactions with Vif required regions in CBF-beta that are not involved in RUNX protein binding(17-19). Considering the importance of the interaction between Vif and CBF-beta, disrupting this interaction represents an attractive pharmacological intervention against HIV-1.	[Zhang, Wenyan; Du, Juan; Yu, Xiao-Fang] Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun 130021, Jilin Province, Peoples R China; [Du, Juan; Evans, Sean L.; Yu, Yunkai; Yu, Xiao-Fang] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA	Jilin University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Yu, XF (corresponding author), Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun 130021, Jilin Province, Peoples R China.	xfyu@jhsph.edu			Chinese Ministry of Science and Technology [2012CB911100]; Chinese Ministry of Education [IRT1016]; Key Laboratory of Molecular Virology, Jilin Province, China [20102209]; NIAID [2R56AI62644-6]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Ministry of Education(Ministry of Education, China); Key Laboratory of Molecular Virology, Jilin Province, China; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank K. Strebel, A. Friedman, N. Speck, D. Yue, R. Siliciano, M. Malim, R. Harris, T. Inoue and D. Gabuzda for critical reagents; T. Wang, K. Zhao, X. Zhou and A. Zhen for technical assistance; R. Markham, J. Margolick and J. Bream for thoughtful discussions; and D. McClellan for editorial assistance. We also wish to thank staff within the Mass Spectrometry Core and the Institute for Basic Biomedical Sciences Microscope Facility at Johns Hopkins School of Medicine for their technical assistance. The following reagents were obtained through the AIDS Research and Reference Reagents Program, Division of AIDS, NIAID, NIH: monoclonal antibodies against HIV-1 p24 (B. Chesebro and H. Chen), pNL4-3 (M. Martin), pcDNA-hVif (S. Bour and K. Strebel), antiserum to HIV-1 Vif (D. Gabuzda) and MAGI-CCR5 cells (J. Overbaugh). This work was supported in part by funding from the Chinese Ministry of Science and Technology (2012CB911100) and Chinese Ministry of Education (IRT1016), the Key Laboratory of Molecular Virology, Jilin Province (20102209), China, and a grant (2R56AI62644-6) from the NIAID.	Bravo J, 2001, NAT STRUCT BIOL, V8, P371, DOI 10.1038/86264; Cao WS, 1998, J BIOL CHEM, V273, P31534, DOI 10.1074/jbc.273.47.31534; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Cullen BR, 2006, J VIROL, V80, P1067, DOI 10.1128/JVI.80.3.1067-1076.2006; de Bruijn MFTR, 2004, ONCOGENE, V23, P4238, DOI 10.1038/sj.onc.1207763; Goila-Gaur R, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-51; He ZW, 2008, J MOL BIOL, V381, P1000, DOI 10.1016/j.jmb.2008.06.061; Ito Y, 2008, ADV CANCER RES, V99, P33, DOI 10.1016/S0065-230X(07)99002-8; Liu BD, 2005, J VIROL, V79, P9579, DOI 10.1128/JVI.79.15.9579-9587.2005; Luo K, 2005, P NATL ACAD SCI USA, V102, P11444, DOI 10.1073/pnas.0502440102; Luo K, 2007, FASEB J, V21, P1742, DOI 10.1096/fj.06-7241com; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mehle A, 2004, GENE DEV, V18, P2861, DOI 10.1101/gad.1249904; Mehle A, 2004, J BIOL CHEM, V279, P7792, DOI 10.1074/jbc.M313093200; Mehle A, 2007, J VIROL, V81, P13235, DOI 10.1128/JVI.00204-07; Navarro F, 2004, CURR OPIN IMMUNOL, V16, P477, DOI 10.1016/j.coi.2004.05.006; Russell RA, 2007, J VIROL, V81, P8201, DOI 10.1128/JVI.00395-07; Schrofelbauer B, 2006, J VIROL, V80, P5984, DOI 10.1128/JVI.00388-06; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Simon V, 2005, PLOS PATHOG, V1, P20, DOI 10.1371/journal.ppat.0010006; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Tahirov TH, 2001, CELL, V104, P755, DOI 10.1016/S0092-8674(01)00271-9; Tian CJ, 2006, J VIROL, V80, P3112, DOI 10.1128/JVI.80.6.3112-3115.2006; Yan JL, 2004, NAT STRUCT MOL BIOL, V11, P901, DOI 10.1038/nsmb819; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Yu YK, 2004, GENE DEV, V18, P2867, DOI 10.1101/gad.1250204; Zhang WY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003963	30	192	198	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 19	2012	481	7381					376	379		10.1038/nature10718	http://dx.doi.org/10.1038/nature10718			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877VK	22190036				2022-12-28	WOS:000299210600045
J	Betts, JR; Atkinson, RC				Betts, Julian R.; Atkinson, Richard C.			Better Research Needed on the Impact of Charter Schools	SCIENCE			English	Editorial Material									[Betts, Julian R.] Univ Calif San Diego, Dept Econ, La Jolla, CA 92093 USA; [Betts, Julian R.] Publ Policy Inst Calif, San Francisco, CA 94111 USA; [Atkinson, Richard C.] Natl Sci Fdn, Arlington, VA 22230 USA	University of California System; University of California San Diego; National Science Foundation (NSF)	Betts, JR (corresponding author), Univ Calif San Diego, Dept Econ, La Jolla, CA 92093 USA.	jbetts@ucsd.edu						ABDULKADIROGLU ATILA, 2009, INFORM DEBATE COMP B; Angrist Joshua D., 2010, AM EC REV PAPERS P, V100, P1; Betts J. R., 2011, EFFECT CHARTER SCH S; Betts J. R., 2010, TAKING MEASURE CHART; Betts JR, 2010, TAKING MEASURE CHART; Center for Research on Education Outcomes, 2010, CHART SCH PERF NEW Y; Dwyer E., 2010, 20104029 NCEE US DEP; Fryer R.G., 2009, W15473 NAT BUR EC RE, DOI DOI 10.3386/W15473; Hanushek EA, 2007, J PUBLIC ECON, V91, P823, DOI 10.1016/j.jpubeco.2006.09.014; Hoxby C. M., 2007, NEW YORK CITYS CHART; Hoxby C. M., 2009, NEW YORK CITYS CHART; Hoxby C. M., 2005, FINDINGS CITY BIG SH; Lake R. J., 2008, HOPES FEARS REALITY, pvi; McClure L., 2005, PREUSS SCH UCSD SCH; McEwan P. J., 2010, TAKING MEASURE CHART; Obama B., 2013, B ATOM SCI	16	4	4	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 13	2012	335	6065					171	172		10.1126/science.1205418	http://dx.doi.org/10.1126/science.1205418			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	875LZ	22246759				2022-12-28	WOS:000299033100035
J	Choi, HK; Soriano, LC; Zhang, YQ; Rodriguez, LAG				Choi, Hyon K.; Soriano, Lucia Cea; Zhang, Yuqing; Garcia Rodriguez, Luis A.			Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study	BRITISH MEDICAL JOURNAL			English	Article							SERUM URIC-ACID; RECEPTOR ANTAGONIST LOSARTAN; MODERATE ESSENTIAL-HYPERTENSION; HEALTHY-SUBJECTS; NORMOTENSIVE SUBJECTS; TRANSPLANT RECIPIENTS; INDUCED HYPERURICEMIA; BLOOD-PRESSURE; DIURETIC USE; VALSARTAN	Objective To determine the independent associations of antihypertensive drugs with the risk of incident gout among people with hypertension. Design Nested case-control study. Setting UK general practice database, 2000-7. Participants All incident cases of gout (n=24 768) among adults aged 20-79 and a random sample of 50 000 matched controls. Main outcome measure Relative risk of incident gout associated with use of antihypertensive drugs. Results After adjusting for age, sex, body mass index, visits to the general practitioner, alcohol intake, and pertinent drugs and comorbidities, the multivariate relative risks of incident gout associated with current use of antihypertensive drugs among those with hypertension (n=29 138) were 0.87 (95% confidence interval 0.82 to 0.93) for calcium channel blockers, 0.81 (0.70 to 0.94) for losartan, 2.36 (2.21 to 2.52) for diuretics, 1.48 (1.40 to 1.57) for beta blockers, 1.24 (1.17 to 1.32) for angiotensin converting enzyme inhibitors, and 1.29 (1.16 to 1.43) for non-losartan angiotensin II receptor blockers. Similar results were obtained among those without hypertension. The multivariate relative risks for the duration of use of calcium channel blockers among those with hypertension were 1.02 for less than one year, 0.88 for 1-1.9 years, and 0.75 for two or more years and for use of losartan they were 0.98, 0.87, and 0.71, respectively (both P<0.05 for trend). Conclusions Compatible with their urate lowering properties, calcium channel blockers and losartan are associated with a lower risk of incident gout among people with hypertension. By contrast, diuretics, beta blockers, angiotensin converting enzyme inhibitors, and non-losartan angiotensin II receptor blockers are associated with an increased risk of gout.	[Choi, Hyon K.; Zhang, Yuqing] Boston Univ, Sch Med, Rheumatol Sect, Boston, MA 02118 USA; [Choi, Hyon K.; Zhang, Yuqing] Boston Univ, Sch Med, Clin Epidemiol Unit, Boston, MA 02118 USA; [Soriano, Lucia Cea; Garcia Rodriguez, Luis A.] Spanish Ctr Pharmacoepidemiol Res CEIFE, Madrid, Spain	Boston University; Boston University	Choi, HK (corresponding author), Boston Univ, Sch Med, Rheumatol Sect, 650 Albany St, Boston, MA 02118 USA.	hchoius@bu.edu	Soriano, Lucia Cea/D-4380-2018; rodriguez, luis a garcia/B-1980-2010; Hug, Balthasar L./G-1568-2010	Soriano, Lucia Cea/0000-0002-7051-0730; Zhang, Yuqing/0000-0001-7954-1149	National Institutes of Health [AR056291, P60AR047785]; Novartis; Takeda Pharmaceuticals; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR047785, R01AR056291] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis(Novartis); Takeda Pharmaceuticals(Takeda Pharmaceutical Company Ltd); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by grants from the National Institutes of Health (AR056291 and P60AR047785). The Spanish Centre for Pharmacoepidemiological Research has received an unrestricted research grant from Novartis to work on other projects related to gout. The funding sources had no role in the design, conduct, or reporting of the study or in the decision to submit the manuscript for publication.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that HKC has received research funding for other projects from Takeda Pharmaceuticals and has served on advisory boards for Takeda Pharmaceuticals, Savient Pharmaceuticals, and URL Pharma; the authors have no relationship with companies that might have an interest in the submitted work in the previous three years; they have no non-financial interests that may be relevant to the submitted work.	Alderman M, 2004, CURR MED RES OPIN, V20, P369, DOI 10.1185/030079904125002982; Alonso A, 2007, NEUROLOGY, V69, P1696, DOI 10.1212/01.wnl.0000279518.10072.df; ANDERSEN GS, 1985, ACTA MED SCAND, V218, P165; [Anonymous], 1981, LANCET, V2, P539; [Anonymous], 1979, N ENGL J MED, V301, P293; Bourke Alison, 2004, Inform Prim Care, V12, P171; Burgess E. D., 2000, American Journal of Hypertension, V13, p183A; Burnier M, 1996, KIDNEY INT, V49, P1787, DOI 10.1038/ki.1996.268; BURNIER M, 1995, J HYPERTENS, V13, pS23, DOI 10.1097/00004872-199507001-00003; Chanard J, 2003, NEPHROL DIAL TRANSPL, V18, P2147, DOI 10.1093/ndt/gfg341; Choi HK, 2005, ARCH INTERN MED, V165, P742, DOI 10.1001/archinte.165.7.742; Choi HK, 2005, ANN INTERN MED, V143, P499, DOI 10.7326/0003-4819-143-7-200510040-00009; Elliott WJ, 2001, CLIN THER, V23, P1166, DOI 10.1016/S0149-2918(01)80099-0; Enomoto A, 2002, NATURE, V417, P447, DOI 10.1038/nature742; Gonzalez-Ortiz M, 2000, J NEPHROL, V13, P126; Hamada T, 2002, INTERNAL MED, V41, P793, DOI 10.2169/internalmedicine.41.793; Hamada T, 2008, AM J HYPERTENS, V21, P1157, DOI 10.1038/ajh.2008.245; Hayashi K, 2003, AM J NEPHROL, V23, P229, DOI 10.1159/000072054; Hoieggen A, 2004, KIDNEY INT, V65, P1041, DOI 10.1111/j.1523-1755.2004.00484.x; Hunter DJ, 2006, J RHEUMATOL, V33, P1341; Ilson BE, 1998, J CLIN PHARMACOL, V38, P437, DOI 10.1002/j.1552-4604.1998.tb04450.x; LEARY WP, 1990, J INT MED RES, V18, P120, DOI 10.1177/030006059001800207; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; MALINI PL, 1987, CLIN EXP HYPERTENS A, V9, P675, DOI 10.3109/10641968709164241; Manolis AJ, 2000, CLIN THER, V22, P1186, DOI 10.1016/S0149-2918(00)83062-3; McIntyre M, 1996, J CARDIOVASC PHARM, V28, P101, DOI 10.1097/00005344-199607000-00016; Meier CR, 1997, BRIT J CLIN PHARMACO, V44, P175, DOI 10.1046/j.1365-2125.1997.00647.x; MESSERLI FH, 1980, ANN INTERN MED, V93, P817, DOI 10.7326/0003-4819-93-6-817; Minghelli G, 1998, TRANSPLANTATION, V66, P268, DOI 10.1097/00007890-199807270-00023; Monterroso VH, 2000, ADV THER, V17, P117, DOI 10.1007/BF02854844; Muller P, 1997, EUR J CLIN PHARMACOL, V52, P441, DOI 10.1007/s002280050317; ONEIL M, 1995, METHOD INFORM MED, V34, P187; PEDERSEN OL, 1985, EUR J CLIN PHARMACOL, V28, P223, DOI 10.1007/BF00609696; PREBIS JW, 1981, J PEDIATR-US, V98, P702, DOI 10.1016/S0022-3476(81)80828-1; Puig JG, 2002, J HYPERTENS, V20, pS29; Puig JG, 1999, J HYPERTENS, V17, P1033, DOI 10.1097/00004872-199917070-00021; Reyes AJ, 2003, CARDIOVASC DRUG THER, V17, P397, DOI 10.1023/B:CARD.0000015855.02485.e3; Ruilope LM, 2007, J HYPERTENS, V25, P1711, DOI 10.1097/HJH.0b013e3281c49d93; Shahinfar S, 1999, KIDNEY INT, V56, P1879, DOI 10.1046/j.1523-1755.1999.00739.x; Stuart-Buttle C D, 1996, Proc AMIA Annu Fall Symp, P75; Wurzner G, 2001, J HYPERTENS, V19, P1855, DOI 10.1097/00004872-200110000-00021; WYNGAARDEN JB, 1976, GOUT HYPERURICEMIA; Zhu Y, AM J MED IN PRESS	43	146	159	0	17	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 12	2012	344								d8190	10.1136/bmj.d8190	http://dx.doi.org/10.1136/bmj.d8190			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877SM	22240117	hybrid, Green Published			2022-12-28	WOS:000299202900013
J	Farrell, L				Farrell, Liam			THE BEST MEDICINE Big tits	BRITISH MEDICAL JOURNAL			English	Editorial Material												drfarrell@hotmail.co.uk							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 11	2012	344								e68	10.1136/bmj.e68	http://dx.doi.org/10.1136/bmj.e68			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	877SI	22236602				2022-12-28	WOS:000299202500001
J	Phelan, EA; Borson, S; Grothaus, L; Balch, S; Larson, EB				Phelan, Elizabeth A.; Borson, Soo; Grothaus, Louis; Balch, Steven; Larson, Eric B.			Association of Incident Dementia With Hospitalizations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARE SENSITIVE CONDITIONS; ALZHEIMERS-DISEASE; PREVENTABLE HOSPITALIZATIONS; HEALTH-CARE; OLDER PATIENTS; MEDICARE; RISK; POPULATION; DIAGNOSIS; ILLNESS	Context Dementia is associated with increased rates and often poorer outcomes of hospitalization, including worsening cognitive status. New evidence is needed to determine whether some admissions of persons with dementia might be potentially preventable. Objective To determine whether dementia onset is associated with higher rates of or different reasons for hospitalization, particularly for ambulatory care-sensitive conditions (ACSCs), for which proactive outpatient care might prevent the need for a hospital stay. Design, Setting, and Participants Retrospective analysis of hospitalizations among 3019 participants in Adult Changes in Thought (ACT), a longitudinal cohort study of adults aged 65 years or older enrolled in an integrated health care system. All participants had no dementia at baseline and those who had a dementia diagnosis during biennial screening contributed nondementia hospitalizations until diagnosis. Automated data were used to identify all hospitalizations of all participants from time of enrollment in ACT until death, disenrollment from the health plan, or end of follow-up, whichever came first. The study period spanned February 1, 1994, to December 31, 2007. Main Outcome Measures Hospital admission rates for patients with and without dementia, for all causes, by type of admission, and for ACSCs. Results Four hundred ninety-four individuals eventually developed dementia and 427 (86%) of these persons were admitted at least once; 2525 remained free of dementia and 1478 (59%) of those were admitted at least once. The unadjusted all-cause admission rate in the dementia group was 419 admissions per 1000 person-years vs 200 admissions per 1000 person-years in the dementia-free group. After adjustment for age, sex, and other potential confounders, the ratio of admission rates for all-cause admissions was 1.41 (95% confidence interval [CI], 1.23-1.61; P<.001), while for ACSCs, the adjusted ratio of admission rates was 1.78 (95% CI, 1.38-2.31; P<.001). Adjusted admission rates classified by body system were significantly higher in the dementia group for most categories. Adjusted admission rates for all types of ACSCs, including bacterial pneumonia, congestive heart failure, dehydration, duodenal ulcer, and urinary tract infection, were significantly higher among those with dementia. Conclusion Among our cohort aged 65 years or older, incident dementia was significantly associated with increased risk of hospitalization, including hospitalization for ACSCs. JAMA. 2012;307(2):165-172 www.jama.com	[Phelan, Elizabeth A.] Univ Washington, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98104 USA; [Phelan, Elizabeth A.] Univ Washington, Dept Hlth Serv, Sch Publ Hlth & Community Med, Seattle, WA 98104 USA; [Borson, Soo] Univ Washington, Dept Psychiat, Div Geriatr Psychiat, Seattle, WA 98104 USA; [Grothaus, Louis; Balch, Steven; Larson, Eric B.] Grp Hlth Res Inst, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Phelan, EA (corresponding author), Univ Washington, Dept Med, Div Gerontol & Geriatr Med, 325 9th Ave,Box 359755, Seattle, WA 98104 USA.	phelane@uw.edu			National Institute on Aging (NIA); Paul Beeson Physician Faculty Scholars in Aging Research; University of Washington Alzheimer's Disease Research Center (NIA) [P50 AG 005136]; NIA [UO1 AG 06781]; NATIONAL INSTITUTE ON AGING [K23AG020982, U01AG006781, P50AG005136] Funding Source: NIH RePORTER	National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Paul Beeson Physician Faculty Scholars in Aging Research; University of Washington Alzheimer's Disease Research Center (NIA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was conducted while Dr Phelan was a K23 recipient from the National Institute on Aging (NIA) and a Paul Beeson Physician Faculty Scholars in Aging Research Award recipient. Dr Borson received support from the University of Washington Alzheimer's Disease Research Center (NIA grant P50 AG 005136). ACT is supported by NIA grant UO1 AG 06781 (principal investigator: Dr Larson).	Albert SM, 1999, J GERONTOL A-BIOL, V54, pM267, DOI 10.1093/gerona/54.5.M267; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; BILLINGS J, 1993, HEALTH AFFAIR, V12, P162, DOI 10.1377/hlthaff.12.1.162; BINDMAN AB, 1995, JAMA-J AM MED ASSOC, V274, P305, DOI 10.1001/jama.274.4.305; Bradford A, 2009, ALZ DIS ASSOC DIS, V23, P306, DOI 10.1097/WAD.0b013e3181a6bebc; Breitner JCS, 2009, NEUROLOGY, V72, P1899, DOI 10.1212/WNL.0b013e3181a18691; BRESLOW NE, 1983, J AM STAT ASSOC, V78, P1, DOI 10.2307/2287093; Breslow NE, 1996, J AM STAT ASSOC, V91, P14, DOI 10.2307/2291379; Bynum JPW, 2004, J AM GERIATR SOC, V52, P187, DOI 10.1111/j.1532-5415.2004.52054.x; CLARK DO, 1995, MED CARE, V33, P783, DOI 10.1097/00005650-199508000-00004; Clark TG, 2002, LANCET, V359, P1309, DOI 10.1016/S0140-6736(02)08272-7; Culler SD, 1998, MED CARE, V36, P804, DOI 10.1097/00005650-199806000-00004; Davison A., 2003, STAT MODELS; Ehlenbach WJ, 2010, JAMA-J AM MED ASSOC, V303, P763, DOI 10.1001/jama.2010.167; Fishman PA, 2003, MED CARE, V41, P84, DOI 10.1097/00005650-200301000-00011; Gutterman EM, 1999, J AM GERIATR SOC, V47, P1065, DOI 10.1111/j.1532-5415.1999.tb05228.x; Harris DP, 2009, J AM GERIATR SOC, V57, P2209, DOI 10.1111/j.1532-5415.2009.02572.x; Hilbe JM, 2007, NEGATIVE BINOMIAL RE; Hill J, 2005, J ALZHEIMERS DIS, V8, P43; Inouye SK, 2006, NEW ENGL J MED, V354, P1157, DOI 10.1056/NEJMra052321; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; JORM AF, 1988, BRIT J PSYCHIAT, V152, P209, DOI 10.1192/bjp.152.2.209; Kruzikas D.T., 2000, HCUP FACT BOOK; Kukull WA, 2002, ARCH NEUROL-CHICAGO, V59, P1737, DOI 10.1001/archneur.59.11.1737; Larson E B, 1990, Aging (Milano), V2, P404; Larson EB, 2006, ANN INTERN MED, V144, P73, DOI 10.7326/0003-4819-144-2-200601170-00004; LEFEVRE F, 1992, ARCH INTERN MED, V152, P2074, DOI 10.1001/archinte.152.10.2074; Lyketsos CG, 2000, AM J PSYCHIAT, V157, P704, DOI 10.1176/appi.ajp.157.5.704; Malone DC, 2009, AM J MANAG CARE, V15, P481; McCall N, 2001, HEALTH CARE FINANC R, V22, P127; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Natalwala A, 2008, DEMENT GERIATR COGN, V26, P499, DOI 10.1159/000171044; Oster A, 2003, MED CARE, V41, P198, DOI 10.1097/00005650-200302000-00002; Rudolph JL, 2010, J AM GERIATR SOC, V58, P1542, DOI 10.1111/j.1532-5415.2010.02924.x; Russo CA, 2006, HOSP ELDERLY POPULAT; Sager MA, 1996, J AM GERIATR SOC, V44, P251, DOI 10.1111/j.1532-5415.1996.tb00910.x; Saha S, 2007, MED CARE, V45, P712, DOI 10.1097/MLR.0b013e318053717c; Saunders KW, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P223; Taylor DH, 2004, J GERONTOL A-BIOL, V59, P762; Teng E L, 1994, Int Psychogeriatr, V6, P45, DOI 10.1017/S1041610294001602; Tuppin P, 2009, DEMENT GERIATR COGN, V28, P225, DOI 10.1159/000238394; US Food and Drug Administration, NAT DRUG COD DIR; WAGNER EH, 1995, PATIENT EDUC COUNS, V26, P225, DOI 10.1016/0738-3991(95)00761-N; WEISSMAN JS, 1992, JAMA-J AM MED ASSOC, V268, P2388, DOI 10.1001/jama.268.17.2388; Zhan CL, 2004, HEALTH SERV RES, V39, P345, DOI 10.1111/j.1475-6773.2004.00231.x; Zhao Y, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-108	47	294	295	3	21	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 11	2012	307	2					165	172		10.1001/jama.2011.1964	http://dx.doi.org/10.1001/jama.2011.1964			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	875NP	22235087	Bronze, Green Accepted			2022-12-28	WOS:000299038300028
J	Morison, J; Kwok, R; Peralta-Ferriz, C; Alkire, M; Rigor, I; Andersen, R; Steele, M				Morison, James; Kwok, Ron; Peralta-Ferriz, Cecilia; Alkire, Matt; Rigor, Ignatius; Andersen, Roger; Steele, Mike			Changing Arctic Ocean freshwater pathways	NATURE			English	Article							BEAUFORT GYRE; ICE; TEMPERATURE; VARIABILITY; RUNOFF; MODEL	Freshening in the Canada basin of the Arctic Ocean began in the 1990s(1,2) and continued(3) to at least the end of 2008. By then, the Arctic Ocean might have gained four times as much fresh water as comprised the Great Salinity Anomaly(4,5) of the 1970s, raising the spectre of slowing global ocean circulation(6). Freshening has been attributed to increased sea ice melting(1) and contributions from runoff(7), but a leading explanation has been a strengthening of the Beaufort High-a characteristic peak in sea level atmospheric pressure(2,8)-which tends to accelerate an anticyclonic (clockwise) wind pattern causing convergence of fresh surface water. Limited observations have made this explanation difficult to verify, and observations of increasing freshwater content under a weakened Beaufort High suggest that other factors(2) must be affecting freshwater content. Here we use observations to show that during a time of record reductions in ice extent from 2005 to 2008, the dominant freshwater content changes were an increase in the Canada basin balanced by a decrease in the Eurasian basin. Observations are drawn from satellite data (sea surface height and ocean-bottom pressure) and in situ data. The freshwater changes were due to a cyclonic (anticlockwise) shift in the ocean pathway of Eurasian runoff forced by strengthening of the west-to-east Northern Hemisphere atmospheric circulation characterized by an increased Arctic Oscillation(9) index. Our results confirm that runoff is an important influence on the Arctic Ocean and establish that the spatial and temporal manifestations of the runoff pathways are modulated by the Arctic Oscillation, rather than the strength of the wind-driven Beaufort Gyre circulation.	[Morison, James; Peralta-Ferriz, Cecilia; Alkire, Matt; Rigor, Ignatius; Andersen, Roger; Steele, Mike] Univ Washington, Appl Phys Lab, Polar Sci Ctr, Seattle, WA 98105 USA; [Kwok, Ron] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	University of Washington; University of Washington Seattle; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Morison, J (corresponding author), Univ Washington, Appl Phys Lab, Polar Sci Ctr, 1013 NE 40th St, Seattle, WA 98105 USA.	morison@apl.washington.edu	Kwok, Ronald/L-3968-2019; Kwok, Ron/A-9762-2008	Kwok, Ronald/0000-0003-4051-5896; Kwok, Ron/0000-0003-4051-5896; Steele, Michael/0000-0001-5083-1775	NSF [OPP 0352754]; NASA [NNX08AH62G]; Jet Propulsion Laboratory, California Institute of Technology; NASA MEASURES;  [ARC-0634226];  [ARC-0856330]; Directorate For Geosciences [0856177, 1022475, 1022710] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); Jet Propulsion Laboratory, California Institute of Technology; NASA MEASURES; ; ; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported chiefly by NSF grants OPP 0352754, ARC-0634226, ARC-0856330 and NASA grant NNX08AH62G. R. K. was supported at the Jet Propulsion Laboratory, California Institute of Technology, under contract with NASA. GRACE ocean data were processed by D. P. Chambers, supported by the NASA MEASURES Program. We thank the NASA ICESat and GRACE programmes, K. Falkner, R. Collier, M. McPhee, W. Ermold, L. de Steur, A. Proshutinsky and the Beaufort Gyre Exploration Project, J. Toole and R. Krishfield and the Ice Tethered Profiler project at WHOI, and W. Smethie of the Switchyard project for the observations that made this work possible.	Alkire MB, 2010, DEEP-SEA RES PT I, V57, P1432, DOI 10.1016/j.dsr.2010.07.011; Bingham RJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032662; Carmack EC, 1997, DEEP-SEA RES PT II, V44, P1487, DOI 10.1016/S0967-0645(97)00056-8; Chambers DP, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027296; Chambers DP, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC002914; DICKSON RR, 1988, PROG OCEANOGR, V20, P103, DOI 10.1016/0079-6611(88)90049-3; Ekwurzel B, 2001, J GEOPHYS RES-OCEANS, V106, P9075, DOI 10.1029/1999JC000024; *EWG, 1997, JOINT US RUSS ATL AR; Koldunov NV, 2010, J CLIMATE, V23, P2520, DOI 10.1175/2009JCLI3065.1; Kwok R, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046063; Kwok R, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2009JC005312; Lique C, 2011, J CLIMATE, V24, P1705, DOI 10.1175/2010JCLI3762.1; Macdonald RW, 1999, GEOPHYS RES LETT, V26, P2223, DOI 10.1029/1999GL900508; McPhee MG, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037525; McPhee MG, 1998, GEOPHYS RES LETT, V25, P1729, DOI 10.1029/98GL00933; Morison J, 1998, DEEP-SEA RES PT I, V45, P15, DOI 10.1016/S0967-0637(97)00025-3; Morison J, 2000, ARCTIC, V53, P359; Morison J, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029016; Proshutinsky A, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015847; Proshutinsky A, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005104; Proshutinsky AY, 1997, J GEOPHYS RES-OCEANS, V102, P12493, DOI 10.1029/97JC00738; Rabe B, 2011, DEEP-SEA RES PT I, V58, P173, DOI 10.1016/j.dsr.2010.12.002; Serreze MC, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003424; Shindell DT, 1999, NATURE, V399, P452, DOI 10.1038/20905; Steele M, 1998, J GEOPHYS RES-OCEANS, V103, P10419, DOI 10.1029/98JC00580; Steele M, 2007, J CLIMATE, V20, P403, DOI 10.1175/JCLI4022.1; Thompson DWJ, 1998, GEOPHYS RES LETT, V25, P1297, DOI 10.1029/98GL00950; Vinogradova NT, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028588; Walsh JE, 2008, J CLIMATE, V21, P6156, DOI 10.1175/2008JCLI2163.1; Willis JK, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004517; Yamamoto-Kawai M, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2006JC003858	31	291	302	3	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2012	481	7379					66	70		10.1038/nature10705	http://dx.doi.org/10.1038/nature10705			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872VD	22222749				2022-12-28	WOS:000298836900030
J	Blumenthal, D				Blumenthal, David			A Physician Goes to Washington ... and Safely Returns	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Blumenthal, D (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.	dblumenthal@partners.org							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 4	2012	307	1					45	46		10.1001/jama.2011.1899	http://dx.doi.org/10.1001/jama.2011.1899			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	872ET	22215164				2022-12-28	WOS:000298792300020
J	Sjostrom, L; Peltonen, M; Jacobson, P; Sjostrom, CD; Karason, K; Wedel, H; Ahlin, S; Anveden, A; Bengtsson, C; Bergmark, G; Bouchard, C; Carlsson, B; Dahlgren, S; Karlsson, J; Lindroos, AK; Lonroth, H; Narbro, K; Naslund, I; Olbers, T; Svensson, PA; Carlsson, LMS				Sjostrom, Lars; Peltonen, Markku; Jacobson, Peter; Sjostrom, C. David; Karason, Kristjan; Wedel, Hans; Ahlin, Sofie; Anveden, Asa; Bengtsson, Calle; Bergmark, Gerd; Bouchard, Claude; Carlsson, Bjorn; Dahlgren, Sven; Karlsson, Jan; Lindroos, Anna-Karin; Lonroth, Hans; Narbro, Kristina; Naslund, Ingmar; Olbers, Torsten; Svensson, Per-Arne; Carlsson, Lena M. S.			Bariatric Surgery and Long-term Cardiovascular Events	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SWEDISH OBESE SUBJECTS; RISK-FACTORS; WEIGHT-LOSS; LIFE-STYLE; SUBJECTS SOS; DIABETES PREVENTION; MORTALITY; INTERVENTION; OVERWEIGHT; HEALTH	Context Obesity is a risk factor for cardiovascular events. Weight loss might protect against cardiovascular events, but solid evidence is lacking. Objective To study the association between bariatric surgery, weight loss, and cardiovascular events. Design, Setting, and Participants The Swedish Obese Subjects (SOS) study is an ongoing, nonrandomized, prospective, controlled study conducted at 25 public surgical departments and 480 primary health care centers in Sweden of 2010 obese participants who underwent bariatric surgery and 2037 contemporaneously matched obese controls who received usual care. Patients were recruited between September 1, 1987, and January 31, 2001. Date of analysis was December 31, 2009, with median follow-up of 14.7 years (range, 0-20 years). Inclusion criteria were age 37 to 60 years and a body mass index of at least 34 in men and at least 38 in women. Exclusion criteria were identical in surgery and control patients. Surgery patients underwent gastric bypass (13.2%), banding (18.7%), or vertical banded gastroplasty (68.1%), and controls received usual care in the Swedish primary health care system. Physical and biochemical examinations and database cross-checks were undertaken at preplanned intervals. Main Outcome Measures The primary end point of the SOS study (total mortality) was published in 2007. Myocardial infarction and stroke were predefined secondary end points, considered separately and combined. Results Bariatric surgery was associated with a reduced number of cardiovascular deaths (28 events among 2010 patients in the surgery group vs 49 events among 2037 patients in the control group; adjusted hazard ratio [HR], 0.47; 95% CI, 0.29-0.76; P=.002). The number of total first time (fatal or nonfatal) cardiovascular events (myocardial infarction or stroke, whichever came first) was lower in the surgery group (199 events among 2010 patients) than in the control group (234 events among 2037 patients; adjusted HR, 0.67; 95% CI, 0.54-0.83; P<.001). Conclusion Compared with usual care, bariatric surgery was associated with reduced number of cardiovascular deaths and lower incidence of cardiovascular events in obese adults. JAMA. 2012;307(1):56-65	[Sjostrom, Lars; Jacobson, Peter; Sjostrom, C. David; Karason, Kristjan; Ahlin, Sofie; Anveden, Asa; Bergmark, Gerd; Carlsson, Bjorn; Svensson, Per-Arne; Carlsson, Lena M. S.] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Gothenburg, Sweden; [Lonroth, Hans; Olbers, Torsten] Univ Gothenburg, Sahlgrenska Acad, Inst Surg, Gothenburg, Sweden; [Bengtsson, Calle] Univ Gothenburg, Sahlgrenska Acad, Inst Primary Hlth Care, Gothenburg, Sweden; [Karlsson, Jan] Univ Gothenburg, Sahlgrenska Acad, Inst Hlth & Care Sci, Gothenburg, Sweden; [Peltonen, Markku] Natl Inst Hlth & Welf, Chron Dis Epidemiol & Prevent Unit, Helsinki, Finland; [Wedel, Hans] Nord Sch Publ Hlth, Gothenburg, Sweden; [Bouchard, Claude] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Dahlgren, Sven] Umea Univ Hosp, Dept Surg, S-90185 Umea, Sweden; [Lindroos, Anna-Karin] Natl Food Adm Toxicol Lab, Dept Nutr, Uppsala, Sweden; [Narbro, Kristina] Dept Hlth Care, Gothenburg, Sweden; [Naslund, Ingmar] Univ Hosp, Dept Surg, Orebro, Sweden	University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Gothenburg; Finland National Institute for Health & Welfare; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Umea University; Orebro University	Sjostrom, L (corresponding author), Sahlgrens Univ Hosp, Inst Med, Vita Straket 15, S-41345 Gothenburg, Sweden.	lars.v.sjostrom@medfak.gu.se	Peltonen, Markku/F-3037-2015; Carlsson, Lena/F-7570-2018; Bouchard, Claude/AAE-2035-2019; Svensson, Per-Arne/R-4626-2019; Bouchard, Claude/A-7637-2009	Peltonen, Markku/0000-0002-3767-4223; Carlsson, Lena/0000-0003-4145-6242; Bouchard, Claude/0000-0002-0048-491X; Karason, Kristjan/0000-0002-2802-1191; Jacobson, Peter/0000-0002-1769-1827; Svensson, Per-Arne/0000-0002-6731-806X; Ahlin, Sofie/0000-0003-0619-2683; Olbers, Torsten/0000-0002-7218-3390	sanofi-aventis; Johnson Johnson; AstraZeneca; Biovitrum; Bristol-Myers Squibb; GlaxoSmithKline; Lenimen; Merck; Novo Nordisk; Hoffmann LaRoche; Servier; MSD; Ethicon; Pfizer; Novartis; Weight Watchers Scientific Advisory Board; Covidien; Swedish Medical Research Council; Swedish Research Council [K2010-55X-11285-13]; Swedish Foundation for Strategic Research; Cederroths	sanofi-aventis(Sanofi-Aventis); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); AstraZeneca(AstraZeneca); Biovitrum; Bristol-Myers Squibb(Bristol-Myers Squibb); GlaxoSmithKline(GlaxoSmithKline); Lenimen; Merck(Merck & Company); Novo Nordisk(Novo Nordisk); Hoffmann LaRoche(Hoffmann-La Roche); Servier(Servier); MSD; Ethicon; Pfizer(Pfizer); Novartis(Novartis); Weight Watchers Scientific Advisory Board; Covidien; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Cederroths	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr L. Sjostrom reported obtaining unrestricted Swedish Obese Subjects grants from sanofi-aventis and Johnson & Johnson since 2007; receiving lecture and consulting fees from AstraZeneca, Biovitrum, Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson, Lenimen, Merck, Novo Nordisk, Hoffmann LaRoche, sanofi-aventis, and Servier; and holding stocks in Lenimen and being chairman of its board. Dr Jacobson reported receiving research grants from Hoffmann LaRoche. Dr C. Sjostrom reported being employed by AstraZeneca and receiving consulting and/or lecture fees from sanofi-aventis, MSD, and Ethicon. Dr Wedel reported receiving consulting fees from AstraZeneca, Pfizer, Novartis, and Hoffmann LaRoche without relation to the submitted work. Dr Bouchard reported receiving consulting fees from the Weight Watchers Scientific Advisory Board and unrestricted grants from Bristol-Myers Squibb. Dr B. Carlsson reported being employed by and holding stocks in AstraZeneca. Dr Karlsson reported serving as consultant for Pfizer. Dr Lindroos reported serving as a consultant for Abbott. Dr Naslund reported receiving lecture fees from Johnson & Johnson. Dr Olbers reported receiving lecture fees on speakers bureaus from Johnson & Johnson and Covidien and receiving travel expenses from Johnson & Johnson. Dr L. Carlsson reported serving as a consultant for AstraZeneca and holding stocks in Sahltech. All other authors declared no conflicts of interest.; This study was supported by grants from the Swedish Medical Research Council, the Swedish Research Council (K2010-55X-11285-13), the Swedish Foundation for Strategic Research to Sahlgrenska Centre for Cardiovascular and Metabolic Research, and the Swedish federal government under the LUA/ALF agreement (Dr L. Sjostrom). These research grants applied for as ordinary Research Council grants are paid by the Swedish State to the university hospitals as compensation for teaching costs. Unconditional support was also obtained from Hoffmann LaRoche, AstraZeneca, Cederroths, sanofi-aventis, and Johnson & Johnson.	Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; [Anonymous], 2009, DIABETES CARE, V32, pS3, DOI 10.2337/dc09-S003; BROLIN RE, 1987, GASTROENTEROL CLIN N, V16, P317; Christou NV, 2004, ANN SURG, V240, P416, DOI 10.1097/01.sla.0000137343.63376.19; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Dixon JB, 2011, DIABETIC MED, V28, P628, DOI 10.1111/j.1464-5491.2011.03306.x; GOLDSTEIN DJ, 1992, INT J OBESITY, V16, P397; James WPT, 2010, NEW ENGL J MED, V363, P905, DOI 10.1056/NEJMoa1003114; Karlsson J, 2007, INT J OBESITY, V31, P1248, DOI 10.1038/sj.ijo.0803573; KARLSSON J, 1995, J CLIN EPIDEMIOL, V48, P817, DOI 10.1016/0895-4356(94)00196-W; LEE IM, 1992, JAMA-J AM MED ASSOC, V268, P2045, DOI 10.1001/jama.268.15.2045; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; National Institutes of Health (USA), 1992, American Journal of Clinical Nutrition, V55, p615S; Nilsson PM, 2002, J INTERN MED, V252, P70, DOI 10.1046/j.1365-2796.2002.01010.x; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1547, DOI 10.1001/jama.299.13.1547; PAMUK ER, 1993, ANN INTERN MED, V119, P744, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00023; Poobalan A, 2004, Obes Rev, V5, P43, DOI 10.1111/j.1467-789X.2004.00127.x; Rubino F, 2010, ANN SURG, V251, P399, DOI 10.1097/SLA.0b013e3181be34e7; Rubino F, 2010, ANNU REV MED, V61, P393, DOI 10.1146/annurev.med.051308.105148; Sjostrom CD, 2011, INT J OBESITY, V35, P1413, DOI 10.1038/ijo.2010.282; Sjostrom L, 1998, LANCET, V352, P167, DOI 10.1016/S0140-6736(97)11509-4; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; SJOSTROM L, 1992, INT J OBESITY, V16, P465; Sjostrom L, 2000, ENDOCRINE, V13, P213, DOI 10.1385/ENDO:13:2:213; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Sjostrom L, 2009, LANCET ONCOL, V10, P653, DOI 10.1016/S1470-2045(09)70159-7; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Tirosh A, 2011, NEW ENGL J MED, V364, P1315, DOI 10.1056/NEJMoa1006992; Torgerson JS, 2004, DIABETES CARE, V27, P155, DOI 10.2337/diacare.27.1.155; Torgerson JS, 2003, AM J GASTROENTEROL, V98, P1032, DOI 10.1016/S0002-9270(03)00147-3; Uusitupa M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005656; WALKER M, 1995, INT J EPIDEMIOL, V24, P694, DOI 10.1093/ije/24.4.694; Wannamethee SG, 2000, AM J EPIDEMIOL, V151, P667, DOI 10.1093/oxfordjournals.aje.a010261; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Williamson DF, 2000, DIABETES CARE, V23, P1499, DOI 10.2337/diacare.23.10.1499; Wing RR, 2010, ARCH INTERN MED, V170, P1566, DOI 10.1001/archinternmed.2010.334; Yaari S, 1998, AM J EPIDEMIOL, V148, P546, DOI 10.1093/oxfordjournals.aje.a009680; Yamaoka K, 2005, DIABETES CARE, V28, P2780, DOI 10.2337/diacare.28.11.2780	39	1035	1063	1	59	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 4	2012	307	1					56	65		10.1001/jama.2011.1914	http://dx.doi.org/10.1001/jama.2011.1914			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	872ET	22215166	Bronze			2022-12-28	WOS:000298792300022
J	Artenstein, AW; Opal, SM				Artenstein, Andrew W.; Opal, Steven M.			MECHANISMS OF DISEASE Proprotein Convertases in Health and Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ALPHA-INHIBITOR PROTEINS; TOXIN PROTECTIVE ANTIGEN; ENZYMATIC CHARACTERIZATION; ANTHRAX TOXIN; TUMOR-CELLS; HUMAN FURIN; PROTEOLYTIC ACTIVATION; THERAPEUTIC STRATEGY; VIRUS GLYCOPROTEIN; PROCESSING ENZYME		[Artenstein, Andrew W.] Mem Hosp Rhode Isl, Ctr Biodef & Emerging Pathogens, Dept Med, Pawtucket, RI 02860 USA; Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA	Brown University	Artenstein, AW (corresponding author), Mem Hosp Rhode Isl, Ctr Biodef & Emerging Pathogens, Dept Med, 111 Brewster St, Pawtucket, RI 02860 USA.	artenstein@brown.edu						Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Abrami L, 1998, J BIOL CHEM, V273, P32656, DOI 10.1074/jbc.273.49.32656; Anderson ED, 2002, J BIOL CHEM, V277, P12879, DOI 10.1074/jbc.M108740200; Arsenault D, 2011, J CELL PHYSL    0418; Artenstein AW, 2007, J INFECT DIS, V195, P471, DOI 10.1086/510859; Basak A, 1999, BIOCHEM J, V343, P29, DOI 10.1042/0264-6021:3430029; Basak A, 2010, CURR MED CHEM, V17, P2214, DOI 10.2174/092986710791331040; Bassi DE, 2010, NEOPLASIA, V12, P516, DOI 10.1593/neo.92030; Bassi DE, 2000, MOL CARCINOGEN, V28, P63, DOI 10.1002/1098-2744(200006)28:2<63::AID-MC1>3.3.CO;2-3; Bassi DE, 2003, AM J PATHOL, V162, P439, DOI 10.1016/S0002-9440(10)63838-2; Bassi DE, 2001, P NATL ACAD SCI USA, V98, P10326, DOI 10.1073/pnas.191199198; Bassi DE, 2001, MOL CARCINOGEN, V31, P224, DOI 10.1002/mc.1057; Bennett BD, 2001, J BIOL CHEM, V276, P15561; Bennett BD, 2000, J BIOL CHEM, V275, P37712, DOI 10.1074/jbc.M005339200; Berthet V, 2000, J BIOL CHEM, V275, P33308, DOI 10.1074/jbc.M004834200; Cain BM, 2002, PROTEIN EXPRES PURIF, V24, P227, DOI 10.1006/prep.2001.1557; Chan JCY, 2009, P NATL ACAD SCI USA, V106, P9820, DOI 10.1073/pnas.0903849106; Cheng M, 1997, INT J CANCER, V71, P966, DOI 10.1002/(SICI)1097-0215(19970611)71:6<966::AID-IJC10>3.3.CO;2-A; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Constam DB, 1996, J CELL BIOL, V134, P181, DOI 10.1083/jcb.134.1.181; Constam DB, 2000, GENE DEV, V14, P1146; Coppola J, 2008, NEOPLASIA, V10, P363, DOI 10.1593/neo.08166; Creemers JWM, 2008, FRONT BIOSCI-LANDMRK, V13, P4960, DOI 10.2741/3055; CREEMERS JWM, 1995, J BIOL CHEM, V270, P2695, DOI 10.1074/jbc.270.6.2695; CREEMERS JWM, 1992, FEBS LETT, V300, P82, DOI 10.1016/0014-5793(92)80169-H; CREEMERS JWM, 1993, J BIOL CHEM, V268, P21826; Day PM, 2009, FUTURE MICROBIOL, V4, P1255, DOI [10.2217/fmb.09.86, 10.2217/FMB.09.86]; De Vos L, 2008, INT J ONCOL, V32, P1073; DeBie I, 1996, J CELL BIOL, V135, P1261, DOI 10.1083/jcb.135.5.1261; Decha P, 2008, BIOPHYS J, V95, P128, DOI 10.1529/biophysj.107.127456; Di Cera E, 2009, IUBMB LIFE, V61, P510, DOI 10.1002/iub.186; Dubois CM, 2001, AM J PATHOL, V158, P305, DOI 10.1016/S0002-9440(10)63970-3; Farooqi IS, 2007, J CLIN ENDOCR METAB, V92, P3369, DOI 10.1210/jc.2007-0687; Furuta M, 1997, P NATL ACAD SCI USA, V94, P6646, DOI 10.1073/pnas.94.13.6646; Gonzalez-Reyes L, 2001, P NATL ACAD SCI USA, V98, P9859, DOI 10.1073/pnas.151098198; Gordon VM, 1997, INFECT IMMUN, V65, P3370, DOI 10.1128/IAI.65.8.3370-3375.1997; Gu ML, 1996, INFECT IMMUN, V64, P524, DOI 10.1128/IAI.64.2.524-527.1996; HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Henrich S, 2005, J MOL BIOL, V345, P211, DOI 10.1016/j.jmb.2004.10.050; Henrich S, 2003, NAT STRUCT BIOL, V10, P669, DOI 10.1038/nsb0803-669b; Henrich S, 2003, NAT STRUCT BIOL, V10, P520, DOI 10.1038/nsb941; Hoshino A, 2011, ENDOCRINOLOGY, V152, P1402, DOI 10.1210/en.2010-1170; Hubbard FC, 1997, CANCER RES, V57, P5226; Hwang EM, 2006, BIOCHEM BIOPH RES CO, V349, P654, DOI 10.1016/j.bbrc.2006.08.077; Jackson RS, 2003, J CLIN INVEST, V112, P1550, DOI 10.1172/JCI18784; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Jean F, 2000, P NATL ACAD SCI USA, V97, P2864, DOI 10.1073/pnas.050504297; Jean F, 1998, P NATL ACAD SCI USA, V95, P7293, DOI 10.1073/pnas.95.13.7293; JEAN F, 1993, BIOCHEM J, V292, P891, DOI 10.1042/bj2920891; Kajiwara Hiroshi, 1999, Tokai Journal of Experimental and Clinical Medicine, V24, P13; Khatib AM, 2001, J BIOL CHEM, V276, P30686, DOI 10.1074/jbc.M101725200; Kirschner M, 1998, FASEB J, V95, P8420; Komiyama T, 2009, J BIOL CHEM, V284, P15729, DOI 10.1074/jbc.M901540200; KONOSHITA T, 1994, MOL CELL ENDOCRINOL, V99, P307, DOI 10.1016/0303-7207(94)90022-1; Lea N, 1999, MICROBIOL-UK, V145, P999, DOI 10.1099/13500872-145-5-999; LEDUC R, 1992, J BIOL CHEM, V267, P14304; Lim YP, 2003, J INFECT DIS, V188, P919, DOI 10.1086/377642; Lloyd DJ, 2008, HUM MOL GENET, V17, P3435, DOI 10.1093/hmg/ddn254; Lloyd DJ, 2006, HUM MOL GENET, V15, P1884, DOI 10.1093/hmg/ddl111; Lopez-Perez E, 1999, J NEUROCHEM, V73, P2056; Mahloogi H, 2002, CARCINOGENESIS, V23, P565, DOI 10.1093/carcin/23.4.565; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Mayer G, 2008, J BIOL CHEM, V283, P31791, DOI 10.1074/jbc.M805971200; Mbikay M, 1997, BRIT J CANCER, V75, P1509, DOI 10.1038/bjc.1997.258; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; Mercapide J, 2002, CLIN CANCER RES, V8, P1740; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Molloy SS, 1999, TRENDS CELL BIOL, V9, P28, DOI 10.1016/S0962-8924(98)01382-8; Munzer JS, 1997, J BIOL CHEM, V272, P19672, DOI 10.1074/jbc.272.32.19672; Munzer JS, 1997, J BIOL CHEM, V272, P30589; Naureckiene S, 2003, ARCH BIOCHEM BIOPHYS, V420, P55, DOI 10.1016/j.abb.2003.09.011; Opal SM, 2005, INFECT IMMUN, V73, P5101, DOI 10.1128/IAI.73.8.5101-5105.2005; Opal SM, 2011, SHOCK, V35, P42, DOI 10.1097/SHK.0b013e3181e83204; ORAHILLY S, 1995, NEW ENGL J MED, V333, P1386, DOI 10.1056/NEJM199511233332104; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; PEI DQ, 1995, NATURE, V375, P244, DOI 10.1038/375244a0; Pesu M, 2008, NATURE, V455, P246, DOI 10.1038/nature07210; Primakoff P, 2000, TRENDS GENET, V16, P83, DOI 10.1016/S0168-9525(99)01926-5; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Remacle AG, 2010, INT J BIOCHEM CELL B, V42, P987, DOI 10.1016/j.biocel.2010.02.013; Roebroek AJM, 2004, J BIOL CHEM, V279, P53442, DOI 10.1074/jbc.M407152200; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Sarac MS, 2002, INFECT IMMUN, V70, P7136, DOI 10.1128/IAI.70.12.7136-7139.2002; Scamuffa N, 2008, J CLIN INVEST, V118, P352, DOI 10.1172/JCI32040; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 2011, ANN NY ACAD SCI, V1220, P149, DOI 10.1111/j.1749-6632.2010.05883.x; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Seidah NG, 1999, P NATL ACAD SCI USA, V96, P1321, DOI 10.1073/pnas.96.4.1321; SHENNAN KIJ, 1995, J BIOL CHEM, V270, P1402, DOI 10.1074/jbc.270.3.1402; Shiryaev SA, 2007, J BIOL CHEM, V282, P20847, DOI 10.1074/jbc.M703847200; Siegfried G, 2003, J CLIN INVEST, V111, P1723, DOI 10.1172/JCI200317220; STEINER DF, 1967, SCIENCE, V157, P697, DOI 10.1126/science.157.3789.697; Sun XW, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-73; Szanto AJP, 2005, MOL CARCINOG, V44, P151; Szumska D, 2008, GENE DEV, V22, P1465, DOI 10.1101/gad.479408; Takumi I, 1998, MODERN PATHOL, V11, P232; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Toure BB, 2000, J BIOL CHEM, V275, P2349, DOI 10.1074/jbc.275.4.2349; Tsuji A, 1999, J BIOCHEM, V126, P591, DOI 10.1093/oxfordjournals.jbchem.a022491; TSUNEOKA M, 1993, J BIOL CHEM, V268, P26461; VANDEVEN WJM, 1990, MOL BIOL REP, V14, P265, DOI 10.1007/BF00429896; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Volchkov VE, 2000, VIROLOGY, V268, P1, DOI 10.1006/viro.1999.0110; Volchkov VE, 1998, P NATL ACAD SCI USA, V95, P5762, DOI 10.1073/pnas.95.10.5762; WATANABE M, 1995, J VIROL, V69, P3206, DOI 10.1128/JVI.69.5.3206-3210.1995; Yana I, 2000, MOL BIOL CELL, V11, P2387, DOI 10.1091/mbc.11.7.2387; Yang SL, 2002, CRIT CARE MED, V30, P617, DOI 10.1097/00003246-200203000-00021; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488; Zhu XR, 2002, P NATL ACAD SCI USA, V99, P10293, DOI 10.1073/pnas.162352599	112	121	130	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2011	365	26					2507	2518		10.1056/NEJMra1106700	http://dx.doi.org/10.1056/NEJMra1106700			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	868SD	22204726				2022-12-28	WOS:000298544600011
J	Volk, RJ; Wolf, AMD				Volk, Robert J.; Wolf, Andrew M. D.			Grading the New US Preventive Services Task Force Prostate Cancer Screening Recommendation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MORTALITY		[Volk, Robert J.] Univ Texas MD Anderson Canc Ctr, Dept Gen Internal Med, Div Gen Internal Med, Houston, TX 77230 USA; [Wolf, Andrew M. D.] Univ Virginia, Sch Med, Dept Med, Div Med Geriatr & Palliat Care, Charlottesville, VA 22908 USA	University of Texas System; UTMD Anderson Cancer Center; University of Virginia	Volk, RJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gen Internal Med, Div Gen Internal Med, POB 301402, Houston, TX 77230 USA.	bvolk@mdanderson.org		Volk, Robert/0000-0001-8811-5854				American Urological Assocation, 2009, AM UR ASS PROST SPEC; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; McNaughton-Collins MF, 2011, NEW ENGL J MED, V365, P1951, DOI 10.1056/NEJMp1111894; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; U.S. Preventive Services Task Force, 2011, SCREEN PROST CANC US; Wolf AMD, 2010, CA-CANCER J CLIN, V60, P70, DOI 10.3322/caac.20066	8	19	19	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 28	2011	306	24					2715	2716		10.1001/jama.2011.1893	http://dx.doi.org/10.1001/jama.2011.1893			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	867VX	22203540				2022-12-28	WOS:000298484000022
J	Bregman, A; Avraham-Kelbert, M; Barkai, O; Duek, L; Guterman, A; Choder, M				Bregman, Almog; Avraham-Kelbert, Moran; Barkai, Oren; Duek, Lea; Guterman, Adi; Choder, Mordechai			Promoter Elements Regulate Cytoplasmic mRNA Decay	CELL			English	Article							GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; CODING REGION; YEAST; PROTEIN; DEGRADATION; TURNOVER; TRANSLATION; STABILITY; SUBUNIT	Promoters are DNA elements that enable transcription and its regulation by trans-acting factors. Here, we demonstrate that yeast promoters can also regulate mRNA decay after the mRNA leaves the nucleus. A conventional yeast promoter consists of a core element and an upstream activating sequence (UAS). We find that changing UASs of a reporter gene without altering the transcript sequence affects the transcript's decay kinetics. A short cis element, comprising two Rap1p-binding sites, and Rap1p itself, are necessary and sufficient to induce enhanced decay of the reporter mRNA. Furthermore, Rap1p stimulates both the synthesis and the decay of a specific population of endogenous mRNAs. We propose that Rap1p association with target promoter in the nucleus affects the composition of the exported mRNP, which in turn regulates mRNA decay in the cytoplasm. Thus, promoters can play key roles in determining mRNA levels and have the capacity to coordinate rates of mRNA synthesis and decay.	[Bregman, Almog; Avraham-Kelbert, Moran; Barkai, Oren; Duek, Lea; Guterman, Adi; Choder, Mordechai] Technion Israel Inst Technol, Dept Mol Microbiol, Rappaport Fac Med, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Choder, M (corresponding author), Technion Israel Inst Technol, Dept Mol Microbiol, Rappaport Fac Med, IL-31096 Haifa, Israel.	choder@technion.ac.il			US-Israel Binational Science Foundation (BSF); Israel Science Foundation, Israel Ministry of Health; Rappaport Foundation	US-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); Israel Science Foundation, Israel Ministry of Health(Israel Science Foundation); Rappaport Foundation	We thank Allan Jacobson for advice during this project. We thank Elite Levin for statistical analyses. Special thanks to Jonathan Warner, whose constructs were used as key reagents in this work. We thank Stephane Marcand for Rap1p-depletable strains, Tony Weil for anti-Rap1p antibodies, and David Shore for critically reading the manuscript before submission. This work was supported by the US-Israel Binational Science Foundation (BSF), by the Israel Science Foundation, Israel Ministry of Health, and by Rappaport Foundation.	Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Araki Y, 2001, EMBO J, V20, P4684, DOI 10.1093/emboj/20.17.4684; Cao D, 2001, RNA, V7, P1192, DOI 10.1017/S1355838201010330; Choder Mordechai, 2011, Cell Logist, V1, P37, DOI 10.4161/cl.1.1.14465; Clark A, 2009, FRONT BIOSCI-LANDMRK, V14, P847, DOI 10.2741/3282; Coller J, 2004, ANNU REV BIOCHEM, V73, P861, DOI 10.1146/annurev.biochem.73.011303.074032; Dahan O, 2011, TRENDS GENET, V27, P316, DOI 10.1016/j.tig.2011.05.008; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Dori-Bachash M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001106; Elkon R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-259; ENSSLE J, 1993, P NATL ACAD SCI USA, V90, P10091, DOI 10.1073/pnas.90.21.10091; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Goler-Baron V, 2008, GENE DEV, V22, P2022, DOI 10.1101/gad.473608; GUARENTE L, 1988, CELL, V52, P303, DOI 10.1016/S0092-8674(88)80020-5; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Harel-Sharvit L, 2010, CELL, V143, P552, DOI 10.1016/j.cell.2010.10.033; Hilleren PJ, 2003, MOL CELL, V12, P1453, DOI 10.1016/S1097-2765(03)00488-X; Johnson AW, 1997, MOL CELL BIOL, V17, P6122, DOI 10.1128/MCB.17.10.6122; Komili S, 2008, NAT REV GENET, V9, P38, DOI 10.1038/nrg2223; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; LaGrandeur T, 1999, RNA, V5, P420, DOI 10.1017/S1355838299981748; LARIMER FW, 1992, GENE, V120, P51, DOI 10.1016/0378-1119(92)90008-D; Lascaris RF, 1999, BIOINFORMATICS, V15, P267, DOI 10.1093/bioinformatics/15.4.267; Leipuviene R, 2007, CELL MOL LIFE SCI, V64, P2945, DOI 10.1007/s00018-007-7198-4; Li BJ, 1999, MOL CELL BIOL, V19, P5393; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Liu H, 2006, BIOCHEM SOC T, V34, P35, DOI 10.1042/BST0340035; Lotan R, 2005, GENE DEV, V19, P3004, DOI 10.1101/gad.353205; Lotan R, 2007, J CELL BIOL, V178, P1133, DOI 10.1083/jcb.200701165; Molin C, 2009, RNA, V15, P600, DOI 10.1261/rna.1403509; Moqtaderi Z, 1996, NATURE, V383, P188, DOI 10.1038/383188a0; MUHLRAD D, 1992, GENE DEV, V6, P2100, DOI 10.1101/gad.6.11.2100; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Pardo B, 2005, EMBO J, V24, P3117, DOI 10.1038/sj.emboj.7600778; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; PARKER R, 1990, P NATL ACAD SCI USA, V87, P2780, DOI 10.1073/pnas.87.7.2780; Pelechano V, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000614; Pina B, 2003, MOL GENET GENOMICS, V268, P791, DOI 10.1007/s00438-002-0801-3; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; SACHS AB, 1989, CELL, V58, P857, DOI 10.1016/0092-8674(89)90938-0; Schawalder SB, 2004, NATURE, V432, P1058, DOI 10.1038/nature03200; Shalem O, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002273; Shalem O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.59; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; TIPPER DJ, 1973, J BACTERIOL, V116, P245, DOI 10.1128/JB.116.1.245-256.1973; van Hoof A, 2000, MOL CELL BIOL, V20, P8230, DOI 10.1128/MCB.20.21.8230-8243.2000; VREKEN P, 1992, MOL CELL BIOL, V12, P2986, DOI 10.1128/MCB.12.7.2986; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Wilusz CJ, 2004, TRENDS GENET, V20, P491, DOI 10.1016/j.tig.2004.07.011	50	128	129	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 23	2011	147	7					1473	1483		10.1016/j.cell.2011.12.005	http://dx.doi.org/10.1016/j.cell.2011.12.005			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	866SP	22196725	Bronze			2022-12-28	WOS:000298403400013
J	Ram, O; Goren, A; Amit, I; Shoresh, N; Yosef, N; Ernst, J; Kellis, M; Gymrek, M; Issner, R; Coyne, M; Durham, T; Zhang, XL; Donaghey, J; Epstein, CB; Regev, A; Bernstein, BE				Ram, Oren; Goren, Alon; Amit, Ido; Shoresh, Noam; Yosef, Nir; Ernst, Jason; Kellis, Manolis; Gymrek, Melissa; Issner, Robbyn; Coyne, Michael; Durham, Timothy; Zhang, Xiaolan; Donaghey, Julie; Epstein, Charles B.; Regev, Aviv; Bernstein, Bradley E.			Combinatorial Patterning of Chromatin Regulators Uncovered by Genome-wide Location Analysis in Human Cells	CELL			English	Article							LINKED MENTAL-RETARDATION; EMBRYONIC STEM-CELLS; HISTONE; POLYCOMB; GENE; TRANSCRIPTION; PROTEINS; CHROMODOMAINS; MECHANISMS; ENHANCERS	Hundreds of chromatin regulators (CRs) control chromatin structure and function by catalyzing and binding histone modifications, yet the rules governing these key processes remain obscure. Here, we present a systematic approach to infer CR function. We developed ChIP-string, a meso-scale assay that combines chromatin immunoprecipitation with a signature readout of 487 representative loci. We applied ChIP-string to screen 145 antibodies, thereby identifying effective reagents, which we used to map the genome-wide binding of 29 CRs in two cell types. We found that specific combinations of CRs colocalize in characteristic patterns at distinct chromatin environments, at genes of coherent functions, and at distal regulatory elements. When comparing between cell types, CRs redistribute to different loci but maintain their modular and combinatorial associations. Our work provides a multiplex method that substantially enhances the ability to monitor CR binding, presents a large resource of CR maps, and reveals common principles for combinatorial CR function.	[Ram, Oren; Goren, Alon; Amit, Ido; Shoresh, Noam; Yosef, Nir; Ernst, Jason; Kellis, Manolis; Gymrek, Melissa; Issner, Robbyn; Coyne, Michael; Durham, Timothy; Zhang, Xiaolan; Donaghey, Julie; Epstein, Charles B.; Regev, Aviv; Bernstein, Bradley E.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Ram, Oren; Goren, Alon; Amit, Ido; Yosef, Nir; Gymrek, Melissa; Regev, Aviv; Bernstein, Bradley E.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Ram, Oren; Goren, Alon; Gymrek, Melissa; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Ram, Oren; Goren, Alon; Gymrek, Melissa; Bernstein, Bradley E.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Ram, Oren; Goren, Alon; Gymrek, Melissa; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Ram, Oren; Goren, Alon; Gymrek, Melissa; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; [Ernst, Jason; Kellis, Manolis] MIT Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Regev, Aviv] MIT, Dept Biol, Cambridge, MA 02140 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Regev, A (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	aregev@broad.mit.edu; bernstein.bradley@mgh.harvard.edu	Kellis, Manolis/ABE-7385-2020	Kellis, Manolis/0000-0001-7113-9630; Epstein, Charles B./0000-0001-8358-8345; Issner, Robbyn/0000-0003-4132-9219; Gymrek, Melissa/0000-0002-6086-3903; Goren, Alon/0000-0001-5669-9357	EMBO; American Recovery and Reinvestment Act (ARRA) [U54 HG004570]; NHGRI; Howard Hughes Medical Institute; NIH; Burroughs Wellcome Fund; NATIONAL CANCER INSTITUTE [DP1CA174427] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004570, R01HG004037] Funding Source: NIH RePORTER	EMBO(European Molecular Biology Organization (EMBO)); American Recovery and Reinvestment Act (ARRA); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank B. Knoechel, C. Ye, J. Jaffe, and R. Mostoslavsky for helpful discussions; G. Geiss and R. Boykin for help with assay development; R. Raychowdhury and the Broad Sequencing Platform for technical assistance; X. Li and Y. Shi for Plu1 antibody; D. Jang, J. Robinson, and T. Liefeld for building the CRome portal; and L. Gaffney for figure preparation. O.R. and A.G. were supported by an EMBO fellowship. The work was supported by American Recovery and Reinvestment Act (ARRA) funds through grant number U54 HG004570 (to B.E.B.), by an NHGRI CEGS grant (A.R. and B.E.B), Howard Hughes Medical Institute (A.R. and B.E.B.), an NIH PIONEER award (A.R.), and the Burroughs Wellcome Fund (A.R. and B.E.B.). A.R. is a researcher of the Merkin Foundation for Stem Cell Research at the Broad Institute.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; David G, 2008, P NATL ACAD SCI USA, V105, P4168, DOI 10.1073/pnas.0710285105; Elsasser SJ, 2011, SCIENCE, V331, P1145, DOI 10.1126/science.1203280; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kleine-Kohlbrecher D, 2010, MOL CELL, V38, P165, DOI 10.1016/j.molcel.2010.03.002; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Nimura K, 2009, NATURE, V460, P287, DOI 10.1038/nature08086; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Ren XJ, 2011, MOL CELL BIOL, V31, P2100, DOI 10.1128/MCB.05088-11; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Smith E, 2010, MOL CELL, V40, P689, DOI 10.1016/j.molcel.2010.11.031; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Venters BJ, 2011, MOL CELL, V41, P480, DOI 10.1016/j.molcel.2011.01.015; Vidal M, 2009, INT J DEV BIOL, V53, P355, DOI 10.1387/ijdb.082690mv; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yosef N, 2011, CELL, V144, P886, DOI 10.1016/j.cell.2011.02.015; Zhang ZH, 2011, CELL, V144, P175, DOI 10.1016/j.cell.2011.01.003; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	41	249	265	0	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 23	2011	147	7					1628	1639		10.1016/j.cell.2011.09.057	http://dx.doi.org/10.1016/j.cell.2011.09.057			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	866SP	22196736	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000298403400025
J	Szathmary, E				Szathmary, Eors			To Group or Not to Group?	SCIENCE			English	Editorial Material							MULTILEVEL SELECTION; COOPERATION; DEFECTION; EVOLUTION; GAMES		Eotvos Lorand Univ, Inst Biol, H-1117 Budapest, Hungary	Eotvos Lorand University	Szathmary, E (corresponding author), Eotvos Lorand Univ, Inst Biol, 1C Pazmany Peter Setany, H-1117 Budapest, Hungary.	szathmary.eors@gmail.com	Szathmary, Eors/AAS-1202-2021	Szathmary, Eors/0000-0001-5227-2997				Archetti M, 2011, EVOLUTION, V65, P1140, DOI 10.1111/j.1558-5646.2010.01185.x; Bickerton D, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-261; Boza G, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-336; DIEKMANN A, 1985, J CONFLICT RESOLUT, V29, P605, DOI 10.1177/0022002785029004003; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hauert C, 2006, J THEOR BIOL, V239, P195, DOI 10.1016/j.jtbi.2005.08.040; MOTRO U, 1991, J THEOR BIOL, V151, P145, DOI 10.1016/S0022-5193(05)80358-3; Odling-Smee F., 2003, NICHE CONSTRUCTION; Powers ST, 2011, EVOLUTION, V65, P1527, DOI 10.1111/j.1558-5646.2011.01250.x; Szathmary E, 1995, MAJOR TRANSITIONS EV; Traulsen A, 2006, P NATL ACAD SCI USA, V103, P10952, DOI 10.1073/pnas.0602530103; WILSON DS, 1975, P NATL ACAD SCI USA, V72, P143, DOI 10.1073/pnas.72.1.143	12	13	15	2	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1648	1649		10.1126/science.1209548	http://dx.doi.org/10.1126/science.1209548			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22194561				2022-12-28	WOS:000298344000049
J	Pattabiraman, VR; Bode, JW				Pattabiraman, Vijaya R.; Bode, Jeffrey W.			Rethinking amide bond synthesis	NATURE			English	Review							NATIVE CHEMICAL LIGATION; TRACELESS STAUDINGER LIGATION; PHASE PEPTIDE-SYNTHESIS; AMINO-ACID; POLYPEPTIDE-SYNTHESIS; OXIDATIVE AMIDATION; CARBOXYLIC-ACIDS; FACILE SYNTHESIS; GENERAL-SOLUTION; AQUEOUS-MEDIUM	One of the most important reactions in organic chemistry-amide bond formation-is often overlooked as a contemporary challenge because of the widespread occurrence of amides in modern pharmaceuticals and biologically active compounds. But existing methods are reaching their inherent limits, and concerns about their waste and expense are becoming sharper. Novel chemical approaches to amide formation are therefore being developed. Here we review and summarize a new generation of amide-forming reactions that may contribute to solving these problems. We also consider their potential application to current synthetic challenges, including the development of catalytic amide formation, the synthesis of therapeutic peptides and the preparation of modified peptides and proteins.	[Pattabiraman, Vijaya R.; Bode, Jeffrey W.] Swiss Fed Inst Technol, Organ Chem Lab, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Bode, JW (corresponding author), Swiss Fed Inst Technol, Organ Chem Lab, CH-8093 Zurich, Switzerland.	bode@org.chem.ethz.ch	Bode, Jeffrey/F-8555-2014	Bode, Jeffrey/0000-0001-8394-8910	ETH	ETH(ETH Zurich)	J.W.B. is grateful for the support of diverse agencies for the development of new methods for amide formation, including the Arnold and Mabel Beckman Foundation, the David and Lucille Packard Foundation, Research Corporation for Science Advancement, the US National Institutes of Health (NIH-NIGMS) and the Swiss National Science Foundation (200021-131957). V. R. P. is supported by an ETH Fellowship. We thank all our past and present co-workers who have contributed to the discovery and development of new amide-forming reactions.	AIMOTO S, 1989, B CHEM SOC JPN, V62, P524, DOI 10.1246/bcsj.62.524; Al-Zoubi RM, 2008, ANGEW CHEM INT EDIT, V47, P2876, DOI 10.1002/anie.200705468; Allen CL, 2011, CHEM SOC REV, V40, P3405, DOI 10.1039/c0cs00196a; Arora JS, 2008, J ORG CHEM, V73, P6182, DOI 10.1021/jo800223j; Arthur G., 2000, AMIDE LINKAGE SELECT; Bang D, 2006, ANGEW CHEM INT EDIT, V45, P3985, DOI 10.1002/anie.200600702; BLAKE J, 1981, INT J PEPT PROT RES, V17, P273; Blanco-Canosa JB, 2008, ANGEW CHEM INT EDIT, V47, P6851, DOI 10.1002/anie.200705471; Bode JW, 2007, J AM CHEM SOC, V129, P13798, DOI 10.1021/ja0768136; Bode JW, 2006, ANGEW CHEM INT EDIT, V45, P1248, DOI 10.1002/anie.200503991; Bray BL, 2003, NAT REV DRUG DISCOV, V2, P587, DOI 10.1038/nrd1133; Carrillo N, 2006, J AM CHEM SOC, V128, P1452, DOI 10.1021/ja057706j; Chan WK, 2006, J AM CHEM SOC, V128, P14796, DOI 10.1021/ja064479s; Charville H, 2010, CHEM COMMUN, V46, P1813, DOI 10.1039/b923093a; Chatterjee J, 2008, ACCOUNTS CHEM RES, V41, P1331, DOI 10.1021/ar8000603; Chiang PC, 2009, CHEM COMMUN, P4566, DOI 10.1039/b909360e; Clark RJ, 2010, ANGEW CHEM INT EDIT, V49, P6545, DOI 10.1002/anie.201000620; Coin I, 2007, NAT PROTOC, V2, P3247, DOI 10.1038/nprot.2007.454; Constable DJC, 2007, GREEN CHEM, V9, P411, DOI 10.1039/b703488c; Crich D, 2007, ORG LETT, V9, P4423, DOI 10.1021/ol701583t; Crich D, 2009, ORG LETT, V11, P3514, DOI 10.1021/ol901370y; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; De Sarkar S, 2010, ORG LETT, V12, P1992, DOI 10.1021/ol1004643; Deming TJ, 2007, PROG POLYM SCI, V32, P858, DOI 10.1016/j.progpolymsci.2007.05.010; Deming TJ, 1997, NATURE, V390, P386, DOI 10.1038/37084; Ekoue-Kovi K, 2008, CHEM-EUR J, V14, P6302, DOI 10.1002/chem.200800353; Fang GM, 2011, ANGEW CHEM INT EDIT, V50, P7645, DOI 10.1002/anie.201100996; Gunanathan C, 2007, SCIENCE, V317, P790, DOI 10.1126/science.1145295; Hirano K, 2009, ANGEW CHEM INT EDIT, V48, P9557, DOI 10.1002/anie.200904376; Hojo H, 2005, J AM CHEM SOC, V127, P13720, DOI 10.1021/ja053711b; Ireland DC, 2010, J NAT PROD, V73, P1610, DOI 10.1021/np1000413; Ishihara K, 1996, J ORG CHEM, V61, P4196, DOI 10.1021/jo9606564; Ishihara K, 2009, TETRAHEDRON, V65, P1085, DOI 10.1016/j.tet.2008.11.004; Kawulka KE, 2004, BIOCHEMISTRY-US, V43, P3385, DOI 10.1021/bi0359527; Kleineweischede R, 2008, ANGEW CHEM INT EDIT, V47, P5984, DOI 10.1002/anie.200801514; Knappe TA, 2009, CHEM BIOL, V16, P1290, DOI 10.1016/j.chembiol.2009.11.009; Kohn M, 2004, ANGEW CHEM INT EDIT, V43, P3106, DOI 10.1002/anie.200401744; Kramer JR, 2010, J AM CHEM SOC, V132, P15068, DOI 10.1021/ja107425f; Kumar KSA, 2010, ANGEW CHEM INT EDIT, V49, P9126, DOI 10.1002/anie.201003763; Li XC, 2008, J AM CHEM SOC, V130, P5446, DOI 10.1021/ja800612r; Li XC, 2010, ORG LETT, V12, P1724, DOI 10.1021/ol1003109; Mandal K, 2009, PROTEIN SCI, V18, P1146, DOI 10.1002/pro.127; Marcelli T, 2010, ANGEW CHEM INT EDIT, V49, P6840, DOI 10.1002/anie.201003188; Marchildon K, 2011, MACROMOL REACT ENG, V5, P22, DOI 10.1002/mren.201000017; Marx V., 2005, CHEM ENG NEWS, V83, P16; Medina SI, 2010, ORG BIOMOL CHEM, V8, P3405, DOI 10.1039/c004490c; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; Messeri T, 1998, TETRAHEDRON LETT, V39, P1669, DOI 10.1016/S0040-4039(98)00017-3; Messeri T, 1998, TETRAHEDRON LETT, V39, P1673, DOI 10.1016/S0040-4039(98)00018-5; Muthaiah S, 2010, J ORG CHEM, V75, P3002, DOI 10.1021/jo100254g; Nilsson BL, 2003, J AM CHEM SOC, V125, P5268, DOI 10.1021/ja029752e; Nilsson BL, 2000, ORG LETT, V2, P1939, DOI 10.1021/ol0060174; Nordstrom LU, 2008, J AM CHEM SOC, V130, P17672, DOI 10.1021/ja808129p; Ouchi M, 2009, CHEM REV, V109, P4963, DOI 10.1021/cr900234b; Pentelute BL, 2008, J AM CHEM SOC, V130, P9702, DOI 10.1021/ja801352j; Rao Y, 2009, J AM CHEM SOC, V131, P12924, DOI 10.1021/ja906005j; Rea MC, 2010, P NATL ACAD SCI USA, V107, P9352, DOI 10.1073/pnas.0913554107; Rebuffat SF, 2010, J PEPT SCI, V16, P38; Rodriguez H, 2010, J PEPT SCI, V16, P136, DOI 10.1002/psc.1209; Rohde H, 2010, BIOPOLYMERS, V94, P551, DOI 10.1002/bip.21442; ROSEN T, 1988, J ORG CHEM, V53, P1580, DOI 10.1021/jo00242a051; Rosengren KJ, 2003, J AM CHEM SOC, V125, P12464, DOI 10.1021/JA0367703; Roughley SD, 2011, J MED CHEM, V54, P3451, DOI 10.1021/jm200187y; Rutledge R. D., 2009, BIOMINERALIZATION PE; Ryadnov MG, 2007, J AM CHEM SOC, V129, P14074, DOI 10.1021/ja072960s; Sanki AK, 2009, J ORG CHEM, V74, P1886, DOI 10.1021/jo802278w; Saxon E, 2000, ORG LETT, V2, P2141, DOI 10.1021/ol006054v; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Shangguan N, 2003, J AM CHEM SOC, V125, P7754, DOI 10.1021/ja0294919; Shen B, 2010, NATURE, V465, P1027, DOI 10.1038/nature09125; Staudinger H, 1919, HELV CHIM ACTA, V2, P635, DOI 10.1002/hlca.19190020164; Stephenson NA, 2009, J AM CHEM SOC, V131, P10003, DOI 10.1021/ja8094262; Sun HL, 2007, ANGEW CHEM INT EDIT, V46, P6068, DOI 10.1002/anie.200700646; Talan RS, 2009, CARBOHYD RES, V344, P2048, DOI 10.1016/j.carres.2009.07.002; Tam JP, 2001, J AM CHEM SOC, V123, P2487, DOI 10.1021/ja0035654; TAMARU Y, 1983, SYNTHESIS-STUTTGART, P474; TANG P, 2005, ORG SYNTH, V81, P262, DOI DOI 10.15227/0RGSYN.081.0262; Torbeev VY, 2007, ANGEW CHEM INT EDIT, V46, P1667, DOI 10.1002/anie.200604087; Vincent PA, 2009, CURR MED CHEM, V16, P538, DOI 10.2174/092986709787458461; Virdee S, 2010, NAT CHEM BIOL, V6, P750, DOI [10.1038/NCHEMBIO.426, 10.1038/nchembio.426]; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Vora HU, 2007, J AM CHEM SOC, V129, P13796, DOI 10.1021/ja0764052; Wang P, 2010, J AM CHEM SOC, V132, P17045, DOI 10.1021/ja1084628; Wieland T., 1991, WORLD PEPTIDES BRIEF, P77, DOI [10.1007/978-3-642-75850-8, DOI 10.1007/978-3-642-75850-8]; Wu J, 2011, CHEM SCI, V2, P1976, DOI 10.1039/c1sc00398d; Wu XY, 2010, J AM CHEM SOC, V132, P4098, DOI 10.1021/ja100517v; Yang RL, 2010, CHEM COMMUN, V46, P7199, DOI 10.1039/c0cc01382j; Yoo WJ, 2006, J AM CHEM SOC, V128, P13064, DOI 10.1021/ja064315b; Yuan Y, 2010, BIOPOLYMERS, V94, P373, DOI 10.1002/bip.21374; Zeng HX, 2011, J AM CHEM SOC, V133, P1159, DOI 10.1021/ja106958s	90	1376	1391	34	765	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2011	480	7378					471	479		10.1038/nature10702	http://dx.doi.org/10.1038/nature10702			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865NQ	22193101				2022-12-28	WOS:000298318000051
J	Wakeford, R				Wakeford, Richard			CHRISTMAS 2011: PROFESSIONAL MATTERS Who gets struck off?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Cambridge, Cambridge CB2 1TN, England	University of Cambridge	Wakeford, R (corresponding author), Univ Cambridge, Hughes Hall, Cambridge CB2 1TN, England.	richardwakeford@hotmail.com						General Medical Council, 2009, ANN STAT 2009; IBM SPSS (Statistical Package for the Social Sciences), IBM SPSS STAT PACK S; L Bruce, 2011, STATE MED ED PRACTIC, P82; SMITH RG, 1994, MED DISCIPLINE PROFE; WAKEFORD R, 1989, BRIT MED J, V298, P604, DOI 10.1136/bmj.298.6673.604; WAKEFORD R, 1987, BRIT MED J, V294, P890, DOI 10.1136/bmj.294.6576.890; Wakeford R, 1996, CAMBRIDGE MED, V12, P10; Watmough S, 2011, MED TEACH, V33, P938, DOI 10.3109/0142159X.2011.588736	8	8	8	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 21	2011	343								d7842	10.1136/bmj.d7842	http://dx.doi.org/10.1136/bmj.d7842			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	874TF	22189130				2022-12-28	WOS:000298980300004
J	Green, M				Green, Malcolm			CHRISTMAS 2011: ORAL TRADITIONS Cod liver oil and tuberculosis	BRITISH MEDICAL JOURNAL			English	Editorial Material							VITAMIN-D DEFICIENCY; RICKETS; ASIANS		Royal Brompton Hosp, London SW3 6HP, England	Royal Brompton Hospital	Green, M (corresponding author), Royal Brompton Hosp, London SW3 6HP, England.	malcolm@malcolmgreen.net						BRYDER L, 1988, BELOW MAGIC MOUNTAIN, P7; DAVIES PD, 2008, CLIN TUBERCULOSIS EN, P377; DAVIES PDO, 1985, TUBERCLE, V66, P301, DOI 10.1016/0041-3879(85)90068-6; FINCH PJ, 1991, THORAX, V46, P1, DOI 10.1136/thx.46.1.1; HOLICK MF, 1980, SCIENCE, V210, P203, DOI 10.1126/science.6251551; *HOSP CONS DIS CHE, 1849, 1 HOSP CONS DIS CHES, P31; Lind J, 1753, TREATISE SCURVY 3 PA; Martineau AR, 2011, LANCET, V377, P242, DOI 10.1016/S0140-6736(10)61889-2; McCollum EV, 1922, J BIOL CHEM, V53, P293; Rajakumar K, 2003, PEDIATRICS, V112, pE132, DOI 10.1542/peds.112.2.e132; ROOK GAW, 1987, IMMUNOLOGY, V62, P229; Rose AMC, 2001, THORAX, V56, P173, DOI 10.1136/thorax.56.3.173; USRTIANOVSKI A, 2005, J INFECTION, V50, P432; VEEN J, 1995, EUR RESPIR J, V8, P1073, DOI 10.1183/09031936.95.08071073; Wilkinson RJ, 2000, LANCET, V355, P618, DOI 10.1016/S0140-6736(99)02301-6	15	30	31	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2011	343								d7505	10.1136/bmj.d7505	http://dx.doi.org/10.1136/bmj.d7505			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	868QK	22187324				2022-12-28	WOS:000298538200004
J	Tung, CTP; Kim, HS; Yoon, KB				Tung Cao Thanh Pham; Kim, Hyun Sung; Yoon, Kyung Byung			Growth of Uniformly Oriented Silica MFI and BEA Zeolite Films on Substrates	SCIENCE			English	Article							ALIGNED INCLUSION; MEMBRANES; HEMICYANINE; SEPARATION	Applications of zeolite films benefit from alignment of the integrated channels, but methods for film growth have nearly always introduced orientational randomization in the direction normal to the substrate. We now report facile methods to grow silicalite-1 films and pure silica beta zeolite films on substrates with straight or sinusoidal channels positioned uniformly upright at a thickness of up to 8 micrometers. Precise gel compositions and processing temperatures are critical to promote secondary growth on pre-formed oriented crystal monolayers while suppressing self-crystallization in the bulk medium. Preliminary results highlight the potential of these uniformly oriented films in the nonlinear optical response and separation of xylene isomers.	[Yoon, Kyung Byung] Sogang Univ, Korea Ctr Artificial Photosynth, Seoul 121742, South Korea; Sogang Univ, Dept Chem, Seoul 121742, South Korea	Sogang University; Sogang University	Yoon, KB (corresponding author), Sogang Univ, Korea Ctr Artificial Photosynth, Seoul 121742, South Korea.	yoonkb@sogang.ac.kr			Korea Center for Artificial Photosynthesis, at Sogang University; Ministry of Education of Science and Technology through the National Research Foundation of Korea (NRFK) [NRF-2009-C1AAA001-2009-0093879]; NRFK	Korea Center for Artificial Photosynthesis, at Sogang University; Ministry of Education of Science and Technology through the National Research Foundation of Korea (NRFK)(Ministry of Education (MOE), Republic of KoreaNational Research Foundation of Korea); NRFK(National Research Foundation of Korea)	This work was supported by the Korea Center for Artificial Photosynthesis, located at Sogang University and funded by the Ministry of Education of Science and Technology through the National Research Foundation of Korea (NRFK) (grant NRF-2009-C1AAA001-2009-0093879) and the acceleration program of the NRFK. We thank J. Y. Lee for help in drawing Fig. 1. Sogang University has filed patents on the results presented here.	Baerlocher C., 2001, ATLAS ZEOLITE FRAMEW, P184; Bein T, 1996, CHEM MATER, V8, P1636, DOI 10.1021/cm960148a; Bhange DS, 2006, MATER RES BULL, V41, P1392, DOI 10.1016/j.materresbull.2005.12.002; Caro J, 2008, MICROPOR MESOPOR MAT, V115, P215, DOI 10.1016/j.micromeso.2008.03.008; Caro J, 2009, ADV NANOPOR MAT, V1, P1, DOI 10.1016/S1878-7959(09)00101-7; Choi J, 2009, SCIENCE, V325, P590, DOI 10.1126/science.1176095; Daramola MO, 2010, SEP SCI TECHNOL, V45, P21, DOI 10.1080/01496390903402141; Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785; Funke HH, 1997, IND ENG CHEM RES, V36, P137, DOI 10.1021/ie960472f; Gump CJ, 2001, IND ENG CHEM RES, V40, P565, DOI 10.1021/ie000553i; Guo HL, 2006, ANGEW CHEM INT EDIT, V45, P7053, DOI 10.1002/anie.200602308; Hedlund J, 2003, J MEMBRANE SCI, V222, P163, DOI 10.1016/S0376-7388(03)00285-0; KARSH H, 1992, ZEOLITES, V12, P728, DOI 10.1016/0144-2449(92)90124-8; Kim HS, 2004, J AM CHEM SOC, V126, P673, DOI 10.1021/ja037772q; Kim HS, 2008, J AM CHEM SOC, V130, P2134, DOI 10.1021/ja0774820; Kim HS, 2007, ADV MATER, V19, P260, DOI 10.1002/adma.200602101; Lai ZP, 2004, ADV FUNCT MATER, V14, P716, DOI 10.1002/adfm.200400040; Lai ZP, 2003, SCIENCE, V300, P456, DOI 10.1126/science.1082169; Larlus O, 2005, CHEM MATER, V17, P881, DOI 10.1021/cm048799r; Larlus O, 2006, MICROPOR MESOPOR MAT, V93, P55, DOI 10.1016/j.micromeso.2006.02.003; Lee JS, 2007, ANGEW CHEM INT EDIT, V46, P3087, DOI 10.1002/anie.200604367; Lew CM, 2010, ACCOUNTS CHEM RES, V43, P210, DOI 10.1021/ar900146w; Li XM, 2011, CRYSTENGCOMM, V13, P3657, DOI 10.1039/c1ce05094j; Li ZJ, 2006, ANGEW CHEM INT EDIT, V45, P6329, DOI 10.1002/anie.200602036; Liu Y, 2010, J AM CHEM SOC, V132, P1768, DOI 10.1021/ja909888v; Marinkovic BA, 2004, MICROPOR MESOPOR MAT, V71, P117, DOI 10.1016/j.micromeso.2004.03.023; Mintova S, 2003, CHEM COMMUN, P326, DOI 10.1039/b210767h; Mitra A, 2004, IND ENG CHEM RES, V43, P2946, DOI 10.1021/ie034062k; Mitra A, 2002, J ELECTROCHEM SOC, V149, pB472, DOI 10.1149/1.1507784; O'Brien-Abraham J., 2010, ZEOLITES IND SEPARAT, P307; O'Brien-Abraham J, 2008, J MEMBRANE SCI, V320, P505, DOI 10.1016/j.memsci.2008.04.023; Singh R., 2003, HDB ZEOLITE SCI TECH; Snyder MA, 2007, ANGEW CHEM INT EDIT, V46, P7560, DOI 10.1002/anie.200604910; Yoon KB, 2007, ACCOUNTS CHEM RES, V40, P29, DOI 10.1021/ar000119c	34	213	230	10	382	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2011	334	6062					1533	1538		10.1126/science.1212472	http://dx.doi.org/10.1126/science.1212472			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	862LE	22174247				2022-12-28	WOS:000298091400047
J	Finnigan, GC; Hanson-Smith, V; Stevens, TH; Thornton, JW				Finnigan, Gregory C.; Hanson-Smith, Victor; Stevens, Tom H.; Thornton, Joseph W.			Evolution of increased complexity in a molecular machine	NATURE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; MEMBRANE H+-ATPASE; VACUOLAR; GENE; SUBUNIT; ACIDIFICATION; ALGORITHM; ROTATION; ACCURATE; ORIGIN	Many cellular processes are carried out by molecular 'machines'-assemblies of multiple differentiated proteins that physically interact to execute biological functions(1-8). Despite much speculation, strong evidence of the mechanisms by which these assemblies evolved is lacking. Here we use ancestral gene resurrection(9-11) and manipulative genetic experiments to determine how the complexity of an essential molecular machine-the hexameric transmembrane ring of the eukaryotic V-ATPase proton pump-increased hundreds of millions of years ago. We show that the ring of Fungi, which is composed of three paralogous proteins, evolved from a more ancient two-paralogue complex because of a gene duplication that was followed by loss in each daughter copy of specific interfaces by which it interacts with other ring proteins. These losses were complementary, so both copies became obligate components with restricted spatial roles in the complex. Reintroducing a single historical mutation from each paralogue lineage into the resurrected ancestral proteins is sufficient to recapitulate their asymmetric degeneration and trigger the requirement for the more elaborate three-component ring. Our experiments show that increased complexity in an essential molecular machine evolved because of simple, high-probability evolutionary processes, without the apparent evolution of novel functions. They point to a plausible mechanism for the evolution of complexity in other multi-paralogue protein complexes.	[Hanson-Smith, Victor; Thornton, Joseph W.] Univ Oregon, Inst Ecol & Evolut, Eugene, OR 97403 USA; [Finnigan, Gregory C.; Stevens, Tom H.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Hanson-Smith, Victor] Univ Oregon, Dept Comp & Informat Sci, Eugene, OR 97403 USA; [Thornton, Joseph W.] Univ Oregon, Howard Hughes Med Inst, Eugene, OR 97403 USA; [Thornton, Joseph W.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Thornton, Joseph W.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Oregon; University of Oregon; University of Oregon; Howard Hughes Medical Institute; University of Oregon; University of Chicago; University of Chicago	Thornton, JW (corresponding author), Univ Oregon, Inst Ecol & Evolut, Eugene, OR 97403 USA.	joet@uoregon.edu	Thornton, Joseph/GSN-4190-2022	Finnigan, Gregory/0000-0002-5710-173X; Stevens, Tom/0000-0001-6427-6848	National Institutes of Health (NIH) [R01-GM081592, R01-GM38006, T32-GM007257]; National Science Foundation (NSF) [IOB-0546906, DEB-0516530]; NSF IGERT [DGE-9972830]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038006, T32GM007257, R01GM081592] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NSF IGERT(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by National Institutes of Health (NIH) grants R01-GM081592 (to J.W.T.) and R01-GM38006 (to T. H. S.), National Science Foundation (NSF) grants IOB-0546906 (to J.W.T.) and DEB-0516530 (to J.W.T.), NIH Genetics Training grant T32-GM007257 (to G. C. F.), NSF IGERT grant DGE-9972830 (to V.H.-S.) and the Howard Hughes Medical Institute (J.W.T.). We thank L. Graham, G. Butler and B. Houser for generating yeast strains and other assistance. We thank members of the Stevens and Thornton laboratories for helpful comments.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Archibald JM, 2000, MOL BIOL EVOL, V17, P1456, DOI 10.1093/oxfordjournals.molbev.a026246; Clements A, 2009, P NATL ACAD SCI USA, V106, P15791, DOI 10.1073/pnas.0908264106; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Fletcher W, 2009, MOL BIOL EVOL, V26, P1879, DOI 10.1093/molbev/msp098; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Gabaldon T, 2005, J MOL BIOL, V348, P857, DOI 10.1016/j.jmb.2005.02.067; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harms MJ, 2010, CURR OPIN STRUC BIOL, V20, P360, DOI 10.1016/j.sbi.2010.03.005; Hietpas RT, 2011, P NATL ACAD SCI USA, V108, P7896, DOI 10.1073/pnas.1016024108; Hirata R, 1997, J BIOL CHEM, V272, P4795, DOI 10.1074/jbc.272.8.4795; Hirata T, 2003, J BIOL CHEM, V278, P23714, DOI 10.1074/jbc.M302756200; Imamura H, 2005, P NATL ACAD SCI USA, V102, P17929, DOI 10.1073/pnas.0507764102; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Liberles DA., 2007, ANCESTRAL SEQUENCE R; Liu RY, 2007, P NATL ACAD SCI USA, V104, P7116, DOI 10.1073/pnas.0700266104; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Lynch M, 2007, P NATL ACAD SCI USA, V104, P8597, DOI 10.1073/pnas.0702207104; Mulkidjanian AY, 2007, NAT REV MICROBIOL, V5, P892, DOI 10.1038/nrmicro1767; Ohno S., 1970, EVOLUTION GENE DUPLI; Pallen MJ, 2006, NAT REV MICROBIOL, V4, P784, DOI 10.1038/nrmicro1493; Pereira-Leal JB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r51; Perez-Sayans M, 2009, CANCER TREAT REV, V35, P707, DOI 10.1016/j.ctrv.2009.08.003; Powell B, 2000, J BIOL CHEM, V275, P23654, DOI 10.1074/jbc.M004440200; Ryan M, 2008, MOL BIOL CELL, V19, P5131, DOI 10.1091/mbc.E08-06-0629; Sambrook J., 2001, MOL CLONING LAB MANU; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; UMEMOTO N, 1991, J BIOL CHEM, V266, P24526; UMEMOTO N, 1990, J BIOL CHEM, V265, P18447; Wang Y, 2007, J BIOL CHEM, V282, P34058, DOI 10.1074/jbc.M704331200; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Xu L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000822; YANG ZH, 1995, GENETICS, V141, P1641; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	47	134	135	2	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 19	2012	481	7381					360	U143		10.1038/nature10724	http://dx.doi.org/10.1038/nature10724			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877VK	22230956	Green Accepted			2022-12-28	WOS:000299210600042
J	Mirabel, IF				Mirabel, I. F.			Gamma-Ray Binaries Revealed	SCIENCE			English	Editorial Material							MICROQUASARS; CYGNUS-X-3; EMISSION		[Mirabel, I. F.] IAFE Conicet, Inst Astron & Fis Espacio, Buenos Aires, DF, Argentina; [Mirabel, I. F.] Commiss Energie Atom & Energies Alternat IRFU CEA, Inst Rech Lois Fondamentales Univers, Saclay, France	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Instituto de Astronomia y Fisica del Espacio (IAFE); CEA	Mirabel, IF (corresponding author), IAFE Conicet, Inst Astron & Fis Espacio, Buenos Aires, DF, Argentina.	felix.mirabel@cea.fr						Abdo AA, 2009, SCIENCE, V326, P1512, DOI 10.1126/science.1182174; Ackermann M, 2012, SCIENCE, V335, P189, DOI 10.1126/science.1213974; Aharonian F, 2006, J PHYS CONF SER, V39, P408, DOI 10.1088/1742-6596/39/1/106; Aharonian FA, 1996, SPACE SCI REV, V75, P357, DOI 10.1007/BF00195045; Bernado MMK, 2002, ASTRON ASTROPHYS, V385, pL10, DOI 10.1051/0004-6361:20020251; de Ona Wilhelmi E., 2010, 38 COSPAR SCI ASS, V38, P2803; Dubus G, 2010, MON NOT R ASTRON SOC, V404, pL55, DOI 10.1111/j.1745-3933.2010.00834.x; Mirabel IF, 2006, SCIENCE, V312, P1759, DOI 10.1126/science.1129815; Mirabel IF, 1998, NATURE, V392, P673, DOI 10.1038/33603; Reynoso MM, 2009, ASTRON ASTROPHYS, V493, P1, DOI 10.1051/0004-6361:200811004; Romero GE, 2003, ASTRON ASTROPHYS, V410, pL1, DOI [10.1051/0004-6361:20031314-1, 10.1051/0004-6361:20031314]; Tavani M, 2009, NATURE, V462, P620, DOI 10.1038/nature08578	12	16	17	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 13	2012	335	6065					175	176		10.1126/science.1215895	http://dx.doi.org/10.1126/science.1215895			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875LZ	22246762	Green Submitted, Green Published			2022-12-28	WOS:000299033100038
J	Matei, D; Baehr, J; Jungclaus, JH; Haak, H; Muller, WA; Marotzke, J				Matei, Daniela; Baehr, Johanna; Jungclaus, Johann H.; Haak, Helmuth; Mueller, Wolfgang A.; Marotzke, Jochem			Multiyear Prediction of Monthly Mean Atlantic Meridional Overturning Circulation at 26.5 degrees N	SCIENCE			English	Article							NORTH-ATLANTIC; CLIMATE; VARIABILITY; PREDICTABILITY	Attempts to predict changes in Atlantic Meridional Overturning Circulation (AMOC) have yielded little success to date. Here, we demonstrate predictability for monthly mean AMOC strength at 26.5 degrees N for up to 4 years in advance. This AMOC predictive skill arises predominantly from the basin-wide upper-mid-ocean geostrophic transport, which in turn can be predicted because we have skill in predicting the upper-ocean zonal density difference. Ensemble forecasts initialized between January 2008 and January 2011 indicate a stable AMOC at 26.5 degrees N until at least 2014, despite a brief wind-induced weakening in 2010. Because AMOC influences many aspects of climate, our results establish AMOC as an important potential carrier of climate predictability.	[Matei, Daniela; Jungclaus, Johann H.; Haak, Helmuth; Mueller, Wolfgang A.; Marotzke, Jochem] Max Planck Inst Meteorol, D-20146 Hamburg, Germany; [Baehr, Johanna] Univ Hamburg, Inst Oceanog, D-20146 Hamburg, Germany	Max Planck Society; University of Hamburg	Matei, D (corresponding author), Max Planck Inst Meteorol, Bundesstr 53, D-20146 Hamburg, Germany.	Daniela.Matei@zmaw.de; Jochem.Marotzke@zmaw.de			Bundesministerium fur Bildung und Forschung; Deutsche Forschungsgemeinschaft; Natural Environment Research Council	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the Bundesministerium fur Bildung und Forschung North Atlantic project (D. M.) and the Deutsche Forschungsgemeinschaft-funded Cluster of Excellence CliSAP (J.B. and W. A. M.). We thank M. Giorgetta, U. Mikolajewicz, and B. Stevens for comments on the manuscript. All model simulations were performed at the German Climate Computing Centre (DKRZ). Data from the RAPID-WATCH MOC monitoring project are funded by the Natural Environment Research Council and are freely available from www.noc.soton.ac.uk/rapidmoc.	Bingham RJ, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031731; Chidichimo MP, 2010, OCEAN SCI, V6, P475, DOI 10.5194/os-6-475-2010; Collins M, 2006, J CLIMATE, V19, P1195, DOI 10.1175/JCLI3654.1; Cunningham SA, 2007, SCIENCE, V317, P935, DOI 10.1126/science.1141304; Domingues CM, 2008, NATURE, V453, P1090, DOI 10.1038/nature07080; Hawkins E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034059; Hirschi J, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016776; Hodson DLR, 2010, CLIM DYNAM, V34, P1041, DOI 10.1007/s00382-009-0571-2; Jung T, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046786; Jungclaus JH, 2006, J CLIMATE, V19, P3952, DOI 10.1175/JCLI3827.1; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kanzow T, 2010, J CLIMATE, V23, P5678, DOI 10.1175/2010JCLI3389.1; Kanzow T, 2007, SCIENCE, V317, P938, DOI 10.1126/science.1141293; Keenlyside NS, 2008, NATURE, V453, P84, DOI 10.1038/nature06921; Knight JR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026242; Knight JR, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024233; Lozier MS, 2010, NAT GEOSCI, V3, P728, DOI 10.1038/NGEO947; Mochizuki T, 2010, P NATL ACAD SCI USA, V107, P1833, DOI 10.1073/pnas.0906531107; Msadek R, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044517; Munoz E, 2011, DEEP-SEA RES PT II, V58, P1848, DOI 10.1016/j.dsr2.2010.10.064; Olsen SM, 2008, NATURE, V455, P519, DOI 10.1038/nature07302; Pohlmann H, 2004, J CLIMATE, V17, P4463, DOI 10.1175/3209.1; Pohlmann H, 2009, J CLIMATE, V22, P3926, DOI 10.1175/2009JCLI2535.1; Pohlmann H, 2006, J CLIMATE, V19, P6062, DOI 10.1175/JCLI3941.1; Smith DM, 2007, SCIENCE, V317, P796, DOI 10.1126/science.1139540; Smith DM, 2010, NAT GEOSCI, V3, P846, DOI 10.1038/NGEO1004; Stammer D., 2006, ICPO PUBLICATION SER, V93; Stammer D., 2006, WCRP INFORMAL PUBLIC, V93; Sutton RT, 2005, SCIENCE, V309, P115, DOI 10.1126/science.1109496; Willis JK, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042372; Zhang R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026267	31	70	70	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2012	335	6064					76	79		10.1126/science.1210299	http://dx.doi.org/10.1126/science.1210299			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872YA	22223804				2022-12-28	WOS:000298846200053
J	Ellis, J				Ellis, John			The need for new physics	NATURE			English	Editorial Material									Kings Coll London, London WC2R 2LS, England	University of London; King's College London	Ellis, J (corresponding author), Kings Coll London, London WC2R 2LS, England.	john.ellis@cern.ch							0	1	1	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 5	2012	481	7379					24	24		10.1038/481024a	http://dx.doi.org/10.1038/481024a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	872VD	22178927	Bronze			2022-12-28	WOS:000298836900012
J	Singh-Manoux, A; Kivimaki, M; Glymour, MM; Elbaz, A; Berr, C; Ebmeier, KP; Ferrie, JE; Dugravot, A				Singh-Manoux, Archana; Kivimaki, Mika; Glymour, M. Maria; Elbaz, Alexis; Berr, Claudine; Ebmeier, Klaus P.; Ferrie, Jane E.; Dugravot, Aline			Timing of onset of cognitive decline: results from Whitehall II prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							ALZHEIMERS-DISEASE; MIDDLE-AGE; LIFE; POPULATION; DEMENTIA; HEALTH; ADULTS	Objectives To estimate 10 year decline in cognitive function from longitudinal data in a middle aged cohort and to examine whether age cohorts can be compared with cross sectional data to infer the effect of age on cognitive decline. Design Prospective cohort study. At study inception in 1985-8, there were 10 308 participants, representing a recruitment rate of 73%. Setting Civil service departments in London, United Kingdom. Participants 5198 men and 2192 women, aged 45-70 at the beginning of cognitive testing in 1997-9. Main outcome measure Tests of memory, reasoning, vocabulary, and phonemic and semantic fluency, assessed three times over 10 years. Results All cognitive scores, except vocabulary, declined in all five age categories (age 45-49, 50-54, 55-59, 60-64, and 65-70 at baseline), with evidence of faster decline in older people. In men, the 10 year decline, shown as change/range of testx100, in reasoning was -3.6% (95% confidence interval -4.1% to -3.0%) in those aged 45-49 at baseline and -9.6% (-10.6% to -8.6%) in those aged 65-70. In women, the corresponding decline was -3.6% (-4.6% to -2.7%) and -7.4% (-9.1% to -5.7%). Comparisons of longitudinal and cross sectional effects of age suggest that the latter overestimate decline in women because of cohort differences in education. For example, in women aged 45-49 the longitudinal analysis showed reasoning to have declined by -3.6% (-4.5% to -2.8%) but the cross sectional effects suggested a decline of -11.4% (-14.0% to -8.9%). Conclusions Cognitive decline is already evident in middle age (age 45-49).	[Singh-Manoux, Archana; Dugravot, Aline] Hop Paul Brousse, INSERM, Ctr Res Epidemiol & Populat Hlth, U1018, F-94807 Villejuif, France; [Singh-Manoux, Archana; Kivimaki, Mika] UCL, Dept Epidemiol & Publ Hlth, London, England; [Glymour, M. Maria] Harvard Univ, Sch Med, Dept Soc Human Dev & Hlth, Boston, MA USA; [Elbaz, Alexis] INSERM, U708, F-75013 Paris, France; [Elbaz, Alexis] Univ Paris 06, UPMC, UMR S708, F-75005 Paris, France; [Berr, Claudine] Univ Montpellier 1, INSERM, U1061, Montpellier, France; [Berr, Claudine] CHU Montpellier, CMRR Languedoc Roussillon, Montpellier, France; [Ebmeier, Klaus P.] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford, England; [Ferrie, Jane E.] Univ Bristol, Bristol, Avon, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of London; University College London; Harvard University; Harvard Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; University of Oxford; University of Bristol	Singh-Manoux, A (corresponding author), Hop Paul Brousse, INSERM, Ctr Res Epidemiol & Populat Hlth, U1018, Bat 15-16,16 Ave Paul Vaillant Couturier, F-94807 Villejuif, France.	Archana.Singh-Manoux@inserm.fr	Elbaz, Alexis/F-8952-2017; Kivimaki, Mika/B-3607-2012; Ebmeier, Klaus Peter/B-4789-2008; berr, Claudine/D-5238-2014; Ferrie, Jane/AAZ-2009-2020; Singh-Manoux, Archana/F-6804-2013	Elbaz, Alexis/0000-0001-9724-5490; Kivimaki, Mika/0000-0002-4699-5627; Ebmeier, Klaus Peter/0000-0002-5190-7038; berr, Claudine/0000-0001-5254-7655; Singh-Manoux, Archana/0000-0002-1244-5037; Dugravot, Aline/0000-0002-4546-0970	European Science Foundation; National Institute on Aging, NIH [R01AG013196, R01AG034454]; BUPA Foundation; National Institutes of Health [R01AG034454, R01HL036310]; Academy of Finland; British Medical Research Council [G0902037]; British Heart Foundation; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Medical Research Council [G1001354, G8802774, G0902037, G19/35, G0100222] Funding Source: researchfish; MRC [G0902037, G1001354] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034454, R01AG013196] Funding Source: NIH RePORTER	European Science Foundation(European Science Foundation (ESF)European Commission); National Institute on Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); BUPA Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland(Academy of Finland); British Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	ASM is supported by a European Young Investigator Award from the European Science Foundation and the National Institute on Aging, NIH (R01AG013196 [PI]; R01AG034454 [PI]). MK is supported by the BUPA Foundation, the National Institutes of Health (R01HL036310 [PI]; R01AG034454 [PI]) and the Academy of Finland. The Whitehall II study is also supported by a grant from the British Medical Research Council (G0902037) and the British Heart Foundation. The funding bodies had no role in the study design, the collection, analysis and interpretation of data, the writing, and the decision to submit the paper.	Alzheimer's Disease International, 2009, WORLD ALZH REP; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; Brayne C, 2007, NAT REV NEUROSCI, V8, P233, DOI 10.1038/nrn2091; Dickens WT, 2001, PSYCHOL REV, V108, P346, DOI 10.1037/0033-295X.108.2.346; Duyckaerts C, 1997, NEUROBIOL AGING, V18, P362, DOI 10.1016/S0197-4580(97)00047-X; Euser SM, 2008, EPIDEMIOLOGY, V19, P440, DOI 10.1097/EDE.0b013e31816a1d31; Finch CE, 2009, NEUROBIOL AGING, V30, P515, DOI 10.1016/j.neurobiolaging.2008.11.011; FINCH CE, 1991, NEUROBIOL AGING, V12, P1, DOI 10.1016/0197-4580(91)90031-E; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goldin C, 1998, J ECON HIST, V58, P345, DOI 10.1017/S0022050700020544; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; Heim A.W., 1970, AH 4 GROUP TEST GEN; HOLLAND CA, 1991, REV CLIN GERONTOLOGY, V1, P81, DOI DOI 10.1017/S0959259800002598; Johnson DK, 2009, ARCH NEUROL-CHICAGO, V66, P1254, DOI 10.1001/archneurol.2009.158; Launer LJ, 2005, NEUROBIOL AGING, V26, P335, DOI 10.1016/j.neurobiolaging.2004.03.016; Lutz W, 2008, NATURE, V451, P716, DOI 10.1038/nature06516; Marmot M, 2005, INT J EPIDEMIOL, V34, P251, DOI 10.1093/ije/dyh372; Nelson PT, 2009, J NEUROPATH EXP NEUR, V68, P1, DOI 10.1097/NEN.0b013e3181919a48; Nilsson LG, 2009, NEUROBIOL AGING, V30, P521, DOI 10.1016/j.neurobiolaging.2008.11.013; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Rabbitt P, 2001, NEUROPSYCHOLOGIA, V39, P532, DOI 10.1016/S0028-3932(00)00099-3; Raven J.C., 1958, GUIDE USING MILL HIL; Richards M, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4670; RYDER NB, 1965, AM SOCIOL REV, V30, P843, DOI 10.2307/2090964; Salthouse TA, 2004, DEV PSYCHOL, V40, P813, DOI 10.1037/0012-1649.40.5.813; Salthouse TA, 2010, NEUROPSYCHOLOGY, V24, P563, DOI 10.1037/a0019026; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; SCHAIE KW, 1974, DEV PSYCHOL, V10, P305, DOI 10.1037/h0036445; SCHAIE KW, 1994, AM PSYCHOL, V49, P304, DOI 10.1037/0003-066X.49.4.304; United Nations Educational SaCOU, 2000, WORLD ED REP 2000; Viswanathan A, 2009, NEUROLOGY, V72, P368, DOI 10.1212/01.wnl.0000341271.90478.8e; Whalley LJ, 2006, LANCET NEUROL, V5, P87, DOI 10.1016/S1474-4422(05)70286-6; Wilson RS, 2010, NEUROLOGY, V75, P1070, DOI 10.1212/WNL.0b013e3181f39adc; Zelinski EM, 1997, PSYCHOL AGING, V12, P503, DOI 10.1037/0882-7974.12.3.503	37	442	455	1	53	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 5	2012	344								d7622	10.1136/bmj.d7622	http://dx.doi.org/10.1136/bmj.d7622			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	874UH	22223828	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000298983100002
J	Moynihan, R				Moynihan, Ray			REALITY CHECK Forget sponsorship and free trips-welcome to Pharmacare	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Newcastle, Callaghan, NSW 2308, Australia	University of Newcastle	Moynihan, R (corresponding author), Univ Newcastle, Callaghan, NSW 2308, Australia.	Ray.Moynihan@newcastle.edu.au	Moynihan, Ray/ABC-3010-2020					Association of the British Pharmaceutical Industry, 2009, ABPI GUID NOT JOINT; Department of Health Association of British Pharmaceutical Industries, 2010, MOV SPONS JOINT WORK; Healy D, 2006, PLOS MED, V3, P441, DOI 10.1371/journal.pmed.0030185; Johnson & Johnson, FORM 10 Q Q REP FIL; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; McCartney M, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d7685; Moynihan R., 2011, CRIKEY          0526; Spurling GK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000352	8	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 4	2012	344								d8316	10.1136/bmj.d8316	http://dx.doi.org/10.1136/bmj.d8316			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	874UF	22218100				2022-12-28	WOS:000298982900027
J	Butterfield, NJ				Butterfield, N. J.			Terminal Developments in Ediacaran Embryology	SCIENCE			English	Editorial Material							ANIMAL EMBRYOS; FOSSIL PRESERVATION		Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England	University of Cambridge	Butterfield, NJ (corresponding author), Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England.	njb1005@esc.cam.ac.uk	Butterfield, Nicholas/AAV-8215-2021	Butterfield, Nicholas/0000-0002-3046-7520				Bailey JV, 2007, NATURE, V445, P198, DOI 10.1038/nature05457; Bengtson S, 2004, SCIENCE, V306; Butterfield NJ, 2007, PALAEONTOLOGY, V50, P41, DOI 10.1111/j.1475-4983.2006.00613.x; Butterfield NJ, 2003, INTEGR COMP BIOL, V43, P166, DOI 10.1093/icb/43.1.166; Chen JY, 2009, PRECAMBRIAN RES, V173, P191, DOI 10.1016/j.precamres.2009.04.004; Cohen PA, 2009, P NATL ACAD SCI USA, V106, P6519, DOI 10.1073/pnas.0902322106; Denitski A. G., 1995, EUR J PROTISTOL, V31, P241; GREEN KJ, 1981, J CELL BIOL, V91, P743, DOI 10.1083/jcb.91.3.743; Hagadorn JW, 2006, SCIENCE, V314, P291, DOI 10.1126/science.1133129; Herron MD, 2010, J PHYCOL, V46, P316, DOI 10.1111/j.1529-8817.2009.00803.x; Huldtgren T, 2011, SCIENCE, V334, P1696, DOI 10.1126/science.1209537; Prochnik SE, 2010, SCIENCE, V329, P223, DOI 10.1126/science.1188800; Smith Gilbert M., 1944, TRANS AMER MICROSC SOC, V63, P265, DOI 10.2307/3223302; Xiao SH, 1999, LETHAIA, V32, P219, DOI 10.1111/j.1502-3931.1999.tb00541.x; Xiao SH, 2000, J PALEONTOL, V74, P767, DOI 10.1666/0022-3360(2000)074<0767:PAEFTN>2.0.CO;2; Xiao SH, 1998, NATURE, V391, P553, DOI 10.1038/35318; Xue Yao-song, 1995, Acta Palaeontologica Sinica, V34, P688; Yin LM, 2007, NATURE, V446, P661, DOI 10.1038/nature05682	18	25	26	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1655	1656		10.1126/science.1216125	http://dx.doi.org/10.1126/science.1216125			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22194566				2022-12-28	WOS:000298344000054
J	Li, LS; Rutlin, M; Abraira, VE; Cassidy, C; Kus, L; Gong, SC; Jankowski, MP; Luo, WQ; Heintz, N; Koerber, HR; Woodbury, CJ; Ginty, DD				Li, Lishi; Rutlin, Michael; Abraira, Victoria E.; Cassidy, Colleen; Kus, Laura; Gong, Shiaoching; Jankowski, Michael P.; Luo, Wenqin; Heintz, Nathaniel; Koerber, H. Richard; Woodbury, C. Jeffery; Ginty, David D.			The Functional Organization of Cutaneous Low-Threshold Mechanosensory Neurons	CELL			English	Article							DORSAL COLUMN PATHWAY; TYROSINE PROTEIN-KINASE; SOMATOTOPIC ORGANIZATION; NERVE PROJECTIONS; GANGLION NEURONS; SENSORY NEURONS; AFFERENT-FIBERS; HAIRY SKIN; MECHANORECEPTORS; MOUSE	Innocuous touch of the skin is detected by distinct populations of neurons, the low-threshold mechano-receptors (LTMRs), which are classified as A beta-, A delta-, and C-LTMRs. Here, we report genetic labeling of LTMR subtypes and visualization of their relative patterns of axonal endings in hairy skin and the spinal cord. We found that each of the three major hair follicle types of trunk hairy skin (guard, awl/auchene, and zigzag hairs) is innervated by a unique and invariant combination of LTMRs; thus, each hair follicle type is a functionally distinct mechanosensory end organ. Moreover, the central projections of A beta-, A delta-, and C-LTMRs that innervate the same or adjacent hair follicles form narrow LTMR columns in the dorsal horn. These findings support a model of mechanosensation in which the activities of A beta-, A delta-, and C-LTMRs are integrated within dorsal horn LTMR columns and processed into outputs that underlie the perception of myriad touch sensations.	[Li, Lishi; Rutlin, Michael; Abraira, Victoria E.; Luo, Wenqin; Ginty, David D.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Li, Lishi; Rutlin, Michael; Abraira, Victoria E.; Luo, Wenqin; Ginty, David D.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Cassidy, Colleen; Woodbury, C. Jeffery] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Kus, Laura; Gong, Shiaoching; Heintz, Nathaniel] Rockefeller Univ, Lab Biochem & Mol Biol, Howard Hughes Med Inst, New York, NY 10065 USA; [Jankowski, Michael P.; Koerber, H. Richard] Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15213 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; University of Wyoming; Howard Hughes Medical Institute; Rockefeller University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ginty, DD (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	dginty@jhmi.edu			NIH [NS023725, NS052848, N01 NS-7-2370, NS34814]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH084020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052848, R01NS023725, R01NS034814, R29NS034814, R01NS044094, R56NS023725, R37NS034814] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Michael Caterina, Xinzhong Dong, Ting Guo, Anthony Harrington, Steven Hsiao, Alex Kolodkin, Frank Rice, Kevin Wright, and members of the Ginty laboratory for discussions and comments on this study, Dori Reimert for help with generation of the TrkB<SUP>tauEGFP</SUP> mouse line, and Jeremy Nathans for providing TH<SUP>CreER</SUP> and Rosa26<SUP>IAP</SUP> animals. We thank K.C. Kent Lloyd and the Mutant Mouse Regional Resource Center at University of California, Davis, for help obtaining mouse lines. This work was supported by NIH grants NS023725 and NS052848 (H.R.K.), NS44094 (C.J.W.), N01 NS-7-2370 (N.H.), NS34814 (D.D.G.), and The Johns Hopkins NINDS core imaging facility MH084020 (D.D.G.). N.H. and D.D.G. are investigators of the Howard Hughes Medical Institute.	Albrecht P., 2008, SENSES COMPREHENSIVE, V6, P1, DOI 10.1016/B978-012370880-9.00340-6; Badea TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007859; BESSOU P, 1971, J NEUROPHYSIOL, V34, P116, DOI 10.1152/jn.1971.34.1.116; Brown, 1981, ORG SPINAL CORD ANAT; BROWN AG, 1981, PROG NEUROBIOL, V17, P59, DOI 10.1016/0301-0082(81)90004-6; BROWN AG, 1969, EXP BRAIN RES, V7, P231; BROWN AG, 1967, J PHYSIOL-LONDON, V193, P707, DOI 10.1113/jphysiol.1967.sp008390; BROWN AG, 1987, J PHYSIOL-LONDON, V382, P331, DOI 10.1113/jphysiol.1987.sp016370; BROWN PB, 1975, J NEUROPHYSIOL, V38, P1; BROWN PB, 1989, SOMATOSENS MOT RES, V6, P309, DOI 10.3109/08990228909144679; Brumovsky P, 2006, J CHEM NEUROANAT, V31, P243, DOI 10.1016/j.jchemneu.2006.02.001; BURGESS PR, 1968, J NEUROPHYSIOL, V31, P833, DOI 10.1152/jn.1968.31.6.833; CLIFFER KD, 1989, J NEUROSCI, V9, P3146; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; DOUGLAS WW, 1960, J PHYSIOL-LONDON, V150, P266, DOI 10.1113/jphysiol.1960.sp006386; Driskell RR, 2009, DEVELOPMENT, V136, P2815, DOI 10.1242/dev.038620; GIESLER GJ, 1985, BRAIN RES, V326, P347, DOI 10.1016/0006-8993(85)90044-7; GIESLER GJ, 1984, J NEUROPHYSIOL, V51, P260, DOI 10.1152/jn.1984.51.2.260; GIUFFRIDA R, 1992, J COMP NEUROL, V316, P206, DOI 10.1002/cne.903160206; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; HORCH KW, 1977, J INVEST DERMATOL, V69, P75, DOI 10.1111/1523-1747.ep12497887; IGGO A, 1960, J PHYSIOL-LONDON, V152, P337, DOI 10.1113/jphysiol.1960.sp006491; IGGO A, 1969, J PHYSIOL-LONDON, V200, P763, DOI 10.1113/jphysiol.1969.sp008721; IGGO A, 1982, ANNU REV NEUROSCI, V5, P1, DOI 10.1146/annurev.ne.05.030182.000245; JOHNSON KO, 1992, ANNU REV NEUROSCI, V15, P227, DOI 10.1146/annurev.ne.15.030192.001303; KLEIN R, 1992, NEURON, V8, P947, DOI 10.1016/0896-6273(92)90209-V; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KOERBER HR, 1982, J NEUROPHYSIOL, V48, P481, DOI 10.1152/jn.1982.48.2.481; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; KUMAZAWA T, 1977, J NEUROPHYSIOL, V40, P1325, DOI 10.1152/jn.1977.40.6.1325; Liu Q, 2007, NAT NEUROSCI, V10, P946, DOI 10.1038/nn1937; Luo WQ, 2009, NEURON, V64, P841, DOI 10.1016/j.neuron.2009.11.003; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; McIlwrath SL, 2007, EUR J NEUROSCI, V26, P1801, DOI 10.1111/j.1460-9568.2007.05821.x; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Olausson H, 2010, NEUROSCI BIOBEHAV R, V34, P185, DOI 10.1016/j.neubiorev.2008.09.011; Rotolo T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004099; Seal RP, 2009, NATURE, V462, P651, DOI 10.1038/nature08505; Stucky CL, 1998, J NEUROSCI, V18, P7040; Takahashi-Iwanaga H, 2000, J COMP NEUROL, V426, P259, DOI 10.1002/1096-9861(20001016)426:2<259::AID-CNE7>3.0.CO;2-N; Vallbo AB, 1999, J NEUROPHYSIOL, V81, P2753, DOI 10.1152/jn.1999.81.6.2753; VIELKIND U, 1995, ACTA ANAT, V152, P93; Wellnitz SA, 2010, J NEUROPHYSIOL, V103, P3378, DOI 10.1152/jn.00810.2009; Woodbury CJ, 2007, J COMP NEUROL, V505, P547, DOI 10.1002/cne.21517; Woodbury CJ, 2001, J COMP NEUROL, V436, P304; WOOLF CJ, 1986, J COMP NEUROL, V251, P517, DOI 10.1002/cne.902510407; Zotterman Y, 1939, J PHYSIOL-LONDON, V95, P1	47	424	432	1	66	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2011	147	7					1615	1627		10.1016/j.cell.2011.11.027	http://dx.doi.org/10.1016/j.cell.2011.11.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	866SP	22196735	Bronze, Green Accepted			2022-12-28	WOS:000298403400024
J	Lin, HT; Liang, XL				Lin, Haotian; Liang, Xiaoling			Eye can see a nest of worms!	LANCET			English	Editorial Material									[Lin, Haotian; Liang, Xiaoling] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510060, Guangdong, Peoples R China	Sun Yat Sen University	Liang, XL (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510060, Guangdong, Peoples R China.	liangxiaolingsums@yahoo.com.cn							0	5	6	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 17	2012	379	9820					E42	E42		10.1016/S0140-6736(11)61455-4	http://dx.doi.org/10.1016/S0140-6736(11)61455-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	911JE	22244656	Bronze			2022-12-28	WOS:000301712300004
J	Drdla-Schutting, R; Benrath, J; Wunderbaldinger, G; Sandkuhler, J				Drdla-Schutting, Ruth; Benrath, Justus; Wunderbaldinger, Gabriele; Sandkuehler, Juergen			Erasure of a Spinal Memory Trace of Pain by a Brief, High-Dose Opioid Administration	SCIENCE			English	Article							LONG-TERM POTENTIATION; EVOKED FIELD POTENTIALS; DORSAL-HORN; PHOSPHORYLATION SITES; SYNAPTIC PLASTICITY; GLUR1 SUBUNIT; LATE-PHASE; RECEPTOR; INDUCTION; MECHANISMS	Painful stimuli activate nociceptive C fibers and induce synaptic long-term potentiation (LTP) at their spinal terminals. LTP at C-fiber synapses represents a cellular model for pain amplification (hyperalgesia) and for a memory trace of pain. m-Opioid receptor agonists exert a powerful but reversible depression at C-fiber synapses that renders the continuous application of low opioid doses the gold standard in pain therapy. We discovered that brief application of a high opioid dose reversed various forms of activity-dependent LTP at C-fiber synapses. Depotentiation involved Ca(2+)-dependent signaling and normalization of the phosphorylation state of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors. This also reversed hyperalgesia in behaving animals. Opioids thus not only temporarily dampen pain but may also erase a spinal memory trace of pain.	[Drdla-Schutting, Ruth; Benrath, Justus; Wunderbaldinger, Gabriele; Sandkuehler, Juergen] Med Univ Vienna, Dept Neurophysiol, Ctr Brain Res, A-1090 Vienna, Austria	Medical University of Vienna	Sandkuhler, J (corresponding author), Med Univ Vienna, Dept Neurophysiol, Ctr Brain Res, A-1090 Vienna, Austria.	juergen.sandkuehler@meduniwien.ac.at	Sandkühler, Jürgen/B-6648-2012	Sandkühler, Jürgen/0000-0002-5209-485X; Drdla-Schutting, Ruth/0000-0003-0645-986X	Vienna Science and Technology Fund, Austria [LS07-040]	Vienna Science and Technology Fund, Austria	This work was supported by grant no. LS07-040 from the Vienna Science and Technology Fund, Austria, to J.S. Remifentanil was kindly provided by GlaxoSmithKline, Austria. The authors declare no conflicts of interest.	Asiedu MN, 2011, J NEUROSCI, V31, P6646, DOI 10.1523/JNEUROSCI.6286-10.2011; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; CHEN L, 1991, NEURON, V7, P319, DOI 10.1016/0896-6273(91)90270-A; Chung HJ, 2000, J NEUROSCI, V20, P7258; Drdla R, 2009, SCIENCE, V325, P207, DOI 10.1126/science.1171759; Drdla R, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-18; Fang L, 2003, NEUROSCIENCE, V122, P237, DOI 10.1016/S0306-4522(03)00526-8; Heinke B, 2011, J NEUROSCI, V31, P1313, DOI 10.1523/JNEUROSCI.4060-10.2011; Heinl C, 2011, J NEUROSCI, V31, P16748, DOI 10.1523/JNEUROSCI.3491-11.2011; Hu NW, 2003, J NEUROPHYSIOL, V89, P2354, DOI 10.1152/jn.01027.2002; Huang CC, 2001, J BIOL CHEM, V276, P48108, DOI 10.1074/jbc.M106388200; Ikeda H, 2003, SCIENCE, V299, P1237, DOI 10.1126/science.1080659; Ikeda H, 2006, SCIENCE, V312, P1659, DOI 10.1126/science.1127233; Jhamandas KH, 1996, J NEUROSCI, V16, P2758; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; King T, 2009, NAT NEUROSCI, V12, P1364, DOI 10.1038/nn.2407; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Nugent FS, 2007, NATURE, V446, P1086, DOI 10.1038/nature05726; Ossipov MH, 2010, J CLIN INVEST, V120, P3779, DOI 10.1172/JCI43766; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Sacktor TC, 2011, NAT REV NEUROSCI, V12, P9, DOI 10.1038/nrn2949; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Terman GW, 2001, J NEUROPHYSIOL, V85, P485, DOI 10.1152/jn.2001.85.2.485; Wang Y, 2011, NEUROCHEM RES, V36, P170, DOI 10.1007/s11064-010-0288-y; Willis WD, 2009, EXP BRAIN RES, V196, P5, DOI 10.1007/s00221-009-1760-2; Yang HW, 2004, J NEUROPHYSIOL, V91, P1122, DOI 10.1152/jn.00735.2003; Zhuo M, 1999, P NATL ACAD SCI USA, V96, P4650, DOI 10.1073/pnas.96.8.4650	28	64	69	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 13	2012	335	6065					235	238		10.1126/science.1211726	http://dx.doi.org/10.1126/science.1211726			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875LZ	22246779				2022-12-28	WOS:000299033100058
J	Maestre, FT; Quero, JL; Gotelli, NJ; Escudero, A; Ochoa, V; Delgado-Baquerizo, M; Garcia-Gomez, M; Bowker, MA; Soliveres, S; Escolar, C; Garcia-Palacios, P; Berdugo, M; Valencia, E; Gozalo, B; Gallardo, A; Aguilera, L; Arredondo, T; Blones, J; Boeken, B; Bran, D; Conceicao, AA; Cabrera, O; Chaieb, M; Derak, M; Eldridge, DJ; Espinosa, CI; Florentino, A; Gaitan, J; Gatica, MG; Ghiloufi, W; Gomez-Gonzalez, S; Gutierrez, JR; Hernandez, RM; Huang, XW; Huber-Sannwald, E; Jankju, M; Miriti, M; Monerris, J; Mau, RL; Morici, E; Naseri, K; Ospina, A; Polo, V; Prina, A; Pucheta, E; Ramirez-Collantes, DA; Romao, R; Tighe, M; Torres-Diaz, C; Val, J; Veiga, JP; Wang, DL; Zaady, E				Maestre, Fernando T.; Quero, Jose L.; Gotelli, Nicholas J.; Escudero, Adrian; Ochoa, Victoria; Delgado-Baquerizo, Manuel; Garcia-Gomez, Miguel; Bowker, Matthew A.; Soliveres, Santiago; Escolar, Cristina; Garcia-Palacios, Pablo; Berdugo, Miguel; Valencia, Enrique; Gozalo, Beatriz; Gallardo, Antonio; Aguilera, Lorgio; Arredondo, Tulio; Blones, Julio; Boeken, Bertrand; Bran, Donaldo; Conceicao, Abel A.; Cabrera, Omar; Chaieb, Mohamed; Derak, Mchich; Eldridge, David J.; Espinosa, Carlos I.; Florentino, Adriana; Gaitan, Juan; Gatica, M. Gabriel; Ghiloufi, Wahida; Gomez-Gonzalez, Susana; Gutierrez, Julio R.; Hernandez, Rosa M.; Huang, Xuewen; Huber-Sannwald, Elisabeth; Jankju, Mohammad; Miriti, Maria; Monerris, Jorge; Mau, Rebecca L.; Morici, Ernesto; Naseri, Kamal; Ospina, Abelardo; Polo, Vicente; Prina, Anibal; Pucheta, Eduardo; Ramirez-Collantes, David A.; Romao, Roberto; Tighe, Matthew; Torres-Diaz, Cristian; Val, James; Veiga, Jose P.; Wang, Deli; Zaady, Eli			Plant Species Richness and Ecosystem Multifunctionality in Global Drylands	SCIENCE			English	Article							DIVERSITY; BIODIVERSITY; PRODUCTIVITY; DESERTIFICATION	Experiments suggest that biodiversity enhances the ability of ecosystems to maintain multiple functions, such as carbon storage, productivity, and the buildup of nutrient pools (multifunctionality). However, the relationship between biodiversity and multifunctionality has never been assessed globally in natural ecosystems. We report here on a global empirical study relating plant species richness and abiotic factors to multifunctionality in drylands, which collectively cover 41% of Earth's land surface and support over 38% of the human population. Multifunctionality was positively and significantly related to species richness. The best-fitting models accounted for over 55% of the variation in multifunctionality and always included species richness as a predictor variable. Our results suggest that the preservation of plant biodiversity is crucial to buffer negative effects of climate change and desertification in drylands.	[Maestre, Fernando T.; Quero, Jose L.; Escudero, Adrian; Ochoa, Victoria; Garcia-Gomez, Miguel; Soliveres, Santiago; Escolar, Cristina; Garcia-Palacios, Pablo; Berdugo, Miguel; Valencia, Enrique; Gozalo, Beatriz; Polo, Vicente] Univ Rey Juan Carlos, Escuela Super Ciencias Expt & Tecnol, Dept Biol & Geol, Area Biodiversidad & Conservac, Mostoles 28933, Spain; [Gotelli, Nicholas J.] Univ Vermont, Dept Biol, Burlington, VT 05405 USA; [Delgado-Baquerizo, Manuel; Gallardo, Antonio] Univ Pablo Olavide, Dept Sistemas Fis Quim & Nat, Seville 41013, Spain; [Garcia-Gomez, Miguel] Univ Politecn Madrid, Escuela Tecn Super Ingn Caminos Canales & Puertos, Dept Ingn & Morfol Terreno, E-28040 Madrid, Spain; [Bowker, Matthew A.] No Arizona Univ, SW Biol Sci Ctr, US Geol Survey, Flagstaff, AZ 86011 USA; [Aguilera, Lorgio; Gutierrez, Julio R.] Univ La Serena, Dept Biol, La Serena, Chile; [Arredondo, Tulio; Huber-Sannwald, Elisabeth] Inst Potosino Invest Cient & Tecnol, Div Ciencias Ambient, San Luis Potosi 78210, Mexico; [Blones, Julio] Univ Simon Rodriguez, Inst Estudios Cient & Tecnol, Ctr Agroecol Trop, Lab Biol Vegetal, Caracas, Venezuela; [Boeken, Bertrand] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, IL-84990 Sede Boqer, Israel; [Bran, Donaldo; Gaitan, Juan; Romao, Roberto] Inst Nacl Tecnol Agropecuaria, Estac Expt San Carlos Bariloche, San Carlos De Bariloche, Rio Negro, Argentina; [Conceicao, Abel A.] Univ Estadual Feira de Santana, Dept Ciencias Biol, Bairro Novo Horizonte, Feira Santana, Brazil; [Cabrera, Omar; Espinosa, Carlos I.] Univ Tecn Particular Loja, Inst Ecol, Loja, Ecuador; [Chaieb, Mohamed; Ghiloufi, Wahida] Univ Sfax, Fac Sci, Unite Rech Plant Divers & Ecosyst Arid Environm, Sfax 3018, Tunisia; [Derak, Mchich] Direct Reg Eaux & Forets & Lutte Desertificat Rif, Tetouan 93000, Morocco; [Eldridge, David J.] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW 2052, Australia; [Florentino, Adriana; Ospina, Abelardo] Cent Univ Venezuela, Fac Agr, Inst Edafol, Caracas, Venezuela; [Gatica, M. Gabriel; Pucheta, Eduardo] Univ Nacl San Juan, Fac Ciencias Exactas & Fis Nat, Dept Biol, San Juan, Argentina; [Gomez-Gonzalez, Susana; Torres-Diaz, Cristian] Univ Bio Bio, Dept Ciencias Basicas, Lab Genom & Biodiversidad, Chillan, Chile; [Hernandez, Rosa M.] Univ Expt Simon Rodriguez, Ctr Agroecol Trop, Lab Biogeoquim, Caracas, Venezuela; [Huang, Xuewen] Hulunbuir Coll, Dept Biol & Chem, Hailar 021008, InnerMongolia, Peoples R China; [Jankju, Mohammad; Naseri, Kamal] Ferdowsi Univ Mashhad, Fac Nat Resources & Environm, Dept Range & Watershed Management, Mashhad 917751363, Iran; [Miriti, Maria] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA; [Monerris, Jorge; Ramirez-Collantes, David A.] Univ Nacl Agraria La Molina, Fac Ciencias, Dept Biol, Lima, Peru; [Mau, Rebecca L.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; [Morici, Ernesto; Prina, Anibal] Univ Nacl La Pampa, Fac Agr, RA-6300 La Pampa, Argentina; [Tighe, Matthew] Univ New England, Sch Environm & Rural Sci, Dept Agron & Soil Sci, Armidale, NSW 2351, Australia; [Val, James] Off Environm & Heritage, Buronga, NSW 2739, Australia; [Veiga, Jose P.] CSIC, Museo Nacl Ciencias Nat, Dept Ecol Evolut, E-28006 Madrid, Spain; [Wang, Deli] NE Normal Univ, Key Lab Vegetat Ecol, Minist Educ, Inst Grassland Sci, Changchun 130024, Jilin, Peoples R China; [Zaady, Eli] Gilat Res Ctr, Minist Agr, Agr Res Org, Dept Nat Resources & Agron, IL-85280 Negev, Israel	Universidad Rey Juan Carlos; University of Vermont; Universidad Pablo de Olavide; Universidad Politecnica de Madrid; Northern Arizona University; United States Department of the Interior; United States Geological Survey; Universidad de La Serena; Instituto Potosino Investigacion Cientifica y Tecnologica; Ben Gurion University; Instituto Nacional de Tecnologia Agropecuaria (INTA); Universidade Estadual de Feira de Santana; Universidad Tecnica Particular de Loja; Universite de Sfax; Faculty of Sciences Sfax; University of New South Wales Sydney; University of Central Venezuela; Universidad Nacional de San Juan; Universidad del Bio-Bio; Ferdowsi University Mashhad; University System of Ohio; Ohio State University; University Nacional Agraria La Molina; Northern Arizona University; University of New England; Office of Environment & Heritage - New South Wales; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Northeast Normal University - China	Maestre, FT (corresponding author), Univ Rey Juan Carlos, Escuela Super Ciencias Expt & Tecnol, Dept Biol & Geol, Area Biodiversidad & Conservac, Mostoles 28933, Spain.	fernando.maestre@urjc.es	Hernández, Rosa/GRF-5998-2022; DELGADO-BAQUERIZO, MANUEL/GLS-0346-2022; Espinosa, Carlos Ivan/AAI-1305-2019; Arredondo Moreno, José/A-9972-2015; Escudero, Adrián/H-5046-2015; Chaieb, Mohamed/AAM-9869-2020; Delgado-Baquerizo, Manuel/L-3653-2017; Tighe, Matt/AAC-5369-2019; Quero, Jose Luis JL/A-4202-2011; Valencia, Enrique/AAR-1438-2021; Codina, Santiago Soliveres/A-2291-2016; Eldridge, David/H-3532-2019; Gutierrez, Julio R/A-8367-2011; Huber-Sannwald, Elisabeth/D-2507-2009; Conceição, Abel Augusto/A-7544-2012; Gómez-González, Susana/AAL-2631-2021; Maestre, Fernando T./A-6825-2008; GOMEZ-GONZALEZ, SUSANA/J-7637-2018; Cabrera, Omar/V-6526-2019; García-Palacios, Pablo/K-7567-2014; Bowker, Matthew/B-6258-2014; Gallardo, Antonio/L-3941-2017; Veiga, José/AAV-1687-2020; Pérez, Jose Luis Quero/M-1074-2013; Farzam, Mohammad/AAU-7275-2020; Alvarez, Sergio/H-9727-2015; Ramirez, David/Q-5522-2017	DELGADO-BAQUERIZO, MANUEL/0000-0002-6499-576X; Espinosa, Carlos Ivan/0000-0002-5330-4505; Arredondo Moreno, José/0000-0003-1969-9942; Escudero, Adrián/0000-0002-1427-5465; Delgado-Baquerizo, Manuel/0000-0002-6499-576X; Tighe, Matt/0000-0003-1027-0082; Quero, Jose Luis JL/0000-0001-5553-506X; Codina, Santiago Soliveres/0000-0001-9661-7192; Eldridge, David/0000-0002-2191-486X; Conceição, Abel Augusto/0000-0001-7461-0133; Gómez-González, Susana/0000-0002-3779-8701; Maestre, Fernando T./0000-0002-7434-4856; GOMEZ-GONZALEZ, SUSANA/0000-0002-3779-8701; García-Palacios, Pablo/0000-0002-6367-4761; Bowker, Matthew/0000-0002-5891-0264; Gallardo, Antonio/0000-0002-2674-4265; Pérez, Jose Luis Quero/0000-0001-5553-506X; Farzam, Mohammad/0000-0003-1947-0187; gaitan, juan/0000-0003-2889-1418; Berdugo, Miguel/0000-0003-1053-8907; Gatica, Gabriel/0000-0003-2883-2565; Huber- Sannwald, Elisabeth/0000-0002-8321-1270; Prina, Anibal/0000-0003-3522-9342; Vicente, Polo/0000-0002-0994-5372; Hernandez Hernandez, Rosa Mary/0000-0003-0689-8862; Valencia, Enrique/0000-0003-3359-0759; Gutierrez, Julio/0000-0002-1099-1341; Wahida, Ghiloufi/0000-0002-9995-3930; Alvarez, Sergio/0000-0001-7204-502X; Ramirez, David/0000-0003-4546-9745; bran, donaldo/0000-0001-7749-2726	European Research Council under the European Community [242658]; The Ciencia y Tecnologia para el Desarrollo program (CYTED) [407AC0323]	European Research Council under the European Community(European Research Council (ERC)); The Ciencia y Tecnologia para el Desarrollo program (CYTED)	We thank all the technicians that assisted with field and laboratory work; T. Navarro and Z. Noumi for their help with plant species identification; and J. Bascompte, J. F. Reynolds, K. J. van Groenigen, W. van der Putten, and two anonymous reviewers for helpful comments. This research was funded by the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement 242658 (BIOCOM). The Ciencia y Tecnologia para el Desarrollo program (CYTED) funded networking activities (EPES, Accion 407AC0323). The data used in the primary analyses are available in the supporting online material. The authors declare no competing financial interests. F. T. M. and A. E. designed the study. Field data were collected by all authors except A. E., A. G., N.J.G., B. G., E. V., and M. B. Laboratory analyses were done by V.O., A. G., M. B., M. D. B., E. V., and B. G. Data analyses were done by F. T. M., assisted by N.J.G. The paper was written by F. T. M., and all authors contributed to the subsequent drafts.	Adler PB, 2011, SCIENCE, V333, P1750, DOI 10.1126/science.1204498; Bunker D.E., 2009, BIODIVERSITY ECOSYST; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Diniz JAF, 2008, GLOBAL ECOL BIOGEOGR, V17, P479, DOI 10.1111/j.1466-8238.2008.00395.x; Evans RD, 2001, ECOL APPL, V11, P1301, DOI 10.1890/1051-0761(2001)011[1301:EPIAND]2.0.CO;2; Flombaum P, 2008, P NATL ACAD SCI USA, V105, P6087, DOI 10.1073/pnas.0704801105; Gamfeldt L, 2008, ECOLOGY, V89, P1223, DOI 10.1890/06-2091.1; Godbold JA, 2009, MAR ECOL PROG SER, V396, P273, DOI 10.3354/meps08401; Guo ZW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013113; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hooper DU, 1998, ECOL MONOGR, V68, P121, DOI 10.1890/0012-9615(1998)068[0121:EOPCAD]2.0.CO;2; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; Maestre FT, 2012, J ECOL, V100, P317, DOI 10.1111/j.1365-2745.2011.01918.x; Maestre FT, 2010, PHILOS T R SOC B, V365, P2057, DOI 10.1098/rstb.2010.0016; Maestre FT, 2009, ECOLOGY, V90, P1729, DOI 10.1890/08-2096.1; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Millennium-Ecosystem-Assessment, 2005, EC HUM WELL BEING DE; Morgan JA, 2011, NATURE, V476, P202, DOI 10.1038/nature10274; O'Connor TG, 2001, J ECOL, V89, P850, DOI 10.1046/j.0022-0477.2001.00605.x; Pringle RM, 2007, P NATL ACAD SCI USA, V104, P193, DOI 10.1073/pnas.0609840104; Reynolds JF, 2007, SCIENCE, V316, P847, DOI 10.1126/science.1131634; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Solomon S., 2007, PHYS SCI BASIS WORKI; Wardle DA, 2010, FRONT ECOL ENVIRON, V8, P10, DOI 10.1890/10.WB.002; White R. P., 2003, DRYLANDS PEOPLE ECOS; Whitford W., 2002, ECOLOGY DESERT SYSTE; Woodward FI, 2008, ECOL LETT, V11, P1229, DOI 10.1111/j.1461-0248.2008.01240.x; Wu TH, 2011, P NATL ACAD SCI USA, V108, P17720, DOI 10.1073/pnas.1103824108; Zavaleta ES, 2010, P NATL ACAD SCI USA, V107, P1443, DOI 10.1073/pnas.0906829107	32	753	811	134	1378	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 13	2012	335	6065					214	218		10.1126/science.1215442	http://dx.doi.org/10.1126/science.1215442			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875LZ	22246775	Green Accepted			2022-12-28	WOS:000299033100052
J	Meselson, M				Meselson, Matthew			Paul Mead Doty (1920-2011)	SCIENCE			English	Biographical-Item									Harvard Univ, Cambridge, MA 02138 USA	Harvard University	Meselson, M (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.	msm@wjh.harvard.edu							0	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 13	2012	335	6065					181	181		10.1126/science.1218031	http://dx.doi.org/10.1126/science.1218031			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875LZ	22246766				2022-12-28	WOS:000299033100042
J	Goyal, A; Spertus, JA; Gosch, K; Venkitachalam, L; Jones, PG; Van den Berghe, G; Kosiborod, M				Goyal, Abhinav; Spertus, John A.; Gosch, Kensey; Venkitachalam, Lakshmi; Jones, Philip G.; Van den Berghe, Greet; Kosiborod, Mikhail			Serum Potassium Levels and Mortality in Acute Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC HEART-FAILURE; VENTRICULAR-ARRHYTHMIAS; MALIGNANT ARRHYTHMIAS; HYPOKALEMIA; FIBRILLATION; TIMOLOL; PROGNOSIS; ELEVATION; OUTCOMES; DISEASE	Context Clinical practice guidelines recommend maintaining serum potassium levels between 4.0 and 5.0 mEq/L in patients with acute myocardial infarction (AMI). These guidelines are based on small studies that associated low potassium levels with ventricular arrhythmias in the pre-beta-blocker and prereperfusion era. Current studies examining the relationship between potassium levels and mortality in AMI patients are lacking. Objective To determine the relationship between serum potassium levels and in-hospital mortality in AMI patients in the era of beta-blocker and reperfusion therapy. Design, Setting, and Patients Retrospective cohort study using the Cerner Health Facts database, which included 38 689 patients with biomarker-confirmed AMI, admitted to 67 US hospitals between January 1, 2000, and December 31, 2008. All patients had in-hospital serum potassium measurements and were categorized by mean postadmission serum potassium level (<3.0, 3.0-<3.5, 3.5-<4.0, 4.0-<4.5, 4.5<5.0, 5.0-<5.5, and <5.5 mEq/L). Hierarchical logistic regression was used to determine the association between potassium levels and outcomes after adjusting for patient-and hospital-level factors. Main Outcome Measures All-cause in-hospital mortality and the composite of ventricular fibrillation or cardiac arrest. Results There was a U-shaped relationship between mean postadmission serum potassium level and in-hospital mortality that persisted after multivariable adjustment. Compared with the reference group of 3.5 to less than 4.0 mEq/L (mortality rate, 4.8%; 95% CI, 4.4%-5.2%), mortality was comparable for mean postadmission potassium of 4.0 to less than 4.5 mEq/L (5.0%; 95% CI, 4.7%-5.3%), multivariable-adjusted odds ratio (OR), 1.19 (95% CI, 1.04-1.36). Mortality was twice as great for potassium of 4.5 to less than 5.0 mEq/L (10.0%; 95% CI, 9.1%-10.9%; multivariable-adjusted OR, 1.99; 95% CI, 1.68-2.36), and even greater for higher potassium strata. Similarly, mortality rates were higher for potassium levels of less than 3.5 mEq/L. In contrast, rates of ventricular fibrillation or cardiac arrest were higher only among patients with potassium levels of less than 3.0 mEq/L and at levels of 5.0 mEq/L or greater. Conclusion Among inpatients with AMI, the lowest mortality was observed in those with postadmission serum potassium levels between 3.5 and <4.5 mEq/L compared with those who had higher or lower potassium levels. JAMA. 2012;307(2):157-164 www.jama.com	[Goyal, Abhinav] Emory Rollins Sch Publ Hlth, Emory Sch Med, Dept Med, Atlanta, GA USA; [Goyal, Abhinav] Emory Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA USA; [Spertus, John A.; Gosch, Kensey; Venkitachalam, Lakshmi; Jones, Philip G.; Kosiborod, Mikhail] St Lukes Mid Amer Heart Inst, Kansas City, MO USA; [Spertus, John A.; Kosiborod, Mikhail] Univ Missouri, Dept Med, Kansas City, MO USA; [Van den Berghe, Greet] Univ Leuven, Univ Hosp Gasthuisberg, Dept Intens Care Med, Louvain, Belgium	Emory University; Rollins School Public Health; Emory University; Rollins School Public Health; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; KU Leuven; University Hospital Leuven	Goyal, A (corresponding author), Emory Sch Publ Hlth & Med, 1518 Clifton Rd NE,Room 3027, Atlanta, GA 30322 USA.	agoyal4@emory.edu	Van den Berghe, Greet/J-6788-2018; Goyal, Abhinav/J-5086-2012; Spertus, John/ABD-3075-2021; Hug, Balthasar L./G-1568-2010; Kosiborod, Mikhail/HDO-1541-2022	Van den Berghe, Greet/0000-0002-5320-1362; Goyal, Abhinav/0000-0002-6286-2349; Kosiborod, Mikhail/0000-0002-3750-9789; Venkitachalam, Lakshmi/0000-0003-0703-3932	Saint Luke's Mid America Heart Institute, Kansas, City, Missouri	Saint Luke's Mid America Heart Institute, Kansas, City, Missouri	The research for this article was funded by internal funds from Saint Luke's Mid America Heart Institute, Kansas, City, Missouri. The Cerner Corporation facilitated the collection of the deidentified Health Facts data but provided no external funding for this study.	Alper AB, 2009, INT J CARDIOL, V137, P1, DOI 10.1016/j.ijcard.2008.05.047; Amin AP, 2012, ARCH INTERN MED, V172, P246, DOI 10.1001/archinternmed.2011.1202; ANTMAN EM, 2004, ACC AHA GUIDELINES M; Bowling CB, 2010, CIRC-HEART FAIL, V3, P253, DOI 10.1161/CIRCHEARTFAILURE.109.899526; BROWN MJ, 1983, NEW ENGL J MED, V309, P1414, DOI 10.1056/NEJM198312083092303; Cohn JN, 2000, ARCH INTERN MED, V160, P2429, DOI 10.1001/archinte.160.16.2429; DUKE M, 1978, JAMA-J AM MED ASSOC, V239, P43, DOI 10.1001/jama.239.1.43; FRIEDENSOHN A, 1991, INT J CARDIOL, V32, P331, DOI 10.1016/0167-5273(91)90295-Z; FRIEDMAN LM, 1982, JAMA-J AM MED ASSOC, V247, P1707; GETTES LS, 1992, CIRCULATION, V85, P70; Hofsten DE, 2007, EUR HEART J, V28, P407, DOI 10.1093/eurheartj/ehl476; HSIA DC, 1990, JAMA-J AM MED ASSOC, V264, P59, DOI 10.1001/jama.264.1.59; Huikuri HV, 2003, J AM COLL CARDIOL, V42, P652, DOI 10.1016/S0735-1097(03)00783-6; HULTING J, 1981, ACTA MED SCAND, P109; JOHANSSON BW, 1984, DRUGS, V28, P77, DOI 10.2165/00003495-198400281-00008; KAFKA H, 1987, ARCH INTERN MED, V147, P465, DOI 10.1001/archinte.147.3.465; Kosiborod M, 2008, CIRCULATION, V117, P1018, DOI 10.1161/CIRCULATIONAHA.107.740498; Kosiborod M, 2009, JAMA-J AM MED ASSOC, V301, P1556, DOI 10.1001/jama.2009.496; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Macdonald JE, 2004, J AM COLL CARDIOL, V43, P155, DOI 10.1016/j.jacc.2003.06.021; Madias JE, 2000, CHEST, V118, P904, DOI 10.1378/chest.118.4.904; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; NORDREHAUG JE, 1985, CIRCULATION, V71, P645, DOI 10.1161/01.CIR.71.4.645; NORDREHAUG JE, 1985, AM J CARDIOL, V56, pD20, DOI 10.1016/0002-9149(85)91110-5; NORDREHAUG JE, 1985, ACTA MED SCAND, V217, P299; NORDREHAUG JE, 1985, BRIT HEART J, V53, P388; NORDREHAUG JE, 1985, AM HEART J, V110, P944, DOI 10.1016/0002-8703(85)90189-9; PACKER M, 1990, AM J CARDIOL, V65, pE52; PEDERSEN TR, 1981, NEW ENGL J MED, V304, P801; Perry G, 1997, NEW ENGL J MED, V336, P525; PODRID PJ, 1990, AM J CARDIOL, V65, pE33, DOI 10.1016/0002-9149(90)90250-5; Rogers WJ, 2008, AM HEART J, V156, P1026, DOI 10.1016/j.ahj.2008.07.030; SOLOMON RJ, 1981, ACTA MED SCAND, P87; VOLPI A, 1990, CIRCULATION, V82, P1279, DOI 10.1161/01.CIR.82.4.1279	34	235	247	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 11	2012	307	2					157	164		10.1001/jama.2011.1967	http://dx.doi.org/10.1001/jama.2011.1967			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	875NP	22235086	Bronze			2022-12-28	WOS:000299038300027
J	O'Shea, M; Cleasby, M				O'Shea, Matthew; Cleasby, Morgan			Lung Herniation after Cough-Induced Rupture of Intercostal Muscle	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[O'Shea, Matthew; Cleasby, Morgan] Good Hope Hosp, Birmingham, W Midlands, England	Birmingham City University; Heart of England NHS Foundation Trust; Good Hope Hospital	O'Shea, M (corresponding author), Good Hope Hosp, Birmingham, W Midlands, England.			O'Shea, Matthew/0000-0001-6414-8088					0	5	7	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 5	2012	366	1					74	74		10.1056/NEJMicm1106070	http://dx.doi.org/10.1056/NEJMicm1106070			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	887XY	22216844				2022-12-28	WOS:000299968800009
J	Cassidy, J				Cassidy, Jane			LOBBY WATCH The Sugar Bureau	BRITISH MEDICAL JOURNAL			English	Editorial Material												janecassi2@googlemail.com							0	0	0	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 4	2012	344								d8315	10.1136/bmj.d8315	http://dx.doi.org/10.1136/bmj.d8315			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	874UF	22218099				2022-12-28	WOS:000298982900026
J	Holmes, MV; Perel, P; Shah, T; Hingorani, AD; Casas, JP				Holmes, Michael V.; Perel, Pablo; Shah, Tina; Hingorani, Aroon D.; Casas, Juan P.			CYP2C19 Genotype, Clopidogrel Metabolism, Platelet Function, and Cardiovascular Events A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							OF-FUNCTION POLYMORPHISM; PERCUTANEOUS CORONARY INTERVENTION; GENOME-WIDE ASSOCIATION; PROTON-PUMP INHIBITORS; STENT THROMBOSIS; ANTIPLATELET TREATMENT; CLINICAL-EFFICACY; TREATED PATIENTS; GENE VARIANTS; REACTIVITY	Context The US Food and Drug Administration recently recommended that CYP2C19 genotyping be considered prior to prescribing clopidogrel, but the American Heart Association and American College of Cardiologists have argued evidence is insufficient to support CYP2C19 genotype testing. Objective To appraise evidence on the association of CYP2C19 genotype and clopidogrel response through systematic review and meta-analysis. Data Sources PubMed and EMBASE from their inception to October 2011. Study Selection Studies that reported clopidogrel metabolism, platelet reactivity or clinically relevant outcomes (cardiovascular disease [CVD] events and bleeding), and information on CYP2C19 genotype were included. Data Extraction We extracted information on study design, genotyping, and disease outcomes and investigated sources of bias. Results We retrieved 32 studies of 42 016 patients reporting 3545 CVD events, 579 stent thromboses, and 1413 bleeding events. Six studies were randomized trials ("effect-modification" design) and the remaining 26 reported individuals exposed to clopidogrel ("treatment-only" design). In treatment-only analysis, individuals with 1 or more CYP2C19 alleles associated with lower enzyme activity had lower levels of active clopidogrel metabolites, less platelet inhibition, lower risk of bleeding (relative risk [RR], 0.84; 95% CI, 0.75-0.94; absolute risk reduction of 5-8 events per 1000 individuals), and higher risk of CVD events (RR, 1.18; 95% CI, 1.09-1.28; absolute risk increase of 8-12 events per 1000 individuals). However, there was evidence of small-study bias (Harbord test P=.001). When analyses were restricted to studies with 200 or more events, the point estimate was attenuated (RR, 0.97; 95% CI, 0.86-1.09). In effect-modification studies, CYP2C19 genotype was not associated with modification of the effect of clopidogrel on CVD end points or bleeding (P>.05 for interaction for both). Other limitations included selective outcome reporting and potential for genotype mis-classification due to problems with the * allele nomenclature for cytochrome enzymes. Conclusion Although there was an association between the CYP2C19 genotype and clopidogrel responsiveness, overall there was no significant association of genotype with cardiovascular events. JAMA. 2011;306(24):2704-2714	[Holmes, Michael V.; Shah, Tina; Hingorani, Aroon D.; Casas, Juan P.] UCL, Dept Epidemiol & Publ Hlth, Genet Epidemiol Grp, London WC1E 6BT, England; [Perel, Pablo; Casas, Juan P.] London Sch Hyg & Trop Med, Fac Epidemiol & Publ Hlth, London, England; [Shah, Tina; Hingorani, Aroon D.] UCL, Div Med, Ctr Clin Pharmacol, London WC1E 6BT, England	University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Holmes, MV (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Genet Epidemiol Grp, 1-19 Torrington Pl, London WC1E 6BT, England.	mvholmes@gmail.com	Holmes, Michael/AAA-2208-2021	Shah, Tina/0000-0001-7724-7210; Hingorani, Aroon/0000-0001-8365-0081; /0000-0002-2342-301X	Medical Research Council [G0802432]; Pfizer; Celera; University College London; British Heart Foundation [FS 05/125]; National Institute for Health [RP-PG-0407-10314]; MRC [G0802432] Funding Source: UKRI; National Institute for Health Research [RP-PG-0407-10314] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Pfizer(Pfizer); Celera; University College London(General Electric); British Heart Foundation(British Heart Foundation); National Institute for Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Hingorani was previously the principal investigator receipt of a Bio-marker Award from the Medical Research Council with Pfizer as an Industrial partner. This award was to investigate complement factor H in the prediction or pathogenesis of age-related macular disease or coronary heart disease. The award is now closed. Dr Hingorani has provided free advice to colleagues at University College London on the design and analysis of pharmacogenetic studies, including an analysis funded in part by Celera through a contract with University College London and Medical Research Council. All other coauthors reported no conflicts of interest.; Dr Holmes is supported by a Medical Research Council Population Health Scientist Fellowship (G0802432); Dr Hingorani was supported by a British Heart Foundation Senior Research Fellowship (FS 05/125) at the time this work was conducted. Dr Hingorani is co-investigator on a National Institute for Health Research program grant (RP-PG-0407-10314).	Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Anderson JL, 2009, J AM COLL CARDIOL, V53, P2903; [Anonymous], MED DEV OCT 2010 510; [Anonymous], 2010, TOP 20 GLOB PROD; [Anonymous], CYP2C19 ALLELE NOMEN; Bauer T, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4588; Berger JS, 2009, J AM COLL CARDIOL, V54, P1935, DOI 10.1016/j.jacc.2009.05.074; Bertrand-Thiebault C, 2008, ANN HUM GENET, V72, P178, DOI 10.1111/j.1469-1809.2007.00417.x; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Bhatt DL, CHARISMA GENOMICS SU; Bouman HJ, 2011, NAT MED, V17, P110, DOI 10.1038/nm.2281; Buonamici P, 2007, J AM COLL CARDIOL, V49, P2312, DOI 10.1016/j.jacc.2007.01.094; Campo G, 2011, J AM COLL CARDIOL, V57, P2474, DOI 10.1016/j.jacc.2010.12.047; Collet JP, 2009, LANCET, V373, P309, DOI 10.1016/S0140-6736(08)61845-0; Connolly SJ, 2009, NEW ENGL J MED, V360, P2066, DOI 10.1056/NEJMoa0901301; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; DEMORAIS SMF, 1994, J BIOL CHEM, V269, P15419; Ferreira-Gonzalez I, 2007, BRIT MED J, V334, P786, DOI 10.1136/bmj.39136.682083.AE; Freemantle N, 2003, JAMA-J AM MED ASSOC, V289, P2554, DOI 10.1001/jama.289.19.2554; Frere C, 2008, AM J CARDIOL, V101, P1088, DOI 10.1016/j.amjcard.2007.11.065; Giusti B, 2007, PHARMACOGENET GENOM, V17, P1057, DOI 10.1097/FPC.0b013e3282f1b2be; Giusti B, 2009, AM J CARDIOL, V103, P806, DOI 10.1016/j.amjcard.2008.11.048; Harmsze AM, 2011, J THROMB HAEMOST, V9, P1892, DOI 10.1111/j.1538-7836.2011.04483.x; Harmsze AM, 2010, EUR HEART J, V31, P3046, DOI 10.1093/eurheartj/ehq321; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hingorani A, 2005, LANCET, V366, P1906, DOI 10.1016/S0140-6736(05)67767-7; Holmes DR, 2010, J AM COLL CARDIOL, V56, P321, DOI 10.1016/j.jacc.2010.05.013; Holmes MV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007960; Jeong YH, 2011, EUR HEART J, V32, P313, DOI [10.1093/eurheartj/ehr323, DOI 10.1093/EURHEARTJ/EHR323]; Kazui M, 2010, DRUG METAB DISPOS, V38, P92, DOI 10.1124/dmd.109.029132; Komarov A, 2011, EUR J CARDIOV PREV R, V18, pS100, DOI [10.1177/1741826711407011, DOI 10.1177/1741826711407011]; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Little J, 2004, HUGE REV HDB; Malek LA, 2008, CIRC J, V72, P1165, DOI 10.1253/circj.72.1165; Malek LA, 2010, CARDIOLOGY, V117, P81, DOI 10.1159/000320093; McMillin G, IMPLEMENTATION CYP2C; Mega JL, 2008, J AM COLL CARDIOL, V51, pA206; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; MOTULSKY AG, 1957, JAMA-J AM MED ASSOC, V165, P835, DOI 10.1001/jama.1957.72980250010016; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Oh IY, 2012, HEART, V98, P139, DOI 10.1136/hrt.2011.227272; Ono T, 2011, THROMB RES, V128, pE130, DOI 10.1016/j.thromres.2011.07.028; Pare G, 2010, NEW ENGL J MED, V363, P1704, DOI 10.1056/NEJMoa1008410; Pena A, 2009, CIRCULATION, V119, P2854, DOI 10.1161/CIRCULATIONAHA.108.857722; Poole C, 1999, AM J EPIDEMIOL, V150, P469, DOI 10.1093/oxfordjournals.aje.a010035; Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549; Robarge J, 2007, CLIN PHARMACOL THER, V82, P244, DOI 10.1038/sj.clpt.6100284; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Sanderson S, 2005, GENET MED, V7, P97, DOI 10.1097/01.GIM.0000153664.65759.CF; Sawada T, 2011, CIRC J, V75, P99, DOI 10.1253/circj.CJ-10-0525; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Sibbing D, 2011, EUR HEART J, V32, P1605, DOI 10.1093/eurheartj/ehr155; Sibbing D, 2010, CIRCULATION, V121, P512, DOI 10.1161/CIRCULATIONAHA.109.885194; Sibbing D, 2009, EUR HEART J, V30, P916, DOI 10.1093/eurheartj/ehp041; Sim SC, 2006, CLIN PHARMACOL THER, V79, P103, DOI 10.1016/j.clpt.2005.10.002; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Tello-Montoliu A, 2011, EUR HEART J, V32, P264; Tiroch KA, 2010, AM HEART J, V160, P506, DOI 10.1016/j.ahj.2010.06.039; Trenk D, 2008, J AM COLL CARDIOL, V51, P1925, DOI 10.1016/j.jacc.2007.12.056; US Food and Drug Administration, FDA DRUG SAF COMM RE; Wallentin L, 2010, LANCET, V376, P1320, DOI 10.1016/S0140-6736(10)61274-3; Wiviott SD, 2004, CIRCULATION, V109, P3064, DOI 10.1161/01.CIR.0000134701.40946.30; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Worrall A, 2009, EUR HEART J, V30, P327; Yamamoto K, 2011, J CARDIOL, V57, P194, DOI 10.1016/j.jjcc.2010.10.007; Yan SD, 2011, CARDIOLOGY, V119, P15, DOI 10.1159/000329048; Yuan J, 2011, EUR HEART J, V32, P238; YUSUF S, 1991, JAMA-J AM MED ASSOC, V266, P93, DOI 10.1001/jama.266.1.93; Yusuf S, 2001, NEW ENGL J MED, V345, P494	72	381	403	1	70	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 28	2011	306	24					2704	2714		10.1001/jama.2011.1880	http://dx.doi.org/10.1001/jama.2011.1880			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	867VX	22203539	Bronze			2022-12-28	WOS:000298484000021
J	Keller, T; Zeller, T; Ojeda, F; Tzikas, S; Lillpopp, L; Sinning, C; Wild, P; Genth-Zotz, S; Warnholtz, A; Giannitsis, E; Mockel, M; Bickel, C; Peetz, D; Lackner, K; Baldus, S; Munzel, T; Blankenberg, S				Keller, Till; Zeller, Tanja; Ojeda, Francisco; Tzikas, Stergios; Lillpopp, Lars; Sinning, Christoph; Wild, Philipp; Genth-Zotz, Sabine; Warnholtz, Ascan; Giannitsis, Evangelos; Moeckel, Martin; Bickel, Christoph; Peetz, Dirk; Lackner, Karl; Baldus, Stephan; Muenzel, Thomas; Blankenberg, Stefan			Serial Changes in Highly Sensitive Troponin I Assay and Early Diagnosis of Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE CORONARY SYNDROMES; CARDIAC TROPONIN; HEART-FAILURE; BIOLOGICAL VARIATION; RISK STRATIFICATION; CLINICAL-PRACTICE; ADVERSE EVENTS; ASSOCIATION; DEFINITION; PREDICTION	Context Introduction of highly sensitive troponin assays into clinical practice has substantially improved the evaluation of patients with chest pain. Objective To evaluate the diagnostic performance of a highly sensitive troponin I (hsTnI) assay compared with a contemporary troponin I (cTnI) assay and their serial changes in the diagnosis of acute myocardial infarction (AMI). Design, Setting, and Patients A total of 1818 patients with suspected acute coronary syndrome were consecutively enrolled at the chest pain units of the University Heart Center Hamburg, the University Medical Center Mainz, and the Federal Armed Forces Hospital Koblenz, all in Germany, from 2007 to 2008. Twelve biomarkers including hsTnI (level of detection, 3.4 pg/mL) and cTnI (level of detection, 10 pg/mL) were measured on admission and after 3 and 6 hours. Main Outcome Measures Diagnostic performance for AMI of baseline and serial changes in hsTnI and cTnI results at 3 hours after admission to the emergency department. Results Of the 1818 patients, 413 (22.7%) were diagnosed as having AMI. For discrimination of AMI, the area under the receiver operating characteristic (ROC) curve was 0.96 (95% CI, 0.95-0.97) for hsTnI on admission and 0.92 (95% CI, 0.90-0.94) for cTnI on admission. Both were superior to the other evaluated diagnostic biomarkers. The use of hsTnI at admission (with the diagnostic cutoff value at the 99th percentile of 30 pg/mL) had a sensitivity of 82.3% and a negative predictive value (for ruling out AMI) of 94.7%. The use of cTnI (with the diagnostic cutoff value at the 99th percentile of 32 pg/mL) at admission had a sensitivity of 79.4% and a negative predictive value of 94.0%. Using levels obtained at 3 hours after admission, the sensitivity was 98.2% and the negative predictive value was 99.4% for both hsTnI and cTnI assays. Combining the 99th percentile cutoff at admission with the serial change in troponin concentration within 3 hours, the positive predictive value (for ruling in AMI) for hsTnI increased from 75.1% at admission to 95.8% after 3 hours, and for cTnI increased from 80.9% at admission to 96.1% after 3 hours. Conclusions Among patients with suspected acute coronary syndrome, hsTnI or cTnI determination 3 hours after admission may facilitate early rule-out of AMI. A serial change in hsTnI or cTnI levels from admission (using the 99th percentile diagnostic cutoff value) to 3 hours after admission may facilitate an early diagnosis of AMI. JAMA. 2011;306(24):2684-2693	[Keller, Till; Zeller, Tanja; Ojeda, Francisco; Sinning, Christoph; Baldus, Stephan; Blankenberg, Stefan] Univ Heart Ctr Hamburg, Dept Gen & Intervent Cardiol, Hamburg, Germany; [Tzikas, Stergios; Lillpopp, Lars; Wild, Philipp; Genth-Zotz, Sabine; Warnholtz, Ascan; Muenzel, Thomas] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med 2, Mainz, Germany; [Lackner, Karl] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Lab Med, Mainz, Germany; [Peetz, Dirk] HELIOS Hosp Berlin Buch, Dept Lab Med, Berlin, Germany; [Bickel, Christoph] Fed Armed Hosp Koblenz, Dept Internal Med, Koblenz, Germany; [Giannitsis, Evangelos] Univ Heidelberg Hosp, Dept Internal Med 3, Heidelberg, Germany; [Moeckel, Martin] Charite, Dept Cardiol, D-13353 Berlin, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Blankenberg, S (corresponding author), Univ Clin Eppendorf, Univ Heart Ctr, Dept Gen & Intervent Cardiol, Martinistr 52, D-20246 Hamburg, Germany.	s.blankenberg@uke.de	Tzikas, Stergios/AAW-2673-2020; Mockel, Martin/AAC-2600-2019; Tzikas, Stergios/A-2234-2010; Munzel, Thomas/A-2912-2014; Wild, Philipp S./M-2106-2019	Tzikas, Stergios/0000-0002-7811-5620; Mockel, Martin/0000-0002-7691-3709; Tzikas, Stergios/0000-0002-7811-5620; Munzel, Thomas/0000-0001-5503-4150; Wild, Philipp/0000-0003-4413-9752; Blankenberg, Stefan/0000-0001-6488-2362; Ojeda, Francisco/0000-0003-4037-144X; Zeller, Tanja/0000-0003-3379-2641; Keller, Till/0000-0002-0895-6491	Brahms AG; Abbott Diagnostics; Siemens; Brahms Thermo Fisher; Johannes Gutenberg-University of Mainz; Brahms AG, Germany	Brahms AG; Abbott Diagnostics(Abbott Laboratories); Siemens(Siemens AG); Brahms Thermo Fisher; Johannes Gutenberg-University of Mainz; Brahms AG, Germany	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Drs Keller, Zeller, Wild, and Mockel reported that their institutions received grant support from Brahms AG and Abbott Diagnostics. Dr Warnholtz reported serving as a consultant to St Jude Medical and receiving payment for lectures provided by Actavis, St Jude Medical, Terumo, AstraZeneca, Novartis, and sanofi-aventis. Dr Giannitsis reported receiving payment for lectures from Roche Diagnostics. Dr Mockel reported serving on the board of Brahms GmbH and reported that his institution received grants from Siemens. Dr Peetz reported that his institution received grant support from Abbott Diagnostics; reported serving as a consultant to Siemens Healthcare Diagnostics and Roche Diagnostics; and reported payment for lectures from Siemens Healthcare Diagnostics. Dr Blankenberg reported receiving lecture fees from and consulting for Brahms Thermo Fisher and receiving lecture fees from Abbott Diagnostics and Siemens.; Support was provided by research programs "Wissen schafft Zukunft" and "Schwerpunkt Vaskulare Pravention" of the Johannes Gutenberg-University of Mainz. In addition, funding was provided by unrestricted grants of the Brahms AG, Germany and Abbott Diagnostics.	Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; AMBROSE JA, 1985, J AM COLL CARDIOL, V5, P609, DOI 10.1016/S0735-1097(85)80384-3; Apple FS, 2008, CLIN CHEM, V54, P723, DOI 10.1373/clinchem.2007.097162; Apple FS, 2010, CLIN CHEM, V56, P886, DOI 10.1373/clinchem.2009.138727; Apple FS, 2009, CLIN CHEM, V55, P930, DOI 10.1373/clinchem.2008.114728; Bjork Jonas, 2006, BMC Med Inform Decis Mak, V6, P28, DOI 10.1186/1472-6947-6-28; Blankenberg S, 2010, CIRCULATION, V121, P2388, DOI 10.1161/CIRCULATIONAHA.109.901413; deFilippi CR, 2010, JAMA-J AM MED ASSOC, V304, P2494, DOI 10.1001/jama.2010.1708; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Frankenstein L, 2011, CLIN CHEM, V57, P1068, DOI 10.1373/clinchem.2010.158964; Giannitsis E, 2010, CLIN CHEM, V56, P642, DOI 10.1373/clinchem.2009.134460; Goldberg J, 2011, CLIN CHEM S, V57, pA97; HARRIS EK, 1983, CLIN CHEM, V29, P25; Hochholzer W, 2011, EUR HEART J, V32, P326, DOI 10.1093/eurheartj/ehq429; Kavsak PA, 2010, CLIN CHEM, V56, P487, DOI 10.1373/clinchem.2009.136689; Keller T, 2010, J AM COLL CARDIOL, V55, P2096, DOI 10.1016/j.jacc.2010.01.029; Keller T, 2009, NEW ENGL J MED, V361, P868, DOI 10.1056/NEJMoa0903515; MacRae AR, 2006, CLIN CHEM, V52, P812, DOI 10.1373/clinchem.2005.059550; Mehta SR, 2009, NEW ENGL J MED, V360, P2165, DOI 10.1056/NEJMoa0807986; NAWAR EW, 2007, ADV DATA, V386, P1; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Reichlin T, 2011, CIRCULATION, V124, P136, DOI 10.1161/CIRCULATIONAHA.111.023937; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; Reichlin T, 2009, J AM COLL CARDIOL, V54, P60, DOI 10.1016/j.jacc.2009.01.076; Saunders JT, 2011, CIRCULATION, V123, P1367, DOI 10.1161/CIRCULATIONAHA.110.005264; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Wu AHB, 2007, CLIN CHEM, V53, P2086, DOI 10.1373/clinchem.2007.095679; Wu AHB, 2009, CLIN CHEM, V55, P52, DOI 10.1373/clinchem.2008.107391	28	379	386	1	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 28	2011	306	24					2684	2693		10.1001/jama.2011.1896	http://dx.doi.org/10.1001/jama.2011.1896			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	867VX	22203537				2022-12-28	WOS:000298484000019
J	Yudkin, JS; Lipska, KJ; Montori, VM				Yudkin, John S.; Lipska, Kasia J.; Montori, Victor M.			The idolatry of the surrogate	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RISK; OUTCOMES; QUALITY; DEATH		[Yudkin, John S.] UCL, London WC1E 6BT, England; [Lipska, Kasia J.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Montori, Victor M.] Mayo Clin, Knowledge & Evaluat Res Unit, Div Endocrinol & Diabet, Dept Med, Rochester, MN USA; [Montori, Victor M.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA	University of London; University College London; Yale University; Mayo Clinic; Mayo Clinic	Yudkin, JS (corresponding author), UCL, London WC1E 6BT, England.	j.yudkin@ucl.ac.uk	Yudkin, John S/C-1988-2008	Montori, Victor/0000-0003-0595-2898				[Anonymous], 1991, OPHTHALMOLOGY, V98, P823; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Calvert M, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1870; Chew EY, 2011, NEW ENGL J MED, V364, P190; Chew EY, 2010, NEW ENGL J MED, V363, P233, DOI 10.1056/NEJMoa1001288; Ferreira-Gonzalez I, 2007, BRIT MED J, V334, P786, DOI 10.1136/bmj.39136.682083.AE; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Gerstein HC, 2000, LANCET, V355, P253; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Haller H, 2011, NEW ENGL J MED, V364, P907, DOI 10.1056/NEJMoa1007994; Hemmingsen B, 2011, COCHRANE DB SYST REV, V2; Institute of Medicine, 2010, EV BIOM SURR ENDP CH; Ismail-Beigi F, 2010, LANCET, V376, P419, DOI 10.1016/S0140-6736(10)60576-4; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Lehman R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4805; Mazhar K, 2011, OPHTHALMOLOGY, V118, P649, DOI 10.1016/j.ophtha.2010.08.003; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; O'Connor PJ, 2011, DIABETES CARE, V34, P1651, DOI 10.2337/dc11-0735; Shah ND, 2010, NEW ENGL J MED, V363, P2081, DOI 10.1056/NEJMp1011042; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Timbie JW, 2010, ARCH INTERN MED, V170, P1037, DOI 10.1001/archinternmed.2010.150; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Yudkin JS, 2010, DIABETOLOGIA, V53, P2079, DOI 10.1007/s00125-010-1864-z; Yudkin JS, 2011, NEW ENGL J MED, V364, P2260, DOI 10.1056/NEJMc1104826; Yudkin JS, 2011, LANCET, V377, P1220, DOI 10.1016/S0140-6736(10)61112-9; Yudkin JS, 1999, DIABETIC MED, V16, P219, DOI 10.1046/j.1464-5491.1999.00026.x	27	125	125	2	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 28	2011	343								d7995	10.1136/bmj.d7995	http://dx.doi.org/10.1136/bmj.d7995			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874TM	22205706				2022-12-28	WOS:000298981000001
J	Drew, LJ; Hen, R				Drew, Liam J.; Hen, Rene			Food for Thought: Linking Caloric Intake to Behavior via Sirtuin Activity	CELL			English	Editorial Material								Sirtuins are thought to form crucial links between energy levels and cellular metabolism. Libert et al. now provide evidence that SIRT1 activity in the brain modifies mammalian emotional behavior via monoamine signaling and that changes in this pathway might contribute to human affective disorders	[Drew, Liam J.; Hen, Rene] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Hen, Rene] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Hen, Rene] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; [Drew, Liam J.; Hen, Rene] New York State Psychiat Inst & Hosp, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute	Hen, R (corresponding author), Columbia Univ, Dept Psychiat, New York, NY 10032 USA.	rh95@columbia.edu						Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; Canto C, 2009, TRENDS ENDOCRIN MET, V20, P325, DOI 10.1016/j.tem.2009.03.008; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Guarente L, 2000, GENE DEV, V14, P1021; Kaeberlein M, 2008, CELL METAB, V8, P4, DOI 10.1016/j.cmet.2008.06.004; Libert S, 2011, CELL, V147, P1459, DOI 10.1016/j.cell.2011.10.054; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Renthal W, 2009, NEURON, V62, P335, DOI 10.1016/j.neuron.2009.03.026; Satoh A, 2010, J NEUROSCI, V30, P10220, DOI 10.1523/JNEUROSCI.1385-10.2010; Wang T, 2006, ANNU REV PHYSIOL, V68, P223, DOI 10.1146/annurev.physiol.68.040104.105739	10	1	1	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 23	2011	147	7					1436	1437		10.1016/j.cell.2011.11.052	http://dx.doi.org/10.1016/j.cell.2011.11.052			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	866SP	22196720	Bronze			2022-12-28	WOS:000298403400007
J	Hombauer, H; Srivatsan, A; Putnam, CD; Kolodner, RD				Hombauer, Hans; Srivatsan, Anjana; Putnam, Christopher D.; Kolodner, Richard D.			Mismatch Repair, But Not Heteroduplex Rejection, Is Temporally Coupled to DNA Replication	SCIENCE			English	Article							CELL NUCLEAR ANTIGEN; SACCHAROMYCES-CEREVISIAE; INSTABILITY; GENOME; MSH6; RECONSTITUTION; REARRANGEMENTS; RECOMBINATION; RECOGNITION; PROTEOLYSIS	In eukaryotes, it is unknown whether mismatch repair (MMR) is temporally coupled to DNA replication and how strand-specific MMR is directed. We fused Saccharomyces cerevisiae MSH6 with cyclins to restrict the availability of the Msh2-Msh6 mismatch recognition complex to either S phase or G2/M phase of the cell cycle. The Msh6-S cyclin fusion was proficient for suppressing mutations at three loci that replicate at mid-S phase, whereas the Msh6-G2/M cyclin fusion was defective. However, the Msh6-G2/M cyclin fusion was functional for MMR at a very late-replicating region of the genome. In contrast, the heteroduplex rejection function of MMR during recombination was partially functional during both S phase and G2/M phase. These results indicate a temporal coupling of MMR, but not heteroduplex rejection, to DNA replication.	[Kolodner, Richard D.] Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Ctr Canc, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Inst Genom Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Kolodner, RD (corresponding author), Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rkolodner@ucsd.edu	Srivatsan, Anjana/S-1518-2017; Srivatsan, Anjana/Q-6312-2017; Hombauer, Hans/B-9712-2019	Srivatsan, Anjana/0000-0003-1645-7075; Srivatsan, Anjana/0000-0003-1645-7075; Putnam, Christopher/0000-0002-6145-1265; Hombauer, Hans/0000-0002-2100-564X	NIH [GM50006]; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050006] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by NIH grant GM50006 (to R.D.K.).	Chen C, 1999, MOL CELL BIOL, V19, P7801; Chen C, 1998, MOL CELL, V2, P9, DOI 10.1016/S1097-2765(00)80109-4; Clark AB, 2000, J BIOL CHEM, V275, P36498, DOI 10.1074/jbc.C000513200; Constantin N, 2005, J BIOL CHEM, V280, P39752, DOI 10.1074/jbc.M509701200; Datta A, 1996, MOL CELL BIOL, V16, P1085; Flores-Rozas H, 2000, NAT GENET, V26, P375, DOI 10.1038/81708; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; Hendrickson C, 2001, CURR BIOL, V11, P1781, DOI 10.1016/S0960-9822(01)00564-4; Hombauer H, 2011, CELL, V147, P1040, DOI 10.1016/j.cell.2011.10.025; Hood JK, 2001, J CELL SCI, V114, P589; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Karras GI, 2010, CELL, V141, P255, DOI 10.1016/j.cell.2010.02.028; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Langston LD, 2006, MOL CELL, V23, P155, DOI 10.1016/j.molcel.2006.05.034; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; MATIC I, 1995, CELL, V80, P507, DOI 10.1016/0092-8674(95)90501-4; Myung K, 2001, NAT GENET, V27, P113, DOI 10.1038/83673; ORRWEAVER TL, 1985, MICROBIOL REV, V49, P33, DOI 10.1128/MMBR.49.1.33-58.1985; Putnam CD, 2009, NATURE, V460, P984, DOI 10.1038/nature08217; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Shell SS, 2007, MOL CELL, V26, P565, DOI 10.1016/j.molcel.2007.04.024; Sia EA, 1997, MOL CELL BIOL, V17, P2851, DOI 10.1128/MCB.17.5.2851; Sugawara N, 2004, P NATL ACAD SCI USA, V101, P9315, DOI 10.1073/pnas.0305749101; Wasch R, 2002, NATURE, V418, P556, DOI 10.1038/nature00856; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	25	90	91	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1713	1716		10.1126/science.1210770	http://dx.doi.org/10.1126/science.1210770			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22194578	Green Accepted			2022-12-28	WOS:000298344000070
J	Schefuss, E; Kuhlmann, H; Mollenhauer, G; Prange, M; Patzold, J				Schefuss, Enno; Kuhlmann, Holger; Mollenhauer, Gesine; Prange, Matthias; Paetzold, Juergen			Forcing of wet phases in southeast Africa over the past 17,000 years	NATURE			English	Article							TERRESTRIAL; VARIABILITY; CLIMATE; RECORD; PLANTS; PROXY	Intense debate persists about the climatic mechanisms governing hydrologic changes in tropical and subtropical southeast Africa since the Last Glacial Maximum, about 20,000 years ago. In particular, the relative importance of atmospheric and oceanic processes is not firmly established(1-5). Southward shifts of the intertropical convergence zone (ITCZ) driven by high-latitude climate changes have been suggested as a primary forcing(2,3), whereas other studies infer a predominant influence of Indian Ocean sea surface temperatures on regional rainfall changes(4,5). To address this question, a continuous record representing an integrated signal of regional climate variability is required, but has until now been missing. Here we show that remote atmospheric forcing by cold events in the northern high latitudes appears to have been the main driver of hydro-climatology in southeast Africa during rapid climate changes over the past 17,000 years. Our results are based on a reconstruction of precipitation and river discharge changes, as recorded in a marine sediment core off the mouth of the Zambezi River, near the southern boundary of the modern seasonal ITCZ migration. Indian Ocean sea surface temperatures did not exert a primary control over southeast African hydrologic variability. Instead, phases of high precipitation and terrestrial discharge occurred when the ITCZ was forced southwards during Northern Hemisphere cold events, such as Heinrich stadial 1 (around 16,000 years ago) and the Younger Dryas (around 12,000 years ago), or when local summer insolation was high in the late Holocene, that is, during the past 4,000 years.	[Schefuss, Enno; Kuhlmann, Holger; Mollenhauer, Gesine; Prange, Matthias; Paetzold, Juergen] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany; [Schefuss, Enno; Kuhlmann, Holger; Mollenhauer, Gesine; Prange, Matthias; Paetzold, Juergen] Univ Bremen, Fac Geosci, D-28359 Bremen, Germany; [Mollenhauer, Gesine] Alfred Wegener Inst Polar & Marine Res, D-27568 Bremerhaven, Germany	University of Bremen; University of Bremen; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Schefuss, E (corresponding author), Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany.	schefuss@uni-bremen.de	Mollenhauer, Gesine/AAD-8167-2019; Mollenhauer, Gesine/B-5190-2015; Schefuß, Enno/A-7101-2015; Patzold, Jurgen/D-5111-2017	Mollenhauer, Gesine/0000-0001-5138-564X; Mollenhauer, Gesine/0000-0001-5138-564X; Schefuß, Enno/0000-0002-5960-930X; Kuhlmann, Holger/0000-0001-8932-7031; Patzold, Jurgen/0000-0001-8074-4103	DFG Research Center/Cluster of Excellence 'The Ocean in the Earth System'; DFG [Sche903/8]	DFG Research Center/Cluster of Excellence 'The Ocean in the Earth System'(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	This work was supported by the DFG Research Center/Cluster of Excellence 'The Ocean in the Earth System' and DFG grant Sche903/8. Laboratory assistance was provided by K. Siedenberg, M. Segl, W. Bevern, B. Meyer-Schack and R. Kreutz. We thank R. Schneider for logistical support and S. Weldeab for sample preparation for radiocarbon analyses. Comments by Y. Huang and J. Russell improved the manuscript.	Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Beilfuss R., 2001, 2 INT CRAN FDN; Beilfuss R., 2001, 3 INT CRAN FDN; Broccoli AJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024546; Burrough SL, 2009, EARTH-SCI REV, V96, P313, DOI 10.1016/j.earscirev.2009.07.001; Castaneda IS, 2007, GEOLOGY, V35, P823, DOI 10.1130/G23916A.1; Clement AC, 2008, REV GEOPHYS, V46, DOI 10.1029/2006RG000204; EGLINTON G, 1967, SCIENCE, V156, P1322, DOI 10.1126/science.156.3780.1322; Ehleringer J.R., 2002, ENCY GLOBAL ENV CHAN, V2, P186; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Frankenberg C, 2009, SCIENCE, V325, P1374, DOI 10.1126/science.1173791; Gasse F, 2008, QUATERNARY SCI REV, V27, P2316, DOI 10.1016/j.quascirev.2008.08.027; Gimeno L, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043712; Hopmans EC, 2004, EARTH PLANET SC LETT, V224, P107, DOI 10.1016/j.epsl.2004.05.012; Hou JZ, 2007, ORG GEOCHEM, V38, P977, DOI 10.1016/j.orggeochem.2006.12.009; Johnson TC, 2002, SCIENCE, V296, P113, DOI 10.1126/science.1070057; Jury MR, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2000JC000507; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Lewis SC, 2010, CLIM PAST, V6, P325, DOI 10.5194/cp-6-325-2010; Nicholson SE, 2000, GLOBAL PLANET CHANGE, V26, P137, DOI 10.1016/S0921-8181(00)00040-0; Partridge TC, 1997, QUATERNARY SCI REV, V16, P1125, DOI 10.1016/S0277-3791(97)00005-X; Risi C, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD009943; Sachse D, 2006, ORG GEOCHEM, V37, P469, DOI 10.1016/j.orggeochem.2005.12.003; Schefuss E, 2005, NATURE, V437, P1003, DOI 10.1038/nature03945; Schulz H, 2011, MAR GEOL, V286, P21, DOI 10.1016/j.margeo.2011.05.003; Stager JC, 2011, SCIENCE, V331, P1299, DOI 10.1126/science.1198322; Still C. J., 2010, UNDERSTANDING MOVEME, P179; Thomas DSG, 2009, QUATERNARY SCI REV, V28, P526, DOI 10.1016/j.quascirev.2008.10.023; Thomas DSG, 2002, QUATERNARY SCI REV, V21, P783, DOI 10.1016/S0277-3791(01)00127-5; Tierney JE, 2008, SCIENCE, V322, P252, DOI 10.1126/science.1160485	30	197	199	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2011	480	7378					509	512		10.1038/nature10685	http://dx.doi.org/10.1038/nature10685			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865NQ	22193106				2022-12-28	WOS:000298318000057
J	Venna, N; Gonzalez, RG; Zukerberg, LR				Venna, Nagagopal; Gonzalez, R. Gilberto; Zukerberg, Lawrence R.			Case 39-2011: A Woman in Her 90s with Unilateral Ptosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GUILLAIN-BARRE-SYNDROME; MYASTHENIA-GRAVIS; CLINICAL-FEATURES; THYMOMA		[Venna, Nagagopal] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Gonzalez, R. Gilberto] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Zukerberg, Lawrence R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Venna, Nagagopal] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Gonzalez, R. Gilberto] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Zukerberg, Lawrence R.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Venna, N (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.							Aarli JA, 2008, ANN NY ACAD SCI, V1132, P238, DOI 10.1196/annals.1405.040; Benatar M, 2006, NEUROMUSCULAR DISORD, V16, P459, DOI 10.1016/j.nmd.2006.05.006; Cabrera AR, 2001, PSYCHOL MED, V31, P1089, DOI 10.1017/S0033291701004354; Chaudhuri A, 2009, QJM-INT J MED, V102, P97, DOI 10.1093/qjmed/hcn152; D'Amelio M, 2007, NEUROL SCI, V28, P104, DOI 10.1007/s10072-007-0796-y; Evoli A, 2007, J NEUROL, V254, P756, DOI 10.1007/s00415-006-0429-z; Guptill JT, 2010, CURR OPIN NEUROL, V23, P530, DOI 10.1097/WCO.0b013e32833c0982; JONES HR, 1980, STROKE, V11, P173, DOI 10.1161/01.STR.11.2.173; Keane JR, 2005, ARCH NEUROL-CHICAGO, V62, P1714, DOI 10.1001/archneur.62.11.1714; LI TM, 1988, J NEUROL NEUROSUR PS, V51, P778, DOI 10.1136/jnnp.51.6.778; Lo YL, 2007, MUSCLE NERVE, V36, P615, DOI 10.1002/mus.20835; Meriggioli MN, 2009, LANCET NEUROL, V8, P475, DOI 10.1016/S1474-4422(09)70063-8; Odaka M, 2003, BRAIN, V126, P2279, DOI 10.1093/brain/awg233; Romi F, 2007, EUR J NEUROL, V14, P617, DOI 10.1111/j.1468-1331.2007.01785.x; ROPPER AH, 1986, ARCH NEUROL-CHICAGO, V43, P1150, DOI 10.1001/archneur.1986.00520110044012; Skeie GO, 2008, EUR J NEUROL, V15, P1029, DOI 10.1111/j.1468-1331.2008.02242.x; Suzuki S, 2009, ARCH NEUROL-CHICAGO, V66, P1334, DOI 10.1001/archneurol.2009.229; Tormoehlen LM, 2008, HEMATOL ONCOL CLIN N, V22, P509, DOI 10.1016/j.hoc.2008.03.004; Travis WD., 2004, TRAVIS WB WHO CLASSI	19	4	4	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2011	365	25					2413	2422		10.1056/NEJMcpc1110048	http://dx.doi.org/10.1056/NEJMcpc1110048			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	865OM	22187989				2022-12-28	WOS:000298320200008
J	Scudeller, L; Del Fante, C; Perotti, C; Pavesi, CF; Coscia, D; Scotti, V; Tinelli, C				Scudeller, Luigia; Del Fante, Claudia; Perotti, Cesare; Pavesi, Claudio Francesco; Coscia, Davide; Scotti, Valeria; Tinelli, Carmine			N of 1, two contemporary arm, randomised controlled clinical trial for bilateral epicondylitis: a new study design	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PLATELET-RICH PLASMA; N-OF-1 TRIALS; TENNIS-ELBOW; LATERAL EPICONDYLITIS; PATIENT; HEALTH	Objective To investigate the use of a novel study design in analysis of bilateral elbow pain. Design N of 1, two contemporary arm, open label, randomised controlled clinical trial. Setting A clinical epidemiologist at a university hospital in Pavia, Italy. Participants Two elbows with epicondylitis. Interventions Autologous platelet lysate versus "wait and see" strategy. Main outcome measures Visual analogue scale for pain on elbow extension and resisted wrist extension. Results Over six months' follow-up, the patient experienced bilateral improvement in pain, but higher in the treated arm, with a drop in visual analogue scale for pain from 28 to 4 for right (control) arm (drop of 24 points) and from 67 to 10.5 for left (treated) arm (drop of 56.5 points). Conclusions Platelet lysate might (or might not) work. Competing interests and lack of blinding might be relevant issues in the interpretation of trial results. However, the new study design can be applied to a number of conditions such as bilateral sport or trauma injuries, bilateral otitis, or any condition affecting chiral organs or limbs.	[Scudeller, Luigia; Tinelli, Carmine] Fdn IRCCS Policlin San Matteo, Sci Direct, I-27100 Pavia, Italy; [Del Fante, Claudia; Perotti, Cesare] Fdn IRCCS Policlin San Matteo, Immunohaematol & Blood Transfus Serv, I-27100 Pavia, Italy; [Pavesi, Claudio Francesco] Fdn IRCCS Policlin San Matteo, Dept Orthopaed, I-27100 Pavia, Italy; [Coscia, Davide] Fdn IRCCS Policlin San Matteo, Inst Radiol, I-27100 Pavia, Italy; [Scotti, Valeria] Fdn IRCCS Policlin San Matteo, Sci Documentat Serv, I-27100 Pavia, Italy	IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo	Scudeller, L (corresponding author), Fdn IRCCS Policlin San Matteo, Sci Direct, Viale Golgi 2, I-27100 Pavia, Italy.	l.scudeller@smatteo.pv.it	cesare, perotti/AAC-3103-2019; Del Fante, Claudia/F-8911-2016; Scotti, Valeria/M-4168-2013; Scudeller, Luigia/K-9625-2014; Del Fante, Claudia/AAC-7685-2019	cesare, perotti/0000-0003-0457-8662; Del Fante, Claudia/0000-0003-0822-0342; Scotti, Valeria/0000-0001-9240-2901; Scudeller, Luigia/0000-0001-7240-9567; Tinelli, Carmine/0000-0002-8749-1978				Altman Lawrence, 1986, WHO GOES 1 STORY SEL; Annas GJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c7103; [Anonymous], 2004, BRIT MED J, P329, DOI [10.1136/bmj.329.7460.0, DOI 10.1136/BMJ.329.7460.0]; Axelsson J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6614; Backman CL, 1999, AM J PHYS MED REHAB, V78, P170, DOI 10.1097/00002060-199903000-00022; CHALMERS I, 1995, BRIT MED J, V310, P1315, DOI 10.1136/bmj.310.6990.1315; Cohen DA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000458; Ehrenfest DMD, 2009, TRENDS BIOTECHNOL, V27, P158, DOI 10.1016/j.tibtech.2008.11.009; Faro F, 2007, J HAND SURG-AM, V32A, P1271, DOI 10.1016/j.jhsa.2007.07.019; Gabler NB, 2011, MED CARE, V49, P761, DOI 10.1097/MLR.0b013e318215d90d; Gosens T, 2011, AM J SPORT MED, V39, P1200, DOI 10.1177/0363546510397173; IRWIG L, 1995, LANCET, V345, P469, DOI 10.1016/S0140-6736(95)90578-2; KELLER JL, 1988, SCAND J GASTROENTERO, V23, P22, DOI 10.3109/00365528809099154; Mahaffey P, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5325; Mishra A, 2006, AM J SPORT MED, V34, P1774, DOI 10.1177/0363546506288850; Morrey BF, 1993, ELBOW ITS DISORDERS, V2nd, P86; O'Connor RF, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5319; Oxman AD, 2001, BRIT MED J, V323, P1464, DOI 10.1136/bmj.323.7327.1464; ROLES N C, 1972, Journal of Bone and Joint Surgery British Volume, V54B, P499; Rolls A, 2011, P NATL ACAD SCI USA, V108, P13305, DOI 10.1073/pnas.1015633108; Rompe JD, 2007, J HAND THER, V20, P3, DOI 10.1197/j.jht.2006.10.003; Sackett DL, 1991, CLIN EPIDEMIOLOGY BA, P187; SHAKESPEARE WILLIAM, MEASURE MEASURE; Shakespeare William, HAMLET; Smith Richard, 2008, Cases J, V1, P78, DOI 10.1186/1757-1626-1-78; Tate RL, 2008, NEUROPSYCHOL REHABIL, V18, P385, DOI 10.1080/09602010802009201; Treasure W, 1996, BMJ-BRIT MED J, V313, P427; Tsapas A, 2009, JAMA-J AM MED ASSOC, V301, P1022, DOI 10.1001/jama.2009.276; Vist GE, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000009.pub3; Wong MWN, 2003, J BONE JOINT SURG AM, V85A, P1914, DOI 10.2106/00004623-200310000-00008; Zucker DR, 2010, J CLIN EPIDEMIOL, V63, P1312, DOI 10.1016/j.jclinepi.2010.04.020	31	5	5	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 20	2011	343								d7653	10.1136/bmj.d7653	http://dx.doi.org/10.1136/bmj.d7653			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	868QK	22187187	Green Published, Green Submitted			2022-12-28	WOS:000298538200007
J	Gluckman, PD; Bergstrom, CT				Gluckman, Peter D.; Bergstrom, Carl T.			CHRISTMAS 2011: FOOD FOR THOUGHT Evolutionary biology within medicine: a perspective of growing value	BRITISH MEDICAL JOURNAL			English	Editorial Material							RESISTANCE; HOSPITALS; DISEASE; HEALTH		[Gluckman, Peter D.] Univ Auckland, Liggins Inst, Ctr Human Evolut Adaptat & Dis, Auckland 1142, New Zealand; [Gluckman, Peter D.] Univ Auckland, Liggins Inst, Natl Res Ctr Growth & Dev, Auckland 1142, New Zealand; [Bergstrom, Carl T.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Bergstrom, Carl T.] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Auckland; University of Auckland; University of Washington; University of Washington Seattle; The Santa Fe Institute	Gluckman, PD (corresponding author), Univ Auckland, Liggins Inst, Ctr Human Evolut Adaptat & Dis, Private Bag 92019, Auckland 1142, New Zealand.	pd.gluckman@auckland.ac.nz	Bergstrom, Carl T./H-2299-2011	Bergstrom, Carl T./0000-0002-2070-385X	NIGMS NIH HHS [5U01GM07649] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AAMC-HHMI Scientific Foundation for Future Physicians Committee, 2009, SCI FDN FUT PHYS; Berg RD, 1996, TRENDS MICROBIOL, V4, P430, DOI 10.1016/0966-842X(96)10057-3; Bergstrom CT, 2004, P NATL ACAD SCI USA, V101, P13285, DOI 10.1073/pnas.0402298101; Bergstrom CT, 2008, EVOLUTION HLTH DIS, P125; Gluckman P, 2011, PUBERTY ADOLESCENCE; Gluckman PD, 2006, TRENDS ENDOCRIN MET, V17, P7, DOI 10.1016/j.tem.2005.11.006; Gluckman PD, 2005, P ROY SOC B-BIOL SCI, V272, P671, DOI 10.1098/rspb.2004.3001; Gluckman PD, 2009, PRINCIPLES EVOLUTION; Gluckman PD, 2006, MISMATCH WHY OUR WOR; Godfrey KM, 2011, DIABETES, V60, P1528, DOI 10.2337/db10-0979; Kaza U, 2007, CURR ALLERGY ASTHM R, V7, P182, DOI 10.1007/s11882-007-0019-x; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Kuzawa CW, 2007, ADIPOSE TISSUE ADIPO, P207; Lipsitch M, 2000, P NATL ACAD SCI USA, V97, P1938, DOI 10.1073/pnas.97.4.1938; MARKS IM, 1994, ETHOL SOCIOBIOL, V15, P247, DOI 10.1016/0162-3095(94)90002-7; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Nesse RM, 2008, EVOL APPL, V1, P28, DOI 10.1111/j.1752-4571.2007.00006.x; Nesse RM, 2011, EVOL APPL, V4, P264, DOI 10.1111/j.1752-4571.2010.00181.x; Nesse RM, 2010, P NATL ACAD SCI USA, V107, P1800, DOI 10.1073/pnas.0906224106; Nesse RM, 1995, WHY WE GET SICK NEW; Nettle D, 2010, BEHAV ECOL, V21, P387, DOI 10.1093/beheco/arp202; Stearns SC, 2008, EVOLUTION HLTH DIS; Tinbergen N., 1963, Zeitschrift fuer Tierpsychologie, V20, P410; Young JH, 2005, PLOS GENET, V1, P730, DOI 10.1371/journal.pgen.0010082	24	8	8	1	15	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 19	2011	343								d7671	10.1136/bmj.d7671	http://dx.doi.org/10.1136/bmj.d7671			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	868QI	22184558	Green Published			2022-12-28	WOS:000298537800001
J	Smith, ESJ; Omerbasic, D; Lechner, SG; Anirudhan, G; Lapatsina, L; Lewin, GR				Smith, Ewan St. John; Omerbasic, Damir; Lechner, Stefan G.; Anirudhan, Gireesh; Lapatsina, Liudmila; Lewin, Gary R.			The Molecular Basis of Acid Insensitivity in the African Naked Mole-Rat	SCIENCE			English	Article							SODIUM-CHANNELS; PAIN; SCN9A; MUTATIONS; CAPSAICIN; NEURONS; PROTONS; TRPV1; MICE	Acid evokes pain by exciting nociceptors; the acid sensors are proton-gated ion channels that depolarize neurons. The naked mole-rat (Heterocephalus glaber) is exceptional in its acid insensitivity, but acid sensors (acid-sensing ion channels and the transient receptor potential vanilloid-1 ion channel) in naked mole-rat nociceptors are similar to those in other vertebrates. Acid inhibition of voltage-gated sodium currents is more profound in naked mole-rat nociceptors than in mouse nociceptors, however, which effectively prevents acid-induced action potential initiation. We describe a species-specific variant of the nociceptor sodium channel Na(V)1.7, which is potently blocked by protons and can account for acid insensitivity in this species. Thus, evolutionary pressure has selected for an Na(V)1.7 gene variant that tips the balance from proton-induced excitation to inhibition of action potential initiation to abolish acid nociception.	[Smith, Ewan St. John; Omerbasic, Damir; Lechner, Stefan G.; Anirudhan, Gireesh; Lapatsina, Liudmila; Lewin, Gary R.] Max Delbruck Ctr Mol Med, Dept Neurosci, D-13125 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine	Smith, ESJ (corresponding author), Max Delbruck Ctr Mol Med, Dept Neurosci, Robert Rossle Str 10, D-13125 Berlin, Germany.	ewan.smith@mdc-berlin.de; glewin@mdc-berlin.de	Anirudhan, Gireesh/AAV-6418-2020; St. John Smith, Ewan/G-1776-2011; Lewin, Gary R/B-8028-2011	St. John Smith, Ewan/0000-0002-2699-1979; Omerbasic, Damir/0000-0003-1839-4856; Anirudhan, Gireesh/0000-0001-7093-0404; Lechner, Stefan/0000-0001-9402-9127; Lewin, Gary/0000-0002-2890-6352	Alexander von Humboldt foundation; MolNeuro Helmholtz Research School; Deutsche Forschungsgemeinschaft [665, Exc 257]	Alexander von Humboldt foundation(Alexander von Humboldt Foundation); MolNeuro Helmholtz Research School; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	E.St.J.S. carried out DRG electrophysiology. E.St.J.S. and D.O. carried out CHO cell electrophysiology. S. L. carried out skin-nerve electrophysiology. D.O., L. L., G. A., and E.St.J.S. carried out molecular biology. E.St.J.S. and G. R. L. designed experimental studies and wrote the paper. E.St.J.S. was supported by the Alexander von Humboldt foundation, and D.O. was supprted by the MolNeuro Helmholtz Research School. Additional funding was obtained from Deutsche Forschungsgemeinschaft collaborative research center 665 and Exc 257 (NeuroCure). We thank H. Thranhardt, A. Wegner, and K. Barda for technical support. Sequences have been submitted to GenBank (SOM).	Babini E, 2002, J BIOL CHEM, V277, P41597, DOI 10.1074/jbc.M205877200; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Cox JJ, 2010, HUM MUTAT, V31, pE1670, DOI 10.1002/humu.21325; Cummins TR, 2004, J NEUROSCI, V24, P8232, DOI 10.1523/JNEUROSCI.2695-04.2004; Dirajlal S, 2003, J NEUROPHYSIOL, V89, P513, DOI 10.1152/jn.00371.2002; Edrey YH, 2011, EXP GERONTOL, V46, P116, DOI 10.1016/j.exger.2010.09.005; Fertleman CR, 2006, NEURON, V52, P767, DOI 10.1016/j.neuron.2006.10.006; Gavva NR, 2005, MOL PHARMACOL, V68, P1524, DOI 10.1124/mol.105.015727; Jones NG, 2004, J NEUROSCI, V24, P10974, DOI 10.1523/JNEUROSCI.2619-04.2004; Khan A, 2006, J PHYSIOL-LONDON, V576, P493, DOI 10.1113/jphysiol.2006.115659; Khan A, 2002, J PHYSIOL-LONDON, V543, P71, DOI 10.1113/jphysiol.2002.021014; Lechner SG, 2009, EMBO J, V28, P1479, DOI 10.1038/emboj.2009.73; Leffler A, 2006, NEUROSCIENCE, V139, P699, DOI 10.1016/j.neuroscience.2005.12.020; Park TJ, 2008, PLOS BIOL, V6, P156, DOI 10.1371/journal.pbio.0060013; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Reeh PW, 1996, PROG BRAIN RES, V113, P143, DOI 10.1016/S0079-6123(08)61085-7; Rush AM, 2007, J PHYSIOL-LONDON, V579, P1, DOI 10.1113/jphysiol.2006.121483; Sharabi K, 2009, J CELL MOL MED, V13, P4304, DOI 10.1111/j.1582-4934.2009.00952.x; Smith ESJ, 2009, J COMP PHYSIOL A, V195, P1089, DOI 10.1007/s00359-009-0482-z; STEEN KH, 1992, J NEUROSCI, V12, P86; TRAUB RJ, 1988, J NEUROPHYSIOL, V59, P41, DOI 10.1152/jn.1988.59.1.41; Yang Y, 2004, J MED GENET, V41, P171, DOI 10.1136/jmg.2003.012153	22	84	85	0	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 16	2011	334	6062					1557	1560		10.1126/science.1213760	http://dx.doi.org/10.1126/science.1213760			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	862LE	22174253				2022-12-28	WOS:000298091400054
J	Livingston, G; Strydom, A				Livingston, Gill; Strydom, Andre			Improving Alzheimer's disease outcomes in Down's syndrome	LANCET			English	Editorial Material							CONTROLLED-TRIAL; DEMENTIA; ADULTS		[Livingston, Gill; Strydom, Andre] UCL, Unit Mental Hlth Sci, London W1W 7EJ, England	University of London; University College London	Livingston, G (corresponding author), UCL, Unit Mental Hlth Sci, London W1W 7EJ, England.	G.Livingston@ucl.ac.uk		Livingston, Gill/0000-0001-6741-5516; Strydom, Andre/0000-0002-2502-6704				Banerjee S, 2011, LANCET, V378, P403, DOI 10.1016/S0140-6736(11)60830-1; Costa ACS, 2011, DEV NEUROSCI-BASEL, V33, P414, DOI 10.1159/000330861; Courtenay K, 2010, J POLICY PRACT INTEL, V7, P26, DOI 10.1111/j.1741-1130.2010.00244.x; Das I, 2011, DIS MODEL MECH, V4, P596, DOI 10.1242/dmm.007716; de Graaf G, 2011, J INTELL DISABIL RES, V55, P462, DOI 10.1111/j.1365-2788.2011.01398.x; Hanney M, 2012, LANCET, V379, P528, DOI 10.1016/S0140-6736(11)61676-0; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Landt J, 2011, ARCH NEUROL-CHICAGO, V68, P890, DOI 10.1001/archneurol.2011.36; Lockrow J, 2011, BEHAV BRAIN RES, V221, P610, DOI 10.1016/j.bbr.2010.03.036; Lott IT, 2011, AM J MED GENET A, V155A, P1939, DOI 10.1002/ajmg.a.34114; Strydom A, 2010, J POLICY PRACT INTEL, V7, P96, DOI 10.1111/j.1741-1130.2010.00253.x; Wiseman FK, 2009, HUM MOL GENET, V18, pR75, DOI 10.1093/hmg/ddp010	12	4	4	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 11	2012	379	9815					498	500		10.1016/S0140-6736(11)61929-6	http://dx.doi.org/10.1016/S0140-6736(11)61929-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	891AO	22236803				2022-12-28	WOS:000300188800006
J	Romundstad, LB				Romundstad, Liv Bente			Number of embryos to transfer: better safe than sorry?	LANCET			English	Editorial Material							ELECTIVE SINGLE		NTNU, St Olavs Univ Hosp, Dept Publ Hlth & Gen Practice, Fertil Clin,Fac Med, NO-7491 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Romundstad, LB (corresponding author), NTNU, St Olavs Univ Hosp, Dept Publ Hlth & Gen Practice, Fertil Clin,Fac Med, NO-7491 Trondheim, Norway.	libero@ntnu.no						Bromer JG, 2011, CURR OPIN OBSTET GYN, V23, P168, DOI 10.1097/GCO.0b013e32834551cd; Connolly MP, 2010, HUM REPROD UPDATE, V16, P603, DOI 10.1093/humupd/dmq013; Karlstrom PO, 2007, HUM REPROD, V22, P2202, DOI 10.1093/humrep/dem120; Lawlor DA, 2012, LANCET, V379, P521, DOI 10.1016/S0140-6736(11)61267-1; McLernon DJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6945; Nelson SM, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000386; Ombelet W, 2005, REPROD BIOMED ONLINE, V11, P76, DOI 10.1016/S1472-6483(10)61302-8; Ombelet W, 2005, HUM REPROD UPDATE, V11, P3, DOI 10.1093/humupd/dmh048; Pandian Z., 2009, COCHRANE DB SYST REV, V2; Pinborg A, 2005, HUM REPROD UPDATE, V11, P575, DOI 10.1093/humupd/dmi027; Thurin A, 2004, NEW ENGL J MED, V351, P2392, DOI 10.1056/NEJMoa041032; Van Landuyt L, 2006, REPROD BIOMED ONLINE, V13, P765, DOI 10.1016/S1472-6483(10)61022-X; van Loendersloot LL, 2011, REPROD BIOMED ONLINE, V22, P597, DOI 10.1016/j.rbmo.2011.02.012	13	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 11	2012	379	9815					497	498		10.1016/S0140-6736(11)61478-5	http://dx.doi.org/10.1016/S0140-6736(11)61478-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	891AO	22243710				2022-12-28	WOS:000300188800005
J	Bonow, RO				Bonow, Robert O.			What's past is prologue: advances in cardiovascular imaging	LANCET			English	Editorial Material							CORONARY-DISEASE; PROGRESS		Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Bonow, RO (corresponding author), Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, Chicago, IL 60611 USA.	r-bonow@northwestern.edu						[Anonymous], PROSPECTIVE MULTICEN; [Anonymous], RANDOMIZED EVALUATIO; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Bonow RO, 2010, J NUCL CARDIOL, V17, P362, DOI 10.1007/s12350-010-9224-4; Douglas PS, 2009, JACC-CARDIOVASC IMAG, V2, P897, DOI 10.1016/j.jcmg.2009.01.018; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Greenwood JP, 2011, LANCET, DOI [10.1016/S0140-6736(11)61671-1, DOI 10.1016/S0140-6736(11)61671-1]; Hardoon SL, 2008, CIRCULATION, V117, P598, DOI 10.1161/CIRCULATIONAHA.107.705947; Iglehart JK, 2006, NEW ENGL J MED, V354, P2822, DOI 10.1056/NEJMhpr061219; Iglehart JK, 2009, NEW ENGL J MED, V360, P1030, DOI 10.1056/NEJMhpr0808703; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Schwitter J, 2008, EUR HEART J, V29, P480, DOI 10.1093/eurheartj/ehm617; Wood P, 1951, DIS HEART CIRCULATIO, P7	13	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 4	2012	379	9814					393	395		10.1016/S0140-6736(11)61671-1	http://dx.doi.org/10.1016/S0140-6736(11)61671-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	891AF	22196943				2022-12-28	WOS:000300187800013
J	Ng, SW; Bakowski, D; Nelson, C; Mehta, R; Almeyda, R; Bates, G; Parekh, AB				Ng, Siaw-Wei; Bakowski, Daniel; Nelson, Charmaine; Mehta, Ravi; Almeyda, Robert; Bates, Grant; Parekh, Anant B.			Cysteinyl leukotriene type I receptor desensitization sustains Ca2+-dependent gene expression	NATURE			English	Article							ACTIVATED CALCIUM CURRENT; BASOPHILIC LEUKEMIA-CELLS; TYROSINE KINASE SYK; DEPENDENT INACTIVATION; FEEDBACK INHIBITION; CA2+ CHANNELS; RBL-2H3 CELLS; C-FOS; CRAC; EXOCYTOSIS	Receptor desensitization is a universal mechanism to turn off a biological response; in this process, the ability of a physiological trigger to activate a cell is lost despite the continued presence of the stimulus. Receptor desensitization of G-protein-coupled receptors involves uncoupling of the receptor from its G-protein or second-messenger pathway followed by receptor internalization(1). G-protein-coupled cysteinyl leukotriene type I (CysLT1) receptors regulate immune-cell function and CysLT1 receptors are an established therapeutic target for allergies, including asthma(2). Desensitization of CysLT1 receptors arises predominantly from protein-kinase-C-dependent phosphorylation of three serine residues in the receptor carboxy terminus(3). Physiological concentrations of the receptor agonist leukotriene C-4 (LTC4) evoke repetitive cytoplasmic Ca2+ oscillations, reflecting regenerative Ca2+ release from stores, which is sustained by Ca2+ entry through store-operated calcium-release-activated calcium (CRAC) channels(4). CRAC channels are tightly linked to expression of the transcription factor c-fos(5), a regulator of numerous genes important to cell growth and development(6). Here we show that abolishing leukotriene receptor desensitization suppresses agonist-driven gene expression in a rat cell line. Mechanistically, stimulation of non-desensitizing receptors evoked prolonged inositol-trisphosphate-mediated Ca2+ release, which led to accelerated Ca2+-dependent slow inactivation of CRAC channels and a subsequent loss of excitation-transcription coupling. Hence, rather than serving to turn off a biological response, reversible desensitization of a Ca2+ mobilizing receptor acts as an 'on' switch, sustaining long-term signalling in the immune system.	[Ng, Siaw-Wei; Bakowski, Daniel; Nelson, Charmaine; Mehta, Ravi; Parekh, Anant B.] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England; [Almeyda, Robert; Bates, Grant] John Radcliffe Hosp, Dept Ear Nose Throat Surg, Oxford OX3 9DH, England	University of Oxford; University of Oxford	Parekh, AB (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Parks Rd, Oxford OX1 3PT, England.	anant.parekh@dpag.ox.ac.uk		Mehta, Ravi/0000-0001-8211-1721	Medical Research Council; BBSRC-Glaxo-Smith-Kline; Medical Research Council [G1000813] Funding Source: researchfish; MRC [G1000813] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC-Glaxo-Smith-Kline(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council grant support to A. B. P. S.-W. N. held a BBSRC-Glaxo-Smith-Kline studentship. We thank G. Miesenboeck and J. Putney for comments on the manuscript.	Bird GS, 2005, J PHYSIOL-LONDON, V562, P697, DOI 10.1113/jphysiol.2004.077289; Deshpande DA, 2007, FASEB J, V21, P2335, DOI 10.1096/fj.06-8060com; Di Capite J, 2009, J ALLERGY CLIN IMMUN, V124, P1014, DOI 10.1016/j.jaci.2009.08.030; Di Capite J, 2009, CURR BIOL, V19, P853, DOI 10.1016/j.cub.2009.03.063; Di Capite J, 2009, FASEB J, V23, P894, DOI 10.1096/fj.08-118935; Fierro L, 1999, J MEMBRANE BIOL, V168, P9, DOI 10.1007/s002329900493; Foletta VC, 1998, J LEUKOCYTE BIOL, V63, P139, DOI 10.1002/jlb.63.2.139; Funk CD, 2005, NAT REV DRUG DISCOV, V4, P664, DOI 10.1038/nrd1796; Glitsch MD, 2002, J PHYSIOL-LONDON, V539, P93, DOI 10.1113/jphysiol.2001.012826; Jousset H, 2007, J BIOL CHEM, V282, P11456, DOI 10.1074/jbc.M609551200; KASAI H, 1994, TRENDS NEUROSCI, V17, P95, DOI 10.1016/0166-2236(94)90112-0; Naik S, 2005, J BIOL CHEM, V280, P8722, DOI 10.1074/jbc.M413014200; Ng SW, 2008, J BIOL CHEM, V283, P31348, DOI 10.1074/jbc.M804942200; Ng SW, 2009, J BIOL CHEM, V284, P24767, DOI 10.1074/jbc.M109.011692; OZAWA K, 1993, J BIOL CHEM, V268, P2280; OZAWA K, 1993, J BIOL CHEM, V268, P1749; Parekh AB, 1998, J BIOL CHEM, V273, P14925, DOI 10.1074/jbc.273.24.14925; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; RAZIN E, 1994, P NATL ACAD SCI USA, V91, P7722, DOI 10.1073/pnas.91.16.7722; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Stephan V, 1997, CELL SIGNAL, V9, P65, DOI 10.1016/S0898-6568(96)00093-9; TAKASAKA T, 1986, ACTA OTO-LARYNGOL, P39; ZWEIFACH A, 1995, J GEN PHYSIOL, V105, P209, DOI 10.1085/jgp.105.2.209; ZWEIFACH A, 1995, J BIOL CHEM, V270, P14445, DOI 10.1074/jbc.270.24.14445	25	31	31	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 2	2012	482	7383					111	U144		10.1038/nature10731	http://dx.doi.org/10.1038/nature10731			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884RN	22230957	Green Accepted			2022-12-28	WOS:000299726000046
J	Welsh, WF; Orosz, JA; Carter, JA; Fabrycky, DC; Ford, EB; Lissauer, JJ; Prsa, A; Quinn, SN; Ragozzine, D; Short, DR; Torres, G; Winn, JN; Doyle, LR; Barclay, T; Batalha, N; Bloemen, S; Brugamyer, E; Buchhave, LA; Caldwell, C; Caldwell, DA; Christiansen, JL; Ciardi, DR; Cochran, WD; Endl, M; Fortney, JJ; Gautier, TN; Gilliland, RL; Haas, MR; Hall, JR; Holman, MJ; Howard, AW; Howell, SB; Isaacson, H; Jenkins, JM; Klaus, TC; Latham, DW; Li, J; Marcy, GW; Mazeh, T; Quintana, EV; Robertson, P; Shporer, A; Steffen, JH; Windmiller, G; Koch, DG; Borucki, WJ				Welsh, William F.; Orosz, Jerome A.; Carter, Joshua A.; Fabrycky, Daniel C.; Ford, Eric B.; Lissauer, Jack J.; Prsa, Andrej; Quinn, Samuel N.; Ragozzine, Darin; Short, Donald R.; Torres, Guillermo; Winn, Joshua N.; Doyle, Laurance R.; Barclay, Thomas; Batalha, Natalie; Bloemen, Steven; Brugamyer, Erik; Buchhave, Lars A.; Caldwell, Caroline; Caldwell, Douglas A.; Christiansen, Jessie L.; Ciardi, David R.; Cochran, William D.; Endl, Michael; Fortney, Jonathan J.; Gautier, Thomas N., III; Gilliland, Ronald L.; Haas, Michael R.; Hall, Jennifer R.; Holman, Matthew J.; Howard, Andrew W.; Howell, Steve B.; Isaacson, Howard; Jenkins, Jon M.; Klaus, Todd C.; Latham, David W.; Li, Jie; Marcy, Geoffrey W.; Mazeh, Tsevi; Quintana, Elisa V.; Robertson, Paul; Shporer, Avi; Steffen, Jason H.; Windmiller, Gur; Koch, David G.; Borucki, William J.			Transiting circumbinary planets Kepler-34 b and Kepler-35 b	NATURE			English	Article							HIERARCHICAL TRIPLE; ECLIPSING BINARIES; STELLAR; STABILITY; CATALOG	Most Sun-like stars in the Galaxy reside in gravitationally bound pairs of stars(1,2) (binaries). Although long anticipated(3-8), the existence of a 'circumbinary planet' orbiting such a pair of normal stars was not definitively established until the discovery(9) of the planet transiting (that is, passing in front of) Kepler-16. Questions remained, however, about the prevalence of circumbinary planets and their range of orbital and physical properties. Here we report two additional transiting circumbinary planets: Kepler-34 (AB)b and Kepler-35 (AB)b, referred to here as Kepler-34 b and Kepler-35 b, respectively. Each is a low-density gas-giant planet on an orbit closely aligned with that of its parent stars. Kepler-34 b orbits two Sun-like stars every 289 days, whereas Kepler-35 b orbits a pair of smaller stars (89% and 81% of the Sun's mass) every 131 days. The planets experience large multi-periodic variations in incident stellar radiation arising from the orbital motion of the stars. The observed rate of circumbinary planets in our sample implies that more than similar to 1% of close binary stars have giant planets in nearly coplanar orbits, yielding a Galactic population of at least several million.	[Welsh, William F.; Orosz, Jerome A.; Short, Donald R.; Windmiller, Gur] San Diego State Univ, Dept Astron, San Diego, CA 92182 USA; [Fabrycky, Daniel C.] Univ Calif Santa Cruz, Lick Observ, UCO, Santa Cruz, CA 95064 USA; [Ford, Eric B.] Univ Florida, Bryant Space Sci Ctr 211, Gainesville, FL 32611 USA; [Lissauer, Jack J.; Barclay, Thomas; Batalha, Natalie; Christiansen, Jessie L.; Haas, Michael R.; Howell, Steve B.; Jenkins, Jon M.; Li, Jie; Quintana, Elisa V.; Koch, David G.; Borucki, William J.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Carter, Joshua A.; Quinn, Samuel N.; Ragozzine, Darin; Torres, Guillermo; Holman, Matthew J.; Latham, David W.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Prsa, Andrej] Villanova Univ, Dept Astron & Astrophys, Villanova, PA 19085 USA; [Quinn, Samuel N.] Georgia State Univ, Dept Phys & Astron, Atlanta, GA 30302 USA; [Winn, Joshua N.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Winn, Joshua N.] MIT, Kavli Inst Astrophys & Space Res, Cambridge, MA 02139 USA; [Doyle, Laurance R.; Caldwell, Douglas A.; Christiansen, Jessie L.; Jenkins, Jon M.; Li, Jie; Quintana, Elisa V.] SETI Inst, Carl Sagan Ctr Study Life Universe, Mountain View, CA 94043 USA; [Barclay, Thomas] Bay Area Environm Res Inst Inc, Sonoma, CA 95476 USA; [Batalha, Natalie] San Jose State Univ, Dept Phys & Astron, San Jose, CA 95192 USA; [Bloemen, Steven] Katholieke Univ Leuven, Inst Sterrenkunde, B-3001 Louvain, Belgium; [Buchhave, Lars A.] Univ Copenhagen, Ctr Star & Planet Format, Nat Hist Museum Denmark, DK-1350 Copenhagen, Denmark; [Brugamyer, Erik; Cochran, William D.; Endl, Michael] Univ Texas Austin, McDonald Observ, Austin, TX 78712 USA; [Buchhave, Lars A.] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Ciardi, David R.] CALTECH, NASA Exoplanet Sci Inst, Pasadena, CA 91125 USA; [Fortney, Jonathan J.] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Gautier, Thomas N., III] Jet Prop Lab, Pasadena, CA 91109 USA; [Gilliland, Ronald L.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Klaus, Todd C.] NASA, Orbital Sci Corp, Ames Res Ctr, Moffett Field, CA 94035 USA; [Marcy, Geoffrey W.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Mazeh, Tsevi] Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel; [Shporer, Avi] Las Cumbres Observ, Global Telescope Network, Santa Barbara, CA 93117 USA; [Shporer, Avi] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Steffen, Jason H.] Fermilab Ctr Particle Astrophys, Batavia, IL 60510 USA	California State University System; San Diego State University; University of California System; University of California Santa Cruz; State University System of Florida; University of Florida; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Villanova University; University System of Georgia; Georgia State University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); California State University System; San Jose State University; KU Leuven; University of Copenhagen; University of Texas System; University of Texas Austin; University of Copenhagen; Niels Bohr Institute; California Institute of Technology; National Aeronautics & Space Administration (NASA); University of California System; University of California Santa Cruz; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Space Telescope Science Institute; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of California System; University of California Berkeley; Tel Aviv University; University of California System; University of California Santa Barbara	Welsh, WF (corresponding author), San Diego State Univ, Dept Astron, 5500 Campanile Dr, San Diego, CA 92182 USA.	wfw@sciences.sdsu.edu; jacarter@cfa.harvard.edu	Welsh, William/AAS-3445-2021; Carter, Joshua A/A-8280-2013; Shporer, Avi/Y-2777-2019; Ragozzine, Darin/C-4926-2013; Cochran, William D/M-4421-2014; Marcy, Geoff/AAC-6050-2019; Robertson, Paul/AEV-0522-2022; Caldwell, Douglas A/L-7911-2014; Ford, Eric B./AAB-5479-2019; Buchhave, Lars A./ABF-2000-2020; Steffen, Jason H./A-4320-2013; Howard, Andrew/D-4148-2015; Fortney, Jonathan/F-8813-2014	Shporer, Avi/0000-0002-1836-3120; Cochran, William D/0000-0001-9662-3496; Robertson, Paul/0000-0003-0149-9678; Caldwell, Douglas A/0000-0003-1963-9616; Ford, Eric B./0000-0001-6545-639X; Buchhave, Lars A./0000-0003-1605-5666; Howard, Andrew/0000-0001-8638-0320; Christiansen, Jessie/0000-0002-8035-4778; Fabrycky, Daniel/0000-0003-3750-0183; Fortney, Jonathan/0000-0002-9843-4354; Batalha, Natalie/0000-0002-7030-9519; Ciardi, David/0000-0002-5741-3047; Steffen, Jason/0000-0003-2202-3847; Barclay, Thomas/0000-0001-7139-2724	NASA's Science Mission Directorate; Kepler Participating Scientist Program; NSF; NASA; STScI; European Research Council under the European Community; Research Council of KU Leuven; FAS Science Division Research Computing Group at Harvard University; Direct For Mathematical & Physical Scien [1109928] Funding Source: National Science Foundation	NASA's Science Mission Directorate; Kepler Participating Scientist Program; NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); STScI(Space Telescope Science Institute); European Research Council under the European Community(European Research Council (ERC)); Research Council of KU Leuven(KU Leuven); FAS Science Division Research Computing Group at Harvard University; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Kepler was selected as the tenth NASA Discovery mission with funding provided by NASA's Science Mission Directorate. We thank the many people who made the Kepler mission a reality. W. F. W., J.A.O., E. B. F., A. P., L. R. D., J.J.F., M.J.H., T. M. and J.H.S. were supported by the Kepler Participating Scientist Program. W. F. W., J.A.O., D. R. S. and G. W. were supported by the NSF. D. C. F. and J.A.C. acknowledge NASA support through Hubble Fellowship grants, awarded by STScI, operated by AURA. J.N.W. was supported by the NASA Origins programme. S. B. acknowledges funding from the European Research Council under the European Community's Seventh Framework Programme (PROSPERITY) and from the Research Council of KU Leuven. Some of the reported computations were run on the Odyssey cluster supported by the FAS Science Division Research Computing Group at Harvard University. This Letter is based in part on observations made with the Nordic Optical Telescope (operated on the island of La Palma jointly by Denmark, Finland, Iceland, Norway and Sweden, in the Spanish Observatorio del Roque de los Muchachos of the Instituto de Astrofisica de Canarias), the W. M. Keck Observatory (operated by the University of California and the California Institute of Technology) and the Hobby-Eberly Telescope (HET; a joint project of the University of Texas at Austin, the Pennsylvania State University, Stanford University, Ludwig-Maximillians-Universitat Munchen, and Georg-August-Universitat Goettingen).	Binnendijk L, 1960, PROPERTIES DOUBLE ST; Borucki WJ, 2010, SCIENCE, V327, P977, DOI 10.1126/science.1185402; Brown TM, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/4/112; Carter JA, 2011, SCIENCE, V331, P562, DOI 10.1126/science.1201274; Chabrier G, 2003, PUBL ASTRON SOC PAC, V115, P763, DOI 10.1086/376392; Deeg HJ, 2008, ASTRON ASTROPHYS, V480, P563, DOI 10.1051/0004-6361:20079000; Doolin S., 2011, NOT R ASTRO IN PRESS; EGGLETON P, 1995, ASTROPHYS J, V455, P640, DOI 10.1086/176611; Haghighipour N, 2010, ASTROPHYS SPACE SC L, V366, P285, DOI 10.1007/978-90-481-8687-7_11; Holman MJ, 1999, ASTRON J, V117, P621, DOI 10.1086/300695; Koch DG, 2010, ASTROPHYS J LETT, V713, pL79, DOI 10.1088/2041-8205/713/2/L79; Prsa A, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/3/83; Quintana EV, 2006, ICARUS, V185, P1, DOI 10.1016/j.icarus.2006.06.016; Raghavan D, 2010, ASTROPHYS J SUPPL S, V190, P1, DOI 10.1088/0067-0049/190/1/1; Ragozzine D., 2010, ASTROPHYS J UNPUB; SCHNEIDER J, 1990, ASTRON ASTROPHYS, V232, P251; Schwarz R, 2011, MON NOT R ASTRON SOC, V414, P2763, DOI 10.1111/j.1365-2966.2011.18594.x; Slawson RW, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/5/160; Sybilski P, 2010, MON NOT R ASTRON SOC, V405, P657, DOI 10.1111/j.1365-2966.2010.16490.x; Yi S, 2001, ASTROPHYS J SUPPL S, V136, P417, DOI 10.1086/321795	22	319	323	2	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2012	481	7382					475	U85		10.1038/nature10768	http://dx.doi.org/10.1038/nature10768			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881GY	22237021	Green Accepted, Green Submitted			2022-12-28	WOS:000299471800033
J	Heravi-Moussavi, A; Anglesio, MS; Cheng, SWG; Senz, J; Yang, W; Prentice, L; Fejes, AP; Chow, C; Tone, A; Kalloger, SE; Hamel, N; Roth, A; Ha, G; Wan, ANC; Maines-Bandiera, S; Salamanca, C; Pasini, B; Clarke, BA; Lee, AF; Lee, CH; Zhao, CQ; Young, RH; Aparicio, SA; Sorensen, PHB; Woo, MMM; Boyd, N; Jones, SJM; Hirst, M; Marra, MA; Gilks, B; Shah, SP; Foulkes, WD; Morin, GB; Huntsman, DG				Heravi-Moussavi, Alireza; Anglesio, Michael S.; Cheng, S. -W. Grace; Senz, Janine; Yang, Winnie; Prentice, Leah; Fejes, Anthony P.; Chow, Christine; Tone, Alicia; Kalloger, Steve E.; Hamel, Nancy; Roth, Andrew; Ha, Gavin; Wan, Adrian N. C.; Maines-Bandiera, Sarah; Salamanca, Clara; Pasini, Barbara; Clarke, Blaise A.; Lee, Anna F.; Lee, Cheng-Han; Zhao, Chengquan; Young, Robert H.; Aparicio, Samuel A.; Sorensen, Poul H. B.; Woo, Michelle M. M.; Boyd, Niki; Jones, Steven J. M.; Hirst, Martin; Marra, Marco A.; Gilks, Blake; Shah, Sohrab P.; Foulkes, William D.; Morin, Gregg B.; Huntsman, David G.			Recurrent Somatic DICER1 Mutations in Nonepithelial Ovarian Cancers	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GRANULOSA-CELL TUMORS; EXPRESSION; MICRORNAS; PROGNOSIS; SELECTION; DROSHA; FOXL2	BACKGROUND Germline truncating mutations in DICER1, an endoribonuclease in the RNase III family that is essential for processing microRNAs, have been observed in families with the pleuropulmonary blastoma-family tumor and dysplasia syndrome. Mutation carriers are at risk for nonepithelial ovarian tumors, notably sex cord-stromal tumors. METHODS We sequenced the whole transcriptomes or exomes of 14 nonepithelial ovarian tumors and noted closely clustered mutations in the region of DICER1 encoding the RNase IIIb domain of DICER1 in four samples. We then sequenced this region of DICER1 in additional ovarian tumors and in certain other tumors and queried the effect of the mutations on the enzymatic activity of DICER1 using in vitro RNA cleavage assays. RESULTS DICER1 mutations in the RNase IIIb domain were found in 30 of 102 nonepithelial ovarian tumors (29%), predominantly in Sertoli-Leydig cell tumors (26 of 43, or 60%), including 4 tumors with additional germline DICER1 mutations. These mutations were restricted to codons encoding metal-binding sites within the RNase IIIb catalytic centers, which are critical for microRNA interaction and cleavage, and were somatic in all 16 samples in which germline DNA was available for testing. We also detected mutations in 1 of 14 nonseminomatous testicular germ-cell tumors, in 2 of 5 embryonal rhabdomyosarcomas, and in 1 of 266 epithelial ovarian and endometrial carcinomas. The mutant DICER1 proteins had reduced RNase IIIb activity but retained RNase IIIa activity. CONCLUSIONS Somatic missense mutations affecting the RNase IIIb domain of DICER1 are common in nonepithelial ovarian tumors. These mutations do not obliterate DICER1 function but alter it in specific cell types, a novel mechanism through which perturbation of microRNA processing may be oncogenic. (Funded by the Terry Fox Research Institute and others.)	[Huntsman, David G.] Univ British Columbia, British Columbia Canc Agcy, Ovarian Canc Res Program, Vancouver, BC V5Z 4E6, Canada; [Heravi-Moussavi, Alireza; Cheng, S. -W. Grace; Roth, Andrew; Ha, Gavin; Wan, Adrian N. C.; Maines-Bandiera, Sarah; Salamanca, Clara; Aparicio, Samuel A.; Sorensen, Poul H. B.; Jones, Steven J. M.; Marra, Marco A.; Shah, Sohrab P.; Morin, Gregg B.; Huntsman, David G.] Univ British Columbia, British Columbia Canc Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Chow, Christine; Kalloger, Steve E.; Gilks, Blake; Huntsman, David G.] Univ British Columbia, Vancouver Gen Hosp, Genet Pathol Evaluat Ctr, Dept Pathol, Vancouver, BC V5Z 1M9, Canada; [Huntsman, David G.] Univ British Columbia, Ctr Translat & Appl Genom, British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; [Jones, Steven J. M.; Marra, Marco A.; Morin, Gregg B.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Anglesio, Michael S.; Lee, Anna F.; Lee, Cheng-Han; Aparicio, Samuel A.; Sorensen, Poul H. B.; Gilks, Blake; Shah, Sohrab P.; Huntsman, David G.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Hamel, Nancy; Foulkes, William D.] McGill Univ, Dept Oncol, Program Canc Genet, Montreal, PQ, Canada; [Hamel, Nancy; Foulkes, William D.] McGill Univ, Dept Human Genet, Program Canc Genet, Montreal, PQ, Canada; [Cheng, S. -W. Grace; Fejes, Anthony P.; Jones, Steven J. M.; Hirst, Martin; Marra, Marco A.; Morin, Gregg B.] Univ British Columbia, British Columbia Canc Agcy, Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; [Hamel, Nancy; Foulkes, William D.] McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ, Canada; [Foulkes, William D.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Segal Canc Ctr, Montreal, PQ H3T 1E2, Canada; [Pasini, Barbara] Univ Turin, Dept Genet, Turin, Italy; [Pasini, Barbara] Univ Turin, Dept Biol, Turin, Italy; [Pasini, Barbara] Univ Turin, Dept Biochem, Turin, Italy; [Clarke, Blaise A.] Univ Toronto, Fac Med, Dept Lab Med, Toronto, ON, Canada; [Clarke, Blaise A.] Univ Toronto, Dept Pathobiol, Fac Med, Toronto, ON, Canada; [Zhao, Chengquan] Univ Pittsburgh, Magee Womens Hosp, Dept Pathol, Med Ctr, Pittsburgh, PA 15213 USA; [Young, Robert H.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Young, Robert H.] Harvard Univ, Sch Med, Boston, MA USA	British Columbia Cancer Agency; University of British Columbia; British Columbia Cancer Agency; University of British Columbia; University of British Columbia; British Columbia Cancer Agency; University of British Columbia; University of British Columbia; University of British Columbia; McGill University; McGill University; British Columbia Cancer Agency; University of British Columbia; McGill University; Lady Davis Institute; McGill University; University of Turin; University of Turin; University of Turin; University of Toronto; University of Toronto; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Huntsman, DG (corresponding author), Univ British Columbia, British Columbia Canc Agcy, Ovarian Canc Res Program, Rm 3427,600 W 10th Ave, Vancouver, BC V5Z 4E6, Canada.	gmorin@bcgsc.ca; dhuntsma@bccancer.bc.ca	Marra, Marco A/B-5987-2008; Ha, Gavin/N-1984-2019; Jones, Steven J/C-3621-2009; Huntsman, David/ABE-6082-2020; Hamel, Nancy/L-5122-2016; Hirst, Martin/B-7684-2016; Pasini, Barbara/AHI-2004-2022; Morin, Gregg B/E-9123-2012; Foulkes, William D./AAR-9586-2021	Marra, Marco A/0000-0001-7146-7175; Ha, Gavin/0000-0001-7578-7272; Jones, Steven J/0000-0003-3394-2208; Hamel, Nancy/0000-0001-8971-0428; Pasini, Barbara/0000-0002-4373-1212; Morin, Gregg B/0000-0001-8949-4374; Foulkes, William D./0000-0001-7427-4651; Aparicio, Samuel/0000-0002-0487-9599; Clarke, Blaise/0000-0002-2585-8391; Lee, Anna/0000-0002-6703-0656; Anglesio, Michael/0000-0003-1639-5003	Terry Fox Research Institute; British Columbia Cancer Foundation; Vancouver General Hospital-University of British Columbia Hospital Foundation; Canadian Institutes of Health Research; Genome Canada; Michael Smith Foundation for Health Research; Marsha Rivkin Centre for Ovarian Cancer Research; Susan G. Komen for the Cure; Weekend to End Women's Cancer; Ovarian Cancer Research Program of British Columbia (OvCaRe), Ovarian Cancer Canada; National Cancer Institute through the Cooperative Human Tissue Network; Gynecologic Oncology Group	Terry Fox Research Institute; British Columbia Cancer Foundation; Vancouver General Hospital-University of British Columbia Hospital Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Marsha Rivkin Centre for Ovarian Cancer Research; Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Weekend to End Women's Cancer; Ovarian Cancer Research Program of British Columbia (OvCaRe), Ovarian Cancer Canada; National Cancer Institute through the Cooperative Human Tissue Network; Gynecologic Oncology Group	Supported by grants from the Terry Fox Research Institute, the British Columbia Cancer Foundation, the Vancouver General Hospital-University of British Columbia Hospital Foundation, the Canadian Institutes of Health Research, Genome Canada, the Michael Smith Foundation for Health Research, the Marsha Rivkin Centre for Ovarian Cancer Research, Susan G. Komen for the Cure, and the Weekend to End Women's Cancer. The contributing tumor banks were supported by the Ovarian Cancer Research Program of British Columbia (OvCaRe), Ovarian Cancer Canada, and the National Cancer Institute through the Cooperative Human Tissue Network and the Gynecologic Oncology Group.	Al-Agha OM, 2011, AM J SURG PATHOL, V35, P484, DOI 10.1097/PAS.0b013e31820a406c; Bahubeshi A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002493; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Colombo N, 2009, ANN ONCOL, V20, P24, DOI 10.1093/annonc/mdp118; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Foulkes WD, 2011, HUM MUTAT, V32, P1381, DOI 10.1002/humu.21600; Frio TR, 2011, JAMA-J AM MED ASSOC, V305, P68, DOI 10.1001/jama.2010.1910; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Goya R, 2010, BIOINFORMATICS, V26, P730, DOI 10.1093/bioinformatics/btq040; Grelier G, 2009, BRIT J CANCER, V101, P673, DOI 10.1038/sj.bjc.6605193; Guo L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011387; Hock J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-210; HORWICH A, 1991, J CLIN ONCOL, V9, P62, DOI 10.1200/JCO.1991.9.1.62; Iida A, 2011, INVEST OPHTH VIS SCI, V52, P3008, DOI 10.1167/iovs.10-6428; Jamieson S, 2010, MODERN PATHOL, V23, P1477, DOI 10.1038/modpathol.2010.145; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Kato M, 2008, BIOL CELL, V100, P71, DOI 10.1042/BC20070078; Kim GJ, 2010, INT J DEV BIOL, V54, P867, DOI 10.1387/ijdb.092874gk; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Lambertz I, 2010, CELL DEATH DIFFER, V17, P633, DOI 10.1038/cdd.2009.202; Megosh HB, 2006, CURR BIOL, V16, P1884, DOI 10.1016/j.cub.2006.08.051; Merritt WM, 2010, NEW ENGL J MED, V363, P1877; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Mudhasani R, 2011, J CELL PHYSIOL, V226, P1399, DOI 10.1002/jcp.22475; Nagalakshmi VK, 2011, KIDNEY INT, V79, P317, DOI 10.1038/ki.2010.385; Noland CL, 2011, MOL CELL, V43, P110, DOI 10.1016/j.molcel.2011.05.028; Papaioannou MD, 2009, DEV BIOL, V326, P250, DOI 10.1016/j.ydbio.2008.11.011; Sand M, 2010, CANCER INVEST, V28, P649, DOI 10.3109/07357901003630918; Schultz KAP, 2011, GYNECOL ONCOL, V122, P246, DOI 10.1016/j.ygyno.2011.03.024; Sekine S, 2009, GASTROENTEROLOGY, V136, P2304, DOI 10.1053/j.gastro.2009.02.067; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Slade I, 2011, J MED GENET, V48, P273, DOI 10.1136/jmg.2010.083790; Takeshita D, 2007, J MOL BIOL, V374, P106, DOI 10.1016/j.jmb.2007.08.069; Ulbright TM, 1999, UROL CLIN N AM, V26, P611, DOI 10.1016/S0094-0143(05)70202-0; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017	40	294	310	1	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 19	2012	366	3					234	242		10.1056/NEJMoa1102903	http://dx.doi.org/10.1056/NEJMoa1102903			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877RZ	22187960	Bronze			2022-12-28	WOS:000299201400009
J	Andreu-Agullo, C; Maurin, T; Thompson, CB; Lai, EC				Andreu-Agullo, Celia; Maurin, Thomas; Thompson, Craig B.; Lai, Eric C.			Ars2 maintains neural stem-cell identity through direct transcriptional activation of Sox2	NATURE			English	Article							CAP-BINDING COMPLEX; SELF-RENEWAL; RNA INTERFERENCE; ANALYSIS REVEALS; TRANSGENIC MICE; EXPRESSION; SERRATE; BRAIN; PROLIFERATION; ARABIDOPSIS	Fundamental questions remain unanswered about the transcriptional networks that control the identity and self-renewal of neural stem cells (NSCs), a specialized subset of astroglial cells that are endowed with stem properties and neurogenic capacity. Here we report that the zinc finger protein Ars2 (arsenite-resistance protein 2; also known as Srrt) is expressed by adult NSCs from the subventricular zone (SVZ) of mice, and that selective knockdown of Ars2 in cells expressing glial fibrillary acidic protein within the adult SVZ depletes the number of NSCs and their neurogenic capacity. These phenotypes are recapitulated in the postnatal SVZ of hGFAP-cre:: Ars2(fl/fl) conditional knockout mice, but are more severe. Ex vivo assays show that Ars2 is necessary and sufficient to promote NSC self-renewal, and that it does so by positively regulating the expression of Sox2. Although plant(1-3) and animal(4,5) orthologues of Ars2 are known for their conserved roles in microRNA biogenesis, we unexpectedly observed that Ars2 retains its capacity to promote self-renewal in Drosha and Dicer1 knockout NSCs. Instead, chromatin immunoprecipitation revealed that Ars2 binds a specific region within the 6-kilobase NSC enhancer of Sox2. This association is RNA-independent, and the region that is bound is required for Ars2-mediated activation of Sox2. We used gel-shift analysis to refine the Sox2 region bound by Ars2 to a specific conserved DNA sequence. The importance of Sox2 as a critical downstream effector is shown by its ability to restore the self-renewal and multipotency defects of Ars2 knockout NSCs. Our findings reveal Ars2 as a new transcription factor that controls the multipotent progenitor state of NSCs through direct activation of the pluripotency factor Sox2.	[Andreu-Agullo, Celia; Maurin, Thomas; Lai, Eric C.] Sloan Kettering Inst, Dept Dev Biol, New York, NY 10065 USA; [Thompson, Craig B.] Sloan Kettering Inst, Dept Canc Biol & Genet, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Andreu-Agullo, C (corresponding author), Sloan Kettering Inst, Dept Dev Biol, 1275 York Ave,Box 252, New York, NY 10065 USA.	andreuac@mskcc.org; laie@mskcc.org	Lai, Eric/AAO-1143-2021; maurin, thomas O/O-7494-2016; Lai, Eric C/A-3412-2008	Lai, Eric/0000-0002-8432-5851; maurin, thomas O/0000-0002-8467-3135; 	Burroughs Wellcome Fund; Starr Cancer Consortium [I3-A139]; NIH [R01-GM083300]; EMBO [ALTF 718-2008]; NYSTEM Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083300] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Starr Cancer Consortium; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO(European Molecular Biology Organization (EMBO)); NYSTEM Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank X. Lu, M. Gotz, A. Rizzino, P. M. LLedo, P. Charneau, M. Segura, P. L. Howard and S. Olejniczak for reagents. We are grateful to K. Hadjantonakis, A. Ferrer-Vaquer, J. Zhang and Y. Ganat for assistance. U. Ruthishauser, V. Tabar and the Molecular Cytology Core Facility at the Memorial Sloan-Kettering Cancer Center shared equipment. S. R. Ferron, H. Mira, A. Joyner, H. Duan, Q. Dai, I. Farinas and S. Shi provided critical comments. Work in E. C. L.'s group was supported by the Burroughs Wellcome Fund, the Starr Cancer Consortium (I3-A139) and the NIH (R01-GM083300). C. A.-A. was funded by a EMBO Long-Term Fellowship (ALTF 718-2008) and a NYSTEM Fellowship.	Alonso M, 2008, J NEUROSCI, V28, P11089, DOI 10.1523/JNEUROSCI.3713-08.2008; Andreu-Agullo C, 2009, NAT NEUROSCI, V12, P1514, DOI 10.1038/nn.2437; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Beckervordersandforth R, 2010, CELL STEM CELL, V7, P744, DOI 10.1016/j.stem.2010.11.017; Boutin C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001883; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Ferron SR, 2007, NAT PROTOC, V2, P849, DOI 10.1038/nprot.2007.104; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gruber JJ, 2009, CELL, V138, P328, DOI 10.1016/j.cell.2009.04.046; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Laubinger S, 2008, P NATL ACAD SCI USA, V105, P8795, DOI 10.1073/pnas.0802493105; Lledo PM, 2008, TRENDS NEUROSCI, V31, P392, DOI 10.1016/j.tins.2008.05.006; Lobbes D, 2006, EMBO REP, V7, P1052, DOI 10.1038/sj.embor.7400806; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Ohtsuka T, 2006, MOL CELL NEUROSCI, V31, P109, DOI 10.1016/j.mcn.2005.09.006; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Potten CS, 1998, PHILOS T R SOC B, V353, P821, DOI 10.1098/rstb.1998.0246; Raponi E, 2007, GLIA, V55, P165, DOI 10.1002/glia.20445; Sabin LR, 2009, CELL, V138, P340, DOI 10.1016/j.cell.2009.04.045; Shi YH, 2008, CRIT REV ONCOL HEMAT, V65, P43, DOI 10.1016/j.critrevonc.2007.06.004; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Whitman MC, 2007, J NEUROSCI, V27, P9951, DOI 10.1523/JNEUROSCI.1633-07.2007; Wilson MD, 2008, MOL CELL BIOL, V28, P1503, DOI 10.1128/MCB.01565-07; Yang L, 2006, PLANT J, V47, P841, DOI 10.1111/j.1365-313X.2006.02835.x; Zencak D, 2005, J NEUROSCI, V25, P5774, DOI 10.1523/JNEUROSCI.3452-04.2005; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	33	60	64	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 12	2012	481	7380					195	+		10.1038/nature10712	http://dx.doi.org/10.1038/nature10712			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	874TO	22198669	Green Accepted			2022-12-28	WOS:000298981200038
J	Cordier, P; Amodeo, J; Carrez, P				Cordier, Patrick; Amodeo, Jonathan; Carrez, Philippe			Modelling the rheology of MgO under Earth's mantle pressure, temperature and strain rates	NATURE			English	Article							INITIO MOLECULAR-DYNAMICS; PEIERLS-NABARRO; SHEAR-STRESS; DISLOCATION; CORE; SIMULATION; CRYSTALS; METALS; ENERGY; DEFORMATION	Plate tectonics, which shapes the surface of Earth, is the result of solid-state convection in Earth's mantle over billions of years. Simply driven by buoyancy forces, mantle convection is complicated by the nature of the convecting materials, which are not fluids but polycrystalline rocks. Crystalline materials can flow as the result of the motion of defects-point defects, dislocations, grain boundaries and so on. Reproducing in the laboratory the extreme deformation conditions of the mantle is extremely challenging. In particular, experimental strain rates are at least six orders of magnitude larger than in nature(1). Here we show that the rheology of MgO at the pressure, temperature and strain rates of the mantle is accessible by multiscale numerical modelling starting from first principles and with no adjustable parameters. Our results demonstrate that extremely low strain rates counteract the influence of pressure. In the mantle, MgO deforms in the athermal regime and this leads to a very weak phase. It is only in the lowermost lower mantle that the pressure effect could dominate and that, under the influence of lattice friction, a viscosity of the order of 10(21)-10(22) pascal seconds can be defined for MgO.	[Cordier, Patrick; Amodeo, Jonathan; Carrez, Philippe] Univ Lille 1, Unite Mat & Transformat, CNRS, UMR 8207, F-59650 Villeneuve Dascq, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Lille - ISITE; Universite de Lille	Cordier, P (corresponding author), Univ Lille 1, Unite Mat & Transformat, CNRS, UMR 8207, F-59650 Villeneuve Dascq, France.	Patrick.Cordier@univ-lille1.fr	Amodeo, Jonathan/I-2934-2012; Cordier, Patrick/D-2357-2012	Cordier, Patrick/0000-0002-1883-2994; Amodeo, Jonathan/0000-0003-0383-891X; Carrez, Philippe/0000-0003-1295-9377	ANR	ANR(French National Research Agency (ANR))	This work was supported by ANR (Diup project).	Ammann MW, 2010, NATURE, V465, P462, DOI 10.1038/nature09052; Amodeo J, 2011, ACTA MATER, V59, P2291, DOI 10.1016/j.actamat.2010.12.020; Amodeo J., PHIL MAG IN PRESS; ANDERSON OL, 1982, PHILOS T R SOC A, V306, P21, DOI 10.1098/rsta.1982.0063; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; BROWN JM, 1981, GEOPHYS J ROY ASTR S, V66, P579, DOI 10.1111/j.1365-246X.1981.tb04891.x; Bulatov VV, 1997, PHYS REV LETT, V78, P4221, DOI 10.1103/PhysRevLett.78.4221; Bulatov VV, 1998, CURR OPIN SOLID ST M, V3, P558, DOI 10.1016/S1359-0286(98)80025-9; Cai W, 2004, DISLOCAT S, V12, P1; Caillard D., 2003, THERMALLY ACTIVATED; de la Rubia TD, 2001, MRS BULL, V26, P169, DOI 10.1557/mrs2001.38; Denoual C, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.024106; Denoual C, 2007, COMPUT METHOD APPL M, V196, P1915, DOI 10.1016/j.cma.2006.10.007; Devincre B, 2001, MAT SCI ENG A-STRUCT, V309, P211, DOI 10.1016/S0921-5093(00)01725-1; Forte AM, 2001, NATURE, V410, P1049, DOI 10.1038/35074000; Frost H.J., 1982, DEFORMATION MECH MAP; GUYOT P, 1967, CAN J PHYS, V45, P983, DOI 10.1139/p67-073; HEARD HC, 1963, J GEOL, V71, P162, DOI 10.1086/626892; Hirth J. P., 1972, THEORY DISLOCATIONS; JOOS B, 1994, PHYS REV B, V50, P5890, DOI 10.1103/PhysRevB.50.5890; Karato SI, 2008, DEFORMATION OF EARTH MATERIALS: AN INTRODUCTION TO THE RHEOLOGY OF SOLID EARTH, P1, DOI 10.1017/CBO9780511804892; KOIZUMI H, 1993, ACTA METALL MATER, V41, P3483, DOI 10.1016/0956-7151(93)90228-K; KRESSE G, 1994, PHYS REV B, V49, P14251, DOI 10.1103/PhysRevB.49.14251; KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Kubin LP, 2003, MATER RES SOC SYMP P, V779, P25; Madec R, 2004, SOLID MECH APPL, V115, P35; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.16.1746; Monnet G, 2004, ACTA MATER, V52, P4317, DOI 10.1016/j.actamat.2004.05.048; Nabarro FRN, 2003, PHILOS MAG, V83, P3047, DOI 10.1080/0141861031000109591; Needleman A, 2000, ACTA MATER, V48, P105, DOI 10.1016/S1359-6454(99)00290-6; Ono S, 2008, PHYS EARTH PLANET IN, V170, P267, DOI 10.1016/j.pepi.2008.06.033; PATERSON MS, 1987, TECTONOPHYSICS, V133, P33, DOI 10.1016/0040-1951(87)90278-2; Paterson MS, 2001, INT J EARTH SCI, V90, P157, DOI 10.1007/s005310000158; Peierls R, 1940, P PHYS SOC, V52, P34, DOI 10.1088/0959-5309/52/1/305; PERDEW JP, 1992, PHYS REV B, V45, P13244, DOI 10.1103/PhysRevB.45.13244; Poirier J., 1985, CREEP CRYSTALS; Raterron P, 2009, J SYNCHROTRON RADIAT, V16, P748, DOI 10.1107/S0909049509034426; SCHOECK G, 1965, PHYS STATUS SOLIDI, V8, P499, DOI 10.1002/pssb.19650080209; Schoeck G, 2006, ACTA MATER, V54, P4865, DOI 10.1016/j.actamat.2006.06.023; Schuberth BSA, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002235; SEEGER A, 1962, ACTA METALL MATER, V10, P348, DOI 10.1016/0001-6160(62)90013-5; Tang M, 1998, ACTA MATER, V46, P3221, DOI 10.1016/S1359-6454(98)00006-8; VITEK V, 1968, PHILOS MAG, V18, P773, DOI 10.1080/14786436808227500	44	83	83	0	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 12	2012	481	7380					177	+		10.1038/nature10687	http://dx.doi.org/10.1038/nature10687			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	874TO	22237109				2022-12-28	WOS:000298981200034
J	Tilg, H				Tilg, Herbert			Diet and Intestinal Immunity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ARYL-HYDROCARBON RECEPTOR		[Tilg, Herbert] Med Univ Innsbruck, Christian Doppler Res Lab Gut Inflammat, Innsbruck, Austria; [Tilg, Herbert] Acad Teaching Hosp, Hall In Tirol, Austria	Medical University of Innsbruck	Tilg, H (corresponding author), Med Univ Innsbruck, Christian Doppler Res Lab Gut Inflammat, Innsbruck, Austria.		Hug, Balthasar L./G-1568-2010					Hou JK, 2011, AM J GASTROENTEROL, V106, P563, DOI 10.1038/ajg.2011.44; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Kiss EA, 2011, SCIENCE         1027; Monteleone I, 2011, GASTROENTEROLOGY, V141, P237, DOI 10.1053/j.gastro.2011.04.007; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491	5	24	25	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 12	2012	366	2					181	183		10.1056/NEJMcibr1113158	http://dx.doi.org/10.1056/NEJMcibr1113158			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874VA	22236230				2022-12-28	WOS:000298985000016
J	Snyder, L				Snyder, Lois		Amer Coll Phys Ethics	American College of Physicians Ethics Manual Sixth Edition	ANNALS OF INTERNAL MEDICINE			English	Article							CONCIERGE MEDICINE; INDUSTRY RELATIONS; PALLIATIVE CARE; OF-PHYSICIANS; PATIENT; HEALTH; COMMUNICATION; CONSULTATION; OBLIGATIONS; PRINCIPLES	Medicine, law, and social values are not static. Reexamining the ethical tenets of medicine and their application in new circumstances is a necessary exercise. The sixth edition of the American College of Physicians (ACP) Ethics Manual covers emerging issues in medical ethics and revisits older ones that are still very pertinent. It reflects on many of the ethical tensions in medicine and attempts to shed light on how existing principles extend to emerging concerns. In addition, by reiterating ethical principles that have provided guidance in resolving past ethical problems, the Manual may help physicians avert future problems. The Manual is not a substitute for the experience and integrity of individual physicians, but it may serve as a reminder of the shared duties of the medical profession.	[Snyder, Lois] Amer Coll Physicians, Philadelphia, PA 19106 USA	American College of Physicians	Snyder, L (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19106 USA.	lsnyder@acponline.org			ACP; American Medical Group Association Hypertention Learning Foundation; Medical College of Wisconsin; RWF; NIH; HRSA; Komen; GlaxoSmithKline; American Cancer Society	ACP; American Medical Group Association Hypertention Learning Foundation; Medical College of Wisconsin(General Electric); RWF; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HRSA(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); Komen(Susan G. Komen Breast Cancer Foundation); GlaxoSmithKline(GlaxoSmithKline); American Cancer Society(American Cancer Society)	Financial support for the development of the Manual came exclusively from the ACP operating budget.; Ms. Snyder: Other relationships: Member of Society of General Internal Medicine Ethics Committee. Dr. Hood: Employment: ACP (president-elect, 2010-2012); Grants/grants pending: American Medical Group Association Hypertention Learning Foundation; Payment for lectures including service on speakers bureaus: American Society of Nephrology; Stock/stock options: mutual funds. Dr. Kutty: Employment: The Medical College of Wisconsin; Royalties: Wolters Kluwer; Stock/stock options: Medtronic. Dr. Fins: Support for travel to meetings for the study or other purposes: ACP; Board membership: ACP Foundation; Employment: Weill Cornell; Grants/grants pending: RWF; Payment for lectures including service on speakers bureaus: various entities; Royalties: Jones and Bartlett; Payment for development of educational presentations: Weill Cornell. Dr. Lopez: Grant: NIH, HRSA, Komen; Consulting fee or honorarium: GlaxoSmithKline; Grants/grants pending: American Cancer Society, NIH, Komen. Dr. Braddock: Board membership: Foundation for Informed Medical Decision Making. Dr. Calvano: Travel/accommodations/meeting expenses unrelated to activities listed: ACP. Dr. Faber-Langendoen: Support for travel to meetings for the study or other purposes: ACP; Employment: SUNY Upstate Medical University; Travel/accommodations/meeting expenses unrelated to activities listed: ACP. Dr. Herrin: Payment for lectures including service on speakers bureaus: Gentech Speakers Bureau. Dr. Mir: Employment: NSLUHS. Dr. Moreno: Support for travel to meetings for the study or other purposes: ACP; Other relationships: Governor, American College of Legal Medicine (February 2011-present); member and pro bono consultant, Physicians for Human Rights (1997-present); member of Board of Directors and President Elect, Texas Chapter of the ACP and ACP Services; pro bono advisor, Center for Survivors of Torture. Mr. Pasha: Support for travel to meetings for the study or other purposes: ACP. Dr. Turner: Employment: Annals of Internal Medicine Executive Deputy Editor, November 2009-November 2010. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M11-1111.	Amdur RJ, 2002, I REV BOARD MANAGEME; Amer College Physicians, 2004, ANN INTERN MED, V141, P226, DOI 10.7326/0003-4819-141-3-200408030-00015; American College of Legal Medicine, 2001, LEG MED; American College of Physicians Ethics Manual, 1989, ANN INTERN MED, V111, P327; American College of Physicians Ethics Manual, 1989, ANN INTERN MED, V111, P245; American Medical Association, 1999, AMA COD MED ETH; American Medical Association, 2006, AMA COD MED ETH; American Medical Association, 2011, GUID PHYS PAT EL COM, P28; Annas GJ, 2009, NEW ENGL J MED, V361, P196, DOI 10.1056/NEJMhle0811035; ANNAS GJ, 1991, NEW ENGL J MED, V324, P1210, DOI 10.1056/NEJM199104253241711; [Anonymous], 2001, PAT ED CAR END LIF P; [Anonymous], 2003, NIH PUBL; [Anonymous], 2001, PAT ED CAR END OF LI; [Anonymous], PHYS ORDERS LIFE SUS; [Anonymous], 2011, COMP ACCR MAN HOSP C; [Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [DOI 10.1001/JAMA.2013.281053, 10.1001/jama.2013.281053]; [Anonymous], 2000, RECR HUM SUBJ SAMPL; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Aulisio MP, 2000, ANN INTERN MED, V133, P59, DOI 10.7326/0003-4819-133-1-200007040-00012; Beauchamp TL, 2008, PRINCIPLES BIOMEDICA, V6th; Berger JT, 2008, ANN INTERN MED, V149, P48, DOI 10.7326/0003-4819-149-1-200807010-00010; Berger JT, 2005, CANCER INVEST, V23, P94, DOI 10.1081/CNV-200046398; Berger JT, 2001, J CLIN ETHIC, V12, P375; Boisaubin EV, 2001, AM J MED SCI, V322, P31, DOI 10.1097/00000441-200107000-00006; Braddock CH, 2005, J GEN INTERN MED, V20, P1057, DOI 10.1111/j.1525-1497.2005.00217.x; Braddock CH, PATIENT CTR IN PRESS; Brendel DH, 2007, HARVARD REV PSYCHIAT, V15, P43, DOI 10.1080/10673220701298399; BUCHAN ML, 1995, J CLIN ETHIC, V6, P53; BURNUM JF, 1991, NEW ENGL J MED, V324, P1130, DOI 10.1056/NEJM199104183241611; Carlisle J, 2006, J MED ETHICS, V32, P133, DOI 10.1136/jme.2004.011262; Carnahan SJ, 2007, J LAW MED ETHICS, V35, P211, DOI 10.1111/j.1748-720X.2007.00125.x; Carrillo JE, 1999, ANN INTERN MED, V130, P829, DOI 10.7326/0003-4819-130-10-199905180-00017; Carroll RJ, 1999, ACP ASIM OBSERVE JAN; Casarett D, 2005, NEW ENGL J MED, V353, P2607, DOI 10.1056/NEJMsb052907; Cassarett D, 2001, ACP OBSERVER     MAR; Chretien KC, 2009, JAMA-J AM MED ASSOC, V302, P1309, DOI 10.1001/jama.2009.1387; Council for International Organizations of Medical Sciences, 2002, Bull Med Ethics, P17; Council of Medical Specialty Societies, 2011, VOL COD INT COMP; Coyle SL, 2002, ANN INTERN MED, V136, P396, DOI 10.7326/0003-4819-136-5-200203050-00014; Coyle SL, 2002, ANN INTERN MED, V136, P403, DOI 10.7326/0003-4819-136-5-200203050-00015; Crawley LM, 2001, PHYS GUIDE END LIFE, P35; Crook ED, 2005, ETHICAL CHOICES CASE, P148; Daugherty CK, 2008, J CLIN ONCOL, V26, P1371, DOI 10.1200/JCO.2007.13.5335; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; Department of Health and Human Services, 1995, INT MISC RES REP COM; Drazen JM, 2010, ANN INTERN MED, V152, P125, DOI [10.7326/0003-4819-152-2-200901190-00160, 10.7326/0000605-200901190-00160]; Drazen JM, 2000, NEW ENGL J MED, V343, P1643, DOI 10.1056/NEJM200011303432212; Eastwood GL, 2009, J GEN INTERN MED, V24, P1333, DOI 10.1007/s11606-009-1127-1; Eggly S, 2006, J CLIN ONCOL, V24, P716, DOI 10.1200/JCO.2005.03.0577; Farber N, 2011, DIFFICULT PATIENT SH; Federation of State Medical Boards of the United States, 2002, MOD GUID APP US INT; Fins JJ, 2005, J PAIN SYMPTOM MANAG, V29, P55, DOI 10.1016/j.jpainsymman.2004.07.004; Fins JJ, 2004, ARCH NEUROL-CHICAGO, V61, P1354, DOI 10.1001/archneur.61.9.1354; Fletcher JC, 1996, J CLIN ETHIC, V7, P122; Fontanarosa PB, 2005, JAMA-J AM MED ASSOC, V294, P110, DOI 10.1001/jama.294.1.110; Gazelle G, 1998, NEW ENGL J MED, V338, P467, DOI 10.1056/NEJM199802123380712; Geller G, 1997, JAMA-J AM MED ASSOC, V277, P1467, DOI 10.1001/jama.277.18.1467; Ginsburg J, 2001, ANN INTERN MED, V134, P787, DOI 10.7326/0003-4819-136-9-200205070-00023; Groves James E., 2002, Prim Care Companion J Clin Psychiatry, V4, P215; Herrin V, 2000, ACP ASIM OBSERVE FEB; Hochman M, 2010, JAMA-J AM MED ASSOC, V303, P951, DOI 10.1001/jama.2010.240; Institute of Medicine, 1997, APP DEATH IMPR CAR E; Institute of Medicine, 2009, GUID EST CRIS STAND; Institute of Medicine, 1999, ERR IS HUM BUILD SAF; International Committee of Medical Journal Editors, 2011, BIOM J UNPUB; Jain SH, 2009, NEW ENGL J MED, V361, P649, DOI 10.1056/NEJMp0901277; Jecker N. S., 2007, FEMINISM MORAL THEOR, V2nd; Jonsen A.R., 1998, BIRTH BIOETHICS; Juarez JA, 2006, FAM MED, V38, P97; Kahn MW, 2009, NEW ENGL J MED, V361, P442, DOI 10.1056/NEJMp0902021; Karlawish JHT, 1999, ANN INTERN MED, V130, P835, DOI 10.7326/0003-4819-130-10-199905180-00018; Karlawish JHT, 2003, NEW ENGL J MED, V348, P1389, DOI 10.1056/NEJMsb030172; Kirschner N, 2010, PATIENT CTR MED HOM; Lampert R, 2010, HRS EXP CONS STAT M; LaPuma J, 1995, Trends Health Care Law Ethics, V10, P73; Lee LM, 2009, JAMA-J AM MED ASSOC, V302, P82, DOI 10.1001/jama.2009.958; LIND SE, 1988, CLIN RES, V36, P546; Lo B, 1999, ANN INTERN MED, V130, P772, DOI 10.7326/0003-4819-130-9-199905040-00018; Lo B, 1999, ANN INTERN MED, V130, P744, DOI 10.7326/0003-4819-130-9-199905040-00015; Lyckholm LJ, 1998, JAMA-J AM MED ASSOC, V280, P1944, DOI 10.1001/jama.280.22.1944; Mann JM, 1999, HLTH HUM RIGHTS READ; Mattke Angela, 2009, Acad Med, V84, P191, DOI 10.1097/01.ACM.0000345394.25069.61; McGuire AL, 2006, SCIENCE, V312, P370, DOI 10.1126/science.1125339; McGuire AL, 2008, JAMA-J AM MED ASSOC, V300, P2669, DOI 10.1001/jama.2008.803; MCMURRAY RJ, 1991, JAMA-J AM MED ASSOC, V266, P2741, DOI 10.1001/jama.1991.03470190089035; Mitnick S, 2010, J GEN INTERN MED, V25, P255, DOI 10.1007/s11606-009-1206-3; Nahan RL, 2007, 18 NAT CTR HLTH STAT; *NAT CTR COMPL ALT, WHAT IS COMPL ALT ME; National Commission on Correctional Health Care, 1996, CHARG INM FEE HLTH C; New York State Department of Health/New York State Task Force on Life & the Law, 2007, ALL VENT INFL PAND; Nunez AE, 2000, ACAD MED, V75, P1071, DOI 10.1097/00001888-200011000-00011; ORENTLICHER D, 1992, JAMA-J AM MED ASSOC, V267, P2366; Peabody FW, 1927, J AMER MED ASSOC, V88, P0877, DOI 10.1001/jama.1927.02680380001001; Pellegrino ED, 1999, JAMA-J AM MED ASSOC, V282, P984, DOI 10.1001/jama.282.10.984; Povar GJ, 1999, ANN INTERN MED, V131, P863, DOI 10.7326/0003-4819-131-11-199912070-00012; Povar GJ, 2004, ANN INTERN MED, V141, P131, DOI 10.7326/0003-4819-141-2-200407200-00012; Quill TE, 2000, ANN INTERN MED, V132, P408, DOI 10.7326/0003-4819-132-5-200003070-00012; Rich EC, 2004, J GEN INTERN MED, V19, P273, DOI 10.1111/j.1525-1497.2004.30401.x; Roter DL, 1997, JAMA-J AM MED ASSOC, V277, P350, DOI 10.1001/jama.277.4.350; Sabatino CP, 1999, J LAW MED ETHICS, V27, P297, DOI 10.1111/j.1748-720X.1999.tb01465.x; Salzman JG, 2007, ANN EMERG MED, V50, P448, DOI 10.1016/j.annemergmed.2006.10.013; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Shelley BM, 2009, ANN FAM MED, V7, P139, DOI 10.1370/afm.947; Snyder L, 2007, BIOMED ETHICS REV, P1, DOI 10.1007/978-1-59745-381-3; SNYDER L, 1990, ANN INTERN MED, V112, P802, DOI 10.7326/0003-4819-112-11-802; Snyder L, 2001, ANN INTERN MED, V135, P209, DOI 10.7326/0003-4819-135-3-200108070-00015; Snyder L, 1998, J AM GERIATR SOC, V46, P378, DOI 10.1111/j.1532-5415.1998.tb01058.x; SNYDER L, 1990, ANN INTERN MED, V113, P789, DOI 10.7326/0003-4819-113-10-789; Snyder L, 1996, ETHICAL CHOICES CASE, P105; Snyder L, 2005, ETHICAL CHOICES CASE, P130; Snyder L, 2005, ETHICAL CHOICES CASE, P77; Snyder L, 2001, PHYS GUIDE END OF LI; Snyder L, 2007, ANN INTERN MED, V147, P792, DOI 10.7326/0003-4819-147-11-200712040-00011; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; Steinbrook R, 2008, NEW ENGL J MED, V359, P2513, DOI 10.1056/NEJMp0809394; Stillman M, 2010, ANN INTERN MED, V152, P391, DOI 10.7326/0003-4819-152-6-201003160-00009; Stott D, 2008, STUDENT BMJ, V16, P280; Sulmasy DP, 2007, J AM GERIATR SOC, V55, P1981, DOI 10.1111/j.1532-5415.2007.01473.x; Sulmasy DP, 2010, JAMA-J AM MED ASSOC, V304, P1946, DOI 10.1001/jama.2010.1595; Sulmasy DP, 1999, ARCH INTERN MED, V159, P545, DOI 10.1001/archinte.159.6.545; SULMASY DP, 1992, ANN INTERN MED, V116, P920, DOI 10.7326/0003-4819-116-11-920; Thompson LA, 2008, J GEN INTERN MED, V23, P954, DOI 10.1007/s11606-008-0538-8; Tulsky JA, 1997, ACP OBSERVER     MAR; Turton FE, 2008, ANN INTERN MED, V148, P887, DOI 10.7326/0003-4819-148-11-200806030-00022; Turton FE, 2007, ANN INTERN MED, V146, P469, DOI 10.7326/0003-4819-146-6-200703200-00019; United Nations, 1955, 1 C PREV CRIM TREATM; Veatch R. M., 2000, TRANSPLANTATION ETHI; Vedula SS, 2009, NEW ENGL J MED, V361, P1963, DOI 10.1056/NEJMsa0906126; Veterans Health Administration's National Center for Ethics in Health Care, 2010, M CHALL PAND INFL ET; Weiner J, 2005, ETHICAL CHOICES CASE, P136; Weiner J, 2005, ETHICAL CHOICES CASE, P99; Weiner J, 2005, ETHICAL CHOICES CASE, P143; WHITE LJ, 1988, ANN INTERN MED, V108, P460, DOI 10.7326/0003-4819-108-3-460; WHITE LJ, 1989, ANN INTERN MED, V111, P843, DOI 10.7326/0003-4819-111-10-843; Williams MA, 2003, CRIT CARE MED, V31, P1568, DOI 10.1097/01.CCM.0000063090.21056.A6; World Health Organization, 2009, PAND INFL PREP RESP	136	207	210	0	21	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 3	2012	156	1	2						73	10.7326/0003-4819-156-1-201201031-00001	http://dx.doi.org/10.7326/0003-4819-156-1-201201031-00001			32	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	886SP	22213573				2022-12-28	WOS:000299874500001
J	Jadad, AR; To, MJ; Emara, M; Jones, J				Jadad, Alejandro R.; To, Matthew J.; Emara, Mohamed; Jones, Jennifer			Consideration of Multiple Chronic Diseases in Randomized Controlled Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Jadad, Alejandro R.; To, Matthew J.; Emara, Mohamed; Jones, Jennifer] Univ Hlth Network, Ctr Hlth Wellness & Canc Survivorship, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto	Jadad, AR (corresponding author), Univ Hlth Network, Ctr Hlth Wellness & Canc Survivorship, Toronto, ON, Canada.	ajadad@ehealthinnovation.org						Anderson G, CHRONIC CARE MAKING; Jadad AR, PEOPLE LIVE MULTIPLE; Parekh AK, 2011, PUBLIC HEALTH REP, V126, P460, DOI 10.1177/003335491112600403; Van Spall HGC, 2007, JAMA-J AM MED ASSOC, V297, P1233, DOI 10.1001/jama.297.11.1233; Weiss KB, 2007, J GEN INTERN MED, V22, P374, DOI 10.1007/s11606-007-0379-x	5	65	65	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 28	2011	306	24					2670	2672		10.1001/jama.2011.1886	http://dx.doi.org/10.1001/jama.2011.1886			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	867VX	22203536	Bronze			2022-12-28	WOS:000298484000016
J	Liao, Y; Pourzal, R; Wimmer, MA; Jacobs, JJ; Fischer, A; Marks, LD				Liao, Y.; Pourzal, R.; Wimmer, M. A.; Jacobs, J. J.; Fischer, A.; Marks, L. D.			Graphitic Tribological Layers in Metal-on-Metal Hip Replacements	SCIENCE			English	Article							DIAMOND-LIKE CARBON; TRIBOCHEMICAL REACTION; AMORPHOUS-CARBON; WEAR MECHANISMS; JOINT BEARINGS; UNITED-STATES; IN-VITRO; FILMS; LUBRICATION; PROSTHESES	Arthritis is a leading cause of disability, and when nonoperative methods have failed, a prosthetic implant is a cost-effective and clinically successful treatment. Metal-on-metal replacements are an attractive implant technology, a lower-wear alternative to metal-on-polyethylene devices. Relatively little is known about how sliding occurs in these implants, except that proteins play a critical role and that there is a tribological layer on the metal surface. We report evidence for graphitic material in the tribological layer in metal-on-metal hip replacements retrieved from patients. As graphite is a solid lubricant, its presence helps to explain why these components exhibit low wear and suggests methods of improving their performance; simultaneously, this raises the issue of the physiological effects of graphitic wear debris.	[Liao, Y.; Jacobs, J. J.; Marks, L. D.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60201 USA; [Pourzal, R.; Fischer, A.] Univ Duisburg Essen, Duisburg, Germany; [Wimmer, M. A.; Jacobs, J. J.; Fischer, A.] Rush Univ, Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA	Northwestern University; University of Duisburg Essen; Rush University	Marks, LD (corresponding author), Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60201 USA.	l-marks@northwestern.edu	Jacobs, Joshua/AGG-8284-2022; Marks, Laurence/B-7527-2009	Pourzal, Robin/0000-0001-9610-4864; Jacobs, Joshua/0000-0003-3902-7334	NIH [1RC2AR058993-01]; Zimmer Holdings; Medtronics; Spinal Motion; Zimmer Winterthur; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [RC2AR058993] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Zimmer Holdings; Medtronics; Spinal Motion; Zimmer Winterthur; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded by the NIH on grant number 1RC2AR058993-01. Northwestern University Atomic and Nanoscale Experimental Center and Biological Imaging Facility are acknowledged for the use of their facilities. We thank K. Shull, K. Wahl, and R. Leapman for invaluable comments and M. Morlock, Hamburg, Germany, for retrievals. The authors have no competing financial interests. As full disclosure of real or potential conflicts of interest, J.J.J. has funding from Zimmer Holdings, Medtronics, and Spinal Motion; consults for Zimmer, Medtronics, Johnson and Johnson, Spinal Motion, and Implant Protection; and has stock options in Implant Protection. A. F. has funding from Zimmer Winterthur and consults for Zimmer, Abbot Vascular, and Ceramtec.	BERGER SD, 1988, PHIL MAG LETT, V57, P285, DOI 10.1080/09500838808214715; Bozic KJ, 2009, J BONE JOINT SURG AM, V91A, P128, DOI 10.2106/JBJS.H.00155; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P421; Chan FW, 1996, CLIN ORTHOP RELAT R, P96; Chu PK, 2006, MATER CHEM PHYS, V96, P253, DOI 10.1016/j.matchemphys.2005.07.048; CUOMO JJ, 1991, APPL PHYS LETT, V58, P466, DOI 10.1063/1.104609; Dowson D, 2000, P I MECH ENG C-J MEC, V214, P75, DOI 10.1243/0954406001522822; Egerton R.F., 2011, ELECT ENERGY LOSS SP; Ferrari AC, 2000, PHYS REV B, V61, P14095, DOI 10.1103/PhysRevB.61.14095; Ferrari AC, 2004, PHILOS T R SOC A, V362, P2477, DOI 10.1098/rsta.2004.1452; Field SK, 2004, TRIBOL INT, V37, P949, DOI 10.1016/j.triboint.2004.07.012; FINK J, 1983, SOLID STATE COMMUN, V47, P687, DOI 10.1016/0038-1098(83)90635-X; Heuberger MP, 2005, BIOMATERIALS, V26, P1165, DOI 10.1016/j.biomaterials.2004.05.020; Jacobsson S. A., 1996, CLIN ORTHOP RELAT R, V329, pS60; Kocijan A, 2003, J MATER SCI-MATER M, V14, P69, DOI 10.1023/A:1021505621388; Langton DJ, 2011, J BONE JOINT SURG BR, V93B, P164, DOI 10.1302/0301-620X.93B2.25099; M'ndange-Pfupfu A, 2011, DIAM RELAT MATER, V20, P1143, DOI 10.1016/j.diamond.2011.06.028; Maskiewicz VK, 2010, J BIOMED MATER RES B, V94B, P429, DOI 10.1002/jbm.b.31671; McKellop H, 1996, CLIN ORTHOP RELAT R, pS128, DOI 10.1097/00003086-199608001-00013; Mishina H, 2008, WEAR, V265, P655, DOI 10.1016/j.wear.2007.12.006; OECD/ European Union, 2010, HLTH GLANC EUR 2010; PAPPAS DL, 1992, J APPL PHYS, V71, P5675, DOI 10.1063/1.350501; Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0; Scholes SC, 2006, P I MECH ENG H, V220, P687, DOI 10.1243/09544119JEIM21; Scholes SC, 2000, P I MECH ENG H, V214, P49, DOI 10.1243/0954411001535237; TUINSTRA F, 1970, J CHEM PHYS, V53, P1126, DOI 10.1063/1.1674108; UNSWORTH A, 1978, PHYS MED BIOL, V23, P253, DOI 10.1088/0031-9155/23/2/004; Wimmer MA, 2003, WEAR, V255, P1007, DOI 10.1016/S0043-1648(03)00127-3; Wimmer MA, 2001, WEAR, V250, P129, DOI 10.1016/S0043-1648(01)00654-8; Wimmer MA, 2010, J ORTHOP RES, V28, P436, DOI 10.1002/jor.21020; WOODMAN JL, 1984, J BIOMED MATER RES, V18, P99, DOI 10.1002/jbm.820180110; Yan Y, 2006, J PHYS D APPL PHYS, V39, P3206, DOI 10.1088/0022-3727/39/15/S11; Yen BK, 1996, WEAR, V192, P208, DOI 10.1016/0043-1648(95)06807-4	33	146	151	4	159	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1687	1690		10.1126/science.1213902	http://dx.doi.org/10.1126/science.1213902			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22194573				2022-12-28	WOS:000298344000062
J	Jiang, J				Jiang, Jessie			PATENTS Protecting China's national treasure	NATURE			English	Editorial Material																			0	2	2	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2011	480	7378					S93	S93		10.1038/480S93a	http://dx.doi.org/10.1038/480S93a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	865NQ	22190090	Bronze			2022-12-28	WOS:000298318000006
J	O'Neill, D				O'Neill, Desmond			CHRISTMAS 2011: FOOD FOR THOUGHT Jellyatrics	BRITISH MEDICAL JOURNAL			English	Editorial Material							OLDER-PEOPLE		Adelaide & Meath Hosp, Trinity Coll Dublin, Ctr Ageing Neurosci & Humanities, Trinity Ctr Hlth Sci, Dublin, Ireland	Trinity College Dublin	O'Neill, D (corresponding author), Adelaide & Meath Hosp, Trinity Coll Dublin, Ctr Ageing Neurosci & Humanities, Trinity Ctr Hlth Sci, Dublin, Ireland.	doneill@tcd.ie	O'Neill, Desmond/D-1486-2013	O'Neill, Desmond/0000-0002-5542-9897				Close JCT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5153; Mulley G, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5391; Quinn TJ, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4681; Young J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5042	4	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 21	2011	343								d7447	10.1136/bmj.d7447	http://dx.doi.org/10.1136/bmj.d7447			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	874TF	22189127				2022-12-28	WOS:000298980300001
J	Stutchbury, J				Stutchbury, Jo			Who's meant to be teaching us?	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Stutchbury, J (corresponding author), The Lancet, 32 Jamestown Rd, London NW1 7BY, England.	jostutchbury@gmail.com							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 17	2011	378	9809					2136	2137		10.1016/S0140-6736(11)61815-1	http://dx.doi.org/10.1016/S0140-6736(11)61815-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	865EL	22177512				2022-12-28	WOS:000298293600035
J	Johnston, C; Saracino, M; Kuntz, S; Magaret, A; Selke, S; Huang, MI; Schiffer, JT; Koelle, DM; Corey, L; Wald, A				Johnston, Christine; Saracino, Misty; Kuntz, Steve; Magaret, Amalia; Selke, Stacy; Huang, Meei-Ii; Schiffer, Joshua T.; Koelle, David M.; Corey, Lawrence; Wald, Anna			Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials	LANCET			English	Article							HERPES-SIMPLEX-VIRUS; RAPIDLY CLEARED EPISODES; DOUBLE-BLIND; ACYCLOVIR; TYPE-2; SUPPRESSION; INFECTION; DNA; TRANSMISSION; WOMEN	Background Skin and mucosal herpes simplex virus type 2 (HSV-2) shedding predominantly occurs in short subclinical episodes. We assessed whether standard-dose or high-dose antiviral therapy reduces the frequency of such shedding. Methods HSV-2-seropositive, HIV-seronegative people were enrolled at the University of Washington Virology Research Clinic (WA, USA). We did three separate but complementary open-label cross-over studies comparing no medication with aciclovir 400 mg twice daily (standard-dose aciclovir), valaciclovir 500 mg daily (standard-dose valaciclovir) with aciclovir 800 mg three times daily (high-dose aciclovir), and standard-dose valaciclovir with valaciclovir 1 g three times daily (high-dose valaciclovir). The allocation sequence was generated by a random number generator. Study drugs were supplied in identical, numbered, sealed boxes. Study periods lasted 4-7 weeks, separated by 1 week wash-out. Participants collected genital swabs four times daily for quantitative HSV DNA PCR. Clinical data were masked from laboratory personnel. The primary endpoint was within-person comparison of shedding rate in each study group. Analysis was per protocol. The trials are registered at ClinicalTrials.gov (NCT00362297, NCT00723229, NCT01346475). Results Of 113 participants randomised, 90 were eligible for analysis of the primary endpoint. Participants collected 23 605 swabs; 1272 (5.4%) were HSV-positive. The frequency of HSV shedding was significantly higher in the no medication group (n=384, 18.1% of swabs) than in the standard-dose aciclovir group (25, 1.2%; incidence rate ratio [IRR] 0.05, 95% CI 0.03-0.08). High-dose aciclovir was associated with less shedding than standard-dose valaciclovir (198 [4.2%] vs 209 [4.5%]; IRR 0.79, 95% CI 0.63-1.00). Shedding was less frequent in the high-dose valaciclovir group than in the standard-dose valaciclovir group (164 [3.3%] vs 292 [5.8%]; 0.54, 0.44-0.66). The number of episodes per person-year did not differ significantly for standard-dose valaciclovir (22.6) versus high-dose aciclovir (20.2; p=0.54), and standard-dose valaciclovir (14.9) versus high-dose valaciclovir (16.5; p=0.34), but did for no medication (28.7) and standard-dose aciclovir (10.0; p=0.001). Median episode duration was longer for no medication than for standard-dose aciclovir (13 h vs 7 h; p=0.01) and for standard-dose valaciclovir than for high-dose valaciclovir (10 h vs 7 h; p=0.03), but did not differ significantly between standard-dose valaciclovir and high-dose aciclovir (8 h vs 8 h; p=0.23). Likewise, maximum log 10 copies of HSV detected per mL was higher for no medication than for standard-dose aciclovir (3.3 vs 2.9; p=0.02), and for standard-dose valaciclovir than for high-dose valaciclovir (2.5 vs 3.0; p=0.001), but no significant difference was recorded for standard-dose valaciclovir versus high-dose aciclovir (2.7 vs 2.8; p=0.66). 80% of episodes were subclinical in all study groups. Except for a higher frequency of headaches with high-dose valaciclovir (n=13, 30%) than with other regimens, all regimens were well tolerated. Interpretation Short bursts of subclinical genital HSV reactivation are frequent, even during high-dose antiherpes therapy, and probably account for continued transmission of HSV during suppressive antiviral therapy. More potent antiviral therapy is needed to eliminate HSV transmission.	[Johnston, Christine] Univ Washington, Virol Res Clin, Dept Med, Seattle, WA 98104 USA; [Saracino, Misty; Kuntz, Steve; Magaret, Amalia; Selke, Stacy; Huang, Meei-Ii; Koelle, David M.; Corey, Lawrence; Wald, Anna] Univ Washington, Dept Lab Med, Seattle, WA 98104 USA; [Koelle, David M.] Univ Washington, Dept Global Hlth, Seattle, WA 98104 USA; [Wald, Anna] Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA; [Johnston, Christine; Magaret, Amalia; Huang, Meei-Ii; Schiffer, Joshua T.; Koelle, David M.; Corey, Lawrence; Wald, Anna] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Johnston, C (corresponding author), Univ Washington, Virol Res Clin, Dept Med, Box 359928,325 9th Ave, Seattle, WA 98104 USA.	cjohnsto@u.washington.edu	Corey, Lawrence/AAE-1796-2020; Wald, Anna/B-6272-2012; Koelle, David/Q-6529-2016	Corey, Lawrence/0000-0002-2179-2436; Wald, Anna/0000-0003-3486-6438; Koelle, David/0000-0003-1255-9023; Johnston, Christine/0000-0002-3073-0843	NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI071113, K23AI087206, K23AI079394, P01AI030731] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The Article is in memory of Laura P Olin, ARNP, a dedicated clinician who participated in the undertaking of these studies and passed away in 2009. This study was supported by NIH. GlaxoSmithKline donated valaciclovir for trial 3 for free.	[Anonymous], COMMON TERMINOLOGY C; ASHLEY RL, 1988, J CLIN MICROBIOL, V26, P662, DOI 10.1128/JCM.26.4.662-667.1988; BEUTNER KR, 1995, ANTIMICROB AGENTS CH, V39, P1546, DOI 10.1128/AAC.39.7.1546; Brandi G, 2001, LIFE SCI, V69, P1285, DOI 10.1016/S0024-3205(01)01213-9; Brown ZA, 2003, JAMA-J AM MED ASSOC, V289, P203, DOI 10.1001/jama.289.2.203; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; Corey L, 2004, NEW ENGL J MED, V350, P11, DOI 10.1056/NEJMoa035144; Czartoski T, 2006, J CLIN MICROBIOL, V44, P1584, DOI 10.1128/JCM.44.4.1584-1586.2006; Diggle PJ, 1994, ANAL LONGITUDINAL DA; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Gupta R, 2004, J INFECT DIS, V190, P1374, DOI 10.1086/424519; Jerome KR, 2002, J CLIN MICROBIOL, V40, P2609, DOI 10.1128/JCM.40.7.2609-2611.2002; Lebrun-Vignes B, 2007, J AM ACAD DERMATOL, V57, P238, DOI 10.1016/j.jaad.2007.02.008; Looker KJ, 2008, B WORLD HEALTH ORGAN, V86, P805, DOI 10.2471/BLT.07.046128; Lycke J, 2003, ANTIMICROB AGENTS CH, V47, P2438, DOI 10.1128/AAC.47.8.2438-2441.2003; Magaret AS, 2009, SEX TRANSM INFECT, V85, P270, DOI 10.1136/sti.2008.034751; Magaret AS, 2007, J CLIN MICROBIOL, V45, P1618, DOI 10.1128/JCM.01405-06; Mark KE, 2008, J INFECT DIS, V198, P1141, DOI 10.1086/591913; Mark KE, 2010, JAIDS-J ACQ IMM DEF, V54, P482, DOI 10.1097/QAI.0b013e3181d91322; MERTZ GJ, 1988, JAMA-J AM MED ASSOC, V260, P201, DOI 10.1001/jama.260.2.201; Morfin F, 2003, J CLIN VIROL, V26, P29, DOI 10.1016/S1386-6532(02)00263-9; Morris SR, 2008, SEX TRANSM DIS, V35, P14, DOI 10.1097/OLQ.0b013e3180f62bc7; Reitano M, 1998, J INFECT DIS, V178, P603, DOI 10.1086/515385; Schiffer JT, 2011, J INFECT DIS, V204, P554, DOI 10.1093/infdis/jir314; Schiffer Joshua T, 2010, Proc Natl Acad Sci U S A, V107, P18973, DOI 10.1073/pnas.1006614107; Schiffer JT, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000193; Wald A, 2000, NEW ENGL J MED, V342, P844, DOI 10.1056/NEJM200003233421203; Wald A, 1996, ANN INTERN MED, V124, P8, DOI 10.7326/0003-4819-124-1_Part_1-199601010-00002; Wald A, 2003, J INFECT DIS, V188, P1345, DOI 10.1086/379043; Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964	33	82	93	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 18	2012	379	9816					641	647		10.1016/S0140-6736(11)61750-9	http://dx.doi.org/10.1016/S0140-6736(11)61750-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	897ES	22225814	Green Accepted			2022-12-28	WOS:000300629000035
J	Edmond, KM; Kortsalioudaki, C; Scott, S; Schrag, SJ; Zaidi, AKM; Cousens, S; Heath, PT				Edmond, Karen M.; Kortsalioudaki, Christina; Scott, Susana; Schrag, Stephanie J.; Zaidi, Anita K. M.; Cousens, Simon; Heath, Paul T.			Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis	LANCET			English	Article							ONSET NEONATAL SEPSIS; INFLUENZAE TYPE-B; BACTERIAL-MENINGITIS; ESCHERICHIA-COLI; INFECTIONS; CHILDREN; ERA; EPIDEMIOLOGY; PREVENTION; BACTEREMIA	Background Despite widespread use of intrapartum antibiotic prophylaxis, group B streptococcus remains a leading cause of morbidity and mortality in infants in Europe, the Americas, and Australia. However, estimates of disease burden in many countries outside of these regions is not available. We aimed to examine the current global burden of invasive disease and the serotype distribution of group B streptococcus isolates. Methods We searched Medline, Embase, and Wholis databases for studies on invasive early-onset (day 0-6) and late-onset (day 7-89) group B streptococcal disease. Eligible studies were those that described incidence, deaths, or serotypes. We also reviewed reference lists and contacted experts to seek unpublished data and data missed by our search. Random effects meta-analysis was used to pool data. Findings 74 studies met the inclusion criteria; 56 studies reported incidence, 29 case fatality, and 19 serotype distribution. An additional search for studies that reported serotype distribution from Jan 1, 1980, yielded a total of 38 articles. Only five low-income countries were represented in the review and contributed 5% weight to the meta-analysis. 47 (69%) studies reported use of any intrapartum antibiotic prophylaxis. Substantial heterogeneity existed between studies. Mean incidence of group B streptococcus in infants aged 0-89 days was 0.53 per 1000 livebirths (95% CI 0.44-0.62) and the mean case fatality ratio was 9.6% (95% CI 7.5-11.8). Incidence of early-onset group B streptococcus (0.43 per 1000 livebirths [95% CI 0.37-0.49]) and case fatality (12.1%, [6.2-18.3]) were two-times higher than late-onset disease. Serotype III (48.9%) was the most frequently identified serotype in all regions with available data followed by serotypes Ia (22.9%), Ib (7.0%), II (6.2%), and V (9.1%). Studies that reported use of any intrapartum antibiotic prophylaxis were associated with lower incidence of early-onset group B streptococcus (0.23 per 1000 livebirths [95% CI 0.13-0.59]) than studies in which patients did not use prophylaxis (0.75 per 1000 livebirths [0.58-0.89]). Interpretation More high-quality studies are needed to accurately estimate the global burden of group B streptococcus, especially in low-income countries. A conjugate vaccine incorporating five serotypes (Ia, Ib, II, III, V) could prevent most global group B streptococcal disease.	[Edmond, Karen M.; Scott, Susana; Cousens, Simon] London Sch Hyg & Trop Med, London WC1 7HT, England; [Heath, Paul T.] Univ London, St Georges Hosp, Child Hlth & Vaccine Inst, London, England; [Schrag, Stephanie J.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Zaidi, Anita K. M.] Aga Khan Univ, Karachi, Pakistan	University of London; London School of Hygiene & Tropical Medicine; St Georges University London; University of London; Centers for Disease Control & Prevention - USA; Aga Khan University	Edmond, KM (corresponding author), London Sch Hyg & Trop Med, Keppel St, London WC1 7HT, England.	karen.edmond@lshtm.ac.uk		Heath, Paul/0000-0002-7540-7433	Child Epidemiology Reference Group (CHERG); WHO; Novartis vaccines	Child Epidemiology Reference Group (CHERG); WHO(World Health Organization); Novartis vaccines	Child Epidemiology Reference Group (CHERG), WHO.; PTH is an investigator for clinical trials done on behalf of St George's, University of London, London, UK, sponsored by vaccine manufacturers including Novartis vaccines and is a consultant to Novartis on group B streptococcus vaccines. Industry-sourced honoraria for consultancy by PTH are paid to an educational/administrative fund held by St George's, University of London, London, UK. All other authors declare no conflicts of interests.	Al-Zwaini E J K, 2002, East Mediterr Health J, V8, P509; American College of Obstetricians and Gynecologists, 2002, Obstet Gynecol, V100, P1405; Andersen J, 2004, ACTA PAEDIATR, V93, P1334, DOI 10.1080/08035250410023016; Andreu A, 2003, ENFERM INFEC MICR CL, V21, P174, DOI 10.1157/13045447; Angstetra D, 2007, AUST NZ J OBSTET GYN, V47, P378, DOI 10.1111/j.1479-828X.2007.00760.x; [Anonymous], GLOBAL BURDEN DIS IN; Ansong AK, 2009, EARLY HUM DEV, V85, pS5, DOI 10.1016/j.earlhumdev.2009.08.003; Apostol M., 2009, Morbidity and Mortality Weekly Report, V58, P109; Bell Y, 2005, ANN TROP PAEDIATR, V25, P293, DOI 10.1179/146532805X72449; Ben Hamida Nouaili Emira, 2008, Tunis Med, V86, P136; Berardi A, 2007, PEDIATRICS, V120, pE487, DOI 10.1542/peds.2006-3246; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Bromberger P, 2000, PEDIATRICS, V106, P244, DOI 10.1542/peds.106.2.244; Brooks S., 2005, Morbidity and Mortality Weekly Report, V54, P1205; Carbonell-Estrany X, 2008, ARCH DIS CHILD-FETAL, V93, pF85, DOI 10.1136/adc.2007.119958; Castrodale L, 2007, MATERN CHILD HLTH J, V11, P91, DOI 10.1007/s10995-006-0144-5; Chang CJ, 2003, PEDIATR NEUROL, V29, P288, DOI 10.1016/S0887-8994(03)00273-X; Chen KT, 2005, AM J OBSTET GYNECOL, V192, P1167, DOI 10.1016/j.ajog.2004.10.610; Cho HK, 2010, J KOREAN MED SCI, V25, P895, DOI 10.3346/jkms.2010.25.6.895; Colbourn T, 2007, EARLY HUM DEV, V83, P149, DOI 10.1016/j.earlhumdev.2007.01.004; Colbourn TE, 2007, BMJ-BRIT MED J, V335, P655, DOI 10.1136/bmj.39325.681806.AD; Cordero L, 2004, AM J INFECT CONTROL, V32, P189, DOI 10.1016/j.ajic.2003.07.004; Cutland CL, 2009, LANCET, V374, P1909, DOI 10.1016/S0140-6736(09)61339-8; Daley AJ, 2004, PEDIATR INFECT DIS J, V23, P630, DOI 10.1097/01.inf.0000128782.20060.79; Darmstadt GL, 2009, J INFECT DIS, V200, P906, DOI 10.1086/605473; DEVANI, 2010, VACC NEON INF DES VA; Edmond K, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000213; Edmond KM, 2008, PAEDIATR PERINAT EP, V22, P430, DOI 10.1111/j.1365-3016.2008.00961.x; Ekelund K, 2004, EPIDEMIOL INFECT, V132, P1083, DOI 10.1017/S0950268804002808; El-Said MF, 2002, SAUDI MED J, V23, P789; Epalza C, 2010, PEDIATRICS, V126, pE631, DOI 10.1542/peds.2010-0183; Fluegge K, 2006, PEDIATRICS, V117, pE1139, DOI 10.1542/peds.2005-2481; Fraile MDR, 2001, CLIN MICROBIOL INFEC, V7, P25, DOI 10.1046/j.1469-0691.2001.00196.x; Gray KJ, 2007, EMERG INFECT DIS, V13, P223, DOI 10.3201/eid1302.060680; Guilbert J, 2010, ACTA PAEDIATR, V99, P47, DOI 10.1111/j.1651-2227.2009.01510.x; Hajdu A, 2006, EUROSURVEILLANCE, V11; Hasseltvedt V, 2001, EUROSURVEILLANCE, V5, P2086; Heath PT, 2011, EXPERT REV VACCINES, V10, P685, DOI [10.1586/erv.11.61, 10.1586/ERV.11.61]; Heath PGT, 2004, LANCET, V363, P292, DOI 10.1016/S0140-6736(03)15389-5; Hyde TB, 2002, PEDIATRICS, V110, P690, DOI 10.1542/peds.110.4.690; Jiang Jia-Horng, 2004, Journal of Microbiology Immunology and Infection, V37, P301; Jordan HT, 2008, PEDIATR INFECT DIS J, V27, P1057, DOI 10.1097/INF.0b013e318180b3b9; Kim JS, 2004, VACCINE, V22, P3952, DOI 10.1016/j.vaccine.2004.04.003; Kuhn P, 2010, PAEDIATR PERINAT EP, V24, P479, DOI 10.1111/j.1365-3016.2010.01132.x; Lea J., 2004, CESKA GYNEKOLOGIE, V69, P91; Madhi SA, 2003, ANN TROP PAEDIATR, V23, P15, DOI 10.1179/000349803125002814; Martin TC, 2007, W INDIAN MED J, V56, P498; Matsubara K, 2009, INT J INFECT DIS, V13, P679, DOI 10.1016/j.ijid.2008.10.007; May M, 2005, ARCH DIS CHILD-FETAL, V90, pF324, DOI 10.1136/adc.2004.066134; Mayor-Lynn K, 2005, AM J OBSTET GYNECOL, V192, P1437, DOI 10.1016/j.ajog.2004.12.031; Milledge J, 2005, ANN TROP PAEDIATR, V25, P101, DOI 10.1179/146532805X45692; Molyneux E, 1998, TROP MED INT HEALTH, V3, P610, DOI 10.1046/j.1365-3156.1998.00278.x; Mulholland K, 1999, PEDIATR INFECT DIS J, V18, pS32; Neto MT, 2008, ARCH DIS CHILD-FETAL, V93, pF90, DOI 10.1136/adc.2007.127464; Niduvaje Krishnamoorthy, 2006, Indian Journal of Pediatrics, V73, P573, DOI 10.1007/BF02759920; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Oddie S, 2002, BRIT MED J, V325, P308, DOI 10.1136/bmj.325.7359.308; Ohlsson A, 2009, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD007467.PUB2; Ojukwu JU, 2006, J PERINAT MED, V34, P166, DOI 10.1515/JPM.2006.030; Park KH, 2011, PEDIATR INT, V53, P236, DOI 10.1111/j.1442-200X.2010.03165.x; Persson E, 2004, CLIN MICROBIOL INFEC, V10, P791, DOI 10.1111/j.1469-0691.2004.00931.x; Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056; Puopolo KM, 2005, PEDIATRICS, V115, P1240, DOI 10.1542/peds.2004-2275; Reingold A., 2007, Morbidity and Mortality Weekly Report, V56, P701; Remington JS, 2011, INFECT DIS FETUS NEW; Sastre JBL, 2005, ACTA PAEDIATR, V94, P451, DOI 10.1080/08035250410025302; Schrag SJ, 2000, NEW ENGL J MED, V342, P15, DOI 10.1056/NEJM200001063420103; Schrag SJ, 2002, NEW ENGL J MED, V347, P233, DOI 10.1056/NEJMoa020205; Schrag SJ, 2011, LANCET, V378, P11, DOI 10.1016/S0140-6736(10)61932-0; Sigauque B, 2009, PEDIATR INFECT DIS J, V28, P108, DOI 10.1097/INF.0b013e318187a87d; Stade B. C., 2004, COCHRANE DB SYST REV, V3, DOI [10.1002/14651858.CD003520.pub2, DOI 10.1002/14651858.CD003520.PUB2]; Stoll BJ, 2011, PEDIATRICS, V127, P817, DOI 10.1542/peds.2010-2217; Stoll BJ, 2002, NEW ENGL J MED, V347, P240, DOI 10.1056/NEJMoa012657; Stoll BJ, 1997, CLIN PERINATOL, V24, P1; Strakova L, 2004, INDIAN J MED RES, V119, P205; Sundaram V, 2009, JPN J INFECT DIS, V62, P46; The World Bank, GNI PER CAP ATL METH; Tiskumara R, 2009, ARCH DIS CHILD-FETAL, V94, pF144, DOI 10.1136/adc.2008.139865; Triibels-Smeulders M, 2007, ARCH DIS CHILD-FETAL, V92, P271, DOI 10.1136/adc.2005.088799; Trotman H, 2006, ANN TROP PAEDIATR, V26, P53, DOI 10.1179/146532806X90619; Trotter CL, 2008, VACCINE, V26, P4434, DOI 10.1016/j.vaccine.2008.05.073; Vaciloto Edinéia, 2002, Braz J Infect Dis, V6, P55, DOI 10.1590/S1413-86702002000200001; van den Hoogen A, 2010, NEONATOLOGY, V97, P22, DOI 10.1159/000226604; Van Dyke MK, 2009, NEW ENGL J MED, V360, P2626, DOI 10.1056/NEJMoa0806820; Vergnano S, 2011, ARCH DIS CHILD-FETAL, V96, pF9, DOI 10.1136/adc.2009.178798; WALSH JA, 1989, PEDIATR INFECT DIS J, V8, P271; Weisner AM, 2004, CLIN INFECT DIS, V38, P1203, DOI 10.1086/382881; Woodgate P, 2004, COCHRANE DB SYST REV, V3; Yossuck Panitan, 2002, Journal of the Medical Association of Thailand, V85, pS479; Zaidi AKM, 2005, LANCET, V365, P1175, DOI 10.1016/S0140-6736(05)71881-X	90	413	452	3	83	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 11	2012	379	9815					547	556		10.1016/S0140-6736(11)61651-6	http://dx.doi.org/10.1016/S0140-6736(11)61651-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	891AO	22226047	Green Accepted			2022-12-28	WOS:000300188800031
J	Brelidze, TI; Carlson, AE; Sankaran, B; Zagotta, WN				Brelidze, Tinatin I.; Carlson, Anne E.; Sankaran, Banumathi; Zagotta, William N.			Structure of the carboxy-terminal region of a KCNH channel	NATURE			English	Article							LONG-QT SYNDROME; FUNCTIONAL-PROPERTIES; POTASSIUM CHANNELS; HERG; ACTIVATION; DOMAIN; VALIDATION	The KCNH family of ion channels, comprising ether-a-go-go (EAG), EAG-related gene (ERG), and EAG-like (ELK) K+-channel subfamilies, is crucial for repolarization of the cardiac action potential(1), regulation of neuronal excitability(2) and proliferation of tumour cells(3). The carboxy-terminal region of KCNH channels contains a cyclic-nucleotide-binding homology domain (CNBHD) and C-linker that couples the CNBHD to the pore(4). The C-linker/CNBHD is essential for proper function and trafficking of ion channels in the KCNH family(5-9). However, despite the importance of the C-linker/CNBHD for the function of KCNH channels, the structural basis of ion-channel regulation by the C-linker/CNBHD is unknown. Here we report the crystal structure of the C-linker/CNBHD of zebrafish ELK channels at 2.2-angstrom resolution. Although the overall structure of the C-linker/CNBHD of ELK channels is similar to the cyclic-nucleotide-binding domain (CNBD) structure of the related hyperpolarization-activated cyclic-nucleotide-modulated (HCN) channels(10), there are marked differences. Unlike the CNBD of HCN, the CNBHD of ELK displays a negatively charged electrostatic profile that explains the lack of binding and regulation of KCNH channels by cyclic nucleotides(4,11). Instead of cyclic nucleotide, the binding pocket is occupied by a short beta-strand. Mutations of the beta-strand shift the voltage dependence of activation to more depolarized voltages, implicating the beta-strand as an intrinsic ligand for the CNBHD of ELK channels. In both ELK and HCN channels the C-linker is the site of virtually all of the intersubunit interactions in the C-terminal region. However, in the zebrafish ELK structure there is a reorientation in the C-linker so that the subunits form dimers instead of tetramers, as observed in HCN channels. These results provide a structural framework for understanding the regulation of ion channels in the KCNH family by the C-linker/CNBHD and may guide the design of specific drugs.	[Brelidze, Tinatin I.; Carlson, Anne E.; Zagotta, William N.] Univ Washington, Dept Physiol & Biophys, Sch Med, Seattle, WA 98195 USA; [Sankaran, Banumathi] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley Ctr Struct Biol, Berkeley, CA 94720 USA	University of Washington; University of Washington Seattle; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Zagotta, WN (corresponding author), Univ Washington, Dept Physiol & Biophys, Sch Med, Box 357290, Seattle, WA 98195 USA.	zagotta@u.washington.edu	Carlson, Anne/I-9495-2019	Carlson, Anne/0000-0003-2724-1325; Brelidze, Tinatin/0000-0003-3046-8184	Howard Hughes Medical Institute; National Institutes of Health (NIH) [R01 EY010329, F32 HL095241]; NIH, National Institute of General Medical Sciences; Office of Science, Office of Basic Energy Sciences, of the US Department of Energy [DE-AC02-05CH11231]; NATIONAL EYE INSTITUTE [R01EY010329] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL095241] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of Science, Office of Basic Energy Sciences, of the US Department of Energy(United States Department of Energy (DOE)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank M. Munari, S. Camp, S. Cunnington and G. Sheridan for excellent technical assistance. We thank the beamline staff at the Advanced Light Source (ALS) and especially P. Zwart for help with data analysis. We also thank the members of the Zagotta laboratory for helpful discussions. This work was supported by the Howard Hughes Medical Institute, National Institutes of Health (NIH) grant R01 EY010329 (W.N.Z.) and NIH grant F32 HL095241 (A. E. C.). The Berkeley Center for Structural Biology is supported in part by the NIH, National Institute of General Medical Sciences and the Howard Hughes Medical Institute. The ALS is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under contract no. DE-AC02-05CH11231.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Al-Owais M, 2009, EUR BIOPHYS J BIOPHY, V38, P569, DOI 10.1007/s00249-009-0408-2; Altieri SL, 2008, J MOL BIOL, V381, P655, DOI 10.1016/j.jmb.2008.06.011; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Becchetti A, 2002, EUR J NEUROSCI, V16, P415, DOI 10.1046/j.1460-9568.2002.02079.x; Brelidze TI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012523; Brelidze TI, 2009, J BIOL CHEM, V284, P27989, DOI 10.1074/jbc.M109.016337; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Camacho J, 2006, CANCER LETT, V233, P1, DOI 10.1016/j.canlet.2005.02.016; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clayton GM, 2004, CELL, V119, P615, DOI 10.1016/j.cell.2004.10.030; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engeland B, 1998, J PHYSIOL-LONDON, V513, P647, DOI 10.1111/j.1469-7793.1998.647ba.x; Ganetzky B, 1999, ANN NY ACAD SCI, V868, P356, DOI 10.1111/j.1749-6632.1999.tb11297.x; Guerrero SA, 2001, APPL MICROBIOL BIOT, V56, P718, DOI 10.1007/s002530100690; Gustina AS, 2011, J GEN PHYSIOL, V137, P315, DOI 10.1085/jgp.201010582; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Li QX, 2010, BIOCHEM BIOPH RES CO, V403, P126, DOI 10.1016/j.bbrc.2010.10.132; Muskett FW, 2011, J BIOL CHEM, V286, P6184, DOI 10.1074/jbc.M110.199364; Napolitano C, 2005, JAMA-J AM MED ASSOC, V294, P2975, DOI 10.1001/jama.294.23.2975; Ng CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016191; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Schonherr R, 1996, J PHYSIOL-LONDON, V493, P635, DOI 10.1113/jphysiol.1996.sp021410; Schunke S, 2011, P NATL ACAD SCI USA, V108, P6121, DOI 10.1073/pnas.1015890108; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Stevens L, 2009, EUR BIOPHYS J BIOPHY, V38, P523, DOI 10.1007/s00249-009-0402-8; Trudeau MC, 1999, J NEUROSCI, V19, P2906; Wang JL, 1998, J GEN PHYSIOL, V112, P637, DOI 10.1085/jgp.112.5.637; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhang XF, 2010, NAT NEUROSCI, V13, P1056, DOI 10.1038/nn.2610; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061; Zou AR, 2003, AM J PHYSIOL-CELL PH, V285, pC1356, DOI 10.1152/ajpcell.00179.2003	38	97	97	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2012	481	7382					530	U147		10.1038/nature10735	http://dx.doi.org/10.1038/nature10735			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881GY	22230959	Green Accepted			2022-12-28	WOS:000299471800045
J	Lehouck, A; Mathieu, C; Carremans, C; Baeke, F; Verhaegen, J; Van Eldere, J; Decallonne, B; Bouillon, R; Decramer, M; Janssens, W				Lehouck, An; Mathieu, Chantal; Carremans, Claudia; Baeke, Femke; Verhaegen, Jan; Van Eldere, Johan; Decallonne, Brigitte; Bouillon, Roger; Decramer, Marc; Janssens, Wim			High Doses of Vitamin D to Reduce Exacerbations in Chronic Obstructive Pulmonary Disease	ANNALS OF INTERNAL MEDICINE			English	Article							NUTRITION EXAMINATION SURVEY; RANDOMIZED CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIAL; LUNG-FUNCTION DECLINE; 3RD NATIONAL-HEALTH; D SUPPLEMENTATION; D DEFICIENCY; DOUBLE-BLIND; TUBERCULOSIS; STANDARDIZATION	Background: Low serum 25-hydroxyvitamin D (25-[OH] D) levels have been associated with lower FEV1, impaired immunologic control, and increased airway inflammation. Because many patients with chronic obstructive pulmonary disease (COPD) have vitamin D deficiency, effects of vitamin D supplementation may extend beyond preventing osteoporosis. Objective: To explore whether supplementation with high doses of vitamin D could reduce the incidence of COPD exacerbations. Design: Randomized, single-center, double-blind, placebo-controlled trial. (ClinicalTrials.gov registration number: NCT00666367) Setting: University Hospitals Leuven, Leuven, Belgium. Patients: 182 patients with moderate to very severe COPD and a history of recent exacerbations. Intervention: 100 000 IU of vitamin D supplementation or placebo every 4 weeks for 1 year. Measurements: The primary outcome was time to first exacerbation. Secondary outcomes were exacerbation rate, time to first hospitalization, time to second exacerbation, FEV1, quality of life, and death. Results: Mean serum 25-(OH) D levels increased significantly in the vitamin D group compared with the placebo group (mean between-group difference, 30 ng/mL [95% CI, 27 to 33 ng/mL]; P < 0.001). The median time to first exacerbation did not significantly differ between the groups (hazard ratio, 1.1 [CI, 0.82 to 1.56]; P = 0.41), nor did exacerbation rates, FEV1, hospitalization, quality of life, and death. However, a post hoc analysis in 30 participants with severe vitamin D deficiency (serum 25-[OH] D levels 10 ng/mL) at baseline showed a significant reduction in exacerbations in the vitamin D group (rate ratio, 0.57 [CI, 0.33 to 0.98]; P = 0.042). Limitation: This was a single-center study with a small sample size. Conclusion: High-dose vitamin D supplementation in a sample of patients with COPD did not reduce the incidence of exacerbations. In participants with severe vitamin D deficiency at baseline, supplementation may reduce exacerbations.	[Lehouck, An; Mathieu, Chantal; Carremans, Claudia; Baeke, Femke; Verhaegen, Jan; Van Eldere, Johan; Decallonne, Brigitte; Bouillon, Roger; Decramer, Marc; Janssens, Wim] Katholieke Univ Leuven Hosp, B-3000 Louvain, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven	Janssens, W (corresponding author), Katholieke Univ Leuven Hosp, Herestr 49,Bus 7003, B-3000 Louvain, Belgium.	wim.janssens@uz.kuleuven.be	mathieu, chantal/ABD-5505-2021; Van Eldere, Johan/AAI-8965-2020	mathieu, chantal/0000-0002-4055-5233; Janssens, Wim/0000-0003-1830-2982	Agency for Innovation by Science and Technology (IWT-TBM) [G.335102]; Laboratoires SMB (Brussels, Belgium); Research Foundation-Flanders (FWO Vlaanderen)	Agency for Innovation by Science and Technology (IWT-TBM); Laboratoires SMB (Brussels, Belgium); Research Foundation-Flanders (FWO Vlaanderen)(FWO)	By the Applied Biomedical Research Program, Agency for Innovation by Science and Technology (IWT-TBM) (G.335102) and Laboratoires SMB (Brussels, Belgium). Drs. Mathieu, Decallonne, and Janssens are supported by Research Foundation-Flanders (FWO Vlaanderen).	ANTHONISEN NR, 1987, ANN INTERN MED, V106, P196, DOI 10.7326/0003-4819-106-2-196; Bischoff-Ferrari HA, 2009, ARCH INTERN MED, V169, P551, DOI 10.1001/archinternmed.2008.600; Black PN, 2005, CHEST, V128, P3792, DOI 10.1378/chest.128.6.3792; Burton JM, 2010, NEUROLOGY, V74, P1852, DOI 10.1212/WNL.0b013e3181e1cec2; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Dawson-Hughes B, 2010, OSTEOPOROSIS INT, V21, P1151, DOI 10.1007/s00198-010-1285-3; Decramer M, 2010, THORAX, V65, P837, DOI 10.1136/thx.2009.133355; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; Essa S, 2010, J STEROID BIOCHEM, V121, P110, DOI 10.1016/j.jsbmb.2010.02.003; Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Janssens W, 2010, THORAX, V65, P215, DOI 10.1136/thx.2009.120659; Janssens W, 2009, AM J RESP CRIT CARE, V179, P630, DOI 10.1164/rccm.200810-1576PP; Kriegel MA, 2011, SEMIN ARTHRITIS RHEU, V40, P512, DOI 10.1016/j.semarthrit.2010.07.009; Krishnan AV, 2010, ENDOCRIN METAB CLIN, V39, P401, DOI 10.1016/j.ecl.2010.02.011; Kunisaki KM, 2011, EUR RESPIR J, V37, P238, DOI 10.1183/09031936.00146509; Lips P, 2006, PROG BIOPHYS MOL BIO, V92, P4, DOI 10.1016/j.pbiomolbio.2006.02.016; Marik R, 2010, CANCER BIOL THER, V10, P44, DOI 10.4161/cbt.10.1.11994; Martineau AR, 2011, LANCET, V377, P242, DOI 10.1016/S0140-6736(10)61889-2; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Nnoaham KE, 2008, INT J EPIDEMIOL, V37, P113, DOI 10.1093/ije/dym247; Puhan MA, 2004, RESP MED, V98, P342, DOI 10.1016/j.rmed.2003.10.013; Roca J, 1998, EUR RESPIR J, V11, P1354, DOI 10.1183/09031936.98.11061354; Ross AC, 2011, PUBLIC HEALTH NUTR, V14, P938, DOI 10.1017/S1368980011000565; Seemungal TAR, 2008, AM J RESP CRIT CARE, V178, P1139, DOI 10.1164/rccm.200801-145OC; Suissa S, 2006, AM J RESP CRIT CARE, V173, P842, DOI 10.1164/rccm.200508-1338PP; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; The National Academies, 2010, IOM REP SETS NEW DIE; Urashima M, 2010, AM J CLIN NUTR, V91, P1255, DOI 10.3945/ajcn.2009.29094; Vieth R, 2006, PROG BIOPHYS MOL BIO, V92, P26, DOI 10.1016/j.pbiomolbio.2006.02.003; von Hurst PR, 2010, BRIT J NUTR, V103, P549, DOI 10.1017/S0007114509992017; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Wejse C, 2009, AM J RESP CRIT CARE, V179, P843, DOI 10.1164/rccm.200804-567OC; Wilson R, 2004, CHEST, V125, P953, DOI 10.1378/chest.125.3.953; Witham MD, 2010, CIRC-HEART FAIL, V3, P195, DOI 10.1161/CIRCHEARTFAILURE.109.907899	39	253	262	8	34	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 17	2012	156	2					105	W20		10.7326/0003-4819-156-2-201201170-00004	http://dx.doi.org/10.7326/0003-4819-156-2-201201170-00004			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	894IW	22250141				2022-12-28	WOS:000300421400001
J	Welz, O; Savee, JD; Osborn, DL; Vasu, SS; Percival, CJ; Shallcross, DE; Taatjes, CA				Welz, Oliver; Savee, John D.; Osborn, David L.; Vasu, Subith S.; Percival, Carl J.; Shallcross, Dudley E.; Taatjes, Craig A.			Direct Kinetic Measurements of Criegee Intermediate (CH2OO) Formed by Reaction of CH2I with O-2	SCIENCE			English	Article							GAS-PHASE OZONOLYSIS; HOX FORMATION; OZONE; OXIDATION; CHEMISTRY; IODINE; COMPLEXES; MECHANISM; RADICALS; AEROSOL	Ozonolysis is a major tropospheric removal mechanism for unsaturated hydrocarbons and proceeds via "Criegee intermediates"-carbonyl oxides-that play a key role in tropospheric oxidation models. However, until recently no gas-phase Criegee intermediate had been observed, and indirect determinations of their reaction kinetics gave derived rate coefficients spanning orders of magnitude. Here, we report direct photoionization mass spectrometric detection of formaldehyde oxide (CH2OO) as a product of the reaction of CH2I with O-2. This reaction enabled direct laboratory determinations of CH2OO kinetics. Upper limits were extracted for reaction rate coefficients with NO and H2O. The CH2OO reactions with SO2 and NO2 proved unexpectedly rapid and imply a substantially greater role of carbonyl oxides in models of tropospheric sulfate and nitrate chemistry than previously assumed.	[Welz, Oliver; Savee, John D.; Osborn, David L.; Vasu, Subith S.; Taatjes, Craig A.] Sandia Natl Labs, Combust Res Facil, Livermore, CA 94551 USA; [Percival, Carl J.] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester M13 9PL, Lancs, England; [Shallcross, Dudley E.] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England	United States Department of Energy (DOE); Sandia National Laboratories; University of Manchester; University of Bristol	Taatjes, CA (corresponding author), Sandia Natl Labs, Combust Res Facil, Mail Stop 9055, Livermore, CA 94551 USA.	cataatj@sandia.gov	Percival, Carl/B-9353-2012; Welz, Oliver/C-1165-2013; Osborn, David/A-2627-2009	Welz, Oliver/0000-0003-1978-2412; Osborn, David/0000-0003-4304-8218; Vasu, Subith/0000-0002-4164-3163; Percival, Carl/0000-0003-2525-160X; Taatjes, Craig/0000-0002-9271-0282	Division of Chemical Sciences, Geosciences, and Biosciences, the Office of Basic Energy Sciences, the U.S. Department of Energy; Natural Environment Research Council; Office of Science, Office of Basic Energy Sciences, Materials Sciences Division, of the U. S. Department of Energy at Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; National Nuclear Security Administration [DE-AC04-94-AL85000]; NERC [NE/I010505/1, NE/I014381/1, NE/J009008/1, NE/G01972X/1] Funding Source: UKRI; Natural Environment Research Council [NE/I010505/1, NE/J009008/1, NE/G01972X/1, NE/I014381/1] Funding Source: researchfish	Division of Chemical Sciences, Geosciences, and Biosciences, the Office of Basic Energy Sciences, the U.S. Department of Energy(United States Department of Energy (DOE)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Office of Science, Office of Basic Energy Sciences, Materials Sciences Division, of the U. S. Department of Energy at Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); National Nuclear Security Administration(National Nuclear Security Administration); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Additional pseudo-first-order rate constants and spectroscopic data underpinning this work are presented in the SOM. This work is supported by the Division of Chemical Sciences, Geosciences, and Biosciences, the Office of Basic Energy Sciences, the U.S. Department of Energy. D. E. S. and C.J.P. thank Natural Environment Research Council for funding. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, Materials Sciences Division, of the U. S. Department of Energy under contract DE-AC02-05CH11231 at Lawrence Berkeley National Laboratory. Sandia is a multiprogram laboratory operated by Sandia Corporation, a Lockheed Martin company, for the National Nuclear Security Administration under contract DE-AC04-94-AL85000. We thank A. Eskola (Helsinki) for drawing our attention to the reaction of CH<INF>2</INF>I with O<INF>2</INF>, H. Johnsen (Sandia) for technical support of this experiment, and H. Huang, J.Zador, and L. Sheps (Sandia) for discussions on data analysis. The experiments were conceived by C. A. T., C.J.P., and D. E. S. and designed and carried out by O.W., J.D.S., C. A. T., and D.L.O., with assistance from S. S. V. All authors participated in the data analysis and interpretation and contributed to the manuscript.	Alam MS, 2011, PHYS CHEM CHEM PHYS, V13, P11002, DOI 10.1039/c0cp02342f; Aloisio S, 2000, ACCOUNTS CHEM RES, V33, P825, DOI 10.1021/ar000097u; Archibald AT, 2010, ATMOS CHEM PHYS, V10, P8097, DOI 10.5194/acp-10-8097-2010; Calvert JG, 2000, MECH ATMOSPHERIC OXI; Carpenter LJ, 2003, CHEM REV, V103, P4953, DOI 10.1021/cr0206465; Cool TA, 2005, INT J MASS SPECTROM, V247, P18, DOI 10.1016/j.ijms.2005.08.018; COX RA, 1971, NATURE, V230, P321, DOI 10.1038/230321a0; CRIEGEE R, 1975, ANGEW CHEM INT EDIT, V14, P745, DOI 10.1002/anie.197507451; Dillon TJ, 2008, PHYS CHEM CHEM PHYS, V10, P1540, DOI 10.1039/b717386e; Donahue NM, 2011, PHYS CHEM CHEM PHYS, V13, P10848, DOI 10.1039/c0cp02564j; Eskola AJ, 2006, PHYS CHEM CHEM PHYS, V8, P1416, DOI 10.1039/b516291b; Fenske JD, 2000, J PHYS CHEM A, V104, P9921, DOI 10.1021/jp0016636; GAB S, 1985, NATURE, V316, P535, DOI 10.1038/316535a0; Gravestock TJ, 2010, CHEMPHYSCHEM, V11, P3928, DOI 10.1002/cphc.201000575; Harrison RM, 2006, SCI TOTAL ENVIRON, V360, P5, DOI 10.1016/j.scitotenv.2005.08.053; Hasson AS, 2003, J PHYS CHEM A, V107, P6176, DOI 10.1021/jp0346007; HATAKEYAMA S, 1994, RES CHEM INTERMEDIAT, V20, P503, DOI 10.1163/156856794X00432; Heard DE, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020544; Heaton KJ, 2009, ENVIRON SCI TECHNOL, V43, P7797, DOI 10.1021/es901214p; Johnson D, 2008, CHEM SOC REV, V37, P699, DOI 10.1039/b704260b; Klemperer W, 2006, P NATL ACAD SCI USA, V103, P10584, DOI 10.1073/pnas.0508231103; Kroll JH, 2008, ATMOS ENVIRON, V42, P3593, DOI 10.1016/j.atmosenv.2008.01.003; Kroll JH, 2001, J PHYS CHEM A, V105, P1554, DOI 10.1021/jp002121r; Kurten T, 2011, J PHYS CHEM A, V115, P8669, DOI 10.1021/jp203907d; Nguyen MT, 2007, CHEM PHYS LETT, V448, P183, DOI 10.1016/j.cplett.2007.10.033; O'Dowd CD, 2002, NATURE, V417, P632, DOI 10.1038/nature00775; Olzmann M, 1997, J PHYS CHEM A, V101, P9421, DOI 10.1021/jp971663e; Paulot F, 2011, ATMOS CHEM PHYS, V11, P1989, DOI 10.5194/acp-11-1989-2011; Presto AA, 2004, J PHYS CHEM A, V108, P9096, DOI 10.1021/jp047162s; SEHESTED J, 1994, INT J CHEM KINET, V26, P259, DOI 10.1002/kin.550260204; Taatjes CA, 2008, J AM CHEM SOC, V130, P11883, DOI 10.1021/ja804165q	31	526	530	19	516	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 13	2012	335	6065					204	207		10.1126/science.1213229	http://dx.doi.org/10.1126/science.1213229			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875LZ	22246773				2022-12-28	WOS:000299033100049
J	Fridman, M; Farsi, A; Okawachi, Y; Gaeta, AL				Fridman, Moti; Farsi, Alessandro; Okawachi, Yoshitomo; Gaeta, Alexander L.			Demonstration of temporal cloaking	NATURE			English	Article							SILICON-CHIP; TIME LENS; FREQUENCIES; PRINCIPLES	Recent research has uncovered a remarkable ability to manipulate and control electromagnetic fields to produce effects such as perfect imaging and spatial cloaking(1,2). To achieve spatial cloaking, the index of refraction is manipulated to flow light from a probe around an object in such a way that a 'hole' in space is created, and the object remains hidden(3-14). Alternatively, it may be desirable to cloak the occurrence of an event over a finite time period, and the idea of temporal cloaking has been proposed in which the dispersion of the material is manipulated in time, producing a 'time hole' in the probe beam to hide the occurrence of the event from the observer(15). This approach is based on accelerating the front part of a probe light beam and slowing down its rear part to create a well controlled temporal gap-inside which an event occurs-such that the probe beam is not modified in any way by the event. The probe beam is then restored to its original form by the reverse manipulation of the dispersion. Here we present an experimental demonstration of temporal cloaking in an optical fibre-based system by applying concepts from the space-time duality between diffraction and dispersive broadening(16). We characterize the performance of our temporal cloak by detecting the spectral modification of a probe beam due to an optical interaction and show that the amplitude of the event (at the picosecond timescale) is reduced by more than an order of magnitude when the cloak is turned on. These results are a significant step towards the development of full spatio-temporal cloaking.	[Fridman, Moti; Farsi, Alessandro; Okawachi, Yoshitomo; Gaeta, Alexander L.] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA	Cornell University	Gaeta, AL (corresponding author), Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA.	alg3@cornell.edu	Okawachi, Yoshitomo/AAO-2644-2020; Gaeta, Alexander/AAE-2095-2019; Fridman, Moti/AAK-5384-2020	fridman, moti/0000-0002-8883-9964; Farsi, Alessandro/0000-0001-8305-1652	Defence Advanced Research Project Agency; Center for Nanoscale Systems; National Science Foundation for Science, Technology, and Innovation (NYSTAR)	Defence Advanced Research Project Agency; Center for Nanoscale Systems; National Science Foundation for Science, Technology, and Innovation (NYSTAR)	We thank D. J. Gauthier for his comments. This work was supported by the Defence Advanced Research Project Agency and by the Center for Nanoscale Systems, supported by the National Science Foundation for Science, Technology, and Innovation (NYSTAR).	Agrawal G. P., 2007, NONLINEAR FIBER OPTI; Bennett CV, 2000, IEEE J QUANTUM ELECT, V36, P649, DOI 10.1109/3.845718; Bennett CV, 2000, IEEE J QUANTUM ELECT, V36, P430, DOI 10.1109/3.831018; Cai WS, 2007, NAT PHOTONICS, V1, P224, DOI 10.1038/nphoton.2007.28; Chen HS, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.063903; Cummer SA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.024301; Foster MA, 2008, NATURE, V456, P81, DOI 10.1038/nature07430; Foster MA, 2009, NAT PHOTONICS, V3, P581, DOI 10.1038/NPHOTON.2009.169; Gabrielli LH, 2009, NAT PHOTONICS, V3, P461, DOI 10.1038/NPHOTON.2009.117; Greenleaf A, 2003, PHYSIOL MEAS, V24, P413, DOI 10.1088/0967-3334/24/2/353; KOLNER BH, 1994, IEEE J QUANTUM ELECT, V30, P1951, DOI 10.1109/3.301659; KOLNER BH, 1989, OPT LETT, V14, P630, DOI 10.1364/OL.14.000630; Lai Y, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.093901; Leonhardt U, 2006, SCIENCE, V312, P1777, DOI 10.1126/science.1126493; Leonhardt U, 2009, SCIENCE, V323, P110, DOI 10.1126/science.1166332; Li JS, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.203901; McCall MW, 2011, J OPTICS-UK, V13, DOI 10.1088/2040-8978/13/2/024003; Miller DAB, 2006, OPT EXPRESS, V14, P12457, DOI 10.1364/OE.14.012457; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Salem R, 2008, OPT LETT, V33, P1047, DOI 10.1364/OL.33.001047; Schurig D, 2006, SCIENCE, V314, P977, DOI 10.1126/science.1133628; Valentine J, 2009, NAT MATER, V8, P568, DOI [10.1038/nmat2461, 10.1038/NMAT2461]; Weder R, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/6/065207	23	157	165	7	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 5	2012	481	7379					62	65		10.1038/nature10695	http://dx.doi.org/10.1038/nature10695			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872VD	22222748	Green Submitted			2022-12-28	WOS:000298836900029
J	Wieseler, B; Kerekes, MF; Vervoelgyi, V; McGauran, N; Kaiser, T				Wieseler, Beate; Kerekes, Michaela F.; Vervoelgyi, Volker; McGauran, Natalie; Kaiser, Thomas			Impact of document type on reporting quality of clinical drug trials: a comparison of registry reports, clinical study reports, and journal publications	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED-TRIALS; STATEMENT; GUIDELINES; PROTOCOLS; BIAS	Objective To investigate to what extent three types of documents for reporting clinical trials provide sufficient information for trial evaluation. Design Retrospective analysis Data sources Primary studies and corresponding documents (registry reports, clinical study reports, journal publications) from 16 health technology assessments of drugs conducted by the German Institute for Quality and Efficiency in Health Care between 2006 and February 2011. Data analysis We assessed reporting quality for each study and each available document for six items on methods and six on outcomes, and dichotomised them as "completely reported" or "incompletely reported." For each document type, we calculated the proportion of studies with complete reporting for methods and outcomes, per item and overall, and compared the findings. Results We identified 268 studies. Publications, study reports and registry reports were available for 192 (72%), 101 (38%), and 78 (29%) studies, respectively. Reporting quality was highest in study reports, which overall provided complete information for 90% of items (1086/1212). Registry reports provided more complete information on outcomes than on methods (overall 330/468 (71%) v 147/468 (31%)); the same applied to publications (594/1152 (52%) v 458/1152 (40%)). In the matched pairs analysis, reporting quality was poorer in registry reports than in study reports for overall methods and outcomes (P<0.001 in each case). Compared with publications, reporting quality was poorer in registry reports for overall methods (P<0.001), but better for outcomes (P=0.005). Conclusion Registry reports and publications insufficiently report clinical trials but may supplement each other. Measures to improve reporting include the mandatory worldwide implementation of adequate standards for results registration.	[Wieseler, Beate; Kerekes, Michaela F.; Vervoelgyi, Volker; McGauran, Natalie; Kaiser, Thomas] Inst Qual & Efficiency Hlth Care, D-51105 Cologne, Germany		Wieseler, B (corresponding author), Inst Qual & Efficiency Hlth Care, Dillenburger Str 27, D-51105 Cologne, Germany.	beate.wieseler@iqwig.de		Wieseler, Beate/0000-0002-3519-754X; Kaiser, Thomas/0000-0003-0795-538X	IQWiG	IQWiG	This work was supported by IQWiG.	[Anonymous], 2010, LANCET, V375, P1225, DOI 10.1016/S0140-6736(10)60523-5; Attorney General of the State of New York, 2004, MATT GLAXOSMITHKLINE; Chan AW, 2008, PLOS MED, V5, P1533, DOI 10.1371/journal.pmed.0050230; Chan AW, 2005, LANCET, V365, P1159, DOI 10.1016/S0140-6736(05)71879-1; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; Dickersin K, 2003, JAMA-J AM MED ASSOC, V290, P516, DOI 10.1001/jama.290.4.516; European Commission, 2010, ANN 1 STRUCT DAT COL; Eyding D, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4737; Ghersi D, 2008, LANCET, V372, P1531, DOI 10.1016/S0140-6736(08)61635-9; Godlee F, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5405; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hopewell Sally, 2010, BMJ, V340, pc723, DOI 10.1136/bmj.c723; Hopewell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000006.pub3; International Federation of Pharmaceutical Manufacturers and Associations, 2009, JOINT POS DISCL CLIN; Krleza-Jeric K, 2005, BMJ-BRIT MED J, V330, P956, DOI 10.1136/bmj.330.7497.956; Lefebvre C., 2011, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9780470712184.CH6; McAuley L, 2000, LANCET, V356, P1228, DOI 10.1016/S0140-6736(00)02786-0; McGauran N, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-37; Miller JD, 2010, JAMA-J AM MED ASSOC, V303, P773, DOI 10.1001/jama.2010.207; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; New York State Attorney General, 2004, SETTL SETS NEW STAND; nternational Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Expert Working Group, 1995, ICH HARM TRIP GUID S; (PhRMA). PRaMoA, 2011, 17 COCHR C SING 11 1; Reveiz L, 2010, J CLIN EPIDEMIOL, V63, P1216, DOI 10.1016/j.jclinepi.2010.01.013; Reveiz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012484; Sawicki PT, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1997; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Tse T, 2009, CHEST, V136, P295, DOI 10.1378/chest.08-3022; Turner EH, 2008, SCIENCE, V322, P44, DOI 10.1126/science.322.5898.44c; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1; Wieseler B, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4942; Wood AJJ, 2009, NEW ENGL J MED, V360, P824, DOI 10.1056/NEJMsr0806582	35	68	70	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 3	2012	344								d8141	10.1136/bmj.d8141	http://dx.doi.org/10.1136/bmj.d8141			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874UE	22214759	hybrid			2022-12-28	WOS:000298982800010
J	Tavare, A				Tavare, Aniket			RESEARCH INTEGRITY Managing research misconduct: is anyone getting it right?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INSTITUTIONAL RESEARCH MISCONDUCT; RETRACTIONS; EUROPE		BMJ, London WC1H 9JR, England		Tavare, A (corresponding author), BMJ, London WC1H 9JR, England.	ATavare@bmj.com						ALLEA, 2010, SEL COD GUID OTH REL; Bosch X, 2011, NATURE, V480, P181, DOI 10.1038/480181c; Bosch X, 2010, EMBO REP, V11, P252, DOI 10.1038/embor.2010.32; Chalmers L, 2006, BRIT MED J, V333, P594, DOI 10.1136/bmj.38968.611296.F7; Council of Canadian Academies The Expert Panel on Research Integrity, 2010, HON ACC TRUST FOST R; Curfman GD, 2003, NEW ENGL J MED, V348, P945, DOI 10.1056/NEJMe030015; Dyer C, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d4017; Eaton L, 2006, BRIT MED J, V332, P193, DOI 10.1136/bmj.332.7535.193-a; [European Science Foundation ALLEA], 2010, EUR COD COND RES INT; Fanelli D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005738; Forstermann U, 2011, ANESTH ANALG, V112, P504, DOI 10.1213/ANE.0b013e31820a1480; Godlee F, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d7890; Godlee F, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d7284; Nimmo W, 2000, P R COLL PHYS EDI S7, V30, P2; Nylenna M, 1999, LANCET, V354, P57, DOI 10.1016/S0140-6736(98)07133-5; Panel on Responsible Conduct of Research, 2011, TRIAG FRAM RESP COND; PEARCE JM, 1994, BRIT J OBSTET GYNAEC, V101, P716, DOI 10.1111/j.1471-0528.1994.tb13194.x; Petrovecki M, 2001, CROAT MED J, V42, P7; Shafer SL, 2011, ANESTH ANALG, V112, P498, DOI 10.1213/ANE.0b013e31820ad3b7; Singapore statement, 2010, SING STAT RES INT; Stanbrook MB, 2011, CAN MED ASSOC J, V183, pE766, DOI 10.1503/cmaj.110442; Titus SL, 2008, NATURE, V453, P980, DOI 10.1038/453980a; Van Noorden R, 2011, NATURE, V478, P26, DOI 10.1038/478026a; Wager E, 2011, J MED ETHICS, V37, P567, DOI 10.1136/jme.2010.040964	24	17	17	1	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 29	2011	343								d8212	10.1136/bmj.d8212	http://dx.doi.org/10.1136/bmj.d8212			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	874TN	22207043				2022-12-28	WOS:000298981100002
J	Lawler, A				Lawler, Andrew			America's Lost City	SCIENCE			English	News Item																			0	1	1	2	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1618	1623		10.1126/science.334.6063.1618	http://dx.doi.org/10.1126/science.334.6063.1618			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22194542				2022-12-28	WOS:000298344000016
J	Fineberg, HV				Fineberg, Harvey V.			CHRISTMAS 2011: EVOLUTION Neo-evolution: is Homo sapiens ready?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Natl Acad Sci, Inst Med, Washington, DC 20418 USA	National Academies of Sciences, Engineering & Medicine	Fineberg, HV (corresponding author), Natl Acad Sci, Inst Med, Washington, DC 20418 USA.	fineberg@nas.edu							0	1	1	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 21	2011	343								d7649	10.1136/bmj.d7649	http://dx.doi.org/10.1136/bmj.d7649			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	874TF	22189128				2022-12-28	WOS:000298980300002
J	McKee, M; Stuckler, D				McKee, Martin; Stuckler, David			CHRISTMAS 2011: FOOD FOR THOUGHT The assault on universalism: how to destroy the welfare state	BRITISH MEDICAL JOURNAL			English	Editorial Material									[McKee, Martin] Univ London London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London WC1E 7HT, England; [Stuckler, David] Univ Cambridge, Dept Sociol, Cambridge, England	University of London; London School of Hygiene & Tropical Medicine; University of Cambridge	McKee, M (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Keppel St, London WC1E 7HT, England.	martin.mckee@lshtm.ac.uk	Stuckler, David/H-2261-2012; McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018	McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683; Stuckler, David/0000-0002-1288-8401				Alesina A., 2004, FIGHTING POVERTY US; Alesina Alberto, 2001, WHY DOESNT US HAVE E; Beveridge William, 1942, SOCIAL INSURANCE ALL; BOFFEY D, 2011, WELFARE WORK POLICY; Borkin Joseph, 1978, CRIME PUNISHMENT IG; DellaVigna Stefano, 2006, 12169 NBER; Dickens Charles, 1993, CHRISTMAS CAROL; Esping-Anderson G., 1990, 3 WORLDS WELFARE CAP; Fenby J, 2010, GEN C DEGAULLE FRANC; Frank Thomas, 2004, WHATS MATTER KANSAS; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; HUBER E, 1993, AM J SOCIOL, V99, P711, DOI 10.1086/230321; Klein, 2008, SHOCK DOCTRINE RISE; Lipset S. M., 1996, AM EXCEPTIONALISM DO; Luttmer EFF, 2001, J POLIT ECON, V109, P500, DOI 10.1086/321019; Lynn N, 2003, DISCOURSE SOC, V14, P425, DOI 10.1177/0957926503014004002; Meister B, 2011, REPRESENTATIONS, P128, DOI 10.1525/rep.2011.116.1.128; MILLWARD D, 2011, TRAINS RICH MANS TOY; Mirrlees J., 2011, TAX DESIGN MIRRLEES; NAVARRO V, 1989, SOC SCI MED, V28, P887, DOI 10.1016/0277-9536(89)90313-4; Newfield C., 2011, UNMAKING PUBLIC U 40; Pierson P, 1996, WORLD POLIT, V48, P143, DOI 10.1353/wp.1996.0004; RAWLS J, 1973, THEORY JUSTICE; RICHARDSON H, 2011, MPS WARN TUITION FEE; STILLE A, 2011, PARADOX NEW ELITE; TIMMINS N, 1995, 5 GIANTS BIOGRAPHY W; Titmuss, 1958, ESSAYS WELFARE STATE; WEARDEN G, 2011, W BUFFETT CALLS HIGH; Westen Drew., 2008, POLITICAL BRAIN ROLE	29	16	18	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2011	343								d7973	10.1136/bmj.d7973	http://dx.doi.org/10.1136/bmj.d7973			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	868QK	22187190	Green Accepted			2022-12-28	WOS:000298538200011
J	Greenwood, JP; Maredia, N; Younger, JF; Brown, JM; Nixon, J; Everett, CC; Bijsterveld, P; Ridgway, JP; Radjenovic, A; Dickinson, CJ; Ball, SG; Plein, S				Greenwood, John P.; Maredia, Neil; Younger, John F.; Brown, Julia M.; Nixon, Jane; Everett, Colin C.; Bijsterveld, Petra; Ridgway, John P.; Radjenovic, Aleksandra; Dickinson, Catherine J.; Ball, Stephen G.; Plein, Sven			Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial	LANCET			English	Article							ARTERY-DISEASE; MYOCARDIAL-PERFUSION; MULTICENTER; ANGIOGRAPHY; CARDIOLOGY; COMMITTEE; ISCHEMIA; RESERVE; CARE	Background In patients with suspected coronary heart disease, single-photon emission computed tomography (SPECT) is the most widely used test for the assessment of myocardial ischaemia, but its diagnostic accuracy is reported to be variable and it exposes patients to ionising radiation. The aim of this study was to establish the diagnostic accuracy of a multi parametric cardiovascular magnetic resonance (CMR) protocol with x-ray coronary angiography as the reference standard, and to compare CMR with SPECT, in patients with suspected coronary heart disease. Methods In this prospective trial patients with suspected angina pectoris and at least one cardiovascular risk factor were scheduled for CMR, SPECT, and invasive x-ray coronary angiography. CMR consisted of rest and adenosine stress perfusion, cine imaging, late gadolinium enhancement, and MR coronary angiography. Gated adenosine stress and rest SPECT used Tc-99m tetrofosmin. The primary outcome was diagnostic accuracy of CMR. This trial is registered at controlled-trials.com, number ISRCTN77246133. Findings In the 752 recruited patients, 39% had significant CHD as identified by x-ray angiography. For multiparametric CMR the sensitivity was 86.5% (95% CI 81.8-90.1), specificity 83.4% (79.5-86.7), positive predictive value 77.2%, (72.1-81.6) and negative predictive value 90.5% (87.1-93.0). The sensitivity of SPECT was 66.5% (95% CI 60.4-72.1), specificity 82.6% (78.5-86.1), positive predictive value 71.4% (65.3-76.9), and negative predictive value 79.1% (74.8-82.8). The sensitivity and negative predictive value of CMR and SPECT differed significantly (p<0.0001 for both) but specificity and positive predictive value did not (p=0.916 and p=0.061, respectively). Interpretation CE-MARC is the largest, prospective, real world evaluation of CMR and has established CMR's high diagnostic accuracy in coronary heart disease and CMR's superiority over SPECT. It should be adopted more widely than at present for the investigation of coronary heart disease.	[Greenwood, John P.; Maredia, Neil; Younger, John F.; Bijsterveld, Petra; Radjenovic, Aleksandra; Ball, Stephen G.; Plein, Sven] Univ Leeds, Multidisciplinary Cardiovasc Res Ctr, Leeds, W Yorkshire, England; [Greenwood, John P.; Maredia, Neil; Younger, John F.; Bijsterveld, Petra; Radjenovic, Aleksandra; Ball, Stephen G.; Plein, Sven] Univ Leeds, Leeds Inst Genet Hlth & Therapeut, Leeds, W Yorkshire, England; [Brown, Julia M.; Nixon, Jane; Everett, Colin C.] Univ Leeds, Clin Trials Res Unit, Leeds, W Yorkshire, England; [Ridgway, John P.] Leeds Gen Infirm, Dept Med Phys, Leeds LS1 3EX, W Yorkshire, England; [Dickinson, Catherine J.] Leeds Gen Infirm, Dept Nucl Cardiol, Leeds LS1 3EX, W Yorkshire, England	University of Leeds; University of Leeds; University of Leeds; Leeds General Infirmary; University of Leeds; Leeds General Infirmary; University of Leeds	Greenwood, JP (corresponding author), Leeds Gen Infirm, Dept Cardiol, G Floor,Jubilee Wing,Great George St, Leeds LS1 3EX, W Yorkshire, England.	j.greenwood@leeds.ac.uk	Radjenovic, Aleksandra/F-2341-2014	Radjenovic, Aleksandra/0000-0002-1742-6863; brown, julia/0000-0002-2719-7064; Bijsterveld, Petra/0000-0002-9257-5850; Younger, John/0000-0002-3860-4972; Plein, Sven/0000-0002-0997-4384	British Heart Foundation; British Heart Foundation [RG/05/004/18607] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	British Heart Foundation.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Al-Saadi N, 2000, CIRCULATION, V101, P1379, DOI 10.1161/01.CIR.101.12.1379; [Anonymous], CARD DIS; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Giang TH, 2004, EUR HEART J, V25, P1657, DOI 10.1016/j.ehj.2004.06.037; Greenwood JP, 2007, HEART, V93, P1363, DOI 10.1136/hrt.2006.106427; Greenwood JP, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-62; Hamon M, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-29; Hendel RC, 2006, J NUCL CARDIOL, V13, P177, DOI 10.1016/j.nuclcard.2006.08.013; Hendel RC, 2006, J AM COLL CARDIOL, V48, P1475, DOI 10.1016/j.jacc.2006.07.003; Henzlova MJ, 2006, J NUCL CARDIOL, V13, pe80, DOI DOI 10.1016/j.nuclcard.2006.08.011; Holly TA, 2010, J NUCL CARDIOL, V17, P941, DOI 10.1007/s12350-010-9246-y; Hundley WG, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-5; Hundley WG, 2010, CIRCULATION, V121, P2462, DOI 10.1161/CIR.0b013e3181d44a8f; Ishida N, 2003, RADIOLOGY, V229, P209, DOI 10.1148/radiol.2291021118; Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003; Kim WY, 2001, NEW ENGL J MED, V345, P1863, DOI 10.1056/NEJMoa010866; Klem I, 2006, J AM COLL CARDIOL, V47, P1630, DOI 10.1016/j.jacc.2005.10.074; Klem I, 2008, JACC-CARDIOVASC IMAG, V1, P436, DOI 10.1016/j.jcmg.2008.03.010; Kwong RY, 2003, CIRCULATION, V107, P531, DOI 10.1161/01.CIR.0000047527.11221.29; Mowatt G, 2004, HEALTH TECHNOL ASSES, V8, P1; NICE, MYOC PERF SCINT DIAG; Paetsch I, 2004, CIRCULATION, V110, P835, DOI 10.1161/01.CIR.0000138927.00357.FB; Panting JR, 2001, J MAGN RESON IMAGING, V13, P192; Plein S, 2004, J AM COLL CARDIOL, V44, P2173, DOI 10.1016/j.jacc.2004.08.056; Schwitter J, 2001, CIRCULATION, V103, P2230; Schwitter J, 2008, EUR HEART J, V29, P480, DOI 10.1093/eurheartj/ehm617; Shaw LJ, 2006, J AM COLL CARDIOL, V47, p4S, DOI 10.1016/j.jacc.2005.01.072; Tilkemeier PL, 2009, J NUCL CARDIOL, V16, P650, DOI [10.1007/s12350-009-9095-8, DOI 10.1007/S12350-009-9095-8]; Tonino PAL, 2010, J AM COLL CARDIOL, V55, P2816, DOI 10.1016/j.jacc.2009.11.096; Wolff SD, 2004, CIRCULATION, V110, P732, DOI 10.1161/01.CIR.0000138106.84335.62	32	736	756	3	55	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 4	2012	379	9814					453	460		10.1016/S0140-6736(11)61335-4	http://dx.doi.org/10.1016/S0140-6736(11)61335-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	891AF	22196944	Bronze, Green Published			2022-12-28	WOS:000300187800035
J	Thompson, LC; Gillberg, C				Thompson, Lucy C.; Gillberg, Christopher			Behavioural problems from perinatal and neonatal insults	LANCET			English	Editorial Material							GIRLS		[Thompson, Lucy C.] Univ Glasgow, RHSC Yorkhill, Glasgow G3 8SJ, Lanark, Scotland; [Gillberg, Christopher] Gillberg Neuropsychiat Ctr, Gothenburg, Sweden	University of Glasgow	Thompson, LC (corresponding author), Univ Glasgow, RHSC Yorkhill, Glasgow G3 8SJ, Lanark, Scotland.	lucy.thompson@glasgow.ac.uk	Thompson, Lucy/HGB-8369-2022	Thompson, Lucy/0000-0001-7461-3262				Bayley N., 2005, BAYLEY SCALES INFANT; Gillberg C, 2010, RES DEV DISABIL, V31, P1543, DOI 10.1016/j.ridd.2010.06.002; Hinshaw SP, 2002, J CONSULT CLIN PSYCH, V70, P1086, DOI 10.1037//0022-006X.70.5.1086; McGrath LM, 2008, J ABNORM CHILD PSYCH, V36, P151, DOI 10.1007/s10802-007-9166-8; Mwaniki MK, 2012, LANCET, V379, P445, DOI 10.1016/S0140-6736(11)61577-8; Pajer K, 2008, J AM ACAD CHILD PSY, V47, P416, DOI 10.1097/CHI.0b013e3181640828; Thompson L, 2010, EUR CHILD ADOLES PSY, V19, P1, DOI 10.1007/s00787-009-0045-4	7	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 4	2012	379	9814					392	393		10.1016/S0140-6736(11)61788-1	http://dx.doi.org/10.1016/S0140-6736(11)61788-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	891AF	22244655				2022-12-28	WOS:000300187800012
J	Mitja, O; Hays, R; Ipai, A; Penias, M; Paru, R; Fagaho, D; de Lazzari, E; Bassat, Q				Mitja, Oriol; Hays, Russell; Ipai, Anthony; Penias, Moses; Paru, Raymond; Fagaho, David; de Lazzari, Elisa; Bassat, Quique			Single-dose azithromycin versus benzathine benzylpenicillin for treatment of yaws in children in Papua New Guinea: an open-label, non-inferiority, randomised trial	LANCET			English	Article							RESISTANT TREPONEMA-PALLIDUM; MACROLIDE RESISTANCE; ENDEMIC TREPONEMATOSES; CEFTRIAXONE; EFFICACY; SYPHILIS	Background Yaws-an endemic treponematosis and, as such, a neglected tropical disease-is re-emerging in children in rural, tropical areas. Oral azithromycin is effective for syphilis. We assessed the efficacy of azithromycin compared with intramuscular long-acting penicillin to treat patients with yaws. Methods We did an open-label, non-inferiority, randomised trial at Lihir Medical Centre, Papua New Guinea, between Sept 1, 2010, and Feb 1, 2011. Children aged 6 months to 15 years with a serologically confirmed diagnosis of yaws were randomly allocated, by a computer-generated randomisation sequence, to receive either one 30 mg/kg oral dose of azithromycin or an intramuscular injection of 50 000 units per kg benzathine benzylpenicillin. Investigators were masked to group assignment. The primary endpoint was treatment efficacy, with cure rate defined serologically as a decrease in rapid plasma reagin titre of at least two dilutions by 6 months after treatment, and, in participants with primary ulcers, also by epithelialisation of lesions within 2 weeks. Non-inferiority was shown if the upper limit of the two-sided 95% CI for the difference in rates was lower than 10%. The primary analysis was per protocol. This trial is registered with ClinicalTrials.gov, number NCT01382004. Findings We allocated 124 patients to the azithromycin group and 126 to the benzathine benzylpenicillin group. In the per-protocol analysis, after 6 months of follow-up, 106 (96%) of 110 patients in the azithromycin group were cured, compared with 105 (93%) of 113 in the benzathine benzylpenicillin group (treatment difference -3.4%; 95% CI -9.3 to 2.4), thus meeting prespecified criteria for non-inferiority. The number of drug-related adverse events (all mild or moderate) was similar in both treatment groups (ten [8%] in the azithromycin group vs eight [7%] in the benzathine benzylpenicillin group). Interpretation A single oral dose of azithromycin is non-inferior to benzathine benzylpenicillin and avoids the need for injection equipment and medically trained personnel. A change to the simpler azithromycin treatment regimen could enable yaws elimination through mass drug administration programmes.	[Mitja, Oriol] Lihir Med Ctr, Dept Med, Int SOS, Lihir Isl, Nip, Papua N Guinea; [Mitja, Oriol; de Lazzari, Elisa; Bassat, Quique] Univ Barcelona, Barcelona Ctr Int Hlth Res, Hosp Clin, Barcelona, Spain	ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona	Mitja, O (corresponding author), Lihir Med Ctr, Dept Med, Int SOS, POB 34, Lihir Isl, Nip, Papua N Guinea.	oriolmitja@hotmail.com	Mitjà, Oriol/W-4181-2018; Bassat, Quique/P-2341-2016	Mitjà, Oriol/0000-0003-3266-8868; Bassat, Quique/0000-0003-0875-7596; De Lazzari, Elisa/0000-0003-2614-6545; Mitja, Oriol/0000-0002-6469-529X	International SOS; Newcrest Mining; International SOS (Australasia) Pty	International SOS; Newcrest Mining; International SOS (Australasia) Pty	Funding International SOS and Newcrest Mining.; The study was funded by International SOS (Australasia) Pty and Newcrest Mining. We thank the field teams for clinical follow-up and specimen collection, laboratory staff of Lihir Medical Centre for serology work, Kingsley Asiedu and Joan-Ramon Laporte for reviewing the manuscript and providing valuable comments, and Maria de Ros Villar for image editing.	Altman DG., 2000, STAT CONFIDENCE CONF, V2nd, P171; ANTAL GM, 1985, REV INFECT DIS, V7, pS220; Antal GM, 2002, MICROBES INFECT, V4, P83, DOI 10.1016/S1286-4579(01)01513-1; Backhouse JL, 1998, AM J TROP MED HYG, V59, P388, DOI 10.4269/ajtmh.1998.59.388; Dunne MW, 2003, ANTIMICROB AGENTS CH, V47, P2663, DOI 10.1128/AAC.47.8.2663-2665.2003; GUTHE T., 1954, Chronicle of the World Health Organization, V8, P37; HANDSFIELD HH, 1994, SEX TRANSM DIS, V21, P107, DOI 10.1097/00007435-199403000-00010; Hook EW, 2010, J INFECT DIS, V201, P1729, DOI 10.1086/652239; Lukehart SA, 2004, NEW ENGL J MED, V351, P154, DOI 10.1056/NEJMoa040216; Manning Laurens A., 2002, Papua New Guinea Medical Journal, V45, P206; MARTIN DH, 1992, NEW ENGL J MED, V327, P921, DOI 10.1056/NEJM199209243271304; MARTIN DH, 1995, CLIN INFECT DIS, V21, P409, DOI 10.1093/clinids/21.2.409; Martin IE, 2009, CLIN INFECT DIS, V49, P515, DOI 10.1086/600878; MEHEUS A, 2005, MEDICINE, V33, P82, DOI DOI 10.1383/MEDC.2005.33.10.82; Meheus AZ, INFECT DIS IN PRESS; Mitja O, 2011, EMERG INFECT DIS, V17, P1083, DOI [10.3201/eid1706.101575, 10.3201/eid/1706.101575]; Riedner G, 2005, NEW ENGL J MED, V353, P1236, DOI 10.1056/NEJMoa044284; Scolnik D, 2003, CLIN INFECT DIS, V36, P1232, DOI 10.1086/374338; Stamm LV, 2010, ANTIMICROB AGENTS CH, V54, P583, DOI 10.1128/AAC.01095-09; Stamm LV, 2000, ANTIMICROB AGENTS CH, V44, P806, DOI 10.1128/AAC.44.3.806-807.2000; TALWAT E, 1986, Southeast Asian Journal of Tropical Medicine and Public Health, V17, P59; U.S. Food and Drug Administration Division of Anti-Infectives Drug Products Advisory Committee, 2001, BRIEF DOC ZITHR ACC; Van Damme K, 2009, SEX TRANSM DIS, V36, P775, DOI 10.1097/OLQ.0b013e3181bd11dd; *WHO, 2007, YAWS FORG DIS; WHO, 2007, B WORLD HEALTH ORGAN, V85, P74; WHO Scientific Group, 1982, WHO SCI GROUP TECHN	26	89	89	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 28	2012	379	9813					342	347		10.1016/S0140-6736(11)61624-3	http://dx.doi.org/10.1016/S0140-6736(11)61624-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	889BA	22240407				2022-12-28	WOS:000300047300041
J	Coovadia, HM; Brown, ER; Fowler, MG; Chipato, T; Moodley, D; Manji, K; Musoke, P; Stranix-Chibanda, L; Chetty, V; Fawzi, W; Nakabiito, C; Msweli, L; Kisenge, R; Guay, L; Mwatha, A; Lynn, DJ; Eshleman, SH; Richardson, P; George, K; Andrew, P; Mofenson, LM; Zwerski, S; Maldonado, Y				Coovadia, Hoosen M.; Brown, Elizabeth R.; Fowler, Mary Glenn; Chipato, Tsungai; Moodley, Dhayendre; Manji, Karim; Musoke, Philippa; Stranix-Chibanda, Lynda; Chetty, Vani; Fawzi, Wafaie; Nakabiito, Clemensia; Msweli, Lindiwe; Kisenge, Roderick; Guay, Laura; Mwatha, Anthony; Lynn, Diana J.; Eshleman, Susan H.; Richardson, Paul; George, Kathleen; Andrew, Philip; Mofenson, Lynne M.; Zwerski, Sheryl; Maldonado, Yvonne		HPTN 046 Protocol Team	Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							RESOURCE-LIMITED SETTINGS; TO-CHILD; ANTIRETROVIRAL DRUGS; DOSE NEVIRAPINE; FREE SURVIVAL; ZIDOVUDINE; PROPHYLAXIS; LAMIVUDINE; MORTALITY; PREGNANCY	Background Nevirapine given once-daily for the first 6, 14, or 28 weeks of life to infants exposed to HIV-1 via breastfeeding reduces transmission through this route compared with single-dose nevirapine at birth or neonatally. We aimed to assess incremental safety and efficacy of extension of such prophylaxis to 6 months. Methods In our phase 3, randomised, double-blind, placebo-controlled HPTN 046 trial, we assessed the incremental benefit of extension of once-daily infant nevirapine from age 6 weeks to 6 months. We enrolled breastfeeding infants born to mothers with HIV-1 in four African countries within 7 days of birth. Following receipt of nevirapine from birth to 6 weeks, infants without HIV infection were randomly allocated (by use of a computer-generated permuted block algorithm with random block sizes and stratified by site and maternal antiretroviral treatment status) to receive extended nevirapine prophylaxis or placebo until 6 months or until breastfeeding cessation, whichever came first. The primary efficacy endpoint was HIV-1 infection in infants at 6 months and safety endpoints were adverse reactions in both groups. We used Kaplan-Meier analyses to compare differences in the primary outcome between groups. This study is registered with ClinicalTrials.gov, number NCT00074412. Findings Between June 19, 2008, and March 12, 2010, we randomly allocated 1527 infants (762 nevirapine and 765 placebo); five of whom had HIV-1 infection at randomisation and were excluded from the primary analyses. In Kaplan-Meier analysis, 1.1% (95% CI 0.3-1.8) of infants who received extended nevirapine developed HIV-1 between 6 weeks and 6 months compared with 2.4% (1.3-3.6) of controls (difference 1.3%, 95% CI 0-2.6), equating to a 54% reduction in transmission (p=0.049). However, mortality (1.2% for nevirapine vs 1.1% for placebo; p=0.81) and combined HIV infection and mortality rates (2.3% vs 3.2%; p=0.27) did not differ between groups at 6 months. 125 (16%) of 758 infants given extended nevirapine and 116 (15%) of 761 controls had serious adverse events, but frequency of adverse events, serious adverse events, and deaths did not differ significantly between treatment groups. Interpretation Nevirapine prophylaxis can safely be used to provide protection from mother-to-child transmission of HIV-1 via breastfeeding for infants up to 6 months of age.	[Coovadia, Hoosen M.] Univ Witwatersrand, Maternal Adolescent & Child Hlth MatCH, Johannesburg, South Africa; [Coovadia, Hoosen M.] Univ Kwazulu Natal, Nelson Mandela Sch Med, Durban, South Africa; [Brown, Elizabeth R.; Mwatha, Anthony; Lynn, Diana J.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Fowler, Mary Glenn; Eshleman, Susan H.; Richardson, Paul] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Chipato, Tsungai; Stranix-Chibanda, Lynda] Univ Zimbabwe, Coll Med, Harare, Zimbabwe; [Moodley, Dhayendre; Chetty, Vani; Msweli, Lindiwe] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Ctr AIDS Programme Res S Africa CAPRISA, Durban, South Africa; [Manji, Karim; Kisenge, Roderick] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania; [Musoke, Philippa; Nakabiito, Clemensia] Makerere Univ Johns Hopkins Univ Res Collaborat, Kampala, Uganda; [Fawzi, Wafaie] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Guay, Laura] George Washington Univ, Sch Publ Hlth, Washington, DC USA; [Guay, Laura] George Washington Univ, Hlth Serv, Washington, DC USA; [George, Kathleen; Andrew, Philip] Family Hlth Int, Res Triangle Pk, NC 27709 USA; [Mofenson, Lynne M.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Rockville, MD USA; [Zwerski, Sheryl] NIAID, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Maldonado, Yvonne] Stanford Univ, Sch Med, Stanford, CA 94305 USA	University of Witwatersrand; University of Kwazulu Natal; Fred Hutchinson Cancer Center; Johns Hopkins University; University of Zimbabwe; University of Kwazulu Natal; Muhimbili University of Health & Allied Sciences; Makerere University; Harvard University; Harvard T.H. Chan School of Public Health; George Washington University; George Washington University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Stanford University	Coovadia, HM (corresponding author), Maternal Adolescent & Child Hlth MatCH, 155 Juniper Rd, ZA-4091 Durban, South Africa.	hcoovadia@match.org.za	Brown, Elizabeth/A-8984-2008; Mofenson, Lynne/P-9631-2019; Manji, Karim/S-9318-2019; Moodley, Dhayendre/U-6802-2019	Mofenson, Lynne/0000-0002-2818-9808; Manji, Karim/0000-0002-7069-6408; 	US National Institutes of Health (NIH); US National Institutes of Health (NIH) through the HPTN [046]; US National Institutes of Health (NIH) through the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) group; National Institute of Allergy and Infectious Diseases (NIAID) [U01AI46749, U01AI068632]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute of Drug Abuse (NIDA); National Institute of Mental Health (NIMH); NICHD; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI046749, U01AI068632] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health (NIH) through the HPTN; US National Institutes of Health (NIH) through the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) group; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	US National Institutes of Health.; The HIV Prevention Trials Network (HPTN) 046 study was funded by the US National Institutes of Health (NIH), initially through the HPTN and later through the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) group. The HPTN (U01AI46749) has been funded by the National Institute of Allergy and Infectious Diseases (NIAID), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute of Drug Abuse (NIDA), and National Institute of Mental Health (NIMH). The IMPAACT Group (U01AI068632) has been funded by NIAID, NICHD, and NIMH. The study products were provided for free by Boehringer-Ingelheim. We thank the mothers and their children who participated in the study; the HPTN 046 study coordinators, counsellors, clinicians, pharmacists, data quality and laboratory staff, and those responsible for recruitment and retention for their dedication and hard work on site; Thomas R Fleming (University of Washington/Fred Hutchinson Cancer Research Center) for his contributions to study design and his strong support throughout study conduct; Scharla Estep (NIAID protocol pharmacist) for her help on pharmaceutical matters; and Avinash Shetty (Wake Forest University Health Sciences) for his contribution to study development and safety data review.	Auld AF, 2010, 18 INT AIDS C JUL 18; Barker PM, 2011, JAIDS-J ACQ IMM DEF, V56, pE45, DOI 10.1097/QAI.0b013e3181fdbf20; Bedri A, 2008, LANCET, V372, P300, DOI 10.1016/S0140-6736(08)61114-9; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; Ciaranello AL, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-59; Coutsoudis A, 2004, J INFECT DIS, V189, P2154, DOI 10.1086/420834; Fowler MG, 2002, J ACQ IMMUN DEF SYND, V30, P230, DOI [10.1097/00042560-200206010-00012, 10.1097/01.QAI.0000018364.28828.14]; Kafulafula G, 2010, JAIDS-J ACQ IMM DEF, V53, P6, DOI 10.1097/QAI.0b013e3181bd5a47; Kuhn L, 2008, NEW ENGL J MED, V359, P130, DOI 10.1056/NEJMoa073788; Kuhn L, 2010, AIDS, V24, P1374, DOI 10.1097/QAD.0b013e3283394f5b; Kuhn L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006059; Kumwenda NI, 2008, NEW ENGL J MED, V359, P119, DOI 10.1056/NEJMoa0801941; Leroy V, 2002, AIDS, V16, P631, DOI 10.1097/00002030-200203080-00016; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Medley A, 2004, B WORLD HEALTH ORGAN, V82, P299; Moodley D, 2003, J INFECT DIS, V187, P725, DOI 10.1086/367898; Nduati RW, 2000, JAMA-J AM MED ASSOC, V283, P1175; Saba J, 2002, LANCET, V359, P1178; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Taha TE, 2011, JAIDS-J ACQ IMM DEF, V57, P319, DOI 10.1097/QAI.0b013e318217877a; Victora CG, 2000, LANCET, V355, P451, DOI 10.1016/S0140-6736(00)82011-5; WHO, GUID HIV INF FEED 20; World Health Organization, ANT DRUGS TREAT PREG	23	86	86	1	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 21	2012	379	9812					221	228		10.1016/S0140-6736(11)61653-X	http://dx.doi.org/10.1016/S0140-6736(11)61653-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879FW	22196945	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000299316100036
J	Sattar, N; Welsh, P; Panarelli, M; Forouhi, NG				Sattar, Naveed; Welsh, Paul; Panarelli, Maurizio; Forouhi, Nita G.			Increasing requests for vitamin D measurement: costly, confusing, and without credibility	LANCET			English	Editorial Material							DIETARY		[Sattar, Naveed; Welsh, Paul] Univ Glasgow, Div Cardiovasc & Med Sci, Glasgow G12 8TA, Lanark, Scotland; [Panarelli, Maurizio] Glasgow Royal Infirm, Dept Biochem, Glasgow G4 0SF, Lanark, Scotland; [Forouhi, Nita G.] Univ Cambridge, Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England	University of Glasgow; University of Glasgow; University of Cambridge	Sattar, N (corresponding author), Univ Glasgow, Div Cardiovasc & Med Sci, Glasgow G12 8TA, Lanark, Scotland.	naveed.sattar@glasgow.ac.uk	Welsh, Paul/H-5249-2019	Welsh, Paul/0000-0002-7970-3643; Forouhi, Nita/0000-0002-5041-248X	British Heart Foundation [FS/10/005/28147] Funding Source: Medline; Medical Research Council [MC_UP_A100_1003] Funding Source: Medline; MRC [MC_UP_A100_1003] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abrahamsen B, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5463; [Anonymous], 1956, BRIT MED J, V2, P149; [Anonymous], MAIL ONLINE; [Anonymous], TELEGRAPH; Brophy Marcus M, 2008, VITAMIN D TESTS SOAR; CBC News, CBC NEWS; Hypponen E, 2007, AM J CLIN NUTR, V85, P860, DOI 10.1093/ajcn/85.3.860; Marniemi J, 2005, NUTR METAB CARDIOVAS, V15, P188, DOI 10.1016/j.numecd.2005.01.001; Pearce SHS, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5664; Schlingmann KP, 2011, NEW ENGL J MED, V365, P410, DOI 10.1056/NEJMoa1103864; Shapses SA, 2011, JAMA-J AM MED ASSOC, V305, P2565, DOI 10.1001/jama.2011.881; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Wehr E, 2010, CLIN ENDOCRINOL, V73, P243, DOI 10.1111/j.1365-2265.2009.03777.x; Welsh P, 2011, ARTHRITIS RHEUM-US, V63, P1763, DOI 10.1002/art.30341	14	102	104	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 14	2012	379	9811					95	96		10.1016/S0140-6736(11)61816-3	http://dx.doi.org/10.1016/S0140-6736(11)61816-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	879GM	22243814				2022-12-28	WOS:000299317700010
J	Costello, C; Gerber, LR; Gaines, S				Costello, Christopher; Gerber, Leah R.; Gaines, Steven			Conservation science: A market approach to saving the whales	NATURE			English	Editorial Material									[Costello, Christopher; Gaines, Steven] Univ Calif Santa Barbara, Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Gerber, Leah R.] Arizona State Univ, Ecol Evolut & Environm Sci Fac, Sch Life Sci, Tempe, AZ 85281 USA	University of California System; University of California Santa Barbara; Arizona State University; Arizona State University-Tempe	Costello, C (corresponding author), Univ Calif Santa Barbara, Sch Environm Sci & Management, Santa Barbara, CA 93106 USA.	costello@bren.ucsb.edu	Gaines, Steven/Y-3234-2019	Gerber, Leah/0000-0002-6763-6842				Anderson T, 2011, ANNU REV RESOUR ECON, V3, P159, DOI 10.1146/annurev-resource-083110-120056; [Anonymous], CATCH LIM CATCH TAK; Black R., 2008, BBC NEWS        0617; CLARK CW, 1982, MAR POLICY, V6, P103, DOI 10.1016/0308-597X(82)90065-3; Gerber LR, 2000, AM SCI, V88, P316, DOI 10.1511/2000.29.773; Goulder LH, 2010, J ENVIRON ECON MANAG, V60, P161, DOI 10.1016/j.jeem.2010.06.002; Haltuch MA, 2009, FISH RES, V100, P42, DOI 10.1016/j.fishres.2009.03.001; Pershing AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012444	8	20	20	0	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 12	2012	481	7380					139	140		10.1038/481139a	http://dx.doi.org/10.1038/481139a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	874TO	22237092	Bronze			2022-12-28	WOS:000298981200015
J	Pletcher, MJ; Vittinghoff, E; Kalhan, R; Richman, J; Safford, M; Sidney, S; Lin, F; Kertesz, S				Pletcher, Mark J.; Vittinghoff, Eric; Kalhan, Ravi; Richman, Joshua; Safford, Monika; Sidney, Stephen; Lin, Feng; Kertesz, Stefan			Association Between Marijuana Exposure and Pulmonary Function Over 20 Years	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HABITUAL SMOKERS; LUNG-FUNCTION; TOBACCO; CANNABIS; SMOKING; RECRUITMENT; DECLINE; COCAINE; FEV(1); CARDIA	Context Marijuana smoke contains many of the same constituents as tobacco smoke, but whether it has similar adverse effects on pulmonary function is unclear. Objective To analyze associations between marijuana (both current and lifetime exposure) and pulmonary function. Design, Setting, and Participants The Coronary Artery Risk Development in Young Adults (CARDIA) study, a longitudinal study collecting repeated measurements of pulmonary function and smoking over 20 years (March 26, 1985-August 19, 2006) in a cohort of 5115 men and women in 4 US cities. Mixed linear modeling was used to account for individual age-based trajectories of pulmonary function and other covariates including tobacco use, which was analyzed in parallel as a positive control. Lifetime exposure to marijuana joints was expressed in joint-years, with 1 joint-year of exposure equivalent to smoking 365 joints or filled pipe bowls. Main Outcome Measures Forced expiratory volume in the first second of expiration (FEV1) and forced vital capacity (FVC). Results Marijuana exposure was nearly as common as tobacco exposure but was mostly light (median, 2-3 episodes per month). Tobacco exposure, both current and lifetime, was linearly associated with lower FEV1 and FVC. In contrast, the association between marijuana exposure and pulmonary function was nonlinear (P<.001): at low levels of exposure, FEV1 increased by 13 mL/joint-year (95% CI, 6.4 to 20; P<.001) and FVC by 20 mL/joint-year (95% CI, 12 to 27; P<.001), but at higher levels of exposure, these associations leveled or even reversed. The slope for FEV1 was -2.2 mL/joint-year (95% CI, -4.6 to 0.3; P=.08) at more than 10 joint-years and -3.2 mL per marijuana smoking episode/mo (95% CI, -5.8 to -0.6; P=.02) at more than 20 episodes/mo. With very heavy marijuana use, the net association with FEV1 was not significantly different from baseline, and the net association with FVC remained significantly greater than baseline (eg, at 20 joint-years, 76 mL [ 95% CI, 34 to 117]; P<.001). Conclusion Occasional and low cumulative marijuana use was not associated with adverse effects on pulmonary function. JAMA. 2012; 307(2): 173-181 www.jama.com	[Pletcher, Mark J.; Vittinghoff, Eric; Lin, Feng] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94107 USA; [Pletcher, Mark J.] Univ Calif San Francisco, Div Gen Internal Med, Dept Med, San Francisco, CA 94107 USA; [Kalhan, Ravi] Northwestern Univ, Div Pulm & Crit Care Med, Feinberg Sch Med, Asthma COPD Program, Chicago, IL 60611 USA; [Richman, Joshua] Univ Alabama Birmingham, Dept Surg, Birmingham, AL USA; [Safford, Monika; Kertesz, Stefan] Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL USA; [Richman, Joshua; Kertesz, Stefan] Vet Affairs Med Ctr, Ctr Surg Med & Acute Care Res & Transit, Birmingham, AL USA; [Sidney, Stephen] Kaiser Permanente No Calif, Div Res, Oakland, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Northwestern University; Feinberg School of Medicine; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Kaiser Permanente	Pletcher, MJ (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, 185 Berry St,Ste 5700, San Francisco, CA 94107 USA.	mpletcher@epi.ucsf.edu	s, s/GYR-2278-2022; s, s/HIK-1178-2022; s, s/HHD-0404-2022	Kalhan, Ravi/0000-0003-2443-0876; Kertesz, Stefan/0000-0001-6101-8421	National Institute on Drug Abuse [R01-DA-025067]; National Heart, Lung, and Blood Institute [N01-HC-95095, N01-HC-48047]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC048047, N01HC095095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025067] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the National Institute on Drug Abuse (R01-DA-025067) and the National Heart, Lung, and Blood Institute (N01-HC-95095 and N01-HC-48047).	Aldington S, 2007, THORAX, V62, P1058, DOI 10.1136/thx.2006.077081; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 2005, NUMB DEATHS EACH CAU; [Anonymous], CANN CANN; [Anonymous], 2009, AIR QUAL MON INF AIR; ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; Barsky SH, 1998, JNCI-J NATL CANCER I, V90, P1198, DOI 10.1093/jnci/90.16.1198; BLOOM JW, 1987, BMJ-BRIT MED J, V295, P1516, DOI 10.1136/bmj.295.6612.1516; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Fligiel SEG, 1997, CHEST, V112, P319, DOI 10.1378/chest.112.2.319; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Hall W, 2009, LANCET, V374, P1383, DOI 10.1016/S0140-6736(09)61037-0; Hancox RJ, 2010, EUR RESPIR J, V35, P42, DOI 10.1183/09031936.00065009; HUGHES GH, 1987, CONTROL CLIN TRIALS, V8, pS68; Joy JE, 1999, MARIJUANA MED ASSESS; Kamholz SL, 2004, MED CLIN N AM, V88, P1415, DOI 10.1016/j.mcna.2004.07.008; Kelly FJ, 2011, CLIN EXP ALLERGY, V41, P1059, DOI 10.1111/j.1365-2222.2011.03776.x; Marrie RA, 2009, J CLIN EPIDEMIOL, V62, P511, DOI 10.1016/j.jclinepi.2008.05.015; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Moore BA, 2005, J GEN INTERN MED, V20, P33, DOI 10.1111/j.1525-1497.2004.40081.x; NOVOTNY M, 1982, J CHROMATOGR, V238, P141, DOI 10.1016/S0021-9673(00)82720-X; Pauwels RA, 2004, LANCET, V364, P613, DOI 10.1016/S0140-6736(04)16855-4; Roth MD, 1998, AM J RESP CRIT CARE, V157, P928, DOI 10.1164/ajrccm.157.3.9701026; SHERMAN MP, 1991, PHARMACOL BIOCHEM BE, V40, P663, DOI 10.1016/0091-3057(91)90379-G; SHERRILL DL, 1991, INT J EPIDEMIOL, V20, P132, DOI 10.1093/ije/20.1.132; Substance Abuse and Mental Health Services Administration, HHS PUBL; Tashkin DP, 2010, EUR RESPIR J, V35, P3, DOI 10.1183/09031936.00109309; TASHKIN DP, 1993, AM REV RESPIR DIS, V147, P97, DOI 10.1164/ajrccm/147.1.97; TASHKIN DP, 1987, AM REV RESPIR DIS, V135, P209; Tashkin DP, 2002, J CLIN PHARMACOL, V42, p71S, DOI 10.1002/j.1552-4604.2002.tb06006.x; Tashkin DP, 1997, AM J RESP CRIT CARE, V155, P141, DOI 10.1164/ajrccm.155.1.9001303; TASHKIN DP, 1980, CHEST, V78, P699, DOI 10.1378/chest.78.5.699; Taylor DR, 2000, ADDICTION, V95, P1669, DOI 10.1046/j.1360-0443.2000.951116697.x; Tetrault JM, 2007, ARCH INTERN MED, V167, P221, DOI 10.1001/archinte.167.3.221; WAGENKNECHT LE, 1992, AM J PUBLIC HEALTH, V82, P33, DOI 10.2105/AJPH.82.1.33	36	148	150	2	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 11	2012	307	2					173	181		10.1001/jama.2011.1961	http://dx.doi.org/10.1001/jama.2011.1961			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	875NP	22235088	Green Accepted, Bronze			2022-12-28	WOS:000299038300029
J	White, DB; Pope, TM				White, Douglas B.; Pope, Thaddeus M.			The Courts, Futility, and the Ends of Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RESOLUTION; LIFE		[White, Douglas B.] Univ Pittsburgh, Program Eth & Decis Making Crit Illness, Dept Crit Care Med, Sch Med, Pittsburgh, PA 15261 USA; [White, Douglas B.] Univ Pittsburgh, Ctr Bioeth & Hlth Law, Pittsburgh, PA 15261 USA; [Pope, Thaddeus M.] Hamline Univ, Hlth Law Inst, Sch Law, St Paul, MN USA; [Pope, Thaddeus M.] Albany Med Coll, Alden March Bioeth Inst, Albany, NY 12208 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Mitchell Hamline School of Law; Albany Medical College	White, DB (corresponding author), Univ Pittsburgh, Program Eth & Decis Making Crit Illness, Dept Crit Care Med, Sch Med, 3550 Terrace St,Scaife Hall,Room 608,HPU010604, Pittsburgh, PA 15261 USA.	whitedb@upmc.edu	Pope, Thaddeus/K-9452-2019	Pope, Thaddeus/0000-0002-7163-505X	NATIONAL INSTITUTE ON AGING [K23AG032875] Funding Source: NIH RePORTER; NIA NIH HHS [K23 AG032875] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		DELGADO R, 1985, WISC LAW REV, P1359; EMANUEL EJ, 1987, HASTINGS CENT REP, V17, P15, DOI 10.2307/3562665; Fine RL, 2003, ANN INTERN MED, V138, P743, DOI 10.7326/0003-4819-138-9-200305060-00011; MNOOKIN RH, 1979, YALE LAW J, V88, P950, DOI 10.2307/795824; MORREIM EH, 1994, HASTINGS CENT REP, V24, P33, DOI 10.2307/3562386; SOLOMON MZ, 1993, AM J PUBLIC HEALTH, V83, P14, DOI 10.2105/AJPH.83.1.14	6	20	20	1	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 11	2012	307	2					151	152		10.1001/jama.2011.1990	http://dx.doi.org/10.1001/jama.2011.1990			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	875NP	22235083	Green Accepted			2022-12-28	WOS:000299038300024
J	Safarova, MS; Ezhov, MV				Safarova, Maya S.; Ezhov, Marat V.			A Head Shot	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Safarova, Maya S.; Ezhov, Marat V.] Cardiol Res Ctr, Moscow 121552, Russia	National Medical Research Center of Cardiology	Safarova, MS (corresponding author), Cardiol Res Ctr, Moscow 121552, Russia.		Ezhov, Marat/M-5598-2019	Safarova, Maya/0000-0003-3069-3752					0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2011	365	26					2519	2519		10.1056/NEJMicm1009118	http://dx.doi.org/10.1056/NEJMicm1009118			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	868SD	22204727				2022-12-28	WOS:000298544600012
J	Tritos, NA; Schaefer, PW; Stein, TD				Tritos, Nicholas A.; Schaefer, Pamela W.; Stein, Thor D.			Case 40-2011: A 52-Year-Old Man with Weakness, Infections, and Enlarged Adrenal Glands	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORTICOTROPIN-RELEASING HORMONE; CUSHINGS-SYNDROME; NELSONS-SYNDROME; DIFFERENTIAL-DIAGNOSIS; CONSENSUS STATEMENT; PITUITARY-ADENOMAS; COMPLETE REMISSION; CYPROHEPTADINE; BROMOCRIPTINE; PROLIFERATION		[Tritos, Nicholas A.] Massachusetts Gen Hosp, Dept Med, Neuroendocrine Unit, Boston, MA 02114 USA; [Schaefer, Pamela W.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Stein, Thor D.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Tritos, Nicholas A.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Schaefer, Pamela W.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Stein, Thor D.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Tritos, NA (corresponding author), Massachusetts Gen Hosp, Dept Med, Neuroendocrine Unit, Boston, MA 02114 USA.		Tritos, Nicholas/W-1594-2019; Schaefer, Pamela/AAA-1323-2019	Tritos, Nicholas/0000-0001-8867-607X; Stein, Thor/0000-0001-6954-4477	Pfizer; Veterans Affairs [I01CX001038] Funding Source: NIH RePORTER	Pfizer(Pfizer); Veterans Affairs(US Department of Veterans Affairs)	Dr. Tritos reports receiving research support, consulting fees, and reimbursement for travel expenses from Pfizer. No other potential conflict of interest relevant to this article was reported.	Arnaldi G, 2003, J CLIN ENDOCR METAB, V88, P5593, DOI 10.1210/jc.2003-030871; Assie G, 2007, J CLIN ENDOCR METAB, V92, P172, DOI 10.1210/jc.2006-1328; Assie Guillaume, 2004, Pituitary, V7, P209, DOI 10.1007/s11102-005-1403-y; Biller BMK, 2008, J CLIN ENDOCR METAB, V93, P2454, DOI 10.1210/jc.2007-2734; Casulari LA, 2004, HORM RES, V62, P300, DOI 10.1159/000082235; Findling JW, 2005, ENDOCRIN METAB CLIN, V34, P385, DOI 10.1016/j.ecl.2005.02.001; Gejman R, 2008, HUM PATHOL, V39, P758, DOI 10.1016/j.humpath.2007.10.004; HALL WA, 1994, ANN INTERN MED, V120, P817, DOI 10.7326/0003-4819-120-10-199405150-00001; Ilias I, 2005, J CLIN ENDOCR METAB, V90, P4955, DOI 10.1210/jc.2004-2527; Machado ALO, 2005, J ENDOCRINOL INVEST, V28, P795, DOI 10.1007/BF03347568; MercadoAsis LB, 1997, J CLIN ENDOCR METAB, V82, P514, DOI 10.1210/jc.82.2.514; NELSON DH, 1960, ANN INTERN MED, V52, P560, DOI 10.7326/0003-4819-52-3-560; NELSON DH, 1958, NEW ENGL J MED, V259, P161, DOI 10.1056/NEJM195807242590403; Newell-Price J, 2006, LANCET, V367, P1605, DOI 10.1016/S0140-6736(06)68699-6; NIEMAN LK, 1986, ANN INTERN MED, V105, P862, DOI 10.7326/0003-4819-105-6-862; Nieman LK, 2008, J CLIN ENDOCR METAB, V93, P1526, DOI 10.1210/jc.2008-0125; OLDFIELD EH, 1991, NEW ENGL J MED, V325, P897, DOI 10.1056/NEJM199109263251301; OLDFIELD EH, 1992, NEW ENGL J MED, V326, P1172; Pivonello R, 1999, J ENDOCRINOL INVEST, V22, P860, DOI 10.1007/BF03343660; Raff H, 2003, ANN INTERN MED, V138, P980, DOI 10.7326/0003-4819-138-12-200306170-00010	20	5	5	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2011	365	26					2520	2530		10.1056/NEJMcpc1100919	http://dx.doi.org/10.1056/NEJMcpc1100919			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	868SD	22204728				2022-12-28	WOS:000298544600013
J	Khurana, JS; Wang, J; Xu, J; Koppetsch, BS; Thomson, TC; Nowosielska, A; Li, CJ; Zamore, PD; Weng, ZP; Theurkauf, WE				Khurana, Jaspreet S.; Wang, Jie; Xu, Jia; Koppetsch, Birgit S.; Thomson, Travis C.; Nowosielska, Anetta; Li, Chengjian; Zamore, Phillip D.; Weng, Zhiping; Theurkauf, William E.			Adaptation to P Element Transposon Invasion in Drosophila melanogaster	CELL			English	Article							MENDELIAN FEMALE STERILITY; M HYBRID DYSGENESIS; HORIZONTAL TRANSMISSION; MEIOTIC RECOMBINATION; GENOME EVOLUTION; ACTIVATION; CHECKPOINT; RNA; MUTATIONS; GERMLINE	Transposons evolve rapidly and can mobilize and trigger genetic instability. Piwi-interacting RNAs (piRNAs) silence these genome pathogens, but it is unclear how the piRNA pathway adapts to invasion of new transposons. In Drosophila, piRNAs are encoded by heterochromatic clusters and maternally deposited in the embryo. Paternally inherited P element transposons thus escape silencing and trigger a hybrid sterility syndrome termed P-M hybrid dysgenesis. We show that P-M hybrid dysgenesis activates both P elements and resident transposons and disrupts the piRNA biogenesis machinery. As dysgenic hybrids age, however, fertility is restored, P elements are silenced, and P element piRNAs are produced de novo. In addition, the piRNA biogenesis machinery assembles, and resident elements are silenced. Significantly, resident transposons insert into piRNA clusters, and these new insertions are transmitted to progeny, produce novel piRNAs, and are associated with reduced transposition. P element invasion thus triggers heritable changes in genome structure that appear to enhance transposon silencing.	[Wang, Jie; Xu, Jia; Li, Chengjian; Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01655 USA; [Khurana, Jaspreet S.; Koppetsch, Birgit S.; Thomson, Travis C.; Nowosielska, Anetta; Theurkauf, William E.] Univ Massachusetts, Sch Med, Program Cell & Dev Dynam, Worcester, MA 01655 USA; [Khurana, Jaspreet S.; Koppetsch, Birgit S.; Thomson, Travis C.; Nowosielska, Anetta; Theurkauf, William E.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01655 USA; [Zamore, Phillip D.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA; [Zamore, Phillip D.] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute	Weng, ZP (corresponding author), Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01655 USA.	zhiping.weng@umassmed.edu; william.theurkauf@umassmed.edu	Xu, Jia/F-7750-2012; Zamore, Phillip D/A-8941-2013	Zamore, Phillip/0000-0002-4505-9618; Theurkauf, William/0000-0001-7342-1912; Xu, Jia/0000-0003-3921-018X	NIH [R01HD049116, GM62862, GM65236]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD049116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062862, R01GM065236, R37GM062862] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the UMass Medical School RNA biology community for stimulating discussions and constructive criticisms. Thanks to Stephane Ronsseray and the Bloomington Stock Center for fly strains, Julius Brennecke and Paul Lasko for antibodies, and the UMass Deep Sequencing Core for technical assistance. This work was supported by grants from the NIH to W.E.T., Z.W., and P.D.Z. (R01HD049116) and to P.D.Z. (GM62862 and GM65236).	Abdu U, 2002, CURR BIOL, V12, P1645, DOI 10.1016/S0960-9822(02)01165-X; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Beauregard A, 2008, ANNU REV GENET, V42, P587, DOI 10.1146/annurev.genet.42.110807.091549; Belgnaoui SM, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-13; Bennetzen JL, 2000, PLANT MOL BIOL, V42, P251, DOI 10.1023/A:1006344508454; Blumenstiel JP, 2005, P NATL ACAD SCI USA, V102, P15965, DOI 10.1073/pnas.0508192102; BRADSHAW VA, 1989, MOL GEN GENET, V218, P465, DOI 10.1007/BF00332411; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Britten RJ, 2010, P NATL ACAD SCI USA, V107, P19945, DOI 10.1073/pnas.1014330107; BUCHETON A, 1979, GENETICS, V93, P131; BUCHETON A, 1976, HEREDITY, V36, P305, DOI 10.1038/hdy.1976.38; BUCHETON A, 1990, TRENDS GENET, V6, P16, DOI 10.1016/0168-9525(90)90044-7; BUCHETON A, 1975, CR ACAD SCI D NAT, V281, P1035; BUCHETON A, 1973, CR ACAD SCI D NAT, V276, P641; Callinan P, 2006, GENOME DYN, V1, P104, DOI 10.1159/000092503; CAPY P, 1994, GENETICA, V93, P161, DOI 10.1007/BF01435248; Chen Y, 2007, CURR BIOL, V17, P637, DOI 10.1016/j.cub.2007.02.027; Clemenson C, 2009, DNA REPAIR, V8, P1101, DOI 10.1016/j.dnarep.2009.04.008; DANIELS SB, 1990, GENETICS, V124, P339; Deininger PL, 2003, CURR OPIN GENET DEV, V13, P651, DOI 10.1016/j.gde.2003.10.013; EDDY EM, 1974, ANAT REC, V178, P731, DOI 10.1002/ar.1091780406; EDDY EM, 1975, INT REV CYTOL, V43, P229; EGGLESTON WB, 1988, NATURE, V331, P368, DOI 10.1038/331368a0; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Ghabrial A, 1999, NAT CELL BIOL, V1, P354, DOI 10.1038/14046; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hedges DJ, 2011, ADV GENET, V73, P219, DOI 10.1016/B978-0-12-380860-8.00006-9; HIRAIZUMI Y, 1971, P NATL ACAD SCI USA, V68, P268, DOI 10.1073/pnas.68.2.268; KAUFMAN PD, 1992, CELL, V69, P27, DOI 10.1016/0092-8674(92)90116-T; Khurana JS, 2010, J CELL BIOL, V191, P905, DOI 10.1083/jcb.201006034; KIDWELL MG, 1985, GENETICS, V111, P337; KIDWELL MG, 1977, GENETICS, V86, P813; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Klattenhoff C, 2007, DEV CELL, V12, P45, DOI 10.1016/j.devcel.2006.12.001; Klattenhoff C, 2009, CELL, V138, P1137, DOI 10.1016/j.cell.2009.07.014; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lazzaro F, 2009, DNA REPAIR, V8, P1055, DOI 10.1016/j.dnarep.2009.04.022; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LIANG L, 1994, DEVELOPMENT, V120, P1201; Lim AK, 2007, P NATL ACAD SCI USA, V104, P6714, DOI 10.1073/pnas.0701920104; Liu H, 2002, GENETICS, V162, P245; Madigan JP, 2002, NUCLEIC ACIDS RES, V30, P3698, DOI 10.1093/nar/gkf496; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; McKim KS, 2002, ANNU REV GENET, V36, P205, DOI 10.1146/annurev.genet.36.041102.113929; Nishida KM, 2007, RNA, V13, P1911, DOI 10.1261/rna.744307; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; PETROV DA, 1995, P NATL ACAD SCI USA, V92, P8050, DOI 10.1073/pnas.92.17.8050; PICARD G, 1972, CR ACAD SCI D NAT, V275, P933; RIO DC, 1991, TRENDS GENET, V7, P282, DOI 10.1016/0168-9525(91)90176-Q; Rozhkov NV, 2010, RNA, V16, P1634, DOI 10.1261/rna.2217810; RUBIN GM, 1982, CELL, V29, P987, DOI 10.1016/0092-8674(82)90462-7; Spradling Allan C., 1993, P1; Staleva LS, 2001, MUTAT RES-FUND MOL M, V474, P93, DOI 10.1016/S0027-5107(00)00165-2; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Van De Bor V, 2005, DEV CELL, V9, P51, DOI 10.1016/j.devcel.2005.04.012	60	154	158	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2011	147	7					1551	1563		10.1016/j.cell.2011.11.042	http://dx.doi.org/10.1016/j.cell.2011.11.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	866SP	22196730	Green Accepted, Bronze			2022-12-28	WOS:000298403400019
J	Micklos, D; Lauter, S; Nisselle, A				Micklos, David; Lauter, Susan; Nisselle, Amy			Lessons from a Science Education Portal	SCIENCE			English	Editorial Material									[Micklos, David; Lauter, Susan; Nisselle, Amy] Cold Spring Harbor Lab, DNA Learning Ctr, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Micklos, D (corresponding author), Cold Spring Harbor Lab, DNA Learning Ctr, POB 100, Cold Spring Harbor, NY 11724 USA.	micklos@cshl.edu	, Amy/M-3622-2019	, Amy/0000-0002-8908-5906				Cohen L., 2011, RES METHODS ED, V7th Ed; Jones B., 2003, DESIGN ANAL CROSS OV, V2nd; Nisselle A., 2011, P WORLD C ED MULT HY, P1403	3	8	8	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1657	1658		10.1126/science.1197074	http://dx.doi.org/10.1126/science.1197074			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	865XK	22194567				2022-12-28	WOS:000298344000055
J	Feldman, RD				Feldman, Ross D.			Review: Home and clinic BP have limited accuracy compared with ambulatory BP for diagnosing hypertension	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							BLOOD-PRESSURE		Univ Western Ontario, London, ON, Canada	Western University (University of Western Ontario)	Feldman, RD (corresponding author), Univ Western Ontario, London, ON, Canada.		Feldman, Ross/G-3293-2011					Mule G, 2002, J CARDIOVASC RISK, V9, P123, DOI 10.1097/00043798-200204000-00008; Myers MG, 2010, HYPERTENSION, V55, P195, DOI 10.1161/HYPERTENSIONAHA.109.141879; Rabi DM, 2011, CAN J CARDIOL, V27, P415, DOI 10.1016/j.cjca.2011.03.015; Stergiou GS, 1998, AM J HYPERTENS, V11, P820, DOI 10.1016/S0895-7061(98)00038-7	4	1	1	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2011	155	12							JC6-10	10.7326/0003-4819-155-12-201112200-02010	http://dx.doi.org/10.7326/0003-4819-155-12-201112200-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	864ZU	22184711				2022-12-28	WOS:000298280500009
J	van der Linde, D; Witsenburg, M; van de Laar, I; Moelker, A; Roos-Hesselink, J				van der Linde, Denise; Witsenburg, Maarten; van de Laar, Ingrid; Moelker, Adriaan; Roos-Hesselink, Jolien			Saccular aneurysm within a persistent ductus arteriosus	LANCET			English	Editorial Material									[van der Linde, Denise; Witsenburg, Maarten; Roos-Hesselink, Jolien] Erasmus MC, Dept Cardiol, Rotterdam, Netherlands; [van de Laar, Ingrid] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Moelker, Adriaan] Erasmus MC, Dept Radiol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Roos-Hesselink, J (corresponding author), Erasmus MC, Dept Cardiol, Gravendijkwal 230, Rotterdam, Netherlands.	j.roos@erasmusmc.nl						van de Laar IMBH, 2011, NAT GENET, V43, P121, DOI 10.1038/ng.744	1	8	8	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 18	2012	379	9816					E33	E33		10.1016/S0140-6736(11)61352-4	http://dx.doi.org/10.1016/S0140-6736(11)61352-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	897ES	22177260	Green Submitted			2022-12-28	WOS:000300629000001
J	Ludwig, DS				Ludwig, David S.			Weight Loss Strategies for Adolescents A 14-Year-Old Struggling to Lose Weight	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; CORONARY-HEART-DISEASE; QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; CHILDHOOD OBESITY; METABOLIC SYNDROME; US CHILDREN; OVERWEIGHT ADOLESCENTS; CARDIOVASCULAR-DISEASE; PEDIATRIC OBESITY	With prevalence approaching 20% in the United States, adolescent obesity has become a common problem for patients, parents, and clinicians. Obese adolescents may experience physical and psychosocial complications, as illustrated by the case of Ms K, a 14-year-old girl with a body mass index of 40. Unfortunately, the effectiveness of pediatric obesity treatment is modest in younger children and declines in older children and adolescents, and few interventions involving adolescents have produced significant long-term weightloss. Nevertheless, novel strategies to alter energy balance have shown preliminary evidence of benefit in clinical trials, including a diet focused on food quality rather than fat restriction and a lifestyle approach to encourage enjoyable physical activity throughout the day rather than intermittent exercise. Parents can have an important influence on weight-related behaviors in adolescents despite typically complicated emotional dynamics at this age, especially through the use of noncoercive methods. A key parenting practice applicable to children of all ages is to create a protective environment in the home, substituting nutritious foods for un-healthful ones and facilitating physical activities instead of sedentary pursuits. Other behaviors that may promote successful long-term weight management include good sleep hygiene, stress reduction, and mindfulness. Ultimately, the obesity epidemic can be attributed to changes in the social environment that hinder healthful lifestyle habits, and prevention will require a comprehensive public health strategy. JAMA. 2012;307(5):498-508	[Ludwig, David S.] Childrens Hosp Boston, Div Endocrinol, Optimal Weight Life OWL Program, Boston, MA 02115 USA; [Ludwig, David S.] Childrens Hosp Boston, New Balance Fdn, Obes Prevent Ctr, Boston, MA 02115 USA; [Ludwig, David S.] Harvard Univ, Sch Med, Boston, MA USA; [Ludwig, David S.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Ludwig, DS (corresponding author), Childrens Hosp Boston, Div Endocrinol, Optimal Weight Life OWL Program, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@childrens.harvard.edu		Ludwig, David/0000-0003-3307-8544	National Institutes of Health; Children's Hospital Boston; National Institute of Diabetes and Digestive and Kidney Diseases [K24DK082730]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082730] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital Boston; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The author has completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Ludwig reports receiving grants from the National Institutes of Health and foundations for obesity-related research, mentoring, and patient care and royalties from a book about childhood obesity.; Dr Ludwig is supported in part by an endowment from Children's Hospital Boston and career award K24DK082730 from the National Institute of Diabetes and Digestive and Kidney Diseases.	Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; American Medical Association, 2004, NAT SUMM OB BUILD PL; Atlantis E, 2006, INT J OBESITY, V30, P1027, DOI 10.1038/sj.ijo.0803286; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Bauer KW, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-25; Berntsen S, 2010, INT J PEDIATR OBES, V5, P64, DOI 10.3109/17477160902957166; Binkin N, 2013, NUTR METAB CARDIOVAS, V23, P410, DOI 10.1016/j.numecd.2011.09.006; Birch LL, 2003, AM J CLIN NUTR, V78, P215, DOI 10.1093/ajcn/78.2.215; Black MM, 2010, PEDIATRICS, V126, P280, DOI 10.1542/peds.2009-1832; Bornstein M. H., 2002, HDB PARENTING CHILDR; Catoira N, 2010, EXPERT OPIN PHARMACO, V11, P2973, DOI 10.1517/14656566.2010.512005; Chanoine JP, 2005, JAMA-J AM MED ASSOC, V293, P2873, DOI 10.1001/jama.293.23.2873; Craigie AM, 2011, MATURITAS, V70, P266, DOI 10.1016/j.maturitas.2011.08.005; Dabelea D, 2007, JAMA-J AM MED ASSOC, V297, P2716; Daley AJ, 2006, PEDIATRICS, V118, P2126, DOI 10.1542/peds.2006-1285; De Vriendt T, 2009, NUTR METAB CARDIOVAS, V19, P511, DOI 10.1016/j.numecd.2009.02.009; Dietz WH, 2005, NEW ENGL J MED, V352, P2100, DOI 10.1056/NEJMcp043052; Din-Dzietham R, 2007, CIRCULATION, V116, P1488, DOI 10.1161/CIRCULATIONAHA.106.683243; Ebbeling CB, 2008, JAMA-J AM MED ASSOC, V299, P2442, DOI 10.1001/jama.299.20.2442; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Ebbeling CB, 2004, JAMA-J AM MED ASSOC, V291, P2828, DOI 10.1001/jama.291.23.2828; Ebbeling CB, 2003, ARCH PEDIAT ADOL MED, V157, P773, DOI 10.1001/archpedi.157.8.773; Epstein L H, 2001, Exerc Sport Sci Rev, V29, P103, DOI 10.1097/00003677-200107000-00003; Epstein LH, 2008, ARCH PEDIAT ADOL MED, V162, P239, DOI 10.1001/archpediatrics.2007.45; EPSTEIN LH, 1994, ADDICT BEHAV, V19, P135, DOI 10.1016/0306-4603(94)90038-8; Epstein LH, 1996, INT J OBESITY, V20, pS14; Epstein LH, 2001, PEDIATR CLIN N AM, V48, P981, DOI 10.1016/S0031-3955(05)70352-7; Epstein LH, 1998, PEDIATRICS, V101, P554; Flynn JT, 2008, AM J HYPERTENS, V21, P605, DOI 10.1038/ajh.2008.159; Galloway AT, 2006, APPETITE, V46, P318, DOI 10.1016/j.appet.2006.01.019; George Mary G, 2011, Ann Neurol, V70, P713, DOI 10.1002/ana.22539; Goldfield GS, 2006, PEDIATRICS, V118, pE157, DOI 10.1542/peds.2005-3052; GORTMAKER SL, 1993, NEW ENGL J MED, V329, P1008, DOI 10.1056/NEJM199309303291406; Grey M, 2004, J SCHOOL HEALTH, V74, P10, DOI 10.1111/j.1746-1561.2004.tb06595.x; Griffiths LJ, 2010, INT J PEDIATR OBES, V5, P282, DOI 10.3109/17477160903473697; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hahn TN, 2010, SAVOR MINDFUL EATING; Hall KD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007940; Halton TL, 2006, NEW ENGL J MED, V355, P1991, DOI 10.1056/NEJMoa055317; Hart CN, 2011, PEDIATR CLIN N AM, V58, P715, DOI 10.1016/j.pcl.2011.03.007; Hart CN, 2010, EAT BEHAV, V11, P217, DOI 10.1016/j.eatbeh.2010.05.001; Hebebrand J, 2009, CHILD ADOL PSYCH CL, V18, P49, DOI 10.1016/j.chc.2008.08.002; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Hofker M, 2009, NAT GENET, V41, P139, DOI 10.1038/ng0209-139; Hu FB, 2002, JAMA-J AM MED ASSOC, V288, P2569, DOI 10.1001/jama.288.20.2569; Inge TH, 2004, PEDIATRICS, V114, P217, DOI 10.1542/peds.114.1.217; Jelalian E, 2006, INT J OBESITY, V30, P31, DOI 10.1038/sj.ijo.0803069; Johnston CA, 2007, PEDIATRICS, V120, pE1450, DOI 10.1542/peds.2006-3321; Johnston CA, 2007, INT J PEDIATR OBES, V2, P144, DOI 10.1080/17477160701305864; Kamath CC, 2008, J CLIN ENDOCR METAB, V93, P4606, DOI 10.1210/jc.2006-2411; Kastorini CM, 2011, J AM COLL CARDIOL, V57, P1299, DOI 10.1016/j.jacc.2010.09.073; Kelley GA, 2007, ATHEROSCLEROSIS, V191, P447, DOI 10.1016/j.atherosclerosis.2006.04.019; Kimm SYS, 2002, NEW ENGL J MED, V347, P709, DOI 10.1056/NEJMoa003277; Krebs NF, 2007, PEDIATRICS, V120, pS193, DOI 10.1542/peds.2007-2329D; Kumar J, 2009, PEDIATRICS, V124, pE362, DOI 10.1542/peds.2009-0051; Latner JD, 2003, OBES RES, V11, P452, DOI 10.1038/oby.2003.61; Lavizzo-Mourey R, 2007, JAMA-J AM MED ASSOC, V298, P920, DOI 10.1001/jama.298.8.920; Lawlor DA, 2007, AM J EPIDEMIOL, V165, P418, DOI 10.1093/aje/kwk030; Lee H, 2009, POPUL RES POLICY REV, V28, P505, DOI 10.1007/s11113-008-9115-4; Levin BE, 1998, AM J PHYSIOL-REG I, V275, pR1374, DOI 10.1152/ajpregu.1998.275.4.R1374; Li W, 2009, OBES REV, V10, P87, DOI 10.1111/j.1467-789X.2008.00528.x; Ludwig DS, 2008, JAMA-J AM MED ASSOC, V300, P1350, DOI 10.1001/jama.300.11.1350; Ludwig DS, 2011, JAMA-J AM MED ASSOC, V305, P1352, DOI 10.1001/jama.2011.380; Ludwig DS, 2010, LANCET, V376, P984, DOI 10.1016/S0140-6736(10)60751-9; Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; Ludwig DS, 1999, JAMA-J AM MED ASSOC, V282, P1539, DOI 10.1001/jama.282.16.1539; Luttikhuis HO, 2009, SAO PAULO MED J, V127, P321, DOI 10.1590/S1516-31802009000500015; McGovern L, 2008, J CLIN ENDOCR METAB, V93, P4600, DOI 10.1210/jc.2006-2409; Monteiro CA, 2011, PUBLIC HEALTH NUTR, V14, P5, DOI 10.1017/S1368980010003241; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Murtagh L, 2011, JAMA-J AM MED ASSOC, V306, P206, DOI 10.1001/jama.2011.903; NEEL JV, 1962, AM J HUM GENET, V14, P353; O'Brien PE, 2010, JAMA-J AM MED ASSOC, V303, P519, DOI 10.1001/jama.2010.81; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Oken E, 2003, OBES RES, V11, P496, DOI 10.1038/oby.2003.69; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Papadaki A, 2010, PEDIATRICS, V126, pE1143, DOI 10.1542/peds.2009-3633; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; Pereira MA, 2001, PEDIATR CLIN N AM, V48, P969, DOI 10.1016/S0031-3955(05)70351-5; Prins JB, 1997, CLIN SCI, V92, P3, DOI 10.1042/cs0920003; Puder JJ, 2010, INT J OBESITY, V34, pS37, DOI 10.1038/ijo.2010.238; Robinson TN, 1999, JAMA-J AM MED ASSOC, V282, P1561, DOI 10.1001/jama.282.16.1561; Roden M, 2006, NAT CLIN PRACT ENDOC, V2, P335, DOI 10.1038/ncpendmet0190; Rolls BJ, 2009, PHYSIOL BEHAV, V97, P609, DOI 10.1016/j.physbeh.2009.03.011; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Saelens BE, 2002, OBES RES, V10, P22, DOI 10.1038/oby.2002.4; Savoye M, 2007, JAMA-J AM MED ASSOC, V297, P2697, DOI 10.1001/jama.297.24.2697; Schwimmer JB, 2003, JAMA-J AM MED ASSOC, V289, P1813, DOI 10.1001/jama.289.14.1813; Schwimmer JB, 2006, PEDIATRICS, V118, P1388, DOI 10.1542/peds.2006-1212; Schwimmer JB, 2008, CIRCULATION, V118, P277, DOI 10.1161/CIRCULATIONAHA.107.739920; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681; Shils ME, 2006, MODERN NUTR HLTH DIS, P982; Skelton JA, 2009, ACAD PEDIATR, V9, P322, DOI 10.1016/j.acap.2009.04.005; Steinberger J, 2009, CIRCULATION, V119, P628, DOI 10.1161/CIRCULATIONAHA.108.191394; Stevelos J, BULLYING BULLYCIDE C; Story M, 2008, ANNU REV PUBL HEALTH, V29, P253, DOI 10.1146/annurev.publhealth.29.020907.090926; Strauss RS, 2001, ARCH PEDIAT ADOL MED, V155, P897, DOI 10.1001/archpedi.155.8.897; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Szajewska H, 2010, CRIT REV FOOD SCI, V50, P113, DOI 10.1080/10408390903467514; Treadwell JR, 2008, ANN SURG, V248, P763, DOI 10.1097/SLA.0b013e31818702f4; Treasure J., 2004, ADV PSYCHIAT TREATME, V10, P331, DOI [DOI 10.1192/APT.10.5.331, 10.1192/apt.10.5.331]; UnitedHealth Group, 2010, US DIAB CHALL OPP DE; Wang YC, 2006, PEDIATRICS, V118, pE1721, DOI 10.1542/peds.2006-0682; Wang YC, 2009, ARCH PEDIAT ADOL MED, V163, P336, DOI 10.1001/archpediatrics.2009.23; Williamson DA, 2006, OBESITY, V14, P1231, DOI 10.1038/oby.2006.140; Wilson DK, 2005, J PEDIATR PSYCHOL, V30, P293, DOI 10.1093/jpepsy/jsi039	107	25	26	1	57	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 1	2012	307	5					498	508		10.1001/jama.2011.2011	http://dx.doi.org/10.1001/jama.2011.2011			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	884SH	22215761				2022-12-28	WOS:000299728000031
J	Ni, XJ; Emani, NK; Kildishev, AV; Boltasseva, A; Shalaev, VM				Ni, Xingjie; Emani, Naresh K.; Kildishev, Alexander V.; Boltasseva, Alexandra; Shalaev, Vladimir M.			Broadband Light Bending with Plasmonic Nanoantennas	SCIENCE			English	Article							REFRACTION		[Shalaev, Vladimir M.] Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA; Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Shalaev, VM (corresponding author), Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA.	shalaev@purdue.edu	Ni, Xingjie/I-2235-2012; Emani, Naresh/F-3903-2011; Emani, Naresh Kumar/AAQ-8706-2020; Kildishev, Alexander V./L-5725-2019; Shalaev, Vladimir M./B-9331-2019; Kildishev, Alexander V/GSN-3724-2022; Boltasseva, Alexandra/C-1674-2019	Ni, Xingjie/0000-0001-7405-5678; Emani, Naresh/0000-0002-0488-921X; Emani, Naresh Kumar/0000-0002-0488-921X; Kildishev, Alexander V./0000-0002-8382-8422; Shalaev, Vladimir M./0000-0001-8976-1102; Kildishev, Alexander V/0000-0002-8382-8422; Boltasseva, Alexandra/0000-0001-8905-2605; IIT Hyderabad, EE Department/0000-0002-5880-4023	Multidisciplinary University Research Initiative (Air Force Office of Scientific Research) [FA9550-10-1-0264]; Multidisciplinary University Research Initiative (Office of Naval Research) [N00014-10-1-0942]; Air Force Research Lab-Materials and Manufacturing Directorate; NSF Division of Materials Research [1120923]	Multidisciplinary University Research Initiative (Air Force Office of Scientific Research); Multidisciplinary University Research Initiative (Office of Naval Research)(MURIOffice of Naval Research); Air Force Research Lab-Materials and Manufacturing Directorate; NSF Division of Materials Research(National Science Foundation (NSF))	This work was supported by Multidisciplinary University Research Initiative grants (Air Force Office of Scientific Research, FA9550-10-1-0264; Office of Naval Research, N00014-10-1-0942), Air Force Research Lab-Materials and Manufacturing Directorate, and NSF Division of Materials Research (1120923).	Liu ZW, 2007, SCIENCE, V315, P1686, DOI 10.1126/science.1137368; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; VESELAGO VG, 1968, SOV PHYS USPEKHI, V10, P509, DOI 10.1070/PU1968v010n04ABEH003699; Yu NF, 2011, SCIENCE, V334, P333, DOI 10.1126/science.1210713	5	1179	1225	34	641	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 27	2012	335	6067					427	427		10.1126/science.1214686	http://dx.doi.org/10.1126/science.1214686			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881FG	22194414				2022-12-28	WOS:000299466800038
J	Shetty, P				Shetty, Priya			Elodie Ghedin: intrepid gene hunter	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 14	2012	379	9811					113	113		10.1016/S0140-6736(12)60051-8	http://dx.doi.org/10.1016/S0140-6736(12)60051-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879GM	22243817				2022-12-28	WOS:000299317700021
J	Baker, JL; Sudarsan, N; Weinberg, Z; Roth, A; Stockbridge, RB; Breaker, RR				Baker, Jenny L.; Sudarsan, Narasimhan; Weinberg, Zasha; Roth, Adam; Stockbridge, Randy B.; Breaker, Ronald R.			Widespread Genetic Switches and Toxicity Resistance Proteins for Fluoride	SCIENCE			English	Article							CHLORIDE CHANNEL; IDENTIFICATION; DICHLOROMETHANE; BACTERIA; REVEALS; ACIDS; IONS	Most riboswitches are metabolite-binding RNA structures located in bacterial messenger RNAs where they control gene expression. We have discovered a riboswitch class in many bacterial and archaeal species whose members are selectively triggered by fluoride but reject other small anions, including chloride. These fluoride riboswitches activate expression of genes that encode putative fluoride transporters, enzymes that are known to be inhibited by fluoride, and additional proteins of unknown function. Our findings indicate that most organisms are naturally exposed to toxic levels of fluoride and that many species use fluoride-sensing RNAs to control the expression of proteins that alleviate the deleterious effects of this anion.	[Sudarsan, Narasimhan; Weinberg, Zasha; Roth, Adam; Breaker, Ronald R.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Baker, Jenny L.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Sudarsan, Narasimhan; Weinberg, Zasha; Roth, Adam; Breaker, Ronald R.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Stockbridge, Randy B.] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA; [Stockbridge, Randy B.] Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02454 USA; [Breaker, Ronald R.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Brandeis University; Brandeis University; Howard Hughes Medical Institute; Yale University	Breaker, RR (corresponding author), Yale Univ, Howard Hughes Med Inst, Box 208103, New Haven, CT 06520 USA.	ronald.breaker@yale.edu	Breaker, Ronald/E-9679-2010	Weinberg, Zasha/0000-0002-6681-3624; Stockbridge, Randy/0000-0001-8848-3032; Breaker, Ronald/0000-0002-2165-536X	NIH [RR19895-02, GM022778]; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM022778] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Breaker laboratory for helpful discussions and G. L. Ryan at Oligos Etc. for information on synthetic dinucleotide preparations. Ion channel flux experiments were conducted by R. B. S. in the laboratory of C. Miller, Brandeis Univ., and we thank him for his support of this project. We also thank N. Carriero and R. Bjornson for assisting our use of the Yale Life Sciences High Performance Computing Center (NIH grant RR19895-02). This work was supported by NIH ( grant GM022778) and by the Howard Hughes Medical Institute. R. R. B. is a cofounder of and consults for BioRelix, a biotechnology company that has licensed intellectual property on riboswitches from Yale University Yale University has filed for patent protection on aspects of the crcB motif and fluoride riboswitches.	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Auffinger P, 2004, STRUCTURE, V12, P379, DOI 10.1016/j.str.2004.02.015; Dobbins J. T., 1935, J CHEM EDUC, V12, P586; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; GALLI R, 1985, CONSERV RECYCLING, V8, P91, DOI 10.1016/0361-3658(85)90028-1; Hamilton I R, 1990, J Dent Res, V69 Spec No, P660; Hu KH, 1996, GENETICS, V143, P1521; Koo H, 2008, Adv Dent Res, V20, P17; LESHER RJ, 1977, ANTIMICROB AGENTS CH, V12, P339, DOI 10.1128/AAC.12.3.339; LEVINE RS, 1976, BRIT DENT J, V140, P9, DOI 10.1038/sj.bdj.4803690; MALTZ M, 1982, J DENT RES, V61, P786, DOI 10.1177/00220345820610062701; Marquis RE, 2003, FEMS MICROBIOL REV, V26, P493, DOI 10.1111/j.1574-6976.2003.tb00627.x; Matulef K, 2007, MOL MEMBR BIOL, V24, P342, DOI 10.1080/09687680701413874; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Regulski Elizabeth E., 2008, V419, P53, DOI 10.1007/978-1-59745-033-1_4; Silver S, 1996, GENE, V179, P9, DOI 10.1016/S0378-1119(96)00323-X; Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891; Van Loveren C, 2001, CARIES RES, V35, P65, DOI 10.1159/000049114; Vuilleumier S, 1997, BIOCHEM BIOPH RES CO, V238, P452, DOI 10.1006/bbrc.1997.7309; Weinberg Z, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r31	21	282	292	3	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 13	2012	335	6065					233	235		10.1126/science.1215063	http://dx.doi.org/10.1126/science.1215063			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875LZ	22194412	Green Accepted			2022-12-28	WOS:000299033100057
J	Senn, MS; Wright, JP; Attfield, JP				Senn, Mark S.; Wright, Jon P.; Attfield, J. Paul			Charge order and three-site distortions in the Verwey structure of magnetite	NATURE			English	Article							X-RAY-DIFFRACTION; TRANSITION; FE3O4; TEMPERATURE; OXIDES	The mineral magnetite (Fe(3)O(4)) undergoes a complex structural distortion and becomes electrically insulating at temperatures less than 125 kelvin. Verwey proposed in 1939 that this transition is driven by a charge ordering of Fe(2+) and Fe(3+) ions(1), but the ground state of the low-temperature phase has remained contentious(2,3) because twinning of crystal domains hampers diffraction studies of the structure(4). Recent powder diffraction refinements(5-7) and resonant X-ray studies(8-12) have led to proposals of a variety of charge-ordered and bond-dimerized ground-state models(13-19). Here we report the full low-temperature superstructure of magnetite, determined by high-energy X-ray diffraction from an almost single-domain, 40-micrometre grain, and identify the emergent order. The acentric structure is described by a superposition of 168 atomic displacement waves (frozen phonon modes), all with amplitudes of less than 0.24 angstroms. Distortions of the FeO(6) octahedra show that Verwey's hypothesis is correct to a first approximation and that the charge and Fe(2+) orbital order are consistent with a recent prediction(17). However, anomalous shortening of some Fe-Fe distances suggests that the localized electrons are distributed over linear three-Fe-site units, which we call 'trimerons'. The charge order and three-site distortions induce substantial off-centre atomic displacements and couple the resulting large electrical polarization to the magnetization. Trimerons may be important quasiparticles in magnetite above the Verwey transition and in other transition metal oxides.	[Senn, Mark S.; Attfield, J. Paul] Univ Edinburgh, Ctr Sci Extreme Condit, Edinburgh EH9 3JZ, Midlothian, Scotland; [Senn, Mark S.; Attfield, J. Paul] Univ Edinburgh, Sch Chem, Edinburgh EH9 3JZ, Midlothian, Scotland; [Wright, Jon P.] European Synchrotron Radiat Facil, F-38043 Grenoble 9, France	University of Edinburgh; University of Edinburgh; European Synchrotron Radiation Facility (ESRF)	Attfield, JP (corresponding author), Univ Edinburgh, Ctr Sci Extreme Condit, W Mains Rd, Edinburgh EH9 3JZ, Midlothian, Scotland.	wright@esrf.fr; j.p.attfield@ed.ac.uk	Wright, Jon/A-4321-2010; Senn, Mark S/J-4726-2017	Wright, Jon/0000-0002-8217-0884; Senn, Mark S/0000-0003-0812-5281	Leverhulme Trust; EPSRC; STFC; Engineering and Physical Sciences Research Council [EP/F02083X/1] Funding Source: researchfish; EPSRC [EP/F02083X/1] Funding Source: UKRI	Leverhulme Trust(Leverhulme Trust); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank C. Morrison for supplying code for electrical polarization calculations, J. Honig for provision of the magnetite sample, the Leverhulme Trust for financial support, and EPSRC and STFC for financial support and provision of continuing access to ESRF.	ANDERSON PW, 1956, PHYS REV, V102, P1008, DOI 10.1103/PhysRev.102.1008; Attfield JP, 2006, SOLID STATE SCI, V8, P861, DOI 10.1016/j.solidstatesciences.2005.02.011; Bland SR, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/48/485601; Blasco J, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.104105; Coey M, 2004, NATURE, V430, P155, DOI 10.1038/430155a; Downward L, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.106401; Fukushima T, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.014709; Goff RJ, 2005, J PHYS-CONDENS MAT, V17, P7633, DOI 10.1088/0953-8984/17/48/015; IIZUMI M, 1982, ACTA CRYSTALLOGR B, V38, P2121, DOI 10.1107/S0567740882008176; Ikeda N, 2005, NATURE, V436, P1136, DOI 10.1038/nature04039; Jeng HT, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.195115; Jeng HT, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.156403; Joly Y, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.134110; Kasama T, 2010, EARTH PLANET SC LETT, V297, P10, DOI 10.1016/j.epsl.2010.05.004; Lorenzo JE, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.226401; Nazarenko E, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.056403; Seo H, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.085107; SHEPHERD JP, 1985, PHYS REV B, V31, P1107, DOI 10.1103/PhysRevB.31.1107; van den Brink J, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/43/434217; Verwey EJW, 1939, NATURE, V144, P327, DOI 10.1038/144327b0; VERWEY EJW, 1947, J CHEM PHYS, V15, P174, DOI 10.1063/1.1746464; Walz F, 2002, J PHYS-CONDENS MAT, V14, pR285, DOI 10.1088/0953-8984/14/12/203; Wright JP, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.266401; Wright JP, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.214422; YAMADA Y, 1980, PHYS REV B, V21, P4642, DOI 10.1103/PhysRevB.21.4642; Yamauchi K, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.212404; Yang MH, 2011, NAT CHEM, V3, P47, DOI [10.1038/nchem.908, 10.1038/NCHEM.908]; YOSHIDA J, 1977, J PHYS SOC JPN, V42, P230, DOI 10.1143/JPSJ.42.230; Zhou F, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.205113	29	367	372	14	339	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 12	2012	481	7380					173	176		10.1038/nature10704	http://dx.doi.org/10.1038/nature10704			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	874TO	22190035	Green Accepted			2022-12-28	WOS:000298981200033
J	Mitchell, SL; Black, BS; Ersek, M; Hanson, LC; Miller, SC; Sachs, GA; Teno, JM; Morrison, RS				Mitchell, Susan L.; Black, Betty S.; Ersek, Mary; Hanson, Laura C.; Miller, Susan C.; Sachs, Greg A.; Teno, Joan M.; Morrison, R. Sean			Advanced Dementia: State of the Art and Priorities for the Next Decade	ANNALS OF INTERNAL MEDICINE			English	Article							NURSING-HOME RESIDENTS; END-STAGE DEMENTIA; ADVANCED COGNITIVE IMPAIRMENT; RANDOMIZED CONTROLLED-TRIAL; ADVANCED ALZHEIMERS-DISEASE; COMMUNITY-DWELLING PERSONS; FEEDING-TUBE INSERTION; LIFE CARE; HEALTH-CARE; ANTIBIOTIC-TREATMENT	Dementia is a leading cause of death in the United States. This article outlines the current understanding of advanced dementia and identifies research priorities for the next decade. Research over the past 25 years has largely focused on describing the experience of patients with advanced dementia. This work has delineated abundant opportunities for improvement, including greater recognition of advanced dementia as a terminal illness, better treatment of distressing symptoms, increased access to hospice and palliative care services, and less use of costly and aggressive treatments that may be of limited clinical benefit. Addressing those opportunities must be the overarching objective for the field in the coming decade. Priority areas include designing and testing interventions that promote high-quality, goal-directed care; health policy research to identify strategies that incentivize cost-effective and evidencebased care; implementation studies of promising interventions and policies; and further development of disease-specific outcome measures. There is great need and opportunity to improve outcomes, contain expenditures, reduce disparities, and better coordinate care for the millions of persons in the United States who have advanced dementia.	[Mitchell, Susan L.] Inst Aging Res, Boston, MA 02131 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA; Berman Inst Bioeth, Baltimore, MD 21205 USA; Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA; Univ N Carolina, Ctr Aging & Hlth, Chapel Hill, NC 27599 USA; Brown Univ, Program Publ Hlth, Providence, RI 02912 USA; Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; Indiana Univ Sch Med, Indianapolis, IN 46202 USA; Indiana Univ Aging Res, Regenstrief Inst, Indianapolis, IN 46202 USA; Mt Sinai Sch Med, New York, NY 10029 USA	Johns Hopkins University; University of Pennsylvania; University of North Carolina; University of North Carolina Chapel Hill; Brown University; Brown University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; Icahn School of Medicine at Mount Sinai	Mitchell, SL (corresponding author), Inst Aging Res, 1200 Ctr St, Boston, MA 02131 USA.		Miller, Susan/J-5450-2014; MUÑOZ, ROSA ANA/H-3964-2018	Miller, Susan/0000-0003-2008-6385; MUÑOZ, ROSA ANA/0000-0002-7504-2163; Hanson, Laura/0000-0001-5120-6058; Ersek, Mary/0000-0002-0520-311X	National Palliative Care Research Center; National Institute on Aging [K24AG033640, K24AG022345]; National Institutes of Health; National Institutes of Health, National Institute on Aging; DEMeasure; New York Department of Health, National Institutes of Health; Alzheimer's Association; Agency for Healthcare Research and Quality; Retirement Research Foundation; NATIONAL INSTITUTE ON AGING [K24AG033640, K24AG022345] Funding Source: NIH RePORTER	National Palliative Care Research Center; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); DEMeasure; New York Department of Health, National Institutes of Health; Alzheimer's Association(Alzheimer's Association); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Retirement Research Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By the National Palliative Care Research Center and grants K24AG033640 (Dr. Mitchell) and K24AG022345 (Dr. Morrison) from the National Institute on Aging.; Dr. Mitchell: Grant (money to institution): National Institutes of Health. Dr. Black: Employment: Johns Hopkins University; Grant (money to institution): National Institutes of Health, National Institute on Aging; Royalties: DEMeasure. Dr. Ersek: Grant (money to institution): National Institutes of Health; Support to travel to meetings for the study or other purposes: National Palliative Care Research Center. Grants/grants pending: New York Department of Health, National Institutes of Health. Dr. Miller: Support for travel to meetings for the study or other purposes: National Palliative Care Research Center; Support for travel to meetings for the study or other purposes (money to institution): National Palliative Care Research Center; Grants/grants pending: Alzheimer's Association; Grants/grants pending (money to institution): Alzheimer's Association. Dr. Sachs: Support for travel to meetings for the study or other purposes (money to institution): National Palliative Care Research Center; Consultancy: CVS Caremark; Grants/grants pending (money to institution): National Institutes of Health, Agency for Healthcare Research and Quality, Alzheimer's Association, National Palliative Care Research Center, Retirement Research Foundation. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum~M11-2121.	Ahronheim JC, 1996, ARCH INTERN MED, V156, P2094, DOI 10.1001/archinte.156.18.2094; Ahronheim JC, 2001, J AM GERIATR SOC, V49, P148, DOI 10.1046/j.1532-5415.2001.49035.x; Alzheimer's Associatio, 2011, 2001 ALZH DIS FACTS; Aminoff Bechor Zvi, 2005, Am J Hosp Palliat Care, V22, P344, DOI 10.1177/104990910502200507; Aminoff BZ, 2006, AGE AGEING, V35, P597, DOI 10.1093/ageing/afl067; [Anonymous], 1996, Hosp J, V11, P47; Black BS, 2006, ALZ DIS ASSOC DIS, V20, P283, DOI 10.1097/01.wad.0000213854.04861.cc; Chen JH, 2006, J AM GERIATR SOC, V54, P290, DOI 10.1111/j.1532-5415.2005.00524.x; D'Agata E, 2008, ARCH INTERN MED, V168, P357, DOI 10.1001/archinternmed.2007.104; Di Giulio P, 2008, J PALLIAT MED, V11, P1023, DOI 10.1089/jpm.2008.0020; Engel SE, 2006, J AM GERIATR SOC, V54, P1567, DOI 10.1111/j.1532-5415.2006.00900.x; FABISZEWSKI KJ, 1990, JAMA-J AM MED ASSOC, V263, P3168, DOI 10.1001/jama.263.23.3168; Finucane TE, 1999, JAMA-J AM MED ASSOC, V282, P1365, DOI 10.1001/jama.282.14.1365; FRIED TR, 1995, J GEN INTERN MED, V10, P246, DOI 10.1007/BF02599879; Gessert CE, 2000, J AM GERIATR SOC, V48, P1593, DOI 10.1111/j.1532-5415.2000.tb03869.x; Gill TM, 2010, NEW ENGL J MED, V362, P1173, DOI 10.1056/NEJMoa0909087; Gillick MR, 2000, NEW ENGL J MED, V342, P206, DOI 10.1056/NEJM200001203420312; Givens JL, 2010, ARCH INTERN MED, V170, P1102, DOI 10.1001/archinternmed.2010.181; Givens JL, 2009, J AM GERIATR SOC, V57, P1149, DOI 10.1111/j.1532-5415.2009.02304.x; Goldfeld KS, 2011, ARCH INTERN MED, V171, P824, DOI 10.1001/archinternmed.2010.478; Gozalo P, 2011, NEW ENGL J MED, V365, P1212, DOI 10.1056/NEJMsa1100347; HANRAHAN P, 1995, J AM GERIATR SOC, V43, P56, DOI 10.1111/j.1532-5415.1995.tb06243.x; Hanson LC, 2011, J AM GERIATR SOC, V59, P2009, DOI 10.1111/j.1532-5415.2011.03629.x; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Kiely DK, 2006, ALZ DIS ASSOC DIS, V20, P176, DOI 10.1097/00002093-200607000-00009; Kiely DK, 2010, J AM GERIATR SOC, V58, P2284, DOI 10.1111/j.1532-5415.2010.03185.x; Kiely DK, 2001, J AM GERIATR SOC, V49, P1346, DOI 10.1046/j.1532-5415.2001.49263.x; Loeb M, 2005, BRIT MED J, V331, P669, DOI 10.1136/bmj.38602.586343.55; Loeb M, 2006, JAMA-J AM MED ASSOC, V295, P2503, DOI 10.1001/jama.295.21.2503; Lopez RP, 2010, ARCH INTERN MED, V170, P83, DOI 10.1001/archinternmed.2009.467; LUCHINS DJ, 1993, J AM GERIATR SOC, V41, P25; Marsh GW, 2000, APPL NURS RES, V13, P187, DOI 10.1053/apnr.2000.7654; McCarthy EP, 2000, J AM GERIATR SOC, V48, pS110, DOI 10.1111/j.1532-5415.2000.tb03120.x; McCarthy M, 1997, INT J GERIATR PSYCH, V12, P404; Mehr DR, 2003, GERONTOLOGIST, V43, P85, DOI 10.1093/geront/43.suppl_2.85; Meier DE, 2001, ARCH INTERN MED, V161, P594, DOI 10.1001/archinte.161.4.594; Miller SC, 2004, J AM GERIATR SOC, V52, P1284, DOI 10.1111/j.1532-5415.2004.52357.x; Miller SC, 2001, AM J MED, V111, P38, DOI 10.1016/S0002-9343(01)00747-1; Miller SC, 2002, J AM GERIATR SOC, V50, P507, DOI 10.1046/j.1532-5415.2002.50118.x; Mitchell SL, 1997, ARCH INTERN MED, V157, P327, DOI 10.1001/archinte.157.3.327; Mitchell SL, 2004, ARCH INTERN MED, V164, P321, DOI 10.1001/archinte.164.3.321; Mitchell SL, 2005, J AM GERIATR SOC, V53, P299, DOI 10.1111/j.1532-5415.2005.53118.x; Mitchell SL, 2003, JAMA-J AM MED ASSOC, V290, P73, DOI 10.1001/jama.290.1.73; Mitchell SL, 2003, J AM GERIATR SOC, V51, P75, DOI 10.1034/j.1601-5215.2002.51021.x; Mitchell SL, 2004, JAMA-J AM MED ASSOC, V291, P2734, DOI 10.1001/jama.291.22.2734; Mitchell SL, 2007, JAMA-J AM MED ASSOC, V298, P2527, DOI 10.1001/jama.298.17.jrr70001; Mitchell SL, 2007, J AM GERIATR SOC, V55, P432, DOI 10.1111/j.1532-5415.2007.01086.x; Mitchell Susan L, 2003, J Am Med Dir Assoc, V4, P27, DOI 10.1097/00130535-200301000-00005; Mitchell SL, 2010, JAMA-J AM MED ASSOC, V304, P1929, DOI 10.1001/jama.2010.1572; Mitchell SL, 2009, NEW ENGL J MED, V361, P1529, DOI 10.1056/NEJMoa0902234; Mitchell Susan L, 2004, J Palliat Med, V7, P808, DOI 10.1089/jpm.2004.7.808; Monteleoni C, 2004, BMJ-BRIT MED J, V329, P491, DOI 10.1136/bmj.329.7464.491; Morrison RS, 2000, JAMA-J AM MED ASSOC, V284, P47, DOI 10.1001/jama.284.1.47; Morrison RS, 1998, J PAIN SYMPTOM MANAG, V15, P91, DOI 10.1016/S0885-3924(97)00261-3; National Center for Health Statistics, 2011, NAT CTR HLTH STAT NA; National Hospice and Palliative Care Organization, 2010, FACTS FIG; Ouslander JG, 2011, NEW ENGL J MED, V365, P1165, DOI 10.1056/NEJMp1105449; Pop-Vicas A, 2008, J AM GERIATR SOC, V56, P1276, DOI 10.1111/j.1532-5415.2008.01787.x; REISBERG B, 1982, AM J PSYCHIAT, V139, P1136; Sachs GA, 2004, J GEN INTERN MED, V19, P1057, DOI 10.1111/j.1525-1497.2004.30329.x; Schonwetter Ronald S, 2003, Am J Hosp Palliat Care, V20, P105, DOI 10.1177/104990910302000208; Shega JW, 2008, J PAIN SYMPTOM MANAG, V35, P499, DOI 10.1016/j.jpainsymman.2007.06.011; Shega JW, 2006, J AM GERIATR SOC, V54, P1892, DOI 10.1111/j.1532-5415.2006.00986.x; Shega JW, 2004, J PAIN SYMPTOM MANAG, V28, P585, DOI 10.1016/j.jpainsymman.2004.04.012; Teno JM, 2002, JAMA-J AM MED ASSOC, V287, P3211, DOI 10.1001/jama.287.24.3211; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; Teno JM, 2011, J AM GERIATR SOC, V59, P1531, DOI 10.1111/j.1532-5415.2011.03505.x; Teno JM, 2011, J AM GERIATR SOC, V59, P881, DOI 10.1111/j.1532-5415.2011.03385.x; Teno JM, 2009, J PALLIAT MED, V12, P359, DOI 10.1089/jpm.2008.0168; van der Steen JT, 2007, J AM MED DIR ASSOC, V8, P464, DOI 10.1016/j.jamda.2007.05.004; van der Steen JT, 2006, J CLIN EPIDEMIOL, V59, P970, DOI 10.1016/j.jclinepi.2005.12.005; van der Steen JT, 2010, J ALZHEIMERS DIS, V22, P37, DOI 10.3233/JAD-2010-100744; van der Steen JT, 2004, J AM GERIATR SOC, V52, P691, DOI 10.1111/j.1532-5415.2004.52204.x; van der Steen JT, 2002, ARCH INTERN MED, V162, P1753, DOI 10.1001/archinte.162.15.1753; Volandes AE, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2159; VOLICER BJ, 1993, J AM GERIATR SOC, V41, P535, DOI 10.1111/j.1532-5415.1993.tb01891.x; VOLICER L, 1986, JAMA-J AM MED ASSOC, V256, P2210, DOI 10.1001/jama.256.16.2210; Volicer L, 2001, ALZ DIS ASSOC DIS, V15, P194, DOI 10.1097/00002093-200110000-00005; VOLICER L, 1994, J GERONTOL, V49, pM223, DOI 10.1093/geronj/49.5.M223; Warden Victoria, 2003, J Am Med Dir Assoc, V4, P9, DOI 10.1097/00130535-200301000-00002; Weeks JC, 1998, JAMA-J AM MED ASSOC, V279, P1709, DOI 10.1001/jama.279.21.1709; Zhu CW, 2006, NEUROLOGY, V66, P1021, DOI 10.1212/01.wnl.0000204189.18698.c7	82	106	108	0	30	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 3	2012	156	1	1				45	U95		10.7326/0003-4819-156-1-201201030-00008	http://dx.doi.org/10.7326/0003-4819-156-1-201201030-00008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	872VK	22213494	Green Accepted, Green Published			2022-12-28	WOS:000298837600007
J	Hunter, DN				Hunter, D. N.			PERSONAL VIEW Follow surgical checklists and take time out, especially in a crisis	BRITISH MEDICAL JOURNAL			English	Editorial Material									Royal Brompton Hosp, London SW3 6NP, England	Royal Brompton Hospital	Hunter, DN (corresponding author), Royal Brompton Hosp, London SW3 6NP, England.	d.hunter@rbht.nhs.uk						2008, BRIT MED J, V337, DOI DOI 10.1136/BMJ.A2370	1	9	10	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 30	2011	343								d8194	10.1136/bmj.d8194	http://dx.doi.org/10.1136/bmj.d8194			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	874TQ	22209820				2022-12-28	WOS:000298981400002
J	DiPersio, JF				DiPersio, John F.			Diabetic Stem-Cell "Mobilopathy"	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Washington Univ, Sch Med, Div Oncol, St Louis, MO 63130 USA	Washington University (WUSTL)	DiPersio, JF (corresponding author), Washington Univ, Sch Med, Div Oncol, St Louis, MO 63130 USA.							DiPersio JF, 2009, J CLIN ONCOL, V27, P4767, DOI 10.1200/JCO.2008.20.7209; Ferraro F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002191; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Pusic I, 2008, BIOL BLOOD MARROW TR, V14, P1045, DOI 10.1016/j.bbmt.2008.07.004; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016	5	69	71	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2011	365	26					2536	2538		10.1056/NEJMcibr1112347	http://dx.doi.org/10.1056/NEJMcibr1112347			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	868SD	22204729	Green Published			2022-12-28	WOS:000298544600016
J	Raffel, JB; Al-Lawati, A; Murch, N				Raffel, Joel B.; Al-Lawati, Adil; Murch, Nick			PICTURE QUIZ Rash and dyspnoea in a 39 year old man	BRITISH MEDICAL JOURNAL			English	Editorial Material							VARICELLA-ZOSTER-VIRUS; CHICKENPOX PNEUMONIA; RISK-FACTORS; ADULTS; VACCINATION; INFECTION; PREGNANCY; ACYCLOVIR; HISTORY		[Raffel, Joel B.; Al-Lawati, Adil; Murch, Nick] Royal London Hosp, London E1 1BB, England	Barts Health NHS Trust; Royal London Hospital	Raffel, JB (corresponding author), Royal London Hosp, London E1 1BB, England.	joelraffel@doctors.org.uk						Adhami N, 2006, RESPIROLOGY, V11, P437, DOI 10.1111/j.1440-1843.2006.00870.x; BOCLES JS, 1964, ANN INTERN MED, V60, P183, DOI 10.7326/0003-4819-60-2-183; Chiner E, 2010, SCAND J INFECT DIS, V42, P215, DOI 10.3109/00365540903428166; Dehecq C, 2009, MED MALADIES INFECT, V39, P101, DOI 10.1016/j.medmal.2008.09.025; ESMONDE TF, 1989, THORAX, V44, P812, DOI 10.1136/thx.44.10.812; GERSHON A, 1972, J PEDIATR-US, V81, P1034, DOI 10.1016/S0022-3476(72)80566-3; Gregorakos L, 2002, RESPIRATION, V69, P330, DOI 10.1159/000063274; HAAKE DA, 1990, REV INFECT DIS, V12, P788; Harger JH, 2002, J INFECT DIS, V185, P422, DOI 10.1086/338832; HOCKBERGER RS, 1986, ANN EMERG MED, V15, P931, DOI 10.1016/S0196-0644(86)80679-5; JOSEPH CA, 1988, BMJ-BRIT MED J, V296, P673, DOI 10.1136/bmj.296.6623.673; KNYVETT AF, 1966, Q J MED, V35, P313; MacMahon E, 2004, BRIT MED J, V329, P551, DOI 10.1136/bmj.38170.691956.AE; Marin M, 2011, PEDIATRICS, V128, P214, DOI 10.1542/peds.2010-3385; Mohsen AH, 2003, EUR RESPIR J, V21, P886, DOI 10.1183/09031936.03.00103202; Mohsen AH, 2001, THORAX, V56, P796, DOI 10.1136/thorax.56.10.796; Nee PA, 1999, J ACCID EMERG MED, V16, P147; ONG ELC, 1991, SCAND J INFECT DIS, V23, P283, DOI 10.3109/00365549109024311; Partridge DG, 2009, EXPERT OPIN PHARMACO, V10, P797, DOI [10.1517/14656560902808502 , 10.1517/14656560902808502]; Popara Mirjana, 2002, International Journal of Infectious Diseases, V6, P6, DOI 10.1016/S1201-9712(02)90128-1; Sauerbrei Andreas, 2007, Indian J Med Sci, V61, P123; Tan MP, 2006, REPROD TOXICOL, V21, P410, DOI 10.1016/j.reprotox.2005.04.011; Tunbridge AJ, 2008, J INFECTION, V57, P95, DOI 10.1016/j.jinf.2008.03.004; TYRING SK, 1992, SEMIN DERMATOL, V11, P211; WEBER DM, 1965, J AMER MED ASSOC, V192, P572, DOI 10.1001/jama.1965.03080190138035; WEINSTEIN L, 1956, ARCH INTERN MED, V98, P91, DOI 10.1001/archinte.1956.00250250097013	26	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 29	2011	343								d8256	10.1136/bmj.d8256	http://dx.doi.org/10.1136/bmj.d8256			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874TN	22207158				2022-12-28	WOS:000298981100003
J	Mondal, BC; Mukherjee, T; Mandal, L; Evans, CJ; Sinenko, SA; Martinez-Agosto, JA; Banerjee, U				Mondal, Bama Charan; Mukherjee, Tina; Mandal, Lolitika; Evans, Cory J.; Sinenko, Sergey A.; Martinez-Agosto, Julian A.; Banerjee, Utpal			Interaction between Differentiating Cell- and Niche-Derived Signals in Hematopoietic Progenitor Maintenance	CELL			English	Article							DROSOPHILA-LYMPH GLAND; STEM-CELL; GENETIC DISSECTION; TISSUE-DAMAGE; RECEPTOR; ADENOSINE; PROLIFERATION; REGENERATION; HOMEOSTASIS; ACTIVATION	Maintenance of a hematopoietic progenitor population requires extensive interaction with cells within a microenvironment or niche. In the Drosophila hematopoietic organ, niche-derived Hedgehog signaling maintains the progenitor population. Here, we show that the hematopoietic progenitors also require a signal mediated by Adenosine deaminase growth factor A (Adgf-A) arising from differentiating cells that regulates extracellular levels of adenosine. The adenosine signal opposes the effects of Hedgehog signaling within the hematopoietic progenitor cells and the magnitude of the adenosine signal is kept in check by the level of Adgf-A secreted from differentiating cells. Our findings reveal signals arising from differentiating cells that are required for maintaining progenitor cell quiescence and that function with the niche-derived signal in maintaining the progenitor state. Similar homeostatic mechanisms are likely to be utilized in other systems that maintain relatively large numbers of progenitors that are not all in direct contact with the cells of the niche.	[Martinez-Agosto, Julian A.] Univ Calif Los Angeles, David Geffen Sch Med UCLA, Dept Human Genet, Los Angeles, CA 90095 USA; [Mondal, Bama Charan; Mukherjee, Tina; Mandal, Lolitika; Evans, Cory J.; Sinenko, Sergey A.; Banerjee, Utpal] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Martinez-Agosto, Julian A.; Banerjee, Utpal] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Banerjee, Utpal] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Martinez-Agosto, Julian A.; Banerjee, Utpal] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Martinez-Agosto, JA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med UCLA, Dept Human Genet, Los Angeles, CA 90095 USA.	julianmartinez@mednet.ucla.edu; banerjee@mbi.ucla.edu	Martinez-Agosto, Julian A/I-9435-2019; Sinenko, Sergey A./C-3703-2016	Martinez-Agosto, Julian A/0000-0001-6776-6949; Sinenko, Sergey A./0000-0001-5517-8218; Mondal, Bama Charan/0000-0001-9694-7714	NHLBI [R01 HL067395, K08 HL087026]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL087026, R01HL067395] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank members of the Banerjee lab for helpful discussions. We acknowledge V.D.R.C., N.I.G., D.H.S.B., B.D.S.C., E. Bach, J. Calderon, J. Darnell, T. Dolezal, J. Hooper, D. Montell, P. Rorth, A. Sehgal, B. Shilo, M. Yoo, and M. Zeidler for reagents. Supported by NHLBI R01 HL067395 to UB and NHLBI K08 HL087026 to JM.	Amcheslavsky A, 2009, CELL STEM CELL, V4, P49, DOI 10.1016/j.stem.2008.10.016; Baldwin SA, 2005, J BIOL CHEM, V280, P15880, DOI 10.1074/jbc.M414337200; Bond D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000655; Collier LS, 2004, GENETICS, V167, P783, DOI 10.1534/genetics.103.024992; Crozatier M, 2004, PLOS BIOL, V2, P1107, DOI 10.1371/journal.pbio.0020196; Dolezal T, 2005, PLOS BIOL, V3, P1213, DOI 10.1371/journal.pbio.0030201; Dolezal T, 2003, GENETICS, V165, P653; Dolezelova E, 2007, INSECT BIOCHEM MOLEC, V37, P318, DOI 10.1016/j.ibmb.2006.12.003; Evans CJ, 2009, NAT METHODS, V6, P603, DOI 10.1038/nmeth.1356; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; FU XY, 1993, CELL, V74, P1135, DOI 10.1016/0092-8674(93)90734-8; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Garrett RW, 2009, CELL STEM CELL, V4, P503, DOI 10.1016/j.stem.2009.05.011; Giansanti MG, 2004, MOL BIOL CELL, V15, P2509, DOI 10.1091/mbc.E03-08-0603; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Ishimaru S, 2004, EMBO J, V23, P3984, DOI 10.1038/sj.emboj.7600417; Janssens K, 2010, P NATL ACAD SCI USA, V107, P7323, DOI 10.1073/pnas.0915075107; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Jude CD, 2008, CELL CYCLE, V7, P586, DOI 10.4161/cc.7.5.5549; Jung SH, 2005, DEVELOPMENT, V132, P2521, DOI 10.1242/dev.01837; Krzemien J, 2007, NATURE, V446, P325, DOI 10.1038/nature05650; Krzemien J, 2010, DEV BIOL, V346, P310, DOI 10.1016/j.ydbio.2010.08.003; Learte AR, 2008, GLIA, V56, P164, DOI 10.1002/glia.20601; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Li WX, 2002, DEVELOPMENT, V129, P4241; Losick VP, 2011, DEV CELL, V21, P159, DOI 10.1016/j.devcel.2011.06.018; Maier SA, 2001, GENE, V280, P27, DOI 10.1016/S0378-1119(01)00762-4; Makki R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000441; Mandal L, 2007, NATURE, V446, P320, DOI 10.1038/nature05585; Martinez-Agosto JA, 2007, GENE DEV, V21, P3044, DOI 10.1101/gad.1602607; Mathieu J, 2007, GENETICS, V176, P1579, DOI 10.1534/genetics.107.071282; Mathur D, 2010, SCIENCE, V327, P210, DOI 10.1126/science.1181958; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Minakhina S, 2010, DEVELOPMENT, V137, P27, DOI 10.1242/dev.043943; Mukherjee T, 2011, SCIENCE, V332, P1210, DOI 10.1126/science.1199643; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; Novakova M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017741; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; ROGGE RD, 1991, CELL, V64, P39, DOI 10.1016/0092-8674(91)90207-F; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Sims D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r20; Sinenko SA, 2009, DEV CELL, V16, P756, DOI 10.1016/j.devcel.2009.03.003; Smelkinson MG, 2006, CURR BIOL, V16, P110, DOI 10.1016/j.cub.2005.12.012; Ten Broek RW, 2010, J CELL PHYSIOL, V224, P7, DOI 10.1002/jcp.22127; Tsai YC, 2004, GENESIS, V39, P141, DOI 10.1002/gene.20035; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Yu FW, 2005, GENE DEV, V19, P1341, DOI 10.1101/gad.1295505; Zavialov AV, 2010, J LEUKOCYTE BIOL, V88, P279, DOI 10.1189/jlb.1109764; Zurovec M, 2002, P NATL ACAD SCI USA, V99, P4403, DOI 10.1073/pnas.062059699	51	133	134	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 23	2011	147	7					1589	1600		10.1016/j.cell.2011.11.041	http://dx.doi.org/10.1016/j.cell.2011.11.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	866SP	22196733	Bronze, Green Accepted			2022-12-28	WOS:000298403400022
J	Cheung, F				Cheung, Felix			TCM Made in China	NATURE			English	Editorial Material																			0	294	300	6	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2011	480	7378					S82	S83		10.1038/480S82a	http://dx.doi.org/10.1038/480S82a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	865NQ	22190085	Bronze			2022-12-28	WOS:000298318000001
J	Tian, P				Tian, Peng			CONVERGENCE Where West meets East	NATURE			English	Editorial Material																		He YT, 2008, AM J CHINESE MED, V36, P675, DOI 10.1142/S0192415X08006144; Wang L, 2008, P NATL ACAD SCI USA, V105, P4826, DOI 10.1073/pnas.0712365105; Wang Z, 2011, J CLIN PHARMACOL, V51, P1132, DOI 10.1177/0091270010382913; Xie GX, 2009, J AGR FOOD CHEM, V57, P3046, DOI 10.1021/jf804000y; Zhang Gongyao, 2006, MED PHILOS, V27, P14	5	65	70	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2011	480	7378					S84	S86		10.1038/480S84a	http://dx.doi.org/10.1038/480S84a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	865NQ	22190086	Bronze			2022-12-28	WOS:000298318000002
J	Baicus, C; Voiosu, T				Baicus, Cristian; Voiosu, Theodor			Review: Antispasmodics and antidepressants were each effective in the irritable bowel syndrome; bulking agents were not	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Baicus, Cristian; Voiosu, Theodor] Colentina Univ Hosp, Bucharest, Romania		Baicus, C (corresponding author), Colentina Univ Hosp, Bucharest, Romania.		Baicus, Cristian/AAU-5435-2021; Baicus, Cristian C/C-3355-2008; Voiosu, Theodor/AAK-1135-2021; Voiosu, Theodor/C-2445-2012	Baicus, Cristian/0000-0002-7954-0098; Baicus, Cristian C/0000-0002-7954-0098; Voiosu, Theodor/0000-0003-3250-4900				Spiegel BM, 2006, GASTROENTEROLOGY, V130, pA112	1	0	0	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2011	155	12							JC6-7	10.7326/0003-4819-155-12-201112200-02007	http://dx.doi.org/10.7326/0003-4819-155-12-201112200-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	864ZU	22184708				2022-12-28	WOS:000298280500006
J	Doyal, L; Muinzer, T				Doyal, Len; Muinzer, Thomas			CHRISTMAS 2011: DEATH'S DOMINION Should the skeleton of "the Irish giant" be buried at sea?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Doyal, Len] Univ London, London WC1E 7HU, England; [Muinzer, Thomas] Queens Univ Belfast, Sch Law, Belfast, Antrim, North Ireland	University of London; Queens University Belfast	Doyal, L (corresponding author), Univ London, London WC1E 7HU, England.	l.doyal@qmul.ac.uk		Muinzer, Thomas/0000-0003-4829-0804				[Anonymous], 2011, TRAGIC STORY C BYRNE; Brazier M., 2002, LEGAL STUDIES, V22, P550, DOI 10.1111/j.1748-121X.2002.tb00668.x; Brennan M, 2009, COMMUNICATION   0325; British Medical Association, 2011, ORG DON BRIEF PAP; Campbell AV, 2009, BIOMED LAW ETHICS LI, P95; Chahal HS, 2011, NEW ENGL J MED, V364, P43, DOI 10.1056/NEJMoa1008020; Conway H, 2002, LEG STUD, V23, P423; Culture northernireland.org, FREE IR GIANT; Donaldson M, 2010, MIRACLE FRUIT; Emson HE, 2003, J MED ETHICS, V29, P125, DOI 10.1136/jme.29.3.125; Frankcom G, 1976, IRISH GIANT, P104; Gallagher S, 2010, INT J CULT PROP, V17, P65, DOI 10.1017/S0940739110000019; Giordano S, 2005, J MED ETHICS, V31, P470, DOI 10.1136/jme.2004.009944; Gutting G, 2009, WHAT PHILOSOPHERS KNOW: CASE STUDIES IN RECENT ANALYTIC PHILOSOPHY, P11; Hamer CL, 2003, J MED ETHICS, V29, P196, DOI 10.1136/jme.29.3.196; Harris J, 2003, J MED ETHICS, V29, P130, DOI 10.1136/jme.29.3.130; Harris John, 2002, Leg Stud (Soc Leg Scholars), V22, P527, DOI 10.1111/j.1748-121X.2002.tb00667.x; Holm S, 2001, THEOR MED BIOETH, V22, P437, DOI 10.1023/A:1013010918460; Liddell K, 2005, MED LAW REV, V13, P170, DOI DOI 10.1093/MEDLAW/FWI012; Malcolm J, 2008, BALLAD C BYRNE SANDS; Mantel H, 1998, GIANT; Mason K, 2001, Mod Law Rev, V64, P710, DOI 10.1111/1468-2230.00347; McGuinness Sheelagh, 2008, OJLS, V28, P297; McNally F, 2008, IRISH TIMES     0910; Moore W, 2006, KNIFE MAN BLOOD BODY, P397; O'Toole F, 2009, IRISH TIMES     0307; Parry V, 2011, GUARDIAN        0111; Royal College of Surgeons, LETT REL PURS MATT M; Royal College of Surgeons, MUS ACQ DISP POL; Savulescu J, 2003, J MED ETHICS, V29, P127, DOI 10.1136/jme.29.3.127; Wilkinson T M, 2002, J Appl Philos, V19, P31, DOI 10.1111/1468-5930.00202	31	14	14	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 20	2011	343								d7597	10.1136/bmj.d7597	http://dx.doi.org/10.1136/bmj.d7597			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	868QK	22187392	Green Submitted			2022-12-28	WOS:000298538200006
J	Choudhry, A; Marchi, C; Stephens, W				Choudhry, Akbar; Marchi, Clive; Stephens, William			CHRISTMAS 2011: DIAGNOSIS Manchester United induced addisonian crisis	BRITISH MEDICAL JOURNAL			English	Editorial Material							DISEASE		[Choudhry, Akbar; Stephens, William] Trafford Gen Hosp, Dept Med, Manchester M41 5BG, Lancs, England; [Marchi, Clive] Conway Rd Hlth Ctr, Manchester, Lancs, England		Choudhry, A (corresponding author), Trafford Gen Hosp, Dept Med, Manchester M41 5BG, Lancs, England.	akbar.choudhry@doctors.org.uk						NERUP J, 1974, ACTA ENDOCRINOL-COP, V76, P127, DOI 10.1530/acta.0.0760127; Ten S, 2001, J CLIN ENDOCR METAB, V86, P2909, DOI 10.1210/jc.86.7.2909; Tsigos C, 2002, J PSYCHOSOM RES, V53, P865, DOI 10.1016/S0022-3999(02)00429-4	3	2	2	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 15	2011	343								d7732	10.1136/bmj.d7732	http://dx.doi.org/10.1136/bmj.d7732			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	888WF	22174325				2022-12-28	WOS:000300034600006
J	Subramanian, P; Kantharuban, S; Subramanian, V; Willis-Owen, SAG; Willis-Owen, CA				Subramanian, P.; Kantharuban, S.; Subramanian, V.; Willis-Owen, S. A. G.; Willis-Owen, C. A.			CHRISTMAS 2011: SURGERY Orthopaedic surgeons: as strong as an ox and almost twice as clever? Multicentre prospective comparative study	BRITISH MEDICAL JOURNAL			English	Editorial Material							STRENGTH; GORILLAS; GRIP	Objective To compare the intelligence and grip strength of orthopaedic surgeons and anaesthetists. Design Multicentre prospective comparative study. Setting Three UK district general hospitals in 2011. Participants 36 male orthopaedic surgeons and 40 male anaesthetists at consultant or specialist registrar grade. Main outcome measures Intelligence test score and dominant hand grip strength. Results Orthopaedic surgeons had a statistically significantly greater mean grip strength (47.25 (SD 6.95) kg) than anaesthetists (43.83 (7.57) kg). The mean intelligence test score of orthopaedic surgeons was also statistically significantly greater at 105.19 (10.85) compared with 98.38 (14.45) for anaesthetists. Conclusions Male orthopaedic surgeons have greater intelligence and grip strength than their male anaesthetic colleagues, who should find new ways to make fun of their orthopaedic friends.	[Subramanian, P.] Whipps Cross Hosp & Chest Clin, London W11 1NR, England; [Kantharuban, S.] Milton Keynes Dist Gen Hosp, Milton Keynes MK6 5LD, Bucks, England; [Subramanian, V.] Southport Gen Hosp, Southport PR8 6PN, England; [Willis-Owen, S. A. G.] Natl Heart & Lung Inst, London SW3 6LY, England; [Willis-Owen, C. A.] Queen Marys Hosp, Sidcup DA14 6LT, Kent, England	University of London; Queen Mary University London; Imperial College London	Subramanian, P (corresponding author), Whipps Cross Hosp & Chest Clin, London W11 1NR, England.	drpad@hotmail.com		Willis-Owen, Saffron/0000-0003-2633-1150				BARRETT DS, 1988, BRIT MED J, V297, P1638, DOI 10.1136/bmj.297.6664.1638; BRENKEL IJ, 1986, BRIT MED J, V293, P1648, DOI 10.1136/bmj.293.6562.1648; British Orthopaedic Association, 2009, ORTRH MANP CENS; FOX JS, 1990, BRIT MED J, V301, P1425, DOI 10.1136/bmj.301.6766.1425; Hambrick DZ, 1999, J EXP PSYCHOL GEN, V128, P131, DOI 10.1037/0096-3445.128.2.131; MATHIOWETZ V, 1984, J HAND SURG-AM, V9A, P222, DOI 10.1016/S0363-5023(84)80146-X; Peters MJH, 2011, J PERIPHER NERV SYST, V16, P47, DOI 10.1111/j.1529-8027.2011.00318.x; Royal College of Anaesthetists, 2007, COLL CENS; YouTube, 2011, ORTH VS AN ORTH AN C	9	29	29	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 15	2011	343								d7506	10.1136/bmj.d7506	http://dx.doi.org/10.1136/bmj.d7506			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	888WF	22174322	Green Published, hybrid			2022-12-28	WOS:000300034600008
J	Fan, L; Wang, J; Varghese, LT; Shen, H; Niu, B; Xuan, Y; Weiner, AM; Qi, MH				Fan, Li; Wang, Jian; Varghese, Leo T.; Shen, Hao; Niu, Ben; Xuan, Yi; Weiner, Andrew M.; Qi, Minghao			An All-Silicon Passive Optical Diode	SCIENCE			English	Article							WAVE-GUIDES; RING RESONATORS; BISTABILITY; CHIP; NONLINEARITIES; PROPAGATION; ISOLATOR; FILTERS; FIBER	A passive optical diode effect would be useful for on-chip optical information processing but has been difficult to achieve. Using a method based on optical nonlinearity, we demonstrate a forward-backward transmission ratio of up to 28 decibels within telecommunication wavelengths. Our device, which uses two silicon rings 5 micrometers in radius, is passive yet maintains optical nonreciprocity for a broad range of input power levels, and it performs equally well even if the backward input power is higher than the forward input. The silicon optical diode is ultracompact and is compatible with current complementary metal-oxide semiconductor processing.	[Fan, Li; Wang, Jian; Varghese, Leo T.; Shen, Hao; Niu, Ben; Xuan, Yi; Weiner, Andrew M.; Qi, Minghao] Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA; [Fan, Li; Wang, Jian; Varghese, Leo T.; Shen, Hao; Niu, Ben; Xuan, Yi; Weiner, Andrew M.; Qi, Minghao] Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA; [Qi, Minghao] Chinese Acad Sci, Shanghai Inst Microsyst & Informat Technol, Shanghai 20050, Peoples R China	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Chinese Academy of Sciences; Shanghai Institute of Microsystem & Information Technology, CAS	Qi, MH (corresponding author), Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA.	mqi@purdue.edu	Wang, Jian/F-3685-2012; Varghese, Leo/M-5396-2013; Wang, Jian/A-7781-2016; Fan, Li/B-1965-2014; Shen, Hao/D-4144-2012		Defense Threat Reduction Agency [HDTRA1-10-1-0106]; Air Force Office of Scientific Research [FA9550-08-1-0379]; NSF [ECCS-0925759]; NIH [1R01RR026273-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR026273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103401] Funding Source: NIH RePORTER; Div Of Electrical, Commun & Cyber Sys [0925759] Funding Source: National Science Foundation	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Electrical, Commun & Cyber Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	We thank D. Leaird for experimental assistance and J. Ouyang for helpful discussions. Supported by Defense Threat Reduction Agency grant HDTRA1-10-1-0106, Air Force Office of Scientific Research grant FA9550-08-1-0379, NSF grant ECCS-0925759, and NIH grant 1R01RR026273-01. Finite-difference time domain simulation work was carried out through the Network for Computational Nanotechnology with resources available at www.nanohub.org. L. F. and L. T. V. fabricated and characterized the devices. J. W. performed simulation and selected device parameters. H. S. helped in device characterization. B.N. helped in the design. M. Q. conceived the idea and supervised the investigation. M. Q., L. T. V., L. F., and J. W. wrote the manuscript. All discussed the results and commented on the manuscript.	Almeida VR, 2004, OPT LETT, V29, P2387, DOI 10.1364/OL.29.002387; Barclay PE, 2005, OPT EXPRESS, V13, P801, DOI 10.1364/OPEX.13.000801; Barwicz T, 2004, OPT EXPRESS, V12, P1437, DOI 10.1364/OPEX.12.001437; Bi L, 2011, NAT PHOTONICS, V5, P758, DOI 10.1038/nphoton.2011.270; Chen XG, 2006, IEEE PHOTONIC TECH L, V18, P2617, DOI 10.1109/LPT.2006.887214; Dinu M, 2003, APPL PHYS LETT, V82, P2954, DOI 10.1063/1.1571665; Driscoll JB, 2010, IEEE J SEL TOP QUANT, V16, P1448, DOI 10.1109/JSTQE.2009.2038352; Espinola RL, 2004, OPT LETT, V29, P941, DOI 10.1364/OL.29.000941; Gallo K, 2001, APPL PHYS LETT, V79, P314, DOI 10.1063/1.1386407; Haus H. A, 1984, WAVES FIELDS OPTOELE, P56; Hwang J, 2005, NAT MATER, V4, P383, DOI 10.1038/nmat1377; Ibrahim SK, 2004, ELECTRON LETT, V40, P1293, DOI 10.1049/el:20045901; Kang MS, 2011, NAT PHOTONICS, V5, P549, DOI [10.1038/nphoton.2011.180, 10.1038/NPHOTON.2011.180]; Khan MH, 2010, NAT PHOTONICS, V4, P117, DOI 10.1038/NPHOTON.2009.266; Little BE, 1997, J LIGHTWAVE TECHNOL, V15, P998, DOI 10.1109/50.588673; Manipatruni S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.213903; Mingaleev SF, 2002, J OPT SOC AM B, V19, P2241, DOI 10.1364/JOSAB.19.002241; Ouyang J., 2007, MEEP MIT ELECTROMAGN; Rostami A, 2007, OPT LASER TECHNOL, V39, P1059, DOI 10.1016/j.optlastec.2006.04.007; Soljacic M, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.055601; Soljacic M, 2003, OPT LETT, V28, P637, DOI 10.1364/OL.28.000637; Sun P, 2010, OPT LETT, V35, P1124, DOI 10.1364/OL.35.001124; Turner-Foster AC, 2010, OPT EXPRESS, V18, P3582, DOI 10.1364/OE.18.003582; Uesugi T, 2006, OPT EXPRESS, V14, P377, DOI 10.1364/OPEX.14.000377; Xiao S., 2008, C LAS EL; Xiao SJ, 2007, OPT EXPRESS, V15, P14467, DOI 10.1364/OE.15.014467; Xu QF, 2006, OPT LETT, V31, P341, DOI 10.1364/OL.31.000341; Xu QF, 2005, NATURE, V435, P325, DOI 10.1038/nature03569; Yu ZF, 2009, NAT PHOTONICS, V3, P91, DOI 10.1038/NPHOTON.2008.273; Zaman TR, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2430931	30	540	552	18	305	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2012	335	6067					447	450		10.1126/science.1214383	http://dx.doi.org/10.1126/science.1214383			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881FG	22194410	Green Accepted			2022-12-28	WOS:000299466800044
J	Marston, G				Marston, George			An Elusive Intermediate Gets Caught	SCIENCE			English	Editorial Material							OZONOLYSIS		Univ Reading, Dept Chem, Reading RG6 6AD, Berks, England	University of Reading	Marston, G (corresponding author), Univ Reading, Dept Chem, Reading RG6 6AD, Berks, England.	g.marston@read-ing.ac.uk	Marston, George/J-9223-2012; Marston, George/B-3116-2015	Marston, George/0000-0002-0050-5928; Marston, George/0000-0002-0050-5928				Calvert JG, 2000, MECH ATMOSPHERIC OXI; CREMER D, 1993, CHEM PHYS LETT, V209, P547, DOI 10.1016/0009-2614(93)80131-8; CRIEGEE R, 1975, ANGEW CHEM INT EDIT, V14, P745, DOI 10.1002/anie.197507451; Donahue NM, 1998, GEOPHYS RES LETT, V25, P59, DOI 10.1029/97GL53560; Johnson D, 2001, J PHYS CHEM A, V105, P2933, DOI 10.1021/jp003975e; Johnson D, 2008, CHEM SOC REV, V37, P699, DOI 10.1039/b704260b; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Taatjes CA, 2008, J AM CHEM SOC, V130, P11883, DOI 10.1021/ja804165q; Welz O, 2012, SCIENCE, V335, P204, DOI 10.1126/science.1213229	9	12	12	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 13	2012	335	6065					178	179		10.1126/science.1217165	http://dx.doi.org/10.1126/science.1217165			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875LZ	22246764				2022-12-28	WOS:000299033100040
J	Kieler, H; Artama, M; Engeland, A; Ericsson, O; Furu, K; Gissler, M; Nielsen, RB; Norgaard, M; Stephansson, O; Valdimarsdottir, U; Zoega, H; Haglund, B				Kieler, Helle; Artama, Miia; Engeland, Anders; Ericsson, Orjan; Furu, Kari; Gissler, Mika; Nielsen, Rikke Beck; Norgaard, Mette; Stephansson, Olof; Valdimarsdottir, Unnur; Zoega, Helga; Haglund, Bengt			Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries	BRITISH MEDICAL JOURNAL			English	Article							MATERNAL USE; WOMEN; FLUOXETINE; REGISTERS; QUALITY; HEALTH	Objective To assess whether maternal use of selective serotonin reuptake inhibitors (SSRIs) increases the risk of persistent pulmonary hypertension in the newborn, and whether such an effect might differ between specific SSRIs. Design Population based cohort study using data from the national health registers. Setting Denmark, Finland, Iceland, Norway, and Sweden, 1996-2007. Participants More than 1.6 million infants born after gestational week 33. Main outcome measures Risks of persistent pulmonary hypertension of the newborn associated with early and late exposure to SSRIs during pregnancy and adjusted for important maternal and pregnancy characteristics. Comparisons were made between infants exposed and not exposed to SSRIs. Results Around 30 000 women had used SSRIs during pregnancy and 11 014 had been dispensed an SSRI later than gestational week 20. Exposure to SSRIs in late pregnancy was associated with an increased risk of persistent pulmonary hypertension in the newborn: 33 of 11 014 exposed infants (absolute risk 3 per 1000 liveborn infants compared with the background incidence of 1.2 per 1000); adjusted odds ratio 2.1 (95% confidence interval 1.5 to 3.0). The increased risks of persistent pulmonary hypertension in the newborn for each of the specific SSRIs (sertraline, citalopram, paroxetine, and fluoxetine) were of similar magnitude. Filling a prescription with SSRIs before gestational week 8 yielded slightly increased risks: adjusted odds ratio 1.4 (95% confidence interval 1.0 to 2.0). Conclusions The risk of persistent pulmonary hypertension of the newborn is low, but use of SSRIs in late pregnancy increases that risk more than twofold. The increased risk seems to be a class effect.	[Kieler, Helle; Stephansson, Olof; Haglund, Bengt] Karolinska Univ Hosp, Karolinska Inst, Dept Med Solna, Ctr Pharmacoepidemiol, SE-17176 Stockholm, Sweden; [Artama, Miia; Gissler, Mika] THL Natl Inst Hlth & Welf, Helsinki, Finland; [Engeland, Anders; Furu, Kari] Norwegian Inst Publ Hlth, Dept Pharmacoepidemiol, Oslo, Norway; [Engeland, Anders] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, N-5020 Bergen, Norway; [Ericsson, Orjan] Natl Board Hlth & Welf, Stockholm, Sweden; [Furu, Kari] Univ Tromso, Dept Pharm, N-9001 Tromso, Norway; [Gissler, Mika] Nord Sch Publ Hlth, Gothenburg, Sweden; [Nielsen, Rikke Beck; Norgaard, Mette] Aarhus Univ Hosp, Inst Clin Med, Dept Clin Epidemiol, Aarhus, Denmark; [Stephansson, Olof] Karolinska Univ Hosp & Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Valdimarsdottir, Unnur; Zoega, Helga] Univ Iceland, Sch Hlth Sci, Ctr Publ Hlth Sci, Reykjavik, Iceland	Karolinska Institutet; Karolinska University Hospital; Finland National Institute for Health & Welfare; Norwegian Institute of Public Health (NIPH); University of Bergen; National Board of Health & Welfare; UiT The Arctic University of Tromso; Aarhus University; Karolinska Institutet; Karolinska University Hospital; University of Iceland	Kieler, H (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Med Solna, Ctr Pharmacoepidemiol, T2, SE-17176 Stockholm, Sweden.	helle.kieler@ki.se	Zoega, Helga/M-1968-2015; Hug, Balthasar L./G-1568-2010; Engeland, Anders/AAG-7437-2021	Norgaard, Mette/0000-0001-6110-5891; Valdimarsdottir, Unnur/0000-0001-5382-946X; Stephansson, Olof/0000-0003-1528-4563; Gissler, Mika/0000-0001-8254-7525; Kieler, Helle/0000-0001-9338-7133	Swedish Pharmacy Company	Swedish Pharmacy Company	This study was funded by the Swedish Pharmacy Company and by the authors' affiliations. The Swedish Pharmacy Company was not involved in the design and conduct of the study; collection, management, analysis, or interpretation of the data; and preparation, review, or approval of the manuscript.	Andrade SE, 2009, PHARMACOEPIDEM DR S, V18, P246, DOI 10.1002/pds.1710; Backe Bjorn, 1997, Tidsskrift for den Norske Laegeforening, V117, P2314; Bakker MK, 2008, BRIT J CLIN PHARMACO, V65, P600, DOI 10.1111/j.1365-2125.2007.03048.x; Chambers CD, 2006, NEW ENGL J MED, V354, P579, DOI 10.1056/NEJMoa052744; Chambers CD, 1996, NEW ENGL J MED, V335, P1010, DOI 10.1056/NEJM199610033351402; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; Cohen LS, 2006, JAMA-J AM MED ASSOC, V295, P499, DOI 10.1001/jama.295.5.499; Eddahibi S, 2002, J LAB CLIN MED, V139, P194, DOI 10.1067/mlc.2002.122181; Elliott R, 2009, J HEALTH SERV RES PO, V14, P58, DOI 10.1258/jhsrp.2008.008088; Farrow KN, 2005, SEMIN PERINATOL, V29, P8, DOI 10.1053/j.semperi.2005.02.003; Furu K, 2010, BASIC CLIN PHARMACOL, V106, P86, DOI 10.1111/j.1742-7843.2009.00494.x; Geirsson R T, 2001, Laeknabladid, V87, P403; GISSLER M, 1995, SCAND J SOC MED, V23, P75, DOI 10.1177/140349489502300113; Gissler M, 1997, EUR J EPIDEMIOL, V13, P169, DOI 10.1023/A:1007379029182; Hernandez-Diaz S, 2007, PEDIATRICS, V120, pE272, DOI 10.1542/peds.2006-3037; Hogberg U, 1997, ACTA OBSTET GYN SCAN, V76, P907, DOI 10.3109/00016349709034900; Kallen B, 2008, PHARMACOEPIDEM DR S, V17, P801, DOI 10.1002/pds.1570; MacLean MR, 2009, CURR OPIN PHARMACOL, V9, P281, DOI 10.1016/j.coph.2009.02.005; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; MCMAHON TJ, 1993, J APPL PHYSIOL, V75, P93, DOI 10.1152/jappl.1993.75.1.93; MunkJorgensen P, 1997, DAN MED BULL, V44, P82; Nickelsen T N, 2001, Ugeskr Laeger, V164, P33; Olesen C, 2001, EPIDEMIOLOGY, V12, P497, DOI 10.1097/00001648-200109000-00006; Perreault T, 2006, PAEDIATR RESPIR REV, V7, pS175, DOI 10.1016/j.prrv.2006.04.211; Qvist Ingelise, 2002, Ugeskr Laeger, V164, P902; Rosen M, 2002, SCAND J PUBLIC HEALT, V30, P81, DOI 10.1080/140349401753683444; Runo JR, 2003, LANCET, V361, P1533, DOI 10.1016/S0140-6736(03)13167-4; Salonen R, 1997, EUR J HUM GENET, V5, P22, DOI 10.1159/000484811; Steinhorn RH, 2010, PEDIATR CRIT CARE ME, V11, pS79, DOI 10.1097/PCC.0b013e3181c76cdc; Stephansson Olof, 2011, Clin Epidemiol, V3, P43, DOI 10.2147/CLEP.S16305; Suhara T, 1998, LANCET, V351, P332, DOI 10.1016/S0140-6736(97)07336-4; Wichman CL, 2009, MAYO CLIN PROC, V84, P23, DOI 10.4065/84.1.23; Wilson KL, 2011, AM J PERINAT, V28, P19, DOI 10.1055/s-0030-1262507; Yaron I, 1999, ARTHRITIS RHEUM, V42, P2561, DOI 10.1002/1529-0131(199912)42:12<2561::AID-ANR8>3.0.CO;2-U	34	72	73	0	36	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 12	2012	344								d8012	10.1136/bmj.d8012	http://dx.doi.org/10.1136/bmj.d8012			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877SM	22240235	hybrid, Green Submitted			2022-12-28	WOS:000299202900012
J	Lau, WCY; Rubinstein, JL				Lau, Wilson C. Y.; Rubinstein, John L.			Subnanometre-resolution structure of the intact Thermus thermophilus H+-driven ATP synthase	NATURE			English	Article							ROTOR RING; V-ATPASE; MEMBRANE TOPOLOGY; CRYSTAL-STRUCTURE; CENTRAL STALK; NA+-ATPASE; SUBUNIT-C; TRANSLOCATION; ARCHITECTURE; MAPS	Ion-translocating rotary ATPases serve either as ATP synthases, using energy from a transmembrane ion motive force to create the cell's supply of ATP, or as transmembrane ion pumps that are powered by ATP hydrolysis(1). The members of this family of enzymes each contain two rotary motors: one that couples ion translocation to rotation and one that couples rotation to ATP synthesis or hydrolysis. During ATP synthesis, ion translocation through the membrane-bound region of the complex causes rotation of a central rotor that drives conformational changes and ATP synthesis in the catalytic region of the complex. There are no structural models available for the intact membrane region of any ion-translocating rotary ATPase. Here we present a 9.7 angstrom resolution map of the H+-driven ATP synthase from Thermus thermophilus obtained by electron cryomicroscopy of single particles in ice. The 600-kilodalton complex has an overall subunit composition of A(3)B(3)CDE(2)FG(2)IL(12). The membrane-bound motor consists of a ring of L subunits and the carboxy-terminal region of subunit I, which are equivalent to the c and a subunits of most other rotary ATPases, respectively. The map shows that the ring contains 12 L subunits(2) and that the I subunit has eight transmembrane helices(3). The L-12 ring and I subunit have a surprisingly small contact area in the middle of the membrane, with helices from the I subunit making contacts with two different L subunits. The transmembrane helices of subunit I form bundles that could serve as half-channels across the membrane, with the first half-channel conducting protons from the periplasm to the L-12 ring and the second half-channel conducting protons from the L-12 ring to the cytoplasm. This structure therefore suggests the mechanism by which a transmembrane proton motive force is converted to rotation in rotary ATPases.	[Lau, Wilson C. Y.; Rubinstein, John L.] Hosp Sick Children, Mol Struct & Funct Program, Res Inst, Toronto, ON M5G 1X8, Canada; [Lau, Wilson C. Y.; Rubinstein, John L.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Rubinstein, John L.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Rubinstein, JL (corresponding author), Hosp Sick Children, Mol Struct & Funct Program, Res Inst, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	john.rubinstein@utoronto.ca		Rubinstein, John/0000-0003-0566-2209	Ontario Graduate Scholarship; Ontario Ministry of Research and Innovation; Canadian Institutes of Health Research [MOP 81294]	Ontario Graduate Scholarship(Ontario Graduate Scholarship); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We thank V. Kanelis, F. Sicheri, P. Rosenthal, L. Kay and R. Henderson for discussions and reading this manuscript, and J. Walker and R. Pomes for discussions. Computations were performed on the general-purpose cluster supercomputer at the SciNet HPC Consortium. W.C.Y.L. was supported by an Ontario Graduate Scholarship. J. L. R. was supported by a New Investigator Award from the Canadian Institutes of Health Research and an Early Researcher Award from the Ontario Ministry of Research and Innovation. This research was funded by operating grant MOP 81294 from the Canadian Institutes of Health Research.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Baker LA, 2011, J STRUCT BIOL, V176, P127, DOI 10.1016/j.jsb.2011.06.012; Baker LA, 2010, J STRUCT BIOL, V169, P431, DOI 10.1016/j.jsb.2009.11.014; CAIN BD, 1989, J BIOL CHEM, V264, P3292; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Iwata M, 2004, P NATL ACAD SCI USA, V101, P59, DOI 10.1073/pnas.0305165101; Junge W, 1997, TRENDS BIOCHEM SCI, V22, P420, DOI 10.1016/S0968-0004(97)01129-8; Kawasaki-Nishi S, 2001, P NATL ACAD SCI USA, V98, P12397, DOI 10.1073/pnas.221291798; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Lau WCY, 2010, P NATL ACAD SCI USA, V107, P1367, DOI 10.1073/pnas.0911085107; Lee LK, 2010, NAT STRUCT MOL BIOL, V17, P373, DOI 10.1038/nsmb.1761; Long JC, 1998, J BIOL CHEM, V273, P16235, DOI 10.1074/jbc.273.26.16235; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Meier T, 2001, FEBS LETT, V505, P353, DOI 10.1016/S0014-5793(01)02837-X; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Muench SP, 2011, Q REV BIOPHYS, V44, P311, DOI 10.1017/S0033583510000338; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Numoto N, 2009, EMBO REP, V10, P1228, DOI 10.1038/embor.2009.202; Pintilie GD, 2010, J STRUCT BIOL, V170, P427, DOI 10.1016/j.jsb.2010.03.007; Pogoryelov D, 2010, NAT CHEM BIOL, V6, P891, DOI 10.1038/NCHEMBIO.457; Pogoryelov D, 2009, NAT STRUCT MOL BIOL, V16, P1068, DOI 10.1038/nsmb.1678; Preiss L, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000443; Press W. H., 2003, NUMERICAL RECIPES FO, V77; Rosenthal P. B., 2003, J MOL BIOL, V333, P743; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Sousa D, 2007, J STRUCT BIOL, V157, P201, DOI 10.1016/j.jsb.2006.08.003; Srinivasan S, 2011, J MOL BIOL, V412, P14, DOI 10.1016/j.jmb.2011.07.014; Steed PR, 2009, J BIOL CHEM, V284, P23243, DOI 10.1074/jbc.M109.002501; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528; Toei M, 2007, P NATL ACAD SCI USA, V104, P20256, DOI 10.1073/pnas.0706914105; Toei M, 2011, J BIOL CHEM, V286, P35176, DOI 10.1074/jbc.M111.273409; Valiyaveetil FI, 1998, J BIOL CHEM, V273, P16241, DOI 10.1074/jbc.273.26.16241; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107	41	96	97	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 12	2012	481	7380					214	+		10.1038/nature10699	http://dx.doi.org/10.1038/nature10699			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	874TO	22178924				2022-12-28	WOS:000298981200042
J	Senguttuvan, NB; Karthikeyan, G				Senguttuvan, Nagendra Boopathy; Karthikeyan, Ganesan			Jugular Venous C-V Wave in Severe Tricuspid Regurgitation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Senguttuvan, Nagendra Boopathy; Karthikeyan, Ganesan] All India Inst Med Sci, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi	Senguttuvan, NB (corresponding author), All India Inst Med Sci, New Delhi, India.		Karthikeyan, Ganesan/D-5767-2012	Karthikeyan, Ganesan/0000-0002-2073-2917; SENGUTTUVAN, NAGENDRA BOOPATHY/0000-0003-4979-596X					0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 12	2012	366	2					E5	E5		10.1056/NEJMicm1012843	http://dx.doi.org/10.1056/NEJMicm1012843			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874VA	22236244				2022-12-28	WOS:000298985000012
J	Appleby, J				Appleby, John			DATA BRIEFING Patient reported outcome measures: how are we feeling today?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Fund, London W1G 0AN, England		Appleby, J (corresponding author), Kings Fund, London W1G 0AN, England.	j.appleby@kingsfund.org.uk						Berwick DM, 1997, BRIT MED J, V314, P1564, DOI 10.1136/bmj.314.7094.1564; Department of Health, 2009, GUID ROUT COLL PAT R; Department of Health, 2011, PAT REP OUTC MEAS PR; Information Centre, 2011, NAT PROMS PROGR; Information Centre, 2011, FIN PROMS DAT 2009 1	5	6	6	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 11	2012	344								d8191	10.1136/bmj.d8191	http://dx.doi.org/10.1136/bmj.d8191			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	877SI	22236797				2022-12-28	WOS:000299202500016
J	Weber, B; Mahapatra, S; Ryu, H; Lee, S; Fuhrer, A; Reusch, TCG; Thompson, DL; Lee, WCT; Klimeck, G; Hollenberg, LCL; Simmons, MY				Weber, B.; Mahapatra, S.; Ryu, H.; Lee, S.; Fuhrer, A.; Reusch, T. C. G.; Thompson, D. L.; Lee, W. C. T.; Klimeck, G.; Hollenberg, L. C. L.; Simmons, M. Y.			Ohm's Law Survives to the Atomic Scale	SCIENCE			English	Article							QUANTUM COMPUTER; SILICON; DEVICES; SPIN	As silicon electronics approaches the atomic scale, interconnects and circuitry become comparable in size to the active device components. Maintaining low electrical resistivity at this scale is challenging because of the presence of confining surfaces and interfaces. We report on the fabrication of wires in silicon-only one atom tall and four atoms wide-with exceptionally low resistivity (similar to 0.3 milliohm-centimeters) and the current-carrying capabilities of copper. By embedding phosphorus atoms within a silicon crystal with an average spacing of less than 1 nanometer, we achieved a diameter-independent resistivity, which demonstrates ohmic scaling to the atomic limit. Atomistic tight-binding calculations confirm the metallicity of these atomic-scale wires, which pave the way for single-atom device architectures for both classical and quantum information processing.	[Weber, B.; Mahapatra, S.; Fuhrer, A.; Reusch, T. C. G.; Thompson, D. L.; Lee, W. C. T.; Simmons, M. Y.] Univ New S Wales, Sch Phys, Ctr Quantum Computat & Commun Technol, Sydney, NSW 2052, Australia; [Ryu, H.; Lee, S.; Klimeck, G.] Purdue Univ, Birck Nanotechnol Ctr, Network Computat Nanotechnol, W Lafayette, IN 47907 USA; [Hollenberg, L. C. L.] Univ Melbourne, Sch Phys, Ctr Quantum Computat & Commun Technol, Parkville, Vic 3010, Australia	University of New South Wales Sydney; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Melbourne	Simmons, MY (corresponding author), Univ New S Wales, Sch Phys, Ctr Quantum Computat & Commun Technol, Sydney, NSW 2052, Australia.	michelle.simmons@unsw.edu.au	Fonseca, James E/G-1018-2011; Weber, Bent/A-2705-2014; Fuhrer, Andreas/C-1109-2018; Klimeck, Gerhard/A-1414-2012; Simmons, Michelle Yvonne/B-2755-2010; Klimeck, Gerhard/H-4616-2019	Weber, Bent/0000-0001-8586-127X; Fuhrer, Andreas/0000-0003-3537-5737; Klimeck, Gerhard/0000-0001-7128-773X; Simmons, Michelle Yvonne/0000-0002-6422-5888; Klimeck, Gerhard/0000-0001-7128-773X; HOLLENBERG, LLOYD/0000-0001-7672-6965	Australian Research Council Centre of Excellence for Quantum Computation and Communication Technology [CE110001027]; US Army Research Office [W911NF-08-1-0527]; ARC Federation; Semiconductor Research Corporation; ARC; National Science Foundation (NSF)	Australian Research Council Centre of Excellence for Quantum Computation and Communication Technology(Australian Research Council); US Army Research Office; ARC Federation(Australian Research Council); Semiconductor Research Corporation; ARC(Australian Research Council); National Science Foundation (NSF)(National Science Foundation (NSF))	This research was conducted by the Australian Research Council Centre of Excellence for Quantum Computation and Communication Technology (project number CE110001027) and the US National Security Agency and the US Army Research Office under contract number W911NF-08-1-0527. M.Y.S. acknowledges an ARC Federation Fellowship and support from the Semiconductor Research Corporation. L. H. is supported under an ARC Professorial Fellowship. National Science Foundation (NSF) supported nanoHUB.org computational resources, TeraGrid resources provided by the National Institute for Computational Sciences (NICS) and the Texas Advanced Computed Center (TACC) computational resources have been extensively used in this work. The authors declare that they have no competing financial interests.	Beenakker CWJ, 1997, REV MOD PHYS, V69, P731, DOI 10.1103/RevModPhys.69.731; Bjork MT, 2009, NAT NANOTECHNOL, V4, P103, DOI [10.1038/nnano.2008.400, 10.1038/NNANO.2008.400]; Diarra M, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.045301; Fuechsle M, 2010, NAT NANOTECHNOL, V5, P502, DOI [10.1038/NNANO.2010.95, 10.1038/nnano.2010.95]; Fuhrer A, 2009, NANO LETT, V9, P707, DOI 10.1021/nl803196f; GAWLINSKI E, 1992, J APPL PHYS, V72, P3562, DOI 10.1063/1.351435; Goh KEJ, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.035401; Hill CD, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.045350; Hollenberg LCL, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.045311; Ieong Meikei, 2004, Science, V306, P2057, DOI 10.1126/science.1100731; Kane BE, 1998, NATURE, V393, P133, DOI 10.1038/30156; Klimeck G, 2007, IEEE T ELECTRON DEV, V54, P2090, DOI 10.1109/TED.2007.904877; Koenraad PM, 2011, NAT MATER, V10, P91, DOI 10.1038/nmat2940; Lansbergen GP, 2008, NAT PHYS, V4, P656, DOI 10.1038/nphys994; LEE PA, 1985, PHYS REV LETT, V55, P1622, DOI 10.1103/PhysRevLett.55.1622; Lee S., 2009, 13 INT WORKSH COMP E, P1; Lundstrom M, 2003, SCIENCE, V299, P210, DOI 10.1126/science.1079567; McKibbin SR, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3269924; Meindl JD, 2001, SCIENCE, V293, P2044, DOI 10.1126/science.293.5537.2044; Morello A, 2010, NATURE, V467, P687, DOI 10.1038/nature09392; Oberbeck L, 2004, THIN SOLID FILMS, V464, P23, DOI 10.1016/j.tsf.2004.05.118; Pierre M, 2010, NAT NANOTECHNOL, V5, P133, DOI [10.1038/nnano.2009.373, 10.1038/NNANO.2009.373]; Qian GF, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.045309; Ruess FJ, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/4/044023; Ruess FJ, 2007, SMALL, V3, P563, DOI 10.1002/smll.200600680; Schmidt V, 2009, ADV MATER, V21, P2681, DOI 10.1002/adma.200803754; Vogel EM, 2007, NAT NANOTECHNOL, V2, P25, DOI 10.1038/nnano.2006.142; Vrijen R, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.012306; YAMADA A, 1989, JPN J APPL PHYS 2, V28, pL2284, DOI 10.1143/JJAP.28.L2284	29	243	246	6	165	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2012	335	6064					64	67		10.1126/science.1214319	http://dx.doi.org/10.1126/science.1214319			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872YA	22223802				2022-12-28	WOS:000298846200049
J	Hsu, DC; Wilkenfeld, P; Joshua, DE				Hsu, Danny C.; Wilkenfeld, Peter; Joshua, Douglas E.			EASILY MISSED? Multiple myeloma	BRITISH MEDICAL JOURNAL			English	Editorial Material							DELAY		[Hsu, Danny C.; Joshua, Douglas E.] Univ Sydney, Sydney, NSW 2050, Australia; [Hsu, Danny C.; Joshua, Douglas E.] Royal Prince Alfred Hosp, Inst Haematol, Sydney, NSW, Australia; [Wilkenfeld, Peter] Bondi Junct, Sydney, NSW 2022, Australia	University of Sydney; University of Sydney	Hsu, DC (corresponding author), Univ Sydney, Sydney, NSW 2050, Australia.	danny.hsu@tpg.com.au		Hsu, Danny/0000-0002-9577-5401				Alexandrakis MG, 2003, CLIN LAB HAEMATOL, V25, P41, DOI 10.1046/j.1365-2257.2003.00492.x; Friese CR, 2009, LEUKEMIA LYMPHOMA, V50, P392, DOI 10.1080/10428190902741471; Huang SY, 2007, CANCER-AM CANCER SOC, V110, P896, DOI 10.1002/cncr.22850; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kariyawasan CC, 2007, QJM-INT J MED, V100, P635, DOI 10.1093/qjmed/hcm077; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Kyle RA, 2003, MAYO CLIN PROC, V78, P21, DOI 10.4065/78.1.21; Kyle RA, 2007, BRIT J HAEMATOL, V139, P730, DOI 10.1111/j.1365-2141.2007.06873.x; Mhaskar R., 2010, COCHRANE DB SYST REV, V3; Morgan GJ, 2010, LANCET, V376, P1989, DOI 10.1016/S0140-6736(10)62051-X; Office for National Statistics, 2010, OFF NAT STAT SER MB1; Phekoo KJ, 2004, BRIT J HAEMATOL, V127, P299, DOI 10.1111/j.1365-2141.2004.05207.x; Waxman AJ, 2010, BLOOD, V116, P5501, DOI 10.1182/blood-2010-07-298760	13	5	5	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 5	2012	344								d7953	10.1136/bmj.d7953	http://dx.doi.org/10.1136/bmj.d7953			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	874UH	22223832				2022-12-28	WOS:000298983100007
J	Chou, R; LeFevre, ML				Chou, Roger; LeFevre, Michael L.			Prostate Cancer Screening-The Evidence, the Recommendations, and the Clinical Implications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MORTALITY; TRENDS		[Chou, Roger] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97239 USA; [Chou, Roger] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97239 USA; [LeFevre, Michael L.] Univ Missouri, Sch Med, Dept Family & Community Med, Columbia, MO 65211 USA	Oregon Health & Science University; Oregon Health & Science University; University of Missouri System; University of Missouri Columbia	Chou, R (corresponding author), Oregon Hlth & Sci Univ, Dept Med, 3181 Sam Jackson Pk Rd SW,Mail Code BICC, Portland, OR 97239 USA.	chour@ohsu.edu		Chou, Roger/0000-0001-9889-8610				Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Chou R, 2011, ANN INTERN MED, V155, P762, DOI 10.7326/0003-4819-155-11-201112060-00375; Cooperberg MR, 2010, J CLIN ONCOL, V28, P1117, DOI 10.1200/JCO.2009.26.0133; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; Lu-Yao G, 2008, J GEN INTERN MED, V23, P1809, DOI 10.1007/s11606-008-0785-8; McDavid K, 2004, PUBLIC HEALTH REP, V119, P174, DOI 10.1177/003335490411900211; NIHR Health Technology Assessment Programme, PROTECT TRIAL EV EFF; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; U. S. Preventive Services Task Force, GRAD DEF; Wilt T J, 1997, Oncology (Williston Park), V11, P1133	10	35	36	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 28	2011	306	24					2721	2722		10.1001/jama.2011.1891	http://dx.doi.org/10.1001/jama.2011.1891			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	867VX	22203543				2022-12-28	WOS:000298484000025
J	Boyer, O; Nevo, F; Plaisier, E; Funalot, B; Gribouval, O; Benoit, G; Cong, EH; Arrondel, C; Tete, MJ; Montjean, R; Richard, L; Karras, A; Pouteil-Noble, C; Balafrej, L; Bonnardeaux, A; Canaud, G; Charasse, C; Dantal, J; Deschenes, G; Deteix, P; Dubourg, O; Petiot, P; Pouthier, D; Leguern, E; Guiochon-Mantel, A; Broutin, I; Gubler, MC; Saunier, S; Ronco, P; Vallat, JM; Alonso, MA; Antignac, C; Mollet, G				Boyer, Olivia; Nevo, Fabien; Plaisier, Emmanuelle; Funalot, Benoit; Gribouval, Olivier; Benoit, Genevieve; Cong, Evelyne Huynh; Arrondel, Christelle; Tete, Marie-Josephe; Montjean, Rodrick; Richard, Laurence; Karras, Alexandre; Pouteil-Noble, Claire; Balafrej, Leila; Bonnardeaux, Alain; Canaud, Guillaume; Charasse, Christophe; Dantal, Jacques; Deschenes, Georges; Deteix, Patrice; Dubourg, Odile; Petiot, Philippe; Pouthier, Dominique; Leguern, Eric; Guiochon-Mantel, Anne; Broutin, Isabelle; Gubler, Marie-Claire; Saunier, Sophie; Ronco, Pierre; Vallat, Jean-Michel; Angel Alonso, Miguel; Antignac, Corinne; Mollet, Geraldine			INF2 Mutations in Charcot-Marie-Tooth Disease with Glomerulopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MEDIATED TRANSPORT; EPITHELIAL-CELLS; MYELIN; PROTEIN; FORMIN; GENE; RHO; GLOMERULOSCLEROSIS; NEPHROPATHY; NEUROPATHY	BACKGROUND Charcot-Marie-Tooth neuropathy has been reported to be associated with renal diseases, mostly focal segmental glomerulosclerosis (FSGS). However, the common mechanisms underlying the neuropathy and FSGS remain unknown. Mutations in INF2 were recently identified in patients with autosomal dominant FSGS. INF2 encodes a formin protein that interacts with the Rho-GTPase CDC42 and myelin and lymphocyte protein (MAL) that are implicated in essential steps of myelination and myelin maintenance. We therefore hypothesized that INF2 may be responsible for cases of Charcot-Marie-Tooth neuropathy associated with FSGS. METHODS We performed direct genotyping of INF2 in 16 index patients with Charcot-Marie-Tooth neuropathy and FSGS who did not have a mutation in PMP22 or MPZ, encoding peripheral myelin protein 22 and myelin protein zero, respectively. Histologic and functional studies were also conducted. RESULTS We identified nine new heterozygous mutations in 12 of the 16 index patients (75%), all located in exons 2 and 3, encoding the diaphanous-inhibitory domain of INF2. Patients presented with an intermediate form of Charcot-Marie-Tooth neuropathy as well as a glomerulopathy with FSGS on kidney biopsy. Immunohistochemical analysis revealed strong INF2 expression in Schwann-cell cytoplasm and podocytes. Moreover, we demonstrated that INF2 colocalizes and interacts with MAL in Schwann cells. The INF2 mutants perturbed the INF2-MAL-CDC42 pathway, resulting in cytoskeleton disorganization, enhanced INF2 binding to CDC42 and mislocalization of INF2, MAL, and CDC42. CONCLUSIONS INF2 mutations appear to cause many cases of FSGS-associated Charcot-Marie-Tooth neuropathy, showing that INF2 is involved in a disease affecting both the kidney glomerulus and the peripheral nervous system. These findings provide new insights into the pathophysiological mechanisms linking formin proteins to podocyte and Schwanncell function. (Funded by the Agence Nationale de la Recherche and others.)	[Boyer, Olivia; Nevo, Fabien; Gribouval, Olivier; Benoit, Genevieve; Cong, Evelyne Huynh; Arrondel, Christelle; Tete, Marie-Josephe; Montjean, Rodrick; Gubler, Marie-Claire; Saunier, Sophie; Antignac, Corinne; Mollet, Geraldine] Hop Necker Enfants Malad, AP HP, INSERM, U983, F-75015 Paris, France; [Plaisier, Emmanuelle; Ronco, Pierre] Hop Necker Enfants Malad, AP HP, Unite 702, F-75015 Paris, France; [Leguern, Eric] Hop Necker Enfants Malad, AP HP, Unite 975, F-75015 Paris, France; [Boyer, Olivia] Hop Necker Enfants Malad, AP HP, Serv Nephrol Pediat, F-75015 Paris, France; [Canaud, Guillaume] Hop Necker Enfants Malad, AP HP, Serv Transplantat & Soins Intensifs, F-75015 Paris, France; [Antignac, Corinne] Hop Necker Enfants Malad, AP HP, Serv Genet, F-75015 Paris, France; [Plaisier, Emmanuelle; Ronco, Pierre] Hop Tenon, AP HP, Serv Nephrol & Dialyses, F-75970 Paris, France; [Karras, Alexandre] Hop Europeen Georges Pompidou, AP HP, Serv Nephrol, Paris, France; [Deschenes, Georges] Hop Robert Debre, AP HP, Serv Nephrol Pediat, F-75019 Paris, France; [Dubourg, Odile] Hop La Pitie Salpetriere, AP HP, Inst Myol, Paris, France; [Boyer, Olivia; Nevo, Fabien; Gribouval, Olivier; Cong, Evelyne Huynh; Arrondel, Christelle; Tete, Marie-Josephe; Montjean, Rodrick; Karras, Alexandre; Canaud, Guillaume; Broutin, Isabelle; Gubler, Marie-Claire; Saunier, Sophie; Antignac, Corinne; Mollet, Geraldine] Univ Paris 05, Paris, France; [Plaisier, Emmanuelle; Leguern, Eric; Ronco, Pierre] Univ Paris 06, Paris, France; [Deschenes, Georges] Univ Paris Diderot, Paris, France; [Leguern, Eric] CNRS, Unite 7225, Paris, France; [Broutin, Isabelle] Lab Cristallog & RMN Biol, Paris, France; [Funalot, Benoit; Richard, Laurence; Vallat, Jean-Michel] CHU, Lab Neurol, Limoges, France; [Funalot, Benoit; Richard, Laurence; Vallat, Jean-Michel] CHU, Serv Neurol, Limoges, France; [Funalot, Benoit; Richard, Laurence; Vallat, Jean-Michel] Univ Limoges, Limoges, France; [Pouteil-Noble, Claire] Univ Lyon, Lyon, France; [Pouteil-Noble, Claire] Ctr Hosp Lyon Sud, Serv Nephrol, Lyon, France; [Petiot, Philippe] Hop Croix Rousse, Serv Neurol, F-69317 Lyon, France; Hosp Civils Lyon, Lyon, France; [Charasse, Christophe] Ctr Hosp St Brieuc, St Brieuc, France; [Dantal, Jacques] CHU Hotel Dieu, Serv Nephrol & Immunol Clin, Nantes, France; [Deteix, Patrice] Univ Auvergne, CHU Gabriel Montpied, Clermont Ferrand, France; [Guiochon-Mantel, Anne] Univ Paris 11, CHU Bicetre, Le Kremlin Bicetre, France; [Benoit, Genevieve] Univ Montreal, CHU St Justine, Serv Nephrol Pediat, Montreal, PQ, Canada; [Bonnardeaux, Alain] Hop Maison Neuve Rosemont, Ctr Rech Guy Bernier, Montreal, PQ H1T 2M4, Canada; [Balafrej, Leila] Ctr Nephrol & Hemodialyse Riad, Rabat, Morocco; [Pouthier, Dominique] Ctr Hosp Luxembourg, Serv Nephrol, Luxembourg, Luxembourg; [Angel Alonso, Miguel] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Consejo Super Invest Cient, Madrid, Spain	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; CHU Limoges; CHU Limoges; Universite de Limoges; CHU Lyon; CHU Lyon; CHU Lyon; Nantes Universite; CHU de Nantes; CHU Clermont Ferrand; Universite Clermont Auvergne (UCA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Luxembourg Hospital Center; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Antignac, C (corresponding author), Hop Necker Enfants Malad, AP HP, INSERM, U983, 6E Etage,149 Rue Sevres, F-75015 Paris, France.	corinne.antignac@inserm.fr	Broutin, Isabelle/A-2003-2017; Alonso, Miguel A/J-3945-2016; Boyer, Olivia Gillion/H-9469-2017; Saunier, Sophie/G-6044-2015; Mollet, Geraldine/E-8049-2017; Gribouval, Olivier/A-7689-2015; ANTIGNAC, Corinne/H-8945-2017; Guiochon-Mantel, Anne S/S-8408-2018; Ronco, Pierre/AAC-8390-2022; ARRONDEL, Christelle/H-8908-2017	Alonso, Miguel A/0000-0002-7001-8826; Boyer, Olivia Gillion/0000-0002-3957-1359; Saunier, Sophie/0000-0002-1069-0047; Mollet, Geraldine/0000-0003-4685-5736; Gribouval, Olivier/0000-0003-0238-8224; ANTIGNAC, Corinne/0000-0002-9934-4940; Guiochon-Mantel, Anne S/0000-0003-1737-1409; Funalot, Benoit/0000-0001-6352-6518; deschenes, georges/0000-0002-5158-2915; Broutin, isabelle/0000-0001-9862-1232; ARRONDEL, Christelle/0000-0001-9522-4186; Gubler, Marie-Claire/0000-0002-3526-5661	Agence Nationale de la Recherche; Association pour l'Utilisation du Rein Artificiel; Association Francaise contre les Myopathies [ANR-08-GENOPAT-017-01]; Agence Nationale de la Recherche [ANR-07-E-RARE-011-01, JTC2007, ANR-06-MRAR-024-01]; Fondation pour la Recherche Medicale [DMP 2010-11-20-386]; Association des Malades du Syndrome Nephrotique; Fonds de la Recherche en Sante du Quebec; Ministerio de Ciencia e Innovacion [BFU2009-07886, CONSOLIDER COAT CSD2009-00016]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Association pour l'Utilisation du Rein Artificiel; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Association des Malades du Syndrome Nephrotique; Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	Funded by the Agence Nationale de la Recherche and others.; Supported by grants from the Association pour l'Utilisation du Rein Artificiel (to Dr. Antignac), Association Francaise contre les Myopathies (ANR-08-GENOPAT-017-01, to Dr. Antignac), Agence Nationale de la Recherche (PodoNet project number ANR-07-E-RARE-011-01 in the ERA-Net Consortium [JTC2007], to Dr. Antignac, and ANR-06-MRAR-024-01, to Dr. Leguern), Fondation pour la Recherche Medicale (project number DMP 2010-11-20-386, to Dr. Antignac, and doctoral funding, to Dr. Boyer), Association des Malades du Syndrome Nephrotique (to Dr. Mollet), Fonds de la Recherche en Sante du Quebec (Fellowship Training Award to Dr. Benoit), and Ministerio de Ciencia e Innovacion (BFU2009-07886 and CONSOLIDER COAT CSD2009-00016, to Dr. Alonso).	Andres-Delgado L, 2010, BLOOD, V116, P5919, DOI 10.1182/blood-2010-08-300665; Bashour AM, 1997, J CELL BIOL, V137, P1555, DOI 10.1083/jcb.137.7.1555; Benninger Y, 2007, J CELL BIOL, V177, P1051, DOI 10.1083/jcb.200610108; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BOUTRY JM, 1992, J NEUROSCI RES, V32, P15, DOI 10.1002/jnr.490320103; Boyer O, 2011, J AM SOC NEPHROL, V22, P239, DOI 10.1681/ASN.2010050518; Brandt DT, 2007, J CELL BIOL, V178, P193, DOI 10.1083/jcb.200612071; Brown EJ, 2010, NAT GENET, V42, P72, DOI 10.1038/ng.505; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Chhabra ES, 2006, J BIOL CHEM, V281, P26754, DOI 10.1074/jbc.M604666200; Chhabra ES, 2009, J CELL SCI, V122, P1430, DOI 10.1242/jcs.040691; D'Agati V, 2003, SEMIN NEPHROL, V23, P117, DOI 10.1053/snep.2003.50012; DENIAU F, 1986, ARCH FR PEDIATR, V43, P791; FILLOD I, 1990, PEDIATRIE, V45, P319; Frank M, 2000, PROG NEUROBIOL, V60, P531, DOI 10.1016/S0301-0082(99)00039-8; Frank M, 1998, J NEUROSCI, V18, P4901; HAYASAKA K, 1993, HUM MOL GENET, V2, P1369, DOI 10.1093/hmg/2.9.1369; LEMIEUX G, 1967, CAN MED ASSOC J, V97, P1193; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; Lynch ED, 1997, SCIENCE, V278, P1315, DOI 10.1126/science.278.5341.1315; Machuca E, 2009, HUM MOL GENET, V18, pR185, DOI 10.1093/hmg/ddp328; Madrid R, 2010, DEV CELL, V18, P814, DOI [10.1016/j.devcel.2010.04.001, 10.1016/j.devce1.2010.04.001]; Marazuela M, 2004, HISTOL HISTOPATHOL, V19, P925, DOI 10.14670/HH-19.925; Pareyson D, 2006, NEUROMOL MED, V8, P3, DOI 10.1385/NMM:8:1:3; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; PAUL MD, 1990, NEPHRON, V54, P80, DOI 10.1159/000185814; Plaisier E, 2005, J AM SOC NEPHROL, V16, P3350, DOI 10.1681/ASN.2005050509; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Schafer DA, 2002, CURR BIOL, V12, P1852, DOI 10.1016/S0960-9822(02)01228-9; SKRE H, 1974, CLIN GENET, V6, P98; Sun H, 2011, P NATL ACAD SCI USA, V108, P2933, DOI 10.1073/pnas.1017010108; Szigeti K, 2009, EUR J HUM GENET, V17, P703, DOI 10.1038/ejhg.2009.31; Verhoeven K, 2003, AM J HUM GENET, V73, P926, DOI 10.1086/378159	33	183	192	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2011	365	25					2377	2388		10.1056/NEJMoa1109122	http://dx.doi.org/10.1056/NEJMoa1109122			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	865OM	22187985	Green Published			2022-12-28	WOS:000298320200004
J	Flohr, F; Geddert, H				Flohr, Felix; Geddert, Helene			Ectopic Cushing's Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Flohr, Felix; Geddert, Helene] St Vincentius Hosp Karlsruhe, Karlsruhe, Germany		Flohr, F (corresponding author), St Vincentius Hosp Karlsruhe, Karlsruhe, Germany.								0	2	3	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2011	365	25					E46	E46		10.1056/NEJMicm1010540	http://dx.doi.org/10.1056/NEJMicm1010540			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	865OM	22188007				2022-12-28	WOS:000298320200001
J	Liu, L; Leung, ELH; Tian, XY				Liu, Liang; Leung, Elaine Lai-Han; Tian, Xiaoying			PERSPECTIVE The clinical trial barriers	NATURE			English	Editorial Material							CELL LUNG-CANCER; GEFITINIB; MUTATIONS; MEDICINE		[Liu, Liang; Leung, Elaine Lai-Han] Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Macao, Peoples R China; [Tian, Xiaoying] Hong Kong Baptist Univ, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China	Macau University of Science & Technology; Hong Kong Baptist University	Liu, L (corresponding author), Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Macao, Peoples R China.	lliu@must.edu.mo						Douillard JY, 2010, J CLIN ONCOL, V28, P744, DOI 10.1200/JCO.2009.24.3030; Frueh FW, 2009, PHARMACOGENOMICS, V10, P1077, DOI [10.2217/pgs.09.62, 10.2217/PGS.09.62]; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Swanton C, 2010, ANN NY ACAD SCI, V1210, P34, DOI 10.1111/j.1749-6632.2010.05776.x; van der Greef J, 2010, PLANTA MED, V76, P2036, DOI 10.1055/s-0030-1250450; van Wietmarschen H., 2009, CLIN RHEUMATOL, V15, P330	7	19	20	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2011	480	7378					S100	S100		10.1038/480S100a	http://dx.doi.org/10.1038/480S100a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	865NQ	22190082				2022-12-28	WOS:000298318000011
J	Mabey, D				Mabey, David			Oral azithromycin for treatment of yaws	LANCET			English	Editorial Material							SINGLE-DOSE AZITHROMYCIN; TREPONEMA-PALLIDUM; TRACHOMA CONTROL; RESISTANCE; CARRIAGE; IMPACT		Univ London London Sch Hyg & Trop Med, Dept Clin Res, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Mabey, D (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Clin Res, Keppel St, London WC1E 7HT, England.	david.mabey@lshtm.ac.uk		Mabey, David/0000-0002-0031-8276				Antal GM, 2002, MICROBES INFECT, V4, P83, DOI 10.1016/S1286-4579(01)01513-1; Batt SL, 2003, ANTIMICROB AGENTS CH, V47, P2765, DOI 10.1128/AAC.47.9.2765-2769.2003; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P197; Hook EW, 2010, J INFECT DIS, V201, P1729, DOI 10.1086/652239; Leach AJ, 1997, CLIN INFECT DIS, V24, P356, DOI 10.1093/clinids/24.3.356; Lukehart SA, 2004, NEW ENGL J MED, V351, P154, DOI 10.1056/NEJMoa040216; Marra CM, 2006, J INFECT DIS, V194, P1771, DOI 10.1086/509512; Mitja O, 2012, LANCET, V379, P342, DOI 10.1016/S0140-6736(11)61624-3; Nerrienet E, 2005, J MED VIROL, V76, P208, DOI 10.1002/jmv.20343; Porco TC, 2009, JAMA-J AM MED ASSOC, V302, P962, DOI 10.1001/jama.2009.1266; Riedner G, 2005, NEW ENGL J MED, V353, P1236, DOI 10.1056/NEJMoa044284; Solomon AW, 2004, NEW ENGL J MED, V351, P1962, DOI 10.1056/NEJMoa040979; Van Damme K, 2009, SEX TRANSM DIS, V36, P775, DOI 10.1097/OLQ.0b013e3181bd11dd; Zhou PY, 2010, SEX TRANSM DIS, V37, P726, DOI 10.1097/OLQ.0b013e3181e2c753	14	11	11	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 28	2012	379	9813					295	297		10.1016/S0140-6736(11)61842-4	http://dx.doi.org/10.1016/S0140-6736(11)61842-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	889BA	22240406				2022-12-28	WOS:000300047300014
J	Person, AL; Raman, IM				Person, Abigail L.; Raman, Indira M.			Purkinje neuron synchrony elicits time-locked spiking in the cerebellar nuclei	NATURE			English	Article							RELEASE SITES; CELLS; SYNAPSES; SINGLE; TRANSMISSION; ORGANIZATION; INHIBITION; DEPRESSION; DISCHARGE; NETWORKS	An unusual feature of the cerebellar cortex is that its output neurons, Purkinje cells, release GABA (gamma-aminobutyric acid). Their high intrinsic firing rates(1) (50 Hz) and extensive convergence(2,3) predict that their target neurons in the cerebellar nuclei would be largely inhibited unless Purkinje cells pause their spiking, yet Purkinje and nuclear neuron firing rates do not always vary inversely(4). One indication of how these synapses transmit information is that populations of Purkinje neurons synchronize their spikes during cerebellar behaviours(5-11). If nuclear neurons respond to Purkinje synchrony, they may encode signals from subsets of inhibitory inputs(7,12-14). Here we show in weanling and adult mice that nuclear neurons transmit the timing of synchronous Purkinje afferent spikes, owing to modest Purkinje-to-nuclear convergence ratios (similar to 40:1), fast inhibitory postsynaptic current kinetics (tau(decay) = 2.5 ms) and high intrinsic firing rates (similar to 90 Hz). In vitro, dynamically clamped asynchronous inhibitory postsynaptic potentials mimicking Purkinje afferents suppress nuclear cell spiking, whereas synchronous inhibitory postsynaptic potentials entrain nuclear cell spiking. With partial synchrony, nuclear neurons time-lock their spikes to the synchronous subpopulation of inputs, even when only 2 out of 40 afferents synchronize. In vivo, nuclear neurons reliably phase-lock to regular trains of molecular layer stimulation. Thus, cerebellar nuclear neurons can preferentially relay the spike timing of synchronized Purkinje cells to downstream premotor areas.	[Person, Abigail L.; Raman, Indira M.] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA	Northwestern University	Raman, IM (corresponding author), Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA.	a-person@northwestern.edu; i-raman@northwestern.edu			NIH [R01-NS39395, F32-NS067831]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039395, F32NS067831] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to J. R. Pugh for new analysis of data from ref. 19 on whole-cell GABA conductances. We thank D. Ferster, D. McLean and C. Woolley for comments on the manuscript. This work was supported by NIH grants R01-NS39395 (I.M.R.) and F32-NS067831 (A.L.P.).	Anchisi D, 2001, J NEUROPHYSIOL, V85, P323, DOI 10.1152/jn.2001.85.1.323; Bartos M, 2002, P NATL ACAD SCI USA, V99, P13222, DOI 10.1073/pnas.192233099; BELL CC, 1969, J NEUROPHYSIOL, V32, P1044, DOI 10.1152/jn.1969.32.6.1044; Bengtsson F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018822; Chan-Palay V, 1977, CEREBELLAR DENTATE N; de Solages C, 2008, NEURON, V58, P775, DOI 10.1016/j.neuron.2008.05.008; Gauck V, 2000, J NEUROSCI, V20, P3006; Gauck V, 2003, J NEUROSCI, V23, P8109; Goossens HHLM, 2004, EUR J NEUROSCI, V19, P687, DOI 10.1111/j.0953-816X.2003.03173.x; Heck DH, 2007, P NATL ACAD SCI USA, V104, P7658, DOI 10.1073/pnas.0609966104; Hoebeek FE, 2010, P NATL ACAD SCI USA, V107, P8410, DOI 10.1073/pnas.0907118107; Kistler WM, 2003, CEREBELLUM, V2, P44, DOI 10.1080/14734220309426; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; MCDEVITT CJ, 1987, BRAIN RES, V425, P1, DOI 10.1016/0006-8993(87)90477-X; Ozden I, 2009, J NEUROSCI, V29, P10463, DOI 10.1523/JNEUROSCI.0967-09.2009; PALKOVITS M, 1977, EXP BRAIN RES, V28, P189; Pedroarena CM, 2003, J NEUROPHYSIOL, V89, P704, DOI 10.1152/jn.00558.2002; Pugh JR, 2005, BIOPHYS J, V88, P1740, DOI 10.1529/biophysj.104.055814; Ruigrok TJH, 2008, EUR J NEUROSCI, V28, P181, DOI 10.1111/j.1460-9568.2008.06294.x; Schultz SR, 2009, J NEUROSCI, V29, P8005, DOI 10.1523/JNEUROSCI.4919-08.2009; SHINODA Y, 1988, BEHAV BRAIN RES, V28, P59, DOI 10.1016/0166-4328(88)90076-9; Sugihara I, 2009, J COMP NEUROL, V512, P282, DOI 10.1002/cne.21889; Tehovnik EJ, 2006, J NEUROPHYSIOL, V96, P512, DOI 10.1152/jn.00126.2006; Telgkamp P, 2002, J NEUROSCI, V22, P8447; Telgkamp P, 2004, NEURON, V41, P113, DOI 10.1016/S0896-6273(03)00802-X; THACH WT, 1968, J NEUROPHYSIOL, V31, P785, DOI 10.1152/jn.1968.31.5.785; TOYAMA K, 1970, EXP BRAIN RES, V11, P187; Uusisaari M, 2008, NEUROSCIENCE, V156, P537, DOI 10.1016/j.neuroscience.2008.07.060; WELSH JP, 1995, NATURE, V374, P453, DOI 10.1038/374453a0; Wise AK, 2010, J PHYSIOL-LONDON, V588, P2373, DOI 10.1113/jphysiol.2010.189704	30	217	217	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 26	2012	481	7382					502	U114		10.1038/nature10732	http://dx.doi.org/10.1038/nature10732			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881GY	22198670	Green Accepted			2022-12-28	WOS:000299471800039
J	Schmidt, D; Schwalie, PC; Wilson, MD; Ballester, B; Goncalves, A; Kutter, C; Brown, GD; Marshall, A; Flicek, P; Odom, DT				Schmidt, Dominic; Schwalie, Petra C.; Wilson, Michael D.; Ballester, Benoit; Goncalves, Angela; Kutter, Claudia; Brown, Gordon D.; Marshall, Aileen; Flicek, Paul; Odom, Duncan T.			Waves of Retrotransposon Expansion Remodel Genome Organization and CTCF Binding in Multiple Mammalian Lineages	CELL			English	Article							INSULATOR PROTEIN CTCF; TRANSCRIPTIONAL REGULATION; REGULATORY NETWORK; ENHANCER BLOCKING; ZINC FINGERS; GENE; EVOLUTION; SITES; REPRESSOR; REVEALS	CTCF-binding locations represent regulatory sequences that are highly constrained over the course of evolution. To gain insight into how these DNA elements are conserved and spread through the genome, we defined the full spectrum of CTCF-binding sites, including a 33/34-mer motif, and identified over five thousand highly conserved, robust, and tissue-independent CTCF-binding locations by comparing ChIP-seq data from six mammals. Our data indicate that activation of retroelements has produced species-specific expansions of CTCF binding in rodents, dogs, and opossum, which often functionally serve as chromatin and transcriptional insulators. We discovered fossilized repeat elements flanking deeply conserved CTCF-binding regions, indicating that similar retrotransposon expansions occurred hundreds of millions of years ago. Repeat-driven dispersal of CTCF binding is a fundamental, ancient, and still highly active mechanism of genome evolution in mammalian lineages.	[Schwalie, Petra C.; Ballester, Benoit; Goncalves, Angela; Flicek, Paul] European Bioinformat Inst EMBL EBI, Cambridge CB10 1SD, England; [Schmidt, Dominic; Wilson, Michael D.; Kutter, Claudia; Brown, Gordon D.; Marshall, Aileen; Odom, Duncan T.] Li Ka Shing Ctr, Cambridge Res Inst, Cambridge CB2 0RE, England; [Schmidt, Dominic; Wilson, Michael D.; Kutter, Claudia; Brown, Gordon D.; Odom, Duncan T.] Univ Cambridge, Hutchison MRC Res Ctr, Dept Oncol, Cambridge CB2 0XZ, England; [Flicek, Paul; Odom, Duncan T.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Marshall, Aileen] Addenbrookes Hosp, Cambridge Hepatobiliary Serv, Cambridge CB2 2QQ, England	European Molecular Biology Laboratory (EMBL); CRUK Cambridge Institute; University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Flicek, P (corresponding author), European Bioinformat Inst EMBL EBI, Wellcome Trust Genome Campus, Cambridge CB10 1SD, England.	flicek@ebi.ac.uk; duncan.odom@cancer.org.uk	Wilson, Michael D/K-6294-2014; Kutter, Claudia/HHD-1391-2022; Ballester, Benoit/N-6127-2016	Wilson, Michael D/0000-0002-4015-3066; Ballester, Benoit/0000-0002-0834-7135; Kutter, Claudia/0000-0002-8047-0058; Schwalie, Petra Catalina/0000-0002-6004-8095; Flicek, Paul/0000-0002-3897-7955; Odom, Duncan/0000-0001-6201-5599	CRI Genomics and Bioinformatics Cores; European Research Council; EMBO; Hutchinson Whampoa; Cancer Research UK; University of Cambridge; Swiss National Science Foundation; Wellcome Trust [WT062023, WT098051]; EMBL; Cancer Research UK [15603] Funding Source: researchfish	CRI Genomics and Bioinformatics Cores; European Research Council(European Research Council (ERC)European Commission); EMBO(European Molecular Biology Organization (EMBO)); Hutchinson Whampoa; Cancer Research UK(Cancer Research UK); University of Cambridge(University of Cambridge); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Wellcome Trust(Wellcome Trust); EMBL; Cancer Research UK(Cancer Research UK)	We thank the CRI Genomics and Bioinformatics Cores for support; E. Fraenkel and S. Goslin for looking at zinc finger interactions with the CTCF-binding motif; S. Watt for experimental support; S. MacKay for reagents. This research was supported by the European Research Council, EMBO Young Investigator Program, Hutchinson Whampoa (D.T.O.), Cancer Research UK (D. S., M. D. W., C. K., A. M., G. D. B.), University of Cambridge (D. S., P. C. S., M. D. W., C. K., D.T.O.), Swiss National Science Foundation (C. K.), the Wellcome Trust (WT062023 and WT098051; D.T.O., B. B., P. F.), and EMBL (P. C. S., A. G., P. F.).	Awad TA, 1999, J BIOL CHEM, V274, P27092, DOI 10.1074/jbc.274.38.27092; BANIAHMAD A, 1990, CELL, V61, P505, DOI 10.1016/0092-8674(90)90532-J; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blewitt ME, 2006, PLOS GENET, V2, P399, DOI 10.1371/journal.pgen.0020049; Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; Bourque G, 2008, GENOME RES, V18, P1752, DOI 10.1101/gr.080663.108; Boyle AP, 2011, GENOME RES, V21, P456, DOI 10.1101/gr.112656.110; Britten RJ, 1997, GENE, V205, P177, DOI 10.1016/S0378-1119(97)00399-5; Burcin M, 1997, MOL CELL BIOL, V17, P1281, DOI 10.1128/MCB.17.3.1281; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; Dunn KL, 2003, BIOCHEM CELL BIOL, V81, P161, DOI 10.1139/o03-052; Fedoriw AM, 2004, SCIENCE, V303, P238, DOI 10.1126/science.1090934; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Heath H, 2008, EMBO J, V27, P2839, DOI 10.1038/emboj.2008.214; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hirakawa M, 2009, GENE, V441, P100, DOI 10.1016/j.gene.2008.12.009; Johnson R, 2009, MOL BIOL EVOL, V26, P1491, DOI 10.1093/molbev/msp058; Johnson R, 2006, NUCLEIC ACIDS RES, V34, P3862, DOI 10.1093/nar/gkl525; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kass DH, 1997, GENETICA, V99, P1, DOI 10.1023/A:1018350810791; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; KLENOVA EM, 1993, MOL CELL BIOL, V13, P7612, DOI 10.1128/MCB.13.12.7612; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lee DH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001224; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; LOBANENKOV VV, 1990, ONCOGENE, V5, P1743; Lynch VJ, 2011, NAT GENET, V43, P1154, DOI 10.1038/ng.917; MacArthur S, 2004, MOL BIOL EVOL, V21, P1064, DOI 10.1093/molbev/msh105; Markljung E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000256; Martin D, 2011, NAT STRUCT MOL BIOL, V18, P708, DOI 10.1038/nsmb.2059; MCCLINTOCK B, 1950, P NATL ACAD SCI USA, V36, P344, DOI 10.1073/pnas.36.6.344; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Moon H, 2005, EMBO REP, V6, P165, DOI 10.1038/sj.embor.7400334; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mortazavi A, 2006, GENOME RES, V16, P1208, DOI 10.1101/gr.4997306; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Quitschke WW, 2000, NUCLEIC ACIDS RES, V28, P3370, DOI 10.1093/nar/28.17.3370; Rand E, 2004, CURR BIOL, V14, P1007, DOI 10.1016/j.cub.2004.05.041; Renda M, 2007, J BIOL CHEM, V282, P33336, DOI 10.1074/jbc.M706213200; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Wang T, 2007, P NATL ACAD SCI USA, V104, P18613, DOI 10.1073/pnas.0703637104; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104	58	368	376	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 20	2012	148	1-2					335	348		10.1016/j.cell.2011.11.058	http://dx.doi.org/10.1016/j.cell.2011.11.058			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	882DC	22244452	Green Published, hybrid			2022-12-28	WOS:000299540700035
J	Chamberlain, K; Baker, MR; Kandaswamy, P; Shaw, EJ; McVeigh, G; Siddiqui, F				Chamberlain, K.; Baker, M. R.; Kandaswamy, P.; Shaw, E. J.; McVeigh, G.; Siddiqui, F.		Guideline Dev Grp	GUIDELINES Donor identification and consent for deceased organ donation: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[McVeigh, G.] Queens Univ Belfast, Dept Therapeut & Pharmacol, Belfast BT9 7BL, Antrim, North Ireland; [Chamberlain, K.; Baker, M. R.; Kandaswamy, P.; Shaw, E. J.; Siddiqui, F.] Natl Inst Hlth & Clin Excellence, Manchester M1 4BD, Lancs, England	Queens University Belfast; National Institute for Health & Care Excellence	McVeigh, G (corresponding author), Queens Univ Belfast, Dept Therapeut & Pharmacol, Whitla Med Bldg, Belfast BT9 7BL, Antrim, North Ireland.	g.mcveigh@qub.ac.uk	O'Carroll, Ronan E/A-5040-2009	O'Carroll, Ronan E/0000-0002-5130-291X				General Medical Council, 2010, TREATM CAR END LIF G; Intensive Care Society British Transplantation Society, 2010, DON CIRC DEATH; National Institute for Health and Clinical Excellence, 2011, NAT I HLTH CLIN EXC; NHS Blood and Transplant, 2011, TRANSPL ACT UK; U. Department of Health, 2009, LEG ISS REL NON HEAR	5	8	8	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 12	2012	344								e341	10.1136/bmj.e341	http://dx.doi.org/10.1136/bmj.e341			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	877SM	22240275				2022-12-28	WOS:000299202900001
J	Stillman, MD				Stillman, Michael D.			On Grace	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Boston Univ, Sch Med, Dept Internal Med, Boston, MA 02118 USA	Boston University	Stillman, MD (corresponding author), Boston Univ, Sch Med, Dept Internal Med, Boston, MA 02118 USA.	michael.stillman@bmc.org							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 11	2012	307	2					155	156		10.1001/jama.2011.1911	http://dx.doi.org/10.1001/jama.2011.1911			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	875NP	22235085				2022-12-28	WOS:000299038300026
J	Degenhardt, L; Hall, W				Degenhardt, Louisa; Hall, Wayne			Extent of illicit drug use and dependence, and their contribution to the global burden of disease	LANCET			English	Article							CANNABIS USE; HEPATITIS-C; SUBSTANCE USE; HEROIN OVERDOSE; INJECT DRUGS; RISK-FACTORS; METHAMPHETAMINE USE; HEALTH OUTCOMES; MENTAL-HEALTH; YOUNG-PEOPLE	This paper summarises data for the prevalence, correlates, and probable adverse health consequences of problem use of amphetamines, cannabis, cocaine, and opioids. We discuss findings from systematic reviews of the prevalence of illicit drug use and dependence, remission from dependence, and mortality in illicit drug users, and evidence for acute and chronic effects of illicit drug use. We outline the regional and global distribution of use and estimated health burden from illicit drugs. These distributions are likely to be underestimates because they have not included all adverse outcomes of drug use and exclude those of cannabis-the mostly widely used illicit drug. In high-income countries, illicit drug use contributes less to the burden of disease than does tobacco but a substantial proportion of that due to alcohol. The major adverse health effects of cannabis use are dependence and probably psychotic disorders and other mental disorders. The health-related harms of cannabis use differ from those of amphetamine, cocaine, and opioid use, in that cannabis contributes little to mortality. Intelligent policy responses to drug problems need better data for the prevalence of different types of illicit drug use and the harms that their use causes globally. This need is especially urgent in high-income countries with substantial rates of illicit drug use and in low-income and middle-income countries close to illicit drug production areas.	[Degenhardt, Louisa] Univ New S Wales, Fac Med, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia; [Degenhardt, Louisa] Univ Melbourne, Sch Populat Hlth, Burnet Inst, Melbourne, Vic, Australia; [Degenhardt, Louisa] Univ Melbourne, Sch Populat Hlth, Ctr Hlth Policy Programs & Econ, Melbourne, Vic, Australia; [Hall, Wayne] Univ Queensland, Clin Res Ctr, Brisbane, Qld 4072, Australia; [Hall, Wayne] Univ Queensland, Ctr Youth Subst Abuse Res, Brisbane, Qld 4072, Australia	University of New South Wales Sydney; Burnet Institute; University of Melbourne; University of Melbourne; University of Queensland; University of Queensland	Degenhardt, L (corresponding author), Univ New S Wales, Fac Med, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia.	l.degenhardt@unsw.edu.au	Degenhardt, Louisa J/D-4515-2012; Hall, Wayne D/A-3283-2008	Degenhardt, Louisa J/0000-0002-8513-2218; Hall, Wayne D/0000-0003-1984-0096				Ali H, 2010, 314 NDARC U NSW; [Anonymous], 2010, LANCET, V375, P1319, DOI 10.1016/S0140-6736(10)60556-9; [Anonymous], WORLD DRUG REP 2011; [Anonymous], 2001, HLTH PSYCHOL CONSEQU; [Anonymous], 307 NDARC U NSW; [Anonymous], HEP C VIR PROJ WORK; Anthony JC, 1994, EXP CLIN PSYCHOPHARM, V2, P244, DOI 10.1037/1064-1297.2.3.244; APA, 1980, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890423349, DOI 10.1176/APPI.BOOKS.9780890423349]; Arseneault L, 2004, BRIT J PSYCHIAT, V184, P110, DOI 10.1192/bjp.184.2.110; Babor T., 2010, DRUG POLICY PUBLIC G; Bachman J. G, 1997, SMOKING DRINKING DRU; Baggaley RF, 2006, AIDS, V20, P805, DOI 10.1097/01.aids.0000218543.46963.6d; Ball A L, 1998, Public Health Rep, V113 Suppl 1, P170; Beautrais AL, 1999, ADDICTION, V94, P1155, DOI 10.1046/j.1360-0443.1999.94811555.x; Begg S., 2007, BURDEN DIS INJURY AU; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Boot BP, 2000, LANCET, V355, P1818, DOI 10.1016/S0140-6736(00)02276-5; Borgwardt SJ, 2008, BIOL PSYCHIAT, V64, P966, DOI 10.1016/j.biopsych.2008.05.011; Bucello C, 2010, 308 NDARC U NSW; Calabria B., 2008, 293 NDARC U NSW; Calabria B, 2010, ADDICT BEHAV, V35, P741, DOI 10.1016/j.addbeh.2010.03.019; Calabria B, 2010, DRUG ALCOHOL REV, V29, P318, DOI 10.1111/j.1465-3362.2009.00149.x; Cannon DS, 1993, PSYCHOL ASSESSMENT, V5, P62; Charlson F, 2009, PHARMACOEPIDEM DR S, V18, P93, DOI 10.1002/pds.1694; COHEN DA, 1994, PEDIATRICS, V94, P368; Collins D, 2007, COSTS TOBACCO ALCOHO; Compton WM, 2006, DRUG ALCOHOL DEPEN, V81, P103, DOI 10.1016/j.drugalcdep.2005.05.009; Coutinho RA, 1998, BRIT MED J, V317, P424, DOI 10.1136/bmj.317.7156.424; Daniel JZ, 2009, DRUG ALCOHOL REV, V28, P142, DOI 10.1111/j.1465-3362.2008.00042.x; Darke S, 1996, ADDICTION, V91, P1765, DOI 10.1111/j.1360-0443.1996.tb03800.x; Darke S., 2006, MORTALITY ILLICIT DR; Darke S., 2011, LIFE HEROIN USER TYP; Darke S, 2008, DRUG ALCOHOL REV, V27, P253, DOI 10.1080/09595230801923702; Darke S, 2006, ADDICTION, V101, P1771, DOI 10.1111/j.1360-0443.2006.01601.x; Darke S, 2010, DRUG ALCOHOL REV, V29, P202, DOI 10.1111/j.1465-3362.2009.00099.x; Degenhardt L, 2006, SEX TRANSM INFECT, V82, pIII56, DOI 10.1136/sti.2005.019273; Degenhardt L, 2004, COMP QUANTIFICATION, P1109; Degenhardt L, 2010, NDARC MONOGRAPH, V62; Degenhardt L, COMP DRUG SITUATION; Degenhardt L, 2010, 310 NDARC U NSW; Degenhardt L, 2006, CAN J PSYCHIAT, V51, P556, DOI 10.1177/070674370605100903; Degenhardt L, 2008, PLOS MED, V5, P1053, DOI 10.1371/journal.pmed.0050141; Degenhardt Louisa, 2010, Lancet, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; Degenhardt L, 2011, DRUG ALCOHOL DEPEN, V117, P85, DOI 10.1016/j.drugalcdep.2010.11.032; Degenhardt L, 2011, DRUG ALCOHOL DEPEN, V113, P88, DOI 10.1016/j.drugalcdep.2010.07.026; Degenhardt L, 2011, ADDICTION, V106, P32, DOI 10.1111/j.1360-0443.2010.03140.x; Degenhardt L, 2010, DRUG ALCOHOL DEPEN, V108, P84, DOI 10.1016/j.drugalcdep.2009.12.001; Degenhardt L, 2010, DRUG ALCOHOL DEPEN, V107, P1, DOI 10.1016/j.drugalcdep.2009.09.009; Degenhardt L, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000133; Degenhardt L, 2009, ADDICTION, V104, P1466, DOI 10.1111/j.1360-0443.2009.02715.x; Donoghoe M, 1996, QUANTIFYING GLOBAL H; Donoghoe MC, 1998, SOC AS AIDS, P42; Dore GJ, 2002, J GASTROEN HEPATOL, V17, P423, DOI 10.1046/j.1440-1746.2002.02730.x; English D.R., 1995, QUANTIFICATION DRUG; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Ezzati M, 2004, COMP QUANTIFICATION, P983; Fergusson DM, 2008, DRUG ALCOHOL DEPEN, V96, P165, DOI 10.1016/j.drugalcdep.2008.03.003; FERGUSSON DM, 1994, J AM ACAD CHILD PSY, V33, P1122, DOI 10.1097/00004583-199410000-00008; FLEWELLING RL, 1990, J MARRIAGE FAM, V52, P171, DOI 10.2307/352848; Foster G, 2004, HEPATITIS C INJECTIN, P79; Glantz MD, 2009, PSYCHOL MED, V39, P1365, DOI 10.1017/S0033291708004510; Gossop M, 1996, BRIT MED J, V313, P402; Hagan H, 2007, INT J DRUG POLICY, V18, P341, DOI 10.1016/j.drugpo.2007.01.016; Hall W, 1999, ADDICTION, V94, P1541, DOI 10.1046/j.1360-0443.1999.9410154110.x; Hall W, 2003, CANNABIS USE DEPENDE; Hall W., 2008, INT ENCY PUBLIC HLTH, P523; Hall W, 2007, CURR OPIN PSYCHIATR, V20, P393, DOI 10.1097/YCO.0b013e32812144cc; Hall W, 2009, LANCET, V374, P1383, DOI 10.1016/S0140-6736(09)61037-0; Hall W, 2009, ADDICT BEHAV, V34, P526, DOI 10.1016/j.addbeh.2009.03.010; Hall WD, 2000, MED J AUSTRALIA, V173, P528, DOI 10.5694/j.1326-5377.2000.tb139321.x; Hall WD, 2005, DRUG ALCOHOL REV, V24, P39, DOI 10.1080/09595230500126698; Hallinan R, 2005, J GASTROEN HEPATOL, V20, P1082, DOI 10.1111/j.1440-1746.2005.03882.x; Hartnoll R, 1997, ESTIMATING PREVALENC, P247; HAWKINS JD, 1992, PSYCHOL BULL, V112, P64, DOI 10.1037/0033-2909.112.1.64; Hickman M., 2002, B NARCOTICS, VLIV, P15, DOI DOI 10.1016/J.DRUGOPO.2005.02.05; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Jurgens R, 2010, LANCET, V376, P475, DOI 10.1016/S0140-6736(10)60830-6; Kandel DB, 2006, ADDICTION, V101, P470, DOI 10.1111/j.1360-0443.2006.01426.x; KANDEL DB, 1987, INT J ADDICT, V22, P319, DOI 10.3109/10826088709027433; Karch SB, 2002, KARCHS PATHOLOGY DRU; Kaye S, 2007, ADDICTION, V102, P1204, DOI 10.1111/j.1360-0443.2007.01874.x; Kelly E, 2004, DRUG ALCOHOL REV, V23, P319, DOI 10.1080/09595230412331289482; Kessler R. C., 2008, The WHO world mental health surveys: global perspectives on the epidemiology of mental disorders, P511; Kuhns JB, 2009, ADDICTION, V104, P1122, DOI 10.1111/j.1360-0443.2009.02583.x; LARANCE B, 2005, RAPID ASSESSMENT PER; Large M, 2011, ARCH GEN PSYCHIAT, V68, P555, DOI 10.1001/archgenpsychiatry.2011.5; LaScala E, 2005, PREVENTING HARMFUL SUBSTANCE USE: THE EVIDENCE BASE FOR POLICY AND PRACTICE, P67, DOI 10.1002/9780470713624.ch6; Laumon B, 2005, BRIT MED J, V331, P1371, DOI 10.1136/bmj.38648.617986.1F; Limberg W., 2004, HEPATITIS C INJECTIN, P21; LIPKUS IM, 1994, HEALTH PSYCHOL, V13, P149, DOI 10.1037/0278-6133.13.2.149; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lynskey M, 2000, ADDICTION, V95, P1621, DOI 10.1046/j.1360-0443.2000.951116213.x; LYNSKEY MT, 1995, J ABNORM CHILD PSYCH, V23, P281, DOI 10.1007/BF01447558; LYNSKEY MT, 1994, ADDICTION, V89, P1277, DOI 10.1111/j.1360-0443.1994.tb03306.x; MacCoun R., 2003, RES DRUGS CRIME LINK, P65; MacDonald M, 1996, EPIDEMIOL REV, V18, P137, DOI 10.1093/oxfordjournals.epirev.a017921; Macleod J, 2004, LANCET, V363, P1579, DOI 10.1016/S0140-6736(04)16200-4; MADDAHIAN E, 1988, ADDICT BEHAV, V13, P191, DOI 10.1016/0306-4603(88)90011-1; Maloney E, 2007, ADDICTION, V102, P1933, DOI 10.1111/j.1360-0443.2007.01971.x; Marincovich B, 2003, SEX TRANSM INFECT, V79, P160, DOI 10.1136/sti.79.2.160; Marshall BDL, 2010, ADDICTION, V105, P991, DOI 10.1111/j.1360-0443.2010.02932.x; Martell BA, 2007, ANN INTERN MED, V146, P116, DOI 10.7326/0003-4819-146-2-200701160-00006; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; McAllister William., 2000, DRUG DIPLOMACY 20 CE; McKetin R, 2006, DRUG ALCOHOL DEPEN, V85, P198, DOI 10.1016/j.drugalcdep.2006.04.007; Merrall ELC, 2010, ADDICTION, V105, P1545, DOI 10.1111/j.1360-0443.2010.02990.x; MOORE MH, 1990, CRIME JUSTICE, V13, P109, DOI 10.1086/449174; Moore THM, 2007, LANCET, V370, P319, DOI 10.1016/S0140-6736(07)61162-3; Murray C.J, 1996, GLOBAL BURDEN DIS CO; Murray CJL, 2007, LANCET, V370, P109, DOI 10.1016/S0140-6736(07)61064-2; Murray Y.M., 2008, GETTY MUSEUM REPRESE; NEEDLE RH, 1990, J MARRIAGE FAM, V52, P157, DOI 10.2307/352847; NELSON P, 2010, 309 NDARC U NSW; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Pedraza MA, 1999, J ACQ IMMUN DEF SYND, V21, P120; PERLMAN DC, 1995, CLIN INFECT DIS, V21, P1253, DOI 10.1093/clinids/21.5.1253; Randall D, 2011, AUST NZ J PUBL HEAL, V35, P220, DOI 10.1111/j.1753-6405.2011.00682.x; Rehm J, 2004, COMP QUANTIFICATION, P959; Rehm J, 2007, J STUD ALCOHOL DRUGS, V68, P886, DOI 10.15288/jsad.2007.68.886; Reuter P., 2009, REPORT GLOBAL ILLICI; Reuter Peter, 1983, DISORGANIZED CRIME E; Rossow I, 1999, ADDICTION, V94, P209, DOI 10.1046/j.1360-0443.1999.9422095.x; SATEL SL, 1991, AM J PSYCHIAT, V148, P495; Singleton J, 2009, DRUG ALCOHOL DEPEN, V105, P1, DOI 10.1016/j.drugalcdep.2009.05.028; Strang J, 2012, LANCET, V379, P71, DOI 10.1016/S0140-6736(11)61674-7; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Toumbourou JW, 2007, LANCET, V369, P1391, DOI 10.1016/S0140-6736(07)60369-9; Townsend L, 2007, CLIN CHILD FAM PSYCH, V10, P295, DOI 10.1007/s10567-007-0023-7; Turk DC, 2008, CLIN J PAIN, V24, P497, DOI 10.1097/AJP.0b013e31816b1070; *UN OFF DRUGS CRIM, 2009, WORLD DRUG REP 2009; UNODC, 2008, WORLD DRUG REP, V2008, P173, DOI [10.18356/4713aa6f-en, DOI 10.18356/4713AA6F-EN]; Vandenbroucke JP., 2007, EXPLAN ELAB, V4, P1628; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003; Volkow ND, 2004, MOL PSYCHIATR, V9, P557, DOI 10.1038/sj.mp.4001507; Warner-Smith M, 2001, ADDICTION, V96, P1113, DOI 10.1046/j.1360-0443.2001.96811135.x; WHO, 2004, GLOB STAT REP ALC; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X; *WORLD BANK, 1993, WORLD DEV REP 1993 I; World Health Organization, 2008, The global burden of disease: 2004 update; World Health Organization, 2010, IMAGE SUBSTANCE; World Health Organization, 1993, ICD 10 CLASS MENT BE, V10th ed.	143	790	800	5	182	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 7	2012	379	9810					55	70		10.1016/S0140-6736(11)61138-0	http://dx.doi.org/10.1016/S0140-6736(11)61138-0			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	873WC	22225671				2022-12-28	WOS:000298913000038
J	Sharma, P; Allison, JP				Sharma, Padmanee; Allison, James P.			Lloyd J. Old (1933-2011)	SCIENCE			English	Biographical-Item									[Sharma, Padmanee] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Sharma, Padmanee] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Sharma, Padmanee; Allison, James P.] Ludwig Ctr Canc Immunotherapy, New York, NY 10021 USA; [Allison, James P.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Allison, James P.] Mem Sloan Kettering Canc Ctr, Dept Immunol, New York, NY 10065 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Sharma, P (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	padsharma@mdanderson.org; allisonj@mskcc.org		Allison, James/0000-0001-8980-5697	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		OLD LJ, PUBLICATION LIST	1	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 6	2012	335	6064					49	49		10.1126/science.1217940	http://dx.doi.org/10.1126/science.1217940			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872YA	22223799				2022-12-28	WOS:000298846200045
J	Ship, AN; Trivedi, NS				Ship, Amy N.; Trivedi, Neha S.			Update: A 52-Year-Old Woman With Disabling Peripheral Neuropathy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material														Trivedi, Neha/0000-0003-1006-1408				Rutkove SB, 2009, JAMA-J AM MED ASSOC, V302, P1451, DOI 10.1001/jama.2009.1377	1	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 4	2012	307	1					85	85		10.1001/jama.2011.1951	http://dx.doi.org/10.1001/jama.2011.1951			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	872ET	22215168				2022-12-28	WOS:000298792300025
J	Chan, AW				Chan, An-Wen			Out of sight but not out of mind: how to search for unpublished clinical trial evidence	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OUTCOME REPORTING BIAS; RANDOMIZED-TRIALS; EMPIRICAL-EVIDENCE; PUBLICATION; DISSEMINATION; ROFECOXIB; DOCUMENTS; LESSONS; ACCESS		Univ Toronto, Womens Coll Res Inst, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital	Chan, AW (corresponding author), Univ Toronto, Womens Coll Res Inst, Toronto, ON, Canada.	anwen.chan@utoronto.ca						Asamoah AK, 2010, NEW ENGL J MED, V362, P2341, DOI 10.1056/NEJMp1005202; Bero L, 2003, ANNU REV PUBL HEALTH, V24, P267, DOI 10.1146/annurev.publhealth.24.100901.140813; Chan AW, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d80; Chan AW, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2299; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chan AW, 2005, BMJ-BRIT MED J, V330, P753, DOI 10.1136/bmj.38356.424606.8F; CLARKE M, 1995, BRIT MED J, V310, P741, DOI 10.1136/bmj.310.6981.741a; Dundar Y, 2006, HEALTH TECHNOL ASSES, V10; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; European Medicines Agency. European Medicines Agency policy on access to documents (related to medicinal products for human and veterinary use), 2010, EMA1101962006; GlaxoSmithKline, 2011, PUBL DISCL CLIN RES; Gotzsche PC, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2686; Hahn S, 2002, J EVAL CLIN PRACT, V8, P353, DOI 10.1046/j.1365-2753.2002.00314.x; Hartling L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017242; HETHERINGTON J, 1989, PEDIATRICS, V84, P374; Higgins J. P., 2008, COCHRANE HDB SYSTEMA, P51, DOI DOI 10.1002/9780470712184.CH4; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hopewell Sally, 2010, BMJ, V340, pc723, DOI 10.1136/bmj.c723; Huic M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025258; Jefferson T, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7258; Kesselheim AS, 2007, HEALTH AFFAIR, V26, P483, DOI 10.1377/hlthaff.26.2.483; Krumholz HM, 2011, JAMA-J AM MED ASSOC, V306, P1593, DOI 10.1001/jama.2011.1459; Lurie P, 2008, LAW CONTEMP PROBL, V69, P85; McGrath J, 1998, BRIT MED J, V316, P631, DOI 10.1136/bmj.316.7131.631a; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Psaty BM, 2008, JAMA-J AM MED ASSOC, V299, P1813, DOI 10.1001/jama.299.15.1813; Reveiz L, 2006, J CLIN EPIDEMIOL, V59, P755, DOI 10.1016/j.jclinepi.2005.11.022; Reveiz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012484; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Ross JS, 2009, ARCH INTERN MED, V169, P1976, DOI 10.1001/archinternmed.2009.394; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; Smyth RMD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7153; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; Vedula SS, 2009, NEW ENGL J MED, V361, P1963, DOI 10.1056/NEJMsa0906126; Viergever RF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014701; Zarin DA, 2011, NEW ENGL J MED, V364, P852, DOI 10.1056/NEJMsa1012065	37	43	44	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 3	2012	344								d8013	10.1136/bmj.d8013	http://dx.doi.org/10.1136/bmj.d8013			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874UE	22214892	Bronze			2022-12-28	WOS:000298982800009
J	Bowden-Jones, H; George, S				Bowden-Jones, Henrietta; George, Sanju			A PATIENT'S JOURNEY Gambling addiction	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bowden-Jones, Henrietta] Cent NW London NHS Fdn Trust, Addict Directorate, London NW1 2PL, England; [Bowden-Jones, Henrietta] Univ London Imperial Coll Sci Technol & Med, Dept Med, London SW7 2AZ, England; [Bowden-Jones, Henrietta] Natl Problem Gambling Clin, London W1D 3HZ, England; [George, Sanju] Birmingham & Solihull Mental Hlth NHS Fdn Trust, Birmingham B37 7UR, W Midlands, England	Imperial College London	Bowden-Jones, H (corresponding author), Cent NW London NHS Fdn Trust, Addict Directorate, London NW1 2PL, England.	h.bowden-jones02@imperial.ac.uk							0	4	4	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 30	2011	343								d7789	10.1136/bmj.d7789	http://dx.doi.org/10.1136/bmj.d7789			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	874TQ	22209819	Bronze			2022-12-28	WOS:000298981400001
J	Marcus, A; Oransky, I				Marcus, Adam; Oransky, Ivan			The paper is not sacred	NATURE			English	Editorial Material												adam.marcus1@gmail.com; ivan-oransky@erols.com	Oransky, Ivan/J-9412-2019	Oransky, Ivan/0000-0002-0746-9288				[Anonymous], 2011, MOL CELL BIOL, V31; [Anonymous], 2011, EMBO J, V30, P627; Redfield RJ, 2010, ARSENIC ASS BACTERIA; Retraction Watch, 2011, RETRACTION WATC 0928; Retraction Watch, 2010, RETRACTION WATC 1026; Retraction Watch, 2010, RETRACTION WATC 1013; Senturk A, 2011, NATURE, V478, DOI 10.1038/nature10420; Wolfe-Simon F, 2011, SCIENCE, V332, P1163, DOI 10.1126/science.1197258; Zimmer C., 2010, DISCOVER MAGAZI 1208; 2011, NATURE, V478, P26; 2011, NATURE, V474, P19; 2011, NATURE, V469, P286	12	19	19	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2011	480	7378					449	450		10.1038/480449a	http://dx.doi.org/10.1038/480449a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	865NQ	22193084	Bronze			2022-12-28	WOS:000298318000035
J	Periago, MR; Frieden, TR; Tappero, JW; De Cock, KM; Aasen, B; Andrus, JK				Periago, Mirta Roses; Frieden, Thomas R.; Tappero, Jordan W.; De Cock, Kevin M.; Aasen, Bernt; Andrus, Jon K.			Elimination of cholera transmission in Haiti and the Dominican Republic	LANCET			English	Editorial Material							INTERVENTIONS; BENEFITS; MEXICO		[Periago, Mirta Roses; Andrus, Jon K.] Pan Amer Hlth Org, Washington, DC 20037 USA; [Frieden, Thomas R.] Ctr Dis Control & Prevent, Off Director, Atlanta, GA USA; [Tappero, Jordan W.; De Cock, Kevin M.] Ctr Dis Control & Prevent, Ctr Global Hlth, Atlanta, GA USA; [Aasen, Bernt] United Nations Childrens Fund, Latin Amer & Caribbean Off, Panama City, Panama	Pan American Health Organization; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Andrus, JK (corresponding author), Pan Amer Hlth Org, Washington, DC 20037 USA.	andrusjo@paho.org		Frieden, Thomas/0000-0002-4759-2256				Andrus JK, 2009, AM J LAW MED, V35, P311, DOI 10.1177/009885880903500204; Gaffga NH, 2007, AM J TROP MED HYG, V77, P705, DOI 10.4269/ajtmh.2007.77.705; Gutierrez G, 1996, B WORLD HEALTH ORGAN, V74, P189; Haiti earthquake PDNA: assessment of damage losses general and sectoral needs, 2010, HAIT EARTHQ PDNA ASS; Haller L, 2007, J WATER HEALTH, V5, P467, DOI 10.2166/wh.2007.008; Inter-American Development Bank, HAIT COUNTR UPD; Inter-American Development Bank, 2010, DRINK WAT SAN MILL D; Ivers LC, 2010, LANCET, V376, P2048, DOI 10.1016/S0140-6736(10)62243-X; Ministere de Sante Publique et de la Population, 2011, RAPP JOURN MSPP EV D; Ministry of Public Health of the Dominican Republic, 2011, WEEKL EP B; Sepulveda J, 2006, INT J INFECT DIS, V10, P4, DOI 10.1016/j.ijid.2005.05.005; Tappero JW, 2011, EMERG INFECT DIS, V17, P2087, DOI 10.3201/eid1711.110827; WHO UNICEF, 2010, PROGR SAN DRINK WAT	13	26	26	0	21	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 21	2012	379	9812					E12	E13		10.1016/S0140-6736(12)60031-2	http://dx.doi.org/10.1016/S0140-6736(12)60031-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	879FW	22240408				2022-12-28	WOS:000299316100001
J	Iglehart, JK				Iglehart, John K.			Confirming the CMS Nominee - Overcoming Poisonous Politics	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Berenson R., CTR MEDICAR IN PRESS; Berwick DM, 2008, HEALTH AFFAIR, V27, P759, DOI 10.1377/hlthaff.27.3.759; Haberkorn J., 2011, POLITICO        1207; Iglehart JK, 2009, HEALTH AFFAIR, V28, pW688, DOI 10.1377/hlthaff.28.4.w688; Meyer H, 2011, HEALTH AFFAIR, V30, P2277, DOI 10.1377/hlthaff.2011.1243	5	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 19	2012	366	3					204	205		10.1056/NEJMp1114863	http://dx.doi.org/10.1056/NEJMp1114863			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	877RZ	22204673				2022-12-28	WOS:000299201400005
J	Cao, C; Bi, MA; Hendel, N; Yan, TD				Cao, Christopher; Bi, Mian; Hendel, Nick; Yan, Tristan D.			An unusual presentation of recurrent pneumonia	LANCET			English	Editorial Material							LUNG		[Cao, Christopher; Bi, Mian; Hendel, Nick; Yan, Tristan D.] Royal Prince Alfred Hosp, Dept Cardiothorac Surg, Sydney, NSW, Australia; [Cao, Christopher; Bi, Mian; Hendel, Nick; Yan, Tristan D.] Baird Inst Appl Heart & Lung Surg Res, Sydney, NSW, Australia	University of Sydney	Yan, TD (corresponding author), Royal Prince Alfred Hosp, Dept Cardiothorac Surg, Missenden Rd, Camperdown, NSW 2050, Australia.	tristan.yan@hotmail.com		Yan, Tristan/0000-0002-7473-1522; Bi, Mian/0000-0002-4383-3606				Do KH, 2001, RADIOGRAPHICS, V21, P387, DOI 10.1148/radiographics.21.2.g01mr06387; PRYCE DM, 1946, J PATHOL BACTERIOL, V58, P457; SAVIC B, 1979, THORAX, V34, P96, DOI 10.1136/thx.34.1.96; STOCKER JT, 1986, SEMIN DIAGN PATHOL, V3, P106	4	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 14	2012	379	9811					192	192		10.1016/S0140-6736(11)61588-2	http://dx.doi.org/10.1016/S0140-6736(11)61588-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	879GM	22243825				2022-12-28	WOS:000299317700042
J	Isakov, SV; Melko, RG; Hastings, MB				Isakov, Sergei V.; Melko, Roger G.; Hastings, Matthew B.			Universal Signatures of Fractionalized Quantum Critical Points	SCIENCE			English	Article							SUPERCONDUCTIVITY	Ground states of certain materials can support exotic excitations with a charge equal to a fraction of the fundamental electron charge. The condensation of these fractionalized particles has been predicted to drive unusual quantum phase transitions. Through numerical and theoretical analysis of a physical model of interacting lattice bosons, we establish the existence of such an exotic critical point, called XY*. We measure a highly nonclassical critical exponent eta = 1.493 and construct a universal scaling function of winding number distributions that directly demonstrates the distinct topological sectors of an emergent Z(2) gauge field. The universal quantities used to establish this exotic transition can be used to detect other fractionalized quantum critical points in future model and material systems.	[Hastings, Matthew B.] Duke Univ, Dept Phys, Durham, NC 27708 USA; [Isakov, Sergei V.] ETH, CH-8093 Zurich, Switzerland; [Melko, Roger G.] Univ Waterloo, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada; [Hastings, Matthew B.] Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA	Duke University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Waterloo; University of California System; University of California Santa Barbara	Hastings, MB (corresponding author), Duke Univ, Dept Phys, Durham, NC 27708 USA.	xhastings@gmail.com			Natural Sciences and Engineering Research Council of Canada; Swiss HP2C initiative	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Swiss HP2C initiative	We thank L. Balents, S. Sachdev, and T. Senthil for enlightening discussions. M. B. H. thanks the Aspen Center for Physics for hospitality. This work has been supported by the Natural Sciences and Engineering Research Council of Canada and the Swiss HP<SUP>2</SUP>C initiative. Simulations were performed on the Brutus cluster at ETH Zurich and the computing facilities of SHARCNET.	Balents L, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.224412; Balents L, 2010, NATURE, V464, P199, DOI 10.1038/nature08917; Ballesteros HG, 1996, PHYS LETT B, V387, P125, DOI 10.1016/0370-2693(96)00984-7; Bid A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.236802; Block MS, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.157202; Calabrese P, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.046115; Campostrini M, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.214503; CHUBUKOV AV, 1994, PHYS REV LETT, V72, P2089, DOI 10.1103/PhysRevLett.72.2089; CHUBUKOV AV, 1994, NUCL PHYS B, V426, P601, DOI 10.1016/0550-3213(94)90023-X; Del Maestro A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.060515; Dorneich A, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.066701; Grover T, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.205102; Helton JS, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.107204; Hermele M, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.214437; Huh Y, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.144432; Isakov SV, 2011, NAT PHYS, V7, P772, DOI 10.1038/nphys2036; Isakov SV, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.174417; Koshnick NC, 2007, SCIENCE, V318, P1440, DOI 10.1126/science.1148758; Kurosaki Y, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.177001; Lee SS, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.036403; Motrunich OI, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.045105; Prokof'ev NV, 1998, PHYS LETT A, V238, P253, DOI 10.1016/S0375-9601(97)00957-2; ROKHSAR DS, 1988, PHYS REV LETT, V61, P2376, DOI 10.1103/PhysRevLett.61.2376; Sandvik AW, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.227202; Senthil T, 2004, SCIENCE, V303, P1490, DOI 10.1126/science.1091806; Senthil T, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.205104; Shimizu Y, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.107001; Syljuasen OF, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.046701; Tang Y, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.157201; Yamashita M, 2010, SCIENCE, V328, P1246, DOI 10.1126/science.1188200	32	64	64	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 13	2012	335	6065					193	195		10.1126/science.1212207	http://dx.doi.org/10.1126/science.1212207			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875LZ	22246770	Green Submitted			2022-12-28	WOS:000299033100046
J	McIlwain, DR; Lang, PA; Maretzky, T; Hamada, K; Ohishi, K; Maney, SK; Berger, T; Murthy, A; Duncan, G; Xu, HFC; Lang, KS; Haussinger, D; Wakeham, A; Itie-Youten, A; Khokha, R; Ohashi, PS; Blobel, CP; Mak, TW				McIlwain, David R.; Lang, Philipp A.; Maretzky, Thorsten; Hamada, Koichi; Ohishi, Kazuhito; Maney, Sathish Kumar; Berger, Thorsten; Murthy, Aditya; Duncan, Gordon; Xu, Haifeng C.; Lang, Karl S.; Haeussinger, Dieter; Wakeham, Andrew; Itie-Youten, Annick; Khokha, Rama; Ohashi, Pamela S.; Blobel, Carl P.; Mak, Tak W.			iRhom2 Regulation of TACE Controls TNF-Mediated Protection Against Listeria and Responses to LPS	SCIENCE			English	Article							NECROSIS-FACTOR-ALPHA; RHEUMATOID-ARTHRITIS; MICE; INFECTION; FAMILY; CELLS; METALLOPROTEINASE; MONOCYTOGENES; DISINTEGRIN; MATURATION	Innate immune responses are vital for pathogen defense but can result in septic shock when excessive. A key mediator of septic shock is tumor necrosis factor-alpha (TNF alpha), which is shed from the plasma membrane after cleavage by the TNF alpha convertase (TACE). We report that the rhomboid family member iRhom2 interacted with TACE and regulated TNF alpha shedding. iRhom2 was critical for TACE maturation and trafficking to the cell surface in hematopoietic cells. Gene-targeted iRhom2-deficient mice showed reduced serum TNFa in response to lipopolysaccharide (LPS) and could survive a lethal LPS dose. Furthermore, iRhom2-deficient mice failed to control the replication of Listeria monocytogenes. Our study has identified iRhom2 as a regulator of innate immunity that may be an important target for modulating sepsis and pathogen defense.	[McIlwain, David R.; Lang, Philipp A.; Berger, Thorsten; Duncan, Gordon; Xu, Haifeng C.; Wakeham, Andrew; Itie-Youten, Annick; Ohashi, Pamela S.; Mak, Tak W.] Univ Hlth Network UHN, Ontario Canc Inst, Campell Family Inst Breast Canc Res, Toronto, ON M5G 2C1, Canada; [McIlwain, David R.; Ohashi, Pamela S.] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A8, Canada; [Lang, Philipp A.; Maney, Sathish Kumar; Xu, Haifeng C.; Lang, Karl S.; Haeussinger, Dieter] Univ Dusseldorf, Dept Gastroenterol Hepatol & Infect Dis, D-40225 Dusseldorf, Germany; [Maretzky, Thorsten; Blobel, Carl P.] Hosp Special Surg, Arthritis & Tissue Degenerat Program, New York, NY 10021 USA; [Hamada, Koichi] Kumamoto Univ, Ctr AIDS Res, Okada Projects, Kumamoto 8600811, Japan; [Ohishi, Kazuhito] Osaka Univ, Grad Sch Med, Dept Pathol, Suita, Osaka 5650871, Japan; [Murthy, Aditya; Khokha, Rama] UHN, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; [Lang, Karl S.] Univ Essen Gesamthsch, Inst Immunol, D-45147 Essen, Germany; [Blobel, Carl P.] Cornell Univ, Weill Med Coll, Dept Med & Physiol, New York, NY 10021 USA; [Blobel, Carl P.] Cornell Univ, Weill Med Coll, Dept Biophys, New York, NY 10021 USA; [Blobel, Carl P.] Cornell Univ, Weill Med Coll, Dept Syst Biol, New York, NY 10021 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Heinrich Heine University Dusseldorf; Kumamoto University; Osaka University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Duisburg Essen; Cornell University; Cornell University; Cornell University	Mak, TW (corresponding author), Univ Hlth Network UHN, Ontario Canc Inst, Campell Family Inst Breast Canc Res, 620 Univ Ave, Toronto, ON M5G 2C1, Canada.	tmak@uhnresearch.ca	Maretzky, Thorsten/GSN-2981-2022; Maretzky, Thorsten/AEN-1915-2022; Berger, Thorsten/J-7632-2012; Lang, Karl S/R-2505-2016; Duncan, Gordon/AIE-7011-2022	Maretzky, Thorsten/0000-0003-1282-6080; Khokha, Rama/0000-0002-6028-1524; Lang, Karl/0000-0001-9783-7605; Ohashi, Pamela S./0000-0003-2915-9317	Alexander von Humboldt Foundation; Heinrich Heine University; Deutsche Forschungsgemeinschaft [LA1419/3-1]; Molecules of Infection Center, Manchot Graduate School (Jurgen Manchot Foundation); NIH [GM64750]; Emerald Foundation; Naito Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Senri Life Science Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan; Canadian Institutes of Health Research; Terry Fox Foundation;  [SFB575]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064750] Funding Source: NIH RePORTER	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Heinrich Heine University; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Molecules of Infection Center, Manchot Graduate School (Jurgen Manchot Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emerald Foundation; Naito Foundation(Naito Memorial Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Senri Life Science Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Terry Fox Foundation; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank S. Le Gall, S. McCracken, A. Elia, E. Arpaia, and J. Height for experimental assistance and M. Saunders for scientific editing. The data reported in this manuscript are tabulated in the main paper and in the Supporting Online Material. P. A. L. was supported by the Sofja Kovalevskaja Award 2010 of the Alexander von Humboldt Foundation and the Strategic Research Fund of the Heinrich Heine University. K. S. L. was funded by the Sofja Kovalevskaja Award 2008 of the Alexander von Humboldt Foundation; Deutsche Forschungsgemeinschaft grant LA1419/3-1; and the Molecules of Infection Center, Manchot Graduate School (Jurgen Manchot Foundation). This study was supported by the Collaborative Research Center 575 (SFB575: Experimental Hepatology; Coordinator: D. H.). C. P. B. was supported by NIH GM64750, and T. M. by the Emerald Foundation. K.O. was supported in part by the Naito Foundation; the Mochida Memorial Foundation for Medical and Pharmaceutical Research; the Senri Life Science Foundation; and the Ministry of Education, Culture, Sports, Science and Technology of Japan. T. W. M., D. R. M., and K.O. have filed U. S. Patent Application 61/426,396 regarding the use of iRhom2 for regulating innate immunity. This work was generously supported by funding from the Canadian Institutes of Health Research and the Terry Fox Foundation.	Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Alexopoulou L, 2006, EUR J IMMUNOL, V36, P2768, DOI 10.1002/eji.200635921; Bhattacharya D, 2002, P NATL ACAD SCI USA, V99, P8838, DOI 10.1073/pnas.132274799; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Feldmann M, 2002, NAT REV IMMUNOL, V2, P364, DOI 10.1038/nri802; Friedmann E, 2006, NAT CELL BIOL, V8, P843, DOI 10.1038/ncb1440; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Koonin EV, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r19; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Nakagawa T, 2005, DEV DYNAM, V233, P1315, DOI 10.1002/dvdy.20450; Palladino MA, 2003, NAT REV DRUG DISCOV, V2, P736, DOI 10.1038/nrd1175; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Scott DL, 2006, NEW ENGL J MED, V355, P704, DOI 10.1056/NEJMct055183; Torres D, 2005, AM J PATHOL, V167, P1677, DOI 10.1016/S0002-9440(10)61250-3; Tsakadze NL, 2006, J BIOL CHEM, V281, P3157, DOI 10.1074/jbc.M510797200; Zettl M, 2011, CELL, V145, P79, DOI 10.1016/j.cell.2011.02.047; Zou HF, 2009, FASEB J, V23, P425, DOI 10.1096/fj.08-112771	23	230	236	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 13	2012	335	6065					229	232		10.1126/science.1214448	http://dx.doi.org/10.1126/science.1214448			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875LZ	22246778	Green Accepted			2022-12-28	WOS:000299033100056
J	Midgley, GF				Midgley, Guy F.			Biodiversity and Ecosystem Function	SCIENCE			English	Editorial Material							SERVICES		[Midgley, Guy F.] S African Natl Biodivers Inst, ZA-7735 Cape Town, South Africa; [Midgley, Guy F.] Univ Kwazulu Natal, Sch Agr Earth & Environm Sci, ZA-3209 Scottsville, South Africa	South African National Biodiversity Institute; University of Kwazulu Natal	Midgley, GF (corresponding author), S African Natl Biodivers Inst, Rhodes Dr, ZA-7735 Cape Town, South Africa.	g.midgley@sanbi.org.za	Midgley, Guy F./H-3585-2014	Midgley, Guy F./0000-0001-8264-0869				Chapin FS, 1997, SCIENCE, V277, P500, DOI 10.1126/science.277.5325.500; Diaz S, 2006, PLOS BIOL, V4, P1300, DOI 10.1371/journal.pbio.0040277; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; Duraiappah A.K., 2005, ECOSYSTEMS HUMAN WEL; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; Maestre FT, 2012, SCIENCE, V335, P214, DOI 10.1126/science.1215442; Perrings C, 2011, SCIENCE, V331, P1139, DOI 10.1126/science.1202400	7	66	99	49	351	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 13	2012	335	6065					174	175		10.1126/science.1217245	http://dx.doi.org/10.1126/science.1217245			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875LZ	22246761				2022-12-28	WOS:000299033100037
J	Barrientos, MA; Carrasco, AU				Arango Barrientos, Marcos; Uriza Carrasco, Alfonso			Paragonimiasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Arango Barrientos, Marcos] Univ Antioquia Sch Med, Medellin, Colombia; [Uriza Carrasco, Alfonso] Hosp Univ San Vicente de Paul, Medellin, Colombia	Universidad de Antioquia	Barrientos, MA (corresponding author), Univ Antioquia Sch Med, Medellin, Colombia.								0	0	0	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 12	2012	366	2					165	165						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874VA	22236227				2022-12-28	WOS:000298985000011
J	Palese, P				Palese, Peter			Don't censor life-saving science	NATURE			English	Editorial Material									Mt Sinai Sch Med, Dept Microbiol, New York, NY USA	Icahn School of Medicine at Mount Sinai	Palese, P (corresponding author), Mt Sinai Sch Med, Dept Microbiol, New York, NY USA.	peter.palese@mssm.edu		Palese, Peter/0000-0002-0337-5823				Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392	1	21	21	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 12	2012	481	7380					115	115		10.1038/481115a	http://dx.doi.org/10.1038/481115a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	874TO	22237069	Bronze			2022-12-28	WOS:000298981200004
J	Ben-Chetrit, E; Munter, G				Ben-Chetrit, Eli; Munter, Gabriel			Purple Urine Purple urine bag syndrome (PUBS)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Ben-Chetrit, Eli; Munter, Gabriel] Hebrew Univ Jerusalem, Sch Med, Shaare Zedek Med Ctr, Dept Internal Med, IL-91031 Jerusalem, Israel	Hebrew University of Jerusalem; Shaare Zedek Medical Center	Ben-Chetrit, E (corresponding author), Hebrew Univ Jerusalem, Sch Med, Shaare Zedek Med Ctr, Dept Internal Med, 12 Bayit St, IL-91031 Jerusalem, Israel.	elibc1@yahoo.com						BUIST NRM, 1978, LANCET, V1, P883; DEALLER SF, 1988, J CLIN MICROBIOL, V26, P2152, DOI 10.1128/JCM.26.10.2152-2156.1988; Lin HH, 2002, J INTERN MED TAIWAN, V13, P209; RAYMOND JR, 1988, SOUTHERN MED J, V81, P837, DOI 10.1097/00007611-198807000-00008; Rich MW, 1999, POSTGRAD MED, V105, P208, DOI 10.3810/pgm.1999.04.691; Su Fu-Hsiung, 2005, Chang Gung Med J, V28, P636; Wang IK, 2005, INTERNAL MED, V44, P859, DOI 10.2169/internalmedicine.44.859	7	6	6	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 11	2012	307	2					193	194		10.1001/jama.2011.1997	http://dx.doi.org/10.1001/jama.2011.1997			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	875NP	22235090				2022-12-28	WOS:000299038300031
J	Athauda, D; Leschziner, G				Athauda, Dilan; Leschziner, Guy			CASE REPORT A restless night's sleep	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LEGS-SYNDROME; DOUBLE-BLIND; AUGMENTATION; EPIDEMIOLOGY; ASSOCIATION; ROPINIROLE; DIAGNOSIS		[Athauda, Dilan; Leschziner, Guy] St Thomas Hosp, Dept Neurol, London SE1 7EH, England	Guy's & St Thomas' NHS Foundation Trust	Athauda, D (corresponding author), St Thomas Hosp, Dept Neurol, London SE1 7EH, England.	dilanathauda@doctors.org.uk		Athauda, Dilan/0000-0001-8594-2483				Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; Allen RP, 1996, SLEEP, V19, P205, DOI 10.1093/sleep/19.3.205; [Anonymous], 2003, Drug Ther Bull, V41, P81; Benes H, 1999, SLEEP, V22, P1073, DOI 10.1093/sleep/22.8.1073; Byrne Ruth, 2006, Neuropsychiatr Dis Treat, V2, P155, DOI 10.2147/nedt.2006.2.2.155; Chaudhuri KR, 2001, J NEUROL NEUROSUR PS, V71, P143, DOI 10.1136/jnnp.71.2.143; Chaudhuri KR, 2009, OXFORD NEUROLOGY LIB; Ekbom K, 2009, J INTERN MED, V266, P419, DOI 10.1111/j.1365-2796.2009.02159.x; Garcia-Borreguero D, 2005, NEUROLOGY, V64, pA42; Garcia-Borreguero D, 2007, SLEEP MED, V8, P520, DOI 10.1016/j.sleep.2007.03.022; Hening W, 2004, SLEEP MED, V5, P237, DOI 10.1016/j.sleep.2004.03.006; Hening WA, 2004, SLEEP, V27, P560, DOI 10.1093/sleep/27.3.560; Montagna P, 2007, NEUROL SCI, V28, pS61, DOI 10.1007/s10072-007-0739-7; Montplaisir J, 2000, EUR J NEUROL, V7, P27, DOI 10.1046/j.1468-1331.2000.0070s1027.x; Muzerengi S, 2006, INT J SLEEP DISORD, V1, P34; Paulus W, 2006, LANCET NEUROL, V5, P878, DOI 10.1016/S1474-4422(06)70576-2; Trenkwalder C, 2004, J NEUROL NEUROSUR PS, V75, P92; Trenkwalder C, 2008, SLEEP MED, V9, P572, DOI 10.1016/j.sleep.2007.07.020; Trenkwalder C, 2008, LANCET NEUROL, V7, P595, DOI 10.1016/S1474-4422(08)70112-1; Ulfberg J, 2001, MOVEMENT DISORD, V16, P1159, DOI 10.1002/mds.1209; WALTERS AS, 1995, MOVEMENT DISORD, V10, P634, DOI 10.1002/mds.870100517; Williams AM, 2009, CURR TREAT OPTION NE, V11, P327, DOI 10.1007/s11940-009-0036-2	22	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 9	2012	344								d8347	10.1136/bmj.d8347	http://dx.doi.org/10.1136/bmj.d8347			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877RV	22232536				2022-12-28	WOS:000299200900010
J	Czapran, A; Doherty, M; Haddon, A; Labib, M				Czapran, Adam; Doherty, Martin; Haddon, Angela; Labib, Mourad			Recurrent aspiration and upper lobe cavitation	LANCET			English	Editorial Material							MORBID-OBESITY; COMPLICATIONS		[Czapran, Adam] Russells Hall Hosp, Coronary Care Unit, Dudley DY1 2HQ, W Midlands, England; [Czapran, Adam; Doherty, Martin] Russells Hall Hosp, Dept Resp Med, Dudley DY1 2HQ, W Midlands, England; [Haddon, Angela; Labib, Mourad] Russells Hall Hosp, Dept Clin Biochem & Metab Med, Dudley DY1 2HQ, W Midlands, England	Russells Hall Hospital; Russells Hall Hospital; Russells Hall Hospital	Czapran, A (corresponding author), Russells Hall Hosp, Coronary Care Unit, Pensnett Rd, Dudley DY1 2HQ, W Midlands, England.	adamczapran@nhs.net						Alamoudi OS, 2006, OBES SURG, V16, P1685, DOI 10.1381/096089206779319329; Belachew M, 2002, OBES SURG, V12, P564, DOI 10.1381/096089202762252352; Chevallier JM, 2004, OBES SURG, V14, P407, DOI 10.1381/096089204322917954; Hofer M, 2007, OBES SURG, V17, P565, DOI 10.1007/s11695-007-9076-4; Matveychuk A, 2011, SCAND J INFECT DIS, V43, P313, DOI 10.3109/00365548.2010.541494	5	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 7	2012	379	9810					92	92		10.1016/S0140-6736(11)61517-1	http://dx.doi.org/10.1016/S0140-6736(11)61517-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	873WC	22196831				2022-12-28	WOS:000298913000041
J	Blackburn, TJ; Bowring, SA; Perron, JT; Mahan, KH; Dudas, FO; Barnhart, KR				Blackburn, Terrence J.; Bowring, Samuel A.; Perron, J. Taylor; Mahan, Kevin H.; Dudas, Francis O.; Barnhart, Katherine R.			An Exhumation History of Continents over Billion-Year Time Scales	SCIENCE			English	Article							THERMOCHRONOMETRY; AMERICA	The continental lithosphere contains the oldest and most stable structures on Earth, where fragments of ancient material have eluded destruction by tectonic and surface processes operating over billions of years. Although present-day erosion of these remnants is slow, a record of how they have uplifted, eroded, and cooled over Earth's history can provide insight into the physical properties of the continents and the forces operating to exhume them over geologic time. We constructed a continuous record of ancient lithosphere cooling with the use of uranium-lead (U-Pb) thermochronology on volcanically exhumed lower crustal fragments. Combining these measurements with thermal and Pb-diffusion models constrains the range of possible erosion histories. Measured U-Pb data are consistent with extremely low erosion rates persisting over time scales approaching the age of the continents themselves.	[Blackburn, Terrence J.; Bowring, Samuel A.; Perron, J. Taylor; Dudas, Francis O.] MIT, Cambridge, MA 02139 USA; [Mahan, Kevin H.; Barnhart, Katherine R.] Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA	Massachusetts Institute of Technology (MIT); University of Colorado System; University of Colorado Boulder	Blackburn, TJ (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	terrence@mit.edu	Perron, J. Taylor/D-8983-2012; Barnhart, Katherine/W-9803-2018	Perron, J. Taylor/0000-0002-0404-8701; Barnhart, Katherine/0000-0001-5682-455X; Mahan, Kevin/0000-0001-6858-2498; Blackburn, Terrence/0000-0003-0029-0709	EarthScope [EAR-0746205, EAR-0746246]; Division Of Earth Sciences [0746246] Funding Source: National Science Foundation	EarthScope(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank B. Hager, K. Burke, S. Hemming, and three anonymous referees for their constructive comments, and C. Hearn for contributions in sample collection. Supported by EarthScope grants EAR-0746205 (S. A. B.) and EAR-0746246 (K. H. M.). Previously unpublished U-Pb data are tabulated in table S1.	Barnhart K., 2011, THESIS U COLORADO BO; Blackburn T, 2011, CONTRIB MINERAL PETR, V162, P479, DOI 10.1007/s00410-011-0607-6; Braun J, 2002, EARTH PLANET SC LETT, V200, P331, DOI 10.1016/S0012-821X(02)00638-6; Braun J, 2010, NAT GEOSCI, V3, P825, DOI 10.1038/NGEO1020; Burdick S, 2008, SEISMOL RES LETT, V79, P384, DOI 10.1785/gssrl.79.3.384; Ehlers TA, 2003, EARTH PLANET SC LETT, V206, P1, DOI 10.1016/S0012-821X(02)01069-5; Fischer KM, 2002, NATURE, V417, P933, DOI 10.1038/nature00855; Forte AM, 2000, SCIENCE, V290, P1940, DOI 10.1126/science.290.5498.1940; Hearn BC, 2004, LITHOS, V77, P473, DOI 10.1016/j.lithos.2004.04.030; HOFFMAN PF, 1988, ANNU REV EARTH PL SC, V16, P543, DOI 10.1146/annurev.ea.16.050188.002551; Jordan T. H., 1988, J PETROL, P11; Mueller PA, 2002, GEOLOGY, V30, P127, DOI 10.1130/0091-7613(2002)030<0127:PCWTGF>2.0.CO;2; Portenga E, 2011, GSA TODAY, V21, P4, DOI DOI 10.1130/G111A.1; Reiners PW, 2003, NATURE, V426, P645, DOI 10.1038/nature02111; Rudnick R.L., 2004, TREATISE GEOCHEMISTR, P1, DOI DOI 10.1016/B0-08-043751-6/03016-4; Rudnick RL, 1998, CHEM GEOL, V145, P395, DOI 10.1016/S0009-2541(97)00151-4; Schmitz MD, 2003, CONTRIB MINERAL PETR, V144, P592, DOI 10.1007/s00410-002-0419-9; Yuan HY, 2010, NATURE, V466, P1063, DOI 10.1038/nature09332	18	40	40	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2012	335	6064					73	76		10.1126/science.1213496	http://dx.doi.org/10.1126/science.1213496			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872YA	22223803				2022-12-28	WOS:000298846200052
J	Lee, CH; Yuen, MMA; Chow, WS; Tso, AWK; Yeung, CK; Chan, JCY; Chau, CH; Lam, KSL				Lee, Chi-Ho; Yuen, Michele M. A.; Chow, Wing-Sun; Tso, Annette W. K.; Yeung, Chi-Keung; Chan, Johnny C. Y.; Chau, Chi-Hung; Lam, Karen S. L.			CASE REPORT A man with a blistering eruption and tuberculosis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEPATITIS-C VIRUS		[Lee, Chi-Ho; Yuen, Michele M. A.; Chow, Wing-Sun; Yeung, Chi-Keung; Chan, Johnny C. Y.; Lam, Karen S. L.] Queen Mary Hosp, Dept Med, Pokfulam, Hong Kong, Peoples R China; [Tso, Annette W. K.; Lam, Karen S. L.] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Chau, Chi-Hung] Grantham Hosp, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Lee, CH (corresponding author), Queen Mary Hosp, Dept Med, Pokfulam, Hong Kong, Peoples R China.	leechihopaul@gmail.com	Yeung, Keung Chi/M-8132-2014; Lee, Paul Chi-Ho/GZG-6173-2022; Hug, Balthasar L./G-1568-2010; Lee, Chi HO/AAS-7948-2021; Yeung, Chi Keung/L-4795-2013	Lee, Chi-Ho/0000-0002-7569-409X				Au W Y, 2005, Haematologica, V90, pECR18; Burns T, 2010, ROOKS TXB DERMATOLOG, V3; DECASTRO M, 1993, HEPATOLOGY, V17, P551, DOI 10.1002/hep.1840170405; FARGION S, 1992, HEPATOLOGY, V16, P1322, DOI 10.1002/hep.1840160603; FERRI C, 1993, EUR J CLIN INVEST, V23, P851, DOI 10.1111/j.1365-2362.1993.tb00741.x; Fung WK, 2001, HONG KONG DERMATOL V, V4, P152; MILLAR JW, 1980, BRIT J DIS CHEST, V74, P405, DOI 10.1016/0007-0971(80)90079-0; Murphy GM, 1999, BRIT J DERMATOL, V140, P573; Sassa S, 2006, BRIT J HAEMATOL, V135, P281, DOI 10.1111/j.1365-2141.2006.06289.x; Tan W C, 2007, Med J Malaysia, V62, P143; Yeh S W, 2003, Dermatol Ther, V16, P214, DOI 10.1046/j.1529-8019.2003.01631.x	11	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 6	2012	344								d8351	10.1136/bmj.d8351	http://dx.doi.org/10.1136/bmj.d8351			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874UJ	22228698	Green Submitted, Green Published			2022-12-28	WOS:000298983300007
J	Leung, J				Leung, Jeffrey			Controlling Hormone Action by Subversion and Deception	SCIENCE			English	Editorial Material							ACTIVATED PROTEIN-KINASES; ABSCISIC-ACID; ARABIDOPSIS; PHOSPHATASES; STRESS		Ctr Natl Rech Sci, Inst Sci Vegetal, Unite Propre Rech 2355, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Leung, J (corresponding author), Ctr Natl Rech Sci, Inst Sci Vegetal, Unite Propre Rech 2355, 1 Ave Terrasse,Batiment 23, F-91198 Gif Sur Yvette, France.	leung@isv.cnrs-gif.fr						Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Fujii H, 2009, P NATL ACAD SCI USA, V106, P8380, DOI 10.1073/pnas.0903144106; Joshi-Saha A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002164; Nishimura N, 2010, PLANT J, V61, P290, DOI 10.1111/j.1365-313X.2009.04054.x; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Soon FF, 2012, SCIENCE, V335, P85, DOI 10.1126/science.1215106; Umezawa T, 2009, P NATL ACAD SCI USA, V106, P17588, DOI 10.1073/pnas.0907095106; Vlad F, 2009, PLANT CELL, V21, P3170, DOI 10.1105/tpc.109.069179; Yoshida R, 2006, J BIOL CHEM, V281, P5310, DOI 10.1074/jbc.M509820200	10	0	1	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2012	335	6064					46	47		10.1126/science.1217667	http://dx.doi.org/10.1126/science.1217667			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872YA	22223797				2022-12-28	WOS:000298846200043
J	Bennett, WL; Odelola, OA; Wilson, LM; Bolen, S; Selvaraj, S; Robinson, KA; Bass, EB; Puhan, MA				Bennett, Wendy L.; Odelola, Olaide A.; Wilson, Lisa M.; Bolen, Shari; Selvaraj, Saranya; Robinson, Karen A.; Bass, Eric B.; Puhan, Milo A.			Evaluation of Guideline Recommendations on Oral Medications for Type 2 Diabetes Mellitus	ANNALS OF INTERNAL MEDICINE			English	Review							CLINICAL-PRACTICE GUIDELINES; CONSENSUS ALGORITHM; EUROPEAN-ASSOCIATION; MANAGEMENT; HYPERGLYCEMIA; ADJUSTMENT; INITIATION; STATEMENT; THERAPY; UPDATE	Background: Clinical practice guidelines have an important role in guiding choices among the numerous medications available to treat type 2 diabetes mellitus, but little is known about their quality. Purpose: To assess whether guidelines on oral medications for type 2 diabetes are consistent with a systematic review of the current evidence and whether the consistency of the guidelines depends on the quality of guideline development. Data Sources: MEDLINE, CINAHL, and guideline-specific databases were searched between July 2007 and August 2011, after the 2007 publication of a peer-reviewed systematic review on oral diabetes medications. Study Selection: Two reviewers independently screened citations to identify English-language guidelines on oral medications to treat type 2 diabetes that were applied in the United States, United Kingdom, and Canada. Data Extraction: Reviewers assessed whether the guidelines addressed and agreed with 7 evidence-based conclusions from the 2007 systematic review. Two reviewers independently rated guideline quality by using 2 domains from the Appraisal of Guidelines Research and Evaluation instrument. Data Synthesis: Of the 1000 screened citations, 11 guidelines met the inclusion criteria. Seven guidelines agreed with the conclusion that metformin is favored as the first-line agent. Ten guidelines agreed that thiazolidinediones are associated with higher rates of edema and congestive heart failure compared with other oral medications to treat type 2 diabetes. One guideline addressed no evidence-based conclusions, and 5 guidelines agreed with all 7 conclusions. The summary scores of the rigor of development (median, 28.6% [range, 16.7% to 100.0%]) and editorial independence (median, 75.0% [range, 8.3% to 100.0%]) domains varied greatly across guidelines. Guidelines that received higher quality scores contained more recommendations that were consistent with the evidence-based conclusions. Limitation: Only English-language guidelines targeting users in the United States, United Kingdom, and Canada that contained recommendations on oral medications were included. Conclusion: Not all practice guidelines on oral treatment of type 2 diabetes were consistent with available evidence from a systematic review. Guidelines judged to be of higher quality contained more recommendations consistent with evidence-based conclusions. The quality of guideline development processes varied substantially.	[Bennett, Wendy L.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; Albert Einstein Med Ctr, Philadelphia, PA 19141 USA; Case Western Reserve Univ, MetroHlth Med Ctr, Cleveland, OH 44106 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Yeshiva University; Case Western Reserve University; MetroHealth System	Bennett, WL (corresponding author), Johns Hopkins Univ, Sch Med, 2024 E Monument St,Room 2-611, Baltimore, MD 21205 USA.	wbennet5@jhmi.edu	Puhan, Milo/ABE-6298-2020	Puhan, Milo/0000-0003-4721-1879; Bennett, Wendy/0000-0001-9828-0706; Bass, Eric/0000-0001-9106-527X	AHRQ [290-02-0018]	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By contract 290-02-0018 from AHRQ.	Abrahamson M, 2007, CLIN GUIDELINE PHARM; ADA, 2011, DIABETES CARE S1, V34, pS1, DOI [10.2337/dc11-S001, DOI 10.2337/DC11-S001]; Al-Arouj M, 2010, DIABETES CARE, V33, P1895, DOI 10.2337/dc10-0896; Alexander GC, 2008, ARCH INTERN MED, V168, P2088, DOI 10.1001/archinte.168.19.2088; Appraisal of Guidelines Research and Evaluation Collaboration, 2010, APPR GUID RES EV COL; Bolen S., 2007, COMP EFFECTIVENESS S; Bolen S, 2007, ANN INTERN MED, V147, P386, DOI 10.7326/0003-4819-147-6-200709180-00178; Burgers JS, 2002, DIABETES CARE, V25, P1933, DOI 10.2337/diacare.25.11.1933; Canadian Diabetes Association Expert Panel Committee, 2008, CAN J DIABETES, V32, pS168; Centre for Clinical Practice at NICE, 2009, NICE SHORT CLIN GUID; Ceriello A, 2007, GUIDELINE MANAGEMENT; Ceriello A, 2008, NUTR METAB CARDIOVAS, V18, pS17, DOI 10.1016/j.numecd.2008.01.012; Choudhry NK, 2002, JAMA-J AM MED ASSOC, V287, P612, DOI 10.1001/jama.287.5.612; Cole Alan, 2009, Crit Pathw Cardiol, V8, P156, DOI 10.1097/HPC.0b013e3181c017e2; DEFRONZO RA, 1995, NEW ENGL J MED, V333, P541, DOI 10.1056/NEJM199508313330902; Ferket BS, 2010, ARCH INTERN MED, V170, P27, DOI 10.1001/archinternmed.2009.434; Field MJ, 1990, CLIN PRACTICE GUIDEL; Graham R, 2011, CLINICAL PRACTICE GUIDELINES WE CAN TRUST, P1; Grilli R, 2000, LANCET, V355, P103, DOI 10.1016/S0140-6736(99)02171-6; Guidelines International Network, 2011, INTR; Institute for Clinical Systems Improvement, 2007, SCI DOC OV; Institute for Clinical Systems Improvement, 2010, DIAGN MAN TYP 2 DIAB; Institute for Clinical Systems Improvement, 2009, DIAGN MAN TYP 2 DIAB; International Diabetes Federation Clinical Guidelines Task Force, 2003, GUID GUID GUID CLIN; Inzucchi S, 2010, DIABETES FACTS GUIDE; Inzucchi SE, 2011, DIABETES FACTS GUIDE; Inzucchi SE, 2009, DIABETES FACTS GUIDE; Joslin Clinical Oversight Committee, 2007, GUID CAR OLD AD DIAB; Joslin Clinical Oversight Committee, 2009, CLIN GUID PHARM MAN; Mann DM, 2009, ARCH INTERN MED, V169, P1718, DOI 10.1001/archinternmed.2009.296; *NAT COLL CTR CHRO, 2008, TYP 2 DIAB NAT CLIN; Nathan DM, 2008, DIABETOLOGIA, V51, P8, DOI 10.1007/s00125-007-0873-z; Nathan D, 2009, DIABETOLOGIA, V52, P17, DOI 10.1007/s00125-008-1157-y; Nathan DM, 2008, DIABETES CARE, V31, P173, DOI [10.2337/dc08-9016, 10.2337/dc08-0545]; Nathan DM, 2006, DIABETES CARE, V29, P1963, DOI 10.2337/dc06-9912; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Nathan DM, 2009, CLIN DIABETES, V27, P4, DOI DOI 10.2337/DIACLIN.27.1.4; National Collaborating Centre for Chronic Conditions and the Centre for Clinical Practice at NICE, 2009, NICE CLIN GUID; Rodbard HW, 2009, ENDOCR PRACT, V15, P540, DOI 10.4158/EP.15.6.540; Schunemann Holger J, 2006, Health Res Policy Syst, V4, P13, DOI 10.1186/1478-4505-4-13; Shaneyfelt TM, 2009, JAMA-J AM MED ASSOC, V301, P868, DOI 10.1001/jama.2009.225; Shiffman Richard N, 2005, BMC Med Inform Decis Mak, V5, P23, DOI 10.1186/1472-6947-5-23; Shorr RI, 1996, J AM GERIATR SOC, V44, P751, DOI 10.1111/j.1532-5415.1996.tb03729.x; Sniderman AD, 2009, JAMA-J AM MED ASSOC, V301, P429, DOI 10.1001/jama.2009.15; Stone MA, 2010, DIABETES RES CLIN PR, V87, P252, DOI 10.1016/j.diabres.2009.10.020; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Tricoci P, 2009, JAMA-J AM MED ASSOC, V301, P831, DOI 10.1001/jama.2009.205; U.S. Food and Drug Administration, 2000, SAF AL HUM MED PROD; U.S. Food and Drug Administration, 2011, RISK EV MIT STRAT	49	76	77	1	19	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 3	2012	156	1	1				27	U77		10.7326/0003-4819-156-1-201201030-00005	http://dx.doi.org/10.7326/0003-4819-156-1-201201030-00005			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	872VK	22213492				2022-12-28	WOS:000298837600004
J	Fingold, DR				Fingold, Diane R.			The Road Less Traveled	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Fingold, Diane R.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Fingold, Diane R.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Fingold, DR (corresponding author), Harvard Univ, Sch Med, Boston, MA 02215 USA.								0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2011	365	26					2449	2451		10.1056/NEJMp1111322	http://dx.doi.org/10.1056/NEJMp1111322			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	868SD	22204722				2022-12-28	WOS:000298544600003
J	Hutchinson, JR; Delmer, C; Miller, CE; Hildebrandt, T; Pitsillides, AA; Boyde, A				Hutchinson, John R.; Delmer, Cyrille; Miller, Charlotte E.; Hildebrandt, Thomas; Pitsillides, Andrew A.; Boyde, Alan			From Flat Foot to Fat Foot: Structure, Ontogeny, Function, and Evolution of Elephant "Sixth Toes"	SCIENCE			English	Article							AFRICAN; BIOMECHANICS; OSTEOLOGY; LIMB	Several groups of tetrapods have expanded sesamoid (small, tendon-anchoring) bones into digit-like structures ("predigits"), such as pandas' "thumbs." Elephants similarly have expanded structures in the fat pads of their fore- and hindfeet, but for three centuries these have been overlooked as mere cartilaginous curiosities. We show that these are indeed massive sesamoids that employ a patchy mode of ossification of a massive cartilaginous precursor and that the predigits act functionally like digits. Further, we reveal clear osteological correlates of predigit joint articulation with the carpals/tarsals that are visible in fossils. Our survey shows that basal proboscideans were relatively "flat-footed" (plantigrade), whereas early elephantiforms evolved the more derived "tip-toed" (subunguligrade) morphology, including the predigits and fat pad, of extant elephants. Thus, elephants co-opted sesamoid bones into a role as false digits and used them for support as they changed their foot posture.	[Hutchinson, John R.; Miller, Charlotte E.; Pitsillides, Andrew A.] Royal Vet Coll, Dept Vet Basic Sci, Hatfield AL9 7TA, Herts, England; [Hutchinson, John R.; Miller, Charlotte E.; Pitsillides, Andrew A.] Royal Vet Coll, Struct & Mot Lab, Hatfield AL9 7TA, Herts, England; [Hutchinson, John R.; Miller, Charlotte E.; Pitsillides, Andrew A.] Univ London Royal Vet Coll, Dept Vet Basic Sci, London NW1 0TU, England; [Hutchinson, John R.; Miller, Charlotte E.; Pitsillides, Andrew A.] Univ London Royal Vet Coll, Struct & Mot Lab, London NW1 0TU, England; [Delmer, Cyrille] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; [Hildebrandt, Thomas] Leibniz Inst Zoo & Wildlife Res, Forsch Verbund Berlin eV, D-10252 Berlin, Germany; [Boyde, Alan] Queen Mary Univ London, Barts & London Sch Med & Dent, London E1 4NS, England	University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College; Natural History Museum London; Leibniz Institut fur Zoo und Wildtierforschung; University of London; Queen Mary University London	Hutchinson, JR (corresponding author), Royal Vet Coll, Dept Vet Basic Sci, Hatfield AL9 7TA, Herts, England.		Miller, Charlotte/ABH-5780-2020; Hutchinson, John/AAH-1593-2020	Hutchinson, John/0000-0002-6767-7038; Miller, Charlotte E/0000-0002-8428-8392	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/C516844/1, BB/H002782/1]; Arthritis Research UK; Veterinary Advisory Committee of the UK Horserace Betting Levy Board; BBSRC [BB/H002782/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H002782/1, BB/C516844/1] Funding Source: researchfish; Versus Arthritis [18768] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Arthritis Research UK(Versus Arthritis); Veterinary Advisory Committee of the UK Horserace Betting Levy Board; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Versus Arthritis(Versus Arthritis)	We thank the staff of the Structure and Motion Laboratory of the Royal Veterinary College for assistance and three anonymous reviewers for constructive criticism. Many individuals assisted with the collection of the cadaveric data; we particularly thank the European-based zoos that provided the specimens and G. Fritsch for CT scans done in Germany. O. Cosar, R. Weller, A. Wilson, and K. Jespers assisted with the ex vivo loading experiments. J. Molnar assisted with Figs. 1 to 4 and the movies. This project was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) (grants BB/C516844/1 and BB/H002782/1 to J. R. H.). Additionally, A. A. P. appreciates funding from Arthritis Research UK and the BBSRC, and A. B. was supported by the Veterinary Advisory Committee of the UK Horserace Betting Levy Board. The data reported in this paper are tabulated in the SOM. The authors declare no conflicts of interest.	BIEWENER AA, 1990, SCIENCE, V250, P1097, DOI 10.1126/science.2251499; Blair Patrick, 1710, PHILOS T, V27, P53, DOI [10.1098/rstl.1710.0008, DOI 10.1098/RSTL.1710.0008]; Bonnan MF, 2005, LIFE O PAST, P346; Boyde A, 1999, CALCIFIED TISSUE INT, V64, P185, DOI 10.1007/s002239900600; CARRIER DR, 1994, SCIENCE, V265, P651, DOI 10.1126/science.8036513; Clifford AB, 2010, J VERTEBR PALEONTOL, V30, P1827, DOI 10.1080/02724634.2010.521216; Court Nicholas, 1993, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V226, P125; Davis D. D., 1964, Fieldiana Zoology Memoir, V3, P1; Delmer C, 2009, ACTA PALAEONTOL POL, V54, P561, DOI 10.4202/app.2007.0036; Endo H, 1999, J ANAT, V195, P295, DOI 10.1046/j.1469-7580.1999.19520295.x; Fabrezi M, 2001, ZOOL J LINN SOC-LOND, V131, P227, DOI 10.1006/zjls.2000.0234; Galis F, 2001, TRENDS ECOL EVOL, V16, P637, DOI 10.1016/S0169-5347(01)02289-3; Gheerbrant E, 2009, CR PALEVOL, V8, P281, DOI 10.1016/j.crpv.2008.08.003; Gheerbrant E, 2009, P NATL ACAD SCI USA, V106, P10717, DOI 10.1073/pnas.0900251106; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; GOULD SJ, 1978, NAT HIST, V87, P20; Hutchinson JR, 2008, ANATOMICAL IMAGING: TOWARDS A NEW MORPHOLOGY, P23, DOI 10.1007/978-4-431-76933-0_3; Lieberman DE, 2010, NATURE, V463, P531, DOI 10.1038/nature08723; Michilsens F, 2009, J ZOOL, V279, P236, DOI 10.1111/j.1469-7998.2009.00611.x; Miller CE, 2008, J R SOC INTERFACE, V5, P465, DOI 10.1098/rsif.2007.1220; Mitgutsch C, 2012, BIOL LETTERS, V8, P74, DOI 10.1098/rsbl.2011.0494; Neuville H., 1935, Arch Mus Paris (6), V13, P111; Prochel J, 2004, J ANAT, V205, P99, DOI 10.1111/j.0021-8782.2004.00321.x; Sanchez-Villagra MR, 2005, ZOOLOGY, V108, P3, DOI 10.1016/j.zool.2004.07.006; Scholz MN, 2008, J EXP BIOL, V211, P3266, DOI 10.1242/jeb.018812; SMUTS MMS, 1993, ONDERSTEPOORT J VET, V60, P1; SMUTS MMS, 1994, ONDERSTEPOORT J VET, V61, P51; von Bardeleben K., 1894, P ZOOL SOC LOND, V1894, P354; Weissengruber GE, 2006, J ANAT, V209, P781, DOI 10.1111/j.1469-7580.2006.00648.x	29	52	52	2	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1699	1703		10.1126/science.1211437	http://dx.doi.org/10.1126/science.1211437			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22194576	Green Published			2022-12-28	WOS:000298344000066
J	Iijima, T; Wu, KR; Witte, H; Hanno-Iijima, Y; Glatter, T; Richard, S; Scheiffele, P				Iijima, Takatoshi; Wu, Karen; Witte, Harald; Hanno-Iijima, Yoko; Glatter, Timo; Richard, Stephane; Scheiffele, Peter			SAM68 Regulates Neuronal Activity-Dependent Alternative Splicing of Neurexin-1	CELL			English	Article							RNA-BINDING PROTEIN; SYNAPSE DEVELOPMENT; ALPHA-NEUREXINS; STRUCTURAL BASIS; BETA-NEUREXINS; GRANULE CELLS; KINASE; RECEPTOR; PHOSPHORYLATION; CEREBELLUM	The assembly of synapses and neuronal circuits relies on an array of molecular recognition events and their modification by neuronal activity. Neurexins are a highly polymorphic family of synaptic receptors diversified by extensive alternative splicing. Neurexin variants exhibit distinct isoform-specific biochemical interactions and synapse assembly functions, but the mechanisms governing splice isoform choice are not understood. We demonstrate that Nrxn1 alternative splicing is temporally and spatially controlled in the mouse brain. Neuronal activity triggers a shift in Nrxn1 splice isoform choice via calcium/calmodulin-dependent kinase IV signaling. Activity-dependent alternative splicing of Nrxn1 requires the KH-domain RNA-binding protein SAM68 that associates with RNA response elements in the Nrxn1 pre-mRNA. Our findings uncover SAM68 as a key regulator of dynamic control of Nrxn1 molecular diversity and activity-dependent alternative splicing in the central nervous system.	[Iijima, Takatoshi; Witte, Harald; Hanno-Iijima, Yoko; Glatter, Timo; Scheiffele, Peter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Wu, Karen; Scheiffele, Peter] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Wu, Karen; Scheiffele, Peter] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Richard, Stephane] McGill Univ, Segal Canc Ctr, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Richard, Stephane] McGill Univ, Dept Oncol, Montreal, PQ H3T 1E2, Canada; [Richard, Stephane] McGill Univ, Dept Med, Montreal, PQ H3T 1E2, Canada	University of Basel; Columbia University; Columbia University; Lady Davis Institute; McGill University; McGill University; McGill University	Scheiffele, P (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	peter.scheiffele@unibas.ch		Glatter, Timo/0000-0001-8716-8516; Scheiffele, Peter/0000-0002-9516-9399	Jane Coffin Childs Fund; Uehara Memorial Foundation; KANAE Foundation for the Promotion of Medical Science; Astellas Foundation for Research on Metabolic Disorders; Canadian Institutes of Health Research; NINDS [R21 NS53936]; Swiss National Science Foundation; Kanton Basel-Stadt; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS053936] Funding Source: NIH RePORTER	Jane Coffin Childs Fund; Uehara Memorial Foundation(Uehara Memorial Foundation); KANAE Foundation for the Promotion of Medical Science; Astellas Foundation for Research on Metabolic Disorders; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Kanton Basel-Stadt; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to Dr. Jane Dodd for generously sharing lab space and resources, to Dr. Leora Gollan who contributed initial findings, to Drs. Yves Barde, Olivier Pertz, Oguz Kanca, Stephane Baudouin, and Thi-Minh-Phuc Nguyen for comments on the manuscript, to Drs. Boukhtouche, Cocas, and Sommer and Ms. Stiefvater for help with in utero electroporations, to Dr. Alex Schmidt for help with proteomics, to Laetitia Burkle and Caroline Bornmann for excellent technical support, to Prof. Michisuke Yuzaki for advice and for generously sharing a GluD2 expression vector, to Dr. Kyo-ichi Emi for advice on cerebellar injections, and to Gillian Vogel and members of the Scheiffele Lab for valuable discussions. We thank Drs. Chabot, Darnell, Ghosh, Konig, Smith, Sette, and Soderling and the Developmental Studies Hybridoma Bank, University of Iowa, for making important reagents available. K. W. is the recipient of a Jane Coffin Childs Fund postdoctoral fellowship award. T. I. was supported by the Uehara Memorial Foundation, KANAE Foundation for the Promotion of Medical Science and Astellas Foundation for Research on Metabolic Disorders. S. R. is funded by the Canadian Institutes of Health Research, and the project was funded by support to P.S. from NINDS (R21 NS53936), the Swiss National Science Foundation, and the Kanton Basel-Stadt.	An P, 2007, PLOS BIOL, V5, P263, DOI 10.1371/journal.pbio.0050036; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; Baudouin S, 2010, CELL, V141, P908, DOI 10.1016/j.cell.2010.05.024; Bingol B, 2011, NEURON, V69, P22, DOI 10.1016/j.neuron.2010.11.006; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Boutz PL, 2007, GENE DEV, V21, P1636, DOI 10.1101/gad.1558107; Chawla G, 2009, MOL CELL BIOL, V29, P201, DOI 10.1128/MCB.01349-08; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Di Fruscio M, 1999, P NATL ACAD SCI USA, V96, P2710, DOI 10.1073/pnas.96.6.2710; Fisette JF, 2010, RNA, V16, P228, DOI 10.1261/rna.1890310; Galarneau A, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-47; Grange J, 2004, J NEUROSCI RES, V75, P654, DOI 10.1002/jnr.20003; Henao-Mejia J, 2009, MOL CELL, V33, P87, DOI 10.1016/j.molcel.2008.11.024; Huang ZJ, 2008, CURR OPIN NEUROBIOL, V18, P77, DOI 10.1016/j.conb.2008.05.008; Huot ME, 2009, MOL CELL BIOL, V29, P1933, DOI 10.1128/MCB.01707-08; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Iijima T, 2009, J NEUROSCI, V29, P5425, DOI 10.1523/JNEUROSCI.4473-08.2009; Kang YH, 2008, J BIOL CHEM, V283, P2323, DOI 10.1074/jbc.M703957200; Kim KK, 2009, J BIOL CHEM, V284, P31052, DOI 10.1074/jbc.M109.052969; Koehnke J, 2010, NEURON, V67, P61, DOI 10.1016/j.neuron.2010.06.001; Lee JA, 2007, PLOS BIOL, V5, P281, DOI 10.1371/journal.pbio.0050040; Li J, 2007, NEURON, V55, P741, DOI 10.1016/j.neuron.2007.08.002; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Lin Q, 1997, J BIOL CHEM, V272, P27274, DOI 10.1074/jbc.272.43.27274; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Lukong KE, 2008, BEHAV BRAIN RES, V189, P357, DOI 10.1016/j.bbr.2008.01.010; Matsuda K, 2011, EUR J NEUROSCI, V33, P1447, DOI 10.1111/j.1460-9568.2011.07638.x; Matsuda K, 2010, SCIENCE, V328, P363, DOI 10.1126/science.1185152; Matter N, 2002, NATURE, V420, P691, DOI 10.1038/nature01153; Mellor JR, 1998, J NEUROSCI, V18, P2822; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; OHMSTEDE CA, 1989, J BIOL CHEM, V264, P5866; Paronetto MP, 2007, J CELL BIOL, V176, P929, DOI 10.1083/jcb.200701005; Reissner C, 2008, P NATL ACAD SCI USA, V105, P15124, DOI 10.1073/pnas.0801639105; Resnick M, 2008, NEUROSCI LETT, V439, P235, DOI 10.1016/j.neulet.2008.05.034; Richard S, 2005, PLOS GENET, V1, P676, DOI 10.1371/journal.pgen.0010074; Rossi P, 1998, J NEUROSCI, V18, P3537; Rowen L, 2002, GENOMICS, V79, P587, DOI 10.1006/geno.2002.6734; Rozic G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018579; Rozic-Kotliroff G, 2007, BIOCHEM BIOPH RES CO, V352, P226, DOI 10.1016/j.bbrc.2006.11.008; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Selenko P, 2003, MOL CELL, V11, P965, DOI 10.1016/S1097-2765(03)00115-1; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Stoss O, 2004, MOL CELL NEUROSCI, V27, P8, DOI 10.1016/j.mcn.2004.04.011; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; Tisserant A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001418; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; Valacca C, 2010, J CELL BIOL, V191, P87, DOI 10.1083/jcb.201001073; Volk T, 2008, TRENDS GENET, V24, P94, DOI 10.1016/j.tig.2007.11.009; Wang X, 1999, EMBO J, V18, P4549, DOI 10.1093/emboj/18.16.4549; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Xie JY, 2001, NATURE, V410, P936, DOI 10.1038/35073593; Xie JY, 2005, RNA, V11, P1825, DOI 10.1261/rna.2171205; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108	68	190	195	1	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 23	2011	147	7					1601	1614		10.1016/j.cell.2011.11.028	http://dx.doi.org/10.1016/j.cell.2011.11.028			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	866SP	22196734	Green Accepted, Bronze			2022-12-28	WOS:000298403400023
J	Karpova, NN; Pickenhagen, A; Lindholm, J; Tiraboschi, E; Kulesskaya, N; Agustsdottir, A; Antila, H; Popova, D; Akamine, Y; Sullivan, R; Hen, R; Drew, LJ; Castren, E				Karpova, Nina N.; Pickenhagen, Anouchka; Lindholm, Jesse; Tiraboschi, Ettore; Kulesskaya, Natalia; Agustsdottir, Arna; Antila, Hanna; Popova, Dina; Akamine, Yumiko; Sullivan, Regina; Hen, Rene; Drew, Liam J.; Castren, Eero			Fear Erasure in Mice Requires Synergy Between Antidepressant Drugs and Extinction Training	SCIENCE			English	Article							PERINEURONAL NETS; PLASTICITY; PHARMACOTHERAPY; MECHANISMS; MATURATION; DEPRESSION; MEMORIES; CIRCUITS; BDNF	Antidepressant drugs and psychotherapy combined are more effective in treating mood disorders than either treatment alone, but the neurobiological basis of this interaction is unknown. To investigate how antidepressants influence the response of mood-related systems to behavioral experience, we used a fear-conditioning and extinction paradigm in mice. Combining extinction training with chronic fluoxetine, but neither treatment alone, induced an enduring loss of conditioned fear memory in adult animals. Fluoxetine treatment increased synaptic plasticity, converted the fear memory circuitry to a more immature state, and acted through local brain-derived neurotrophic factor. Fluoxetine-induced plasticity may allow fear erasure by extinction-guided remodeling of the memory circuitry. Thus, the pharmacological effects of antidepressants need to be combined with psychological rehabilitation to reorganize networks rendered more plastic by the drug treatment.	[Karpova, Nina N.; Lindholm, Jesse; Tiraboschi, Ettore; Kulesskaya, Natalia; Agustsdottir, Arna; Antila, Hanna; Popova, Dina; Akamine, Yumiko; Castren, Eero] Univ Helsinki, Ctr Neurosci, Sigrid Juselius Lab, FIN-00014 Helsinki, Finland; [Lindholm, Jesse] Univ Helsinki, Dept Biosci & Physiol, FIN-00014 Helsinki, Finland; [Pickenhagen, Anouchka; Sullivan, Regina] NYU, Med Ctr, Emot Brain Inst Nathan Kline Inst, New York, NY 10016 USA; [Hen, Rene; Drew, Liam J.; Castren, Eero] Columbia Univ, Dept Psychiat & Neurosci, New York, NY 10032 USA	Sigrid Juselius Foundation; University of Helsinki; University of Helsinki; Nathan Kline Institute for Psychiatric Research; New York University; Columbia University	Castren, E (corresponding author), Univ Helsinki, Ctr Neurosci, Sigrid Juselius Lab, FIN-00014 Helsinki, Finland.	eero.castren@helsinki.fi	Karpova, Nina/L-6724-2013	Karpova, Nina/0000-0002-3197-4559; BAHI, Amine/0000-0003-2873-2249; Castren, Eero/0000-0002-1402-2791; Sullivan, Regina Marie/0000-0002-2406-8857; Antila, Hanna/0000-0001-8317-4564; Tiraboschi, Ettore/0000-0001-6872-6738; Akamine, Yumiko/0000-0002-3950-2572; Kulesskaya, Natalia/0000-0001-5517-8525	Sigrid Juselius Foundation; Academy of Finland Center of Excellence; NIH [DC003906, NIH-DC009910]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003906, R01DC009910] Funding Source: NIH RePORTER	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland Center of Excellence(Academy of Finland); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank O. Nikkila, T. Rantamaki, V. Voikar, and M. Kislin for technical help; Jean-Luc Dreyer for the gift of BDNF lentivirus; F. Battaglia for help with electrophysiology; C. Rivera for the KCC2 antibody; and J. Sallinen, Orion Pharma, for the gift of fluoxetine. E. C. is a shareholder of Hermo Pharma, Incorporated. This work was supported by Sigrid Juselius Foundation and Academy of Finland Center of Excellence program (E. C.) and NIH grants DC003906 and NIH-DC009910 (R.M.S.).	Balmer TS, 2009, J NEUROSCI, V29, P12878, DOI 10.1523/JNEUROSCI.2974-09.2009; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI 10.1038/nrdp.2016.65; Bisson J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003388.pub3; Castren E, 2005, NAT REV NEUROSCI, V6, P241, DOI 10.1038/nrn1629; Castren E, 2010, DEV NEUROBIOL, V70, P289, DOI 10.1002/dneu.20758; Deschaux O, 2011, PSYCHOPHARMACOLOGY, V215, P231, DOI 10.1007/s00213-010-2134-y; Drephal C, 2006, NEUROBIOL LEARN MEM, V85, P272, DOI 10.1016/j.nlm.2005.11.004; Gascon E, 2007, BRAIN RES REV, V56, P101, DOI 10.1016/j.brainresrev.2007.05.014; Gogolla N, 2009, SCIENCE, V325, P1258, DOI 10.1126/science.1174146; Herry C, 2010, EUR J NEUROSCI, V31, P599, DOI 10.1111/j.1460-9568.2010.07101.x; Hetrick SE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007316.pub2; Holmes A, 2010, TRENDS PHARMACOL SCI, V31, P2, DOI 10.1016/j.tips.2009.10.003; Kim JH, 2010, BIOL PSYCHIAT, V67, P297, DOI 10.1016/j.biopsych.2009.09.003; Kobayashi K, 2010, P NATL ACAD SCI USA, V107, P8434, DOI 10.1073/pnas.0912690107; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Mahan AL, 2012, TRENDS NEUROSCI, V35, P24, DOI 10.1016/j.tins.2011.06.007; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; Milad MR, 2006, BIOL PSYCHOL, V73, P61, DOI 10.1016/j.biopsycho.2006.01.008; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; Pampallona S, 2004, ARCH GEN PSYCHIAT, V61, P714, DOI 10.1001/archpsyc.61.7.714; Peters J, 2010, SCIENCE, V328, P1288, DOI 10.1126/science.1186909; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Saarelainen T, 2003, J NEUROSCI, V23, P349; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; Soliman F, 2010, SCIENCE, V327, P863, DOI 10.1126/science.1181886; Stein DJ, 2009, CNS SPECTRUMS, V14, P25; Sullivan RM, 2000, NATURE, V407, P38, DOI 10.1038/35024156; Walker DL, 2002, J NEUROSCI, V22, P2343, DOI 10.1523/JNEUROSCI.22-06-02343.2002; Wang JW, 2008, J NEUROSCI, V28, P1374, DOI 10.1523/JNEUROSCI.3632-07.2008; Yehuda R, 2007, NEURON, V56, P19, DOI 10.1016/j.neuron.2007.09.006	31	254	262	0	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1731	1734		10.1126/science.1214592	http://dx.doi.org/10.1126/science.1214592			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22194582	Green Accepted			2022-12-28	WOS:000298344000075
J	Ulitsky, I; Shkumatava, A; Jan, CH; Sive, H; Bartel, DP				Ulitsky, Igor; Shkumatava, Alena; Jan, Calvin H.; Sive, Hazel; Bartel, David P.			Conserved Function of lincRNAs in Vertebrate Embryonic Development despite Rapid Sequence Evolution	CELL			English	Article							LONG NONCODING RNAS; GENOME DUPLICATION; CHROMATIN STATE; GENE-EXPRESSION; TELEOST FISH; ZEBRAFISH; REVEALS; CELLS; DIFFERENTIATION; MAMMALS	Thousands of long intervening noncoding RNAs (lincRNAs) have been identified in mammals. To better understand the evolution and functions of these enigmatic RNAs, we used chromatin marks, poly(A)-site mapping and RNA-Seq data to identify more than 550 distinct lincRNAs in zebrafish. Although these shared many characteristics with mammalian lincRNAs, only 29 had detectable sequence similarity with putative mammalian orthologs, typically restricted to a single short region of high conservation. Other lincRNAs had conserved genomic locations without detectable sequence conservation. Antisense reagents targeting conserved regions of two zebrafish lincRNAs caused developmental defects. Reagents targeting splice sites caused the same defects and were rescued by adding either the mature lincRNA or its human or mouse ortholog. Our study provides a roadmap for identification and analysis of lincRNAs in model organisms and shows that lincRNAs play crucial biological roles during embryonic development with functionality conserved despite limited sequence conservation.	[Ulitsky, Igor; Shkumatava, Alena; Jan, Calvin H.; Sive, Hazel; Bartel, David P.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Ulitsky, Igor; Shkumatava, Alena; Jan, Calvin H.; Bartel, David P.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Ulitsky, Igor; Shkumatava, Alena; Jan, Calvin H.; Sive, Hazel; Bartel, David P.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Bartel, DP (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dbartel@wi.mit.edu	Ulitsky, Igor/HCH-7453-2022	Ulitsky, Igor/0000-0003-0555-6561; Sive, Hazel/0000-0002-4890-424X	NIH [GM067031]; EMBO; Human Frontiers Science Program; NSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067031] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO(European Molecular Biology Organization (EMBO)); Human Frontiers Science Program(Human Frontier Science Program); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank V. Auyeung, O. Rissland, I. Drinnenberg, R. Shalgi, S. Hong, and D. Garcia for comments on the manuscript; T. DiCesare for illustration; M. Guenther for help with the ChIP-Seq protocol; WI genome technology core for sequencing and W. Johnston, O. Paugois and G. Lafkas for technical support. The Tg(neurod:egfp) transgenic line was kindly provided by the Nicolson lab. RNA-Seq data was kindly made available by the Wellcome Trust Sanger Institute. This work was supported by a grant (GM067031) from the NIH (D.P.B.), an EMBO long-term fellowship (I.U.), a Human Frontiers Science Program long-term fellowship (A.S.), and an NSF predoctoral fellowship (C.H.J.).	Aanes H, 2011, GENOME RES, V21, P1328, DOI 10.1101/gr.116012.110; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Bill BR, 2009, ZEBRAFISH, V6, P69, DOI 10.1089/zeb.2008.0555; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chodroff RA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r72; Choi WY, 2007, SCIENCE, V318, P271, DOI 10.1126/science.1147535; Chooniedass-Kothari S, 2004, FEBS LETT, V566, P43, DOI 10.1016/j.febslet.2004.03.104; De Lucia F, 2011, CURR OPIN PLANT BIOL, V14, P168, DOI 10.1016/j.pbi.2010.11.006; Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; Duret L, 2006, SCIENCE, V312, P1653, DOI 10.1126/science.1126316; Guenther MG, 2008, GENE DEV, V22, P3403, DOI 10.1101/gad.1741408; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; He S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-102; Heasman J, 2000, DEV BIOL, V222, P124, DOI 10.1006/dbio.2000.9720; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hube F, 2006, DNA CELL BIOL, V25, P418, DOI 10.1089/dna.2006.25.418; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Jia H, 2010, RNA, V16, P1478, DOI 10.1261/rna.1951310; Jouannet V, 2011, PROG MOL SUBCELL BIO, V51, P179, DOI 10.1007/978-3-642-16502-3_9; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kolasinska-Zwierz P., 2009, NAT GENET, V41, P376; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Marques AC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r124; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nakagawa S, 2011, J CELL BIOL, V193, P31, DOI 10.1083/jcb.201011110; Obholzer N, 2008, J NEUROSCI, V28, P2110, DOI 10.1523/JNEUROSCI.5230-07.2008; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Ponjavic J, 2007, GENOME RES, V17, P556, DOI 10.1101/gr.6036807; Ponjavic J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000617; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sarma Kavitha, 2010, Proc Natl Acad Sci U S A, V107, P22196, DOI 10.1073/pnas.1009785107; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Semon M, 2007, MOL BIOL EVOL, V24, P860, DOI 10.1093/molbev/msm003; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Stadler P.F., 2010, ADV BIOINFORMATICS C; Taher L, 2009, BIOINFORMATICS, V25, P578, DOI 10.1093/bioinformatics/btp043; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wilusz JE, 2008, CELL, V135, P919, DOI 10.1016/j.cell.2008.10.012; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	57	847	898	3	109	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2011	147	7					1537	1550		10.1016/j.cell.2011.11.055	http://dx.doi.org/10.1016/j.cell.2011.11.055			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	866SP	22196729	Green Accepted, Green Submitted, Green Published, Bronze			2022-12-28	WOS:000298403400018
J	Angus, DC				Angus, Derek C.			The Search for Effective Therapy for Sepsis Back to the Drawing Board?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Angus, DC (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, 3550 Terrace St,604 Scaife Hall, Pittsburgh, PA 15261 USA.	angusdc@upmc.edu	Angus, Derek C/E-9671-2012					Angus DC, 2010, JAMA-J AM MED ASSOC, V304, P1833, DOI 10.1001/jama.2010.1546; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Beutler BA, NOBEL PRIZE PHYSL ME; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Kellum JA, 2007, ARCH INTERN MED, V167, P1655, DOI 10.1001/archinte.167.15.1655; Levy MM, 2010, CRIT CARE MED, V38, P367, DOI 10.1097/CCM.0b013e3181cb0cdc; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Matsuyama K, EISAIS SEPSIS DRUG E; van der Poll T, 2008, LANCET INFECT DIS, V8, P32, DOI 10.1016/S1473-3099(07)70265-7; XIGRIS DROTRECOGIN A	10	186	199	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 21	2011	306	23					2614	2615		10.1001/jama.2011.1853	http://dx.doi.org/10.1001/jama.2011.1853			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	864YQ	22187284				2022-12-28	WOS:000298276800026
J	Lingegowda, V				Lingegowda, Vijaykumar			Review: Intensive glucose lowering does not reduce mortality in type 2 diabetes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Srishti Med Ctr, Mysore, Karnataka, India		Lingegowda, V (corresponding author), Srishti Med Ctr, Mysore, Karnataka, India.							Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795	4	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2011	155	12							JC6-4	10.7326/0003-4819-155-12-201112200-02004	http://dx.doi.org/10.7326/0003-4819-155-12-201112200-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	864ZU	22184705				2022-12-28	WOS:000298280500003
J	Walker, J; Leveille, SG; Ngo, L; Vodicka, E; Darer, JD; Dhanireddy, S; Elmore, JG; Feldman, HJ; Lichtenfeld, MJ; Oster, N; Ralston, JD; Ross, SE; Delbanco, T				Walker, Jan; Leveille, Suzanne G.; Ngo, Long; Vodicka, Elisabeth; Darer, Jonathan D.; Dhanireddy, Shireesha; Elmore, Joann G.; Feldman, Henry J.; Lichtenfeld, Marc J.; Oster, Natalia; Ralston, James D.; Ross, Stephen E.; Delbanco, Tom			Inviting Patients to Read Their Doctors' Notes: Patients and Doctors Look Ahead Patient and Physician Surveys	ANNALS OF INTERNAL MEDICINE			English	Article							ELECTRONIC MEDICAL-RECORD; CONGESTIVE-HEART-FAILURE; PERSONAL HEALTH RECORDS; RANDOMIZED-TRIAL; CARE; COMMUNICATION; EXPERIENCES; ACCESS	Background: Little is known about what primary care physicians (PCPs) and patients would expect if patients were invited to read their doctors' office notes. Objective: To explore attitudes toward potential benefits or harms if PCPs offered patients ready access to visit notes. Design: The PCPs and patients completed surveys before joining a voluntary program that provided electronic links to doctors' notes. Setting: Primary care practices in 3 U.S. states. Participants: Participating and nonparticipating PCPs and adult patients at primary care practices in Massachusetts, Pennsylvania, and Washington. Measurements: Doctors' and patients' attitudes toward and expectations of open visit notes, their ideas about the potential benefits and risks, and demographic characteristics. Results: 110 of 114 participating PCPs (96%), 63 of 140 nonparticipating PCPs (45%), and 37 856 of 90 203 patients (42%) completed surveys. Overall, 69% to 81% of participating PCPs across the 3 sites and 92% to 97% of patients thought open visit notes were a good idea, compared with 16% to 33% of nonparticipating PCPs. Similarly, participating PCPs and patients generally agreed with statements about potential benefits of open visit notes, whereas nonparticipating PCPs were less likely to agree. Among participating PCPs, 74% to 92% anticipated improved communication and patient education, in contrast to 45% to 67% of non-participating PCPs. More than one half of participating PCPs (50% to 58%) and most nonparticipating PCPs (88% to 92%) expected that open visit notes would result in greater worry among patients; far fewer patients concurred (12% to 16%). Thirty-six percent to 50% of participating PCPs and 83% to 84% of nonparticipating PCPs anticipated more patient questions between visits. Few PCPs (0% to 33%) anticipated increased risk for lawsuits. Patient enthusiasm extended across age, education, and health status, and 22% anticipated sharing visit notes with others, including other doctors. Limitations: Access to electronic patient portals is not widespread, and participation was limited to patients using such portals. Response rates were higher among participating PCPs than nonparticipating PCPs; many participating PCPs had small patient panels. Conclusion: Among PCPs, opinions about open visit notes varied widely in terms of predicting the effect on their practices and benefits for patients. In contrast, patients expressed considerable enthusiasm and few fears, anticipating both improved understanding and more involvement in care. Sharing visit notes has broad implications for quality of care, privacy, and shared accountability.	[Walker, Jan] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; Univ Massachusetts, Coll Nursing & Hlth Sci, Boston, MA 02125 USA; Geisinger Hlth Syst, Danville, PA USA; Univ Washington, Harborview Med Ctr, Sch Med, Seattle, WA 98104 USA; Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; Univ Colorado, Hlth Sci Ctr, Aurora, CO USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Massachusetts System; University of Massachusetts Boston; Geisinger Health System; Harborview Medical Center; University of Washington; University of Washington Seattle; Group Health Cooperative; University of Colorado System; University of Colorado Anschutz Medical Campus	Walker, J (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, 330 Brookline Ave, Boston, MA 02215 USA.	jwalker1@bidmc.harvard.edu	Leveille, Suzanne G/ACS-6588-2022	Leveille, Suzanne G/0000-0003-0427-1580	Robert Wood Johnson Foundation's Pioneer Portfolio [65921]; Drane Family Fund; Koplow Charitable Foundation; NATIONAL CANCER INSTITUTE [K05CA104699] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025014] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation's Pioneer Portfolio(Robert Wood Johnson Foundation (RWJF)); Drane Family Fund; Koplow Charitable Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Grant Support: By The Robert Wood Johnson Foundation's Pioneer Portfolio (grant 65921 to Ms. Walker and Dr. Delbanco), the Drane Family Fund, and the Koplow Charitable Foundation.	Delbanco T, 2010, ANN INTERN MED, V153, P121, DOI 10.7326/0003-4819-153-2-201007200-00008; Earnest MA, 2004, J AM MED INFORM ASSN, V11, P410, DOI 10.1197/jamia.M1479; Green BB, 2008, JAMA-J AM MED ASSOC, V299, P2857, DOI 10.1001/jama.299.24.2857; Greenhalgh T, 2008, BMJ-BRIT MED J, V336, P1290, DOI 10.1136/bmj.a114; Maly RC, 1998, J AM GERIATR SOC, V46, P889, DOI 10.1111/j.1532-5415.1998.tb02725.x; Mostaghimi A, 2011, ANN INTERN MED, V154, P560, DOI 10.7326/0003-4819-154-8-201104190-00008; NHS Connecting for Health, ACC YOUR SUMM CAR RE; Pagliari C, 2007, BMJ-BRIT MED J, V335, P330, DOI 10.1136/bmj.39279.482963.AD; Ralston JD, 2009, MED CARE RES REV, V66, P703, DOI 10.1177/1077558709338486; Ralston JD, 2009, DIABETES CARE, V32, P234, DOI 10.2337/dc08-1220; Ralston JD, 2004, BMJ-BRIT MED J, V328, P1159, DOI 10.1136/bmj.328.7449.1159; Reti SR, 2010, J AM MED INFORM ASSN, V17, P192, DOI 10.1136/jamia.2009.000927; Roblin DW, 2009, J AM MED INFORM ASSN, V16, P683, DOI 10.1197/jamia.M3169; Ross SE, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.2.e13; Ross SE, 2004, J MED INTERNET RES, V6, DOI 10.2196/jmir.6.2.e12; Safran DG, 2006, J GEN INTERN MED, V21, P13, DOI 10.1111/j.1525-1497.2005.00311.x; Sarkar U, 2011, J AM MED INFORM ASSN, V18, P318, DOI [10.1136/jamia.2010.006015, 10.1136/amiajnl.2010.006015]; Simon GE, 2011, J GEN INTERN MED, V26, P698, DOI 10.1007/s11606-011-1679-8; Weppner WG, 2010, DIABETES CARE, V33, P2314, DOI 10.2337/dc10-1124	19	142	143	1	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2011	155	12					811	U57		10.7326/0003-4819-155-12-201112200-00003	http://dx.doi.org/10.7326/0003-4819-155-12-201112200-00003			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	864ZU	22184688	Green Accepted			2022-12-28	WOS:000298280500015
J	King, BL; Gillis, JA; Carlisle, HR; Dahn, RD				King, Benjamin L.; Gillis, J. Andrew; Carlisle, Heather R.; Dahn, Randall D.			A Natural Deletion of the HoxC Cluster in Elasmobranch Fishes	SCIENCE			English	Article							GENE CLUSTERS; GNATHOSTOMES; EVOLUTION; INSIGHTS		[King, Benjamin L.; Carlisle, Heather R.; Dahn, Randall D.] Mt Desert Isl Biol Lab, Kathryn W Davis Ctr Regenerat Biol & Med, Salsbury Cove, ME 04672 USA; [Gillis, J. Andrew] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England	Mount Desert Island Biological Laboratory; University of Cambridge	King, BL (corresponding author), Mt Desert Isl Biol Lab, Kathryn W Davis Ctr Regenerat Biol & Med, Salsbury Cove, ME 04672 USA.	bking@mdibl.org	King, Benjamin/AAI-1492-2019	King, Benjamin/0000-0001-6463-1336; Gillis, Andrew/0000-0003-2062-3777	National Center for Research Resources, NIH [P20RR016463]; Newton International Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016463] Funding Source: NIH RePORTER	National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Newton International Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank B. Kingham for genome sequencing. B. L. K., H. R. C., and R. D. D. were funded by the National Center for Research Resources, NIH (P20RR016463). J.A.G. was funded by a Newton International Fellowship. The skate genome was sequenced by the North East Cyberinfrastructure Consortium. Sequence data are available at the National Center for Biotechnology Information in Gene Expression Omnibus (GSE26235), GenBank (AESE010000000), and Sequence Read Archive (SRA026856).	Lund AH, 2010, CELL DEATH DIFFER, V17, P209, DOI 10.1038/cdd.2009.58; Oulion S, 2010, MOL BIOL EVOL, V27, P2829, DOI 10.1093/molbev/msq172; Ravi V, 2009, P NATL ACAD SCI USA, V106, P16327, DOI 10.1073/pnas.0907914106; Smith JJ, 2010, CHROMOSOMA, V119, P381, DOI 10.1007/s00412-010-0263-z; Suemori H, 2000, DEV BIOL, V220, P333, DOI 10.1006/dbio.2000.9651; Woltering JM, 2006, NAT GENET, V38, P601, DOI 10.1038/ng0606-601	6	45	45	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 16	2011	334	6062					1517	1517		10.1126/science.1210912	http://dx.doi.org/10.1126/science.1210912			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	862LE	22174244	Green Accepted			2022-12-28	WOS:000298091400043
J	Cotton, MF; Rabie, H				Cotton, Mark F.; Rabie, Helena			Group B streptococcal disease in infants	LANCET			English	Editorial Material							NEONATAL SEPSIS; INFECTIONS; PREVENTION		[Cotton, Mark F.; Rabie, Helena] Univ Stellenbosch, Dept Paediat & Child Hlth, Tygerberg Childrens Hosp, ZA-7505 Tygerberg, South Africa	Stellenbosch University	Cotton, MF (corresponding author), Univ Stellenbosch, Dept Paediat & Child Hlth, Tygerberg Childrens Hosp, ZA-7505 Tygerberg, South Africa.	mcot@sun.ac.za	Cotton, Mark/AAQ-9936-2020; Rabie, Helena/ABH-1437-2020	Cotton, Mark/0000-0003-2559-6034; Rabie, Helena/0000-0001-6336-2963				BOYER KM, 1986, NEW ENGL J MED, V314, P1665, DOI 10.1056/NEJM198606263142603; Centers for Disease Control, 1996, MMWR-MORBID MORTAL W, V45, P679; Colbourn TE, 2007, BMJ-BRIT MED J, V335, P655, DOI 10.1136/bmj.39325.681806.AD; Edmond KM, 2012, LANCET, V379, P547, DOI 10.1016/S0140-6736(11)61651-6; EICKHOFF TC, 1964, NEW ENGL J MED, V271, P1221, DOI 10.1056/NEJM196412102712401; Gray KJ, 2007, EMERG INFECT DIS, V13, P223, DOI 10.3201/eid1302.060680; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S1; Madhi SA, 2003, ANN TROP PAEDIATR, V23, P15, DOI 10.1179/000349803125002814; Madzivhandila M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017861; MCCRACKEN GH, 1973, J PEDIATR-US, V82, P703, DOI 10.1016/S0022-3476(73)80603-1; Moore MR, 2003, LANCET INFECT DIS, V3, P201, DOI 10.1016/S1473-3099(03)00577-2; Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1; World Health Organization, 2021, ANT DRUGS TREAT PREG	15	3	3	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 11	2012	379	9815					502	503		10.1016/S0140-6736(11)61881-3	http://dx.doi.org/10.1016/S0140-6736(11)61881-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	891AO	22226045				2022-12-28	WOS:000300188800008
J	Mallory, GB				Mallory, George B., Jr.			Pulmonary hypertension in early life	LANCET			English	Editorial Material							ARTERIAL-HYPERTENSION; DIAGNOSIS		Texas Childrens Hosp, Sect Pediat Pulmonol, Houston, TX 77030 USA	Baylor College of Medicine	Mallory, GB (corresponding author), Texas Childrens Hosp, Sect Pediat Pulmonol, Houston, TX 77030 USA.	gbmallor@texaschildrens.org		Mallory, George/0000-0001-8099-4567				Abman SH, 2011, CURR OPIN PEDIATR, V23, P298, DOI 10.1097/MOP.0b013e3283464a52; Appelbaum L, 2001, CHEST, V119, P1801, DOI 10.1378/chest.119.6.1801; Barst RJ, 2011, EUR RESPIR J, V37, P665, DOI 10.1183/09031936.00056110; Berger RMF, 2012, LANCET, V379, P537, DOI 10.1016/S0140-6736(11)61621-8; Frost AE, 2011, CHEST, V139, P128, DOI 10.1378/chest.10-0075; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; McGoon M, 2004, CHEST, V126, p14S, DOI 10.1378/chest.126.1_suppl.14S; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; Rosenzweig EB, 2004, PEDIATR PULM, V38, P2, DOI 10.1002/ppul.20051; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; van Loon RLE, 2009, J PEDIATR-US, V155, P176, DOI 10.1016/j.jpeds.2009.02.036	11	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 11	2012	379	9815					500	501		10.1016/S0140-6736(11)61916-8	http://dx.doi.org/10.1016/S0140-6736(11)61916-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	891AO	22240410				2022-12-28	WOS:000300188800007
J	Mak, ANS; Bradley, P; Cernadas, RA; Bogdanove, AJ; Stoddard, BL				Mak, Amanda Nga-Sze; Bradley, Philip; Cernadas, Raul A.; Bogdanove, Adam J.; Stoddard, Barry L.			The Crystal Structure of TAL Effector PthXo1 Bound to Its DNA Target	SCIENCE			English	Article							ORYZAE PV.-ORYZAE; III EFFECTORS; RECOGNITION; SPECIFICITY; PROTEINS; PATHOGEN; REPEAT; GENE	DNA recognition by TAL effectors is mediated by tandem repeats, each 33 to 35 residues in length, that specify nucleotides via unique repeat-variable diresidues (RVDs). The crystal structure of PthXo1 bound to its DNA target was determined by high-throughput computational structure prediction and validated by heavy-atom derivatization. Each repeat forms a left-handed, two-helix bundle that presents an RVD-containing loop to the DNA. The repeats self-associate to form a right-handed superhelix wrapped around the DNA major groove. The first RVD residue forms a stabilizing contact with the protein backbone, while the second makes a base-specific contact to the DNA sense strand. Two degenerate amino-terminal repeats also interact with the DNA. Containing several RVDs and noncanonical associations, the structure illustrates the basis of TAL effector-DNA recognition.	[Mak, Amanda Nga-Sze; Stoddard, Barry L.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98019 USA; [Bradley, Philip] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; [Cernadas, Raul A.; Bogdanove, Adam J.] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA 50011 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Iowa State University	Stoddard, BL (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N,A3-025 Seattle, Seattle, WA 98019 USA.	bstoddar@fhcrc.org	De Bruyn, Hugo/B-3628-2018; Bogdanove, Adam/ABE-6252-2020	De Bruyn, Hugo/0000-0003-0200-9546; 	NIH [RL1 0CA833133, R01GM098861, R01 GM088277]; NSF [0820831]; Searles Scholars Fellowship; Northwest Genome Engineering Consortium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088277, R01GM098861] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Searles Scholars Fellowship; Northwest Genome Engineering Consortium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was funded by NIH (grants RL1 0CA833133 to B.L.S., R01GM098861 to B.L.S. and A.J.B., and R01 GM088277 to P.H.B.), NSF grant 0820831 to A.J.B., and a Searles Scholars Fellowship to P.H.B. A.N-S.M. was supported by a training grant from the Northwest Genome Engineering Consortium. We thank the staff of the Advanced Light Source beamline 5.0.2 and L. Doyle, B. Shen, R. Takeuchi, J. Bolduc, and C. Schmidt for technical assistance and advice; T. Edwards and M. Clifton for collecting SeMet data; and C. Pabo for helpful discussion. A.J.B. is an inventor on a patent application titled "TAL effector-mediated DNA modification" (US-2011/0145940-A1 and PCT/US2010/059932). This intellectual property, co-owned by Iowa State University and the University of Minnesota, has been licensed to Cellectis. The refined coordinates and corresponding x-ray intensities for the PthXo1-DNA structure have been deposited in the RCSB Protein Database (accession code 3UGM).	Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Bogdanove AJ, 2010, CURR OPIN PLANT BIOL, V13, P394, DOI 10.1016/j.pbi.2010.04.010; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Hopcroft NH, 2004, J MOL BIOL, V338, P43, DOI 10.1016/j.jmb.2004.02.038; Jimenez-Menendez N, 2010, NAT STRUCT MOL BIOL, V17, P891, DOI 10.1038/nsmb.1859; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Murakami MT, 2010, PROTEINS, V78, P3386, DOI 10.1002/prot.22846; Romer P, 2007, SCIENCE, V318, P645, DOI 10.1126/science.1144958; Romer P, 2010, NEW PHYTOL, V187, P1048, DOI 10.1111/j.1469-8137.2010.03217.x; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Yu YH, 2011, MOL PLANT MICROBE IN, V24, P1102, DOI 10.1094/MPMI-11-10-0254	16	373	448	5	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2012	335	6069					716	719		10.1126/science.1216211	http://dx.doi.org/10.1126/science.1216211			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	889AY	22223736	Green Accepted			2022-12-28	WOS:000300047100052
J	Zhang, WC; Shyh-Chang, N; Yang, H; Rai, A; Umashankar, S; Ma, SM; Soh, BS; Sun, LL; Tai, BC; Nga, ME; Bhakoo, KK; Jayapal, SR; Nichane, M; Yu, Q; Ahmed, DA; Tan, C; Sing, WP; Tam, J; Thirugananam, A; Noghabi, MS; Pang, YH; Ang, HS; Robson, P; Kaldis, P; Soo, RA; Swarup, S; Lim, EH; Lim, B				Zhang, Wen Cai; Shyh-Chang, Ng; Yang, He; Rai, Amit; Umashankar, Shivshankar; Ma, Siming; Soh, Boon Seng; Sun, Li Li; Tai, Bee Choo; Nga, Min En; Bhakoo, Kishore Kumar; Jayapal, Senthil Raja; Nichane, Massimo; Yu, Qiang; Ahmed, Dokeu A.; Tan, Christie; Sing, Wong Poo; Tam, John; Thirugananam, Agasthian; Noghabi, Monireh Soroush; Pang, Yin Huei; Ang, Haw Siang; Robson, Paul; Kaldis, Philipp; Soo, Ross Andrew; Swarup, Sanjay; Lim, Elaine Hsuen; Lim, Bing			Glycine Decarboxylase Activity Drives Non-Small Cell Lung Cancer Tumor-Initiating Cells and Tumorigenesis	CELL			English	Article							STEM-CELL; CLEAVAGE SYSTEM; IDENTIFICATION; METABOLISM; EXPRESSION; PROTEIN	Identification of the factors critical to the tumor-initiating cell (TIC) state may open new avenues in cancer therapy. Here we show that the metabolic enzyme glycine decarboxylase (GLDC) is critical for TICs in non-small cell lung cancer (NSCLC). TICs from primary NSCLC tumors express high levels of the oncogenic stem cell factor LIN28B and GLDC, which are both required for TIC growth and tumorigenesis. Overexpression of GLDC and other glycine/serine enzymes, but not catalytically inactive GLDC, promotes cellular transformation and tumorigenesis. We found that GLDC induces dramatic changes in glycolysis and glycine/serine metabolism, leading to changes in pyrimidine metabolism to regulate cancer cell proliferation. In the clinic, aberrant activation of GLDC correlates with poorer survival in lung cancer patients, and aberrant GLDC expression is observed in multiple cancer types. This link between glycine metabolism and tumorigenesis may provide novel targets for advancing anticancer therapy.	[Zhang, Wen Cai; Lim, Elaine Hsuen] Tan Tock Seng Hosp, Dept Resp Med, Singapore 308433, Singapore; [Zhang, Wen Cai; Shyh-Chang, Ng; Ma, Siming; Soh, Boon Seng; Sun, Li Li; Nichane, Massimo; Yu, Qiang; Noghabi, Monireh Soroush; Robson, Paul; Lim, Bing] Genome Inst Singapore, Singapore 138672, Singapore; [Yang, He; Ang, Haw Siang; Soo, Ross Andrew] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117456, Singapore; [Ahmed, Dokeu A.; Tan, Christie] Tan Tock Seng Hosp, Dept Thorac Surg, Singapore 308433, Singapore; [Rai, Amit; Umashankar, Shivshankar; Swarup, Sanjay] Natl Univ Singapore, Dept Biol Sci, Metabolites Biol Lab, Singapore 117543, Singapore; [Umashankar, Shivshankar; Swarup, Sanjay] Natl Univ Singapore, T Lab Bldg TL, NUS Environm Res Inst NERI, Singapore 117411, Singapore; [Soo, Ross Andrew; Lim, Elaine Hsuen] Natl Univ Singapore Hosp, Dept Haematol Oncol, Singapore 119074, Singapore; [Nga, Min En; Pang, Yin Huei] Natl Univ Singapore Hosp, Dept Pathol, Singapore 119074, Singapore; [Sing, Wong Poo; Tam, John] Natl Univ Singapore Hosp, Dept Thorac Surg, Singapore 119074, Singapore; [Tai, Bee Choo] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Community Occupat & Family Med, Singapore 117597, Singapore; [Bhakoo, Kishore Kumar] Singapore BioImaging Consortium SBIC, Lab Mol Imaging LMI, Translat Mol Imaging Grp TMIG, Singapore 138667, Singapore; [Jayapal, Senthil Raja; Kaldis, Philipp] Inst Mol & Cell Biol, Cell Div, Singapore 138673, Singapore; [Jayapal, Senthil Raja; Kaldis, Philipp] Inst Mol & Cell Biol, Canc Lab PRK, Singapore 138673, Singapore; [Thirugananam, Agasthian] Natl Canc Ctr, Dept Thorac Surg, Singapore 169610, Singapore; [Lim, Elaine Hsuen] Natl Canc Ctr, Dept Med Oncol, Singapore 169610, Singapore; [Lim, Bing] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Tan Tock Seng Hospital; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; Tan Tock Seng Hospital; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National Cancer Centre Singapore (NCCS); National Cancer Centre Singapore (NCCS); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Lim, EH (corresponding author), Tan Tock Seng Hosp, Dept Resp Med, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.	elainelim77@ymail.com; limb1@gis.a-star.edu.sg	Robson, Paul/A-3464-2009; Tam, John/B-6048-2012; Umashankar, Shivshankar/K-1137-2013; Kaldis, Philipp/G-2714-2010; Rai, Amit/J-6288-2016; Swarup, Sanjay/I-1592-2012; Zhang, Wencai/D-8662-2013	Robson, Paul/0000-0002-0191-3958; Umashankar, Shivshankar/0000-0001-7478-1194; Kaldis, Philipp/0000-0002-7247-7591; Rai, Amit/0000-0002-5715-8541; Swarup, Sanjay/0000-0001-6391-0624; Zhang, Wencai/0000-0002-5274-527X; Jayapal, Senthil Raja/0000-0002-0670-7766; Ma, Siming/0000-0002-1810-8357; Yu, Qiang/0000-0003-2132-8278; Shyh-Chang, Ng/0000-0003-3138-9525; Bhakoo, Kishore/0000-0002-4735-9737	Biomedical Research Council (BMRC); Agency for Science, Technology and Research (A*STAR); Singapore Cancer Syndicate; Singapore Lung Cancer Consortium	Biomedical Research Council (BMRC)(Agency for Science Technology & Research (A*STAR)); Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Singapore Cancer Syndicate; Singapore Lung Cancer Consortium	This work is supported by grants from Biomedical Research Council (BMRC) and Agency for Science, Technology and Research (A*STAR) (B. L.) and grants from the Singapore Cancer Syndicate and Singapore Lung Cancer Consortium (E. H. L.). We gratefully acknowledge assistance from Y.P.R. Yip, S. L. Long, and J. Xu for collection of lung tissues. We are grateful to the Biopolis Shared Facilities Histopathology Laboratory staff for their support with immunohistochemistry and image analysis. We thank Z.M. Li for assistance with making transformed breast cell lines. We greatly acknowledge V. Gaddemane, C. S. Gan, and T. Hennessy from Agilent Technologies, Singapore for their support in acquiring and analyzing the mass spectrometry data for the differential analysis of the metabolites. We thank W. L. Tam and F. McKeon for comments on the manuscript.	Avril-Delplanque A, 2005, STEM CELLS, V23, P992, DOI 10.1634/stemcells.2004-0197; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Chua SW, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl024; Civenni G, 2011, CANCER RES, V71, P3098, DOI 10.1158/0008-5472.CAN-10-3997; Curtis SJ, 2010, CELL STEM CELL, V7, P127, DOI 10.1016/j.stem.2010.05.021; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hennrick KT, 2007, AM J RESP CRIT CARE, V175, P1158, DOI 10.1164/rccm.200607-941OC; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ishizawa K, 2010, CELL STEM CELL, V7, P279, DOI 10.1016/j.stem.2010.08.009; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; KUME A, 1991, J BIOL CHEM, V266, P3323; Kure S, 2006, HUM MUTAT, V27, P343, DOI 10.1002/humu.20293; Levesque BM, 2007, AM J RESP CELL MOL, V36, P427, DOI 10.1165/rcmb.2006-0314OC; Liu YR, 2003, DEV BIOL, V261, P10, DOI 10.1016/S0012-1606(03)00359-2; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Murakami Y, 2007, MECH DEVELOP, V124, P830, DOI 10.1016/j.mod.2007.09.004; Nakai T, 2005, EMBO J, V24, P1523, DOI 10.1038/sj.emboj.7600632; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Sabatini F, 2005, LAB INVEST, V85, P962, DOI 10.1038/labinvest.3700300; Sequist LV, 2007, ONCOLOGIST, V12, P90, DOI 10.1634/theoncologist.12-1-90; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yang DH, 2003, GENE EXPR PATTERNS, V3, P719, DOI 10.1016/S1567-133X(03)00140-6; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	43	484	506	2	112	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 20	2012	148	1-2					259	272		10.1016/j.cell.2011.11.050	http://dx.doi.org/10.1016/j.cell.2011.11.050			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	882DC	22225612	Bronze			2022-12-28	WOS:000299540700029
J	Campos-Rodriguez, F; Martinez-Garcia, MA; de la Cruz-Moron, I; Almeida-Gonzalez, C; Catalan-Serra, P; Montserrat, JM				Campos-Rodriguez, Francisco; Martinez-Garcia, Miguel A.; de la Cruz-Moron, Ines; Almeida-Gonzalez, Carmen; Catalan-Serra, Pablo; Montserrat, Josep M.			Cardiovascular Mortality in Women With Obstructive Sleep Apnea With or Without Continuous Positive Airway Pressure Treatment A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							ALL-CAUSE MORTALITY; RISK-FACTOR; FOLLOW-UP; HYPOPNEA; STROKE; DIAGNOSIS; SURVIVAL; OUTCOMES; DISEASE; DEATH	Background: Obstructive sleep apnea (OSA) is a risk factor for cardiovascular death in men, but whether it is also a risk factor in women is unknown. Objective: To investigate whether OSA is a risk factor for cardiovascular death in women and assess whether continuous positive airway pressure (CPAP) treatment is associated with a change in risk. Design: Prospective, observational cohort study. Setting: 2 sleep clinics in Spain. Patients: All women consecutively referred for suspected OSA between 1998 and 2007. Intervention: Every woman had a diagnostic sleep study. Women with an apnea-hypopnea index (AHI) less than 10 were the control group. Obstructive sleep apnea was diagnosed when the AHI was 10 or higher (classified as mild to moderate [AHI of 10 to 29] or severe [AHI >= 30]).Patients with OSA were classified as CPAP-treated (adherence >= 4 hours per day) or untreated (adherence >= 4 hours per day or not prescribed). Participants were followed until December 2009. Measurements: The end point was cardiovascular death. Results: 1116 women were studied (median follow-up, 72 months [interquartile range, 52 to 88 months]). The control group had a lower cardiovascular mortality rate (0.28 per 100 person-years [95% CI, 0.10 to 0.91]) than the untreated groups with mild to moderate OSA (0.94 per 100 person-years [CI, 0.10 to 2.40]; P = 0.034) or severe OSA (3.71 per 100 person-years [CI, 0.09 to 7.50]; P < 0.001). Compared with the control group, the fully adjusted hazard ratios for cardiovascular mortality were 3.50 (CI, 1.23 to 9.98) for the untreated, severe OSA group; 0.55 (CI, 0.17 to 1.74) for the CPAP-treated, severe OSA group; 1.60 (CI, 0.52 to 4.90) for the untreated, mild to moderate OSA group; and 0.19 (CI, 0.02 to 1.67) for the CPAP-treated, mild to moderate OSA group. Limitation: The study was observational and not randomized, and OSA was diagnosed by 2 different methods. Conclusion: Severe OSA is associated with cardiovascular death in women, and adequate CPAP treatment may reduce this risk.	[Campos-Rodriguez, Francisco] Valme Univ Hosp, Sleep Disordered Breathing Unit, Resp Dept, Seville 41014, Spain; La Fe Univ, Valencia, Spain; Polytech Hosp, Valencia, Spain; Requena Gen Hosp, Valencia, Spain; Hosp Clin Barcelona, Barcelona, Spain; CIBERes Enfermedades Respiratorias, Madrid, Spain	Hospital Valme; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Campos-Rodriguez, F (corresponding author), Valme Univ Hosp, Sleep Disordered Breathing Unit, Resp Dept, Ctra Cadiz S-N, Seville 41014, Spain.	fracamrod@gmail.com	González, Carmen Victoria Almeida/P-7944-2019; Almeida-González, Carmen V./O-9461-2017; Martinez-Garcia, Miguel/AAA-6349-2019	González, Carmen Victoria Almeida/0000-0001-8202-0790; Almeida-González, Carmen V./0000-0001-8202-0790; Martinez-Garcia, Miguel/0000-0002-7321-1891; MONTSERRAT, Josep Maria/0000-0003-3098-4605; Catalan Serra, Pablo/0000-0001-6001-1850; Campos-Rodriguez, Francisco/0000-0002-2632-3073				AncoliIsrael S, 1996, SLEEP, V19, P277, DOI 10.1093/sleep/19.4.277; Martinez-Garcia MA, 2009, AM J RESP CRIT CARE, V180, P36, DOI 10.1164/rccm.200808-1341OC; Bixler EO, 2001, AM J RESP CRIT CARE, V163, P608, DOI 10.1164/ajrccm.163.3.9911064; Campos-Rodriguez F, 2005, CHEST, V128, P624, DOI 10.1378/chest.128.2.624; Chiner E, 1999, Arch Bronconeumol, V35, P422; Doherty LS, 2005, CHEST, V127, P2076, DOI 10.1378/chest.127.6.2076; Duran J, 2001, AM J RESP CRIT CARE, V163, P685, DOI 10.1164/ajrccm.163.3.2005065; Duran J, 1996, ARCH BRONCONEUMOL, V32, P3; Faux MD, 2004, SLEEP, V27, P1113, DOI 10.1093/sleep/27.6.1113; Gami AS, 2005, NEW ENGL J MED, V352, P1206, DOI 10.1056/NEJMoa041832; Gottlieb DJ, 2010, CIRCULATION, V122, P352, DOI 10.1161/CIRCULATIONAHA.109.901801; Gugger M, 1997, EUR RESPIR J, V10, P587; Lavie P, 2005, EUR RESPIR J, V25, P514, DOI 10.1183/09031936.05.00051504; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Marshall NS, 2008, SLEEP, V31, P1079; Montserrat J M, 1998, Arch Bronconeumol, V34, P204; Morrish E, 2008, RESP MED, V102, P1231, DOI 10.1016/j.rmed.2008.04.014; Peker Y, 2006, EUR RESPIR J, V28, P596, DOI 10.1183/09031936.06.00107805; Peker Y, 2000, AM J RESP CRIT CARE, V162, P81, DOI 10.1164/ajrccm.162.1.9905035; Punjabi NM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000132; Quintana-Gallego E, 2004, RESP MED, V98, P984, DOI 10.1016/j.rmed.2004.03.002; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Redline S, 2010, AM J RESP CRIT CARE, V182, P269, DOI 10.1164/rccm.200911-1746OC; Sahlin C, 2008, ARCH INTERN MED, V168, P297, DOI 10.1001/archinternmed.2007.70; Shepertycky MR, 2005, SLEEP, V28, P309; Tordera MP, 2005, ARCH BRONCONEUMOL, V41, P1; Veale D, 2000, EUR RESPIR J, V15, P326, DOI 10.1034/j.1399-3003.2000.15b18.x; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; Young T, 1998, THORAX, V53, pS16, DOI 10.1136/thx.53.2008.S16; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Young T, 1996, ARCH INTERN MED, V156, P2445, DOI 10.1001/archinte.156.21.2445; Young T, 2008, SLEEP, V31, P1071	32	261	270	3	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 17	2012	156	2					115	W22		10.7326/0003-4819-156-2-201201170-00006	http://dx.doi.org/10.7326/0003-4819-156-2-201201170-00006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	894IW	22250142				2022-12-28	WOS:000300421400002
J	Braun, DM				Braun, David M.			SWEET! The Pathway Is Complete	SCIENCE			English	Editorial Material							SUCROSE-TRANSPORTERS; CARBON		Univ Missouri, Missouri Maize Ctr, Interdisciplinary Plant Grp, Div Biol Sci, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Braun, DM (corresponding author), Univ Missouri, Missouri Maize Ctr, Interdisciplinary Plant Grp, Div Biol Sci, Columbia, MO 65211 USA.	braundm@missouri.edu						Ainsworth EA, 2011, PLANT PHYSIOL, V155, P64, DOI 10.1104/pp.110.167684; Ayre BG, 2011, MOL PLANT, V4, P377, DOI 10.1093/mp/ssr014; Braun DM, 2009, PLANT PHYSIOL, V149, P71, DOI 10.1104/pp.108.129049; Chaudhuri B, 2008, PLANT J, V56, P948, DOI 10.1111/j.1365-313X.2008.03652.x; Chen LQ, 2012, SCIENCE, V335, P207, DOI 10.1126/science.1213351; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Hou BH, 2011, NAT PROTOC, V6, P1818, DOI 10.1038/nprot.2011.392; Kuhn C, 2010, CURR OPIN PLANT BIOL, V13, P287, DOI 10.1016/j.pbi.2010.02.001; Lager I, 2006, J BIOL CHEM, V281, P30875, DOI 10.1074/jbc.M605257200; Lalonde S, 2004, ANNU REV PLANT BIOL, V55, P341, DOI 10.1146/annurev.arplant.55.031903.141758; MINCHIN PEH, 1987, J EXP BOT, V38, P211, DOI 10.1093/jxb/38.2.211; Sauer N, 2007, FEBS LETT, V581, P2309, DOI 10.1016/j.febslet.2007.03.048; Slewinski TL, 2010, PLANT SCI, V178, P341, DOI 10.1016/j.plantsci.2010.01.010; Zhang WH, 2007, FUNCT PLANT BIOL, V34, P314, DOI 10.1071/FP06271	14	67	80	5	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 13	2012	335	6065					173	174		10.1126/science.1216828	http://dx.doi.org/10.1126/science.1216828			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875LZ	22246760				2022-12-28	WOS:000299033100036
J	Brown, MJ; Cruickshank, JK; MacDonald, TM				Brown, Morris J.; Cruickshank, J. Kennedy; MacDonald, Thomas M.			Navigating the shoals in hypertension: discovery and guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							AMBULATORY BLOOD-PRESSURE; CARDIOVASCULAR EVENTS; MORTALITY; DIAGNOSIS; RISK; VARIABILITY; TRIAL; HOME; SPIRONOLACTONE; AMLODIPINE		[Brown, Morris J.] Univ Cambridge, Addenbrookes Hosp, Clin Pharmacol Unit, Cambridge CB2 2QQ, England; [Cruickshank, J. Kennedy] Kings Coll London, London SE1 9NH, England; [Cruickshank, J. Kennedy] St Thomas Hosp, London SE1 9NH, England; [MacDonald, Thomas M.] Ninewells Hosp & Med Sch, Med Res Inst, Med Monitoring Unit, Dundee DD1 9SY, Scotland; [MacDonald, Thomas M.] Ninewells Hosp & Med Sch, Med Res Inst, Hypertens Res Ctr, Dundee DD1 9SY, Scotland	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of Dundee; University of Dundee	Brown, MJ (corresponding author), Univ Cambridge, Addenbrookes Hosp, Clin Pharmacol Unit, Cambridge CB2 2QQ, England.	m.j.brown@cai.cam.ac.uk		MacDonald, Thomas/0000-0001-5189-6669				British Hypertension Society, 2011, BEN SALT RED AR CLEA; Brown MJ, 2000, LANCET, V356, P366, DOI 10.1016/S0140-6736(00)02527-7; Brown MJ, 2011, HEART, V97, P1547, DOI 10.1136/heartjnl-2011-300710; Brown MJ, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4697; Brown MJ, 2011, LANCET, V377, P312, DOI 10.1016/S0140-6736(10)62003-X; Chapman N, 2007, HYPERTENSION, V49, P839, DOI 10.1161/01.HYP.0000259805.18468.8c; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Dickerson JEC, 1999, LANCET, V353, P2008, DOI 10.1016/S0140-6736(98)07614-4; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Glen SK, 1996, LANCET, V348, P654, DOI 10.1016/S0140-6736(96)02303-3; GREENBERG G, 1985, BMJ-BRIT MED J, V291, P97; Head Geoffrey A, 2010, BMJ, V340, pc1104, DOI 10.1136/bmj.c1104; Hodgkinson J, 2011, BMJ, V342, pd3621, DOI 10.1136/bmj.d3621; Hood SJ, 2007, CIRCULATION, V116, P268, DOI 10.1161/CIRCULATIONAHA.107.690396; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lovibond K, 2011, LANCET, V378, P1219, DOI 10.1016/S0140-6736(11)61184-7; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Mancia G, 1997, LANCET, V349, P454, DOI 10.1016/S0140-6736(96)07099-7; Mancia G, 1995, J HYPERTENS, V13, P1377; Mancia G, 2006, HYPERTENSION, V47, P846, DOI 10.1161/01.HYP.0000215363.69793.bb; MEADE TW, 1992, BMJ-BRIT MED J, V304, P405; NICE, 2019, HYP AD DIAGN MAN; NICE British Hypertension Society, 2006, HYP MAN HYP AD PRIM; Poulter NR, 2005, LANCET, V366, P907, DOI 10.1016/S0140-6736(05)67186-3; Rawlins M, CLIN PHARM IN PRESS; Ritchie LD, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5644; Rothwell PM, 2010, LANCET, V375, P938, DOI 10.1016/S0140-6736(10)60309-1; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Stergiou GS, 2011, AM J HYPERTENS, V24, P123, DOI 10.1038/ajh.2010.194; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Turnbull F, 2003, LANCET, V362, P1527; Verdecchia P, 2007, CIRCULATION, V115, P2091, DOI 10.1161/CIRCULATIONAHA.107.697086; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Webb AJS, 2011, STROKE, V42, P2860, DOI 10.1161/STROKEAHA.110.611566; Williams B, 2004, J HUM HYPERTENS, V18, P139, DOI 10.1038/sj.jhh.1001683	38	8	8	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	2012	344								d8218	10.1136/bmj.d8218	http://dx.doi.org/10.1136/bmj.d8218			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877SR	22246268				2022-12-28	WOS:000299203500013
J	McCartney, M				McCartney, Margaret			MEDICINE AND THE MEDIA Consultant cover and mortality among hospital patients	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				2011, BRIT MED J, V343, DOI DOI 10.1136/BMJ.D7791	1	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 11	2012	344								d8276	10.1136/bmj.d8276	http://dx.doi.org/10.1136/bmj.d8276			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	877SI	22236597				2022-12-28	WOS:000299202500017
J	Brandt, AM				Brandt, Allan M.			A Reader's Guide to 200 Years of the New England Journal of Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Review									[Brandt, Allan M.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02114 USA; [Brandt, Allan M.] Harvard Univ, Dept Hist Sci, Grad Sch Arts & Sci, Cambridge, MA 02138 USA; [Brandt, Allan M.] Harvard Univ, Off Dean, Grad Sch Arts & Sci, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University	Brandt, AM (corresponding author), Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02114 USA.							Brandt Allan M., 1987, NO MAGIC BULLET SOCI; Rosenberg Charles E., 1987, CARE STRANGERS RISE; Stevens Rosemary, 1971, AM MED PUBLIC INTERE; Tomes Nancy, 1998, GOSPEL GERMS MEN WOM; Wait Thomas B., 1811, NEW ENGLAND J ME SEP; Warner J.H., 1986, THERAPEUTIC PERSPECT	6	7	9	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 5	2012	366	1					1	7						7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	887XY	22216839	Bronze			2022-12-28	WOS:000299968800001
J	Bray, GA; Smith, SR; de Jonge, L; Xie, H; Rood, J; Martin, CK; Most, M; Brock, C; Mancuso, S; Redman, LM				Bray, George A.; Smith, Steven R.; de Jonge, Lilian; Xie, Hui; Rood, Jennifer; Martin, Corby K.; Most, Marlene; Brock, Courtney; Mancuso, Susan; Redman, Leanne M.			Effect of Dietary Protein Content on Weight Gain, Energy Expenditure, and Body Composition During Overeating A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							METABOLIC-RATE; YOUNG MEN; THERMOGENESIS; HUMANS; GLUTTONY; FAT; RESTRICTION; MAINTENANCE; PREVALENCE; OBESITY	Context The role of diet composition in response to overeating and energy dissipation in humans is unclear. Objective To evaluate the effects of overconsumption of low, normal, and high protein diets on weight gain, energy expenditure, and body composition. Design, Setting, and Participants A single-blind, randomized controlled trial of 25 US healthy, weight-stable male and female volunteers, aged 18 to 35 years with a body mass index between 19 and 30. The first participant was admitted to the inpatient metabolic unit in June 2005 and the last in October 2007. Intervention After consuming a weight-stabilizing diet for 13 to 25 days, participants were randomized to diets containing 5% of energy from protein (low protein), 15% (normal protein), or 25% (high protein), which they were overfed during the last 8 weeks of their 10- to 12-week stay in the inpatient metabolic unit. Compared with energy intake during the weight stabilization period, the protein diets provided approximately 40% more energy intake, which corresponds to 954 kcal/d (95% CI, 884-1022 kcal/d). Main Outcome Measures Body composition was measured by dual-energy x-ray absorptiometry biweekly, resting energy expenditure was measured weekly by ventilated hood, and total energy expenditure by doubly labeled water prior to the overeating and weight stabilization periods and at weeks 7 to 8. Results Overeating produced significantly less weight gain in the low protein diet group (3.16 kg; 95% CI, 1.88-4.44 kg) compared with the normal protein diet group (6.05 kg; 95% CI, 4.84-7.26 kg) or the high protein diet group (6.51 kg; 95% CI, 5.23-7.79 kg) (P=.002). Body fat increased similarly in all 3 protein diet groups and represented 50% to more than 90% of the excess stored calories. Resting energy expenditure, total energy expenditure, and body protein did not increase during over-feeding with the low protein diet. In contrast, resting energy expenditure (normal protein diet: 160 kcal/d [95% CI, 102-218 kcal/d]; high protein diet: 227 kcal/d [95% CI, 165-289 kcal/d]) and body protein (lean body mass) (normal protein diet: 2.87 kg [95% CI, 2.11-3.62 kg]; high protein diet: 3.18 kg [95% CI, 2.37-3.98 kg]) increased significantly with the normal and high protein diets. Conclusions Among persons living in a controlled setting, calories alone account for the increase in fat; protein affected energy expenditure and storage of lean body mass, but not body fat storage.	[Bray, George A.; Rood, Jennifer; Martin, Corby K.; Brock, Courtney; Mancuso, Susan; Redman, Leanne M.] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Smith, Steven R.; Xie, Hui] Florida Hosp, Translat Res Inst Metab & Diabet, Orlando, FL USA; [Smith, Steven R.; Xie, Hui] Sanford Burnham Med Res Inst, Orlando, FL USA; [de Jonge, Lilian] NIH, Bethesda, MD 20892 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Adventist Health Services; AdventHealth; Sanford Burnham Prebys Medical Discovery Institute; National Institutes of Health (NIH) - USA	Bray, GA (corresponding author), Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	George.bray@pbrc.edu	Redman, Leanne M/N-1986-2017; Smith, Steven/HDM-9496-2022; Martin, Corby K./N-1976-2017	Martin, Corby K./0000-0002-8125-4015; de Jonge, Lilian/0000-0001-5900-0695; Smith, Steven/0000-0002-5098-8147	US Department of Agriculture [2010-34323-21052]; Louisiana State University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R00HD060762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER	US Department of Agriculture(United States Department of Agriculture (USDA)); Louisiana State University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported in part by the US Department of Agriculture grant 2010-34323-21052 and by funding from Louisiana State University.	Church TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019657; DALLOSSO HM, 1984, BRIT J NUTR, V52, P49, DOI 10.1079/BJN19840070; Deriaz O, 1993, Obes Res, V1, P179; DIAZ EO, 1992, AM J CLIN NUTR, V56, P641, DOI 10.1093/ajcn/56.4.641; Dulloo AG, 1999, INT J OBESITY, V23, P1118, DOI 10.1038/sj.ijo.0801110; Flatt JP, 1978, OBES RES, P211; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; FORBES GB, 1986, BRIT J NUTR, V56, P1, DOI 10.1079/BJN19860080; Goldman R, 1975, OBESITY PERSPECTIVE, P165; Grafe E, 1911, H-S Z PHYSIOL CHEM, V73, P1, DOI 10.1515/bchm2.1911.73.1-2.1; Gulick A, 1922, AM J PHYSIOL, V60, P371, DOI 10.1152/ajplegacy.1922.60.2.371; Halton TL, 2004, J AM COLL NUTR, V23, P373, DOI 10.1080/07315724.2004.10719381; Harris AM, 2006, OBESITY, V14, P690, DOI 10.1038/oby.2006.78; Joosen AMCP, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-25; Lammert O, 2000, BRIT J NUTR, V84, P233; Levine JA, 1999, SCIENCE, V283, P212, DOI 10.1126/science.283.5399.212; Martin CK, 2007, OBESITY, V15, P2964, DOI 10.1038/oby.2007.354; MILLER DS, 1967, AM J CLIN NUTR, V20, P1212, DOI 10.1093/ajcn/20.11.1212; MILLER DS, 1967, AM J CLIN NUTR, V20, P1223, DOI 10.1093/ajcn/20.11.1223; Neumann RO, 1902, ARCH HYG, V45, P1; NORGAN NG, 1980, AM J CLIN NUTR, V33, P978, DOI 10.1093/ajcn/33.5.978; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; RACETTE SB, 1994, AM J PHYSIOL-ENDOC M, V267, pE585, DOI 10.1152/ajpendo.1994.267.4.E585; RAVUSSIN E, 1989, AM J CLIN NUTR, V49, P968, DOI 10.1093/ajcn/49.5.968; Redman LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004377; SCHOELLER DA, 1988, J NUTR, V118, P1278, DOI 10.1093/jn/118.11.1278; Stock MJ, 1999, INT J OBESITY, V23, P1105, DOI 10.1038/sj.ijo.0801108; Sumithran P, 2011, NEW ENGL J MED, V365, P1597, DOI 10.1056/NEJMoa1105816; Swinburn B, 2009, AM J CLIN NUTR, V90, P1453, DOI 10.3945/ajcn.2009.28595; TAVES DR, 1974, CLIN PHARMACOL THER, V15, P443; WEBB P, 1983, HUM NUTR-CLIN NUTR, V37, P117; Westerterp-Plantenga MS, 2009, ANNU REV NUTR, V29, P21, DOI 10.1146/annurev-nutr-080508-141056; Wiley FH, 1931, J CLIN INVEST, V10, P733, DOI 10.1172/JCI100379	34	190	225	3	56	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 4	2012	307	1					47	55		10.1001/jama.2011.1918	http://dx.doi.org/10.1001/jama.2011.1918			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	872ET	22215165	Green Accepted, Bronze			2022-12-28	WOS:000298792300021
J	Han, CZ; Ravichandran, KS				Han, Claudia Z.; Ravichandran, Kodi S.			Metabolic Connections during Apoptotic Cell Engulfment	CELL			English	Review							DEAD CELLS; CLEARANCE; PHAGOCYTOSIS; DISEASE; GAMMA	Billions of cells die via apoptosis every day and are swiftly removed. When a phagocyte engulfs an apoptotic cell, it essentially doubles its cellular contents, raising the question of how a phagocyte may manage the excess metabolic load. This Minireview discusses phagocyte cellular metabolism, the digestion of the ingested apoptotic cell, and the impact of these processes on engulfment.	[Han, Claudia Z.; Ravichandran, Kodi S.] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Carter Immunol Ctr, Charlottesville, VA 22908 USA; [Han, Claudia Z.; Ravichandran, Kodi S.] Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Ravichandran, KS (corresponding author), Univ Virginia, Dept Microbiol Immunol & Canc Biol, Carter Immunol Ctr, Charlottesville, VA 22908 USA.	ravi@virginia.edu		Ravichandran, Kodi/0000-0001-9049-1410	NIAID NIH HHS [T32 AI007496, T32 AI007496-16A1] Funding Source: Medline; NIGMS NIH HHS [R01 GM055761-13, T32 GM008136, R01 GM055761, R01 GM064709, R01 GM064709-08] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064709, T32GM008136, R01GM055761] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bae HB, 2011, FASEB J, V25, P4358, DOI 10.1096/fj.11-190587; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Elliott MR, 2010, NATURE, V467, P333, DOI 10.1038/nature09356; Florey O, 2011, NAT CELL BIOL, V13, P1335, DOI 10.1038/ncb2363; GONZALEZ N, 2009, IMMUNITY, V31, P245, DOI DOI 10.1016/J.IMMUNI.2009.06.018; Gregory CD, 2011, J PATHOL, V223, P177, DOI 10.1002/path.2792; Kao AW, 2011, P NATL ACAD SCI USA, V108, P4441, DOI 10.1073/pnas.1100650108; Kiss RS, 2006, CURR BIOL, V16, P2252, DOI 10.1016/j.cub.2006.09.043; Lee HK, 2010, IMMUNITY, V32, P227, DOI 10.1016/j.immuni.2009.12.006; Majai G, 2010, J LEUKOCYTE BIOL, V88, P981, DOI 10.1189/jlb.0310144; Martinez J, 2011, P NATL ACAD SCI USA, V108, P17396, DOI 10.1073/pnas.1113421108; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mukundan L, 2009, NAT MED, V15, P1266, DOI 10.1038/nm.2048; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Park D, 2011, NATURE, V477, P220, DOI 10.1038/nature10340; Pecqueur C, 2008, FASEB J, V22, P9, DOI 10.1096/fj.07-8945com; Pezzolesi MG, 2009, DIABETES, V58, P2698, DOI 10.2337/db09-0641; Roszer T, 2011, J IMMUNOL, V186, P621, DOI 10.4049/jimmunol.1002230; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675	20	91	94	1	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 23	2011	147	7					1442	1445		10.1016/j.cell.2011.12.006	http://dx.doi.org/10.1016/j.cell.2011.12.006			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	866SP	22196723	Bronze, Green Accepted			2022-12-28	WOS:000298403400010
J	Huldtgren, T; Cunningham, JA; Yin, CY; Stampanoni, M; Marone, F; Donoghue, PCJ; Bengtson, S				Huldtgren, Therese; Cunningham, John A.; Yin, Chongyu; Stampanoni, Marco; Marone, Federica; Donoghue, Philip C. J.; Bengtson, Stefan			Fossilized Nuclei and Germination Structures Identify Ediacaran "Animal Embryos" as Encysting Protists	SCIENCE			English	Article							IN-VITRO; PALEONTOLOGY; MICROFOSSILS; EVOLUTION; PISCES; ORIGIN; ALGAE; NOV; GEN	Globular fossils showing palintomic cell cleavage in the Ediacaran Doushantuo Formation, China, are widely regarded as embryos of early metazoans, although metazoan synapomorphies, tissue differentiation, and associated juveniles or adults are lacking. We demonstrate using synchrotron-based x-ray tomographic microscopy that the fossils have features incompatible with multicellular metazoan embryos. The developmental pattern is comparable with nonmetazoan holozoans, including germination stages that preclude postcleavage embryology characteristic of metazoans. We conclude that these fossils are neither animals nor embryos. They belong outside crown-group Metazoa, within total-group Holozoa (the sister clade to Fungi that includes Metazoa, Choanoflagellata, and Mesomycetozoea) or perhaps on even more distant branches in the eukaryote tree. They represent an evolutionary grade in which palintomic cleavage served the function of producing propagules for dispersion.	[Cunningham, John A.; Donoghue, Philip C. J.] Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England; [Huldtgren, Therese; Bengtson, Stefan] Swedish Museum Nat Hist, Dept Palaeozool, S-10405 Stockholm, Sweden; [Huldtgren, Therese] Stockholm Univ, Dept Geol Sci, S-10691 Stockholm, Sweden; [Yin, Chongyu] Chinese Acad Geol Sci, Inst Geol, Beijing 100037, Peoples R China; [Stampanoni, Marco; Marone, Federica] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; [Stampanoni, Marco] Univ Zurich, Inst Biomed Engn, CH-8092 Zurich, Switzerland; [Bengtson, Stefan] Swedish Museum Nat Hist, Nord Ctr Earth Evolut, S-10405 Stockholm, Sweden; [Stampanoni, Marco] ETH, CH-8092 Zurich, Switzerland	University of Bristol; Swedish Museum of Natural History; Stockholm University; Chinese Academy of Geological Sciences; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Zurich; Swedish Museum of Natural History; Swiss Federal Institutes of Technology Domain; ETH Zurich	Donoghue, PCJ (corresponding author), Univ Bristol, Dept Earth Sci, Wills Mem Bldg, Bristol BS8 1RJ, Avon, England.	phil.donoghue@bristol.ac.uk; stefan.bengtson@nrm.se	Stampanoni, Marco/AAZ-3033-2021; Stampanoni, Marco/J-4099-2013; Stampanoni, Marco/GRR-9695-2022; Donoghue, Philip/A-3873-2008; Marone, Federica/J-4420-2013	Stampanoni, Marco/0000-0001-7486-6681; Stampanoni, Marco/0000-0001-7486-6681; Stampanoni, Marco/0000-0001-7486-6681; Donoghue, Philip/0000-0003-3116-7463; Bengtson, Stefan/0000-0003-0206-5791; Cunningham, John/0000-0002-2870-1832	Swedish Research Council; Natural Environment Research Council; Ministry of Science and Technology of China; National Natural Science Foundation of China; EU; Paul Scherrer Institute; NERC [NE/F00348X/1] Funding Source: UKRI; Natural Environment Research Council [NE/F00348X/1] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); EU(European Commission); Paul Scherrer Institute; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank S. Xiao, T. Cavalier-Smith, and B. Landfald for discussion; T. Hode and Z. Yue for field-work collaboration; A. Groso for assistance with the srXTM work; and P. Varvarigos and D. Elliott for the use of fig. S7. The work was supported by the Swedish Research Council, Natural Environment Research Council, Ministry of Science and Technology of China, National Natural Science Foundation of China, EU FP7, and the Paul Scherrer Institute. Figured or measured specimens are deposited at the Swedish Museum of Natural History and the Museum of Earth Science, Chinese Academy of Geological Sciences. The srXTM investigations were conducted at the X04SA and X02DA (TOMCAT) beamlines of the Swiss Light Source. The data were visualized and analyzed by using Avizo software. Data are available in the SOM. S. B. and P.C.J.D. designed the research and wrote the paper; T. H. found the nucleic structures, prepared the corresponding visualizations, and wrote the specimen descriptions in the SOM; J.A.C. found the propagule-like structures and performed taphonomic analyses and volumetric measurements; C.Y. and S. B. did the field work; C.Y. provided the additional data from Hubei; and M. S., F. M., S. B. and P.C.J.D. designed the srXTM experiments.	Bailey JV, 2007, NATURE, V446, pE10, DOI 10.1038/nature05754; Bailey JV, 2007, NATURE, V445, P198, DOI 10.1038/nature05457; Bonner John Tyler, 1998, Integrative Biology, V1, P27; Chen JY, 2006, SCIENCE, V312, P1644, DOI 10.1126/science.1125964; Chen JY, 2009, P NATL ACAD SCI USA, V106, P19056, DOI 10.1073/pnas.0904805106; Cohen PA, 2009, P NATL ACAD SCI USA, V106, P6519, DOI 10.1073/pnas.0902322106; Donoghue PCJ, 2007, NATURE, V445, P155, DOI 10.1038/nature05520; ELBRACHTER M, 1988, HELGOLANDER MEERESUN, V42, P593, DOI 10.1007/BF02365629; Franco-Sierra A, 1999, PARASITOL RES, V85, P562, DOI 10.1007/s004360050596; GREEN KJ, 1981, J CELL BIOL, V91, P743, DOI 10.1083/jcb.91.3.743; Hagadorn JW, 2006, SCIENCE, V314, P291, DOI 10.1126/science.1133129; Hanamura K, 2001, ZOOL SCI, V18, P381, DOI 10.2108/zsj.18.381; Herron MD, 2010, J PHYCOL, V46, P316, DOI 10.1111/j.1529-8817.2009.00803.x; Horodyski R.J., 1992, P185; Leander BS, 2008, J EUKARYOT MICROBIOL, V55, P59, DOI 10.1111/j.1550-7408.2008.00308.x; Liu Peng-ju, 2009, Acta Geoscientia Sinica, V30, P457; Marshall WL, 2011, PROTIST, V162, P33, DOI 10.1016/j.protis.2010.06.002; Mendoza L, 1999, MYCOPATHOLOGIA, V148, P9, DOI 10.1023/A:1007108910025; Mendoza L, 2002, ANNU REV MICROBIOL, V56, P315, DOI 10.1146/annurev.micro.56.012302.160950; Mikhailov KV, 2009, BIOESSAYS, V31, P758, DOI 10.1002/bies.200800214; Molloy DP, 2005, DIS AQUAT ORGAN, V65, P237, DOI 10.3354/dao065237; Pekkarinen M, 2003, J NAT HIST, V37, P1155, DOI 10.1080/00222930110120999; Raff EC, 2008, P NATL ACAD SCI USA, V105, P19360, DOI 10.1073/pnas.0810106105; RAGHUKUMAR S, 1987, BOT MAR, V30, P83, DOI 10.1515/botm.1987.30.1.83; Rose Annkatrin, 2008, V9, P207, DOI 10.1007/7089_2007_128; Schiffbauer JD, 2012, GEOLOGY, V40, P223, DOI 10.1130/G32546.1; Xiao SH, 1998, NATURE, V391, P553, DOI 10.1038/35318; Xiao SH, 2002, PALEOBIOLOGY, V28, P244, DOI 10.1666/0094-8373(2002)028<0244:MTAMON>2.0.CO;2; Xiao SH, 2007, NATURE, V446, pE9, DOI 10.1038/nature05753; Xiao SH, 2007, GEOLOGY, V35, P115, DOI 10.1130/G23277A.1; Xue Yao-song, 1995, Acta Palaeontologica Sinica, V34, P688; Yin CY, 2004, ACTA PALAEONTOL POL, V49, P1; Yin LM, 2007, NATURE, V446, P661, DOI 10.1038/nature05682; Yin ZJ, 2013, PRECAMBRIAN RES, V225, P44, DOI 10.1016/j.precamres.2011.08.011	34	115	125	2	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1696	1699		10.1126/science.1209537	http://dx.doi.org/10.1126/science.1209537			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22194575				2022-12-28	WOS:000298344000065
J	Trcek, T; Larson, DR; Moldon, A; Query, CC; Singer, RH				Trcek, Tatjana; Larson, Daniel R.; Moldon, Alberto; Query, Charles C.; Singer, Robert H.			Single-Molecule mRNA Decay Measurements Reveal Promoter-Regulated mRNA Stability in Yeast	CELL			English	Article							CELL-CYCLE PROGRESSION; SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; BUDDING YEAST; IN-VIVO; TRANSCRIPTION; GENE; DBF2; VISUALIZATION; DEGRADATION	Messenger RNA decay measurements are typically performed on a population of cells. However, this approach cannot reveal sufficient complexity to provide information on mechanisms that may regulate mRNA degradation, possibly on short timescales. To address this deficiency, we measured cell cycle-regulated decay in single yeast cells using single-molecule FISH. We found that two genes responsible for mitotic progression, SWI5 and CLB2, exhibit a mitosis-dependent mRNA stability switch. Their transcripts are stable until mitosis, when a precipitous decay eliminates the mRNA complement, preventing carryover into the next cycle. Remarkably, the specificity and timing of decay is entirely regulated by their promoter, independent of specific cis mRNA sequences. The mitotic exit network protein Dbf2p binds to SWI5 and CLB2 mRNAs cotranscriptionally and regulates their decay. This work reveals the promoter-dependent control of mRNA stability, a regulatory mechanism that could be employed by a variety of mRNAs and organisms.	[Singer, Robert H.] Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Bronx, NY 10461 USA; [Larson, Daniel R.] NCI, NIH, Bethesda, MD 20892 USA	Yeshiva University; Albert Einstein College of Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Singer, RH (corresponding author), Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	robert.singer@einstein.yu.edu	Larson, Daniel R/B-9829-2008	Larson, Daniel R/0000-0001-9253-3055	EMBO [GM57829, GM57071]; NATIONAL CANCER INSTITUTE [ZIABC011409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057829, R01GM057071] Funding Source: NIH RePORTER	EMBO(European Molecular Biology Organization (EMBO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Drs. Jeffrey Chao and Kevin Czaplinski for helpful discussion of the project and Xiuhua Meng for her help with cloning. We thank Drs. Ian Willis, Michael Keogh, and Angelika Amon for sharing Delta SWI5 (TT012), Pab1p-TAP (TT065) strains, and Dbf2p-kinase dead plasmid with us, respectively. This work was supported by an EMBO fellowship awarded to A.M., GM57829 to C.C.Q., and GM57071 to R.H.S.	Ardehali MB, 2009, NAT STRUCT MOL BIOL, V16, P1123, DOI 10.1038/nsmb1109-1123; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Bean JM, 2006, MOL CELL, V21, P3, DOI 10.1016/j.molcel.2005.10.035; BREWER BJ, 1984, MOL CELL BIOL, V4, P2529, DOI 10.1128/MCB.4.11.2529; Cai T, 2002, GENETICS, V161, P1029; Clement SL, 2011, MOL CELL BIOL, V31, P256, DOI 10.1128/MCB.00717-10; Darieva Z, 2006, NATURE, V444, P494, DOI 10.1038/nature05339; Dori-Bachash M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001106; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Femino AM, 2003, METHOD ENZYMOL, V361, P245; FITCH I, 1992, MOL BIOL CELL, V3, P805, DOI 10.1091/mbc.3.7.805; Gilbert C, 2004, MOL CELL, V14, P457, DOI 10.1016/S1097-2765(04)00239-4; Gill T, 2004, MOL CELL BIOL, V24, P945, DOI 10.1128/MCB.24.3.945-953.2004; Goler-Baron V, 2008, GENE DEV, V22, P2022, DOI 10.1101/gad.473608; Grigull J, 2004, MOL CELL BIOL, V24, P5534, DOI 10.1128/MCB.24.12.5534-5547.2004; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; Harel-Sharvit L, 2010, CELL, V143, P552, DOI 10.1016/j.cell.2010.10.033; HARTWELL LH, 1974, BACTERIOL REV, V38, P164, DOI 10.1128/MMBR.38.2.164-198.1974; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; JIMENEZ A, 1973, ANTIMICROB AGENTS CH, V3, P729, DOI 10.1128/AAC.3.6.729; Koranda M, 2000, NATURE, V406, P94, DOI 10.1038/35017589; Larson DR, 2011, SCIENCE, V332, P475, DOI 10.1126/science.1202142; Larson DR, 2005, P NATL ACAD SCI USA, V102, P15453, DOI 10.1073/pnas.0504812102; Liu HY, 1997, EMBO J, V16, P5289, DOI 10.1093/emboj/16.17.5289; LORD PG, 1980, J BACTERIOL, V142, P808, DOI 10.1128/JB.142.3.808-818.1980; Mah AS, 2001, P NATL ACAD SCI USA, V98, P7325, DOI 10.1073/pnas.141098998; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Moldon A, 2008, NATURE, V455, P997, DOI 10.1038/nature07325; Niu W, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000120; OSLEY MA, 1991, ANNU REV BIOCHEM, V60, P827, DOI 10.1146/annurev.biochem.60.1.827; Passos DO, 2008, METHOD ENZYMOL, V448, P409, DOI 10.1016/S0076-6879(08)02620-7; Pelechano V, 2008, YEAST, V25, P85, DOI 10.1002/yea.1548; SANDLER H, 2001, NUCLEIC ACIDS RES, V39, P4373; Shen ZF, 2010, GENE DEV, V24, P1914, DOI 10.1101/gad.1937510; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Talarek N, 2010, MOL CELL, V38, P345, DOI 10.1016/j.molcel.2010.02.039; TOYN JH, 1991, GENE, V104, P63, DOI 10.1016/0378-1119(91)90465-N; TOYN JH, 1994, EMBO J, V13, P1103, DOI 10.1002/j.1460-2075.1994.tb06359.x; Trcek T, 2010, GENE DEV, V24, P1827, DOI 10.1101/gad.1972810; Tucker M, 2002, EMBO J, V21, P1427, DOI 10.1093/emboj/21.6.1427; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; Visintin R, 2001, MOL BIOL CELL, V12, P2961, DOI 10.1091/mbc.12.10.2961; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514; Zhu GF, 2000, NATURE, V406, P90, DOI 10.1038/35017581	47	183	185	1	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 23	2011	147	7					1484	1497		10.1016/j.cell.2011.11.051	http://dx.doi.org/10.1016/j.cell.2011.11.051			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	866SP	22196726	Green Accepted, Bronze			2022-12-28	WOS:000298403400014
J	D'Agati, VD; Kaskel, FJ; Falk, RJ				D'Agati, Vivette D.; Kaskel, Frederick J.; Falk, Ronald J.			Focal Segmental Glomerulosclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							RESISTANT NEPHROTIC SYNDROME; HIV-ASSOCIATED NEPHROPATHY; PARIETAL EPITHELIAL-CELLS; GLOMERULAR TIP LESION; RENAL-DISEASE; COLLAPSING GLOMERULOPATHY; KIDNEY-DISEASE; PATHOLOGICAL FEATURES; UROKINASE RECEPTOR; AFRICAN-AMERICANS	Focal segmental glomerulosclerosis accounts for approximately 20% of cases of the nephrotic syndrome in children and 40% of such cases in adults, with an estimated incidence of 7 per 1 million.(1) It is the most common primary glomerular disorder causing end-stage renal disease in the United States, with a prevalence of 4%.(2) The cardinal feature is progressive glomerular scarring. Early in the disease course, glomerulosclerosis is both focal, involving a minority of glomeruli, and segmental, affecting a portion of the glomerular globe. With progression, more widespread and global glomerulosclerosis develops. Since the first clinical-pathological studies of the disease in the 1970s,(3) there has been renewed interest because of the increasing incidence of the disease,(4) better understanding of causation, and identification of the podocyte as the major cellular target.(5) The discovery that mutations in podocyte genes are associated with genetic focal segmental glomerulosclerosis has advanced the field of podocyte biology and stimulated new approaches to diagnosis and management.(6)	[D'Agati, Vivette D.] Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; [Kaskel, Frederick J.] Albert Einstein Coll Med, Div Pediat Nephrol, New York, NY USA; [Falk, Ronald J.] Univ N Carolina, UNC Kidney Ctr, Chapel Hill, NC USA; [Falk, Ronald J.] Univ N Carolina, Div Nephrol & Hypertens, Chapel Hill, NC USA	Columbia University; Yeshiva University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	D'Agati, VD (corresponding author), Columbia Univ, Med Ctr, Div Renal Pathol, Rm VC14-224,630 W 168th St, New York, NY 10032 USA.	vdd1@columbia.edu						Abbate M, 2002, AM J PATHOL, V161, P2179, DOI 10.1016/S0002-9440(10)64495-1; [Anonymous], 1978, KIDNEY INT, V13, P159; Appel D, 2009, J AM SOC NEPHROL, V20, P333, DOI 10.1681/ASN.2008070795; BANFI G, 1991, CLIN NEPHROL, V36, P53; Barisoni L, 1999, J AM SOC NEPHROL, V10, P51; Barisoni L, 2007, CLIN J AM SOC NEPHRO, V2, P529, DOI 10.2215/CJN.04121206; Berkovic SE, 2008, AM J HUM GENET, V82, P673, DOI 10.1016/j.ajhg.2007.12.019; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; BRENNER BM, 1982, NEW ENGL J MED, V307, P652, DOI 10.1056/NEJM198209093071104; Brown EJ, 2010, NAT GENET, V42, P72, DOI 10.1038/ng.505; Bruggeman LA, 2000, J AM SOC NEPHROL, V11, P2079, DOI 10.1681/ASN.V11112079; Cattran DC, 1999, KIDNEY INT, V56, P2220, DOI 10.1046/j.1523-1755.1999.00778.x; Chen P, 2011, J AM SOC NEPHROL, V22, P496, DOI 10.1681/ASN.2010040379; Chun MJ, 2004, J AM SOC NEPHROL, V15, P2169, DOI 10.1097/01.ASN.0000135051.62500.97; Crew VK, 2004, BLOOD, V104, P2217, DOI 10.1182/blood-2004-04-1512; D'Agati VD, 2004, AM J KIDNEY DIS, V43, P368, DOI 10.1053/j.ajkd.2003.10.024; D'Agati VD, 2008, CURR OPIN NEPHROL HY, V17, P271, DOI 10.1097/MNH.0b013e3282f94a96; Denamur E, 1999, J AM SOC NEPHROL, V10, P2219; Diomedi-Camassei F, 2007, J AM SOC NEPHROL, V18, P2773, DOI 10.1681/ASN.2006080833; EDDY AA, 1995, KIDNEY INT, V47, P1546, DOI 10.1038/ki.1995.218; Faul C, 2008, NAT MED, V14, P931, DOI 10.1038/nm.1857; Fervenza FC, 2004, NEPHROL DIAL TRANSPL, V19, P1288, DOI 10.1093/ndt/gfh079; Fornoni A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002231; FRIEDMAN EA, 1995, AM J KIDNEY DIS, V25, P689, DOI 10.1016/0272-6386(95)90543-X; Friedrich C, 2006, AM J PHYSIOL-RENAL, V291, pF856, DOI 10.1152/ajprenal.00196.2005; Gbadegesin R, 2011, PEDIATR NEPHROL, V26, P1001, DOI 10.1007/s00467-010-1692-x; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Ghiggeri GM, 2003, AM J KIDNEY DIS, V41, P95, DOI 10.1053/ajkd.2003.50028; Gipson DS, 2011, KIDNEY INT, V80, P868, DOI 10.1038/ki.2011.195; Guery B, 2003, J AM SOC NEPHROL, V14, P2099, DOI 10.1097/01.ASN.0000080180.51098.02; Haas M, 1997, AM J KIDNEY DIS, V30, P621, DOI 10.1016/S0272-6386(97)90485-6; He JCJ, 2004, J CLIN INVEST, V114, P643, DOI 10.1172/JCI200421004; Heeringa SF, 2011, J CLIN INVEST, V121, P2013, DOI 10.1172/JCI45693; Herlitz LC, 2010, J AM SOC NEPHROL, V21, P163, DOI 10.1681/ASN.2009040450; Hinkes B, 2006, NAT GENET, V38, P1397, DOI 10.1038/ng1918; Hinkes BG, 2007, PEDIATRICS, V119, pE907, DOI 10.1542/peds.2006-2164; Hodgin JB, 2010, AM J PATHOL, V177, P1674, DOI 10.2353/ajpath.2010.090746; Hodgin JB, 2009, CLIN J AM SOC NEPHRO, V4, P71, DOI 10.2215/CJN.01700408; Howie AJ, 2005, KIDNEY INT, V67, P987, DOI 10.1111/j.1523-1755.2005.00162.x; Ijpelaar DHT, 2008, J AM SOC NEPHROL, V19, P2219, DOI 10.1681/ASN.2007121365; Inagi R, 2005, KIDNEY INT, V68, P2639, DOI 10.1111/j.1523-1755.2005.00736.x; Kambham N, 2000, AM J KIDNEY DIS, V36, P190, DOI 10.1053/ajkd.2000.8293; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kim JM, 2003, SCIENCE, V300, P1298, DOI 10.1126/science.1081068; Kitiyakara C, 2003, SEMIN NEPHROL, V23, P172, DOI 10.1053/snep.2003.50025; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Korbet SM, 1998, J AM SOC NEPHROL, V9, P1333; Li RM, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000028249.06596.CF; Lowik MM, 2009, EUR J PEDIATR, V168, P1291, DOI 10.1007/s00431-009-1017-x; Lucke T, 2005, AM J MED GENET A, V135A, P202, DOI 10.1002/ajmg.a.30691; Markowitz GS, 2010, CLIN J AM SOC NEPHRO, V5, P1353; Markowitz GS, 2010, CLIN J AM SOC NEPHRO, V5, P607, DOI 10.2215/CJN.07311009; Markowitz GS, 2001, J AM SOC NEPHROL, V12, P1164, DOI 10.1681/ASN.V1261164; Matsusaka T, 2005, J AM SOC NEPHROL, V16, P1013, DOI 10.1681/ASN.2004080720; Matsusaka T, 2011, J AM SOC NEPHROL, V22, P1275, DOI 10.1681/ASN.2010090963; McCarthy ET, 2010, CLIN J AM SOC NEPHRO, V5, P2115, DOI 10.2215/CJN.03800609; Mele C, 2011, NEW ENGL J MED, V365, P295, DOI 10.1056/NEJMoa1101273; Moudgil A, 2001, KIDNEY INT, V59, P2126, DOI 10.1046/j.1523-1755.2001.00727.x; Nadasdy T, 2002, HUM PATHOL, V33, P437, DOI 10.1053/hupa.2002.124333; NAGATA M, 1992, KIDNEY INT, V42, P148, DOI 10.1038/ki.1992.272; Ozaltin F, 2011, AM J HUM GENET, V89, P139, DOI 10.1016/j.ajhg.2011.05.026; Papeta N, 2010, J CLIN INVEST, V120, P4055, DOI 10.1172/JCI43721; Peti-Peterdi J, 2010, J AM SOC NEPHROL, V21, P1835, DOI 10.1681/ASN.2010040378; Puliti A, 2011, AM J PATHOL, V178, P1257, DOI 10.1016/j.ajpath.2010.11.050; Renal Data System, 2010, USRDS 2010 ANN DAT R; RENNKE HG, 1989, AM J KIDNEY DIS, V13, P443, DOI 10.1016/S0272-6386(89)80001-0; Ronconi E, 2009, J AM SOC NEPHROL, V20, P322, DOI 10.1681/ASN.2008070709; Rosenstiel P, 2009, J AM SOC NEPHROL, V20, P2296, DOI 10.1681/ASN.2008121230; Rosenstiel PE, 2008, KIDNEY INT, V74, P1049, DOI 10.1038/ki.2008.303; Santin S, 2011, CLIN J AM SOC NEPHRO, V6, P1139, DOI 10.2215/CJN.05260610; Santin S, 2009, KIDNEY INT, V76, P1268, DOI 10.1038/ki.2009.381; Sato Y, 2009, J AM SOC NEPHROL, V20, P1041, DOI 10.1681/ASN.2007121328; Schonenberger E, 2011, NEPHROL DIAL TRANSPL, V26, P18, DOI 10.1093/ndt/gfq617; Sekine T, 2010, KIDNEY INT, V78, P207, DOI 10.1038/ki.2010.21; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Smeets B, 2011, J AM SOC NEPHROL, V22, P1262, DOI 10.1681/ASN.2010090970; Smeets B, 2009, J AM SOC NEPHROL, V20, P2604, DOI 10.1681/ASN.2009010122; Snyder A, 2010, AIDS, V24, P1107, DOI 10.1097/QAD.0b013e328337b0ab; Stokes MB, 2006, KIDNEY INT, V70, P1783, DOI 10.1038/sj.ki.5001903; Stokes MB, 1999, AM J KIDNEY DIS, V33, P658, DOI 10.1016/S0272-6386(99)70216-7; Stokes MB, 2004, KIDNEY INT, V65, P1690, DOI 10.1111/j.1523-1755.2004.00563.x; Thomas DB, 2006, KIDNEY INT, V69, P920, DOI 10.1038/sj.ki.5000160; Tomlinson L, 2003, NEPHROL DIAL TRANSPL, V18, P187, DOI 10.1093/ndt/18.1.187; Troyanov S, 2005, J AM SOC NEPHROL, V16, P1061, DOI 10.1681/ASN.2004070593; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; Vinai M, 2010, PEDIATR TRANSPLANT, V14, P314, DOI 10.1111/j.1399-3046.2009.01261.x; Vollenbroker B, 2009, AM J PHYSIOL-RENAL, V296, pF418, DOI 10.1152/ajprenal.90319.2008; Wei C, 2008, NAT MED, V14, P55, DOI 10.1038/nm1696; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; Weins A, 2007, P NATL ACAD SCI USA, V104, P16080, DOI 10.1073/pnas.0702451104; Wharram BL, 2005, J AM SOC NEPHROL, V16, P2941, DOI 10.1681/ASN.2005010055; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Wyatt CM, 2008, SEMIN NEPHROL, V28, P513, DOI 10.1016/j.semnephrol.2008.08.005; Zenker M, 2004, HUM MOL GENET, V13, P2625, DOI 10.1093/hmg/ddh284; Zenker M, 2009, J MOL MED, V87, P849, DOI 10.1007/s00109-009-0505-9; Zuo YQ, 2006, J AM SOC NEPHROL, V17, P2832, DOI 10.1681/ASN.2005080878	101	505	531	0	59	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2011	365	25					2398	2411		10.1056/NEJMra1106556	http://dx.doi.org/10.1056/NEJMra1106556			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	865OM	22187987				2022-12-28	WOS:000298320200006
J	Beaman, L; Duflo, E; Pande, R; Topalova, P				Beaman, Lori; Duflo, Esther; Pande, Rohini; Topalova, Petia			Female Leadership Raises Aspirations and Educational Attainment for Girls: A Policy Experiment in India	SCIENCE			English	Article							SOCIAL COGNITIVE THEORY; CAREER ASPIRATIONS; ROLE MODELS; WOMEN; STUDENTS; MINORITY; BELIEFS; SCIENCE	Exploiting a randomized natural experiment in India, we show that female leadership influences adolescent girls' career aspirations and educational attainment. A 1993 law reserved leadership positions for women in randomly selected village councils. Using 8453 surveys of adolescents aged 11 to 15 and their parents in 495 villages, we found that, relative to villages in which such positions were never reserved, the gender gap in aspirations closed by 20% in parents and 32% in adolescents in villages assigned a female leader for two election cycles. The gender gap in adolescent educational attainment was erased, and girls spent less time on household chores. We found no evidence of changes in young women's labor market opportunities, which suggests that the impact of women leaders primarily reflects a role model effect.	[Beaman, Lori] Northwestern Univ, Dept Econ, Evanston, IL 60208 USA; [Duflo, Esther] MIT, Dept Econ, Cambridge, MA 02142 USA; [Pande, Rohini] Harvard Univ, Harvard Kennedy Sch, Cambridge, MA 02138 USA; [Topalova, Petia] Int Monetary Fund, Washington, DC 20434 USA	Northwestern University; Massachusetts Institute of Technology (MIT); Harvard University; International Monetary Fund	Beaman, L (corresponding author), Northwestern Univ, Dept Econ, Evanston, IL 60208 USA.	l-beaman@northwestern.edu; eduflo@mit.edu; rohini_pande@ksg.harvard.edu; ptopalova@imf.org			Ash Institute Harvard; Nike Foundation; MIT; National Institute of Child Health and Human Development [R01 HD039922-06]; Yale University; UNICEF; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD039922] Funding Source: NIH RePORTER	Ash Institute Harvard; Nike Foundation; MIT; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Yale University; UNICEF; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank R. Chattopadhyay, with whom we initiated this research agenda and we collaborated on previous studies, and P. Chakraborthy and SRG Consulting for data collection. The views expressed in this paper are those of the authors and do not implicate the International Monetary Fund, its management, or its executive board. Supported by Ash Institute Harvard, Nike Foundation, MIT, National Institute of Child Health and Human Development grant R01 HD039922-06, Yale University, and UNICEF. The data are accessible at the Harvard-MIT data center Web site: http://dvn.iq.harvard.edu/dvn/dv/mit/faces/StudyListingPage.xhtml?mode=1&collectionId=24.	[Anonymous], 2010, INDIA POLICY FORUM; Asgari S, 2010, SOC PSYCHOL-GERMANY, V41, P203, DOI 10.1027/1864-9335/a000028; Bandura A, 2001, CHILD DEV, V72, P187, DOI 10.1111/1467-8624.00273; Bandura A, 2001, ANNU REV PSYCHOL, V52, P1, DOI 10.1146/annurev.psych.52.1.1; Beaman L, 2009, Q J ECON, V124, P1497, DOI 10.1162/qjec.2009.124.4.1497; Bussey K, 1999, PSYCHOL REV, V106, P676, DOI 10.1037/0033-295X.106.4.676; CANES BJ, 1995, IND LABOR RELAT REV, V48, P486, DOI 10.2307/2524777; Chattopadhyay R, 2004, ECONOMETRICA, V72, P1409, DOI 10.1111/j.1468-0262.2004.00539.x; Cohen GL, 2009, SCIENCE, V324, P400, DOI 10.1126/science.1170769; Eagly A. H., 1987, SEX DIFFERENCES SOCI, DOI [10.1037/0022-3514.65.5.1010, DOI 10.4324/]; Eagly AH, 2002, PSYCHOL REV, V109, P573, DOI 10.1037//0033-295X.109.3.573; Gardiner M., 2007, HIGH EDUC RES DEV, V26, P425, DOI [10.1080/07294360701658633, DOI 10.1080/07294360701658633]; GREENE AL, 1982, J EDUC PSYCHOL, V74, P393, DOI 10.1037/0022-0663.74.3.393; Jensen R., 2010, 16021 NBER; Karlan D, 2011, SCIENCE, V332, P1278, DOI 10.1126/science.1200138; Kaul S., 2009, STUDIES HOME COMMUNI, V3, P29; Kling JR, 2007, ECONOMETRICA, V75, P83, DOI 10.1111/j.1468-0262.2007.00733.x; Krook M.L., 2010, QUOTAS WOMEN POLITIC; Lips HM, 2001, J SOC ISSUES, V57, P799, DOI 10.1111/0022-4537.00242; Lips HM, 2000, PSYCHOL WOMEN QUART, V24, P39, DOI 10.1111/j.1471-6402.2000.tb01020.x; Lockwood P, 2006, PSYCHOL WOMEN QUART, V30, P36, DOI 10.1111/j.1471-6402.2006.00260.x; Nauta MM, 1998, J COUNS PSYCHOL, V45, P483, DOI 10.1037/0022-0167.45.4.483; Nguyen Trang, 2008, INFORM ROLE MO UNPUB; Nixon LA, 1999, DEMOGRAPHY, V36, P185, DOI 10.2307/2648107; Richman LS, 2011, J SOC ISSUES, V67, P492, DOI 10.1111/j.1540-4560.2011.01711.x; Rudman LA, 2010, SOC PSYCHOL-GERMANY, V41, P192, DOI 10.1027/1864-9335/a000027; SMITH WS, 1986, J RES SCI TEACH, V23, P667, DOI 10.1002/tea.3660230802; Stout JG, 2011, J PERS SOC PSYCHOL, V100, P255, DOI 10.1037/a0021385; Wolbrecht C, 2007, AM J POLIT SCI, V51, P921, DOI 10.1111/j.1540-5907.2007.00289.x; Wright JC, 1995, CHILD DEV, V66, P1706	30	375	378	9	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2012	335	6068					582	586		10.1126/science.1212382	http://dx.doi.org/10.1126/science.1212382			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	885HI	22245740	Green Accepted, Green Submitted			2022-12-28	WOS:000299769200043
J	Alhassani, A; Chandra, A; Chernew, ME				Alhassani, Ali; Chandra, Amitabh; Chernew, Michael E.			The Sources of the SGR "Hole"	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Alhassani, Ali; Chernew, Michael E.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Chandra, Amitabh] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University	Alhassani, A (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA.							[Anonymous], MED MED STAT SUPPL; Congressional Budget Office, MED PAYM PHYS BUDG I	2	38	38	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 26	2012	366	4					289	291		10.1056/NEJMp1113059	http://dx.doi.org/10.1056/NEJMp1113059			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	881EQ	22187962				2022-12-28	WOS:000299464100012
J	Jemec, GBE				Jemec, Gregor B. E.			Hidradenitis Suppurativa	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONTROLLED CROSSOVER TRIAL; DIOXIDE LASER-SURGERY; QUALITY-OF-LIFE; ACNE INVERSA; DOUBLE-BLIND; CYPROTERONE-ACETATE; LESIONS; DISEASE; ISOTRETINOIN; CLINDAMYCIN	A 36-year-old woman has recurrent boils under both arms and in the groin. They flare premenstrually, causing pain, suppuration, and an offensive odor. Scarring has developed in the groin area, and chronically draining sinus tracts are interspersed with normal skin. Treatment with short courses of antibiotics or with incision and drainage has had no apparent effect, and she has become socially isolated because of embarrassment about her condition. How would you manage this case?	[Jemec, Gregor B. E.] Roskilde Hosp, Dept Dermatol, DK-4000 Roskilde, Denmark; [Jemec, Gregor B. E.] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	University of Copenhagen	Jemec, GBE (corresponding author), Roskilde Hosp, Dept Dermatol, DK-4000 Roskilde, Denmark.	gbj@regionsjaelland.dk		Jemec, Gregor/0000-0002-0712-2540	Abbott Laboratories; Merck; Pfizer; Dumex-Alpharma; Galderma; Photocure; LEO Pharma	Abbott Laboratories(Abbott Laboratories); Merck(Merck & Company); Pfizer(Pfizer); Dumex-Alpharma; Galderma; Photocure; LEO Pharma(LEO Pharma)	Dr. Jemec reports receiving consulting fees from Abbott Laboratories, Merck, Pfizer, and Dumex-Alpharma, lecture fees from Galderma and Pfizer, and grant support from Abbott Laboratories, Photocure, and LEO Pharma; receiving equipment on loan from Michelson Diagnostics; and receiving reimbursement for travel expenses from Abbott Laboratories, Galderma, and Photocure. No other potential conflict of interest relevant to this article was reported.	Adams DR, 2010, ARCH DERMATOL, V146, P501, DOI 10.1001/archdermatol.2010.72; Altenburg J, 2011, RESPIRATION, V81, P67, DOI 10.1159/000320319; Boer J, 1996, BRIT J DERMATOL, V135, P721; Boer J, 1999, J AM ACAD DERMATOL, V40, P73, DOI 10.1016/S0190-9622(99)70530-X; Buckley DA, 1995, J R SOC MED, V88, p289P; CLEMMENSEN OJ, 1983, INT J DERMATOL, V22, P325, DOI 10.1111/j.1365-4362.1983.tb02150.x; Frohlich D, 2000, STRAHLENTHER ONKOL, V176, P286; Gener G, 2009, DERMATOLOGY, V219, P148, DOI 10.1159/000228334; Grant A, 2010, J AM ACAD DERMATOL, V62, P205, DOI 10.1016/j.jaad.2009.06.050; Hurley HJ, 1996, ROENIGK ROENIGKS DER, V2nd, P623; Jemec GB, 2006, HIDRADENITIS SUPPURA; Jemec GBE, 1998, J AM ACAD DERMATOL, V39, P971, DOI 10.1016/S0190-9622(98)70272-5; Jemec GBE, 1996, DERMATOLOGY, V193, P203, DOI 10.1159/000246246; Jemec GBE, 1996, J AM ACAD DERMATOL, V35, P191, DOI 10.1016/S0190-9622(96)90321-7; Jemec GBE, 1996, J AM ACAD DERMATOL, V34, P994, DOI 10.1016/S0190-9622(96)90277-7; Jemec GBE, 1996, CLIN EXP DERMATOL, V21, P419, DOI 10.1111/j.1365-2230.1996.tb00145.x; Jemec GBE, 1996, ACTA DERM-VENEREOL, V76, P482; Kamp S, 2011, BRIT J DERMATOL, V164, P1017, DOI 10.1111/j.1365-2133.2011.10224.x; Konig A, 1999, DERMATOLOGY, V198, P261, DOI 10.1159/000018126; Kurokawa I, 2002, J INT MED RES, V30, P131, DOI 10.1177/147323000203000205; Kurzen H, 2008, EXP DERMATOL, V17, P455, DOI [10.1111/j.1600-0625.2008.00712.x, 10.1111/j.1600-0625.2008.00712_1.x]; LAPINS J, 1994, BRIT J DERMATOL, V131, P551; Lapins J, 2002, J AM ACAD DERMATOL, V47, P280, DOI 10.1067/mjd.2002.124601; Lapins J, 2001, ARCH DERMATOL, V137, P730; Lapins J, 2001, ACTA DERM-VENEREOL, V81, P28, DOI 10.1080/000155501750208146; Lapins J, 1999, BRIT J DERMATOL, V140, P90; Mandal A, 2005, SURG-J R COLL SURG E, V3, P23, DOI 10.1016/S1479-666X(05)80006-X; Matusiak L, 2010, J AM ACAD DERMATOL, V62, P706, DOI 10.1016/j.jaad.2009.09.021; Matusiak L, 2009, ACTA DERM-VENEREOL, V89, P601, DOI 10.2340/00015555-0749; Mebazaa A, 2009, ACTA DERMATOVEN ALP, V18, P165; Miller I, 2011, BRIT J DERMATOL, V165, P391, DOI 10.1111/j.1365-2133.2011.10339.x; MORTIMER PS, 1986, BRIT J DERMATOL, V115, P263, DOI 10.1111/j.1365-2133.1986.tb05740.x; Palmer RA, 2001, CLIN EXP DERMATOL, V26, P501, DOI 10.1046/j.1365-2230.2001.00876.x; Revuz JE, 2008, J AM ACAD DERMATOL, V59, P596, DOI 10.1016/j.jaad.2008.06.020; Ritz JP, 1998, INT J COLORECTAL DIS, V13, P164, DOI 10.1007/s003840050159; Rose RF, 2006, CLIN EXP DERMATOL, V31, P154, DOI 10.1111/j.1365-2230.2005.01983.x; Sartorius K, 2009, BRIT J DERMATOL, V161, P831, DOI 10.1111/j.1365-2133.2009.09198.x; SAWERS RS, 1986, BRIT J DERMATOL, V115, P269, DOI 10.1111/j.1365-2133.1986.tb05741.x; Schlapbach C, 2011, J AM ACAD DERMATOL, V65, P790, DOI 10.1016/j.jaad.2010.07.010; Soria A, 2009, DERMATOLOGY, V218, P134, DOI 10.1159/000182261; Tierney E, 2009, DERMATOL SURG, V35, P1188, DOI 10.1111/j.1524-4725.2009.01214.x; van der Zee HH, 2010, BRIT J DERMATOL, V162, P195, DOI 10.1111/j.1365-2133.2009.09430.x; van der Zee HH, 2010, J AM ACAD DERMATOL, V63, P475, DOI 10.1016/j.jaad.2009.12.018; van der Zee HH, 2009, DERMATOLOGY, V219, P143, DOI 10.1159/000228337; von der Werth JM, 2000, J EUR ACAD DERMATOL, V14, P389, DOI 10.1046/j.1468-3083.2000.00087.x; von Laffert M, 2010, EXP DERMATOL, V19, P533, DOI 10.1111/j.1600-0625.2009.00915.x; Wang BX, 2010, SCIENCE, V330, P1065, DOI 10.1126/science.1196284; Wolkenstein P, 2007, J AM ACAD DERMATOL, V56, P621, DOI 10.1016/j.jaad.2006.08.061; Wortsman X, 2007, DERMATOL SURG, V33, P1340, DOI 10.1111/j.1524-4725.2007.33286.x; YU CCW, 1990, BRIT J DERMATOL, V122, P763	50	518	537	4	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 12	2012	366	2					158	164		10.1056/NEJMcp1014163	http://dx.doi.org/10.1056/NEJMcp1014163			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874VA	22236226				2022-12-28	WOS:000298985000010
J	Kim, C; Schmidt, T; Cho, EG; Ye, F; Ulmer, TS; Ginsberg, MH				Kim, Chungho; Schmidt, Thomas; Cho, Eun-Gyung; Ye, Feng; Ulmer, Tobias S.; Ginsberg, Mark H.			Basic amino-acid side chains regulate transmembrane integrin signalling	NATURE			English	Article							MEMBRANE-PROTEINS; ACTIVATION; COMPLEX; ALPHA-IIB-BETA-3; RESIDUES; SEGMENT; DOMAINS	Side chains of Lys/Arg near transmembrane domain (TMD)(1-3) membrane-water interfaces can 'snorkel', placing their positive charge near negatively charged phospholipid head groups(4-6); however, snorkelling's functional effects are obscure. Integrin beta TMDs have such conserved basic amino acids. Here we use NMR spectroscopy(7,8) to show that integrin beta(3)(Lys 716) helps determine beta(3) TMD topography. The alpha(IIb)beta(3) TMD structure indicates that precise beta(3) TMD crossing angles enable the assembly of outer and inner membrane 'clasps' that hold the ab TMD together to limit transmembrane signalling(9). Mutation of beta(3)(Lys 716) caused dissociation of alpha(IIb)beta(3) TMDs and integrin activation. To confirm that altered topography of beta(3)(Lys 716) mutants activated alpha(IIb)beta(3), we used directed evolution of beta(3)(K716A) to identify substitutions restoring default state. Introduction of Pro(711) at the midpoint of beta(3) TMD (A711P) increased alpha(IIb)beta(3) TMD association and inactivated integrin alpha(IIb)beta(3)(A711P, K716A). beta(3)(Pro 711) introduced a TMD kink of 30 +/- 1 degrees precisely at the border of the outer and inner membrane clasps, thereby decoupling the tilt between these segments. Thus, widely occurring snorkelling residues in TMDs can help maintain TMD topography and membrane-embedding, thereby regulating transmembrane signalling.	[Kim, Chungho; Ye, Feng; Ginsberg, Mark H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Schmidt, Thomas; Ulmer, Tobias S.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Cho, Eun-Gyung] Sanford Burnham Med Res Inst, Ctr Neurosci Aging & Stem Cell Res, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of Southern California; Sanford Burnham Prebys Medical Discovery Institute	Ginsberg, MH (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	tulmer@usc.edu; mhginsberg@ucsd.edu	ye, Fangmao/A-7438-2012		National Institutes of Health of the USA; National Institutes of Health [HL089726]; American Institute for Cancer Research;  [HL078784];  [HL57900];  [AR27214]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL078784, R01HL106489, P01HL057900, R01HL089726] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR027214, R01AR027214] Funding Source: NIH RePORTER	National Institutes of Health of the USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Institute for Cancer Research; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the National Institutes of Health of the USA. T. S. U. acknowledges support from the National Institutes of Health (HL089726) and M. H. G. was supported by HL078784, HL57900 and AR27214. C. K. is a recipient of a postdoctoral fellowship from the American Institute for Cancer Research.	Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Berger BW, 2010, P NATL ACAD SCI USA, V107, P703, DOI 10.1073/pnas.0910873107; Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Kim C, 2009, BLOOD, V113, P4747, DOI 10.1182/blood-2008-10-186551; Krishnakumar SS, 2007, J MOL BIOL, V374, P1251, DOI 10.1016/j.jmb.2007.10.032; Lau TL, 2008, J BIOL CHEM, V283, P16162, DOI 10.1074/jbc.M801748200; Lau TL, 2008, BIOCHEMISTRY-US, V47, P4008, DOI 10.1021/bi800107a; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; SIPOS L, 1993, EUR J BIOCHEM, V213, P1333, DOI 10.1111/j.1432-1033.1993.tb17885.x; Stefansson A, 2004, J BIOL CHEM, V279, P21200, DOI 10.1074/jbc.M400771200; Strandberg E, 2003, FEBS LETT, V544, P69, DOI 10.1016/S0014-5793(03)00475-7; Strandberg E, 2002, BIOCHEMISTRY-US, V41, P7190, DOI 10.1021/bi012047i; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; VONHEIJNE G, 1994, ANNU REV BIOPH BIOM, V23, P167; Ye F, 2010, J CELL BIOL, V188, P157, DOI 10.1083/jcb.200908045; Zhu JQ, 2007, BLOOD, V110, P2475, DOI 10.1182/blood-2007-03-080077; Zhu J, 2009, MOL CELL, V34, P234, DOI 10.1016/j.molcel.2009.02.022	25	95	97	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 12	2012	481	7380					209	+		10.1038/nature10697	http://dx.doi.org/10.1038/nature10697			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	874TO	22178926	Green Accepted			2022-12-28	WOS:000298981200041
J	Prasad, V; Cifu, A; Ioannidis, JPA				Prasad, Vinay; Cifu, Adam; Ioannidis, John P. A.			Reversals of Established Medical Practices Evidence to Abandon Ship	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							STABLE CORONARY-DISEASE; RANDOMIZED-TRIAL; VERTEBROPLASTY; FRACTURES; PCI		[Ioannidis, John P. A.] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Prasad, Vinay] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Cifu, Adam] Univ Chicago, Dept Med, Chicago, IL 60637 USA	Stanford University; Stanford University; Stanford University; Northwestern University; University of Chicago	Ioannidis, JPA (corresponding author), Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Med Sch Off Bldg,Room X306,1265 Welch Rd, Stanford, CA 94305 USA.	jioannid@stanford.edu	Ioannidis, John P. A./G-9836-2011	Prasad, Vinayak/0000-0002-6110-8221				Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Buchbinder R, 2009, NEW ENGL J MED, V361, P557, DOI 10.1056/NEJMoa0900429; COBB LA, 1959, NEW ENGL J MED, V260, P1115, DOI 10.1056/NEJM195905282602204; Elshaug AG, 2011, NEW ENGL J MED, V364, P1390, DOI 10.1056/NEJMp1101475; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Kallmes DF, 2009, NEW ENGL J MED, V361, P569, DOI 10.1056/NEJMoa0900563; Luetmer MT, 2011, AM J NEURORADIOL, V32, P647, DOI 10.3174/ajnr.A2371; Prasad V, 2011, ARCH INTERN MED, V171, P1675, DOI 10.1001/archinternmed.2011.295; Tatsioni A, 2007, JAMA-J AM MED ASSOC, V298, P2517, DOI 10.1001/jama.298.21.2517; Weintraub WS, 2008, NEW ENGL J MED, V359, P677, DOI 10.1056/NEJMoa072771	10	148	148	2	22	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 4	2012	307	1					37	38		10.1001/jama.2011.1960	http://dx.doi.org/10.1001/jama.2011.1960			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	872ET	22215160				2022-12-28	WOS:000298792300016
J	Bronfort, G; Evans, R; Anderson, AV; Svendsen, KH; Bracha, Y; Grimm, RH				Bronfort, Gert; Evans, Roni; Anderson, Alfred V.; Svendsen, Kenneth H.; Bracha, Yiscah; Grimm, Richard H.			Spinal Manipulation, Medication, or Home Exercise With Advice for Acute and Subacute Neck Pain A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							LOW-BACK-PAIN; 2000-2010 TASK-FORCE; WHIPLASH-ASSOCIATED DISORDERS; CLINICAL-TRIAL; MANUAL THERAPY; PHYSICAL-THERAPY; GENERAL-PRACTITIONER; COVARIATE ADJUSTMENT; CHIROPRACTIC CARE; DISABILITY INDEX	Background: Mechanical neck pain is a common condition that affects an estimated 70% of persons at some point in their lives. Little research exists to guide the choice of therapy for acute and subacute neck pain. Objective: To determine the relative efficacy of spinal manipulation therapy (SMT), medication, and home exercise with advice (HEA) for acute and subacute neck pain in both the short and long term. Design: Randomized, controlled trial. (ClinicalTrials.gov registration number: NCT00029770) Setting: 1 university research center and 1 pain management clinic in Minnesota. Participants: 272 persons aged 18 to 65 years who had nonspecific neck pain for 2 to 12 weeks. Intervention: 12 weeks of SMT, medication, or HEA. Measurements: The primary outcome was participant-rated pain, measured at 2, 4, 8, 12, 26, and 52 weeks after randomization. Secondary measures were self-reported disability, global improvement, medication use, satisfaction, general health status (Short Form-36 Health Survey physical and mental health scales), and adverse events. Blinded evaluation of neck motion was performed at 4 and 12 weeks. Results: For pain, SMT had a statistically significant advantage over medication after 8, 12, 26, and 52 weeks (P <= 0.010), and HEA was superior to medication at 26 weeks (P = 0.02). No important differences in pain were found between SMT and HEA at any time point. Results for most of the secondary outcomes were similar to those of the primary outcome. Limitations: Participants and providers could not be blinded. No specific criteria for defining clinically important group differences were prespecified or available from the literature. Conclusion: For participants with acute and subacute neck pain, SMT was more effective than medication in both the short and long term. However, a few instructional sessions of HEA resulted in similar outcomes at most time points.	NW Hlth Sci Univ, Pain Management & Rehabil Ctr, Minneapolis, MN USA; Minneapolis Med Res Fdn Inc, Berman Ctr Outcomes & Clin Res, Minneapolis, MN 55404 USA	Minneapolis Medical Research Foundation	Bronfort, G (corresponding author), NW Hlth Sci Univ, Wolfe Harris Ctr Clin Studies, 2501 W 84th St, Bloomington, MN 55431 USA.	gbronfort@nwhealth.edu			National Institutes of Health's National Center for Complementary and Alternative Medicine [R01 AT000707]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT000707] Funding Source: NIH RePORTER	National Institutes of Health's National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	By the National Institutes of Health's National Center for Complementary and Alternative Medicine (grant R01 AT000707).	Barnes PM, 2004, ADV DATA, P1; Bendtsen L, 2010, CEPHALALGIA, V30, P1, DOI 10.1111/j.1468-2982.2009.01948.x; Bergmann TF, 2011, CHIROPRACTIC TECHNIQ, V3rd; Bronfort G, 1996, J Manipulative Physiol Ther, V19, P570; Bronfort G, 2001, SPINE, V26, P788, DOI 10.1097/00007632-200104010-00020; Brown H., 1999, APPL MIXED MODELS ME; CARLSSON AM, 1983, PAIN, V16, P87, DOI 10.1016/0304-3959(83)90088-X; Cleland JA, 2007, PHYS THER, V87, P431, DOI 10.2522/ptj.20060217; Cote P, 1998, SPINE, V23, P1689, DOI 10.1097/00007632-199808010-00015; Cote P, 2008, SPINE, V33, pS60, DOI 10.1097/BRS.0b013e3181643ee4; Cote P, 2008, SPINE, V33, pS192, DOI 10.1097/BRS.0b013e3181644616; Coulter ID, 2002, SPINE, V27, P291, DOI 10.1097/00007632-200202010-00018; Daffner SD, 2003, SPINE, V28, P2030, DOI 10.1097/01.BRS.0000083325.27357.39; DEYO RA, 1990, NEW ENGL J MED, V322, P1627, DOI 10.1056/NEJM199006073222303; DVORAK J, 1992, SPINE, V17, pS393, DOI 10.1097/00007632-199210001-00009; Dworkin RH, 2009, PAIN, V146, P238, DOI 10.1016/j.pain.2009.08.019; Evans R, 2003, J MANIP PHYSIOL THER, V26, P403, DOI 10.1016/S0161-4754(03)00093-9; Evans R, 2002, SPINE, V27, P2383, DOI 10.1097/00007632-200211010-00013; Fejer R, 2006, EUR SPINE J, V15, P834, DOI 10.1007/s00586-004-0864-4; Fritz JM, 2009, SPINE, V34, P2803, DOI 10.1097/BRS.0b013e3181ae2bd4; Gross A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004249.pub3; Guyatt GH, 1998, BRIT MED J, V316, P690, DOI 10.1136/bmj.316.7132.690; Guzman J, 2008, SPINE, V33, pS14, DOI 10.1097/BRS.0b013e3181643efb; Guzman J, 2008, SPINE, V33, pS199, DOI 10.1097/BRS.0b013e3181644641; Haines T.A., 2004, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD004249.PUB2; HANSEN FR, 1993, SPINE, V18, P98, DOI 10.1097/00007632-199301000-00015; Hill J, 2004, SPINE, V29, P1648, DOI 10.1097/01.BRS.0000132307.06321.3C; Hogg-Johnson S, 2008, SPINE, V33, pS39, DOI 10.1097/BRS.0b013e31816454c8; Hoving JL, 2006, CLIN J PAIN, V22, P370, DOI 10.1097/01.ajp.0000180185.79382.3f; Hoving JL, 2002, ANN INTERN MED, V136, P713, DOI 10.7326/0003-4819-136-10-200205210-00006; HUSKISSON EC, 1974, LANCET, V2, P1127, DOI 10.1016/S0140-6736(74)90884-8; JAESCHKE R, 1990, CONTROL CLIN TRIALS, V11, P43, DOI 10.1016/0197-2456(90)90031-V; JENNRICH RI, 1986, BIOMETRICS, V42, P805, DOI 10.2307/2530695; JENSEN MP, 1986, PAIN, V27, P117, DOI 10.1016/0304-3959(86)90228-9; Kay TM, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004250.pub3; KOES BW, 1992, J MANIP PHYSIOL THER, V15, P16; LEVIN JR, 1994, PSYCHOL BULL, V115, P153, DOI 10.1037/0033-2909.115.1.153; Linton SJ, 1998, SPINE, V23, P1457, DOI 10.1097/00007632-199807010-00006; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Little R.J.A., 2002, STAT ANAL MISSING DA; Martin BI, 2008, JAMA-J AM MED ASSOC, V299, P656, DOI 10.1001/jama.299.6.656; McKenzie R, 2002, TREAT YOUR OWN NECK; Ostelo RWJG, 2008, SPINE, V33, P90, DOI 10.1097/BRS.0b013e31815e3a10; Ostelo RWJG, 2005, BEST PRACT RES CL RH, V19, P593, DOI 10.1016/j.berh.2005.03.003; Peloso P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000319.pub4; Petersen CM, 2000, MANUAL THER, V5, P82, DOI 10.1054/math.2000.0232; Pocock SJ, 2002, STAT MED, V21, P2917, DOI 10.1002/sim.1296; Pocock SJ, 1986, CLIN TRIALS PRACTICA; Pool JJM, 2007, SPINE, V32, P3047, DOI 10.1097/BRS.0b013e31815cf75b; Pool JJM, 2006, MANUAL THER, V11, P297, DOI 10.1016/j.math.2005.07.006; Riddle DL, 2007, SPINE, V32, P132, DOI 10.1097/01.brs.0000250999.69978.24; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581; Scholten-Peeters GGM, 2002, SPINE, V27, P412, DOI 10.1097/00007632-200202150-00018; Seffinger MA, 2004, SPINE, V29, pE413, DOI 10.1097/01.brs.0000141178.98157.8e; Sherman KJ, 2009, CLIN J PAIN, V25, P233, DOI 10.1097/AJP.0b013e31818b7912; Sherman KJ, 2005, ANN INTERN MED, V143, P849, DOI 10.7326/0003-4819-143-12-200512200-00003; SPITZER WO, 1995, SPINE, V20, pS1; Tierney LM, 1997, CURRENT MED DIAGNOSI; Verbeke G, 1997, LINEAR MIXED MODELS; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; Yu LM, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-59	61	109	114	0	29	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 3	2012	156	1	1				1	U47		10.7326/0003-4819-156-1-201201030-00002	http://dx.doi.org/10.7326/0003-4819-156-1-201201030-00002			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	872VK	22213489				2022-12-28	WOS:000298837600001
J	Dekkers, OM; Egger, M; Altman, DG; Vandenbroucke, JP				Dekkers, Olaf M.; Egger, Matthias; Altman, Douglas G.; Vandenbroucke, Jan P.			Distinguishing Case Series From Cohort Studies	ANNALS OF INTERNAL MEDICINE			English	Article							TRIALS; DESIGN	Case series are a commonly reported study design, but the label "case series" is used inconsistently and sometimes incorrectly. Mislabeling impairs the appropriate indexing and sorting of evidence. This article tries to clarify the concept of case series and proposes a way to distinguish them from cohort studies. In a cohort study, patients are sampled on the basis of exposure and are followed over time, and the occurrence of outcomes is assessed. A cohort study may include a comparison group, although this is not a necessary feature. A case series may be a study that samples patients with both a specific outcome and a specific exposure, or one that samples patients with a specific outcome and includes patients regardless of whether they have specific exposures. Whereas a cohort study, in principle, enables the calculation of an absolute risk or a rate for the outcome, such a calculation is not possible in a case series.	[Dekkers, Olaf M.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2300 RC Leiden, Netherlands; Univ Bern, CH-3012 Bern, Switzerland; Univ Oxford, Ctr Stat Med, Oxford OX2 6UD, England	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Bern; University of Oxford	Dekkers, OM (corresponding author), Leiden Univ, Med Ctr, Dept Clin Epidemiol, Box 9600, NL-2300 RC Leiden, Netherlands.	o.m.dekkers@lumc.nl	Vandenbroucke, Jan/AAM-3928-2020; Altman, Douglas G/A-9714-2012	Vandenbroucke, Jan/0000-0001-5668-6716; Egger, Matthias/0000-0001-7462-5132; Dekkers, Olaf/0000-0002-1333-7580				Albrecht J, 2005, J CLIN EPIDEMIOL, V58, P1227, DOI 10.1016/j.jclinepi.2005.04.003; [Anonymous], 1985, THEORETICAL EPIDEMIO; Brownson CS, 1998, APPL EPIDEMIOLOGY; Bryant DM, 2009, J BONE JOINT SURG AM, V91A, P10, DOI 10.2106/JBJS.H.01597; Dekkers OM, 2010, INT J EPIDEMIOL, V39, P89, DOI 10.1093/ije/dyp174; Ergina PL, 2009, LANCET, V374, P1097, DOI 10.1016/S0140-6736(09)61086-2; Feinstein A.R., 1985, CLIN EPIDEMIOLOGY; Fletcher HR, 1996, CLIN EPIDEMIOLOGY ES; Friedman GD, 2004, PRIMER EPIDEMIOLOGY; Friedrich N, 2009, J CLIN ENDOCR METAB, V94, P1732, DOI 10.1210/jc.2008-2138; Glasziou P, 2007, BMJ-BRIT MED J, V334, P349, DOI 10.1136/bmj.39070.527986.68; Gokaraju K, 2010, J BONE JOINT SURG BR, V92B, P1685, DOI 10.1302/0301-620X.92B12.23566; Gordis L, 2008, EPIDEMIOLOGY; Greenberg GS, 2004, MED EPIDEMIOLOGY; Grimes DA, 2009, OBSTET GYNECOL, V114, P1284, DOI 10.1097/AOG.0b013e3181c03421; Grobbee D.E., 2009, CLIN EPIDEMIOLOGY PR; Habot-Wilner Z, 2010, ACTA OPHTHALMOL, V88, pe299, DOI 10.1111/j.1755-3768.2010.02025.x; Hartling L, 2011, J CLIN EPIDEMIOL, V64, P861, DOI 10.1016/j.jclinepi.2011.01.010; Hennekens C.H., 1987, EPIDEMIOLOGY MED; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Hoppe DJ, 2009, J BONE JOINT SURG AM, V91A, P2, DOI 10.2106/JBJS.H.01571; Hulley SB, 2007, DESIGNING CLIN RES; Jabs DA, 2005, AM J OPHTHALMOL, V139, P900, DOI 10.1016/j.ajo.2004.12.009; Jenicek M., 1995, EPIDEMIOLOGY LOGIC M; KELSEY JL, 1986, METHODS OBSERVATIONA; Kempen JH, 2011, AM J OPHTHALMOL, V151, P7, DOI 10.1016/j.ajo.2010.08.047; Khan KS, 2002, BJOG-INT J OBSTET GY, V109, P849, DOI 10.1111/j.1471-0528.2002.01017.x; Kleinbaum DG, 1982, EPIDEMIOLOGIC RES PR; Kooistra B, 2009, J BONE JOINT SURG AM, V91A, P21, DOI 10.2106/JBJS.H.01573; Kramer M.S., 1988, CLIN EPIDEMIOLOGY BI; Last JM., 2001, DICT EPIDEMIOLOGY, V4th; LILIENFELD DE, 1994, FDN EPIDEMIOLOGY; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; MacMahon S, 1996, EPIDEMIOLOGY PRINCIP; Mayo NE, 2009, J REHABIL MED, V41, P209, DOI 10.2340/16501977-0343; Norell SE, 1992, SHORT COURSE EPIDEMI; Olsen J., 2010, TEACHING EPIDEMIOLOG; Osada H, 2011, REPROD BIOMED ONLINE, V22, P94, DOI 10.1016/j.rbmo.2010.09.014; Parfrey P, 2008, CLIN EPIDEMIOLOGY PR; Ramulu VG, 2005, INT J CLIN PRACT, V59, P457, DOI 10.1111/j.1368-5031.2005.00319.x; Rothman KJ, 2002, EPIDEMIOLOGY INTRO; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Sackett DL, 1991, CLIN EPIDEMIOLOGY BA, V2nd; Silman A. J., 2002, EPIDEMIOLOGICAL STUD; Straus S. E., 2011, EVIDENCE BASED MED P; Szklo M., 2007, EPIDEMIOLOGY BASICS; TIMMRECK TC, 1994, INTRO EPIDEMIOLOGY; Valanis B, 1998, EPIDEMIOLOGY HLTH CA; Vandenbroucke JP, 2007, ANN INTERN MED, V147, pW163, DOI 10.7326/0003-4819-147-8-200710160-00010-w1; Vandenbroucke JP, 2001, ANN INTERN MED, V134, P330, DOI 10.7326/0003-4819-134-4-200102200-00017; Weiss N., 2006, CLIN EPIDEMIOLOGY ST; Yamazaki ES, 2011, AM J OPHTHALMOL, V151, P35, DOI 10.1016/j.ajo.2010.07.028	52	175	184	0	25	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 3	2012	156	1	1				37	U82		10.7326/0003-4819-156-1-201201030-00006	http://dx.doi.org/10.7326/0003-4819-156-1-201201030-00006			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	872VK	22213493				2022-12-28	WOS:000298837600005
J	Jones, OM; Lindsey, I; Cunningham, C				Jones, Oliver M.; Lindsey, Ian; Cunningham, Chris			Laparoscopic colorectal surgery	BMJ-BRITISH MEDICAL JOURNAL			English	Review							HOSPITAL STAY; CLASICC TRIAL; FOLLOW-UP; RESECTION; CANCER; MULTICENTER; MANAGEMENT; COLECTOMY; RECOVERY		[Jones, Oliver M.; Lindsey, Ian; Cunningham, Chris] Churchill Hosp, Dept Colorectal Surg Surg & Diagnost, Oxford OX3 7LJ, England	University of Oxford	Jones, OM (corresponding author), Churchill Hosp, Dept Colorectal Surg Surg & Diagnost, Oxford OX3 7LJ, England.	oliver.jones@ouh.nhs.uk						Adamina M, 2011, SURGERY, V149, P830, DOI 10.1016/j.surg.2010.11.003; Baik SH, 2009, ANN SURG ONCOL, V16, P1480, DOI 10.1245/s10434-009-0435-3; Basse L, 2005, ANN SURG, V241, P416, DOI 10.1097/01.sla.0000154149.85506.36; Bretagnol F, 2010, ANN SURG, V252, P863, DOI 10.1097/SLA.0b013e3181fd8ea9; Cahill RA, 2010, DIS COLON RECTUM, V53, P1143, DOI 10.1007/DCR.0b013e3181dd062f; Dasari BV, 2011, COCHRANE DB SYST REV, V1; Faiz O, 2011, COLORECTAL DIS, V13, P816, DOI 10.1111/j.1463-1318.2010.02277.x; Gervaz P, 2010, ANN SURG, V252, P3, DOI 10.1097/SLA.0b013e3181dbb5a5; Guenaga KF, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001544.pub4; Guillou PJ, 2005, LANCET, V365, P1718, DOI 10.1016/S0140-6736(05)66545-2; Jayne DG, 2010, BRIT J SURG, V97, P1638, DOI 10.1002/bjs.7160; Jones OM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7099; Jones OM, 2008, ANN SURG, V248, P1092, DOI 10.1097/SLA.0b013e3181884923; Kehlet H, 1999, BRIT J SURG, V86, P227, DOI 10.1046/j.1365-2168.1999.01023.x; Klarenbeek BR, 2009, ANN SURG, V249, P39, DOI 10.1097/SLA.0b013e31818e416a; Kuhry E, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003432.pub2; Larson DW, 2008, DIS COLON RECTUM, V51, P392, DOI 10.1007/s10350-007-9180-5; Levy BF, 2009, DIS COLON RECTUM, V52, P1239, DOI 10.1007/DCR.0b013e3181a0b32d; Maeso S, 2010, ANN SURG, V252, P254, DOI 10.1097/SLA.0b013e3181e6239e; Myers E, 2008, BRIT J SURG, V95, P97, DOI 10.1002/bjs.6024; National Institute for Health and Clinical Excellence, 2010, NICE IMPL UPT REP LA; National Institute for Health and Clinical Excellence, 2006, LAP SURG COL CANC; Sammour T, 2011, ANN SURG, V253, P35, DOI 10.1097/SLA.0b013e318204a8b4; Schwenk W, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003145.pub2; Tan JJY, 2006, COLORECTAL DIS, V8, P626, DOI 10.1111/j.1463-1318.2006.00971.x; Taylor GW, 2010, BRIT J SURG, V97, P70, DOI 10.1002/bjs.6742; [The Colon cancer Laparoscopic Open Resection Study Group], 2005, SURG LAPARO ENDO PER, V6, P477; Vlug MS, 2011, ANN SURG, V254, P868, DOI 10.1097/SLA.0b013e31821fd1ce; Wilhelm D, 2009, SURG ENDOSC, V23, P688, DOI 10.1007/s00464-008-0282-5	29	16	17	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 29	2011	343								d8029	10.1136/bmj.d8029	http://dx.doi.org/10.1136/bmj.d8029			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874TN	22207042				2022-12-28	WOS:000298981100001
J	Carothers, JM; Goler, JA; Juminaga, D; Keasling, JD				Carothers, James M.; Goler, Jonathan A.; Juminaga, Darmawi; Keasling, Jay D.			Model-Driven Engineering of RNA Devices to Quantitatively Program Gene Expression	SCIENCE			English	Article							SYNTHETIC BIOLOGY; RIBOZYMES; MOLECULES	The models and simulation tools available to design functionally complex synthetic biological devices are very limited. We formulated a design-driven approach that used mechanistic modeling and kinetic RNA folding simulations to engineer RNA-regulated genetic devices that control gene expression. Ribozyme and metabolite-controlled, aptazyme-regulated expression devices with quantitatively predictable functions were assembled from components characterized in vitro, in vivo, and in silico. The models and design strategy were verified by constructing 28 Escherichia coli expression devices that gave excellent quantitative agreement between the predicted and measured gene expression levels (r = 0.94). These technologies were applied to engineer RNA-regulated controls in metabolic pathways. More broadly, we provide a framework for studying RNA functions and illustrate the potential for the use of biochemical and biophysical modeling to develop biological design methods.	[Carothers, James M.; Juminaga, Darmawi; Keasling, Jay D.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Carothers, James M.; Juminaga, Darmawi; Keasling, Jay D.] Joint Bioenergy Inst, Emeryville, CA 95608 USA; [Goler, Jonathan A.; Keasling, Jay D.] Univ Calif Berkeley, Synthet Biol Engn Res Ctr, Berkeley, CA 94720 USA; [Goler, Jonathan A.; Keasling, Jay D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Lawrence Berkeley Natl Lab, Berkeley & Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Keasling, JD (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA.	keasling@berkeley.edu	Keasling, Jay D/J-9162-2012	Keasling, Jay D/0000-0003-4170-6088; Carothers, James/0000-0001-6728-7833	Synthetic Biology Engineering Research Center (SynBERC) through NSF [0540879]; JBEI through Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; JBEI through U.S. Department of Energy [DE-AC02-05CH11231]; Jane Coffin Childs Postdoctoral Fellowship	Synthetic Biology Engineering Research Center (SynBERC) through NSF; JBEI through Lawrence Berkeley National Laboratory; JBEI through U.S. Department of Energy; Jane Coffin Childs Postdoctoral Fellowship	Thanks to J. C. Anderson for the pLASC-lacpw plasmid; S. Lee and M. Hajimorad for technical advice; Y. Kapoor for technical assistance; and G. Bokinsky, W. Holtz, N. Hillson, and L. Katz for manuscript comments. D. J. and J. D. K. filed a provisional application for a U. S. Patent on the shikimate production module. Expression device sequences are presented in the supporting online material and in the Joint BioEnergy Institute (JBEI) Public Parts Registry at http://registry.jbei.org. Plasmids will be available from http://addgene.org upon publication. Supported by the Synthetic Biology Engineering Research Center (SynBERC) through NSF grant 0540879 and by JBEI through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the U.S. Department of Energy. J. M. C. was supported in part by a Jane Coffin Childs Postdoctoral Fellowship.	Adami C, 2002, BIOESSAYS, V24, P1085, DOI 10.1002/bies.10192; Benenson Y, 2009, CURR OPIN BIOTECH, V20, P471, DOI 10.1016/j.copbio.2009.08.002; Carothers JM, 2010, NUCLEIC ACIDS RES, V38, P2736, DOI 10.1093/nar/gkq082; Carothers JM, 2009, CURR OPIN BIOTECH, V20, P498, DOI 10.1016/j.copbio.2009.08.001; Chen X, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000620; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; Duffy JL, 2007, BIOORG MED CHEM LETT, V17, P2879, DOI 10.1016/j.bmcl.2007.02.066; Flamm C, 2008, MONATSH CHEM, V139, P447, DOI 10.1007/s00706-008-0895-3; Garst AD, 2009, BBA-GENE REGUL MECH, V1789, P584, DOI 10.1016/j.bbagrm.2009.06.004; Hazen RM, 2007, P NATL ACAD SCI USA, V104, P8574, DOI 10.1073/pnas.0701744104; Holtz WJ, 2010, CELL, V140, P19, DOI 10.1016/j.cell.2009.12.029; Isambert H, 2009, METHODS, V49, P189, DOI 10.1016/j.ymeth.2009.06.005; Keasling JD, 2010, SCIENCE, V330, P1355, DOI 10.1126/science.1193990; Kelly Jason R, 2009, J Biol Eng, V3, P4, DOI 10.1186/1754-1611-3-4; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Link KH, 2007, BIOL CHEM, V388, P779, DOI 10.1515/BC.2007.105; Liu CC, 2010, SCIENCE, V330, P1185, DOI 10.1126/science.1199495; Martick M, 2006, CELL, V126, P309, DOI 10.1016/j.cell.2006.06.036; Mehl RA, 2003, J AM CHEM SOC, V125, P935, DOI 10.1021/ja0284153; Pan T, 2006, ANNU REV BIOPH BIOM, V35, P161, DOI 10.1146/annurev.biophys.35.040405.102053; Pfleger BF, 2006, NAT BIOTECHNOL, V24, P1027, DOI 10.1038/nbt1226; Saito H, 2009, INT J BIOCHEM CELL B, V41, P398, DOI 10.1016/j.biocel.2008.08.017; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Saltelli A., 2008, GLOBAL SENSITIVITY A; Sarlaslani FS, 2007, ANNU REV MICROBIOL, V61, P51, DOI 10.1146/annrev.micro.61.080706.093248; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Webb CHT, 2009, SCIENCE, V326, P953, DOI 10.1126/science.1178084; Win MN, 2007, P NATL ACAD SCI USA, V104, P14283, DOI 10.1073/pnas.0703961104; Zhang J, 2010, BIOCHEMISTRY-US, V49, P9123, DOI 10.1021/bi1012645	29	138	143	2	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1716	1719		10.1126/science.1212209	http://dx.doi.org/10.1126/science.1212209			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22194579				2022-12-28	WOS:000298344000071
J	Nakano, S; Stillman, B; Horvitz, HR				Nakano, Shunji; Stillman, Bruce; Horvitz, H. Robert			Replication-Coupled Chromatin Assembly Generates a Neuronal Bilateral Asymmetry in C. elegans	CELL			English	Article							NEWLY SYNTHESIZED HISTONES; NUCLEOSOME CORE PARTICLE; CAENORHABDITIS-ELEGANS; DNA-REPLICATION; BINDING-PROTEIN; GENE; INVERSUS; COMPLEX; BRAIN; MICE	Although replication-coupled chromatin assembly is known to be important for the maintenance of patterns of gene expression through sequential cell divisions, the role of replication-coupled chromatin assembly in controlling cell differentiation during animal development remains largely unexplored. Here we report that the CAF-1 protein complex, an evolutionarily conserved histone chaperone that deposits histone H3-H4 proteins onto replicating DNA, is required to generate a bilateral asymmetry in the C. elegans nervous system. A mutation in 1 of 24 C. elegans histone H3 genes specifically eliminates this aspect of neuronal asymmetry by causing a defect in the formation of a histone H3-H4 tetramer and the consequent inhibition of CAF-1-mediated nucleosome formation. Our results reveal that replication-coupled nucleosome assembly is necessary to generate a bilateral asymmetry in C. elegans neuroanatomy and suggest that left-right asymmetric epigenetic regulation can establish bilateralasymmetry in the nervous system.	[Nakano, Shunji; Horvitz, H. Robert] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Nakano, Shunji; Horvitz, H. Robert] MIT, Dept Biol, Cambridge, MA 02139 USA; [Stillman, Bruce] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Cold Spring Harbor Laboratory	Horvitz, HR (corresponding author), MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA.	horvitz@mit.edu	Nakano, Shunji/I-7211-2014	Nakano, Shunji/0000-0002-6565-9450; Stillman, Bruce/0000-0002-9453-4091	NIH National Center for Research Resources (NCRR), for strains; Howard Hughes Medical Institute; National Cancer Institute [CA13106]; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER	NIH National Center for Research Resources (NCRR), for strains; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank P. Wendel for her help with the supercoiling assay; A. Fire for expression vectors; the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR), for strains; N. An, R. Droste, and T. Ljungars for technical assistance; and D. Denning, K. Boulias, and M. Nakano for comments about the manuscript. H.R.H. is an Investigator of the Howard Hughes Medical Institute and the David H. Koch Professor of Biology at MIT. This work was supported by the Howard Hughes Medical Institute and a grant from the National Cancer Institute (CA13106).	ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; Armakolas A, 2007, SCIENCE, V315, P100, DOI 10.1126/science.1129429; Beck K, 2009, J EXP MED, V206, P2271, DOI 10.1084/jem.20090756; BRENNER S, 1974, GENETICS, V77, P71; BURHANS WC, 1990, CELL, V62, P955, DOI 10.1016/0092-8674(90)90270-O; EDGLEY ML, 2006, GENETIC BALANCERS, DOI DOI 10.1895/WORM-BOOK.1.89.1; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Escalante-Mead PR, 2003, J AUTISM DEV DISORD, V33, P539, DOI 10.1023/A:1025887713788; Grigsby MF, 2008, DEV BIOL, V319, P100, DOI 10.1016/j.ydbio.2008.04.013; Hamada H, 2008, DEV GROWTH DIFFER, V50, pS71, DOI 10.1111/j.1440-169X.2008.01008.x; Hobert O, 2002, NAT REV NEUROSCI, V3, P629, DOI 10.1038/nrn897; Hummel K. P., 1959, Journal of Heredity, V50, P9; JACKSON V, 1988, BIOCHEMISTRY-US, V27, P2109, DOI 10.1021/bi00406a044; KAUFMAN PD, 1995, CELL, V81, P1105, DOI 10.1016/S0092-8674(05)80015-7; Kawakami R, 2003, SCIENCE, V300, P990, DOI 10.1126/science.1082609; Kawakami R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001945; LEFFAK IM, 1977, CELL, V12, P837, DOI 10.1016/0092-8674(77)90282-3; Levin M, 2005, MECH DEVELOP, V122, P3, DOI 10.1016/j.mod.2004.08.006; Li XB, 2007, SCHIZOPHR RES, V96, P14, DOI 10.1016/j.schres.2007.07.013; Liu LX, 1999, GENOME RES, V9, P859, DOI 10.1101/gr.9.9.859; Loyola A, 2004, BBA-GENE STRUCT EXPR, V1677, P3, DOI 10.1016/j.bbaexp.2003.09.012; Lu XW, 1998, CELL, V95, P981, DOI 10.1016/S0092-8674(00)81722-5; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Nakano S, 2010, DEVELOPMENT, V137, P4017, DOI 10.1242/dev.058834; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; Pettitt J, 2002, J CELL SCI, V115, P857; Priess J. R., 1997, C ELEGANS 2; Pujadas G, 2011, DIFFERENTIATION, V82, P66, DOI 10.1016/j.diff.2011.05.006; Quivy JP, 2001, EMBO J, V20, P2015, DOI 10.1093/emboj/20.8.2015; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Richards KL, 2000, MOL BIOL CELL, V11, P1887, DOI 10.1091/mbc.11.5.1887; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; Shiratori H, 2006, DEVELOPMENT, V133, P2095, DOI 10.1242/dev.02384; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; Solari F, 2000, CURR BIOL, V10, P223, DOI 10.1016/S0960-9822(00)00343-2; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Supp DM, 1997, NATURE, V389, P963, DOI 10.1038/40140; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Xu M, 2010, SCIENCE, V328, P94, DOI 10.1126/science.1178994	47	69	81	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2011	147	7					1525	1536		10.1016/j.cell.2011.11.053	http://dx.doi.org/10.1016/j.cell.2011.11.053			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	866SP	22177093	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000298403400017
J	Berryman, R; Currie, I; McCarthy, R				Berryman, Rosanna; Currie, Ian; McCarthy, Robert			CASE REPORT Ischaemia of the extremities in a smoker	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OBLITERANS		[Berryman, Rosanna; Currie, Ian; McCarthy, Robert] S Devon Healthcare NHS Fdn Trust, Torbay Hosp, Torquay TQ2 7AA, Devon, England		Berryman, R (corresponding author), S Devon Healthcare NHS Fdn Trust, Torbay Hosp, Torquay TQ2 7AA, Devon, England.	rberryman@nhs.net						Baumann G, 2011, CLIN RES CA IN PRESS; Buerger L, 1908, AM J MED SCI, V136, P567, DOI 10.1097/00000441-190810000-00011; Di Nisio M, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004982.pub3; FIESSINGER JN, 1990, LANCET, V335, P555, DOI 10.1016/0140-6736(90)90346-7; MATSUSHITA M, 1991, J VASC SURG, V14, P53; OLIN JW, 1990, CIRCULATION, V82, P3; Piazza G, 2010, CIRCULATION, V121, P1858, DOI 10.1161/CIRCULATIONAHA.110.942383; Sasaki S, 2000, INT J CARDIOL, V75, pS175, DOI 10.1016/S0167-5273(00)00190-X; Shionoya S, 1998, INT J CARDIOL, V66, pS243, DOI 10.1016/S0167-5273(98)00175-2; Shionoya S, 1993, CARDIOVASC SURG, V75, P259	10	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 21	2011	343								d8193	10.1136/bmj.d8193	http://dx.doi.org/10.1136/bmj.d8193			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874TF	22188944				2022-12-28	WOS:000298980300008
J	Boomer, JS; To, K; Chang, KC; Takasu, O; Osborne, DF; Walton, AH; Bricker, TL; Jarman, SD; Kreisel, D; Krupnick, AS; Srivastava, A; Swanson, PE; Green, JM; Hotchkiss, RS				Boomer, Jonathan S.; To, Kathleen; Chang, Kathy C.; Takasu, Osamu; Osborne, Dale F.; Walton, Andrew H.; Bricker, Traci L.; Jarman, Stephen D., II; Kreisel, Daniel; Krupnick, Alexander S.; Srivastava, Anil; Swanson, Paul E.; Green, Jonathan M.; Hotchkiss, Richard S.			Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							T-CELLS; INFLAMMATORY RESPONSE; DOWN-REGULATION; WHOLE-BLOOD; PATHOPHYSIOLOGY; MECHANISMS; EXPRESSION; MONOCYTES; RECEPTOR; INNATE	Context Severe sepsis is typically characterized by initial cytokine-mediated hyperinflammation. Whether this hyperinflammatory phase is followed by immunosuppression is controversial. Animal studies suggest that multiple immune defects occur in sepsis, but data from humans remain conflicting. Objectives To determine the association of sepsis with changes in host innate and adaptive immunity and to examine potential mechanisms for putative immunosuppression. Design, Setting, and Participants Rapid postmortem spleen and lung tissue harvest was performed at the bedsides of 40 patients who died in intensive care units (ICUs) of academic medical centers with active severe sepsis to characterize their immune status at the time of death (2009-2011). Control spleens (n=29) were obtained from patients who were declared brain-dead or had emergent splenectomy due to trauma; control lungs (n=20) were obtained from transplant donors or from lung cancer resections. Main Outcome Measures Cytokine secretion assays and immunophenotyping of cell surface receptor-ligand expression profiles were performed to identify potential mechanisms of immune dysfunction. Immunohistochemical staining was performed to evaluate the loss of immune effector cells. Results The mean ages of patients with sepsis and controls were 71.7 (SD, 15.9) and 52.7 (SD, 15.0) years, respectively. The median number of ICU days for patients with sepsis was 8 (range, 1-195 days), while control patients were in ICUs for 4 or fewer days. The median duration of sepsis was 4 days (range, 1-40 days). Compared with controls, anti-CD3/anti-CD28-stimulated splenocytes from sepsis patients had significant reductions in cytokine secretion at 5 hours: tumor necrosis factor, 5361 (95% CI, 3327-7485) pg/mL vs 418 (95% CI, 98-738) pg/mL; interferon gamma, 1374 (95% CI, 550-2197) pg/mL vs 37.5 (95% CI, -5 to 80) pg/mL; interleukin 6, 3691 (95% CI, 2313-5070) vs 365 (95% CI, 87-642) pg/mL; and interleukin 10, 633 (95% CI, -269 to 1534) vs 58 (95% CI, -39 to 156) pg/mL; (P < .001 for all). There were similar reductions in 5-hour lipopolysaccharide-stimulated cytokine secretion. Cytokine secretion in sepsis patients was generally less than 10% that in controls, independent of age, duration of sepsis, corticosteroid use, and nutritional status. Although differences existed between spleen and lung, flow cytometric analysis showed increased expression of selected inhibitory receptors and ligands and expansion of suppressor cell populations in both organs. Unique differences in cellular inhibitory molecule expression existed in immune cells isolated from lungs of sepsis patients vs cancer patients and vs transplant donors. Immunohistochemical staining showed extensive depletion of splenic CD4, CD8, and HLA-DR cells and expression of ligands for inhibitory receptors on lung epithelial cells. Conclusions Patients who die in the ICU following sepsis compared with patients who die of nonsepsis etiologies have biochemical, flow cytometric, and immunohistochemical findings consistent with immunosuppression. Targeted immune-enhancing therapy may be a valid approach in selected patients with sepsis. JAMA. 2011;306(23):2594-2605	[Chang, Kathy C.; Takasu, Osamu; Osborne, Dale F.; Walton, Andrew H.; Hotchkiss, Richard S.] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Boomer, Jonathan S.; Bricker, Traci L.; Green, Jonathan M.; Hotchkiss, Richard S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [To, Kathleen; Jarman, Stephen D., II; Kreisel, Daniel; Krupnick, Alexander S.; Hotchkiss, Richard S.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Srivastava, Anil] St Johns Mercy Med Ctr, Dept Surg, St Louis, MO 63141 USA; [Swanson, Paul E.] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Saint Johns Mercy Medical Center; University of Washington; University of Washington Seattle	Hotchkiss, RS (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, 660 S Euclid, St Louis, MO 63110 USA.	hotch@wustl.edu		Green, Jonathan/0000-0002-7449-4387	Pfizer; Bristol-Meyers Squibb; Aurigene; National Institutes of Health [GM44118, GM55194, HL104985]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL104985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098391, R01GM044118, R37GM044118, R01GM055194] Funding Source: NIH RePORTER	Pfizer(Pfizer); Bristol-Meyers Squibb(Bristol-Myers Squibb); Aurigene; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Hotchkiss reports receiving grant support from Pfizer, Bristol-Meyers Squibb, and Aurigene. No other disclosures were reported.; This research was supported by National Institutes of Health grants GM44118, GM55194, and HL104985.	Abraham E, 2007, CRIT CARE MED, V35, P2408, DOI 10.1097/01.CCM.0000282072.56245.91; Adib-Conquy M, 2009, THROMB HAEMOSTASIS, V101, P36, DOI 10.1160/TH08-07-0421; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus DC, 2011, JAMA-J AM MED ASSOC, V305, P1469, DOI 10.1001/jama.2011.438; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bedke T, 2010, J IMMUNOL, V184, P5562, DOI 10.4049/jimmunol.0902458; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brahmamdam P, 2010, J LEUKOCYTE BIOL, V88, P233, DOI 10.1189/jlb.0110037; Cavaillon JM, 2006, J ENDOTOXIN RES, V12, P151, DOI 10.1179/096805106X102246; Delano MJ, 2007, J EXP MED, V204, P1463, DOI 10.1084/jem.20062602; Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678; ERTEL W, 1995, BLOOD, V85, P1341, DOI 10.1182/blood.V85.5.1341.bloodjournal8551341; Hotchkiss RS, 2010, NEW ENGL J MED, V363, P87, DOI 10.1056/NEJMcibr1004371; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952, DOI 10.4049/jimmunol.166.11.6952; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Huang X, 2009, P NATL ACAD SCI USA, V106, P6303, DOI 10.1073/pnas.0809422106; Hughes SM, 2009, J IMMUNOL, V183, P2818, DOI 10.4049/jimmunol.0803518; Kollef KE, 2008, CHEST, V134, P281, DOI 10.1378/chest.08-1116; Lazar-Molnar E, 2008, P NATL ACAD SCI USA, V105, P2658, DOI 10.1073/pnas.0711918105; Levy MM, 2010, INTENS CARE MED, V36, P222, DOI 10.1007/s00134-009-1738-3; Levy Y, 2009, J CLIN INVEST, V119, P997, DOI 10.1172/JCI38052; Limaye AP, 2008, JAMA-J AM MED ASSOC, V300, P413, DOI 10.1001/jama.300.4.413; Luyt CE, 2007, AM J RESP CRIT CARE, V175, P935, DOI 10.1164/rccm.200609-1322OC; Meisel C, 2009, AM J RESP CRIT CARE, V180, P640, DOI 10.1164/rccm.200903-0363OC; Monneret G, 2008, MOL MED, V14, P64, DOI 10.2119/2007-00102.Monneret; Munford RS, 2001, AM J RESP CRIT CARE, V163, P316, DOI 10.1164/ajrccm.163.2.2007102; MUNOZ C, 1991, J CLIN INVEST, V88, P1747, DOI 10.1172/JCI115493; Murphy TJ, 2004, J LEUKOCYTE BIOL, V75, P400, DOI 10.1189/jlb.0503233; Oberholzer A, 2001, SHOCK, V16, P83, DOI 10.1097/00024382-200116020-00001; Patel A, 2010, J ANTIMICROB CHEMOTH, V65, P2697, DOI 10.1093/jac/dkq359; Pellegrini M, 2011, CELL, V144, P601, DOI 10.1016/j.cell.2011.01.011; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Remick DG, 2007, AM J PATHOL, V170, P1435, DOI 10.2353/ajpath.2007.060872; Rigato O, 2003, SHOCK, V19, P113, DOI 10.1097/00024382-200302000-00004; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Rodig N, 2003, EUR J IMMUNOL, V33, P3117, DOI 10.1002/eji.200324270; Schefold JC, 2008, CRIT CARE MED, V36, P3118, DOI 10.1097/CCM.0b013e31818bdd8f; SHI SR, 1993, J HISTOCHEM CYTOCHEM, V41, P1599, DOI 10.1177/41.11.7691930; Shiao SL, 2005, J IMMUNOL, V175, P4886, DOI 10.4049/jimmunol.175.8.4886; Shui JW, 2011, J LEUKOCYTE BIOL, V89, P517, DOI 10.1189/jlb.0910528; Sinistro A, 2008, CLIN VACCINE IMMUNOL, V15, P1851, DOI 10.1128/CVI.00184-08; Unsinger J, 2010, J IMMUNOL, V184, P3768, DOI 10.4049/jimmunol.0903151; Venet F, 2008, J LEUKOCYTE BIOL, V83, P523, DOI 10.1189/jlb.0607371; Ward NS, 2008, CLIN CHEST MED, V29, P617, DOI 10.1016/j.ccm.2008.06.010; Warren HS, 1997, NEW ENGL J MED, V336, P952, DOI 10.1056/NEJM199703273361311; Wheeler AP, 1999, NEW ENGL J MED, V340, P207, DOI 10.1056/NEJM199901213400307; Yi JS, 2010, IMMUNOLOGY, V129, P474, DOI 10.1111/j.1365-2567.2010.03255.x; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	49	1037	1160	4	129	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 21	2011	306	23					2594	2605		10.1001/jama.2011.1829	http://dx.doi.org/10.1001/jama.2011.1829			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	864YQ	22187279	Green Accepted, Bronze			2022-12-28	WOS:000298276800021
J	Polis, MA				Polis, Michael A.			Early antiretroviral therapy reduced HIV-1 transmission in serodiscordant couples	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									NIAID, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Polis, MA (corresponding author), NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA.			Polis, Michael/0000-0002-9151-2268				Dieffenbach CW, 2011, ANN INTERN MED, V154, P766, DOI 10.7326/0003-4819-154-11-201106070-00345; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303	4	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2011	155	12							JC6-8	10.7326/0003-4819-155-12-201112200-02008	http://dx.doi.org/10.7326/0003-4819-155-12-201112200-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	864ZU	22184709				2022-12-28	WOS:000298280500007
J	Chan, WL; Ligges, M; Jailaubekov, A; Kaake, L; Miaja-Avila, L; Zhu, XY				Chan, Wai-Lun; Ligges, Manuel; Jailaubekov, Askat; Kaake, Loren; Miaja-Avila, Luis; Zhu, X. -Y.			Observing the Multiexciton State in Singlet Fission and Ensuing Ultrafast Multielectron Transfer	SCIENCE			English	Article							PENTACENE THIN-FILMS; CARRIER MULTIPLICATION; SEMICONDUCTOR NANOCRYSTALS; QUANTUM COHERENCE; ELECTRON-TRANSFER; TRIPLET EXCITONS; SOLAR-CELLS; GENERATION; DYNAMICS; TEMPERATURE	Multiple exciton generation (MEG) refers to the creation of two or more electron-hole pairs from the absorption of one photon. Although MEG holds great promise, it has proven challenging to implement, and questions remain about the underlying photo-physical dynamics in nanocrystalline as well as molecular media. Using the model system of pentacene/fullerene bilayers and femtosecond nonlinear spectroscopies, we directly observed the multiexciton (ME) state ensuing from singlet fission (a molecular manifestation of MEG) in pentacene. The data suggest that the state exists in coherent superposition with the singlet populated by optical excitation. We also found that multiple electron transfer from the ME state to the fullerene occurs on a subpicosecond time scale, which is one order of magnitude faster than that from the triplet exciton state.	[Chan, Wai-Lun; Ligges, Manuel; Jailaubekov, Askat; Kaake, Loren; Miaja-Avila, Luis; Zhu, X. -Y.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Zhu, XY (corresponding author), Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA.	zhu@cm.utexas.edu	Chan, Wai-Lun/A-7833-2008; Avila, Luis Miaja/H-5505-2018; Chan, Wai-Lun/J-8721-2019; Ligges, Manuel/B-9966-2011	Chan, Wai-Lun/0000-0001-8697-9894; Avila, Luis Miaja/0000-0003-0864-8357; Chan, Wai-Lun/0000-0001-8697-9894; Ligges, Manuel/0000-0001-8172-0568; Kaake, Loren/0000-0002-2085-8501	National Science Foundation [DMR-0804583]; Energy Frontier Research Center; U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences [DE-SC0001085]; DOE, Office of Science, Office of Basic Energy Sciences [DE-SC0001091]; Leopoldina Fellowship Program LPDS [2009-41];  [SFB616]	National Science Foundation(National Science Foundation (NSF)); Energy Frontier Research Center; U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Leopoldina Fellowship Program LPDS; 	This work was supported by the National Science Foundation under grant DMR-0804583. The SHG results presented in Fig. 4 were based on work supported as part of the program "Center for Re-Defining Photovoltaic Efficiency Through Molecule Scale Control," an Energy Frontier Research Center funded by the U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences under award DE-SC0001085. Development of the SHG technique used for Fig. 4 was supported as part of the program " Understanding Charge Separation and Transfer at Interfaces in Energy Materials (EFRC:CST)", an Energy Frontier Research Center funded by the DOE, Office of Science, Office of Basic Energy Sciences under award DE-SC0001091. M. L. acknowledges financial support through SFB616 and the Leopoldina Fellowship Program LPDS 2009-41. X.-Y.Z. acknowledges fruitful discussions with R. E. Wyatt, F. Spano, A. Shabaev, and A. L. Efros.	Beard MC, 2010, NANO LETT, V10, P3019, DOI 10.1021/nl101490z; Ben-Lulu M, 2008, NANO LETT, V8, P1207, DOI 10.1021/nl080199u; Brus L, 2010, NANO LETT, V10, P363, DOI 10.1021/nl904263b; Collini E, 2010, NATURE, V463, P644, DOI 10.1038/nature08811; Dougherty DB, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3046721; Engel GS, 2007, NATURE, V446, P782, DOI 10.1038/nature05678; Gabor NM, 2009, SCIENCE, V325, P1367, DOI 10.1126/science.1176112; Greyson EC, 2010, J PHYS CHEM B, V114, P14168, DOI 10.1021/jp907392q; Hanna MC, 2006, J APPL PHYS, V100, DOI 10.1063/1.2356795; Heringdorf FJMZ, 2001, NATURE, V412, P517, DOI 10.1038/35087532; Huang J, 2010, J AM CHEM SOC, V132, P4858, DOI 10.1021/ja100106z; Johnson JC, 2010, J AM CHEM SOC, V132, P16302, DOI 10.1021/ja104123r; JOHNSON RC, 1970, PHYS REV B-SOLID ST, V1, P896, DOI 10.1103/PhysRevB.1.896; JUNDT C, 1995, CHEM PHYS LETT, V241, P84, DOI 10.1016/0009-2614(95)00603-2; Kakuta H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.247601; Klimov VI, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2356314; Kuhlman TS, 2010, J AM CHEM SOC, V132, P3431, DOI 10.1021/ja909166s; Lee J, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3182787; Marciniak H, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.235318; Mcguire JA, 2008, ACCOUNTS CHEM RES, V41, P1810, DOI 10.1021/ar800112v; Nair G, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.125325; Panitchayangkoon G, 2010, P NATL ACAD SCI USA, V107, P12766, DOI 10.1073/pnas.1005484107; Rao A, 2010, J AM CHEM SOC, V132, P12698, DOI 10.1021/ja1042462; Sambur JB, 2010, SCIENCE, V330, P63, DOI 10.1126/science.1191462; Shabaev A, 2006, NANO LETT, V6, P2856, DOI 10.1021/nl062059v; SHOCKLEY W, 1961, J APPL PHYS, V32, P510, DOI 10.1063/1.1736034; Smith MB, 2010, CHEM REV, V110, P6891, DOI 10.1021/cr1002613; Sukhovatkin V, 2009, SCIENCE, V324, P1542, DOI 10.1126/science.1173812; Thorsmolle VK, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.017401; Tisdale WA, 2010, SCIENCE, V328, P1543, DOI 10.1126/science.1185509; Wilson MWB, 2011, J AM CHEM SOC, V133, P11830, DOI 10.1021/ja201688h; Winzer T, 2010, NANO LETT, V10, P4839, DOI 10.1021/nl1024485; Yamagata H, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3590871; Yoo S, 2004, APPL PHYS LETT, V85, P5427, DOI 10.1063/1.1829777; Zimmerman PM, 2010, NAT CHEM, V2, P648, DOI [10.1038/NCHEM.694, 10.1038/nchem.694]	35	413	418	4	379	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 16	2011	334	6062					1541	1545		10.1126/science.1213986	http://dx.doi.org/10.1126/science.1213986			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	862LE	22174249				2022-12-28	WOS:000298091400049
J	Mayer, KH; Krakower, D				Mayer, Kenneth H.; Krakower, Douglas			Antiretroviral Medication and HIV Prevention: New Steps Forward and New Questions	ANNALS OF INTERNAL MEDICINE			English	Article								During the past 2 years, several pivotal clinical trials have proven that the use of antiretrovirals by HIV-infected and at-risk uninfected persons can decrease the probability of HIV being transmitted sexually. The initial chemoprophylaxis studies evaluated tenofovir administered topically or orally (with or without emtricitabine). However, several questions remain. Some subsequent primary prevention studies did not replicate the results of the initial studies, raising questions about differences in the behaviors of participants in each study (in particular about medication adherence), as well as whether pharmacologic or local mucosal factors might explain the variable efficacy estimates. Other antiretrovirals and delivery systems are being evaluated to maximize the efficacy of primary chemoprophylactic approaches. At present, increasing access to antiretroviral treatment globally is a priority, because expanding access to medication that can prevent morbidity and mortality is itself an important public health goal and may reasonably be expected to decrease HIV incidence. However, for treatment as prevention to be maximally effective, increases in HIV testing, health care workers, and infrastructure are needed, in addition to medications and laboratory support for clinical monitoring. A combination of approaches is needed to most quickly decrease the current trends in HIV incidence, including early diagnosis and initiation of treatment for HIV-infected persons. These approaches can be coupled with appropriately tailored interventions for populations at greatest risk for infection (for example, men who have sex with men and sex workers), including male circumcision, behavioral interventions, and chemoprophylaxis. However, a substantial gap exists between current expenditures and unmet needs, which suggests that mobilization of political will is needed for this combination approach to be successful.	Fenway Hlth, Boston, MA USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Fenway Health; Harvard University; Beth Israel Deaconess Medical Center	Mayer, KH (corresponding author), Fenway Community Hlth, 1340 Boylson St, Boston, MA 02215 USA.	kmayer@fenwayhealth.org			HIV Clinical Research Fellowship (NIAID) [AI 007433]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007433] Funding Source: NIH RePORTER	HIV Clinical Research Fellowship (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Dr. Krakower is supported by the Harvard T32 postdoctoral HIV Clinical Research Fellowship (NIAID AI 007433).	Abbas U, 2011, 18 C RETR OPP INF BO; [Anonymous], 6 INT AIDS SOC C HIV; [Anonymous], 18 C RETR OPP INF BO; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; FACTS Consortium, 2011, FACTS 001 STUD; Family Health International, FEM PREP JUN 2011 UP; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hallett TB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001123; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kashuba AD, 2011, LANCET; Office of the Press Secretary The White House, 2011, FACT SHEET BEG END A; Thigpen MC, 2011, 6 INT AIDS SOC C HIV; UNAIDS, 2010, REP GLOB AIDS EP 201	13	11	11	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2012	156	4					312	U105		10.7326/0003-4819-156-4-201202210-00383	http://dx.doi.org/10.7326/0003-4819-156-4-201202210-00383			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	896YO	22250077	Green Accepted			2022-12-28	WOS:000300607600009
J	Wilkinson, TA; Fahey, N; Suther, E; Cabral, HJ; Silverstein, M				Wilkinson, Tracey A.; Fahey, Nisha; Suther, Emily; Cabral, Howard J.; Silverstein, Michael			Access to Emergency Contraception for Adolescents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Wilkinson, Tracey A.; Suther, Emily; Silverstein, Michael] Boston Med Ctr, Boston, MA USA; [Cabral, Howard J.] Boston Univ, Sch Publ Hlth, Boston, MA USA	Boston Medical Center; Boston University	Wilkinson, TA (corresponding author), Boston Med Ctr, Boston, MA USA.	tracey.wilkinson@bmc.org		Fahey, Nisha/0000-0001-9059-1470; Cabral, Howard/0000-0002-1185-8331; Silverstein, Michael/0000-0002-9474-7548				Agency for Healthcare Research and Quality, 2010, NAT HEALTHC DISP REP; GeoLytics Inc, OFF CENS 2010 DAT; Hastings Julia, 2005, J Health Soc Policy, V21, P33, DOI 10.1300/J045v21n01_02; Kost K., 2010, US TEENAGE PREGNANCI; KowaleskiJones L, 2006, FRAGILE FAMILIES AND THE MARRIAGE AGENDA, P1; Miller BC, 2001, DEV REV, V21, P1, DOI 10.1006/drev.2000.0513	6	28	28	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 25	2012	307	4					362	363		10.1001/jama.2011.1949	http://dx.doi.org/10.1001/jama.2011.1949			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	881EP	22182591	Bronze			2022-12-28	WOS:000299464000015
J	Lia, G; Michel, B; Allemand, JF				Lia, Giuseppe; Michel, Benedicte; Allemand, Jean-Francois			Polymerase Exchange During Okazaki Fragment Synthesis Observed in Living Cells (Retracted, see vol 346, pg 1466, 2014)	SCIENCE			English	Article							LAGGING-STRAND SYNTHESIS; SINGLE-MOLECULE; REPLICATION FORK; DNA-REPLICATION; ESCHERICHIA-COLI; LIVE CELLS; REPLISOME; PROCESSIVITY; MECHANISM; DYNAMICS	DNA replication machineries have been studied extensively, but the kinetics of action of their components remains largely unknown. We report a study of DNA synthesis during replication in living Escherichia coli cells. Using single-molecule microscopy, we observed repetitive fluorescence bursts of single polymerase IIIs (Pol IIIs), indicating polymerase exchange at the replication fork. Fluctuations in the amount of DNA-bound single-stranded DNA-binding protein (SSB) reflect different speeds for the leading-and lagging-strand DNA polymerases. Coincidence analyses of Pol III and SSB fluctuations show that they correspond to the lagging-strand synthesis and suggest the use of a new Pol III for each Okazaki fragment. Based on exchanges involving two Pol IIIs, we propose that the third polymerase in the replisome is involved in lagging-strand synthesis.	[Lia, Giuseppe; Michel, Benedicte] CNRS, UPR3404, Ctr Genet Mol, F-91198 Gif Sur Yvette, France; [Lia, Giuseppe; Michel, Benedicte] Univ Paris 11, F-91405 Orsay, France; [Lia, Giuseppe; Allemand, Jean-Francois] Univ Paris 06, CNRS, UMR 8550, ENS,Lab Phys Stat,Dept Phys, F-75231 Paris 05, France; [Lia, Giuseppe; Allemand, Jean-Francois] Univ Paris Diderot, CNRS, UMR 8550, ENS,Lab Phys Stat,Dept Phys, F-75231 Paris 05, France; [Allemand, Jean-Francois] Ecole Normale Super, CNRS, UMR 8542, Inst Biol,Dept Biol, F-75231 Paris 05, France; [Allemand, Jean-Francois] IUF, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS)	Lia, G (corresponding author), CNRS, UPR3404, Ctr Genet Mol, F-91198 Gif Sur Yvette, France.	lia@cgm.cnrs-gif.fr; allemand@lps.ens.fr	Lia, Giuseppe/AAD-5541-2022	Allemand, Jean - Francois/0000-0001-7496-0977	"Prix coup d'elan" from the foundation Bettencourt-Schueller; Association pour la Recherche sur le Cancer [A2009]; Agence Nationale de la Recherche; IUF;  [ANR-BLAN08-3_309268]	"Prix coup d'elan" from the foundation Bettencourt-Schueller; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Agence Nationale de la Recherche(French National Research Agency (ANR)); IUF; 	This work was initiated in S. X. Xie's laboratory with the help of G. W. Li. We thank V. Croquette and D. Bensimon (ENS Paris), N. Dixon (University of Wollongong, Australia), S. X. Xie (Harvard University), and T. R. Strick (Institut J. Monod, Paris) for very helpful readings of the manuscript; A. Langlois de Septenville and S. Duigou for support and discussions all along this work; M. LeMasson for excellent technical assistance; J. Quintas, C. Goncalves-Domingues, and E. Nicolau for their help in the microscope mechanical manufacturing; R. Reyes-Lamothe and D. Sherratt for providing strains and sharing results; M. Cox for providing SSB antibodies; and S. Duigou for performing the Western experiment. Work in B.M.'s laboratory was supported by ANR-BLAN08-3_309268 and by a "Prix coup d'elan" from the foundation Bettencourt-Schueller. G. L. was supported by an Association pour la Recherche sur le Cancer postdoctoral grant A2009. Work in J-F.A. laboratory was supported by Agence Nationale de la Recherche and by IUF.	Benkovic SJ, 2001, ANNU REV BIOCHEM, V70, P181, DOI 10.1146/annurev.biochem.70.1.181; Downey CD, 2010, MOL CELL, V37, P481, DOI 10.1016/j.molcel.2010.01.013; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248; Hamdan SM, 2009, NATURE, V457, P336, DOI 10.1038/nature07512; Johnson DE, 2007, P NATL ACAD SCI USA, V104, P5312, DOI 10.1073/pnas.0701062104; Leu FP, 2003, MOL CELL, V11, P315, DOI 10.1016/S1097-2765(03)00042-X; Li XJ, 2000, J BIOL CHEM, V275, P34757, DOI 10.1074/jbc.M006556200; Loparo JJ, 2011, P NATL ACAD SCI USA, V108, P3584, DOI 10.1073/pnas.1018824108; McHenry CS, 2011, ANNU REV BIOCHEM, V80, P403, DOI 10.1146/annurev-biochem-061208-091655; McInerney P, 2007, MOL CELL, V27, P527, DOI 10.1016/j.molcel.2007.06.019; OKAZAKI R, 1968, P NATL ACAD SCI USA, V59, P598, DOI 10.1073/pnas.59.2.598; Perumal SK, 2010, BBA-PROTEINS PROTEOM, V1804, P1094, DOI 10.1016/j.bbapap.2009.07.022; Pomerantz RT, 2010, SCIENCE, V327, P590, DOI 10.1126/science.1179595; Reyes-Lamothe R, 2008, CELL, V133, P90, DOI 10.1016/j.cell.2008.01.044; Reyes-Lamothe R, 2010, SCIENCE, V328, P498, DOI 10.1126/science.1185757; Tanner NA, 2011, EMBO J, V30, P1830, DOI 10.1038/emboj.2011.84; Trakselis MA, 2003, J BIOL CHEM, V278, P49839, DOI 10.1074/jbc.M307405200; van Oijen AM, 2010, ANNU REV BIOPHYS, V39, P429, DOI 10.1146/annurev.biophys.093008.131327; Xie XS, 2008, ANNU REV BIOPHYS, V37, P417, DOI 10.1146/annurev.biophys.37.092607.174640; Yang JS, 2004, P NATL ACAD SCI USA, V101, P8289, DOI 10.1073/pnas.0402625101; Yao NY, 2010, CELL, V141, P1088, DOI 10.1016/j.cell.2010.05.042; Yao NY, 2009, P NATL ACAD SCI USA, V106, P13236, DOI 10.1073/pnas.0906157106; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623	24	45	45	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 20	2012	335	6066					328	331		10.1126/science.1210400	http://dx.doi.org/10.1126/science.1210400			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878RE	22194411				2022-12-28	WOS:000299273400045
J	Fouchier, R; Osterhaus, AB; Steinbruner, J; Yuen, KY; Henderson, DA; Klotz, L; Sylvester, ED				Fouchier, Ron; Osterhaus, A. B.; Steinbruner, John; Yuen, Kwok-Yung; Henderson, D. A.; Klotz, Lynn; Sylvester, E. D.			The fight over flu	NATURE			English	Editorial Material									[Fouchier, Ron; Osterhaus, A. B.] Erasmus MC, Rotterdam, Netherlands; [Steinbruner, John] Univ Maryland, Ctr Int & Secur Studies Maryland, College Pk, MD USA; [Yuen, Kwok-Yung] Univ Hong Kong, Dept Microbiol, Chair Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Henderson, D. A.] Univ Pittsburgh, Ctr Biosecur, Med Ctr, Pittsburgh, PA 15260 USA; [Klotz, Lynn; Sylvester, E. D.] Ctr Arms Control & Non Proliferat, Washington, DC USA; [Klotz, Lynn; Sylvester, E. D.] Arizona State Univ, Walter Cronkite Sch Journalism, Tempe, AZ 85287 USA	Erasmus University Rotterdam; Erasmus MC; University System of Maryland; University of Maryland College Park; University of Hong Kong; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Arizona State University; Arizona State University-Tempe	Fouchier, R (corresponding author), Erasmus MC, Rotterdam, Netherlands.		Fouchier, Ron A/A-1911-2014; Ebright, Richard/O-3321-2019	Fouchier, Ron A/0000-0001-8095-2869; Ebright, Richard/0000-0001-8915-7140; Yuen, Kwok-yung/0000-0002-2083-1552	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000986] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		2012, NATURE, V481, P9; 2011, NATURE, V480, P421	2	20	20	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 19	2012	481	7381					257	259						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	877VK	22246325	Bronze, Green Published			2022-12-28	WOS:000299210600013
J	Gill, TM; Gahbauer, EA; Murphy, TE; Han, L; Allore, HG				Gill, Thomas M.; Gahbauer, Evelyne A.; Murphy, Terrence E.; Han, Ling; Allore, Heather G.			Risk Factors and Precipitants of Long-Term Disability in Community Mobility A Cohort Study of Older Persons	ANNALS OF INTERNAL MEDICINE			English	Article							LIFE-STYLE INTERVENTIONS; LOWER-EXTREMITY FUNCTION; BODY-MASS INDEX; SUBSEQUENT DISABILITY; PHYSICAL PERFORMANCE; MAINTAINING MOBILITY; RESTRICTED ACTIVITY; BATHING DISABILITY; DRIVING CESSATION; RANDOMIZED-TRIAL	Background: Relatively little is known about why older persons develop long-term disability in community mobility. Objective: To identify the risk factors and precipitants for long-term disability in walking a quarter mile and driving a car. Design: Prospective cohort study from March 1998 to December 2009. Setting: Greater New Haven, Connecticut. Participants: 641 persons, aged 70 years or older, who were active drivers or nondisabled in walking a quarter mile. Persons who were physically frail were oversampled. Measurements: Candidate risk factors were assessed every 18 months. Disability in community mobility and exposure to potential precipitants, including illnesses or injuries leading to hospitalization or restricted activity, were assessed every month. Disability that lasted 6 or more consecutive months was considered long-term. Results: 318 (56.0%) and 269 (53.1%) participants developed long-term disability in walking and driving, respectively. Seven risk factors were independently associated with walking disability and 8 were associated with driving disability; the strongest associations for each outcome were found for older age and lower score on the Short Physical Performance Battery. The precipitants had a large effect on long-term disability, with multivariate hazard ratios for each outcome greater than 6.2 for hospitalization and greater than 2.4 for restricted activity. The largest differences in absolute risk were generally observed in participants with a specific risk factor who were subsequently hospitalized. Limitations: The observed associations may not be causal. The severity of precipitants was not assessed. The effect of the precipitants may have been underestimated because their exposure after the initial onset of disability was not evaluated. Conclusion: Long-term disability in community mobility is common among older persons. Multiple risk factors, together with subsequent precipitants, greatly increase the likelihood of long-term mobility disability.	[Gill, Thomas M.] Yale Univ, Sch Med, Adler Geriatr Assessment Ctr, New Haven, CT 06504 USA	Yale University	Gill, TM (corresponding author), Yale Univ, Sch Med, Adler Geriatr Assessment Ctr, 20 York St, New Haven, CT 06504 USA.	thomas.gill@yale.edu; heather.allore@yale.edu	Gill, Thomas M./H-7043-2019	Gill, Thomas M./0000-0002-6450-0368; Allore, Heather/0000-0001-7685-8175	National Institute on Aging [R37AG17560, K24AG021507]; National Institutes of Health [P30AG21342]; National Institute on Aging, National Institutes of Health; NATIONAL INSTITUTE ON AGING [R37AG017560, P30AG021342, K24AG021507] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By grant R37AG17560 from the National Institute on Aging and Midcareer Investigator Award in Patient-Oriented Research K24AG021507 from the National Institute on Aging (Dr. Gill). The study was conducted at the Yale Claude D. Pepper Older Americans Independence Center (funded by National Institutes of Health grant P30AG21342).; National Institute on Aging, National Institutes of Health.	[Anonymous], 1955, ARCH OPHTHALMOL-CHIC, V54, P462; Baker PS, 2003, J AM GERIATR SOC, V51, P1610, DOI 10.1046/j.1532-5415.2003.51512.x; BENICHOU J, 1990, BIOMETRICS, V46, P813, DOI 10.2307/2532098; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Brown CJ, 2009, ANN INTERN MED, V150, P372, DOI 10.7326/0003-4819-150-6-200903170-00005; Bruce ML, 2001, AM J GERIAT PSYCHIAT, V9, P102, DOI 10.1176/appi.ajgp.9.2.102; Chaves PHM, 2000, ARCH INTERN MED, V160, P2525, DOI 10.1001/archinte.160.16.2525; Clark DO, 1998, J AGING HEALTH, V10, P422, DOI 10.1177/089826439801000402; CORTI MC, 1994, JAMA-J AM MED ASSOC, V272, P1036, DOI 10.1001/jama.272.13.1036; Daniels R, 2010, EUR J AGEING, V7, P37, DOI 10.1007/s10433-010-0141-9; Daviglus ML, 2010, ANN INTERN MED, V153, P176, DOI 10.7326/0003-4819-153-3-201008030-00260; Edwards JD, 2008, J GERONTOL B-PSYCHOL, V63, pP6, DOI 10.1093/geronb/63.1.P6; Edwards JD, 2009, J GERONTOL A-BIOL, V64, P1290, DOI 10.1093/gerona/glp114; Ettinger WH, 1997, JAMA-J AM MED ASSOC, V277, P25, DOI 10.1001/jama.277.1.25; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fragoso CAV, 2008, J AM GERIATR SOC, V56, P1014, DOI 10.1111/j.1532-5415.2008.01687.x; Fried LP, 1997, J AM GERIATR SOC, V45, P92, DOI 10.1111/j.1532-5415.1997.tb00986.x; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gill TM, 2008, J AM GERIATR SOC, V56, P436, DOI 10.1111/j.1532-5415.2007.01603.x; Gill TM, 2007, J AM GERIATR SOC, V55, P534, DOI 10.1111/j.1532-5415.2007.01099.x; Gill TM, 2006, J GERONTOL A-BIOL, V61, P821, DOI 10.1093/gerona/61.8.821; Gill TM, 2011, J GERONTOL A-BIOL, V66, P1238, DOI 10.1093/gerona/glr142; Gill TM, 2009, J AM GERIATR SOC, V57, P1850, DOI 10.1111/j.1532-5415.2009.02443.x; Gill TM, 2006, J AM GERIATR SOC, V54, P248, DOI 10.1111/j.1532-5415.2005.00586.x; Gill TM, 2004, JAMA-J AM MED ASSOC, V292, P2115, DOI 10.1001/jama.292.17.2115; Gill TM, 2006, ARCH INTERN MED, V166, P418, DOI 10.1001/.418; GILL TM, 1995, J AM GERIATR SOC, V43, P603, DOI 10.1111/j.1532-5415.1995.tb07192.x; Gill TM, 2002, J AM GERIATR SOC, V50, P1492, DOI 10.1046/j.1532-5415.2002.50403.x; Gill TM, 2001, ANN INTERN MED, V135, P313, DOI 10.7326/0003-4819-135-5-200109040-00007; Guralnik JM, 2000, J GERONTOL A-BIOL, V55, pM221, DOI 10.1093/gerona/55.4.M221; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; GURALNIK JM, 1993, AM J EPIDEMIOL, V137, P845, DOI 10.1093/oxfordjournals.aje.a116746; Guralnik JM, 2001, J AM GERIATR SOC, V49, P1463, DOI 10.1046/j.1532-5415.2001.4911238.x; Hardy SE, 2005, ARCH INTERN MED, V165, P106, DOI 10.1001/archinte.165.1.106; Hardy SE, 2004, JAMA-J AM MED ASSOC, V291, P1596, DOI 10.1001/jama.291.13.1596; Hardy SE, 2011, J GEN INTERN MED, V26, P130, DOI 10.1007/s11606-010-1543-2; Harrell FEJr, 2001, REGRESSION MODELING, DOI DOI 10.1007/978-1-4757-3462-1; Ho SC, 1997, J GERONTOL A-BIOL, V52, pM356, DOI 10.1093/gerona/52A.6.M356; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Iezzoni LI, 2003, WALKING FAILS MOBILI; Katula JA, 2007, J AM GERIATR SOC, V55, P674, DOI 10.1111/j.1532-5415.2007.01136.x; Kohout F J, 1993, J Aging Health, V5, P179, DOI 10.1177/089826439300500202; LACROIX AZ, 1993, AM J EPIDEMIOL, V137, P858, DOI 10.1093/oxfordjournals.aje.a116747; LANDEFELD CS, 1995, NEW ENGL J MED, V332, P1338, DOI 10.1056/NEJM199505183322006; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LAUNER LJ, 1994, JAMA-J AM MED ASSOC, V271, P1093, DOI 10.1001/jama.271.14.1093; LICHTENSTEIN MJ, 1988, JAMA-J AM MED ASSOC, V259, P2875, DOI 10.1001/jama.259.19.2875; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; Marottoli RA, 1999, PRINCIPLES GERIATRIC, P267; Newman AB, 2006, JAMA-J AM MED ASSOC, V295, P2018, DOI 10.1001/jama.295.17.2018; Pahor M, 2006, J GERONTOL A-BIOL, V61, P1157; Rantanen T, 2001, J AM GERIATR SOC, V49, P21, DOI 10.1046/j.1532-5415.2001.49005.x; Reid MC, 2003, J AM GERIATR SOC, V51, P1092, DOI 10.1046/j.1532-5415.2003.51357.x; Rich MW, 2001, J GERONTOL A-BIOL, V56, pM88, DOI 10.1093/gerona/56.2.M88; Shumway-Cook A, 2003, J AM GERIATR SOC, V51, P393, DOI 10.1046/j.1532-5415.2003.51114.x; Straus SE, 2002, JAMA-J AM MED ASSOC, V288, P1396, DOI 10.1001/jama.288.11.1396; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; Studenski S, 2003, J AM GERIATR SOC, V51, P314, DOI 10.1046/j.1532-5415.2003.51104.x; Tinetti ME, 2003, NEW ENGL J MED, V348, P42, DOI 10.1056/NEJMcp020719; Tinetti ME, 2002, JAMA-J AM MED ASSOC, V287, P2098, DOI 10.1001/jama.287.16.2098; U.S. Census Bureau, 2011, AM FACTFINDER; Wang ML, 2006, BIOMETRICAL J, V48, P302, DOI 10.1002/bimj.200510188; Washburn RA, 1999, J CLIN EPIDEMIOL, V52, P643, DOI 10.1016/S0895-4356(99)00049-9; Webber SC, 2010, GERONTOLOGIST, V50, P443, DOI 10.1093/geront/gnq013	64	114	115	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 17	2012	156	2					131	W25		10.7326/0003-4819-156-2-201201170-00009	http://dx.doi.org/10.7326/0003-4819-156-2-201201170-00009			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	894IW	22250144	Green Accepted			2022-12-28	WOS:000300421400004
J	Greer, N; Brasure, M; Wilt, TJ				Greer, Nancy; Brasure, Michelle; Wilt, Timothy J.			Wheeled Mobility (Wheelchair) Service Delivery: Scope of the Evidence	ANNALS OF INTERNAL MEDICINE			English	Review							POWERED WHEELCHAIRS; MOTORIZED SCOOTERS; MANUAL WHEELCHAIRS; CLINICAL-TRIAL; OLDER-ADULTS; SATISFACTION; PARTICIPATION; INDIVIDUALS; PERFORMANCE; TECHNOLOGY	Identifying the appropriate wheelchair for a person who needs one has implications for both disabled persons and society. For someone with severe locomotive problems, the right wheelchair can affect mobility and quality of life. However, policymakers are concerned about the increasing demand for unnecessarily elaborate chairs. The Office of Inspector General, U. S. Department of Health and Human Services, issued 4 reports between 2009 and 2011 detailing fraud and misapplication of Medicare funds for powered wheelchairs, more than a decade after similar concerns were first raised by 4 contractors who process claims for durable medical equipment. Subsequent concerns have arisen about whether some impaired persons who need wheeled mobility devices may now be inappropriately denied coverage. A transparent, evidence-based approach to wheeled mobility service delivery (the matching of mobility-impaired persons to appropriate devices and supporting services) might lessen these concerns. This review describes the process of wheeled mobility service delivery for long-term wheelchair users with complex rehabilitation needs and presents findings from a survey of the literature ( published and gray) and interviews with key informants. Recommended steps in the delivery process were identified in textbooks, guidelines, and published literature. Delivery processes shared many commonalities; however, no research supports the recommended approaches. A search of bibliographic databases through March 2011 identified 24 studies that evaluated aspects of wheeled mobility service delivery. Most were observational, exploratory studies designed to determine consumer use of and satisfaction with the process. The evidence base for the effectiveness of approaches to wheeled mobility service delivery is insufficient, and additional research is needed to develop standards and guidelines.	[Greer, Nancy] Minneapolis Vet Affairs Hlth Care Syst, Ctr Chron Dis Outcomes Res, Minnesota Evidence Based Practice Ctr, Minneapolis, MN 55417 USA; Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities	Greer, N (corresponding author), Minneapolis Vet Affairs Hlth Care Syst, Ctr Chron Dis Outcomes Res, Minnesota Evidence Based Practice Ctr, 1 Vet Dr,Mail Code 111-O, Minneapolis, MN 55417 USA.	nancy.greer@va.gov			Minnesota Evidence-based Practice Center [290-07-10064-I]	Minnesota Evidence-based Practice Center	By the Minnesota Evidence-based Practice Center, under contract to AHRQ (grant 290-07-10064-I).	[Anonymous], CURRENT POPULATION R; Armstrong W., 2008, GUIDELINES PROVISION; Aronovitz LG, 2004, CMS DID NOT CONTROL; Barlow IG, 2009, INT J TELEREHABILITA, V1, P17, DOI 10.5195/IJT.2009.868; BATAVIA A I, 1990, Journal of Rehabilitation Research and Development, V27, P425, DOI 10.1682/JRRD.1990.10.0425; Batavia M., 2010, WHEELCHAIR EVALUATIO, V2nd; BeaumontWhite S, 1997, PROSTHET ORTHOT INT, V21, P62; Bergstrom AL, 2006, DISABIL REHABIL-ASSI, V1, P175, DOI 10.1080/17483100600573230; Clinician Task Force, 2004, WHEEL MOB DEV COV PO; Consortium for Spinal Cord Medicine, 2005, PRES UPP LIMB FUNCT; Cook Albert M., 2008, COOK HUSSEYS ASSISTI; Cooper R., 2009, BRIDGE, V39, P13; Cooper R. A., 1998, WHEELCHAIR SELECTION; Cooper RA, 2003, INT WORKSH SPAC REQ; di Marco A., 2003, AUST OCCUP THER J, V50, P30, DOI DOI 10.1046/J.1440-1630.2003.00316.X; Dicianno BE, 2009, AM J PHYS MED REHAB, V88, P533, DOI 10.1097/PHM.0b013e3181aa41d4; Eggers SL, 2009, ARCH PHYS MED REHAB, V90, P1030, DOI 10.1016/j.apmr.2008.12.007; Evans S, 2007, DISABIL REHABIL, V29, P1281, DOI 10.1080/09638280600964406; Evans S, 2007, AGE AGEING, V36, P431, DOI 10.1093/ageing/afm034; Garber SL, 2002, J REHABIL RES DEV, V39, P521; Gavin-Dreschnack D, 2005, J NURS CARE QUAL, V20, P119, DOI 10.1097/00001786-200504000-00006; Hansen R, 2004, CLIN REHABIL, V18, P631, DOI 10.1191/0269215504cr777oa; Hoenig H, 2005, J AM GERIATR SOC, V53, P1712, DOI 10.1111/j.1532-5415.2005.53502.x; Hoenig H, 2007, ARCH PHYS MED REHAB, V88, P279, DOI 10.1016/j.apmr.2006.11.022; Karmarkar AM, 2009, DISABIL REHABIL-ASSI, V4, P337, DOI 10.1080/17483100903038543; Kilkens OJE, 2005, J REHABIL RES DEV, V42, P65, DOI 10.1682/JRRD.2004.08.0093; KIRBY RL, 1995, AM J PHYS MED REHAB, V74, P308, DOI 10.1097/00002060-199507000-00009; Kittel A, 2002, DISABIL REHABIL, V24, P106, DOI 10.1080/09638280110066785; Levinson DR, 2011, MOST POWER WHEELCHAI; Levinson DR, 2009, MEDICARE POWER WHEEL; Levinson DR, 2009, POWER WHEELCHAIRS ME; MacPhee AH, 2004, ARCH PHYS MED REHAB, V85, P41, DOI 10.1016/S0003-9993(03)00364-2; McDonald RL, 2007, DISABIL REHABIL-ASSI, V2, P319, DOI 10.1080/17483100701456053; Minkel J, 2002, CLIN GUIDE ASSISTIVE, P55; National Coalition for Assistive and Rehab Technology, 2011, PROP CREAT SEP BEN C; Nitz JC, 2008, PATIENT EDUC COUNS, V70, P276, DOI 10.1016/j.pec.2007.10.014; Paralyzed Veterans of America, 1997, WHEELCH YOUR OPT RIG; Phillips B, 1993, Assist Technol, V5, P36; Pimentel S, 2008, INT J THER REHABIL, V15, P491, DOI 10.12968/ijtr.2008.15.11.31545; Post MWM, 1997, SPINAL CORD, V35, P109, DOI 10.1038/sj.sc.3100362; Richardson M, 2009, DISABIL REHABIL-ASSI, V4, P181, DOI 10.1080/17483100802543114; Salminen AL, 2009, J REHABIL MED, V41, P697, DOI 10.2340/16501977-0427; Samuelsson K, 2001, DISABIL REHABIL, V23, P677; Samuelsson K, 2008, DISABIL REHABIL, V30, P551, DOI 10.1080/09638280701355777; Scheiman M., 2002, CLIN MANAGEMENT BINO, P3; Schein RM, 2010, ARCH PHYS MED REHAB, V91, P874, DOI 10.1016/j.apmr.2010.01.017; Schmeler M, 1999, LECT SERIES APPL USE; Suzuki KM., 2000, PHYS OCCUP THER GERI, V17, P55; Taylor SJ, 2009, IND PROFILE WHEELED, P258; Telfer S, 2010, DISABIL REHABIL-ASSI, V5, P14, DOI 10.3109/17483100903191334; Ward AL, 2010, ARCH PHYS MED REHAB, V91, P268, DOI 10.1016/j.apmr.2009.10.023; White E., 1998, BR J OCCUP THER, V61, P301; Wressle E., 2004, SCAND J OCCUP THER, V11, P143, DOI DOI 10.1080/11038120410020728; Wright S, 2009, MISCODED CLAIMS POWE; Xiang H, 2006, INJURY PREV, V12, P8, DOI 10.1136/ip.2005.010033	55	55	55	0	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 17	2012	156	2					141	W30		10.7326/0003-4819-156-2-201201170-00010	http://dx.doi.org/10.7326/0003-4819-156-2-201201170-00010			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	894IW	22250145				2022-12-28	WOS:000300421400005
J	Schaefer, BE; Pagnotta, A				Schaefer, Bradley E.; Pagnotta, Ashley			An absence of ex-companion stars in the type Ia supernova remnant SNR 05092-67.5	NATURE			English	Article							LARGE-MAGELLANIC-CLOUD; X-RAY PHASE; LIGHT ECHOES; WHITE-DWARFS; PROGENITORS; BINARIES; IDENTIFICATION; GALAXIES; IMPACT	A type Ia supernova is thought to begin with the explosion of a white dwarf star(1). The explosion could be triggered by the merger of two white dwarfs(2,3) (a 'double-degenerate' origin), or by mass transfer from a companion star(4,5) (the 'single-degenerate' path). The identity of the progenitor is still controversial; for example, a recent argument against the single-degenerate origin(6) has been widely rejected(7-11). One way to distinguish between the double-and single-degenerate progenitors is to look at the centre of a known type Ia supernova remnant to see whether any former companion star is present(12,13). A likely ex-companion star for the progenitor of the supernova observed by Tycho Brahe has been identified(14), but that claim is still controversial(15-18). Here we report that the central region of the supernova remnant SNR 0509-67.5 (the site of a type Ia supernova 400650 years ago, based on its light echo(19,20)) in the Large Magellanic Cloud contains no ex-companion star to a visualmagnitude limit of 26.9 (an absolute magnitude of M-V = +8.4) within a region of radius 1.43 arcseconds. (This corresponds to the 3 sigma maximum distance to which a companion could have been 'kicked' by the explosion.) This lack of any ex-companion star to deep limits rules out all published single-degenerate models for this supernova. The only remaining possibility is that the progenitor of this particular type Ia supernova was a double-degenerate system.	[Schaefer, Bradley E.; Pagnotta, Ashley] Louisiana State Univ, Dept Phys & Astron, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Schaefer, BE (corresponding author), Louisiana State Univ, Dept Phys & Astron, Baton Rouge, LA 70803 USA.	schaefer@lsu.edu		Pagnotta, Ashley/0000-0002-8669-217X	National Science Foundation; Division Of Astronomical Sciences [1109420] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The HST images were taken as part of two programmes with Principal Investigators J. P. Hughes and K. Noll. This work was supported by the National Science Foundation.	Badenes C, 2009, ASTROPHYS J, V700, P727, DOI 10.1088/0004-637X/700/1/727; Borkowski KJ, 2006, ASTROPHYS J, V642, pL141, DOI 10.1086/504472; BRANCH D, 1995, PUBL ASTRON SOC PAC, V107, P1019, DOI 10.1086/133657; Canal R, 2001, ASTROPHYS J, V550, pL53, DOI 10.1086/319479; Di Stefano R, 2010, ASTROPHYS J, V719, P474, DOI 10.1088/0004-637X/719/1/474; Gilfanov M, 2010, NATURE, V463, P924, DOI 10.1038/nature08685; Hachisu I, 2010, ASTROPHYS J LETT, V724, pL212, DOI 10.1088/2041-8205/724/2/L212; Helder EA, 2010, ASTROPHYS J LETT, V719, pL140, DOI 10.1088/2041-8205/719/2/L140; Hernandez JIG, 2009, ASTROPHYS J, V691, P1, DOI 10.1088/0004-637X/691/1/1; HUGHES JP, 1995, ASTROPHYS J, V444, pL81, DOI 10.1086/187865; IBEN I, 1984, ASTROPHYS J SUPPL S, V54, P335, DOI 10.1086/190932; Ihara Y, 2007, PUBL ASTRON SOC JPN, V59, P811, DOI 10.1093/pasj/59.4.811; Kerzendorf WE, 2009, ASTROPHYS J, V701, P1665, DOI 10.1088/0004-637X/701/2/1665; Lipunov VM, 2011, NEW ASTRON, V16, P250, DOI 10.1016/j.newast.2010.09.001; Mannucci F, 2006, MON NOT R ASTRON SOC, V370, P773, DOI 10.1111/j.1365-2966.2006.10501.x; Marietta E, 2000, ASTROPHYS J SUPPL S, V128, P615, DOI 10.1086/313392; Meng XC, 2011, RES ASTRON ASTROPHYS, V11, P965, DOI 10.1088/1674-4527/11/8/008; Orio M, 2010, ASTROPHYS J, V717, P739, DOI 10.1088/0004-637X/717/2/739; Ozaki J, 2006, ASTROPHYS J, V644, P954, DOI 10.1086/503737; Pan KC, 2010, ASTROPHYS J, V715, P78, DOI 10.1088/0004-637X/715/1/78; Podsiadlowski P., 2003, EVOLUTION APPEARANCE; Rest A, 2008, ASTROPHYS J, V680, P1137, DOI 10.1086/587158; Rest A, 2005, NATURE, V438, P1132, DOI 10.1038/nature04365; Ruiz-Lapuente P, 2004, NATURE, V431, P1069, DOI 10.1038/nature03006; RuizLapuente P, 1997, SCIENCE, V276, P1813, DOI 10.1126/science.276.5320.1813; van Kerkwijk MH, 2010, ASTROPHYS J LETT, V722, pL157, DOI 10.1088/2041-8205/722/2/L157; WEBBINK RF, 1984, ASTROPHYS J, V277, P355, DOI 10.1086/161701; WHELAN J, 1973, ASTROPHYS J, V186, P1007, DOI 10.1086/152565	28	212	214	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 12	2012	481	7380					164	166		10.1038/nature10692	http://dx.doi.org/10.1038/nature10692			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	874TO	22237107				2022-12-28	WOS:000298981200030
J	Rosario, DJ; Lane, JA; Metcalfe, C; Donovan, JL; Doble, A; Goodwin, L; Davis, M; Catto, JWF; Avery, K; Neal, DE; Hamdy, FC				Rosario, Derek J.; Lane, J. Athene; Metcalfe, Chris; Donovan, Jenny L.; Doble, Andy; Goodwin, Louise; Davis, Michael; Catto, James W. F.; Avery, Kerry; Neal, David E.; Hamdy, Freddie C.			Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ULTRASOUND-GUIDED BIOPSY; TRANSRECTAL NEEDLE-BIOPSY; ANTIBIOTIC-PROPHYLAXIS; POPULATION; CIPROFLOXACIN; METAANALYSIS; MORTALITY; DIAGNOSIS; PLACEBO; POLICY	Objectives To measure the effect of the adverse events within 35 days of transrectal ultrasound guided biopsy from the perspective of asymptomatic men having prostate specific antigen (PSA) testing; to assess early attitude to re-biopsy; to estimate healthcare resource use associated with adverse events due to biopsy; and to develop a classification scheme for reporting adverse events after prostate biopsy. Design Prospective cohort study (Prostate Biopsy Effects: ProBE) nested within Prostate Testing for Cancer and Treatment (ProtecT) study. Participants Between 1999 and 2008, 227 000 community dwelling men aged 5069 years were identified at 352 practices and invited to counselling about PSA testing. 111 148 attended a nurse led clinic in the community, and 10 297 with PSA concentrations of 3-20 ng/mL were offered biopsy within ProtecT. Between February 2006 and May 2008, 1147/1753 (65%) eligible men (mean age 62.1 years, mean PSA 5.4 ng/mL) having 10 core transrectal ultrasound guided biopsy under antibiotic cover in the context of ProtecT were recruited to the ProBE study. Outcome measures Purpose designed questionnaire administered at biopsy and 7 and 35 days after the procedure to measure frequency and effect of symptoms related to pain, infection, and bleeding; patients' attitude to repeat biopsy assessed immediately after biopsy and 7 days later; participants' healthcare resource use within 35 days of biopsy evaluated by questionnaire, telephone follow-up, and medical note review; each man's adverse event profile graded according to symptoms and healthcare use. Results Pain was reported by 429/984 (43.6%), fever by 172/985 (17.5%), haematuria by 642/976 (65.8%), haematochezia by 356/967 (36.8%), and haemoejaculate by 605/653 (92.6%) men during the 35 days after biopsy. Fewer men rated these symptoms as a major/moderate problem-71/977 (7.3%) for pain, 54/981 (5.5%) for fever, 59/958 (6.2%) for haematuria, 24/951 (2.5%) for haematochezia, and 172/646 (26.6%) for haemoejaculate. Immediately after biopsy, 124/1142 (10.9%, 95% confidence interval 9.2 to 12.8) men reported that they would consider further biopsy a major or moderate problem: seven days after biopsy, this proportion had increased to 213/1085 (19.6%, 17.4% to 22.1%). A negative attitude to repeat biopsy was associated with unfavourable experience after the first biopsy, particularly pain at biopsy (odds ratio 8.2, P<0.001) and symptoms related to infection (7.9, P<0.001) and bleeding (4.2, P<0.001); differences were evident between centres (P<0.001). 119/1147 (10.4%, 8.7% to 12.3%) men reported consultation with a healthcare professional (usually their general practitioner), most commonly for infective symptoms. Complete data for all index symptoms at all time points were available in 851 participants. Symptoms and healthcare use could be used to grade these men as follows: grade 0 (no symptoms/contact) 18 (2.1%, 1.3% to 3.3%); grade 1 (minor problem/no contact) 550 (64.6%, 61.4% to 67.8%); grade 2 (moderate/major problem or contact) 271 (31.8%, 28.8% to 35.1%); grade 3 (hospital admission) 12 (1.4%, 0.8% to 2.4%); and grade 4 (death) 0. Grade of adverse event was associated with an unfavourable attitude to repeat biopsy (Kendall's t-b ordinal by ordinal 0.29, P<0.001). Conclusion This study with a high response rate of 89% at 35 days in men undergoing biopsy in the context of a randomised controlled trial has shown that although prostate biopsy is well tolerated by most men, it is associated with significant symptoms in a minority and affects attitudes to repeat biopsy and primary care resource use. These findings will inform men who seek PSA testing for detection of prostate cancer and assist their physicians during counselling about the potential risks and effect of biopsy. Variability in the adverse event profile between centres suggests that patients' outcomes could be improved and healthcare use reduced with more effective administration of local anaesthetic and antibiotics.	[Rosario, Derek J.; Goodwin, Louise; Catto, James W. F.] Univ Sheffield, Royal Hallamshire Hosp, Dept Oncol, Acad Urol Unit, Sheffield S10 2JF, S Yorkshire, England; [Lane, J. Athene; Metcalfe, Chris; Donovan, Jenny L.; Davis, Michael; Avery, Kerry] Univ Bristol, Sch Social & Community Med, Bristol BS8 2PS, Avon, England; [Doble, Andy] Addenbrookes Hosp, Dept Urol, Cambridge CB2 0QQ, England; [Neal, David E.] Univ Cambridge, Addenbrookes Hosp, Dept Oncol, Cambridge CB2 1TN, England; [Hamdy, Freddie C.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg Sci, Oxford OX3 9DU, England	University of Sheffield; University of Bristol; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Oxford	Rosario, DJ (corresponding author), Univ Sheffield, Royal Hallamshire Hosp, Dept Oncol, Acad Urol Unit, Sheffield S10 2JF, S Yorkshire, England.	d.j.rosario@shef.ac.uk	Rosario, Derek/C-2028-2017	Rosario, Derek/0000-0002-9086-3592; Neal, David/0000-0002-6033-5086; Metcalfe, Chris/0000-0001-8318-8907; catto, james/0000-0003-2787-8828; Avery, Kerry/0000-0001-5477-2418; Hamdy, Freddie/0000-0003-2627-2154	Prostate Cancer Risk Management Group; NIHR HTA; ESRC [ES/G007543/1] Funding Source: UKRI; MRC [G0800800] Funding Source: UKRI; Economic and Social Research Council [ES/G007543/1] Funding Source: researchfish; Medical Research Council [G0800800] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10242] Funding Source: researchfish	Prostate Cancer Risk Management Group; NIHR HTA; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The ProBE study was funded by the Prostate Cancer Risk Management Group. The study and authors are independent of the funding body. The ProtecT study is funded by NIHR HTA.	Aron M, 2000, BJU INT, V85, P682, DOI 10.1046/j.1464-410x.2000.00576.x; Avery K, 2004, NEUROUROL URODYNAM, V23, P322, DOI 10.1002/nau.20041; Braun KP, 2009, UROLOGE, V48, P163, DOI 10.1007/s00120-008-1860-9; Burden HP, 2008, BJU INT, V101, P1202, DOI 10.1111/j.1464-410X.2008.07556.x; Cannon Glenn M Jr, 2007, Can J Urol, V14, P3653; Carlson WH, 2010, CAN J UROL, V17, P5135; Chappell B, 2009, BJU INT, V103, P409, DOI 10.1111/j.1464-410X.2009.08387_1.x; Djavan B, 2001, J UROLOGY, V166, P856, DOI 10.1016/S0022-5347(05)65851-X; Djulbegovic M, 2011, BMJ-BRIT MED J, V341, pc4543, DOI DOI 10.1136/BMJ.C4543; Donovan J, 2002, BMJ-BRIT MED J, V325, P766, DOI 10.1136/bmj.325.7367.766; Donovan JL, 2000, J UROLOGY, V164, P1948, DOI 10.1016/S0022-5347(05)66926-1; Eichler K, 2006, J UROLOGY, V175, P1605, DOI 10.1016/S0022-5347(05)00957-2; Eskicorapci SY, 2004, EUR UROL, V45, P444, DOI 10.1016/j.eururo.2003.11.024; Ferlay J, 2010, IARC CANCERBASE, V10; Gallina A, 2008, INT J CANCER, V123, P647, DOI 10.1002/ijc.23559; Hambrock T, 2010, J UROLOGY, V183, P520, DOI 10.1016/j.juro.2009.10.022; Hergan L, 2007, UROLOGY, V69, P520, DOI 10.1016/j.urology.2006.12.005; Herranz AF, 1996, ACTAS UROL ESP, V20, P858; Hodge KK, 1974, J UROLOGY, V142, P71; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; Ingber MS, 2010, INT UROL NEPHROL, V42, P23, DOI 10.1007/s11255-009-9621-2; Irani J, 1997, BRIT J UROL, V79, P608, DOI 10.1046/j.1464-410X.1997.00120.x; Kapoor DA, 1998, UROLOGY, V52, P552, DOI 10.1016/S0090-4295(98)00296-9; KEETCH DW, 1994, J UROLOGY, V151, P1571, DOI 10.1016/S0022-5347(17)35304-1; Lane JA, 2010, EUR J CANCER, V46, P3095, DOI 10.1016/j.ejca.2010.09.016; Lee G, 2007, INT UROL NEPHROL, V39, P185, DOI 10.1007/s11255-006-6654-7; Leippold T, 2008, SCAND J UROL NEPHROL, V42, P18, DOI 10.1080/00365590701520503; Litwin MS, 1998, MED CARE, V36, P1002, DOI 10.1097/00005650-199807000-00007; Loeb S, 2010, J UROLOGY, V183, P852, DOI 10.1016/j.juro.2009.12.063; Makinen T, 2002, UROLOGY, V60, P846; Nam RK, 2010, J UROLOGY, V183, P963, DOI 10.1016/j.juro.2009.11.043; Patel AR, 2009, CURR OPIN UROL, V19, P232, DOI 10.1097/MOU.0b013e328329a33e; Raaijmakers R, 2002, UROLOGY, V60, P826, DOI 10.1016/S0090-4295(02)01958-1; Rosario DJ, 2008, EUR UROL, V53, P777, DOI 10.1016/j.eururo.2007.11.064; Schaeffer AJ, 2007, BJU INT, V100, P51, DOI 10.1111/j.1464-410X.2007.06848.x; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Sexton WJ, 2010, J UROLOGY, V183, P969, DOI 10.1016/j.juro.2009.11.118; Thompson PM, 2009, BJU INT, V104, P271, DOI 10.1111/j.1464-410X.2009.08750_4.x; Tiong HY, 2007, PROSTATE CANCER P D, V10, P127, DOI 10.1038/sj.pcan.4500935; Trotti A, 2004, J CLIN ONCOL, V22, P19, DOI 10.1200/JCO.2004.10.911; Welch HG, 2007, J NATL CANCER I, V99, P1395, DOI 10.1093/jnci/djm119; Wolf JS, 2008, J UROLOGY, V179, P1379, DOI [10.1016/j.juro.2008.01.068, 10.1016/S0022-5347(08)62119-9]	42	164	169	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 9	2012	344								d7894	10.1136/bmj.d7894	http://dx.doi.org/10.1136/bmj.d7894			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877RV	22232535	Green Submitted, Green Published, hybrid, Green Accepted			2022-12-28	WOS:000299200900008
J	Room, R; Reuter, P				Room, Robin; Reuter, Peter			How well do international drug conventions protect public health?	LANCET			English	Article							ILLICIT OPIOID USE; TRENDS; POLICIES; BURDEN; ABUSE	The Single Convention on Narcotic Drugs in 1961 aimed to eliminate the illicit production and non-medical use of cannabis, cocaine, and opioids, an aim later extended to many pharmaceutical drugs. Over the past 50 years international drug treaties have neither prevented the globalisation of the illicit production and non-medical use of these drugs, nor, outside of developed countries, made these drugs adequately available for medical use. The system has also arguably worsened the human health and wellbeing of drug users by increasing the number of drug users imprisoned, discouraging effective countermeasures to the spread of HIV by injecting drug users, and creating an environment conducive to the violation of drug users' human rights. The international system has belatedly accepted measures to reduce the harm from injecting drug use, but national attempts to reduce penalties for drug use while complying with the treaties have often increased the number of drug users involved with the criminal justice system. The international treaties have also constrained national policy experimentation because they require nation states to criminalise drug use. The adoption of national policies that are more aligned with the risks of different drugs and the effectiveness of controls will require the amendment of existing treaties, the formulation of new treaties, or withdrawal of states from existing treaties and re-accession with reservations.	[Room, Robin] Univ Melbourne, Ctr Alcohol Policy Res, Turning Point Alcohol & Drug Ctr, Melbourne, Vic 3065, Australia; [Room, Robin] Univ Melbourne, Sch Populat Hlth, Melbourne, Vic 3065, Australia; [Reuter, Peter] Univ Maryland, Sch Publ Policy, College Pk, MD 20742 USA; [Reuter, Peter] Univ Maryland, Dept Criminol, College Pk, MD 20742 USA	Turning Point Alcohol & Drug Centre - Australia; University of Melbourne; University of Melbourne; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Room, R (corresponding author), Univ Melbourne, Ctr Alcohol Policy Res, Turning Point Alcohol & Drug Ctr, 54-62 Gertrude St, Melbourne, Vic 3065, Australia.	robinr@turningpoint.org.au	Room, Robin/ABF-7460-2021; Room, Robin/ABH-8505-2020	Room, Robin/0000-0002-5618-385X; 	Victorian Department of Health; Foundation for Alcohol Research and Education (FARE)	Victorian Department of Health; Foundation for Alcohol Research and Education (FARE)	RR has been provided with support for travel by the Beckley Foundation for drug policy research project meetings and reports. RR's professorship is supported by the Victorian Department of Health and the Foundation for Alcohol Research and Education (FARE), and his research by FARE and government research grants. PR has been provided with travel support and honoraria by the Beckley Foundation for drug policy research project meetings and reports.	Babor T., 2010, DRUG POLICY PUBLIC G; Babor T.F., 2010, ALCHOL NO ORDINARY C, V2nd, DOI DOI 10.1093/ACPROF:OSO/9780199551149.003.002; Begg SVT, 2003, BURDEN DIS INJURY AU, pPHE82; Bewley-Taylor D, 2010, INT NARCOTICS CONTRO; Braithwaite J., 2000, GLOBAL BUSINESS REGU, P539; Bruun K., 1975, GENTLEMENS CLUB INT; Burci Gian Luca, 2004, WORLD HLTH ORG, P124; Carstairs C, 2005, DRUG ALCOHOL REV, V24, P57, DOI 10.1080/09595230500125179; Caulkins JP, 2006, CRIME DELINQUENCY, V52, P619, DOI 10.1177/0011128705284793; Compton WM, 2006, DRUG ALCOHOL DEPEN, V81, P103, DOI 10.1016/j.drugalcdep.2005.05.009; Costa AM, 2009, WORLD DRUG REPORT 20, P1; Costa AM, 2011, MAKING DRUG CONTROL; Courtwright DT, 2010, BIOSOCIETIES, V5, P137, DOI 10.1057/biosoc.2009.3; de Cordoba J, 2011, MEXICO DEATH TOLL DR; Degenhardt L, 2006, DRUG ALCOHOL REV, V25, P403, DOI 10.1080/09595230600868504; Degenhardt L, 2012, LANCET, V379, P55, DOI 10.1016/S0140-6736(11)61138-0; Degenhardt L, 2010, LANCET, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; Donnelly N, 2011, EFFECTS CANNABIS EXP; Elliott Richard, 2005, Health Hum Rights, V8, P104, DOI 10.2307/4065336; European Monitoring Centre for Drugs and Drug Addiction, 2011, ANN REP 2010 STAT DR; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Fetherston J, 2011, EFFECTS W AUSTR CANN; Fischer B, 1997, PUBLIC HEALTH, V111, P271, DOI 10.1016/S0033-3506(97)00053-X; Fischer B, 2007, ADDICTION, V102, P499, DOI 10.1111/j.1360-0443.2006.01738.x; Fischer B, 2006, CAN MED ASSOC J, V175, P1385, DOI 10.1503/cmaj.060729; Fong GT, 2006, TOB CONTROL, V15, P1, DOI 10.1136/tc.2006.017244; Golub Andrew, 2007, Criminol Public Policy, V6, P131, DOI 10.1111/j.1745-9133.2007.00426.x; Gorman DA, 2007, INT J DRUG POLICY, V18, P160, DOI 10.1016/j.drugpo.2006.10.001; Hall W, 2009, LANCET, V374, P1383, DOI 10.1016/S0140-6736(09)61037-0; Helfer L, 2006, YALE J INT L, V31, P367; Helfer LR, 2005, VA LAW REV, V91, P1579; Hibell B, 2007 ESPAD REPORT SU; Hughes CE, 2010, BRIT J CRIMINOL, V50, P999, DOI 10.1093/bjc/azq038; International Drug Policy Consortium, 2010, 2009 COMM NARC DRUGS; International Drug Policy Consortium, 2010, 2010 COMM NARC DRUGS; International Drug Policy Consortium, 2010, 2007 COMM NARC DRUGS; International Drug Policy Consortium, 2010, WHY IS OUTC UN DRUG; International Narcotics Control Board, REP INT NARC CONTR B; Jelsma M, 2011, BOLIVIAS DENUNCIATIO; Jelsma M, 2011, DEV INT DRUG CONTROL; Kilmer B, 2011, ALTERED STATE ASSESS; Kleiman M, 2009, BRUTE FORCE FAILS; Kleiman M, 1992, EXCESS DRUG POLICY R; Korf DJ, 2002, ADDICT BEHAV, V27, P851, DOI 10.1016/S0306-4603(02)00291-5; Krajewski, 1999, INT J DRUG POLICY, V10, P328; Kuziemko Y, 2004, J PUBLIC ECON, V88, P2043, DOI 10.1016/S0047-2727(03)00020-3; MacCoun R, 1997, SCIENCE, V278, P47, DOI 10.1126/science.278.5335.47; MacCoun RJ., 2001, DRUG WAR HERESIES LE; McAllister William., 2000, DRUG DIPLOMACY 20 CE; O'Keefe K, 2011, MARIJUANA USE YOUNG; Office of National Drug Control Policy, 2010, WHAT AM US SPEND ILL; ProCon.org, 2011, MAN PEOPL US US MED; Rehm J, COSTS SUBSTANCE ABUS; Reuter P, 2006, ADDICTION, V101, P315, DOI 10.1111/j.1360-0443.2005.01336.x; Reuter P, 2001, ADDICTION, V96, P373, DOI 10.1046/j.1360-0443.2001.9633731.x; Reuter P, 2010, ASSESSING CHANGES GL; Reuter P., 2009, REPORT GLOBAL ILLICI; Room R, 2005, J PSYCHOACTIVE DRUGS, V37, P373, DOI 10.1080/02791072.2005.10399810; Room R, 1999, SUBST USE MISUSE, V34, P1689, DOI 10.3109/10826089909039422; Room R., 2010, CANNABIS POLICY MOVI; Room R, 2006, DRUG ALCOHOL REV, V25, P581, DOI 10.1080/09595230600944503; Room Robin, 2006, Soc Hist Alcohol Drugs, V21, P276; Samuels D, 2010, KUSH MED MARIJUANA I; Seblova J, 2005, J EMERG MED, V28, P95, DOI 10.1016/j.jemermed.2004.05.010; Strang J, 2012, LANCET, V379, P71, DOI 10.1016/S0140-6736(11)61674-7; Transnational Institute, 2010, TNI DRUGS DEM PROGR; United Nations Offi ce on Drugs and Crime, 2010, COERC COH TREAT DRUG; United Nations Office on Drugs and Crime, 2010, RESP DRUG US HIV IR; United Nations Office on Drugs and Crime, WORLD DRUG REP 2009; United Nations Office on Drugs and Crime, WORLD DRUG REP 2010; WHO, 2010, IMPR ACC MED CONTR I; WHO Expert Committee on Drug Dependence, 2010, 28 WHO EXP COMM DRUG; WHO Expert Committee on Drug Dependence, 2010, 33 WHO EXP COMM DRUG; Zabransky T, 2011, PAD IMPACT ANAL PROJ	74	72	72	1	30	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 7	2012	379	9810					84	91		10.1016/S0140-6736(11)61423-2	http://dx.doi.org/10.1016/S0140-6736(11)61423-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	873WC	22225673				2022-12-28	WOS:000298913000040
J	Inamori, K; Yoshida-Moriguchi, T; Hara, Y; Anderson, ME; Yu, LP; Campbell, KP				Inamori, Kei-ichiro; Yoshida-Moriguchi, Takako; Hara, Yuji; Anderson, Mary E.; Yu, Liping; Campbell, Kevin P.			Dystroglycan Function Requires Xylosyl- and Glucuronyltransferase Activities of LARGE	SCIENCE			English	Article							ALPHA-DYSTROGLYCAN; MUSCULAR-DYSTROPHY; CRYSTAL-STRUCTURE; LAMININ-BINDING; GLYCOSYLATION; GLYCOSYLTRANSFERASES; FAMILY	Posttranslational modification of alpha-dystroglycan (alpha-DG) by the like-acetylglucosaminyltransferase (LARGE) is required for it to function as an extracellular matrix (ECM) receptor. Mutations in the LARGE gene have been identified in congenital muscular dystrophy patients with brain abnormalities. However, the precise function of LARGE remains unclear. Here we found that LARGE could act as a bifunctional glycosyltransferase, with both xylosyltransferase and glucuronyltransferase activities, which produced repeating units of [-3-xylose-alpha 1,3-glucuronic acid-beta 1-]. This modification allowed alpha-DG to bind laminin-G domain-containing ECM ligands.	[Inamori, Kei-ichiro; Yoshida-Moriguchi, Takako; Hara, Yuji; Anderson, Mary E.; Campbell, Kevin P.] Univ Iowa, Howard Hughes Med Inst, Dept Mol Physiol & Biophys,Roy J & Lucille A Carv, Dept Neurol,Dept Internal Med, Iowa City, IA 52242 USA; [Yu, Liping] Univ Iowa, Med Nucl Magnet Resonance Facil, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	Howard Hughes Medical Institute; University of Iowa; University of Iowa	Campbell, KP (corresponding author), Univ Iowa, Howard Hughes Med Inst, Dept Mol Physiol & Biophys,Roy J & Lucille A Carv, Dept Neurol,Dept Internal Med, 4283 Carver Biomed Res Bldg,285 Newton Rd, Iowa City, IA 52242 USA.	kevin-campbell@uiowa.edu	Inamori, Kei-ichiro/ABA-2926-2020	Inamori, Kei-ichiro/0000-0002-5947-3633; Yu, Liping/0000-0003-3536-6427; Campbell, Kevin/0000-0003-2066-5889	Paul D. Wellstone Muscular Dystrophy Cooperative Research Center [1U54NS053672]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS053672] Funding Source: NIH RePORTER	Paul D. Wellstone Muscular Dystrophy Cooperative Research Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all members of the Campbell laboratory for fruitful discussions and D. Venzke and Z. Zhu for technical assistance, J. D. Esko for providing pgsI-208 cells, and the University of Iowa Proteomics Facility and Flow Cytometry Facility, Iowa State University Hybridoma Facility, and the Glycotechnology Core Resource (UCSD) for their services. This work was supported in part by a Paul D. Wellstone Muscular Dystrophy Cooperative Research Center grant (1U54NS053672). K. P. C. is an Investigator of the Howard Hughes Medical Institute.	Bakker H, 2009, J BIOL CHEM, V284, P2576, DOI 10.1074/jbc.M804394200; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Barresi R, 2004, NAT MED, V10, P696, DOI 10.1038/nm1059; Brockington M, 2005, HUM MOL GENET, V14, P657, DOI 10.1093/hmg/ddi062; Combs AC, 2005, BIOCHEM J, V390, P303, DOI 10.1042/BJ20050375; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Godfrey C, 2011, CURR OPIN GENET DEV, V21, P278, DOI 10.1016/j.gde.2011.02.001; Grewal PK, 2001, NAT GENET, V28, P151, DOI 10.1038/88865; Harrison D, 2007, J BIOL CHEM, V282, P11573, DOI 10.1074/jbc.M610657200; Hohenester E, 1999, MOL CELL, V4, P783, DOI 10.1016/S1097-2765(00)80388-3; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Longman C, 2003, HUM MOL GENET, V12, P2853, DOI 10.1093/hmg/ddg307; SCHWARTZ NB, 1974, P NATL ACAD SCI USA, V71, P4047, DOI 10.1073/pnas.71.10.4047; Varki A., 2009, ESSENTIALS GLYCOBIOL; Yamada H, 1996, J NEUROCHEM, V66, P1518; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512	18	207	218	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 6	2012	335	6064					93	96		10.1126/science.1214115	http://dx.doi.org/10.1126/science.1214115			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872YA	22223806	Green Accepted			2022-12-28	WOS:000298846200058
J	McMichael, L				McMichael, Louise			PRACTICE POINTER Skin camouflage	BRITISH MEDICAL JOURNAL			English	Editorial Material									British Assoc Skin Camouflage, Stourbridge DY9 9QA, England		McMichael, L (corresponding author), British Assoc Skin Camouflage, Stourbridge DY9 9QA, England.	louise.mcmichael@tiscali.co.uk						*ALL PART PARL GRO, 2003, REP ENQ IMP SKIN DIS; [Anonymous], 2005, EUR J DERMATOL, V15, P284; British Association of Skin Camouflage, 2010, COV PRINC ART PAR SK; Gawkrodger D. J., 2002, DERMATOLOGY ILLUSTRA; Holme SA, 2002, BRIT J DERMATOL, V147, P956; Schofield J., 2009, SKIN CONDITIONS UK H; Sreedhar K, 2009, OPEN DERMATOL J, V3, P54	7	10	10	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 5	2012	344								d7921	10.1136/bmj.d7921	http://dx.doi.org/10.1136/bmj.d7921			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	874UH	22223831				2022-12-28	WOS:000298983100006
J	Ravetz, J				Ravetz, Jerome			Keep standards high	NATURE			English	Editorial Material									Univ Oxford, Inst Sci Innovat & Soc, Oxford OX1 1HP, England	University of Oxford	Ravetz, J (corresponding author), Univ Oxford, Inst Sci Innovat & Soc, Oxford OX1 1HP, England.	jerome-ravetz@ntlworld.com						2011, NATURE, V478, P428	1	8	8	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 5	2012	481	7379					25	25		10.1038/481025a	http://dx.doi.org/10.1038/481025a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	872VD	22222736	Bronze			2022-12-28	WOS:000298836900013
J	Schneider, T; Graves, SDB; Schaller, EL; Brown, ME				Schneider, T.; Graves, S. D. B.; Schaller, E. L.; Brown, M. E.			Polar methane accumulation and rainstorms on Titan from simulations of the methane cycle	NATURE			English	Article							MIDLATITUDE CLOUDS; LAKES; ATMOSPHERE; TROPICS; STORMS	Titan has a methane cycle akin to Earth's water cycle. It has lakes in polar regions(1,2), preferentially in the north(3); dry low latitudes with fluvial features(4,5) and occasional rainstorms(6,7); and tropospheric clouds mainly (so far) in southern middle latitudes and polar regions(8-15). Previous models have explained the low-latitude dryness as a result of atmospheric methane transport into middle and high latitudes(16). Hitherto, no model has explained why lakes are found only in polar regions and preferentially in the north; how low-latitude rainstorms arise; or why clouds cluster in southern middle and high latitudes. Here we report simulations with a three-dimensional atmospheric model coupled to a dynamic surface reservoir of methane. We find that methane is cold-trapped and accumulates in polar regions, preferentially in the north because the northern summer, at aphelion, is longer and has greater net precipitation than the southern summer. The net precipitation in polar regions is balanced in the annual mean by slow along-surface methane transport towards mid-latitudes, and subsequent evaporation. In low latitudes, rare but intense storms occur around the equinoxes, producing enough precipitation to carve surface features. Tropospheric clouds form primarily in middle and high latitudes of the summer hemisphere, which until recently has been the southern hemisphere. We predict that in the northern polar region, prominent clouds will form within about two (Earth) years and lake levels will rise over the next fifteen years.	[Schneider, T.; Graves, S. D. B.; Brown, M. E.] CALTECH, Pasadena, CA 91125 USA; [Schaller, E. L.] Natl Suborbital Educ & Res Ctr, NASA Dryden Aircraft Operat Facil, Palmdale, CA 93550 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA)	Schneider, T (corresponding author), CALTECH, Pasadena, CA 91125 USA.	tapio@caltech.edu	Schneider, Tapio/A-7038-2014	Schneider, Tapio/0000-0001-5687-2287; Schaller, Emily/0000-0001-8967-5423; Brown, Michael E./0000-0002-8255-0545	NASA; David and Lucile Packard Fellowship	NASA(National Aeronautics & Space Administration (NASA)); David and Lucile Packard Fellowship(The David & Lucile Packard Foundation)	We are grateful for support by a NASA Earth and Space Science Fellowship and a David and Lucile Packard Fellowship. We thank I. Eisenman for code for the insolation calculations, and O. Aharonson, A. Hayes and A. Soto for comments on a draft. The simulations were done on the California Institute of Technology's Division of Geological and Planetary Sciences Dell cluster.	Aharonson O, 2009, NAT GEOSCI, V2, P851, DOI 10.1038/ngeo698; Brown ME, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL035964; Brown ME, 2002, NATURE, V420, P795, DOI 10.1038/nature01302; Brown ME, 2010, ICARUS, V205, P571, DOI 10.1016/j.icarus.2009.08.024; CHARNEY JG, 1963, J ATMOS SCI, V20, P607, DOI 10.1175/1520-0469(1963)020<0607:ANOLSM>2.0.CO;2; Flasar FM, 2009, TITAN FROM CASSINI-HUYGENS, P323, DOI 10.1007/978-1-4020-9215-2_13; Griffith CA, 2005, SCIENCE, V310, P474, DOI 10.1126/science.1117702; Griffith CA, 2008, ASTROPHYS J LETT, V687, pL41, DOI 10.1086/593117; Hayes A, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033409; Hayes AG, 2011, ICARUS, V211, P655, DOI 10.1016/j.icarus.2010.08.017; Jennings DE, 2009, ASTROPHYS J LETT, V691, pL103, DOI 10.1088/0004-637X/691/2/L103; Lebreton JP, 2005, NATURE, V438, P758, DOI 10.1038/nature04347; Lorenz RD, 2006, SCIENCE, V312, P724, DOI 10.1126/science.1123257; Mitchell JL, 2006, P NATL ACAD SCI USA, V103, P18421, DOI 10.1073/pnas.0605074103; Mitchell JL, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE003017; Mitri G, 2007, ICARUS, V186, P385, DOI 10.1016/j.icarus.2006.09.004; NEELIN JD, 1987, MON WEATHER REV, V115, P3, DOI 10.1175/1520-0493(1987)115<0003:MTCBOT>2.0.CO;2; Penteado PF, 2005, ASTROPHYS J, V629, pL53, DOI 10.1086/444353; Perron JT, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002602; Porco CC, 2005, NATURE, V434, P159, DOI 10.1038/nature03436; Rannou P, 2006, SCIENCE, V311, P201, DOI 10.1126/science.1118424; Roe HG, 2005, SCIENCE, V310, P477, DOI 10.1126/science.1116760; Roe HG, 2005, ASTROPHYS J, V618, pL49, DOI 10.1086/427499; Schaller EL, 2009, NATURE, V460, P873, DOI 10.1038/nature08193; Schaller EL, 2006, ICARUS, V184, P517, DOI 10.1016/j.icarus.2006.05.025; Schneider T, 2006, ANNU REV EARTH PL SC, V34, P655, DOI 10.1146/annurev.earth.34.031405.125144; Stofan ER, 2007, NATURE, V445, P61, DOI 10.1038/nature05438; Tokano T, 2006, NATURE, V442, P432, DOI 10.1038/nature04948; Turtle EP, 2011, SCIENCE, V331, P1414, DOI 10.1126/science.1201063; Turtle EP, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046266	30	93	95	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 5	2012	481	7379					58	61		10.1038/nature10666	http://dx.doi.org/10.1038/nature10666			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872VD	22222747				2022-12-28	WOS:000298836900028
J	Fisher, ES; McClellan, MB; Safran, DG				Fisher, Elliott S.; McClellan, Mark B.; Safran, Dana G.			Building the Path to Accountable Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ALTERNATIVE QUALITY CONTRACT		[Fisher, Elliott S.] Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH 03766 USA; [McClellan, Mark B.] Brookings Inst, Engleberg Ctr Hlth Care Reform, Washington, DC 20036 USA; [Safran, Dana G.] Blue Cross & Blue Shield Massachusetts, Boston, MA USA	Dartmouth College; Brookings Institution	Fisher, ES (corresponding author), Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH 03766 USA.							Berwick DM, 2011, NEW ENGL J MED, V365, P1753, DOI 10.1056/NEJMp1111671; Chernew ME, 2011, HEALTH AFFAIR, V30, P51, DOI 10.1377/hlthaff.2010.0980; Haywood TT, 2011, NEW ENGL J MED, V364, DOI 10.1056/NEJMp1100950; Song Z, 2011, NEW ENGL J MED, V365, P909, DOI 10.1056/NEJMsa1101416; Van Citters AD, 2011, ACCOUNTABLE CARE 4 H	5	106	106	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2011	365	26					2445	2447		10.1056/NEJMp1112442	http://dx.doi.org/10.1056/NEJMp1112442			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	868SD	22204720				2022-12-28	WOS:000298544600001
J	Kelch, BA; Makino, DL; O'Donnell, M; Kuriyan, J				Kelch, Brian A.; Makino, Debora L.; O'Donnell, Mike; Kuriyan, John			How a DNA Polymerase Clamp Loader Opens a Sliding Clamp	SCIENCE			English	Article							ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; PROCESSIVITY FACTOR; REPLICATION SYSTEM; DELTA-SUBUNIT; GAMMA-COMPLEX; ATP BINDING; MECHANISM; HYDROLYSIS; REPLISOME	Processive chromosomal replication relies on sliding DNA clamps, which are loaded onto DNA by pentameric clamp loader complexes belonging to the AAA+ family of adenosine triphosphatases (ATPases). We present structures for the ATP-bound state of the clamp loader complex from bacteriophage T4, bound to an open clamp and primer-template DNA. The clamp loader traps a spiral conformation of the open clamp so that both the loader and the clamp match the helical symmetry of DNA. One structure reveals that ATP has been hydrolyzed in one subunit and suggests that clamp closure and ejection of the loader involves disruption of the ATP-dependent match in symmetry. The structures explain how synergy among the loader, the clamp, and DNA can trigger ATP hydrolysis and release of the closed clamp on DNA.	[Kelch, Brian A.; Makino, Debora L.; Kuriyan, John] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Kelch, Brian A.; Makino, Debora L.; Kuriyan, John] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [O'Donnell, Mike] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; [Kuriyan, John] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Kuriyan, John] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Kuriyan, John] Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; Rockefeller University; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Kuriyan, J (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	kuriyan@berkeley.edu		O'Donnell, Michael/0000-0001-9002-4214	U.S. Department of Energy [DE-AC03-76SF00098]; NIH [F32-087888, R01-GM308839, R01-GM45547]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045547, R01GM038839, F32GM087888] Funding Source: NIH RePORTER	U.S. Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Morikawa for providing the molecular envelope from the electron microscopic reconstruction of the archaeal clamp loader complex, P. von Hippel, S. Tsutakawa, and S. Benkovic as well as Kuriyan lab members for helpful discussions. We thank K. Engel for creating Fig. 6, K. Simonetta for providing E. coli clamp loader protein for ADP-BeF<INF>x</INF> titrations, and the staff at Beamlines 8.2.1, 8.2.2 and 8.3.1 of the Advanced Light Source, which is supported by U.S. Department of Energy under contract DE-AC03-76SF00098. This work was partially supported by NIH grants F32-087888 (B. K.), R01-GM308839 (M. OD.), and R01-GM45547 (J.K.). The authors declare no conflict of interest. B. K., D. M. and J.K. designed experiments. B. K. and D. M. performed experiments. B. K., D. M., M. OD., and J.K. analyzed the data. B. K. and J.K. wrote the paper. Coordinates and structure factors have been deposited in the Protein Data Bank with accession codes 3U5Z, 3U60, and 3U61 for crystal forms I, II, and III, respectively.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Alley SC, 1999, BIOCHEMISTRY-US, V38, P7696, DOI 10.1021/bi9827971; Bailey S, 2006, CELL, V126, P893, DOI 10.1016/j.cell.2006.07.027; Benkovic SJ, 2001, ANNU REV BIOCHEM, V70, P181, DOI 10.1146/annurev.biochem.70.1.181; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; FEDOROFF OY, 1993, J MOL BIOL, V233, P509, DOI 10.1006/jmbi.1993.1528; Gao YQ, 2005, CELL, V123, P195, DOI 10.1016/j.cell.2005.10.001; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Goedken ER, 2005, NAT STRUCT MOL BIOL, V12, P183, DOI 10.1038/nsmb889; Guenther B, 1997, CELL, V91, P335, DOI 10.1016/S0092-8674(00)80417-1; Helt CE, 2005, CELL CYCLE, V4, P529, DOI 10.4161/cc.4.4.1598; Hingorani MM, 1998, J BIOL CHEM, V273, P24550, DOI 10.1074/jbc.273.38.24550; JARVIS TC, 1989, J BIOL CHEM, V264, P12717; JARVIS TC, 1989, J BIOL CHEM, V264, P12709; Jeruzalmi D, 2001, CELL, V106, P429, DOI 10.1016/S0092-8674(01)00463-9; Jeruzalmi D, 2001, CELL, V106, P417, DOI 10.1016/S0092-8674(01)00462-7; Johnson A, 2003, J BIOL CHEM, V278, P14406, DOI 10.1074/jbc.M212708200; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Lamers MH, 2006, CELL, V126, P881, DOI 10.1016/j.cell.2006.07.028; McNally R, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-3; Miyata T, 2005, P NATL ACAD SCI USA, V102, P13795, DOI 10.1073/pnas.0506447102; Moarefi I, 2000, J MOL BIOL, V296, P1215, DOI 10.1006/jmbi.1999.3511; Neuwald AF, 1999, GENOME RES, V9, P27; ONRUST R, 1991, J BIOL CHEM, V266, P21681; Oyama T, 2001, MOL CELL, V8, P455, DOI 10.1016/S1097-2765(01)00328-8; Pietroni P, 2001, J MOL BIOL, V309, P869, DOI 10.1006/jmbi.2001.4687; Pietroni P, 2008, J BIOL CHEM, V283, P28338, DOI 10.1074/jbc.M804371200; Pomerantz RT, 2007, TRENDS MICROBIOL, V15, P156, DOI 10.1016/j.tim.2007.02.007; SANCAR A, 1993, SCIENCE, V259, P1415, DOI 10.1126/science.8451638; Seybert A, 2006, EMBO J, V25, P2209, DOI 10.1038/sj.emboj.7601093; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; Simonetta KR, 2009, CELL, V137, P659, DOI 10.1016/j.cell.2009.03.044; STUKENBERG PT, 1991, J BIOL CHEM, V266, P11328; Turner J, 1999, EMBO J, V18, P771, DOI 10.1093/emboj/18.3.771; Wang J, 2001, STRUCTURE, V9, P1107, DOI 10.1016/S0969-2126(01)00670-0; Yao N, 1996, GENES CELLS, V1, P101, DOI 10.1046/j.1365-2443.1996.07007.x; YOUNG MC, 1992, BIOCHEMISTRY-US, V31, P8675, DOI 10.1021/bi00152a001; Zhuang ZH, 2006, P NATL ACAD SCI USA, V103, P2546, DOI 10.1073/pnas.0511263103	44	120	122	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1675	1680		10.1126/science.1211884	http://dx.doi.org/10.1126/science.1211884			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22194570	Green Accepted			2022-12-28	WOS:000298344000059
J	Stone, R				Stone, Richard			HIGHER EDUCATION Crunch Time for North Korea's Revolutionary New University	SCIENCE			English	News Item																		2009, SCIENCE         0925, P1610	1	3	3	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1624	1625		10.1126/science.334.6063.1624	http://dx.doi.org/10.1126/science.334.6063.1624			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22194545				2022-12-28	WOS:000298344000019
J	Worsnop, FS; Craythorne, EE; du Vivier, AWP				Worsnop, F. S.; Craythorne, E. E.; du Vivier, Anthony W. P.			PICTURE QUIZ A blistering eruption after a holiday in India	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PARA-PHENYLENEDIAMINE; HENNA		[Worsnop, F. S.; Craythorne, E. E.; du Vivier, Anthony W. P.] Kings Coll Hosp London, Dept Dermatol, London SE5 9RS, England	King's College Hospital NHS Foundation Trust; King's College Hospital	Craythorne, EE (corresponding author), Kings Coll Hosp London, Dept Dermatol, London SE5 9RS, England.	emma_craythorne@hotmail.com	Hug, Balthasar L./G-1568-2010					Al-Suwaidi A, 2010, INT J ENV RES PUB HE, V7, P1681, DOI 10.3390/ijerph7041681; Birnie AJ, 2007, CONTACT DERMATITIS, V56, P240, DOI 10.1111/j.1600-0536.2007.00914.x; Onder M., 2004, J COSMET DERMATOL, V2, P126; Patel S, 2007, CONTACT DERMATITIS, V56, P35, DOI 10.1111/j.1600-0536.2007.00779.x; Redlick F, 2007, CAN MED ASSOC J, V176, P445, DOI 10.1503/cmaj.061109; Sonnen Gregory, 2007, Proc (Bayl Univ Med Cent), V20, P36; Van den Keybus C, 2005, CONTACT DERMATITIS, V53, P180, DOI 10.1111/j.0105-1873.2005.0407m.x; White JML, 2007, CLIN EXP ALLERGY, V37, P1848, DOI 10.1111/j.1365-2222.2007.02846.x	8	2	2	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 20	2011	343								d7474	10.1136/bmj.d7474	http://dx.doi.org/10.1136/bmj.d7474			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874SZ	22187186				2022-12-28	WOS:000298979700001
J	Thurston, TLM; Wandel, MP; von Muhlinen, N; Foeglein, A; Randow, F				Thurston, Teresa L. M.; Wandel, Michal P.; von Muhlinen, Natalia; Foeglein, Agnes; Randow, Felix			Galectin 8 targets damaged vesicles for autophagy to defend cells against bacterial invasion	NATURE			English	Article							GENOME-WIDE ASSOCIATION; CROHN-DISEASE; UBIQUITIN; IMMUNITY; SUSCEPTIBILITY; SALMONELLA; ADAPTER; RECOGNITION; RESTRICTS; PROTEINS	Autophagy defends the mammalian cytosol against bacterial infection(1-3). Efficient pathogen engulfment is mediated by cargo-selecting autophagy adaptors that rely on unidentified pattern-recognition or danger receptors to label invading pathogens as autophagy cargo, typically by polyubiquitin coating(4-9). Here we show in human cells that galectin 8 (also known as LGALS8), a cytosolic lectin, is a danger receptor that restricts Salmonella proliferation. Galectin 8 monitors endosomal and lysosomal integrity and detects bacterial invasion by binding host glycans exposed on damaged Salmonella-containing vacuoles. By recruiting NDP52 (also known as CALCOCO2), galectin 8 activates antibacterial autophagy. Galectin-8-dependent recruitment of NDP52 to Salmonella-containing vesicles is transient and followed by ubiquitin-dependent NDP52 recruitment. Because galectin 8 also detects sterile damage to endosomes or lysosomes, as well as invasion by Listeria or Shigella, we suggest that galectin 8 serves as a versatile receptor for vesicle-damaging pathogens. Our results illustrate how cells deploy the danger receptor galectin 8 to combat infection by monitoring endosomal and lysosomal integrity on the basis of the specific lack of complex carbohydrates in the cytosol.	[Thurston, Teresa L. M.; Wandel, Michal P.; von Muhlinen, Natalia; Foeglein, Agnes; Randow, Felix] MRC Lab Mol Biol, Div Prot & Nucle Acid Chem, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Randow, F (corresponding author), MRC Lab Mol Biol, Div Prot & Nucle Acid Chem, Hills Rd, Cambridge CB2 0QH, England.	randow@mrc-lmb.cam.ac.uk	Wandel, Michal/AAL-7946-2021; Thurston, Teresa/AAZ-9938-2020	Wandel, Michal/0000-0002-5275-5881; Thurston, Teresa/0000-0001-6139-3723	Medical Research Council [MC_U105170648, U.1051.03.011(78825)] Funding Source: Medline; MRC [MC_U105170648] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; BERG TO, 1994, EUR J BIOCHEM, V221, P595, DOI 10.1111/j.1432-1033.1994.tb18771.x; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Bloor S, 2008, P NATL ACAD SCI USA, V105, P1279, DOI 10.1073/pnas.0706552105; Cemma M, 2011, AUTOPHAGY, V7, P341, DOI 10.4161/auto.7.3.14046; Collins CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000430; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Deretic V, 2011, IMMUNOL REV, V240, P92, DOI 10.1111/j.1600-065X.2010.00995.x; Dupont N, 2009, CELL HOST MICROBE, V6, P137, DOI 10.1016/j.chom.2009.07.005; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Houzelstein D, 2004, MOL BIOL EVOL, V21, P1177, DOI 10.1093/molbev/msh082; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; Mostowy S, 2010, CELL HOST MICROBE, V8, P433, DOI 10.1016/j.chom.2010.10.009; Ng ACY, 2011, P NATL ACAD SCI USA, V108, P4631, DOI 10.1073/pnas.1000093107; Patnaik SK, 2006, METHOD ENZYMOL, V416, P159, DOI 10.1016/S0076-6879(06)16011-5; Paz I, 2010, CELL MICROBIOL, V12, P530, DOI 10.1111/j.1462-5822.2009.01415.x; Perrin AJ, 2004, CURR BIOL, V14, P806, DOI 10.1016/j.cub.2004.04.033; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Randow Felix, 2006, Subcell Biochem, V40, P383; Randow F, 2011, AUTOPHAGY, V7, P304, DOI 10.4161/auto.7.3.14539; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Ryzhakov G, 2007, EMBO J, V26, P3180, DOI 10.1038/sj.emboj.7601743; Shahnazari S, 2011, CURR OPIN MICROBIOL, V14, P68, DOI 10.1016/j.mib.2010.11.001; Shahnazari S, 2010, CELL HOST MICROBE, V8, P137, DOI 10.1016/j.chom.2010.07.002; Shaughnessy LM, 2007, CELL MICROBIOL, V9, P1695, DOI 10.1111/j.1462-5822.2007.00903.x; Stowell SR, 2010, NAT MED, V16, P295, DOI 10.1038/nm.2103; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441	37	674	686	8	136	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2012	482	7385					414	U1515		10.1038/nature10744	http://dx.doi.org/10.1038/nature10744			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	892LG	22246324	Green Accepted, Green Submitted			2022-12-28	WOS:000300287100049
J	Bang, YJ; Kim, YW; Yang, HK; Chung, HC; Park, YK; Lee, KH; Lee, KW; Kim, YH; Noh, SI; Cho, JY; Mok, YJ; Kim, YH; Ji, JF; Yeh, TS; Button, P; Sirzen, F; Noh, SH				Bang, Yung-Jue; Kim, Young-Woo; Yang, Han-Kwang; Chung, Hyun Cheol; Park, Young-Kyu; Lee, Kyung Hee; Lee, Keun-Wook; Kim, Yong Ho; Noh, Sang-Ik; Cho, Jae Yong; Mok, Young Jae; Kim, Yeul Hong; Ji, Jiafu; Yeh, Ta-Sen; Button, Peter; Sirzen, Florin; Noh, Sung Hoon		CLASSIC Trial Investigators	Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial	LANCET			English	Article							PLUS OXALIPLATIN; 1ST-LINE THERAPY; UNITED-STATES; III TRIAL; CHEMOTHERAPY; RESECTION; SURGERY; ADENOCARCINOMA; DISSECTION; SURVIVAL	Background D2 gastrectomy is recommended in US and European guidelines, and is preferred in east Asia, for patients with resectable gastric cancer. Adjuvant chemo therapy improves patient outcomes after surgery, but the benefits after a D2 resection have not been extensively investigated in large-scale trials. We investigated the effect on disease-free survival of adjuvant chemotherapy with capecitabine plus oxaliplatin after D2 gastrectomy compared with D2 gastrectomy only in patients with stage II-IIIB gastric cancer. Methods The capecitabine and oxaliplatin adjuvant study in stomach cancer (CLASSIC) study was an open-label, parallel-group, phase 3, randomised controlled trial undertaken in 37 centres in South Korea, China, and Taiwan. Patients with stage II-IIIB gastric cancer who had had curative D2 gastrectomy were randomly assigned to receive adjuvant chemotherapy of eight 3-week cycles of oral capecitabine (1000 mg/m(2) twice daily on days 1 to 14 of each cycle) plus intravenous oxaliplatin (130 mg/m(2) on day 1 of each cycle) for 6 months or surgery only. Block randomisation was done by a central interactive computerised system, stratified by country and disease stage. Patients, and investigators giving interventions, assessing outcomes, and analysing data were not masked. The primary endpoint was 3 year disease-free survival, analysed by intention to treat. This study reports a prespecified interim efficacy analysis, after which the trial was stopped after a recommendation by the data monitoring committee. The trial is registered at ClinicalTrials.gov (NCT00411229). Findings 1035 patients were randomised (520 to receive chemotherapy and surgery, 515 surgery only). Median follow-up was 34.2 months (25.4-41.7) in the chemotherapy and surgery group and 34.3 months (25.6-41.9) in the surgery only group. 3 year disease-free survival was 74% (95% CI 69-79) in the chemotherapy and surgery group and 59% (53-64) in the surgery only group (hazard ratio 0.56, 95% CI 0.44-0.72; p<0.0001). Grade 3 or 4 adverse events were reported in 279 of 496 patients (56%) in the chemotherapy and surgery group and in 30 of 478 patients (6%) in the surgery only group. The most common adverse events in the intervention group were nausea (n=326), neutropenia (n=300), and decreased appetite (n=294). Interpretation Adjuvant capecitabine plus oxaliplatin treatment after curative D2 gastrectomy should be considered as a treatment option for patients with operable gastric cancer.	[Bang, Yung-Jue] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 110744, South Korea; [Yang, Han-Kwang] Seoul Natl Univ, Coll Med, Dept Surg, Seoul 110744, South Korea; [Kim, Young-Woo] Natl Canc Ctr, Res Inst & Hosp, Gastr Canc Branch, Goyang Si, Gyeonggi Do, South Korea; [Noh, Sung Hoon] Yonsei Univ, Coll Med, Dept Surg, Seoul 120749, South Korea; [Chung, Hyun Cheol; Cho, Jae Yong] Yonsei Univ, Coll Med, Metastasis Res Ctr, Yonsei Canc Ctr,Dept Med Oncol, Seoul 120749, South Korea; [Park, Young-Kyu] Chonnam Natl Univ, Hwasun Hosp, Dept Surg, Jeonnam, South Korea; [Lee, Kyung Hee] Yeungnam Univ, Coll Med, Taegu, South Korea; [Lee, Keun-Wook] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, Gyeonggi Do, South Korea; [Kim, Yong Ho] Kyung Hee Univ, Sch Med, Dept Surg, Seoul, South Korea; [Noh, Sang-Ik] Seoul Vet Hosp, Dept Surg, Seoul, South Korea; [Mok, Young Jae] Korea Univ, Coll Med, Dept Surg, Seoul 136705, South Korea; [Kim, Yeul Hong] Korea Univ, Coll Med, Dept Internal Med, Seoul 136705, South Korea; [Ji, Jiafu] Beijing Canc Hosp, Beijing, Peoples R China; [Yeh, Ta-Sen] Chang Gung Mem Hosp Linkou, Dept Surg, Taipei, Taiwan; [Button, Peter] Infopeople, Sydney, NSW, Australia; [Sirzen, Florin] F Hoffmann La Roche, Basel, Switzerland	Seoul National University (SNU); Seoul National University (SNU); National Cancer Center - Korea (NCC); Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Chonnam National University; Yeungnam University; Seoul National University (SNU); Kyung Hee University; Seoul Veterans Hospital; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Peking University; Chang Gung Memorial Hospital; Roche Holding	Bang, YJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 110744, South Korea.	bangyj@snu.ac.kr	Yang, Han-Kwang/J-2767-2012; Bang, Yung Jue/J-2759-2012	Bang, Yung Jue/0000-0001-6000-4597; Noh, Sung Hoon/0000-0003-4386-6886; Cho, Jae Yong/0000-0002-0926-1819; JI, JIAFU/0000-0001-6878-5543; Kim, Yeul Hong/0000-0002-2555-2333; Kim, Young-Woo/0000-0002-1559-9672; Chung, Hyun/0000-0002-0920-9471	F Hoffmann-La Roche; Sanofi-Aventis	F Hoffmann-La Roche(Hoffmann-La Roche); Sanofi-Aventis(Sanofi-Aventis)	Funding F Hoffmann-La Roche and Sanofi-Aventis.	*AM JOINT COMM CAN, 2003, CANC STAG MAN; Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; Bonenkamp JJ, 1999, NEW ENGL J MED, V340, P908, DOI 10.1056/NEJM199903253401202; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Cuschieri A, 1999, BRIT J CANCER, V79, P1522, DOI 10.1038/sj.bjc.6690243; Deng JY, 2011, SURG TODAY, V41, P210, DOI 10.1007/s00595-009-4251-y; Ferlay J, 2010, IARC CANCERBASE, V10; Gallo A, 2006, WORLD J GASTROENTERO, V12, P3237, DOI 10.3748/wjg.v12.i20.3237; Gunderson LL, 2002, SEMIN RADIAT ONCOL, V12, P150, DOI 10.1053/srao.2002.30817; Haller DG, 2011, J CLIN ONCOL, V29, P1465, DOI 10.1200/JCO.2010.33.6297; Japanese Gastric Cancer Society, GUID DIAGN TREATM CA; Jatoi A, 2006, ANN ONCOL, V17, P29, DOI 10.1093/annonc/mdj063; Jenison C, 2000, GROUP SEQUENTIAL MET; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Liu CY, 2008, ANTI-CANCER DRUG, V19, P825, DOI 10.1097/CAD.0b013e32830c457e; Luo HY, 2010, CHEMOTHERAPY, V56, P94, DOI 10.1159/000305256; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; NCCN, 2019, NCCN CLIN PRACTICE G; Ohtsu A, 2005, SEMIN ONCOL, V32, pS101, DOI 10.1053/j.seminoncol.2005.06.001; Ohtsu A, 2006, J CLIN ONCOL, V24, P2188, DOI 10.1200/JCO.2006.05.9758; Okines A, 2010, ANN ONCOL, V21, pv50, DOI 10.1093/annonc/mdq164; Paoletti X, 2010, JAMA-J AM MED ASSOC, V303, P1729, DOI 10.1001/jama.2010.534; Park Joong-Min, 2008, Gastrointest Cancer Res, V2, P137; Park YH, 2008, CANCER CHEMOTH PHARM, V61, P623, DOI 10.1007/s00280-007-0515-7; Rougier P, 2011, ANN ONCOL, V22, pv10; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Schmoll HJ, 2007, J CLIN ONCOL, V25, P102, DOI 10.1200/JCO.2006.08.1075; Songun I, 2010, LANCET ONCOL, V11, P439, DOI 10.1016/S1470-2045(10)70070-X; Strong VE, 2010, ANN SURG, V251, P640, DOI 10.1097/SLA.0b013e3181d3d29b; Wu CW, 2006, LANCET ONCOL, V7, P309, DOI 10.1016/S1470-2045(06)70623-4	31	1124	1226	6	110	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 28	2012	379	9813					315	321		10.1016/S0140-6736(11)61873-4	http://dx.doi.org/10.1016/S0140-6736(11)61873-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	889BA	22226517				2022-12-28	WOS:000300047300038
J	Fuertes, N				Fuertes, Natalia			End-of-life decisions in Argentina	LANCET			English	Editorial Material									Univ Buenos Aires, Fac Med, Buenos Aires, DF, Argentina	University of Buenos Aires	Fuertes, N (corresponding author), Univ Buenos Aires, Fac Med, C1121ABG, Buenos Aires, DF, Argentina.	nvfuertes@gmail.com						Anon, 2011, TELAM ARGENTINA 1201; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Field C, 2009, BRIT J HOSP MED, V70, P280, DOI 10.12968/hmed.2009.70.5.42226; Ramsay C, 2011, ARGENTINA INDEP 1026; Rietjens JAC, 2009, J BIOETHIC INQ, V6, P271, DOI 10.1007/s11673-009-9172-3; The commission on assisted dying, 2012, REP COMM ASS DYING	6	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 14	2012	379	9811					105	105		10.1016/S0140-6736(12)60042-7	http://dx.doi.org/10.1016/S0140-6736(12)60042-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	879GM	22243815				2022-12-28	WOS:000299317700016
J	Duclos, A; Peix, JL; Colin, C; Kraimps, JL; Menegaux, F; Pattou, F; Sebag, F; Touzet, S; Bourdy, S; Voirin, N; Lifante, JC				Duclos, Antoine; Peix, Jean-Louis; Colin, Cyrille; Kraimps, Jean-Louis; Menegaux, Fabrice; Pattou, Francois; Sebag, Frederic; Touzet, Sandrine; Bourdy, Stephanie; Voirin, Nicolas; Lifante, Jean-Christophe		CATHY Study Grp	Influence of experience on performance of individual surgeons in thyroid surgery: prospective cross sectional multicentre study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EXPLAINED VARIATION; HOSPITAL VOLUME; HEALTH-CARE; MORTALITY; QUALITY; PHYSICIAN; OUTCOMES; COMPLICATIONS; INPATIENT; PATIENT	Objective To determine the association between surgeons' experience and postoperative complications in thyroid surgery. Design Prospective cross sectional multicentre study. Setting High volume referral centres in five academic hospitals in France. Participants All patients who underwent a thyroidectomy undertaken by every surgeon in these hospitals from 1 April 2008 to 31 December 2009. Main outcome measures Presence of two permanent major complications (recurrent laryngeal nerve palsy or hypoparathyroidism), six months after thyroid surgery. We used mixed effects logistic regression to determine the association between length of experience and postoperative complications. Results 28 surgeons completed 3574 thyroid procedures during a one year period. Overall rates of recurrent laryngeal nerve palsy and hypoparathyroidism were 2.08% (95% confidence interval 1.53% to 2.67%) and 2.69% (2.10% to 3.31%), respectively. In a multivariate analysis, 20 years or more of practice was associated with increased probability of both recurrent laryngeal nerve palsy (odds ratio 3.06 (1.07 to 8.80), P=0.04) and hypoparathyroidism (7.56 (1.79 to 31.99), P=0.01). Surgeons' performance had a concave association with their length of experience (P=0.036) and age (P=0.035); surgeons aged 35 to 50 years had better outcomes than their younger and older colleagues. Conclusions Optimum individual performance in thyroid surgery cannot be passively achieved or maintained by accumulating experience. Factors contributing to poor performance in very experienced surgeons should be explored further.	[Duclos, Antoine; Peix, Jean-Louis; Lifante, Jean-Christophe] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Serv Chirurg Gen & Endocrinienne, F-69003 Lyon, France; [Duclos, Antoine; Colin, Cyrille; Touzet, Sandrine; Bourdy, Stephanie] Univ Lyon, Equipe Accueil Mixte 4128, Sante Individu Soc, F-69002 Lyon, France; [Kraimps, Jean-Louis] Univ Poitiers, Jean Bernard Hosp, Dept Endocrine Surg, Poitiers, France; [Menegaux, Fabrice] Hop La Pitie Salpetriere, AP HP, Serv Chirurg Gen Viscerale & Endocrinienne, Paris, France; [Pattou, Francois] Ctr Hosp Reg Univ Lille, Lille, France; [Pattou, Francois] Univ Lille Nord France, INSERM, Lille, France; [Sebag, Frederic] Ctr Hosp Univ Timone Adulte, Assistance Publ Hop Marseille, Marseille, France; [Voirin, Nicolas] Hosp Civils Lyon, Hop Edouard Herriot, Serv Hyg Epidemiol & Prevent, F-69003 Lyon, France; [Voirin, Nicolas] Univ Lyon, CNRS, UMR 5558, Lab Biometrie & Biol Evolut, F-69002 Lyon, France; [Duclos, Antoine] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Surg & Publ Hlth, Boston, MA 02115 USA	CHU Lyon; CHU Poitiers; Universite de Poitiers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite de Lille - ISITE; CHU Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Duclos, A (corresponding author), Hosp Civils Lyon, Ctr Hosp Lyon Sud, Serv Chirurg Gen & Endocrinienne, F-69003 Lyon, France.	antoineduclos@yahoo.fr	Triponez, Frederic/A-6237-2013; Pattou, Francois/O-6151-2017; Duclos, Antoine/N-3756-2016; Lifante, Jean-Christophe/AAX-2606-2020; Le Pogam, Marie-Annick/AAU-5486-2020; Colombet, Isabelle/J-8186-2017	Triponez, Frederic/0000-0001-7808-496X; Pattou, Francois/0000-0001-8388-3766; Duclos, Antoine/0000-0002-8915-4203; Le Pogam, Marie-Annick/0000-0003-1672-3644; Colombet, Isabelle/0000-0002-8721-1526; LEPAPE, Alain/0000-0001-5950-7533	French Ministry of Health (Ministere charge de la Sante, Direction de l'Hospitalisation et de l'Organisation des Soins); Hospices Civils de Lyon, Lyon; French Ministry of Health	French Ministry of Health (Ministere charge de la Sante, Direction de l'Hospitalisation et de l'Organisation des Soins); Hospices Civils de Lyon, Lyon; French Ministry of Health	This study was supported by a grant from the Programme de Recherche en Qualite Hospitaliere 2007 of the French Ministry of Health (Ministere charge de la Sante, Direction de l'Hospitalisation et de l'Organisation des Soins), Hospices Civils de Lyon, Lyon. The funding source had no involvement in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. Researchers were independent from the funder.; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: that all authors received support from the French Ministry of Health for the submitted work; no relationships with any company that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that could appear to have influenced the submitted work.	Agence Nationale d'Accreditation et d'Evaluation en Sante, 2003, ANN OTOLARYNGOL CHIR, V120, P182; Barbash GI, 2010, NEW ENGL J MED, V363, P701, DOI 10.1056/NEJMp1006602; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; British Thyroid Association, 2007, GUID MAN THYR CANC; Brookhart MA, 2006, J CLIN EPIDEMIOL, V59, P18, DOI 10.1016/j.jclinepi.2005.07.005; Carty MJ, 2009, PLAST RECONSTR SURG, V124, P706, DOI 10.1097/PRS.0b013e3181b17a13; Catchpole K, 2008, ANN SURG, V247, P699, DOI 10.1097/SLA.0b013e3181642ec8; Choudhry NK, 2005, ANN INTERN MED, V142, P260, DOI 10.7326/0003-4819-142-4-200502150-00008; de Vries EN, 2008, QUAL SAF HEALTH CARE, V17, P216, DOI 10.1136/qshc.2007.023622; Dionigi G, 2008, EXPERT REV MED DEVIC, V5, P747, DOI 10.1586/17434440.5.6.747; Direction de la Recherche des Etudes de l'Evaluation et des Statistiques, 2008, STAT ANN ET SANT; Duclos A, 2009, BRIT J SURG, V96, P171, DOI 10.1002/bjs.6418; Duclos A, 2011, WORLD J SURG, V35, P773, DOI 10.1007/s00268-011-0963-4; Eggli Y, 2010, MED CARE, V48, P962, DOI 10.1097/MLR.0b013e3181eaf9f6; Ergina PL, 2009, LANCET, V374, P1097, DOI 10.1016/S0140-6736(09)61086-2; Ericsson KA, 2008, ACAD EMERG MED, V15, P988, DOI 10.1111/j.1553-2712.2008.00227.x; Fung V, 2010, MED CARE, V48, P140, DOI 10.1097/MLR.0b013e3181bd4dc3; Ghaferi AA, 2009, NEW ENGL J MED, V361, P1368, DOI 10.1056/NEJMsa0903048; Hartz AJ, 1999, MED CARE, V37, P93, DOI 10.1097/00005650-199901000-00013; Hegner CF, 1932, ANN SURG, V95, P481, DOI 10.1097/00000658-193204000-00001; Jeannon JP, 2009, INT J CLIN PRACT, V63, P624, DOI 10.1111/j.1742-1241.2008.01875.x; Lifante JC, 2009, BRIT J SURG, V96, P1284, DOI 10.1002/bjs.6741; LUFT HS, 1979, NEW ENGL J MED, V301, P1364, DOI 10.1056/NEJM197912203012503; Munch S, 2001, JAMA-J AM MED ASSOC, V285, P1131, DOI 10.1001/jama.285.9.1131; Neily J, 2010, JAMA-J AM MED ASSOC, V304, P1693, DOI 10.1001/jama.2010.1506; O'Neill L, 2000, NEUROLOGY, V55, P773, DOI 10.1212/WNL.55.6.773; Pattou F, 1998, WORLD J SURG, V22, P718, DOI 10.1007/s002689900459; Pettker CM, 2010, JAMA-J AM MED ASSOC, V303, P977, DOI 10.1001/jama.2010.256; R Core Team, 2020, R LANG ENV STAT COMP; Ramsay C R, 2001, Health Technol Assess, V5, P1; Raval MV, 2011, J AM COLL SURGEONS, V212, P889, DOI 10.1016/j.jamcollsurg.2010.12.029; Reznick RK, 2006, NEW ENGL J MED, V355, P2664, DOI 10.1056/NEJMra054785; Rothschild JM, 2009, JAMA-J AM MED ASSOC, V302, P1565, DOI 10.1001/jama.2009.1423; Schemper M, 2003, STAT MED, V22, P2299, DOI 10.1002/sim.1486; Shahian DM, 2011, ANN THORAC SURG, V92, pS2, DOI 10.1016/j.athoracsur.2011.06.100; Shanafelt TD, 2010, ANN SURG, V251, P995, DOI 10.1097/SLA.0b013e3181bfdab3; Sosa JA, 1998, ANN SURG, V228, P320, DOI 10.1097/00000658-199809000-00005; Southern WN, 2011, AM J MED, V124, P868, DOI 10.1016/j.amjmed.2011.04.011; Stavrakis AI, 2007, SURGERY, V142, P887, DOI 10.1016/j.surg.2007.09.003; Stone AA, 2010, P NATL ACAD SCI USA, V107, P9985, DOI 10.1073/pnas.1003744107; Terry R, 2011, PHYSICIAN EXEC, V37, P30; Terry Richard, 2011, Physician Exec, V37, P26; Vincent C, 2004, ANN SURG, V239, P475, DOI 10.1097/01.sla.0000118753.22830.41; Volpp KG, 2008, JAMA-J AM MED ASSOC, V300, P1197, DOI 10.1001/jama.300.10.1197; Wallace JE, 2009, LANCET, V374, P1714, DOI 10.1016/S0140-6736(09)61424-0; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8	46	142	145	0	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 11	2012	344								d8041	10.1136/bmj.d8041	http://dx.doi.org/10.1136/bmj.d8041			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877SI	22236412	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000299202500015
J	Tarkin, JM; Kelion, A; Mittal, T; Dalby, MC				Tarkin, Jason M.; Kelion, Andrew; Mittal, Tarun; Dalby, Miles C.			CASE REPORT Exertional dyspnoea and syncope	BRITISH MEDICAL JOURNAL			English	Editorial Material							AMYLOID HEART-DISEASE; PRIMARY SYSTEMIC AMYLOIDOSIS; CARDIAC AMYLOIDOSIS; ELECTROCARDIOGRAPHIC FINDINGS; AL AMYLOIDOSIS; SURVIVAL; INVOLVEMENT; DIAGNOSIS; FEATURES		[Tarkin, Jason M.; Kelion, Andrew; Mittal, Tarun; Dalby, Miles C.] Royal Brompton & Harefield NHS Trust, Harefield Hosp, Harefield UB9 6JH, Middx, England	Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; Royal Brompton Hospital	Dalby, MC (corresponding author), Royal Brompton & Harefield NHS Trust, Harefield Hosp, Harefield UB9 6JH, Middx, England.	m.dalby@rbht.nhs.uk	Mittal, Tarun K/G-4275-2017	Tarkin, Jason/0000-0002-9132-120X; Dalby, Miles/0000-0003-0823-5093				Chamarthi B, 2007, NEW ENGL J MED, V356, P2361; Charaf E, 2009, CURR CARDIOL REV, V5, P228, DOI 10.2174/157340309788970360; CHEW C, 1975, AM J CARDIOL, V36, P438, DOI 10.1016/0002-9149(75)90891-7; Dispenzieri A, 2003, LANCET, V361, P1787, DOI 10.1016/S0140-6736(03)13396-X; Dubrey SW, 2011, HEART, V97, P75, DOI 10.1136/hrt.2009.190405; Dubrey SW, 1998, QJM-MON J ASSOC PHYS, V91, P141, DOI 10.1093/qjmed/91.2.141; Dubrey SW, 2001, HEART, V85, P202, DOI 10.1136/heart.85.2.202; Falk RH, 2005, CIRCULATION, V112, P2047, DOI 10.1161/CIRCULATIONAHA.104.489187; Falk RH, 2010, PROG CARDIOVASC DIS, V52, P347, DOI 10.1016/j.pcad.2009.11.007; Feng DL, 2009, CIRCULATION, V119, P2490, DOI 10.1161/CIRCULATIONAHA.108.785014; Halwani O, 2010, EXPERT REV CARDIOVAS, V8, P1007, DOI 10.1586/ERC.10.41; HAMER JPM, 1992, EUR HEART J, V13, P623, DOI 10.1093/oxfordjournals.eurheartj.a060225; Hare JM, 2007, BRAUNWALDS HEART DIS, P1561; Hess OM, 2009, ESC TXB CARDIOVASCUL, P689; Imran SS, 2010, J AM COLL CARDIOL CA, V3, P155; KLEIN AL, 1991, ECHOCARDIOGR-J CARD, V8, P233, DOI 10.1111/j.1540-8175.1991.tb01394.x; Maceira AM, 2005, CIRCULATION, V111, P186, DOI 10.1161/01.CIR.0000152819.97857.9D; Murtagh B, 2005, AM J CARDIOL, V95, P535, DOI 10.1016/j.amjcard.2004.10.028; Palladini G, 2006, BLOOD, V107, P3854, DOI 10.1182/blood-2005-11-4385; Patel AR, 1997, AM J CARDIOL, V80, P486, DOI 10.1016/S0002-9149(97)00400-1; PICANO E, 1991, ECHOCARDIOGR-J CARD, V8, P253, DOI 10.1111/j.1540-8175.1991.tb01395.x; ROBERTS WC, 1983, AM J CARDIOL, V52, P137, DOI 10.1016/0002-9149(83)90084-X; SIQUEIRAFILHO AG, 1981, CIRCULATION, V63, P188, DOI 10.1161/01.CIR.63.1.188	23	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 11	2012	344								d8317	10.1136/bmj.d8317	http://dx.doi.org/10.1136/bmj.d8317			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877SI	22236798				2022-12-28	WOS:000299202500020
J	Yurtsever, A; van der Veen, RM; Zewail, AH				Yurtsever, Aycan; van der Veen, Renske M.; Zewail, Ahmed H.			Subparticle Ultrafast Spectrum Imaging in 4D Electron Microscopy	SCIENCE			English	Article							SPECTROSCOPY; RESOLUTION; STEM; FLUORESCENCE; ABSORPTION; EMISSION	Single-particle imaging of structures has become a powerful methodology in nanoscience and molecular and cell biology. We report the development of subparticle imaging with space, time, and energy resolutions of nanometers, femtoseconds, and millielectron volts, respectively. By using scanning electron probes across optically excited nanoparticles and interfaces, we simultaneously constructed energy-time and space-time maps. Spectrum images were then obtained for the nanoscale dielectric fields, with the energy resolution set by the photon rather than the electron, as demonstrated here with two examples (silver nanoparticles and the metallic copper-vacuum interface). This development thus combines the high spatial resolution of electron microscopy with the high energy resolution of optical techniques and ultrafast temporal response, opening the door to various applications in elemental analysis as well as mapping of interfaces and plasmonics.	[Yurtsever, Aycan; van der Veen, Renske M.; Zewail, Ahmed H.] CALTECH, Arthur Amos Noyes Lab Chem Phys, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA	California Institute of Technology	Zewail, AH (corresponding author), CALTECH, Arthur Amos Noyes Lab Chem Phys, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA.	zewail@caltech.edu	van der Veen, Renske M/A-1834-2011	van der Veen, Renske M/0000-0003-0584-4045; gaber, sarah/0000-0002-5995-7291	NSF [DMR-0964886]; Air Force Office of Scientific Research [FA9550-11-1-0055]; Swiss National Science Foundation	NSF(National Science Foundation (NSF)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Supported by NSF grant DMR-0964886 and Air Force Office of Scientific Research grant FA9550-11-1-0055 to the Gordon and Betty Moore Center for Physical Biology at the California Institute of Technology. R. M. V. was supported by the Swiss National Science Foundation. We thank S. T. Park for helpful discussions regarding the theoretical calculations.	Atwater HA, 2010, NAT MATER, V9, P205, DOI [10.1038/nmat2629, 10.1038/NMAT2629]; Barwick B, 2009, NATURE, V462, P902, DOI 10.1038/nature08662; BATSON PE, 1993, NATURE, V366, P727, DOI 10.1038/366727a0; Batson PE, 2002, NATURE, V418, P617, DOI 10.1038/nature00972; Colliex C, 2009, PHILOS T R SOC A, V367, P3845, DOI 10.1098/rsta.2009.0128; Colliex C, 2007, NATURE, V450, P622, DOI 10.1038/450622a; Egerton R.F., 2011, ELECT ENERGY LOSS SP; Girit CO, 2009, SCIENCE, V323, P1705, DOI 10.1126/science.1166999; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Howie A, 2011, EUR PHYS J-APPL PHYS, V54, DOI 10.1051/epjap/2010100353; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; de Abajo FJG, 2010, NANO LETT, V10, P1859, DOI 10.1021/nl100613s; Kimoto K, 2007, NATURE, V450, P702, DOI 10.1038/nature06352; Maier S.A., 2007, PLASMONICS FUNDAMENT, DOI DOI 10.1007/0-387-37825-1; Min W, 2009, NATURE, V461, P1105, DOI 10.1038/nature08438; Muller DA, 2008, SCIENCE, V319, P1073, DOI 10.1126/science.1148820; MULLER DA, 1993, NATURE, V366, P725, DOI 10.1038/366725a0; Nelayah J, 2007, NAT PHYS, V3, P348, DOI 10.1038/nphys575; Ortalan V, 2011, J AM CHEM SOC, V133, P10732, DOI 10.1021/ja203821y; Park ST, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/12/123028; Spence JCH, 2006, REP PROG PHYS, V69, P725, DOI 10.1088/0034-4885/69/3/R04; Suenaga K, 2000, SCIENCE, V290, P2280, DOI 10.1126/science.290.5500.2280; Thomas JM, 2011, CHEM PHYS, V385, P1, DOI 10.1016/j.chemphys.2011.04.023; Varela M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.095502; Yamamoto N, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.205419; Yurtsever A, 2011, P NATL ACAD SCI USA, V108, P3152, DOI 10.1073/pnas.1018733108; Yurtsever A, 2009, SCIENCE, V326, P708, DOI 10.1126/science.1179314; Yurtsever A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.217402; Zewail A H, 2009, 4D ELECT MICROSCOPY; Zewail AH, 2010, SCIENCE, V328, P187, DOI 10.1126/science.1166135	30	112	117	1	167	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 6	2012	335	6064					59	64		10.1126/science.1213504	http://dx.doi.org/10.1126/science.1213504			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872YA	22223801				2022-12-28	WOS:000298846200048
J	Nabel, EG; Braunwald, E				Nabel, Elizabeth G.; Braunwald, Eugene			A Tale of Coronary Artery Disease and Myocardial Infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							GENOMIC MEDICINE GENOMICS; ADVANCED HEART-FAILURE; CARDIOVASCULAR-DISEASE; CARDIAC-DISEASE; ATHEROSCLEROSIS; THERAPY; ANGIOPLASTY; TRIAL; CATHETERIZATION; ACETYLCHOLINE		[Nabel, Elizabeth G.] Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Nabel, EG (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	enabel@partners.org						[Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1986, LANCET, V1, P397; [Anonymous], 2010, PROM CARD HLTH DEV W; [Anonymous], 2010, NHLBI FACT BOOK FISC; Borissoff JI, 2011, NEW ENGL J MED, V364, P1746, DOI 10.1056/NEJMra1011670; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Brown MS, ONLINE METABOLIC MOL; Burkhardt JD, 2007, CIRCULATION, V115, P2208, DOI 10.1161/CIRCULATIONAHA.106.655712; Cannon CP, 2010, NEW ENGL J MED, V363, P2406, DOI 10.1056/NEJMoa1009744; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Cannon CP, 2006, NEW ENGL J MED, V354, P778; CHAZOV EI, 1976, TERAPEVT ARKH, V48, P8; Courmand A, 1941, P SOC EXP BIOL MED, V46, P462; Daar AS, 2007, NATURE, V450, P494, DOI 10.1038/450494a; Daar AS, 2009, SCIENCE, V324, P1642, DOI 10.1126/science.324_1642; DAVIES MJ, 1976, BRIT HEART J, V38, P659; ENDO A, 1992, J LIPID RES, V33, P1569; Forssmann W., 1929, KLIN WOCHENSCHR, V8, P2085, DOI DOI 10.1007/BF01875120; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; GIBBON J H Jr, 1954, Minn Med, V37, P171; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; GRINES CL, 1993, NEW ENGL J MED, V328, P673, DOI 10.1056/NEJM199303113281001; GRUNTZIG AR, 1979, NEW ENGL J MED, V301, P61, DOI 10.1056/NEJM197907123010201; Hansson EM, 2009, CELL STEM CELL, V5, P364, DOI 10.1016/j.stem.2009.09.004; Heberden W., 1772, MED T COLL PHYSICIAN, V2, P59; Hektoen L, 1892, MEDICAL NEWSLETTER, V61, P210; Herrick JB, 1912, J AMER MED ASSOC, V59, P2015; Herrick JB, 1919, J AMER MED ASSOC, V72, P387, DOI 10.1001/jama.1919.02610060001001; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; Jessup M, 2011, CIRCULATION, V124, P304, DOI 10.1161/CIRCULATIONAHA.111.022889; JULIAN DG, 1961, LANCET, V2, P840; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; LUDMER PL, 1986, NEW ENGL J MED, V315, P1046, DOI 10.1056/NEJM198610233151702; MAROKO PR, 1971, CIRCULATION, V43, P67, DOI 10.1161/01.CIR.43.1.67; McWilliam J A, 1889, Br Med J, V1, P6; Mega JL, 2012, NEW ENGL J MED, V366, P9, DOI 10.1056/NEJMoa1112277; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; MUELLER RL, 1995, AM HEART J, V129, P146, DOI 10.1016/0002-8703(95)90055-1; Musunuru K, 2010, ANNU REV CELL DEV BI, V26, P667, DOI 10.1146/annurev-cellbio-100109-103948; Nabel EG, 2003, NEW ENGL J MED, V349, P60, DOI 10.1056/NEJMra035098; O'Donnell CJ, 2011, NEW ENGL J MED, V365, P2098, DOI 10.1056/NEJMra1105239; OBRASTZOW WP, 1910, Z KLIN MED, V71, P116; Parry CH., 1799, INQUIRY SYMPTOMS CAU; PEDERSEN TR, 1994, LANCET, V344, P1383; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Porter W T, 1893, J Physiol, V15, P121; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; RAPOPORT RM, 1983, NATURE, V306, P174, DOI 10.1038/306174a0; Ridker PM, 2009, LANCET, V373, P1175, DOI 10.1016/S0140-6736(09)60447-5; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Serruys PW, 2002, CIRCULATION, V106, P798, DOI 10.1161/01.CIR.0000025585.63486.59; Slaughter MS, 2009, NEW ENGL J MED, V361, P2241, DOI 10.1056/NEJMoa0909938; SONES F M Jr, 1962, Mod Concepts Cardiovasc Dis, V31, P735; Wang LW, 2011, NEW ENGL J MED, V364, P1144, DOI 10.1056/NEJMra1010600; Warren J., 1812, N ENGL J MED SURG, V1, P1; Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147; Willis R, 1628, ANATOMICAL DISQUISIT; 2007, ECONOMIST       0811	63	629	665	10	106	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 5	2012	366	1					54	63		10.1056/NEJMra1112570	http://dx.doi.org/10.1056/NEJMra1112570			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	887XY	22216842				2022-12-28	WOS:000299968800007
J	Drye, EE; Normand, SLT; Wang, Y; Ross, JS; Schreiner, GC; Han, L; Rapp, M; Krumholz, HM				Drye, Elizabeth E.; Normand, Sharon-Lise T.; Wang, Yun; Ross, Joseph S.; Schreiner, Geoffrey C.; Han, Lein; Rapp, Michael; Krumholz, Harlan M.			Comparison of Hospital Risk-Standardized Mortality Rates Calculated by Using In-Hospital and 30-Day Models: An Observational Study With Implications for Hospital Profiling	ANNALS OF INTERNAL MEDICINE			English	Article							HEART-FAILURE; PERFORMANCE; OUTCOMES; LENGTH; TRENDS; STAY	Background: In-hospital mortality measures, which are widely used to assess hospital quality, are not based on a standardized follow-up period and may systematically favor hospitals with shorter lengths of stay (LOSs). Objective: To assess the agreement between performance measures of U.S. hospitals by using risk-standardized in-hospital and 30-day mortality rates. Design: Observational study. Setting: Nonfederal acute care hospitals in the United States with at least 30 admissions for acute myocardial infarction (AMI), heart failure (HF), and pneumonia from 2004 to 2006. Patients: Medicare fee-for-service patients admitted for AMI, HF, or pneumonia from 2004 to 2006. Measurements: The primary outcomes were in-hospital and 30-day risk-standardized mortality rates (RSMRs). Results: Included patients comprised 718 508 admissions to 3135 hospitals for AMI, 1 315 845 admissions to 4209 hospitals for HF, and 1 415 237 admissions to 4498 hospitals for pneumonia. The hospital-level mean patient LOS varied across hospitals for each condition, ranging from 2.3 to 13.7 days for AMI, 3.5 to 11.9 days for HF, and 3.8 to 14.8 days for pneumonia. The mean RSMR differences (30-day RSMR minus in-hospital RSMR) were 5.3% (SD, 1.3) for AMI, 6.0% (SD, 1.3) for HF, and 5.7% (SD, 1.4) for pneumonia; distributions varied widely across hospitals. Performance classifications differed between the in-hospital and 30-day models for 257 hospitals (8.2%) for AMI, 456 (10.8%) for HF, and 662 (14.7%) for pneumonia. Hospital mean LOS was positively correlated with in-hospital RSMRs for all 3 conditions. Limitation: Medicare claims data were used for risk adjustment. Conclusion: In-hospital mortality measures provide a different assessment of hospital performance than 30-day mortality and are biased in favor of hospitals with shorter LOSs.	[Drye, Elizabeth E.] Yale Univ, Sch Med, Ctr Outcomes Res & Evaluat, Yale New Haven Hosp, New Haven, CT 06510 USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Dartmouth Med Sch, Hanover, NH 03755 USA; Ctr Medicare Serv, Baltimore, MD USA; Ctr Medicaid Serv, Baltimore, MD USA; George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA	Yale University; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Dartmouth College; Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services; George Washington University	Drye, EE (corresponding author), Yale Univ, Sch Med, Ctr Outcomes Res & Evaluat, Yale New Haven Hosp, 1 Church St,Suite 200, New Haven, CT 06510 USA.	Elizabeth.Drye@yale.edu	, Harlan/AAI-2875-2020	Normand, Sharon-Lise/0000-0001-7027-4769; Ross, Joseph/0000-0002-9218-3320	CMS [HHSM-500-2008-0025I, T0001]; National Heart, Lung, and Blood Institute [U01-HL105270-02]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER	CMS; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By the CMS (contract HHSM-500-2008-0025I, task order T0001) and the National Heart, Lung, and Blood Institute (award U01-HL105270-02).	Agency for Healthcare Research and Quality, 2011, HLTH CAR REP CARD CO; Agency for Healthcare Research and Quality, 2006, INP QUAL IND OV AHRQ; [Anonymous], FED REG; Baker DW, 2002, MED CARE, V40, P879, DOI 10.1097/00005650-200210000-00006; Bhat K. R., 2008, ACUTE MYOCARDIAL INF; Bratzler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017401; Bueno H, 2010, JAMA-J AM MED ASSOC, V303, P2141, DOI 10.1001/jama.2010.748; Centers for Medicare and Medicaid Services, 2011, HOSP COMP; Centers for Medicare & Medicaid Services, 2011, CMS MEAS MAN SYST BL; CHASSIN MR, 1989, HEALTH SERV RES, V24, P1; Grosso LM, 2009, 2009 MEASURES MAINTE; Iezzoni LI, 2003, RISK ADJUSTMENT MEAS; JENCKS SF, 1988, JAMA-J AM MED ASSOC, V260, P2240, DOI 10.1001/jama.260.15.2240; Krumholz H, 2006, RISK ADJUSTMENT M S1; Krumholz HM, 2006, CIRCULATION, V113, P1683, DOI 10.1161/CIRCULATIONAHA.105.611186; Krumholz HM, 2006, CIRCULATION, V113, P1693, DOI 10.1161/CIRCULATIONAHA.105.611194; Krumholz HM, 2006, CIRCULATION, V113, P456, DOI 10.1161/CIRCULATIONAHA.105.170769; Krumholz HM, 2007, RISK RISK ADJUSTMENT, P1; National Quality Forum, 2010, NQF END STAND; Normand SLT, 2007, STAT SCI, V22, P206, DOI 10.1214/088342307000000096; PIANTADOSI S, 1997, CLIN TRIALS METHODOL; Rosenthal GE, 2000, HEALTH SERV RES, V34, P1449; Zaslavsky AM, 2001, INT J QUAL HEALTH C, V13, P481, DOI 10.1093/intqhc/13.6.481	23	121	124	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 3	2012	156	1	1				19	U66		10.7326/0003-4819-156-1-201201030-00004	http://dx.doi.org/10.7326/0003-4819-156-1-201201030-00004			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	872VK	22213491				2022-12-28	WOS:000298837600003
J	Elkin, PL; Froehling, DA; Wahner-Roedler, DL; Brown, SH; Bailey, KR				Elkin, Peter L.; Froehling, David A.; Wahner-Roedler, Dietlind L.; Brown, Steven H.; Bailey, Kent R.			Comparison of Natural Language Processing Biosurveillance Methods for Identifying Influenza From Encounter Notes	ANNALS OF INTERNAL MEDICINE			English	Article							COVERAGE; PATIENT	Background: An effective national biosurveillance system expedites outbreak recognition and facilitates response coordination at the federal, state, and local levels. The BioSense system, used at the Centers for Disease Control and Prevention, incorporates chief complaints but not data from the whole encounter note into its surveillance algorithms. Objective: To evaluate whether biosurveillance by using data from the whole encounter note is superior to that using data from the chief complaint field alone. Design: 6-year retrospective case-control cohort study. Setting: Mayo Clinic, Rochester, Minnesota. Participants: 17 243 persons tested for influenza A or B virus between 1 January 2000 and 31 December 2006. Measurements: The accuracy of a model based on signs and symptoms to predict influenza virus infection in patients with upper respiratory tract symptoms, and the ability of a natural language processing technique to identify definitional clinical features from free-text encounter notes. Results: Surveillance based on the whole encounter note was superior to the chief complaint field alone. For the case definition used by surveillance of the whole encounter note, the normalized partial area under the receiver-operating characteristic curve (specificity, 0.1 to 0.4) for surveillance using the whole encounter note was 92.9% versus 70.3% for surveillance with the chief complaint field (difference, 22.6%; P < 0.001). Comparison of the 2 models at the fixed specificity of 0.4 resulted in sensitivities of 89.0% and 74.4%, respectively (P < 0.001). The relative risk for missing a true case of influenza was 2.3 by using the chief complaint field model. Limitations: Participants were seen at 1 tertiary referral center. The cost of comprehensive biosurveillance monitoring was not studied. Conclusion: A biosurveillance model for influenza using the whole encounter note is more accurate than a model that uses only the chief complaint field. Because case-defining signs and symptoms of influenza are commonly available in health records, the investigators believe that the national strategy for biosurveillance should be changed to incorporate data from the whole health record.	Vanderbilt Univ, Nashville, TN USA; Vet Hlth Adm, Nashville, TN USA; Mayo Clin, Rochester, MN 55905 USA; Mt Sinai Sch Med, New York, NY 10128 USA	Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Mayo Clinic; Icahn School of Medicine at Mount Sinai	Elkin, PL (corresponding author), 212 E 95th St,Suite 3B, New York, NY 10128 USA.				CDC [PH00022, HK00014]; Veterans Administration [V249P-0525, 330]; Centers for Disease Control and Prevention; PUBLIC HEALTH PRACTICE PROGRAM OFFICE [R01PH000022] Funding Source: NIH RePORTER	CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Veterans Administration(US Department of Veterans Affairs); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); PUBLIC HEALTH PRACTICE PROGRAM OFFICE(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	By the CDC (grants PH00022 and HK00014) and a research contract from the Veterans Administration (contract V249P-0525; Biosurveillance SDR Project 330).; Centers for Disease Control and Prevention.	Adisasmito W, 2010, J INFECT DIS, V202, P1154, DOI 10.1086/656316; Bradley Colleen A, 2005, MMWR Suppl, V54, P11; Brown SH, 2006, MAYO CLIN PROC, V81, P1472, DOI 10.4065/81.11.1472; Brown Steven H, 2008, AMIA Annu Symp Proc, P71; Call SA, 2005, JAMA-J AM MED ASSOC, V293, P987, DOI 10.1001/jama.293.8.987; Centers for Disease Control and Prevention, 2011, BIOSENSE HOME   0913; Centers for Disease Control and Prevention, 2010, FLU ACTIVITY SU 1015; Centers for Disease Control and Prevention, 2011, FLUVIEW WEEKL INFL S; Centers for Disease Control and Prevention, 2011, FASTSTATS AMB CAR PH; Cornet R, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-S1-S2; Dodd LE, 2003, BIOMETRICS, V59, P614, DOI 10.1111/1541-0420.00071; Eban K, 2007, SCI NEWSBLOG    0401; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Elkin PL, 2006, MAYO CLIN PROC, V81, P741, DOI 10.4065/81.6.741; Elkin PL, 2008, STUD HEALTH TECHNOL, V136, P797; Kohane IS, 2002, J AM MED INFORM ASSN, V9, P116, DOI 10.1197/jamia.M1054; Loonsk John W, 2004, MMWR Suppl, V53, P53; Murff HJ, 2011, JAMA-J AM MED ASSOC, V306, P848, DOI 10.1001/jama.2011.1204; Sokolow Leslie Z, 2005, MMWR Suppl, V54, P133	19	45	45	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 3	2012	156	1	1				11	U57		10.7326/0003-4819-156-1-201201030-00003	http://dx.doi.org/10.7326/0003-4819-156-1-201201030-00003			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	872VK	22213490				2022-12-28	WOS:000298837600002
J	Ramamoorthi, K; Fropf, R; Belfort, GM; Fitzmaurice, HL; McKinney, RM; Neve, RL; Otto, T; Lin, YX				Ramamoorthi, Kartik; Fropf, Robin; Belfort, Gabriel M.; Fitzmaurice, Helen L.; McKinney, Ross M.; Neve, Rachael L.; Otto, Tim; Lin, Yingxi			Npas4 Regulates a Transcriptional Program in CA3 Required for Contextual Memory Formation	SCIENCE			English	Article							IMMEDIATE-EARLY GENES; LONG-TERM-MEMORY; SYNAPTIC PLASTICITY; C-FOS; PROTEIN-SYNTHESIS; FEAR; HIPPOCAMPUS; EXPRESSION; ELEMENT; DORSAL	The rapid encoding of contextual memory requires the CA3 region of the hippocampus, but the necessary genetic pathways remain unclear. We found that the activity-dependent transcription factor Npas4 regulates a transcriptional program in CA3 that is required for contextual memory formation. Npas4 was specifically expressed in CA3 after contextual learning. Global knockout or selective deletion of Npas4 in CA3 both resulted in impaired contextual memory, and restoration of Npas4 in CA3 was sufficient to reverse the deficit in global knockout mice. By recruiting RNA polymerase II to promoters and enhancers of target genes, Npas4 regulates a learning-specific transcriptional program in CA3 that includes many well-known activity-regulated genes, which suggests that Npas4 is a master regulator of activity-regulated gene programs and is central to memory formation.	[Ramamoorthi, Kartik; Fropf, Robin; Belfort, Gabriel M.; Fitzmaurice, Helen L.; McKinney, Ross M.; Lin, Yingxi] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Ramamoorthi, Kartik; Fropf, Robin; Belfort, Gabriel M.; Fitzmaurice, Helen L.; McKinney, Ross M.; Neve, Rachael L.; Lin, Yingxi] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Ramamoorthi, Kartik] MIT, Mol & Cellular Neurosci Grad Program, Cambridge, MA 02139 USA; [Otto, Tim] Rutgers State Univ, Dept Psychol, Program Behav Neurosci, New Brunswick, NJ 08854 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Rutgers State University New Brunswick	Lin, YX (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	yingxi@mit.edu		/0000-0002-7002-1275	McGovern Institute for Brain Research at MIT; MIT; MIT Simons Initiative on Autism and the Brain; NSF [IOS 0919159]; Whitehall Foundation; Anonymous Foundation; John Merck Scholar Program; NIH [MH091220-01]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091220] Funding Source: NIH RePORTER; Direct For Biological Sciences [0919159] Funding Source: National Science Foundation	McGovern Institute for Brain Research at MIT; MIT; MIT Simons Initiative on Autism and the Brain; NSF(National Science Foundation (NSF)); Whitehall Foundation; Anonymous Foundation; John Merck Scholar Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank C. M. Fletcher, A. Heynen, C. Alberini, C. Jennings, R. Desimone, M. Baratta, J. Biedenkapp, R. Froemke, J. Czerniawski, and D. Bambah-Mukku for critical reading of the manuscript. We also thank G. Hale and M. Wilson for help characterizing the Npas4<SUP>-/-</SUP> mice and S. Ramirez for help with the open field assay. Y.L. acknowledges the generous support of the McGovern Institute for Brain Research at MIT. This work was supported by the MIT Presidential Marcus Fellowship to Honor Norman B. Leventhal (K. R.), a postdoctoral fellowship from the MIT Simons Initiative on Autism and the Brain (G. M. B), NSF grant IOS 0919159 (T.O.), a Whitehall Foundation research grant, an Anonymous Foundation research grant, the John Merck Scholar Program, and NIH grant MH091220-01 (Y.L.).	Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Athos J, 2002, NAT NEUROSCI, V5, P1119, DOI 10.1038/nn951; Balschun D, 2003, J NEUROSCI, V23, P6304; Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; BENARI Y, 1990, TRENDS NEUROSCI, V13, P312, DOI 10.1016/0166-2236(90)90135-W; Coulon V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011235; Cui YJ, 2008, CELL, V135, P549, DOI 10.1016/j.cell.2008.09.060; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Fanselow MS, 2000, BEHAV BRAIN RES, V110, P73, DOI 10.1016/S0166-4328(99)00186-2; Fleischmann A, 2003, J NEUROSCI, V23, P9116; Guzowski JF, 2002, HIPPOCAMPUS, V12, P86, DOI 10.1002/hipo.10010; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kesner RP, 2007, LEARN MEMORY, V14, P771, DOI 10.1101/lm.688207; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Kubik S, 2007, LEARN MEMORY, V14, P758, DOI 10.1101/lm.698107; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Landeira-Fernandez J, 2006, BEHAV NEUROSCI, V120, P873, DOI 10.1037/0735-7044.120.4.873; Lee I, 2004, HIPPOCAMPUS, V14, P301, DOI 10.1002/hipo.10177; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Lonergan ME, 2010, NEURAL PLAST, V2010, P1, DOI 10.1155/2010/139891; Lonze BE, 2002, NEURON, V34, P371, DOI 10.1016/S0896-6273(02)00686-4; Lu Y, 2008, NEUROBIOL LEARN MEM, V89, P312, DOI 10.1016/j.nlm.2007.08.018; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Maren S, 2008, EUR J NEUROSCI, V28, P1661, DOI 10.1111/j.1460-9568.2008.06485.x; Minichiello L, 2009, NAT REV NEUROSCI, V10, P850, DOI 10.1038/nrn2738; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Pruunsild P, 2011, J NEUROSCI, V31, P3295, DOI 10.1523/JNEUROSCI.4540-10.2011; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462; Rudy JW, 1999, BEHAV NEUROSCI, V113, P867, DOI 10.1037/0735-7044.113.5.867; Ruediger S, 2011, NATURE, V473, P514, DOI 10.1038/nature09946; Scoville WB, 2000, J NEUROPSYCH CLIN N, V12, P103; SHENG M, 1988, MOL CELL BIOL, V8, P2787, DOI 10.1128/MCB.8.7.2787; Tischmeyer W, 1999, CELL MOL LIFE SCI, V55, P564, DOI 10.1007/s000180050315; TREISMAN R, 1985, CELL, V42, P889, DOI 10.1016/0092-8674(85)90285-5; TREISMAN R, 1986, CELL, V46, P567, DOI 10.1016/0092-8674(86)90882-2; WAGNER BJ, 1990, EMBO J, V9, P4477, DOI 10.1002/j.1460-2075.1990.tb07898.x	47	191	196	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1669	1675		10.1126/science.1208049	http://dx.doi.org/10.1126/science.1208049			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22194569	Green Submitted, Green Accepted			2022-12-28	WOS:000298344000058
J	Yildirim, O; Li, RW; Hung, JH; Chen, PB; Dong, XJ; Ee, LS; Weng, ZP; Rando, OJ; Fazzio, TG				Yildirim, Ozlem; Li, Ruowang; Hung, Jui-Hung; Chen, Poshen B.; Dong, Xianjun; Ee, Ly-Sha; Weng, Zhiping; Rando, Oliver J.; Fazzio, Thomas G.			Mbd3/NURD Complex Regulates Expression of 5-Hydroxymethylcytosine Marked Genes in Embryonic Stem Cells	CELL			English	Article							CHROMATIN-REMODELING COMPLEX; SELF-RENEWAL; LINEAGE COMMITMENT; DNA METHYLATION; BINDING DOMAIN; ES CELLS; PLURIPOTENCY; COMPONENT; GENOME; PROTEINS	Numerous chromatin regulators are required for embryonic stem (ES) cell self-renewal and pluripotency, but few have been studied in detail. Here, we examine the roles of several chromatin regulators whose loss affects the pluripotent state of ES cells. We find that Mbd3 and Brg1 antagonistically regulate a common set of genes by regulating promoter nucleosome occupancy. Furthermore, both Mbd3 and Brg1 play key roles in the biology of 5-hydroxymethylcytosine (5hmC): Mbd3 colocalizes with Tet1 and 5hmC in vivo, Mbd3 knockdown preferentially affects expression of 5hmC-marked genes, Mbd3 localization is Tet1-dependent, and Mbd3 preferentially binds to 5hmC relative to 5-methylcytosine in vitro. Finally, both Mbd3 and Brg1 are themselves required for normal levels of 5hmC in vivo. Together, our results identify an effector for 5hmC, and reveal that control of gene expression by antagonistic chromatin regulators is a surprisingly common regulatory strategy in ES cells.	[Yildirim, Ozlem; Weng, Zhiping; Rando, Oliver J.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Li, Ruowang; Hung, Jui-Hung; Dong, Xianjun; Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA; [Chen, Poshen B.; Ee, Ly-Sha; Fazzio, Thomas G.] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Fazzio, Thomas G.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Rando, OJ (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	oliver.rando@umassmed.edu; thomas.fazzio@umassmed.edu	Hung, Jui-Hung/G-2673-2012; Dong, Xianjun/B-5334-2012; Dong, Xianjun/N-3867-2014; Chen, Benson/GYD-5518-2022	Hung, Jui-Hung/0000-0003-2208-9213; Dong, Xianjun/0000-0002-8052-9320; Chen, Benson/0000-0002-5122-5192; Rando, Oliver/0000-0003-1516-9397	NCI [CA140854]; NIGMS [GM088618]; Harold and Leila Mathers Charitable Foundation; NSF [DBI-0850008]; NATIONAL CANCER INSTITUTE [R00CA140854, K99CA140854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088618] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Harold and Leila Mathers Charitable Foundation; NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Rando and Fazzio labs for critical reading of the manuscript; J. Benanti and P. Kaufman for technical advice; C. Li for assistance with TLC; D. Carone for assistance with IF; and J. M. Bishop, in whose lab some of these experiments were performed. We thank C. He and C. Song for the generous gift of reagents for isolation of 5hmC. T.G.F. is supported in part by grant CA140854 from NCI and is a Pew Scholar in the Biomedical Sciences. O.J.R. is supported in part by grant GM088618 from NIGMS, and by the Harold and Leila Mathers Charitable Foundation. Z.W. is supported by NSF grant DBI-0850008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. O.Y., T.G.F., and O.J.R. designed all experiments. O.Y. and T.G.F. carried out mapping experiments. O.Y. performed 5hmC quantitation, T.G.F. carried out gene expression and gel-shift experiments, and L. E. and P.B.C. performed experiments in Figures 4A and 4B. T.G.F. analyzed gene expression data. O.J.R., X.D., J.H.H., R.L., and Z.W. analyzed localization data. O.J.R., O.Y., and T.G.F. wrote the paper.	Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Barski A, 2009, GENOME RES, V19, P1742, DOI 10.1101/gr.090951.109; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Creyghton MP, 2008, CELL, V135, P649, DOI 10.1016/j.cell.2008.09.056; Culhane AC, 2005, BIOINFORMATICS, V21, P2789, DOI 10.1093/bioinformatics/bti394; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Fazzio TG, 2008, CELL CYCLE, V7, P3302, DOI 10.4161/cc.7.21.6928; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Fazzio TG, 2010, CURR OPIN GENET DEV, V20, P500, DOI 10.1016/j.gde.2010.08.001; Feng Q, 2001, GENE DEV, V15, P827; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Guertin MJ, 2010, COLD SH Q B, V75, P1, DOI 10.1101/sqb.2010.75.039; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Ho L, 2011, NAT CELL BIOL, V13, P903, DOI 10.1038/ncb2285; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106; HOLM S, 1979, SCAND J STAT, V6, P65; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jiang H, 2011, CELL, V144, P513, DOI 10.1016/j.cell.2011.01.020; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kaji K, 2007, DEVELOPMENT, V134, P1123, DOI 10.1242/dev.02802; Keenen B, 2009, J CELL PHYSIOL, V219, P1, DOI 10.1002/jcp.21654; Kidder BL, 2009, STEM CELLS, V27, P317, DOI 10.1634/stemcells.2008-0710; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Mahajan MC, 2005, P NATL ACAD SCI USA, V102, P15012, DOI 10.1073/pnas.0507596102; Niwa H, 2007, GENE DEV, V21, P2071, DOI 10.1101/gad.1615707; Ohki I, 2001, CELL, V105, P487, DOI 10.1016/S0092-8674(01)00324-5; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Reese KJ, 2007, PLOS GENET, V3, P1407, DOI 10.1371/journal.pgen.0030137; Saito M, 2002, J BIOL CHEM, V277, P35434, DOI 10.1074/jbc.M203455200; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; van Lohuizen M, 1998, CELL MOL LIFE SCI, V54, P71, DOI 10.1007/s000180050126; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Yan Z, 2008, STEM CELLS, V26, P1155, DOI 10.1634/stemcells.2007-0846; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhu DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007684	59	331	341	1	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2011	147	7					1498	1510		10.1016/j.cell.2011.11.054	http://dx.doi.org/10.1016/j.cell.2011.11.054			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	866SP	22196727	Green Accepted, Bronze			2022-12-28	WOS:000298403400015
J	Lake, JA				Lake, James A.			Lynn Margulis (1938-2011) OBITUARY	NATURE			English	Biographical-Item									[Lake, James A.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Lake, James A.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Lake, JA (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	lake@mbi.ucla.edu						MARGULIS L, PUBLICATION LIST	1	5	6	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2011	480	7378					458	458		10.1038/480458a	http://dx.doi.org/10.1038/480458a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865NQ	22193092	Bronze			2022-12-28	WOS:000298318000044
J	Schwartz, R				Schwartz, Robert			The Emperor of All Maladies - The Beginning of the Beginning	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MUTATION		Tufts Med Ctr, Dept Med, Boston, MA USA	Tufts Medical Center	Schwartz, R (corresponding author), Tufts Med Ctr, Dept Med, Boston, MA USA.							Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Dlugosz AA, 2009, NEW ENGL J MED, V361, P1202, DOI 10.1056/NEJMe0906092; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Mirowski Philip, 2011, SCI MART PRIVATIZING	5	2	2	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2011	365	25					2353	2355		10.1056/NEJMp1111377	http://dx.doi.org/10.1056/NEJMp1111377			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	865OM	22187984				2022-12-28	WOS:000298320200014
J	Taylor, AL; Hwenda, L; Larsen, BI; Daulaire, N				Taylor, Allyn L.; Hwenda, Lenias; Larsen, Bjorn-Inge; Daulaire, Nils			Stemming the Brain Drain - A WHO Global Code of Practice on International Recruitment of Health Personnel	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Taylor, Allyn L.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC USA; [Daulaire, Nils] US Dept HHS, Off Secretary, Off Global Affairs, Washington, DC 20201 USA; [Hwenda, Lenias] World Hlth Org, African Grp Hlth Diplomats, Geneva, Switzerland; [Larsen, Bjorn-Inge] Norwegian Directorate Hlth, Oslo, Norway	Georgetown University; World Health Organization	Taylor, AL (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC USA.							Bethesda MD, 2010, MED ED PARTN IN MEPI; Bethesda MD, 2010, HHS PARTN PEPFAR TRA; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5	3	53	55	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2011	365	25					2348	2351		10.1056/NEJMp1108658	http://dx.doi.org/10.1056/NEJMp1108658			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	865OM	22187983				2022-12-28	WOS:000298320200012
J	van der Greef, J				van der Greef, Jan			PERSPECTIVE All systems go	NATURE			English	Editorial Material									[van der Greef, Jan] Leiden Univ, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC		jan.vandergreef@tno.nl						Huber M, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4163; Li S, 2007, IET SYST BIOL, V1, P51, DOI 10.1049/iet-syb:20060032; van Wietmarschen H., 2009, CLIN RHEUMATOL, V15, P330; Wei HY, PLOS ONE IN PRESS	4	47	48	2	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2011	480	7378					S87	S87		10.1038/480S87a	http://dx.doi.org/10.1038/480S87a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	865NQ	22190087	Bronze			2022-12-28	WOS:000298318000003
J	Chung, M; Lee, J; Terasawa, T; Lau, J; Trikalinos, TA				Chung, Mei; Lee, Jounghee; Terasawa, Teruhiko; Lau, Joseph; Trikalinos, Thomas A.			Vitamin D With or Without Calcium Supplementation for Prevention of Cancer and Fractures: An Updated Meta-analysis for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							SERUM 25-HYDROXYVITAMIN D; RANDOMIZED CLINICAL-TRIAL; D METABOLITE LEVELS; PROSTATE-CANCER; COLORECTAL-CANCER; BREAST-CANCER; PLASMA 25-HYDROXYVITAMIN-D; SECONDARY HYPERPARATHYROIDISM; POSTMENOPAUSAL WOMEN; ELDERLY-PEOPLE	Background: Studies suggest that vitamin D supplementation may reduce cancer and fracture risks. Purpose: To examine the benefits and harms of vitamin D with or without calcium supplementation on clinical outcomes of cancer and fractures in adults. Data Sources: English-language studies identified from MEDLINE and the Cochrane Central Register of Controlled Trials through July 2011. Study Selection: Randomized, controlled trials (RCTs), prospective cohort studies, and nested case-control studies reporting incidence of or death from cancer and fracture outcomes. Data Extraction: Multiple reviewers extracted details about participant characteristics, including baseline vitamin D status and use of supplements; details of statistical analyses, including adjustments for confounding; and methodological quality. Differences were resolved by consensus. Data Synthesis: 19 RCTs (3 for cancer and 16 for fracture outcomes) and 28 observational studies (for cancer outcomes) were analyzed. Limited data from RCTs suggested that high-dose (1000 IU/d) vitamin D supplementation can reduce the risk for total cancer, and data from observational studies suggested that higher blood 25-hydroxyvitamin D (25-[OH]D) concentrations might be associated with increased risk for cancer. Mixed-effects dose-response meta-analyses showed that each 10-nmol/L increase in blood 25-(OH) D concentration was associated with a 6% (95% CI, 3% to 9%) reduced risk for colorectal cancer but no statistically significant dose-response relationships for prostate and breast cancer. Random-effects model meta-analysis showed that combined vitamin D and calcium supplementation reduced fracture risk (pooled relative risk, 0.88 [CI, 0.78 to 0.99]) in older adults, but the effects differed according to study setting: institution (relative risk, 0.71 [CI, 0.57 to 0.89]) versus community-dwelling (relative risk, 0.89 [CI, 0.76 to 1.04]). One RCT showed adverse outcomes associated with supplementation, including increased risk for renal and urinary tract stones. Limitations: Most trial participants were older (aged >= 65 years) postmenopausal women. Observational studies were heterogeneous and were limited by potential confounders. Conclusion: Combined vitamin D and calcium supplementation can reduce fracture risk, but the effects may be smaller among community-dwelling older adults than among institutionalized elderly persons. Appropriate dose and dosing regimens, however, require further study. Evidence is not sufficiently robust to draw conclusions regarding the benefits or harms of vitamin D supplementation for the prevention of cancer.	[Chung, Mei] Tufts Med Ctr, Tufts Evidence Based Practice Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA; Fujita Hlth Univ, Dept Med, Sch Med, Tsu, Mie, Japan	Tufts Medical Center; Fujita Health University	Chung, M (corresponding author), Tufts Med Ctr, Tufts Evidence Based Practice Ctr, Inst Clin Res & Hlth Policy Studies, Box 63,800 Washington St, Boston, MA 02111 USA.	mchung1@tuftsmedicalcenter.org			Agency for Healthcare Research and Quality [HHSA 290-2007-10055-I]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Grant Support: By Agency for Healthcare Research and Quality contract HHSA 290-2007-10055-I.	Agency for Healthcare Research and Quality, 2007, METH REF GUID EFF CO; Ahn J, 2008, JNCI-J NATL CANCER I, V100, P796, DOI 10.1093/jnci/djn152; Ahonen MH, 2000, CANCER CAUSE CONTROL, V11, P847, DOI 10.1023/A:1008923802001; Almquist M, 2010, INT J CANCER, V127, P2159, DOI 10.1002/ijc.25215; Baron JA, 2005, CANCER EPIDEM BIOMAR, V14, P586, DOI 10.1158/1055-9965.EPI-04-0319; BERKEY CS, 1995, STAT MED, V14, P395, DOI 10.1002/sim.4780140406; Bertone-Johnson ER, 2005, CANCER EPIDEM BIOMAR, V14, P1991, DOI 10.1158/1055-9965.EPI-04-0722; BRAUN MM, 1995, CANCER CAUSE CONTROL, V6, P235, DOI 10.1007/BF00051795; BRAUN MM, 1995, AM J EPIDEMIOL, V142, P608, DOI 10.1093/oxfordjournals.aje.a117682; Cawthon PM, 2010, J CLIN ENDOCR METAB, V95, P4625, DOI 10.1210/jc.2010-0638; Chapuy MC, 2002, OSTEOPOROSIS INT, V13, P257, DOI 10.1007/s001980200023; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; Chlebowski RT, 2008, JNCI-J NATL CANCER I, V100, P1581, DOI 10.1093/jnci/djn360; Chung Mei, 2009, Evid Rep Technol Assess (Full Rep), P1; Cranney Ann, 2007, Evid Rep Technol Assess (Full Rep), P1; DawsonHughes B, 1997, NEW ENGL J MED, V337, P670, DOI 10.1056/NEJM199709043371003; DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Favus MJ, 2011, AM J CLIN NUTR, V94, P5, DOI 10.3945/ajcn.111.018481; Feskanich D, 2004, CANCER EPIDEM BIOMAR, V13, P1502; Finkelstein JS, 2006, NEW ENGL J MED, V354, P750, DOI 10.1056/NEJMe068007; Flicker L, 2005, J AM GERIATR SOC, V53, P1881, DOI 10.1111/j.1532-5415.2005.00468.x; Forman MR, 2006, NEW ENGL J MED, V354, P752, DOI 10.1056/NEJMe068006; Freedman DM, 2008, CANCER EPIDEM BIOMAR, V17, P889, DOI 10.1158/1055-9965.EPI-07-2594; Freedman DM, 2010, CANCER RES, V70, P8587, DOI 10.1158/0008-5472.CAN-10-1420; GARLAND CF, 1989, LANCET, V2, P1176, DOI 10.1016/s0140-6736(89)91789-3; Grant AM, 2005, LANCET, V365, P1621, DOI 10.1016/S0140-6736(05)63013-9; Guallar E, 2010, ANN INTERN MED, V152, P327, DOI 10.7326/0003-4819-152-5-201003020-00013; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Harwood RH, 2004, AGE AGEING, V33, P45, DOI 10.1093/ageing/afh002; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2006, NEW ENGL J MED, V354, P2287; Institute of Medicine, 2011, DIETARY REFERENCE IN; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Jacobs ET, 2004, J STEROID BIOCHEM, V89-90, P533, DOI 10.1016/j.jsbmb.2004.03.063; Jenab Mazda, 2010, BMJ, V340, pb5500, DOI 10.1136/bmj.b5500; Knapp G, 2003, STAT MED, V22, P2693, DOI 10.1002/sim.1482; Komulainen MH, 1998, MATURITAS, V31, P45, DOI 10.1016/S0378-5122(98)00085-1; Lappe JM, 2007, AM J CLIN NUTR, V85, P1586, DOI 10.1093/ajcn/85.6.1586; Law M, 2006, AGE AGEING, V35, P482, DOI 10.1093/ageing/afj080; Li HJ, 2007, PLOS MED, V4, P562, DOI 10.1371/journal.pmed.0040103; Lips P, 1996, ANN INTERN MED, V124, P400, DOI 10.7326/0003-4819-124-4-199602150-00003; Lyman Gary H, 2005, BMC Med Res Methodol, V5, P14, DOI 10.1186/1471-2288-5-14; Lyons RA, 2007, OSTEOPOROSIS INT, V18, P811, DOI 10.1007/s00198-006-0309-5; McCullough ML, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2356; Michaelsson K, 2010, AM J CLIN NUTR, V92, P841, DOI 10.3945/ajcn.2010.29749; Mikhak B, 2007, PROSTATE, V67, P911, DOI 10.1002/pros.20570; Moher D, 2001, BMC Med Res Methodol, V1, P2, DOI 10.1186/1471-2288-1-2; Nomura AMY, 1998, CANCER CAUSE CONTROL, V9, P425, DOI 10.1023/A:1008875819232; Norman AW, 2010, EXP BIOL MED, V235, P1034, DOI 10.1258/ebm.2010.010014; Norman AW, 2008, AM J CLIN NUTR, V88, P1455, DOI 10.3945/ajcn.2008.27049; Otani T, 2007, BRIT J CANCER, V97, P446, DOI 10.1038/sj.bjc.6603892; Park SY, 2010, EUR J CANCER, V46, P932, DOI 10.1016/j.ejca.2009.12.030; Pfeifer M, 2000, J BONE MINER RES, V15, P1113, DOI 10.1359/jbmr.2000.15.6.1113; Porthouse J, 2005, BMJ-BRIT MED J, V330, P1003, DOI 10.1136/bmj.330.7498.1003; Rejnmark L, 2009, CANCER EPIDEM BIOMAR, V18, P2655, DOI 10.1158/1055-9965.EPI-09-0531; Salovaara K, 2010, J BONE MINER RES, V25, P1487, DOI 10.1002/jbmr.48; Sanders KM, 2010, JAMA-J AM MED ASSOC, V303, P1815, DOI 10.1001/jama.2010.594; Tangrea J, 1997, CANCER CAUSE CONTROL, V8, P615, DOI 10.1023/A:1018450531136; Travis RC, 2009, AM J EPIDEMIOL, V169, P1223, DOI 10.1093/aje/kwp022; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469; Tuohimaa P, 2004, INT J CANCER, V108, P104, DOI 10.1002/ijc.11375; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Wactawski-Wende J, 2006, NEW ENGL J MED, V354, P684, DOI 10.1056/NEJMoa055222; Wallace RB, 2011, AM J CLIN NUTR, V94, P270, DOI 10.3945/ajcn.110.003350; Weinstein SJ, 2011, AM J EPIDEMIOL, V173, P499, DOI 10.1093/aje/kwq398; Woolcott CG, 2010, CANCER EPIDEM BIOMAR, V19, P130, DOI 10.1158/1055-9965.EPI-09-0475; Wu K, 2007, J NATL CANCER I, V99, P1120, DOI 10.1093/jnci/djm038	69	294	305	0	61	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2011	155	12					827	U83		10.7326/0003-4819-155-12-201112200-00005	http://dx.doi.org/10.7326/0003-4819-155-12-201112200-00005			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	864ZU	22184690				2022-12-28	WOS:000298280500017
J	Wang, TY; Granger, CB				Wang, Tracy Y.; Granger, Christopher B.			Review: Reduced function CYP2C19 genotypes may increase risk for stent clots in patients receiving clopidogrel	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ASSOCIATION		[Wang, Tracy Y.; Granger, Christopher B.] Duke Clin Res Inst, Durham, NC USA	Duke University	Wang, TY (corresponding author), Duke Clin Res Inst, Durham, NC USA.		Granger, Christopher B/D-3458-2014	Granger, Christopher B/0000-0002-0045-3291				Holmes DR, 2010, CIRCULATION, V122, P537, DOI 10.1161/CIR.0b013e3181ee08ed; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Wallentin L, 2010, LANCET, V376, P1320, DOI 10.1016/S0140-6736(10)61274-3	3	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2011	155	12							JC6-13	10.7326/0003-4819-155-12-201112200-02013	http://dx.doi.org/10.7326/0003-4819-155-12-201112200-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	864ZU	22184714				2022-12-28	WOS:000298280500012
J	Wasielewski, PG; Uchino, K				Wasielewski, Paul G.; Uchino, Ken			Review: Insulin to maintain normoglycemia within 24 hours of ischemic stroke does not reduce death or dependency	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							EARLY MANAGEMENT; ASSOCIATION; GUIDELINES; THERAPY; COUNCIL		Cleveland Clin, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Wasielewski, PG (corresponding author), Cleveland Clin, Cleveland, OH 44106 USA.		Uchino, Ken/ABC-1611-2021	Uchino, Ken/0000-0001-9468-4172				Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Adams HP, 2003, STROKE, V34, P1056, DOI 10.1161/01.STR.0000064841.47697.22; Gray CS, 2007, LANCET NEUROL, V6, P397, DOI 10.1016/S1474-4422(07)70080-7; Kansagara D, 2011, ANN INTERN MED, V154, P268, DOI 10.7326/0003-4819-154-4-201102150-00008; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300	5	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2011	155	12							JC6-5	10.7326/0003-4819-155-12-201112200-02005	http://dx.doi.org/10.7326/0003-4819-155-12-201112200-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	864ZU	22184706				2022-12-28	WOS:000298280500004
J	Liu, KSY; Siebert, M; Mertel, S; Knoche, E; Wegener, S; Wichmann, C; Matkovic, T; Muhammad, K; Depner, H; Mettke, C; Buckers, J; Hell, SW; Muller, M; Davis, GW; Schmitz, D; Sigrist, SJ				Liu, Karen S. Y.; Siebert, Matthias; Mertel, Sara; Knoche, Elena; Wegener, Stephanie; Wichmann, Carolin; Matkovic, Tanja; Muhammad, Karzan; Depner, Harald; Mettke, Christoph; Bueckers, Johanna; Hell, Stefan W.; Mueller, Martin; Davis, Graeme W.; Schmitz, Dietmar; Sigrist, Stephan J.			RIM-Binding Protein, a Central Part of the Active Zone, Is Essential for Neurotransmitter Release	SCIENCE			English	Article							SYNAPTIC CALCIUM-CHANNEL; CA2+ CHANNELS; DROSOPHILA; BRUCHPILOT; MATURATION; MOLECULES; CACOPHONY; FAMILY	The molecular machinery mediating the fusion of synaptic vesicles (SVs) at presynaptic active zone (AZ) membranes has been studied in detail, and several essential components have been identified. AZ-associated protein scaffolds are viewed as only modulatory for transmission. We discovered that Drosophila Rab3-interacting molecule (RIM)-binding protein (DRBP) is essential not only for the integrity of the AZ scaffold but also for exocytotic neurotransmitter release. Two-color stimulated emission depletion microscopy showed that DRBP surrounds the central Ca(2+) channel field. In drbp mutants, Ca(2+) channel clustering and Ca(2+) influx were impaired, and synaptic release probability was drastically reduced. Our data identify RBP family proteins as prime effectors of the AZ scaffold that are essential for the coupling of SVs, Ca(2+) channels, and the SV fusion machinery.	[Siebert, Matthias; Knoche, Elena; Wegener, Stephanie; Wichmann, Carolin; Schmitz, Dietmar; Sigrist, Stephan J.] Charite, NeuroCure Cluster Excellence, D-10117 Berlin, Germany; [Liu, Karen S. Y.; Mertel, Sara; Matkovic, Tanja; Muhammad, Karzan; Depner, Harald; Mettke, Christoph; Sigrist, Stephan J.] Free Univ Berlin, Inst Biol, Dept Genet, D-14195 Berlin, Germany; [Bueckers, Johanna; Hell, Stefan W.] Max Planck Inst Biophys Chem, Dept Nanobiophoton, D-37077 Gottingen, Germany; [Mueller, Martin; Davis, Graeme W.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Schmitz, Dietmar] DZNE German Ctr Neurodegenerat Dis, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Max Planck Society; University of California System; University of California San Francisco; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Schmitz, D (corresponding author), Charite, NeuroCure Cluster Excellence, Charitepl 1, D-10117 Berlin, Germany.	dietmar.schmitz@charite.de; stephan.sigrist@fu-berlin.de	Siebert, Matthias/K-8494-2014; Knoche, Elena/P-5013-2015	Siebert, Matthias/0000-0002-1739-5825; Knoche, Elena/0000-0002-6725-9549; Schmitz, Dietmar/0000-0003-2741-5241; Wegener, Stephanie/0000-0002-5809-2222	Deutsche Forschungsgemeinschaft (DFG) [SFB 665, SFB 958, EXC 257]; Bundesministerium fur Bildung und Forschung (The German Federal Agency of Education and Research); Max Delbruck Center for Molecular Medicine; Boehringer Ingelheim Fonds; DFG [GRK 1123]; Swiss National Science Foundation [PBSKP3-123456/1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (The German Federal Agency of Education and Research)(Federal Ministry of Education & Research (BMBF)); Max Delbruck Center for Molecular Medicine(Helmholtz Association); Boehringer Ingelheim Fonds(Boehringer Ingelheim); DFG(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Deutsche Forschungsgemeinschaft (DFG) grants (SFB 665, SFB 958, and EXC 257) to S.J.S and D. S., as well as Bundesministerium fur Bildung und Forschung (The German Federal Agency of Education and Research) funding for Deutsche Zentrum fur Neurodegenerative Erkrankungen (DZNE) to D. S. Also, M. S. was supported by a Ph.D. fellowship from the Max Delbruck Center for Molecular Medicine and a Boehringer Ingelheim Fonds Ph.D. fellowship. E. K. and S. W. were supported by Ph.D. fellowships from the graduate school GRK 1123 funded by the DFG. M. M. was supported by a fellowship of the Swiss National Science Foundation (PBSKP3-123456/1).	Bucan M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000536; Buckers J, 2011, OPT EXPRESS, V19, P3130, DOI 10.1364/OE.19.003130; Fouquet W, 2009, J CELL BIOL, V186, P129, DOI 10.1083/jcb.200812150; Gracheva Elena O, 2010, Front Synaptic Neurosci, V2, P141, DOI 10.3389/fnsyn.2010.00141; Hallermann S, 2010, J NEUROSCI, V30, P14340, DOI 10.1523/JNEUROSCI.2495-10.2010; Han YY, 2011, NEURON, V69, P304, DOI 10.1016/j.neuron.2010.12.014; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Hibino H, 2002, NEURON, V34, P411, DOI 10.1016/S0896-6273(02)00667-0; Hou J, 2008, J NEUROPHYSIOL, V100, P2833, DOI 10.1152/jn.90342.2008; Jin Y, 2008, ANNU REV CELL DEV BI, V24, P237, DOI 10.1146/annurev.cellbio.23.090506.123417; Jockusch WJ, 2007, CELL, V131, P796, DOI 10.1016/j.cell.2007.11.002; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Kawasaki F, 2002, J NEUROSCI, V22, P5856; Kawasaki F, 2004, J NEUROSCI, V24, P282, DOI 10.1523/JNEUROSCI.3553-03.2004; Kawasaki F, 2000, J NEUROSCI, V20, P4885; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Mittelstaedt T, 2007, GENE, V403, P70, DOI 10.1016/j.gene.2007.08.004; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; Rostaing P, 2004, J HISTOCHEM CYTOCHEM, V52, P1, DOI 10.1177/002215540405200101; Schoch S, 2006, CELL TISSUE RES, V326, P379, DOI 10.1007/s00441-006-0244-y; Sigrist SJ, 2011, CURR OPIN NEUROBIOL, V21, P144, DOI 10.1016/j.conb.2010.08.012; Siksou L, 2007, J NEUROSCI, V27, P6868, DOI 10.1523/JNEUROSCI.1773-07.2007; Siksou L, 2011, CURR OPIN NEUROBIOL, V21, P261, DOI 10.1016/j.conb.2010.12.003; Spangler SA, 2007, BIOCHEM SOC T, V35, P1278, DOI 10.1042/BST0351278; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Wang Y, 2000, J BIOL CHEM, V275, P20033, DOI 10.1074/jbc.M909008199	28	187	192	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 16	2011	334	6062					1565	1569		10.1126/science.1212991	http://dx.doi.org/10.1126/science.1212991			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	862LE	22174254	Green Published			2022-12-28	WOS:000298091400056
J	Kanner, LC; Burns, SJ; Cheng, H; Edwards, RL				Kanner, Lisa C.; Burns, Stephen J.; Cheng, Hai; Edwards, R. Lawrence			High-Latitude Forcing of the South American Summer Monsoon During the Last Glacial	SCIENCE			English	Article							CLIMATE-CHANGE; MILLENNIAL-SCALE; ATMOSPHERIC CH4; STABLE-ISOTOPES; ATLANTIC-OCEAN; ICE CORES; GREENLAND; PRECIPITATION; VARIABILITY; ANTARCTICA	The climate of the Last Glacial period (10,000 to 110,000 years ago) was characterized by rapid millennial-scale climate fluctuations termed Dansgaard/Oeschger (D/O) and Heinrich events. We present results from a speleothem-derived proxy of the South American summer monsoon (SASM) from 16,000 to 50,000 years ago that demonstrate the occurrence of D/O cycles and Heinrich events. This tropical Southern Hemisphere monsoon reconstruction illustrates an antiphase relationship to Northern Hemisphere monsoon intensity at the millennial scale. Our results also show an influence of Antarctic millennial-scale climate fluctuations on the SASM. This high-resolution, precisely dated, tropical precipitation record can be used to establish the timing of climate events in the high latitudes of the Northern and Southern Hemispheres.	[Kanner, Lisa C.; Burns, Stephen J.] Univ Massachusetts, Dept Geosci, Amherst, MA 01002 USA; [Cheng, Hai] Xi An Jiao Tong Univ, Inst Global Environm Change, Xian 710049, Peoples R China; [Cheng, Hai; Edwards, R. Lawrence] Univ Minnesota, Dept Geol & Geophys, Minneapolis, MN 55455 USA	University of Massachusetts System; University of Massachusetts Amherst; Xi'an Jiaotong University; University of Minnesota System; University of Minnesota Twin Cities	Kanner, LC (corresponding author), Univ Massachusetts, Dept Geosci, Amherst, MA 01002 USA.	lkanner@geo.umass.edu	Burns, Stephen/H-9419-2013; CHENG, HAI/H-3413-2017; Edwards, R. Lawrence/I-3124-2014	CHENG, HAI/0000-0002-5305-9458; Edwards, R. Lawrence/0000-0002-7027-5881	NSF [ATM-1003466, 0502535, 1103403]; Geological Society of America [9308-10]; Directorate For Geosciences [1003466] Funding Source: National Science Foundation; Div Atmospheric & Geospace Sciences [1103403] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Geological Society of America; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work is supported by NSF grant ATM-1003466 to S.J.B., NSF grants 0502535 and 1103403 to R. L. E. and H. C., and Geological Society of America Student Award 9308-10 to L. C. K. We thank C. Morales-Bermudez for his invaluable assistance in the field. Comments from two anonymous reviewers substantially improved the manuscript. The data in this paper are tabulated in the supporting online material and are archived online at ftp://ftp.ncdc.noaa.gov/pub/data/paleo.	Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Barbante C, 2006, NATURE, V444, P195, DOI 10.1038/nature05301; Blunier T, 2001, SCIENCE, V291, P109, DOI 10.1126/science.291.5501.109; Bock M, 2010, SCIENCE, V328, P1686, DOI 10.1126/science.1187651; BOND G, 1992, NATURE, V360, P245, DOI 10.1038/360245a0; Boyle EA, 1997, P NATL ACAD SCI USA, V94, P8300, DOI 10.1073/pnas.94.16.8300; Broccoli AJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024546; Burns SJ, 2003, SCIENCE, V301, P1365, DOI 10.1126/science.1086227; CHAPPELLAZ J, 1993, NATURE, V366, P443, DOI 10.1038/366443a0; Cheng H, 2009, GEOLOGY, V37, P1007, DOI 10.1130/G30126A.1; Chiang JCH, 2005, CLIM DYNAM, V25, P477, DOI 10.1007/s00382-005-0040-5; Clement AC, 2008, REV GEOPHYS, V46, DOI 10.1029/2006RG000204; Cobbing E. J., 1981, GEOLOGY W CORDILLERA, P143; Cruz FW, 2005, NATURE, V434, P63, DOI 10.1038/nature03365; Dallenbach A, 2000, GEOPHYS RES LETT, V27, P1005, DOI 10.1029/1999GL010873; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; DANSGAARD W, 1964, TELLUS, V16, P436; Denton GH, 2010, SCIENCE, V328, P1652, DOI 10.1126/science.1184119; Fluckiger J, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002122; HEINRICH H, 1988, QUATERNARY RES, V29, P142, DOI 10.1016/0033-5894(88)90057-9; Hemming SR, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000128; HENDY CH, 1971, GEOCHIM COSMOCHIM AC, V35, P801, DOI 10.1016/0016-7037(71)90127-X; Hoffmann G, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL014870; Jaeschke A, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001391; Jennerjahn TC, 2004, SCIENCE, V306, P2236, DOI 10.1126/science.1102490; Lemieux-Dudon B, 2010, QUATERNARY SCI REV, V29, P8, DOI 10.1016/j.quascirev.2009.11.010; Roche D, 2004, NATURE, V432, P379, DOI 10.1038/nature03059; Sachs JP, 1999, SCIENCE, V286, P756, DOI 10.1126/science.286.5440.756; Seltzer G, 2000, GEOLOGY, V28, P35; Skinner LC, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001338; Smith JA, 2010, J QUATERNARY SCI, V25, P243, DOI 10.1002/jqs.1393; Stocker TF, 1998, RADIOCARBON, V40, P359; VICTORIA RL, 1991, AMBIO, V20, P384; Vimeux F, 2005, EARTH PLANET SC LETT, V240, P205, DOI 10.1016/j.epsl.2005.09.031; Vuille M, 2000, J GEOPHYS RES-ATMOS, V105, P12447, DOI 10.1029/2000JD900134; Vuille M, 2005, CLIM DYNAM, V25, P401, DOI 10.1007/s00382-005-0049-9; Vuille M, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD002038; Wang XF, 2004, NATURE, V432, P740, DOI 10.1038/nature03067; Wang XF, 2006, QUATERNARY SCI REV, V25, P3391, DOI 10.1016/j.quascirev.2006.02.009; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Wang YJ, 2008, NATURE, V451, P1090, DOI 10.1038/nature06692; Weaver AJ, 2003, SCIENCE, V299, P1709, DOI 10.1126/science.1081002; Zhang R, 2005, J CLIMATE, V18, P1853, DOI 10.1175/JCLI3460.1	43	155	158	3	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2012	335	6068					570	573		10.1126/science.1213397	http://dx.doi.org/10.1126/science.1213397			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885HI	22245741				2022-12-28	WOS:000299769200040
J	Trounson, A; Grieshammer, U				Trounson, Alan; Grieshammer, Uta			Chimeric Primates: Embryonic Stem Cells Need Not Apply	CELL			English	Editorial Material							MOUSE; BLASTOCYST	In this issue, Tachibana et al. report the generation of the first chimeras from a nonhuman primate, the rhesus monkey. Unlike mice, rhesus chimeras fail to form when embryonic stem cells are injected into blastocysts. Instead, chimera formation is achieved by aggregation of several four-cell embryos.	[Trounson, Alan; Grieshammer, Uta] Calif Inst Regenerat Med, San Francisco, CA 94107 USA		Trounson, A (corresponding author), Calif Inst Regenerat Med, 210 King St, San Francisco, CA 94107 USA.	atrounson@cirm.ca.gov		Trounson, Alan/0000-0001-5469-0500				Chung Y, 2006, NATURE, V439, P216, DOI 10.1038/nature04277; Cockburn K, 2010, J CLIN INVEST, V120, P995, DOI 10.1172/JCI41229; GARDNER RL, 1968, NATURE, V220, P596, DOI 10.1038/220596a0; Ilic D, 2009, STEM CELLS DEV, V18, P1343, DOI 10.1089/scd.2008.0416; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Nichols J, 2011, DEVELOPMENT, V138, P3, DOI 10.1242/dev.050831; Ohta H, 2008, REPRODUCTION, V136, P581, DOI 10.1530/REP-08-0184; Roode M, 2012, DEV BIOL, V361, P358, DOI 10.1016/j.ydbio.2011.10.030; Tachibana M, 2012, CELL, V148, P285, DOI 10.1016/j.cell.2011.12.007; Xu Y, 2010, P NATL ACAD SCI USA, V107, P8129, DOI 10.1073/pnas.1002024107	10	4	4	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 20	2012	148	1-2					19	21		10.1016/j.cell.2011.12.016	http://dx.doi.org/10.1016/j.cell.2011.12.016			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	882DC	22225613	Bronze			2022-12-28	WOS:000299540700008
J	Zwyns, N; Roebroeks, W; McPherron, SP; Jagich, A; Hublin, JJ				Zwyns, Nicolas; Roebroeks, Wil; McPherron, Shannon P.; Jagich, Adam; Hublin, Jean-Jacques			Comment on "Late Mousterian Persistence near the Arctic Circle"	SCIENCE			English	Editorial Material								Slimak et al. (Reports, 13 May 2011, p. 841) reanalyzed the lithic assemblage from the northern site of Byzovaya (Russia) and concluded that it was Mousterian and produced by Neandertals. The previous interpretation of this assemblage as falling within Early Upper Paleolithic variability remains the most parsimonious explanation; pending additional fossil discoveries, there is no evidence supporting the occurrence of Neandertals at these high latitudes.	[Zwyns, Nicolas; McPherron, Shannon P.; Hublin, Jean-Jacques] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; [Roebroeks, Wil; Jagich, Adam] Leiden Univ, Fac Archaeol, NL-2300 RA Leiden, Netherlands	Max Planck Society; Leiden University; Leiden University - Excl LUMC	Zwyns, N (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Deutsch Pl, D-04103 Leipzig, Germany.	nicolas_zwyns@eva.mpg.de	McPherron, Shannon/C-9958-2010	McPherron, Shannon/0000-0002-2063-468X; Roebroeks, Wil/0000-0002-5075-6899				Boeda E., 1994, CONCEPT LEVALLOIS VA; Brantingham PJ, 2004, EARLY UPPER PALEOLITHIC BEYOND WESTERN EUROPE, P223; Chabai V.P., 2003, CHRONOLOGY AURIGNACI, V33, P71; GUSLITZER BI, 1993, KOSTENKI CLOVIS UPPE, P175; Krause J, 2007, NATURE, V449, P902, DOI 10.1038/nature06193; Krause J, 2010, CURR BIOL, V20, P231, DOI 10.1016/j.cub.2009.11.068; Kuzmin Y. V., 2004, NUCL INSTRUM METHODS, V2004, P223; Pavlov P, 2004, J HUM EVOL, V47, P3, DOI 10.1016/j.jhevol.2004.05.002; Pavlov P, 2001, NATURE, V413, P64, DOI 10.1038/35092552; Pavlov PY, 2008, ARCHAEOL ETHNOL ANTH, V33, P33, DOI 10.1016/j.aeae.2008.04.014; Pinhasi R, 2011, P NATL ACAD SCI USA, V108, P8611, DOI 10.1073/pnas.1018938108; Slimak L, 2011, SCIENCE, V332, P841, DOI 10.1126/science.1203866; Svendsen JI, 2010, QUATERNARY SCI REV, V29, P3138, DOI 10.1016/j.quascirev.2010.06.043; Usik VI, 1993, PALEORIENT, V19, P5, DOI DOI 10.3406/PALE0.1993.4593	14	13	13	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 13	2012	335	6065								10.1126/science.1209908	http://dx.doi.org/10.1126/science.1209908			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	875LZ	22246757				2022-12-28	WOS:000299033100031
J	Libby, T; Moore, TY; Chang-Siu, E; Li, D; Cohen, DJ; Jusufi, A; Full, RJ				Libby, Thomas; Moore, Talia Y.; Chang-Siu, Evan; Li, Deborah; Cohen, Daniel J.; Jusufi, Ardian; Full, Robert J.			Tail-assisted pitch control in lizards, robots and dinosaurs	NATURE			English	Article							BODY; BALANCE	In 1969, a palaeontologist proposed(1) that theropod dinosaurs used their tails as dynamic stabilizers during rapid or irregular movements, contributing to their depiction as active and agile predators. Since then the inertia of swinging appendages has been implicated in stabilizing human walking(2,3), aiding acrobatic manoeuvres by primates(4-8) and rodents(9), and enabling cats to balance on branches(10). Recent studies on geckos(11-13) suggest that active tail stabilization occurs during climbing, righting and gliding. By contrast, studies on the effect of lizard tail loss show evidence of a decrease, an increase or no change in performance(14,15). Application of a control-theoretic framework could advance our general understanding of inertial appendage use in locomotion. Here we report that lizards control the swing of their tails in a measured manner to redirect angular momentum from their bodies to their tails, stabilizing body attitude in the sagittal plane. We video-recorded Red-Headed Agama lizards (Agama agama) leaping towards a vertical surface by first vaulting onto an obstacle with variable traction to induce a range of perturbations in body angular momentum. To examine a known controlled tail response, we built a lizard-sized robot with an active tail that used sensory feedback to stabilize pitch as it drove off a ramp. Our dynamics model revealed that a body swinging its tail experienced less rotation than a body with a rigid tail, a passively compliant tail or no tail. To compare a range of tails, we calculated tail effectiveness as the amount of tailless body rotation a tail could stabilize. A model Velociraptor mongoliensis supported the initial tail stabilization hypothesis(1), showing as it did a greater tail effectiveness than the Agama lizards. Leaping lizards show that inertial control of body attitude can advance our understanding of appendage evolution and provide biological inspiration for the next generation of manoeuvrable search-and-rescue robots.	[Moore, Talia Y.; Li, Deborah; Jusufi, Ardian; Full, Robert J.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Libby, Thomas] Univ Calif Berkeley, Ctr Interdisciplinary Bioinspirat Educ & Res, Berkeley, CA 94720 USA; [Chang-Siu, Evan] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA; [Cohen, Daniel J.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Full, RJ (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	rjfull@berkeley.edu	Moore, Talia Y/E-1210-2012; Moore, Talia/AAB-1590-2019	Moore, Talia/0000-0003-0867-4512; Jusufi, Ardian/0000-0003-4250-2984	US NSF FIBR; MAST CTA; NSF IGERT [DGE-0903711]; Swiss NSF	US NSF FIBR; MAST CTA; NSF IGERT(National Science Foundation (NSF)); Swiss NSF(Swiss National Science Foundation (SNSF))	We thank P. Jennings for video editing and figure production, T. Full for digitizing the lizard video and K. Padian for his advice on the dinosaur reconstruction and capability. We thank O. O'Reilly, S. Sponberg and N. Sapir for advice on analysis. This work was supported by a US NSF FIBR grant to R.J.F., a MAST CTA grant to R.J.F, an NSF IGERT under award DGE-0903711 and a Swiss NSF Fellowship to A.	Alexander RM, 2006, P ROY SOC B-BIOL SCI, V273, P1849, DOI 10.1098/rspb.2006.3532; BARTHOLOMEW GA, 1951, J MAMMAL, V32, P155, DOI 10.2307/1375371; Bateman PW, 2009, J ZOOL, V277, P1, DOI 10.1111/j.1469-7998.2008.00484.x; Berkemeier M. D., 1992, Proceedings. 1992 IEEE International Conference on Robotics And Automation (Cat. No.92CH3140-1), P286, DOI 10.1109/ROBOT.1992.220249; Carrier DR, 2001, J EXP BIOL, V204, P3917; Chang-Siu E., 2011, 2011 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS 2011), P1887, DOI 10.1109/IROS.2011.6048342; Demes B, 1996, J HUM EVOL, V31, P367, DOI 10.1006/jhev.1996.0066; Dowling JJ, 2006, MED ENG PHYS, V28, P837, DOI 10.1016/j.medengphy.2005.11.007; DUNBAR DC, 1988, AM J PRIMATOL, V16, P291, DOI 10.1002/ajp.1350160402; Gillis GB, 2009, J EXP BIOL, V212, P604, DOI 10.1242/jeb.024349; Gunther M.M., 1991, Zeitschrift fuer Morphologie und Anthropologie, V78, P341; Hyun Soo P, 2009, IEEE INT C ROB AUT 2, P2655; Jusufi A, 2010, BIOINSPIR BIOMIM, V5, DOI 10.1088/1748-3182/5/4/045001; Jusufi A, 2008, P NATL ACAD SCI USA, V105, P4215, DOI 10.1073/pnas.0711944105; Jusufi A, 2011, INTEGR COMP BIOL, V51, P937, DOI 10.1093/icb/icr114; Larson SG, 2006, AM J PHYS ANTHROPOL, V129, P71, DOI 10.1002/ajpa.20236; Mather TW, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P5905, DOI 10.1109/IROS.2009.5354027; Ostrom J. H, 1969, B PEABODY MUS NAT HI, V30, P68; Ostrom J. H, 1969, B PEABODY MUS NAT HI, V30, P144; Paul G. S, 2002, DINOSAURS AIR EVOLUT, V45; Paul G. S, 2010, PRINCETON FIELDGUIDE, V137; Peters A., 1984, P227; Pijnappels M, 2010, EXP BRAIN RES, V201, P689, DOI 10.1007/s00221-009-2088-7; Roos PE, 2008, GAIT POSTURE, V27, P352, DOI 10.1016/j.gaitpost.2007.05.001; Saunders A, 2006, PROC SPIE, V6230, DOI 10.1117/12.666150; Sellers WI, 2007, P ROY SOC B-BIOL SCI, V274, P2711, DOI 10.1098/rspb.2007.0846; Walker C, 1998, BEHAV BRAIN RES, V91, P41, DOI 10.1016/S0166-4328(97)00101-0	27	193	203	6	138	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 12	2012	481	7380					181	+		10.1038/nature10710	http://dx.doi.org/10.1038/nature10710			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	874TO	22217942				2022-12-28	WOS:000298981200035
J	Greenhalgh, T				Greenhalgh, Trisha			OUTSIDE THE BOX The feminisation of nature	BRITISH MEDICAL JOURNAL			English	Editorial Material									Barts & London Queen Marys Sch Med & Dent, London, England	University of London; Queen Mary University London	Greenhalgh, T (corresponding author), Barts & London Queen Marys Sch Med & Dent, London, England.	p.greenhalgh@qmul.ac.uk	Greenhalgh, Trisha/B-1825-2015	Greenhalgh, Trisha/0000-0003-2369-8088				2008, J ENVIRON MONITOR, V10, P1476, DOI DOI 10.1039/B815741N	1	0	0	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 30	2011	343								d8348	10.1136/bmj.d8348	http://dx.doi.org/10.1136/bmj.d8348			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	874TQ	22209822				2022-12-28	WOS:000298981400005
J	Kakkar, AK; Cimminiello, C; Goldhaber, SZ; Parakh, R; Wang, C; Bergmann, JF				Kakkar, Ajay K.; Cimminiello, Claudio; Goldhaber, Samuel Z.; Parakh, Rajiv; Wang, Chen; Bergmann, Jean-Francois		LIFENOX Investigators	Low-Molecular-Weight Heparin and Mortality in Acutely Ill Medical Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEEP-VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM RISK; FATAL PULMONARY-EMBOLISM; MAJOR ORTHOPEDIC-SURGERY; LOW-DOSE HEPARIN; CONTROLLED-TRIAL; SETTING ENDORSE; ASIAN PATIENTS; PREVENTION; PROPHYLAXIS	BACKGROUND Although thromboprophylaxis reduces the incidence of venous thromboembolism in acutely ill medical patients, an associated reduction in the rate of death from any cause has not been shown. METHODS We conducted a double-blind, placebo-controlled, randomized trial to assess the effect of subcutaneous enoxaparin (40 mg daily) as compared with placebo - both administered for 10 +/- 4 days in patients who were wearing elastic stockings with graduated compression - on the rate of death from any cause among hospitalized, acutely ill medical patients at participating sites in China, India, Korea, Malaysia, Mexico, the Philippines, and Tunisia. Inclusion criteria were an age of at least 40 years and hospitalization for acute decompensated heart failure, severe systemic infection with at least one risk factor for venous thromboembolism, or active cancer. The primary efficacy outcome was the rate of death from any cause at 30 days after randomization. The primary safety outcome was the rate of major bleeding during and up to 48 hours after the treatment period. RESULTS A total of 8307 patients were randomly assigned to receive enoxaparin plus elastic stockings with graduated compression (4171 patients) or placebo plus elastic stockings with graduated compression (4136 patients) and were included in the intention-to-treat population. The rate of death from any cause at day 30 was 4.9% in the enoxaparin group as compared with 4.8% in the placebo group (risk ratio, 1.0; 95% confidence interval [CI], 0.8 to 1.2; P=0.83). The rate of major bleeding was 0.4% in the enoxaparin group and 0.3% in the placebo group (risk ratio, 1.4; 95% CI, 0.7 to 3.1; P=0.35). CONCLUSIONS The use of enoxaparin plus elastic stockings with graduated compression, as compared with elastic stockings with graduated compression alone, was not associated with a reduction in the rate of death from any cause among hospitalized, acutely ill medical patients. (Funded by Sanofi; LIFENOX ClinicalTrials.gov number, NCT00622648.)	[Kakkar, Ajay K.] Thrombosis Res Inst, London SW3 6LR, England; [Kakkar, Ajay K.] UCL, London WC1E 6BT, England; [Cimminiello, Claudio] Osped Civile Vimercate, Dept Med, Vimercate, Italy; [Goldhaber, Samuel Z.] Harvard Univ, Sch Med, Boston, MA USA; [Goldhaber, Samuel Z.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Parakh, Rajiv] Medanta Medicity, Gurgaon, Haryana, India; [Bergmann, Jean-Francois] Univ Paris Diderot, Hop Lariboisiere, AP HP, Paris, France; [Wang, Chen] Beijing Inst Resp Med, Beijing, Peoples R China; [Wang, Chen] Minist Hlth, Beijing Hosp, Beijing, Peoples R China	Thrombosis Research Institute; University of London; University College London; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Beijing Hospital	Kakkar, AK (corresponding author), Thrombosis Res Inst, Manresa Rd,Emmanuel Kaye Bldg, London SW3 6LR, England.	akkakkar@tri-london.ac.uk	Hug, Balthasar L./G-1568-2010; sharma, kamal/AAG-7271-2019; Kaynar, Leylagul/F-6991-2013; Bergmann, Jean-Francois/L-6044-2017	sharma, kamal/0000-0001-5866-2566; Kaynar, Leylagul/0000-0002-2035-9462; Bergmann, Jean-Francois/0000-0001-6861-9748; gupta, amit/0000-0001-9247-9204	Sanofi; Bayer Healthcare; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; Eisai; GlaxoSmithKline; Pfizer; EKOS; Medscape; Merck; Portola; Johnson Johnson; AstraZeneca; Association des Pharmaciens de l'Industrie-Communication Globale Sante-Prioritis; Bayer; Lilly; Agence Nationale de Recherche contre le SIDA	Sanofi; Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Daiichi Sankyo(Daiichi Sankyo Company Limited); Eisai(Eisai Co Ltd); GlaxoSmithKline(GlaxoSmithKline); Pfizer(Pfizer); EKOS; Medscape; Merck(Merck & Company); Portola; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); AstraZeneca(AstraZeneca); Association des Pharmaciens de l'Industrie-Communication Globale Sante-Prioritis; Bayer(Bayer AG); Lilly(Eli Lilly); Agence Nationale de Recherche contre le SIDA(French National Research Agency (ANR))	Supported by Sanofi.; Dr. Kakkar reports receiving consulting fees, grant support through his institution, and lecture fees from Bayer Healthcare, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Eisai, GlaxoSmithKline, Pfizer, and Sanofi; Dr. Cimminiello, receiving consulting fees from Sanofi; Dr. Goldhaber, receiving consulting fees from Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Eisai, EKOS, Medscape, Merck, Portola, and Sanofi and grant support through his institution from Boehringer Ingelheim, Bristol-Myers Squibb, Eisai, EKOS, Johnson & Johnson, and Sanofi; Dr. Parakh, receiving consulting fees from Bayer, Boehringer Ingelheim, Daiichi Sankyo, GlaxoSmithKline, Novartis, Pfizer, and Sanofi and support for travel, accommodations, or meeting expenses from Bayer, Daiichi Sankyo, and Sanofi; and Dr. Bergmann, receiving consulting fees from AstraZeneca, Association des Pharmaciens de l'Industrie-Communication Globale Sante-Prioritis, Bayer, GlaxoSmithKline, Lilly, Novartis, Pfizer, and Sanofi and grant support through his institution from Agence Nationale de Recherche contre le SIDA, Bayer, GlaxoSmithKline, and Pfizer. No other potential conflict of interest relevant to this article was reported.	Alikhan R, 2004, J CLIN PATHOL, V57, P1254, DOI 10.1136/jcp.2003.013581; ANDERSON FA, 1992, ARCH INTERN MED, V152, P1660, DOI 10.1001/archinte.152.8.1660; [Anonymous], 2008, SURG GEN CALL ACT PR; Bergmann JF, 2010, THROMB HAEMOSTASIS, V103, P736, DOI 10.1160/TH09-09-0667; CLAGETT GP, 1988, ANN SURG, V208, P227, DOI 10.1097/00000658-198808000-00016; Cohen AT, 2008, LANCET, V371, P387, DOI 10.1016/S0140-6736(08)60202-0; Cohen AT, 2006, BMJ-BRIT MED J, V332, P325, DOI 10.1136/bmj.38733.466748.7C; COLLINS R, 1988, NEW ENGL J MED, V318, P1162, DOI 10.1056/NEJM198805053181805; DAHAN R, 1986, HAEMOSTASIS, V16, P159; Dennis M, 2010, ANN INTERN MED, V153, P553, DOI 10.7326/0003-4819-153-9-201011020-00280; Dennis M, 2009, LANCET, V373, P1958, DOI 10.1016/S0140-6736(09)60941-7; Dentali F, 2007, ANN INTERN MED, V146, P278, DOI 10.7326/0003-4819-146-4-200702200-00007; Fraisse F, 2000, AM J RESP CRIT CARE, V161, P1109, DOI 10.1164/ajrccm.161.4.9807025; Gardlund B, 1996, LANCET, V347, P1357; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; HALKIN H, 1982, ANN INTERN MED, V96, P561, DOI 10.7326/0003-4819-96-5-561; Hull RD, 2010, ANN INTERN MED, V153, P8, DOI 10.7326/0003-4819-153-1-201007060-00004; HWANG W S, 1968, SMJ Singapore Medical Journal, V9, P276; Kakkar AK, 2010, ANN SURG, V251, P330, DOI 10.1097/SLA.0b013e3181c0e58f; KAKKAR VV, 1969, LANCET, V2, P230; KAKKAR VV, 1975, LANCET, V2, P674; KARWINSKI B, 1989, J CLIN PATHOL, V42, P135, DOI 10.1136/jcp.42.2.135; Leizorovicz A, 2005, J THROMB HAEMOST, V3, P28, DOI 10.1111/j.1538-7836.2004.01094.x; Leizorovicz A, 2004, CIRCULATION, V110, P874, DOI 10.1161/01.CIR.0000138928.83266.24; Leizorovicz A, 2007, HAEMATOLOGICA, V92, P1194, DOI 10.3324/haematol.10819; Mahe I, 2005, EUR J CLIN PHARMACOL, V61, P347, DOI 10.1007/s00228-005-0944-3; MORENOCABRAL R, 1976, SURGERY, V80, P735; Nicolaides AN, 2006, INT ANGIOL, V25, P101; Oger E, 2002, THROMB HAEMOSTASIS, V88, P592; Piovella F, 2005, J THROMB HAEMOST, V3, P2664, DOI 10.1111/j.1538-7836.2005.01621.x; Sachdeva A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001484.pub2; Samama MM, 1999, NEW ENGL J MED, V341, P793, DOI 10.1056/NEJM199909093411103; SANDLER DA, 1989, J ROY SOC MED, V82, P203, DOI 10.1177/014107688908200407; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; STEIN PD, 1995, CHEST, V108, P978, DOI 10.1378/chest.108.4.978; Vaitkus PT, 2005, THROMB HAEMOSTASIS, V93, P76, DOI 10.1160/TH04-05-0323	36	114	119	0	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2011	365	26					2463	2472		10.1056/NEJMoa1111288	http://dx.doi.org/10.1056/NEJMoa1111288			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	868SD	22204723				2022-12-28	WOS:000298544600007
J	Welch, HG				Welch, H. Gilbert			Making the Call	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PROSTATE-CANCER; MORTALITY		Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH 03755 USA	Dartmouth College	Welch, HG (corresponding author), Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH 03755 USA.	h.gilbert.welch@dartmouth.edu						Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; [Anonymous], CANC STAT REV SEER 1; Kiellman A, 2009, J UROLOGY, V181, P1615, DOI 10.1016/j.juro.2008.11.115; Loeb S, 2011, J UROLOGY, V186, P1830, DOI 10.1016/j.juro.2011.06.057; Merrill RM, 1997, CANCER EPIDEM BIOMAR, V6, P763; Napoli M, 2003, PSA SCREENING TEST P; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; US Preventive Services Task Force, 2011, US PREV SERV TASK FO; Welch HG, 2002, J NATL CANCER I, V94, P1066; Welch HG, 2001, JAMA-J AM MED ASSOC, V285, P2776, DOI 10.1001/jama.285.21.2776; Welch HG, 2011, OVERDIAGNOSED MAKING	11	10	10	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 28	2011	306	24					2649	2650		10.1001/jama.2011.1898	http://dx.doi.org/10.1001/jama.2011.1898			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	867VX	22203530				2022-12-28	WOS:000298484000001
J	Scarf, D; Hayne, H; Colombo, M				Scarf, Damian; Hayne, Harlene; Colombo, Michael			Pigeons on Par with Primates in Numerical Competence	SCIENCE			English	Article									[Scarf, Damian; Hayne, Harlene; Colombo, Michael] Univ Otago, Dept Psychol, Dunedin 9054, New Zealand	University of Otago	Scarf, D (corresponding author), Univ Otago, Dept Psychol, Dunedin 9054, New Zealand.	damianscarf@gmail.com		Scarf, Damian/0000-0002-9486-8059; Colombo, Michael/0000-0002-2574-4888				BOYSEN ST, 1989, J COMP PSYCHOL, V103, P23, DOI 10.1037/0735-7036.103.1.23; Brannon EM, 1998, SCIENCE, V282, P746, DOI 10.1126/science.282.5389.746; Clayton N, 2005, CURR BIOL, V15, pR80, DOI 10.1016/j.cub.2005.01.020; Clayton NS, 1998, NATURE, V395, P272, DOI 10.1038/26216; Dacke M, 2008, ANIM COGN, V11, P683, DOI 10.1007/s10071-008-0159-y; Dehaene S., 2011, NUMBER SENSE MIND CR; Nieder A, 2005, NAT REV NEUROSCI, V6, P177, DOI 10.1038/nrn1626; Roberts WA, 2010, LEARN MOTIV, V41, P241, DOI 10.1016/j.lmot.2010.08.002; Rutz C, 2010, SCIENCE, V329, P1523, DOI 10.1126/science.1192053; Weber E. H, 1834, TACTU	10	101	103	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1664	1664		10.1126/science.1213357	http://dx.doi.org/10.1126/science.1213357			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22194568				2022-12-28	WOS:000298344000056
J	Reed, S				Reed, Steve			CHRISTMAS 2011: FOOD FOR THOUGHT Hand-out Britain	BRITISH MEDICAL JOURNAL			English	Editorial Material									Lambeth Council, London SW2 1RW, England		Reed, S (corresponding author), Lambeth Council, London SW2 1RW, England.	steve.reed100@btinternet.com						ActionAid, 2011, ADD TAX HAV; Equality and Human Rights Commission, 2011, CLOS HOM INQ OLD PEO; Left Foot Forward, 2011, WHY IS OSB REL ANT H; Low Pay Commission, 2011, NAT MIN WAG	4	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 21	2011	343								d7828	10.1136/bmj.d7828	http://dx.doi.org/10.1136/bmj.d7828			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	874TF	22189129				2022-12-28	WOS:000298980300003
J	Mani, N; Slevin, N; Hudson, A				Mani, Navin; Slevin, Nick; Hudson, Andrew			CHRISTMAS 2011: FOOD FOR THOUGHT What Three Wise Men have to say about diagnosis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ERROR		[Mani, Navin] Christie Hosp, Dept Head & Neck Surg Oncol, Manchester M20 4BX, Lancs, England; [Slevin, Nick; Hudson, Andrew] Christie Hosp, Dept Head & Neck Clin Oncol, Manchester M20 4BX, Lancs, England	Christie NHS Foundation Trust; Christie Hospital; Christie NHS Foundation Trust; Christie Hospital	Mani, N (corresponding author), Christie Hosp, Dept Head & Neck Surg Oncol, Manchester M20 4BX, Lancs, England.	navmani@hotmail.com	slevin, nicholas/O-5346-2015	slevin, nicholas/0000-0002-3367-7013				Bennett B, 1997, CRABTREE ORATIONS 19; Bennett B, 2004, CRABTREE ORATIONS 19; Berner ES, 2008, AM J MED, V121, P2, DOI 10.1016/j.amjmed.2008.01.001; CRICO/RMF, 2010, PROT PROV PROM SAF; Foot MRD, 1997, INDEPENDENT     1219; Graber ML, 2005, ARCH INTERN MED, V165, P1493, DOI 10.1001/archinte.165.13.1493; Hilliard AA, 2004, NEW ENGL J MED, V350, P599, DOI 10.1056/NEJMcps031794; JONES RV, 1989, REFLECTIONS INTELLIG; King P., 1999, CAMBRIDGE COMPANION, P227; Lindsay R, 1997, INDEPENDENT     1224; McGrayne S.B, 2011, THEORY WOULD NOT BAY; McIntosh H D, 1971, Trans Am Clin Climatol Assoc, V82, plx; Michelson J, 2004, J EVAL CLIN PRACT, V10, P157, DOI 10.1111/j.1365-2753.2003.00478.x; MONFORTE R, 1987, CHEST, V92, P1122, DOI 10.1378/chest.92.6.1122; MORITA M, 1994, INT J CANCER, V58, P207, DOI 10.1002/ijc.2910580211; Neale G, 2011, CLIN MED, V11, P317, DOI 10.7861/clinmedicine.11-4-317; Redelmeier DA, 1998, NEW ENGL J MED, V338, P1516, DOI 10.1056/NEJM199805213382106; Stachel J, 2005, NATURE, V433, P215, DOI 10.1038/433215a; Tsubochi H, 2005, GEN THORAC CARDIOVAS, V53, P455; WILLIAMS T, BIOGRAPHICAL DICT SC	20	25	24	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 20	2011	343								d7769	10.1136/bmj.d7769	http://dx.doi.org/10.1136/bmj.d7769			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	868QK	22187188				2022-12-28	WOS:000298538200008
J	Wichmann, D; Obbelode, F; Vogel, H; Hoepker, WW; Nierhaus, A; Braune, S; Sauter, G; Pueschel, K; Kluge, S				Wichmann, Dominic; Obbelode, Frieder; Vogel, Hermann; Hoepker, Wilhelm Wolfgang; Nierhaus, Axel; Braune, Stephan; Sauter, Guido; Pueschel, Klaus; Kluge, Stefan			Virtual Autopsy as an Alternative to Traditional Medical Autopsy in the Intensive Care Unit A Prospective Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							INVASIVE AUTOPSY; POSTMORTEM; VISUALIZATION; EMBOLISM; DECLINE; RATES; MRI	Background: Autopsy is an important educational and quality-control tool in the intensive care unit (ICU), but rates of traditional medical autopsies have declined worldwide. "Virtual" autopsy involving only advanced radiographic techniques might provide an alternative approach to postmortem examinations. Objective: To assess the value of postmortem multidetector computed tomography as an alternative to medical autopsy. Design: Prospective cohort study. (ClinicalTrials.gov registration number: NCT01040520) Setting: 9 ICUs in a single academic medical center. Consent for both medical and virtual autopsies was sought from the families of all consecutive patients who died in the ICU between 1 January and 30 June 2010. Clinical records were reviewed to determine whether unsuspected autopsy findings would have altered care if known (major diagnosis) or would not have altered care (minor diagnosis). Results: Of 285 patients, 47 underwent both virtual and medical autopsy. Of 196 clinical diagnoses made before death, 173 (88%) were identified by virtual autopsy and 183 (93%) by medical autopsy. Fourteen new major and 88 new minor diagnoses were detected by any autopsy method. The main diagnoses missed by virtual autopsy were cardiovascular events (9 of 72) and cancer (12 of 30). In contrast, medical autopsy missed 13 traumatic fractures and 2 pneumothoraces. Among 115 additional patients in whom only virtual autopsy was performed, 11 new major diagnoses were made. Limitation: Virtual autopsy was performed in only 57% of patients (n = 162); among this group, consent for traditional medical autopsy was obtained for only one third. Conclusion: Virtual autopsy may be useful for identifying diagnoses that traditionally have been identified by medical autopsy. This may also hold true, at least in part, for the educational aspect of medical autopsy (confirming antemortem clinical diagnoses). Further studies are required to confirm these preliminary results.	[Wichmann, Dominic] Univ Med Ctr Hamburg Eppendorf, Dept Intens Care Med, D-20246 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Wichmann, D (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Intens Care Med, Martinistr 52, D-20246 Hamburg, Germany.	d.wichmann@uke.de; s.kluge@uke.de	Braune, Stephan/AAC-4714-2021		University Medical Center Hamburg-Eppendorf; University Medical Center Hamburg-Eppendorf, Germany	University Medical Center Hamburg-Eppendorf; University Medical Center Hamburg-Eppendorf, Germany	By University Medical Center Hamburg-Eppendorf.; University Medical Center Hamburg-Eppendorf, Germany.	Aghayev E, 2006, AM J ROENTGENOL, V187, P209, DOI 10.2214/AJR.05.0222; Aghayev Emin, 2008, J Forensic Leg Med, V15, P382, DOI 10.1016/j.jflm.2008.02.007; Bisset RAL, 2002, BRIT MED J, V324, P1423, DOI 10.1136/bmj.324.7351.1423; Bolliger SA, 2008, EUR RADIOL, V18, P273, DOI 10.1007/s00330-007-0737-4; Bombi JA, 2003, PATHOL RES PRACT, V199, P9, DOI 10.1078/0344-0338-00346; Carbot R, 1912, JAMA-J AM MED ASSOC, V59, P2295; CHAMP C, 1992, J PATHOL, V166, P405, DOI 10.1002/path.1711660413; Chariot P, 2000, ARCH PATHOL LAB MED, V124, P739; Christe A, 2009, J TRAUMA, V66, P1302, DOI 10.1097/TA.0b013e31818c1441; Cohen MC, 2008, PEDIATR DEVEL PATHOL, V11, P1, DOI 10.2350/07-01-0213.1; Combes A, 2004, ARCH INTERN MED, V164, P389, DOI 10.1001/archinte.164.4.389; De Vlieger GYA, 2010, CRIT CARE, V14, DOI 10.1186/cc8925; Dimopoulos G, 2004, INTENS CARE MED, V30, P2080, DOI 10.1007/s00134-004-2448-5; Esteban A, 1999, INTENS CARE MED, V25, P343, DOI 10.1007/s001340050853; GOLDMAN L, 1983, NEW ENGL J MED, V308, P1000, DOI 10.1056/NEJM198304283081704; Harrington DE, 2010, SOC SCI MED, V70, P191, DOI 10.1016/j.socscimed.2009.09.018; Jackowski C, 2004, J FORENSIC SCI, V49, P1339; Jackowski C, 2008, J FORENSIC SCI, V53, P465, DOI 10.1111/j.1556-4029.2008.00673.x; LANDEFELD CS, 1988, NEW ENGL J MED, V318, P1249, DOI 10.1056/NEJM198805123181906; Levy AD, 2006, RADIOLOGY, V240, P522, DOI 10.1148/radiol.2402050972; O'Grady G, 2003, BRIT MED J, V327, P802, DOI 10.1136/bmj.327.7418.802; Persson A, 2011, ACTA RADIOL, V52, P522, DOI 10.1258/ar.2011.100460; ROBERTS WC, 1978, NEW ENGL J MED, V299, P332, DOI 10.1056/NEJM197808172990704; Ryu JH, 1998, MAYO CLIN PROC, V73, P873, DOI 10.4065/73.9.873; Saunders SL, 2011, FORENSIC SCI MED PAT, V7, P271, DOI 10.1007/s12024-010-9208-3; Shojania KG, 2003, JAMA-J AM MED ASSOC, V289, P2849, DOI 10.1001/jama.289.21.2849; START RD, 1993, J PATHOL, V171, P63, DOI 10.1002/path.1711710113; Veress B, 1993, Qual Assur Health Care, V5, P281; Weustink AC, 2009, RADIOLOGY, V250, P897, DOI 10.1148/radiol.2503080421; Wichmann Dominic, 2008, Neurosurgery, V63, pE820, DOI 10.1227/01.NEU.0000325691.37721.73; World Health Organization, 2010, INT CLASS DIS ICD	31	88	92	1	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 17	2012	156	2					123	W24		10.7326/0003-4819-156-2-201201170-00008	http://dx.doi.org/10.7326/0003-4819-156-2-201201170-00008			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	894IW	22250143				2022-12-28	WOS:000300421400003
J	Farrell, A; Thirugnanam, S; Lorestani, A; Dvorin, JD; Eidell, KP; Ferguson, DJP; Anderson-White, BR; Duraisingh, MT; Marth, GT; Gubbels, MJ				Farrell, Andrew; Thirugnanam, Sivasakthivel; Lorestani, Alexander; Dvorin, Jeffrey D.; Eidell, Keith P.; Ferguson, David J. P.; Anderson-White, Brooke R.; Duraisingh, Manoj T.; Marth, Gabor T.; Gubbels, Marc-Jan			A DOC2 Protein Identified by Mutational Profiling Is Essential for Apicomplexan Parasite Exocytosis	SCIENCE			English	Article							TOXOPLASMA-GONDII; INTRACELLULAR CA2+; CELL INVASION; C2 DOMAINS; PLASMODIUM; CALCIUM; MOTILITY; RELEASE; MECHANISMS; SECRETION	Exocytosis is essential to the lytic cycle of apicomplexan parasites and required for the pathogenesis of toxoplasmosis and malaria. DOC2 proteins recruit the membrane fusion machinery required for exocytosis in a Ca(2+)-dependent fashion. Here, the phenotype of a Toxoplasma gondii conditional mutant impaired in host cell invasion and egress was pinpointed to a defect in secretion of the micronemes, an apicomplexan-specific organelle that contains adhesion proteins. Whole-genome sequencing identified the etiological point mutation in TgDOC2.1. A conditional allele of the orthologous gene engineered into Plasmodium falciparum was also defective in microneme secretion. However, the major effect was on invasion, suggesting that microneme secretion is dispensable for Plasmodium egress.	[Dvorin, Jeffrey D.; Duraisingh, Manoj T.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Farrell, Andrew; Thirugnanam, Sivasakthivel; Lorestani, Alexander; Eidell, Keith P.; Anderson-White, Brooke R.; Marth, Gabor T.; Gubbels, Marc-Jan] Boston Coll, Dept Biol, Chestnut Hill, MA 02467 USA; [Dvorin, Jeffrey D.] Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Ferguson, David J. P.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England	Harvard University; Harvard T.H. Chan School of Public Health; Boston College; Harvard University; Boston Children's Hospital; University of Oxford	Duraisingh, MT (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	mduraisi@hsph.harvard.edu; marth@bc.edu; gubbelsj@bc.edu		Dvorin, Jeffrey/0000-0002-5883-7271; Ferguson, David/0000-0001-5045-819X; Eidell, Keith/0000-0002-5971-218X; Anderson-White, Brooke/0000-0001-8325-955X; Gubbels, Marc-Jan/0000-0002-2769-8600	National Institutes of Health [AI081220, AI057919, AI088314, HG004719, AI087874]; Knights Templar Eye Foundation; Wellcome Trust; Burroughs Wellcome Fund New Investigator in the Pathogenesis of Infectious Disease Fellowship; American Heart Association [0635480N]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081220, R21AI088314, R01AI057919, K08AI087874] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Knights Templar Eye Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); Burroughs Wellcome Fund New Investigator in the Pathogenesis of Infectious Disease Fellowship; American Heart Association(American Heart Association); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. Nussbaum and C. Russ of the "Broad Sequencing Platform" and D. Sibley, J.-F. Dubremetz, M.-F. Cesbron-Delauw, J.-C. Doury, and M. Makler (Flow Inc.) for kindly sharing reagents. F-P2 was originally generated in the laboratory of B. Striepen. This work was supported by National Institutes of Health grants AI081220 to M.-J.G. and G. T. M., AI057919 and AI088314 to M. T. D., HG004719 to G. T. M., and AI087874 to J.D.D.; a Knights Templar Eye Foundation grant to S. T., a Wellcome Trust equipment grant to D.J.P.F., a Burroughs Wellcome Fund New Investigator in the Pathogenesis of Infectious Disease Fellowship to M. T. D., and an American Heart Association Scientist Development Grant (0635480N) to M.-J.G. Toxoplasma gondii GT1 sequence and annotation are from L. Caler at the J. Craig Venter Institute. Sequence reads have been deposited at the National Center for Biotechnology Information sequence read archive under accession no. SRA046023.	Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Baum J, 2008, TRENDS PARASITOL, V24, P557, DOI 10.1016/j.pt.2008.08.006; Carey KL, 2004, P NATL ACAD SCI USA, V101, P7433, DOI 10.1073/pnas.0307769101; Carruthers VB, 1999, BIOCHEM J, V342, P379, DOI 10.1042/0264-6021:3420379; Cho W, 2006, BBA-MOL CELL BIOL L, V1761, P838, DOI 10.1016/j.bbalip.2006.06.014; Dvorin JD, 2010, SCIENCE, V328, P910, DOI 10.1126/science.1188191; Eidell KP, 2010, MOL BIOCHEM PARASIT, V171, P97, DOI 10.1016/j.molbiopara.2010.03.004; ERXLEBEN C, 1994, J CELL BIOL, V127, P935, DOI 10.1083/jcb.127.4.935; Friedrich R, 2010, MOL NEUROBIOL, V41, P42, DOI 10.1007/s12035-009-8094-8; Del Carmen MG, 2009, CELL MICROBIOL, V11, P967, DOI 10.1111/j.1462-5822.2009.01304.x; Groffen AJ, 2010, SCIENCE, V327, P1614, DOI 10.1126/science.1183765; Gubbels MJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040036; Hakansson S, 1999, MOL BIOL CELL, V10, P3539, DOI 10.1091/mbc.10.11.3539; Hegge S, 2010, FASEB J, V24, P2222, DOI 10.1096/fj.09-148700; Huynh MH, 2006, PLOS PATHOG, V2, P753, DOI 10.1371/journal.ppat.0020084; Kafsack BFC, 2009, SCIENCE, V323, P530, DOI 10.1126/science.1165740; Koussis K, 2009, EMBO J, V28, P725, DOI 10.1038/emboj.2009.22; Leander BS, 2003, TRENDS ECOL EVOL, V18, P395, DOI 10.1016/S0169-5347(03)00152-6; Lourido S, 2010, NATURE, V465, P359, DOI 10.1038/nature09022; Lovett JL, 2002, J BIOL CHEM, V277, P25870, DOI 10.1074/jbc.M202553200; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Martens S, 2010, BIOCHEM SOC T, V38, P213, DOI 10.1042/BST0380213; Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570; Munter S, 2009, CELL HOST MICROBE, V6, P551, DOI 10.1016/j.chom.2009.11.007; Nagamune Kisaburo, 2008, V47, P70; Smith DR, 2008, GENOME RES, V18, P1638, DOI 10.1101/gr.077776.108; Wetzel DM, 2004, J CELL SCI, V117, P5739, DOI 10.1242/jcs.01495	27	99	100	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 13	2012	335	6065					218	221		10.1126/science.1210829	http://dx.doi.org/10.1126/science.1210829			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875LZ	22246776	Green Accepted			2022-12-28	WOS:000299033100053
J	Seghers, AC; Breathnach, S				Seghers, A. C.; Breathnach, S.			PICTURE QUIZ A reticulated eruption on the lower abdomen in a 17 year old girl	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ERYTHEMA-AB-IGNE		[Seghers, A. C.; Breathnach, S.] Guys & St Thomas Fdn Trust, St Johns Inst Dermatol, London SE1 7EH, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Seghers, AC (corresponding author), Guys & St Thomas Fdn Trust, St Johns Inst Dermatol, London SE1 7EH, England.	aseghers@doctors.org.uk						Arnold AW, 2010, PEDIATRICS, V126, pE1227, DOI 10.1542/peds.2010-1390; Cho S, 2011, DERMATOL SURG, V37, P551, DOI 10.1111/j.1524-4725.2011.01923.x; Iacocca MV, 1998, J AM ACAD DERMATOL, V39, P882, DOI 10.1016/S0190-9622(98)70372-X; Molina Alexandra R, 2010, JRSM Short Rep, V1, P48, DOI 10.1258/shorts.2010.100034; Naldi L, 2011, INTERN EMERG MED, V6, P175, DOI 10.1007/s11739-010-0400-y; PETERKIN GAG, 1955, BMJ-BRIT MED J, V2, P1599, DOI 10.1136/bmj.2.4956.1599; Riahi RR, 2010, INT J DERMATOL, V49, P1314, DOI 10.1111/j.1365-4632.2009.04433.x; SAHL WJ, 1992, J AM ACAD DERMATOL, V27, P109, DOI 10.1016/S0190-9622(08)80818-3; Tan S, 2000, CAN MED ASSOC J, V162, P77; Wharton J, 2010, J AM ACAD DERMATOL, V62, P1080, DOI 10.1016/j.jaad.2009.08.005; Wilson NJE, 1999, CLIN EXP DERMATOL, V24, P337	11	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	2012	344								e359	10.1136/bmj.e359	http://dx.doi.org/10.1136/bmj.e359			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877SR	22246271				2022-12-28	WOS:000299203500003
J	Zhang, F; Vierock, J; Yizhar, O; Fenno, LE; Tsunoda, S; Kianianmomeni, A; Prigge, M; Berndt, A; Cushman, J; Polle, J; Magnuson, J; Hegemann, P; Deisseroth, K				Zhang, Feng; Vierock, Johannes; Yizhar, Ofer; Fenno, Lief E.; Tsunoda, Satoshi; Kianianmomeni, Arash; Prigge, Matthias; Berndt, Andre; Cushman, John; Polle, Juergen; Magnuson, Jon; Hegemann, Peter; Deisseroth, Karl			The Microbial Opsin Family of Optogenetic Tools	CELL			English	Article							CHLORIDE PUMP HALORHODOPSIN; RHODOPSIN-LIKE PROTEIN; NATRONOBACTERIUM-PHARAONIS; OPTICAL TECHNOLOGIES; SENSORY RHODOPSIN; GENOME SEQUENCE; PURPLE MEMBRANE; CELLULAR CAMP; LIGHT; CHANNELRHODOPSIN-2	The capture and utilization of light is an exquisitely evolved process. The single-component microbial opsins, although more limited than multicomponent cascades in processing, display unparalleled compactness and speed. Recent advances in understanding microbial opsins have been driven by molecular engineering for optogenetics and by comparative genomics. Here we provide a Primer on these light-activated ion channels and pumps, describe a group of opsins bridging prior categories, and explore the convergence of molecular engineering and genomic discovery for the utilization and understanding of these remarkable molecular machines.	[Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Zhang, Feng] MIT, McGovern Inst Brain Res, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Vierock, Johannes; Tsunoda, Satoshi; Kianianmomeni, Arash; Prigge, Matthias; Berndt, Andre; Hegemann, Peter] Univ Berlin, Inst Biol, D-10115 Berlin, Germany; [Yizhar, Ofer] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Fenno, Lief E.; Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, CNC Program, Dept Bioengn, Stanford, CA 94305 USA; [Fenno, Lief E.; Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, CNC Program, Dept Psychiat, Stanford, CA 94305 USA; [Cushman, John] Univ Nevada, Dept Biochem & Mol Biol, Reno, NV 89557 USA; [Polle, Juergen] CUNY, Dept Biol, Brooklyn Coll, Brooklyn, NY 11210 USA; [Magnuson, Jon] Pacific NW Natl Lab, Chem & Biol Proc Dev Grp, Richland, WA 99352 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Weizmann Institute of Science; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University; Nevada System of Higher Education (NSHE); University of Nevada Reno; City University of New York (CUNY) System; Brooklyn College (CUNY); United States Department of Energy (DOE); Pacific Northwest National Laboratory	Zhang, F (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	zhang_f@mit.edu; hegemape@rz.hu-berlin.de; deissero@stanford.edu	Fenno, Lief/AAK-2924-2020; Tsunoda, Satoshi/AAN-7023-2021; Macrae, Rhiannon/AAX-1536-2020; YIZHAR, OFER/AAV-8497-2021; Fenno, Lief/AAF-9638-2019	Berndt, Andre/0000-0003-4758-5598; Vierock, Johannes/0000-0001-7368-5539; Magnuson, Jon/0000-0001-7712-7024; Yizhar, Ofer/0000-0003-4228-1448; Tsunoda, Satoshi/0000-0003-3636-1521	NIH [TR01]; Robert Metcalfe; Michael Boylan; McKnight; Gates; Simons; Damon Runyon Foundation; DFG; DOE's Office of Science [DE-AC02-05CH11231]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Metcalfe; Michael Boylan; McKnight; Gates; Simons; Damon Runyon Foundation; DFG(German Research Foundation (DFG)); DOE's Office of Science(United States Department of Energy (DOE))	Full funding information for K.D. is listed at http:// www.optogenetics.org/ funding and includes the Gatsby Charitable Foundation and the Keck, Snyder, Woo, and Yu Foundations, as well as CIRM, NIMH, NINDS, NIDA, and the DARPA REPAIR program. F.Z. is supported by the NIH TR01, Robert Metcalfe, Michael Boylan, and the McKnight, Gates, Simons, and Damon Runyon Foundations. L. E. F. is supported by the NIH MSTP program. P. H. is supported by the DFG. We thank the entire Deisseroth laboratory for their support and Dr. Duc Tran for assistance. Genome and transcriptome sequencing and assembly were performed by the Department of Energy (DOE) Joint Genome Institute and supported by the DOE's Office of Science under Contract No. DE-AC02-05CH11231.	Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Baliga NS, 2004, GENOME RES, V14, P2221, DOI 10.1101/gr.2700304; Bamann C, 2008, J MOL BIOL, V375, P686, DOI 10.1016/j.jmb.2007.10.072; Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; Bamberg E, 1984, Prog Clin Biol Res, V164, P73; Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Berthold P, 2008, PLANT CELL, V20, P1665, DOI 10.1105/tpc.108.057919; Bieszke JA, 1999, P NATL ACAD SCI USA, V96, P8034, DOI 10.1073/pnas.96.14.8034; BOGOMOLNI RA, 1982, P NATL ACAD SCI-BIOL, V79, P6250, DOI 10.1073/pnas.79.20.6250; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Buldt G, 1998, J PROTEIN CHEM, V17, P536; Chen XP, 2002, BIOCHEMISTRY-US, V41, P3891, DOI 10.1021/bi015966h; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; DUNN R, 1981, P NATL ACAD SCI-BIOL, V78, P6744, DOI 10.1073/pnas.78.11.6744; Ehlenbeck S, 2002, BIOPHYS J, V82, P740, DOI 10.1016/S0006-3495(02)75436-2; Espagne E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r77; Essen LO, 2002, CURR OPIN STRUC BIOL, V12, P516, DOI 10.1016/S0959-440X(02)00356-1; Facciotti MT, 2001, BIOPHYS J, V81, P3442, DOI 10.1016/S0006-3495(01)75976-0; Feldbauer K, 2009, P NATL ACAD SCI USA, V106, P12317, DOI 10.1073/pnas.0905852106; Frassanito AM, 2010, CELL MOL LIFE SCI, V67, P965, DOI 10.1007/s00018-009-0225-x; Geibel S, 2001, BIOPHYS J, V81, P2059, DOI 10.1016/S0006-3495(01)75855-9; Govorunova EG, 2004, BIOPHYS J, V86, P2342, DOI 10.1016/S0006-3495(04)74291-5; Govorunova EG, 2011, MBIO, V2, DOI 10.1128/mBio.00115-11; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; HARZ H, 1992, PHILOS T R SOC B, V338, P39, DOI 10.1098/rstb.1992.0127; Haupts U, 1997, BIOCHEMISTRY-US, V36, P2, DOI 10.1021/bi962014g; Hegemann P, 2001, J PHYCOL, V37, P668, DOI 10.1046/j.1529-8817.2001.01095.x; HILDEBRAND E, 1975, NATURE, V257, P46, DOI 10.1038/257046a0; Idnurm A, 2001, GENOME, V44, P167, DOI 10.1139/gen-44-2-167; Ihara K, 1999, J MOL BIOL, V285, P163, DOI 10.1006/jmbi.1998.2286; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Kateriya S, 2004, NEWS PHYSIOL SCI, V19, P133, DOI 10.1152/nips.01517.2004; Kianianmomeni A, 2009, PLANT PHYSIOL, V151, P347, DOI 10.1104/pp.109.143297; KIM JM, 2002, BIOCHEMISTRY-US, V44, P2284; Kleinlogel S, 2011, NAT NEUROSCI, V14, P513, DOI 10.1038/nn.2776; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; Kralj JM, 2012, NAT METHODS, V9, P90, DOI [10.1038/NMETH.1782, 10.1038/nmeth.1782]; Lanyi JK, 2004, ANNU REV PHYSIOL, V66, P665, DOI 10.1146/annurev.physiol.66.032102.150049; LANYI JK, 1990, J BIOL CHEM, V265, P1253; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Lorinczi E, 2009, J MOL BIOL, V393, P320, DOI 10.1016/j.jmb.2009.07.055; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Man DL, 2003, EMBO J, V22, P1725, DOI 10.1093/emboj/cdg183; MARWAN W, 1987, J MOL BIOL, V195, P333, DOI 10.1016/0022-2836(87)90654-1; MATSUNOYAGI A, 1977, BIOCHEM BIOPH RES CO, V78, P237, DOI 10.1016/0006-291X(77)91245-1; MICHEL H, 1976, FEBS LETT, V65, P175, DOI 10.1016/0014-5793(76)80473-5; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; OESTERHELT D, 1985, EMBO J, V4, P2351, DOI 10.1002/j.1460-2075.1985.tb03938.x; Oh E, 2010, J BIOL CHEM, V285, P30825, DOI 10.1074/jbc.M110.147298; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Prochnik SE, 2010, SCIENCE, V329, P223, DOI 10.1126/science.1188800; RACKER E, 1974, J BIOL CHEM, V249, P662; Radu I, 2009, J AM CHEM SOC, V131, P7313, DOI 10.1021/ja8084274; Ritter E, 2008, J BIOL CHEM, V283, P35033, DOI 10.1074/jbc.M806353200; Sakmar TP, 2002, CURR OPIN CELL BIOL, V14, P189, DOI 10.1016/S0955-0674(02)00306-X; SCHARF B, 1994, BIOCHEMISTRY-US, V33, P6387, DOI 10.1021/bi00187a002; Scharf BE, 2010, CURR OPIN MICROBIOL, V13, P246, DOI 10.1016/j.mib.2010.01.006; SCHOBERT B, 1982, J BIOL CHEM, V257, P306; Schoenenberger P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008185; Schroder-Lang S, 2007, NAT METHODS, V4, P39, DOI 10.1038/NMETH975; Shichida Y, 2003, PHOTOCH PHOTOBIO SCI, V2, P1237, DOI 10.1039/b300434a; Sineshchekov OA, 1999, TRENDS PLANT SCI, V4, P58, DOI 10.1016/S1360-1385(98)01370-3; Sineshchekov OA, 2005, BIOPHYS J, V89, P4310, DOI 10.1529/biophysj.105.070920; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; SPUDICH JL, 1984, NATURE, V312, P509, DOI 10.1038/312509a0; Spudich JL, 1998, MOL MICROBIOL, V28, P1051, DOI 10.1046/j.1365-2958.1998.00859.x; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Spudich JL, 2006, TRENDS MICROBIOL, V14, P480, DOI 10.1016/j.tim.2006.09.005; Stehfest K, 2010, CHEMPHYSCHEM, V11, P1120, DOI 10.1002/cphc.200900980; Stierl M, 2011, J BIOL CHEM, V286, P1181, DOI 10.1074/jbc.M110.185496; Suzuki T, 2003, BIOCHEM BIOPH RES CO, V301, P711, DOI 10.1016/S0006-291X(02)03079-6; TAKAHASHI T, 1985, BIOCHEM BIOPH RES CO, V127, P99, DOI 10.1016/S0006-291X(85)80131-5; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TATENO M, 1994, ARCH BIOCHEM BIOPHYS, V315, P127, DOI 10.1006/abbi.1994.1480; TOMIOKA H, 1986, BIOCHEM BIOPH RES CO, V139, P389, DOI 10.1016/S0006-291X(86)80003-1; Tsunoda SP, 2006, BIOPHYS J, V91, P1471, DOI 10.1529/biophysj.106.086421; Tsunoda SP, 2009, PHOTOCHEM PHOTOBIOL, V85, P564, DOI 10.1111/j.1751-1097.2008.00519.x; Varo G, 2003, BIOPHYS J, V84, P1202, DOI 10.1016/S0006-3495(03)74934-0; Vogeley L, 2004, SCIENCE, V306, P1390, DOI 10.1126/science.1103943; Wang HX, 2009, J BIOL CHEM, V284, P5685, DOI 10.1074/jbc.M807632200; Wang WW, 2003, J BIOL CHEM, V278, P33985, DOI 10.1074/jbc.M305716200; Witten IB, 2010, SCIENCE, V330, P1677, DOI 10.1126/science.1193771; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Yoshitsugu M, 2009, BIOCHEMISTRY-US, V48, P4324, DOI 10.1021/bi900228a; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226	100	357	377	7	120	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2011	147	7					1446	1457		10.1016/j.cell.2011.12.004	http://dx.doi.org/10.1016/j.cell.2011.12.004			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	866SP	22196724	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000298403400011
J	Kostis, JB; Cabrera, J; Cheng, JQ; Cosgrove, NM; Deng, YZ; Pressel, SL; Davis, BR				Kostis, John B.; Cabrera, Javier; Cheng, Jerry Q.; Cosgrove, Nora M.; Deng, Yingzi; Pressel, Sara L.; Davis, Barry R.			Association Between Chlorthalidone Treatment of Systolic Hypertension and Long-term Survival	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANTIHYPERTENSIVE DRUG-TREATMENT; 10-YEAR FOLLOW-UP; CARDIOVASCULAR-DISEASE; LIFE EXPECTANCY; BLOOD-PRESSURE; HEART-FAILURE; METAANALYSIS; OUTCOMES	Context In the Systolic Hypertension in the Elderly Program (SHEP) trial, conducted between 1985 and 1990, antihypertensive therapy with chlorthalidone-based stepped-care therapy resulted in a lower rate of cardiovascular events than placebo but effects on mortality were not significant. Objective To study the gain in life expectancy of participants randomized to active therapy at the 22-year follow-up. Design, Setting, and Participants A National Death Index ascertainment of death in the long-term follow-up of a randomized, placebo-controlled, clinical trial (SHEP) of patients aged 60 years or older with isolated systolic hypertension. Recruitment was between March 1, 1985, and January 15, 1988. After the end of a 4.5-year randomized phase of the SHEP trial, all participants were advised to receive active therapy. The time interval between the beginning of recruitment and the ascertainment of death by National Death Index (December 31, 2006) was approximately 22 years (21 years 10 months). Main Outcome Measures Cardiovascular death and all-cause mortality. Results At the 22-year follow-up, life expectancy gain, expressed as the area between active (n=2365) and placebo (n=2371) survival curves, was 105 days (95% CI, -39 to 242; P=.07) for all-cause mortality and 158 days (95% CI, 36-287; P=.009) for cardiovascular death. Each month of active treatment was therefore associated with approximately 1 day extension in life expectancy. The active treatment group had higher survival free from cardiovascular death vs the placebo group (hazard ratio [HR], 0.89; 95% CI, 0.80-0.99; P=.03) but similar survival for all-cause mortality (HR, 0.97; 95% CI, 0.90-1.04; P=.42). There were 1416 deaths (59.9%) in the active treatment group and 1435 deaths (60.5%) in the placebo group (log-rank P=.38, Wilcoxon P=.24). Cardiovascular death was lower in the active treatment group(669 deaths[28.3%]) vs the placebo group(735 deaths[31.0%]; log-rank P=.03, Wilcoxon P=.02). Time to 70th percentile survival was 0.56 years (95% CI, -0.14 to 1.23) longer in the active treatment group vs the placebo group (11.53 vs 10.98 years; P=.03) for all-cause mortality and 1.41 years (95% CI, 0.34-2.61; 17.81 vs 16.39 years; P=.01) for survival free from cardiovascular death. Conclusion In the SHEP trial, treatment of isolated systolic hypertension with chlorthalidone stepped-care therapy for 4.5 years was associated with longer life expectancy at 22 years of follow-up. JAMA. 2011;306(23):2588-2593	[Kostis, John B.; Cheng, Jerry Q.; Cosgrove, Nora M.; Deng, Yingzi] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Cardiovasc Inst, New Brunswick, NJ 08903 USA; [Cabrera, Javier] Rutgers State Univ, Dept Stat, Piscataway, NJ USA; [Pressel, Sara L.; Davis, Barry R.] Univ Texas Hlth Sci Ctr, Houston, TX USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; University of Texas System; University of Texas Health Science Center Houston	Kostis, JB (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Cardiovasc Inst, 1 Robert Wood Johnson Pl, New Brunswick, NJ 08903 USA.	kostis@umdnj.edu	Hug, Balthasar L./G-1568-2010		National Heart, Lung, and Blood Institute (NHLBI); National Institute on Aging (NIA); UMDNJ; Robert Wood Johnson Foundation	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); UMDNJ; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Kostis reported receiving grant support and travel to meetings from the National Heart, Lung, and Blood Institute (NHLBI) and the National Institute on Aging (NIA). Dr Cabrera reported receiving consulting fees or honorarium from UMDNJ. Ms Cosgrove reported receiving support for travel to meetings from the NHLBI and the NIA. Ms Pressel reported receiving grant support and travel to meetings from the NHLBI and the NIA. Dr Davis reported receiving grant support and travel to meetings from the NHLBI and the NIA, and being a board member of data monitoring committees of Amgen and Merck. Drs Cheng and Deng reported no disclosures.; This work was supported in part by a grant from the National Heart, Lung, and Blood Institute, the National Institute on Aging, and the Robert Wood Johnson Foundation (Drs Kostis and Davis and Ms Pressel).	[Anonymous], 1990, Circulation, V82, P1616; BLACK HR, 1991, HYPERTENSION, V17, P77; Chalmers J, 2008, NEW ENGL J MED, V359, P1618, DOI 10.1056/NEJMe0807625; EFRON B, 1981, J AM STAT ASSOC, V76, P312, DOI 10.2307/2287832; Gueyffier F, 1997, ANN INTERN MED, V126, P761, DOI 10.7326/0003-4819-126-10-199705150-00002; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Hyman DJ, 2001, NEW ENGL J MED, V345, P479, DOI 10.1056/NEJMoa010273; Hypertension Detection Follow-up Program Cooperative Group, 1979, JAMA-J AM MED ASSOC, V242, P2562, DOI DOI 10.1001/JAMA.1979.03300230018021; Kassai B, 2005, VASC HEALTH RISK MAN, V1, P163, DOI 10.2147/vhrm.1.2.163.64086; Kostis JB, 1997, JAMA-J AM MED ASSOC, V278, P212; Kostis JB, 1995, AM J HYPERTENS, V8, P1147, DOI 10.1016/0895-7061(95)00363-0; Kostis WJ, 2011, J CLIN LIPIDOL, V5, P97, DOI 10.1016/j.jacl.2011.01.006; Kostis WJ, 2010, HYPERTENSION, V56, P1060, DOI 10.1161/HYPERTENSIONAHA.110.160291; LAMBERSHEERSPIN.HJ, 2009, LANCET, V373, P1009, DOI DOI 10.1016/S0140-6736(09)60212-9; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; NAIMARK D, 1994, J GEN INTERN MED, V9, P702, DOI 10.1007/BF02599016; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Neal B, 2000, LANCET, V356, P1955; PETROVITCH H, 1991, HYPERTENSION, V17, P16; PROBSTFIELD JL, 1991, JAMA-J AM MED ASSOC, V265, P3255; Redon J, 2010, J HYPERTENS, V28, P1770, DOI 10.1097/HJH.0b013e32833b4953; Staessen JA, 2000, LANCET, V355, P865, DOI 10.1016/S0140-6736(99)07330-4; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; Swedberg K, 1999, EUR HEART J, V20, P136, DOI 10.1053/euhj.1998.1098; Wing LMH, 2003, NEW ENGL J MED, V348, P583, DOI 10.1056/NEJMoa021716; Wong ND, 2007, ARCH INTERN MED, V167, P2431, DOI 10.1001/archinte.167.22.2431; Wright JC, 1998, NEW ENGL J MED, V339, P380, DOI 10.1056/NEJM199808063390606	27	58	61	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 21	2011	306	23					2588	2593		10.1001/jama.2011.1821	http://dx.doi.org/10.1001/jama.2011.1821			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	864YQ	22187278				2022-12-28	WOS:000298276800020
J	Fressin, F; Torres, G; Rowe, JF; Charbonneau, D; Rogers, LA; Ballard, S; Batalha, NM; Borucki, WJ; Bryson, ST; Buchhave, LA; Ciardi, DR; Desert, JM; Dressing, CD; Fabrycky, DC; Ford, EB; Gautier, TN; Henze, CE; Holman, MJ; Howard, A; Howell, SB; Jenkins, JM; Koch, DG; Latham, DW; Lissauer, JJ; Marcy, GW; Quinn, SN; Ragozzine, D; Sasselov, DD; Seager, S; Barclay, T; Mullally, F; Seader, SE; Still, M; Twicken, JD; Thompson, SE; Uddin, K				Fressin, Francois; Torres, Guillermo; Rowe, Jason F.; Charbonneau, David; Rogers, Leslie A.; Ballard, Sarah; Batalha, Natalie M.; Borucki, William J.; Bryson, Stephen T.; Buchhave, Lars A.; Ciardi, David R.; Desert, Jean-Michel; Dressing, Courtney D.; Fabrycky, Daniel C.; Ford, Eric B.; Gautier, Thomas N., III; Henze, Christopher E.; Holman, Matthew J.; Howard, Andrew; Howell, Steve B.; Jenkins, Jon M.; Koch, David G.; Latham, David W.; Lissauer, Jack J.; Marcy, Geoffrey W.; Quinn, Samuel N.; Ragozzine, Darin; Sasselov, Dimitar D.; Seager, Sara; Barclay, Thomas; Mullally, Fergal; Seader, Shawn E.; Still, Martin; Twicken, Joseph D.; Thompson, Susan E.; Uddin, Kamal			Two Earth-sized planets orbiting Kepler-20	NATURE			English	Article							TRANSITING PLANET; BLEND SCENARIOS; MULTIPLE SYSTEM; GIANT IMPACTS; CANDIDATES; VALIDATION; EXOPLANETS; COMPANION	Since the discovery of the first extrasolar giant planets around Sun-like stars(1,2), evolving observational capabilities have brought us closer to the detection of true Earth analogues. The size of an exoplanet can be determined when it periodically passes in front of (transits) its parent star, causing a decrease in starlight proportional to its radius. The smallest exoplanet hitherto discovered(3) has a radius 1.42 times that of the Earth's radius (R-circle plus), and hence has 2.9 times its volume. Here we report the discovery of two planets, one Earth-sized (1.03 R-circle plus) and the other smaller than the Earth (0.87 R-circle plus), orbiting the star Kepler-20, which is already known to host three other, larger, transiting planets(4). The gravitational pull of the new planets on the parent star is too small to measure with current instrumentation. We apply a statistical method to show that the likelihood of the planetary interpretation of the transit signals is more than three orders of magnitude larger than that of the alternative hypothesis that the signals result from an eclipsing binary star. Theoretical considerations imply that these planets are rocky, with a composition of iron and silicate. The outer planet could have developed a thick water vapour atmosphere.	[Fressin, Francois; Torres, Guillermo; Charbonneau, David; Ballard, Sarah; Desert, Jean-Michel; Dressing, Courtney D.; Holman, Matthew J.; Latham, David W.; Quinn, Samuel N.; Ragozzine, Darin; Sasselov, Dimitar D.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Rowe, Jason F.; Borucki, William J.; Bryson, Stephen T.; Henze, Christopher E.; Howell, Steve B.; Koch, David G.; Lissauer, Jack J.; Barclay, Thomas; Still, Martin] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Rogers, Leslie A.; Seager, Sara] MIT, Dept Phys, Cambridge, MA 02139 USA; [Batalha, Natalie M.] San Jose State Univ, Dept Phys & Astron, San Jose, CA 95192 USA; [Buchhave, Lars A.] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Buchhave, Lars A.] Univ Copenhagen, Ctr Star & Planet Format, DK-1350 Copenhagen, Denmark; [Ciardi, David R.] CALTECH, NASA Exoplanet Sci Inst, Pasadena, CA 91125 USA; [Fabrycky, Daniel C.] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Ford, Eric B.] Univ Florida, Dept Astron, Gainesville, FL 32111 USA; [Gautier, Thomas N., III] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Howard, Andrew; Marcy, Geoffrey W.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Jenkins, Jon M.; Mullally, Fergal; Seader, Shawn E.; Twicken, Joseph D.; Thompson, Susan E.] NASA, Ames Res Ctr, SETI Inst, Moffett Field, CA 94035 USA; [Uddin, Kamal] NASA, Ames Res Ctr, Orbital Sci Corp, Moffett Field, CA 94035 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Massachusetts Institute of Technology (MIT); California State University System; San Jose State University; University of Copenhagen; Niels Bohr Institute; University of Copenhagen; California Institute of Technology; National Aeronautics & Space Administration (NASA); University of California System; University of California Santa Cruz; State University System of Florida; University of Florida; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of California System; University of California Berkeley; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Fressin, F (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	ffressin@cfa.harvard.edu	Marcy, Geoff/AAC-6050-2019; Buchhave, Lars A./ABF-2000-2020; Ragozzine, Darin/C-4926-2013; Ford, Eric B./AAB-5479-2019	Buchhave, Lars A./0000-0003-1605-5666; Ford, Eric B./0000-0001-6545-639X; Charbonneau, David/0000-0002-9003-484X; Latham, David/0000-0001-9911-7388; Batalha, Natalie/0000-0002-7030-9519; Barclay, Thomas/0000-0001-7139-2724; Fabrycky, Daniel/0000-0003-3750-0183; Ballard, Sarah/0000-0002-3247-5081; Dressing, Courtney/0000-0001-8189-0233; Rowe, Jason/0000-0002-5904-1865; Rogers, Leslie/0000-0003-0638-3455; Ciardi, David/0000-0002-5741-3047	NASA's Science Mission Directorate	NASA's Science Mission Directorate	Kepler was competitively selected as the tenth Discovery mission. Funding for this mission is provided by NASA's Science Mission Directorate.	Batalha NM, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/27; Borucki WJ, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/1/19; Brown TM, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/4/112; Bryson ST, 2010, ASTROPHYS J LETT, V713, pL97, DOI 10.1088/2041-8205/713/2/L97; Cochran WD, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/1/7; Fressin F., 2011, ASTROPHYS J, V669, P1279; Fressin F, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/1/5; Gautier T. N., ASTROPHYS J UNPUB; Koch DG, 2010, ASTROPHYS J LETT, V713, pL79, DOI 10.1088/2041-8205/713/2/L79; LATHAM DW, 1989, NATURE, V339, P38, DOI 10.1038/339038a0; Lissauer JJ, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/1/8; Morton TD, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/2/170; Queloz D, 2009, ASTRON ASTROPHYS, V506, P303, DOI 10.1051/0004-6361/200913096; Raghavan D, 2010, ASTROPHYS J SUPPL S, V190, P1, DOI 10.1088/0067-0049/190/1/1; Robin AC, 2003, ASTRON ASTROPHYS, V409, P523, DOI 10.1051/0004-6361:20031117; Rogers LA, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/1/59; Schneider J, 2011, ASTRON ASTROPHYS, V532, DOI 10.1051/0004-6361/201116713; Seager S, 2007, ASTROPHYS J, V669, P1279, DOI 10.1086/521346; Selsis F, 2007, ICARUS, V191, P453, DOI 10.1016/j.icarus.2007.04.010; Slawson RW, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/5/160; Torres G, 2004, ASTROPHYS J, V614, P979, DOI 10.1086/423734; Torres G, 2011, ASTROPHYS J, V727, DOI 10.1088/0004-637X/727/1/24; Valenti JA, 1996, ASTRON ASTROPHYS SUP, V118, P595, DOI 10.1051/aas:1996222; Yi S, 2001, ASTROPHYS J SUPPL S, V136, P417, DOI 10.1086/321795	28	123	123	0	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 9	2012	482	7384					195	198		10.1038/nature10780	http://dx.doi.org/10.1038/nature10780			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888HI	22186831	Green Accepted, Green Submitted			2022-12-28	WOS:000299994100033
J	Brar, GA; Yassour, M; Friedman, N; Regev, A; Ingolia, NT; Weissman, JS				Brar, Gloria A.; Yassour, Moran; Friedman, Nir; Regev, Aviv; Ingolia, Nicholas T.; Weissman, Jonathan S.			High-Resolution View of the Yeast Meiotic Program Revealed by Ribosome Profiling	SCIENCE			English	Article							UNFOLDED PROTEIN-RESPONSE; SACCHAROMYCES-CEREVISIAE; TRANSLATION INITIATION; ENDOPLASMIC-RETICULUM; SYNAPTONEMAL COMPLEX; TRANSCRIPTION FACTOR; BUDDING YEAST; MEIOSIS; GAMETOGENESIS; CHROMOSOMES	Meiosis is a complex developmental process that generates haploid cells from diploid progenitors. We measured messenger RNA (mRNA) abundance and protein production through the yeast meiotic sporulation program and found strong, stage-specific expression for most genes, achieved through control of both mRNA levels and translational efficiency. Monitoring of protein production timing revealed uncharacterized recombination factors and extensive organellar remodeling. Meiotic translation is also shifted toward noncanonical sites, including short open reading frames (ORFs) on unannnotated transcripts and upstream regions of known transcripts (uORFs). Ribosome occupancy at near-cognate uORFs was associated with more efficient ORF translation; by contrast, some AUG uORFs, often exposed by regulated 5' leader extensions, acted competitively. This work reveals pervasive translational control in meiosis and helps to illuminate the molecular basis of the broad restructuring of meiotic cells.	[Brar, Gloria A.; Ingolia, Nicholas T.; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Brar, Gloria A.; Ingolia, Nicholas T.; Weissman, Jonathan S.] Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [Yassour, Moran; Regev, Aviv] Massachusetts Inst Technol & Harvard, Broad Inst, Cambridge, MA 02142 USA; [Yassour, Moran; Regev, Aviv] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; [Yassour, Moran; Friedman, Nir] Hebrew Univ Jerusalem, Sch Engn & Comp Sci, IL-91904 Jerusalem, Israel; [Friedman, Nir] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, IL-91904 Jerusalem, Israel	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Hebrew University of Jerusalem; Hebrew University of Jerusalem	Ingolia, NT (corresponding author), Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA.	ingolia@ciwemb.edu; weissman@cmp.ucsf.edu	Friedman, Nir/H-9692-2012; Yassour, Moran/ABE-7415-2020	Friedman, Nir/0000-0002-9678-3550; Yassour, Moran/0000-0002-7344-5188; Weissman, Jonathan/0000-0003-2445-670X	American Cancer Society [117945-PF-09-136-01-RMC]; Clore Fellowship; U.S.-Israel Binational Science Foundation; NIH [AG10770]; Ruth L. Kirschstein National Research Service Award [GM080853]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM080853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG010770] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Clore Fellowship; U.S.-Israel Binational Science Foundation(US-Israel Binational Science Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank E. Unal, A. Amon, and members of the Weissman laboratory for critical reading of this manuscript; C. Chu for sequencing assistance; J. Dunn for protocol development assistance; F. Van Werven for the MATa/a strain; and F. Klein for the the Zip1 antibody. G. A. B. is supported by American Cancer Society Postdoctoral Fellowship 117945-PF-09-136-01-RMC. M.Y. is supported by a Clore Fellowship. This work was supported by a grant from the U.S.-Israel Binational Science Foundation (N.F. and A. R.), an NIH P01 award (AG10770; N.T.I.), a Ruth L. Kirschstein National Research Service Award (GM080853; N.T.I.), and Howard Hughes Medical Institute funding (J. S. W. and A. R.). A patent on the ribosome profiling approach has been assigned to the University of California. Supporting files are in the SOM and at www.ncbi.nlm.nih.gov/geo/ with series accession no. GSE34082.	Badhai J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017672; BELL SP, 1993, SCIENCE, V262, P1844, DOI 10.1126/science.8266072; Benjamin KR, 2003, GENE DEV, V17, P1524, DOI 10.1101/gad.1101503; Carlile TM, 2008, CELL, V133, P280, DOI 10.1016/j.cell.2008.02.032; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Chu S, 1998, MOL CELL, V1, P685, DOI 10.1016/S1097-2765(00)80068-4; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; FRIESEN H, 1994, GENE DEV, V8, P2162, DOI 10.1101/gad.8.18.2162; Gelfand B, 2011, MOL CELL BIOL, V31, P1701, DOI 10.1128/MCB.01071-10; Gilbert WV, 2007, SCIENCE, V317, P1224, DOI 10.1126/science.1144467; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Hood HM, 2009, ANNU REV MICROBIOL, V63, P385, DOI 10.1146/annurev.micro.62.081307.162835; Imai K, 2005, J BIOL CHEM, V280, P8275, DOI 10.1074/jbc.M409428200; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jambhekar A, 2008, CURR BIOL, V18, P969, DOI 10.1016/j.cub.2008.05.047; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Keeney S, 2006, BIOCHEM SOC T, V34, P523, DOI 10.1042/BST0340523; Kolitz SE, 2009, RNA, V15, P138, DOI 10.1261/rna.1318509; Kondo T, 2010, SCIENCE, V329, P336, DOI 10.1126/science.1188158; Lardenois A, 2011, P NATL ACAD SCI USA, V108, P1058, DOI 10.1073/pnas.1016459108; Law GL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r111; Lynn A, 2007, CHROMOSOME RES, V15, P591, DOI 10.1007/s10577-007-1150-1; Marston AL, 2004, NAT REV MOL CELL BIO, V5, P983, DOI 10.1038/nrm1526; MITCHELL AP, 1994, MICROBIOL REV, V58, P56, DOI 10.1128/MMBR.58.1.56-70.1994; Mori K, 1996, GENES CELLS, V1, P803, DOI 10.1046/j.1365-2443.1996.d01-274.x; Neiman AM, 1998, J CELL BIOL, V140, P29, DOI 10.1083/jcb.140.1.29; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Page SL, 2004, ANNU REV CELL DEV BI, V20, P525, DOI 10.1146/annurev.cellbio.19.111301.155141; Piekarska I, 2010, EUR J CELL BIOL, V89, P780, DOI 10.1016/j.ejcb.2010.06.009; ROCKMILL B, 1988, P NATL ACAD SCI USA, V85, P6057, DOI 10.1073/pnas.85.16.6057; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; Tachikawa H, 2001, J CELL BIOL, V155, P797, DOI 10.1083/jcb.200107008; Wu HY, 2006, CURR BIOL, V16, P2473, DOI 10.1016/j.cub.2006.10.069; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Xu YY, 2010, J VIROL, V84, P5465, DOI 10.1128/JVI.02705-09; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	40	352	371	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 3	2012	335	6068					552	557		10.1126/science.1215110	http://dx.doi.org/10.1126/science.1215110			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885HI	22194413	Green Accepted, Green Submitted			2022-12-28	WOS:000299769200035
J	Nishida, T				Nishida, Toshirou			Adjuvant therapy for gastric cancer after D2 gastrectomy	LANCET			English	Editorial Material							CHEMOTHERAPY; SURGERY; S-1		[Nishida, Toshirou] Osaka Police Hosp, Dept Surg, Osaka 5430035, Japan; [Nishida, Toshirou] Osaka Univ, Grad Sch Med, Dept Surg, Osaka, Japan	Osaka Police Hospital; Osaka University	Nishida, T (corresponding author), Osaka Police Hosp, Dept Surg, Osaka 5430035, Japan.	toshin@mvb.biglobe.ne.jp						Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Paoletti X, 2010, JAMA-J AM MED ASSOC, V303, P1729, DOI 10.1001/jama.2010.534; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908	5	26	27	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 28	2012	379	9813					291	292		10.1016/S0140-6736(11)61928-4	http://dx.doi.org/10.1016/S0140-6736(11)61928-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	889BA	22226518				2022-12-28	WOS:000300047300011
J	Ding, L; Ley, TJ; Larson, DE; Miller, CA; Koboldt, DC; Welch, JS; Ritchey, JK; Young, MA; Lamprecht, T; McLellan, MD; McMichael, JF; Wallis, JW; Lu, C; Shen, D; Harris, CC; Dooling, DJ; Fulton, RS; Fulton, LL; Chen, K; Schmidt, H; Kalicki-Veizer, J; Magrini, VJ; Cook, L; McGrath, SD; Vickery, TL; Wendl, MC; Heath, S; Watson, MA; Link, DC; Tomasson, MH; Shannon, WD; Payton, JE; Kulkarni, S; Westervelt, P; Walter, MJ; Graubert, TA; Mardis, ER; Wilson, RK; DiPersio, JF				Ding, Li; Ley, Timothy J.; Larson, David E.; Miller, Christopher A.; Koboldt, Daniel C.; Welch, John S.; Ritchey, Julie K.; Young, Margaret A.; Lamprecht, Tamara; McLellan, Michael D.; McMichael, Joshua F.; Wallis, John W.; Lu, Charles; Shen, Dong; Harris, Christopher C.; Dooling, David J.; Fulton, Robert S.; Fulton, Lucinda L.; Chen, Ken; Schmidt, Heather; Kalicki-Veizer, Joelle; Magrini, Vincent J.; Cook, Lisa; McGrath, Sean D.; Vickery, Tammi L.; Wendl, Michael C.; Heath, Sharon; Watson, Mark A.; Link, Daniel C.; Tomasson, Michael H.; Shannon, William D.; Payton, Jacqueline E.; Kulkarni, Shashikant; Westervelt, Peter; Walter, Matthew J.; Graubert, Timothy A.; Mardis, Elaine R.; Wilson, Richard K.; DiPersio, John F.			Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing	NATURE			English	Article							ACUTE MYELOGENOUS LEUKEMIA; STEM-CELL TRANSPLANTATION; LYMPHOBLASTIC-LEUKEMIA; MISMATCHED HLA; MUTATIONS; METASTASIS; RESOLUTION; CANCER	Most patients with acute myeloid leukaemia (AML) die from progressive disease after relapse, which is associated with clonal evolution at the cytogenetic level(1,2). To determine the mutational spectrum associated with relapse, we sequenced the primary tumour and relapse genomes from eight AML patients, and validated hundreds of somatic mutations using deep sequencing; this allowed us to define clonality and clonal evolution patterns precisely at relapse. In addition to discovering novel, recurrently mutated genes (for example, WAC, SMC3, DIS3, DDX41 and DAXX) in AML, we also found two major clonal evolution patterns during AML relapse: (1) the founding clone in the primary tumour gained mutations and evolved into the relapse clone, or (2) a subclone of the founding clone survived initial therapy, gained additional mutations and expanded at relapse. In all cases, chemotherapy failed to eradicate the founding clone. The comparison of relapse-specific versus primary tumour mutations in all eight cases revealed an increase in transversions, probably due to DNA damage caused by cytotoxic chemotherapy. These data demonstrate that AML relapse is associated with the addition of new mutations and clonal evolution, which is shaped, in part, by the chemotherapy that the patients receive to establish and maintain remissions.	[Ding, Li; Ley, Timothy J.; Larson, David E.; Miller, Christopher A.; Koboldt, Daniel C.; McLellan, Michael D.; McMichael, Joshua F.; Wallis, John W.; Lu, Charles; Shen, Dong; Harris, Christopher C.; Dooling, David J.; Fulton, Robert S.; Fulton, Lucinda L.; Chen, Ken; Schmidt, Heather; Kalicki-Veizer, Joelle; Magrini, Vincent J.; Cook, Lisa; McGrath, Sean D.; Vickery, Tammi L.; Wendl, Michael C.; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Genome Inst, St Louis, MO 63108 USA; [Ding, Li; Wallis, John W.; Dooling, David J.; Fulton, Robert S.; Fulton, Lucinda L.; Chen, Ken; Magrini, Vincent J.; Wendl, Michael C.; Kulkarni, Shashikant; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [Ley, Timothy J.; Welch, John S.; Ritchey, Julie K.; Young, Margaret A.; Lamprecht, Tamara; Heath, Sharon; Link, Daniel C.; Tomasson, Michael H.; Westervelt, Peter; Walter, Matthew J.; Graubert, Timothy A.; DiPersio, John F.] Washington Univ, Dept Internal Med, Div Oncol, St Louis, MO 63110 USA; [Ley, Timothy J.; Link, Daniel C.; Tomasson, Michael H.; Kulkarni, Shashikant; Westervelt, Peter; Walter, Matthew J.; Graubert, Timothy A.; Mardis, Elaine R.; Wilson, Richard K.; DiPersio, John F.] Washington Univ, Siteman Canc Ctr, St Louis, MO 63110 USA; [Watson, Mark A.; Payton, Jacqueline E.; Kulkarni, Shashikant] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Shannon, William D.] Washington Univ, Div Biostat, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Ley, TJ (corresponding author), Washington Univ, Genome Inst, St Louis, MO 63108 USA.	timley@wustl.edu	Miller, Christopher A./A-1060-2009; Mardis, Elaine/W-2202-2019; Magrini, Vincent/AAT-5830-2020; McGrath, Sean David/AAT-3540-2020; Wendl, Michael C/A-2741-2008; Wilson, Richard K./AAF-4139-2019; Walter, Matthew J/S-7758-2018; Chen, Ken/AAU-1432-2021	Miller, Christopher A./0000-0003-4266-6700; Magrini, Vincent/0000-0002-2019-4872; McGrath, Sean David/0000-0001-9064-8449; Wilson, Richard K./0000-0002-1992-1358; Chen, Ken/0000-0003-4013-5279; Graubert, Timothy/0000-0002-7710-1171; Larson, David/0000-0001-7934-5906; Tomasson, Michael/0000-0003-4518-7123; MCLELLAN, MICHAEL/0000-0002-2703-8784; Westover, Tamara/0000-0002-1000-6698	Washington University Cancer Genome Initiative; National Human Genome Research Institute (NHGRI) [U54 HG003079]; National Cancer Institute [PO1 CA101937]; Barnes-Jewish Hospital Foundation [00335-0505-02]; NATIONAL CANCER INSTITUTE [P01CA101937] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079] Funding Source: NIH RePORTER	Washington University Cancer Genome Initiative; National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Barnes-Jewish Hospital Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the Analysis Pipeline group for developing the automated sequence analysis pipelines; the LIMS group for developing tools and software to manage samples and sequencing; the Systems group for providing the IT infrastructure and HPC solutions required for sequencing and analysis; and R. T. Demeter for experimental support. We also thank The Cancer Genome Atlas for allowing us to use unpublished data for this study, and the Washington University Cancer Genome Initiative for their support. This work was funded by grants to R. K. W. and the National Human Genome Research Institute (NHGRI U54 HG003079), and grants to T.J.L. from the National Cancer Institute (PO1 CA101937) and the Barnes-Jewish Hospital Foundation (00335-0505-02).	Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; GAO JZ, 1991, P NATL ACAD SCI USA, V88, P4882, DOI 10.1073/pnas.88.11.4882; GARSON OM, 1989, CANCER GENET CYTOGEN, V40, P187, DOI 10.1016/0165-4608(89)90024-1; KingUnderwood L, 1996, BLOOD, V87, P2171, DOI 10.1182/blood.V87.6.2171.bloodjournal8762171; Kirito K, 2007, HAEMATOLOGICA, V93, P155, DOI 10.3324/haematol.12050; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Larson D. E., BIOINFORMAT IN PRESS; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Nakao M, 1996, LEUKEMIA, V10, P1911; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; TESTA JR, 1979, CANCER RES, V39, P3619; Vago L, 2009, NEW ENGL J MED, V361, P478, DOI 10.1056/NEJMoa0811036; van Doorn-Khosrovani SBV, 2005, ONCOGENE, V24, P4129, DOI 10.1038/sj.onc.1208588; Van Vlierberghe P, 2011, LEUKEMIA, V25, P130, DOI 10.1038/leu.2010.247; Villalobos IB, 2010, BLOOD, V115, P3158, DOI 10.1182/blood-2009-11-254284; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	28	1464	1548	6	189	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 26	2012	481	7382					506	510		10.1038/nature10738	http://dx.doi.org/10.1038/nature10738			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881GY	22237025	Green Accepted, hybrid			2022-12-28	WOS:000299471800040
J	Zhang, JH; Benavente, CA; McEvoy, J; Flores-Otero, J; Ding, L; Chen, X; Ulyanov, A; Wu, G; Wilson, M; Wang, JM; Brennan, R; Rusch, M; Manning, AL; Ma, J; Easton, J; Shurtleff, S; Mullighan, C; Pounds, S; Mukatira, S; Gupta, P; Neale, G; Zhao, D; Lu, C; Fulton, RS; Fulton, LL; Hong, X; Dooling, DJ; Ochoa, K; Naeve, C; Dyson, NJ; Mardis, ER; Bahrami, A; Ellison, D; Wilson, RK; Downing, JR; Dyer, MA				Zhang, Jinghui; Benavente, Claudia A.; McEvoy, Justina; Flores-Otero, Jacqueline; Ding, Li; Chen, Xiang; Ulyanov, Anatoly; Wu, Gang; Wilson, Matthew; Wang, Jianmin; Brennan, Rachel; Rusch, Michael; Manning, Amity L.; Ma, Jing; Easton, John; Shurtleff, Sheila; Mullighan, Charles; Pounds, Stanley; Mukatira, Suraj; Gupta, Pankaj; Neale, Geoff; Zhao, David; Lu, Charles; Fulton, Robert S.; Fulton, Lucinda L.; Hong, Xin; Dooling, David J.; Ochoa, Kerri; Naeve, Clayton; Dyson, Nicholas J.; Mardis, Elaine R.; Bahrami, Armita; Ellison, David; Wilson, Richard K.; Downing, James R.; Dyer, Michael A.			A novel retinoblastoma therapy from genomic and epigenetic analyses	NATURE			English	Article							TYROSINE KINASE; SYK INHIBITOR; CANCER; ANEUPLOIDY; GROWTH; CELLS; TUMOR; MCL-1; GENE	Retinoblastoma is an aggressive childhood cancer of the developing retina that is initiated by the biallelic loss of RB1. Tumours progress very quickly following RB1 inactivation but the underlying mechanism is not known. Here we show that the retinoblastoma genome is stable, but that multiple cancer pathways can be epigenetically deregulated. To identify the mutations that cooperate with RB1 loss, we performed whole-genome sequencing of retinoblastomas. The overall mutational rate was very low; RB1 was the only known cancer gene mutated. We then evaluated the role of RB1 in genome stability and considered non-genetic mechanisms of cancer pathway deregulation. For example, the proto-oncogene SYK is upregulated in retinoblastoma and is required for tumour cell survival. Targeting SYK with a small-molecule inhibitor induced retinoblastoma tumour cell death in vitro and in vivo. Thus, retinoblastomas may develop quickly as a result of the epigenetic deregulation of key cancer pathways as a direct or indirect result of RB1 loss.	[Benavente, Claudia A.; McEvoy, Justina; Flores-Otero, Jacqueline; Brennan, Rachel; Dyer, Michael A.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Zhang, Jinghui; Chen, Xiang; Ulyanov, Anatoly; Wu, Gang; Rusch, Michael; Easton, John] St Jude Childrens Res Hosp, Dept Computat Biol & Bioinformat, Memphis, TN 38105 USA; [Ding, Li; Lu, Charles; Fulton, Robert S.; Fulton, Lucinda L.; Hong, Xin; Dooling, David J.; Ochoa, Kerri; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Sch Med St Louis, Genome Inst, St Louis, MO 63108 USA; [Ding, Li; Fulton, Robert S.; Fulton, Lucinda L.; Hong, Xin; Dooling, David J.; Ochoa, Kerri; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Sch Med St Louis, Dept Genet, St Louis, MO 63108 USA; [Wilson, Matthew; Dyer, Michael A.] Univ Tennessee, Hlth Sci Ctr, Dept Ophthalmol, Memphis, TN 38163 USA; [Wilson, Matthew] St Jude Childrens Res Hosp, Dept Surg, Memphis, TN 38105 USA; [Wang, Jianmin; Mukatira, Suraj; Gupta, Pankaj; Neale, Geoff] St Jude Childrens Res Hosp, Hartwell Ctr Biotechnol & Bioinformat, Memphis, TN 38105 USA; [Manning, Amity L.; Dyson, Nicholas J.] Massachusetts Gen Hosp, Charlestown, MA 02129 USA; [Ma, Jing; Shurtleff, Sheila; Mullighan, Charles; Bahrami, Armita; Ellison, David; Downing, James R.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Pounds, Stanley] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Zhao, David; Naeve, Clayton] St Jude Childrens Res Hosp, Dept Informat Sci, Memphis, TN 38105 USA; [Mardis, Elaine R.] Washington Univ, Sch Med St Louis, Siteman Canc Ctr, St Louis, MO 63108 USA; [Wilson, Richard K.] Washington Univ, Sch Med St Louis, Dept Med, St Louis, MO 63108 USA; [Dyer, Michael A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; Saint Louis University; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Harvard University; Massachusetts General Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Saint Louis University; Siteman Cancer Center; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); Howard Hughes Medical Institute	Dyer, MA (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	rwilson@wustl.edu; james.downing@stjude.org; michael.dyer@stjude.org	Rusch, Michael/AAG-1998-2019; Wilson, Richard K./AAF-4139-2019; Mardis, Elaine/W-2202-2019; Mullighan, Charles/H-3253-2011; Dyer, Michael/N-8134-2018; Wu, Gang/M-8012-2014; Manning, Amity/AAC-8205-2019; Pounds, Stanley B/N-2480-2018; Downing, James R./N-8102-2018; Zhang, Jing/GWZ-7332-2022; Bahrami, Armita/N-3262-2018; wang, jian/GVS-0711-2022; Chen, Xiang/N-2524-2018	Rusch, Michael/0000-0002-5363-1848; Wilson, Richard K./0000-0002-1992-1358; Mullighan, Charles/0000-0002-1871-1850; Wu, Gang/0000-0002-1678-5864; Manning, Amity/0000-0003-1332-9086; Pounds, Stanley B/0000-0002-9167-2114; Bahrami, Armita/0000-0002-8515-2649; Chen, Xiang/0000-0002-2499-8261; Benavente, Claudia/0000-0002-6875-3186; McEvoy, Justina/0000-0003-0382-1288; Easton, John/0000-0003-4503-6608	St Jude Children's Research Hospital - Washington University; St Jude Children's Research Hospital; NCI [CA21765]; NIH [EY014867, EY018599, GM81607, CA64402]; American Cancer Society; Research to Prevent Blindness Foundation; American Lebanese Syrian Associated Charities; MGH Cancer Center Saltonstall Foundation; AstraZeneca; NATIONAL CANCER INSTITUTE [R01CA155202, P30CA021765, R01CA064402] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018599, R01EY014867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081607] Funding Source: NIH RePORTER	St Jude Children's Research Hospital - Washington University; St Jude Children's Research Hospital; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); MGH Cancer Center Saltonstall Foundation; AstraZeneca(AstraZeneca); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The WGS was supported as part of the St Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project. We thank J. Lahti, J. Dalton and M. Valentine for help with FISH analysis, L. Holmfeldt, J. Zhang and M. Barbato for help with sample preparation, and V. Valentine for spectral karyotype analysis. We thank I. Qaddoumi, C. Rodriguez-Galindo and B. Haik for the support of the St Jude Children's Research Hospital retinoblastoma clinical research and W. Lei, D. McGoldrick, D. Alford, S. Espy, J. Obenauer and K. Johnson for assistance with data acquisition, handling and analysis. We thank A. McArthur and C. Guess for editing the manuscript, J. Temirov for help with sister chromatid analysis, J. Thurman for help with histology, F. Krafcik for help with cell culture, J. Wu and C. Billups for statistical analysis, J. Jeon for help with lentiviral preparations and C. Bradley for assistance with preclinical testing. This work was supported, in part, by Cancer Center Support (CA21765) from the NCI; grants to M. A. D. from the NIH (EY014867 and EY018599), the American Cancer Society and the Research to Prevent Blindness Foundation; and the American Lebanese Syrian Associated Charities. M. A. D. is a Howard Hughes Medical Institute Early Career Scientist. This work was also supported by an American Cancer Society Fellowship to A. L. M., the MGH Cancer Center Saltonstall Foundation Scholarship to N.J.D. and funding from AstraZeneca and NIH grants GM81607 and CA64402 to N.J.D.	Amato A, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-79; Baudot AD, 2009, ONCOGENE, V28, P3261, DOI 10.1038/onc.2009.179; Benetti R, 2008, NAT STRUCT MOL BIOL, V15, P998, DOI 10.1038/nsmb0908-998b; Bourgo RJ, 2009, MOL BIOL CELL, V20, P3192, DOI 10.1091/mbc.E08-12-1224; Brennan RC, 2011, CANCER RES, V71, P4205, DOI 10.1158/0008-5472.CAN-11-0058; Buchner M, 2010, BLOOD, V115, P4497, DOI 10.1182/blood-2009-07-233692; Chen LF, 2008, BLOOD, V111, P2230, DOI 10.1182/blood-2007-07-100115; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Corson TW, 2007, GENE CHROMOSOME CANC, V46, P617, DOI 10.1002/gcc.20457; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Feldman AL, 2008, LEUKEMIA, V22, P1139, DOI 10.1038/leu.2008.77; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gobessi S, 2009, LEUKEMIA, V23, P686, DOI 10.1038/leu.2008.346; Hahn CK, 2009, CANCER CELL, V16, P281, DOI 10.1016/j.ccr.2009.08.018; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; Iovino F, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-38; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Laird PW, 2005, HUM MOL GENET, V14, pR65, DOI 10.1093/hmg/ddi113; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Lu JR, 2007, P NATL ACAD SCI USA, V104, P9381, DOI 10.1073/pnas.0610279104; Manning AL, 2010, GENE DEV, V24, P1364, DOI 10.1101/gad.1917310; McEvoy J, 2011, CANCER CELL, V20, P260, DOI 10.1016/j.ccr.2011.07.005; SQUIRE J, 1985, HUM GENET, V70, P291, DOI 10.1007/BF00295364; Suljagic M, 2010, BLOOD, V116, P4894, DOI 10.1182/blood-2010-03-275180; Weinblatt ME, 2010, NEW ENGL J MED, V363, P1303, DOI 10.1056/NEJMoa1000500; Wen H, 2008, GENE DEV, V22, P601, DOI 10.1101/gad.1626308; Yan Y, 2000, EUR J CANCER, V36, P221, DOI 10.1016/S0959-8049(99)00277-4; Young RM, 2009, BLOOD, V113, P2508, DOI 10.1182/blood-2008-05-158618	32	342	358	0	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 19	2012	481	7381					329	334		10.1038/nature10733	http://dx.doi.org/10.1038/nature10733			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877VK	22237022	Green Accepted, Green Submitted, hybrid			2022-12-28	WOS:000299210600035
J	Zhang, JH; Ding, L; Holmfeldt, L; Wu, G; Heatley, SL; Payne-Turner, D; Easton, J; Chen, X; Wang, JM; Rusch, M; Lu, C; Chen, SC; Wei, L; Collins-Underwood, JR; Ma, J; Roberts, KG; Pounds, SB; Ulyanov, A; Becksfort, J; Gupta, P; Huether, R; Kriwacki, RW; Parker, M; McGoldrick, DJ; Zhao, D; Alford, D; Espy, S; Bobba, KC; Song, GC; Pei, DQ; Cheng, C; Roberts, S; Barbato, MI; Campana, D; Coustan-Smith, E; Shurtleff, SA; Raimondi, SC; Kleppe, M; Cools, J; Shimano, KA; Hermiston, ML; Doulatov, S; Eppert, K; Laurenti, E; Notta, F; Dick, JE; Basso, G; Hunger, SP; Loh, ML; Devidas, M; Wood, B; Winter, S; Dunsmore, KP; Fulton, RS; Fulton, LL; Hong, X; Harris, CC; Dooling, DJ; Ochoa, K; Johnson, KJ; Obenauer, JC; Evans, WE; Pui, CH; Naeve, CW; Ley, TJ; Mardis, ER; Wilson, RK; Downing, JR; Mullighan, CG				Zhang, Jinghui; Ding, Li; Holmfeldt, Linda; Wu, Gang; Heatley, Sue L.; Payne-Turner, Debbie; Easton, John; Chen, Xiang; Wang, Jianmin; Rusch, Michael; Lu, Charles; Chen, Shann-Ching; Wei, Lei; Collins-Underwood, J. Racquel; Ma, Jing; Roberts, Kathryn G.; Pounds, Stanley B.; Ulyanov, Anatoly; Becksfort, Jared; Gupta, Pankaj; Huether, Robert; Kriwacki, Richard W.; Parker, Matthew; McGoldrick, Daniel J.; Zhao, David; Alford, Daniel; Espy, Stephen; Bobba, Kiran Chand; Song, Guangchun; Pei, Deqing; Cheng, Cheng; Roberts, Stefan; Barbato, Michael I.; Campana, Dario; Coustan-Smith, Elaine; Shurtleff, Sheila A.; Raimondi, Susana C.; Kleppe, Maria; Cools, Jan; Shimano, Kristin A.; Hermiston, Michelle L.; Doulatov, Sergei; Eppert, Kolja; Laurenti, Elisa; Notta, Faiyaz; Dick, John E.; Basso, Giuseppe; Hunger, Stephen P.; Loh, Mignon L.; Devidas, Meenakshi; Wood, Brent; Winter, Stuart; Dunsmore, Kimberley P.; Fulton, Robert S.; Fulton, Lucinda L.; Hong, Xin; Harris, Christopher C.; Dooling, David J.; Ochoa, Kerri; Johnson, Kimberly J.; Obenauer, John C.; Evans, William E.; Pui, Ching-Hon; Naeve, Clayton W.; Ley, Timothy J.; Mardis, Elaine R.; Wilson, Richard K.; Downing, James R.; Mullighan, Charles G.			The genetic basis of early T-cell precursor acute lymphoblastic leukaemia	NATURE			English	Article							ACTIVATING FLT3 MUTATIONS; RAS; REARRANGEMENT; EXPRESSION; CRLF2; RUNX1; ETV6	Early T-cell precursor acute lymphoblastic leukaemia (ETP ALL) is an aggressive malignancy of unknown genetic basis. We performed whole-genome sequencing of 12 ETP ALL cases and assessed the frequency of the identified somatic mutations in 94 T-cell acute lymphoblastic leukaemia cases. ETP ALL was characterized by activating mutations in genes regulating cytokine receptor and RAS signalling (67% of cases; NRAS, KRAS, FLT3, IL7R, JAK3, JAK1, SH2B3 and BRAF), inactivating lesions disrupting haematopoietic development (58%; GATA3, ETV6, RUNX1, IKZF1 and EP300) and histone-modifying genes (48%; EZH2, EED, SUZ12, SETD2 and EP300). We also identified new targets of recurrent mutation including DNM2, ECT2L and RELN. The mutational spectrum is similar to myeloid tumours, and moreover, the global transcriptional profile of ETP ALL was similar to that of normal and myeloid leukaemia haematopoietic stem cells. These findings suggest that addition of myeloid-directed therapies might improve the poor outcome of ETP ALL.	[Holmfeldt, Linda; Heatley, Sue L.; Payne-Turner, Debbie; Chen, Shann-Ching; Wei, Lei; Collins-Underwood, J. Racquel; Ma, Jing; Roberts, Kathryn G.; Song, Guangchun; Shurtleff, Sheila A.; Raimondi, Susana C.; Downing, James R.; Mullighan, Charles G.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Zhang, Jinghui; Wu, Gang; Chen, Xiang; Rusch, Michael; Ulyanov, Anatoly; Huether, Robert] St Jude Childrens Res Hosp, Dept Computat Biol & Bioinformat, Memphis, TN 38105 USA; [Ding, Li; Lu, Charles; Fulton, Robert S.; Fulton, Lucinda L.; Hong, Xin; Harris, Christopher C.; Dooling, David J.; Ochoa, Kerri; Johnson, Kimberly J.; Ley, Timothy J.; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Genome Inst, St Louis, MO 63108 USA; [Ding, Li; Fulton, Robert S.; Fulton, Lucinda L.; Dooling, David J.; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Dept Genet, Sch Med, St Louis, MO 63110 USA; [Easton, John; Parker, Matthew; Roberts, Stefan; Barbato, Michael I.] St Jude Childrens Res Hosp, Pediat Canc Genome Project Lab, Memphis, TN 38105 USA; [Wang, Jianmin; Becksfort, Jared; Gupta, Pankaj; McGoldrick, Daniel J.; Zhao, David; Alford, Daniel; Espy, Stephen; Bobba, Kiran Chand; Obenauer, John C.; Naeve, Clayton W.] St Jude Childrens Res Hosp, Dept Informat Sci, Memphis, TN 38105 USA; [Pounds, Stanley B.; Pei, Deqing; Cheng, Cheng] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Huether, Robert; Kriwacki, Richard W.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Campana, Dario; Coustan-Smith, Elaine; Pui, Ching-Hon] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Kleppe, Maria; Cools, Jan] Katholieke Univ Leuven, Dept Mol & Dev Genet, Ctr Human Genet, VIB, B-3000 Louvain, Belgium; [Shimano, Kristin A.; Hermiston, Michelle L.; Loh, Mignon L.] Univ Calif San Francisco, Dept Pediat, Sch Med, San Francisco, CA 94143 USA; [Doulatov, Sergei; Eppert, Kolja; Laurenti, Elisa; Notta, Faiyaz; Dick, John E.] Univ Hlth Network, Dept Stem Cell & Dev Biol, Campbell Family Canc Res Inst, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; [Doulatov, Sergei; Eppert, Kolja; Laurenti, Elisa; Notta, Faiyaz] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Basso, Giuseppe] Univ Padua, Oncohematol Lab, Dept Pediat, I-35122 Padua, Italy; [Hunger, Stephen P.] Univ Colorado, Sect Pediat Hematol Oncol Bone Marrow Transplanta, Aurora, CO 80045 USA; [Hunger, Stephen P.] Univ Colorado, Ctr Canc & Blood Disorders, Denver Sch Med, Childrens Hosp Colorado, Aurora, CO 80045 USA; [Devidas, Meenakshi] Univ Florida, Dept Biostat, Coll Med, Gainesville, FL 32603 USA; [Wood, Brent] Seattle Childrens Hosp, Dept Lab Med, Seattle, WA 98105 USA; [Winter, Stuart] Univ New Mexico, Albuquerque, NM 87131 USA; [Dunsmore, Kimberley P.] Univ Virginia, Charlottesville, VA 22903 USA; [Evans, William E.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Ley, Timothy J.] Washington Univ, Div Oncol, St Louis, MO 63110 USA; [Ley, Timothy J.] Washington Univ, Siteman Canc Ctr, St Louis, MO 63110 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; Washington University (WUSTL); Washington University (WUSTL); St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Flanders Institute for Biotechnology (VIB); KU Leuven; University of California System; University of California San Francisco; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Padua; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; State University System of Florida; University of Florida; Seattle Children's Hospital; University of New Mexico; University of Virginia; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL)	Downing, JR (corresponding author), St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA.	james.downing@stjude.org; charles.mullighan@stjude.org	Cheng, Cheng/N-8075-2018; Pui, Ching-Hon/N-8076-2018; Pounds, Stanley B/N-2480-2018; Wu, Gang/M-8012-2014; Chen, Xiang/N-2524-2018; wang, jian/GVS-0711-2022; Zhang, Jing/GWZ-7332-2022; Devidas, Meenakshi/H-1170-2019; Espy, Stephen/GXN-2069-2022; Mullighan, Charles/H-3253-2011; Kleppe, Maria/C-6341-2014; Espy, Stephen/A-9823-2016; Ganesh, Dunna Sai/AGX-5170-2022; Wilson, Richard K./AAF-4139-2019; Huether, Robert/E-9638-2012; Kriwacki, Richard/N-8154-2018; Heatley, Susan/AGP-2179-2022; Evans, William E./C-2069-2012; Rusch, Michael/AAG-1998-2019; Mardis, Elaine/W-2202-2019; Downing, James R./N-8102-2018; Raimondi, Susana C/N-8166-2018	Pui, Ching-Hon/0000-0003-0303-5658; Pounds, Stanley B/0000-0002-9167-2114; Wu, Gang/0000-0002-1678-5864; Chen, Xiang/0000-0002-2499-8261; Devidas, Meenakshi/0000-0002-1099-3478; Mullighan, Charles/0000-0002-1871-1850; Kleppe, Maria/0000-0002-4372-6704; Espy, Stephen/0000-0003-0698-914X; Wilson, Richard K./0000-0002-1992-1358; Huether, Robert/0000-0001-7077-7470; Kriwacki, Richard/0000-0002-9798-6018; Evans, William E./0000-0002-9333-5322; Rusch, Michael/0000-0002-5363-1848; Parker, Matthew/0000-0003-2999-3870; Heatley, Susan/0000-0001-7497-6477; Cools, Jan/0000-0001-6626-5843; Holmfeldt, Linda/0000-0003-4140-3423; BASSO, GIUSEPPE/0000-0002-2634-9302; Loh, Mignon/0000-0003-4099-4700; Dunsmore, Kimberly/0000-0002-6631-5174; Easton, John/0000-0003-4503-6608; Laurenti, Elisa/0000-0002-9917-9092; Eppert, Kolja/0000-0001-9061-8856; Dick, John/0000-0002-9527-8317	St Jude Children's Research Hospital; The Genome Institute and Siteman Cancer Center at Washington University in St Louis; The St Jude Children's Research Hospital-Washington University Pediatric Cancer; ALSAC of St JudeChildren's Research Hospital; Cancer Center [P30CA021765]; Washington University in St Louis [NIHU 01GM92666-PAAR4Kids]; National Human Genome Research Institute (NHGRI) [U54 HG003079]; NCI [CA98543, CA98413, CA114766]; Alex's Lemonade Stand; St. Baldrick's Foundation; Haematology Society of Australasia; New Zealand New Investigator Scholarship; NATIONAL CANCER INSTITUTE [U10CA098413, P30CA021765, R25CA023944, U10CA098543, U24CA114766] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092666] Funding Source: NIH RePORTER	St Jude Children's Research Hospital; The Genome Institute and Siteman Cancer Center at Washington University in St Louis; The St Jude Children's Research Hospital-Washington University Pediatric Cancer; ALSAC of St JudeChildren's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); Cancer Center; Washington University in St Louis; National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Alex's Lemonade Stand; St. Baldrick's Foundation; Haematology Society of Australasia; New Zealand New Investigator Scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the many members of St Jude Children's Research Hospital and The Genome Institute and Siteman Cancer Center at Washington University in St Louis for support. We thank H. Mulder for project sample management, M. Stine for assistance with data deposition, B. Pappas and S. Malone for information technology infrastructure, J. Morris, E. Walker, A. Merriman and G. Neale for performing single-nucleotide polymorphism and gene expression microarrays, W. Yang for assistance with analysis of genomic data, and J. Stokes for artwork. We thank the Tissue Resources Laboratory, the Flow Cytometry and Cell Sorting Core, and the Clinical Applications of Core Technology Laboratories of the Hartwell Center for Bioinformatics and Biotechnology of St Jude Children's Research Hospital. We thank S. Kehoe of Beckman Coulter Genomics for assistance with Sanger sequencing. This work was funded by The St Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project, ALSAC of St JudeChildren's Research Hospital, Cancer Center support grant P30CA021765, NIHU 01GM92666-PAAR4Kids, grants to R. K. W. from Washington University in St Louis and the National Human Genome Research Institute (NHGRI U54 HG003079), grants to the Children's Oncology Group (NCI CA98543, CA98413, CA114766), and grants from Alex's Lemonade Stand and St. Baldrick's Foundation (to M. L. H.). S. L. H. was supported by a Haematology Society of Australasia and New Zealand New Investigator Scholarship. S. P. H. is the Ergen Family Chair in Pediatric Cancer. C. G. M. is a Pew Scholar in the Biomedical Sciences and a St. Baldrick's Scholar.	Bohlander SK, 2005, SEMIN CANCER BIOL, V15, P162, DOI 10.1016/j.semcancer.2005.01.008; Coustan-Smith E, 2009, LANCET ONCOL, V10, P147, DOI 10.1016/S1470-2045(08)70314-0; Dicker F, 2010, LEUKEMIA, V24, P1528, DOI 10.1038/leu.2010.124; DOWNING JR, 1993, BLOOD, V81, P2860; Durieux AC, 2010, J MOL MED, V88, P339, DOI 10.1007/s00109-009-0587-4; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Flex E, 2008, J EXP MED, V205, P751, DOI 10.1084/jem.20072182; Gaidzik VI, 2011, J CLIN ONCOL, V29, P1364, DOI 10.1200/JCO.2010.30.7926; Gelsi-Boyer V, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-299; Gilliland DG, 2002, SEMIN HEMATOL, V39, P6, DOI 10.1053/shem.2002.36921; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Hosoya T, 2010, IMMUNOL REV, V238, P110, DOI 10.1111/j.1600-065X.2010.00954.x; Kawamura M, 1999, LEUKEMIA RES, V23, P115, DOI 10.1016/S0145-2126(98)00146-5; Kleppe M, 2011, HAEMATOL-HEMATOL J, V96, P779, DOI 10.3324/haematol.2010.035931; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Malinge S, 2008, BLOOD, V112, P4220, DOI 10.1182/blood-2008-01-136366; Margolin AA, 2006, NAT PROTOC, V1, P663, DOI 10.1038/nprot.2006.106; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Mullighan CG, 2009, NAT GENET, V41, P1243, DOI 10.1038/ng.469; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Neumann M, 2010, BLOOD, V116, P453, DOI 10.1182/blood.V116.21.1031.1031; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Paietta E, 2004, BLOOD, V104, P558, DOI 10.1182/blood-2004-01-0168; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Russell LJ, 2009, BLOOD, V114, P2688, DOI 10.1182/blood-2009-03-208397; Shochat C, 2011, J EXP MED, V208, P901, DOI 10.1084/jem.20110580; Shurtleff SA, 1995, LEUKEMIA, V9, P1985; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Tosello V, 2009, BLOOD, V114, P1038, DOI 10.1182/blood-2008-12-192039; van Doorn-Khosrovani SBV, 2005, ONCOGENE, V24, P4129, DOI 10.1038/sj.onc.1208588; Van Vlierberghe P, 2005, BLOOD, V106, P4414, DOI 10.1182/blood-2005-06-2267; Van Vlierberghe P, 2010, NAT GENET, V42, P338, DOI 10.1038/ng.542; Wada H, 2008, NATURE, V452, P768, DOI 10.1038/nature06839; Wang JM, 2011, NAT METHODS, V8, P652, DOI [10.1038/nmeth.1628, 10.1038/NMETH.1628]; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yamashita Y, 2010, ONCOGENE, V29, P3723, DOI 10.1038/onc.2010.117; Yokota S, 1998, INT J HEMATOL, V67, P379; Zahirieh A, 2005, J CLIN ENDOCR METAB, V90, P2445, DOI 10.1210/jc.2004-1969; Ziegler SF, 2006, NAT IMMUNOL, V7, P709, DOI 10.1038/ni1360	43	1096	1131	4	145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 12	2012	481	7380					157	163		10.1038/nature10725	http://dx.doi.org/10.1038/nature10725			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	874TO	22237106	Green Accepted, hybrid			2022-12-28	WOS:000298981200029
J	Deplancke, B; Verstrepen, KJ				Deplancke, Bart; Verstrepen, Kevin J.			Variable Outcome of Mutations	SCIENCE			English	Editorial Material							GENE-EXPRESSION; SINGLE-CELL; BREAST		[Deplancke, Bart] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, Lab Syst Biol & Genet, CH-1015 Lausanne, Switzerland; [Verstrepen, Kevin J.] Katholieke Univ Leuven, VIB Lab Syst Biol, B-3001 Louvain, Belgium; [Verstrepen, Kevin J.] Katholieke Univ Leuven, CMPG Lab Genet & Genom, B-3001 Louvain, Belgium	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven	Deplancke, B (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, Lab Syst Biol & Genet, CH-1015 Lausanne, Switzerland.	bart.deplancke@epfl.ch; kevin.verstrepen@biw.vib-kuleuven.be	Verstrepen, Kevin/AAA-4343-2021	Verstrepen, Kevin/0000-0002-3077-6219; Deplancke, Bart/0000-0001-9935-843X				Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Burga A, 2011, NATURE, V480, P250, DOI 10.1038/nature10665; Dowell RD, 2010, SCIENCE, V328, P469, DOI 10.1126/science.1189015; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Casanueva MO, 2012, SCIENCE, V335, P82, DOI 10.1126/science.1213491; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; SPUDICH JL, 1976, NATURE, V262, P467, DOI 10.1038/262467a0; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918	12	2	2	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 6	2012	335	6064					44	45		10.1126/science.1216823	http://dx.doi.org/10.1126/science.1216823			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872YA	22223795				2022-12-28	WOS:000298846200041
J	Parle, J; Ross, N; Jones, J				Parle, Jim; Ross, Nick; Jones, June			DRUG MONITORING Investigating beneficial drug reactions	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Parle, Jim; Jones, June] Univ Birmingham, Coll Med & Dent Sci, Sch Hlth & Populat Sci, Birmingham B15 2SP, W Midlands, England; [Ross, Nick] Univ Birmingham, Coll Med & Dent Sci, Educ Unit, Birmingham B15 2SP, W Midlands, England	University of Birmingham; University of Birmingham	Parle, J (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Sch Hlth & Populat Sci, Birmingham B15 2SP, W Midlands, England.	j.v.parle@bham.ac.uk						Biswas P, 2001, INT J CLIN PHARM TH, V39, P529; Calabrese L, 2000, AM J MED, V108, P487, DOI 10.1016/S0002-9343(99)00408-8; Campbell SF, 2000, CLIN SCI, V99, P255, DOI 10.1042/CS20000140; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Shaughnessy AF, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d741; Sukhai MA, 2011, BLOOD, V117, P6747, DOI 10.1182/blood-2011-02-315283	6	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 4	2012	344								d8337	10.1136/bmj.d8337	http://dx.doi.org/10.1136/bmj.d8337			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874UF	22218102				2022-12-28	WOS:000298982900028
J	Miller, DC; Hollenbeck, BK				Miller, David C.; Hollenbeck, Brent K.			Missing the Mark on Prostate-Specific Antigen Screening	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CANCER MORTALITY		[Miller, David C.] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Miller, DC (corresponding author), Univ Michigan, Dept Urol, 2800 Plymouth Rd,NCRC Bldg 520,3rd Floor, Ann Arbor, MI 48109 USA.	dcmiller@umich.edu						Albertsen PC, 2005, JAMA-J AM MED ASSOC, V293, P2095, DOI 10.1001/jama.293.17.2095; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Bill-Axelson A, 2011, NEW ENGL J MED, V364, P1708, DOI 10.1056/NEJMoa1011967; Carroll PR, 2005, J UROLOGY, V173, P1061, DOI 10.1097/01.ju.0000156838.67623.10; Collin SM, 2008, LANCET ONCOL, V9, P445, DOI 10.1016/S1470-2045(08)70104-9; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; Phillips C, STUDY QUESTIONS BENE; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; US Preventive Services Task Force, SCREEN PROST CANC US; Walter LC, 2006, JAMA-J AM MED ASSOC, V296, P2336, DOI 10.1001/jama.296.19.2336	10	15	15	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 28	2011	306	24					2719	2720		10.1001/jama.2011.1879	http://dx.doi.org/10.1001/jama.2011.1879			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	867VX	22203542				2022-12-28	WOS:000298484000024
J	Gilbert, N				Gilbert, Natasha			REGULATIONS Herbal medicine rule book	NATURE			English	Editorial Material																		Lam W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001270	1	24	25	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2011	480	7378					S98	S99		10.1038/480S98a	http://dx.doi.org/10.1038/480S98a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	865NQ	22190094	Bronze			2022-12-28	WOS:000298318000010
J	Mellman, I; Coukos, G; Dranoff, G				Mellman, Ira; Coukos, George; Dranoff, Glenn			Cancer immunotherapy comes of age	NATURE			English	Review							REGULATORY T-CELLS; ENDOTHELIAL GROWTH-FACTOR; COLONY-STIMULATING FACTOR; DENDRITIC CELLS; ANTITUMOR IMMUNITY; PEPTIDE VACCINE; IN-VITRO; TUMOR; TOLERANCE; ANTIBODY	Activating the immune system for therapeutic benefit in cancer has long been a goal in immunology and oncology. After decades of disappointment, the tide has finally changed due to the success of recent proof-of-concept clinical trials. Most notable has been the ability of the anti-CTLA4 antibody, ipilimumab, to achieve a significant increase in survival for patients with metastatic melanoma, for which conventional therapies have failed. In the context of advances in the understanding of how tolerance, immunity and immunosuppression regulate antitumour immune responses together with the advent of targeted therapies, these successes suggest that active immunotherapy represents a path to obtain a durable and long-lasting response in cancer patients.	[Mellman, Ira] Genentech Inc, San Francisco, CA 94080 USA; [Coukos, George] Univ Penn, Sch Med, Ovarian Canc Res Ctr, Philadelphia, PA 19104 USA; [Dranoff, Glenn] Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Dranoff, Glenn] Brigham & Womens Hosp, Dana Farber Canc Inst, Canc Vaccine Ctr, Boston, MA 02115 USA; [Dranoff, Glenn] Harvard Univ, Sch Med, Boston, MA 02115 USA	Roche Holding; Genentech; University of Pennsylvania; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Mellman, I (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	mellman.ira@gene.com	Mellman, Ira/ABG-5896-2020; Coukos, George/ABG-7389-2020	Coukos, George/0000-0001-8813-7367	NCI NIH HHS [R01 CA143083, P01 CA155258, P50 CA100707, P01 CA078378] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA143083, P01CA078378, P01CA155258, P50CA100707] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Alagkiozidis I, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-77; Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; Bouzin C, 2007, J IMMUNOL, V178, P1505, DOI 10.4049/jimmunol.178.3.1505; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Buckanovich RJ, 2008, NAT MED, V14, P28, DOI 10.1038/nm1699; Chambers CA, 2001, ANNU REV IMMUNOL, V19, P565, DOI 10.1146/annurev.immunol.19.1.565; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Cheever MA, 2008, CLIN CANCER RES, V14, P5692, DOI 10.1158/1078-0432.CCR-08-1266; Cipponi A, 2011, CANCER IMMUNOL IMMUN, V60, P1153, DOI 10.1007/s00262-011-1026-2; Cohen AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010436; Copier J, 2010, CURR OPIN MOL THER, V12, P14; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Darrasse-Jeze G, 2009, J EXP MED, V206, P1853, DOI 10.1084/jem.20090746; Disis ML, 1997, J CLIN ONCOL, V15, P3363, DOI 10.1200/JCO.1997.15.11.3363; Dougan M, 2010, J EXP MED, V207, P2195, DOI 10.1084/jem.20101123; Dougan M, 2009, ANNU REV IMMUNOL, V27, P83, DOI 10.1146/annurev.immunol.021908.132544; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Emens LA, 2009, J CLIN ONCOL, V27, P5911, DOI 10.1200/JCO.2009.23.3494; Facciabene A, 2011, NATURE, V475, P226, DOI 10.1038/nature10169; Ferrer IR, 2010, J IMMUNOL, V185, P2004, DOI 10.4049/jimmunol.1001176; Freedman A, 2009, J CLIN ONCOL, V27, P3036, DOI 10.1200/JCO.2008.19.8903; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gadiot J, 2011, CANCER-AM CANCER SOC, V117, P2192, DOI 10.1002/cncr.25747; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gao Q, 2009, CLIN CANCER RES, V15, P971, DOI 10.1158/1078-0432.CCR-08-1608; Ghiringhelli F, 2007, CANCER IMMUNOL IMMUN, V56, P641, DOI 10.1007/s00262-006-0225-8; Gogas H, 2006, NEW ENGL J MED, V354, P709, DOI 10.1056/NEJMoa053007; Golovina TN, 2010, CANCER J, V16, P342, DOI 10.1097/PPO.0b013e3181eb336d; Hall S. S., 1997, COMMOTION BLOOD LIFE; Hamanishi J, 2007, P NATL ACAD SCI USA, V104, P3360, DOI 10.1073/pnas.0611533104; Hodi FS, 2008, P NATL ACAD SCI USA, V105, P3005, DOI 10.1073/pnas.0712237105; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hoos A, 2010, JNCI-J NATL CANCER I, V102, P1388, DOI 10.1093/jnci/djq310; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; Ito T, 2006, P NATL ACAD SCI USA, V103, P13138, DOI 10.1073/pnas.0603107103; Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015; June CH, 2007, J CLIN INVEST, V117, P1204, DOI 10.1172/JCI31446; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kantoff PW, 2010, J CLIN ONCOL, V28, P1099, DOI 10.1200/JCO.2009.25.0597; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; Kono K, 2006, CANCER IMMUNOL IMMUN, V55, P1064, DOI 10.1007/s00262-005-0092-8; Kooi S, 1996, CELL IMMUNOL, V174, P116, DOI 10.1006/cimm.1996.0301; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Leffers N, 2009, INT J CANCER, V125, P2104, DOI 10.1002/ijc.24597; Machiels JPH, 2001, CANCER RES, V61, P3689; Manning EA, 2007, CLIN CANCER RES, V13, P3951, DOI 10.1158/1078-0432.CCR-07-0374; Marigo I, 2008, IMMUNOL REV, V222, P162, DOI 10.1111/j.1600-065X.2008.00602.x; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Muller AJ, 2006, NAT REV CANCER, V6, P613, DOI 10.1038/nrc1929; Munn DH, 2004, TRENDS MOL MED, V10, P15, DOI 10.1016/j.molmed.2003.11.003; Nahta R, 2006, CANCER LETT, V232, P123, DOI 10.1016/j.canlet.2005.01.041; Neller MA, 2008, SEMIN IMMUNOL, V20, P286, DOI 10.1016/j.smim.2008.09.006; Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Novellino L, 2005, CANCER IMMUNOL IMMUN, V54, P187, DOI 10.1007/s00262-004-0560-6; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Ohta A, 2006, P NATL ACAD SCI USA, V103, P13132, DOI 10.1073/pnas.0605251103; Okazaki T, 2011, J EXP MED, V208, P395, DOI 10.1084/jem.20100466; Palucka K, 2010, IMMUNITY, V33, P464, DOI 10.1016/j.immuni.2010.10.007; Parsa AT, 2007, NAT MED, V13, P84, DOI 10.1038/nm1517; Phillips GDL, 2008, CANCER RES, V68, P9280, DOI 10.1158/0008-5472.CAN-08-1776; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Rammensee HG, 2002, IMMUNOL REV, V188, P164, DOI 10.1034/j.1600-065X.2002.18815.x; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Schuler G, 2010, EUR J IMMUNOL, V40, P2123, DOI 10.1002/eji.201040630; Schwartzentruber DJ, 2011, NEW ENGL J MED, V364, P2119, DOI 10.1056/NEJMoa1012863; Segal NH, 2008, CANCER RES, V68, P889, DOI 10.1158/0008-5472.CAN-07-3095; Senzer NN, 2009, J CLIN ONCOL, V27, P5763, DOI 10.1200/JCO.2009.24.3675; Shin JY, 2009, CELL IMMUNOL, V256, P72, DOI 10.1016/j.cellimm.2009.01.006; Shrimali RK, 2010, CANCER RES, V70, P6171, DOI 10.1158/0008-5472.CAN-10-0153; Small EJ, 2000, J CLIN ONCOL, V18, P3894, DOI 10.1200/JCO.2000.18.23.3894; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Sylvester RJ, 2011, INT J UROL, V18, P113, DOI 10.1111/j.1442-2042.2010.02678.x; Taylor C, 2007, CLIN CANCER RES, V13, P5133, DOI 10.1158/1078-0432.CCR-07-0507; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Topp MS, 2011, J CLIN ONCOL, V29, P2493, DOI 10.1200/JCO.2010.32.7270; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Vansteenkiste J, 2007, J CLIN ONCOL, V25, DOI 10.1200/JCO.2006.09.7097; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; Watanabe T, 2010, J VIRAL HEPATITIS, V17, P453, DOI 10.1111/j.1365-2893.2010.01313.x; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624; Woo SR, 2010, EUR J IMMUNOL, V40, P1768, DOI 10.1002/eji.200939874; Workman CJ, 2005, J IMMUNOL, V174, P688, DOI 10.4049/jimmunol.174.2.688; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zitvogel L, 2009, J CLIN INVEST, V119, P2127, DOI 10.1172/JCI39991	99	2387	2591	43	1342	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2011	480	7378					480	489		10.1038/nature10673	http://dx.doi.org/10.1038/nature10673			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865NQ	22193102	Green Accepted			2022-12-28	WOS:000298318000052
J	Lindford, AJ; Vuola, J				Lindford, Andrew J.; Vuola, Jyrki			PICTURE QUIZ Helsinki-20 degrees C	BRITISH MEDICAL JOURNAL			English	Editorial Material							FROSTBITE INJURIES; EXTREMITIES; AMPUTATION		[Lindford, Andrew J.; Vuola, Jyrki] Toolo Hosp, Helsinki Burn Ctr, Dept Plast Surg, Helsinki Univ Hosp, FIN-00029 Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital	Lindford, AJ (corresponding author), Toolo Hosp, Helsinki Burn Ctr, Dept Plast Surg, Helsinki Univ Hosp, FIN-00029 Helsinki, Finland.	andrew.lindford@hus.fi						Bruen KJ, 2007, ARCH SURG-CHICAGO, V142, P546, DOI 10.1001/archsurg.142.6.546; Cauchy E, 2000, J HAND SURG-AM, V25A, P969, DOI 10.1053/jhsu.2000.16357; Cauchy E, 2011, NEW ENGL J MED, V364, P189, DOI 10.1056/NEJMc1000538; GROECHENIG E, 1994, LANCET, V344, P1152, DOI 10.1016/S0140-6736(94)90657-2; Hallam MJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5864; Imray C, 2009, POSTGRAD MED J, V85, P481, DOI 10.1136/pgmj.2008.068635; Juopperi Kimmo, 2002, Int J Circumpolar Health, V61, P352; Koljonen V, 2004, J TRAUMA, V57, P1315, DOI 10.1097/01.TA.0000151258.06910.83; MCCAULEY RL, 1983, J TRAUMA, V23, P143, DOI 10.1097/00005373-198302000-00013; Mohr WJ, 2009, HAND CLIN, V25, P481, DOI 10.1016/j.hcl.2009.06.004; Murphy JV, 2000, J TRAUMA, V48, P171, DOI 10.1097/00005373-200001000-00036; von Heimburg D, 2001, BURNS, V27, P404, DOI 10.1016/S0305-4179(00)00132-7	12	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2011	343								d8020	10.1136/bmj.d8020	http://dx.doi.org/10.1136/bmj.d8020			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874SZ	22187192				2022-12-28	WOS:000298979700002
J	Lota, AS; Manisty, CH; Sutton, R; Francis, DP				Lota, Amrit S.; Manisty, Charlotte H.; Sutton, Richard; Francis, Darrel P.			CHRISTMAS 2011: PROFESSIONAL MATTERS When is a "free" registrar in clinic not free?	BRITISH MEDICAL JOURNAL			English	Editorial Material								Objective To investigate whether using registrars (doctors undergoing higher specialist training, whose salary is reimbursed) rather than consultants in outpatient clinics saves money Design Development of a formula calculating the economic breakeven point and application to retrospective audit data from 273 outpatient consultations. Setting General cardiology outpatient clinic in a secondary and tertiary referral NHS hospital. Outcomes Difference in probability of a registrar and a consultant making a diagnostic decision that completes a clinical episode. Use of UK costings for consultant salaries and outpatient attendances to determine the economic breakeven point. Results The formula showed that if a registrar's episode completing probability is 12 percentage points lower than that of a consultant, then using a registrar costs the hospital more. Real life data showed that episode completion probabilities are 43 percentage points lower for registrars than for consultants (26% versus 69%, 95% CI 32% to 54%, P<0.0001). Conclusion It is wrong to assume that external reimbursement of registrar salaries makes them a money saving option for staffing clinics. The apparent service role of a registrar can be a disservice.	[Lota, Amrit S.; Manisty, Charlotte H.; Sutton, Richard; Francis, Darrel P.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Int Ctr Circulatory Hlth, London W2 1LA, England	Imperial College London	Lota, AS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Int Ctr Circulatory Hlth, London W2 1LA, England.	amrit.lota@doctors.org.uk	Manisty, Charlotte/AAN-3723-2021	Manisty, Charlotte/0000-0003-0245-7090	British Heart Foundation [FS/10/38/28268] Funding Source: Medline	British Heart Foundation(British Heart Foundation)		[Anonymous], 2011, BMJ CAREERS; Department of Health, NHS PAYM RES 2010 11; KASHIWAGI DT, 2011, AM J MED QUAL   0810; Medford ARL, 2008, QUAL SAF HEALTH CARE, V17, P79, DOI 10.1136/qshc.2007.023234; ROBINSON S, 2011, NHS INNOVATIONS 0125; Virgil, AENEID, VII; WYNNE K, 2009, BMJ CAREERS	7	3	3	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2011	343								d7869	10.1136/bmj.d7869	http://dx.doi.org/10.1136/bmj.d7869			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	868QK	22187189				2022-12-28	WOS:000298538200010
J	Mathur, PN				Mathur, Praveen N.			Intrapleural t-PA plus DNase improved clinical outcomes in patients with pleural infection	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Indiana Univ Sch Med, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington	Mathur, PN (corresponding author), Indiana Univ Sch Med, Indianapolis, IN USA.							Colicc GL, 2000, CHEST, V118, P1158, DOI 10.1378/chest.118.4.1158; Maskell NA, 2005, NEW ENGL J MED, V352, P865, DOI 10.1056/NEJMoa042473	2	1	1	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2011	155	12							JC6-9	10.7326/0003-4819-155-12-201112200-02009	http://dx.doi.org/10.7326/0003-4819-155-12-201112200-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	864ZU	22184710				2022-12-28	WOS:000298280500008
J	Semonin, OE; Luther, JM; Choi, S; Chen, HY; Gao, JB; Nozik, AJ; Beard, MC				Semonin, Octavi E.; Luther, Joseph M.; Choi, Sukgeun; Chen, Hsiang-Yu; Gao, Jianbo; Nozik, Arthur J.; Beard, Matthew C.			Peak External Photocurrent Quantum Efficiency Exceeding 100% via MEG in a Quantum Dot Solar Cell	SCIENCE			English	Article							MULTIPLE EXCITON GENERATION; CARRIER-MULTIPLICATION; SEMICONDUCTOR NANOCRYSTALS; PBSE; FILMS; PHOTODIODES; PROSPECTS	Multiple exciton generation (MEG) is a process that can occur in semiconductor nanocrystals, or quantum dots (QDs), whereby absorption of a photon bearing at least twice the bandgap energy produces two or more electron-hole pairs. Here, we report on photocurrent enhancement arising from MEG in lead selenide (PbSe) QD-based solar cells, as manifested by an external quantum efficiency (the spectrally resolved ratio of collected charge carriers to incident photons) that peaked at 114 +/- 1% in the best device measured. The associated internal quantum efficiency (corrected for reflection and absorption losses) was 130%. We compare our results with transient absorption measurements of MEG in isolated PbSe QDs and find reasonable agreement. Our findings demonstrate that MEG charge carriers can be collected in suitably designed QD solar cells, providing ample incentive to better understand MEG within isolated and coupled QDs as a research path to enhancing the efficiency of solar light harvesting technologies.	[Semonin, Octavi E.; Luther, Joseph M.; Choi, Sukgeun; Chen, Hsiang-Yu; Gao, Jianbo; Nozik, Arthur J.; Beard, Matthew C.] Natl Renewable Energy Lab, Golden, CO 80401 USA; [Semonin, Octavi E.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Gao, Jianbo] Univ Toledo, Dept Phys & Astron, Toledo, OH 43606 USA; [Nozik, Arthur J.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; University of Colorado System; University of Colorado Boulder; University System of Ohio; University of Toledo; University of Colorado System; University of Colorado Boulder	Nozik, AJ (corresponding author), Natl Renewable Energy Lab, 1617 Cole Blvd, Golden, CO 80401 USA.	arthur.nozik@nrel.gov; matt.beard@nrel.gov	GAO, JIANBO/A-1633-2014; GAO, JIANBO/A-3923-2011; Nozik, Arthur J./P-2641-2016; Beard, MATTHEW C/E-4270-2015; Luther, Joseph/Y-2782-2019; Choi, Sukgeun/J-2345-2014; Nozik, Arthur J/A-1481-2012; Selopal, Gurpreet Singh/D-5801-2018	Nozik, Arthur J./0000-0001-7176-7645; Beard, MATTHEW C/0000-0002-2711-1355; Luther, Joseph/0000-0002-4054-8244; Semonin, Octavi Escala/0000-0002-4262-6955	Center for Advanced Solar Photophysics, an Energy Frontier Research Center; U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences (BES); DOE [DE-AC36-08GO28308]	Center for Advanced Solar Photophysics, an Energy Frontier Research Center; U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences (BES)(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE))	We thank M. C. Hanna, K. Emery, B. K. Hughes, K. S. Mistry, and M. R. Bergren for helpful discussions and B. To for SEM imaging. This work was supported by the Center for Advanced Solar Photophysics, an Energy Frontier Research Center funded by the U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences (BES). DOE funding was provided to the National Renewable Energy Laboratory (NREL) through contract DE-AC36-08GO28308. NREL has filed a patent related to this work.	Beard MC, 2011, J PHYS CHEM LETT, V2, P1282, DOI 10.1021/jz200166y; Beard MC, 2010, NANO LETT, V10, P3019, DOI 10.1021/nl101490z; Beard MC, 2009, NANO LETT, V9, P836, DOI 10.1021/nl803600v; Canfield LR, 1998, METROLOGIA, V35, P329, DOI 10.1088/0026-1394/35/4/19; Choi JJ, 2009, NANO LETT, V9, P3749, DOI 10.1021/nl901930g; Cunningham PD, 2011, NANO LETT, V11, P3476, DOI 10.1021/nl202014a; Delerue C, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.125306; Gabor NM, 2009, SCIENCE, V325, P1367, DOI 10.1126/science.1176112; Gao JB, 2011, NANO LETT, V11, P1002, DOI 10.1021/nl103814g; Hanna MC, 2006, J APPL PHYS, V100, DOI 10.1063/1.2356795; Law M, 2008, NANO LETT, V8, P3904, DOI 10.1021/nl802353x; Leschkies KS, 2009, ACS NANO, V3, P3638, DOI 10.1021/nn901139d; Liu Y, 2010, NANO LETT, V10, P1960, DOI 10.1021/nl101284k; Luther JM, 2008, NANO LETT, V8, P3488, DOI 10.1021/nl802476m; Luther JM, 2008, ACS NANO, V2, P271, DOI 10.1021/nn7003348; Luther JM, 2007, NANO LETT, V7, P1779, DOI 10.1021/nl0708617; Ma WL, 2011, ACS NANO, V5, P8140, DOI 10.1021/nn202786g; McGuire JA, 2010, NANO LETT, V10, P2049, DOI 10.1021/nl100177c; Mcguire JA, 2008, ACCOUNTS CHEM RES, V41, P1810, DOI 10.1021/ar800112v; Midgett AG, 2010, J PHYS CHEM C, V114, P17486, DOI 10.1021/jp1057786; Nair G, 2011, NANO LETT, V11, P2145, DOI 10.1021/nl200798x; Nozik AJ, 2002, PHYSICA E, V14, P115, DOI 10.1016/S1386-9477(02)00374-0; Pijpers JJH, 2009, NAT PHYS, V5, P811, DOI 10.1038/NPHYS1393; Sambur JB, 2010, SCIENCE, V330, P63, DOI 10.1126/science.1191462; SHOCKLEY W, 1961, J APPL PHYS, V32, P510, DOI 10.1063/1.1736034; Sukhovatkin V, 2009, SCIENCE, V324, P1542, DOI 10.1126/science.1173812; Talapin DV, 2010, CHEM REV, V110, P389, DOI 10.1021/cr900137k; Talapin DV, 2005, SCIENCE, V310, P86, DOI 10.1126/science.1116703; Tang J, 2011, NAT MATER, V10, P765, DOI [10.1038/NMAT3118, 10.1038/nmat3118]; Wang RY, 2008, NANO LETT, V8, P2283, DOI 10.1021/nl8009704; Wang SJ, 2010, NANO LETT, V10, P2381, DOI 10.1021/nl100343j; Wolf M, 1998, J APPL PHYS, V83, P4213, DOI 10.1063/1.367177	32	1339	1360	25	891	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 16	2011	334	6062					1530	1533		10.1126/science.1209845	http://dx.doi.org/10.1126/science.1209845			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	862LE	22174246				2022-12-28	WOS:000298091400046
J	Stanaway, FF; Gnjidic, D; Blyth, FM; Le Couteur, DG; Naganathan, V; Waite, L; Seibel, MJ; Handelsman, DJ; Sambrook, PN; Cumming, RG				Stanaway, Fiona F.; Gnjidic, Danijela; Blyth, Fiona M.; Le Couteur, David G.; Naganathan, Vasi; Waite, Louise; Seibel, Markus J.; Handelsman, David J.; Sambrook, Philip N.; Cumming, Robert G.			CHRISTMAS 2011: DEATH'S DOMINION How fast does the Grim Reaper walk? Receiver operating characteristics curve analysis in healthy men aged 70 and over	BRITISH MEDICAL JOURNAL			English	Editorial Material							OLDER-ADULTS; OSTEOPOROTIC FRACTURES; BODY-COMPOSITION; GAIT SPEED; INDEX	Objective To determine the speed at which the Grim Reaper (or Death) walks. Design Population based prospective study. Setting Older community dwelling men living in Sydney, Australia. Participants 1705 men aged 70 or more participating in CHAMP (Concord Health and Ageing in Men Project). Main outcome measures Walking speed (m/s) and mortality. Receiver operating characteristics curve analysis was used to calculate the area under the curve for walking speed and determine the walking speed of the Grim Reaper. The optimal walking speed was estimated using the Youden index (sensitivity+specificity-1), a common summary measure of the receiver operating characteristics curve, and represents the maximum potential effectiveness of a marker. Results The mean walking speed was 0.88 (range 0.15-1.60) m/s. The highest Youden index (0.293) was observed at a walking speed of 0.82 m/s (2 miles (about 3 km) per hour), corresponding to a sensitivity of 63% and a specificity of 70% for mortality. Survival analysis showed that older men who walked faster than 0.82 m/s were 1.23 times less likely to die (95% confidence interval 1.10 to 1.37) than those who walked slower (P=0.0003). A sensitivity of 1.0 was obtained when a walking speed of 1.36 m/s (3 miles (about 5 km) per hour) or greater was used, indicating that no men with walking speeds of 1.36 m/s or greater had contact with Death. Conclusion The Grim Reaper's preferred walking speed is 0.82 m/s (2 miles (about 3 km) per hour) under working conditions. As none of the men in the study with walking speeds of 1.36 m/s (3 miles (about 5 km) per hour) or greater had contact with Death, this seems to be the Grim Reaper's most likely maximum speed; for those wishing to avoid their allotted fate, this would be the advised walking speed.	[Gnjidic, Danijela; Blyth, Fiona M.; Le Couteur, David G.; Naganathan, Vasi; Waite, Louise; Handelsman, David J.; Sambrook, Philip N.; Cumming, Robert G.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Stanaway, Fiona F.; Cumming, Robert G.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Gnjidic, Danijela] Royal N Shore Hosp, Dept Clin Pharmacol, Sydney, NSW, Australia; [Gnjidic, Danijela] Royal N Shore Hosp, Dept Aged Care, Sydney, NSW, Australia; [Gnjidic, Danijela; Blyth, Fiona M.; Le Couteur, David G.; Naganathan, Vasi; Waite, Louise; Cumming, Robert G.] Concord Hosp, Ctr Educ & Res Ageing, Sydney, NSW, Australia; [Blyth, Fiona M.] Sax Inst, Sydney, NSW, Australia; [Le Couteur, David G.; Seibel, Markus J.; Handelsman, David J.] Concord Hosp, ANZAC Res Inst, Sydney, NSW, Australia; [Sambrook, Philip N.] Royal N Shore Hosp, Inst Bone & Joint Res, Kolling Inst Med Res, Sydney, NSW, Australia	University of Sydney; University of Sydney; Royal North Shore Hospital; University of Sydney; Royal North Shore Hospital; University of Sydney; Concord Repatriation General Hospital; University of Sydney; Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research	Gnjidic, D (corresponding author), Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.	danijela.gnjidic@sydney.edu.au	Research Institute, ANZAC/CAE-9030-2022; Handelsman, David/AAR-9580-2021; Ekanayake, Kanchana/P-8817-2016; Cumming, Robert G/R-1548-2016	Cumming, Robert G/0000-0002-0261-6103; Le Couteur, David/0000-0002-4227-5817; Waite, Louise/0000-0001-9056-6996; Naganathan, Vasikaran/0000-0001-7243-0796; Seibel, Markus J/0000-0002-2701-378X; Handelsman, David/0000-0002-4200-7476	Australian National Health and Medical Research Council [301916]; Sydney Medical School Foundation; Ageing and Alzheimer's Research Foundation	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Sydney Medical School Foundation; Ageing and Alzheimer's Research Foundation	The CHAMP study is funded by the Australian National Health and Medical Research Council (grant No 301916), Sydney Medical School Foundation, and Ageing and Alzheimer's Research Foundation. The funding source had no involvement in the study design, analysis, interpretation, or decision to submit this work.	Andrew SG, 1989, AUST J AGEING, V8, P31; Bergman I, 1957, 7 INSEGLET; Cesari M, 2005, J AM GERIATR SOC, V53, P1675, DOI 10.1111/j.1532-5415.2005.53501.x; Cesari M, 2009, J AM GERIATR SOC, V57, P251, DOI 10.1111/j.1532-5415.2008.02126.x; Cumming RG, 2009, INT J EPIDEMIOL, V38, P374, DOI 10.1093/ije/dyn071; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gnjidic D., 2011, ANN MED; Gnjidic D, 2009, BRIT J CLIN PHARMACO, V68, P97, DOI 10.1111/j.1365-2125.2009.03411.x; Longfellow HW., 1902, COMPLETE POETICAL WO, P345; NGUYEN T, 1993, BRIT MED J, V307, P1111, DOI 10.1136/bmj.307.6912.1111; Orwoll E, 2005, CONTEMP CLIN TRIALS, V26, P569, DOI 10.1016/j.cct.2005.05.006; Pratchett T., 1985, COLOUR MAGIC; Pratchett T., 1998, MORT; Pratchett Terry, 1992, REAPER MAN; Rosano C, 2008, J AM GERIATR SOC, V56, P1618, DOI 10.1111/j.1532-5415.2008.01856.x; Rowling J.K, 2007, HARRY POTTER DEATHLY; Ruopp MD, 2008, BIOMETRICAL J, V50, P419, DOI 10.1002/bimj.200710415; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923	18	67	67	2	14	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 15	2011	343								d7679	10.1136/bmj.d7679	http://dx.doi.org/10.1136/bmj.d7679			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	888WF	22174324	hybrid, Green Published			2022-12-28	WOS:000300034600009
J	Rauch, PJ; Chudnovskiy, A; Robbins, CS; Weber, GF; Etzrodt, M; Hilgendorf, I; Tiglao, E; Figueiredo, JL; Iwamoto, Y; Theurl, I; Gorbatov, R; Waring, MT; Chicoine, AT; Mouded, M; Pittet, MJ; Nahrendorf, M; Weissleder, R; Swirski, FK				Rauch, Philipp J.; Chudnovskiy, Aleksey; Robbins, Clinton S.; Weber, Georg F.; Etzrodt, Martin; Hilgendorf, Ingo; Tiglao, Elizabeth; Figueiredo, Jose-Luiz; Iwamoto, Yoshiko; Theurl, Igor; Gorbatov, Rostic; Waring, Michael T.; Chicoine, Adam T.; Mouded, Majd; Pittet, Mikael J.; Nahrendorf, Matthias; Weissleder, Ralph; Swirski, Filip K.			Innate Response Activator B Cells Protect Against Microbial Sepsis	SCIENCE			English	Article							COLONY-STIMULATING FACTOR; MARGINAL-ZONE; SURVIVAL; MICE; AUTOIMMUNITY; LYMPHOCYTES; CLEARANCE; ENDOTOXIN; SUBSETS; MODELS	Recognition and clearance of a bacterial infection are fundamental properties of innate immunity. Here, we describe an effector B cell population that protects against microbial sepsis. Innate response activator (IRA) B cells are phenotypically and functionally distinct, develop and diverge from B1a B cells, depend on pattern-recognition receptors, and produce granulocyte-macrophage colony-stimulating factor. Specific deletion of IRA B cell activity impairs bacterial clearance, elicits a cytokine storm, and precipitates septic shock. These observations enrich our understanding of innate immunity, position IRA B cells as gatekeepers of bacterial infection, and identify new treatment avenues for infectious diseases.	[Rauch, Philipp J.; Chudnovskiy, Aleksey; Robbins, Clinton S.; Weber, Georg F.; Etzrodt, Martin; Hilgendorf, Ingo; Tiglao, Elizabeth; Figueiredo, Jose-Luiz; Iwamoto, Yoshiko; Theurl, Igor; Gorbatov, Rostic; Pittet, Mikael J.; Nahrendorf, Matthias; Weissleder, Ralph; Swirski, Filip K.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Rauch, Philipp J.; Chudnovskiy, Aleksey; Robbins, Clinton S.; Weber, Georg F.; Etzrodt, Martin; Hilgendorf, Ingo; Tiglao, Elizabeth; Figueiredo, Jose-Luiz; Iwamoto, Yoshiko; Theurl, Igor; Gorbatov, Rostic; Waring, Michael T.; Chicoine, Adam T.; Pittet, Mikael J.; Nahrendorf, Matthias; Weissleder, Ralph; Swirski, Filip K.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Weissleder, Ralph] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Theurl, Igor] Massachusetts Gen Hosp, Program Membrane Biol, Boston, MA 02114 USA; [Theurl, Igor] Massachusetts Gen Hosp, Div Nephrol, Boston, MA 02114 USA; [Waring, Michael T.; Chicoine, Adam T.] Massachusetts Gen Hosp, Ragon Inst Imaging Core, Boston, MA 02114 USA; [Mouded, Majd] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Sch Med, Pittsburgh, PA 15213 USA; [Hilgendorf, Ingo] Univ Hosp Freiburg, Dept Cardiol, D-79106 Freiburg, Germany; [Theurl, Igor] Univ Innsbruck Hosp, Dept Gen Internal Med Clin Immunol & Infect Dis, A-6020 Innsbruck, Austria	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Freiburg; Medical University of Innsbruck	Robbins, CS (corresponding author), Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA.	robbins.clinton@mgh.harvard.edu; fswirski@mgh.harvard.edu	Swirski, Filip/AAF-1340-2019; Pittet, Mikael/ABD-6300-2021; Etzrodt, Martin/P-3325-2015; Hilgendorf, Ingo/AFM-6379-2022	Etzrodt, Martin/0000-0003-1928-3904; Hilgendorf, Ingo/0000-0002-0024-1643; Rauch, Philipp/0000-0001-8677-0986; Theurl, Igor/0000-0003-3180-4784; Robbins, Clinton/0000-0001-9848-1495; /0000-0003-0828-4143; Swirski, Filip/0000-0002-3163-9152	NIH [1R01HL095612, U01 HL080731, P50 CA86355, R24 CA69246, P01-A154904]; Boehringer Ingelheim Fonds; American Heart Association; MGH Executive Committee on Research (ECOR); German Research Foundation; Max Kade Foundation; NATIONAL CANCER INSTITUTE [P01CA069246, P50CA086355] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026360] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095612, U01HL080731] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim Fonds(Boehringer Ingelheim); American Heart Association(American Heart Association); MGH Executive Committee on Research (ECOR); German Research Foundation(German Research Foundation (DFG)); Max Kade Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by NIH grants 1R01HL095612 (to F. K. S.), as well as U01 HL080731, P50 CA86355, R24 CA69246, and P01-A154904 (to R. W.). P.J.R. was supported by the Boehringer Ingelheim Fonds; C. S. R. was supported by an American Heart Association postdoctoral fellowship and the MGH Executive Committee on Research (ECOR) Postdoctoral Award; G. F. W. and I. H. were supported by the German Research Foundation; and I. T. was supported by the Max Kade Foundation. We thank K. Rajewsky, D. Scadden, A. Luster, and K. Otipoby (Harvard Medical School) for helpful discussions and critical reading of the manuscript and M. Greene for secretarial assistance. The data reported in this paper are tabulated in the main paper and in the supporting online material. MIAME (minimum information about a microarray experiment)-compliant expression data have been deposited under the accession no. GSE32372.	Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; Allman D, 2008, CURR OPIN IMMUNOL, V20, P149, DOI 10.1016/j.coi.2008.03.014; Basu S, 1997, J IMMUNOL, V159, P1412; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Doi K, 2009, J CLIN INVEST, V119, P2868, DOI 10.1172/JCI39421; GENNARI R, 1994, ANN SURG, V220, P68, DOI 10.1097/00000658-199407000-00010; Griffin DO, 2011, J EXP MED, V208, P2591, DOI 10.1084/jem.20110978; Ha SA, 2006, J EXP MED, V203, P2541, DOI 10.1084/jem.20061041; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Hao ZY, 2001, J EXP MED, V194, P1151, DOI 10.1084/jem.194.8.1151; Harris RJ, 2000, J IMMUNOL, V164, P3887, DOI 10.4049/jimmunol.164.7.3887; Hotchkiss RS, 2010, NEW ENGL J MED, V363, P87, DOI 10.1056/NEJMcibr1004371; Kawahara T, 2003, J IMMUNOL, V171, P5406, DOI 10.4049/jimmunol.171.10.5406; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; LeBien TW, 2008, BLOOD, V112, P1570, DOI 10.1182/blood-2008-02-078071; Lu TT, 2002, SCIENCE, V297, P409, DOI 10.1126/science.1071632; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Metcalf D, 1999, BLOOD, V93, P1579, DOI 10.1182/blood.V93.5.1579.405k01_1579_1585; Montecino-Rodriguez E, 2006, TRENDS IMMUNOL, V27, P428, DOI 10.1016/j.it.2006.07.005; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Sonderegger I, 2008, J EXP MED, V205, P2281, DOI 10.1084/jem.20071119; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017	27	286	295	0	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 3	2012	335	6068					597	601		10.1126/science.1215173	http://dx.doi.org/10.1126/science.1215173			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885HI	22245738	Green Accepted			2022-12-28	WOS:000299769200047
J	Cohen, IG				Cohen, I. Glenn			Selling Bone Marrow - Flynn v. Holder	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Law, Cambridge, MA 02138 USA	Harvard University	Cohen, IG (corresponding author), Harvard Univ, Sch Law, Cambridge, MA 02138 USA.								0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 26	2012	366	4					296	297		10.1056/NEJMp1114288	http://dx.doi.org/10.1056/NEJMp1114288			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	881EQ	22187961	Bronze			2022-12-28	WOS:000299464100015
J	Weimerskirch, H; Louzao, M; de Grissac, S; Delord, K				Weimerskirch, Henri; Louzao, Maite; de Grissac, Sophie; Delord, Karine			Changes in Wind Pattern Alter Albatross Distribution and Life-History Traits	SCIENCE			English	Article							OCEAN; RESPONSES; SEABIRDS; DYNAMICS; SPEEDS; TRENDS	Westerly winds in the Southern Ocean have increased in intensity and moved poleward. Using long-term demographic and foraging records, we show that foraging range in wandering albatrosses has shifted poleward in conjunction with these changes in wind pattern, while their rates of travel and flight speeds have increased. Consequently, the duration of foraging trips has decreased, breeding success has improved, and birds have increased in mass by more than 1 kilogram. These positive consequences of climate change may be temporary if patterns of wind in the southern westerlies follow predicted climate change scenarios. This study stresses the importance of foraging performance as the key link between environmental changes and population processes.	[Weimerskirch, Henri; Louzao, Maite; de Grissac, Sophie; Delord, Karine] CNRS, Ctr Etud Biol Chize, F-79360 Villiers En Bois, France; [Louzao, Maite] UFZ Helmholtz Ctr Environm Res, D-04318 Leipzig, Germany	Centre National de la Recherche Scientifique (CNRS); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Weimerskirch, H (corresponding author), CNRS, Ctr Etud Biol Chize, F-79360 Villiers En Bois, France.	henriw@cebc.cnrs.fr	Louzao, Maite/N-5379-2014; de Grissac, Sophie/Q-6666-2017; Weimerskirch, Henri/F-5562-2013; Weimerskirch, Henri/K-7306-2019	de Grissac, Sophie/0000-0002-1589-8066; Weimerskirch, Henri/0000-0002-0457-586X; Louzao, Maite/0000-0002-9997-5144	French Polar Institute IPEV [109]; Prince Albert II de Monaco Foundation; Spanish Ministry of Education and Science [EX2007-1148]; Marie Curie Individual Fellowship [PIEF-GA-2008-220063]	French Polar Institute IPEV; Prince Albert II de Monaco Foundation; Spanish Ministry of Education and Science(Spanish Government); Marie Curie Individual Fellowship(European Commission)	The long-term data on the demography and foraging ecology of wandering albatrosses at Possession Island, Crozet Islands, were supported by the French Polar Institute IPEV (program no. 109 to H. W.), with additional funding from the Prince Albert II de Monaco Foundation. The study is a contribution to the Program ANR Biodiversite 2005-11 REMIGE. We acknowledge the modeling groups, the Program for Climate Model Diagnosis and Intercomparison (PCMDI), and the World Climate Research Programme's (WCRP's) Working Group on Coupled Modeling (WGCM) for their roles in making available the WCRP CMIP-3 multimodel data set. Support for data and model selection was provided by S. Jenouvrier. We thank the many field workers involved in the Crozet long-term monitoring since 1966 and in tracking programs since 1989, and D. Besson for help with the management of the demographic database. M. L. was funded by a postdoctoral contract of the Spanish Ministry of Education and Science (Ref. EX2007-1148) and Marie Curie Individual Fellowship (PIEF-GA-2008-220063). We are grateful to L. Riotte-Lambert for help with data analysis and C. Barbraud, C. A. Bost, Y. Cherel, and S. Jenouvrier for comments on the manuscript.	ALERSTAM T, 1993, PHILOS T ROY SOC B, V340, P55, DOI 10.1098/rstb.1993.0048; Alerstam T, 1993, BIRD MIGRATION; Davies RG, 2010, GLOBAL ECOL BIOGEOGR, V19, P98, DOI 10.1111/j.1466-8238.2009.00498.x; Felicisimo AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002928; Gillett NP, 2003, SCIENCE, V302, P273, DOI 10.1126/science.1087440; Gonzalez-Solis J, 2009, MAR ECOL PROG SER, V391, P221, DOI 10.3354/meps08128; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pennycuick C.J., 1989, BIRD FLIGHT PERFORMA; Peron C, 2010, GLOBAL CHANGE BIOL, V16, P1895, DOI 10.1111/j.1365-2486.2010.02169.x; Shaffer SA, 2001, FUNCT ECOL, V15, P203, DOI 10.1046/j.1365-2435.2001.00514.x; Solomon S., 2007, PHYS SCI BASIS WORKI; Suryan RM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004016; Thompson DWJ, 2002, SCIENCE, V296, P895, DOI 10.1126/science.1069270; Tuck GN, 2003, BIOL CONSERV, V114, P1, DOI 10.1016/S0006-3207(02)00378-6; Tuck GN, 2001, J APPL ECOL, V38, P1182, DOI 10.1046/j.0021-8901.2001.00661.x; Wakefield ED, 2009, ECOL MONOGR, V79, P663, DOI 10.1890/07-2111.1; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Weimerskirch H, 2005, ECOLOGY, V86, P2611, DOI 10.1890/04-1866; Weimerskirch H, 2000, P ROY SOC B-BIOL SCI, V267, P1869, DOI 10.1098/rspb.2000.1223; Weimerskirch H, 1997, BIOL CONSERV, V79, P257, DOI 10.1016/S0006-3207(96)00084-5; WEIMERSKIRCH H, 1995, OECOLOGIA, V102, P37, DOI 10.1007/BF00333308; Young IR, 2011, SCIENCE, V332, P451, DOI 10.1126/science.1197219	22	232	234	5	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 13	2012	335	6065					211	214		10.1126/science.1210270	http://dx.doi.org/10.1126/science.1210270			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875LZ	22246774				2022-12-28	WOS:000299033100051
J	Modi, BG; Neustadter, J; Binda, E; Lewis, J; Filler, RB; Roberts, SJ; Kwong, BY; Reddy, S; Overton, JD; Galan, A; Tigelaar, R; Cai, LN; Fu, P; Shlomchik, M; Kaplan, DH; Hayday, A; Girardi, M				Modi, Badri G.; Neustadter, Jason; Binda, Elisa; Lewis, Julia; Filler, Renata B.; Roberts, Scott J.; Kwong, Bernice Y.; Reddy, Swapna; Overton, John D.; Galan, Anjela; Tigelaar, Robert; Cai, Lining; Fu, Peter; Shlomchik, Mark; Kaplan, Daniel H.; Hayday, Adrian; Girardi, Michael			Langerhans Cells Facilitate Epithelial DNA Damage and Squamous Cell Carcinoma	SCIENCE			English	Article							ARYL-HYDROCARBON RECEPTOR; CONTACT HYPERSENSITIVITY; MOUSE SKIN; T-CELLS; RAS GENE; H-RAS; MICE; CARCINOGENESIS; 7,12-DIMETHYLBENZ(A)ANTHRACENE; EXPRESSION	Polyaromatic hydrocarbons (PAHs) are prevalent, potent carcinogens, and 7,12-dimethylbenz[a]anthracene (DMBA) is a model PAH widely used to study tumorigenesis. Mice lacking Langerhans cells (LCs), a signatory epidermal dendritic cell (DC), are protected from cutaneous chemical carcinogenesis, independent of T cell immunity. Investigation of the underlying mechanism revealed that LC-deficient skin was relatively resistant to DMBA-induced DNA damage. LCs efficiently metabolized DMBA to DMBA-trans-3,4-diol, an intermediate proximal to oncogenic Hras mutation, and DMBA-treated LC-deficient skin contained significantly fewer Hras mutations. Moreover, DMBA-trans-3,4-diol application bypassed tumor resistance in LC-deficient mice. Additionally, the genotoxic impact of DMBA on human keratinocytes was significantly increased by prior incubation with human-derived LC. Thus, tissue-associated DC can enhance chemical carcinogenesis via PAH metabolism, highlighting the complex relation between immune cells and carcinogenesis.	[Modi, Badri G.; Neustadter, Jason; Lewis, Julia; Filler, Renata B.; Roberts, Scott J.; Kwong, Bernice Y.; Reddy, Swapna; Galan, Anjela; Tigelaar, Robert; Girardi, Michael] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06520 USA; [Shlomchik, Mark] Yale Univ, Sch Med, Dept Lab Med & Immunobiol, New Haven, CT 06520 USA; [Overton, John D.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Overton, John D.] Yale Univ, Sch Med, Yale Ctr Genome Anal, New Haven, CT 06520 USA; [Cai, Lining] Biotranex, Monmouth Jct, NJ 08852 USA; [Fu, Peter] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [Kaplan, Daniel H.] Univ Minnesota, Dept Dermatol, Minneapolis, MN 55455 USA; [Kaplan, Daniel H.] Univ Minnesota, Dept Immunobiol, Minneapolis, MN 55455 USA; [Binda, Elisa; Hayday, Adrian] Kings Coll London, Guys & St Thomas Hosp, Peter Gorer Dept Immunobiol, Comprehens Biomed Res Ctr, London SE1 9RT, England; [Binda, Elisa; Hayday, Adrian] Canc Res UK CRUK, London Res Inst, London WC2 A, England	Yale University; Yale University; Yale University; Yale University; US Food & Drug Administration (FDA); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Cancer Research UK	Girardi, M (corresponding author), Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06520 USA.	girardi@yale.edu	Kaplan, Daniel H/N-2779-2013; Shlomchik, Mark J./AAN-6189-2020	Kaplan, Daniel H/0000-0002-7851-7320; Shlomchik, Mark J./0000-0002-2152-0959; HAYDAY, ADRIAN/0000-0002-9495-5793; Girardi, Michael/0000-0003-1887-9343	NIH [R01CA102703, T32, RO1-AR044077, RO1-AR056632]; Richard K. Gershon Research Fellowship; National Cancer Institute of the Yale Comprehensive Cancer Center [P30 CA016359]; Wellcome Trust; Cancer Research UK; Department of Health via the National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre; St. Thomas' NHS Foundation Trust; Cancer Research UK [19309] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA102703, P30CA016359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007016, R01AR056632, K08AR002072, R01AR044077] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Richard K. Gershon Research Fellowship; National Cancer Institute of the Yale Comprehensive Cancer Center; Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Department of Health via the National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); St. Thomas' NHS Foundation Trust; Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding for this work was provided by the NIH grants R01CA102703 (to M. G.), T32 (to J.N.), RO1-AR044077 (to M. S.), and RO1-AR056632 (to D. H. K.) and the Richard K. Gershon Research Fellowship (to B. G. M.). This work was supported by resources of the National Cancer Institute (grant P30 CA016359) of the Yale Comprehensive Cancer Center, the Wellcome Trust (to A. H.), Cancer Research UK (to A. H.), and the Department of Health via the National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre award to Guy's and St. Thomas' NHS Foundation Trust in partnership with King's College London (KCL) and King's College Hospital NHS Foundation Trust (to A. H. and E. B.). This paper is not an official guidance or policy statement of the U. S. FDA, and no official support or endorsement by the FDA is intended or should be inferred. We thank E. Gulcicek for HPLC support and M. Choi for sequence analysis support; M. Udey (NIH), A. Balmain [Univ. of California San Francisco (UCSF)], A. Behrens (CRUK), F. Nestle (KCL), and R. Groves (KCL) for protocol advice; O. Sobolev (KCL), J. Strid (KCL), F. Geissmann (KCL), K. Golubets (Yale), D. Smith (Yale), and G. Tokmoulina (Yale) for assistance; and A. Takashima (Univ. of Toledo) for XS106 cells and A. Balmain (UCSF) for CarC cells. The data tabulated in this paper are reported in the main text and in the supporting online material. Illumina sequence data are available from the National Center for Biotechnology Information Sequence Read Archive, accession no. SRA048406. Sites of experiments: New Haven, CT, USA, and London, UK.	ANDERSON C, 1995, J IMMUNOL, V155, P3530; BALMAIN A, 1984, NATURE, V307, P658, DOI 10.1038/307658a0; Brown K, 1998, CURR BIOL, V8, P516, DOI 10.1016/S0960-9822(98)70203-9; Buters J, 2003, CARCINOGENESIS, V24, P327, DOI 10.1093/carcin/24.2.327; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Daniel D, 2003, J EXP MED, V197, P1017, DOI 10.1084/jem.20021047; Esser C, 2009, TRENDS IMMUNOL, V30, P447, DOI 10.1016/j.it.2009.06.005; Girardi M, 2003, J EXP MED, V198, P747, DOI 10.1084/jem.20021282; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; GOULD MN, 1982, CARCINOGENESIS, V3, P667, DOI 10.1093/carcin/3.6.667; HENNINGS H, 1981, CANCER RES, V41, P773; Jux B, 2009, J IMMUNOL, V182, P6709, DOI 10.4049/jimmunol.0713344; Kaplan DH, 2008, EUR J IMMUNOL, V38, P2369, DOI 10.1002/eji.200838397; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; Matsumoto Y, 2007, ENVIRON SCI TECHNOL, V41, P3775, DOI 10.1021/es062793g; Miyata M, 1999, J BIOL CHEM, V274, P23963, DOI 10.1074/jbc.274.34.23963; NELSON MA, 1992, P NATL ACAD SCI USA, V89, P6398, DOI 10.1073/pnas.89.14.6398; Paus R, 1998, J INVEST DERMATOL, V111, P7, DOI 10.1046/j.1523-1747.1998.00243.x; PIERCEALL WE, 1991, MOL CARCINOGEN, V4, P196, DOI 10.1002/mc.2940040306; Plazter B., 2009, J IMMUNOL, V183, P66; POTTENGER LH, 1991, ARCH BIOCHEM BIOPHYS, V286, P488, DOI 10.1016/0003-9861(91)90070-Y; Roberts SJ, 2007, P NATL ACAD SCI USA, V104, P6770, DOI 10.1073/pnas.0604982104; Romani N, 2010, IMMUNOL REV, V234, P120, DOI 10.1111/j.0105-2896.2009.00886.x; Saeki M, 2002, INT ARCH ALLERGY IMM, V127, P333, DOI 10.1159/000057751; Savas U, 1997, ARCH BIOCHEM BIOPHYS, V347, P181, DOI 10.1006/abbi.1997.0339; SLAGA TJ, 1979, CANCER RES, V39, P1934; Strid J, 2008, NAT IMMUNOL, V9, P146, DOI 10.1038/ni1556; Tang MS, 2000, CANCER RES, V60, P5688; Trempus CS, 2007, CANCER RES, V67, P4173, DOI 10.1158/0008-5472.CAN-06-3128; Wakabayashi Y, 2007, NATURE, V445, P761, DOI 10.1038/nature05489; WISLOCKI PG, 1980, CANCER RES, V40, P3661; Xiao MJ, 2009, CANCER RES, V69, P2010, DOI 10.1158/0008-5472.CAN-08-3479; YUSPA SH, 1976, CANCER RES, V36, P947	33	93	96	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 6	2012	335	6064					104	108		10.1126/science.1211600	http://dx.doi.org/10.1126/science.1211600			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872YA	22223807	Green Accepted			2022-12-28	WOS:000298846200061
J	Racaniello, V				Racaniello, Vincent			An Exit Strategy for Measles Virus	SCIENCE			English	Editorial Material							CELLULAR RECEPTOR; POLIOVIRUS; ENTRY		Columbia Univ, New York, NY 10032 USA	Columbia University	Racaniello, V (corresponding author), Columbia Univ, New York, NY 10032 USA.	vrr1@columbia.edu						COHEN JI, 2007, FIELDS VIROLOGY, P2773; de Swart RL, 2007, PLOS PATHOG, V3, P1771, DOI 10.1371/journal.ppat.0030178; Geraghty RJ, 1998, SCIENCE, V280, P1618, DOI 10.1126/science.280.5369.1618; Lemon K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001263; Leonard VHJ, 2008, J CLIN INVEST, V118, P2448, DOI 10.1172/JCI35454; Ludlow M, 2010, J GEN VIROL, V91, P971, DOI 10.1099/vir.0.016428-0; MENDELSOHN CL, 1989, CELL, V56, P855, DOI 10.1016/0092-8674(89)90690-9; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; Noyce RS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002240; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Vermeer PD, 2007, J VIROL, V81, P9891, DOI 10.1128/JVI.00601-07	11	22	23	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1650	1651		10.1126/science.1217378	http://dx.doi.org/10.1126/science.1217378			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	865XK	22194562				2022-12-28	WOS:000298344000050
J	Shelton, JD				Shelton, James D.			ARVs as HIV Prevention: A Tough Road to Wide Impact	SCIENCE			English	Editorial Material							ANTIRETROVIRAL THERAPY; DRUG-RESISTANCE; INFECTION; TRANSMISSION; HIV/AIDS; AFRICA; COHORT		Bur Global Hlth, Washington, DC 20523 USA		Shelton, JD (corresponding author), Bur Global Hlth, Washington, DC 20523 USA.	jshelton@usaid.gov						[Anonymous], 2011, WORLD AIDS DAY REP; Brenner BG, 2008, AIDS, V22, P2509, DOI 10.1097/QAD.0b013e3283121c90; Cohen J., 2011, SCIENCEINSIDER  0928; Cohen J, 2011, SCIENCE, V333, P393, DOI 10.1126/science.333.6041.393; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Dalal RP, 2008, JAIDS-J ACQ IMM DEF, V47, P101, DOI 10.1097/QAI.0b013e31815b833a; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Fernandez-Fernandez B, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/354908; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Goodreau SM, 2012, AIDS BEHAV, V16, P312, DOI 10.1007/s10461-010-9858-x; Granich R, 2011, CURR HIV RES, V9, P446, DOI 10.2174/157016211798038597; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Grulich AE, 2010, LANCET, V376, P1824, DOI 10.1016/S0140-6736(10)62162-9; Halperin DT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000414; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Hasse B, 2010, CLIN INFECT DIS, V51, P1314, DOI 10.1086/656809; Hurt CB, 2011, CLIN INFECT DIS, V53, P1265, DOI 10.1093/cid/cir684; Jansen IAV, 2011, AIDS, V25, P493, DOI 10.1097/QAD.0b013e328342fbe9; Kajubi P, 2005, JAIDS-J ACQ IMM DEF, V40, P77, DOI 10.1097/01.qai.0000157391.63127.b2; Lesotho Ministry of Health and Social Welfare ICF Macro, 2010, LES DEM HLTH SURV 20; Millett GA, 2010, JAIDS-J ACQ IMM DEF, V55, pS144, DOI 10.1097/QAI.0b013e3181fbcb04; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Patterson KB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003174; Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863; PEPFAR, 2011, PEPFAR; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Shelton JD, 2010, LANCET, V376, P1824, DOI 10.1016/S0140-6736(10)62163-0; Trubo R, 2011, JAMA-J AM MED ASSOC, V306, P253, DOI 10.1001/jama.2011.979; UNAIDS, 2011, AIDS 30 NAT CROSSR	33	29	31	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1645	1646		10.1126/science.1212353	http://dx.doi.org/10.1126/science.1212353			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	865XK	22194560				2022-12-28	WOS:000298344000047
J	Kane, G				Kane, Gordon			Particle physics is at a turning point	NATURE			English	Editorial Material									Michigan Ctr Theoret Phys, Ann Arbor, MI USA		Kane, G (corresponding author), Michigan Ctr Theoret Phys, Ann Arbor, MI USA.	gkane@umich.edu							0	3	3	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2011	480	7378					415	415		10.1038/480415a	http://dx.doi.org/10.1038/480415a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865NQ	22193063	Bronze			2022-12-28	WOS:000298318000016
J	Trowbridge, RL				Trowbridge, Robert L.			Review: Insufficient evidence exists to determine the benefits and risks of statins for acute ischemic stroke or TIA	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							TRIALS		Maine Med Ctr, Portland, ME 04102 USA	Maine Medical Center	Trowbridge, RL (corresponding author), Maine Med Ctr, Portland, ME 04102 USA.		Trowbridge, Robert/U-8278-2019	Trowbridge, Robert/0000-0002-0460-2733				Amarenco P, 2009, LANCET NEUROL, V8, P453, DOI 10.1016/S1474-4422(09)70058-4; Blanco M, 2007, NEUROLOGY, V69, P904, DOI 10.1212/01.wnl.0000269789.09277.47; Gladstone DJ, 2002, STROKE, V33, P2123, DOI 10.1161/01.STR.0000025518.34157.51; Goldstein LB, 2009, CURR ATHEROSCLER REP, V11, P296, DOI 10.1007/s11883-009-0045-3; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6	5	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2011	155	12							JC6-6	10.7326/0003-4819-155-12-201112200-02006	http://dx.doi.org/10.7326/0003-4819-155-12-201112200-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	864ZU	22184707				2022-12-28	WOS:000298280500005
J	Mwaniki, MK; Atieno, M; Lawn, JE; Newton, CRJC				Mwaniki, Michael K.; Atieno, Maurine; Lawn, Joy E.; Newton, Charles R. J. C.			Long-term neurodevelopmental outcomes after intrauterine and neonatal insults: a systematic review	LANCET			English	Article							VIRUS TYPE-1 INFECTION; CHILDREN; TRANSMISSION; TETANUS; INFANTS; BIRTH; HIV; IMPAIRMENT; MORTALITY; JAUNDICE	Background Neonatal interventions are largely focused on reduction of mortality and progression towards Millennium Development Goal 4 (child survival). However, little is known about the global burden of long-term consequences of intrauterine and neonatal insults. We did a systematic review to estimate risks of long-term neurocognitive and other sequelae after intrauterine and neonatal insults, especially in low-income and middle-income countries. Methods We searched Medline, Cumulative Index to Nursing and Allied Health Literature, the Cochrane Library, and Embase for studies published between Jan 1, 1966, and June 30, 2011, that reported neurodevelopmental sequelae after preterm or neonatal insult. For unpublished studies and grey literature, we searched Dissertation Abstracts Inter national and the WHO library. We reviewed publications that had data for long-term outcome after defined neonatal insults. We summarised the results with medians and IQRs, and calculated the risk of at least one sequela after insult. Findings Of 28 212 studies identified by our search, 153 studies were suitable for inclusion, documenting 22 161 survivors of intrauterine or neonatal insults. The overall median risk of at least one sequela in any domain was 39.4% (IQR 20.0-54.8), with a risk of at least one severe impairment in any insult domain of 18.5% (7.7-33.3), of at least one moderate impairment of 5.0% (0.0-13.3%), and of at least one mild impairment of 10.0% (1.4-17.9%). The pooled risk estimate of at least one sequela (weighted mean) associated with one or more of the insults studied (excluding HIV) was 37.0% (95% CI 27.0-48.0%) and this risk was not significantly affected by region, duration of the follow-up, study design, or period of data collection. The most common sequelae were learning difficulties, cognition, or develop mental delay (n=4032; 59%); cerebral palsy (n=1472; 21%); hearing impairment (n=1340; 20%); and visual impairment (n=1228; 18%). Only 40 (26%) studies included data for multidomain impairments. These studies included 2815 individuals, of whom 1048 (37%) had impairments, with 334 (32%) having multiple impairments. Interpretation Intrauterine and neonatal insults have a high risk of causing substantial long-term neurological morbidity. Comparable cohort studies in resource-poor regions should be done to properly assess the burden of these conditions, and long-term outcomes, such as chronic disease, and to inform policy and programme investments.	[Mwaniki, Michael K.; Atieno, Maurine; Newton, Charles R. J. C.] Kenya Govt Med Res Ctr, Ctr Geog Med Res Coast, Kilifi, Kenya; [Lawn, Joy E.] Save Children, Saving Newborn Lives, Cape Town, South Africa; [Newton, Charles R. J. C.] UCL, Inst Child Hlth, Neurosci Unit, London, England; [Newton, Charles R. J. C.] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford, England	Kenya Medical Research Institute; Save the Children; University of London; University College London; University of Oxford	Mwaniki, MK (corresponding author), Kenya Govt Med Res Ctr, Ctr Geog Med Res Coast, POB 230, Kilifi, Kenya.	michael.kivkiv@gmail.com	Newton, Charles RJC/B-7578-2014; Lawn, Joy/ABE-6382-2020; pan, tao/O-7308-2014; Newton, Charles/V-7872-2019	Newton, Charles RJC/0000-0002-6999-5507; Lawn, Joy/0000-0002-4573-1443; Newton, Charles/0000-0002-6999-5507	Bill & Melinda Gates Foundation; Saving Newborn Lives; Wellcome Trust	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Saving Newborn Lives; Wellcome Trust(Wellcome TrustEuropean Commission)	The Bill & Melinda Gates Foundation, Saving Newborn Lives, and the Wellcome Trust.	ANLAR B, 1989, DEV MED CHILD NEUROL, V31, P76; Barlow JL, 2001, TROP MED INT HEALTH, V6, P305, DOI 10.1046/j.1365-3156.2001.00705.x; Battin MR, 2001, PEDIATRICS, V107, P480, DOI 10.1542/peds.107.3.480; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Blencowe H, 2011, BMC PUBLIC HEALTH, V11, DOI [10.1186/1471-2458-11-S3-S9, 10.1186/1471-2458-11-S3-S11]; Carter JA, 2003, BRAIN RES REV, V43, P57, DOI 10.1016/S0165-0173(03)00192-9; Chopra M, 2002, SAMJ S AFR MED J, V92, P298; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; CRICHTON JU, 1972, PEDIATRICS, V49, P656; Diaz C, 1998, J ACQ IMMUN DEF SYND, V18, P221, DOI 10.1097/00042560-199807010-00004; Dickover RE, 1998, J INFECT DIS, V178, P375, DOI 10.1086/515637; EREGIE CO, 1993, E AFR MED J, V70, P434; Ganz ML, 2006, PEDIATRICS, V117, P2138, DOI 10.1542/peds.2005-1531; Gordon AL, 2005, TROP MED INT HEALTH, V10, P1114, DOI 10.1111/j.1365-3156.2005.01496.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jeremiah Theresa A, 2009, East Afr J Public Health, V6, P17; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2006, INT J EPIDEMIOL, V35, P706, DOI 10.1093/ije/dyl043; Lawn JE, 2010, SEMIN PERINATOL, V34, P371, DOI 10.1053/j.semperi.2010.09.011; Leyenaar JK, PEDIAT INFECT DIS J, V29, P340; Ma XL, 2009, J PERINAT MED, V37, P695, DOI 10.1515/JPM.2009.130; McGrath N, 2006, PEDIATR INFECT DIS J, V25, P47, DOI 10.1097/01.inf.0000195638.80578.e0; Melamed N, 2009, OBSTET GYNECOL, V114, P253, DOI 10.1097/AOG.0b013e3181af6931; Mwansa-Kambafwile J, 2010, INT J EPIDEMIOL, V39, P122, DOI 10.1093/ije/dyq029; Oestergaard MZ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001080; Offor E, 2000, J Obstet Gynaecol, V20, P589, DOI 10.1080/0144361001396; Olusanya BO, 2007, PLOS MED, V4, P391, DOI 10.1371/journal.pmed.0040084; Paul VK, 2006, SEMIN FETAL NEONAT M, V11, P7, DOI 10.1016/j.siny.2005.10.005; Roper MH, 2007, LANCET, V370, P1947, DOI 10.1016/S0140-6736(07)61261-6; Rudan I, 2005, LANCET, V365, P2031, DOI 10.1016/S0140-6736(05)66697-4; Smith R, 2000, PEDIATR INFECT DIS J, V19, P862, DOI 10.1097/00006454-200009000-00010; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; Swai RO, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-91; TEKNETZI P, 1983, ARCH DIS CHILD, V58, P68, DOI 10.1136/adc.58.1.68; Theng T, 2004, INT J STD AIDS, V15, P419, DOI 10.1258/095646204774195290; THOMAS PA, 1994, PEDIATR INFECT DIS J, V13, P489, DOI 10.1097/00006454-199406000-00005; Vreeman RC, 2009, QUAL HEALTH RES, V19, P1716, DOI 10.1177/1049732309353047; WHO, 2009, WHOIVB0902; World Health Organization, 2001, GLOB BURD DIS COMPR	39	508	537	5	77	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 4	2012	379	9814					445	452		10.1016/S0140-6736(11)61577-8	http://dx.doi.org/10.1016/S0140-6736(11)61577-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	891AF	22244654	Green Published, Green Accepted			2022-12-28	WOS:000300187800034
J	Gutmann, A; Wagner, JW				Gutmann, Amy; Wagner, James W.			Moral science and the Presidential Commission for the Study of Bioethical Issues	LANCET			English	Editorial Material									[Gutmann, Amy; Wagner, James W.] Presidential Commiss, Study Bioeth Issues, Washington, DC 20005 USA		Gutmann, A (corresponding author), Presidential Commiss, Study Bioeth Issues, Washington, DC 20005 USA.	president@upenn.edu						Equivalent Protections Working Group, 2003, REP EQ PROT WORK GRO; Franklin B, 1839, WORKS B FRANKLIN, VVIII; Institute of Medicine, 2003, RESP RES SYST APPR P; Presidential Commission for the Study of Bioethical Issues, 2011, P INT RES PAN PRES C, P11; Presidential Commission for the Study of Bioethical Issues, 2011, ETH IMP STD RES GUAT; Presidential Commission for the Study of Bioethical Issues, 2011, MOR SCI PROT PART HU; Reverby SM, 2011, J POLICY HIST, V23, P6, DOI 10.1017/S0898030610000291; The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, 1978, DEP HLTH ED WELF PUB, P10; *US DEP HHS, INF 1946 1948 US PUB	9	4	4	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 28	2012	379	9813					E20	E21		10.1016/S0140-6736(11)61884-9	http://dx.doi.org/10.1016/S0140-6736(11)61884-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	889BA	22177261				2022-12-28	WOS:000300047300001
J	Jager, S; Kim, DY; Hultquist, JF; Shindo, K; LaRue, RS; Kwon, E; Li, M; Anderson, BD; Yen, L; Stanley, D; Mahon, C; Kane, J; Franks-Skiba, K; Cimermancic, P; Burlingame, A; Sali, A; Craik, CS; Harris, RS; Gross, JD; Krogan, NJ				Jaeger, Stefanie; Kim, Dong Young; Hultquist, Judd F.; Shindo, Keisuke; LaRue, Rebecca S.; Kwon, Eunju; Li, Ming; Anderson, Brett D.; Yen, Linda; Stanley, David; Mahon, Cathal; Kane, Joshua; Franks-Skiba, Kathy; Cimermancic, Peter; Burlingame, Alma; Sali, Andrej; Craik, Charles S.; Harris, Reuben S.; Gross, John D.; Krogan, Nevan J.			Vif hijacks CBF-beta to degrade APOBEC3G and promote HIV-1 infection	NATURE			English	Article							UBIQUITIN-LIGASE COMPLEX; SOCS-BOX; RESTRICTION FACTORS; ANTIVIRAL ACTIVITY; PROTEIN; SPECIFICITY; PROTEASOME; MECHANISM; TARGETS; TISSUES	Restriction factors, such as the retroviral complementary DNA deaminase APOBEC3G, are cellular proteins that dominantly block virus replication(1-3). The AIDS virus, human immuno deficiency virus type 1 (HIV-1), produces the accessory factor Vif, which counteracts the host's antiviral defence by hijacking a ubiquitin ligase complex, containing CUL5, ELOC, ELOB and a RING-box protein, and targeting APOBEC3G for degradation(4-10). Here we reveal, using an affinity tag/purification mass spectrometry approach, that Vif additionally recruits the transcription cofactor CBF-beta to this ubiquitin ligase complex. CBF-beta, which normally functions in concert with RUNX DNA binding proteins, allows the reconstitution of a recombinant six-protein assembly that elicits specific polyubiquitination activity with APOBEC3G, but not the related deaminase APOBEC3A. Using RNA knockdown and genetic complementation studies, we also demonstrate that CBF-beta is required for Vif-mediated degradation of APOBEC3G and therefore for preserving HIV-1 infectivity. Finally, simian immunodeficiency virus (SIV) Vif also binds to and requires CBF-beta to degrade rhesus macaque APOBEC3G, indicating functional conservation. Methods of disrupting the CBF-beta-Vif interaction might enable HIV-1 restriction and provide a supplement to current antiviral therapies that primarily target viral proteins.	[Hultquist, Judd F.; Shindo, Keisuke; LaRue, Rebecca S.; Li, Ming; Anderson, Brett D.; Harris, Reuben S.] Univ Minnesota, Inst Mol Virol, Dept Biochem Mol Biol & Biophys, Ctr Genome Engn, Minneapolis, MN 55455 USA; [Jaeger, Stefanie; Mahon, Cathal; Kane, Joshua; Franks-Skiba, Kathy; Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Jaeger, Stefanie; Mahon, Cathal; Kane, Joshua; Franks-Skiba, Kathy; Cimermancic, Peter; Burlingame, Alma; Sali, Andrej; Craik, Charles S.; Gross, John D.; Krogan, Nevan J.] QB3, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [Kim, Dong Young; Kwon, Eunju; Yen, Linda; Stanley, David; Mahon, Cathal; Burlingame, Alma; Sali, Andrej; Craik, Charles S.; Gross, John D.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Cimermancic, Peter; Sali, Andrej] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Sali, Andrej; Gross, John D.; Krogan, Nevan J.] Univ Calif San Francisco, HPC Host Pathogen Circuitry Grp, San Francisco, CA 94158 USA; [Krogan, Nevan J.] J David Gladstone Inst, San Francisco, CA 94158 USA	University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes	Harris, RS (corresponding author), Univ Minnesota, Inst Mol Virol, Dept Biochem Mol Biol & Biophys, Ctr Genome Engn, Minneapolis, MN 55455 USA.	rsh@umn.edu; jdgross@cgl.ucsf.edu; krogan@cmp.ucsf.edu		Kim, Dong Young/0000-0001-7594-9083; Shindo, Keisuke/0000-0001-8793-8189; Anderson, Brett/0000-0002-5537-8663; Hultquist, Judd/0000-0001-6424-4280	QB3 at University of California, San Francisco; National Institutes of Health [P50 GM082250, P01 AI090935, P50 GM081879, U54 RR022220, R01 AI064046, P01 GM091743, P41RR001614, P50GM081879]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022220, P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064046, T32AI083196, P01AI090935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082250, P50GM081879, P41GM103481, P01GM091743] Funding Source: NIH RePORTER	QB3 at University of California, San Francisco; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Krogan, Gross and Harris laboratories for comments, J. R. Johnson for mass spectrometry, B. Leonard for sharing unpublished data, M. Shales for help with figures, and B. Chesebro, D. Gabuzda, J. Lingappa, M. Malim, K. Wehrly, X. F. Yu, A. Bullock, B. Schulman and the AIDS Research and Reference Reagent Program for reagents. This research was funded by grants from QB3 at University of California, San Francisco, and the National Institutes of Health (P50 GM082250, P01 AI090935 and P50 GM081879 to N.J.K.; U54 RR022220 to A. S.; R01 AI064046 and P01 GM091743 to R. S. H.; P50 GM082250 to J. D. G. and C. S. C.; P41RR001614 and P50GM081879 to A. B.). N.J.K. is a Searle Scholar and a Keck Young Investigator.	Albin JS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001343; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; DeHart JL, 2008, J VIROL, V82, P9265, DOI 10.1128/JVI.00377-08; Goff SP, 2004, MOL CELL, V16, P849, DOI 10.1016/j.molcel.2004.12.001; Huang DT, 2009, MOL CELL, V33, P483, DOI 10.1016/j.molcel.2009.01.011; Hultquist JF, 2011, J VIROL, V85, P11220, DOI 10.1128/JVI.05238-11; Jager S, 2011, METHODS, V53, P13, DOI 10.1016/j.ymeth.2010.08.007; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Koning FA, 2009, J VIROL, V83, P9474, DOI 10.1128/JVI.01089-09; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Mehle A, 2004, GENE DEV, V18, P2861, DOI 10.1101/gad.1249904; Mehle A, 2004, J BIOL CHEM, V279, P7792, DOI 10.1074/jbc.M313093200; Passmore LA, 2004, BIOCHEM J, V379, P513, DOI 10.1042/BJ20040198; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stanley BJ, 2008, J VIROL, V82, P8656, DOI 10.1128/JVI.00767-08; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Wong WF, 2011, IMMUNOLOGY, V132, P157, DOI 10.1111/j.1365-2567.2010.03381.x; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591	27	268	274	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 19	2012	481	7381					371	375		10.1038/nature10693	http://dx.doi.org/10.1038/nature10693			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877VK	22190037	Green Accepted			2022-12-28	WOS:000299210600044
J	Ackermann, M; Ajello, M; Ballet, J; Barbiellini, G; Bastieri, D; Belfiore, A; Bellazzini, R; Berenji, B; Blandford, RD; Bloom, ED; Bonamente, E; Borgland, AW; Bregeon, J; Brigida, M; Bruel, P; Buehler, R; Buson, S; Caliandro, GA; Cameron, RA; Caraveo, PA; Cavazzuti, E; Cecchi, C; Celik, O; Charles, E; Chaty, S; Chekhtman, A; Cheung, CC; Chiang, J; Ciprini, S; Claus, R; Cohen-Tanugi, J; Corbel, S; Corbet, RHD; Cutini, S; de Luca, A; den Hartog, PR; de Palma, F; Dermer, CD; Digel, SW; Silva, EDE; Donato, D; Drell, PS; Drlica-Wagner, A; Dubois, R; Dubus, G; Favuzzi, C; Fegan, SJ; Ferrara, EC; Focke, WB; Fortin, P; Fukazawa, Y; Funk, S; Fusco, P; Gargano, F; Gasparrini, D; Gehrels, N; Germani, S; Giglietto, N; Giordano, F; Giroletti, M; Glanzman, T; Godfrey, G; Grenier, IA; Grove, JE; Guiriec, S; Hadasch, D; Hanabata, Y; Harding, AK; Hayashida, M; Hays, E; Hill, AB; Hughes, RE; Johannesson, G; Johnson, AS; Johnson, TJ; Kamae, T; Katagiri, H; Kataoka, J; Kerr, M; Knodlseder, J; Kuss, M; Lande, J; Longo, F; Loparco, F; Lovellette, MN; Lubrano, P; Mazziotta, MN; McEnery, JE; Michelson, PF; Mitthumsiri, W; Mizuno, T; Monte, C; Monzani, ME; Morselli, A; Moskalenko, IV; Murgia, S; Nakamori, T; Naumann-Godo, M; Norris, JP; Nuss, E; Ohno, M; Ohsugi, T; Okumura, A; Omodei, N; Orlando, E; Ozaki, M; Paneque, D; Parent, D; Pesce-Rollins, M; Pierbattista, M; Piron, F; Pivato, G; Porter, TA; Raino, S; Rando, R; Razzano, M; Reimer, A; Reimer, O; Ritz, S; Romani, RW; Roth, M; Parkinson, PMS; Sgro, C; Siskind, EJ; Spandre, G; Spinelli, P; Suson, DJ; Takahashi, H; Tanaka, T; Thayer, JG; Thayer, JB; Thompson, DJ; Tibaldo, L; Tinivella, M; Torres, DF; Tosti, G; Troja, E; Uchiyama, Y; Usher, TL; Vandenbroucke, J; Vianello, G; Vitale, V; Waite, AP; Winer, BL; Wood, KS; Wood, M; Yang, Z; Zimmer, S; Coe, MJ; Di Mille, F; Edwards, PG; Filipovic, MD; Payne, JL; Stevens, J; Torres, MAP				Ackermann, M.; Ajello, M.; Ballet, J.; Barbiellini, G.; Bastieri, D.; Belfiore, A.; Bellazzini, R.; Berenji, B.; Blandford, R. D.; Bloom, E. D.; Bonamente, E.; Borgland, A. W.; Bregeon, J.; Brigida, M.; Bruel, P.; Buehler, R.; Buson, S.; Caliandro, G. A.; Cameron, R. A.; Caraveo, P. A.; Cavazzuti, E.; Cecchi, C.; Celik, Oe.; Charles, E.; Chaty, S.; Chekhtman, A.; Cheung, C. C.; Chiang, J.; Ciprini, S.; Claus, R.; Cohen-Tanugi, J.; Corbel, S.; Corbet, R. H. D.; Cutini, S.; de Luca, A.; den Hartog, P. R.; de Palma, F.; Dermer, C. D.; Digel, S. W.; do Couto e Silva, E.; Donato, D.; Drell, P. S.; Drlica-Wagner, A.; Dubois, R.; Dubus, G.; Favuzzi, C.; Fegan, S. J.; Ferrara, E. C.; Focke, W. B.; Fortin, P.; Fukazawa, Y.; Funk, S.; Fusco, P.; Gargano, F.; Gasparrini, D.; Gehrels, N.; Germani, S.; Giglietto, N.; Giordano, F.; Giroletti, M.; Glanzman, T.; Godfrey, G.; Grenier, I. A.; Grove, J. E.; Guiriec, S.; Hadasch, D.; Hanabata, Y.; Harding, A. K.; Hayashida, M.; Hays, E.; Hill, A. B.; Hughes, R. E.; Johannesson, G.; Johnson, A. S.; Johnson, T. J.; Kamae, T.; Katagiri, H.; Kataoka, J.; Kerr, M.; Knoedlseder, J.; Kuss, M.; Lande, J.; Longo, F.; Loparco, F.; Lovellette, M. N.; Lubrano, P.; Mazziotta, M. N.; McEnery, J. E.; Michelson, P. F.; Mitthumsiri, W.; Mizuno, T.; Monte, C.; Monzani, M. E.; Morselli, A.; Moskalenko, I. V.; Murgia, S.; Nakamori, T.; Naumann-Godo, M.; Norris, J. P.; Nuss, E.; Ohno, M.; Ohsugi, T.; Okumura, A.; Omodei, N.; Orlando, E.; Ozaki, M.; Paneque, D.; Parent, D.; Pesce-Rollins, M.; Pierbattista, M.; Piron, F.; Pivato, G.; Porter, T. A.; Raino, S.; Rando, R.; Razzano, M.; Reimer, A.; Reimer, O.; Ritz, S.; Romani, R. W.; Roth, M.; Parkinson, P. M. Saz; Sgro, C.; Siskind, E. J.; Spandre, G.; Spinelli, P.; Suson, D. J.; Takahashi, H.; Tanaka, T.; Thayer, J. G.; Thayer, J. B.; Thompson, D. J.; Tibaldo, L.; Tinivella, M.; Torres, D. F.; Tosti, G.; Troja, E.; Uchiyama, Y.; Usher, T. L.; Vandenbroucke, J.; Vianello, G.; Vitale, V.; Waite, A. P.; Winer, B. L.; Wood, K. S.; Wood, M.; Yang, Z.; Zimmer, S.; Coe, M. J.; Di Mille, F.; Edwards, P. G.; Filipovic, M. D.; Payne, J. L.; Stevens, J.; Torres, M. A. P.		Fermi LAT Collaboration	Periodic Emission from the Gamma-Ray Binary 1FGL J1018.6-5856	SCIENCE			English	Article							LARGE-AREA TELESCOPE; LS 5039; MICROQUASAR LS-5039; FERMI; MODULATION; DISCOVERY; PULSARS; CATALOG; STARS; MASS	Gamma-ray binaries are stellar systems containing a neutron star or black hole, with gamma-ray emission produced by an interaction between the components. These systems are rare, even though binary evolution models predict dozens in our Galaxy. A search for gamma-ray binaries with the Fermi Large Area Telescope (LAT) shows that 1FGL J1018.6-5856 exhibits intensity and spectral modulation with a 16.6-day period. We identified a variable x-ray counterpart, which shows a sharp maximum coinciding with maximum gamma-ray emission, as well as an O6V((f)) star optical counterpart and a radio counterpart that is also apparently modulated on the orbital period. 1FGL J1018.6-5856 is thus a gamma-ray binary, and its detection suggests the presence of other fainter binaries in the Galaxy.	[Ackermann, M.; Ajello, M.; Berenji, B.; Blandford, R. D.; Bloom, E. D.; Borgland, A. W.; Buehler, R.; Cameron, R. A.; Charles, E.; Chiang, J.; Claus, R.; den Hartog, P. R.; Digel, S. W.; do Couto e Silva, E.; Drell, P. S.; Drlica-Wagner, A.; Dubois, R.; Focke, W. B.; Funk, S.; Glanzman, T.; Godfrey, G.; Hayashida, M.; Johnson, A. S.; Kamae, T.; Kerr, M.; Lande, J.; Michelson, P. F.; Mitthumsiri, W.; Monzani, M. E.; Moskalenko, I. V.; Murgia, S.; Okumura, A.; Omodei, N.; Orlando, E.; Paneque, D.; Porter, T. A.; Reimer, A.; Reimer, O.; Romani, R. W.; Tanaka, T.; Thayer, J. G.; Thayer, J. B.; Uchiyama, Y.; Usher, T. L.; Vandenbroucke, J.; Vianello, G.; Waite, A. P.; Wood, M.] Stanford Univ, Dept Phys, Kavli Inst Particle Astrophys & Cosmol, WW Hansen Expt Phys Lab, Stanford, CA 94305 USA; [Ackermann, M.; Ajello, M.; Berenji, B.; Blandford, R. D.; Bloom, E. D.; Borgland, A. W.; Buehler, R.; Cameron, R. A.; Charles, E.; Chiang, J.; Claus, R.; den Hartog, P. R.; Digel, S. W.; do Couto e Silva, E.; Drell, P. S.; Drlica-Wagner, A.; Dubois, R.; Focke, W. B.; Funk, S.; Glanzman, T.; Godfrey, G.; Hayashida, M.; Johnson, A. S.; Kamae, T.; Kerr, M.; Lande, J.; Michelson, P. F.; Mitthumsiri, W.; Monzani, M. E.; Moskalenko, I. V.; Murgia, S.; Okumura, A.; Omodei, N.; Orlando, E.; Paneque, D.; Porter, T. A.; Reimer, A.; Reimer, O.; Romani, R. W.; Tanaka, T.; Thayer, J. G.; Thayer, J. B.; Uchiyama, Y.; Usher, T. L.; Vandenbroucke, J.; Vianello, G.; Waite, A. P.; Wood, M.] Stanford Univ, SLAC Natl Accelerator Lab, Stanford, CA 94305 USA; [Ballet, J.; Chaty, S.; Corbel, S.; Grenier, I. A.; Naumann-Godo, M.; Pierbattista, M.] Univ Paris Diderot, CNRS, CEA IRFU, Lab AIM,Serv Astrophys,CEA Saclay, F-91191 Gif Sur Yvette, France; [Barbiellini, G.; Longo, F.] Ist Nazl Fis Nucl, Sez Trieste, I-34127 Trieste, Italy; [Barbiellini, G.; Longo, F.] Univ Trieste, Dipartimento Fis, I-34127 Trieste, Italy; [Bastieri, D.; Buson, S.; Rando, R.; Tibaldo, L.] Ist Nazl Fis Nucl, Sez Padova, I-35131 Padua, Italy; [Bastieri, D.; Buson, S.; Pivato, G.; Rando, R.; Tibaldo, L.] Univ Padua, Dipartimento Fis G Galilei, I-35131 Padua, Italy; [Belfiore, A.; Razzano, M.; Ritz, S.; Parkinson, P. M. Saz] Univ Calif Santa Cruz, Dept Phys, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA; [Belfiore, A.; Razzano, M.; Ritz, S.; Parkinson, P. M. Saz] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Belfiore, A.] Univ Pavia, I-27100 Pavia, Italy; [Belfiore, A.; Caraveo, P. A.] INAF Ist Astrofis Spaziale & Fis Cosm, I-20133 Milan, Italy; [Bellazzini, R.; Bregeon, J.; Kuss, M.; Pesce-Rollins, M.; Razzano, M.; Sgro, C.; Spandre, G.; Tinivella, M.] Ist Nazl Fis Nucl, Sez Pisa, I-56127 Pisa, Italy; [Bonamente, E.; Cecchi, C.; Germani, S.; Lubrano, P.; Tosti, G.] Ist Nazl Fis Nucl, Sez Perugia, I-06123 Perugia, Italy; [Bonamente, E.; Cecchi, C.; Ciprini, S.; Germani, S.; Lubrano, P.; Tosti, G.] Univ Perugia, Dipartimento Fis, I-06123 Perugia, Italy; [Brigida, M.; de Palma, F.; Favuzzi, C.; Fusco, P.; Giglietto, N.; Giordano, F.; Loparco, F.; Monte, C.; Raino, S.; Spinelli, P.] Univ Bari, Dipartimento Fis M Merlin, I-70126 Bari, Italy; [Brigida, M.; de Palma, F.; Favuzzi, C.; Fusco, P.; Giglietto, N.; Giordano, F.; Loparco, F.; Monte, C.; Raino, S.; Spinelli, P.] Politecn Bari, I-70126 Bari, Italy; [Brigida, M.; de Palma, F.; Favuzzi, C.; Fusco, P.; Gargano, F.; Giglietto, N.; Giordano, F.; Loparco, F.; Mazziotta, M. N.; Monte, C.; Raino, S.; Spinelli, P.] Ist Nazl Fis Nucl, Sez Bari, I-70126 Bari, Italy; [Bruel, P.; Fegan, S. J.; Fortin, P.] Ecole Polytech, CNRS, IN2P3, Lab Leprince Ringuet, F-91128 Palaiseau, France; [Caliandro, G. A.; Hadasch, D.; Torres, D. F.] Inst Ciencies Espai IEEE CSIC, Barcelona 08193, Spain; [Cavazzuti, E.; Cutini, S.; Gasparrini, D.] Agenzia Spaziale Italiana ASI Sci Data Ctr, I-00044 Rome, Italy; [Celik, Oe.; Corbet, R. H. D.; Ferrara, E. C.; Gehrels, N.; Harding, A. K.; Hays, E.; McEnery, J. E.; Thompson, D. J.; Troja, E.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Celik, Oe.; Donato, D.] Ctr Res & Explorat Space Sci & Technol, Greenbelt, MD 20771 USA; [Celik, Oe.; Corbet, R. H. D.] Univ Maryland Baltimore Cty, Ctr Space Sci & Technol, Baltimore, MD 21250 USA; [Chekhtman, A.] Artep Inc, Ellicott City, MD 21042 USA; [Cheung, C. C.; Johnson, T. J.] Natl Acad Sci, Natl Res Council, Washington, DC 20001 USA; [Ciprini, S.] ASI Sci Data Ctr, I-00044 Rome, Italy; [Cohen-Tanugi, J.; Nuss, E.; Piron, F.] Univ Montpellier 2, CNRS, IN2P3, Lab Universe & Particules Montpellier, Montpellier, France; [Corbel, S.] Inst Univ France, F-75005 Paris, France; [de Luca, A.] Ist Univ Super, I-27100 Pavia, Italy; [Dermer, C. D.; Grove, J. E.; Lovellette, M. N.; Wood, K. S.] USN, Res Lab, Div Space Sci, Washington, DC 20375 USA; [Donato, D.; McEnery, J. E.] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [Donato, D.; McEnery, J. E.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Dubus, G.] Univ Grenoble 1, CNRS, UMR 5274, Inst Planetol & Astrophys Grenoble,INSU, F-38041 Grenoble, France; [Fukazawa, Y.; Hanabata, Y.; Kataoka, J.; Mizuno, T.] Hiroshima Univ, Dept Phys Sci, Hiroshima 7398526, Japan; [Giroletti, M.] INAF Ist Radioastron, I-40129 Bologna, Italy; [Guiriec, S.] Univ Alabama, Ctr Space Plasma & Aeron Res, Huntsville, AL 35899 USA; [Hayashida, M.] Kyoto Univ, Grad Sch Sci, Dept Astron, Sakyo Ku, Kyoto 6068502, Japan; [Hill, A. B.; Coe, M. J.] Univ Southampton, Sch Phys & Astron, Southampton SO17 1BJ, Hants, England; [Hughes, R. E.; Winer, B. L.] Ohio State Univ, Ctr Cosmol & Astroparticle Phys, Dept Phys, Columbus, OH 43210 USA; [Johannesson, G.] Univ Iceland, Inst Sci, IS-107 Reykjavik, Iceland; [Katagiri, H.] Ibaraki Univ, Coll Sci, Mito, Ibaraki 3108512, Japan; [Nakamori, T.] Waseda Univ, Res Inst Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Knoedlseder, J.] IRAP, CNRS, F-31028 Toulouse 4, France; [Knoedlseder, J.] Univ Toulouse, UPS OMP, IRAP, GAHEC, Toulouse, France; [Morselli, A.] Ist Nazl Fis Nucl, Sez Roma Tor Vergata, I-00133 Rome, Italy; [Norris, J. P.; Vitale, V.] Boise State Univ, Dept Phys, Boise, ID 83725 USA; [Ohno, M.; Okumura, A.; Ozaki, M.] JAXA, Inst Space & Astronaut Sci, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan; [Ohsugi, T.; Takahashi, H.] Hiroshima Univ, Hiroshima Astrophys Sci Ctr, Hiroshima 7398526, Japan; [Orlando, E.] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [Paneque, D.] Max Planck Inst Phys & Astrophys, D-80805 Munich, Germany; [Parent, D.] George Mason Univ, Coll Sci, Ctr Earth Observing & Space Res, Fairfax, VA 22030 USA; [Reimer, A.; Reimer, O.] Leopold Franzens Univ Innsbruck, Inst Astro & Teilchenphys, A-6020 Innsbruck, Austria; [Reimer, A.; Reimer, O.] Leopold Franzens Univ Innsbruck, Inst Theoret Phys, A-6020 Innsbruck, Austria; [Roth, M.] Univ Washington, Dept Phys, Seattle, WA 98195 USA; [Siskind, E. J.] NYCB Real Time Comp Inc, Lattingtown, NY 11560 USA; [Suson, D. J.] Purdue Univ Calumet, Dept Chem & Phys, Hammond, IN 46323 USA; [Torres, D. F.] ICREA, Barcelona, Spain; [Vianello, G.] CIFS, I-10133 Turin, Italy; [Vitale, V.] Univ Roma Tor Vergata, Dipartimento Fis, I-00133 Rome, Italy; [Yang, Z.; Zimmer, S.] Stockholm Univ, Dept Phys, SE-10691 Stockholm, Sweden; [Yang, Z.; Zimmer, S.] Oskar Klein Ctr Cosmoparticle Phys, SE-10691 Stockholm, Sweden; [Di Mille, F.] Las Campanas Observ, Australian Astron Observ, La Serena, Chile; [Edwards, P. G.] CSIRO Astron & Space Sci, Australia Telescope Natl Facil, Narrabri, NSW 2390, Australia; [Filipovic, M. D.; Payne, J. L.] Univ Western Sydney, Penrith, NSW 2751, Australia; [Stevens, J.] CSIRO Astron & Space Sci, Epping, NSW 1710, Australia; [Torres, M. A. P.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA	Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; Istituto Nazionale di Fisica Nucleare (INFN); University of Trieste; Istituto Nazionale di Fisica Nucleare (INFN); University of Padua; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of Pavia; Istituto Nazionale Astrofisica (INAF); Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale di Fisica Nucleare (INFN); University of Perugia; Universita degli Studi di Bari Aldo Moro; Politecnico di Bari; Istituto Nazionale di Fisica Nucleare (INFN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Institut Polytechnique de Paris; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Agenzia Spaziale Italiana (ASI); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland Baltimore County; Artep Inc; National Academies of Sciences, Engineering & Medicine; Agenzia Spaziale Italiana (ASI); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite de Montpellier; Institut Universitaire de France; United States Department of Defense; United States Navy; Naval Research Laboratory; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Planetologie et d'Astrophysique de Grenoble (IPAG); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Hiroshima University; Istituto Nazionale Astrofisica (INAF); University of Alabama System; University of Alabama Huntsville; Kyoto University; University of Southampton; University System of Ohio; Ohio State University; University of Iceland; Ibaraki University; Waseda University; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Istituto Nazionale di Fisica Nucleare (INFN); Idaho; Boise State University; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); Hiroshima University; Max Planck Society; Max Planck Society; George Mason University; University of Innsbruck; University of Innsbruck; University of Washington; University of Washington Seattle; Purdue University System; Purdue University; ICREA; University of Rome Tor Vergata; Stockholm University; Oskar Klein Centre; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Western Sydney University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Cheung, CC (corresponding author), USN, Res Lab, Div Space Sci, Washington, DC 20375 USA.	teddy.cheung.ctr@nrl.navy.mil; robin.corbet@nasa.gov; kerrm@stanford.edu	Edwards, Philip/AAV-5623-2021; Okumura, Akira/I-2468-2014; Jóhannesson, Guðlaugur/ABC-7216-2020; Bastieri, Denis/AAC-5917-2020; Funk, Stefan/B-7629-2015; Funk, Stefan/AAI-1568-2021; Morselli, Aldo/G-6769-2011; lubrano, pasquale/F-7269-2012; Reimer, Olaf/A-3117-2013; Gargano, Fabio/AAD-5121-2021; Rando, Riccardo/M-7179-2013; Hadasch, Daniela/N-7819-2016; Jóhannesson, Guðlaugur/O-8741-2015; Gasparrini, Dario/X-6699-2019; Caraveo, Patrizia/AAL-5708-2020; Torres, Manuel Angel Perez/AAE-5006-2019; Moskalenko, Igor V/A-1301-2007; Mazziotta, Mario N/O-8867-2015; Ozaki, Masanobu/K-1165-2013; Reimer, Anita/K-5822-2015; Torres, Diego F/ABD-7940-2020; McEnery, Julie E/D-6612-2012; Gargano, Fabio/O-8934-2015; giglietto, nicola/I-8951-2012; Hays, Elizabeth/D-3257-2012; Kuss, Michael W/H-8959-2012; Torres, Diego F./O-9422-2016; Troja, Eleonora/I-5282-2017; Stevens, Jamie/AAY-4369-2020; cohen-tanugi, Johann/ABB-1481-2021; Parkinson, Pablo Miguel Saz/I-7980-2013; Loparco, Francesco/O-8847-2015; Giglietto, Nicola/Y-2425-2019; Gehrels, Neil/D-2971-2012; Torres, Diego F./AAF-7931-2019; Rando, Riccardo/O-1302-2019; Cutini, Sara/ABB-1787-2020; Thompson, David J/D-2939-2012; Takahashi, Hiromitsu H/T-2713-2017; Tosti, Gino/E-9976-2013; Harding, Alice K/D-3160-2012; Fukazawa, Yasushi/G-2081-2017; Troja, Eleonora/AAB-3604-2020; Orlando, Elena/R-5594-2016; Filipovic, Miroslav/AAN-9577-2020; Sgrò, Carmelo/K-3395-2016; Chaty, Sylvain/B-8671-2016	Edwards, Philip/0000-0002-8186-4753; Okumura, Akira/0000-0002-3055-7964; Jóhannesson, Guðlaugur/0000-0003-1458-7036; Bastieri, Denis/0000-0002-6954-8862; Funk, Stefan/0000-0002-2012-0080; Funk, Stefan/0000-0002-2012-0080; Morselli, Aldo/0000-0002-7704-9553; lubrano, pasquale/0000-0003-0221-4806; Reimer, Olaf/0000-0001-6953-1385; Gargano, Fabio/0000-0002-5055-6395; Hadasch, Daniela/0000-0001-8663-6461; Jóhannesson, Guðlaugur/0000-0003-1458-7036; Gasparrini, Dario/0000-0002-5064-9495; Caraveo, Patrizia/0000-0003-2478-8018; Torres, Manuel Angel Perez/0000-0002-5297-2683; Moskalenko, Igor V/0000-0001-6141-458X; Mazziotta, Mario N/0000-0001-9325-4672; Reimer, Anita/0000-0001-8604-7077; Gargano, Fabio/0000-0002-5055-6395; giglietto, nicola/0000-0002-9021-2888; Torres, Diego F./0000-0002-1522-9065; Troja, Eleonora/0000-0002-1869-7817; Stevens, Jamie/0000-0002-5841-3348; cohen-tanugi, Johann/0000-0001-9022-4232; Loparco, Francesco/0000-0002-1173-5673; Giglietto, Nicola/0000-0002-9021-2888; Torres, Diego F./0000-0002-1522-9065; Rando, Riccardo/0000-0001-6992-818X; Cutini, Sara/0000-0002-1271-2924; Thompson, David J/0000-0001-5217-9135; Takahashi, Hiromitsu H/0000-0001-6314-5897; Fukazawa, Yasushi/0000-0002-0921-8837; Troja, Eleonora/0000-0002-1869-7817; Orlando, Elena/0000-0001-6406-9910; Filipovic, Miroslav/0000-0002-4990-9288; Vianello, Giacomo/0000-0002-2553-0839; Tibaldo, Luigi/0000-0001-7523-570X; Pesce-Rollins, Melissa/0000-0003-1790-8018; Buehler, Rolf/0000-0003-4425-6641; Giroletti, Marcello/0000-0002-8657-8852; Hill, Adam/0000-0003-3470-4834; Charles, Eric/0000-0002-3925-7802; de Palma, Francesco/0000-0001-5898-2834; Cecchi, Claudia/0000-0002-2192-8233; Katagiri, Hideaki/0000-0003-2347-8819; Raino', Silvia/0000-0002-9181-0345; Cavazzuti, Elisabetta/0000-0001-7150-9638; De Luca, Andrea/0000-0001-6739-687X; Ajello, Marco/0000-0002-6584-1703; Chaty, Sylvain/0000-0002-5769-8601; Cameron, Robert/0000-0003-0942-2747; Sgro', Carmelo/0000-0001-5676-6214; Buson, Sara/0000-0002-3308-324X; Grenier, Isabelle/0000-0003-3274-674X; Cheung, Chi (Teddy)/0000-0002-4377-0174; Kerr, Matthew/0000-0002-0893-4073; Spandre, Gloria/0000-0003-0802-3453; Ciprini, Stefano/0000-0002-0712-2479; Fusco, Piergiorgio/0000-0002-9383-2425; Omodei, Nicola/0000-0002-5448-7577; Porter, Troy/0000-0002-2621-4440; Coe, Malcolm/0000-0002-0763-8547; Ackermann, Markus/0000-0001-8952-588X; Tanaka, Takaaki/0000-0002-4383-0368; RAZZANO, MASSIMILIANO/0000-0003-4825-1629; belfiore, andrea/0000-0002-2526-1309; Dubus, Guillaume/0000-0002-5130-2514; Johnson, Tyrel/0000-0002-2771-472X; Di Mille, Francesco/0000-0003-0483-5083	NASA (United States); U.S. Department of Energy (United States); CEA/Irfu (France); IN2P3/CNRS (France); ASI (Italy); INFN (Italy); MEXT (Japan); KEK (Japan); JAXA (Japan); K. A. Wallenberg Foundation; Swedish Research Council; National Space Board (Sweden); CNES in France; European Community [ERC-StG-200911]; STFC [ST/G003084/1] Funding Source: UKRI; ICREA Funding Source: Custom; Science and Technology Facilities Council [ST/G003084/1] Funding Source: researchfish	NASA (United States)(National Aeronautics & Space Administration (NASA)); U.S. Department of Energy (United States)(United States Department of Energy (DOE)); CEA/Irfu (France)(French Atomic Energy Commission); IN2P3/CNRS (France)(Centre National de la Recherche Scientifique (CNRS)); ASI (Italy)(Agenzia Spaziale Italiana (ASI)); INFN (Italy)(Istituto Nazionale di Fisica Nucleare (INFN)); MEXT (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); KEK (Japan)(High Energy Accelerator Research Organization (KEK)); JAXA (Japan); K. A. Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); National Space Board (Sweden); CNES in France; European Community(European Commission); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); ICREA(ICREA); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	The Fermi LAT Collaboration acknowledges support from a number of agencies and institutes for both development and the operation of the LAT as well as scientific data analysis. These include NASA and the U.S. Department of Energy (United States); CEA/Irfu and IN2P3/CNRS (France); ASI and INFN (Italy); MEXT, KEK, and JAXA (Japan); and the K. A. Wallenberg Foundation, the Swedish Research Council, and the National Space Board (Sweden). Additional support from INAF in Italy and CNES in France for science analysis during the operations phase is also gratefully acknowledged. Fermi LAT data are available from the Fermi Science Support Center (http://fermi.gsfc.nasa.gov/ssc). This work made use of data supplied by the UK Swift Science Data Centre at the University of Leicester. G. D. was supported by European Community contract ERC-StG-200911.	Abdo AA, 2011, ASTROPHYS J LETT, V736, DOI 10.1088/2041-8205/736/1/L11; Abdo AA, 2010, ASTROPHYS J SUPPL S, V188, P405, DOI 10.1088/0067-0049/188/2/405; Abdo AA, 2009, SCIENCE, V326, P1512, DOI 10.1126/science.1182174; Abdo AA, 2009, ASTROPHYS J LETT, V706, pL56, DOI 10.1088/0004-637X/706/1/L56; Abdo AA, 2009, ASTROPHYS J LETT, V701, pL123, DOI 10.1088/0004-637X/701/2/L123; Atwood WB, 2009, ASTROPHYS J, V697, P1071, DOI 10.1088/0004-637X/697/2/1071; Bongiorno SD, 2011, ASTROPHYS J LETT, V737, DOI 10.1088/2041-8205/737/1/L11; Casares J, 2005, MON NOT R ASTRON SOC, V364, P899, DOI 10.1111/j.1365-2966.2005.09617.x; Clark JS, 2001, ASTRON ASTROPHYS, V376, P476, DOI 10.1051/0004-6361:20010919; de Ona Wilhelmi E., 2010, 38 COSPAR SCI ASS 23; Dubus G, 2008, ASTRON ASTROPHYS, V477, P691, DOI 10.1051/0004-6361:20078261; Dubus G, 2006, ASTRON ASTROPHYS, V456, P801, DOI 10.1051/0004-6361:20054779; HORNE JH, 1986, ASTROPHYS J, V302, P757, DOI 10.1086/164037; Kishishita T, 2009, ASTROPHYS J LETT, V697, pL1, DOI 10.1088/0004-637X/697/1/L1; Marti J, 2004, ASTRON ASTROPHYS, V418, P271, DOI 10.1051/0004-6361:20035886; McSwain MV, 2004, ASTROPHYS J, V600, P927, DOI 10.1086/379892; Mirabel IF, 2006, SCIENCE, V312, P1759, DOI 10.1126/science.1129815; Paredes JM, 2000, SCIENCE, V288, P2340, DOI 10.1126/science.288.5475.2340; Parkinson PMS, 2010, ASTROPHYS J, V725, P571, DOI 10.1088/0004-637X/725/1/571; Pojmanski G, 2002, ACTA ASTRONOM, V52, P397; Roming PWA, 2005, SPACE SCI REV, V120, P95, DOI 10.1007/s11214-005-5095-4; Sarty GE, 2011, MON NOT R ASTRON SOC, V411, P1293, DOI 10.1111/j.1365-2966.2010.17757.x; Takahashi T, 2009, ASTROPHYS J, V697, P592, DOI 10.1088/0004-637X/697/1/592; Tavani M, 2009, NATURE, V462, P620, DOI 10.1038/nature08578; WALBORN NR, 1990, PUBL ASTRON SOC PAC, V102, P379, DOI 10.1086/132646	26	68	68	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 13	2012	335	6065					189	193		10.1126/science.1213974	http://dx.doi.org/10.1126/science.1213974			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875LZ	22246769	Green Submitted			2022-12-28	WOS:000299033100045
J	Shindell, D; Kuylenstierna, JCI; Vignati, E; van Dingenen, R; Amann, M; Klimont, Z; Anenberg, SC; Muller, N; Janssens-Maenhout, G; Raes, F; Schwartz, J; Faluvegi, G; Pozzoli, L; Kupiainen, K; Hoglund-Isaksson, L; Emberson, L; Streets, D; Ramanathan, V; Hicks, K; Oanh, NTK; Milly, G; Williams, M; Demkine, V; Fowler, D				Shindell, Drew; Kuylenstierna, Johan C. I.; Vignati, Elisabetta; van Dingenen, Rita; Amann, Markus; Klimont, Zbigniew; Anenberg, Susan C.; Muller, Nicholas; Janssens-Maenhout, Greet; Raes, Frank; Schwartz, Joel; Faluvegi, Greg; Pozzoli, Luca; Kupiainen, Kaarle; Hoeglund-Isaksson, Lena; Emberson, Lisa; Streets, David; Ramanathan, V.; Hicks, Kevin; Oanh, N. T. Kim; Milly, George; Williams, Martin; Demkine, Volodymyr; Fowler, David			Simultaneously Mitigating Near-Term Climate Change and Improving Human Health and Food Security	SCIENCE			English	Article							AIR-QUALITY; OZONE; EMISSIONS; IMPACTS; PROJECTIONS; AEROSOLS; NOX	Tropospheric ozone and black carbon (BC) contribute to both degraded air quality and global warming. We considered similar to 400 emission control measures to reduce these pollutants by using current technology and experience. We identified 14 measures targeting methane and BC emissions that reduce projected global mean warming similar to 0.5 degrees C by 2050. This strategy avoids 0.7 to 4.7 million annual premature deaths from outdoor air pollution and increases annual crop yields by 30 to 135 million metric tons due to ozone reductions in 2030 and beyond. Benefits of methane emissions reductions are valued at $700 to $5000 per metric ton, which is well above typical marginal abatement costs ( less than $250). The selected controls target different sources and influence climate on shorter time scales than those of carbon dioxide-reduction measures. Implementing both substantially reduces the risks of crossing the 2 degrees C threshold.	[Shindell, Drew; Faluvegi, Greg; Milly, George] NASA, Goddard Inst Space Studies, New York, NY 10025 USA; [Shindell, Drew; Faluvegi, Greg; Milly, George] Columbia Univ, Columbia Earth Inst, New York, NY 10025 USA; [Kuylenstierna, Johan C. I.; Emberson, Lisa; Hicks, Kevin] Univ York, Dept Environm, Stockholm Environm Inst, York YO10 5DD, N Yorkshire, England; [Vignati, Elisabetta; van Dingenen, Rita; Janssens-Maenhout, Greet; Raes, Frank; Pozzoli, Luca] European Commiss, Joint Res Ctr, I-21027 Ispra, Italy; [Amann, Markus; Klimont, Zbigniew; Kupiainen, Kaarle; Hoeglund-Isaksson, Lena] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; [Anenberg, Susan C.] US EPA, Washington, DC 20460 USA; [Muller, Nicholas] Middlebury Coll, Dept Econ, Middlebury, VT 05753 USA; [Schwartz, Joel] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02215 USA; [Streets, David] Argonne Natl Lab, Argonne, IL 60439 USA; [Ramanathan, V.] Univ Calif San Diego, Scripps Inst Oceanog, San Diego, CA 92093 USA; [Oanh, N. T. Kim] Asian Inst Technol, Bangkok 10400, Thailand; [Williams, Martin] Kings Coll London, Environm Res Grp, London SE1 9NH, England; [Demkine, Volodymyr] UNEP, Nairobi 00100, Kenya; [Fowler, David] Ctr Ecol & Hydrol, Penicuik EH26 0QB, Midlothian, Scotland	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Columbia University; University of York - UK; European Commission Joint Research Centre; EC JRC ISPRA Site; International Institute for Applied Systems Analysis (IIASA); United States Environmental Protection Agency; Harvard University; Harvard T.H. Chan School of Public Health; United States Department of Energy (DOE); Argonne National Laboratory; University of California System; University of California San Diego; Scripps Institution of Oceanography; Asian Institute of Technology; University of London; King's College London; UK Centre for Ecology & Hydrology (UKCEH)	Shindell, D (corresponding author), NASA, Goddard Inst Space Studies, New York, NY 10025 USA.	drew.t.shindell@nasa.gov	fowler, david/B-5446-2010; Klimont, Zbigniew/P-7641-2015; Van Dingenen, Rita/AAI-3197-2021; Nguyen, Kim Oanh/D-9160-2019; Klimont, Zbigniew/O-6683-2019; Shindell, Drew/D-4636-2012; Emberson, Lisa/ABA-8711-2021	fowler, david/0000-0002-2999-2627; Klimont, Zbigniew/0000-0003-2630-198X; Van Dingenen, Rita/0000-0003-2521-4972; Nguyen, Kim Oanh/0000-0002-0367-0013; Klimont, Zbigniew/0000-0003-2630-198X; Shindell, Drew/0000-0003-1552-4715; Hoglund-Isaksson, Lena/0000-0001-7514-3135; Williams, Martin/0000-0002-4677-6491; Streets, David/0000-0002-0223-1350; Pozzoli, Luca/0000-0003-0485-9624; Faluvegi, Gregory/0000-0001-9011-3663	UNEP; World Meteorlogical Organization (WMO), NASA; Clean Air Task Force; Medical Research Council [G0801056B] Funding Source: researchfish; Natural Environment Research Council [ceh010023] Funding Source: researchfish	UNEP; World Meteorlogical Organization (WMO), NASA; Clean Air Task Force; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding was provided by UNEP and the World Meteorlogical Organization (WMO), NASA's Applied Sciences and Atmospheric Chemistry Modeling and Analysis Programs, and the Clean Air Task Force to IIASA. We thank all the authors and reviewers who contributed to the UNEP/WMO Integrated Assessment of Black Carbon and Tropospheric Ozone.	Alexandratos N, 2006, WORLD AGR 2030 2050; Amann M, 2011, ENVIRON MODELL SOFTW, V26, P1489, DOI 10.1016/j.envsoft.2011.07.012; Bauer SE, 2010, ATMOS CHEM PHYS, V10, P7439, DOI 10.5194/acp-10-7439-2010; Boucher O, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/044007; Chen WT, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042886; Cofala J, 2007, ATMOS ENVIRON, V41, P8486, DOI 10.1016/j.atmosenv.2007.07.010; Flanner MG, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008003; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Fuglestvedt JS, 2010, ATMOS ENVIRON, V44, P4648, DOI 10.1016/j.atmosenv.2009.04.044; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; International Energy Agency, 2003, BUILD COST CURV IND; International Energy Agency, 2009, WORLD EN OUTL; Jacobson MZ, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013795; Jerrett M, 2009, NEW ENGL J MED, V360, P1085, DOI 10.1056/NEJMoa0803894; Klimont Z, 2009, TELLUS B, V61, P602, DOI 10.1111/j.1600-0889.2009.00428.x; Koch D, 2010, ATMOS CHEM PHYS, V10, P7685, DOI 10.5194/acp-10-7685-2010; Koch D, 2009, J CLIMATE, V22, P2659, DOI 10.1175/2008JCLI2573.1; Kopacz M, 2011, ATMOS CHEM PHYS, V11, P2837, DOI 10.5194/acp-11-2837-2011; Krewski D, 2009, EXTENDED FOLLOW UP S; Kupiainen K, 2007, ATMOS ENVIRON, V41, P2156, DOI 10.1016/j.atmosenv.2006.10.066; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Meehl GA, 2008, J CLIMATE, V21, P2869, DOI 10.1175/2007JCLI1777.1; Pozzoli L, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009007; Qian Y, 2011, ATMOS CHEM PHYS, V11, P1929, DOI 10.5194/acp-11-1929-2011; Ramanathan V, 2005, P NATL ACAD SCI USA, V102, P5326, DOI 10.1073/pnas.0500656102; Ramanathan V, 2008, NAT GEOSCI, V1, P221, DOI 10.1038/ngeo156; Ramanathan V, 2010, P NATL ACAD SCI USA, V107, P8055, DOI 10.1073/pnas.1002293107; Ramaswamy V, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P349; Shindell D, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006348; Shindell D, 2010, ATMOS CHEM PHYS, V10, P3247, DOI 10.5194/acp-10-3247-2010; Shindell DT, 2006, ATMOS CHEM PHYS, V6, P4427, DOI 10.5194/acp-6-4427-2006; Shindell D, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014108; Sillman S, 1999, ATMOS ENVIRON, V33, P1821, DOI 10.1016/S1352-2310(98)00345-8; Stier P, 2006, ATMOS CHEM PHYS, V6, P3059, DOI 10.5194/acp-6-3059-2006; Tol R.S., 2008, ECONOMICS-KIEL, V2, DOI DOI 10.5018/ECONOMICS-EJOURNAL.JA.2008-25; United Nations Environment Programme and World Meteorological Organization, 2011, INT ASS BLACK C CARB; Van Dingenen R, 2009, ATMOS ENVIRON, V43, P604, DOI 10.1016/j.atmosenv.2008.10.033; Wang C, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040114; West JJ, 2005, ENVIRON SCI TECHNOL, V39, P4685, DOI 10.1021/es048629f; Winiwarter L, 2010, POTENTIALS COSTS MIT	40	805	825	45	720	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 13	2012	335	6065					183	189		10.1126/science.1210026	http://dx.doi.org/10.1126/science.1210026			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875LZ	22246768				2022-12-28	WOS:000299033100044
J	Wu, WM; Thomas, JA; Cheng, NQ; Black, LW; Steven, AC				Wu, Weimin; Thomas, Julie A.; Cheng, Naiqian; Black, Lindsay W.; Steven, Alasdair C.			Bubblegrams Reveal the Inner Body of Bacteriophage phi KZ	SCIENCE			English	Article							RADIATION-DAMAGE; T7		[Wu, Weimin; Cheng, Naiqian; Steven, Alasdair C.] Natl Inst Arthrit & Musculoskeletal & Skin Dis NI, Struct Biol Lab, NIH, Bethesda, MD 20892 USA; [Thomas, Julie A.; Black, Lindsay W.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University System of Maryland; University of Maryland Baltimore	Steven, AC (corresponding author), Natl Inst Arthrit & Musculoskeletal & Skin Dis NI, Struct Biol Lab, NIH, Bethesda, MD 20892 USA.	stevena@mail.nih.gov	Wu, Weimin/B-4063-2012; Thomas, Julie/N-9616-2019	Thomas, Julie/0000-0001-6612-0724	Intramural NIH HHS [Z01 AR027015-13] Funding Source: Medline; NIAID NIH HHS [AI11676, R21 AI011676, R01 AI011676] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI011676, R37AI011676, R21AI011676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR027015, ZIAAR027002, Z01AR027015] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Agirrezabala X, 2005, EMBO J, V24, P3820, DOI 10.1038/sj.emboj.7600840; Black L. W., 2011, VIRAL MOL MACHINES, P469; Chang CY, 2010, VIROLOGY, V398, P176, DOI 10.1016/j.virol.2009.12.002; CONWAY JF, 1993, J STRUCT BIOL, V111, P222, DOI 10.1006/jsbi.1993.1052; Fokine A, 2007, STRUCTURE, V15, P1099, DOI 10.1016/j.str.2007.07.008; KRYLOV VN, 1984, CAN J MICROBIOL, V30, P758, DOI 10.1139/m84-116; LEAPMAN RD, 1995, ULTRAMICROSCOPY, V59, P71, DOI 10.1016/0304-3991(95)00019-W; Mesyanzhinov VV, 2002, J MOL BIOL, V317, P1, DOI 10.1006/jmbi.2001.5396	8	41	43	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 13	2012	335	6065					182	182		10.1126/science.1214120	http://dx.doi.org/10.1126/science.1214120			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875LZ	22246767	Green Accepted			2022-12-28	WOS:000299033100043
J	Gehrett, BK				Gehrett, Barbara K.			A Prescription for Drug Shortages	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											Gehrett, BK (corresponding author), 14612 SE Green Valley Rd, Auburn, WA 98092 USA.	thebkg17@gmail.com	Mendoza, Elvia/A-9361-2012					[Anonymous], NAVIGATING DRUG SHOR; [Anonymous], DRUG SHORT CURR DRUG; Assistant Secretary for Planning and Evaluation US Department of Health and Human Services, ASPE ISS BRIEF EC AN; Davenport-Ennis N, 2011, IMPROVING PATIENT CA; Fox E, 2011, DRUG SHORT WORKSH SP; Jensen V, 2010, NEW ENGL J MED, V363, P806, DOI 10.1056/NEJMp1005849; McBride A, 2011, DRUG SHORT WORKSH SP	7	11	12	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 11	2012	307	2					153	154		10.1001/jama.2011.2000	http://dx.doi.org/10.1001/jama.2011.2000			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	875NP	22235084				2022-12-28	WOS:000299038300025
J	Klohn, PC; Farmer, M; Linehan, JM; O'Malley, C; de Marco, MF; Taylor, W; Farrow, M; Khalili-Shirazi, A; Brandner, S; Collinge, J				Kloehn, Peter-Christian; Farmer, Michael; Linehan, Jacqueline M.; O'Malley, Catherine; de Marco, Mar Fernandez; Taylor, William; Farrow, Mark; Khalili-Shirazi, Azy; Brandner, Sebastian; Collinge, John			PrP Antibodies Do Not Trigger Mouse Hippocampal Neuron Apoptosis	SCIENCE			English	Article							MONOCLONAL-ANTIBODIES; PRION; DISEASE		[Collinge, John] UCL, Inst Neurol, Med Res Council MRC, Prion Unit, London WC1N 3BG, England; UCL, Dept Neurodegenerat Dis, London WC1N 3BG, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; University College London; University of London; University College London	Collinge, J (corresponding author), UCL, Inst Neurol, Med Res Council MRC, Prion Unit, London WC1N 3BG, England.	j.collinge@prion.ucl.ac.uk	Brandner, Sebastian/J-4562-2014; Kloehn, Peter/AAS-3719-2021	Brandner, Sebastian/0000-0002-9821-0342; 	UK Medical Research Council; Medical Research Council [MC_U123182016, MC_U123192748] Funding Source: researchfish; MRC [MC_U123182016, MC_U123192748] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank R. Young for graphics, C. Andrews for technical assistance, and A. Williamson (Scripps) for kindly supplying antibodies IgG P, D13, D18, and b12. Funded by the UK Medical Research Council. The data described in this paper are in the supporting online material (SOM). J.C. is a director and shareholder of, and P.-C. K. is a consultant to, D-Gen Limited, an academic spin-out company working in the field of prion disease diagnosis, decontamination, and therapeutics. J.C. is an inventor of patents on the use of PrP antibodies for therapeutics.	Antonyuk SV, 2009, P NATL ACAD SCI USA, V106, P2554, DOI 10.1073/pnas.0809170106; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Khalill-Shirazi A, 2007, BBA-PROTEINS PROTEOM, V1774, P1438, DOI 10.1016/j.bbapap.2007.08.028; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mallucci GR, 2007, NEURON, V53, P325, DOI 10.1016/j.neuron.2007.01.005; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273; White AR, 2003, NATURE, V422, P80, DOI 10.1038/nature01457	8	53	54	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 6	2012	335	6064					52	52		10.1126/science.1215579	http://dx.doi.org/10.1126/science.1215579			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872YA	22223800				2022-12-28	WOS:000298846200046
J	Newman, JC; Feldman, R				Newman, John C.; Feldman, Robin			Copyright and Open Access at the Bedside	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Newman, John C.] San Francisco VA Med Ctr, Div Geriatr, San Francisco, CA 94121 USA; [Newman, John C.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Feldman, Robin] Univ Calif Hastings Coll Law, Law & Biosci Project, San Francisco, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco	Newman, JC (corresponding author), San Francisco VA Med Ctr, Div Geriatr, San Francisco, CA 94121 USA.		Newman, John C/L-8112-2013					FELDMAN R, 2008, NW J TECHNOLOGY FALL, P14; Fong TG, 2011, ARCH INTERN MED, V171, P432, DOI 10.1001/archinternmed.2010.423; Martin R, 2009, LANCET, V373, P2009, DOI 10.1016/S0140-6736(09)60349-4; Powsner S, 2005, AM J PSYCHIAT, V162, P627, DOI 10.1176/appi.ajp.162.3.627-a	4	47	48	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2011	365	26					2447	2449		10.1056/NEJMp1110652	http://dx.doi.org/10.1056/NEJMp1110652			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	868SD	22204721				2022-12-28	WOS:000298544600002
J	Bellofatto, V; Wilusz, J				Bellofatto, Vivian; Wilusz, Jeffrey			Transcription and mRNA Stability: Parental Guidance Suggested	CELL			English	Editorial Material							DECAY; SUBUNIT; YEAST	The level of an mRNA within a cell depends on both its rate of synthesis and rate of decay. Now, independent studies by Bregman et al. and Trcek et al. provide evidence that these two processes are integrated. They show that transcription factors and DNA promoters can directly influence the relative stability of transcripts that they produce.	[Bellofatto, Vivian] UMDNJ New Jersey Med Sch, Dept Microbiol & Mol Genet, Newark, NJ 07103 USA; [Wilusz, Jeffrey] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Colorado State University	Bellofatto, V (corresponding author), UMDNJ New Jersey Med Sch, Dept Microbiol & Mol Genet, Newark, NJ 07103 USA.	bellofat@umdnj.edu; jeffrey.wilusz@colostate.edu						Bregman A, 2011, CELL, V147, P1473, DOI 10.1016/j.cell.2011.12.005; Darieva Z, 2006, NATURE, V444, P494, DOI 10.1038/nature05339; Dori-Bachash M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001106; ENSSLE J, 1993, P NATL ACAD SCI USA, V90, P10091, DOI 10.1073/pnas.90.21.10091; Harel-Sharvit L, 2010, CELL, V143, P552, DOI 10.1016/j.cell.2010.10.033; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; Lotan R, 2005, GENE DEV, V19, P3004, DOI 10.1101/gad.353205; Lotan R, 2007, J CELL BIOL, V178, P1133, DOI 10.1083/jcb.200701165; Nagaike T, 2011, MOL CELL, V41, P409, DOI 10.1016/j.molcel.2011.01.022; Trcek T, 2011, CELL, V147, P1484, DOI 10.1016/j.cell.2011.11.051	10	13	13	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 23	2011	147	7					1438	1439		10.1016/j.cell.2011.12.002	http://dx.doi.org/10.1016/j.cell.2011.12.002			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	866SP	22196721	Bronze			2022-12-28	WOS:000298403400008
J	Guo, D; Knight, TE; McCusker, JK				Guo, Dong; Knight, Troy E.; McCusker, James K.			Angular Momentum Conservation in Dipolar Energy Transfer	SCIENCE			English	Article							SPIN; ELECTRON; LUMINESCENCE; REACTIVITY; DEPENDENCE; KINETICS; RULE	Conservation of angular momentum is a familiar tenet in science but has seldom been invoked to understand (or predict) chemical processes. We have developed a general formalism based on Wigner's original ideas concerning angular momentum conservation to interpret the photo-induced reactivity of two molecular donor-acceptor assemblies with physical properties synthetically tailored to facilitate intramolecular energy transfer. Steady-state and time-resolved spectroscopic data establishing excited-state energy transfer from a rhenium(I)-based charge-transfer state to a chromium(III) acceptor can be fully accounted for by Forster theory, whereas the corresponding cobalt(III) adduct does not undergo an analogous reaction despite having a larger cross-section for dipolar coupling. Because this pronounced difference in reactivity is easily explained within the context of the angular momentum conservation model, this relatively simple construct may provide a means for systematizing a broad range of chemical reactions.	[Guo, Dong; Knight, Troy E.; McCusker, James K.] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA	Michigan State University	McCusker, JK (corresponding author), Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA.	jkm@chemistry.msu.edu			NSF [CHE-0911592]	NSF(National Science Foundation (NSF))	We thank G. Blanchard for assistance with the time-correlated single-photon counting emission measurements, and A. Brown and C. McCusker for preliminary spectroscopic measurements on the CoRe<INF>3</INF> assembly. Supported by NSF grant CHE-0911592. Metrical parameters for the structure of compound 3 can be obtained free of charge from the Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif under reference number CCDC 831982.	Achim C, 2001, INORG CHEM, V40, P4389, DOI 10.1021/ic010498l; Baldo MA, 1998, NATURE, V395, P151, DOI 10.1038/25954; Buchachenko AL, 1996, J PHYS CHEM-US, V100, P18292, DOI 10.1021/jp961008r; Burgert R, 2008, SCIENCE, V319, P438, DOI 10.1126/science.1148643; CLAUDE JP, 1995, J PHYS CHEM-US, V99, P51, DOI 10.1021/j100001a010; DEMAS JN, 1976, J AM CHEM SOC, V98, P5800, DOI 10.1021/ja00435a010; DEXTER DL, 1953, J CHEM PHYS, V21, P836, DOI 10.1063/1.1699044; ENOS CS, 1992, INT J MASS SPECTROM, V122, P361, DOI 10.1016/0168-1176(92)87026-B; FORSTER LS, 1990, CHEM REV, V90, P331, DOI 10.1021/cr00100a001; Forster T., 1959, DISCUSS FARADAY SOC, V27, P7; Gust D, 2009, ACCOUNTS CHEM RES, V42, P1890, DOI 10.1021/ar900209b; Harvey JN, 2007, PHYS CHEM CHEM PHYS, V9, P331, DOI 10.1039/b614390c; Kahn O., 1993, MOL MAGNETISM; Kestell JD, 2002, J PHYS CHEM A, V106, P5768, DOI 10.1021/jp0204758; Knight TE, 2008, INORG CHEM, V47, P7249, DOI 10.1021/ic800670b; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Landau L. D., 1995, CLASSICAL THEORY FIE; LEI YB, 1990, J AM CHEM SOC, V112, P8820, DOI 10.1021/ja00180a025; Manner VW, 2012, CHEM SCI, V3, P230, DOI 10.1039/c1sc00387a; Marti AA, 2007, J AM CHEM SOC, V129, P8680, DOI 10.1021/ja0717257; MOORE JH, 1973, PHYS REV A, V8, P2359, DOI 10.1103/PhysRevA.8.2359; REHM D, 1970, ISRAEL J CHEM, V8, P259; Rohatgi-Mukherjee K.K., 1978, FUNDAMENTALS PHOTOCH; Weldon BT, 2001, INORG CHEM, V40, P6802, DOI 10.1021/ic010659l; Wigner E., 1927, NACHR GES WISS GO MP, P375	25	28	28	6	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1684	1687		10.1126/science.1211459	http://dx.doi.org/10.1126/science.1211459			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22194572				2022-12-28	WOS:000298344000061
J	Hall, MI; Kirk, EC; Kamilar, JM; Carrano, MT				Hall, Margaret I.; Kirk, E. Christopher; Kamilar, Jason M.; Carrano, Matthew T.			Comment on "Nocturnality in Dinosaurs Inferred from Scleral Ring and Orbit Morphology"	SCIENCE			English	Editorial Material							ACTIVITY PATTERNS; EYE; PERSPECTIVES; PRIMATES		[Hall, Margaret I.] Midwestern Univ, Dept Physiol, Glendale, AZ 85308 USA; [Kirk, E. Christopher] Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA; [Kamilar, Jason M.] Midwestern Univ, Dept Anat, Glendale, AZ 85308 USA; [Kamilar, Jason M.] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA; [Carrano, Matthew T.] Smithsonian Inst, Dept Paleobiol, Washington, DC 20013 USA	Midwestern University; University of Texas System; University of Texas Austin; Midwestern University; Arizona State University; Arizona State University-Tempe; Smithsonian Institution; Smithsonian National Museum of Natural History	Hall, MI (corresponding author), Midwestern Univ, Dept Physiol, 19555 N 59th Ave, Glendale, AZ 85308 USA.	mhallx1@midwestern.edu	Carrano, Matthew/C-7601-2011	Carrano, Matthew/0000-0003-2129-1612; Kamilar, Jason/0000-0001-6082-9396				Franz-Odendaal TA, 2006, DEV DYNAM, V235, P1244, DOI 10.1002/dvdy.20718; Hall MI, 2008, J ANAT, V212, P781, DOI 10.1111/j.1469-7580.2008.00897.x; Hall MI, 2009, ANAT REC, V292, P798, DOI 10.1002/ar.20889; Hughes A., 1977, VISUAL SYSTEM VERTEB, P613; KAY RF, 1977, J HUM EVOL, V6, P19, DOI 10.1016/S0047-2484(77)80040-7; Kirk EC, 2006, J HUM EVOL, V51, P76, DOI 10.1016/j.jhevol.2006.01.005; McGarigal K., 2000, MULTIVARIATE STAT WI; Motani R, 2011, EVOLUTION, V65, P2245, DOI 10.1111/j.1558-5646.2011.01271.x; Nowak RM, 1991, WALKERS MAMMALS WORL; Ritland S., 1982, THESIS U CHICAGO; Rohlf FJ, 2001, EVOLUTION, V55, P2143; Schmitz L, 2011, SCIENCE, V332, P705, DOI 10.1126/science.1200043; Schmitz L, 2010, VISION RES, V50, P936, DOI 10.1016/j.visres.2010.03.009; Schultz AH, 1940, AM J PHYS ANTHROPOL, V26, P389, DOI 10.1002/ajpa.1330260138; Sokal RR, 1995, BIOMETRY	15	13	13	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063								10.1126/science.1208442	http://dx.doi.org/10.1126/science.1208442			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22194558				2022-12-28	WOS:000298344000041
J	Lefevre, CT; Menguy, N; Abreu, F; Lins, U; Posfai, M; Prozorov, T; Pignol, D; Frankel, RB; Bazylinski, DA				Lefevre, Christopher T.; Menguy, Nicolas; Abreu, Fernanda; Lins, Ulysses; Posfai, Mihaly; Prozorov, Tanya; Pignol, David; Frankel, Richard B.; Bazylinski, Dennis A.			A Cultured Greigite-Producing Magnetotactic Bacterium in a Novel Group of Sulfate-Reducing Bacteria	SCIENCE			English	Article							CANDIDATUS MAGNETOGLOBUS-MULTICELLULARIS; MAGNETOSOME FORMATION; MAGNETITE FE3O4; FE3S4; BIOMINERALIZATION; PROKARYOTE; ULTRASTRUCTURE; CRYSTALS	Magnetotactic bacteria contain magnetosomes-intracellular, membrane-bounded, magnetic nanocrystals of magnetite (Fe3O4) or greigite (Fe3S4)-that cause the bacteria to swim along geomagnetic field lines. We isolated a greigite-producing magnetotactic bacterium from a brackish spring in Death Valley National Park, California, USA, strain BW-1, that is able to biomineralize greigite and magnetite depending on culture conditions. A phylogenetic comparison of BW-1 and similar uncultured greigite- and/or magnetite-producing magnetotactic bacteria from freshwater to hypersaline habitats shows that these organisms represent a previously unknown group of sulfate-reducing bacteria in the Deltaproteobacteria. Genomic analysis of BW-1 reveals the presence of two different magnetosome gene clusters, suggesting that one may be responsible for greigite biomineralization and the other for magnetite.	[Bazylinski, Dennis A.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [Lefevre, Christopher T.; Pignol, David] Inst Biol Environm & Biotechnol, Commissariat Energie Atom Cadarache, Lab Bioenerget Cellulaire, Direct Sci Vivant,UMR 6191, F-13108 St Paul Les Durance, France; [Lefevre, Christopher T.; Pignol, David] CNRS, Biol Vegetale & Microbiol Environm, UMR 6191, F-13108 St Paul Les Durance, France; [Lefevre, Christopher T.; Pignol, David] Univ Aix Marseille, F-13108 St Paul Les Durance, France; [Menguy, Nicolas] Univ Paris 06, Inst Mineral & Phys Milieux Condenses, CNRS, Inst Rech Dev 4,UMR 7590, F-75005 Paris, France; [Abreu, Fernanda; Lins, Ulysses] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, BR-21941590 Rio De Janeiro, Brazil; [Posfai, Mihaly] Univ Pannonia, Dept Earth & Environm Sci, H-8200 Veszprem, Hungary; [Prozorov, Tanya] US DOE, Ames Lab, Ames, IA 50011 USA; [Frankel, Richard B.] Calif Polytech State Univ San Luis Obispo, Dept Phys, San Luis Obispo, CA 93407 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; CEA; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Universidade Federal do Rio de Janeiro; University of Pannonia; United States Department of Energy (DOE); Ames National Laboratory; California State University System; California Polytechnic State University San Luis Obispo	Bazylinski, DA (corresponding author), Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA.	dennis.bazylinski@unlv.edu	Pósfai, Mihály/C-1792-2012; MENGUY, Nicolas/F-5607-2012; Abreu, Fernanda/N-4824-2017; Lefevre, Christopher T/H-6072-2013; Lins, Ulysses/N-7282-2015	Pósfai, Mihály/0000-0001-9355-3533; MENGUY, Nicolas/0000-0003-4613-2490; Abreu, Fernanda/0000-0003-2356-5840; Lefevre, Christopher T/0000-0002-1692-0245; Lins, Ulysses/0000-0002-1786-1144; PIGNOL, David/0000-0002-8070-0319	U.S. National Science Foundation [EAR-0920718]; Fondation pour la Recherche Medicale [SPF20101220993]; U.S. Department of Energy, Basic Energy Sciences, Materials Sciences and Engineering Division; U.S. Department of Energy by Iowa State University [DE-AC02-07CH11358]; Directorate For Geosciences [0920718] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); U.S. Department of Energy, Basic Energy Sciences, Materials Sciences and Engineering Division(United States Department of Energy (DOE)); U.S. Department of Energy by Iowa State University(United States Department of Energy (DOE)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was partially supported by U.S. National Science Foundation grant EAR-0920718 (D. A. B.) and by a grant from the Fondation pour la Recherche Medicale SPF20101220993 (C. T. L.). Part of the transmission electron microscopy characterization was carried out in Ames Lab and was supported by the U.S. Department of Energy, Basic Energy Sciences, Materials Sciences and Engineering Division. The Ames Laboratory is operated for the U.S. Department of Energy by Iowa State University under contract DE-AC02-07CH11358. We thank F. Mahlaoui and M. L. Schmidt for help with sampling; the National Park Service staff of Death Valley National Park; and the team at the Laboratorio de Bioinformatica, Laboratorio Nacional de Computacao Cientifica, Rio de Janeiro, Brazil, for their help in the sequencing and annotation of the genome of strain BW-1. Samples at Death Valley National Park were collected under Sampling Permit DEVA-2010-SCI-0038 issued by the U. S. Department of the Interior National Park Service. 16S rRNA gene sequences (accession nos. JN015483 to JN015507, JN252194, and JN25219), gene for adenosine-5'-phosphate reductase (aprA; JN705544) and mam genes of BW-1 (JN830627 to JN830646 and JN845570 to JN845575) are published in GenBank. Strain BW-1 has been deposited to the Japan Collection of Microorganisms, RIKEN BioResource Center under the provisional name Candidatus Desulfamplus magnetomortis and carries accession no. JCM 18010.	Abreu F, 2008, INT MICROBIOL, V11, P75, DOI 10.2436/20.1501.01.46; Abreu F, 2007, INT J SYST EVOL MICR, V57, P1318, DOI 10.1099/ijs.0.64857-0; Abreu F, 2011, ISME J, V5, P1634, DOI 10.1038/ismej.2011.35; Amann R., 2007, MAGNETORECEPTION MAG, P25, DOI DOI 10.1007/7171_037; Bazylinski DA, 2004, NAT REV MICROBIOL, V2, P217, DOI 10.1038/nrmicro842; BAZYLINSKI DA, 1995, APPL ENVIRON MICROB, V61, P3232, DOI 10.1128/AEM.61.9.3232-3239.1995; BAZYLINSKI DA, 1993, NATURE, V366, P218, DOI 10.1038/366218a0; DELONG EF, 1993, SCIENCE, V259, P803, DOI 10.1126/science.259.5096.803; FARINA M, 1990, NATURE, V343, P256, DOI 10.1038/343256a0; Frankel RB, 2003, REV MINERAL GEOCHEM, V54, P95, DOI 10.2113/0540095; Kasama T, 2006, AM MINERAL, V91, P1216, DOI 10.2138/am.2006.2227; Komelli A, 2007, ANNU REV BIOCHEM, V76, P351, DOI 10.1146/annurev.biochem.74.082803.133444; Lane DJ, 1991, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Lefevre CT, 2012, ISME J, V6, P440, DOI 10.1038/ismej.2011.97; Lefevre CT, 2011, EARTH PLANET SC LETT, V312, P194, DOI 10.1016/j.epsl.2011.10.003; Lefevre CT, 2011, ENVIRON MICROBIOL, V13, P538, DOI 10.1111/j.1462-2920.2010.02361.x; Lefevre CT, 2010, APPL ENVIRON MICROB, V76, P3740, DOI 10.1128/AEM.03018-09; Lins U, 2007, GEOMICROBIOL J, V24, P43, DOI 10.1080/01490450601134317; MANN S, 1990, NATURE, V343, P258, DOI 10.1038/343258a0; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Nakazawa H, 2009, GENOME RES, V19, P1801, DOI 10.1101/gr.088906.108; Schueler D., 2002, International Microbiology, V5, P209; Schuler D, 2008, FEMS MICROBIOL REV, V32, P654, DOI 10.1111/j.1574-6976.2008.00116.x; Simmons SL, 2007, ENVIRON MICROBIOL, V9, P206, DOI 10.1111/j.1462-2920.2006.01129.x; Simmons SL, 2004, APPL ENVIRON MICROB, V70, P6230, DOI 10.1128/AEM.70.10.6230-6239.2004; Spring S., 2006, PROKARYOTES, V2, P842; Wenter R, 2009, ENVIRON MICROBIOL, V11, P1493, DOI 10.1111/j.1462-2920.2009.01877.x; WOLFE RS, 1987, FEMS MICROBIOL ECOL, V45, P31, DOI 10.1016/0378-1097(87)90039-5	28	151	157	8	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1720	1723		10.1126/science.1212596	http://dx.doi.org/10.1126/science.1212596			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22194580	Green Submitted			2022-12-28	WOS:000298344000072
J	Shao, SC; Hegde, RS				Shao, Sichen; Hegde, Ramanujan S.			A Calmodulin-Dependent Translocation Pathway for Small Secretory Proteins	CELL			English	Article							SIGNAL RECOGNITION PARTICLE; PREPRO-ALPHA-FACTOR; MAMMALIAN ENDOPLASMIC-RETICULUM; IN-VIVO; INTRACELLULAR CALCIUM; SEC PROTEINS; ER MEMBRANE; TRANSPORT; MICROSOMES; COMPLEX	Metazoans secrete an extensive array of small proteins essential for intercellular communication, defense, and physiologic regulation. Their synthesis takes mere seconds, leaving minimal time for recognition by the machinery for cotranslational protein translocation into the ER. The pathway taken by these substrates to enter the ER is not known. Here, we show that both in vivo and in vitro, small secretory proteins can enter the ER posttranslationally via a transient cytosolic intermediate. This intermediate contained calmodulin selectively bound to the signal peptides of small secretory proteins. Calmodulin maintained the translocation competence of small-protein precursors, precluded their aggregation and degradation, and minimized their inappropriate interactions with other cytosolic polypeptide-binding proteins. Acute inhibition of calmodulin specifically impaired small-protein translocation in vitro and in cells. These findings establish a mammalian posttranslational pathway for small-protein secretion and identify an unexpected role for calmodulin in chaperoning these precursors safely through the cytosol.	[Shao, Sichen; Hegde, Ramanujan S.] NICHHD, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA; [Shao, Sichen] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Johns Hopkins University	Hegde, RS (corresponding author), MRC Lab Mol Biol, Hills Rd, Cambridge CB2 0QH, England.	rhegde@mrc-lmb.cam.ac.uk		Shao, Sichen/0000-0003-2679-5537; Hegde, Ramanujan/0000-0001-8338-852X	JHU-NIH; NICHD; Medical Research Council; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008752, ZIAHD008752] Funding Source: NIH RePORTER	JHU-NIH; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We are grateful to M. Mariappan for useful discussions; S. Appathurai for initial experiments and reagents; A. Sharma for technical help; other Hegde lab members for support; and K. Strub for sharing results prior to publication. This work was supported by the JHU-NIH Graduate Partnership Program, the Intramural Research Program of the NICHD, and the Medical Research Council.	BRODSKY JL, 1993, J CELL BIOL, V123, P1355, DOI 10.1083/jcb.123.6.1355; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.bi.56.070187.002143; CHIRICO WJ, 1988, NATURE, V332, P805, DOI 10.1038/332805a0; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; Do H, 1996, CELL, V85, P369, DOI 10.1016/S0092-8674(00)81115-0; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; Emerman AB, 2010, MOL BIOL CELL, V21, P4325, DOI 10.1091/mbc.E10-09-0742; Erdmann F, 2011, EMBO J, V30, P17, DOI 10.1038/emboj.2010.284; Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095; Frith MC, 2006, PLOS GENET, V2, P515, DOI 10.1371/journal.pgen.0020052; GARCIA PD, 1988, J CELL BIOL, V106, P1043, DOI 10.1083/jcb.106.4.1043; GERMAN MS, 1990, J BIOL CHEM, V265, P22063; Goder V, 2000, EMBO J, V19, P6704, DOI 10.1093/emboj/19.24.6704; HESSA T, 2011, NATURE IN PRESS, DOI DOI 10.1038/NATURE10181; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Keenan RJ, 1998, CELL, V94, P181, DOI 10.1016/S0092-8674(00)81418-X; KRIEG UC, 1986, P NATL ACAD SCI USA, V83, P8604, DOI 10.1073/pnas.83.22.8604; Krisanaprakornkit S, 2003, J DENT RES, V82, P877, DOI 10.1177/154405910308201106; Martoglio B, 1997, EMBO J, V16, P6636, DOI 10.1093/emboj/16.22.6636; Mateja A, 2009, NATURE, V461, P361, DOI 10.1038/nature08319; Matlack KES, 1999, CELL, V97, P553, DOI 10.1016/S0092-8674(00)80767-9; MCCONOUGH H, 2003, CELL STRESS CHAPERON, V8, P303; MEANS AR, 1991, CELLULAR CALCIUM PRA, P205; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; NICCHITTA CV, 1993, CELL, V73, P989, DOI 10.1016/0092-8674(93)90276-V; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Panzner S, 1995, COLD SPRING HARB SYM, V60, P31, DOI 10.1101/SQB.1995.060.01.006; PELHAM HRB, 1976, EUR J BIOCHEM, V67, P247, DOI 10.1111/j.1432-1033.1976.tb10656.x; Pernet I, 2003, EXP DERMATOL, V12, P755, DOI 10.1111/j.0906-6705.2003.00086.x; Plath K, 2000, J CELL BIOL, V151, P167, DOI 10.1083/jcb.151.1.167; Plath K, 2004, MOL BIOL CELL, V15, P1, DOI 10.1091/mbc.E03-06-0390; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; ROTHBLATT JA, 1987, EMBO J, V6, P3455, DOI 10.1002/j.1460-2075.1987.tb02669.x; SCHLENSTEDT G, 1990, J BIOL CHEM, V265, P13960; SCHLENSTEDT G, 1987, EMBO J, V6, P699, DOI 10.1002/j.1460-2075.1987.tb04810.x; SCHLENSTEDT G, 1992, J BIOL CHEM, V267, P24328; Schluger NW, 1997, CURR OPIN IMMUNOL, V9, P504, DOI 10.1016/S0952-7915(97)80102-1; Shan SO, 2005, FEBS LETT, V579, P921, DOI 10.1016/j.febslet.2004.11.049; Sharma A, 2010, METHODS MOL BIOL, V619, P339, DOI 10.1007/978-1-60327-412-8_20; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; WALTER P, 1983, METHOD ENZYMOL, V96, P84; ZIMMERMANN R, 1990, J BIOENERG BIOMEMBR, V22, P711; ZIMMERMANN R, 1986, J BIOL CHEM, V261, P2889	47	90	92	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 23	2011	147	7					1576	1588		10.1016/j.cell.2011.11.048	http://dx.doi.org/10.1016/j.cell.2011.11.048			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	866SP	22196732	Green Accepted, Bronze			2022-12-28	WOS:000298403400021
J	Graham-Rowe, D				Graham-Rowe, Duncan			BIODIVERSITY Endangered and in demand	NATURE			English	Editorial Material																		[Anonymous], 2011, ENV INVESTIGATION AG; Chunyu S., 2011, 41 CITES, V41; Venkataraman B., 2007, TRAFFIC SE ASIA; Wasser R. M, 2010, TRAFFIC E ASIA REPOR; Wyler L. S., 2009, C RES SERVICE	5	53	57	7	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2011	480	7378					S101	S103		10.1038/480S101a	http://dx.doi.org/10.1038/480S101a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	865NQ	22190083	Bronze			2022-12-28	WOS:000298318000012
J	Attreed, NJ; Shields, SA				Attreed, Natalie J.; Shields, Simon A.			CASE REPORT A woman with rapidly progressive weakness and sensory loss	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GUILLAIN-BARRE-SYNDROME; CLINICAL-FEATURES; VACCINATION		[Attreed, Natalie J.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Shields, Simon A.] Norfolk & Norwich Univ Hosp NHS Fdn Trust, Norwich, Norfolk, England	University of East Anglia; Norfolk & Norwich University Hospitals NHS Foundation Trust	Attreed, NJ (corresponding author), Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England.	tillyjaneattreed@gmail.com						Ahrens N, 2008, CLIN EXP IMMUNOL, V151, P455, DOI 10.1111/j.1365-2249.2007.03483.x; Alshekhlee A, 2008, NEUROLOGY, V70, P1608, DOI 10.1212/01.wnl.0000310983.38724.d4; Bernsen RAJAM, 1999, NEUROLOGY, V53, P409, DOI 10.1212/WNL.53.2.409; Burns TM, 2008, SEMIN NEUROL, V28, P152, DOI 10.1055/s-2008-1062261; CHIBA A, 1992, ANN NEUROL, V31, P677, DOI 10.1002/ana.410310619; Dieleman J, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3908; FISHER M, 1956, NEW ENGL J MED, V255, P57, DOI 10.1056/NEJM195607122550201; Hughes RA, 2010, COCHRANE DB SYST REV, V6; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; MCKHANN, 1985, NEUROLOGY, V35, P1096; Price LC, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3577; Raphael JC, 2002, COCHRANE DB SYST REV, V2; Ruts L, 2010, NEUROLOGY, V74, P1680, DOI 10.1212/WNL.0b013e3181e07d14; SCHONBERGER LB, 1979, AM J EPIDEMIOL, V110, P105, DOI 10.1093/oxfordjournals.aje.a112795; Stowe J, 2009, AM J EPIDEMIOL, V169, P382, DOI 10.1093/aje/kwn310; van Doorn PA, 2008, LANCET NEUROL, V7, P939, DOI 10.1016/S1474-4422(08)70215-1; VANDERMECHE FGA, 1992, NEW ENGL J MED, V326, P1123, DOI 10.1056/NEJM199204233261705; Vucic S, 2009, J CLIN NEUROSCI, V16, P733, DOI 10.1016/j.jocn.2008.08.033; Willison HJ, 2002, BRAIN, V125, P2591, DOI 10.1093/brain/awf272; WINER JB, 1988, J NEUROL NEUROSUR PS, V51, P605, DOI 10.1136/jnnp.51.5.605; Winer JB, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a671	21	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 21	2011	343								d7845	10.1136/bmj.d7845	http://dx.doi.org/10.1136/bmj.d7845			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874TF	22188943				2022-12-28	WOS:000298980300005
J	Holtgrieve, GW; Schindler, DE; Hobbs, WO; Leavitt, PR; Ward, EJ; Bunting, L; Chen, GJ; Finney, BP; Gregory-Eaves, I; Holmgren, S; Lisac, MJ; Lisi, PJ; Nydick, K; Rogers, LA; Saros, JE; Selbie, DT; Shapley, MD; Walsh, PB; Wolfe, AP				Holtgrieve, Gordon W.; Schindler, Daniel E.; Hobbs, William O.; Leavitt, Peter R.; Ward, Eric J.; Bunting, Lynda; Chen, Guangjie; Finney, Bruce P.; Gregory-Eaves, Irene; Holmgren, Sofia; Lisac, Mark J.; Lisi, Peter J.; Nydick, Koren; Rogers, Lauren A.; Saros, Jasmine E.; Selbie, Daniel T.; Shapley, Mark D.; Walsh, Patrick B.; Wolfe, Alexander P.			A Coherent Signature of Anthropogenic Nitrogen Deposition to Remote Watersheds of the Northern Hemisphere	SCIENCE			English	Article							MOUNTAIN NATIONAL-PARK; LAKES; ISOTOPES; CLIMATE; SHIFTS; ENRICHMENT; COLORADO; NITRATE; DRIVEN; CYCLE	Humans have more than doubled the amount of reactive nitrogen (Nr) added to the biosphere, yet most of what is known about its accumulation and ecological effects is derived from studies of heavily populated regions. Nitrogen (N) stable isotope ratios (N-15:N-14) in dated sediments from 25 remote Northern Hemisphere lakes show a coherent signal of an isotopically distinct source of N to ecosystems beginning in 1895 +/- 10 years (+/- 1 standard deviation). Initial shifts in N isotope composition recorded in lake sediments coincide with anthropogenic CO2 emissions but accelerate with widespread industrial Nr production during the past half century. Although current atmospheric Nr deposition rates in remote regions are relatively low, anthropogenic N has probably influenced watershed N budgets across the Northern Hemisphere for over a century.	[Holtgrieve, Gordon W.; Schindler, Daniel E.; Lisi, Peter J.; Rogers, Lauren A.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Hobbs, William O.] Sci Museum Minnesota, St Croix Watershed Res Stn, Marine St Croix, MN USA; [Leavitt, Peter R.; Bunting, Lynda] Univ Regina, Dept Biol, Limnol Lab, Regina, SK S4S 0A2, Canada; [Ward, Eric J.] Natl Ocean & Atmospher Adm, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Seattle, WA USA; [Chen, Guangjie; Gregory-Eaves, Irene] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Chen, Guangjie] Yunnan Normal Univ, Sch Tourism & Geog, Key Lab Plateau Lake Ecol & Global Change, Kunming, Yunnan, Peoples R China; [Finney, Bruce P.; Shapley, Mark D.] Idaho State Univ, Dept Geosci, Pocatello, ID 83209 USA; [Finney, Bruce P.; Shapley, Mark D.] Idaho State Univ, Dept Biol Sci, Pocatello, ID 83209 USA; [Holmgren, Sofia] Lund Univ, Div Geol, Dept Earth & Ecosyst Sci, S-22100 Lund, Sweden; [Lisac, Mark J.; Walsh, Patrick B.] US Fish & Wildlife Serv, Dillingham, AK USA; [Nydick, Koren] Mt Studies Inst, Silverton, CO USA; [Saros, Jasmine E.] Univ Maine, Climate Change Inst, Orono, ME USA; [Selbie, Daniel T.] Fisheries & Oceans Canada, Sci Branch, Cultus Lake Salmon Res Lab, Pacific Reg, Cultus Lake, BC, Canada; [Wolfe, Alexander P.] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB, Canada	University of Washington; University of Washington Seattle; University of Regina; National Oceanic Atmospheric Admin (NOAA) - USA; McGill University; Yunnan Normal University; Idaho; Idaho State University; Idaho; Idaho State University; Lund University; United States Department of the Interior; US Fish & Wildlife Service; University of Maine System; University of Maine Orono; Fisheries & Oceans Canada; University of Alberta	Holtgrieve, GW (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	gholt@uw.edu	Leavitt, Peter R/A-1048-2013; Gregory-Eaves, Irene/U-9325-2019; Chen, Guangjie/J-3826-2017; Chen, Guangjie/AEO-1991-2022; Bunting, Lynda/K-2039-2013; Hobbs, William/P-1110-2016; Holtgrieve, Gordon/C-5371-2009	Leavitt, Peter R/0000-0001-9805-9307; Gregory-Eaves, Irene/0000-0002-0380-5061; Chen, Guangjie/0000-0001-8035-6565; Hobbs, William/0000-0001-7321-0779; Holtgrieve, Gordon/0000-0002-4451-3567; Rogers, Lauren/0000-0003-3305-6441; Walsh, Patrick/0000-0003-4168-4122; Shapley, Mark/0000-0003-4770-1878	Gordon and Betty Moore Foundation; U.S. Fish and Wildlife Service; Togiak National Wildlife Refuge; Alberta Water Research Institute; Natural Sciences and Engineering Research Council of Canada; NSF; Canada Foundation for Innovation	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); U.S. Fish and Wildlife Service(US Fish & Wildlife Service); Togiak National Wildlife Refuge; Alberta Water Research Institute; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NSF(National Science Foundation (NSF)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	The Gordon and Betty Moore Foundation, the U.S. Fish and Wildlife Service, Togiak National Wildlife Refuge, the Alberta Water Research Institute, the Natural Sciences and Engineering Research Council of Canada, and NSF provided funding for this work. The Canada Foundation for Innovation provided funding to P. R. L. for the University of Regina stable isotope lab. Original data used in this study are available as an R workspace along with example R code in the SOM.	Baron JS, 2011, BIOSCIENCE, V61, P602, DOI 10.1525/bio.2011.61.8.6; Bergstrom AK, 2006, GLOBAL CHANGE BIOL, V12, P635, DOI 10.1111/j.1365-2486.2006.01129.x; Bunting L, 2010, LIMNOL OCEANOGR, V55, P333, DOI 10.4319/lo.2010.55.1.0333; Dentener F., 2006, CYCLES, V20; Elser JJ, 2009, SCIENCE, V326, P835, DOI 10.1126/science.1176199; Enders SK, 2008, LIMNOL OCEANOGR, V53, P1468, DOI 10.4319/lo.2008.53.4.1468; Fenn ME, 2003, BIOSCIENCE, V53, P404, DOI [10.1641/0006-3568(2003)053[0404:EEONDI]2.0.CO;2, 10.1641/0006-3568(2003)053[0391:NEDAMI]2.0.CO;2]; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Galloway JN, 2003, BIOSCIENCE, V53, P341, DOI 10.1641/0006-3568(2003)053[0341:TNC]2.0.CO;2; Galman V, 2009, LIMNOL OCEANOGR, V54, P917, DOI 10.4319/lo.2009.54.3.0917; Hastings MG, 2009, SCIENCE, V324, P1288, DOI 10.1126/science.1170510; Heaton THE, 2004, ATMOS ENVIRON, V38, P5611, DOI 10.1016/j.atmosenv.2004.06.028; Higgins MB, 2010, EARTH PLANET SC LETT, V290, P102, DOI 10.1016/j.epsl.2009.12.009; Hobbs WO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010026; Holland E.A., 2005, Global N cycle: Fluxes and N2O mixing ratios originating from human activity, DOI [10.3334/ORNLDAAC/797, DOI 10.3334/ORNLDAAC/797]; *INT PAN CLIM CHAN, 2007, CLIM CHANG 2007 PHYS; Kohzu A, 2011, ORG GEOCHEM, V42, P173, DOI 10.1016/j.orggeochem.2010.10.010; Marland G., 2008, TRENDS COMPENDIUM DA; McLauchlan KK, 2007, P NATL ACAD SCI USA, V104, P7466, DOI 10.1073/pnas.0701779104; Ruhland K, 2008, GLOBAL CHANGE BIOL, V14, P2740, DOI 10.1111/j.1365-2486.2008.01670.x; Saros JE, 2010, ENVIRON SCI TECHNOL, V44, P4891, DOI 10.1021/es100147j; Smol JP, 2005, P NATL ACAD SCI USA, V102, P4397, DOI 10.1073/pnas.0500245102; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Wolfe AP, 2003, GEOBIOLOGY, V1, P153, DOI 10.1046/j.1472-4669.2003.00012.x	24	244	255	4	259	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 16	2011	334	6062					1545	1548		10.1126/science.1212267	http://dx.doi.org/10.1126/science.1212267			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	862LE	22174250				2022-12-28	WOS:000298091400050
J	Stephenson, BM; Kingsnorth, AN				Stephenson, Brian M.; Kingsnorth, Andrew N.			CHRISTMAS 2011: SURGERY Inguinal hernioplasty using mosquito net mesh in low income countries: an alternative and cost effective prosthesis	BRITISH MEDICAL JOURNAL			English	Editorial Material							HERNIA REPAIR; COMMERCIAL MESH; GHANA		[Stephenson, Brian M.] Royal Gwent Hosp, Dept Surg, Newport NP20 2UB, Wales; [Kingsnorth, Andrew N.] Derriford Hosp, Dept Surg, Plymouth PL6 8DH, Devon, England	Royal Gwent Hospital; Derriford Hospital	Stephenson, BM (corresponding author), Royal Gwent Hosp, Dept Surg, Newport NP20 2UB, Wales.	brian.stephenson@wales.nhs.uk						Airoldi M, 2009, HEALTH ECON, V18, P1237, DOI 10.1002/hec.1424; Clarke MG, 2009, HERNIA, V13, P155, DOI 10.1007/s10029-008-0460-3; Freudenberg S, 2006, WORLD J SURG, V30, P1784, DOI 10.1007/s00268-006-0108-3; Hodges AM, 2001, TROP DOCT, V31, P98, DOI 10.1177/004947550103100215; Kingsnorth A N, 2006, Hernia, V10, P376, DOI 10.1007/s10029-006-0118-y; Klinge U, 2008, BRIT J SURG, V95, P539, DOI 10.1002/bjs.6159; Klosterhalfen B, 2003, EUR SURG, V35, P16, DOI DOI 10.1046/J.1563-2563.2003.03011.X; Shillcutt SD, 2010, ARCH SURG-CHICAGO, V145, P954, DOI 10.1001/archsurg.2010.208; Spiegel DA, 2007, LANCET, V370, P1013, DOI 10.1016/S0140-6736(07)61457-3; Stephenson BM, 2003, SURG CLIN N AM, V83, P1255, DOI 10.1016/S0039-6109(03)00128-2; Stephenson BM, 2011, WORLD J SURG, V35, P1957, DOI 10.1007/s00268-011-1176-6; Tongaonkar RR, 2003, INDIAN J SURG, V65, P89; Wilhelm TJ, 2007, EUR SURG RES, V39, P312, DOI 10.1159/000104402; Wilhelm TJ, 2006, TROP DOCT, V36, P147, DOI 10.1258/004947506777978046	14	22	22	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 15	2011	343								d7448	10.1136/bmj.d7448	http://dx.doi.org/10.1136/bmj.d7448			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	888WF	22174320				2022-12-28	WOS:000300034600003
J	Ombrello, MJ; Remmers, EF; Sun, GP; Freeman, AF; Datta, S; Torabi-Parizi, P; Subramanian, N; Bunney, TD; Baxendale, RW; Martins, MS; Romberg, N; Komarow, H; Aksentijevich, I; Kim, HS; Ho, J; Cruse, G; Jung, MY; Gilfillan, AM; Metcalfe, DD; Nelson, C; O'Brien, M; Wisch, L; Stone, K; Douek, DC; Gandhi, C; Wanderer, AA; Lee, H; Nelson, SF; Shianna, KV; Cirulli, ET; Goldstein, DB; Long, EO; Moir, S; Meffre, E; Holland, SM; Kastner, DL; Katan, M; Hoffman, HM; Milner, JD				Ombrello, Michael J.; Remmers, Elaine F.; Sun, Guangping; Freeman, Alexandra F.; Datta, Shrimati; Torabi-Parizi, Parizad; Subramanian, Naeha; Bunney, Tom D.; Baxendale, Rhona W.; Martins, Marta S.; Romberg, Neil; Komarow, Hirsh; Aksentijevich, Ivona; Kim, Hun Sik; Ho, Jason; Cruse, Glenn; Jung, Mi-Yeon; Gilfillan, Alasdair M.; Metcalfe, Dean D.; Nelson, Celeste; O'Brien, Michelle; Wisch, Laura; Stone, Kelly; Douek, Daniel C.; Gandhi, Chhavi; Wanderer, Alan A.; Lee, Hane; Nelson, Stanley F.; Shianna, Kevin V.; Cirulli, Elizabeth T.; Goldstein, David B.; Long, Eric O.; Moir, Susan; Meffre, Eric; Holland, Steven M.; Kastner, Daniel L.; Katan, Matilda; Hoffman, Hal M.; Milner, Joshua D.			Cold Urticaria, Immunodeficiency, and Autoimmunity Related to PLCG2 Deletions	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMMON VARIABLE IMMUNODEFICIENCY; ANTIBODY-DEFICIENCY SYNDROME; B-CELL RECEPTOR; PHOSPHOLIPASE C-GAMMA-2; GENE; MUTATIONS; PROTEIN; ENTEROPATHY; ACTIVATION; SIGNALS	Background Mendelian analysis of disorders of immune regulation can provide insight into molecular pathways associated with host defense and immune tolerance. Methods We identified three families with a dominantly inherited complex of cold-induced urticaria, antibody deficiency, and susceptibility to infection and autoimmunity. Immunophenotyping methods included flow cytometry, analysis of serum immunoglobulins and autoantibodies, lymphocyte stimulation, and enzymatic assays. Genetic studies included linkage analysis, targeted Sanger sequencing, and next-generation whole-genome sequencing. Results Cold urticaria occurred in all affected subjects. Other, variable manifestations included atopy, granulomatous rash, autoimmune thyroiditis, the presence of antinuclear antibodies, sinopulmonary infections, and common variable immunodeficiency. Levels of serum IgM and IgA and circulating natural killer cells and class-switched memory B cells were reduced. Linkage analysis showed a 7-Mb candidate interval on chromosome 16q in one family, overlapping by 3.5 Mb a disease-associated haplotype in a smaller family. This interval includes PLCG2, encoding phospholipase C gamma(2) (PLC gamma(2)), a signaling molecule expressed in B cells, natural killer cells, and mast cells. Sequencing of complementary DNA revealed heterozygous transcripts lacking exon 19 in two families and lacking exons 20 through 22 in a third family. Genomic sequencing identified three distinct in-frame deletions that cosegregated with disease. These deletions, located within a region encoding an autoinhibitory domain, result in protein products with constitutive phospholipase activity. PLCG2-expressing cells had diminished cellular signaling at 37 degrees C but enhanced signaling at subphysiologic temperatures. Conclusions Genomic deletions in PLCG2 cause gain of PLC gamma(2) function, leading to signaling abnormalities in multiple leukocyte subsets and a phenotype encompassing both excessive and deficient immune function. (Funded by the National Institutes of Health Intramural Research Programs and others.)	[Sun, Guangping; Datta, Shrimati; Komarow, Hirsh; Cruse, Glenn; Jung, Mi-Yeon; Gilfillan, Alasdair M.; Metcalfe, Dean D.; Nelson, Celeste; O'Brien, Michelle; Wisch, Laura; Stone, Kelly; Milner, Joshua D.] NIAID, Lab Allerg Dis, NIH, Bethesda, MD 20892 USA; [Ombrello, Michael J.; Remmers, Elaine F.; Aksentijevich, Ivona; Kastner, Daniel L.] NHGRI, Inflammatory Dis Sect, NIH, Bethesda, MD 20892 USA; [Freeman, Alexandra F.; Holland, Steven M.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Torabi-Parizi, Parizad; Subramanian, Naeha] NIAID, Lab Syst Biol, NIH, Bethesda, MD 20892 USA; [Kim, Hun Sik; Long, Eric O.] NIAID, Immunogenet Lab, NIH, Bethesda, MD 20892 USA; [Ho, Jason; Moir, Susan] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Douek, Daniel C.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Torabi-Parizi, Parizad] NIH, Dept Crit Care Med, Ctr Clin, Bethesda, MD 20892 USA; [Bunney, Tom D.; Baxendale, Rhona W.; Martins, Marta S.; Katan, Matilda] UCL, Dept Struct & Mol Biol, Div Biosci, London WC1E 6BT, England; [Romberg, Neil; Meffre, Eric] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Kim, Hun Sik] Univ Ulsan, Grad Sch, Med Res Ctr, Dept Med, Ulsan 680749, South Korea; [Gandhi, Chhavi; Hoffman, Hal M.] Univ Calif San Diego, Dept Pediat & Med, Div Allergy Immunol & Rheumatol, San Diego, CA 92103 USA; [Hoffman, Hal M.] Rady Childrens Hosp San Diego, San Diego, CA USA; [Hoffman, Hal M.] Ludwig Inst Canc Res, San Diego, CA USA; [Wanderer, Alan A.] Univ Colorado, Hlth Sci Ctr, Aurora, CO USA; [Lee, Hane; Nelson, Stanley F.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; [Shianna, Kevin V.; Cirulli, Elizabeth T.; Goldstein, David B.] Duke Univ, Sch Med, Ctr Human Genome Variat, Durham, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); University of London; University College London; Yale University; University of Ulsan; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; Ludwig Institute for Cancer Research; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Los Angeles; Duke University	Milner, JD (corresponding author), NIAID, Lab Allerg Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jdmilner@niaid.nih.gov	Moir, Susan/AAC-3676-2020; Cruse, Glenn/B-4597-2012; Long, Eric O/G-5475-2011; Cruse, Glenn/AAZ-1093-2021; Martins, Marta/A-9905-2013; Aksentijevich, Ivona/AAF-1335-2019; Goldstein, David/AAY-8125-2020; Nelson, Stanley F/D-4771-2009	Long, Eric O/0000-0002-7793-3728; Martins, Marta/0000-0003-0429-9380; Nelson, Stanley F/0000-0002-2082-3114; Cruse, Glenn/0000-0002-7511-0082; Remmers, Elaine F/0000-0002-9522-1249; Romberg, Neil/0000-0002-1881-5318; Bunney, Tom/0000-0002-0281-8813; Cirulli Rogers, Liz/0000-0001-7808-2809; Subramanian, Naeha/0000-0003-3754-0521; Ombrello, Michael/0000-0003-3322-4089	National Human Genome Research Institute; National Institute of Allergy and Infectious Diseases (NIAID) [AI061093, AI071087, AI082713]; National Institute of Arthritis and Musculoskeletal and Skin Diseases; University of California, San Diego (UCSD) Department of Pediatrics; National Institutes of Health [T32 AI07469]; UCSD Clinical Translational Research Institute [UL1RR031980]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031980] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000825, ZIAAI000545, R21AI095848, ZIAAI000965, ZIAAI000967, ZIAAI005031, P01AI061093, T32AI007469, ZIAAI000525, U19AI082713, ZIAAI001091, ZIEAI001148, R01AI071087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIDAR041180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007754] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); University of California, San Diego (UCSD) Department of Pediatrics; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSD Clinical Translational Research Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by the Intramural Research Programs of the National Human Genome Research Institute, the National Institute of Allergy and Infectious Diseases (NIAID), and the National Institute of Arthritis and Musculoskeletal and Skin Diseases; grants from NIAID (AI061093, AI071087, and AI082713, to Dr. Meffre); the University of California, San Diego (UCSD) Department of Pediatrics; a National Institutes of Health training grant (T32 AI07469); and the UCSD Clinical Translational Research Institute, which has funding from awards issued by the National Center for Research Resources (UL1RR031980, to Dr. Hoffman).	Abe K, 2011, ARTHRITIS RHEUM-US, V63, P1301, DOI 10.1002/art.30280; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Aspalter RM, 2000, CLIN EXP IMMUNOL, V121, P506, DOI 10.1046/j.1365-2249.2000.01317.x; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Bryceson YT, 2007, BLOOD, V110, P1906, DOI 10.1182/blood-2007-02-074468; Bunney TD, 2011, TRENDS BIOCHEM SCI, V36, P88, DOI 10.1016/j.tibs.2010.08.003; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; Daniels RL, 2009, J BIOL CHEM, V284, P1570, DOI 10.1074/jbc.M807270200; Dolmetsch RE, 1997, NATURE, V388, P308, DOI 10.1038/40912; Dufour JF, 1997, J BIOL CHEM, V272, P2675, DOI 10.1074/jbc.272.5.2675; Everett KL, 2009, J BIOL CHEM, V284, P23083, DOI 10.1074/jbc.M109.019265; Foerster C, 2010, J IMMUNOL, V184, P7305, DOI 10.4049/jimmunol.1000434; Gandhi C, 2009, J ALLERGY CLIN IMMUN, V124, P1245, DOI 10.1016/j.jaci.2009.09.035; Gresset A, 2010, J BIOL CHEM, V285, P35836, DOI 10.1074/jbc.M110.166512; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; Healy JI, 1997, IMMUNITY, V6, P419, DOI 10.1016/S1074-7613(00)80285-X; Ho J, 2011, AIDS, V25, P295, DOI 10.1097/QAD.0b013e328342328b; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; KAPLAN AP, 1981, NEW ENGL J MED, V305, P1074, DOI 10.1056/NEJM198110293051808; Kim HS, 2010, IMMUNITY, V32, P175, DOI 10.1016/j.immuni.2010.02.004; Losi CG, 2005, J CLIN IMMUNOL, V25, P496, DOI 10.1007/s10875-005-5637-2; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Ng YS, 2004, J EXP MED, V200, P927, DOI 10.1084/jem.20040920; Pan-Hammarstrom Q, 2007, NAT GENET, V39, P429, DOI 10.1038/ng0407-429; Pelak K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001111; Poulin B, 2005, P NATL ACAD SCI USA, V102, P4276, DOI 10.1073/pnas.0409590102; Rodriguez R, 2003, BIOCHEM J, V374, P269, DOI 10.1042/BJ20021778; SHERMAN WB, 1950, J ALLERGY, V21, P414, DOI 10.1016/0021-8707(50)90017-7; Tassi I, 2005, J IMMUNOL, V175, P749, DOI 10.4049/jimmunol.175.2.749; van Blitterswijk WJ, 2008, CURR PHARM DESIGN, V14, P2061, DOI 10.2174/138161208785294636; van Rossum DB, 2005, NATURE, V434, P99, DOI 10.1038/nature03340; van Zelm MC, 2006, NEW ENGL J MED, V354, P1901, DOI 10.1056/NEJMoa051568; Wanderer AA, 2004, IMMUNOL ALLERGY CLIN, V24, P259, DOI 10.1016/j.iac.2004.01.001; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Warnatz K, 2009, P NATL ACAD SCI USA, V106, P13945, DOI 10.1073/pnas.0903543106; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Yu P, 2005, IMMUNITY, V22, P451, DOI 10.1016/j.immuni.2005.01.018	40	258	266	2	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 26	2012	366	4					330	338		10.1056/NEJMoa1102140	http://dx.doi.org/10.1056/NEJMoa1102140			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	881EQ	22236196	Green Accepted			2022-12-28	WOS:000299464100004
J	Duffy, KR; Wellard, CJ; Markham, JF; Zhou, JHS; Holmberg, R; Hawkins, ED; Hasbold, J; Dowling, MR; Hodgkin, PD				Duffy, Ken R.; Wellard, Cameron J.; Markham, John F.; Zhou, Jie H. S.; Holmberg, Ross; Hawkins, Edwin D.; Hasbold, Jhagvaral; Dowling, Mark R.; Hodgkin, Philip D.			Activation-Induced B Cell Fates Are Selected by Intracellular Stochastic Competition	SCIENCE			English	Article							IMMUNE-RESPONSES; PLASMA-CELL; T-CELLS; LYMPHOCYTE DIVISION; POPULATION-DYNAMICS; DIFFERENTIATION; MECHANISM; MODEL; PROLIFERATION; VARIABILITY	In response to stimulation, B lymphocytes pursue a large number of distinct fates important for immune regulation. Whether each cell's fate is determined by external direction, internal stochastic processes, or directed asymmetric division is unknown. Measurement of times to isotype switch, to develop into a plasmablast, and to divide or to die for thousands of cells indicated that each fate is pursued autonomously and stochastically. As a consequence of competition between these processes, censorship of alternative outcomes predicts intricate correlations that are observed in the data. Stochastic competition can explain how the allocation of a proportion of B cells to each cell fate is achieved. The B cell may exemplify how other complex cell differentiation systems are controlled.	[Wellard, Cameron J.; Zhou, Jie H. S.; Holmberg, Ross; Hasbold, Jhagvaral; Dowling, Mark R.; Hodgkin, Philip D.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia; [Duffy, Ken R.] Natl Univ Ireland, Hamilton Inst, Maynooth, Kildare, Ireland; [Wellard, Cameron J.; Zhou, Jie H. S.; Hasbold, Jhagvaral; Dowling, Mark R.; Hodgkin, Philip D.] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3052, Australia; [Markham, John F.] Univ Melbourne, Natl Informat & Commun Technol ICT Australia, Victoria Res Lab, Melbourne, Vic 3010, Australia; [Hawkins, Edwin D.] Peter MacCallum Canc Ctr, Immune Signalling Lab, Melbourne, Vic 3002, Australia	Walter & Eliza Hall Institute; Maynooth University; University of Melbourne; University of Melbourne; Peter Maccallum Cancer Center	Hodgkin, PD (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia.	hodgkin@wehi.edu.au	Duffy, Ken/D-7955-2011	Duffy, Ken/0000-0001-5587-9356; Dowling, Mark/0000-0002-8056-5348; Markham, John/0000-0002-5738-3861; Wellard, Cameron/0000-0002-6115-5394; Zhou, Jie/0000-0002-9113-800X; Hawkins, Edwin/0000-0002-3686-8261; Hodgkin, Philip/0000-0002-8604-1940	Australian National Health and Medical Research Council (NHMRC) [575500]; Victorian State Government; Australian Government NHMRC Independent Research Institute; Science Foundation Ireland [RFP-ENEF530]; National ICT Australia (NICTA); Australian government's Backing Australia's Ability initiative through the Australian Research Council	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government; Australian Government NHMRC Independent Research Institute(National Health and Medical Research Council (NHMRC) of Australia); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National ICT Australia (NICTA)(NICTA); Australian government's Backing Australia's Ability initiative through the Australian Research Council(Australian Research Council)	The data presented in this paper are tabulated in the main paper and in the Supporting Online Material. This work was supported by the Australian National Health and Medical Research Council (NHMRC) (program grant 575500; fellowships, E. D. H., M. R. D. and P. D. H.), Victorian State Government Operational Infrastructure support, Australian Government NHMRC Independent Research Institute Infrastructure Support Scheme (IRIIS), and Science Foundation Ireland (grant RFP-ENEF530, K. R. D.). J.F.M. was supported by National ICT Australia (NICTA), which is funded by the Australian government's Backing Australia's Ability initiative, in part through the Australian Research Council. The authors thank D. Day (Swinburne University of Technology) and Microsurfaces Pty. Ltd. for providing the microgrids (30), S. Nutt and A. Kallies for Blimp1 reporter mice, and R. DeBoer and D. Tarlinton for helpful feedback on the manuscript. "A cell population system and process" (U. S. Patent Application 12/312,933) describes computational algorithms based on competing fates that can be used to calculate and predict immune outcomes. Authors who are listed inventors are P. D. H., M.R.D., C.J.W, J.F.M., and E.D.H.	Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Cedar H, 2011, NAT REV IMMUNOL, V11, P478, DOI 10.1038/nri2991; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; COFFMAN RL, 1993, ADV IMMUNOL, V54, P229, DOI 10.1016/S0065-2776(08)60536-2; Day D, 2009, IMMUNOL CELL BIOL, V87, P154, DOI 10.1038/icb.2008.79; De Boer RJ, 2003, J IMMUNOL, V171, P3928, DOI 10.4049/jimmunol.171.8.3928; Deenick EK, 2003, J IMMUNOL, V170, P4963, DOI 10.4049/jimmunol.170.10.4963; Duffy KR, 2009, J MATH BIOL, V59, P255, DOI 10.1007/s00285-008-0231-x; Germain RN, 2001, SCIENCE, V293, P240, DOI 10.1126/science.1062946; Gett AV, 2000, NAT IMMUNOL, V1, P239, DOI 10.1038/79782; Hasbold J, 2004, NAT IMMUNOL, V5, P55, DOI 10.1038/ni1016; Hawkins ED, 2007, P NATL ACAD SCI USA, V104, P5032, DOI 10.1073/pnas.0700026104; Hawkins ED, 2009, P NATL ACAD SCI USA, V106, P13457, DOI 10.1073/pnas.0905629106; Hodgkin PD, 1996, J EXP MED, V184, P277, DOI 10.1084/jem.184.1.277; Hume DA, 2000, BLOOD, V96, P2323, DOI 10.1182/blood.V96.7.2323.h8002323_2323_2328; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; MacLennan ICM, 2003, IMMUNOL REV, V194, P8, DOI 10.1034/j.1600-065X.2003.00058.x; Markham JF, 2010, J R SOC INTERFACE, V7, P1049, DOI 10.1098/rsif.2009.0488; Nutt SL, 2011, SEMIN IMMUNOL, V23, P341, DOI 10.1016/j.smim.2011.08.010; PARKER DC, 1993, ANNU REV IMMUNOL, V11, P331, DOI 10.1146/annurev.iy.11.040193.001555; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Slifka MK, 1998, CURR OPIN IMMUNOL, V10, P252, DOI 10.1016/S0952-7915(98)80162-3; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Subramanian VG, 2008, J MATH BIOL, V56, P861, DOI 10.1007/s00285-007-0142-2; Tangye SG, 2003, J IMMUNOL, V170, P686, DOI 10.4049/jimmunol.170.2.686; Turner ML, 2008, J IMMUNOL, V181, P374, DOI 10.4049/jimmunol.181.1.374; Wellard C, 2010, J THEOR BIOL, V264, P443, DOI 10.1016/j.jtbi.2010.02.019; Yule GU, 1912, J R STAT SOC, V75, P579, DOI 10.2307/2340126	29	154	156	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 20	2012	335	6066					338	341		10.1126/science.1213230	http://dx.doi.org/10.1126/science.1213230			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878RE	22223740	Green Accepted			2022-12-28	WOS:000299273400048
J	Segev, E; Smith, Y; Ben-Yehuda, S				Segev, Einat; Smith, Yoav; Ben-Yehuda, Sigal			RNA Dynamics in Aging Bacterial Spores	CELL			English	Article							BACILLUS-SUBTILIS SPORES; DORMANT SPORES; PHOSPHATE METABOLISM; ENDOSPORE FORMATION; VEGETATIVE CELLS; HEAT-RESISTANCE; MESSENGER-RNA; SPORULATION; GERMINATION; COAT	Upon starvation, the bacterium Bacillus subtilis enters the process of sporulation, lasting several hours and culminating in formation of a spore, the most resilient cell type known. We show that a few days following sporulation, the RNA profile of spores is highly dynamic. In aging spores incubated at high temperatures, RNA content is globally decreased by degradation over several days. This degradation might be a strategy utilized by the spore to facilitate its dormancy. However, spores kept at low temperature exhibit a different RNA profile with evidence supporting transcription. Further, we demonstrate that germination is affected by spore age, incubation temperature, and RNA state, implying that spores can acquire dissimilar characteristics at a time they are considered dormant. We propose that, in contrast to current thinking, entering dormancy lasts a few days, during which spores are affected by the environment and undergo corresponding molecular changes influencing their emergence from quiescence.	[Segev, Einat; Ben-Yehuda, Sigal] Hebrew Univ Jerusalem, IMRIC, Hebrew Univ Hadassah Med Sch, Dept Microbiol & Mol Genet, IL-91120 Jerusalem, Israel; [Smith, Yoav] Hebrew Univ Jerusalem, Genom Data Anal Unit, Hebrew Univ Hadassah Med Sch, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Ben-Yehuda, S (corresponding author), Hebrew Univ Jerusalem, IMRIC, Hebrew Univ Hadassah Med Sch, Dept Microbiol & Mol Genet, IL-91120 Jerusalem, Israel.	sigalb@ekmd.huji.ac.il			European Research Council (ERC) [209130]; Israel Science Foundation [696/07]	European Research Council (ERC)(European Research Council (ERC)); Israel Science Foundation(Israel Science Foundation)	We thank M. Kott-Gutkowski (Hebrew University, Israel), A. Sol (Hebrew University), B. Fhanetzky (Tamar, Ltd.), and A. Grundwag (Eisenberg bros., Ltd.) for valuable technical support. We are grateful to A. Rosenberg and other members of the Ben-Yehuda laboratory for technical help and valuable discussions and comments. We thank G. Bachrach (Hebrew University), R. Losick (Harvard University, USA), A. Rouvinski (Hebrew University), I. Simon (Hebrew University), and J. Stulke (Gottingen University, Germany) for valuable comments on the manuscript. We thank the National BioResource Project National Institute of Genetics, Japan (NBRP [NIG, Japan]), D. Bechhofer (Mt. Sinai School of Medicine, USA), C. Condon (CNRS, France), J. Errington (Newcastle University, UK), H. Putzer (CNRS), and J. Stulke (Gottingen University) for kindly providing strains. This work was supported by the European Research Council (ERC) Starting Grant (209130) and by the Israel Science Foundation (696/07) awarded to S.B.-Y.	Abel-Santos E, 2007, NEW J CHEM, V31, P748, DOI 10.1039/b616695d; Bettegowda C, 2006, NAT BIOTECHNOL, V24, P1573, DOI 10.1038/nbt1256; BLACK SH, 1962, J BACTERIOL, V83, P960, DOI 10.1128/JB.83.5.960-967.1962; Camp AH, 2009, GENE DEV, V23, P1014, DOI 10.1101/gad.1781709; CARSTENSEN EL, 1971, J BACTERIOL, V107, P106, DOI 10.1128/JB.107.1.106-113.1971; CHAMBON P, 1968, J BIOL CHEM, V243, P5110; CHAMBON P, 1968, J BIOL CHEM, V243, P5101; Cohn F., 1877, BEITR BIOL PFLANZ, V2, P26; Commichau FM, 2009, MOL CELL PROTEOMICS, V8, P1350, DOI 10.1074/mcp.M800546-MCP200; Cowan AE, 2003, P NATL ACAD SCI USA, V100, P4209, DOI 10.1073/pnas.0636762100; Driks A, 2002, TRENDS MICROBIOL, V10, P251, DOI 10.1016/S0966-842X(02)02373-9; DURBAN E, 1974, J BACTERIOL, V118, P129, DOI 10.1128/JB.118.1.129-138.1974; Dworkin J, 2010, NAT REV MICROBIOL, V8, P890, DOI 10.1038/nrmicro2453; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; Francis CA, 2002, APPL ENVIRON MICROB, V68, P874, DOI 10.1128/AEM.68.2.874-880.2002; Gerhardt P, 1989, REGULATION PROCARYOT; Harwood C.R., 1990, MOL BIOL METHODS BAC; Keijser BJF, 2007, J BACTERIOL, V189, P3624, DOI 10.1128/JB.01736-06; Koch R, 1876, COHNS BEITR BIOLOGIE, V2, P13; Kuwana R, 2006, J BIOCHEM, V139, P887, DOI 10.1093/jb/mvj096; Leuschner RGK, 2000, MICROBIOL-UK, V146, P49, DOI 10.1099/00221287-146-1-49; McKenney PT, 2010, CURR BIOL, V20, P934, DOI 10.1016/j.cub.2010.03.060; Meisner J, 2008, P NATL ACAD SCI USA, V105, P15100, DOI 10.1073/pnas.0806301105; Melly E, 2002, J APPL MICROBIOL, V92, P1105, DOI 10.1046/j.1365-2672.2002.01644.x; Moeller R, 2006, CURR MICROBIOL, V53, P227, DOI 10.1007/s00284-006-0099-1; Moir A, 2006, J APPL MICROBIOL, V101, P526, DOI 10.1111/j.1365-2672.2006.02885.x; NAKASHIO S, 1985, J BACTERIOL, V162, P571, DOI 10.1128/JB.162.2.571-578.1985; NELSON DL, 1970, J BIOL CHEM, V245, P1137; NELSON DL, 1970, J BIOL CHEM, V245, P1146; Nevo-Dinur K, 2011, SCIENCE, V331, P1081, DOI 10.1126/science.1195691; Pelczar PL, 2007, J BACTERIOL, V189, P1090, DOI 10.1128/JB.01606-06; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; Piir K, 2011, EMBO REP, V12, P458, DOI 10.1038/embor.2011.47; Ragkousi K, 2004, J BACTERIOL, V186, P5567, DOI 10.1128/JB.186.17.5567-5575.2004; Riesenman PJ, 2000, APPL ENVIRON MICROB, V66, P620, DOI 10.1128/AEM.66.2.620-626.2000; Sanchez-Salas JL, 2011, APPL ENVIRON MICROB, V77, P6746, DOI 10.1128/AEM.05031-11; SANTO LY, 1974, J BACTERIOL, V120, P475, DOI 10.1128/JB.120.1.475-481.1974; SCHAEFFER P, 1965, P NATL ACAD SCI USA, V54, P704, DOI 10.1073/pnas.54.3.704; Setlow P, 2003, CURR OPIN MICROBIOL, V6, P550, DOI 10.1016/j.mib.2003.10.001; SETLOW P, 1970, J BIOL CHEM, V245, P3637; SETLOW P, 1995, ANNU REV MICROBIOL, V49, P29, DOI 10.1146/annurev.mi.49.100195.000333; Shah IM, 2008, CELL, V135, P486, DOI 10.1016/j.cell.2008.08.039; Stragier P, 1996, ANNU REV GENET, V30, P297, DOI 10.1146/annurev.genet.30.1.297; VASANTHA N, 1980, J BACTERIOL, V144, P1119, DOI 10.1128/JB.144.3.1119-1125.1980; Yao SY, 2010, J BACTERIOL, V192, P3279, DOI 10.1128/JB.00230-10; YOUNGMAN P, 1984, PLASMID, V12, P1, DOI 10.1016/0147-619X(84)90061-1; Zilhao R, 2005, J BACTERIOL, V187, P7753, DOI 10.1128/JB.187.22.7753-7764.2005	47	76	78	1	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 20	2012	148	1-2					139	149		10.1016/j.cell.2011.11.059	http://dx.doi.org/10.1016/j.cell.2011.11.059			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	882DC	22209493	Bronze			2022-12-28	WOS:000299540700020
J	Psaty, BM; Rivara, FP				Psaty, Bruce M.; Rivara, Frederick P.			Universal Screening and Drug Treatment of Dyslipidemia in Children and Adolescents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK; RHABDOMYOLYSIS; DISEASE		[Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98101 USA; [Psaty, Bruce M.; Rivara, Frederick P.] Univ Washington, Dept Epidemiol, Seattle, WA 98101 USA; [Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98101 USA; [Psaty, Bruce M.] Grp Hlth Res Inst, Seattle, WA USA; [Rivara, Frederick P.] Seattle Childrens Hosp, Ctr Child Hlth Behav & Dev, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital	Psaty, BM (corresponding author), Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, 1730 Minor Ave,Ste 1360, Seattle, WA 98101 USA.	psaty@u.washington.edu			NHLBI NIH HHS [HL105756, HL103612, HL087652, HL085251, HL080295, HL078888] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085251, R01HL078888, R01HL080295, R01HL087652, R01HL103612, R01HL105756, U01HL080295] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alsheikh-Ali AA, 2007, J AM COLL CARDIOL, V50, P409, DOI 10.1016/j.jacc.2007.02.073; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; BRUGTS JJ, 2009, BMJ-BRIT MED J, V338, DOI DOI 10.1136/BMJ.B2376; Cooper WO, 2011, NEW ENGL J MED, V365, P1896, DOI 10.1056/NEJMoa1110212; Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, 2011, Pediatrics, V128 Suppl 5, pS213, DOI 10.1542/peds.2009-2107C; Graham DJ, 2004, JAMA-J AM MED ASSOC, V292, P2585, DOI 10.1001/jama.292.21.2585; Juonala M, 2011, NEW ENGL J MED, V365, P1876, DOI 10.1056/NEJMoa1010112; OLIVER MF, 1984, LANCET, V2, P600; Taylor AJ, 2009, NEW ENGL J MED, V361, P2113, DOI 10.1056/NEJMoa0907569; US Food and Drug Administration, TRIL FEN AC DRUG SAF	10	43	43	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 18	2012	307	3					257	258		10.1001/jama.2011.1916	http://dx.doi.org/10.1001/jama.2011.1916			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877EY	22174386				2022-12-28	WOS:000299161200018
J	Gower, EW				Gower, Emily W.			Solving the trachoma elimination puzzle, one piece at a time	LANCET			English	Editorial Material							INFECTIOUS TRACHOMA		Wake Forest Sch Med, Dept Epidemiol & Prevent, Winston Salem, NC 27157 USA	Wake Forest University	Gower, EW (corresponding author), Wake Forest Sch Med, Dept Epidemiol & Prevent, Winston Salem, NC 27157 USA.	egower@wakehealth.edu						Gebre T, 2012, LANCET, V379, P143, DOI 10.1016/S0140-6736(11)61515-8; Lakew T, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000376; Melese M, 2008, JAMA-J AM MED ASSOC, V299, P778, DOI 10.1001/jama.299.7.778; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Schachter J, 1999, LANCET, V354, P630, DOI 10.1016/S0140-6736(98)12387-5; *WHO, 1998, WHOPBLGET982; World Health Organization, 2011, WORLD HLTH STAT 2011	7	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 14	2012	379	9811					102	103		10.1016/S0140-6736(11)61707-8	http://dx.doi.org/10.1016/S0140-6736(11)61707-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	879GM	22192487				2022-12-28	WOS:000299317700014
J	Loth, S; Baumann, S; Lutz, CP; Eigler, DM; Heinrich, AJ				Loth, Sebastian; Baumann, Susanne; Lutz, Christopher P.; Eigler, D. M.; Heinrich, Andreas J.			Bistability in Atomic-Scale Antiferromagnets	SCIENCE			English	Article							SPIN; MAGNETIZATION; RESOLUTION; EXCHANGE	Control of magnetism on the atomic scale is becoming essential as data storage devices are miniaturized. We show that antiferromagnetic nanostructures, composed of just a few Fe atoms on a surface, exhibit two magnetic states, the Neel states, that are stable for hours at low temperature. For the smallest structures, we observed transitions between Neel states due to quantum tunneling of magnetization. We sensed the magnetic states of the designed structures using spin-polarized tunneling and switched between them electrically with nanosecond speed. Tailoring the properties of neighboring antiferromagnetic nanostructures enables a low-temperature demonstration of dense nonvolatile storage of information.	[Loth, Sebastian; Baumann, Susanne; Lutz, Christopher P.; Eigler, D. M.; Heinrich, Andreas J.] IBM Res Div, Almaden Res Ctr, San Jose, CA 95120 USA; [Loth, Sebastian] Max Planck Res Grp Dynam Nanoelect Syst, Ctr Free Electron Laser Sci, Hamburg, Germany; [Loth, Sebastian] Max Planck Inst Solid State Res, Stuttgart, Germany; [Baumann, Susanne] Univ Basel, Dept Phys, CH-4056 Basel, Switzerland	International Business Machines (IBM); Max Planck Society; University of Basel	Loth, S (corresponding author), IBM Res Div, Almaden Res Ctr, 650 Harry Rd, San Jose, CA 95120 USA.	sebastian.loth@mpsd.cfel.de; heinrich@almaden.ibm.com	Loth, Sebastian/ABG-5237-2020	Loth, Sebastian/0000-0002-1587-3678; Baumann, Susanne/0000-0002-3821-494X	Office of Naval Research	Office of Naval Research(Office of Naval Research)	We acknowledge B. Melior for expert technical assistance. S.L., C.P.L., and A.J.H. thank the Office of Naval Research for financial support. A patent application regarding information storage in antiferromagnetic nanostructures was filed with the U. S. Patent and Trademark Office.	BARBARA B, 1990, PHYS LETT A, V145, P205, DOI 10.1016/0375-9601(90)90682-E; Barth JV, 2005, NATURE, V437, P671, DOI 10.1038/nature04166; Bose I, 2010, EUR PHYS J B, V77, P139, DOI 10.1140/epjb/e2010-00240-1; Chappert C, 2007, NAT MATER, V6, P813, DOI 10.1038/nmat2024; Chen X, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2388149; Friedman JR, 1996, PHYS REV LETT, V76, P3830, DOI 10.1103/PhysRevLett.76.3830; Fullerton EE, 2000, APPL PHYS LETT, V77, P3806, DOI 10.1063/1.1329868; Gambardella P, 2002, NATURE, V416, P301, DOI 10.1038/416301a; Gao CL, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.267205; Gatteschi D, 2006, MESOSCOPIC PHYS NANO, P1; Haney PM, 2008, J MAGN MAGN MATER, V320, P1300, DOI 10.1016/j.jmmm.2007.12.020; Heinze S, 2000, SCIENCE, V288, P1805, DOI 10.1126/science.288.5472.1805; Herzog G, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3354023; Hirjibehedin CF, 2006, SCIENCE, V312, P1021, DOI 10.1126/science.1125398; Hirjibehedin CF, 2007, SCIENCE, V317, P1199, DOI 10.1126/science.1146110; Iben I. E. T., 2009, 31 EOS ESD S ESD ASS, P1; Kaiser U, 2007, NATURE, V446, P522, DOI 10.1038/nature05617; Khajetoorians AA, 2011, SCIENCE, V332, P1062, DOI 10.1126/science.1201725; Kimel AV, 2009, NAT PHYS, V5, P727, DOI 10.1038/NPHYS1369; Krause S, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.127202; Lau JW, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/30/303001; Loth S, 2010, SCIENCE, V329, P1628, DOI [10.1126/science.1191688, 10.1126/science.191688]; Morup S, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/21/213202; Nolting F, 2000, NATURE, V405, P767, DOI 10.1038/35015515; Rinehart JD, 2011, NAT CHEM, V3, P538, DOI 10.1038/nchem.1063; Thomas L, 1996, NATURE, V383, P145, DOI 10.1038/383145a0; Urazhdin S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.046602; Waldmann O, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.237202; Wernsdorfer W, 1997, PHYS REV LETT, V79, P4014, DOI 10.1103/PhysRevLett.79.4014; WIESENDANGER R, 1990, PHYS REV LETT, V65, P247, DOI 10.1103/PhysRevLett.65.247	30	486	489	4	313	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 13	2012	335	6065					196	199		10.1126/science.1214131	http://dx.doi.org/10.1126/science.1214131			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875LZ	22246771				2022-12-28	WOS:000299033100047
J	McManus, RJ; Caulfield, M; Williams, B				McManus, Richard J.; Caulfield, Mark; Williams, Bryan			NICE hypertension guideline 2011: evidence based evolution	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BLOOD-PRESSURE; CARDIOVASCULAR EVENTS; AMLODIPINE; DIAGNOSIS; MANAGEMENT; OUTCOMES; DISEASE; RISK		[McManus, Richard J.] Univ Oxford, NIHR English Sch Primary Care Res, Dept Primary Care Hlth Sci, Oxford OX1 2ET, England; [Caulfield, Mark] Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England; [Caulfield, Mark] Queen Mary Univ London, NIHR Cardiovasc Biomed Res Unit, London EC1M 6BQ, England; [Williams, Bryan] Univ Leicester, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Williams, Bryan] Glenfield Hosp, Leicester NIHR Biomed Res Unit Cardiovasc Dis, Leicester LE3 9QP, Leics, England	University of Oxford; University of London; Queen Mary University London; University of London; Queen Mary University London; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital	McManus, RJ (corresponding author), Univ Oxford, NIHR English Sch Primary Care Res, Dept Primary Care Hlth Sci, Oxford OX1 2ET, England.	richard.mcmanus@phc.ox.ac.uk		Williams, Bryan/0000-0002-8094-1841; Caulfield, Mark/0000-0001-9295-3594	National Institute for Health Research [NF-SI-0509-10222, CDF/01/017] Funding Source: researchfish; Department of Health [CDF/01/017] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Brown MR, 2011, BMJ-BRIT MED J, V344, pd8218; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Fagard RH, 2007, J HYPERTENS, V25, P2193, DOI 10.1097/HJH.0b013e3282ef6185; GREENBERG G, 1985, BMJ-BRIT MED J, V291, P97; Head GA, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1104; Hodgkinson J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3621; JACKSON R, 1993, BRIT MED J, V307, P107, DOI 10.1136/bmj.307.6896.107; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; Krause T, 2011, BMJ-BRIT MED J, V343, pd4891; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Lovibond K, 2011, LANCET, V378, P1219, DOI 10.1016/S0140-6736(11)61184-7; National Institute for Health and Care Excellence, 2009, GUID MAN; National Institute for Health and Clinical Excellence, 2011, CLIN MAN PRIM HYP AD; PROBSTFIELD JL, 1991, JAMA-J AM MED ASSOC, V265, P3255; Ramsay LE, 1999, J HUM HYPERTENS, V13, P569, DOI 10.1038/sj.jhh.1000917; Rothwell PM, 2010, LANCET, V375, P938, DOI 10.1016/S0140-6736(10)60309-1; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Sofat R, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8078; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Wright JM, 2009, COCHRANE DB SYST REV, V1; Wright JT, 2005, JAMA-J AM MED ASSOC, V293, P1595, DOI 10.1001/jama.293.13.1595	22	86	86	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	2012	344								e181	10.1136/bmj.e181	http://dx.doi.org/10.1136/bmj.e181			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877SR	22246269				2022-12-28	WOS:000299203500001
J	Jacobs, M				Jacobs, Michael			Climate policy: Deadline 2015	NATURE			English	Editorial Material									Univ London London Sch Econ & Polit Sci, Grantham Res Inst Climate Change & Environm, London WC2A 2AE, England	University of London; London School Economics & Political Science	Jacobs, M (corresponding author), Univ London London Sch Econ & Polit Sci, Grantham Res Inst Climate Change & Environm, Houghton St, London WC2A 2AE, England.	m.u.jacobs@lse.ac.uk							0	9	10	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 12	2012	481	7380					137	138		10.1038/481137a	http://dx.doi.org/10.1038/481137a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	874TO	22237091	Bronze			2022-12-28	WOS:000298981200014
J	Mccoy, D				McCoy, David			PERSONAL VIEW Commercialisation is bad for public health	BRITISH MEDICAL JOURNAL			English	Editorial Material									UCL, Ctr Int Hlth & Dev, London WC1N 1EH, England	University of London; University College London	Mccoy, D (corresponding author), UCL, Ctr Int Hlth & Dev, London WC1N 1EH, England.	d.mccoy@ucl.ac.uk							0	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 11	2012	344								e149	10.1136/bmj.e149	http://dx.doi.org/10.1136/bmj.e149			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	877SI	22236598				2022-12-28	WOS:000299202500003
J	Berridge, V				Berridge, Virginia			The art of medicine The rise, fall, and revival of recovery in drug policy	LANCET			English	Editorial Material									London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Ctr Hist Publ Hlth, London WC1H 9SH, England	University of London; London School of Hygiene & Tropical Medicine	Berridge, V (corresponding author), London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Ctr Hist Publ Hlth, London WC1H 9SH, England.	virginia.berridge@lshtm.ac.uk		berridge, virginia/0000-0001-8011-8348				[Anonymous], 1973, AM DIS ORIGINS NARCO; Berridge V., 1999, OPIUM PEOPLE OPIATE; Berridge V., 1996, AIDS UK MAKING POLIC; Campbell Nancy., 2007, DISCOVERING ADDICTIO; Duke K, 2003, DRUGS, PRISONS AND POLICY-MAKING, P1, DOI 10.1057/9780230006133; Mold A, 2010, SCI TECHNOL MED MOD, P1, DOI 10.1057/9780230274693; Mold Alex, 2008, HEROIN TREATMENT ADD; SHIMAN LL, 1988, CRUSADE DRINK VICTOR	8	35	35	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 7	2012	379	9810					22	23		10.1016/S0140-6736(12)60011-7	http://dx.doi.org/10.1016/S0140-6736(12)60011-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	873WC	22232800				2022-12-28	WOS:000298913000020
J	Kim, J; Davis, JW				Kim, Jeri; Davis, John W.			Prostate Cancer Screening-Time to Abandon One-Size-Fits-All Approach?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES		[Kim, Jeri] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Davis, John W.] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Kim, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, 1155 Pressler St,Unit 1374, Houston, TX 77030 USA.	jekim@mdanderson.org						Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; Arias Elizabeth, 2011, Natl Vital Stat Rep, V59, P1; Bill-Axelson A, 2011, NEW ENGL J MED, V364, P1708, DOI 10.1056/NEJMoa1011967; Etzioni R, 2008, MED DECIS MAKING, V28, P323, DOI 10.1177/0272989X07312719; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Smith BD, 2009, J CLIN ONCOL, V27, P2758, DOI 10.1200/JCO.2008.20.8983; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; US Preventive Services Task Force, SCREEN PROST CANC US; Welch HG, 2009, J NATL CANCER I, V101, P1325, DOI 10.1093/jnci/djp278	10	11	11	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 28	2011	306	24					2717	2718		10.1001/jama.2011.1881	http://dx.doi.org/10.1001/jama.2011.1881			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	867VX	22203541				2022-12-28	WOS:000298484000023
J	Kaiser, CM; Goldman, DH; Chodera, JD; Tinoco, I; Bustamante, C				Kaiser, Christian M.; Goldman, Daniel H.; Chodera, John D.; Tinoco, Ignacio, Jr.; Bustamante, Carlos			The Ribosome Modulates Nascent Protein Folding	SCIENCE			English	Article							EXPLORING SUBDOMAIN COOPERATIVITY; EXIT TUNNEL; T4 LYSOZYME; POLYPEPTIDE-CHAINS; MESSENGER-RNA; IN-VITRO; TRANSLATION; SPECTROSCOPY; DYNAMICS; LANDSCAPES	The blood-brain barrier (BBB) is composed of tightly bound endothelial cells (ECs) and perivascular astrocytes that regulate central nervous system (CNS) homeostasis. We showed that astrocytes secrete Sonic hedgehog and that BBB ECs express Hedgehog (Hh) receptors, which together promote BBB formation and integrity during embryonic development and adulthood. Using pharmacological inhibition and genetic inactivation of the Hh signaling pathway in ECs, we also demonstrated a critical role of the Hh pathway in promoting the immune quiescence of BBB ECs by decreasing the expression of proinflammatory mediators and the adhesion and migration of leukocytes, in vivo and in vitro. Overall, the Hh pathway provides a barrier-promoting effect and an endogenous anti-inflammatory balance to CNS-directed immune attacks, as occurs in multiple sclerosis.	[Kaiser, Christian M.; Chodera, John D.; Tinoco, Ignacio, Jr.; Bustamante, Carlos] Univ Calif Berkeley, Inst Quantitat Biosci QB3, Berkeley, CA 94720 USA; [Kaiser, Christian M.; Bustamante, Carlos] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Goldman, Daniel H.; Tinoco, Ignacio, Jr.; Bustamante, Carlos] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Bustamante, C (corresponding author), Univ Calif Berkeley, Inst Quantitat Biosci QB3, Berkeley, CA 94720 USA.	carlos@alice.berkeley.edu		Bustamante, Carlos/0000-0002-2970-0073; Chodera, John/0000-0003-0542-119X	NIH [5K99GM086516, 5R01GM10840, 5R01GM32543]; QB3 Institute, Berkeley; NSF; Human Frontiers of Science Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM086516, R01GM010840, R01GM032543] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); QB3 Institute, Berkeley; NSF(National Science Foundation (NSF)); Human Frontiers of Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Marqusee for the T4 lysozyme source plasmid and for helpful discussions, O. Dudko for help with the analysis of force-ramp data, and J. R. Moffitt and members of the Bustamante and Tinoco laboratories for helpful discussions on the manuscript. C. M. K. acknowledges support from the NIH K99 Award 5K99GM086516; C. M. K. and J. D. C. acknowledge funding from the QB3 Institute, Berkeley (Distinguished Postdoctoral Fellowship); D. H. G. acknowledges the NSF's Graduate Research Fellowship; I. T. acknowledges support from NIH grant 5R01GM10840 and the Human Frontiers of Science Program; and C. B. acknowledges support from NIH grant 5R01GM32543.	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288; Baase WA, 2010, PROTEIN SCI, V19, P631, DOI 10.1002/pro.344; Bhushan S, 2010, NAT STRUCT MOL BIOL, V17, P313, DOI 10.1038/nsmb.1756; Brandt F, 2009, CELL, V136, P261, DOI 10.1016/j.cell.2008.11.016; Brockwell DJ, 2007, CURR OPIN STRUC BIOL, V17, P30, DOI 10.1016/j.sbi.2007.01.003; Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cannarrozzi G, 2010, CELL, V141, P355, DOI 10.1016/j.cell.2010.02.036; Cellitti J, 2007, PROTEIN SCI, V16, P852, DOI 10.1110/ps.062632807; Cellitti J, 2007, PROTEIN SCI, V16, P842, DOI 10.1110/ps.062628607; Chow CC, 2003, BIOCHEMISTRY-US, V42, P7090, DOI 10.1021/bi0273056; Dietz H, 2006, P NATL ACAD SCI USA, V103, P1244, DOI 10.1073/pnas.0509217103; Dudko OK, 2008, P NATL ACAD SCI USA, V105, P15755, DOI 10.1073/pnas.0806085105; Elcock AH, 2006, PLOS COMPUT BIOL, V2, P824, DOI 10.1371/journal.pcbi.0020098; Ellis JP, 2008, ACS CHEM BIOL, V3, P555, DOI 10.1021/cb800059u; Evans MS, 2008, J MOL BIOL, V383, P683, DOI 10.1016/j.jmb.2008.07.035; GAY GD, 1995, J MOL BIOL, V254, P968, DOI 10.1006/jmbi.1995.0669; Green R, 1997, ANNU REV BIOCHEM, V66, P679, DOI 10.1146/annurev.biochem.66.1.679; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hsu STD, 2007, P NATL ACAD SCI USA, V104, P16516, DOI 10.1073/pnas.0704664104; Khushoo A, 2011, MOL CELL, V41, P682, DOI 10.1016/j.molcel.2011.02.027; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kiraga J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-163; Kubelka J, 2006, J MOL BIOL, V359, P546, DOI 10.1016/j.jmb.2006.03.034; Liang ST, 2000, J BACTERIOL, V182, P3037, DOI 10.1128/JB.182.11.3037-3044.2000; Liu RH, 2000, METHOD ENZYMOL, V318, P268; Llinas M, 1998, PROTEIN SCI, V7, P96, DOI 10.1002/pro.5560070110; Lu JL, 2005, NAT STRUCT MOL BIOL, V12, P1123, DOI 10.1038/nsmb1021; MATSUMURA M, 1989, SCIENCE, V243, P792, DOI 10.1126/science.2916125; Mittal J, 2008, P NATL ACAD SCI USA, V105, P20233, DOI 10.1073/pnas.0807742105; Moffitt JR, 2008, ANNU REV BIOCHEM, V77, P205, DOI 10.1146/annurev.biochem.77.043007.090225; Neira JL, 1999, J MOL BIOL, V285, P1309, DOI 10.1006/jmbi.1998.2249; O'Brien EP, 2010, J AM CHEM SOC, V132, P16928, DOI 10.1021/ja106530y; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; Qu XH, 2011, NATURE, V475, P118, DOI 10.1038/nature10126; Schuler B, 2002, NATURE, V419, P743, DOI 10.1038/nature01060; Shank EA, 2010, NATURE, V465, P637, DOI 10.1038/nature09021; Siller E, 2010, J MOL BIOL, V396, P1310, DOI 10.1016/j.jmb.2009.12.042; TANIUCHI H, 1970, J BIOL CHEM, V245, P5459; Udgaonkar JB, 2008, ANNU REV BIOPHYS, V37, P489, DOI 10.1146/annurev.biophys.37.032807.125920; VARENNE S, 1984, J MOL BIOL, V180, P549, DOI 10.1016/0022-2836(84)90027-5; Voisset C, 2011, BIOTECHNOL J, V6, P668, DOI 10.1002/biot.201100021; Voss NR, 2006, J MOL BIOL, V360, P893, DOI 10.1016/j.jmb.2006.05.023; Weinkam P, 2009, P NATL ACAD SCI USA, V106, P1796, DOI 10.1073/pnas.0813120106; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554; Zhou HX, 2001, BIOCHEMISTRY-US, V40, P11289, DOI 10.1021/bi0155504	48	199	201	2	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1723	1727		10.1126/science.1209740	http://dx.doi.org/10.1126/science.1209740			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22194581	Green Accepted			2022-12-28	WOS:000298344000073
J	Reynolds, KA; McLaughlin, RN; Ranganathan, R				Reynolds, Kimberly A.; McLaughlin, Richard N.; Ranganathan, Rama			Hot Spots for Allosteric Regulation on Protein Surfaces	CELL			English	Article							DIHYDROFOLATE-REDUCTASE CATALYSIS; ENZYME CATALYSIS; SIGNAL-TRANSDUCTION; STRUCTURAL BASIS; AVENA-SATIVA; PDZ DOMAIN; K+ CHANNEL; COMMUNICATION; FLUCTUATIONS; ACTIVATION	Recent work indicates a general architecture for proteins in which sparse networks of physically contiguous and coevolving amino acids underlie basic aspects of structure and function. These networks, termed sectors, are spatially organized such that active sites are linked to many surface sites distributed throughout the structure. Using the metabolic enzyme dihydrofolate reductase as a model system, we show that: (1) the sector is strongly correlated to a network of residues undergoing millisecond conformational fluctuations associated with enzyme catalysis, and (2) sector-connected surface sites are statistically preferred locations for the emergence of allosteric control in vivo. Thus, sectors represent an evolutionarily conserved "wiring'' mechanism that can enable perturbations at specific surface positions to rapidly initiate conformational control over protein function. These findings suggest that sectors enable the evolution of intermolecular communication and regulation.	[Reynolds, Kimberly A.; McLaughlin, Richard N.; Ranganathan, Rama] Univ Texas SW Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA; [Reynolds, Kimberly A.; McLaughlin, Richard N.; Ranganathan, Rama] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Ranganathan, R (corresponding author), Univ Texas SW Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA.	rama.ranganathan@utsouthwestern.edu		McLaughlin, Richard/0000-0003-0950-2253; Reynolds, Kimberly/0000-0003-4805-0317	Robert A. Welch foundation [I-1366]; NIH [1RO1 EY018720]; Green Center for Systems Biology at UT Southwestern Medical Center; NATIONAL EYE INSTITUTE [R01EY018720] Funding Source: NIH RePORTER	Robert A. Welch foundation(The Welch Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Green Center for Systems Biology at UT Southwestern Medical Center; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank P. E. Wright for sharing data and discussion. We are also appreciative to S.J. Benkovic for discussions of DHFR mechanism and providing the E. coli auxotroph strain, M. Socolich for technical assistance, and members of the R. R. laboratory for critical review of the work. This study was supported by the Robert A. Welch foundation (R.R., I-1366), the NIH (1RO1 EY018720), and the Green Center for Systems Biology at UT Southwestern Medical Center.	Agarwal PK, 2002, P NATL ACAD SCI USA, V99, P2794, DOI 10.1073/pnas.052005999; ALMASAN A, 1995, P NATL ACAD SCI USA, V92, P5436, DOI 10.1073/pnas.92.12.5436; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Bhabha G, 2011, SCIENCE, V332, P234, DOI 10.1126/science.1198542; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Boehr DD, 2010, P NATL ACAD SCI USA, V107, P1373, DOI 10.1073/pnas.0914163107; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Chen J, 2007, J MOL BIOL, V374, P250, DOI 10.1016/j.jmb.2007.08.047; Clarkson MW, 2006, BIOCHEMISTRY-US, V45, P7693, DOI 10.1021/bi060652l; Cui Q, 2008, PROTEIN SCI, V17, P1295, DOI 10.1110/ps.03259908; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Ferguson AD, 2007, P NATL ACAD SCI USA, V104, P513, DOI 10.1073/pnas.0609887104; FIERKE CA, 1987, BIOCHEMISTRY-US, V26, P4085, DOI 10.1021/bi00387a052; Fraser JS, 2009, NATURE, V462, P669, DOI 10.1038/nature08615; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Halavaty AS, 2007, BIOCHEMISTRY-US, V46, P14001, DOI 10.1021/bi701543e; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Hatley ME, 2003, P NATL ACAD SCI USA, V100, P14445, DOI 10.1073/pnas.1835919100; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Lee J, 2008, SCIENCE, V322, P438, DOI 10.1126/science.1159052; Lee SY, 2009, PLOS BIOL, V7, P676, DOI 10.1371/journal.pbio.1000047; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Luque I, 2002, ANNU REV BIOPH BIOM, V31, P235, DOI 10.1146/annurev.biophys.31.082901.134215; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; McElheny D, 2005, P NATL ACAD SCI USA, V102, P5032, DOI 10.1073/pnas.0500699102; Menon ST, 2001, PHYSIOL REV, V81, P1659, DOI 10.1152/physrev.2001.81.4.1659; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Peterson FC, 2004, MOL CELL, V13, P665, DOI 10.1016/S1097-2765(04)00086-3; Rajagopalan PTR, 2002, CHEM REC, V2, P24, DOI 10.1002/tcr.10009; Rajagopalan PTR, 2002, BIOCHEMISTRY-US, V41, P12618, DOI 10.1021/bi026369d; Russ WP, 2005, NATURE, V437, P579, DOI 10.1038/nature03990; Sadovsky E, 2007, P NATL ACAD SCI USA, V104, P19813, DOI 10.1073/pnas.0708120104; Salomon M, 2001, P NATL ACAD SCI USA, V98, P12357, DOI 10.1073/pnas.221455298; Saraf MC, 2004, P NATL ACAD SCI USA, V101, P4142, DOI 10.1073/pnas.0400065101; Schnell JR, 2004, ANNU REV BIOPH BIOM, V33, P119, DOI 10.1146/annurev.biophys.33.110502.133613; Shulman AI, 2004, CELL, V116, P417, DOI 10.1016/S0092-8674(04)00119-9; Smock RG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.65; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Socolich M, 2005, NATURE, V437, P512, DOI 10.1038/nature03991; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Thompson DA, 2006, CURR BIOL, V16, P1581, DOI 10.1016/j.cub.2006.06.070; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9	46	236	240	0	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2011	147	7					1564	1575		10.1016/j.cell.2011.10.049	http://dx.doi.org/10.1016/j.cell.2011.10.049			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	866SP	22196731	Bronze, Green Accepted			2022-12-28	WOS:000298403400020
J	Crow, JM				Crow, James Mitchell			MICROBIOME That healthy gut feeling	NATURE			English	Editorial Material																		Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; Jia W, 2008, NAT REV DRUG DISCOV, V7, P123, DOI 10.1038/nrd2505; Kim YS, 2008, J MICROBIOL BIOTECHN, V18, P1109; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Zhang X, 2011, WORLD SCI TECHNOLOGY, V13, P202	6	29	33	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2011	480	7378					S88	S89		10.1038/480S88a	http://dx.doi.org/10.1038/480S88a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	865NQ	22190088	Bronze			2022-12-28	WOS:000298318000004
J	Jena, AB; Goldman, DP; Foster, SE; Califano, JA				Jena, Anupam B.; Goldman, Dana P.; Foster, Susan E.; Califano, Joseph A., Jr.			Prescription Medication Abuse and Illegitimate Internet-Based Pharmacies	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							UNITED-STATES; DRUGS	Abuse of controlled prescription medications in the United States exceeds that of all illicit drugs combined except marijuana and has grown considerably in the past decade. Although available through traditional channels, controlled prescription medications can also be purchased on the Internet without a prescription. This issue has gained the attention of federal regulators, law enforcement, and the media, but physician awareness of the problem is scarce. This article describes the nature of the problem and its magnitude, discusses the challenges to federal and private efforts to combat illegitimate online pharmacies, and outlines strategies for physicians to recognize and minimize the unwarranted effects of the availability of these medications on the Internet.	[Jena, Anupam B.] Harvard Univ, Sch Med, Dept Med, Massachusetts Gen Hosp,Wang Ambulatory Care Ctr, Boston, MA 02114 USA; Univ So Calif, Leonard D Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA USA; RAND Corp, Santa Monica, CA USA; Columbia Univ, Natl Ctr Addict & Substance Abuse, New York, NY USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Southern California; RAND Corporation; Columbia University	Jena, AB (corresponding author), Harvard Univ, Sch Med, Dept Med, Massachusetts Gen Hosp,Wang Ambulatory Care Ctr, 15 Parkman St, Boston, MA 02114 USA.	jena.anupam@mgh.harvard.edu	Goldman, Dana P/E-7667-2013	Goldman, Dana P/0000-0001-8498-6396				Cai R., 2010, Morbidity and Mortality Weekly Report, V59, P705; Cicero TJ, 2008, PAIN MED, V9, P718, DOI 10.1111/j.1526-4637.2007.00323.x; Cramer RJ, 2004, GAO04892T; [Drug Enforcement Administration (DEA) Department of Justice], 2009, FED REG, V74, P15595; Fentiman LC, 2003, RUTGERS LAW REV, V56, P119; Forman RF, 2003, JAMA-J AM MED ASSOC, V290, P889, DOI 10.1001/jama.290.7.889; Gordon SM, 2006, J SUBST ABUSE TREAT, V30, P271, DOI 10.1016/j.jsat.2005.08.013; Inciardi JA, 2010, DRUG ALCOHOL DEPEN, V110, P21, DOI 10.1016/j.drugalcdep.2010.01.015; Jena AB, 2011, HEALTH AFFAIR, V30, P1192, DOI 10.1377/hlthaff.2011.0155; KAUFMAN M, 2005, WASH POST, pA03; Miller C.C., 2011, NY TIMES, pB1; National Center on Addiction and Substance Abuse, 2008, YOUV GOT DRUGS; [National Drug Intelligence Center U.S. Department of Justice], 2009, US DEP JUST PUBL; Saitz R, 1997, AM J DRUG ALCOHOL AB, V23, P343, DOI 10.3109/00952999709016881; Siva N, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3457; Substance Abuse and Mental Health Services Administration (Office of Applied Studies), 2009, HHS PUBL; The National Center on Addiction and Substance Abuse, 2005, COUNT DIV AB CONTR P; U.S. Food and Drug Administration Internet Pharmacy Task Force, 2009, WARN LETT US FOOD DR	18	20	20	1	41	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2011	155	12					848	850		10.7326/0003-4819-155-12-201112200-00008	http://dx.doi.org/10.7326/0003-4819-155-12-201112200-00008			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	864ZU	22184692				2022-12-28	WOS:000298280500019
J	Daranlot, J; Jorfi, M; Xie, CJ; Bergeat, A; Costes, M; Caubet, P; Xie, DQ; Guo, H; Honvault, P; Hickson, KM				Daranlot, Julien; Jorfi, Mohamed; Xie, Changjian; Bergeat, Astrid; Costes, Michel; Caubet, Philippe; Xie, Daiqian; Guo, Hua; Honvault, Pascal; Hickson, Kevin M.			Revealing Atom-Radical Reactivity at Low Temperature Through the N plus OH Reaction	SCIENCE			English	Article							NEUTRAL-NEUTRAL REACTIONS; RATE CONSTANTS; KINETICS	More than 100 reactions between stable molecules and free radicals have been shown to remain rapid at low temperatures. In contrast, reactions between two unstable radicals have received much less attention due to the added complexity of producing and measuring excess radical concentrations. We performed kinetic experiments on the barrierless N(S-4) + OH((2)Pi) -> H(S-2) + NO((2)Pi) reaction in a supersonic flow (Laval nozzle) reactor. We used a microwave-discharge method to generate atomic nitrogen and a relative-rate method to follow the reaction kinetics. The measured rates agreed well with the results of exact and approximate quantum mechanical calculations. These results also provide insight into the gas-phase formation mechanisms of molecular nitrogen in interstellar clouds.	[Daranlot, Julien; Bergeat, Astrid; Costes, Michel; Caubet, Philippe; Hickson, Kevin M.] Univ Bordeaux, Inst Mol Sci, CNRS, UMR 5255, F-33400 Talence, France; [Jorfi, Mohamed] Univ Poitiers, CNRS, UMR 6503, Catalyse Chim Organ Lab, F-86022 Poitiers, France; [Xie, Changjian; Xie, Daiqian] Nanjing Univ, Sch Chem & Chem Engn, Key Lab Mesoscop Chem, Inst Theoret & Computat Chem, Nanjing 210093, Peoples R China; [Guo, Hua] Univ New Mexico, Dept Chem & Chem Biol, Albuquerque, NM 87131 USA; [Honvault, Pascal] Univ Bourgogne, CNRS, UMR 5209, Lab Interdisciplinaire Carnot de Bourgogne, F-21078 Dijon, France; [Honvault, Pascal] Univ Franche Comte, UFR Sci & Tech, F-25030 Besancon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; Nanjing University; University of New Mexico; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Universite de Technologie de Belfort-Montbeliard (UTBM); Universite de Franche-Comte	Hickson, KM (corresponding author), Univ Bordeaux, Inst Mol Sci, CNRS, UMR 5255, F-33400 Talence, France.	km.hickson@ism.u-bordeaux1.fr	Bergeat, Astrid/K-6780-2016; Hickson, Kevin M/A-2443-2012; Guo, H./J-2685-2014; Hickson, Kevin/AAA-4572-2019; HONVAULT, Pascal/B-2993-2010	Bergeat, Astrid/0000-0002-3961-5710; Hickson, Kevin M/0000-0001-8317-2606; Guo, H./0000-0001-9901-053X; Hickson, Kevin/0000-0001-8317-2606; HONVAULT, Pascal/0000-0001-6857-5511	Agence Nationale de la Recherche [ANR-JC08_311018]; Conseil Regional d'Aquitaine [20091102002]; European Union [PERG03-GA-2008-230805]; Mesocentre de Calcul de Franche-Comte; U.S. Department of Energy; National Natural Science Foundation of China [21133006, 91021010, 20725312]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); European Union(European Commission); Mesocentre de Calcul de Franche-Comte; U.S. Department of Energy(United States Department of Energy (DOE)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Our experimental work was supported by the Agence Nationale de la Recherche (grant ANR-JC08_311018), the Conseil Regional d'Aquitaine (grant 20091102002), and the European Union (grant PERG03-GA-2008-230805). Our theoretical work was supported by the Mesocentre de Calcul de Franche-Comte (M.J. and P. H.), the U.S. Department of Energy (H. G.) and the National Natural Science Foundation of China (grants 21133006, 91021010, and 20725312) (D. X.). The data described in this work can be obtained from the corresponding author on request.	Bergeat A, 2009, PHYS CHEM CHEM PHYS, V11, P8149, DOI 10.1039/b905702a; Berteloite C, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.203201; BOWMAN JM, 1991, J PHYS CHEM-US, V95, P4960, DOI 10.1021/j100166a014; BRUNE WH, 1983, J PHYS CHEM-US, V87, P4503, DOI 10.1021/j100245a034; Carty D, 2006, J PHYS CHEM A, V110, P3101, DOI 10.1021/jp054429u; Daranlot J, 2010, CHEMPHYSCHEM, V11, P4002, DOI 10.1002/cphc.201000467; Edvardsson D, 2006, CHEM PHYS LETT, V431, P261, DOI 10.1016/j.cplett.2006.10.005; Gamallo P, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3364867; Ge MH, 2008, J THEOR COMPUT CHEM, V7, P607, DOI 10.1142/S021963360800399X; GRAFF MM, 1990, J CHEM PHYS, V92, P2423, DOI 10.1063/1.457986; HERBST E, 1994, MON NOT R ASTRON SOC, V268, P335, DOI 10.1093/mnras/268.2.335; Herbst E., 2005, OHIO STATE U ASTROCH; Honvault P, 2004, NATO SCI SER II-MATH, V145, P187; HOWARD MJ, 1981, J CHEM SOC FARAD T 2, V77, P997, DOI 10.1039/f29817700997; Jorfi A, 2009, J PHYS CHEM A, V113, P10648, DOI 10.1021/jp907865a; Jorfi M, 2009, CHEM PHYS LETT, V471, P65, DOI 10.1016/j.cplett.2009.02.029; Li AY, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3592375; Lique F, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3274226; Maret S, 2006, NATURE, V442, P425, DOI 10.1038/nature04919; SIMS IR, 1992, J CHEM PHYS, V97, P8798, DOI 10.1063/1.463349; SMITH IWM, 1994, J CHEM SOC FARADAY T, V90, P3221, DOI 10.1039/ft9949003221; Sun ZG, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3328109; Wakelam V, 2010, SPACE SCI REV, V156, P13, DOI 10.1007/s11214-010-9712-5; Woodall J, 2007, ASTRON ASTROPHYS, V466, P1197, DOI 10.1051/0004-6361:20064981	24	67	67	3	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2011	334	6062					1538	1541		10.1126/science.1213789	http://dx.doi.org/10.1126/science.1213789			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	862LE	22174248				2022-12-28	WOS:000298091400048
J	Gibaud, T; Barry, E; Zakhary, MJ; Henglin, M; Ward, A; Yang, YS; Berciu, C; Oldenbourg, R; Hagan, MF; Nicastro, D; Meyer, RB; Dogic, Z				Gibaud, Thomas; Barry, Edward; Zakhary, Mark J.; Henglin, Mir; Ward, Andrew; Yang, Yasheng; Berciu, Cristina; Oldenbourg, Rudolf; Hagan, Michael F.; Nicastro, Daniela; Meyer, Robert B.; Dogic, Zvonimir			Reconfigurable self-assembly through chiral control of interfacial tension	NATURE			English	Article							TWIST PENETRATION; MICROSCOPE; LENGTH; MODEL; LAYER	From determining the optical properties of simple molecular crystals to establishing the preferred handedness in highly complex vertebrates, molecular chirality profoundly influences the structural, mechanical and optical properties of both synthetic and biological matter on macroscopic length scales(1,2). In soft materials such as amphiphilic lipids and liquid crystals, the competition between local chiral interactions and global constraints imposed by the geometry of the self-assembled structures leads to frustration and the assembly of unique materials(3-6). An example of particular interest is smectic liquid crystals, where the two-dimensional layered geometry cannot support twist and chirality is consequently expelled to the edges in a manner analogous to the expulsion of a magnetic field from superconductors(7-10). Here we demonstrate a consequence of this geometric frustration that leads to a new design principle for the assembly of chiral molecules. Using a model system of colloidal membranes(11), we show that molecular chirality can control the interfacial tension, an important property of multi-component mixtures. This suggests an analogy between chiral twist, which is expelled to the edges of two-dimensional membranes, and amphiphilic surfactants, which are expelled to oil-water interfaces(12). As with surfactants, chiral control of interfacial tension drives the formation of many polymorphic assemblages such as twisted ribbons with linear and circular topologies, starfish membranes, and double and triple helices. Tuning molecular chirality in situ allows dynamical control of line tension, which powers polymorphic transitions between various chiral structures. These findings outline a general strategy for the assembly of reconfigurable chiral materials that can easily be moved, stretched, attached to one another and transformed between multiple conformational states, thus allowing precise assembly and nanosculpting of highly dynamical and designable materials with complex topologies.	[Gibaud, Thomas; Barry, Edward; Zakhary, Mark J.; Henglin, Mir; Ward, Andrew; Yang, Yasheng; Hagan, Michael F.; Meyer, Robert B.; Dogic, Zvonimir] Brandeis Univ, Martin Fisher Sch Phys, 415 South St, Waltham, MA 02454 USA; [Berciu, Cristina; Nicastro, Daniela] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; [Oldenbourg, Rudolf] Marine Biol Lab, Woods Hole, MA 02543 USA	Brandeis University; Brandeis University; Marine Biological Laboratory - Woods Hole	Dogic, Z (corresponding author), Brandeis Univ, Martin Fisher Sch Phys, 415 South St, Waltham, MA 02454 USA.	zdogic@brandeis.edu	Gibaud, Thomas/O-1910-2019; Hagan, Michael F/N-2177-2014; Gibaud, Thomas/D-1276-2009	Gibaud, Thomas/0000-0003-4826-8025; Hagan, Michael F/0000-0002-9211-2434; Gibaud, Thomas/0000-0003-4826-8025; Nicastro, Daniela/0000-0002-0122-7173; Ward, Andrew/0000-0001-5147-4140	US National Science Foundation [NSF-MRSEC-0820492, NSF-DMR-0955776, NSF-MRI-0923057, NSF-CMMI-1068566]; Petroleum Research Fund [ACS-PRF 50558-DNI7]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002583] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); Petroleum Research Fund(American Chemical Society); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the US National Science Foundation (NSF-MRSEC-0820492, NSF-DMR-0955776, NSF-MRI-0923057, NSF-CMMI-1068566) and the Petroleum Research Fund (ACS-PRF 50558-DNI7). We acknowledge use of the Brandeis MRSEC optical microscopy facility.	Aarts DGAL, 2004, SCIENCE, V304, P847, DOI 10.1126/science.1097116; Aggeli A, 2001, P NATL ACAD SCI USA, V98, P11857, DOI 10.1073/pnas.191250198; Barry E, 2010, P NATL ACAD SCI USA, V107, P10348, DOI 10.1073/pnas.1000406107; Barry E, 2009, J PHYS CHEM B, V113, P3910, DOI 10.1021/jp8067377; Barry E, 2009, SOFT MATTER, V5, P2563, DOI 10.1039/b822478a; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Chung WJ, 2011, NATURE, V478, P364, DOI 10.1038/nature10513; Claessens MMAE, 2008, P NATL ACAD SCI USA, V105, P8819, DOI 10.1073/pnas.0711149105; DEGENNES PG, 1993, SOLID STATE COMMUN, V88, P1039, DOI 10.1016/0038-1098(93)90291-T; Dogic Z, 2000, LANGMUIR, V16, P7820, DOI 10.1021/la000446t; Fradin C, 2000, NATURE, V403, P871, DOI 10.1038/35002533; Grason GM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.098101; Harris AB, 1999, REV MOD PHYS, V71, P1745, DOI 10.1103/RevModPhys.71.1745; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Honerkamp-Smith AR, 2008, BIOPHYS J, V95, P236, DOI 10.1529/biophysj.107.128421; Hough LE, 2009, SCIENCE, V325, P456, DOI 10.1126/science.1170027; Kamien RD, 2001, J PHYS-CONDENS MAT, V13, pR1, DOI 10.1088/0953-8984/13/3/201; Kaplan CN, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021701; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lau AWC, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/48006; LEE KYC, 1993, J PHYS CHEM-US, V97, P9532, DOI 10.1021/j100139a044; Lettinga MP, 2005, EUROPHYS LETT, V71, P692, DOI 10.1209/epl/i2005-10127-x; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Matsumoto EA, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.257804; Nguyen TD, 2010, ACS NANO, V4, P2585, DOI 10.1021/nn901725b; Nguyen TD, 2009, SMALL, V5, P2092, DOI 10.1002/smll.200900168; Oda R, 1999, NATURE, V399, P566, DOI 10.1038/21154; Oldenbourg R, 2008, J MICROSC-OXFORD, V231, P419, DOI 10.1111/j.1365-2818.2008.02053.x; OLDENBOURG R, 1995, J MICROSC-OXFORD, V180, P140, DOI 10.1111/j.1365-2818.1995.tb03669.x; Pasteur L., 1848, ANN CHIM PHYS, V24, P442; Pelcovits RA, 2009, LIQ CRYST, V36, P1157, DOI 10.1080/02678290902921752; Purdy KR, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.031708; RENN SR, 1988, PHYS REV A, V38, P2132, DOI 10.1103/PhysRevA.38.2132; Safran S. A., 1994, STAT THERMODYNAMICS; Sambrook J., 1989, MOL CLONING, P1847; Srivastava S, 2010, SCIENCE, V327, P1355, DOI 10.1126/science.1177218; Tang JX, 1996, BIOPOLYMERS, V39, P13, DOI 10.1002/(SICI)1097-0282(199607)39:1<13::AID-BIP2>3.3.CO;2-H; Yang YS, 2012, SOFT MATTER, V8, P707, DOI 10.1039/c1sm06201h	38	178	178	7	378	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 19	2012	481	7381					348	+		10.1038/nature10769	http://dx.doi.org/10.1038/nature10769			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877VK	22217941				2022-12-28	WOS:000299210600039
J	Ross-Innes, CS; Stark, R; Teschendorff, AE; Holmes, KA; Ali, HR; Dunning, MJ; Brown, GD; Gojis, O; Ellis, IO; Green, AR; Ali, S; Chin, SF; Palmieri, C; Caldas, C; Carroll, JS				Ross-Innes, Caryn S.; Stark, Rory; Teschendorff, Andrew E.; Holmes, Kelly A.; Ali, H. Raza; Dunning, Mark J.; Brown, Gordon D.; Gojis, Ondrej; Ellis, Ian O.; Green, Andrew R.; Ali, Simak; Chin, Suet-Feung; Palmieri, Carlo; Caldas, Carlos; Carroll, Jason S.			Differential oestrogen receptor binding is associated with clinical outcome in breast cancer	NATURE			English	Article							GENE-EXPRESSION SIGNATURE; ER-ALPHA; SURVIVAL; REVEALS; FOXA1; RNA	Oestrogen receptor-alpha (ER) is the defining and driving transcription factor in the majority of breast cancers and its target genes dictate cell growth and endocrine response, yet genomic understanding of ER function has been restricted to model systems(1-3). Here we map genome-wide ER-binding events, by chromatin immunoprecipitation followed by high-throughput sequencing (ChIP-seq), in primary breast cancers from patients with different clinical outcomes and in distant ER-positive metastases. We find that drug-resistant cancers still recruit ER to the chromatin, but that ER binding is a dynamic process, with the acquisition of unique ER-binding regions in tumours from patients that are likely to relapse. The acquired ER regulatory regions associated with poor clinical outcome observed in primary tumours reveal gene signatures that predict clinical outcome in ER-positive disease exclusively. We find that the differential ER-binding programme observed in tumours from patients with poor outcome is not due to the selection of a rare subpopulation of cells, but is due to the FOXA1-mediated reprogramming of ER binding on a rapid time-scale. The parallel redistribution of ER and FOXA1 binding events in drug-resistant cellular contexts is supported by histological co-expression of ER and FOXA1 in metastatic samples. By establishing transcription-factor mapping in primary tumour material, we show that there is plasticity in ER-binding capacity, with distinct combinations of cis-regulatory elements linked with the different clinical outcomes.	[Ross-Innes, Caryn S.; Stark, Rory; Holmes, Kelly A.; Ali, H. Raza; Dunning, Mark J.; Brown, Gordon D.; Chin, Suet-Feung; Caldas, Carlos; Carroll, Jason S.] Li Ka Shing Ctr, Cambridge Res Inst, Canc Res UK, Cambridge CB2 0RE, England; [Teschendorff, Andrew E.] UCL, UCL Canc Inst, London WC1E 6BT, England; [Gojis, Ondrej; Ali, Simak; Palmieri, Carlo] Univ London Imperial Coll Sci Technol & Med, London W12 0NN, England; [Gojis, Ondrej] Charles Univ Prague, Fac Med 3, Dept Obstet & Gynaecol, Prague 10000 10, Czech Republic; [Gojis, Ondrej] Charles Univ Prague, Fac Med 3, Dept Pathol, Prague 10000 10, Czech Republic; [Ellis, Ian O.; Green, Andrew R.] Nottingham Univ Hosp NHS Trust, City Hosp Nottingham, Dept Histopathol, Nottingham NG5 1PB, England; [Caldas, Carlos; Carroll, Jason S.] Univ Cambridge, Dept Oncol, Cambridge CB2 0XZ, England; [Ali, H. Raza; Caldas, Carlos] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Cambridge Breast Unit, Cambridge CB2 2QQ, England; [Ali, H. Raza; Caldas, Carlos] NIHR Cambridge Biomed Res Ctr, Cambridge CB2 2QQ, England; [Caldas, Carlos] Cambridge Expt Canc Med Ctr ECMC, Cambridge CB2 0RE, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of London; University College London; Imperial College London; Charles University Prague; Charles University Prague; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Carroll, JS (corresponding author), Li Ka Shing Ctr, Cambridge Res Inst, Canc Res UK, Robinson Way, Cambridge CB2 0RE, England.	carlos.caldas@cancer.org.uk; jason.carroll@cancer.org.uk	Caldas, Carlos/A-7543-2008; Green, Andrew/AAF-1991-2020; Ali, Simak/N-4740-2019; Ali, Simak/M-6912-2018; Caldas, Carlos/U-7250-2019	Ali, Simak/0000-0002-1320-0816; Ali, Simak/0000-0002-1320-0816; Caldas, Carlos/0000-0003-3547-1489; chin, suet-feung/0000-0001-5697-1082; Dunning, Mark/0000-0002-8853-9435; Green, Andrew/0000-0002-0488-5913; Stark, Rory/0000-0002-1790-5469; Coombes, Raoul Charles/0000-0002-4811-1100; Carroll, Jason/0000-0003-3643-0080; Ellis, Ian/0000-0001-5292-8474	University of Cambridge; Cancer Research UK; Hutchison Whampoa Limited; NIHR Biomedical Research Centre; Experimental Cancer Medicine Centre; Commonwealth Scholarship; Ministry of Education of the Czech Republic [MSM0021620808]; European Society of Medical Oncology; ERC; EMBO; Cancer Research UK [12011, 15602] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10154] Funding Source: researchfish	University of Cambridge(University of Cambridge); Cancer Research UK(Cancer Research UK); Hutchison Whampoa Limited; NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Experimental Cancer Medicine Centre; Commonwealth Scholarship; Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); European Society of Medical Oncology; ERC(European Research Council (ERC)European Commission); EMBO(European Molecular Biology Organization (EMBO)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors would like to thank D. Schmidt for assistance with figures, J. Hadfield for Illumina sequencing, S. MacArthur, O. Rueda, S. Vowler, R. Russell and M. Wilson for technical and bioinformatics help. We thank J. Stingl and his laboratory for help with the normal mammary gland work. We would like to acknowledge the support of The University of Cambridge, Cancer Research UK and Hutchison Whampoa Limited. The authors would like to thank Imperial College Healthcare NHS Trust, Human Biomaterials Resource Centre (Tissue Bank). Tumour samples from Cambridge were obtained with support from NIHR Biomedical Research Centre and the Experimental Cancer Medicine Centre. C.S.R.-I. is supported by a Commonwealth Scholarship. O. G. is part funded by a grant awarded by the Ministry of Education of the Czech Republic (Project "Oncology" MSM0021620808) and is also a recipient of a Translational Research Fellowship from the European Society of Medical Oncology. C. P. is funded by Cancer Research UK. J. S. C. is supported by an ERC starting grant and an EMBO Young investigator award.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Arpino G, 2005, JNCI-J NATL CANCER I, V97, P1254, DOI 10.1093/jnci/dji249; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Buffa FM, 2011, CANCER RES, V71, P5635, DOI 10.1158/0008-5472.CAN-11-0489; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; GOMM JJ, 1995, ANAL BIOCHEM, V226, P91, DOI 10.1006/abio.1995.1196; Hoadley KA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-258; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Knowlden JM, 2003, ENDOCRINOLOGY, V144, P1032, DOI 10.1210/en.2002-220620; Kun Y, 2003, HUM MOL GENET, V12, P3245, DOI 10.1093/hmg/ddg347; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Lupien M, 2010, GENE DEV, V24, P2219, DOI 10.1101/gad.1944810; Naderi A, 2007, ONCOGENE, V26, P1507, DOI 10.1038/sj.onc.1209920; Nagashima T, 2007, J BIOL CHEM, V282, P4045, DOI 10.1074/jbc.M608653200; Pavesi G, 2006, NUCLEIC ACIDS RES, V34, pW566, DOI 10.1093/nar/gkl285; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Stark R., DIFFBIND DIFFERENTIA; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	30	973	987	4	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 19	2012	481	7381					389	U177		10.1038/nature10730	http://dx.doi.org/10.1038/nature10730			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877VK	22217937	Green Accepted, Green Submitted			2022-12-28	WOS:000299210600048
J	Gebre, T; Ayele, B; Zerihun, M; Genet, A; Stoller, NE; Zhou, ZX; House, JI; Yu, SN; Ray, KJ; Emerson, PM; Keenan, JD; Porco, TC; Lietman, TM; Gaynor, BD				Gebre, Teshome; Ayele, Berhan; Zerihun, Mulat; Genet, Asrat; Stoller, Nicole E.; Zhou, Zhaoxia; House, Jenafir I.; Yu, Sun N.; Ray, Kathryn J.; Emerson, Paul M.; Keenan, Jeremy D.; Porco, Travis C.; Lietman, Thomas M.; Gaynor, Bruce D.			Comparison of annual versus twice-yearly mass azithromycin treatment for hyperendemic trachoma in Ethiopia: a cluster-randomised trial	LANCET			English	Article							OCULAR CHLAMYDIAL INFECTION; ANTIBIOTIC DISTRIBUTIONS; RESISTANCE; COMMUNITIES; PREVALENCE; ELIMINATION; REDUCTION; MORTALITY; CHILDREN; ADVERSE	Background In trachoma control programmes, azithromycin is distributed to treat the strains of chlamydia that cause ocular disease. We aimed to compare the effect of annual versus twice-yearly distribution of azithromycin on infection with these strains. Methods We did a cluster-randomised trial in 24 subdistricts in northern Ethiopia, which we randomly assigned to receive annual or twice-yearly treatment for all residents of all ages. Random assignment was done with the RANDOM and SORT functions of Microsoft Excel. All individuals were offered their assigned treatment of a single, directly observed, oral dose of azithromycin. A 6 week course of topical 1% tetracycline ointment, applied twice daily to both eyes but not directly observed, was offered as an alternative to azithromycin in patients younger than 12 months, and in patients with self-reported pregnancy, with allergy, or who refused azithromycin. Our primary, prespecified outcome was the prevalence of ocular chlamydial infection in a random sample of children aged 0-9 years at baseline and every 6 months for a total of 42 months within sentinel villages. Our analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00322972. Findings Antibiotic coverage of children aged 1-9 years was greater than 80% (range 80.9 to 93.0) at all study visits. In the groups treated annually, the prevalence of infection in children aged 0-9 years was reduced from a mean 41.9% (95% CI 31.5 to 52.2) at baseline to 1.9% (0.3 to 3.5) at 42 months. In the groups treated twice yearly, the prevalence of infection was reduced from a mean 38.3% (29.0 to 47.6) at baseline to 3.2 % (0.0 to 6.5) at 42 months. The prevalence of ocular chlamydial infection in children aged 0-9 years in groups treated annually was not different from that of the groups treated twice yearly at 18, 30, and 42 months (pooled regression p>0.99, 95 % CI -0.06 to 0.06). The mean elimination time in the twice-yearly treatment group was 7.5 months earlier (2.3 to 17.3) than that of the annual group (p=0.10, Cox proportional hazards model). Interpretation After 42 months of treatment, the prevalence of ocular infection with chlamydia was similar in the groups treated annually and twice yearly. However, elimination of infection might have been more rapid in the groups of villages that received treatment twice yearly.	[Keenan, Jeremy D.; Lietman, Thomas M.; Gaynor, Bruce D.] Univ Calif San Francisco, Dept Ophthalmol, FI Proctor Fdn, San Francisco, CA 94143 USA; [Gebre, Teshome; Ayele, Berhan; Zerihun, Mulat; Emerson, Paul M.] Carter Ctr, Addis Ababa, Ethiopia; [Gebre, Teshome; Ayele, Berhan; Zerihun, Mulat; Emerson, Paul M.] Emory Univ, Carter Ctr, Atlanta, GA 30322 USA; [Genet, Asrat] Amhara Reg Hlth Bur, Addis Ababa, Ethiopia; [Porco, Travis C.; Lietman, Thomas M.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Porco, Travis C.; Lietman, Thomas M.] Univ Calif San Francisco, Inst Global Hlth, San Francisco, CA 94143 USA; [Porco, Travis C.] Univ Calif Berkeley, Ctr Infect Dis & Emergency Readiness, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; Emory University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley	Gaynor, BD (corresponding author), Univ Calif San Francisco, Dept Ophthalmol, FI Proctor Fdn, 513 Parnassus, San Francisco, CA 94143 USA.	bruce.gaynor@ucsf.edu	AMNIE, ASRAT G/J-7522-2019; Keenan, Jeremy David/AAO-5882-2020; Gebre, Teshome/F-2973-2011	AMNIE, ASRAT G/0000-0002-9745-3377; Keenan, Jeremy David/0000-0002-7118-1457; Gebre, Teshome/0000-0002-9884-0344; Emerson, Paul/0000-0002-6478-8816	National Institutes of Health [NEI U10 EY016214, NEI K12EX017269, NEI K23 EYO19881-01]; NCRR/OD UCSF-CTSI [KL2 RR024130]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [U10EY016214, K23EY019881] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR/OD UCSF-CTSI; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The National Institutes of Health (NEI U10 EY016214, NEI K12EX017269, NEI K23 EYO19881-01, and NCRR/OD UCSF-CTSI Grant Number KL2 RR024130) was the main supporter of this trial. We thank the International Trachoma Initiative for their generous donation of azithromycin, the Bernard Osher Foundation, That Man May See, the Harper Inglis Trust, the Bodri Foundation, the South Asia Research Fund, and Research to Prevent Blindness; the data safety and monitoring committee including William Barlow (University of Washington, Washington, DC, USA), Donald Everett (National Eye Institute, Bethesda, MD, USA), Larry Schwab (International Eye Foundation, Kensington, MD, USA), Arthur Reingold (University of California, Berkeley, CA, USA), and Serge Resnikoff (WHO, Geneva, Switzerland), who were generous with their time and advice and met before, during, and after this study; the Amhara Region Health Bureau; and the nurses and health workers who helped collect samples for the study, including Tesfaye Belay, Melese Temesgen, Manahlosh Berihun, Melkam Andualem, Mitselal Abrhale, Banchu Gedamu, Tessema Eneyew, and Muluken Gobezie. The trachoma control programme in Amhara is a partnership between the Regional Health Bureau and the Lions-Carter Center Sight First Initiative.	[Anonymous], 2004, 8 M WHO ALL GLOB EL; Ayele B, 2011, AM J TROP MED HYG, V85, P291, DOI 10.4269/ajtmh.2011.11-0056; Burton MJ, 2005, LANCET, V365, P1321, DOI 10.1016/S0140-6736(05)61029-X; Chidambaram JD, 2006, JAMA-J AM MED ASSOC, V295, P1142, DOI 10.1001/jama.295.10.1142; Chidambaram JD, 2004, EMERG INFECT DIS, V10, P1895; Diamant J, 2001, Ophthalmic Epidemiol, V8, P109, DOI 10.1076/opep.8.2.109.4156; Dolin PJ, 1997, LANCET, V349, P1511, DOI 10.1016/S0140-6736(97)01355-X; Evans JR, 2011, COCHRANE DB SYST REV, V3; Feikin DR, 2000, AM J PUBLIC HEALTH, V90, P223, DOI 10.2105/AJPH.90.2.223; Fry AM, 2002, CLIN INFECT DIS, V35, P395, DOI 10.1086/341414; Gaydos CA, 2002, J CLIN MICROBIOL, V40, P758, DOI 10.1128/JCM.40.3.758-761.2002; Gaynor BD, 2005, BRIT J OPHTHALMOL, V89, P1097, DOI 10.1136/bjo.2005.068981; Good PI., 2005, RESAMPLING METHODS P, V3rd ed.; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Haug S, 2010, CLIN INFECT DIS, V51, P571, DOI 10.1086/655697; Hoechsmann A, 2001, Ophthalmic Epidemiol, V8, P145, DOI 10.1076/opep.8.2.145.4169; House JI, 2009, LANCET, V373, P1111, DOI 10.1016/S0140-6736(09)60323-8; Jha H, 2002, CLIN INFECT DIS, V35, P765, DOI 10.1086/342298; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; Keenan JD, 2011, ARCH OPHTHALMOL-CHIC, V129, P512, DOI 10.1001/archophthalmol.2011.46; Lakew T, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000376; Leach AJ, 1997, CLIN INFECT DIS, V24, P356, DOI 10.1093/clinids/24.3.356; Lee S, 2007, AM J TROP MED HYG, V76, P129; Melese M, 2004, JAMA-J AM MED ASSOC, V292, P721, DOI 10.1001/jama.292.6.721; Melese M, 2008, JAMA-J AM MED ASSOC, V299, P778, DOI 10.1001/jama.299.7.778; Michel CEC, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000986; Miller K, 2004, OPHTHAL EPIDEMIOL, V11, P255, DOI 10.1080/09286580490514577; Porco TC, 2009, JAMA-J AM MED ASSOC, V302, P962, DOI 10.1001/jama.2009.1266; Ray KJ, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-91; Ray KJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000458; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Schachter J, 1999, LANCET, V354, P630, DOI 10.1016/S0140-6736(98)12387-5; Shah NA, 2010, OPHTHAL EPIDEMIOL, V17, P113, DOI 10.3109/09286581003624921; Skalet AH, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000377; Solomon AW, 2004, NEW ENGL J MED, V351, P1962, DOI 10.1056/NEJMoa040979; Stoller NE, 2011, INT HEALTH, V3, P75, DOI 10.1016/j.inhe.2011.03.004; Thein J, 2002, OPHTHALMIC EPIDEMIOL, V9, P263, DOI 10.1076/opep.9.4.263.1508; THYLEFORS B, 1987, B WORLD HEALTH ORGAN, V65, P477; West SK, 2005, LANCET, V366, P1296, DOI 10.1016/S0140-6736(05)67529-0; *WHO, 1998, 2 M WHO ALL GLOB EL; Wright HR, 2008, LANCET, V371, P1945, DOI 10.1016/S0140-6736(08)60836-3; Wright HR, 2005, LANCET INFECT DIS, V5, P313, DOI 10.1016/S1473-3099(05)70116-X	42	65	65	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 14	2012	379	9811					143	151		10.1016/S0140-6736(11)61515-8	http://dx.doi.org/10.1016/S0140-6736(11)61515-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879GM	22192488				2022-12-28	WOS:000299317700036
J	Cassan, A; Kubas, D; Beaulieu, JP; Dominik, M; Horne, K; Greenhill, J; Wambsganss, J; Menzies, J; Williams, A; Jorgensen, UG; Udalski, A; Bennett, DP; Albrow, MD; Batista, V; Brillant, S; Caldwell, JAR; Cole, A; Coutures, C; Cook, KH; Dieters, S; Prester, DD; Donatowicz, J; Fouque, P; Hill, K; Kains, N; Kane, S; Marquette, JB; Martin, R; Pollard, KR; Sahu, KC; Vinter, C; Warren, D; Watson, B; Zub, M; Sumi, T; Szymanski, MK; Kubiak, M; Poleski, R; Soszynski, I; Ulaczyk, K; Pietrzynski, G; Wyrzykowski, L				Cassan, A.; Kubas, D.; Beaulieu, J. -P.; Dominik, M.; Horne, K.; Greenhill, J.; Wambsganss, J.; Menzies, J.; Williams, A.; Jorgensen, U. G.; Udalski, A.; Bennett, D. P.; Albrow, M. D.; Batista, V.; Brillant, S.; Caldwell, J. A. R.; Cole, A.; Coutures, Ch.; Cook, K. H.; Dieters, S.; Prester, D. Dominis; Donatowicz, J.; Fouque, P.; Hill, K.; Kains, N.; Kane, S.; Marquette, J. -B.; Martin, R.; Pollard, K. R.; Sahu, K. C.; Vinter, C.; Warren, D.; Watson, B.; Zub, M.; Sumi, T.; Szymanski, M. K.; Kubiak, M.; Poleski, R.; Soszynski, I.; Ulaczyk, K.; Pietrzynski, G.; Wyrzykowski, L.			One or more bound planets per Milky Way star from microlensing observations	NATURE			English	Article							EXTRASOLAR PLANETS; GALACTIC PLANETS; MASS PLANET; SYSTEMS; EVENTS; COMPANION; DISCOVERY; FREQUENCY; NEPTUNES; COMMON	Most known extrasolar planets (exoplanets) have been discovered using the radial velocity(1,2) or transit(3) methods. Both are biased towards planets that are relatively close to their parent stars, and studies find that around 17-30% (refs 4, 5) of solar-like stars host a planet. Gravitational microlensing(6-9), on the other hand, probes planets that are further away from their stars. Recently, a population of planets that are unbound or very far from their stars was discovered by microlensing(10). These planets are at least as numerous as the stars in the Milky Way(10). Here we report a statistical analysis of microlensing data (gathered in 2002-07) that reveals the fraction of bound planets 0.5-10 AU (Sun-Earth distance) from their stars. We find that 17(-9)(+6)% of stars host Jupiter-mass planets (0.3-10M(J), where M-J = 318 M-circle plus and M-circle plus is Earth's mass). Cool Neptunes (10-30 M-circle plus) and super-Earths (5-10 M-circle plus) are even more common: their respective abundances per star are 52(-29)(+22)% and 62(-37)(+35)%. We conclude that stars are orbited by planets as a rule, rather than the exception.	[Cassan, A.; Kubas, D.; Beaulieu, J. -P.; Dominik, M.; Horne, K.; Greenhill, J.; Wambsganss, J.; Menzies, J.; Williams, A.; Jorgensen, U. G.; Bennett, D. P.; Albrow, M. D.; Batista, V.; Brillant, S.; Caldwell, J. A. R.; Cole, A.; Coutures, Ch.; Cook, K. H.; Dieters, S.; Prester, D. Dominis; Donatowicz, J.; Fouque, P.; Hill, K.; Kains, N.; Kane, S.; Marquette, J. -B.; Martin, R.; Pollard, K. R.; Sahu, K. C.; Vinter, C.; Warren, D.; Watson, B.] Univ Paris 06, Probing Lensing Anomalies Network PLANET Collabro, Inst Astrophys Paris, UPMC CNRS,UMR7095, F-75014 Paris, France; [Cassan, A.; Wambsganss, J.] Heidelberg Univ, ARI, Zentrum Astron, D-69120 Heidelberg, Germany; [Kubas, D.; Brillant, S.] European So Observ, Santiago 19001, Chile; [Horne, K.] Univ St Andrews, SUPA, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland; [Greenhill, J.; Dieters, S.] Univ Tasmania, Sch Maths & Phys, Hobart, Tas 7001, Australia; [Menzies, J.] S African Astron Observ, ZA-7935 Observatory, South Africa; [Williams, A.; Martin, R.] Perth Observ, Perth, WA 6076, Australia; [Jorgensen, U. G.] Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Udalski, A.; Szymanski, M. K.; Kubiak, M.; Poleski, R.; Soszynski, I.; Ulaczyk, K.; Pietrzynski, G.; Wyrzykowski, L.] Univ Warsaw Observ, OGLE Collaborat, PL-00478 Warsaw, Poland; [Bennett, D. P.] Univ Notre Dame, Dept Phys, Baltimore, MD 21218 USA; [Albrow, M. D.] Univ Canterbury, Dept Phys & Astron, Christchurch 8140, New Zealand; [Cook, K. H.] Lawrence Livermore Natl Lab, Inst Geophys & Planetary Phys, Livermore, CA 94550 USA; [Prester, D. Dominis] Univ Rijeka, Dept Phys, Rijeka 51000, Croatia; [Donatowicz, J.] Vienna Univ Technol, Dept Comp, A-1040 Vienna, Austria; [Kane, S.] CALTECH, NASA Exoplanet Sci Inst, Pasadena, CA 91125 USA; [Sumi, T.] Osaka Univ, Dept Earth & Space Sci, MOA Collaborat, Osaka 5600043, Japan; [Sumi, T.] Osaka Univ, Dept Earth & Space Sci, Osaka 5600043, Japan; [Wyrzykowski, L.] Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; [Wyrzykowski, L.] UCL, Dept Phys & Astron, London WC1E 6BT, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Ruprecht Karls University Heidelberg; European Southern Observatory; University of St Andrews; University of Tasmania; National Research Foundation - South Africa; South African Astronomical Observatory; University of Copenhagen; Niels Bohr Institute; University of Warsaw; Warsaw University Observatory; University of Notre Dame; University of Canterbury; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of Rijeka; Technische Universitat Wien; California Institute of Technology; National Aeronautics & Space Administration (NASA); Osaka University; Osaka University; University of Cambridge; University of London; University College London	Cassan, A (corresponding author), Univ Paris 06, Probing Lensing Anomalies Network PLANET Collabro, Inst Astrophys Paris, UPMC CNRS,UMR7095, 98 Bis Blvd Arago, F-75014 Paris, France.	cassan@iap.fr	Greenhill, John G/C-8367-2013; Szymański, Michał K/H-6951-2018; Poleski, Radoslaw/AAM-7565-2021; Prester, Dijana Dominis/O-5014-2018; Williams, Andrew J/K-2931-2013; Kane, Stephen/B-4798-2013; Szymański, Michał Krzysztof/X-5627-2019; Dominik, Martin/AAA-9501-2020; Cole, Andrew/J-7683-2014	Szymański, Michał K/0000-0002-0548-8995; Poleski, Radoslaw/0000-0002-9245-6368; Prester, Dijana Dominis/0000-0002-9880-5039; Williams, Andrew J/0000-0001-9080-0105; Szymański, Michał Krzysztof/0000-0002-0548-8995; Dominik, Martin/0000-0002-3202-0343; Wyrzykowski, Lukasz/0000-0002-9658-6151; Cole, Andrew/0000-0003-0303-3855; Fouque, Pascal/0000-0002-1436-7351; Pietrzynski, Grzegorz/0000-0002-9443-4138; Brillant, Stephane/0000-0001-8217-8686; Udalski, Andrzej/0000-0001-5207-5619; Ulaczyk, Krzysztof/0000-0001-6364-408X; Albrow, Michael/0000-0003-3316-4012; Sahu, Kailash/0000-0001-6008-1955; Soszynski, Igor/0000-0002-7777-0842; Beaulieu, Jean-Philippe/0000-0003-0014-3354	French Agence Nationale de la Recherche (ANR); French National Centre for Scientific Research (CNRS); NASA; US National Science Foundation; Lawrence Livermore National Laboratory/National Nuclear Security Administration/Department of Energy; French National Programme of Planetology; Program of International Cooperation in Science France-Australia; German Research Foundation; Instrument Center for Danish Astronomy; Danish Natural Science Research Council; European Research Council; Qatar National Research Fund; STFC [ST/G001987/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/G001987/1] Funding Source: researchfish	French Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); French National Centre for Scientific Research (CNRS)(Centre National de la Recherche Scientifique (CNRS)); NASA(National Aeronautics & Space Administration (NASA)); US National Science Foundation(National Science Foundation (NSF)); Lawrence Livermore National Laboratory/National Nuclear Security Administration/Department of Energy; French National Programme of Planetology; Program of International Cooperation in Science France-Australia; German Research Foundation(German Research Foundation (DFG)); Instrument Center for Danish Astronomy; Danish Natural Science Research Council(Danish Natural Science Research Council); European Research Council(European Research Council (ERC)European Commission); Qatar National Research Fund(Qatar National Research Fund (QNRF)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	Support for the PLANET project was provided by the HOLMES grant from the French Agence Nationale de la Recherche (ANR), the French National Centre for Scientific Research (CNRS), NASA, the US National Science Foundation, the Lawrence Livermore National Laboratory/National Nuclear Security Administration/Department of Energy, the French National Programme of Planetology, the Program of International Cooperation in Science France-Australia, D. Warren, the German Research Foundation, the Instrument Center for Danish Astronomy and the Danish Natural Science Research Council. The OGLE collaboration is grateful for funding from the European Research Council Advanced Grants Program. K. Ho. acknowledges support from the Qatar National Research Fund. M. D. is a Royal Society University Research Fellow.	Albrow M, 1998, ASTROPHYS J, V509, P687, DOI 10.1086/306513; Beaulieu JP, 2006, NATURE, V439, P437, DOI 10.1038/nature04441; Bennett DP, 1996, ASTROPHYS J, V472, P660, DOI 10.1086/178096; Bond IA, 2001, MON NOT R ASTRON SOC, V327, P868, DOI 10.1046/j.1365-8711.2001.04776.x; Cassan A, 2008, ASTRON ASTROPHYS, V491, P587, DOI 10.1051/0004-6361:200809795; Charbonneau D, 2000, ASTROPHYS J, V529, pL45, DOI 10.1086/312457; Cumming A, 2008, PUBL ASTRON SOC PAC, V120, P531, DOI 10.1086/588487; Dominik M, 2006, MON NOT R ASTRON SOC, V367, P669, DOI 10.1111/j.1365-2966.2006.10004.x; Dong SB, 2009, ASTROPHYS J, V695, P970, DOI 10.1088/0004-637X/695/2/970; Einstein A, 1936, Science, V84, P506, DOI 10.1126/science.84.2188.506; Gaudi BS, 2008, SCIENCE, V319, P927, DOI 10.1126/science.1151947; Gaudi BS, 2002, ASTROPHYS J, V566, P463, DOI 10.1086/337987; Gould A., 2006, Astrophysical Journal, Letters, V644, pL37, DOI 10.1086/505421; GOULD A, 1992, ASTROPHYS J, V396, P104, DOI 10.1086/171700; Gould A, 2010, ASTROPHYS J, V720, P1073, DOI 10.1088/0004-637X/720/2/1073; Howard A, 2011, ASTROPHYS J UNPUB; Howard AW, 2010, SCIENCE, V330, P653, DOI 10.1126/science.1194854; Kubas D, 2008, ASTRON ASTROPHYS, V483, P317, DOI 10.1051/0004-6361:20077449; MAO S, 1991, ASTROPHYS J, V374, pL37, DOI 10.1086/186066; Marcy GW, 1996, ASTROPHYS J, V464, pL147, DOI 10.1086/310096; Mayor M, 2011, ASTRON ASTROPH UNPUB; Pollack JB, 1996, ICARUS, V124, P62, DOI 10.1006/icar.1996.0190; Snodgrass C, 2004, MON NOT R ASTRON SOC, V351, P967, DOI 10.1111/j.1365-2966.2004.07839.x; Sumi T, 2011, NATURE, V473, P349, DOI 10.1038/nature10092; Sumi T, 2010, ASTROPHYS J, V710, P1641, DOI 10.1088/0004-637X/710/2/1641; Tsapras Y, 2003, MON NOT R ASTRON SOC, V343, P1131, DOI 10.1046/j.1365-8711.2003.06720.x; Udalski A, 2005, ASTROPHYS J, V628, pL109, DOI 10.1086/432795; Wambsganss J, 1997, MON NOT R ASTRON SOC, V284, P172, DOI 10.1093/mnras/284.1.172	30	382	384	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 12	2012	481	7380					167	169		10.1038/nature10684	http://dx.doi.org/10.1038/nature10684			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	874TO	22237108	Green Submitted			2022-12-28	WOS:000298981200031
J	Huang, HS; Allen, JA; Mabb, AM; King, IF; Miriyala, J; Taylor-Blake, B; Sciaky, N; Dutton, JW; Lee, HM; Chen, X; Jin, J; Bridges, AS; Zylka, MJ; Roth, BL; Philpot, BD				Huang, Hsien-Sung; Allen, John A.; Mabb, Angela M.; King, Ian F.; Miriyala, Jayalakshmi; Taylor-Blake, Bonnie; Sciaky, Noah; Dutton, J. Walter, Jr.; Lee, Hyeong-Min; Chen, Xin; Jin, Jian; Bridges, Arlene S.; Zylka, Mark J.; Roth, Bryan L.; Philpot, Benjamin D.			Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons	NATURE			English	Article							ANGELMAN SYNDROME GENE; ANTISENSE TRANSCRIPT; UBIQUITIN LIGASE; I INHIBITORS; EXPRESSION; SNRPN; CAMPTOTHECIN; UBE3A/E6-AP; MUTATIONS; DELETION	Angelman syndrome is a severe neurodevelopmental disorder caused bydeletion ormutation of the maternal allele of the ubiquitin protein ligase E3A (UBE3A)(1-3). In neurons, the paternal allele of UBE3A is intact but epigenetically silenced(4-6), raising the possibility that Angelman syndrome could be treated by activating this silenced allele to restore functional UBE3A protein(7,8). Using an unbiased, high-content screen in primary cortical neurons from mice, we identify twelve topoisomerase I inhibitors and four topoisomerase II inhibitors that unsilence the paternal Ube3a allele. These drugs included topotecan, irinotecan, etoposide and dexrazoxane (ICRF-187). At nanomolar concentrations, topotecan upregulated catalytically active UBE3A in neurons from maternal Ube3a-null mice. Topotecan concomitantly downregulated expression of the Ube3a antisense transcript that overlaps the paternal copy of Ube3a(9-11). These results indicate that topotecan unsilences Ube3a in cis by reducing transcription of an imprinted antisense RNA. When administered in vivo, topotecan unsilenced the paternal Ube3a allele in several regions of the nervous system, including neurons in the hippocampus, neocortex, striatum, cerebellum and spinal cord. Paternal expression of Ube3a remained elevated in a subset of spinal cord neurons for at least 12 weeks after cessation of topotecan treatment, indicating that transient topoisomerase inhibition can have enduring effects on gene expression. Although potential off-target effects remain to be investigated, our findings suggest a therapeutic strategy for reactivating the functional but dormant allele of Ube3a in patients with Angelman syndrome.	[Huang, Hsien-Sung; Mabb, Angela M.; King, Ian F.; Miriyala, Jayalakshmi; Taylor-Blake, Bonnie; Dutton, J. Walter, Jr.; Zylka, Mark J.; Philpot, Benjamin D.] Univ N Carolina, Sch Med, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; [Allen, John A.; Sciaky, Noah; Lee, Hyeong-Min; Roth, Bryan L.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Chen, Xin; Jin, Jian] Univ N Carolina, Eshelman Sch Pharm, Ctr Integrat Chem Biol & Drug Discovery, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA; [Bridges, Arlene S.] Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Zylka, Mark J.; Roth, Bryan L.; Philpot, Benjamin D.] Univ N Carolina, Carolina Inst Dev Disabil, Chapel Hill, NC 27599 USA; [Zylka, Mark J.; Roth, Bryan L.; Philpot, Benjamin D.] Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA; [Roth, Bryan L.] Univ N Carolina, Div Chem Biol & Med Chem, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA; [Roth, Bryan L.] Univ N Carolina, NIMH, Psychoact Drug Screening Program, Dept Pharmacol,Sch Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Zylka, MJ (corresponding author), Univ N Carolina, Sch Med, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA.	zylka@med.unc.edu; bryan_roth@med.unc.edu; bphilpot@med.unc.edu	Lee, HM/D-2777-2011; Lee, HM/ABC-2680-2020; , UNC Neuroscience Microscopy Core/AAE-8305-2022; Roth, Bryan/ABE-7032-2020; Roth, Bryan L/F-3928-2010; Allen, John A/D-6141-2011	Lee, HM/0000-0002-9381-3611; Lee, HM/0000-0002-9381-3611; Roth, Bryan/0000-0002-0561-6520; King, Ian/0000-0003-3405-9767; Chen, Xin/0000-0002-5208-2154; Huang, Hsien-Sung/0000-0003-2657-3635; Mabb, Angela/0000-0002-3000-8690	Simons Foundation Autism Research Initiative (SFARI); Angelman Syndrome Foundation; National Institute of Mental Health (NIMH) [R01MH093372]; National Eye Institute [R01EY018323]; NC TraCS [50KR41016, 10KR20910]; National Institute of Neurological Disorders and Stroke (NINDS) [R01NS060725, R01NS067688, 5F32NS067712, 5P30NS045892]; National Institutes of Health (NIH) [HHSN-271-2008-00025-C, T32HD040127-07]; Michael Hooker Distinguished Chair of Pharmacology; National Institute on Drug Abuse (NIDA); Brain and Behavior Research Foundation; University of North Carolina-Carolina Institute for Developmental Disabilities; US Department of Defense [AR093464]; National Institute of Child Health and Human Development (NICHD) [P30HD03110]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD040127, P30HD003110] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018323] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS067712, R01NS067688, P30NS045892, R01NS060725] Funding Source: NIH RePORTER	Simons Foundation Autism Research Initiative (SFARI); Angelman Syndrome Foundation; National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NC TraCS; National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael Hooker Distinguished Chair of Pharmacology; National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Brain and Behavior Research Foundation; University of North Carolina-Carolina Institute for Developmental Disabilities; US Department of Defense(United States Department of Defense); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Beaudet and Y.-h. Jiang for providing Ube3a-YFP and Ube3a<SUP>m-/rho+</SUP> mice; T. Riday and J. E. Han for assistance in i.c.v. mini-osmotic pump infusion; A. Burns for assistance in maintaining mouse colonies; V. Gukassyan for help with the Surveyor and confocal imaging systems; K. McNaughton for help with tissue sectioning; W. Zamboni for providing belotecan, rubitecan and silatecan; and W. Janzen and the Center of Integrative Chemical Biology and Drug Discovery for providing the epigenetic library. B. D. P., M.J.Z. and B. L. R. were supported by the Simons Foundation Autism Research Initiative (SFARI) and by the Angelman Syndrome Foundation. B. D. P. and M.J.Z. were supported by the National Institute of Mental Health (NIMH) (R01MH093372). B. D. P. was supported by the National Eye Institute (R01EY018323) and NC TraCS (50KR41016). M.J.Z. was supported by the National Institute of Neurological Disorders and Stroke (NINDS) (R01NS060725, R01NS067688). B. L. R. was supported by national Institutes of Health (NIH) HHSN-271-2008-00025-C, the NIMH Psychoactive Drug Screening Program, the Michael Hooker Distinguished Chair of Pharmacology, and grants from NIMH and the National Institute on Drug Abuse (NIDA). H.-S. H. was supported by a NARSAD grant from the Brain and Behavior Research Foundation Young Investigator Award and NC TraCS (10KR20910). J. A. A. was supported by NIH T32HD040127-07, the University of North Carolina-Carolina Institute for Developmental Disabilities, and an Autism Concept Award AR093464 from the US Department of Defense. A. M. M. was supported by a National Research Service Award from NINDS (5F32NS067712). I. F. K. was supported by a Joseph E. Wagstaff Postdoctoral Research Fellowship from the Angelman Syndrome Foundation. Assay development costs were partially supported by NINDS (5P30NS045892). Confocal and montage imaging was performed at the University of North Carolina at Chapel Hill Confocal and Multiphoton Imaging Facility, which is co-funded by grants from NINDS (5P30NS045892) and the National Institute of Child Health and Human Development (NICHD) (P30HD03110).	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; Beaudenon S, 2005, METHOD ENZYMOL, V398, P112, DOI 10.1016/S0076-6879(05)98011-7; Bomgaars L, 2001, ONCOLOGIST, V6, P506, DOI 10.1634/theoncologist.6-6-506; Bressler J, 2001, NAT GENET, V28, P232, DOI 10.1038/90067; Chamberlain SJ, 2001, GENOMICS, V73, P316, DOI 10.1006/geno.2001.6543; Cushman M, 2000, J MED CHEM, V43, P3688, DOI 10.1021/jm000029d; Dindot SV, 2008, HUM MOL GENET, V17, P111, DOI 10.1093/hmg/ddm288; Fairbanks CA, 2003, ADV DRUG DELIVER REV, V55, P1007, DOI 10.1016/S0169-409X(03)00101-7; Gammon DC, 2006, AM J HEALTH-SYST PH, V63, P2083, DOI 10.2146/ajhp060165; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; HERTZBERG RP, 1989, J MED CHEM, V32, P715, DOI 10.1021/jm00123a038; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Kumar S, 1997, J BIOL CHEM, V272, P13548, DOI 10.1074/jbc.272.21.13548; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Landers M, 2004, NUCLEIC ACIDS RES, V32, P3480, DOI 10.1093/nar/gkh670; Lyu YL, 2006, MOL CELL BIOL, V26, P7929, DOI 10.1128/MCB.00617-06; Mabb AM, 2011, TRENDS NEUROSCI, V34, P293, DOI 10.1016/j.tins.2011.04.001; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Miura K, 2002, NEUROBIOL DIS, V9, P149, DOI 10.1006/nbdi.2001.0463; Nagarajan M, 2006, J MED CHEM, V49, P6283, DOI 10.1021/jm060564z; Nakatani J, 2009, CELL, V137, P1235, DOI 10.1016/j.cell.2009.04.024; Numata K, 2011, NUCLEIC ACIDS RES, V39, P2649, DOI 10.1093/nar/gkq1201; Peery EG, 2007, MAMM GENOME, V18, P255, DOI 10.1007/s00335-007-9019-3; Peters SU, 2010, AM J MED GENET A, V152A, P1994, DOI 10.1002/ajmg.a.33509; Pierce AA, 2010, J NEUROSCI, V30, P723, DOI 10.1523/JNEUROSCI.2479-09.2010; Plaschkes I, 2005, J COMP NEUROL, V493, P357, DOI 10.1002/cne.20793; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rougeulle C, 1998, NAT GENET, V19, P15, DOI 10.1038/ng0598-15; Rougeulle C, 1997, NAT GENET, V17, P14, DOI 10.1038/ng0997-14; Runte M, 2001, HUM MOL GENET, V10, P2687, DOI 10.1093/hmg/10.23.2687; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Sutcliffe JS, 1997, GENOME RES, V7, P368, DOI 10.1101/gr.7.4.368; Tsai TF, 1999, HUM MOL GENET, V8, P1357, DOI 10.1093/hmg/8.8.1357; Vu TH, 1997, NAT GENET, V17, P12, DOI 10.1038/ng0997-12; Watanabe Y, 2010, GENOMICS, V96, P333, DOI 10.1016/j.ygeno.2010.08.007	38	250	265	2	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 12	2012	481	7380					185	+		10.1038/nature10726	http://dx.doi.org/10.1038/nature10726			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	874TO	22190039	Green Accepted, Green Submitted			2022-12-28	WOS:000298981200036
J	Walker, J; McKethan, A				Walker, James; McKethan, Aaron			Achieving Accountable Care - "It's Not About the Bike"	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Walker, James] Geisinger Hlth Syst, Danville, PA USA; [McKethan, Aaron] RxAnte, Mclean, VA USA; [McKethan, Aaron] Univ N Carolina, Chapel Hill, NC USA	Geisinger Health System; University of North Carolina; University of North Carolina Chapel Hill	Walker, J (corresponding author), Geisinger Hlth Syst, Danville, PA USA.							Armstrong L, 2000, ITS NOT BIKE MY JOUR; Berwick DM, 2011, NEW ENGL J MED, V365, P1753, DOI 10.1056/NEJMp1111671; Blumenthal D, 2010, NEW ENGL J MED, V363, P501, DOI 10.1056/NEJMp1006114; McClellan M, 2010, HEALTH AFFAIR, V29, P982, DOI 10.1377/hlthaff.2010.0194	4	12	12	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 12	2012	366	2								10.1056/NEJMp1112293	http://dx.doi.org/10.1056/NEJMp1112293			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	874VA	22204674				2022-12-28	WOS:000298985000004
J	Fan, SH; Baets, R; Petrov, A; Yu, ZF; Joannopoulos, JD; Freude, W; Melloni, A; Popovic, M; Vanwolleghem, M; Jalas, D; Eich, M; Krause, M; Renner, H; Brinkmeyer, E; Doerr, CR				Fan, Shanhui; Baets, Roel; Petrov, Alexander; Yu, Zongfu; Joannopoulos, John D.; Freude, Wolfgang; Melloni, Andrea; Popovic, Milos; Vanwolleghem, Mathias; Jalas, Dirk; Eich, Manfred; Krause, Michael; Renner, Hagen; Brinkmeyer, Ernst; Doerr, Christopher R.			Comment on "Nonreciprocal Light Propagation in a Silicon Photonic Circuit"	SCIENCE			English	Editorial Material								We show that the structure demonstrated by Feng et al. (Reports, 5 August 2011, p. 729) cannot enable optical isolation because it possesses a symmetric scattering matrix. Moreover, one cannot construct an optical isolator by incorporating this structure into any system as long as the system is linear and time-independent and is described by materials with a scalar dielectric function.	[Fan, Shanhui; Yu, Zongfu] Stanford Univ, Dept Elect Engn, Ginzton Lab, Stanford, CA 94305 USA; [Baets, Roel] Ghent Univ IMEC, Dept Informat Technol, Photon Res Grp, B-9000 Ghent, Belgium; [Baets, Roel] Univ Ghent, Ctr Nano & Biophoton, B-9000 Ghent, Belgium; [Petrov, Alexander; Jalas, Dirk; Eich, Manfred] Hamburg Univ Technol, Inst Opt & Elect Mat, D-21073 Hamburg, Germany; [Joannopoulos, John D.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Freude, Wolfgang] Karlsruhe Inst Technol KIT, Inst Photon & Quantum Elect IPQ, Karlsruhe, Germany; [Freude, Wolfgang] Karlsruhe Inst Technol KIT, Inst Microstruct Technol IMT, Karlsruhe, Germany; [Melloni, Andrea] Politecn Milan, Dipartimento Elettron & Informaz, I-20133 Milan, Italy; [Popovic, Milos] Univ Colorado, Dept Elect Comp & Energy Engn, Boulder, CO 80309 USA; [Vanwolleghem, Mathias] Univ Paris 11, Inst Elect Fondamentale, UMR8622, F-91405 Orsay, France; [Vanwolleghem, Mathias] CNRS, F-91405 Orsay, France; [Krause, Michael; Renner, Hagen; Brinkmeyer, Ernst] Hamburg Univ Technol, Inst Opt Commun Technol, D-21073 Hamburg, Germany; [Doerr, Christopher R.] Acacia Commun Inc, Maynard, MA 01754 USA	Stanford University; Ghent University; IMEC; Ghent University; Hamburg University of Technology; Massachusetts Institute of Technology (MIT); Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Polytechnic University of Milan; University of Colorado System; University of Colorado Boulder; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Hamburg University of Technology	Fan, SH (corresponding author), Stanford Univ, Dept Elect Engn, Ginzton Lab, Stanford, CA 94305 USA.	shanhui@stanford.edu; roel.baets@ugent.be; a.petrov@tuhh.de	Freude, Wolfgang/P-9257-2015; Vanwolleghem, Mathias/P-9292-2019; Vanwolleghem, Mathias/F-8771-2011; Petrov, Alexander Yu./I-7699-2016; Joannopoulos, John D/E-6401-2013; Fan, Shanhui/B-4659-2012; Popović, Miloš A./AAC-6940-2020	Freude, Wolfgang/0000-0002-8797-7687; Vanwolleghem, Mathias/0000-0003-1759-459X; Petrov, Alexander Yu./0000-0002-9213-9645; Popović, Miloš A./0000-0002-8048-0678; MELLONI, Andrea Ivano/0000-0002-6015-3290; Jalas, Dirk/0000-0003-2589-2765				Collin R., 1960, FIELD THEORY GUIDED, DOI 10.1109/9780470544648; Feng L, 2011, SCIENCE, V333, P729, DOI 10.1126/science.1206038; Fujii M, 2006, OPT EXPRESS, V14, P12782, DOI 10.1364/OE.14.012782; Gallo K, 2001, APPL PHYS LETT, V79, P314, DOI 10.1063/1.1386407; Greenberg M, 2004, OPT EXPRESS, V12, P4013, DOI 10.1364/OPEX.12.004013; Greenberg M, 2004, OPT LETT, V29, P451, DOI 10.1364/OL.29.000451; Haus H. A, 1984, WAVES FIELDS OPTOELE, P56; Kang MS, 2011, NAT PHOTONICS, V5, P549, DOI [10.1038/nphoton.2011.180, 10.1038/NPHOTON.2011.180]; Landau LD., 1984, ELECTRODYNAMICS CONT; Yu ZF, 2009, NAT PHOTONICS, V3, P91, DOI 10.1038/NPHOTON.2008.273	10	106	106	1	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 6	2012	335	6064								10.1126/science.1216682	http://dx.doi.org/10.1126/science.1216682			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872YA	22223793	Green Published			2022-12-28	WOS:000298846200036
J	Ebert, MPA; Tanzer, M; Balluff, B; Burgermeister, E; Kretzschmar, AK; Hughes, DJ; Tetzner, R; Lofton-Day, C; Rosenberg, R; Reinacher-Schick, AC; Schulmann, K; Tannapfel, A; Hofheinz, R; Rocken, C; Keller, G; Langer, R; Specht, K; Porschen, R; Stohlmacher-Williams, J; Schuster, T; Strobel, P; Schmid, RM				Ebert, Matthias P. A.; Taenzer, Marc; Balluff, Benjamin; Burgermeister, Elke; Kretzschmar, Antje Karen; Hughes, David J.; Tetzner, Reimo; Lofton-Day, Catherine; Rosenberg, Robert; Reinacher-Schick, Anke C.; Schulmann, Karsten; Tannapfel, Andrea; Hofheinz, Ralf; Roecken, Christoph; Keller, Gisela; Langer, Rupert; Specht, Katja; Porschen, Rainer; Stoehlmacher-Williams, Jan; Schuster, Tibor; Stroebel, Philipp; Schmid, Roland M.			TFAP2E-DKK4 and Chemoresistance in Colorectal Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							THYMIDYLATE SYNTHASE; GENE-EXPRESSION; BREAST-CANCER; PHASE-III; METHYLATION; MUTATIONS; 5-FLUOROURACIL; IDENTIFICATION; INSTABILITY; CARCINOMA	BACKGROUND Chemotherapy for advanced colorectal cancer leads to improved survival; however, predictors of response to systemic treatment are not available. Genomic and epigenetic alterations of the gene encoding transcription factor AP-2 epsilon (TFAP2E) are common in human cancers. The gene encoding dickkopf homolog 4 protein (DKK4) is a potential downstream target of TFAP2E and has been implicated in chemotherapy resistance. We aimed to further evaluate the role of TFAP2E and DKK4 as predictors of the response of colorectal cancer to chemotherapy. METHODS We analyzed the expression, methylation, and function of TFAP2E in colorectal-cancer cell lines in vitro and in patients with colorectal cancer. We examined an initial cohort of 74 patients, followed by four cohorts of patients (total, 220) undergoing chemotherapy or chemoradiation. RESULTS TFAP2E was hypermethylated in 38 of 74 patients (51%) in the initial cohort. Hyper-methylation was associated with decreased expression of TFAP2E in primary and metastatic colorectal-cancer specimens and cell lines. Colorectal-cancer cell lines overexpressing DKK4 showed increased chemoresistance to fluorouracil but not irinotecan or oxaliplatin. In the four other patient cohorts, TFAP2E hypermethylation was significantly associated with nonresponse to chemotherapy (P<0.001). Conversely, the probability of response among patients with hypomethylation was approximately six times that in the entire population (overall estimated risk ratio, 5.74; 95% confidence interval, 3.36 to 9.79). Epigenetic alterations of TFAP2E were independent of mutations in key regulatory cancer genes, microsatellite instability, and other genes that affect fluorouracil metabolism. CONCLUSIONS TFAP2E hypermethylation is associated with clinical nonresponsiveness to chemotherapy in colorectal cancer. Functional assays confirm that TFAP2E-dependent resistance is mediated through DKK4. In patients who have colorectal cancer with TFAP2E hypermethylation, targeting of DKK4 may be an option to overcome TFAP2E-mediated drug resistance. (Funded by Deutsche Forschungsgemeinschaft and others.)	[Ebert, Matthias P. A.; Burgermeister, Elke] Univ Heidelberg, Univ Med Mannheim, Dept Med 2, D-68167 Mannheim, Germany; [Hofheinz, Ralf] Univ Heidelberg, Univ Med Mannheim, Dept Med 3, D-68167 Mannheim, Germany; [Stroebel, Philipp] Univ Heidelberg, Univ Med Mannheim, Inst Pathol, D-68167 Mannheim, Germany; [Taenzer, Marc; Balluff, Benjamin; Kretzschmar, Antje Karen; Schmid, Roland M.] Tech Univ Munich, Klinikum Rechts Isar, Dept Med 2, D-8000 Munich, Germany; [Rosenberg, Robert] Tech Univ Munich, Klinikum Rechts Isar, Chirurg Klin & Poliklin, D-8000 Munich, Germany; [Keller, Gisela; Specht, Katja] Tech Univ Munich, Klinikum Rechts Isar, Inst Pathol, D-8000 Munich, Germany; [Schuster, Tibor] Tech Univ Munich, Klinikum Rechts Isar, Inst Med Stat & Epidemiol, D-8000 Munich, Germany; [Balluff, Benjamin] Tech Univ Munich, Inst Pathol, D-8000 Munich, Germany; [Balluff, Benjamin] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Pathol, Munich, Germany; [Reinacher-Schick, Anke C.; Schulmann, Karsten] Ruhr Univ Bochum, Knappschafts Krankenhaus, Dept Med, Bochum, Germany; [Tannapfel, Andrea] Ruhr Univ Bochum, Dept Pathol, Bochum, Germany; [Roecken, Christoph] Univ Kiel, Inst Pathol, Kiel, Germany; [Porschen, Rainer] Bremen Ost Hosp, Dept Med, Bremen, Germany; [Stoehlmacher-Williams, Jan] Tech Univ Dresden, Univ Hosp, Dept Med 1, D-01062 Dresden, Germany; [Hughes, David J.] Royal Coll Surgeons Ireland, Ctr Syst Med, Dept Physiol & Med Phys, Dublin 2, Ireland; [Tetzner, Reimo] Epigenomics, Berlin, Germany; [Lofton-Day, Catherine] Epigenomics, Seattle, WA USA	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Technical University of Munich; Technical University of Munich; University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Ruhr University Bochum; Ruhr University Bochum; University of Kiel; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Royal College of Surgeons - Ireland	Ebert, MPA (corresponding author), Univ Heidelberg, Univ Med Mannheim, Dept Med 2, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany.	matthias.ebert@umm.de	Röcken, Christoph/A-9239-2010; Reinacher-Schick, Anke C/F-2722-2012; giovannetti, elisa/F-4261-2011; Langer, Rupert/AAU-1174-2021; Schulmann, Karsten/N-2230-2016; Codacci-Pisanelli, Giovanni/W-4813-2017	Röcken, Christoph/0000-0002-6989-8002; giovannetti, elisa/0000-0002-7565-7504; Langer, Rupert/0000-0001-9491-3609; Codacci-Pisanelli, Giovanni/0000-0003-4662-7944; Hughes, David John/0000-0003-1668-8770	Deutsche Krebshilfe [107885, 108096]; Deutsche Forschungsgemeinschaft [SFB 824]; Else Kroner Stiftung [P14/07//A104/06]; Bundesministerium fur Bildung und Forschung [01EZ0802, 0315116B]	Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Else Kroner Stiftung; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	Supported by grants from Deutsche Krebshilfe (107885 and 108096), Deutsche Forschungsgemeinschaft (SFB 824), Else Kroner Stiftung (Nr P14/07//A104/06), and Bundesministerium fur Bildung und Forschung (01EZ0802 and 0315116B).	Bardelli A, 2010, J CLIN ONCOL, V28, P1254, DOI 10.1200/JCO.2009.24.6116; Boland CR, 1998, CANCER RES, V58, P5248; Chung W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002079; Dalgin GS, 2008, J UROLOGY, V180, P1126, DOI 10.1016/j.juro.2008.04.137; Ebert MPA, 2006, GASTROENTEROLOGY, V131, P1418, DOI 10.1053/j.gastro.2006.08.034; Eckert D, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-246; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Giaretti W, 2004, CELL ONCOL, V26, P301; Guler G, 2007, CLIN CANCER RES, V13, P6115, DOI 10.1158/1078-0432.CCR-07-1282; Heinrich MC, 2008, J CLIN ONCOL, V26, P5360, DOI 10.1200/JCO.2008.17.4284; Hirsch FR, 2006, J CLIN ONCOL, V24, P5034, DOI 10.1200/JCO.2006.06.3958; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; Maeda S, 2005, J HUM GENET, V50, P283, DOI 10.1007/s10038-005-0253-9; Maehata T, 2008, WORLD J GASTROENTERO, V14, P2702, DOI 10.3748/wjg.14.2702; Orso F, 2007, ADV EXP MED BIOL, V604, P87, DOI 10.1007/978-0-387-69116-9_6; Porschen R, 2007, J CLIN ONCOL, V25, P4217, DOI 10.1200/JCO.2006.09.2684; Prix L, 2002, CLIN CHEM, V48, P428; Rosenberg R, 2008, J SURG ONCOL, V97, P8, DOI 10.1002/jso.20844; Weichert W, 2008, CLIN CANCER RES, V14, P1669, DOI 10.1158/1078-0432.CCR-07-0990; Wojdacz TK, 2008, NAT PROTOC, V3, P1903, DOI 10.1038/nprot.2008.191; Woodfield GW, 2007, CANCER RES, V67, P8439, DOI 10.1158/0008-5472.CAN-07-2293; Xi Y, 2008, ONCOL REP, V19, P257; Xi YG, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-68; You J, 2008, DIGEST DIS SCI, V53, P1013, DOI 10.1007/s10620-007-9973-3	26	126	134	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 5	2012	366	1					44	53		10.1056/NEJMoa1009473	http://dx.doi.org/10.1056/NEJMoa1009473			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	887XY	22216841	Green Published			2022-12-28	WOS:000299968800006
J	Susan, L; Robinson, KA; Dickersin, K				Susan, L.; Robinson, Karen A.; Dickersin, Kay			Understanding why evidence from randomised clinical trials may not be retrieved from Medline: comparison of indexed and non-indexed records	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PUBLICATIONS; PROTOCOLS	Objective To explore why reports that seem to describe randomised controlled trials are sometimes not indexed ("tagged") with RCT (randomised controlled trial) [pt] (publication type) in Medline. Design Cross sectional study. Setting The Cochrane Collaboration and US National Library of Medicine worked together to identify and retag records of randomised controlled trials with RCT [pt], 1994 to 2006. Data source Published reports entered into Medline in 2005. Main outcome measures Type of trial information presented (for example, main results, design, and methods), trial design, and other Medline indexing terms applied. Results 572/591 (97%) untagged records and 578/594 (97%) tagged records contained information from randomised controlled trials. Type of trial information and design differed between untagged and tagged reports. Fewer than half (234/572, 41%, 95% confidence interval 37% to 45%) of untagged reports but most tagged reports (526/578, 91%, 89% to 93%) described the main results of the trial. Untagged reports were more likely than tagged reports to contain information on design and methods, baseline characteristics, long term follow-up, and secondary analyses. Untagged reports of main results were more likely than tagged reports to be from trials using a crossover design (36% v 10%, difference 25%, 95% confidence interval 19% to 32%). The Medical Subject Heading "Randomized Controlled Trials" was the most common clinical trial term applied to untagged reports, although more than half of untagged reports had no indexing related to trials. Conclusion Based on the results for 2005, at least 3000 records describing randomised controlled trials but not indexed using RCT [pt] may have been entered into Medline between 2006 and 2011. Researchers and healthcare decision makers relying on using RCT [pt] may be missing important evidence in their searches, particularly for design and methods, baseline characteristics, long term follow-up, and secondary data analyses.	[Susan, L.] Univ Maryland, Sch Med, Ctr Integrat Med, Baltimore, MD 21201 USA; [Susan, L.; Dickersin, Kay] US Cochrane Ctr, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Robinson, Karen A.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Robinson, Karen A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Susan, L (corresponding author), Univ Maryland, Sch Med, Ctr Integrat Med, Baltimore, MD 21201 USA.	lswieland@gmail.com						Agency for Healthcare Research and Quality, 2011, METH GUID EFF COMP E; Agostoni E, 2005, NEUROL SCI, V26, pS31, DOI 10.1007/s10072-005-0401-1; Aranda JM, 2005, AM J CARDIOL, V95, P889, DOI 10.1016/j.amjcard.2004.12.023; Blumle A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1828; Bo K, 2005, OBSTET GYNECOL, V105, P999, DOI 10.1097/01.AOG.0000157207.95680.6d; Boaz M, 2005, CLIN NEPHROL, V63, P98; Carozzi FM, 2005, AM J CLIN PATHOL, V124, P716, DOI 10.1309/84E5WHJQHK83BGQD; Chan AW, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2299; Cleland JGF, 2005, EUR J HEART FAIL, V7, P205, DOI 10.1016/j.ejheart.2005.01.010; DICKERSIN K, 1994, BMJ-BRIT MED J, V309, P1286, DOI 10.1136/bmj.309.6964.1286; Dickersin K, 2002, EVAL HEALTH PROF, V25, P38, DOI 10.1177/0163278702025001004; Glanville JM, 2006, J MED LIBR ASSOC, V94, P130; HARLAN WR, 1994, JAMA-J AM MED ASSOC, V271, P1729, DOI 10.1001/jama.271.22.1729; Haynes RB, 2005, BMJ-BRIT MED J, V330, P1179, DOI 10.1136/bmj.38446.498542.8F; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Hopewell S, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000001.pub2, 10.1002/14651858.MR000011.pub2]; Hrobjartsson A, 2009, J CLIN EPIDEMIOL, V62, P967, DOI 10.1016/j.jclinepi.2009.04.003; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; Robinson KA, 2002, INT J EPIDEMIOL, V31, P150, DOI 10.1093/ije/31.1.150; Royle PL, 2007, DIABETIC MED, V24, P308, DOI 10.1111/j.1464-5491.2007.02046.x; Whiting P, 2011, J CLIN EPIDEMIOL, V64, P602, DOI 10.1016/j.jclinepi.2010.07.006; Willis J, 1995, NLM TECH B, V283, P18	22	20	20	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 3	2012	344								d7501	10.1136/bmj.d7501	http://dx.doi.org/10.1136/bmj.d7501			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874UE	22214757	hybrid			2022-12-28	WOS:000298982800007
J	Cury, PM; Boyd, IL; Bonhommeau, S; Anker-Nilssen, T; Crawford, RJM; Furness, RW; Mills, JA; Murphy, EJ; Osterblom, H; Paleczny, M; Piatt, JF; Roux, JP; Shannon, L; Sydeman, WJ				Cury, Philippe M.; Boyd, Ian L.; Bonhommeau, Sylvain; Anker-Nilssen, Tycho; Crawford, Robert J. M.; Furness, Robert W.; Mills, James A.; Murphy, Eugene J.; Oesterblom, Henrik; Paleczny, Michelle; Piatt, John F.; Roux, Jean-Paul; Shannon, Lynne; Sydeman, William J.			Global Seabird Response to Forage Fish Depletion-One-Third for the Birds	SCIENCE			English	Article							FOOD AVAILABILITY; CLIMATE; ECOSYSTEMS; CONSERVATION; BIODIVERSITY; ENVIRONMENT; POPULATION; INDICATORS; MANAGEMENT; PREDATORS	Determining the form of key predator-prey relationships is critical for understanding marine ecosystem dynamics. Using a comprehensive global database, we quantified the effect of fluctuations in food abundance on seabird breeding success. We identified a threshold in prey (fish and krill, termed "forage fish") abundance below which seabirds experience consistently reduced and more variable productivity. This response was common to all seven ecosystems and 14 bird species examined within the Atlantic, Pacific, and Southern Oceans. The threshold approximated one-third of the maximum prey biomass observed in long-term studies. This provides an indicator of the minimal forage fish biomass needed to sustain seabird productivity over the long term.	[Cury, Philippe M.] Ctr Rech Halieut Mediterraneenne & Trop, Inst Rech Dev, UMR EME 212, F-34203 Sete, France; [Boyd, Ian L.] Univ St Andrews, Scottish Oceans Inst, St Andrews KY16 8LB, Fife, Scotland; [Bonhommeau, Sylvain] IFREMER, Ctr Rech Halieut Mediterraneenne & Trop, UMR EME 212, F-34203 Sete, France; [Anker-Nilssen, Tycho] Norwegian Inst Nat Res, NO-7485 Trondheim, Norway; [Crawford, Robert J. M.] Dept Environm Affairs, Branch Oceans & Coasts, ZA-8012 Cape Town, South Africa; [Crawford, Robert J. M.] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Murphy, Eugene J.] British Antarctic Survey, Cambridge CB3 0ET, England; [Oesterblom, Henrik] Stockholm Univ, Stockholm Resilience Ctr, Balt Nest Inst, SE-10691 Stockholm, Sweden; [Paleczny, Michelle] Univ British Columbia, Fisheries Ctr, AERL, Vancouver, BC V6T 1Z4, Canada; [Piatt, John F.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA; [Roux, Jean-Paul] Luderitz Marine Res, Minist Fisheries & Marine Resources, Ecosyst Anal Sect, Luderitz, Namibia; [Roux, Jean-Paul] Univ Cape Town, Dept Zool, Anim Demog Unit, ZA-7701 Cape Town, South Africa; [Shannon, Lynne] Univ Cape Town, Marine Res Inst, ZA-7701 Cape Town, South Africa; [Shannon, Lynne] Univ Cape Town, Dept Zool, ZA-7701 Cape Town, South Africa; [Sydeman, William J.] Farallon Inst Adv Ecosyst Res, Petaluma, CA 94952 USA	Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of St Andrews; Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Norwegian Institute Nature Research; Department of Environment, Forestry & Fisheries; University of Glasgow; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Stockholm University; University of British Columbia; United States Department of the Interior; United States Geological Survey; University of Cape Town; University of Cape Town; University of Cape Town	Cury, PM (corresponding author), Ctr Rech Halieut Mediterraneenne & Trop, Inst Rech Dev, UMR EME 212, Ave Jean Monnet,BP 171, F-34203 Sete, France.	philippe.cury@ird.fr; ilb@st-andrews.ac.uk	Osterblom, Henrik/D-4249-2012; murphy, eugene/GZL-1620-2022; Shannon, Lynne J/A-1612-2015; Anker-Nilssen, Tycho/AAB-7666-2022; Bonhommeau, Sylvain/P-8654-2014	Shannon, Lynne J/0000-0001-7842-0636; Anker-Nilssen, Tycho/0000-0002-1030-5524; Bonhommeau, Sylvain/0000-0002-0882-5918; Cury, philippe/0000-0002-4622-4208; Osterblom, Henrik/0000-0002-1913-5197; Piatt, John/0000-0002-4417-5748	Eur-Oceans Consortium; Institut de Recherche pour le Developpement (IRD); Lenfest Forage Fish Task Force; Mistra; Sea Around Us Project; South African Research Chair Initiative; NERC [bas0100025] Funding Source: UKRI; Natural Environment Research Council [bas0100025] Funding Source: researchfish	Eur-Oceans Consortium; Institut de Recherche pour le Developpement (IRD); Lenfest Forage Fish Task Force; Mistra; Sea Around Us Project; South African Research Chair Initiative; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was partly funded by Eur-Oceans Consortium, the Institut de Recherche pour le Developpement (IRD), the Lenfest Forage Fish Task Force, Mistra, the Sea Around Us Project, and the South African Research Chair Initiative. Disclaimers and acknowledgment of institutes and collaborators are provided in the SOM. Data, methods, and codes are available in the SOM.	Abrams PA, 2000, TRENDS ECOL EVOL, V15, P337, DOI 10.1016/S0169-5347(00)01908-X; Agnew DJ, 1997, ANTARCT SCI, V9, P235, DOI 10.1017/S095410209700031X; Andersen T, 2009, TRENDS ECOL EVOL, V24, P49, DOI 10.1016/j.tree.2008.07.014; Boyd IL, 2002, AQUAT CONSERV, V12, P119, DOI 10.1002/aqc.481; Boyd IL, 2001, J ANIM ECOL, V70, P747, DOI 10.1046/j.0021-8790.2001.00534.x; CAIRNS D K, 1987, Biological Oceanography, V5, P261; Coll M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003881; Cury P, 2000, ICES J MAR SCI, V57, P603, DOI 10.1006/jmsc.2000.0712; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Durant JM, 2003, P ROY SOC B-BIOL SCI, V270, P1461, DOI 10.1098/rspb.2003.2397; Field JC, 2010, ECOL APPL, V20, P2223, DOI 10.1890/09-0428.1; Furness RW, 2007, J ORNITHOL, V148, pS247, DOI 10.1007/s10336-007-0152-2; Furness RW, 1997, ICES J MAR SCI, V54, P726, DOI 10.1006/jmsc.1997.0243; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Hunsicker ME, 2011, ECOL LETT, V14, P1288, DOI 10.1111/j.1461-0248.2011.01696.x; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kitaysky AS, 2010, FUNCT ECOL, V24, P625, DOI 10.1111/j.1365-2435.2009.01679.x; Lotze HK, 2009, TRENDS ECOL EVOL, V24, P254, DOI 10.1016/j.tree.2008.12.004; Mills JA, 2008, J ANIM ECOL, V77, P1129, DOI 10.1111/j.1365-2656.2008.01383.x; Naylor RL, 2009, P NATL ACAD SCI USA, V106, P15103, DOI 10.1073/pnas.0905235106; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; PIATT JF, 1992, MAR ECOL PROG SER, V84, P205, DOI 10.3354/meps084205; Piatt JF, 2007, MAR ECOL PROG SER, V352, P221, DOI 10.3354/meps07078; Pichegru L, 2010, BIOL LETTERS, V6, P498, DOI 10.1098/rsbl.2009.0913; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Reid K, 2005, ICES J MAR SCI, V62, P366, DOI 10.1016/j.icesjms.2004.11.003; Smith ADM, 2011, SCIENCE, V333, P1147, DOI 10.1126/science.1209395; Stige LC, 2010, P ROY SOC B-BIOL SCI, V277, P3411, DOI 10.1098/rspb.2010.0602; WOOLLER RD, 1992, TRENDS ECOL EVOL, V7, P111, DOI 10.1016/0169-5347(92)90143-Y	29	484	493	14	287	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1703	1706		10.1126/science.1212928	http://dx.doi.org/10.1126/science.1212928			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22194577	Green Published			2022-12-28	WOS:000298344000067
J	Bakr, WS; Preiss, PM; Tai, ME; Ma, RC; Simon, J; Greiner, M				Bakr, Waseem S.; Preiss, Philipp M.; Tai, M. Eric; Ma, Ruichao; Simon, Jonathan; Greiner, Markus			Orbital excitation blockade and algorithmic cooling in quantum gases	NATURE			English	Article							MOTT INSULATOR; OPTICAL LATTICES; RYDBERG BLOCKADE; ATOMS; TRANSITION; SUPERFLUID; PHYSICS	Interaction blockade occurs when strong interactions in a confined, few-body system prevent a particle from occupying an otherwise accessible quantum state. Blockade phenomena reveal the underlying granular nature of quantum systems and allow for the detection and manipulation of the constituent particles, be they electrons(1), spins(2), atoms(3-5) or photons(6). Applications include single-electron transistors based on electronic Coulomb blockade(7) and quantum logic gates in Rydberg atoms(8,9). Here we report a form of interaction blockade that occurs when transferring ultracold atoms between orbitals in an optical lattice. We call this orbital excitation blockade (OEB). In this system, atoms at the same lattice site undergo coherent collisions described by a contact interaction whose strength depends strongly on the orbital wavefunctions of the atoms. We induce coherent orbital excitations by modulating the lattice depth, and observe staircase-like excitation behaviour as we cross the interaction-split resonances by tuning the modulation frequency. As an application of OEB, we demonstrate algorithmic cooling(10,11) of quantum gases: a sequence of reversible OEB-based quantum operations isolates the entropy in one part of the system and then an irreversible step removes the entropy from the gas. This technique may make it possible to cool quantum gases to have the ultralow entropies required for quantum simulation(12,13) of strongly correlated electron systems. In addition, the close analogy between OEB and dipole blockade in Rydberg atoms provides a plan for the implementation of two-quantum-bit gates(14) in a quantum computing architecture with natural scalability.	[Bakr, Waseem S.; Preiss, Philipp M.; Tai, M. Eric; Ma, Ruichao; Simon, Jonathan; Greiner, Markus] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University	Greiner, M (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	greiner@physics.harvard.edu	Greiner, Markus/E-9512-2017; Greiner, Markus/A-8502-2010; Ma, Ruichao/P-3604-2014	Ma, Ruichao/0000-0003-4516-874X; Simon, Jonathan/0000-0001-7854-4647	US Army Research Office; DARPA OLE; AFOSR MURI; US NSF	US Army Research Office; DARPA OLE(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); AFOSR MURI(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI); US NSF(National Science Foundation (NSF))	We would like to thank S. Folling for discussions. This work was supported by grants from the US Army Research Office with funding from the DARPA OLE program, an AFOSR MURI programme and by grants from the US NSF.	Bakr WS, 2010, SCIENCE, V329, P547, DOI 10.1126/science.1192368; Baugh J, 2005, NATURE, V438, P470, DOI 10.1038/nature04272; Birnbaum KM, 2005, NATURE, V436, P87, DOI 10.1038/nature03804; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Boykin PO, 2002, P NATL ACAD SCI USA, V99, P3388, DOI 10.1073/pnas.241641898; Campbell GK, 2006, SCIENCE, V313, P649, DOI 10.1126/science.1130365; Cheinet P, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.090404; Gaetan A, 2009, NAT PHYS, V5, P115, DOI 10.1038/NPHYS1183; Grabert H., 1992, SINGLE CHARGE TUNNEL, P21; Isenhower L, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.010503; KASTNER MA, 1992, REV MOD PHYS, V64, P849, DOI 10.1103/RevModPhys.64.849; Lewenstein M, 2007, ADV PHYS, V56, P243, DOI 10.1080/00018730701223200; McKay DC, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/5/054401; Medley P, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.195301; Muller T, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.200405; Nelson KD, 2007, NAT PHYS, V3, P556, DOI 10.1038/nphys645; Nikolopoulos GM, 2010, J PHYS B-AT MOL OPT, V43, DOI 10.1088/0953-4075/43/13/131001; Ono K, 2002, SCIENCE, V297, P1313, DOI 10.1126/science.1070958; Popp M, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.013622; Rabl P, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.110403; Schneider P., 2011, QUANTUM COMPUTATION; Sherson J. F., 2010, SHAKING ENTROPY OUT; Soltan-Panahi P, 2011, NAT PHYS, V7, P434, DOI [10.1038/nphys1916, 10.1038/NPHYS1916]; Urban E, 2009, NAT PHYS, V5, P110, DOI 10.1038/NPHYS1178; Weiss DS, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.040302; Weitenberg C, 2011, NATURE, V471, P319, DOI 10.1038/nature09827; Wilk T, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.010502; Wirth G, 2011, NAT PHYS, V7, P147, DOI [10.1038/nphys1857, 10.1038/NPHYS1857]	31	75	75	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2011	480	7378					500	U118		10.1038/nature10668	http://dx.doi.org/10.1038/nature10668			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865NQ	22193104	Green Submitted			2022-12-28	WOS:000298318000055
J	Cheung, F				Cheung, Felix			MODERN TCM Enter the clinic	NATURE			English	Editorial Material																			0	23	23	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2011	480	7378					S94	S95		10.1038/480S94a	http://dx.doi.org/10.1038/480S94a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	865NQ	22190091	Bronze			2022-12-28	WOS:000298318000007
J	Marcocci, C; Cetani, F				Marcocci, Claudio; Cetani, Filomena			Primary Hyperparathyroidism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ASYMPTOMATIC PRIMARY HYPERPARATHYROIDISM; 3RD INTERNATIONAL WORKSHOP; MILD PRIMARY HYPERPARATHYROIDISM; SERUM-CALCIUM; POSTMENOPAUSAL WOMEN; PARATHYROID SURGERY; CONTROLLED-TRIAL; CLINICAL-TRIAL; VITAMIN-D; DISEASE	A 62-year-old woman is found on routine laboratory testing to have a serum calcium level of 10.8 mg per deciliter (2.7 mmol per liter) (normal range, 8.4 to 10.4 [2.1 to 2.7]). The serum intact parathyroid hormone (PTH) concentration is 70 pg per milliliter (normal range, 15 to 75). Her history is notable only for hypertension that is well controlled with an angiotensin-receptor blocker; there is no history of kidney stones or fractures. Her family history is negative for hypercalcemia or endocrine tumors. Her 24-hour urinary calcium and creatinine levels are 280 mg and 1050 mg, respectively, and the ratio of calcium to creatinine clearance is 0.025. Bone densitometry shows T scores at the lumbar spine of -1.8, at the total hip of -2.2, and at the distal third of the radius of -3.0. How should she be further evaluated and treated?	[Marcocci, Claudio; Cetani, Filomena] Univ Pisa, Dept Endocrinol & Metab, Sect Endocrinol & Bone Metab, Pisa, Italy	University of Pisa	Marcocci, C (corresponding author), Via Paradisa 2, I-56124 Pisa, Italy.	claudio.marcocci@med.unipi.it		Cetani, Filomena/0000-0003-2558-9547	Amgen	Amgen(Amgen)	Dr. Marcocci reports receiving consulting fees, board membership fees, and speaker's fees from Amgen. No other potential conflict of interest relevant to this article was reported.	Ambrogini E, 2007, J CLIN ENDOCR METAB, V92, P3114, DOI 10.1210/jc.2007-0219; Ayturk S, 2006, J CLIN ENDOCR METAB, V91, P4260, DOI 10.1210/jc.2005-2825; Bilezikian JP, 2009, J CLIN ENDOCR METAB, V94, P335, DOI 10.1210/jc.2008-1763; Bilezikian JP, 2000, INT J FERTIL WOMEN M, V45, P158; Bilezikian JP, PRIMARY HYPERPARATHY; Bollerslev J, 2007, J CLIN ENDOCR METAB, V92, P1687, DOI 10.1210/jc.2006-1836; Bollerslev J, 2009, J CLIN ENDOCR METAB, V94, P2255, DOI 10.1210/jc.2008-2742; BOONSTRA CE, 1971, AM J CLIN PATHOL, V55, P523; CHRISTENSSON T, 1976, ACTA MED SCAND, V200, P131; COHEN J, 1990, JAMA-J AM MED ASSOC, V264, P581; DEACONSON TF, 1987, SURGERY, V102, P910; Eastell R, 2009, J CLIN ENDOCR METAB, V94, P340, DOI 10.1210/jc.2008-1758; Grey AB, 1996, ANN INTERN MED, V125, P360, DOI 10.7326/0003-4819-125-5-199609010-00002; Hagstrom E, 2002, CLIN ENDOCRINOL, V56, P251, DOI 10.1046/j.0300-0664.2001.01468.x; Jacobs TP, 2005, J CLIN ENDOCR METAB, V90, P6316, DOI 10.1210/jc.2005-0675; Khan AA, 2004, J CLIN ENDOCR METAB, V89, P3319, DOI 10.1210/jc.2003-030908; Lowe H, 2007, J CLIN ENDOCR METAB, V92, P3001, DOI 10.1210/jc.2006-2802; Lundgren E, 1997, SURGERY, V121, P287, DOI 10.1016/S0039-6060(97)90357-3; Marcocci C, 2009, J CLIN ENDOCR METAB, V94, P2766, DOI 10.1210/jc.2008-2640; Marcocci C, 2008, J BONE MINER RES, V23, P1869, DOI 10.1359/JBMR.081018; MARX SJ, 1981, MEDICINE, V60, P397, DOI 10.1097/00005792-198111000-00002; Marx SJ, 2011, ENDOCR PRACT, V17, P18, DOI 10.4158/EP11067.RA; Miccoli P, 1999, SURGERY, V126, P1117, DOI 10.1067/msy.2099.102269; Peacock M, 2011, J CLIN ENDOCR METAB, V96, pE9, DOI 10.1210/jc.2010-1221; Peacock M, 2009, J CLIN ENDOCR METAB, V94, P4860, DOI 10.1210/jc.2009-1472; Procopio M, 2002, DIABETIC MED, V19, P958, DOI 10.1046/j.1464-5491.2002.00809.x; Rao DS, 2004, J CLIN ENDOCR METAB, V89, P5415, DOI 10.1210/jc.2004-0028; Rao DS, 2002, J BONE MINER RES, V17, pN75; RAO DS, 1988, J CLIN ENDOCR METAB, V67, P1294, DOI 10.1210/jcem-67-6-1294; Rao DS, 2000, J CLIN ENDOCR METAB, V85, P1054, DOI 10.1210/jc.85.3.1054; Rejnmark L, 2011, J CLIN ENDOCR METAB, V96, P2377, DOI 10.1210/jc.2011-0569; Rubin MR, 2008, J CLIN ENDOCR METAB, V93, P3462, DOI 10.1210/jc.2007-1215; Silverberg SJ, 2007, J BONE MINER RES, V22, pV100, DOI 10.1359/JBMR.07S202; Silverberg SJ, 2009, J CLIN ENDOCR METAB, V94, P351, DOI 10.1210/jc.2008-1760; Silverberg SJ, 2003, J CLIN ENDOCR METAB, V88, P5348, DOI 10.1210/jc.2003-031014; SILVERBERG SJ, 1989, J BONE MINER RES, V4, P283, DOI 10.1002/jbmr.5650040302; Silverberg SJ, 1996, J CLIN ENDOCR METAB, V81, P4007, DOI 10.1210/jc.81.11.4007; Silverberg SJ, 1999, NEW ENGL J MED, V341, P1249, DOI 10.1056/NEJM199910213411701; Silverberg SJ, 2000, NEW ENGL J MED, V342, P144; Soreide JA, 1997, SURGERY, V122, P1117, DOI 10.1016/S0039-6060(97)90216-6; Sun JM, 2008, AM J ROENTGENOL, V191, P908; Szalat A, 2009, EUR J ENDOCRINOL, V160, P317, DOI 10.1530/EJE-08-0620; Udelsman R, 2011, ANN SURG, V253, P585, DOI 10.1097/SLA.0b013e318208fed9; Vestergaard P, 2000, BRIT MED J, V321, P598, DOI 10.1136/bmj.321.7261.598; Vignali E, 2002, EUR J ENDOCRINOL, V146, P783, DOI 10.1530/eje.0.1460783; Vignali E, 2009, J CLIN ENDOCR METAB, V94, P2306, DOI 10.1210/jc.2008-2006; Walker MD, 2010, J CLIN ENDOCR METAB, V95, P2172, DOI 10.1210/jc.2009-2072; Walker MD, 2008, J ENDOCRINOL INVEST, V31, P925, DOI 10.1007/BF03346443; Wermers RA, 1998, AM J MED, V104, P115, DOI 10.1016/S0002-9343(97)00270-2; Wermers RA, 2006, J BONE MINER RES, V21, P171, DOI 10.1359/JBMR.050910; Yu N, 2010, CLIN ENDOCRINOL, V73, P30, DOI 10.1111/j.1365-2265.2009.03766.x	51	200	213	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2011	365	25					2389	2397		10.1056/NEJMcp1106636	http://dx.doi.org/10.1056/NEJMcp1106636			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	865OM	22187986				2022-12-28	WOS:000298320200005
J	Rao, RC; Perry, LJP				Rao, Rajesh C.; Perry, Lynn J. Poole			Decreased Vision Following Eye Trauma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INTRALENTICULAR FOREIGN-BODY; BODIES; LENS		[Rao, Rajesh C.; Perry, Lynn J. Poole] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Rao, RC (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, Retina Serv, 4921 Parkview Pl,Ste 12C, St Louis, MO 63110 USA.	rajeshcrao@gmail.com	Rao, Rajesh C./N-1107-2017	Rao, Rajesh C./0000-0002-5776-8366				FOSS AJE, 1993, BRIT J OPHTHALMOL, V77, P828, DOI 10.1136/bjo.77.12.828; GOOD P, 1988, OPHTHALMOLOGICA, V196, P204, DOI 10.1159/000309902; Grewal SPS, 2006, AM J OPHTHALMOL, V142, P675, DOI 10.1016/j.ajo.2006.04.064; KEENEY AH, 1971, ARCH OPHTHALMOL-CHIC, V86, P499; Lee W, 2007, J CATARACT REFR SURG, V33, P550, DOI 10.1016/j.jcrs.2006.09.043; MACKEN PL, 1995, OPHTHALMIC SURG LAS, V26, P250; Patel SN, 2012, EUR J OPHTHALMOL, V22, P259, DOI 10.5301/EJO.2011.8347; PERCIVAL SP, 1972, BRIT J OPHTHALMOL, V56, P462, DOI 10.1136/bjo.56.6.462; THOMPSON JT, 1993, OPHTHALMOLOGY, V100, P1468	9	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 21	2011	306	23					2606	2607		10.1001/jama.2011.1832	http://dx.doi.org/10.1001/jama.2011.1832			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	864YQ	22187280				2022-12-28	WOS:000298276800022
J	Zhang, SY; Bryant, DA				Zhang, Shuyi; Bryant, Donald A.			The Tricarboxylic Acid Cycle in Cyanobacteria	SCIENCE			English	Article							OBLIGATE AUTOTROPHY; PCC 6803; METABOLISM; DECARBOXYLASE	It is generally accepted that cyanobacteria have an incomplete tricarboxylic acid (TCA) cycle because they lack 2-oxoglutarate dehydrogenase and thus cannot convert 2-oxoglutarate to succinyl-coenzyme A (CoA). Genes encoding a novel 2-oxoglutarate decarboxylase and succinic semialdehyde dehydrogenase were identified in the cyanobacterium Synechococcus sp. PCC 7002. Together, these two enzymes convert 2-oxoglutarate to succinate and thus functionally replace 2-oxoglutarate dehydrogenase and succinyl-CoA synthetase. These genes are present in all cyanobacterial genomes except those of Prochlorococcus and marine Synechococcus species. Closely related genes occur in the genomes of some methanogens and other anaerobic bacteria, which are also thought to have incomplete TCA cycles.	[Zhang, Shuyi; Bryant, Donald A.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Bryant, Donald A.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Montana State University System; Montana State University Bozeman	Bryant, DA (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	dab14@psu.edu		Zhang, Shuyi/0000-0001-8500-5836	Air Force Office of Scientific Research (MURI) [FA9550-05-1-0365]; U.S. Department of Energy, Office of Biological and Environmental Research	Air Force Office of Scientific Research (MURI)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI); U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE))	We thank W. R. Cannon, L. A. McCue, A. Konopka, S. Stolyar, A. Beliaev, J. K. Fredrickson, and M. Romine for encouragement and stimulating discussions. D. A. B. thanks W. Martin for long ago pointing out the unusual TCA cycle in E. gracilis. Supported by the Air Force Office of Scientific Research (MURI grant FA9550-05-1-0365) and by the Genomic Science Program of the U.S. Department of Energy, Office of Biological and Environmental Research. This contribution originates from the GSP Foundational Scientific Focus Area and Biofuels Scientific Focus Area of the Pacific Northwest National Laboratory.	[Anonymous], 1973, BLUE GREEN ALGAE, DOI DOI 10.1007/BF02920994; Bender RA, 2011, J BACTERIOL, V193, P4574, DOI 10.1128/JB.05666-11; Bryant D.A., 1994, MOL BIOL CYANOBACTER; Cannon WR, 2011, J PROTEOME RES, V10, P2306, DOI 10.1021/pr101130b; Chipman DM, 2005, CURR OPIN CHEM BIOL, V9, P475, DOI 10.1016/j.cbpa.2005.07.002; Cooley JW, 2000, J BACTERIOL, V182, P714, DOI 10.1128/JB.182.3.714-722.2000; Forchhammer K, 2010, ADV EXP MED BIOL, V675, P71, DOI 10.1007/978-1-4419-1528-3_5; Fu PC, 2009, J CHEM TECHNOL BIOT, V84, P473, DOI 10.1002/jctb.2065; Hong SJ, 2007, BIOTECHNOL BIOPROC E, V12, P165, DOI 10.1007/BF03028644; Ludwig M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00041; Ohashi Y, 2011, J EXP BOT, V62, P1411, DOI 10.1093/jxb/erq427; PEARCE J, 1967, BIOCHEM J, V105, pP45; Schwarz D, 2011, PLANT PHYSIOL, V155, P1640, DOI 10.1104/pp.110.170225; Shastri AA, 2005, BIOTECHNOL PROGR, V21, P1617, DOI 10.1021/bp050246d; SHIGEOKA S, 1986, FEBS LETT, V195, P43, DOI 10.1016/0014-5793(86)80126-0; SMITH AJ, 1967, J BACTERIOL, V94, P972, DOI 10.1128/JB.94.4.972-983.1967; STANIER RY, 1977, ANNU REV MICROBIOL, V31, P225, DOI 10.1146/annurev.mi.31.100177.001301; Tian J, 2005, P NATL ACAD SCI USA, V102, P10670, DOI 10.1073/pnas.0501605102; Wood AP, 2004, FEMS MICROBIOL REV, V28, P335, DOI 10.1016/j.femsre.2003.12.001	19	231	244	5	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 16	2011	334	6062					1551	1553		10.1126/science.1210858	http://dx.doi.org/10.1126/science.1210858			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	862LE	22174252				2022-12-28	WOS:000298091400052
J	Barouch, DH; Liu, JY; Li, HL; Maxfield, LF; Abbink, P; Lynch, DM; Iampietro, MJ; SanMiguel, A; Seaman, MS; Ferrari, G; Forthal, DN; Ourmanov, I; Hirsch, VM; Carville, A; Mansfield, KG; Stablein, D; Pau, MG; Schuitemaker, H; Sadoff, JC; Billings, EA; Rao, M; Robb, ML; Kim, JH; Marovich, MA; Goudsmit, J; Michael, NL				Barouch, Dan H.; Liu, Jinyan; Li, Hualin; Maxfield, Lori F.; Abbink, Peter; Lynch, Diana M.; Iampietro, M. Justin; SanMiguel, Adam; Seaman, Michael S.; Ferrari, Guido; Forthal, Donald N.; Ourmanov, Ilnour; Hirsch, Vanessa M.; Carville, Angela; Mansfield, Keith G.; Stablein, Donald; Pau, Maria G.; Schuitemaker, Hanneke; Sadoff, Jerald C.; Billings, Erik A.; Rao, Mangala; Robb, Merlin L.; Kim, Jerome H.; Marovich, Mary A.; Goudsmit, Jaap; Michael, Nelson L.			Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys	NATURE			English	Article							CELLULAR IMMUNE-RESPONSES; LOW-DOSE CHALLENGE; INFECTION; ANTIBODIES; MACAQUES; VECTORS; MEMORY; BREADTH	Preclinical studies of human immunodeficiency virus type 1 (HIV-1) vaccine candidates have typically shown post-infection virological control, but protection against acquisition of infection has previously only been reported against neutralization-sensitive virus challenges(1-3). Here we demonstrate vaccine protection against acquisition of fully heterologous, neutralization-resistant simian immunodeficiency virus (SIV) challenges in rhesus monkeys. Adenovirus/poxvirus and adenovirus/adenovirus-vector-based vaccines expressing SIVSME543 Gag, Pol and Env antigens resulted in an 80% or greater reduction in the per-exposure probability of infection(4,5) against repetitive, intrarectal SIVMAC251 challenges in rhesus monkeys. Protection against acquisition of infection showed distinct immunological correlates compared with post-infection virological control and required the inclusion of Env in the vaccine regimen. These data demonstrate the proof-of-concept that optimized HIV-1 vaccine candidates can block acquisition of stringent, heterologous, neutralization-resistant virus challenges in rhesus monkeys.	[Barouch, Dan H.; Liu, Jinyan; Li, Hualin; Maxfield, Lori F.; Abbink, Peter; Lynch, Diana M.; Iampietro, M. Justin; SanMiguel, Adam; Seaman, Michael S.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Vaccine Res, Boston, MA 02215 USA; [Barouch, Dan H.] Ragon Inst MGH MIT & Harvard, Boston, MA 02114 USA; [Ferrari, Guido] Duke Univ, Med Ctr, Durham, NC 27710 USA; [Forthal, Donald N.] Univ Calif Irvine, Sch Med, Irvine, CA 92717 USA; [Ourmanov, Ilnour; Hirsch, Vanessa M.] NIAID, Bethesda, MA 20892 USA; [Carville, Angela; Mansfield, Keith G.] New England Primate Res Ctr, Southborough, MA 01772 USA; [Stablein, Donald] EMMES Corp, Rockville, MD 20850 USA; [Pau, Maria G.; Schuitemaker, Hanneke; Sadoff, Jerald C.; Goudsmit, Jaap] Crucell Holland BV, NL-2301 CA Leiden, Netherlands; [Billings, Erik A.; Rao, Mangala; Robb, Merlin L.; Kim, Jerome H.; Marovich, Mary A.; Michael, Nelson L.] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Duke University; University of California System; University of California Irvine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Emmes Corporation; Johnson & Johnson; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Barouch, DH (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Vaccine Res, Boston, MA 02215 USA.	dbarouch@bidmc.harvard.edu	Barouch, Dan/Y-3918-2019; Ferrari, Guido/A-6088-2015; Ferrari, Guido/Z-2137-2019	Ferrari, Guido/0000-0001-7747-3349; Maxfield, Lori/0000-0002-7595-6205	US Military Research and Material Command; US Military HIV Research Program [W81XWH-07-2-0067]; Ragon Institute of MGH, MIT and Harvard; National Institutes of Health [AI066924, AI078526, AI084794, AI095985, AI060354, AI002642, RR000168]; Bill and Melinda Gates Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI078526, N01AI002642, P30AI060354, U19AI066305, U19AI095985, ZIAAI000686, R01AI084794, R01AI066924] Funding Source: NIH RePORTER	US Military Research and Material Command; US Military HIV Research Program; Ragon Institute of MGH, MIT and Harvard; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Pensiero, A. Fauci, E. Borducchi, S. Clark, R. Hamel, S. King, P. Kozlowski, A. La Porte, G. Landucci, A. Oza, J. Perry, L. Peter, A. Riggs, G. Shaw, N. Simmons, K. Smith, K. Stanley, F. Stephens, Y.-H. Sun, G. Weverling and E. Zablowsky for advice, assistance and reagents. We thank L. Picker, G. Silvestri and B. Walker for critically reviewing this manuscript. The SIV<INF>MAC239</INF> peptide pools were obtained from the NIH AIDS Research and Reference Reagent Program. We acknowledge support from the US Military Research and Material Command and the US Military HIV Research Program (W81XWH-07-2-0067); the Ragon Institute of MGH, MIT and Harvard; the National Institutes of Health (AI066924, AI078526, AI084794, AI095985, AI060354, AI002642, RR000168); and the Bill and Melinda Gates Foundation. The opinions in this manuscript are those of the authors and do not reflect the views of the US Department of Defense.	Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; Barnett SW, 2010, J VIROL, V84, P5975, DOI 10.1128/JVI.02533-09; Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Ferrari G, 2011, J VIROL, V85, P7029, DOI 10.1128/JVI.00171-11; Forthal DN, 2001, J VIROL, V75, P6953, DOI 10.1128/JVI.75.15.6953-6961.2001; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Haynes B, 2011, AIDS VACC C 2011; Hudgens MG, 2009, BIOMETRICS, V65, P1223, DOI 10.1111/j.1541-0420.2009.01189.x; Hudgens MG, 2009, J INFECT DIS, V200, P609, DOI 10.1086/600891; Keele BF, 2009, J EXP MED, V206, P1117, DOI 10.1084/jem.20082831; Lai LL, 2011, J INFECT DIS, V204, P164, DOI 10.1093/infdis/jir199; Letvin NL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002351; Lim SY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000738; Liu JY, 2008, J VIROL, V82, P4844, DOI 10.1128/JVI.02616-07; Liu JY, 2010, J VIROL, V84, P10406, DOI 10.1128/JVI.01155-10; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07; Montefiori D. C, 2004, CURR PROTOC IMMUNOL, V12, P11; Mothe BR, 2003, J VIROL, V77, P2736, DOI 10.1128/JVI.77.4.2736-2740.2003; Nkolola JP, 2010, J VIROL, V84, P3270, DOI 10.1128/JVI.02252-09; Okoye A, 2007, J EXP MED, V204, P2171, DOI 10.1084/jem.20070567; Ourmanov I, 2000, J VIROL, V74, P2740, DOI 10.1128/JVI.74.6.2740-2751.2000; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Vogels R, 2003, J VIROL, V77, P8263, DOI 10.1128/JVI.77.15.8263-8271.2003; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wilson NA, 2006, J VIROL, V80, P5875, DOI 10.1128/JVI.00171-06; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yant LJ, 2006, J VIROL, V80, P5074, DOI 10.1128/JVI.80.10.5074-5077.2006	30	385	397	5	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 2	2012	482	7383					89	U115		10.1038/nature10766	http://dx.doi.org/10.1038/nature10766			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884RN	22217938	Green Submitted, Green Accepted			2022-12-28	WOS:000299726000041
J	Contreras, FX; Ernst, AM; Haberkant, P; Bjorkholm, P; Lindahl, E; Gonen, B; Tischer, C; Elofsson, A; von Heijne, G; Thiele, C; Pepperkok, R; Wieland, F; Brugger, B				Contreras, F. -Xabier; Ernst, Andreas M.; Haberkant, Per; Bjoerkholm, Patrik; Lindahl, Erik; Goenen, Basak; Tischer, Christian; Elofsson, Arne; von Heijne, Gunnar; Thiele, Christoph; Pepperkok, Rainer; Wieland, Felix; Bruegger, Britta			Molecular recognition of a single sphingolipid species by a protein's transmembrane domain	NATURE			English	Article							TO-GOLGI TRANSPORT; GXXXG MOTIF; SPHINGOMYELIN; CHOLESTEROL; REVEALS; SYSTEM	Functioning and processing of membrane proteins critically depend on the way their transmembrane segments are embedded in the membrane(1). Sphingolipids are structural components of membranes and can also act as intracellular second messengers. Not much is known of sphingolipids binding to transmembrane domains (TMDs) of proteins within the hydrophobic bilayer, and how this could affect protein function. Here we show a direct and highly specific interaction of exclusively one sphingomyelin species, SM 18, with the TMD of the COPI machinery protein p24 (ref. 2). Strikingly, the interaction depends on both the head-group and the backbone of the sphingolipid, and on a signature sequence (VXXTLXXIY) within the TMD. Molecular dynamics simulations show a close interaction of SM 18 with the TMD. We suggest a role of SM 18 in regulating the equilibrium between an inactive monomeric and an active oligomeric state of the p24 protein(3,4), which in turn regulates COPI-dependent transport. Bioinformatic analyses predict that the signature sequence represents a conserved sphingolipid-binding cavity in a variety of mammalian membrane proteins. Thus, in addition to a function as second messengers, sphingolipids can act as cofactors to regulate the function of transmembrane proteins. Our discovery of an unprecedented specificity of interaction of a TMD with an individual sphingolipid species adds to our understanding of why biological membranes are assembled from such a large variety of different lipids.	[Contreras, F. -Xabier; Ernst, Andreas M.; Haberkant, Per; Goenen, Basak; Wieland, Felix; Bruegger, Britta] Heidelberg Univ, Biochem Ctr, D-69120 Heidelberg, Germany; [Bjoerkholm, Patrik; Lindahl, Erik; Elofsson, Arne; von Heijne, Gunnar] Stockholm Univ, Ctr Biomembrane Res, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden; [Bjoerkholm, Patrik; Elofsson, Arne; von Heijne, Gunnar] Stockholm Univ, Stockholm Bioinformat Ctr, Sci Life Lab, SE-17121 Solna, Sweden; [Lindahl, Erik] AlbaNova Univ Ctr, Royal Inst Technol, SE-10691 Stockholm, Sweden; [Tischer, Christian; Pepperkok, Rainer] EMBL, ALMF, D-69117 Heidelberg, Germany; [Thiele, Christoph] LIMES Life & Med Sci Inst, D-53115 Bonn, Germany	Ruprecht Karls University Heidelberg; Stockholm University; Stockholm University; Royal Institute of Technology; European Molecular Biology Laboratory (EMBL); University of Bonn	Brugger, B (corresponding author), Heidelberg Univ, Biochem Ctr, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	britta.bruegger@bzh.uni-heidelberg.de	Lindahl, Erik/D-4590-2013; von Heijne, Gunnar/AAH-9389-2019; Contreras, Xabier/AAA-8885-2019; von Heijne, Gunnar/F-5576-2011; Ernst, Andreas/ABA-7601-2020	Lindahl, Erik/0000-0002-2734-2794; von Heijne, Gunnar/0000-0002-4490-8569; Ernst, Andreas/0000-0001-7359-7184; Haberkant, Per/0000-0002-5608-9062; Elofsson, Arne/0000-0002-7115-9751; Contreras, Xabier/0000-0003-0875-634X; Pepperkok, Rainer/0000-0002-9762-3583; Bjorkholm, Patrik/0000-0002-9131-4122	German research foundation (DFG) [TRR83]; ERC [209825, AdG232648]; FEBS; Peter and Traudl Engelhorn foundation	German research foundation (DFG)(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission); FEBS; Peter and Traudl Engelhorn foundation	The authors would like to thank T. Sachsenheimer for technical assistance, A. Brodde for help with lipid synthesis, D. Cassel for comments on the manuscript, and the members of the Wieland laboratory for discussion. This work was supported by a grant of the German research foundation (DFG, TRR83) to B. B. and F. W. and by ERC grants to E. L. (209825) and G. v. H. (AdG232648); F.-X. C. was supported by a FEBS fellowship and A. M. E. by the Peter and Traudl Engelhorn foundation.	Bakrac B, 2010, J BIOL CHEM, V285, P22186, DOI 10.1074/jbc.M110.105122; Beck R, 2009, FEBS LETT, V583, P3541, DOI 10.1016/j.febslet.2009.10.027; Beck R, 2009, FEBS LETT, V583, P2701, DOI 10.1016/j.febslet.2009.07.032; Bethune J, 2006, MOL CELL BIOL, V26, P8011, DOI 10.1128/MCB.01055-06; Brugger B, 2000, J CELL BIOL, V151, P507, DOI 10.1083/jcb.151.3.507; Contreras FX, 2005, BIOPHYS J, V88, P348, DOI 10.1529/biophysj.104.050690; Coskun U, 2011, STRUCTURE, V19, P1543, DOI 10.1016/j.str.2011.10.010; Haberkant P, 2008, J LIPID RES, V49, P251, DOI 10.1194/jlr.D700023-JLR200; Jackson ME, 1999, J CELL SCI, V112, P467; JONES DT, 1994, FEBS LETT, V339, P269, DOI 10.1016/0014-5793(94)80429-X; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Kuerschner L, 2005, NAT METHODS, V2, P39, DOI 10.1038/NMETH728; Li XM, 2000, BIOPHYS J, V78, P1921, DOI 10.1016/S0006-3495(00)76740-3; Niemela P, 2004, BIOPHYS J, V87, P2976, DOI 10.1529/biophysj.104.048702; Niemela PS, 2006, BIOPHYS J, V90, P851, DOI 10.1529/biophysj.105.067371; Popoff V, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005231; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Reinhard C, 1999, P NATL ACAD SCI USA, V96, P1224, DOI 10.1073/pnas.96.4.1224; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Scales SJ, 1997, CELL, V90, P1137, DOI 10.1016/S0092-8674(00)80379-7; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Simpson JC, 2007, J BIOTECHNOL, V129, P352, DOI 10.1016/j.jbiotec.2006.12.027; Thiele C, 2000, NAT CELL BIOL, V2, P42, DOI 10.1038/71366	23	253	254	0	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2012	481	7382					525	529		10.1038/nature10742	http://dx.doi.org/10.1038/nature10742			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881GY	22230960	Green Submitted			2022-12-28	WOS:000299471800044
J	Zhang, DS; Piazza, V; Perrin, BJ; Rzadzinska, AK; Poczatek, JC; Wang, M; Prosser, HM; Ervasti, JM; Corey, DP; Lechene, CP				Zhang, Duan-Sun; Piazza, Valeria; Perrin, Benjamin J.; Rzadzinska, Agnieszka K.; Poczatek, J. Collin; Wang, Mei; Prosser, Haydn M.; Ervasti, James M.; Corey, David P.; Lechene, Claude P.			Multi-isotope imaging mass spectrometry reveals slow protein turnover in hair-cell stereocilia	NATURE			English	Article							MOLECULAR TREADMILL; BUNDLES; RENEWAL	Hair cells of the inner ear are not normally replaced during an animal's life, and must continually renew components of their various organelles(1). Among these are the stereocilia, each with a core of several hundred actin filaments that arise from their apical surfaces and that bear the mechanotransduction apparatus at their tips. Actin turnover in stereocilia has previously been studied(2) by transfecting neonatal rat hair cells in culture with a beta-actin-GFP fusion, and evidence was found that actin is replaced, from the top down, in 2-3 days. Overexpression of the actin-binding protein espin causes elongation of stereocilia within 12-24 hours, also suggesting rapid regulation of stereocilia lengths(3). Similarly, the mechanosensory 'tip links' are replaced in 5-10 hours after cleavage in chicken and mammalian hair cells(4,5). In contrast, turnover in chick stereocilia in vivo is much slower(6). It might be that only certain components of stereocilia turn over quickly, that rapid turnover occurs only in neonatal animals, only in culture, or only in response to a challenge like breakage or actin overexpression. Here we quantify protein turnover by feeding animals with a (15)N-labelled precursor amino acid and using multi-isotope imaging mass spectrometry to measure appearance of new protein. Surprisingly, in adult frogs and mice and in neonatal mice, in vivo and in vitro, the stereocilia were remarkably stable, incorporating newly synthesized protein at <10% per day. Only stereocilia tips had rapid turnover and no treadmilling was observed. Other methods confirmed this: in hair cells expressing beta-actin-GFP we bleached fiducial lines across hair bundles, but they did not move in 6 days. When we stopped expression of beta- or gamma-actin with tamoxifen-inducible recombination, neither actin isoform left the stereocilia, except at the tips. Thus, rapid turnover in stereocilia occurs only at the tips and not by a treadmilling process.	[Poczatek, J. Collin; Wang, Mei; Lechene, Claude P.] Brigham & Womens Hosp, Div Genet, Cambridge, MA 02139 USA; [Zhang, Duan-Sun; Piazza, Valeria; Corey, David P.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Perrin, Benjamin J.; Ervasti, James M.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Rzadzinska, Agnieszka K.; Prosser, Haydn M.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Minnesota System; University of Minnesota Twin Cities; Wellcome Trust Sanger Institute	Lechene, CP (corresponding author), Brigham & Womens Hosp, Div Genet, Cambridge, MA 02139 USA.	dcorey@hms.harvard.edu; cpl@harvard.edu	Ervasti, James/AAZ-4786-2020	Prosser, Haydn/0000-0002-9897-2152; Corey, David/0000-0003-4497-6016	National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering (NIH/NIBIB) [P41RR14579, P41EB001974]; NIH [R01DC00033, R01DC03463, R01DC04179, R37DK39773, R01EY12963, R01GM47214, R01D K58762, R01DC02281, F32DC009539, R01AR049899]; National Science Foundation Division of Integrative Biology and Neuroscience (NSF/IBN) [IBN-998298]; Wellcome Trust [WT079643]; NIH National Center for Research Resources (NIH/NCRR) Center for Integrative Biomedical Computing [2P41 RR0112553-12]; Department of Energy SciDAC Visualization and Analytics Center for Enabling Technologies [DEFC0206ER25781]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014579] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049899, R01AR042423] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058762, R37DK039773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004179, F32DC009539, R01DC000033, R01DC002281, Z01DC000033] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering (NIH/NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Division of Integrative Biology and Neuroscience (NSF/IBN); Wellcome Trust(Wellcome TrustEuropean Commission); NIH National Center for Research Resources (NIH/NCRR) Center for Integrative Biomedical Computing; Department of Energy SciDAC Visualization and Analytics Center for Enabling Technologies(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	C.P.L. thanks M. Raff for numerous discussions; T. Bloom for her insight, foresight and support at the origin of MIMS development. We thank D. Cotanche and G. Benichou for providing additional mouse cochlear samples, L. Trakimas for histological assistance, Z. Kaufman for assisting data analysis, and J. Hill for electronic and mechanical maintenance of the prototype instrument. G. McMahon contributed to operating the instrument and data analysis. This work was supported by National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering (NIH/NIBIB) grants P41RR14579, P41EB001974, NIH grants R01DC00033, R01DC03463, R01DC04179, R37DK39773, R01EY12963, R01GM47214 and R01D K58762, and National Science Foundation Division of Integrative Biology and Neuroscience (NSF/IBN) grant IBN-998298 to C. P. L., by NIH grant R01DC02281 to D. P. C., and by NIH grants F32DC009539 to B. J. P. and R01AR049899 to J. M. E., and by Wellcome Trust grant WT079643 to the Wellcome Trust Sanger Institute. Development of the SIMS instrument was supported by ONERA, CNRS, Universite Paris Sud and Cameca (France). The work was also helped in part by software funded by the NIH National Center for Research Resources (NIH/NCRR) Center for Integrative Biomedical Computing, 2P41 RR0112553-12 and the Department of Energy SciDAC Visualization and Analytics Center for Enabling Technologies, DEFC0206ER25781. D.-S.Z. is a Research Associate, V. P. was a Research Associate and D. P. C. is an Investigator of the Howard Hughes Medical Institute.	Grati M, 2006, J NEUROSCI, V26, P6386, DOI 10.1523/JNEUROSCI.1215-06.2006; Hanft LM, 2006, P NATL ACAD SCI USA, V103, P5385, DOI 10.1073/pnas.0600980103; Holt JR, 2002, CELL, V108, P371, DOI 10.1016/S0092-8674(02)00629-3; Jia SP, 2009, J NEUROSCI, V29, P15277, DOI 10.1523/JNEUROSCI.3231-09.2009; Kirkegaard M, 2005, J COMP NEUROL, V492, P132, DOI 10.1002/cne.20736; Lechene Claude, 2006, J Biol, V5, P20, DOI 10.1186/jbiol42; Lechene CP, 2007, SCIENCE, V317, P1563, DOI 10.1126/science.1145557; Perrin BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001158; Pickles JO, 1996, HEARING RES, V101, P45, DOI 10.1016/S0378-5955(96)00129-3; Prosser HM, 2008, MOL CELL BIOL, V28, P1702, DOI 10.1128/MCB.01282-07; Rzadzinska A, 2005, CELL MOTIL CYTOSKEL, V62, P157, DOI 10.1002/cm.20094; Rzadzinska AK, 2004, J CELL BIOL, V164, P887, DOI 10.1083/jcb.200310055; Schneider ME, 2002, NATURE, V418, P837, DOI 10.1038/418837a; Schoenheimer R., 1942, DYNAMIC STATE BODY C; SHEPHERD GMG, 1989, P NATL ACAD SCI USA, V86, P4973, DOI 10.1073/pnas.86.13.4973; Shin JB, 2007, NEURON, V53, P371, DOI 10.1016/j.neuron.2006.12.021; Zhao YD, 1996, P NATL ACAD SCI USA, V93, P15469, DOI 10.1073/pnas.93.26.15469	17	156	156	1	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 26	2012	481	7382					520	U137		10.1038/nature10745	http://dx.doi.org/10.1038/nature10745			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881GY	22246323	Green Accepted			2022-12-28	WOS:000299471800043
J	Lichtenthaler, SF				Lichtenthaler, Stefan F.			Sheddase Gets Guidance	SCIENCE			English	Editorial Material							NECROSIS-FACTOR-ALPHA; METALLOPROTEINASE; DISINTEGRIN; PROTEOLYSIS; PROTEIN; CELLS; ER		[Lichtenthaler, Stefan F.] DZNE German Ctr Neurodegenerat Dis Munich, D-80336 Munich, Germany; [Lichtenthaler, Stefan F.] Univ Munich, Butenandt Inst, D-80336 Munich, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich	Lichtenthaler, SF (corresponding author), DZNE German Ctr Neurodegenerat Dis Munich, D-80336 Munich, Germany.	stefan.lichtenthaler@dzne.lmu.de	Lichtenthaler, Stefan F/B-6587-2016	Lichtenthaler, Stefan F/0000-0003-2211-2575				Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Freeman M, 2009, SEMIN CELL DEV BIOL, V20, P231, DOI 10.1016/j.semcdb.2008.10.006; Greenblatt EJ, 2011, NAT STRUCT MOL BIOL, V18, P1147, DOI 10.1038/nsmb.2111; Hayashida K, 2010, ANAT REC, V293, P925, DOI 10.1002/ar.20757; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Lichtenthaler SF, 2011, J NEUROCHEM, V117, P779, DOI 10.1111/j.1471-4159.2011.07248.x; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Zettl M, 2011, CELL, V145, P79, DOI 10.1016/j.cell.2011.02.047	14	8	8	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 13	2012	335	6065					179	180		10.1126/science.1216815	http://dx.doi.org/10.1126/science.1216815			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875LZ	22246765				2022-12-28	WOS:000299033100041
J	Ewing, CM; Ray, AM; Lange, EM; Zuhlke, KA; Robbins, CM; Tembe, WD; Wiley, KE; Isaacs, SD; Johng, D; Wang, YF; Bizon, C; Yan, GF; Gielzak, M; Partin, AW; Shanmugam, V; Izatt, T; Sinari, S; Craig, DW; Zheng, SL; Walsh, PC; Montie, JE; Xu, JF; Carpten, JD; Isaacs, WB; Cooney, KA				Ewing, Charles M.; Ray, Anna M.; Lange, Ethan M.; Zuhlke, Kimberly A.; Robbins, Christiane M.; Tembe, Waibhav D.; Wiley, Kathleen E.; Isaacs, Sarah D.; Johng, Dorhyun; Wang, Yunfei; Bizon, Chris; Yan, Guifang; Gielzak, Marta; Partin, Alan W.; Shanmugam, Vijayalakshmi; Izatt, Tyler; Sinari, Shripad; Craig, David W.; Zheng, S. Lilly; Walsh, Patrick C.; Montie, James E.; Xu, Jianfeng; Carpten, John D.; Isaacs, William B.; Cooney, Kathleen A.			Germline Mutations in HOXB13 and Prostate-Cancer Risk	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY GENES; LINKAGE SCAN; VARIANTS; FAMILIES; GENETICS; BRCA1; CHROMOSOME-17; LOCI	BACKGROUND Family history is a significant risk factor for prostate cancer, although the molecular basis for this association is poorly understood. Linkage studies have implicated chromosome 17q21-22 as a possible location of a prostate-cancer susceptibility gene. METHODS We screened more than 200 genes in the 17q21-22 region by sequencing germline DNA from 94 unrelated patients with prostate cancer from families selected for linkage to the candidate region. We tested family members, additional case subjects, and control subjects to characterize the frequency of the identified mutations. RESULTS Probands from four families were discovered to have a rare but recurrent mutation (G84E) in HOXB13 (rs138213197), a homeobox transcription factor gene that is important in prostate development. All 18 men with prostate cancer and available DNA in these four families carried the mutation. The carrier rate of the G84E mutation was increased by a factor of approximately 20 in 5083 unrelated subjects of European descent who had prostate cancer, with the mutation found in 72 subjects (1.4%), as compared with 1 in 1401 control subjects (0.1%) (P = 8.5x10(-7)). The mutation was significantly more common in men with early-onset, familial prostate cancer (3.1%) than in those with late-onset, nonfamilial prostate cancer (0.6%) (P = 2.0x10(-6)). CONCLUSIONS The novel HOXB13 G84E variant is associated with a significantly increased risk of hereditary prostate cancer. Although the variant accounts for a small fraction of all prostate cancers, this finding has implications for prostate-cancer risk assessment and may provide new mechanistic insights into this common cancer. (Funded by the National Institutes of Health and others.)	[Ray, Anna M.; Zuhlke, Kimberly A.; Montie, James E.; Cooney, Kathleen A.] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Ray, Anna M.; Zuhlke, Kimberly A.; Montie, James E.; Cooney, Kathleen A.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Ewing, Charles M.; Wiley, Kathleen E.; Isaacs, Sarah D.; Johng, Dorhyun; Yan, Guifang; Gielzak, Marta; Partin, Alan W.; Walsh, Patrick C.; Isaacs, William B.] Johns Hopkins Univ, Baltimore, MD USA; [Ewing, Charles M.; Wiley, Kathleen E.; Isaacs, Sarah D.; Johng, Dorhyun; Yan, Guifang; Gielzak, Marta; Partin, Alan W.; Walsh, Patrick C.; Isaacs, William B.] James Buchanan Brady Urol Inst, Baltimore, MD USA; [Lange, Ethan M.; Wang, Yunfei] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Bizon, Chris] Renaissance Comp Inst, Chapel Hill, NC USA; [Robbins, Christiane M.; Tembe, Waibhav D.; Shanmugam, Vijayalakshmi; Izatt, Tyler; Sinari, Shripad; Craig, David W.; Carpten, John D.] Translat Genom Res Inst, Phoenix, AZ USA; [Zheng, S. Lilly; Xu, Jianfeng] Wake Forest Univ, Bowman Gray Sch Med, Ctr Canc Genom, Winston Salem, NC USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; Translational Genomics Research Institute; Wake Forest University; Wake Forest Baptist Medical Center	Cooney, KA (corresponding author), Univ Michigan Hlth Syst, Dept Internal Med, 7216 CC,SPC 5948,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	kcooney@med.umich.edu	Craig, David Wesley/K-6961-2019	Craig, David Wesley/0000-0003-2040-1955; Zuhlke, Kimberly/0000-0001-6941-5376; Cooney, Kathleen/0000-0003-3831-6943	National Institutes of Health [R01-CA79596, R01-CA079596-10-S1, R01-CA136621, P50-CA69568, U01-CA89600, U01-CA86323]; NATIONAL CANCER INSTITUTE [P50CA069568, U01CA089600, R01CA079596, U01CA086323, R01CA136621] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants (R01-CA79596, R01-CA079596-10-S1, R01-CA136621, P50-CA69568, U01-CA89600, and U01-CA86323) from the National Institutes of Health; by William Gerrard, Mario Duhon, John and Jennifer Chalsty, and P. Kevin Jaffe; and by the Patrick C. Walsh Cancer Research Fund (to Dr. Isaacs).	1000 Genomes, 1000 GEN DEEP CAT HU; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; [Anonymous], EX VAR SERV; Economides KD, 2003, DEVELOPMENT, V130, P2061, DOI 10.1242/dev.00432; Economides KD, 2003, DEV BIOL, V256, P317, DOI 10.1016/S0012-1606(02)00137-9; Edwards S, 2005, BRIT J CANCER, V92, P376, DOI 10.1038/sj.bjc.6602261; Fukasawa S, 2008, PROSTATE CANCER P D, V11, P303, DOI 10.1038/sj.pcan.4501017; Gillanders EM, 2004, JNCI-J NATL CANCER I, V96, P1240, DOI 10.1093/jnci/djh228; Goodman FR, 2001, CLIN GENET, V59, P1, DOI 10.1034/j.1399-0004.2001.590101.x; GRAHAM A, 1994, CURR BIOL, V4, P1135, DOI 10.1016/S0960-9822(00)00256-6; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Haiman CA, 2011, NAT GENET, V43, P570, DOI 10.1038/ng.839; Jung C, 2004, CANCER RES, V64, P9185, DOI 10.1158/0008-5472.CAN-04-1330; Kim JH, 2007, CANCER RES, V67, P8229, DOI 10.1158/0008-5472.CAN-07-1297; Kim ST, 2010, PROSTATE, V70, P1729, DOI 10.1002/pros.21208; Kote-Jarai Z, 2011, NAT GENET, V43, P785, DOI 10.1038/ng.882; Lange EM, 2003, PROSTATE, V57, P326, DOI 10.1002/pros.10307; Lange EM, 2011, PROSTATE        0502; Lange EM, 2007, HUM GENET, V121, P49, DOI 10.1007/s00439-006-0274-2; Lange EM, 2009, PROSTATE, V69, P385, DOI 10.1002/pros.20891; Langeberg WJ, 2007, FRONT BIOSCI-LANDMRK, V12, P4101, DOI 10.2741/2374; Liu WN, 2008, NEOPLASIA, V10, P897, DOI 10.1593/neo.08428; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Norris JD, 2009, MOL CELL, V36, P405, DOI 10.1016/j.molcel.2009.10.020; Ostrander EA, 2008, CANCER EPIDEM BIOMAR, V17, P1843, DOI 10.1158/1055-9965.EPI-08-0556; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Schehl Sinclair Colleen, 2000, Cancer Research, V60, P1371; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Thompson D, 2002, JNCI-J NATL CANCER I, V94, P1358, DOI 10.1093/jnci/94.18.1358; Thorsteinsdottir U, 2001, MOL CELL BIOL, V21, P224, DOI 10.1128/MCB.21.1.224-234.2001; Williams TM, 2005, DEV BIOL, V277, P457, DOI 10.1016/j.ydbio.2004.10.004; Xu JF, 2002, NAT GENET, V32, P321, DOI 10.1038/ng994; Xu JF, 2005, AM J HUM GENET, V77, P219, DOI 10.1086/432377; Zheng SL, 2007, JNCI-J NATL CANCER I, V99, P1525, DOI 10.1093/jnci/djm169; Zuhlke KA, 2004, CLIN CANCER RES, V10, P5975, DOI 10.1158/1078-0432.CCR-04-0554	35	428	446	1	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 12	2012	366	2					141	149		10.1056/NEJMoa1110000	http://dx.doi.org/10.1056/NEJMoa1110000			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874VA	22236224	Green Accepted			2022-12-28	WOS:000298985000008
J	Strang, J; Babor, T; Caulkins, J; Fischer, B; Foxcroft, D; Humphreys, K				Strang, John; Babor, Thomas; Caulkins, Jonathan; Fischer, Benedikt; Foxcroft, David; Humphreys, Keith			Drug policy and the public good: evidence for effective interventions	LANCET			English	Article							BRIEF MOTIVATIONAL INTERVENTION; PREVENTING HEPATITIS-C; SELF-HELP GROUPS; THERAPEUTIC-COMMUNITY; COST-EFFECTIVENESS; CONTINGENCY MANAGEMENT; METHADONE-MAINTENANCE; GENERAL-PRACTITIONERS; PRESCRIPTION DRUGS; RANDOMIZED-TRIAL	Debates about which policy initiatives can prevent or reduce the damage that illicit drugs cause to the public good are rarely informed by scientific evidence. Fortunately, evidence-based interventions are increasingly being identified that are capable of making drugs less available, reducing violence in drug markets, lessening misuse of legal pharmaceuticals, preventing drug use initiation in young people, and reducing drug use and its consequences in established drug users. We review relevant evidence and outline the likely effects of fuller implementation of existing interventions. The reasoning behind the final decisions for action might be of a non-scientific nature, focused more on what the public and policy-makers deem of value. Nevertheless, important opportunities exist for science to inform these deliberations and guide the selection of policies that maximise the public good.	[Strang, John] Kings Coll London, Natl Addict Ctr, London WC2R 2LS, England; [Babor, Thomas] Univ Connecticut, Sch Med, Dept Community Med & Hlth Care, Farmington, CT USA; [Caulkins, Jonathan] Carnegie Mellon Univ, Heinz Coll, Pittsburgh, PA 15213 USA; [Fischer, Benedikt] Simon Fraser Univ, Fac Hlth Sci, CARMHA, Vancouver, BC, Canada; [Fischer, Benedikt] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Foxcroft, David] Oxford Brookes Univ, Oxford OX3 0BP, England; [Humphreys, Keith] Stanford Univ, Dept Vet Affairs, Palo Alto, CA 94304 USA	University of London; King's College London; University of Connecticut; Carnegie Mellon University; Simon Fraser University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Oxford Brookes University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Strang, J (corresponding author), Addict Sci Bldg,4 Windsor Walk,Denmark Hill, London SE5 8BB, England.	john.strang@kcl.ac.uk	Strang, John/H-5460-2011	Strang, John/0000-0002-5413-2725; Babor, Thomas/0000-0002-2580-0835; Foxcroft, David/0000-0001-9752-7527; Fischer, B/0000-0002-2186-4030	Genus (Britannia); Viropharma (Auralis); Martindale (Catalent); Reckitt-Benckiser; Schering-Plough; Lundbeck; UCB; Napp (MundiPharma); Lightlake; Fidelity International; NIHR Biomedical Research Centre for Mental Health at the Institute of Psychiatry, Kings College London; Medical Research Council; UK Society for the Study of Addiction	Genus (Britannia); Viropharma (Auralis); Martindale (Catalent); Reckitt-Benckiser; Schering-Plough(Merck & CompanySchering Plough Corporation); Lundbeck(Lundbeck Corporation); UCB(UCB Pharma SA); Napp (MundiPharma); Lightlake; Fidelity International; NIHR Biomedical Research Centre for Mental Health at the Institute of Psychiatry, Kings College London; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Society for the Study of Addiction	JS declares that he has worked with UK and international government agencies on treatment guidelines, including chairing UK Department of Health and NICE clinical guidelines committees; has contributed to the work of organisations that review evidence of effectiveness of drug policy; has received research and educational grant support or honoraria, consultancy payments, and travelling, accommodation, or conference expenses from pharmaceutical companies who produce, or have been considering producing, new medicines or new formulations for use in the addiction treatment field, including (past 3 years) Genus (Britannia), Viropharma (Auralis), Martindale (Catalent), Reckitt-Benckiser, Schering-Plough, Lundbeck, UCB, Napp (MundiPharma), Lightlake, and Fidelity International; works within an integrated university and NHS academic health sciences centre (Kings Health Partners AHSC) and is supported by the NIHR Biomedical Research Centre for Mental Health at the Institute of Psychiatry, Kings College London and South London and Maudsley NHS Foundation Trust that provides treatments and undertakes research study; and has close links with various other treatment provider organisations. DF's Department has received funding from the alcohol industry for alcohol education and prevention materials that are being assessed in a randomised controlled trial funded by the Medical Research Council and led by Cardiff University. DF is a Trustee of the UK alcohol education charity, the Drinkaware Trust. BF has consulted for government and non-governmental organisations at national and supranational levels with regard to drug policy and related interventions; travel costs and activity honoraria were received for some of these activities. All other authors declare that they have no conflicts of interest.; Views expressed in this paper are the authors' individual personal judgments and are not the official views of any government or other organisation with which the authors have worked or been associated. The paper uses information collected for the publication of a document entitled Drug Policy and the Public Good, 2 which was funded by the UK Society for the Study of Addiction-all authors were involved with this project. We thank John Witton for assistance with the search of published studies. BF holds the CIHR/PHAC Chair In Applied Public Health; KH holds an honorary professorship at King's College London. Tables 2-5 are adapted from the appendices of the book 'Drug Policy and the Public Good' (reference 2). We also wish to thank our co-authors of this book (Griffith Edwards, Isidore Obot, Jurgen Rehm, Peter Reuter, Robin Room, and Ingeborg Rossow) from whose structure and earlier examination we have drawn on in the preparation of this paper.	Amato L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006306; Babor T., 2010, DRUG POLICY PUBLIC G; Babor T.F., 2010, ALCHOL NO ORDINARY C, V2nd, DOI DOI 10.1093/ACPROF:OSO/9780199551149.003.002; Babor Thomas F, 2007, Subst Abus, V28, P7, DOI 10.1300/J465v28n03_03; Baker A, 2005, ADDICTION, V100, P367, DOI 10.1111/j.1360-0443.2005.01002.x; BALE RN, 1980, ARCH GEN PSYCHIAT, V37, P179; BASHIR K, 1994, BRIT J GEN PRACT, V44, P408; Bernstein J, 2005, DRUG ALCOHOL DEPEN, V77, P49, DOI 10.1016/j.drugalcdep.2004.07.006; Berstein JE, 2005, DRUG ALCOHOL DEPEN, V77, P49; Best D, 2001, BRIT J CRIMINOL, V41, P738, DOI 10.1093/bjc/41.4.738; Braga AA, 2001, J RES CRIME DELINQ, V38, P195, DOI 10.1177/0022427801038003001; BRILL H, 1969, SEMIN PSYCHIAT, V1, P179; Catalano RF, 1999, ADDICTION, V94, P241, DOI 10.1046/j.1360-0443.1999.9422418.x; Caulkins JP, 2009, SAFER COMMUNITIES, V8, P9, DOI 10.1108/17578043200900003; Caulkins JP, 2010, ADDICTION, V105, P575, DOI 10.1111/j.1360-0443.2009.02844.x; Caulkins JP, 2011, CRIME JUSTICE REV RE, V39; Connock M, 2007, HEALTH TECHNOL ASSES, V11, P1; Conrod PJ, 2010, ARCH GEN PSYCHIAT, V67, P85, DOI 10.1001/archgenpsychiatry.2009.173; CORMACK MA, 1994, BRIT J GEN PRACT, V44, P5; Courtwright DT, 2001, FORCES HABIT DRUGS M; Crane Barry, 1997, EMPIRICAL EXAMINATIO; Cunningham JK, 2009, ADDICTION, V104, P441, DOI 10.1111/j.1360-0443.2008.02458.x; Cunningham JK, 2005, ADDICTION, V100, P479, DOI 10.1111/j.1360-0443.2005.01032.x; Cunningham JK, 2003, ADDICTION, V98, P1229, DOI 10.1046/j.1360-0443.2003.00450.x; Dave D, 2006, J HEALTH ECON, V25, P311, DOI 10.1016/j.jhealeco.2005.08.003; Davis WR, 2008, DRUG ALCOHOL DEPEN, V92, P267, DOI 10.1016/j.drugalcdep.2007.08.008; Davoli M, 2007, ADDICTION, V102, P1954, DOI 10.1111/j.1360-0443.2007.02025.x; Day C, 2006, DRUG ALCOHOL REV, V25, P307, DOI 10.1080/09595230600741040; De Leon G, 2000, J SUBST ABUSE TREAT, V19, P375, DOI 10.1016/S0740-5472(00)00124-0; Degenhardt L, 2005, ADDICTION, V100, P459, DOI 10.1111/j.1360-0443.2005.01000.x; Degenhardt L, 2012, LANCET, V379, P55, DOI 10.1016/S0140-6736(11)61138-0; Dobkin C, 2009, AM ECON REV, V99, P324, DOI 10.1257/aer.99.1.324; DuPont RL, 2009, J SUBST ABUSE TREAT, V36, P159, DOI 10.1016/j.jsat.2008.01.004; Edelen MO, 2007, J SUBST ABUSE TREAT, V32, P415, DOI 10.1016/j.jsat.2006.10.006; Eder H, 2005, ADDICTION, V100, P1101, DOI 10.1111/j.1360-0443.2005.001128.x; Eibner C, 2006, J SUBST ABUSE TREAT, V31, P75, DOI 10.1016/j.jsat.2006.03.011; ENNETT ST, 1994, AM J PUBLIC HEALTH, V84, P1394, DOI 10.2105/AJPH.84.9.1394; Faggiano F, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003020.pub2; Faggiano F., 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002208; Faggiano F, 2010, DRUG ALCOHOL DEPEN, V108, P56, DOI 10.1016/j.drugalcdep.2009.11.018; Fals-Stewart W, 2001, BEHAV THER, V32, P391, DOI 10.1016/S0005-7894(01)80010-1; Finney JW, 1998, J STUD ALCOHOL, V59, P371, DOI 10.15288/jsa.1998.59.371; Fischer B, 2008, CONTEMP DRUG PROBL, V35, P397; Fischer B, 2006, CANADIAN MED ASS J, V175, P1; Fischer B, 2007, J URBAN HEALTH, V84, P552, DOI 10.1007/s11524-007-9198-y; Fischer B, 2010, ADDICTION, V105, P2062, DOI 10.1111/j.1360-0443.2010.03092.x; Fountain J, 1999, DRUG-EDUC PREV POLIC, V6, P61, DOI 10.1080/09687639997296; Foxcroft D, 2007, ADDICTION, V102, P1350, DOI 10.1111/j.1360-0443.2007.01933.x; Frieden TR, 2010, AM J PUBLIC HEALTH, V100, P590, DOI 10.2105/AJPH.2009.185652; Gates S, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD005030.PUB2; Gossop M, 2008, ADDICTION, V103, P119, DOI 10.1111/j.1360-0443.2007.02050.x; Grabowski J, 2004, ADDICT BEHAV, V29, P1439, DOI 10.1016/j.addbeh.2004.06.018; Gray E, 2005, ALCOHOL ALCOHOLISM, V40, P535, DOI 10.1093/alcalc/agh199; Greenwood GL, 2001, J SUBST ABUSE TREAT, V20, P15, DOI 10.1016/S0740-5472(00)00147-1; Hall W, 2000, DRUG ALCOHOL DEPEN, V57, P247, DOI 10.1016/S0376-8716(99)00057-5; Humeniuk R, ADDICTION IN PRESS; Humeniuk R., 2008, EFFECTIVENESS BRIEF; Humphreys K, 2001, ALCOHOL CLIN EXP RES, V25, P711; Humphreys K, 2004, CIRCLES RECOVERY SEL; Inciardi JA, 2007, PAIN MED, V8, P171, DOI 10.1111/j.1526-4637.2006.00255.x; Kellam SG, 2008, DRUG ALCOHOL DEPEN, V95, pS1, DOI 10.1016/j.drugalcdep.2008.01.006; Kennedy DM, 2008, DETERRENCE CRIME PRE; Kleiman MAR, 2009, BRUTE FORCE FAILS ST; Kraft MK, 1997, AM J PSYCHIAT, V154, P1214; Kuziemko Y, 2004, J PUBLIC ECON, V88, P2043, DOI 10.1016/S0047-2727(03)00020-3; Littlejohn C, 2005, DRUG-EDUC PREV POLIC, V12, P75, DOI 10.1080/0968763042000275326; Lussier JP, 2006, ADDICTION, V101, P192, DOI 10.1111/j.1360-0443.2006.01311.x; Maher L, 2001, CURRENT ISSUES CRIMI, V13, P5, DOI DOI 10.1080/10345329.2001.12036213; Marsden J, 2006, ADDICTION, V101, P1014, DOI 10.1111/j.1360-0443.2006.01290.x; Martell BA, 2009, ARCH GEN PSYCHIAT, V66, P1116, DOI 10.1001/archgenpsychiatry.2009.128; Mattick RP, 2009, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD002209; McCabe SE, 2005, ADDICT BEHAV, V30, P1342, DOI 10.1016/j.addbeh.2005.01.012; McCambridge J, 2005, ADDICTION, V100, P470, DOI 10.1111/j.1360-0443.2005.01013.x; McCambridge J, 2004, ADDICTION, V99, P39, DOI 10.1111/j.1360-0443.2004.00564.x; McCambridge J, 2011, DRUG ALCOHOL DEPEN, V114, P177, DOI 10.1016/j.drugalcdep.2010.07.028; Miles JNV, 2008, AM J DRUG ALCOHOL AB, V34, P667, DOI 10.1080/00952990802308130; Minozzi S, 2011, COCHRANE DB SYST REV, V16, DOI DOI 10.1002/14651858.CD001333.PUB3; Nagin DS, 1998, HDB CRIME PUNISHMENT; National Institute for Health and Clinical Excellence (NICE), 2007, NALTR PREV REL HER A; Nemes S, 1999, J SUBST ABUSE TREAT, V17, P339, DOI 10.1016/S0740-5472(99)00009-4; NICE, 2017, DRUGS MIS TARG INT N; O'Leary-Barrett M, 2010, J AM ACAD CHILD PSY, V49, P954, DOI 10.1016/j.jaac.2010.04.011; Pacula RL, 2005, ADV HEALTH ECON HEAL, V16, P347; Palmateer N, 2010, ADDICTION, V105, P844, DOI 10.1111/j.1360-0443.2009.02888.x; Paoli L., 2009, WORLD HEROIN MARKET, DOI DOI 10.1192/bjp.bp.114.149195; Paulozzi LJ, 2006, PHARMACOEPIDEM DR S, V15, P618, DOI 10.1002/pds.1276; Pollack HA, 2001, MED DECIS MAKING, V21, P357, DOI 10.1177/02729890122062659; Popova S, 2006, CONTEMP DRUG PROBL, V33, P343; Prendergast M, 2006, ADDICTION, V101, P1546, DOI 10.1111/j.1360-0443.2006.01581.x; REIDENBERG MM, 1991, CLIN PHARMACOL THER, V50, P129, DOI 10.1038/clpt.1991.116; Reuter P, 1986, CRIME JUSTICE ANN RE; Robertson JR, 2006, ADDICTION, V101, P1752, DOI 10.1111/j.1360-0443.2006.01603.x; Room R., 2010, CANNABIS POLICY MOVI; Room R, 2012, LANCET, V379, P84, DOI 10.1016/S0140-6736(11)61423-2; Rydell CP, 1994, CONTROLLING COCAINE; SCHWARTZ HI, 1991, NEW YORK STATE J MED, V91, pS9; Seal KH, 2003, DRUG ALCOHOL DEPEN, V71, P127, DOI 10.1016/S0376-8716(03)00074-7; SEVIGNY EL, 2004, CRIMINOLOGY PUBLIC P, V0003; Sorensen JL, 2007, DRUG ALCOHOL DEPEN, V88, P54, DOI 10.1016/j.drugalcdep.2006.09.019; Stitzer M, 2006, ANNU REV CLIN PSYCHO, V2, P411, DOI 10.1146/annurev.clinpsy.2.022305.095219; Strang J, 2008, ADDICTION, V103, P1648, DOI 10.1111/j.1360-0443.2008.02314.x; Strang J, 2008, DRUG-EDUC PREV POLIC, V15, P211, DOI 10.1080/09687630701731205; Strang J, 2007, ADDICTION, V102, P761, DOI 10.1111/j.1360-0443.2007.01762.x; Strang J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4851; Strang J, 2010, LANCET, V375, P1885, DOI 10.1016/S0140-6736(10)60349-2; Timko C, 2006, ADDICTION, V101, P678, DOI 10.1111/j.1360-0443.2006.01391.x; Voas RB, 2011, ADDICTION, V106, P1221, DOI 10.1111/j.1360-0443.2010.03339.x; Wood E, 2006, NEW ENGL J MED, V354, P2512, DOI 10.1056/NEJMc052939	108	137	139	2	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 7	2012	379	9810					71	83		10.1016/S0140-6736(11)61674-7	http://dx.doi.org/10.1016/S0140-6736(11)61674-7			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	873WC	22225672				2022-12-28	WOS:000298913000039
J	Batson, PE				Batson, Philip E.			Plasmonic Modes Revealed	SCIENCE			English	Editorial Material							FAST ELECTRONS; SMALL SPHERES; MICROSCOPY; CLUSTERS; FILMS		Rutgers State Univ, Inst Adv Mat Devices & Nanotechnol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Batson, PE (corresponding author), Rutgers State Univ, Inst Adv Mat Devices & Nanotechnol, Piscataway, NJ 08854 USA.	batson@physics.rutgers.edu	Batson, Philip E/C-3107-2012					Aubry A, 2010, NANO LETT, V10, P2574, DOI 10.1021/nl101235d; BATSON PE, 1982, PHYS REV LETT, V49, P936, DOI 10.1103/PhysRevLett.49.936; BATSON PE, 1985, SURF SCI, V156, P720, DOI 10.1016/0039-6028(85)90242-0; BETZIG E, 1986, BIOPHYS J, V49, P269, DOI 10.1016/S0006-3495(86)83640-2; de Abajo FJG, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/7/073035; Domer H, 2003, APPL SURF SCI, V208, P442, DOI 10.1016/S0169-4332(02)01430-7; INOUYE Y, 1994, OPT LETT, V19, P159, DOI 10.1364/OL.19.000159; Kim JS, 2008, SCIENCE, V321, P1472, DOI 10.1126/science.1161517; Liu N, 2011, NAT MATER, V10, P631, DOI [10.1038/NMAT3029, 10.1038/nmat3029]; MIZUNO K, 1987, NATURE, V328, P45, DOI 10.1038/328045a0; Park ST, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/12/123028; RITCHIE RH, 1957, PHYS REV, V106, P874, DOI 10.1103/PhysRev.106.874; SMITH SJ, 1953, PHYS REV, V92, P1069, DOI 10.1103/PhysRev.92.1069; Yurtsever A, 2012, SCIENCE, V335, P59, DOI 10.1126/science.1213504; Zewail AH, 2010, SCIENCE, V328, P187, DOI 10.1126/science.1166135	15	14	14	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 6	2012	335	6064					47	48		10.1126/science.1215588	http://dx.doi.org/10.1126/science.1215588			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872YA	22223798				2022-12-28	WOS:000298846200044
J	Ferry, DK				Ferry, David K.			Ohm's Law in a Quantum World	SCIENCE			English	Editorial Material							NANOWIRES; NANOELECTRONICS; TRANSPORT; COMPUTER		Arizona State Univ, Sch Elect Comp & Energy Engn, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Ferry, DK (corresponding author), Arizona State Univ, Sch Elect Comp & Energy Engn, Tempe, AZ 85287 USA.	ferry@asu.edu						AHARONOV Y, 1959, PHYS REV, V115, P485, DOI 10.1103/PhysRev.115.485; Ferry DK, 2008, IEEE T ELECTRON DEV, V55, P2820, DOI 10.1109/TED.2008.2005171; Ferry DK, 2008, SCIENCE, V319, P579, DOI 10.1126/science.1154446; Kane BE, 1998, NATURE, V393, P133, DOI 10.1038/30156; LANDAUER R, 1957, IBM J RES DEV, V1, P223, DOI 10.1147/rd.13.0223; O'Brien JL, 2002, SMART MATER STRUCT, V11, P741, DOI 10.1088/0964-1726/11/5/318; Ohm G, 1827, GALVANISCHE KETTE MA, P181; VANWEES BJ, 1988, PHYS REV LETT, V60, P848, DOI 10.1103/PhysRevLett.60.848; Weber B, 2012, SCIENCE, V335, P64, DOI 10.1126/science.1214319; WHARAM DA, 1988, J PHYS C SOLID STATE, V21, pL209, DOI 10.1088/0022-3719/21/8/002; Zhou X, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2236589	11	13	14	2	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 6	2012	335	6064					45	46		10.1126/science.1215900	http://dx.doi.org/10.1126/science.1215900			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872YA	22223796				2022-12-28	WOS:000298846200042
J	Fromme, EK; Zive, D; Schmidt, TA; Olszewski, E; Tolle, SW				Fromme, Erik K.; Zive, Dana; Schmidt, Terri A.; Olszewski, Elizabeth; Tolle, Susan W.			POLST Registry Do-Not-Resuscitate Orders and Other Patient Treatment Preferences	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Fromme, Erik K.; Tolle, Susan W.] Oregon Hlth & Sci Univ, Ctr Eth Hlth Care, Portland, OR 97239 USA; [Zive, Dana; Schmidt, Terri A.; Olszewski, Elizabeth] Oregon Hlth & Sci Univ, Dept Emergency Med, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	Fromme, EK (corresponding author), Oregon Hlth & Sci Univ, Ctr Eth Hlth Care, UHN 86,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	frommee@ohsu.edu			NATIONAL CANCER INSTITUTE [K07CA109511] Funding Source: NIH RePORTER; NCI NIH HHS [K07CA109511] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 1983, DEC FORG LIF SUST TR, P251; Beach MC, 2002, J AM GERIATR SOC, V50, P2057, DOI 10.1046/j.1532-5415.2002.50620.x; Happ MB, 2002, J AM GERIATR SOC, V50, P829, DOI 10.1046/j.1532-5415.2002.50207.x; Hickman SE, 2010, J AM GERIATR SOC, V58, P1241, DOI 10.1111/j.1532-5415.2010.02955.x; McLaughlin M, EXACT CONFIDENCE INT; OHSU Center for Ethics in Health Care, POLST PAR PROGR	6	58	58	1	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 4	2012	307	1					34	35		10.1001/jama.2011.1956	http://dx.doi.org/10.1001/jama.2011.1956			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	872ET	22215159				2022-12-28	WOS:000298792300015
J	Simpson, SA; Shaw, C; McNamara, R				Simpson, Sharon A.; Shaw, Christine; McNamara, Rachel			UNCERTAINTIES PAGE What is the most effective way to maintain weight loss in adults?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LOSS MAINTENANCE; OBESE ADULTS; OVERWEIGHT; METAANALYSIS; EXERCISE; PROGRAM		[Simpson, Sharon A.; McNamara, Rachel] Cardiff Univ, SE Wales Trials Unit, Cardiff CF14 4XN, S Glam, Wales; [Shaw, Christine] Univ Glamorgan, Fac Hlth & Sports Sci, Pontypridd CF37 1DL, M Glam, Wales	Cardiff University; University of South Wales	Simpson, SA (corresponding author), Cardiff Univ, SE Wales Trials Unit, Cardiff CF14 4XN, S Glam, Wales.	simpsonsa@cf.ac.uk		Simpson, Sharon Anne/0000-0002-6219-1768; McNamara, Rachel/0000-0002-7280-1611	National Institute for Health Research [08/44/04] Funding Source: researchfish; Department of Health [08/44/04] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		[Anonymous], 1995, WEIGH OPT CRIT EV WE; Avenell A, 2004, HEALTH TECHNOL ASSES, V8, P1; Collins CE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-669; Curioni CC, 2005, INT J OBESITY, V29, P1168, DOI 10.1038/sj.ijo.0803015; Douketis JD, 2005, INT J OBESITY, V29, P1153, DOI 10.1038/sj.ijo.0802982; FLETCHER SW, 1993, ANN INTERN MED, V119, P764, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00026; Fogelholm M, 2000, Obes Rev, V1, P95, DOI 10.1046/j.1467-789x.2000.00016.x; Franz MJ, 2007, J AM DIET ASSOC, V107, P1755, DOI 10.1016/j.jada.2007.07.017; Jakicic JM, 2008, ARCH INTERN MED, V168, P1550, DOI 10.1001/archinte.168.14.1550; Neve M, 2010, OBES REV, V11, P306, DOI 10.1111/j.1467-789X.2009.00646.x; NICE, 2006, OB PREV ID ASS MAN O; Nordmann AJ, 2006, ARCH INTERN MED, V166, P285, DOI 10.1001/archinte.166.3.285; Padwal RS, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004094.pub2, DOI 10.1002/14651858.CD004094.PUB2]; Picot J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13410; Svetkey LP, 2008, JAMA-J AM MED ASSOC, V299, P1139, DOI 10.1001/jama.299.10.1139; Topol EJ, 2010, LANCET, V376, P517, DOI 10.1016/S0140-6736(10)60935-X; Wing RR, 2006, NEW ENGL J MED, V355, P1563, DOI 10.1056/NEJMoa061883	17	38	38	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 28	2011	343								d8042	10.1136/bmj.d8042	http://dx.doi.org/10.1136/bmj.d8042			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	874TM	22205707				2022-12-28	WOS:000298981000002
J	Fuyuno, I				Fuyuno, Ichiko			JAPAN Will the sun set on Kampo?	NATURE			English	Editorial Material																			0	24	24	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2011	480	7378					S96	S96		10.1038/480S96a	http://dx.doi.org/10.1038/480S96a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	865NQ	22190092	Bronze			2022-12-28	WOS:000298318000008
J	Drekonja, DM; Butler, M; MacDonald, R; Bliss, D; Filice, GA; Rector, TS; Wilt, TJ				Drekonja, Dimitri M.; Butler, Mary; MacDonald, Roderick; Bliss, Donna; Filice, Gregory A.; Rector, Thomas S.; Wilt, Timothy J.			Comparative Effectiveness of Clostridium difficile Treatments A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIAL; ORAL VANCOMYCIN; PSEUDOMEMBRANOUS COLITIS; FUSIDIC ACID; METRONIDAZOLE; DISEASE; DIARRHEA; THERAPY; INFECTION; EPIDEMIOLOGY	Background: Clostridium difficile infection is increasing in incidence and severity. The optimal treatment is unknown. Purpose: To determine whether, among adults with C. difficile infection, treatment with certain antibiotics compared with others results in differences in initial cure, recurrence, and harms. Data Sources: MEDLINE, AMED, ClinicalTrials.gov, and Cochrane databases (search dates: inception through August 2011, limited to English-language reports); bibliography review. Study Selection: Randomized, controlled trials of adults with C. difficile infection, independent of outcomes, who were treated with medications available in the United States. Observational studies reporting strain were included. Data Extraction: Study design, inclusion and exclusion criteria, quality and strength of evidence as assessed by 2 reviewers, study definitions, and duration of treatment and follow-up. Outcomes included initial cure, recurrence, and treatment harms. Data Synthesis: 11 trials that included 1463 participants were identified. Three trials compared metronidazole with vancomycin; 8 compared metronidazole or vancomycin with another agent, combined agents, or placebo. Strain was analyzed in 1 trial and 2 cohort studies. No study comparing 2 antimicrobial agents demonstrated a statistically significant difference for initial cure; all comparisons were of low to moderate strength of evidence. Moderate-strength evidence from 1 study demonstrated that recurrence was decreased with fidaxomicin versus vancomycin (15% vs. 25%; difference, -10 percentage points [95% CI, -17 to -3 percentage points]; P = 0.005). Subgroup analysis of a single study comparing metronidazole with vancomycin for patients who have severe C. difficile infection showed no difference by intention-to-treat analysis; this was rated as insufficient-strength evidence. Harms, when reported, did not differ between treatments in any study. Limitations: Definitions of diarrhea, C. difficile infection, initial cure, and relapse varied. Some studies reported insufficient detail to allow assessment of all randomly assigned participants or of harms. Conclusion: No antimicrobial agent is clearly superior for the initial cure of C. difficile infection. Recurrence is less frequent with fidaxomicin than with vancomycin.	[Drekonja, Dimitri M.] Univ Minnesota, Sch Med, Sch Publi Hlth,Minneapolis Vet Affairs Hlth Care, Minnesota Evidence Based Practice Ctr,Infect Dis, Minneapolis, MN 55417 USA; Univ Minnesota, Sch Nursing, Minneapolis, MN 55417 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Drekonja, DM (corresponding author), Univ Minnesota, Sch Med, Sch Publi Hlth,Minneapolis Vet Affairs Hlth Care, Minnesota Evidence Based Practice Ctr,Infect Dis, 1 Vet Dr, Minneapolis, MN 55417 USA.	drek0002@umn.edu			AHRQ, U.S. Department of Health and Human Services [HHSA 290 2007 10064 I]; Minneapolis Veterans Affairs Center for Epidemiological and Clinical Research; Veterans Affairs Health Services Research and Development Service [HFP-98-001]	AHRQ, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Minneapolis Veterans Affairs Center for Epidemiological and Clinical Research; Veterans Affairs Health Services Research and Development Service(US Department of Veterans Affairs)	Grant Support: By contract HHSA 290 2007 10064 I from AHRQ, U.S. Department of Health and Human Services, and a Veterans Affairs Career Development Award through the Minneapolis Veterans Affairs Center for Epidemiological and Clinical Research (Dr. Drekonja) and Veterans Affairs Health Services Research and Development Service grant HFP-98-001 (Dr. Rector).	Al-Nassir WN, 2008, ANTIMICROB AGENTS CH, V52, P2403, DOI 10.1128/AAC.00090-08; Al-Nassir WN, 2008, CLIN INFECT DIS, V47, P56, DOI 10.1086/588293; [Anonymous], 1995, INFECT CONT HOSP EP, V16, P105; [Anonymous], 2010, EV BAS PRACT CTR SYS; Bishara J, 2007, CLIN INFECT DIS, V45, P1646, DOI 10.1086/523720; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; DELALLA F, 1992, ANTIMICROB AGENTS CH, V36, P2192, DOI 10.1128/AAC.36.10.2192; Dubberke ER, 2009, INFECT CONT HOSP EP, V30, P57, DOI 10.1086/592981; DUDLEY MN, 1986, ARCH INTERN MED, V146, P1101, DOI 10.1001/archinte.146.6.1101; Fekety R, 1997, CLIN INFECT DIS, V24, P324, DOI 10.1093/clinids/24.3.324; FEKETY R, 1989, AM J MED, V86, P15, DOI 10.1016/0002-9343(89)90223-4; Gerding DN, 2008, CLIN INFECT DIS, V46, pS32, DOI 10.1086/521860; GERDING DN, 1995, INFECT CONT HOSP EP, V16, P459; Huggan PJ, 2007, CLIN INFECT DIS, V45, P1647, DOI 10.1086/523719; JOHNSON S, 1992, ANN INTERN MED, V117, P297, DOI 10.7326/0003-4819-117-4-297; KEIGHLEY MRB, 1978, BRIT MED J, V2, P1667, DOI 10.1136/bmj.2.6153.1667; KELLY CP, 1994, NEW ENGL J MED, V330, P257, DOI 10.1056/NEJM199401273300406; Lagrotteria D, 2006, CLIN INFECT DIS, V43, P547, DOI 10.1086/506354; Lawrence SJ, 2007, CLIN INFECT DIS, V45, P1648, DOI 10.1086/523718; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Louie TJ, 2011, NEW ENGL J MED, V364, P422, DOI 10.1056/NEJMoa0910812; McFarland LV, 1999, INFECT CONT HOSP EP, V20, P43, DOI 10.1086/501553; Miller M, 2010, 48 ANN M INF DIS SOC; Musher DM, 2006, CLIN INFECT DIS, V43, P421, DOI 10.1086/506351; Musher DM, 2009, CLIN INFECT DIS, V48, pE41, DOI 10.1086/596552; Nelson R, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004610.pub3; OLSON MM, 1994, INFECT CONT HOSP EP, V15, P371; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Pakyz AL, 2010, INFECT CONT HOSP EP, V31, P867, DOI 10.1086/655442; Pepin J, 2008, CLIN INFECT DIS, V46, P1493, DOI 10.1086/587656; Pepin J, 2007, AM J GASTROENTEROL, V102, P2781, DOI 10.1111/j.1572-0241.2007.01539.x; Polgreen PM, 2007, INFECT CONT HOSP EP, V28, P212, DOI 10.1086/512174; Redelings MD, 2007, EMERG INFECT DIS, V13, P1417, DOI 10.3201/eid1309.061116; Riedel DJ, 2008, ANTIMICROB AGENTS CH, V52, P2463, DOI 10.1128/AAC.00300-08; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; TEASLEY DG, 1983, LANCET, V2, P1043; Wenisch C, 1996, CLIN INFECT DIS, V22, P813, DOI 10.1093/clinids/22.5.813; Wullt M, 2004, J ANTIMICROB CHEMOTH, V54, P211, DOI 10.1093/jac/dkh278; YOUNG GP, 1985, GASTROENTEROLOGY, V89, P1038, DOI 10.1016/0016-5085(85)90206-9; Zar FA, 2007, CLIN INFECT DIS, V45, P1649, DOI 10.1086/523717; Zar FA, 2007, CLIN INFECT DIS, V45, P302, DOI 10.1086/519265	41	85	89	0	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2011	155	12					839	U96		10.7326/0003-4819-155-12-201112200-00007	http://dx.doi.org/10.7326/0003-4819-155-12-201112200-00007			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	864ZU	22184691				2022-12-28	WOS:000298280500018
J	Saccenti, E; Smilde, AK; Saris, WHM				Saccenti, Edoardo; Smilde, Age K.; Saris, Wim H. M.			CHRISTMAS 2011: DIAGNOSIS Beethoven's deafness and his three styles	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MUSIC		[Saccenti, Edoardo; Smilde, Age K.] Univ Amsterdam, Swammerdam Inst Life Sci, Biosyst Data Anal Grp, NL-1098 XH Amsterdam, Netherlands; [Saccenti, Edoardo; Smilde, Age K.; Saris, Wim H. M.] Netherlands Metabol Ctr, NL-2333 CC Leiden, Netherlands; [Saris, Wim H. M.] Maastricht Univ, Med Ctr, Dept Human Biol, NL-6229 ER Maastricht, Netherlands	University of Amsterdam; Maastricht University	Saccenti, E (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Biosyst Data Anal Grp, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands.	e.saccenti@uva.nl		Smilde, Age/0000-0002-3052-4644; Saccenti, Edoardo/0000-0001-8284-4829				Anderson Emily, 1986, LETT BEETHOVEN; CAWTHORNE T, 1960, Laryngoscope, V70, P1110; de Marliave Joseph, 2004, BEETHOVENS QUARTETS; DeMarie Dreblow D, 1991, CHILD DEV, V62, P484; Donnenberg MS, 2000, AM J MED, V108, P475, DOI 10.1016/S0002-9343(00)00316-8; Ealy GT, 1994, 19 CENTURY MUSIC, V17, P262; HARRISON P, 1988, J ROY SOC MED, V81, P598, DOI 10.1177/014107688808101016; Hui A. C. F., 2000, Hong Kong Medical Journal, V6, P433; Karmody CS, 2005, OTOL NEUROTOL, V26, P809, DOI 10.1097/01.mao.0000178149.36881.df; KERMAN J, 1979, BEETHOVEN QUARTETS; Knittel KM, 1998, J AM MUSIC SOC, V51, P49, DOI 10.1525/jams.1998.51.1.03a00020; LISTON SL, 1989, LARYNGOSCOPE, V99, P1301; McDermott JH, 2008, CURR OPIN NEUROBIOL, V18, P452, DOI 10.1016/j.conb.2008.09.005; Peretz I, 2005, ANNU REV PSYCHOL, V56, P89, DOI 10.1146/annurev.psych.56.091103.070225; Sachs H, 1968, HIST MUSICAL INSTRUM; Schindler A, 2011, BEETHOVEN I KNEW HIM; Sorsby M, 1930, J LARYNGOL OTOL, V45, P329, DOI [10.1017/S0022215100035118, DOI 10.1017/S0022215100035118]; STEVENS K M, 1970, Journal of the American Medical Association, V213, P434, DOI 10.1001/jama.213.3.434; Von Lenz W, 2010, BEETHOVEN SES TROIS; Wagner R.Beethoven, 2009, BEETHOVEN; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7	21	5	5	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 20	2011	343								d7589	10.1136/bmj.d7589	http://dx.doi.org/10.1136/bmj.d7589			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	868QK	22187391				2022-12-28	WOS:000298538200005
J	Couzin, ID; Ioannou, CC; Demirel, G; Gross, T; Torney, CJ; Hartnett, A; Conradt, L; Levin, SA; Leonard, NE				Couzin, Iain D.; Ioannou, Christos C.; Demirel, Gueven; Gross, Thilo; Torney, Colin J.; Hartnett, Andrew; Conradt, Larissa; Levin, Simon A.; Leonard, Naomi E.			Uninformed Individuals Promote Democratic Consensus in Animal Groups	SCIENCE			English	Article							DECISION-MAKING	Conflicting interests among group members are common when making collective decisions, yet failure to achieve consensus can be costly. Under these circumstances individuals may be susceptible to manipulation by a strongly opinionated, or extremist, minority. It has previously been argued, for humans and animals, that social groups containing individuals who are uninformed, or exhibit weak preferences, are particularly vulnerable to such manipulative agents. Here, we use theory and experiment to demonstrate that, for a wide range of conditions, a strongly opinionated minority can dictate group choice, but the presence of uninformed individuals spontaneously inhibits this process, returning control to the numerical majority. Our results emphasize the role of uninformed individuals in achieving democratic consensus amid internal group conflict and informational constraints.	[Couzin, Iain D.; Ioannou, Christos C.; Torney, Colin J.; Hartnett, Andrew; Levin, Simon A.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Demirel, Gueven; Gross, Thilo] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany; [Conradt, Larissa] Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England; [Leonard, Naomi E.] Princeton Univ, Dept Mech & Aerosp Engn, Princeton, NJ 08544 USA	Princeton University; Max Planck Society; University of Sussex; Princeton University	Couzin, ID (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	icouzin@princeton.edu	Levin, Simon A/J-1218-2014; Gross, Thilo/B-4444-2010; Couzin, Iain D./Q-6862-2018; Conradt, Larissa/H-6309-2011; Torney, Colin/C-6082-2015	Levin, Simon A/0000-0002-8216-5639; Gross, Thilo/0000-0002-1356-6690; Couzin, Iain D./0000-0001-8556-4558; Torney, Colin/0000-0003-1673-7835; Ioannou, Christos/0000-0002-9739-889X; Demirel, Guven/0000-0002-5748-5622	NSF [PHY-0848755]; Searle Scholars Program; Office of Naval Research [N00014-09-1-1074]; Defense Advanced Research Projects Agency [HR0011-09-1-0055]; Royal Society; Division Of Physics [0848755] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Searle Scholars Program; Office of Naval Research(Office of Naval Research); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Royal Society(Royal Society of London); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank H. Li, L. Petzold, J. Moehlis, A. Kolpas, Y. Katz, and A. Kao for help with CUDA and the Couzin lab for discussions. This work was supported by NSF grant PHY-0848755, the Searle Scholars Program, Office of Naval Research grant N00014-09-1-1074, Defense Advanced Research Projects Agency grant HR0011-09-1-0055, and The Royal Society. I. D. C. devised the study and performed and analyzed the spatial simulations, C. C. I. performed and analyzed the fish experiments, and G. D. and T. G. performed the adaptive networks model and C. J. T. the convention model. All authors participated in some aspects of model formulation and analysis. I. D. C. wrote the paper with input from all authors. Data and code freely available at http://icouzin.princeton.edu/uninformed-individuals-promote-democratic-consensus-in-animal-groups/.	Arrow K., 1963, SOCIAL CHOICES INDIV; Buchanan J. M., 1958, CALCULUS CONSENT LOG; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Conradt L, 2009, AM NAT, V173, P304, DOI 10.1086/596532; Conradt L, 2003, NATURE, V421, P155, DOI 10.1038/nature01294; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Holme P, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.056108; Huepe C, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/7/073022; Issacharoff S, 2008, ICON-INT J CONST LAW, V6, P231, DOI 10.1093/icon/mon003; Katz Y, 2011, P NATL ACAD SCI USA, V108, P18720, DOI 10.1073/pnas.1107583108; King AJ, 2009, CURR BIOL, V19, pR911, DOI 10.1016/j.cub.2009.07.027; Krause J, 2002, LIVING GROUPS; Mansbridge J. J., 1983, ADVERSARY DEMOCRACY; OLSON M., 1971, LOGIC COLLECTIVE ACT; Reebs SG, 2000, ANIM BEHAV, V59, P403, DOI 10.1006/anbe.1999.1314; Riker, 1982, LIBERALISM POPULISM; Seeley T.D., 2010, HONEYBEE DEMOCRACY; Spence R, 2008, ETHOLOGY, V114, P582, DOI 10.1111/j.1439-0310.2008.01515.x; Vazquez F, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.108702; Ward AJW, 2011, P NATL ACAD SCI USA, V108, P2312, DOI 10.1073/pnas.1007102108; Young H.P., 1998, INDIVIDUAL STRATEGY, DOI DOI 10.1515/9780691214252; Zanette DH, 2006, PHYSICA D, V224, P156, DOI 10.1016/j.physd.2006.09.010	22	279	283	4	232	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2011	334	6062					1578	1580		10.1126/science.1210280	http://dx.doi.org/10.1126/science.1210280			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	862LE	22174256	Green Submitted			2022-12-28	WOS:000298091400059
J	Egli, A; Khanna, N; Schmid, T; Rudin, S; Frei, R; Blaich, A				Egli, Adrian; Khanna, Nina; Schmid, Thomas; Rudin, Sonja; Frei, Reno; Blaich, Annette			CASE REPORT Recurrent fever after a holiday in Turkey	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Rudin, Sonja; Frei, Reno; Blaich, Annette] Univ Basel Hosp, Div Clin Microbiol, Basel, Switzerland; [Egli, Adrian; Khanna, Nina] Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, CH-4031 Basel, Switzerland; [Schmid, Thomas] Univ Basel Hosp, Dept Internal Med, CH-4031 Basel, Switzerland	University of Basel; University of Basel; University of Basel	Blaich, A (corresponding author), Univ Basel Hosp, Div Clin Microbiol, Basel, Switzerland.	blaicha@uhbs.ch		Khanna, Nina/0000-0002-2642-419X				Ariza J, 2007, PLOS MED, V4, P1872, DOI 10.1371/journal.pmed.0040317; Baysallar M, 2006, MED SCI MONITOR, V12, pBR235; Buzgan T, 2010, INT J INFECT DIS, V14, pE469, DOI 10.1016/j.ijid.2009.06.031; Centers for Disease Control and Prevention, 2007, BRUC; Franco MP, 2007, LANCET INFECT DIS, V7, P775, DOI 10.1016/S1473-3099(07)70286-4; Lecaroz C, 2006, J ANTIMICROB CHEMOTH, V58, P549, DOI 10.1093/jac/dkl257; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Pappas G, 2005, NEW ENGL J MED, V352, P2325, DOI 10.1056/NEJMra050570; PELOQUIN CA, 2005, ANTIMICROBIAL CHEMOT, V2, P383; Roop RM, 2009, MED MICROBIOL IMMUN, V198, P221, DOI 10.1007/s00430-009-0123-8; Sabundayo BP, 2005, ANTIMICROBIAL THERAP, VII, P461; Young EJ., 2005, PRINCIPLES PRACTICE, V6	12	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2011	343								d7832	10.1136/bmj.d7832	http://dx.doi.org/10.1136/bmj.d7832			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	888WG	22180453				2022-12-28	WOS:000300034700006
J	Lawlor, DA; Nelson, SM				Lawlor, Debbie A.; Nelson, Scott M.			Effect of age on decisions about the numbers of embryos to transfer in assisted conception: a prospective study	LANCET			English	Article							ELECTIVE SINGLE; LEGISLATION	Background Elective single-embryo transfer has been proposed as a strategy to reduce the risk of multiple birth and adverse pregnancy outcomes after in-vitro fertilisation (IVF). Whether this approach should be restricted to young women is unclear. Methods In a prospective study of UK Human Fertilisation and Embryology Authority data, we investigated whether perinatal livebirth outcomes varied by the number of embryos transferred in relation to maternal age. We compared rates of livebirth, multiple births, low birthweight (<2.5 kg), preterm birth (<37 weeks), and severe preterm birth (<33 weeks) in women younger than 40 years and those aged 40 years or older. We used logistic and binomial regression methods to assess, respectively, relative risk and absolute differences in risk. Findings We assessed 124 148 IVF cycles overall, which yielded 33 514 livebirths. The odds ratios of livebirth were higher in women aged 40 years or older than in those younger than 40 years when two embryos were transferred compared with one embryo (3.12, 95% CI 2.56-3.77 vs 2.33, 2.20-2.46; p=0.0006 for interaction), but the absolute difference in risk of livebirth was smaller (0.090, 0.080-0.099 for women >= 40 years vs 0.156, 0.148-0.163 for those <40 years; p<0.0001). The odds ratios and absolute risk differences for multiple birth, preterm birth, and low birthweight were all smaller in older than in younger women (analyses were done in 32 732 cycles in which a livebirth had resulted and data on gestational age and birthweight were complete). Livebirth rates did not increase with transfer of three embryos, but the risk of adverse perinatal outcomes did increase. Interpretation Transfer of three or more embryos at any age should be avoided. The decision to transfer one or two embryos should be based on prognostic indicators, such as age.	[Lawlor, Debbie A.] Univ Bristol, MRC Ctr Causal Anal Translat Epidemiol, Sch Social & Community Med, Bristol BS8 2BN, Avon, England; [Nelson, Scott M.] Univ Glasgow, Sch Med, Glasgow, Lanark, Scotland	University of Bristol; University of Glasgow	Lawlor, DA (corresponding author), Univ Bristol, MRC Ctr Causal Anal Translat Epidemiol, Sch Social & Community Med, Oakfield House, Bristol BS8 2BN, Avon, England.	d.a.lawlor@bristol.ac.uk; scott.nelson@glasgow.ac.uk		Nelson, Scott/0000-0002-9099-3047; Lawlor, Debbie A/0000-0002-6793-2262	UK Medical Research Council (MRC) [G0600705]; MRC [G0600705] Funding Source: UKRI; Medical Research Council [G0600705] Funding Source: researchfish	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the staff of the HFEA and the contributing UK clinics for providing data. We thank D Barlow, University of Glasgow, Glasgow, UK, and D Leon, London School of Hygiene and Tropical Medicine, London, UK, for providing valuable comments on an earlier draft of this paper. All views are those of the authors and not necessarily those of anyone acknowledged here. DAL works in the MRC Centre for Causal Analyses in Translational Epidemiology, which receives funding from the UK Medical Research Council (MRC; G0600705). No funding specifically covered the work presented.	Cutting Rachel, 2008, Hum Fertil (Camb), V11, P131, DOI 10.1080/14647270802302629; Devroey P, 2009, HUM REPROD UPDATE, V15, P391, DOI 10.1093/humupd/dmp012; Fauser BCJM, 2005, LANCET, V365, P1807, DOI 10.1016/S0140-6736(05)66478-1; Gleicher N, 2009, FERTIL STERIL, V91, P2426, DOI 10.1016/j.fertnstert.2008.02.160; Gordts S, 2005, REPROD BIOMED ONLINE, V10, P436, DOI 10.1016/S1472-6483(10)60818-8; Hojgaard A, 2007, HUM REPROD, V22, P2673, DOI 10.1093/humrep/dem173; Karlstrom PO, 2007, HUM REPROD, V22, P2202, DOI 10.1093/humrep/dem120; Leese B, 2010, HUM FERTIL, V13, P28, DOI 10.3109/14647270903586364; McLernon DJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6945; Nelson SM, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000386; Newton CR, 2007, FERTIL STERIL, V87, P269, DOI 10.1016/j.fertnstert.2006.06.043; Nyboe Andersen A, 2009, Hum Reprod, V24, P1267, DOI 10.1093/humrep/dep035; Reddy UM, 2007, OBSTET GYNECOL, V109, P967, DOI 10.1097/01.AOG.0000259316.04136.30; Saldeen P, 2005, HUM REPROD, V20, P4, DOI 10.1093/humrep/deh610; Soc Assisted Reproductive Te, 2008, FERTIL STERIL, V90, pS163, DOI 10.1016/j.fertnstert.2008.08.053; Templeton A, 1998, NEW ENGL J MED, V339, P573, DOI 10.1056/NEJM199808273390901; Templeton A, 1996, LANCET, V348, P1402, DOI 10.1016/S0140-6736(96)05291-9; Templeton A, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c7083; Van Landuyt L, 2006, REPROD BIOMED ONLINE, V13, P765, DOI 10.1016/S1472-6483(10)61022-X; Weisberg S, 2005, APPL LINEAR REGRESSI, P253	20	52	60	0	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 11	2012	379	9815					521	527		10.1016/S0140-6736(11)61267-1	http://dx.doi.org/10.1016/S0140-6736(11)61267-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	891AO	22243709				2022-12-28	WOS:000300188800028
J	Cross, M				Cross, Michael			OUTCOMES DATA Show us the data: why clinical outcomes matter	BRITISH MEDICAL JOURNAL			English	Editorial Material												michaelcross@fastmail.fm						Brown I, 2011, LAW INNOVATION TECHN, V2, P219; OHara Kieron, 2011, TRANSPARENT GOVT NOT	2	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 10	2012	344								e66	10.1136/bmj.e66	http://dx.doi.org/10.1136/bmj.e66			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	877SD	22234912				2022-12-28	WOS:000299202000002
J	Elhauge, E				Elhauge, Einer			The Irrelevance of the Broccoli Argument against the Insurance Mandate	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Law, Cambridge, MA 02138 USA	Harvard University	Elhauge, E (corresponding author), Harvard Univ, Sch Law, Cambridge, MA 02138 USA.								0	5	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 5	2012	366	1								10.1056/NEJMp1113618	http://dx.doi.org/10.1056/NEJMp1113618			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	887XY	22187959				2022-12-28	WOS:000299968800002
J	Prayle, AP; Hurley, MN; Smyth, AR				Prayle, Andrew P.; Hurley, Matthew N.; Smyth, Alan R.			Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PUBLICATION BIAS; REGISTRATION	Objective To examine compliance with mandatory reporting of summary clinical trial results (within one year of completion of trial) on ClinicalTrials.gov for studies that fall under the recent Food and Drug Administration Amendments Act (FDAAA) legislation. Design Registry based study of clinical trial summaries. Data sources ClinicalTrials.gov, searched on 19 January 2011, with cross referencing with Drugs@FDA to determine for which trials mandatory reporting was required within one year. Selection criteria Studies registered on ClinicalTrials.gov with US sites which completed between 1 January and 31 December 2009. Main outcome measure Proportion of trials for which results had been reported. Results The ClinicalTrials.gov registry contained 83 579 entries for interventional trials, of which 5642 were completed within the timescale of interest. We identified trials as falling within the mandatory reporting rules if they were covered by the FDAAA (trials of a drug, device, or biological agent, which have at least one US site, and are of phase II or later) and if they investigated a drug that already had approval from the Food and Drug Administration. Of these, 163/738 (22%) had reported results within one year of completion of the trial compared with 76/727 (10%) trials that were not subject to mandatory reporting (95% confidence interval for the difference in proportions 7.8% to 15.5%; chi(2) test, P=2.6x10(-9)). Later phase trials were more likely to report results (P=4.4x10(-11)), as were industry funded trials (P=2.2x10(-16)). Conclusion Most trials subject to mandatory reporting did not report results within a year of completion.	[Prayle, Andrew P.; Hurley, Matthew N.; Smyth, Alan R.] Univ Nottingham, Queens Med Ctr, Div Child Hlth, Sch Clin Sci, Nottingham NG7 2UH, England	University of Nottingham	Prayle, AP (corresponding author), Univ Nottingham, Queens Med Ctr, Div Child Hlth, Sch Clin Sci, Nottingham NG7 2UH, England.	andrew.prayle@nottingham.ac.uk		Smyth, Alan/0000-0001-5494-5438; Prayle, Andrew/0000-0002-1514-2840; Hurley, Matthew/0000-0002-2439-8522	National Institute for Health [DRF-2009-02-112]; Wellcome Trust [WT092295AIA]; National Institute for Health Research [PB-PG-1207-15025, DRF-2009-02-112] Funding Source: researchfish	National Institute for Health; Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that APP is supported by a National Institute for Health Research fellowship (DRF-2009-02-112) and MNH is supported by a Wellcome Trust fellowship (WT092295AIA). ARS declares relevant activities outside the submitted work of membership of a REMPEX steering committee, consultancies for Novartis and Biocontrol, and a lecture paid for by Chiesi Pharma. ARS has registered trials on ClinicalTrials.gov and other registries.	[Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], COCHRANE HDB SYSTEMA; Dickersin K, 2002, JAMA-J AM MED ASSOC, V287, P2829, DOI 10.1001/jama.287.21.2829; Dwan K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000031.pub2; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Hopewell S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000010.pub3; Hopewell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000006.pub3; Laine C, 2007, NEW ENGL J MED, V356, P2734, DOI 10.1056/NEJMe078110; McCray AT, 2000, J AM MED INFORM ASSN, V7, P313, DOI 10.1136/jamia.2000.0070313; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640; Tse T, 2009, CHEST, V136, P295, DOI 10.1378/chest.08-3022; Wood AJJ, 2009, NEW ENGL J MED, V360, P824, DOI 10.1056/NEJMsr0806582; Zarin DA, 2011, NEW ENGL J MED, V364, P852, DOI 10.1056/NEJMsa1012065	13	192	193	0	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 3	2012	344								d7373	10.1136/bmj.d7373	http://dx.doi.org/10.1136/bmj.d7373			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874UE	22214756	Green Submitted, Green Accepted, hybrid			2022-12-28	WOS:000298982800006
J	Sakurai, M				Sakurai, Masatomo			PERSPECTIVE Herbal dangers	NATURE			English	Editorial Material									Kitasato Univ, Oriental Med Res Ctr, Tokyo, Japan	Kitasato University	Sakurai, M (corresponding author), Kitasato Univ, Oriental Med Res Ctr, Tokyo, Japan.	sakuraim@insti.kitasato-u.ac.jp						Arai S, 2009, KAMPOUIGAKU, P124; Gono Y, 2010, KAMPO MED, V61, P828, DOI DOI 10.3937/KAMPOMED.61.828; Ito T, 2010, KAMPO MED, V61, P299; Nortier JL, 2000, NEW ENGL J MED, V342, P1686, DOI 10.1056/NEJM200006083422301; VANHERWEGHEM JL, 1993, LANCET, V341, P387, DOI 10.1016/0140-6736(93)92984-2	5	11	13	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2011	480	7378					S97	S97		10.1038/480S97a	http://dx.doi.org/10.1038/480S97a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	865NQ	22190093	Bronze			2022-12-28	WOS:000298318000009
J	Tachibana, M; Sparman, M; Ramsey, C; Ma, H; Lee, HS; Penedo, MCT; Mitalipov, S				Tachibana, Masahito; Sparman, Michelle; Ramsey, Cathy; Ma, Hong; Lee, Hyo-Sang; Penedo, Maria Cecilia T.; Mitalipov, Shoukhrat			Generation of Chimeric Rhesus Monkeys	CELL			English	Article							EMBRYONIC STEM-CELLS; NUCLEAR TRANSFER; MOUSE EMBRYO; MICROSATELLITE LOCI; LINEAGE DEVELOPMENT; NONHUMAN-PRIMATES; TETRAPLOID CELLS; DIFFERENTIATION; BLASTOCYSTS; ENDODERM	Totipotent cells in early embryos are progenitors of all stem cells and are capable of developing into a whole organism, including extraembryonic tissues such as placenta. Pluripotent cells in the inner cell mass (ICM) are the descendants of totipotent cells and can differentiate into any cell type of a body except extraembryonic tissues. The ability to contribute to chimeric animals upon reintroduction into host embryos is the key feature of murine totipotent and pluripotent cells. Here, we demonstrate that rhesus monkey embryonic stem cells (ESCs) and isolated ICMs fail to incorporate into host embryos and develop into chimeras. However, chimeric offspring were produced following aggregation of totipotent cells of the four-cell embryos. These results provide insights into the species-specific nature of primate embryos and suggest that a chimera assay using pluripotent cells may not be feasible.	[Tachibana, Masahito; Sparman, Michelle; Ramsey, Cathy; Ma, Hong; Lee, Hyo-Sang; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; [Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Oregon Stem Cell Ctr, Beaverton, OR 97006 USA; [Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Beaverton, OR 97006 USA; [Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Beaverton, OR 97006 USA; [Penedo, Maria Cecilia T.] Univ Calif Davis, Vet Genet Lab, Davis, CA 95616 USA	Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University of California System; University of California Davis	Mitalipov, S (corresponding author), Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, 505 NW 185th Ave, Beaverton, OR 97006 USA.	mitalipo@ohsu.edu			Oregon National Primate Research Center; National Institutes of Health [HD057121, HD059946, HD063276, HD047675, HD018185, RR000163]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD063276, R01HD059946, R01HD057121] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD018185, P01HD047675, P30HD018185] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163, K01RR000163] Funding Source: NIH RePORTER	Oregon National Primate Research Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The authors would like to acknowledge the Assisted Reproductive Technology & Embryonic Stem Cell Core, Division of Animal Resources, Surgery Team, Endocrine Technology Core, and Molecular & Cellular Biology Core at the Oregon National Primate Research Center for providing expertise and services that contributed to this project. We are grateful to Dr. Warren Sanger from Human Cytogenetic Laboratory, Nebraska Medical Center for proving karyotyping services. We are obliged to Hathaitip Sritanaudomchai, Keith Masterson, Lisa Clepper, Joy Woodward, Maidina Touhetahuntila, and Erin Wolff for their technical support, Joel Ito for help with illustrative materials, and Dr. Mary Herbert for providing a GFP-RNA vector. We are indebted to Drs. Richard Stouffer and Don Wolf for consulting, helpful discussions, and critical reading of the manuscript. This study was supported by startup funds from the Oregon National Primate Research Center and grants from the National Institutes of Health, HD057121, HD059946, HD063276, HD047675, HD018185, and RR000163.	BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; BREM G, 1984, THERIOGENOLOGY, V22, P609, DOI 10.1016/0093-691X(84)90061-X; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Byrne JA, 2007, NATURE, V450, P497, DOI 10.1038/nature06357; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Chan AWS, 2000, SCIENCE, V287, P317, DOI 10.1126/science.287.5451.317; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Cockburn K, 2010, J CLIN INVEST, V120, P995, DOI 10.1172/JCI41229; Cunningham FG, 2005, WILLIAMS OBSTET; DELHAISE F, 1993, MOL REPROD DEV, V34, P127, DOI 10.1002/mrd.1080340203; DomingoRoura X, 1997, AM J PRIMATOL, V43, P357, DOI 10.1002/(SICI)1098-2345(1997)43:4<357::AID-AJP7>3.0.CO;2-W; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FEHILLY CB, 1984, NATURE, V307, P634, DOI 10.1038/307634a0; GARDNER RL, 1968, NATURE, V220, P596, DOI 10.1038/220596a0; GARDNER RL, 1974, NATURE, V250, P146, DOI 10.1038/250146a0; GARDNER RL, 1979, J EMBRYOL EXP MORPH, V52, P141; GARDNER RL, 1982, J EMBRYOL EXP MORPH, V68, P175; GARDNER RL, 1983, INT REV EXP PATHOL, V24, P63; GARDNER RL, 1984, J EMBRYOL EXP MORPH, V80, P251; GENGOZIAN N, 1964, CYTOGENETICS, V3, P384, DOI 10.1159/000129828; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; JAMES RM, 1995, DEV BIOL, V167, P213, DOI 10.1006/dbio.1995.1018; Lanza R, 2007, SCIENCE, V318, P1865; MacKay GE, 2005, MECH DEVELOP, V122, P1266, DOI 10.1016/j.mod.2005.09.001; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; MAYER JF, 1974, J REPROD FERTIL, V39, P1, DOI 10.1530/jrf.0.0390001; MINTZ B, 1962, SCIENCE, V138, P594, DOI 10.1126/science.138.3540.594; MINTZ B, 1975, P NATL ACAD SCI USA, V72, P3585, DOI 10.1073/pnas.72.9.3585; Mitalipov SM, 2007, HUM REPROD, V22, P2232, DOI 10.1093/humrep/dem136; Mitalipov S, 2006, STEM CELLS, V24, P2177, DOI 10.1634/stemcells.2006-0125; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; NAGY A, 1990, DEVELOPMENT, V110, P815; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Ohta H, 2008, REPRODUCTION, V136, P581, DOI 10.1530/REP-08-0184; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Quintero R A, 2003, J Matern Fetal Neonatal Med, V14, P279, DOI 10.1080/713606661; Rogers J, 2006, GENOMICS, V87, P30, DOI 10.1016/j.ygeno.2005.10.004; Rossant J, 2008, CELL, V132, P527, DOI 10.1016/j.cell.2008.01.039; Rossant J, 2007, REPROD FERT DEVELOP, V19, P111, DOI 10.1071/RD06125; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; Souter VL, 2003, NEW ENGL J MED, V349, P154, DOI 10.1056/NEJMoa030050; Sparman M, 2009, STEM CELLS, V27, P1255, DOI 10.1002/stem.60; Sparman ML, 2010, INT J DEV BIOL, V54, P1671, DOI 10.1387/ijdb.103196ms; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368; Tam PPL, 2003, DEVELOPMENT, V130, P6155, DOI 10.1242/dev.00893; TARKOWSKI AK, 1961, NATURE, V190, P857, DOI 10.1038/190857a0; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; TUCKER EM, 1974, IMMUNOLOGY, V26, P613; vanDijk BA, 1996, AM J MED GENET, V61, P264, DOI 10.1002/(SICI)1096-8628(19960122)61:3<264::AID-AJMG11>3.0.CO;2-R; Wakayama T, 2001, SCIENCE, V292, P740, DOI 10.1126/science.1059399; Wolf DP, 2004, BIOL REPROD, V71, P486, DOI 10.1095/biolreprod.103.025932; WOOD SA, 1993, P NATL ACAD SCI USA, V90, P4582, DOI 10.1073/pnas.90.10.4582	57	119	133	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 20	2012	148	1-2					285	295		10.1016/j.cell.2011.12.007	http://dx.doi.org/10.1016/j.cell.2011.12.007			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	882DC	22225614	Green Accepted, Bronze			2022-12-28	WOS:000299540700031
J	Jager, S; Cimermancic, P; Gulbahce, N; Johnson, JR; McGovern, KE; Clarke, SC; Shales, M; Mercenne, G; Pache, L; Li, K; Hernandez, H; Jang, GM; Roth, SL; Akiva, E; Marlett, J; Stephens, M; D'Orso, I; Fernandes, J; Fahey, M; Mahon, C; O'Donoghue, AJ; Todorovic, A; Morris, JH; Maltby, DA; Alber, T; Cagney, G; Bushman, FD; Young, JA; Chanda, SK; Sundquist, WI; Kortemme, T; Hernandez, RD; Craik, CS; Burlingame, A; Sali, A; Frankel, AD; Krogan, NJ				Jaeger, Stefanie; Cimermancic, Peter; Gulbahce, Natali; Johnson, Jeffrey R.; McGovern, Kathryn E.; Clarke, Starlynn C.; Shales, Michael; Mercenne, Gaelle; Pache, Lars; Li, Kathy; Hernandez, Hilda; Jang, Gwendolyn M.; Roth, Shoshannah L.; Akiva, Eyal; Marlett, John; Stephens, Melanie; D'Orso, Ivan; Fernandes, Jason; Fahey, Marie; Mahon, Cathal; O'Donoghue, Anthony J.; Todorovic, Aleksandar; Morris, John H.; Maltby, David A.; Alber, Tom; Cagney, Gerard; Bushman, Frederic D.; Young, John A.; Chanda, Sumit K.; Sundquist, Wesley I.; Kortemme, Tanja; Hernandez, Ryan D.; Craik, Charles S.; Burlingame, Alma; Sali, Andrej; Frankel, Alan D.; Krogan, Nevan J.			Global landscape of HIV-human protein complexes	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; INTERACTION MAP; REPLICATION; INTERACTOME; PURIFICATION; INFECTION; RESOURCE; CLEAVAGE; DATABASE; NETWORK	Human immunodeficiency virus (HIV) has a small genome and therefore relies heavily on the host cellular machinery to replicate. Identifying which host proteins and complexes come into physical contact with the viral proteins is crucial for a comprehensive understanding of how HIV rewires the host's cellular machinery during the course of infection. Here we report the use of affinity tagging and purification mass spectrometry(1-3) to determine systematically the physical interactions of all 18 HIV-1 proteins and polyproteins with host proteins in two different human cell lines (HEK293 and Jurkat). Using a quantitative scoring system that we call MiST, we identified with high confidence 497 HIV-human protein-protein interactions involving 435 individual human proteins, with similar to 40% of the interactions being identified in both cell types. We found that the host proteins hijacked by HIV, especially those found interacting in both cell types, are highly conserved across primates. We uncovered a number of host complexes targeted by viral proteins, including the finding that HIV protease cleaves eIF3d, a subunit of eukaryotic translation initiation factor 3. This host protein is one of eleven identified in this analysis that act to inhibit HIV replication. This data set facilitates a more comprehensive and detailed understanding of how the host machinery is manipulated during the course of HIV infection.	[Jaeger, Stefanie; Gulbahce, Natali; Johnson, Jeffrey R.; McGovern, Kathryn E.; Shales, Michael; Li, Kathy; Hernandez, Hilda; Jang, Gwendolyn M.; Fahey, Marie; Mahon, Cathal; Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Jaeger, Stefanie; Cimermancic, Peter; Gulbahce, Natali; Johnson, Jeffrey R.; McGovern, Kathryn E.; Shales, Michael; Li, Kathy; Hernandez, Hilda; Jang, Gwendolyn M.; Akiva, Eyal; Fahey, Marie; Mahon, Cathal; Kortemme, Tanja; Hernandez, Ryan D.; Craik, Charles S.; Burlingame, Alma; Sali, Andrej; Frankel, Alan D.; Krogan, Nevan J.] QB3, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [Cimermancic, Peter; Akiva, Eyal; Kortemme, Tanja; Hernandez, Ryan D.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Johnson, Jeffrey R.; Krogan, Nevan J.] J David Gladstone Inst, San Francisco, CA 94158 USA; [Clarke, Starlynn C.; Li, Kathy; Hernandez, Hilda; Mahon, Cathal; O'Donoghue, Anthony J.; Morris, John H.; Maltby, David A.; Craik, Charles S.; Burlingame, Alma; Sali, Andrej] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Mercenne, Gaelle; Sundquist, Wesley I.] Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA; [Pache, Lars; Chanda, Sumit K.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Jang, Gwendolyn M.; D'Orso, Ivan; Fernandes, Jason; Bushman, Frederic D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Roth, Shoshannah L.; Stephens, Melanie; Bushman, Frederic D.] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA; [Marlett, John; Young, John A.] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Todorovic, Aleksandar] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Alber, Tom] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Cagney, Gerard] Univ Coll Dublin, Conway Inst, Dublin 4, Ireland; [Kortemme, Tanja; Hernandez, Ryan D.; Sali, Andrej; Frankel, Alan D.; Krogan, Nevan J.] Univ Calif San Francisco, Host Pathogen Circuitry Grp, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Utah System of Higher Education; University of Utah; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Francisco; University of Pennsylvania; Salk Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University College Dublin; University of California System; University of California San Francisco	Krogan, NJ (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	krogan@cmp.ucsf.edu	Kortemme, Tanja/AAN-3180-2021	Fernandes, Jason/0000-0002-8625-1796; Kortemme, Tanja/0000-0002-8494-680X; Bushman, Frederic/0000-0003-4740-4056; McGovern, Kathryn/0000-0001-8770-2619; Morris, John "Scooter"/0000-0003-0290-7979; Cagney, Gerard/0000-0001-7189-9496	QB3@UCSF; National Institutes of Health [P50 GM082250, P01 AI090935, P50 GM081879, P50 GM082545, P41RR001614, U54 RR022220, P01 GM073732-05, CHRP-ID08-TBI-063, P41 RR001081]; Nomis Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614, U54RR022220, P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI090935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081879, P41GM103481, P01GM073732, P50GM082545, P50GM082250] Funding Source: NIH RePORTER	QB3@UCSF; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nomis Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Choi, Z. Rizvi and E. Kwon for cloning of human genes and J. Cate for purified eIF3. We also thank J. Gross, R. Andino, R. Harris, M. Daugherty and members of the Krogan lab for discussion. This research was funded by grants from QB3@UCSF and the National Institutes of Health (P50 GM082250 to N.J.K., A. D. F., C. S. C. and T. A.; P01 AI090935 to N.J.K., S. K. C., J.A.Y. and F. D. B.; P50 GM081879 to N.J.K. and A. B.; P50 GM082545 to W. I. S.; P41RR001614 to A. B.; U54 RR022220 to A. S.; P01 GM073732-05 to A. T.; CHRP-ID08-TBI-063 to S. K. C.; P41 RR001081 to J. H. M.) and from the Nomis Foundation (to J.A.Y.). N.J.K. is a Searle Scholar and a Keck Young Investigator.	Alvarez E, 2006, BIOCHEM J, V396, P219, DOI 10.1042/BJ20060108; Asano K, 1997, J BIOL CHEM, V272, P27042, DOI 10.1074/jbc.272.43.27042; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Calderwood MA, 2007, P NATL ACAD SCI USA, V104, P7606, DOI 10.1073/pnas.0702332104; Chatr-aryamontri A, 2009, NUCLEIC ACIDS RES, V37, pD669, DOI 10.1093/nar/gkn739; Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Fahey ME, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-298; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Jager S, 2011, METHODS, V53, P13, DOI 10.1016/j.ymeth.2010.08.007; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Strack PR, 1996, P NATL ACAD SCI USA, V93, P9571, DOI 10.1073/pnas.93.18.9571; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Valente ST, 2009, P NATL ACAD SCI USA, V106, P4071, DOI 10.1073/pnas.0900557106; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yeung ML, 2009, J BIOL CHEM, V284, P19463, DOI 10.1074/jbc.M109.010033; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004; Zhou M, 2008, P NATL ACAD SCI USA, V105, P18139, DOI 10.1073/pnas.0801313105	28	486	496	2	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 19	2012	481	7381					365	370		10.1038/nature10719	http://dx.doi.org/10.1038/nature10719			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877VK	22190034	Green Accepted			2022-12-28	WOS:000299210600043
J	Qaseem, A; Alguire, P; Dallas, P; Feinberg, LE; Fitzgerald, FT; Horwitch, C; Humphrey, L; LeBlond, R; Moyer, D; Wiese, JG; Weinberger, S				Qaseem, Amir; Alguire, Patrick; Dallas, Paul; Feinberg, Lawrence E.; Fitzgerald, Faith T.; Horwitch, Carrie; Humphrey, Linda; LeBlond, Richard; Moyer, Darilyn; Wiese, Jeffrey G.; Weinberger, Steven			Appropriate Use of Screening and Diagnostic Tests to Foster High-Value, Cost-Conscious Care	ANNALS OF INTERNAL MEDICINE			English	Article							HEALTH-CARE	Unsustainable rising health care costs in the United States have made reducing costs while maintaining high-quality health care a national priority. The overuse of some screening and diagnostic tests is an important component of unnecessary health care costs. More judicious use of such tests will improve quality and reflect responsible awareness of costs. Efforts to control expenditures should focus not only on benefits, harms, and costs but on the value of diagnostic tests-meaning an assessment of whether a test provides health benefits that are worth its costs or harms. To begin to identify ways that practicing clinicians can contribute to the delivery of high-value, cost-conscious health care, the American College of Physicians convened a workgroup of physicians to identify, using a consensus-based process, common clinical situations in which screening and diagnostic tests are used in ways that do not reflect high-value care. The intent of this exercise is to promote thoughtful discussions about these tests and other health care interventions to promote high-value, cost-conscious care.	[Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA 19106 USA; Temple Univ, Sch Med, Philadelphia, PA 19122 USA; Virginia Tech Carilion Sch Med & Res Inst, Roanoke, VA USA; Univ Colorado, Hlth Sci Ctr, Aurora, CO USA; Univ Calif Davis, Sacramento, CA 95817 USA; Univ Washington, Virginia Mason Med Ctr, Seattle, WA 98195 USA; Oregon Hlth & Sci Univ, Portland, OR 97201 USA; Univ Iowa, Carver Coll Med, Iowa City, IA USA; Tulane Univ, Hlth Sci Ctr, New Orleans, LA 70118 USA	American College of Physicians; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Davis; University of Washington; University of Washington Seattle; Virginia Mason Medical Center; Oregon Health & Science University; University of Iowa; Tulane University	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19106 USA.	aqaseem@acponline.org			American College of Physicians	American College of Physicians	Financial support for the development of this paper comes exclusively from the American College of Physicians operating budget.	Brody H, 2010, NEW ENGL J MED, V362, P283, DOI 10.1056/NEJMp0911423; Center for Medicare and Medicaid Services, 2010, NAT HLTH CAR EXP DAT; Chou R, 2011, ANN INTERN MED, V154, P181, DOI 10.7326/0003-4819-154-3-201102010-00008; Fuchs VR, 2010, NEW ENGL J MED, V362, P965, DOI 10.1056/NEJMp1000200; Kaiser Family Foundation and Health Research & Educational Trust, EMPL HLTH BEN 2010 S; Owens D., 2006, BIOMEDICAL INFORM, p80 129; Owens DK, 2011, ANN INTERN MED, V154, P174, DOI 10.7326/0003-4819-154-3-201102010-00007; Smith S, 2009, HEALTH AFFAIR, V28, P1276, DOI 10.1377/hlthaff.28.5.1276; SOX HC, 1986, ANN INTERN MED, V104, P60, DOI 10.7326/0003-4819-104-1-60	9	186	190	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 17	2012	156	2					147	W31		10.7326/0003-4819-156-2-201201170-00011	http://dx.doi.org/10.7326/0003-4819-156-2-201201170-00011			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	894IW	22250146				2022-12-28	WOS:000300421400006
J	Healey, JS; Connolly, SJ; Gold, MR; Israel, CW; Van Gelder, IC; Capucci, A; Lau, CP; Fain, E; Yang, S; Bailleul, C; Morillo, CA; Carlson, M; Themeles, E; Kaufman, ES; Hohnloser, SH				Healey, Jeff S.; Connolly, Stuart J.; Gold, Michael R.; Israel, Carsten W.; Van Gelder, Isabelle C.; Capucci, Alessandro; Lau, C. P.; Fain, Eric; Yang, Sean; Bailleul, Christophe; Morillo, Carlos A.; Carlson, Mark; Themeles, Ellison; Kaufman, Elizabeth S.; Hohnloser, Stefan H.		ASSERT Investigators	Subclinical Atrial Fibrillation and the Risk of Stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CANADIAN TRIAL; FOLLOW-UP; PREVENTION; FLUTTER; TACHYARRHYTHMIA; FREQUENCY; OUTCOMES; BURDEN	BACKGROUND One quarter of strokes are of unknown cause, and subclinical atrial fibrillation may be a common etiologic factor. Pacemakers can detect subclinical episodes of rapid atrial rate, which correlate with electrocardiographically documented atrial fibrillation. We evaluated whether subclinical episodes of rapid atrial rate detected by implanted devices were associated with an increased risk of ischemic stroke in patients who did not have other evidence of atrial fibrillation. METHODS We enrolled 2580 patients, 65 years of age or older, with hypertension and no history of atrial fibrillation, in whom a pacemaker or defibrillator had recently been implanted. We monitored the patients for 3 months to detect subclinical atrial tachyarrhythmias (episodes of atrial rate >190 beats per minute for more than 6 minutes) and followed them for a mean of 2.5 years for the primary outcome of ischemic stroke or systemic embolism. Patients with pacemakers were randomly assigned to receive or not to receive continuous atrial overdrive pacing. RESULTS By 3 months, subclinical atrial tachyarrhythmias detected by implanted devices had occurred in 261 patients (10.1%). Subclinical atrial tachyarrhythmias were associated with an increased risk of clinical atrial fibrillation (hazard ratio, 5.56; 95% confidence interval [CI], 3.78 to 8.17; P<0.001) and of ischemic stroke or systemic embolism (hazard ratio, 2.49; 95% CI, 1.28 to 4.85; P = 0.007). Of 51 patients who had a primary outcome event, 11 had had subclinical atrial tachyarrhythmias detected by 3 months, and none had had clinical atrial fibrillation by 3 months. The population attributable risk of stroke or systemic embolism associated with subclinical atrial tachyarrhythmias was 13%. Subclinical atrial tachyarrhythmias remained predictive of the primary outcome after adjustment for predictors of stroke (hazard ratio, 2.50; 95% CI, 1.28 to 4.89; P = 0.008). Continuous atrial overdrive pacing did not prevent atrial fibrillation. CONCLUSIONS Subclinical atrial tachyarrhythmias, without clinical atrial fibrillation, occurred frequently in patients with pacemakers and were associated with a significantly increased risk of ischemic stroke or systemic embolism. (Funded by St. Jude Medical; ASSERT ClinicalTrials.gov number, NCT00256152.)	[Healey, Jeff S.; Connolly, Stuart J.; Yang, Sean; Morillo, Carlos A.; Themeles, Ellison] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada; [Gold, Michael R.] Med Univ S Carolina, Charleston, SC USA; [Israel, Carsten W.; Hohnloser, Stefan H.] Goethe Univ Frankfurt, Frankfurt, Germany; [Van Gelder, Isabelle C.] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Capucci, Alessandro] Univ Politecn Marche, Clin Cardiol, Ancona, Italy; [Lau, C. P.] Univ Hong Kong, Dept Med, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China; [Fain, Eric; Bailleul, Christophe; Carlson, Mark] St Jude Med, Sylmar, CA USA; [Kaufman, Elizabeth S.] Case Western Reserve Univ, Cleveland, OH 44106 USA	McMaster University; Population Health Research Institute; Medical University of South Carolina; Goethe University Frankfurt; University of Groningen; Marche Polytechnic University; University of Hong Kong; Case Western Reserve University	Connolly, SJ (corresponding author), McMaster Univ, Populat Hlth Res Inst, 237 Barton St E, Hamilton, ON L8L 2X2, Canada.	connostu@phri.ca	Turazza, Fabio/AAB-8736-2020; Tang, Anthony S/E-6203-2014	Turazza, Fabio/0000-0002-2348-5309; Talajic, Mario/0000-0001-8469-4748; tuininga, ype/0000-0002-7861-8623; Telfer, Evelyn/0000-0003-1468-4610	St. Jude Medical; Boehringer Ingelheim; Bayer; Boston Scientific; AstraZeneca; Medtronic; Sorin; Biotronik; Sanofi-Aventis; Merck; Meda Pharmaceuticals; Bristol-Myers Squibb; Cardiome; Pfizer	St. Jude Medical(St. Jude Medical); Boehringer Ingelheim(Boehringer Ingelheim); Bayer(Bayer AG); Boston Scientific(Boston Scientific); AstraZeneca(AstraZeneca); Medtronic(Medtronic); Sorin; Biotronik; Sanofi-Aventis(Sanofi-Aventis); Merck(Merck & Company); Meda Pharmaceuticals; Bristol-Myers Squibb(Bristol-Myers Squibb); Cardiome; Pfizer(Pfizer)	Dr. Healey reports receiving consulting fees from St. Jude Medical, Boehringer Ingelheim, and Bayer and grant support from Boehringer Ingelheim, Boston Scientific, and AstraZeneca; Dr. Connolly, receiving grant support and lecture fees from St. Jude Medical; Dr. Gold, receiving fees for board membership from St. Jude Medical and Medtronic, consulting fees from St. Jude Medical and Medtronic, grant support from St. Jude Medical, Boston Scientific, Sorin, and Medtronic, and lecture fees from St. Jude Medical, Boston Scientific, Sorin, Medtronic, and Biotronik; Dr. Israel, receiving fees for board membership from Medtronic and lecture fees and reimbursement for travel expenses from Boston Scientific, Medtronic, Sorin, St. Jude Medical, and Biotronik; Dr. Van Gelder, receiving consulting fees from Boehringer Ingelheim, Medtronic, and Sanofi-Aventis, grant support from Medtronic and Biotronik, and lecture fees from Boehringer Ingelheim, Medtronic, Merck, and Sanofi-Aventis; Dr. Capucci, receiving consulting fees from Merck, Sanofi-Aventis, and Meda Pharmaceuticals, lecture fees from Merck and Sanofi-Aventis, and reimbursement for meeting expenses from Sorin, Boston Scientific, Merck, and Sanofi-Aventis; Dr. Fain, being employed by and receiving stock, fees for patents, and reimbursement for meeting expenses from St. Jude Medical; Dr. Bailleul, being employed by and receiving stock from St. Jude Medical; Dr. Morillo, receiving consulting fees from St. Jude Medical, Biotronik, Medtronic, Boston Scientific, Sanofi-Aventis, and Boehringer Ingelheim, grant support from St. Jude Medical, Medtronic, and Boston Scientific, and lecture fees from Boston Scientific, St. Jude Medical, Medtronic, Boehringer Ingelheim, Sanofi-Aventis, and Biotronik; Dr. Carlson, being employed by and receiving grant support, stock, and reimbursement for meeting expenses from St. Jude Medical; Mr. Themeles, receiving grant support from St. Jude Medical; and Dr. Hohnloser, receiving consulting fees from Sanofi-Aventis, Bristol-Myers Squibb, Pfizer, Boehringer Ingelheim, and Cardiome and lecture fees from Sanofi-Aventis, St. Jude Medical, Boehringer Ingelheim, Bristol-Myers Squibb, and Pfizer. No other potential conflict of interest relevant to this article was reported.	Birnie D, 2006, AM J CARDIOL, V98, P93, DOI 10.1016/j.amjcard.2006.01.069; Carlson MD, 2003, J AM COLL CARDIOL, V42, P627, DOI 10.1016/S0735-1097(03)00780-0; Curtis JP, 2009, JAMA-J AM MED ASSOC, V301, P1661, DOI 10.1001/jama.2009.547; Flaker GC, 2005, AM HEART J, V149, P657, DOI 10.1016/j.ahj.2004.06.032; FURBERG CD, 1994, AM J CARDIOL, V74, P236, DOI 10.1016/0002-9149(94)90363-8; Glotzer TV, 2009, CIRC-ARRHYTHMIA ELEC, V2, P474, DOI 10.1161/CIRCEP.109.849638; Glotzer TV, 2003, CIRCULATION, V107, P1614, DOI 10.1161/01.CIR.0000057981.70380.45; Gold MR, 2009, HEART RHYTHM, V6, P295, DOI 10.1016/j.hrthm.2008.11.033; Healey JS, 2006, CIRCULATION, V114, P11, DOI 10.1161/CIRCULATIONAHA.105.610303; Hemels MEW, 2008, EUROPACE, V10, P304, DOI 10.1093/europace/eum301; Holnloser SH, 2006, AM HEART J, V152, P442, DOI 10.1016/j.ahj.2006.02.016; Israel CW, 2004, J AM COLL CARDIOL, V43, P47, DOI 10.1016/j.jacc.2003.08.027; Jabaudon D, 2004, STROKE, V35, P1647, DOI 10.1161/01.STR.0000131269.69502.d9; Kerr CR, 2004, CIRCULATION, V109, P357, DOI 10.1161/01.CIR.0000109490.72104.EE; Lee MA, 2003, J AM COLL CARDIOL, V41, P1926, DOI 10.1016/S0735-1097(03)00426-1; Liao J, 2007, STROKE, V38, P2935, DOI 10.1161/STROKEAHA.106.478685; Ogawa H, 2008, CIRC J, V72, P700, DOI 10.1253/circj.72.700; Padeletti L, 2003, J CARDIOVASC ELECTR, V14, P1189, DOI 10.1046/j.1540-8167.2003.03191.x; PETERSEN P, 1986, STROKE, V17, P622, DOI 10.1161/01.STR.17.4.622; Pollak WM, 2001, PACE, V24, P424, DOI 10.1046/j.1460-9592.2001.00424.x; Sinha AM, 2010, AM HEART J, V160; Skanes AC, 2001, J AM COLL CARDIOL, V38, P167, DOI 10.1016/S0735-1097(01)01326-2; Tayal AH, 2008, NEUROLOGY, V71, P1696, DOI 10.1212/01.wnl.0000325059.86313.31; Wilkoff BL, 2008, EUROPACE, V10, P707, DOI 10.1093/europace/eun122; WOLF PA, 1987, ARCH INTERN MED, V147, P1561, DOI 10.1001/archinte.147.9.1561; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; WOLF PA, 1978, NEUROLOGY, V28, P973, DOI 10.1212/WNL.28.10.973	27	1303	1347	5	69	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 12	2012	366	2					120	129		10.1056/NEJMoa1105575	http://dx.doi.org/10.1056/NEJMoa1105575			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874VA	22236222	Green Published			2022-12-28	WOS:000298985000006
J	Vilsboll, T; Christensen, M; Junker, AE; Knop, FK; Gluud, LL				Vilsboll, Tina; Christensen, Mikkel; Junker, Anders E.; Knop, Filip K.; Gluud, Lise Lotte			Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BIPHASIC INSULIN ASPART; BETA-CELL FUNCTION; GLYCEMIC CONTROL; OPEN-LABEL; EXENATIDE EXENDIN-4; PARALLEL-GROUP; TYPE-2; METFORMIN; LIRAGLUTIDE; EFFICACY	Objective To determine whether treatment with agonists of glucagon-like peptide-1 receptor (GLP-1R) result in weight loss in overweight or obese patients with or without type 2 diabetes mellitus. Design Systematic review with meta-analyses. Data sources Electronic searches (Cochrane Library, Medline, Embase, and Web of Science) and manual searches (up to May 2011). Review methods Randomised controlled trials of adult participants with a body mass index of 25 or higher; with or without type 2 diabetes mellitus; and who received exenatide twice daily, exenatide once weekly, or liraglutide once daily at clinically relevant doses for at least 20 weeks. Control interventions assessed were placebo, oral antidiabetic drugs, or insulin. Data extraction Three authors independently extracted data. We used random effects models for the primary meta-analyses. We also did subgroup, sensitivity, regression, and sequential analyses to evaluate sources of intertrial heterogeneity, bias, and the robustness of results after adjusting for multiple testing and random errors. Results 25 trials were included in the analysis. GLP-1R agonist groups achieved a greater weight loss than control groups (weighted mean difference -2.9 kg, 95% confidence interval -3.6 to -2.2; 21 trials, 6411 participants). We found evidence of intertrial heterogeneity, but no evidence of bias or small study effects in regression analyses. The results were confirmed in sequential analyses. We recorded weight loss in the GLP-1R agonist groups for patients without diabetes (-3.2 kg, -4.3 to -2.1; three trials) as well as patients with diabetes (-2.8 kg, -3.4 to -2.3; 18 trials). In the overall analysis, GLP-1R agonists had beneficial effects on systolic and diastolic blood pressure, plasma concentrations of cholesterol, and glycaemic control, but did not have a significant effect on plasma concentrations of liver enzymes. GLP-1R agonists were associated with nausea, diarrhoea, and vomiting, but not with hypoglycaemia. Conclusions The present review provides evidence that treatment with GLP-1R agonists leads to weight loss in overweight or obese patients with or without type 2 diabetes mellitus.	[Vilsboll, Tina; Christensen, Mikkel; Junker, Anders E.; Knop, Filip K.; Gluud, Lise Lotte] Univ Copenhagen, Gentofte Hosp, Dept Internal Med F, Diabet Res Div, DK-2900 Hellerup, Denmark	University of Copenhagen; Herlev & Gentofte Hospital	Vilsboll, T (corresponding author), Univ Copenhagen, Gentofte Hosp, Dept Internal Med F, Diabet Res Div, DK-2900 Hellerup, Denmark.	t.vilsboll@dadlnet.dk	Vilsboll, Tina/I-6562-2016; Gluud, Lise L/AAY-2120-2020; Knop, Filip K/GQI-2604-2022; Christensen, Mikkel/H-5861-2013	Gluud, Lise L/0000-0002-9462-4468; Knop, Filip K/0000-0002-2495-5034; Christensen, Mikkel/0000-0002-8774-1797	Novo Nordisk; Eli Lilly/Amylin; Novo Nordisk Fonden [NNF12OC1015904] Funding Source: researchfish	Novo Nordisk(Novo Nordisk); Eli Lilly/Amylin; Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank Novo Nordisk and Eli Lilly/Amylin who provided additional data from the trials funded by the two pharmaceutical companies; Jorn Wetterslev for his help with the sequential analyses; and Anne-Marie Demuth Jorgensen for technical assistance.	Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS12, DOI 10.2337/dc08-S012; Apovian CM, 2010, AM J MED, V123, DOI 10.1016/j.amjmed.2009.11.019; Astrup A, 2009, LANCET, V374, P1606, DOI 10.1016/S0140-6736(09)61375-1; Bergenstal R, 2009, CURR MED RES OPIN, V25, P65, DOI 10.1185/03007990802597951 ; Bergenstal RM, 2010, LANCET, V376, P431, DOI 10.1016/S0140-6736(10)60590-9; Blevins T, 2011, J CLIN ENDOCR METAB, V96, P1301, DOI 10.1210/jc.2010-2081; Bolen S, 2007, ANN INTERN MED, V147, P386, DOI 10.7326/0003-4819-147-6-200709180-00178; Breitfelder A, 2011, ECON HUM BIOL, V9, P302, DOI 10.1016/j.ehb.2011.02.001; Bunck MC, 2009, DIABETES CARE, V32, P762, DOI 10.2337/dc08-1797; Buse JB, 2004, DIABETES CARE, V27, P2628, DOI 10.2337/diacare.27.11.2628; Buse JB, 2009, LANCET, V374, P39, DOI 10.1016/S0140-6736(09)60659-0; Cao Y, 2011, CANCER PREV RES, V4, P486, DOI 10.1158/1940-6207.CAPR-10-0229; Cheung BMY, 2009, AM J MED, V122, P443, DOI 10.1016/j.amjmed.2008.09.047; Cochrane Collaboration, 2011, COCHRANE HDB SYSTEMA; Davies M, 2011, DIABETIC MED, V28, P333, DOI 10.1111/j.1464-5491.2010.03074.x; Davis SN, 2007, DIABETES CARE, V30, P2767, DOI 10.2337/dc06-2532; DeFronzo RA, 2010, DIABETES CARE, V33, P951, DOI [10.2337/dc09-1521, 10.2337/dc10-0646]; Derosa G, 2010, DIABETES TECHNOL THE, V12, P233, DOI 10.1089/dia.2009.0141; Diamant M, 2010, LANCET, V375, P2234, DOI 10.1016/S0140-6736(10)60406-0; Drucker DJ, 2008, LANCET, V372, P1240, DOI 10.1016/S0140-6736(08)61206-4; Elkind-Hirsch K, 2008, J CLIN ENDOCR METAB, V93, P2670, DOI 10.1210/jc.2008-0115; European Medicines Agency, 2011, E LILL CO SUMM PROD; European Medicines Agency, 2010, NOV NORD SUMM PROD C; FABRICATORE AN, 2011, INT J OBES LOND; Fezeu L, 2011, OBES REV, V12, P653, DOI 10.1111/j.1467-789X.2011.00864.x; Field AE, 2001, ARCH INTERN MED, V161, P1581, DOI 10.1001/archinte.161.13.1581; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Franz MJ, 2007, J AM DIET ASSOC, V107, P1755, DOI 10.1016/j.jada.2007.07.017; Garber A, 2009, LANCET, V373, P473, DOI 10.1016/S0140-6736(08)61246-5; Gourlan MJ, 2011, OBES REV, V12, pE633, DOI 10.1111/j.1467-789X.2011.00874.x; Heine RJ, 2005, ANN INTERN MED, V143, P559, DOI 10.7326/0003-4819-143-8-200510180-00006; Ismail MH, 2011, AM J MED SCI, V341, P485, DOI 10.1097/MAJ.0b013e3182018598; Kendall DM, 2005, DIABETES CARE, V28, P1083, DOI 10.2337/diacare.28.5.1083; Kjaergard LL, 2002, AM J GASTROENTEROL, V97, P2708; Li MF, 2009, BRIT J CLIN PHARMACO, V68, P804, DOI 10.1111/j.1365-2125.2009.03453.x; Marre M, 2009, DIABETIC MED, V26, P268, DOI 10.1111/j.1464-5491.2009.02666.x; Moretto TJ, 2008, CLIN THER, V30, P1448, DOI 10.1016/j.clinthera.2008.08.006; Nauck MA, 2007, DIABETOLOGIA, V50, P259, DOI 10.1007/s00125-006-0510-2; Nauck M, 2009, DIABETES CARE, V32, P84, DOI 10.2337/dc08-1355; Norris SL, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004096.pub2, 10.1002/14651858.CD004095.pub2, 10.1002/14651858.CD005270]; Padwal R, 2011, OBES REV, V12, P602, DOI 10.1111/j.1467-789X.2011.00866.x; Padwal RS, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004094.pub2, DOI 10.1002/14651858.CD004094.PUB2]; Pontiroli AE, 2011, ANN SURG, V253, P484, DOI 10.1097/SLA.0b013e31820d98cb; Pratley RE, 2010, LANCET, V375, P1447, DOI 10.1016/S0140-6736(10)60307-8; Rosenstock J, 2010, DIABETES CARE, V33, P1173, DOI 10.2337/dc09-1203; Rucker D, 2007, BMJ-BRIT MED J, V335, P1194, DOI 10.1136/bmj.39385.413113.25; Russell-Jones D, 2009, DIABETOLOGIA, V52, P2046, DOI 10.1007/s00125-009-1472-y; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; World Health Organization, 2016, OB OV; Zinman B, 2009, DIABETES CARE, V32, P1224, DOI 10.2337/dc08-2124	52	577	600	1	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 11	2012	344								d7771	10.1136/bmj.d7771	http://dx.doi.org/10.1136/bmj.d7771			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877SI	22236411	Green Published, hybrid			2022-12-28	WOS:000299202500014
J	Sarewitz, D				Sarewitz, Daniel			Blue-sky bias should be brought down to Earth	NATURE			English	Editorial Material									Arizona State Univ, Consortium Sci Policy & Outcomes, Washington, DC USA	Arizona State University	Sarewitz, D (corresponding author), Arizona State Univ, Consortium Sci Policy & Outcomes, Washington, DC USA.	daniel.sarewitz@gmail.com						Leshner AI, 2011, SCIENCE, V334, P738, DOI 10.1126/science.1215299	1	4	4	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 5	2012	481	7379					7	7		10.1038/481007a	http://dx.doi.org/10.1038/481007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	872VD	22222726	Bronze			2022-12-28	WOS:000298836900002
J	Ross, JS; Tse, T; Zarin, DA; Xu, H; Zhou, L; Krumholz, HM				Ross, Joseph S.; Tse, Tony; Zarin, Deborah A.; Xu, Hui; Zhou, Lei; Krumholz, Harlan M.			Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OUTCOME REPORTING BIAS; RANDOMIZED-TRIALS; EMPIRICAL-EVIDENCE; CLINICAL-RESEARCH; REGISTRATION; COMMITTEE; PROTOCOLS; EFFICACY; COHORT	Objective To review patterns of publication of clinical trials funded by US National Institutes of Health (NIH) in peer reviewed biomedical journals indexed by Medline. Design Cross sectional analysis. Setting Clinical trials funded by NIH and registered within ClinicalTrials.gov (clinicaltrials.gov), a trial registry and results database maintained by the US National Library of Medicine, after 30 September 2005 and updated as having been completed by 31 December 2008, allowing at least 30 months for publication after completion of the trial. Main outcome measures Publication and time to publication in the biomedical literature, as determined through Medline searches, the last of which was performed in June 2011. Results Among 635 clinical trials completed by 31 December 2008, 294 (46%) were published in a peer reviewed biomedical journal, indexed by Medline, within 30 months of trial completion. The median period of follow-up after trial completion was 51 months (25th-75th centiles 40-68 months), and 432 (68%) were published overall. Among published trials, the median time to publication was 23 months (14-36 months). Trials completed in either 2007 or 2008 were more likely to be published within 30 months of study completion compared with trials completed before 2007 (54% (196/366) v 36% (98/269); P<0.001). Conclusions Despite recent improvement in timely publication, fewer than half of trials funded by NIH are published in a peer reviewed biomedical journal indexed by Medline within 30 months of trial completion. Moreover, after a median of 51 months after trial completion, a third of trials remained unpublished.	[Ross, Joseph S.] Yale Univ, Sch Med, Gen Internal Med Sect, Dept Med, New Haven, CT 06520 USA; [Ross, Joseph S.; Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Tse, Tony; Zarin, Deborah A.] NIH, Lister Hill Natl Ctr Biomed Commun, Natl Lib Med, Bethesda, MD 20892 USA; [Xu, Hui; Zhou, Lei] Chinese Acad Med Sci, Fuwai Hosp, Beijing 100730, Peoples R China; [Xu, Hui; Zhou, Lei] Chinese Acad Med Sci, Cardiovasc Inst, Beijing 100730, Peoples R China; [Xu, Hui; Zhou, Lei] Peking Union Med Coll, Beijing 100021, Peoples R China; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, New Haven, CT USA; [Krumholz, Harlan M.] Yale Univ, Sch Epidemiol & Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT USA	Yale University; Yale University; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Yale University; Yale University; Yale University	Ross, JS (corresponding author), Yale Univ, Sch Med, Gen Internal Med Sect, Dept Med, POB 208093, New Haven, CT 06520 USA.	joseph.ross@yale.edu	Zhou, Lei/E-6314-2012; , Harlan/AAI-2875-2020	Ross, Joseph/0000-0002-9218-3320; Tse, Tony/0000-0002-9906-6864	US National Library of Medicine, National Institutes of Health, Department of Health and Human Services [HHSN276201000788P]; Medtronic; Centers of Medicare and Medicaid Services (CMS); National Institute on Aging [K08 AG032886]; American Federation for Aging Research; National Institutes of Health, National Library of Medicine; National Heart, Lung, and Blood Institute Cardiovascular Outcomes Center [1U01HL105270-02]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM008926] Funding Source: NIH RePORTER	US National Library of Medicine, National Institutes of Health, Department of Health and Human Services; Medtronic(Medtronic); Centers of Medicare and Medicaid Services (CMS); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Federation for Aging Research; National Institutes of Health, National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Heart, Lung, and Blood Institute Cardiovascular Outcomes Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The analyses on which this publication is based were performed under Contract No. HHSN276201000788P, entitled "Evaluating Time-to-Publication Following Completion of Clinical Trials and Related Factors," funded by the US National Library of Medicine, National Institutes of Health, Department of Health and Human Services. The ideas and opinions expressed are those of the authors. The content of this publication does not necessarily reflect the views or policies of the US National Institutes of Health, Public Health Service, or Department of Health and Human Services. The authors assume full responsibility for the accuracy and completeness of the ideas presented. JSR and HMK receive support from Medtronic and from the Centers of Medicare and Medicaid Services (CMS) to develop and maintain performance measures that are used for public reporting. JSR is supported by the National Institute on Aging (K08 AG032886) and by the American Federation for Aging Research through the Paul B Beeson Career Development Award Program. DAZ and TT are supported by the Intramural Research Program of the National Institutes of Health, National Library of Medicine. HMK is supported by a National Heart, Lung, and Blood Institute Cardiovascular Outcomes Center Award (1U01HL105270-02).	Bardy AH, 1998, BRIT J CLIN PHARMACO, V46, P147, DOI 10.1046/j.1365-2125.1998.00759.x; Bourgeois FT, 2010, ANN INTERN MED, V153, P158, DOI 10.7326/0003-4819-153-3-201008030-00006; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; Decullier E, 2005, BMJ-BRIT MED J, V331, P19, DOI 10.1136/bmj.38488.385995.8F; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; Dickersin K, 1993, ONLINE J CURR C 0428; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Emerson GB, 2010, ARCH INTERN MED, V170, P1934, DOI 10.1001/archinternmed.2010.406; Giffin RB, 2010, HEALTH AFFAIR, V29, P2075, DOI 10.1377/hlthaff.2010.0669; International Committee of Medical Journal Editors, UN REQ BIOM J UNPUB; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P281, DOI 10.1001/jama.279.4.281; Krall RL, 2011, CLIN PHARMACOL THER, V89, P225, DOI 10.1038/clpt.2010.292; Krzyzanowska MK, 2003, JAMA-J AM MED ASSOC, V290, P495, DOI 10.1001/jama.290.4.495; Lee K, 2008, PLOS MED, V5, P1348, DOI 10.1371/journal.pmed.0050191; Misakian AL, 1998, JAMA-J AM MED ASSOC, V280, P250, DOI 10.1001/jama.280.3.250; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; US Department of Health and Human Services, 2011, RES PORTF ONL REP TO; US Department of Health and Human Services, 2009, NIH PUBL ACC POL DET; US Department of Health and Human Services National Institutes of Health Office of Extramural Research, 2007, NIH DAT SHAR POL; US National Institutes of Health, GLOSS CLIN TRIAL TER; US National Institutes of Health, AB CLINICALTRIALS GO; US National Institutes of Health, CLINICALTRIALS GOV P; von Elm E, 2008, SWISS MED WKLY, V138, P197, DOI 2008/13/smw-12027; World Medical Association, 2008, 59 WMA GEN ASS SEOUL; Zarin DA, 2005, NEW ENGL J MED, V353, P2779, DOI 10.1056/NEJMsa053234; Zarin DA, 2011, NEW ENGL J MED, V364, P852, DOI 10.1056/NEJMsa1012065	32	246	247	0	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 3	2012	344								d7292	10.1136/bmj.d7292	http://dx.doi.org/10.1136/bmj.d7292			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874UE	22214755	Green Published, hybrid			2022-12-28	WOS:000298982800005
J	Brody, H; Miller, FG				Brody, Howard; Miller, Franklin G.			Lessons From Recent Research About the Placebo Effect-From Art to Science	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Brody, Howard] Univ Texas Med Branch, Inst Med Humanities, Dept Family Med, Galveston, TX 77555 USA; [Miller, Franklin G.] NIH, Dept Bioeth, Ctr Clin, Bethesda, MD 20892 USA	University of Texas System; University of Texas Medical Branch Galveston; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Brody, H (corresponding author), Univ Texas Med Branch, Inst Med Humanities, Dept Family Med, 301 Univ Blvd, Galveston, TX 77555 USA.	habrody@utmb.edu	Brody, Howard/GQA-6310-2022					Brody H, 2000, J FAM PRACTICE, V49, P649; Colloca L, 2004, LANCET NEUROL, V3, P679, DOI 10.1016/S1474-4422(04)00908-1; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Kaptchuk TJ, 2008, BMJ-BRIT MED J, V336, P999, DOI 10.1136/bmj.39524.439618.25; Kaptchuk TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015591; Kermen R, 2010, FAM MED, V42, P636; Miller FG, 2009, AM J BIOETHICS, V9, P39, DOI 10.1080/15265160903316263; Miller FG, 2009, PERSPECT BIOL MED, V52, P518, DOI 10.1353/pbm.0.0115; Tilburt JC, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1938	9	38	38	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 21	2011	306	23					2612	2613		10.1001/jama.2011.1850	http://dx.doi.org/10.1001/jama.2011.1850			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	864YQ	22187283				2022-12-28	WOS:000298276800025
J	Barer, D				Barer, David			Review: Inpatient comprehensive geriatric assessment improves the likelihood of living at home at 12 months	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Barer, D (corresponding author), Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.							Gill TM, 2010, JAMA-J AM MED ASSOC, V304, P1919, DOI 10.1001/jama.2010.1568	1	0	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2011	155	12							JC6-2	10.7326/0003-4819-155-12-201112200-02002	http://dx.doi.org/10.7326/0003-4819-155-12-201112200-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	864ZU	22184703				2022-12-28	WOS:000298280500001
J	Wolkewitz, M; Allignol, A; Graves, N; Barnett, AG				Wolkewitz, Martin; Allignol, Arthur; Graves, Nicholas; Barnett, Adrian G.			CHRISTMAS 2011: DEATH'S DOMINION Is 27 really a dangerous age for famous musicians? Retrospective cohort study	BRITISH MEDICAL JOURNAL			English	Editorial Material								Objective To test the "27 club" hypothesis that famous musicians are at an increased risk of death at age 27. Design Cohort study using survival analysis with age as a time dependent exposure. Comparison was primarily made within musicians, and secondarily relative to the general UK population. Setting The popular music scene from a UK perspective. Participants Musicians (solo artists and band members) who had a number one album in the UK between 1956 and 2007 (n=1046 musicians, with 71 deaths, 7%). Main outcome measures Risk of death by age of musician, accounting for time dependent study entry and the number of musicians at risk. Risk was estimated using a flexible spline which would allow a bump at age 27 to appear. Results We identified three deaths at age 27 amongst 522 musicians at risk, giving a rate of 0.57 deaths per 100 musician years. Similar death rates were observed at ages 25 (rate=0.56) and 32 (0.54). There was no peak in risk around age 27, but the risk of death for famous musicians throughout their 20s and 30s was two to three times higher than the general UK population. Conclusions The 27 club is unlikely to be a real phenomenon. Fame may increase the risk of death among musicians, but this risk is not limited to age 27.	[Graves, Nicholas; Barnett, Adrian G.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia; [Graves, Nicholas; Barnett, Adrian G.] Queensland Univ Technol, Sch Publ Hlth, Brisbane, Qld 4059, Australia; [Wolkewitz, Martin; Allignol, Arthur] Univ Freiburg, Freiburg Ctr Data Anal & Modelling, D-79106 Freiburg, Germany; [Wolkewitz, Martin; Allignol, Arthur] Univ Med Ctr, Inst Med Biometry & Med Informat, Freiburg, Germany	Queensland University of Technology (QUT); Queensland University of Technology (QUT); University of Queensland; University of Freiburg; University of Freiburg	Barnett, AG (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia.	a.barnett@qut.edu.au	Barnett, Adrian/I-9850-2012	Barnett, Adrian/0000-0001-6339-0374; Wolkewitz, Martin/0000-0002-1268-5057; Graves, Nicholas/0000-0002-5559-3267				Beyersmann J, 2011, COMPETING RISKS MULT; Blastland M., 2008, TIGER ISNT SEEING WO; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; Darke S, 1996, ADDICTION, V91, P1765, DOI 10.1111/j.1360-0443.1996.tb03800.x; Giles J, 2005, NATURE, V438, P900, DOI 10.1038/438900a; Goldacre B., 2010, BAD SCI QUACKS HACKS; Grimes DA, 2002, LANCET, V359, P341, DOI 10.1016/S0140-6736(02)07500-1; HOWLAND J, 1988, ACCIDENT ANAL PREV, V20, P19, DOI 10.1016/0001-4575(88)90011-5; KEIDING N, 1990, PHILOS T ROY SOC A, V332, P487, DOI 10.1098/rsta.1990.0128; Rosenthal VD, 2011, EPIDEMIOL INFECT, V139, P1757, DOI 10.1017/S0950268811000094; Ruppert D., 2003, CAMBRIDGE SERIES STA; Segalstad Eric, 2009, 27S GREATEST MYTH RO	12	11	11	0	14	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2011	343								d7799	10.1136/bmj.d7799	http://dx.doi.org/10.1136/bmj.d7799			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	868QK	22187325	hybrid, Green Published			2022-12-28	WOS:000298538200009
J	Rispoli, P; Varetto, G; Santovito, D; Castagno, C; Tallia, C				Rispoli, Pietro; Varetto, Gianfranco; Santovito, Davide; Castagno, Claudio; Tallia, Caterina			A severe cause of pulsating varicose veins	LANCET			English	Editorial Material									[Rispoli, Pietro; Varetto, Gianfranco; Santovito, Davide; Castagno, Claudio; Tallia, Caterina] Univ Turin, Dept Med & Surg Disciplines, Div Vasc Surg, I-10126 Turin, Italy	University of Turin	Rispoli, P (corresponding author), Univ Turin, Dept Med & Surg Disciplines, Div Vasc Surg, Molinette Hosp Corso AM, Dogliotti 14, I-10126 Turin, Italy.	pietro.rispoli@unito.it		RISPOLI, PIETRO/0000-0003-3336-9122; Varetto, Gianfranco/0000-0003-4262-886X				Abbas M, 2006, ANZ J SURG, V76, P264, DOI 10.1111/j.1445-2197.2006.03597.x; Barnett N, 2000, J ROY SOC MED, V93, P29, DOI 10.1177/014107680009300111; BLACKETT RL, 1988, BRIT J SURG, V75, P865, DOI 10.1002/bjs.1800750911; CHOW WH, 1990, BRIT J CLIN PRACT, V44, P669; Moawad MR, 1998, LANCET, V352, P1030, DOI 10.1016/S0140-6736(98)04471-7	5	2	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 17	2011	378	9809					2138	2138		10.1016/S0140-6736(11)61578-X	http://dx.doi.org/10.1016/S0140-6736(11)61578-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	865EL	22177513				2022-12-28	WOS:000298293600036
J	Lander, GC; Estrin, E; Matyskiela, ME; Bashore, C; Nogales, E; Martin, A				Lander, Gabriel C.; Estrin, Eric; Matyskiela, Mary E.; Bashore, Charlene; Nogales, Eva; Martin, Andreas			Complete subunit architecture of the proteasome regulatory particle	NATURE			English	Article							UBIQUITIN CHAINS; NEW-GENERATION; TRANSLOCATION; DEGRADATION; PROTEINS; DOCKING; RPN1; ATP; DEUBIQUITINATION; IDENTIFICATION	The proteasome is the major ATP-dependent protease in eukaryotic cells, but limited structural information restricts a mechanistic understanding of its activities. The proteasome regulatory particle, consisting of the lid and base subcomplexes, recognizes and processes polyubiquitinated substrates. Here we used electron microscopy and a new heterologous expression system for the lid to delineate the complete subunit architecture of the regulatory particle from yeast. Our studies reveal the spatial arrangement of ubiquitin receptors, deubiquitinating enzymes and the protein unfolding machinery at subnanometre resolution, outlining the substrate's path to degradation. Unexpectedly, the ATPase subunits within the base unfoldase are arranged in a spiral staircase, providing insight into potential mechanisms for substrate translocation through the central pore. Large conformational rearrangements of the lid upon holoenzyme formation suggest allosteric regulation of deubiquitination. We provide a structural basis for the ability of the proteasome to degrade a diverse set of substrates and thus regulate vital cellular processes.	[Estrin, Eric; Matyskiela, Mary E.; Bashore, Charlene; Martin, Andreas] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Lander, Gabriel C.; Nogales, Eva] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Nogales, Eva] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Nogales, Eva; Martin, Andreas] Univ Calif Berkeley, Inst QB3, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Martin, A (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	a.martin@berkeley.edu		Martin, Andreas/0000-0003-0923-3284; Lander, Gabriel C./0000-0003-4921-1135	Damon Runyon Cancer Research Foundation; American Cancer Society [121453-PF-11-178-01-TBE]; NSF; Searle Scholars Program; UC Berkeley MCB Department; NIH [R01-GM094497-01A1]; Lawrence Berkeley National Laboratory; Howard Hughes Medical Institute; NIH through the NCRR [RR017573]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094497, T32GM007232] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; American Cancer Society(American Cancer Society); NSF(National Science Foundation (NSF)); Searle Scholars Program; UC Berkeley MCB Department; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH through the NCRR; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of the Martin and Nogales labs for helpful discussions, and G. Cardone for help with local resolution calculations. G. C. L. acknowledges support from Damon Runyon Cancer Research Foundation, M. E. M. acknowledges support by the American Cancer Society grant 121453-PF-11-178-01-TBE, C. B. acknowledges support from the NSF Graduate Research Fellowship. This research was funded in part by the Searle Scholars Program (A. M.), start-up funds from the UC Berkeley MCB Department (A. M.), the NIH grant R01-GM094497-01A1 (A. M.), the Lawrence Berkeley National Laboratory (G. C. L.), and the Howard Hughes Medical Institute (E.N.). Some of the work presented here was conducted at the National Resource for Automated Molecular Microscopy, which is supported by the NIH through the NCRR P41 program (RR017573).	Aubin-Tam ME, 2011, CELL, V145, P257, DOI 10.1016/j.cell.2011.03.036; Bohn S, 2010, P NATL ACAD SCI USA, V107, P20992, DOI 10.1073/pnas.1015530107; Bremm A, 2010, NAT STRUCT MOL BIOL, V17, P939, DOI 10.1038/nsmb.1873; COOK WJ, 1992, J BIOL CHEM, V267, P16467; Eddins MJ, 2007, J MOL BIOL, V367, P204, DOI 10.1016/j.jmb.2006.12.065; Effantin G, 2009, J MOL BIOL, V386, P1204, DOI 10.1016/j.jmb.2009.01.039; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Forster F, 2009, BIOCHEM BIOPH RES CO, V388, P228, DOI 10.1016/j.bbrc.2009.07.145; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Gomez TA, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-33; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Inobe T, 2011, NAT CHEM BIOL, V7, P161, DOI 10.1038/NCHEMBIO.521; Kim HC, 2009, MOL CELL BIOL, V29, P3307, DOI 10.1128/MCB.00240-09; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Leggett David S., 2005, V301, P57; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Maillard RA, 2011, CELL, V145, P459, DOI 10.1016/j.cell.2011.04.010; Mallick SP, 2005, ULTRAMICROSCOPY, V104, P8, DOI 10.1016/j.ultramic.2005.02.004; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Nickell S, 2009, P NATL ACAD SCI USA, V106, P11943, DOI 10.1073/pnas.0905081106; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Riedinger C, 2010, J BIOL CHEM, V285, P33992, DOI 10.1074/jbc.M110.134510; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Schug ZT, 2008, J BIOL CHEM, V283, P2939, DOI [10.1074/jbc.M706645200, 10.1074/jbc.M802716200]; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Sone T, 2004, J BIOL CHEM, V279, P28807, DOI 10.1074/jbc.M403165200; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Thomsen ND, 2009, CELL, V139, P523, DOI 10.1016/j.cell.2009.08.043; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tian G, 2011, NAT STRUCT MOL BIOL, V18, P1259, DOI 10.1038/nsmb.2147; Tomko RJ, 2010, MOL CELL, V38, P393, DOI 10.1016/j.molcel.2010.02.035; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Zhang F, 2009, MOL CELL, V34, P473, DOI 10.1016/j.molcel.2009.04.021	56	450	465	2	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2012	482	7384					186	U75		10.1038/nature10774	http://dx.doi.org/10.1038/nature10774			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888HI	22237024	Green Submitted, Green Accepted			2022-12-28	WOS:000299994100031
J	Brunoud, G; Wells, DM; Oliva, M; Larrieu, A; Mirabet, V; Burrow, AH; Beeckman, T; Kepinski, S; Traas, J; Bennett, MJ; Vernoux, T				Brunoud, Geraldine; Wells, Darren M.; Oliva, Marina; Larrieu, Antoine; Mirabet, Vincent; Burrow, Amy H.; Beeckman, Tom; Kepinski, Stefan; Traas, Jan; Bennett, Malcolm J.; Vernoux, Teva			A novel sensor to map auxin response and distribution at high spatio-temporal resolution	NATURE			English	Article							BOX PROTEIN TIR1; ARABIDOPSIS ROOT; AUX/IAA PROTEINS; PLANT DEVELOPMENT; GENE-EXPRESSION; TRANSPORT; GROWTH; DEGRADATION; MERISTEM; RECEPTOR	Auxin is a key plant morphogenetic signal(1) but tools to analyse dynamically its distribution and signalling during development are still limited. Auxin perception directly triggers the degradation of Aux/IAA repressor proteins(2-6). Here we describe a novel Aux/IAA-based auxin signalling sensor termed DII-VENUS that was engineered in the model plant Arabidopsis thaliana. The VENUS fast maturing form of yellow fluorescent protein(7) was fused in-frame to the Aux/IAA auxin-interaction domain (termed domain II; DII)(5) and expressed under a constitutive promoter. We initially show that DII-VENUS abundance is dependent on auxin, its TIR1/AFBs co-receptors(4-6,8) and proteasome activities. Next, we demonstrate that DII-VENUS provides a map of relative auxin distribution at cellular resolution in different tissues. DII-VENUS is also rapidly degraded in response to auxin and we used it to visualize dynamic changes in cellular auxin distribution successfully during two developmental responses, the root gravitropic response and lateral organ production at the shoot apex. Our results illustrate the value of developing response input sensors such as DII-VENUS to provide high-resolution spatio-temporal information about hormone distribution and response during plant growth and development.	[Brunoud, Geraldine; Oliva, Marina; Mirabet, Vincent; Traas, Jan; Vernoux, Teva] Univ Lyon, Lab Reprod & Dev Plantes, UCBL, ENS Lyon,INRA,CNRS, F-69364 Lyon, France; [Wells, Darren M.; Larrieu, Antoine; Bennett, Malcolm J.] Univ Nottingham, Ctr Plant Integrat Biol, Loughborough LE12 5RD, England; [Larrieu, Antoine; Beeckman, Tom] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Burrow, Amy H.; Kepinski, Stefan] Univ Leeds, Fac Biol Sci, Ctr Plant Sci, Leeds LS2 9JT, W Yorkshire, England	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); University of Nottingham; Flanders Institute for Biotechnology (VIB); Ghent University; University of Leeds	Vernoux, T (corresponding author), Univ Lyon, Lab Reprod & Dev Plantes, UCBL, ENS Lyon,INRA,CNRS, F-69364 Lyon, France.	teva.vernoux@ens-lyon.fr	Beeckman, Tom/ABA-1164-2020; Beeckman, Tom/ABI-1703-2020; Wells, Darren/GOJ-9739-2022; Larrieu, Antoine /O-9558-2017; Traas, Jan/AAZ-7004-2020; Vernoux, Teva/J-1695-2019; Bennett, Malcolm/G-4004-2010	Beeckman, Tom/0000-0001-8656-2060; Wells, Darren/0000-0002-4246-4909; Larrieu, Antoine /0000-0002-9024-5348; Traas, Jan/0000-0001-5107-1472; Vernoux, Teva/0000-0002-8257-4088; Oliva, Marina/0000-0001-8096-6857; Bennett, Malcolm/0000-0003-0475-390X	Human Frontier Science Program Organization [CDA 0047/2007 HFSPO]; Agence National de la Recherche [ANR-07-JCJC-0115, EraSysBio+ iSAM]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F013981/1, BB/F007418/1]; Engineering and Physical Sciences Research Council (EPSRC); Biotechnology and Biological Sciences Research Council [BB/F013981/1, BB/J009717/1, REI20541, BB/D019613/1, BB/F007418/1] Funding Source: researchfish; BBSRC [BB/J009717/1, BB/D019613/1, BB/F007418/1, BB/F013981/1] Funding Source: UKRI	Human Frontier Science Program Organization(Human Frontier Science Program); Agence National de la Recherche(French National Research Agency (ANR)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank A. Erktan and C. Cellier for help with marker expression analysis; J. Neve, A. Miyawaki, M. Heisler and M. Estelle for providing the 35S::Flag-TIR1 line, VENUS complementary DNA, DR5::VENUS plasmids and TIR/AFB GUS lines, respectively; the PLATIM for access to confocal microscopes; F. Parcy, O. Hamant, A. Boudaoud and P. Das for discussions. T. V. was supported by the Human Frontier Science Program Organization (CDA 0047/2007 HFSPO) and the Agence National de la Recherche (ANR-07-JCJC-0115 and EraSysBio+ iSAM). D. M. W., A. L. and M. J. B. acknowledge the support of the Biotechnology and Biological Sciences Research Council (BBSRC) and Engineering and Physical Sciences Research Council (EPSRC) funding to the Centre for Plant Integrative Biology (CPIB); BBSRC grants BB/F013981/1 and BB/F007418/1 to S. K.; BBSRC Professorial Research Fellowship funding to D. M. W. & M. J. B.; and Belgian Scientific policy (BELSPO contract BARN) to A. L., T.B. and M.J.B.	ABEL S, 1994, P NATL ACAD SCI USA, V91, P326, DOI 10.1073/pnas.91.1.326; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Boonsirichai K, 2003, PLANT CELL, V15, P2612, DOI 10.1105/tpc.015560; Boonsirichai K, 2002, ANNU REV PLANT BIOL, V53, P421, DOI 10.1146/annurev.arplant.53.100301.135158; Chapman EJ, 2009, ANNU REV GENET, V43, P265, DOI 10.1146/annurev-genet-102108-134148; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; de Reuille PB, 2005, PLANT J, V44, P1045, DOI 10.1111/j.1365-313X.2005.02576.x; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dreher KA, 2006, PLANT CELL, V18, P699, DOI 10.1105/tpc.105.039172; Fernandez R, 2010, NAT METHODS, V7, P547, DOI [10.1038/nmeth.1472, 10.1038/NMETH.1472]; French A, 2009, PLANT PHYSIOL, V150, P1784, DOI 10.1104/pp.109.140558; Friml J, 2003, CURR OPIN PLANT BIOL, V6, P7, DOI 10.1016/S1369526602000031; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Fu XD, 2003, NATURE, V421, P740, DOI 10.1038/nature01387; Grandjean O, 2004, PLANT CELL, V16, P74, DOI 10.1105/tpc.017962; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Greenham K, 2011, CURR BIOL, V21, P520, DOI 10.1016/j.cub.2011.02.029; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Holman TJ, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-9; Karimi M, 2005, TRENDS PLANT SCI, V10, P103, DOI 10.1016/j.tplants.2005.01.008; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Levesque MP, 2006, PLOS BIOL, V4, P739, DOI 10.1371/journal.pbio.0040143; Lohmann D, 2010, PLANT CELL, V22, P335, DOI 10.1105/tpc.109.071498; Ottenschlager I, 2003, P NATL ACAD SCI USA, V100, P2987, DOI 10.1073/pnas.0437936100; Parry G, 2009, P NATL ACAD SCI USA, V106, P22540, DOI 10.1073/pnas.0911967106; Petersson SV, 2009, PLANT CELL, V21, P1659, DOI 10.1105/tpc.109.066480; Ramos JA, 2001, PLANT CELL, V13, P2349, DOI 10.1105/tpc.13.10.2349; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Rogg LE, 2001, PLANT CELL, V13, P465, DOI 10.1105/tpc.13.3.465; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Santuari L, 2011, CURR BIOL, V21, P1918, DOI 10.1016/j.cub.2011.10.002; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Ulmasov T, 1997, SCIENCE, V276, P1865, DOI 10.1126/science.276.5320.1865; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Vernoux T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.39; Zenser N, 2001, P NATL ACAD SCI USA, V98, P11795, DOI 10.1073/pnas.211312798	42	502	512	11	304	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 2	2012	482	7383					103	U132		10.1038/nature10791	http://dx.doi.org/10.1038/nature10791			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884RN	22246322				2022-12-28	WOS:000299726000044
J	Azimzadeh, J; Wong, ML; Downhour, DM; Alvarado, AS; Marshall, WF				Azimzadeh, Juliette; Wong, Mei Lie; Downhour, Diane Miller; Alvarado, Alejandro Sanchez; Marshall, Wallace F.			Centrosome Loss in the Evolution of Planarians	SCIENCE			English	Article							CELLULAR FUNCTION; STEM-CELL; REGENERATION; CENTRIOLE; CILIA; NEOBLASTS; EMBRYOS; BODY	The centrosome, a cytoplasmic organelle formed by cylinder-shaped centrioles surrounded by a microtubule-organizing matrix, is a hallmark of animal cells. The centrosome is conserved and essential for the development of all animal species described so far. Here, we show that planarians, and possibly other flatworms, lack centrosomes. In planarians, centrioles are only assembled in terminally differentiating ciliated cells through the acentriolar pathway to trigger the assembly of cilia. We identified a large set of conserved proteins required for centriole assembly in animals and note centrosome protein families that are missing from the planarian genome. Our study uncovers the molecular architecture and evolution of the animal centrosome and emphasizes the plasticity of animal cell biology and development.	[Azimzadeh, Juliette; Wong, Mei Lie; Marshall, Wallace F.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Downhour, Diane Miller] Univ Utah, Sch Med, Dept Genet, Salt Lake City, UT 84132 USA; [Alvarado, Alejandro Sanchez] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Alvarado, Alejandro Sanchez] Howard Hughes Med Inst, Kansas City, MO 64110 USA	University of California System; University of California San Francisco; Utah System of Higher Education; University of Utah; Stowers Institute for Medical Research; Howard Hughes Medical Institute	Azimzadeh, J (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	juliette.azimzadeh@ucsf.edu; wallace.marshall@ucsf.edu		Azimzadeh, Juliette/0000-0002-7292-9973	W. M. Keck Foundation; NIH [GM077004, GM57260]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077004, R01GM057260, R37GM057260] Funding Source: NIH RePORTER	W. M. Keck Foundation(W.M. Keck Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Rink for sharing reagents and helping with planarian embryo analysis; R. Zalpuri and K. McDonald for help with TEM sample preparation; N. Tang for help with cryostat sectioning; K. Thorn and the Nikon Imaging Center for help with confocal imaging; Y. Chen and M. Braunfeld for help with TEM acquisition; L. Holt, D. David, M. Bettencourt-Dias, and M. Bornens for critical reading of the manuscript; and the Marshall lab and the Sanchez lab for insightful comments. This work was supported by the W. M. Keck Foundation (W. F. M.) and NIH grants GM077004 (W. F. M.) and GM57260 (A. S. A.). A. S. A. is a Howard Hughes Medical Institute investigator. All accession numbers for sequences associated with this study are provided in table S1.	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Azimzadeh J, 2010, CURR BIOL, V20, pR816, DOI 10.1016/j.cub.2010.08.010; Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Bobinnec Y, 1998, J CELL BIOL, V143, P1575, DOI 10.1083/jcb.143.6.1575; CALARCOGILLAM PD, 1983, CELL, V35, P621, DOI 10.1016/0092-8674(83)90094-6; Cardona A, 2006, DEV GENES EVOL, V216, P667, DOI 10.1007/s00427-006-0094-3; Dawe HR, 2007, J CELL SCI, V120, P7, DOI 10.1242/jcs.03305; Delaval B, 2010, J CELL BIOL, V188, P181, DOI 10.1083/jcb.200908114; Egger B, 2007, DEV GENES EVOL, V217, P89, DOI 10.1007/s00427-006-0120-5; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Jurberg AD, 2009, DEV GENES EVOL, V219, P219, DOI 10.1007/s00427-009-0285-9; Kraemer N, 2011, CELL MOL LIFE SCI, V68, P1719, DOI 10.1007/s00018-011-0635-4; Mayor T, 2002, J CELL SCI, V115, P3275; MORITA M, 1974, J EXP ZOOL, V187, P345, DOI 10.1002/jez.1401870305; Reddien PW, 2005, DEV CELL, V8, P635, DOI 10.1016/j.devcel.2005.02.014; Rink JC, 2009, SCIENCE, V326, P1406, DOI 10.1126/science.1178712; Rodrigues-Martins A, 2008, CELL CYCLE, V7, P11, DOI 10.4161/cc.7.1.5226; Rompolas P, 2010, MOL BIOL CELL, V21, P3669, DOI 10.1091/mbc.E10-04-0373; SAKAIWADA A, 1985, CHROMOSOMA, V93, P43, DOI 10.1007/BF01259445; Stevens NR, 2007, CURR BIOL, V17, P1498, DOI 10.1016/j.cub.2007.07.060; TYLER S, 1981, HYDROBIOLOGIA, V84, P231, DOI 10.1007/BF00026184; Wagner DE, 2011, SCIENCE, V332, P811, DOI 10.1126/science.1203983	23	110	111	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 27	2012	335	6067					461	463		10.1126/science.1214457	http://dx.doi.org/10.1126/science.1214457			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881FG	22223737	Green Accepted			2022-12-28	WOS:000299466800048
J	Erb, RM; Libanori, R; Rothfuchs, N; Studart, AR				Erb, Randall M.; Libanori, Rafael; Rothfuchs, Nuria; Studart, Andre R.			Composites Reinforced in Three Dimensions by Using Low Magnetic Fields	SCIENCE			English	Article							MECHANISMS; IMPACT; NACRE	The orientation and distribution of reinforcing particles in artificial composites are key to enable effective reinforcement of the material in mechanically loaded directions, but remain poor if compared to the distinctive architectures present in natural structural composites such as teeth, bone, and seashells. We show that micrometer-sized reinforcing particles coated with minimal concentrations of superparamagnetic nanoparticles (0.01 to 1 volume percent) can be controlled by using ultralow magnetic fields (1 to 10 milliteslas) to produce synthetic composites with tuned three-dimensional orientation and distribution of reinforcements. A variety of structures can be achieved with this simple method, leading to composites with tailored local reinforcement, wear resistance, and shape memory effects.	[Erb, Randall M.; Libanori, Rafael; Rothfuchs, Nuria; Studart, Andre R.] Swiss Fed Inst Technol, Dept Mat, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Studart, AR (corresponding author), Swiss Fed Inst Technol, Dept Mat, CH-8093 Zurich, Switzerland.	andre.studart@mat.ethz.ch	Erb, Randall M/E-6337-2014; Studart, Andre R/A-2550-2008; Libanori, Rafael/F-9071-2012; Erb, Randall M/O-1984-2018; Erb, Randall M/B-1986-2012	Libanori, Rafael/0000-0003-3965-6974; Erb, Randall M/0000-0002-6351-395X; 	Swiss National Science Foundation [200021_135306/1]; Electron Microscopy Center of ETH Zurich (EMEZ); ETH Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Electron Microscopy Center of ETH Zurich (EMEZ); ETH Zurich(ETH Zurich)	We thank T. Tervoort, L. van Breemen, K. Feldman, M. Imhof, J. Hofstetter, R. Stahel, R. Ehrbar, P. Zweifel, B. Wegmann, and M. Schinhammer for experimental assistance, and Antaria, Huntsman Advanced Materials, Rosen and BASF for supplying the alumina platelets, polymers, and resins. We acknowledge internal funding from ETH Zurich and the Swiss National Science Foundation (grant 200021_135306/1), as well as support by the Electron Microscopy Center of ETH Zurich (EMEZ). ETH Zurich has applied for the following patent: A. R. Studart, R. M. Erb, R. Libanori, Method for the production of reinforced materials and reinforced materials obtained using the method, European patent application 10003358.8, priority date 29 March 2010.	Barthelat F, 2006, J MATER RES, V21, P1977, DOI 10.1557/JMR.2006.0239; Bonderer LJ, 2008, SCIENCE, V319, P1069, DOI 10.1126/science.1148726; Bubenhofer SB, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/48/485302; Burghard Z, 2009, NANO LETT, V9, P4103, DOI 10.1021/nl902324x; CANTWELL WJ, 1991, COMPOSITES, V22, P347, DOI 10.1016/0010-4361(91)90549-V; Chou T.W., 1992, NASA STI RECON TECH, V92, P50452; Correa-Duarte MA, 2005, J PHYS CHEM B, V109, P19060, DOI 10.1021/jp0544890; Deville S, 2006, SCIENCE, V311, P515, DOI 10.1126/science.1120937; Faivre D, 2008, CHEM REV, V108, P4875, DOI 10.1021/cr078258w; Fratzl P, 2008, FARADAY DISCUSS, V139, P275, DOI 10.1039/b716663j; Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001; FREITAS G, 1994, J ADV MATER, V25, P36; Hull D., 1996, INTRO COMPOSITE MAT; Imbeni V, 2005, NAT MATER, V4, P229, DOI 10.1038/nmat1323; JELF PM, 1992, J COMPOS MATER, V26, P2706, DOI 10.1177/002199839202601804; Mouritz AP, 1999, COMPOS PART A-APPL S, V30, P1445, DOI 10.1016/S1359-835X(99)00034-2; Munch E, 2008, SCIENCE, V322, P1516, DOI 10.1126/science.1164865; ONSAGER L, 1949, ANN NY ACAD SCI, V51, P627, DOI 10.1111/j.1749-6632.1949.tb27296.x; Ortiz C, 2008, SCIENCE, V319, P1053, DOI 10.1126/science.1154295; Ozcan S, 2005, WEAR, V259, P642, DOI 10.1016/j.wear.2005.02.112; Podsiadlo P, 2007, SCIENCE, V318, P80, DOI 10.1126/science.1143176; Qian H, 2010, J MATER CHEM, V20, P4751, DOI 10.1039/c000041h; Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906; Tong L, 2002, 3D FIBRE REINFORCED; van der Beek D, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.041402; Veedu VP, 2006, NAT MATER, V5, P457, DOI 10.1038/nmat1650; Wagermaier W, 2006, BIOINTERPHASES, V1, P1, DOI 10.1116/1.2178386; Walther A, 2010, NANO LETT, V10, P2742, DOI 10.1021/nl1003224; [No title captured]	29	471	485	31	717	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 13	2012	335	6065					199	204		10.1126/science.1210822	http://dx.doi.org/10.1126/science.1210822			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875LZ	22246772				2022-12-28	WOS:000299033100048
J	Fratzl, P				Fratzl, Peter			A Composite Matter of Alignment	SCIENCE			English	Editorial Material							BIOINSPIRED DESIGN; TOUGHNESS; FRACTURE; BONE		Max Planck Inst Colloids & Interfaces, D-14424 Potsdam, Germany	Max Planck Society	Fratzl, P (corresponding author), Max Planck Inst Colloids & Interfaces, D-14424 Potsdam, Germany.	peter.fratzl@mpikg.mpg.de	Fratzl, Peter/H-9095-2012	Fratzl, Peter/0000-0003-4437-7830				Aizenberg J, 2005, SCIENCE, V309, P275, DOI 10.1126/science.1112255; Bonderer LJ, 2008, SCIENCE, V319, P1069, DOI 10.1126/science.1148726; Dunlop JWC, 2010, ANNU REV MATER RES, V40, P1, DOI 10.1146/annurev-matsci-070909-104421; Erb RM, 2012, SCIENCE, V335, P199, DOI 10.1126/science.1210822; Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001; Kamat S, 2000, NATURE, V405, P1036, DOI 10.1038/35016535; Kerschnitzki M, 2011, J STRUCT BIOL, V173, P303, DOI 10.1016/j.jsb.2010.11.014; Kieback B, 2003, MAT SCI ENG A-STRUCT, V362, P81, DOI 10.1016/S0921-5093(03)00578-1; Kolednik O, 2011, ADV FUNCT MATER, V21, P3634, DOI 10.1002/adfm.201100443; Mortensen A, 1995, INT MATER REV, V40, P239, DOI 10.1179/imr.1995.40.6.239; Munch E, 2008, SCIENCE, V322, P1516, DOI 10.1126/science.1164865; Peterlik H, 2006, NAT MATER, V5, P52, DOI 10.1038/nmat1545; Ritchie RO, 2009, PHYS TODAY, V62, P41, DOI 10.1063/1.3156332; Rozvany GIN, 2009, STRUCT MULTIDISCIP O, V37, P217, DOI 10.1007/s00158-007-0217-0; Sellinger A, 1998, NATURE, V394, P256, DOI 10.1038/28354	15	16	16	2	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 13	2012	335	6065					177	178		10.1126/science.1215841	http://dx.doi.org/10.1126/science.1215841			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875LZ	22246763				2022-12-28	WOS:000299033100039
J	Sofat, R; Casas, JP; Grosso, AM; Prichard, BNC; Smeeth, L; MacAllister, R; Hingorani, AD				Sofat, Reecha; Casas, Juan P.; Grosso, Anthony M.; Prichard, Brian N. C.; Smeeth, Liam; MacAllister, Raymond; Hingorani, Aroon D.			Could NICE guidance on the choice of blood pressure lowering drugs be simplified?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BETA-BLOCKERS; ANTIHYPERTENSIVE TREATMENT; CARDIOVASCULAR EVENTS; DIABETES-MELLITUS; HYPERTENSION; METAANALYSIS; GLUCOSE; DISEASE; OLDER; ALDOSTERONE		[Sofat, Reecha; Grosso, Anthony M.; Prichard, Brian N. C.; MacAllister, Raymond; Hingorani, Aroon D.] UCL, Ctr Clin Pharmacol, London WC1E 6JJ, England; [Casas, Juan P.; Hingorani, Aroon D.] UCL, Fac Populat Hlth Sci, London WC1E 6JJ, England; [Casas, Juan P.; Smeeth, Liam] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England; [Grosso, Anthony M.] Univ Coll London Hosp NHS Fdn Trust, Dept Pharm, London, England; [Grosso, Anthony M.] UCL, Sch Pharm, London WC1E 6JJ, England	University of London; University College London; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; University of London School of Pharmacy	Sofat, R (corresponding author), UCL, Ctr Clin Pharmacol, London WC1E 6JJ, England.	r.sofat@ucl.ac.uk	Smeeth, Liam/X-5862-2018	Smeeth, Liam/0000-0002-9168-6022; Hingorani, Aroon/0000-0001-8365-0081; Sofat, Reecha/0000-0002-0242-6115	National Institute for Health Research [NF-SI-0510-10090] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Barzilay JI, 2006, ARCH INTERN MED, V166, P2191, DOI 10.1001/archinte.166.20.2191; BELMIN J, 1994, DRUG AGING, V5, P391, DOI 10.2165/00002512-199405050-00007; Bradley HA, 2006, J HYPERTENS, V24, P2131, DOI 10.1097/01.hjh.0000249685.58370.28; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; De Bruin RA, 2004, CLIN CHEM, V50, P2111, DOI 10.1373/clinchem.2004.032052; Dickerson JEC, 1999, LANCET, V353, P2008, DOI 10.1016/S0140-6736(98)07614-4; Elliott WJ, 2007, LANCET, V369, P201, DOI 10.1016/S0140-6736(07)60108-1; Khan N, 2006, CAN MED ASSOC J, V174, P1737, DOI 10.1503/cmaj.060110; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Lawes CMM, 2004, DIABETES CARE, V27, P2836; Lawes CMM, 2006, J HYPERTENS, V24, P423, DOI 10.1097/01.hjh.0000209973.67746.f0; Lawlor DA, 2007, PLOS MED, V4, P1396, DOI 10.1371/journal.pmed.0040263; Lindholm LH, 2005, LANCET, V366, P1545, DOI 10.1016/S0140-6736(05)67573-3; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; New Zealand Guidelines Group, 2009, NZ CARD GUID HDB SUM, VSecond; NICE British Hypertension Society, 2006, NICE CLIN GUID 34 HY; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Poulter NR, 2005, LANCET, V366, P907, DOI 10.1016/S0140-6736(05)67186-3; Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Sarwar N, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000278; Scottish Intercollegiate Guidelines Network, 2007, RISK EST PREV CARD D; Seifarth C, 2002, CLIN ENDOCRINOL, V57, P457, DOI 10.1046/j.1365-2265.2002.01613.x; Staessen JA, 2005, LANCET, V366, P869, DOI 10.1016/S0140-6736(05)67147-4; Turnbull F, 2008, BMJ-BRIT MED J, V336, P1121, DOI 10.1136/bmj.39548.738368.BE; Wald DS, 2009, AM J MED, V122, P290, DOI 10.1016/j.amjmed.2008.09.038	28	4	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	2012	344								d8078	10.1136/bmj.d8078	http://dx.doi.org/10.1136/bmj.d8078			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877SR	22246267	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000299203500012
J	Kim, JH; Malhotra, R; Chiampas, G; d'Hemecourt, P; Troyanos, C; Cianca, J; Smith, RN; Wang, TJ; Roberts, WO; Thompson, PD; Baggish, AL				Kim, Jonathan H.; Malhotra, Rajeev; Chiampas, George; d'Hemecourt, Pierre; Troyanos, Chris; Cianca, John; Smith, Rex N.; Wang, Thomas J.; Roberts, William O.; Thompson, Paul D.; Baggish, Aaron L.		Race Associated Cardiac Arrest	Cardiac Arrest during Long-Distance Running Races	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; AMERICAN-HEART-ASSOCIATION; SUDDEN-DEATH; HYPERTROPHIC CARDIOMYOPATHY; PLATELET ACTIVATION; STANDARDIZED RATES; BOSTON MARATHON; EXERTION; ATHEROSCLEROSIS; RUNNERS	BACKGROUND Approximately 2 million people participate in long-distance running races in the United States annually. Reports of race-related cardiac arrests have generated concern about the safety of this activity. METHODS We assessed the incidence and outcomes of cardiac arrest associated with marathon and half-marathon races in the United States from January 1, 2000, to May 31, 2010. We determined the clinical characteristics of the arrests by interviewing survivors and the next of kin of nonsurvivors, reviewing medical records, and analyzing postmortem data. RESULTS Of 10.9 million runners, 59 (mean [+/-SD] age, 42+/-13 years; 51 men) had cardiac arrest (incidence rate, 0.54 per 100,000 participants; 95% confidence interval [CI], 0.41 to 0.70). Cardiovascular disease accounted for the majority of cardiac arrests. The incidence rate was significantly higher during marathons (1.01 per 100,000; 95% CI, 0.72 to 1.38) than during half-marathons (0.27; 95% CI, 0.17 to 0.43) and among men (0.90 per 100,000; 95% CI, 0.67 to 1.18) than among women (0.16; 95% CI, 0.07 to 0.31). Male marathon runners, the highest-risk group, had an increased incidence of cardiac arrest during the latter half of the study decade (2000-2004, 0.71 per 100,000 [95% CI, 0.31 to 1.40]; 2005-2010, 2.03 per 100,000 [95% CI, 1.33 to 2.98]; P = 0.01). Of the 59 cases of cardiac arrest, 42 (71%) were fatal (incidence, 0.39 per 100,000; 95% CI, 0.28 to 0.52). Among the 31 cases with complete clinical data, initiation of bystander-administered cardiopulmonary resuscitation and an underlying diagnosis other than hypertrophic cardiomyopathy were the strongest predictors of survival. CONCLUSIONS Marathons and half-marathons are associated with a low overall risk of cardiac arrest and sudden death. Cardiac arrest, most commonly attributable to hypertrophic cardiomyopathy or atherosclerotic coronary disease, occurs primarily among male marathon participants; the incidence rate in this group increased during the past decade.	[Baggish, Aaron L.] Massachusetts Gen Hosp, Cardiovasc Performance Program, Div Cardiol, Boston, MA 02114 USA; [Smith, Rex N.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [d'Hemecourt, Pierre] Harvard Univ, Sch Med, Boston, MA USA; [d'Hemecourt, Pierre] Childrens Hosp, Div Sports Med, Boston, MA 02115 USA; [Troyanos, Chris] Boston Athlet Assoc, Boston, MA USA; [Chiampas, George] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Cianca, John] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Roberts, William O.] Univ Minnesota, Sch Med, Dept Family Med, St Paul, MN 55108 USA; [Thompson, Paul D.] Univ Connecticut, Sch Med, Hartford Hosp, Div Cardiol, Hartford, CT 06112 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Northwestern University; Feinberg School of Medicine; Baylor College of Medicine; University of Minnesota System; University of Minnesota Twin Cities; Hartford Hospital; University of Connecticut	Baggish, AL (corresponding author), Massachusetts Gen Hosp, Cardiovasc Performance Program, Div Cardiol, 55 Fruit St,YAW-5800, Boston, MA 02114 USA.	abaggish@partners.org	Thompson, Paul M/C-4194-2018	Thompson, Paul M/0000-0002-4720-8867; Roberts, William O/0000-0003-4517-4330; Wang, Thomas/0000-0003-4063-6508; Malhotra, Rajeev/0000-0003-0120-4630	Regeneron; Lupin Pharmaceuticals; GlaxoSmithKline; Genomas; Novartis; Furiex Pharmaceuticals; Merck; Pfizer; AstraZeneca; Kowa; Abbott	Regeneron(Regeneron); Lupin Pharmaceuticals; GlaxoSmithKline(GlaxoSmithKline); Genomas; Novartis(Novartis); Furiex Pharmaceuticals; Merck(Merck & Company); Pfizer(Pfizer); AstraZeneca(AstraZeneca); Kowa; Abbott(Abbott Laboratories)	Dr. Roberts reports holding a board membership with UCare Minnesota, receiving writing fees from Runner's World, and serving as an unpaid, volunteer medical director for the Medtronic Twin Cities Marathon; and Dr. Thompson, receiving consulting fees from Regeneron, Furiex Pharmaceuticals, and Lupin Pharmaceuticals, legal fees for expert testimony in cases related to cardiac arrest in exercise- and statin-related muscle injury, grant funding from GlaxoSmithKline, Genomas, Novartis, Furiex Pharmaceuticals, B. Braun, and Aventis, lecture fees from Merck, Pfizer, AstraZeneca, Kowa, Abbott, and GlaxoSmithKline, support for the development of educational presentations from Merck, and holding stock in Zoll Medical, J.A. Wiley Publishing, General Electric, Zimmer, Medtronic, Johnson & Johnson, Sanofi-Aventis, and Abbott. No other potential conflict of interest relevant to this article was reported.	Albert CM, 2000, NEW ENGL J MED, V343, P1355, DOI 10.1056/NEJM200011093431902; Allday E, 2009, SAN FRANCISCO C 1006; Almond CSD, 2005, NEW ENGL J MED, V352, P1550, DOI 10.1056/NEJMoa043901; Aretz H T, 1987, Am J Cardiovasc Pathol, V1, P3; BLACK A, 1975, ANGIOLOGY, V26, P759; Burfoot A, 2008, RUNNERS WORLD    DEC; Carriere KC, 1997, MED CARE, V35, P57, DOI 10.1097/00005650-199701000-00005; CARRIERE KC, 1994, AM J EPIDEMIOL, V140, P472, DOI 10.1093/oxfordjournals.aje.a117269; Donoghue ER, 1997, AM J FOREN MED PATH, V18, P11, DOI 10.1097/00000433-199703000-00002; Elliott PM, 1999, J AM COLL CARDIOL, V33, P1596, DOI 10.1016/S0735-1097(99)00056-X; Gibbons RJ, 1997, J AM COLL CARDIOL, V30, P260; Giri S, 1999, JAMA-J AM MED ASSOC, V282, P1731, DOI 10.1001/jama.282.18.1731; GORDON T, 1972, J AMER MED ASSOC, V221, P661, DOI 10.1001/jama.221.7.661; Hanke AA, 2010, EUR J MED RES, V15, P59, DOI 10.1186/2047-783X-15-2-59; HANSON PG, 1979, JAMA-J AM MED ASSOC, V242, P154, DOI 10.1001/jama.242.2.154; Harmon KG, 2011, CIRCULATION, V123, P1594, DOI 10.1161/CIRCULATIONAHA.110.004622; Harris KM, 2010, JAMA-J AM MED ASSOC, V303, P1255, DOI 10.1001/jama.2010.368; Kratz A, 2006, AM J CLIN PATHOL, V125, P296, DOI 10.1309/PRF5N7P2XM6E243H; Lamppa R., 2010, 2010 MARATHON HALF M; Maron BJ, 2009, CIRCULATION, V119, P1085, DOI 10.1161/CIRCULATIONAHA.108.804617; Maron BJ, 1996, J AM COLL CARDIOL, V28, P428, DOI 10.1016/0735-1097(96)00137-4; Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199; MCKENNA WJ, 1994, BRIT HEART J, V71, P215; Mohlenkamp S, 2008, EUR HEART J, V29, P1903, DOI 10.1093/eurheartj/ehn163; Mousavi N, 2009, AM J CARDIOL, V103, P1467, DOI 10.1016/j.amjcard.2009.01.294; Neilan TG, 2006, CIRCULATION, V114, P2325, DOI 10.1161/CIRCULATIONAHA.106.647461; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Olivotto I, 2005, J AM COLL CARDIOL, V46, P480, DOI 10.1016/j.jacc.2005.04.043; Parker-Pope T, 2009, NY TIMES        1020; Redelmeier DA, 2007, BRIT MED J, V335, P1275, DOI 10.1136/bmj.39384.551539.25; Roberts WO, 2005, J AM COLL CARDIOL, V46, P1373, DOI 10.1016/j.jacc.2005.07.008; Robinson J, 2008, NY TIMES        1103; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; THOMPSON PD, 1982, JAMA-J AM MED ASSOC, V247, P2535, DOI 10.1001/jama.247.18.2535; Thompson PD, 2005, CIRCULATION, V112, P2354, DOI 10.1161/CIRCULATIONAHA.104.502591; Wilkins K, 2009, DETROIT FREE PR 1018; WILLICH SN, 1993, NEW ENGL J MED, V329, P1684, DOI 10.1056/NEJM199312023292302; Yared K, 2009, RADIOLOGY, V251, P3, DOI 10.1148/radiol.2511090041; Zinser L, 2007, NY TIMES        1104	39	371	379	4	60	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 12	2012	366	2					130	140		10.1056/NEJMoa1106468	http://dx.doi.org/10.1056/NEJMoa1106468			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874VA	22236223	Bronze			2022-12-28	WOS:000298985000007
J	Brett, AS; McCullough, LB				Brett, Allan S.; McCullough, Laurence B.			Addressing Requests by Patients for Nonbeneficial Interventions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH-CARE; REFORM; LIMITS		[Brett, Allan S.] Univ S Carolina, Dept Med, Sch Med, Columbia, SC 29203 USA; [McCullough, Laurence B.] Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Baylor College of Medicine	Brett, AS (corresponding author), Univ S Carolina, Dept Med, Sch Med, 2 Med Pk,Ste 502, Columbia, SC 29203 USA.	abrett@sc.edu						BRETT AS, 1986, NEW ENGL J MED, V315, P1347, DOI 10.1056/NEJM198611203152109; Brody H, 2010, NEW ENGL J MED, V362, P283, DOI 10.1056/NEJMp0911423; Buys SS, 2011, JAMA-J AM MED ASSOC, V305, P2295, DOI 10.1001/jama.2011.766; Lantos J, 2011, JAMA-J AM MED ASSOC, V305, P495, DOI 10.1001/jama.2011.32; Reuben DB, 2011, JAMA-J AM MED ASSOC, V306, P430, DOI 10.1001/jama.2011.999; Sniderman AD, 2009, JAMA-J AM MED ASSOC, V301, P429, DOI 10.1001/jama.2009.15; Swindell JS, 2011, CHEST, V139, P424, DOI 10.1378/chest.10-0605	7	78	79	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 11	2012	307	2					149	150		10.1001/jama.2011.1999	http://dx.doi.org/10.1001/jama.2011.1999			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	875NP	22235082				2022-12-28	WOS:000299038300023
J	Gigerenzer, G; Galesic, M				Gigerenzer, Gerd; Galesic, Mirta			THE ART OF RISK COMMUNICATION Why do single event probabilities confuse patients?	BRITISH MEDICAL JOURNAL			English	Editorial Material							NUMERACY		[Gigerenzer, Gerd; Galesic, Mirta] Max Planck Inst Human Dev, Ctr Adapt Behav & Cognit, Berlin, Germany	Max Planck Society	Gigerenzer, G (corresponding author), Max Planck Inst Human Dev, Ctr Adapt Behav & Cognit, Berlin, Germany.	gigerenzer@mpib-berlin.mpg.de	Gigerenzer, Gerd/M-5595-2013; Galesic, Mirta/B-8327-2012; Gigerenzer, Gerd/A-6250-2012	Galesic, Mirta/0000-0002-3537-8359; Gigerenzer, Gerd/0000-0002-6163-5419				Centers for Disease Control and Prevention, UN PREGN PREV CONTR; eMedicineHealth, EFF RAT BIRTH CONTR; Gigerenzer G, 2005, RISK ANAL, V25, P623, DOI 10.1111/j.1539-6924.2005.00608.x; Gigerenzer G., 2002, RECKONING RISK LEARN; Hanoch Y, 2010, JUDGM DECIS MAK, V5, P116; Lipkus IM, 2001, MED DECIS MAKING, V21, P37, DOI 10.1177/0272989X0102100105; Mayo Clinic, ANT CHILDR EXPL PROS; Prostate.net, PROST CANC TREATM SI; Schwartz LM, 1997, ANN INTERN MED, V127, P966, DOI 10.7326/0003-4819-127-11-199712010-00003; Slovic P, 2000, LAW HUMAN BEHAV, V24, P271, DOI 10.1023/A:1005595519944	10	32	33	0	19	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 11	2012	344								e245	10.1136/bmj.e245	http://dx.doi.org/10.1136/bmj.e245			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	877SI	22236599	Green Submitted			2022-12-28	WOS:000299202500005
J	Yourman, LC; Lee, SJ; Schonberg, MA; Widera, EW; Smith, AK				Yourman, Lindsey C.; Lee, Sei J.; Schonberg, Mara A.; Widera, Eric W.; Smith, Alexander K.			Prognostic Indices for Older Adults A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							MORTALITY-RELATED FACTORS; NURSING-HOME; BREAST-CANCER; ADMINISTRATIVE DATA; MEDICAL LITERATURE; 1-YEAR MORTALITY; USERS GUIDES; VALIDATION; PREDICTION; RISK	Context To better target services to those who may benefit, many guidelines recommend incorporating life expectancy into clinical decisions. Objective To assess the quality and limitations of prognostic indices for mortality in older adults through systematic review. Data Sources We searched MEDLINE, EMBASE, Cochrane, and Google Scholar from their inception through November 2011. Study Selection We included indices if they were validated and predicted absolute risk of mortality in patients whose average age was 60 years or older. We excluded indices that estimated intensive care unit, disease-specific, or in-hospital mortality. Data Extraction For each prognostic index, we extracted data on clinical setting, potential for bias, generalizability, and accuracy. Results We reviewed 21 593 titles to identify 16 indices that predict risk of mortality from 6 months to 5 years for older adults in a variety of clinical settings: the community (6 indices), nursing home (2 indices), and hospital (8 indices). At least 1 measure of transportability (the index is accurate in more than 1 population) was tested for all but 3 indices. By our measures, no study was free from potential bias. Although 13 indices had C statistics of 0.70 or greater, none of the indices had C statistics of 0.90 or greater. Only 2 indices were independently validated by investigators who were not involved in the index's development. Conclusion We identified several indices for predicting overall mortality in different patient groups; future studies need to independently test their accuracy in heterogeneous populations and their ability to improve clinical outcomes before their widespread use can be recommended. JAMA. 2012; 307(2):182-192 www.jama.com	[Yourman, Lindsey C.; Lee, Sei J.; Widera, Eric W.; Smith, Alexander K.] Univ Calif San Francisco, Div Geriatr, Dept Med, San Francisco, CA 94121 USA; [Lee, Sei J.; Widera, Eric W.; Smith, Alexander K.] San Francisco VA Med Ctr, San Francisco, CA USA; [Schonberg, Mara A.] Beth Israel Deaconess Med Ctr, Dept Med, Div Gen Med & Primary Care, Boston, MA 02215 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Harvard University; Beth Israel Deaconess Medical Center	Smith, AK (corresponding author), Univ Calif San Francisco, Div Geriatr, Dept Med, 4150 Clement St 181G, San Francisco, CA 94121 USA.	aksmith@ucsf.edu			National Institute on Aging [5T32AG000212]; Greenwall Foundation; National Center for Research Resources [UL1 RR024131]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130, UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000212, K23AG040779, K23AG040772] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Greenwall Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr Yourman was supported by a National Institute on Aging T32 predoctoral fellowship position (5T32AG000212). Dr Smith was supported by career development grants from the Greenwall Foundation and the National Center for Research Resources to the Clinical and Translational Science Institute-University of California, San Francisco (UL1 RR024131).	Akhoundi FH, 2011, NEUROLOGY, V77, P349, DOI 10.1212/WNL.0b013e3182267ba0; Amer Geriatrics Soc Clinical Pract, 2000, J AM GERIATR SOC, V48, P842; [Anonymous], 2000, J AM GERIATR SOC, V48, P333; [Anonymous], MDS 3 0 TECHN INF; Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Braitman LE, 1996, ANN INTERN MED, V125, P406, DOI 10.7326/0003-4819-125-5-199609010-00008; Buchholz TA, 2009, NEW ENGL J MED, V360, P63, DOI 10.1056/NEJMct0803525; Carey EC, 2004, J GEN INTERN MED, V19, P1027, DOI 10.1111/j.1525-1497.2004.40016.x; Carey EC, 2008, J AM GERIATR SOC, V56, P68, DOI 10.1111/j.1532-5415.2007.01496.x; Casarett D, 2005, JAMA-J AM MED ASSOC, V294, P211, DOI 10.1001/jama.294.2.211; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Conway KP, 2001, J VASC SURG, V33, P752, DOI 10.1067/mva.2001.112800; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Desai MM, 2002, J AM GERIATR SOC, V50, P474, DOI 10.1046/j.1532-5415.2002.50113.x; Di Bari M, 2010, J GERONTOL A-BIOL, V65, P159, DOI 10.1093/gerona/glp043; Drame M, 2008, EUR J EPIDEMIOL, V23, P783, DOI 10.1007/s10654-008-9290-y; Einhorn H.J., 1988, DECISION MAKING DESC, P113, DOI DOI 10.1017/CBO9780511598951; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fillinger M, 2007, SEMIN VASC SURG, V20, P121, DOI 10.1053/j.semvascsurg.2007.04.001; Fischer SM, 2006, J PAIN SYMPTOM MANAG, V31, P285, DOI 10.1016/j.jpainsymman.2005.08.012; Flacker JM, 2003, J AM GERIATR SOC, V51, P213, DOI 10.1046/j.1532-5415.2003.51060.x; Flacker JM, 1998, J AM GERIATR SOC, V46, P1012, DOI 10.1111/j.1532-5415.1998.tb02759.x; Gagne JJ, 2011, J CLIN EPIDEMIOL, V64, P749, DOI 10.1016/j.jclinepi.2010.10.004; Geiger AM, 2007, CANCER-AM CANCER SOC, V109, P966, DOI 10.1002/cncr.22472; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010; Holmes HM, 2006, ARCH INTERN MED, V166, P605, DOI 10.1001/archinte.166.6.605; HSIA DC, 1988, NEW ENGL J MED, V318, P352, DOI 10.1056/NEJM198802113180604; Huang ES, 2008, ANN INTERN MED, V149, P11, DOI 10.7326/0003-4819-149-1-200807010-00005; Ickowicz E, 2003, J AM GERIATR SOC, V51, pS265; INOUYE SK, 1993, J GEN INTERN MED, V8, P645, DOI 10.1007/BF02598279; Inouye SK, 2003, MED CARE, V41, P70, DOI 10.1097/00005650-200301000-00010; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; Kruse RL, 2010, J GERONTOL A-BIOL, V65, P1235, DOI 10.1093/gerona/glq120; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; LAUPACIS A, 1994, JAMA-J AM MED ASSOC, V272, P234, DOI 10.1001/jama.272.3.234; Lederle FA, 2002, JAMA-J AM MED ASSOC, V287, P2968, DOI 10.1001/jama.287.22.2968; Lee SJ, 2006, JAMA-J AM MED ASSOC, V295, P801, DOI 10.1001/jama.295.7.801; Levine SK, 2007, AM J MED, V120, P455, DOI 10.1016/j.amjmed.2006.09.021; Mazzaglia G, 2007, J AM GERIATR SOC, V55, P1955, DOI 10.1111/j.1532-5415.2007.01446.x; McGinn TG, 2000, JAMA-J AM MED ASSOC, V284, P79, DOI 10.1001/jama.284.1.79; Mehta KM, 2010, AM J PUBLIC HEALTH, V100, P1917, DOI 10.2105/AJPH.2008.158485; Mohan I V, 2000, Semin Interv Cardiol, V5, P15; Oliver DP, 2009, J NURS CARE QUAL, V24, P100, DOI 10.1097/NCQ.0b013e3181922d08; Pilotto A, 2008, REJUV RES, V11, P151, DOI 10.1089/rej.2007.0569; Porock D, 2005, J GERONTOL A-BIOL, V60, P491, DOI 10.1093/gerona/60.4.491; Porock Davina, 2010, BMC Res Notes, V3, P200, DOI 10.1186/1756-0500-3-200; Rahimtoola SH, 2010, J AM COLL CARDIOL, V55, P2413, DOI 10.1016/j.jacc.2009.10.085; Randolph A, 2008, USERS GUIDES MED LIT; Rietbrock S, 2008, AM HEART J, V156, P57, DOI 10.1016/j.ahj.2008.03.010; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Ross Phillip L, 2002, Semin Urol Oncol, V20, P82, DOI 10.1053/suro.2002.32490; Rozzini R, 2001, JAMA-J AM MED ASSOC, V286, P1315, DOI 10.1001/jama.286.11.1315-a; Sancarlo D, 2011, J NUTR HEALTH AGING, V15, P169, DOI 10.1007/s12603-010-0293-5; Schonberg MA, 2011, J AM GERIATR SOC, V59, P1444, DOI 10.1111/j.1532-5415.2011.03523.x; Schonberg MA, 2009, J GEN INTERN MED, V24, P1115, DOI 10.1007/s11606-009-1073-y; Sima CS, 2010, JAMA-J AM MED ASSOC, V304, P1584, DOI 10.1001/jama.2010.1449; Skyler JS, 2009, J AM COLL CARDIOL, V53, P298, DOI [10.1016/j.jacc.2008.10.008, 10.2337/dc08-9026]; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Teno JM, 2000, J AM GERIATR SOC, V48, pS16, DOI 10.1111/j.1532-5415.2000.tb03126.x; U. S. Preventive Services Task Force, SCREEN COL CANC; U.S. Preventive Services Task Force, 2011, SCREEN BREAST CANC; van Walraven Carl, 2009, Med Care, V47, P626, DOI 10.1097/MLR.0b013e31819432e5; Van Zee KJ, 2003, ANN SURG ONCOL, V10, P1140, DOI 10.1245/ASO.2003.03.015; Vollrath Annette M, 2005, J Palliat Med, V8, P876, DOI 10.1089/jpm.2005.8.876; Walter LC, 2005, AM J MED, V118, P1078, DOI 10.1016/j.amjmed.2005.01.063; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2750, DOI 10.1001/jama.285.21.2750; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2987, DOI 10.1001/jama.285.23.2987; Walter LC, 2006, JAMA-J AM MED ASSOC, V296, P2336, DOI 10.1001/jama.296.19.2336; Walter LC, 2009, ANN INTERN MED, V150, P465, DOI 10.7326/0003-4819-150-7-200904070-00006; Warner E, 2011, NEW ENGL J MED, V365, P1025, DOI 10.1056/NEJMcp1101540; Wolf AMD, 2010, CA-CANCER J CLIN, V60, P70, DOI 10.3322/caac.20066; Youngwerth J, 2011, J PAIN SYMPTOM MANAG, V41, P192, DOI 10.1016/j.jpainsymman.2010.10.050	74	497	501	0	58	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 11	2012	307	2					182	192		10.1001/jama.2011.1966	http://dx.doi.org/10.1001/jama.2011.1966			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	875NP	22235089	Green Accepted, Bronze			2022-12-28	WOS:000299038300030
J	Belshe, RB; Leone, PA; Bernstein, DI; Wald, A; Levin, MJ; Stapleton, JT; Gorfinkel, I; Morrow, RLA; Ewell, MG; Stokes-Riner, A; Dubin, G; Heineman, TC; Schulte, JM; Deal, CD				Belshe, Robert B.; Leone, Peter A.; Bernstein, David I.; Wald, Anna; Levin, Myron J.; Stapleton, Jack T.; Gorfinkel, Iris; Morrow, Rhoda L. Ashley; Ewell, Marian G.; Stokes-Riner, Abbie; Dubin, Gary; Heineman, Thomas C.; Schulte, Joann M.; Deal, Carolyn D.		Herpevac Trial Women	Efficacy Results of a Trial of a Herpes Simplex Vaccine	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VIRUS TYPE-1; GENITAL HERPES; UNITED-STATES; INFECTION; SEROPREVALENCE; EPIDEMIOLOGY; SAFETY	BACKGROUND Two previous studies of a herpes simplex virus type 2 (HSV-2) subunit vaccine containing glycoprotein D in HSV-discordant couples revealed 73% and 74% efficacy against genital disease in women who were negative for both HSV type 1 (HSV-1) and HSV-2 antibodies. Efficacy was not observed in men or HSV-1 seropositive women. METHODS We conducted a randomized, double-blind efficacy field trial involving 8323 women 18 to 30 years of age who were negative for antibodies to HSV-1 and HSV-2. At months 0, 1, and 6, some subjects received the investigational vaccine, consisting of 20 mu g of glycoprotein D from HSV-2 with alum and 3-O-deacylated monophosphoryl lipid A as an adjuvant; control subjects received the hepatitis A vaccine, at a dose of 720 enzyme-linked immunosorbent assay (ELISA) units. The primary end point was occurrence of genital herpes disease due to either HSV-1 or HSV-2 from month 2 (1 month after dose 2) through month 20. RESULTS The HSV vaccine was associated with an increased risk of local reactions as compared with the control vaccine, and it elicited ELISA and neutralizing antibodies to HSV-2. Overall, the vaccine was not efficacious; vaccine efficacy was 20% (95% confidence interval [CI], -29 to 50) against genital herpes disease. However, efficacy against HSV-1 genital disease was 58% (95% CI, 12 to 80). Vaccine efficacy against HSV-1 infection (with or without disease) was 35% (95% CI, 13 to 52), but efficacy against HSV-2 infection was not observed (-8%; 95% CI, 59 to 26). CONCLUSIONS In a study population that was representative of the general population of HSV-1 and HSV-2 seronegative women, the investigational vaccine was effective in preventing HSV-1 genital disease and infection but not in preventing HSV-2 disease or infection. (Funded by the National Institute of Allergy and Infectious Diseases and GlaxoSmithKline; ClinicalTrials.gov number, NCT00057330.)	[Belshe, Robert B.] St Louis Univ, Sch Med, Div Infect Dis Allergy & Immunol, St Louis, MO 63104 USA; [Leone, Peter A.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Bernstein, David I.] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH USA; [Wald, Anna] Univ Washington, Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Dept Med Epidemiol & Lab Med, Seattle, WA 98195 USA; [Morrow, Rhoda L. Ashley] Univ Washington, Childrens Hosp Virol, Dept Lab Med, Seattle, WA 98195 USA; [Levin, Myron J.] Univ Colorado, Sect Pediat Infect Dis, Denver, CO 80202 USA; [Stapleton, Jack T.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Stapleton, Jack T.] Vet Affairs Med Ctr, Iowa City, IA 52242 USA; [Gorfinkel, Iris] PrimeHlth Clin Res Org, Toronto, ON, Canada; [Ewell, Marian G.; Stokes-Riner, Abbie] EMMES Corp, Rockville, MD USA; [Schulte, Joann M.; Deal, Carolyn D.] NIAID, Bethesda, MD 20892 USA; [Dubin, Gary; Heineman, Thomas C.] GlaxoSmithKline Inc, King Of Prussia, PA USA	Saint Louis University; University of North Carolina; University of North Carolina Chapel Hill; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Colorado System; University of Colorado Denver; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; Emmes Corporation; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); GlaxoSmithKline	Belshe, RB (corresponding author), St Louis Univ, Sch Med, Div Infect Dis Allergy & Immunol, 1100 S Grand Blvd,DRC-8, St Louis, MO 63104 USA.	belsherb@slu.edu	Wald, Anna/B-6272-2012	Wald, Anna/0000-0003-3486-6438; Stapleton, Jack/0000-0002-2302-9055	National Institute of Allergy and Infectious Diseases [N01-AI-45250]; GlaxoSmithKline; MedImmune; Merck; Novartis; Abbott Diagnostics; Genocea; Roche; AiCuris; Washington Vaccine Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI045250] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); GlaxoSmithKline(GlaxoSmithKline); MedImmune(AstraZenecaMedimmune); Merck(Merck & Company); Novartis(Novartis); Abbott Diagnostics(Abbott Laboratories); Genocea; Roche(Roche Holding); AiCuris; Washington Vaccine Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by a contract with the National Institute of Allergy and Infectious Diseases (N01-AI-45250) and by GlaxoSmithKline.; Dr. Belshe reports serving as a board member of Vivaldi Bio-sciences, receiving consulting fees from GlaxoSmithKline, receiving consulting fees and lecture fees from MedImmune, and receiving lecture fees from Merck. Dr. Bernstein reports receiving lecture fees and royalties from GlaxoSmithKline. Dr. Dubin reports being an employee of and receiving stock and travel, accommodation, and meeting expenses from GlaxoSmithKline and receiving royalties from Pfizer. Dr. Gorfinkel reports receiving grants, consulting fees, travel expenses to meetings, fees for participating in review activities, equipment and technical assistance, lecture fees, and payment for developing educational presentations from GlaxoSmithKline, having stock equity in and serving as an investigator for GlaxoSmithKline, and serving as an investigator for AstraZeneca, Bristol-Myers Squibb, Janssen-Ortho, Bayer, PharmaNet, Wyeth, Berlex, Lundbeck, and CombinatoR.x. Dr. Heineman reports being an employee of GlaxoSmithKline and receiving stock equity in GlaxoSmithKline as part of his compensation. Dr. Leone reports receiving consulting fees and speaker fees from GlaxoSmithKline, lecture fees from Novartis and Abbott Diagnostics, and grant support from Genocea. Dr. Levin reports receiving consulting fees and grants from GlaxoSmithKline. Dr. Morrow reports receiving consulting fees from Roche. Dr. Schulte reports owning stock in Pfizer. Dr. Stapleton reports receiving grant support from GlaxoSmithKline. Dr. Wald reports receiving consulting fees from AiCuris and grant support from the Washington Vaccine Alliance. No other potential conflict of interest relevant to this article was reported.	ASHLEY R, 1991, ANN INTERN MED, V115, P520, DOI 10.7326/0003-4819-115-7-520; Bernstein DI, 2005, CLIN INFECT DIS, V40, P1271, DOI 10.1086/429240; Buxbaum S, 2003, MED MICROBIOL IMMUN, V192, P177, DOI 10.1007/s00430-003-0183-0; Corey L, 2009, NEW ENGL J MED, V361, P2681; Corey L, 2009, NEW ENGL J MED, V361, P1376, DOI 10.1056/NEJMra0807633; Cunningham AL, 2006, SEX TRANSM INFECT, V82, P164, DOI 10.1136/sti.2005.016899; GARLAND SM, 1995, J VIROL METHODS, V55, P285, DOI 10.1016/0166-0934(95)00061-9; KOUTSKY LA, 1992, NEW ENGL J MED, V326, P1533, DOI 10.1056/NEJM199206043262305; Langenberg A, 1989, ANN INTERN MED, V110, P822; LANGENBERG AG, 1995, ANN INTERN MED, V123, P395; LANGENBERG AGM, 1995, ANN INTERN MED, V122, P889, DOI 10.7326/0003-4819-122-12-199506150-00001; Margaret AS, 2007, J CLIN MICROBIOL, V45, P1618; Roberts CM, 2003, SEX TRANSM DIS, V30, P797, DOI 10.1097/01.OLQ.0000092387.58746.C7; Ryder N, 2009, SEX TRANSM INFECT, V85, P416, DOI 10.1136/sti.2008.033902; Samra Z, 2003, SEX TRANSM DIS, V30, P794, DOI 10.1097/01.OLQ.0000079517.04451.79; Stanberry LR, 2002, NEW ENGL J MED, V347, P1652, DOI 10.1056/NEJMoa011915; Suligoi B, 2004, SEX TRANSM DIS, V31, P608, DOI 10.1097/01.olq.0000140013.60224.ba; Vyse AJ, 2000, SEX TRANSM INFECT, V76, P183, DOI 10.1136/sti.76.3.183; Wald A, 2000, NEW ENGL J MED, V342, P844, DOI 10.1056/NEJM200003233421203; Xu FJ, 2007, J PEDIATR-US, V151, P374, DOI 10.1016/j.jpeds.2007.04.065; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964	21	350	369	5	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 5	2012	366	1					34	43		10.1056/NEJMoa1103151	http://dx.doi.org/10.1056/NEJMoa1103151			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	887XY	22216840	Green Published, Green Accepted			2022-12-28	WOS:000299968800005
J	Morrison, EA; DeKoster, GT; Dutta, S; Vafabakhsh, R; Clarkson, MW; Bahl, A; Kern, D; Ha, T; Henzler-Wildman, KA				Morrison, Emma A.; DeKoster, Gregory T.; Dutta, Supratik; Vafabakhsh, Reza; Clarkson, Michael W.; Bahl, Arjun; Kern, Dorothee; Ha, Taekjip; Henzler-Wildman, Katherine A.			Antiparallel EmrE exports drugs by exchanging between asymmetric structures	NATURE			English	Article							MULTIDRUG TRANSPORTER EMRE; ESCHERICHIA-COLI; CONFORMATIONAL-CHANGES; MEMBRANE TOPOLOGY; SUBSTRATE-BINDING; LIGAND-BINDING; PROTON RELEASE; MODEL; STATE; MECHANISM	Small multidrug resistance transporters provide an ideal system to study the minimal requirements for active transport. EmrE is one such transporter in Escherichia coli. It exports a broad class of polyaromatic cation substrates, thus conferring resistance to drug compounds matching this chemical description. However, a great deal of controversy has surrounded the topology of the EmrE homodimer. Here we show that asymmetric antiparallel EmrE exchanges between inward-and outward-facing states that are identical except that they have opposite orientation in the membrane. We quantitatively measure the global conformational exchange between these two states for substrate-bound EmrE in bicelles using solution NMR dynamics experiments. Forster resonance energy transfer reveals that the monomers within each dimer are antiparallel, and paramagnetic relaxation enhancement NMR experiments demonstrate differential water accessibility of the two monomers within each dimer. Our experiments reveal a 'dynamic symmetry' that reconciles the asymmetric EmrE structure with the functional symmetry of residues in the active site.	[Morrison, Emma A.; DeKoster, Gregory T.; Dutta, Supratik; Bahl, Arjun; Henzler-Wildman, Katherine A.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Vafabakhsh, Reza; Ha, Taekjip] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Vafabakhsh, Reza; Ha, Taekjip] Univ Illinois, Howard Hughes Med Inst, Urbana, IL 61801 USA; [Clarkson, Michael W.; Kern, Dorothee] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA; [Clarkson, Michael W.; Kern, Dorothee] Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02454 USA	Washington University (WUSTL); University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign; Brandeis University; Brandeis University; Howard Hughes Medical Institute	Henzler-Wildman, KA (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.	khenzler@wustl.edu	Ha, Taekjip/B-9506-2009	Ha, Taekjip/0000-0003-2195-6258; Morrison, Emma/0000-0001-6722-7961; Henzler-Wildman, Katherine/0000-0002-5295-2121; Clarkson, Michael W/0000-0002-4323-3424; DeKoster, Gregory/0000-0001-9928-8195	National Institutes of Health [1R01GM095839]; Searle Scholars Program; US Department of Energy, Office of Basic Energy Sciences; Howard Hughes Medical Institute; NSF [DGE-1143954]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholars Program; US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Liu for assistance replicating the ITC data. We thank J. Villali for assistance growing isotopically labelled EmrE. We are grateful to Y. Li and A. Palmer for providing pulse programs and G. Chang for providing the EmrE expression plasmid. This work was supported by the National Institutes of Health (1R01GM095839) and the Searle Scholars Program (K. H. W.), the US Department of Energy, Office of Basic Energy Sciences (D. K.), the Howard Hughes Medical Institute (D. K. and T. H.), and an NSF graduate research fellowship to E. M. (DGE-1143954).	Adam Y, 2007, P NATL ACAD SCI USA, V104, P17989, DOI 10.1073/pnas.0704425104; Agarwal V, 2007, BBA-BIOMEMBRANES, V1768, P3036, DOI 10.1016/j.bbamem.2007.09.012; Amadi ST, 2010, J BIOL CHEM, V285, P26710, DOI 10.1074/jbc.M110.132621; Arkin IT, 1996, BIOCHEMISTRY-US, V35, P7233, DOI 10.1021/bi960094i; Butler PJG, 2004, J MOL BIOL, V340, P797, DOI 10.1016/j.jmb.2004.05.014; Charalambous Kalypso, 2008, BMC Biochemistry, V9, P31, DOI 10.1186/1471-2091-9-31; Chen YJ, 2007, P NATL ACAD SCI USA, V104, P18999, DOI 10.1073/pnas.0709387104; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Glover KJ, 2001, BIOPHYS J, V81, P2163, DOI 10.1016/S0006-3495(01)75864-X; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kneller, 2003, SPARKY 3; Korkhov VM, 2008, J MOL BIOL, V377, P1094, DOI 10.1016/j.jmb.2008.01.056; Korkhov VM, 2009, ACTA CRYSTALLOGR D, V65, P186, DOI 10.1107/S0907444908036640; Lehner I, 2008, J BIOL CHEM, V283, P3281, DOI 10.1074/jbc.M707899200; Li Y, 2009, J BIOMOL NMR, V45, P357, DOI 10.1007/s10858-009-9385-0; Mchaourab HS, 2008, BIOCHEMISTRY-US, V47, P7980, DOI 10.1021/bi800628d; Miller D, 2009, J MOL BIOL, V393, P815, DOI 10.1016/j.jmb.2009.08.039; Miloushev VZ, 2008, STRUCTURE, V16, P1195, DOI 10.1016/j.str.2008.05.009; Mordoch SS, 1999, J BIOL CHEM, V274, P19480, DOI 10.1074/jbc.274.27.19480; Muth TR, 2000, EMBO J, V19, P234, DOI 10.1093/emboj/19.2.234; Nara T, 2007, J BIOCHEM, V142, P621, DOI 10.1093/jb/mvm169; Nasie I, 2010, J BIOL CHEM, V285, P15234, DOI 10.1074/jbc.M110.108746; Ninio S, 2004, FEBS LETT, V562, P193, DOI 10.1016/S0014-5793(04)00240-6; Rapp M, 2007, SCIENCE, V315, P1282, DOI 10.1126/science.1135406; Raschle T, 2010, CURR OPIN STRUC BIOL, V20, P471, DOI 10.1016/j.sbi.2010.05.006; Rotem D, 2004, J BIOL CHEM, V279, P48787, DOI 10.1074/jbc.M408187200; Rotem D, 2001, J BIOL CHEM, V276, P48243, DOI 10.1074/jbc.M108229200; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Sanders CR, 2006, MAGN RESON CHEM, V44, pS24, DOI 10.1002/mrc.1816; Schuldiner S, 2009, BBA-PROTEINS PROTEOM, V1794, P748, DOI 10.1016/j.bbapap.2008.12.018; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; Sharoni M, 2005, J BIOL CHEM, V280, P32849, DOI 10.1074/jbc.M504910200; Sikora CW, 2005, BIOPHYS J, V88, P475, DOI 10.1529/biophysj.104.049247; Soskine M, 2004, J BIOL CHEM, V279, P9951, DOI 10.1074/jbc.M312853200; Soskine M, 2006, J BIOL CHEM, V281, P36205, DOI 10.1074/jbc.M607186200; Steiner-Mordoch S, 2008, EMBO J, V27, P17, DOI 10.1038/sj.emboj.7601951; Tate CG, 2003, J MOL BIOL, V332, P229, DOI 10.1016/S0022-2836(03)00895-7; Ubarretxena-Belandia I, 2004, FEBS LETT, V564, P234, DOI 10.1016/S0014-5793(04)00228-5; Ubarretxena-Belandia I, 2003, EMBO J, V22, P6175, DOI 10.1093/emboj/cdg611; Weinglass AB, 2005, J BIOL CHEM, V280, P7487, DOI 10.1074/jbc.M413555200; West IC, 1997, BBA-REV BIOMEMBRANES, V1331, P213, DOI 10.1016/S0304-4157(97)00007-5; Whiles JA, 2002, BIOORG CHEM, V30, P431, DOI 10.1016/S0045-2068(02)00527-8; Yerushalmi H, 2000, BIOCHEMISTRY-US, V39, P14711, DOI 10.1021/bi001892i; YERUSHALMI H, 1995, J BIOL CHEM, V270, P6856, DOI 10.1074/jbc.270.12.6856; Yerushalmi H, 2001, J BIOL CHEM, V276, P12744, DOI 10.1074/jbc.M010979200	49	153	154	1	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 5	2012	481	7379					45	U50		10.1038/nature10703	http://dx.doi.org/10.1038/nature10703			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872VD	22178925	Green Accepted			2022-12-28	WOS:000298836900025
J	Prindle, A; Samayoa, P; Razinkov, I; Danino, T; Tsimring, LS; Hasty, J				Prindle, Arthur; Samayoa, Phillip; Razinkov, Ivan; Danino, Tal; Tsimring, Lev S.; Hasty, Jeff			A sensing array of radically coupled genetic 'biopixels'	NATURE			English	Article							ESCHERICHIA-COLI; SUPEROXIDE-DISMUTASE; CELL COMMUNICATION; SYNTHETIC BIOLOGY; BACTERIA; NETWORKS; CIRCUITS; DESIGN; SYSTEM; NOISE	Although there has been considerable progress in the development of engineering principles for synthetic biology, a substantial challenge is the construction of robust circuits in a noisy cellular environment. Such an environment leads to considerable intercellular variability in circuit behaviour, which can hinder functionality at the colony level. Here we engineer the synchronization of thousands of oscillating colony 'biopixels' over centimetre-length scales through the use of synergistic intercellular coupling involving quorum sensing within a colony and gas-phase redox signalling between colonies. We use this platform to construct a liquid crystal display (LCD)-like macroscopic clock that can be used to sense arsenic via modulation of the oscillatory period. Given the repertoire of sensing capabilities of bacteria such as Escherichia coli, the ability to coordinate their behaviour over large length scales sets the stage for the construction of low cost genetic biosensors that are capable of detecting heavy metals and pathogens in the field.	[Prindle, Arthur; Razinkov, Ivan; Danino, Tal; Hasty, Jeff] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Samayoa, Phillip; Hasty, Jeff] Univ Calif San Diego, Bioinformat Program, La Jolla, CA 92093 USA; [Tsimring, Lev S.; Hasty, Jeff] Univ Calif San Diego, BioCircuits Inst, La Jolla, CA 92093 USA; [Hasty, Jeff] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Hasty, J (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	hasty@bioeng.ucsd.edu		Tsimring, Lev/0000-0003-0709-3548	National Institutes of Health and General Medicine [R01GM69811]; San Diego Center for Systems Biology [P50GM085764]; DoD NDSEG; NSF; Office of Naval Research [MURI N00014-07-0741]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069811, P50GM085764] Funding Source: NIH RePORTER	National Institutes of Health and General Medicine; San Diego Center for Systems Biology; DoD NDSEG; NSF(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health and General Medicine (R01GM69811), the San Diego Center for Systems Biology (P50GM085764), the DoD NDSEG (A. P.) and NSF Graduate Research (P. S.) Fellowship Programs. L. T. was supported, in part, by the Office of Naval Research (MURI N00014-07-0741). We would like to thank J. Imlay, S. Ali and J. Collins for helpful discussions and J. Hickman, B. Taylor and K. Lomax for their help with illustrations.	Austin DW, 2006, NATURE, V439, P608, DOI 10.1038/nature04194; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Berg JM, 2006, BIOCHEMISTRY; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Bose JL, 2007, MOL MICROBIOL, V65, P538, DOI 10.1111/j.1365-2958.2007.05809.x; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Daunert S, 2000, CHEM REV, V100, P2705, DOI 10.1021/cr990115p; Ellis T, 2009, NAT BIOTECHNOL, V27, P465, DOI 10.1038/nbt.1536; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Ferry MS, 2011, METHOD ENZYMOL, V497, P295, DOI 10.1016/B978-0-12-385075-1.00014-7; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GAST T, 1985, J PHYS E SCI INSTRUM, V18, P783, DOI 10.1088/0022-3735/18/9/008; Georgellis D, 2001, SCIENCE, V292, P2314, DOI 10.1126/science.1059361; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Grilly C, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100168; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; KELNER MJ, 1990, J BIOL CHEM, V265, P1306; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; Leveau JHJ, 2002, CURR OPIN MICROBIOL, V5, P259, DOI 10.1016/S1369-5274(02)00321-1; Lewandowski W, 1999, P IEEE, V87, P163, DOI 10.1109/5.736348; Lu TK, 2007, P NATL ACAD SCI USA, V104, P11197, DOI 10.1073/pnas.0704624104; Mather W, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.068105; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Messner KR, 1999, J BIOL CHEM, V274, P10119, DOI 10.1074/jbc.274.15.10119; Mondragon-Palomino O, 2011, SCIENCE, V333, P1315, DOI 10.1126/science.1205369; Mukherji S, 2009, NAT REV GENET, V10, P859, DOI 10.1038/nrg2697; Nordstrom DK, 2002, SCIENCE, V296, P2143, DOI 10.1126/science.1072375; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Quan JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006441; Remington SJ, 2006, CURR OPIN STRUC BIOL, V16, P714, DOI 10.1016/j.sbi.2006.10.001; Seaver LC, 2001, J BACTERIOL, V183, P7182, DOI 10.1128/JB.183.24.7182-7189.2001; Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335; Stocker J, 2003, ENVIRON SCI TECHNOL, V37, P4743, DOI 10.1021/es034258b; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Tabor JJ, 2009, CELL, V137, P1272, DOI 10.1016/j.cell.2009.04.048; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; TOUATI D, 1995, J BACTERIOL, V177, P2305, DOI 10.1128/jb.177.9.2305-2314.1995; van der Meer JR, 2010, NAT REV MICROBIOL, V8, P511, DOI 10.1038/nrmicro2392; Vladimirov AG, 2003, EUROPHYS LETT, V61, P613, DOI 10.1209/epl/i2003-00115-8; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Westinghouse G., 1887, US patent, Patent No. [373 035, 373035]; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491	50	262	274	14	191	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 5	2012	481	7379					39	44		10.1038/nature10722	http://dx.doi.org/10.1038/nature10722			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872VD	22178928	Green Accepted			2022-12-28	WOS:000298836900024
J	Beckett, N; Peters, R; Tuomilehto, J; Swift, C; Sever, P; Potter, J; McCormack, T; Forette, F; Gil-Extremera, B; Dumitrascu, D; Staessen, JA; Thijs, L; Fletcher, A; Bulpitt, C				Beckett, N.; Peters, R.; Tuomilehto, J.; Swift, C.; Sever, P.; Potter, J.; McCormack, T.; Forette, F.; Gil-Extremera, B.; Dumitrascu, D.; Staessen, J. A.; Thijs, L.; Fletcher, A.; Bulpitt, C.		HYVET Study Grp	Immediate and late benefits of treating very elderly people with hypertension: results from active treatment extension to Hypertension in the Very Elderly randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SYSTOLIC HYPERTENSION; BLOOD-PRESSURE; DOUBLE-BLIND; HYVET-COG; DEMENTIA; PROTOCOL; THERAPY; AGE	Objective To assess if very elderly people with hypertension obtain early benefit from antihypertensive treatment. Design One year open label active treatment extension of randomised controlled trial (Hypertension in the Very Elderly Trial (HYVET)). Setting Hospital and general practice based centres mainly in eastern and western Europe, China, and Tunisia. Participants People on double blind treatment at the end of HYVET were eligible to enter the extension. Interventions Participants on active blood pressure lowering treatment continued taking active drug; those on placebo were given active blood pressure lowering treatment. The treatment regimen was as used in the main trial-indapamide SR 1.5 mg (plus perindopril 2-4 mg if required)-with the same target blood pressure of less than 150/80 mm Hg. Main outcome measures The primary outcome was all stroke; other outcomes included total mortality, cardiovascular mortality, and cardiovascular events. Results Of 1882 people eligible for entry to the extension, 1712 (91%) agreed to participate. During the extension period, 1682 patient years were accrued. By six months, the difference in blood pressure between the two groups was 1.2/0.7 mm Hg. Comparing people previously treated with active drug and those previously on placebo, no significant differences were seen for stroke (n=13; hazard ratio 1.92, 95% confidence interval 0.59 to 6.22) or cardiovascular events (n=25; 0.78, 0.36 to 1.72). Differences were seen for total mortality (47 deaths; hazard ratio 0.48, 0.26 to 0.87; P=0.02) and cardiovascular mortality (11 deaths; 0.19, 0.04 to 0.87; P=0.03). Conclusion Very elderly patients with hypertension may gain immediate benefit from treatment. Sustained differences in reductions of total mortality and cardiovascular mortality reinforce the benefits and support the need for early and long term treatment.	[Beckett, N.; Bulpitt, C.] Univ London Imperial Coll Sci Technol & Med, Dept Med, London SW7 2AZ, England; [Peters, R.] Univ London Imperial Coll Sci Technol & Med, Clin Trials Unit, London SW7 2AZ, England; [Tuomilehto, J.] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Tuomilehto, J.] S Ostrobothnia Cent Hosp, Seinajoki, Finland; [Swift, C.] Kings Coll London, Dept Clin Gerontol, Clin Age Res Unit, London WC2R 2LS, England; [Sever, P.] Univ London Imperial Coll Sci Technol & Med, Int Ctr Circulatory Hlth, London SW7 2AZ, England; [Potter, J.] Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England; [McCormack, T.] Spring Vale Med Ctr, Whitby, ON, Canada; [Forette, F.] Univ Paris 05, Hop Broca, Paris, France; [Gil-Extremera, B.] Dept Med Granada, FAC Med, Granada, Spain; [Dumitrascu, D.] Spitalul Judetean Cluj, Cluj Napoca, Romania; [Staessen, J. A.] Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands; [Thijs, L.] Katholieke Univ Leuven, Studies Coordinating Ctr, Div Hypertens & Cardiovasc Rehabil, Louvain, Belgium; [Fletcher, A.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	Imperial College London; Imperial College London; University of Helsinki; University of London; King's College London; Imperial College London; University of East Anglia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Broca - APHP; UDICE-French Research Universities; Universite Paris Cite; Maastricht University; KU Leuven; University of London; London School of Hygiene & Tropical Medicine	Beckett, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, London SW7 2AZ, England.	n.beckett@imperial.ac.uk	Nedogoda, Sergey V/O-4656-2014; Karpov, Rostislav S./F-5406-2014; Senior, Hugh/H-1579-2011; de Voogt, Pim/C-5683-2017; Staessen, Jan A/A-1065-2011; Mordovin, Victor/F-8913-2017; Zadionchenko, Vladimir/A-7445-2016; Ripp, Tatiana M./P-6586-2015; Peters, Ruth/D-4047-2011	Nedogoda, Sergey V/0000-0001-5981-1754; Karpov, Rostislav S./0000-0002-7011-4316; de Voogt, Pim/0000-0001-9065-9797; Staessen, Jan A/0000-0002-3026-1637; Mordovin, Victor/0000-0002-2238-4573; Zadionchenko, Vladimir/0000-0003-2377-5266; Ripp, Tatiana M./0000-0001-5898-0361; Senior, Hugh/0000-0002-7081-2499; Thijs, Lutgarde/0000-0002-8108-2356; Narkiewicz, Krzysztof/0000-0001-5949-5018; Waldman, Adam D/0000-0003-4398-6431; Peters, Ruth/0000-0003-0148-3617; Beckett, Nigel/0000-0002-7736-3817	Imperial College; British Heart Foundation; Institute de Recherches Internationales Servier; Boehringer Ingelheim; MSD	Imperial College; British Heart Foundation(British Heart Foundation); Institute de Recherches Internationales Servier(Servier); Boehringer Ingelheim(Boehringer Ingelheim); MSD	The trial was coordinated by the Department of Care of the Elderly, Imperial College London. Imperial College was the sponsor of the trial and required confidentiality agreements with all committee members and investigators.; HYVET was funded by grants from the British Heart Foundation and the Institute de Recherches Internationales Servier. The analysis, interpretation of the data, generation of the manuscript, and decision to submit for publication were carried out independently of the funding bodies.; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: for the submitted work, NB and RP received salary support from a grant made to Imperial College London by the Institute de Recherches Internationales Servier, CB received consultancy fees from the grant from 2005, and the other co-authors received reimbursement for travel costs from the grant; NB has received honorariums from Servier; CB, JP, and TMcC have received honorariums from various companies that manufacture antihypertensive medications; JP sits on an advisory board for MSD and Bayer; TMcC does consultancy for Servier, Daichii Sankyo, Boehringer Ingelheim, and Takeday, has received travel expenses from Boehringer Ingelheim and MSD, and holds shares in Astra Zeneca; no other relationships or activities that could appear to have influenced the submitted work.	Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Bulpitt C, 2001, DRUG AGING, V18, P151, DOI 10.2165/00002512-200118030-00001; Chalmers J, 1999, J HYPERTENS, V17, P151; Colvez A, 1996, EPIDEMIOLOGY OLD AGE, P41; Kostis JB, 2005, AM J CARDIOL, V95, P29, DOI 10.1016/j.amjcard.2004.08.059; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Peters R, 2006, DRUG AGING, V23, P83, DOI 10.2165/00002512-200623010-00008; Peters R, 2008, LANCET NEUROL, V7, P683, DOI 10.1016/S1474-4422(08)70143-1; Peters R, 2010, AGE AGEING, V39, P609, DOI 10.1093/ageing/afq071; Staessen JA, 2004, J HYPERTENS, V22, P847, DOI 10.1097/00004872-200404000-00029; Sutton-Tyrrell K, 2003, ARCH INTERN MED, V163, P2728, DOI 10.1001/archinte.163.22.2728	12	93	102	0	29	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 4	2012	344								d7541	10.1136/bmj.d7541	http://dx.doi.org/10.1136/bmj.d7541			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874UF	22218098	Green Accepted, hybrid, Green Submitted			2022-12-28	WOS:000298982900007
J	Kociol, RD; Lopes, RD; Clare, R; Thomas, L; Mehta, RH; Kaul, P; Pieper, KS; Hochman, JS; Weaver, WD; Armstrong, PW; Granger, CB; Patel, MR				Kociol, Robb D.; Lopes, Renato D.; Clare, Robert; Thomas, Laine; Mehta, Rajendra H.; Kaul, Padma; Pieper, Karen S.; Hochman, Judith S.; Weaver, W. Douglas; Armstrong, Paul W.; Granger, Christopher B.; Patel, Manesh R.			International Variation in and Factors Associated With Hospital Readmission After Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERCUTANEOUS CORONARY INTERVENTION; HEART-DISEASE MORTALITY; TEMPORAL TRENDS; EARLY DISCHARGE; FOLLOW-UP; PEXELIZUMAB; TRIAL; FAILURE; US	Context ST-segment elevation myocardial infarction (STEMI) treatment has improved outcomes and shortened hospital stay. Recently, 30-day readmission rates have been proposed as a metric for care of patients with STEMI. However, international rates and predictors of 30-day readmission after STEMI have not been studied. Objective To determine international variation in and predictors of 30-day readmission rates after STEMI and country-level care patterns. Design, Setting, and Patients Post hoc analysis of the Assessment of Pexelizumab in Acute Myocardial Infarction trial that enrolled 5745 patients with STEMI at 296 sites in the United States, Canada, Australia, New Zealand, and 13 European countries from July 13, 2004, to May 11, 2006. Multivariable logistic regression analysis was used to identify independent predictors of all-cause and non-elective 30-day postdischarge readmission. Main Outcome Measures Predictors of 30-day postdischarge all-cause and non-elective readmissions. Results Of 5571 patients with STEMI who survived to hospital discharge, 631 (11.3%) were readmitted within 30 days. Thirty-day readmission rates were higher for the United States than other countries (14.5% vs 9.9%; P<.001). Median length of stay was shortest for US patients (3 days; interquartile range, 2-4 days) and longest for Germany (8 days; interquartile range, 6-11 days). In multivariable regression, the predictors of 30-day readmission included multivessel disease (odds ratio [OR], 1.97; 95% CI, 1.65-2.35) and US location (OR, 1.68; 95% CI, 1.37-2.07). Excluding elective readmission for revascularization, US enrollment was still an independent predictor of readmission (OR, 1.53; 95% CI, 1.20-1.96). After adjustment of the models for country-level median length of stay, US location was no longer an independent predictor of 30-day all-cause or nonelective readmission. Location in the United States was not a predictor of in-hospital death (OR, 0.88; 95% CI, 0.60-1.30) or 30-day postadmission death (OR, 1.0; 95% CI, 0.72-1.39). Conclusions In this multinational study, there was variation across countries in 30-day readmission rates after STEMI, with readmission rates higher in the United States than in other countries. However, this difference was greatly attenuated after adjustment for length of stay. JAMA. 2012;307(1):66-74	[Kociol, Robb D.; Lopes, Renato D.; Clare, Robert; Thomas, Laine; Mehta, Rajendra H.; Pieper, Karen S.; Granger, Christopher B.; Patel, Manesh R.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27715 USA; [Kaul, Padma; Armstrong, Paul W.] Univ Alberta, Edmonton, AB, Canada; [Hochman, Judith S.] NYU, Sch Med, Cardiovasc Clin Res Ctr, New York, NY USA; [Weaver, W. Douglas] Henry Ford Hosp, Henry Ford Heart & Vasc Inst, Detroit, MI 48202 USA	Duke University; University of Alberta; New York University; Henry Ford Health System; Henry Ford Hospital	Patel, MR (corresponding author), Duke Univ, Med Ctr, Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	manesh.patel@duke.edu	Granger, Christopher B/D-3458-2014; Patel, Manesh/AAC-5385-2019	Granger, Christopher B/0000-0002-0045-3291; Hochman, Judith/0000-0002-5889-5981; Kociol, Robb/0000-0002-8759-9997; Kaul, Padma/0000-0003-2239-3944; Armstrong, Paul/0000-0002-0460-3445	Duke Clinical Research Institute; Procter & Gamble Pharmaceuticals; Alexion Pharmaceuticals; American Heart Association-Pharmaceutical Roundtable	Duke Clinical Research Institute; Procter & Gamble Pharmaceuticals(Procter & Gamble); Alexion Pharmaceuticals; American Heart Association-Pharmaceutical Roundtable(American Heart Association)	This research was supported by unrestricted funding from the Duke Clinical Research Institute. Procter & Gamble Pharmaceuticals and Alexion Pharmaceuticals jointly funded the Assessment of Pexelizumab in Acute Myocardial Infarction trial. This work was supported by an award from the American Heart Association-Pharmaceutical Roundtable and David and Stevie Spina.	Anderson GF, 2008, MULTINATIONAL COMP H; Armstrong PW, 2007, JAMA-J AM MED ASSOC, V297, P43; Armstrong PW, 2005, AM HEART J, V149, P402, DOI 10.1016/j.ahj.2004.12.015; Baker DW, 2004, ARCH INTERN MED, V164, P538, DOI 10.1001/archinte.164.5.538; Betriu A, 1997, NEW ENGL J MED, V336, P1621; Brener SJ, 2006, AM HEART J, V151, pS4, DOI 10.1016/j.ahj.2006.04.007; Capewell S, 1999, HEART, V81, P380, DOI 10.1136/hrt.81.4.380; Curtis JP, 2009, J AM COLL CARDIOL, V54, P903, DOI 10.1016/j.jacc.2009.04.076; Daugherty SL, 2008, ARCH INTERN MED, V168, P485, DOI 10.1001/archinte.168.5.485; Desai MM, 2009, CIRC-CARDIOVASC QUAL, V2, P500, DOI 10.1161/CIRCOUTCOMES.108.832949; DEWOOD MA, 1980, NEW ENGL J MED, V303, P897, DOI 10.1056/NEJM198010163031601; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Fox CS, 2004, CIRCULATION, V110, P522, DOI 10.1161/01.CIR.0000136993.34344.41; Hernandez AF, 2010, JAMA-J AM MED ASSOC, V303, P1716, DOI 10.1001/jama.2010.533; Joynt KE, 2011, ANN INTERN MED, V154, P94, DOI 10.7326/0003-4819-154-2-201101180-00008; Kaul P, 2004, LANCET, V363, P511, DOI 10.1016/S0140-6736(04)15536-0; Krumholz HM, 2009, CIRC-CARDIOVASC QUAL, V2, P407, DOI 10.1161/CIRCOUTCOMES.109.883256; LAU YK, 1980, BRIT MED J, V280, P1489, DOI 10.1136/bmj.280.6230.1489; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Movahed MR, 2009, AM J CARDIOL, V104, P1030, DOI 10.1016/j.amjcard.2009.05.051; Rogers WJ, 2000, J AM COLL CARDIOL, V36, P2056, DOI 10.1016/S0735-1097(00)00996-7; Schroder R, 2004, CIRCULATION, V110, pE506, DOI 10.1161/01.CIR.0000147778.05979.E6; Spertus John A., 2003, Circulation, V107, P1681, DOI 10.1161/01.CIR.0000062026.90014.63; Stebbins A, 2010, CIRC-CARDIOVASC INTE, V3, P414, DOI 10.1161/CIRCINTERVENTIONS.109.925180; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011	25	99	99	0	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 4	2012	307	1					66	74		10.1001/jama.2011.1926	http://dx.doi.org/10.1001/jama.2011.1926			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	872ET	22215167	Bronze, Green Published			2022-12-28	WOS:000298792300023
J	Burger, RA; Brady, MF; Bookman, MA; Fleming, GF; Monk, BJ; Huang, H; Mannel, RS; Homesley, HD; Fowler, J; Greer, BE; Boente, M; Birrer, MJ; Liang, SX				Burger, Robert A.; Brady, Mark F.; Bookman, Michael A.; Fleming, Gini F.; Monk, Bradley J.; Huang, Helen; Mannel, Robert S.; Homesley, Howard D.; Fowler, Jeffrey; Greer, Benjamin E.; Boente, Matthew; Birrer, Michael J.; Liang, Sharon X.		Gynecologic Oncology Grp	Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOTHELIAL GROWTH-FACTOR; FACTOR EXPRESSION; PROGNOSTIC-SIGNIFICANCE; ANTIANGIOGENIC THERAPY; MONOCLONAL-ANTIBODY; TUMOR ANGIOGENESIS; SOLID TUMORS; PHASE-II; CARCINOMA; ASCITES	BACKGROUND Vascular endothelial growth factor is a key promoter of angiogenesis and disease progression in epithelial ovarian cancer. Bevacizumab, a humanized anti-vascular endothelial growth factor monoclonal antibody, has shown single-agent activity in women with recurrent tumors. Thus, we aimed to evaluate the addition of bevacizumab to standard front-line therapy. METHODS In our double-blind, placebo-controlled, phase 3 trial, we randomly assigned eligible patients with newly diagnosed stage III (incompletely resectable) or stage IV epithelial ovarian cancer who had undergone debulking surgery to receive one of three treatments. All three included chemotherapy consisting of intravenous paclitaxel at a dose of 175 mg per square meter of body-surface area, plus carboplatin at an area under the curve of 6, for cycles 1 through 6, plus a study treatment for cycles 2 through 22, each cycle of 3 weeks' duration. The control treatment was chemotherapy with placebo added in cycles 2 through 22; bevacizumab-initiation treatment was chemotherapy with bevacizumab (15 mg per kilogram of body weight) added in cycles 2 through 6 and placebo added in cycles 7 through 22. Bevacizumab-throughout treatment was chemotherapy with bevacizumab added in cycles 2 through 22. The primary end point was progression-free survival. RESULTS Overall, 1873 women were enrolled. The median progression-free survival was 10.3 months in the control group, 11.2 in the bevacizumab-initiation group, and 14.1 in the bevacizumab-throughout group. Relative to control treatment, the hazard ratio for progression or death was 0.908 (95% confidence interval [CI], 0.795 to 1.040; P=0.16) with bevacizumab initiation and 0.717 (95% CI, 0.625 to 0.824; P<0.001) with bevacizumab throughout. At the time of analysis, 76.3% of patients were alive, with no significant differences in overall survival among the three groups. The rate of hypertension requiring medical therapy was higher in the bevacizumab-initiation group (16.5%) and the bevacizumab-throughout group (22.9%) than in the control group (7.2%). Gastrointestinal-wall disruption requiring medical intervention occurred in 1.2%, 2.8%, and 2.6% of patients in the control group, the bevacizumab-initiation group, and the bevacizumab-throughout group, respectively. CONCLUSIONS The use of bevacizumab during and up to 10 months after carboplatin and paclitaxel chemotherapy prolongs the median progression-free survival by about 4 months in patients with advanced epithelial ovarian cancer. (Funded by the National Cancer Institute and Genentech; ClinicalTrials.gov number, NCT00262847.)	[Burger, Robert A.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Brady, Mark F.; Huang, Helen] Roswell Pk Canc Inst, Gynecol Oncol Grp, Stat & Data Ctr, Buffalo, NY 14263 USA; [Bookman, Michael A.] Arizona Canc Ctr, Tucson, AZ USA; [Fleming, Gini F.] Univ Chicago, Chicago, IL 60637 USA; [Monk, Bradley J.] Creighton Univ, Sch Med, St Josephs Hosp & Med Ctr, Phoenix, AZ USA; [Mannel, Robert S.] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA; [Homesley, Howard D.] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA; [Fowler, Jeffrey] Ohio State Univ, James Canc Hosp, Hilliard, OH 43026 USA; [Greer, Benjamin E.] Seattle Canc Care Alliance, Seattle, WA USA; [Boente, Matthew] Minnesota Oncol & Hematol, Minneapolis, MN USA; [Birrer, Michael J.] Harvard Univ, Sch Med, Boston, MA USA; [Birrer, Michael J.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Liang, Sharon X.] N Shore Long Isl Jewish Hlth Syst, New Hyde Pk, NY USA	Fox Chase Cancer Center; Roswell Park Cancer Institute; Arizona Center Cancer Care; University of Chicago; Creighton University; St. Joseph's Hospital and Medical Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Wake Forest University; Wake Forest Baptist Medical Center; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Seattle Cancer Care Alliance; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Northwell Health	Burger, RA (corresponding author), Fox Chase Canc Ctr, 333 Cottman Ave, Philadelphia, PA 19111 USA.	robert.a.burger@fccc.edu			National Cancer Institute; Genentech; NATIONAL CANCER INSTITUTE [P50CA083638] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Genentech(Roche HoldingGenentech); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by the National Cancer Institute and Genentech; ClinicalTrials.gov number, NCT00262847.; Supported by the National Cancer Institute and Genentech.	Aghajanian CAF, 2011, 2011 AM SOC CLIN ONC; Alvarez AA, 1999, CLIN CANCER RES, V5, P587; [Anonymous], AVASTIN BEVACIZUMAB; Bagri A, 2010, CLIN CANCER RES, V16, P3887, DOI 10.1158/1078-0432.CCR-09-3100; Basen-Engquist K, 2001, J CLIN ONCOL, V19, P1809, DOI 10.1200/JCO.2001.19.6.1809; BAST RC, 1981, J CLIN INVEST, V68, P1331, DOI 10.1172/JCI110380; Belotti D, 2008, MOL CANCER RES, V6, P525, DOI 10.1158/1541-7786.MCR-07-0366; Burger RA, 2007, J CLIN ONCOL, V25, P5165, DOI 10.1200/JCO.2007.11.5345; Byrne AT, 2003, CLIN CANCER RES, V9, P5721; Cancer Therapy Evaluation Program, 2006, COMM TERM CRIT ADV E; Cannistra SA, 2008, J CLIN ONCOL, V26, P3665, DOI 10.1200/JCO.2008.17.2676; Cannistra SA, 2007, J CLIN ONCOL, V25, P5180, DOI 10.1200/JCO.2007.12.0782; COX DR, 1972, J R STAT SOC B, V34, P187; Duncan TJ, 2008, CLIN CANCER RES, V14, P3030, DOI 10.1158/1078-0432.CCR-07-1888; Gasparini G, 1996, INT J CANCER, V69, P205, DOI 10.1002/(SICI)1097-0215(19960621)69:3<205::AID-IJC10>3.0.CO;2-6; Geiger-Gritsch S, 2010, ONCOLOGIST, V15, P1373, DOI 10.1634/theoncologist.2009-0155erratum; Geiger-Gritsch S, 2010, ONCOLOGIST, V15, P1179, DOI 10.1634/theoncologist.2009-0155; Gerber HP, 2005, CANCER RES, V65, P671; Goodheart MJ, 2005, CLIN CANCER RES, V11, P3733, DOI 10.1158/1078-0432.CCR-04-0056; Han ES, 2007, GYNECOL ONCOL, V105, P3, DOI 10.1016/j.ygyno.2007.01.038; HOLLINGSWORTH HC, 1995, AM J PATHOL, V147, P33; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kerbel RS, 2006, SCIENCE, V312, P1171, DOI 10.1126/science.1125950; Manenti L, 2005, MOL CANCER THER, V4, P715, DOI 10.1158/1535-7163.MCT-04-0305; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; MEHTA CR, 1983, J AM STAT ASSOC, V78, P427, DOI 10.2307/2288652; Mesiano S, 1998, AM J PATHOL, V153, P1249, DOI 10.1016/S0002-9440(10)65669-6; Paley PJ, 1997, CANCER, V80, P98, DOI 10.1002/(SICI)1097-0142(19970701)80:1<98::AID-CNCR13>3.0.CO;2-A; Perren TS, 2010, 35 ANN M EUR SOC MED; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Presta LG, 1997, CANCER RES, V57, P4593; Rustin GJS, 2001, J CLIN ONCOL, V19, P4054, DOI 10.1200/JCO.2001.19.20.4054; Shen GH, 2000, BRIT J CANCER, V83, P196; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Stuart GCE, 2011, INT J GYNECOL CANCER, V21, P750, DOI 10.1097/IGC.0b013e31821b2568; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Willett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988; Xu L, 2000, INT J ONCOL, V16, P445; Yost KJ, 2005, EVAL HEALTH PROF, V28, P172, DOI 10.1177/0163278705275340	39	1579	1624	5	106	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2011	365	26					2473	2483		10.1056/NEJMoa1104390	http://dx.doi.org/10.1056/NEJMoa1104390			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	868SD	22204724				2022-12-28	WOS:000298544600008
J	Piers, RD; Azoulay, E; Ricou, B; Ganz, FD; Decruyenaere, J; Max, A; Michalsen, A; Maia, PA; Owczuk, R; Rubulotta, F; Depuydt, P; Meert, AP; Reyners, AK; Aquilina, A; Bekaert, M; Van den Noortgate, NJ; Schrauwen, WJ; Benoit, DD				Piers, Ruth D.; Azoulay, Elie; Ricou, Bara; Ganz, Freda DeKeyser; Decruyenaere, Johan; Max, Adeline; Michalsen, Andrej; Maia, Paulo Azevedo; Owczuk, Radoslaw; Rubulotta, Francesca; Depuydt, Pieter; Meert, Anne-Pascale; Reyners, Anna K.; Aquilina, Andrew; Bekaert, Maarten; Van den Noortgate, Nele J.; Schrauwen, Wim J.; Benoit, Dominique D.		ESICM	Perceptions of Appropriateness of Care Among European and Israeli Intensive Care Unit Nurses and Physicians	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OF-LIFE CARE; MORAL DISTRESS; ETHICAL DILEMMAS; CRITICALLY-ILL; NURSING STAFF; FUTILE CARE; END; DECISIONS; BURNOUT; COMMUNICATION	Context Clinicians in intensive care units (ICUs) who perceive the care they provide as inappropriate experience moral distress and are at risk for burnout. This situation may jeopardize patient quality of care and increase staff turnover. Objective To determine the prevalence of perceived inappropriateness of care among ICU clinicians and to identify patient-related situations, personal characteristics, and work-related characteristics associated with perceived inappropriateness of care. Design, Setting, and Participants Cross-sectional evaluation on May 11, 2010, of 82 adult ICUs in 9 European countries and Israel. Participants were 1953 ICU nurses and physicians providing bedside care. Main Outcome Measure Perceived inappropriateness of care, defined as a specific patient-care situation in which the clinician acts in a manner contrary to his or her personal and professional beliefs, as assessed using a questionnaire designed for the study. Results Of 1651 respondents (median response rate, 93% overall; interquartile range, 82%-100% [medians 93% among nurses and 100% among physicians]), perceived inappropriateness of care in at least 1 patient was reported by 439 clinicians overall (27%; 95% CI, 24%-29%), 300 of 1218 were nurses (25%), 132 of 407 were physicians (32%), and 26 had missing answers describing job title. Of these 439 individuals, 397 reported 445 situations associated with perceived inappropriateness of care. The most common reports were perceived disproportionate care (290 situations [65%; 95% CI, 58%-73%], of which "too much care" was reported in 89% of situations, followed by "other patients would benefit more" (168 situations [38%; 95% CI, 32%-43%]). Independently associated with perceived inappropriateness of care rates both among nurses and physicians were symptom control decisions directed by physicians only (odds ratio [OR], 1.73; 95% CI, 1.17-2.56; P=.006); involvement of nurses in end-of-life decision making (OR, 0.76; 95% CI, 0.60-0.96; P=.02); good collaboration between nurses and physicians (OR, 0.72; 95% CI, 0.56-0.92; P=.009); and freedom to decide how to perform work-related tasks (OR, 0.72; 95% CI, 0.59-0.89; P=.002); while a high perceived workload was significantly associated among nurses only(OR, 1.49; 95% CI, 1.07-2.06; P=.02). Perceived inappropriateness of care was independently associated with higher intent to leave a job (OR, 1.65; 95% CI, 1.04-2.63; P=.03). In the subset of 69 ICUs for which patient data could be linked, clinicians reported received inappropriateness of care in 207 patients, representing 23% (95% CI, 20%-27%) of 883 ICU beds. Conclusion Among a group of European and Israeli ICU clinicians, perceptions of inappropriate care were frequently reported and were inversely associated with factors indicating good teamwork. JAMA. 2011;306(24):2694-2703	[Piers, Ruth D.; Decruyenaere, Johan; Depuydt, Pieter; Benoit, Dominique D.] Ghent Univ Hosp, Dept Intens Care Med, B-9000 Ghent, Belgium; [Piers, Ruth D.; Van den Noortgate, Nele J.] Ghent Univ Hosp, Dept Geriatr, B-9000 Ghent, Belgium; [Schrauwen, Wim J.] Ghent Univ Hosp, Dept Med Oncol, B-9000 Ghent, Belgium; [Azoulay, Elie; Max, Adeline] Hop St Louis, Med ICU, Paris, France; [Azoulay, Elie; Max, Adeline] Univ Paris 07, Paris, France; [Ricou, Bara] Univ Hosp Geneva, Dept Intens Care, Geneva, Switzerland; [Ricou, Bara] Univ Geneva, Geneva, Switzerland; [Ganz, Freda DeKeyser] Hadassah Hebrew Univ, Sch Nursing, Jerusalem, Israel; [Michalsen, Andrej] Tuttlingen Hosp, Dept Anaesthesiol & Crit Care Med, Tuttlingen, Germany; [Maia, Paulo Azevedo] Ctr Hosp Porto, Hosp Santo Antonio, Serv Cuidados Intens 1, Oporto, Portugal; [Owczuk, Radoslaw] Med Univ Gdansk, Dept Anaesthesiol & Intens Therapy, Gdansk, Poland; [Rubulotta, Francesca] Imperial Coll NHS Trust, Charing Cross Hosp, Ctr Perioperat Med & Crit Care Res, London, England; [Meert, Anne-Pascale] Inst Jules Bordet, Serv Soins Intensifs Medicochirurg & Oncol Thorac, B-1000 Brussels, Belgium; [Reyners, Anna K.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, NL-9713 AV Groningen, Netherlands; [Aquilina, Andrew] Mater Dei Hosp, Dept Anaesthesia, Msida, Malta; [Bekaert, Maarten] Univ Ghent, Dept Appl Math & Comp Sci, B-9000 Ghent, Belgium	Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Geneva; University of Geneva; Hebrew University of Jerusalem; Hadassah University Medical Center; Fahrenheit Universities; Medical University Gdansk; Imperial College London; Institut Jules Bordet; University of Groningen; Ghent University	Piers, RD (corresponding author), Ghent Univ Hosp, Dept Intens Care Med, Pintelaan 185, B-9000 Ghent, Belgium.	ruth.piers@ugent.be	Owczuk, Radoslaw/AAK-9305-2020; Rubulotta, Francesca/AAE-3246-2021; Swinnen, Walter/GZG-2677-2022; Philippart, Francois/AAF-2791-2019; Piers, Ruth/GNH-2561-2022	Rubulotta, Francesca/0000-0001-8644-1728; Swinnen, Walter/0000-0001-5387-149X; Philippart, Francois/0000-0002-7323-0742; Megarbane, Bruno/0000-0002-2522-2764	European Society of Intensive Care Medicine/European Critical Care Research Network (ESICM/ECCRN); Gilead; Pfizer; Merck, Sharp, and Dohme; Astra-Zeneca; Bayer; General Electric; Abbott Laboratories, Poland	European Society of Intensive Care Medicine/European Critical Care Research Network (ESICM/ECCRN); Gilead(Gilead Sciences); Pfizer(Pfizer); Merck, Sharp, and Dohme(Merck & Company); Astra-Zeneca(AstraZeneca); Bayer(Bayer AG); General Electric(General Electric); Abbott Laboratories, Poland	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Drs Piers, Decruyenaere, Van Den Noortgate, and Benoit report receipt of a grant from the European Society of Intensive Care Medicine/European Critical Care Research Network (ESICM/ECCRN). Dr Azoulay reports board membership, consultancy, grants received or pending, and speakers bureau participation with Gilead, Pfizer, and Merck, Sharp, and Dohme. Dr Decruyenaere reports receipt of meeting expenses from the European Society of Clinical Microbiology and Infectious Diseases; and other research grants from Astra-Zeneca, Bayer, Pfizer, Merck, Sharp, and Dohme, and General Electric. Dr Owczuk reports receipt of consultancy fees from Abbott Laboratories, Poland. Dr Depuydt reports receipt of a grant or a pending grant from Pfizer. The remaining authors report no disclosures.	Altun I, 2002, NURS ETHICS, V9, P269, DOI 10.1191/0969733002ne509oa; Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Azoulay E, 2009, AM J RESP CRIT CARE, V180, P853, DOI 10.1164/rccm.200810-1614OC; Corley MC, 2005, NURS ETHICS, V12, P381, DOI 10.1191/0969733005ne809oa; Corley MC, 2001, J ADV NURS, V33, P250, DOI 10.1046/j.1365-2648.2001.01658.x; Corley MC, 2002, NURS ETHICS, V9, P636, DOI 10.1191/0969733002ne557oa; Curtis JR, 2010, LANCET, V376, P1347, DOI 10.1016/S0140-6736(10)60143-2; Curtis JR, 2001, CRIT CARE MED, V29, pN26, DOI 10.1097/00003246-200102001-00006; Daly K, 2001, BRIT MED J, V322, P1274, DOI 10.1136/bmj.322.7297.1274; De Dreu C, 2007, PSYCHOL CONFLICT CON, P3; Embriaco N, 2007, AM J RESP CRIT CARE, V175, P686, DOI 10.1164/rccm.200608-1184OC; Epstein EG, 2009, J CLIN ETHIC, V20, P330; Fassier T, 2005, CURR OPIN CRIT CARE, V11, P616, DOI 10.1097/01.ccx.0000184299.91254.ff; Ferrand E, 2003, AM J RESP CRIT CARE, V167, P1310, DOI 10.1164/rccm.200207-752OC; Goleman D, 2020, EMOTIONAL INTELLIGEN, V25th; Gutierrez KM, 2005, DIMENS CRIT CARE NUR, V24, P229, DOI 10.1097/00003465-200509000-00011; Hamric AB, 2007, CRIT CARE MED, V35, P422, DOI 10.1097/01.CCM.0000254722.50608.2D; Ho KM, 2005, INTENS CARE MED, V31, P668, DOI 10.1007/s00134-005-2613-5; Kalvemark S, 2004, SOC SCI MED, V58, P1075, DOI 10.1016/S0277-9536(03)00279-X; Karasek R., 1989, JOB CONTROL WORKER H, P129; Karasek R., 1990, HLTH WORK STRESS PRO; Krasner MS, 2009, JAMA-J AM MED ASSOC, V302, P1284, DOI 10.1001/jama.2009.1384; Lilly CM, 2000, AM J MED, V109, P469, DOI 10.1016/S0002-9343(00)00524-6; Lilly CM, 2003, CRIT CARE MED, V31, pS394, DOI 10.1097/01.CCM.0000065279.77449.B4; McNarry AF, 2004, INTENS CARE MED, V30, P325, DOI 10.1007/s00134-003-2072-9; Meier DE, 2001, JAMA-J AM MED ASSOC, V286, P3007, DOI 10.1001/jama.286.23.3007; Meltzer LS, 2004, AM J CRIT CARE, V13, P202, DOI 10.4037/ajcc2004.13.3.202; Mobley Melinda J, 2007, Intensive Crit Care Nurs, V23, P256, DOI 10.1016/j.iccn.2007.03.011; Nussbaum Martha, 2003, UPHEAVALS THOUGHT IN; Oberle K, 2001, J ADV NURS, V33, P707, DOI 10.1046/j.1365-2648.2001.01710.x; Palda VA, 2005, J CRIT CARE, V20, P207, DOI 10.1016/j.jcrc.2005.05.006; Penticuff JH, 2000, NURS RES, V49, P64, DOI 10.1097/00006199-200003000-00002; Piers RD, J AM MED DIR ASS; Poncet MC, 2007, AM J RESP CRIT CARE, V175, P698, DOI 10.1164/rccm.200606-806OC; Puntillo KA, 2006, CRIT CARE MED, V34, pS332, DOI 10.1097/01.CCM.0000237047.31376.28; Raines M L, 2000, JONAS Healthc Law Ethics Regul, V2, P29, DOI 10.1097/00128488-200002010-00006; Rushton CH, 2006, AACN ADV CRIT CARE, V17, P161, DOI 10.1097/01256961-200604000-00011; Schaufeli W.B., 1996, MASLACH BURNOUT INVE, V3rd, P22; Schluter J, 2008, NURS ETHICS, V15, P304, DOI 10.1177/0969733007088357; Schwenzer KJ, 2006, CRIT CARE MED, V34, P2967, DOI 10.1097/01.CCM.0000248879.19054.73; Seale C, 2010, J MED ETHICS, V36, P677, DOI 10.1136/jme.2010.036194; Sprung CL, 2008, INTENS CARE MED, V34, P271, DOI 10.1007/s00134-007-0927-1; Sprung CL, 1999, CRIT CARE MED, V27, P1073, DOI 10.1097/00003246-199906000-00021; Thompson BT, 2004, CRIT CARE MED, V32, P1781, DOI 10.1097/01.CCM.0000126895.66850.14; Vanheule S, 2003, HUM RELAT, V56, P321, DOI 10.1177/0018726703056003614; Vincent JL, 1999, CRIT CARE MED, V27, P1626, DOI 10.1097/00003246-199908000-00042; Visser MRM, 2003, CAN MED ASSOC J, V168, P271; Weiner Joseph S, 2004, J Palliat Med, V7, P817, DOI 10.1089/jpm.2004.7.817; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665	49	217	221	0	37	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 28	2011	306	24					2694	2703		10.1001/jama.2011.1888	http://dx.doi.org/10.1001/jama.2011.1888			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	867VX	22203538	Green Published, Bronze			2022-12-28	WOS:000298484000020
J	Heyner, D; Wicht, J; Gomez-Perez, N; Schmitt, D; Auster, HU; Glassmeier, KH				Heyner, Daniel; Wicht, Johannes; Gomez-Perez, Natalia; Schmitt, Dieter; Auster, Hans-Ulrich; Glassmeier, Karl-Heinz			Evidence from Numerical Experiments for a Feedback Dynamo Generating Mercury's Magnetic Field	SCIENCE			English	Article							PLANETARY DYNAMOS; DRIVEN; BEPICOLOMBO; MESSENGER; EVOLUTION; MISSION; MODELS; CORE	The observed weakness of Mercury's magnetic field poses a long-standing puzzle to dynamo theory. Using numerical dynamo simulations, we show that it could be explained by a negative feedback between the magnetospheric and the internal magnetic fields. Without feedback, a small internal field was amplified by the dynamo process up to Earth-like values. With feedback, the field strength saturated at a much lower level, compatible with the observations at Mercury. The classical saturation mechanism via the Lorentz force was replaced by the external field impact. The resulting surface field was dominated by uneven harmonic components. This will allow the feedback model to be distinguished from other models once a more accurate field model is constructed from MErcury Surface, Space ENvironment, GEochemistry, and Ranging (MESSENGER) and BepiColombo data.	[Heyner, Daniel; Auster, Hans-Ulrich; Glassmeier, Karl-Heinz] Tech Univ Carolo Wilhelmina Braunschweig, Inst Geophys & Extraterr Phys, D-38106 Braunschweig, Germany; [Wicht, Johannes; Schmitt, Dieter; Glassmeier, Karl-Heinz] Max Planck Inst Sonnensyst Forsch, D-37191 Katlenburg Lindau, Germany; [Gomez-Perez, Natalia] Univ Los Andes, Dept Fis, Bogota, Colombia	Braunschweig University of Technology; Max Planck Society; Universidad de los Andes (Colombia)	Heyner, D (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Geophys & Extraterr Phys, D-38106 Braunschweig, Germany.	d.heyner@tu-braunschweig.de	Gomez Perez, Natalia/E-3453-2012; Heyner, Daniel/ABC-7737-2020	Gomez Perez, Natalia/0000-0001-7751-2686; 	German Ministerium fur Wirtschaft und Technologie; German Zentrum fur Luft- und Raumfahrt [50 QW 1101]	German Ministerium fur Wirtschaft und Technologie; German Zentrum fur Luft- und Raumfahrt	We appreciated fruitful discussions with U. Christensen. The computing resources of the Gesellschaft fur wissenschaftliche Datenverarbeitung (GWDG), Germany, and the Norddeutscher Verbund fur Hoch- und Hochstleistungsrechnen (HLRN), Germany, are gratefully acknowledged. This work was financially supported by the German Ministerium fur Wirtschaft und Technologie and the German Zentrum fur Luft- und Raumfahrt under contract 50 QW 1101.	Anderson BJ, 2010, SPACE SCI REV, V152, P307, DOI 10.1007/s11214-009-9544-3; Arkani-Hamed J, 2011, ICARUS, V212, P920, DOI 10.1016/j.icarus.2011.01.020; Benkhoff J, 2010, PLANET SPACE SCI, V58, P2, DOI 10.1016/j.pss.2009.09.020; Breuer D, 2007, SPACE SCI REV, V132, P229, DOI 10.1007/s11214-007-9228-9; Breuer D, 2010, SPACE SCI REV, V152, P449, DOI 10.1007/s11214-009-9587-5; Christensen U., 2007, TREATISE GEOPHYS; Christensen UR, 2006, GEOPHYS J INT, V166, P97, DOI 10.1111/j.1365-246X.2006.03009.x; Christensen UR, 2010, EARTH PLANET SC LETT, V296, P487, DOI 10.1016/j.epsl.2010.06.009; Christensen UR, 2006, NATURE, V444, P1056, DOI 10.1038/nature05342; Glassmeier KH, 2010, PLANET SPACE SCI, V58, P287, DOI 10.1016/j.pss.2008.06.018; Glassmeier KH, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031662; Gomez-Perez N, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044533; Gomez-Perez N, 2010, ICARUS, V209, P53, DOI 10.1016/j.icarus.2010.04.006; Grosser J, 2004, PLANET SPACE SCI, V52, P1251, DOI 10.1016/j.pss.2004.08.005; Heyner D, 2011, ASTRON NACHR, V332, P36, DOI 10.1002/asna.201011466; Heyner D, 2010, GEOPHYS ASTRO FLUID, V104, P419, DOI 10.1080/03091921003776839; Hori K, 2010, PHYS EARTH PLANET IN, V182, P85, DOI 10.1016/j.pepi.2010.06.011; Johnson C. L., 2009, LUNAR PLANET SCI C, V40, P1385; Korth H, 2004, PLANET SPACE SCI, V52, P733, DOI 10.1016/j.pss.2003.12.008; Olsen N, 2010, SPACE SCI REV, V152, P135, DOI 10.1007/s11214-009-9563-0; Olson P, 2006, EARTH PLANET SC LETT, V250, P561, DOI 10.1016/j.epsl.2006.08.008; Sakuraba A, 2009, NAT GEOSCI, V2, P802, DOI 10.1038/NGEO643; Schubert G, 2011, PHYS EARTH PLANET IN, V187, P92, DOI 10.1016/j.pepi.2011.05.013; Solomon SC, 2007, SPACE SCI REV, V131, P3, DOI 10.1007/s11214-007-9247-6; Spohn T, 2001, PLANET SPACE SCI, V49, P1561, DOI 10.1016/S0032-0633(01)00093-9; Stanley S, 2005, EARTH PLANET SC LETT, V234, P27, DOI 10.1016/j.epsl.2005.02.040; Stanley S, 2010, SPACE SCI REV, V152, P617, DOI 10.1007/s11214-009-9573-y; SUESS ST, 1979, J GEOPHYS RES-SPACE, V84, P3306, DOI 10.1029/JA084iA07p03306; Takahashi F, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025792; Uno H, 2009, EARTH PLANET SC LETT, V285, P328, DOI 10.1016/j.epsl.2009.02.032; Vilim R, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2009JE003528; Wicht J, 2007, SPACE SCI REV, V132, P261, DOI 10.1007/s11214-007-9280-5; Wicht J, 2002, PHYS EARTH PLANET IN, V132, P281, DOI 10.1016/S0031-9201(02)00078-X; Wicht J., 2010, NUMERICAL DYNAMO SIM	34	35	36	2	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1690	1693		10.1126/science.1207290	http://dx.doi.org/10.1126/science.1207290			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22194574				2022-12-28	WOS:000298344000063
J	Blumenthal, D				Blumenthal, David			Implementation of the Federal Health Information Technology Initiative	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									[Blumenthal, David] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Blumenthal, David] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Blumenthal, D (corresponding author), Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA.							[Anonymous], 2010, HLTH INF TECHN US MO; Blumenthal D, 2011, NEW ENGL J MED, V365, P2323, DOI 10.1056/NEJMsr1110507; Blumenthal D, 2010, NEW ENGL J MED, V362, P382, DOI 10.1056/NEJMp0912825; Blumenthal Dr. David, 2010, COMMUNICATION   0901; Center for Medicare and Medicaid Services, 2011, EHR INC PROGR; Harris Interactive/Xerox Survey, IMP EL HLTH REC; Office of the National Coordinator for Health Information Technology, STAT HLTH INF EXCH C; Office of the National Coordinator for Health Information Technology, CERT HLTH IT PROD LI; Office of the National Coordinator for Health Information Technology U. S Department of Health & Human Services, CURR DEV CTR PROGR; Office of the National Coordinator for Health Information Technology US Department of Health & Human Services, EL HLTH REC MEAN US; Rollins Genna, 2010, J AHIMA, V81, P28; The Office of the National Coordinator for Health Information Technology, STAND CERT; The Office of the National Coordinator for Health Information Technology, COMP EX NOND TRAIN P; The Office of the National Coordinator for Health Information Technology, COMM COLL CONS ED HL; The Office of the National Coordinator for Health Information Technology, PROGR ASS U BAS TRAI; The Office of the National Coordinator for Health Information Technology Health Information Technology Extension Program, LIST REG EXT CTR	16	88	88	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2011	365	25					2426	2431		10.1056/NEJMsr1112158	http://dx.doi.org/10.1056/NEJMsr1112158			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	865OM	22187990				2022-12-28	WOS:000298320200010
J	Esserman, LJ; Woodcock, J				Esserman, Laura J.; Woodcock, Janet			Accelerating Identification and Regulatory Approval of Investigational Cancer Drugs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Esserman, Laura J.] Univ Calif San Francisco, San Francisco, CA 94115 USA; [Woodcock, Janet] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA	University of California System; University of California San Francisco; US Food & Drug Administration (FDA)	Esserman, LJ (corresponding author), Univ Calif San Francisco, 1600 Divisadero St,POB 1710, San Francisco, CA 94115 USA.	laura.esserman@ucsfmedctr.org						[Anonymous], 1 SPY2 CLIN TRIAL; Barker AD, 2009, CLIN PHARMACOL THER, V86, P97, DOI 10.1038/clpt.2009.68; Centers for Medicare & Medicaid Services, NAT HLTH EXP FACT SH; DiMasi JA, 2010, CLIN PHARMACOL THER, V87, P272, DOI 10.1038/clpt.2009.295; DiMasi JA, 2007, J CLIN ONCOL, V25, P209, DOI 10.1200/JCO.2006.09.0803; Esserman LJ, BREAST CANC RES TREA, DOI [10.1007/sl0549-011-1895-2, DOI 10.1007/SL0549-011-1895-2]; Olson S., 2011, ESTABLISHING PRECOMP; Patlak M, 2010, EXTENDING SPECTRUM P; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a	9	46	48	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 21	2011	306	23					2608	2609		10.1001/jama.2011.1837	http://dx.doi.org/10.1001/jama.2011.1837			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	864YQ	22187281				2022-12-28	WOS:000298276800023
J	Boyce, N				Boyce, Niall			The Wakley Prize 2011: all that matters	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Boyce, N (corresponding author), The Lancet, London NW1 7BY, England.	niall.boyce@lancet.com							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 17	2011	378	9809					2060	2060		10.1016/S0140-6736(11)61882-5	http://dx.doi.org/10.1016/S0140-6736(11)61882-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	865EL	22177501				2022-12-28	WOS:000298293600016
J	Berger, RMF; Beghetti, M; Humpl, T; Raskob, GE; Ivy, DD; Jing, ZC; Bonnet, D; Schulze-Neick, I; Barst, RJ				Berger, Rolf M. F.; Beghetti, Maurice; Humpl, Tilman; Raskob, Gary E.; Ivy, D. Dunbar; Jing, Zhi-Cheng; Bonnet, Damien; Schulze-Neick, Ingram; Barst, Robyn J.			Clinical features of paediatric pulmonary hypertension: a registry study	LANCET			English	Article							ARTERIAL-HYPERTENSION; CHILDREN; SURVIVAL; BOSENTAN; ADULTS	Background Paediatric pulmonary hypertension, is an important cause of morbidity and mortality, and is insufficiently characterised in children. The Tracking Outcomes and Practice in Pediatric Pulmonary Hypertension (TOPP) registry is a global, prospective study designed to provide information about demographics, treatment, and outcomes in paediatric pulmonary hypertension. Methods Consecutive patients aged 18 years or younger at diagnosis with pulmonary hypertension and increased pulmonary vascular resistance were enrolled in TOPP at 31 centres in 19 countries from Jan 31, 2008, to Feb 15, 2010. Patient and disease characteristics, including age at diagnosis and at enrolment, sex, ethnicity, presenting symptoms, pulmonary hypertension classification, comorbid disorders, medical and family history, haemodynamic indices, and functional class were recorded. Follow-up was decided by the patients' physicians according to the individual's health-care needs. Findings 362 of 456 consecutive patients had confirmed pulmonary hypertension (defined as mean pulmonary artery pressure >= 25 mm Hg, pulmonary capillary wedge pressure <= 12 mm Hg, and pulmonary vascular resistance index >= 3 WU/m(-2)). 317 (88%) patients had pulmonary arterial hypertension (PAH), which was idiopathic [IPAH] or familial [FPAH] in 182 (57%), and associated with other disorders in 135 (43%), of which 115 (85%) cases were associated with congenital heart disease. 42 patients (12%) had pulmonary hypertension associated with respiratory disease or hypoxaemia, with bronchopulmonary dysplasia most frequent. Finally, only three patients had either chronic thromboembolic pulmonary hypertension or miscellaneous causes of pulmonary hypertension. Chromosomal anomalies, mainly trisomy 21, were reported in 47 (13%) of patients with confirmed disease. Median age at diagnosis was 7 years (IQR 3-12); 59% (268 of 456) were female. Although dyspnoea and fatigue were the most frequent symptoms, syncope occurred in 31% (57 of 182) of patients with IPAH or FPAH and in 18% (eight of 45) of those with repaired congenital heart disease; no children with unrepaired congenital systemic-to-pulmonary shunts had syncope. Despite severe pulmonary hypertension, functional class was I or II in 230 of 362 (64%) patients, which is consistent with preserved right-heart function. Interpretation TOPP identifies important clinical features specific to the care of paediatric pulmonary hypertension, which draw attention to the need for paediatric data rather than extrapolation from adult studies.	[Berger, Rolf M. F.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp,Dept Paediat Cardiol, Ctr Congenital Heart Dis Paediat Cardiol, NL-9700 RB Groningen, Netherlands; [Beghetti, Maurice] Childrens Univ Hosp, Geneva, Switzerland; [Humpl, Tilman] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Raskob, Gary E.] Univ Oklahoma, Hlth Sci Ctr, Coll Publ Hlth, Oklahoma City, OK USA; [Ivy, D. Dunbar] Univ Colorado, Sch Med, Aurora, CO USA; [Jing, Zhi-Cheng] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Cardiopulm Circulat, Shanghai 200092, Peoples R China; [Bonnet, Damien] Univ Paris 05, Paris, France; [Schulze-Neick, Ingram] Great Ormond St Hosp Sick Children, London, England; [Barst, Robyn J.] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA	University of Groningen; University of Geneva; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Colorado System; University of Colorado Anschutz Medical Campus; Tongji University; UDICE-French Research Universities; Universite Paris Cite; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Columbia University	Berger, RMF (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp,Dept Paediat Cardiol, Ctr Congenital Heart Dis Paediat Cardiol, POB 30 001, NL-9700 RB Groningen, Netherlands.	r.m.f.berger@umcg.nl	Jing, Zhi-Cheng/AAT-9081-2021	Jing, Zhi-Cheng/0000-0003-0493-0929	Actelion Pharmaceuticals; Pfizer; Bayer; Bristol-Myers Squibb; Daiichy Sankyo; Sanofi-Aventis; Gilead; United Therapeutics; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER	Actelion Pharmaceuticals; Pfizer(Pfizer); Bayer(Bayer AG); Bristol-Myers Squibb(Bristol-Myers Squibb); Daiichy Sankyo; Sanofi-Aventis(Sanofi-Aventis); Gilead(Gilead Sciences); United Therapeutics; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	All authors or their institutions have received travel costs to visit executive board or investigator meetings related to the TOPP-registry from the Association for Pediatric Pulmonary Hypertension. GR has been a consultant for the Association for Pediatric Pulmonary Hypertension. RMFB has been a consultant for Actelion Pharmaceuticals, GlaxoSmithKline, Novartis, and United Therapeutics; his institution has received or has grants pending from Actelion Pharmaceuticals and Pfizer; and has received lecture fees from Actelion Pharmaceuticals. MB has been a consultant and board member for Actelion Pharmaceuticals, Pfizer, Bayer, Novartis, Eli Lilly, and GlaxoSmithKline; has received grants from Bayer and lecture fees from Actelion Pharmaceuticals, Pfizer, and Bayer; and has developed educational material for Actelion Pharmaceuticals. GER has been a consultant for Bayer, Bristol-Myers Squibb, Johnson&Johnson, Pfizer, Actelion Pharmaceuticals, Daiichi-Sankyo, Sanofi-Aventis, Boehringer Ingelheim, GlaxoSmithKline, and Takeda R & D; and has received writer's fees from Bristol-Myers Squibb, Daiichy Sankyo, Bayer, and Sanofi-Aventis. DDI has been a consultant for Actelion Pharmaceuticals, Gilead, United Therapeutics, and Pfizer; and has received grants from Gilead and developed educational material for United Therapeutics. ZCJ has been a consultant and board member for Pfizer, GlaxoSmithKline, Actelion Pharmaceuticals, United Therapeutics, and Bayer; has received grants from Actelion Pharmaceuticals, Bayer, Pfizer, and United Therapeutics; and has received lecture fees from Actelion Pharmaceuticals and Bayer. RJB has been a consultant for Actelion Pharmaceuticals, Eli Lilly, GlaxoSmithKline, Gilead, Merck, Novartis, Bayer, and Pfizer. TH, IS-N, and DB declare that they have no conflicts of interests.	Association for Pediatric Pulmonary Hypertension, MAIN OBJ TOPP DIS RE; Badesch DB, 2010, CHEST, V137, P376, DOI 10.1378/chest.09-1140; Barst RJ, 2011, EUR RESPIR J, V37, P665, DOI 10.1183/09031936.00056110; Berger RMF, 2010, EUR RESPIR REV, V19, P321, DOI 10.1183/09059180.00008410; CHI TL, 1975, J PEDIATR-US, V86, P533, DOI 10.1016/S0022-3476(75)80142-9; COONEY TP, 1982, NEW ENGL J MED, V307, P1170, DOI 10.1056/NEJM198211043071902; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Frost AE, 2011, CHEST, V139, P128, DOI 10.1378/chest.10-0075; Galie N, 2006, CIRCULATION, V114, P48, DOI 10.1161/CIRCULATIONAHA.106.630715; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Haworth SG, 2009, HEART, V95, P312, DOI 10.1136/hrt.2008.150086; Humbert M, 2006, AM J RESP CRIT CARE, V173, P1023, DOI 10.1164/rccm.200510-1668OC; Jobe AH, 2011, CURR OPIN PEDIATR, V23, P167, DOI 10.1097/MOP.0b013e3283423e6b; Kessler R, 2001, AM J RESP CRIT CARE, V164, P219, DOI 10.1164/ajrccm.164.2.2006129; Khemani E, 2007, PEDIATRICS, V120, P1260, DOI 10.1542/peds.2007-0971; Le RJ, 2011, J AM COLL CARDIOL, V58, P863, DOI 10.1016/j.jacc.2011.04.026; MARCUS CL, 1991, PEDIATRICS, V88, P132; McDowell KM, 2011, J PEDIATR-US, V158, P319, DOI 10.1016/j.jpeds.2010.07.023; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; Pfizer, EXP REV SILD PED PRO; Rosenzweig EB, 2008, CURR OPIN PEDIATR, V20, P288, DOI 10.1097/MOP.0b013e3282ff5fdc; Simonneau G, 2004, J AM COLL CARDIOL, V43, p5S, DOI 10.1016/j.jacc.2004.02.037; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Singh TP, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.09.006; Stenmark KR, 2005, ANNU REV PHYSIOL, V67, P623, DOI 10.1146/annurev.physiol.67.040403.102229; van Loon RLE, 2007, AM HEART J, V154, P776, DOI 10.1016/j.ahj.2007.06.003; van Loon RLE, 2011, CIRCULATION, V124, P1755, DOI 10.1161/CIRCULATIONAHA.110.969584; van Loon RLE, 2009, J PEDIATR-US, V155, P176, DOI 10.1016/j.jpeds.2009.02.036	28	273	292	2	47	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 11	2012	379	9815					537	546		10.1016/S0140-6736(11)61621-8	http://dx.doi.org/10.1016/S0140-6736(11)61621-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	891AO	22240409	Green Accepted			2022-12-28	WOS:000300188800030
J	Ku, MJH; Sommer, AT; Cheuk, LW; Zwierlein, MW				Ku, Mark J. H.; Sommer, Ariel T.; Cheuk, Lawrence W.; Zwierlein, Martin W.			Revealing the Superfluid Lambda Transition in the Universal Thermodynamics of a Unitary Fermi Gas	SCIENCE			English	Article							CONDENSATION	Fermi gases, collections of fermions such as neutrons and electrons, are found throughout nature, from solids to neutron stars. Interacting Fermi gases can form a superfluid or, for charged fermions, a superconductor. We have observed the superfluid phase transition in a strongly interacting Fermi gas by high-precision measurements of the local compressibility, density, and pressure. Our data completely determine the universal thermodynamics of these gases without any fit or external thermometer. The onset of superfluidity is observed in the compressibility, the chemical potential, the entropy, and the heat capacity, which displays a characteristic lambda-like feature at the critical temperature T-c/T-F = 0.167(13). The ground-state energy is 3/5 xi N E-F with xi = 0.376(4). Our measurements provide a benchmark for many-body theories of strongly interacting fermions.	[Zwierlein, Martin W.] MIT, Dept Phys, Harvard Ctr Ultracold Atoms, Cambridge, MA 02139 USA; MIT, Elect Res Lab, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Zwierlein, MW (corresponding author), MIT, Dept Phys, Harvard Ctr Ultracold Atoms, Cambridge, MA 02139 USA.	zwierlein@mit.edu		Cheuk, Lawrence/0000-0002-8329-8812; /0000-0001-8120-8548; Ku, Mark Jen-Hao/0000-0003-3144-3069; Sommer, Ariel/0000-0003-3390-4455; /0000-0003-1391-0428	NSERC; NSF; Air Force Office of Scientific Research (AFOSR) - Multidisciplinary Research Program of the University Research Initiative (MURI); Army Research Office (ARO) - MURI; Office of Naval Research; Defense Advanced Research Projects Agency (DARPA); ARO; AFOSR; David and Lucile Packard Foundation; Alfred P. Sloan Foundation	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSF(National Science Foundation (NSF)); Air Force Office of Scientific Research (AFOSR) - Multidisciplinary Research Program of the University Research Initiative (MURI); Army Research Office (ARO) - MURI(MURI); Office of Naval Research(Office of Naval Research); Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); ARO; AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	We thank B. Svistunov, N. Prokof'ev, and F. Werner for fruitful discussions; Z. Hadzibabic for a critical reading of the manuscript; the authors of (11, 12, 23, 26, 27, 36) for kindly providing us with their data; and Andre Schirotzek for help during the early stages of the experiment. M.J.H.K. acknowledges financial support from NSERC. This work was supported by the NSF, Air Force Office of Scientific Research (AFOSR) - Multidisciplinary Research Program of the University Research Initiative (MURI), Army Research Office (ARO) - MURI, Office of Naval Research, Defense Advanced Research Projects Agency (DARPA) Young Faculty Award, a grant from the ARO with funding from the DARPA Optical Lattice Emulator program, an AFOSR Presidential Early Career Award in Science and Engineering, the David and Lucile Packard Foundation, and the Alfred P. Sloan Foundation.	Arnold P, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.043605; Astrakharchik GE, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.200404; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Bulgac A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.090404; Burovski E, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.160402; Carlson J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.050401; Castin Y., 2012, BCS BEC CROSSOVER UN; Cheng CH, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.014526; Ensher JR, 1996, PHYS REV LETT, V77, P4984, DOI 10.1103/PhysRevLett.77.4984; Forbes MM, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.235303; Gaebler JP, 2010, NAT PHYS, V6, P569, DOI 10.1038/NPHYS1709; Giorgini S, 2008, REV MOD PHYS, V80, P1215, DOI 10.1103/RevModPhys.80.1215; Goulko O, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.053621; Haussmann R, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.023610; Ho TL, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.090402; Horikoshi M, 2010, SCIENCE, V327, P442, DOI 10.1126/science.1183012; Ketterle W, 2008, RIV NUOVO CIMENTO, V31, P247, DOI 10.1393/ncr/i2008-10033-1; Kinast J, 2005, SCIENCE, V307, P1296, DOI 10.1126/science.1109220; Lipa JA, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.174518; Liu XJ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.160401; Luo L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.080402; Luo L, 2009, J LOW TEMP PHYS, V154, P1, DOI 10.1007/s10909-008-9850-2; Nascimbene S, 2010, NATURE, V463, P1057, DOI 10.1038/nature08814; Nascimbene S., 2010, THESIS ECOLE NORMALE; Partridge GB, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.190407; Pollet L, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.245705; Rakshit D., ARXIV11065958; Regal CA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.040403; Shin Y, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.030401; Stewart JT, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.220406; Tinkham M., 2004, INTRO SUPERCONDUCTIV, V2nd; Van Houcke K., 2011, ARXIV11103747; Vollhardt D., 1990, SUPERFLUID PHASES HE, V3; Zwierlein MW, 2005, NATURE, V435, P1047, DOI 10.1038/nature03858; Zwierlein MW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.120403	35	501	504	0	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2012	335	6068					563	567		10.1126/science.1214987	http://dx.doi.org/10.1126/science.1214987			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885HI	22245739	Bronze, Green Submitted			2022-12-28	WOS:000299769200038
J	Veraart, AJ; Faassen, EJ; Dakos, V; van Nes, EH; Lurling, M; Scheffer, M				Veraart, Annelies J.; Faassen, Elisabeth J.; Dakos, Vasilis; van Nes, Egbert H.; Lurling, Miquel; Scheffer, Marten			Recovery rates reflect distance to a tipping point in a living system	NATURE			English	Article							SLOWING-DOWN; LIGHT; COMMUNITIES; COMPETITION; ECOSYSTEMS; SHIFTS	Tipping points, at which complex systems can shift abruptly from one state to another, are notoriously difficult to predict(1). Theory proposes that early warning signals may be based on the phenomenon that recovery rates from small perturbations should tend to zero when approaching a tipping point(2,3); however, evidence that this happens in living systems is lacking. Here we test such 'critical slowing down' using a microcosmin which photo-inhibition drives a cyanobacterial population to a classical tipping point when a critical light level is exceeded. We show that over a large range of conditions, recovery from small perturbations becomes slower as the system comes closer to the critical point. In addition, autocorrelation in the subtle fluctuations of the system's state rose towards the tipping point, supporting the idea that this metric can be used as an indirect indicator of slowing down(4,5). Although stochasticity prohibits prediction of the timing of critical transitions, our results suggest that indicators of slowing down may be used to rank complex systems on a broad scale from resilient to fragile.	[Veraart, Annelies J.; Faassen, Elisabeth J.; Dakos, Vasilis; van Nes, Egbert H.; Lurling, Miquel; Scheffer, Marten] Wageningen Univ, Dept Aquat Ecol & Water Qual Management, NL-6700 AA Wageningen, Netherlands; [Lurling, Miquel] Royal Netherlands Acad Arts & Sci, Netherlands Inst Ecol, Dept Aquat Ecol, NL-6700 AB Wageningen, Netherlands	Wageningen University & Research; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	van Nes, EH (corresponding author), Wageningen Univ, Dept Aquat Ecol & Water Qual Management, POB 47, NL-6700 AA Wageningen, Netherlands.	egbert.vannes@wur.nl	Faassen, Elisabeth/P-5411-2015; Veraart, Annelies/AFR-8009-2022; Wrbka, Thomas/A-5699-2010; Scheffer, Marten/C-1852-2012; Veraart, Annelies J/E-1927-2014; Dakos, Vasilis/D-6488-2012; van Nes, Egbert H/F-2681-2011; KNAW, NIOO-KNAW/A-4320-2012	Faassen, Elisabeth/0000-0001-9098-8662; Wrbka, Thomas/0000-0002-1451-9108; Veraart, Annelies J/0000-0001-6286-7484; KNAW, NIOO-KNAW/0000-0002-3835-159X; Dakos, Vasilis/0000-0001-8862-718X; van Nes, Egbert/0000-0002-6345-104X	European Research Council; Spinoza award	European Research Council(European Research Council (ERC)European Commission); Spinoza award	We thank M. B. Goncalves Souza for discussions on the experimental set up. We thank D. Waasdorp and W. Beekman-Lukassen for assistance with the experiments and C. ter Braak for statistical advice. A.J.V., E.J.F., V. D., E.H.v.N. and M. S. are supported by a European Research Council Advanced grant and M. S. is the recipient of a Spinoza award.	Andersen RA., 2005, ALGAL CULTURING TECH, P435; Carpenter SR, 2011, SCIENCE, V332, P1079, DOI 10.1126/science.1203672; Carpenter SR, 2006, ECOL LETT, V9, P308, DOI 10.1111/j.1461-0248.2005.00877.x; Dakos V., ECOLOGY UNPUB; Dakos V, 2008, P NATL ACAD SCI USA, V105, P14308, DOI 10.1073/pnas.0802430105; Dakos V, 2011, AM NAT, V177, pE153, DOI 10.1086/659945; Drake J. M., 2010, NATURE; Gerla DJ, 2011, OIKOS, V120, P359, DOI 10.1111/j.1600-0706.2010.18573.x; Held H, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020972; Holmgren Milena, 1997, Ecology (Washington D C), V78, P1966, DOI 10.1890/0012-9658(1997)078[1966:TIOFAC]2.0.CO;2; HUISMAN J, 1994, ECOLOGY, V75, P507, DOI 10.2307/1939554; Huisman J, 2002, ANTON LEEUW INT J G, V81, P117, DOI 10.1023/A:1020537928216; HUISMAN J, 1997, THESIS U GRONINGEN; IVES AR, 1995, ECOL MONOGR, V65, P217, DOI 10.2307/2937138; Kleinen T., 2003, OCEAN DYNAM, V53, P53, DOI DOI 10.1007/S10236-002-0023-6; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M., 2020, CRITICAL TRANSITIONS, V16, DOI 10.2307/j.ctv173f1g1; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; van Nes EH, 2007, AM NAT, V169, P738, DOI 10.1086/516845; WISSEL C, 1984, OECOLOGIA, V65, P101, DOI 10.1007/BF00384470	21	266	274	4	207	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 19	2012	481	7381					357	U137		10.1038/nature10723	http://dx.doi.org/10.1038/nature10723			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877VK	22198671				2022-12-28	WOS:000299210600041
J	Thrumurthy, G; Karthikesalingam, A; Patterson, BO; Holt, PJE; Thompson, MM				Thrumurthy, G.; Karthikesalingam, Alan; Patterson, Benjamin O.; Holt, Peter J. E.; Thompson, Matt M.			The diagnosis and management of aortic dissection	BMJ-BRITISH MEDICAL JOURNAL			English	Review							STENT-GRAFT PLACEMENT; LONG-TERM SURVIVAL; INTERNATIONAL REGISTRY; MARFAN-SYNDROME; REPAIR; OUTCOMES; IRAD; ANEURYSM		[Thrumurthy, G.; Karthikesalingam, Alan; Patterson, Benjamin O.; Holt, Peter J. E.; Thompson, Matt M.] St Georges Vasc Inst, Dept Outcomes Res, London SW17 0QT, England	St Georges University London	Holt, PJE (corresponding author), St Georges Vasc Inst, Dept Outcomes Res, London SW17 0QT, England.	pholt@sgul.ac.uk	Holt, Peter J.E./B-2003-2013	Holt, Peter J.E./0000-0002-5739-2813	Department of Health [NIHR-CS-011-008] Funding Source: Medline; National Institute for Health Research [CL-2007-16-002] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Albornoz G, 2006, ANN THORAC SURG, V82, P1400, DOI 10.1016/j.athoracsur.2006.04.098; Chan YC, 2011, EUR J VASC ENDOVASC, V42, P464, DOI 10.1016/j.ejvs.2011.05.022; Collins JS, 2004, CIRCULATION, V110, pII237, DOI 10.1161/01.CIR.0000138219.67028.2a; Dake MD, 1999, NEW ENGL J MED, V340, P1546, DOI 10.1056/NEJM199905203402004; Eggebrecht H, 2006, EUR HEART J, V27, P489, DOI 10.1093/eurheartj/ehi493; Erbel R, 2001, EUR HEART J, V22, P1642, DOI 10.1053/euhj.2001.2782; Fattori R, 2000, AM J CARDIOL, V86, P868, DOI 10.1016/S0002-9149(00)01108-5; FINKBOHNER R, 1995, CIRCULATION, V91, P728, DOI 10.1161/01.CIR.91.3.728; Hinchliffe RJ, 2008, J CARDIOVASC SURG, V49, P449; Hiratzka LF, 2010, CIRCULATION, V121, pE266, DOI 10.1161/CIR.0b013e3181d4739e; Ince H, 2007, HEART, V93, P266, DOI 10.1136/hrt.2005.078550; Januzzi JL, 2004, J AM COLL CARDIOL, V43, P665, DOI 10.1016/j.jacc.2003.08.054; Karthikesalingam A, 2010, VASC ENDOVASC SURG, V44, P165, DOI 10.1177/1538574410362118; Nienaber C A, 1999, Cardiol Rev, V7, P332, DOI 10.1097/00045415-199911000-00011; Nienaber CA, 2003, CIRCULATION, V108, P628, DOI 10.1161/01.CIR.0000087009.16755.E4; NIENABER CA, 1993, NEW ENGL J MED, V328, P1, DOI 10.1056/NEJM199301073280101; Nienaber CA, 2009, CIRCULATION, V120, P2519, DOI 10.1161/CIRCULATIONAHA.109.886408; Olsson C, 2006, CIRCULATION, V114, P2611, DOI 10.1161/CIRCULATIONAHA.106.630400; Ranasinghe AM, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4487; Rogers AM, 2010, CIRCULATION, V123, P2213; SILVERMAN DI, 1995, AM J CARDIOL, V75, P157, DOI 10.1016/S0002-9149(00)80066-1; Subramanian S, 2009, SEMIN VASC SURG, V22, P61, DOI 10.1053/j.semvascsurg.2009.04.006; Suzuki T, 2003, CIRCULATION, V108, P312, DOI 10.1161/01.cir.0000087386.07204.09; Svensson LG, 2008, ANN THORAC SURG, V85, pS1, DOI 10.1016/j.athoracsur.2007.10.099; Thrumurthy SG, 2011, EUR J VASC ENDOVASC, V42, P632, DOI 10.1016/j.ejvs.2011.08.009; Trimarchi S, 2006, CIRCULATION, V114, pI357, DOI 10.1161/CIRCULATIONAHA.105.000620; Tsai TT, 2009, EUR J VASC ENDOVASC, V37, P149, DOI 10.1016/j.ejvs.2008.11.032; Tsai TT, 2006, CIRCULATION, V114, P2226, DOI 10.1161/CIRCULATIONAHA.106.622340; Umana JP, 2002, J THORAC CARDIOV SUR, V124, P896, DOI 10.1067/mtc.2002.123131; von Kodolitsch Y, 2000, ARCH INTERN MED, V160, P2977, DOI 10.1001/archinte.160.19.2977	30	27	31	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 11	2012	344								d8290	10.1136/bmj.d8290	http://dx.doi.org/10.1136/bmj.d8290			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877SI	22236596				2022-12-28	WOS:000299202500019
J	Gavin, MC; Morse, D; Partridge, AH; Levy, BD; Loscalzo, J				Gavin, Michael C.; Morse, Danielle; Partridge, Ann H.; Levy, Bruce D.; Loscalzo, Joseph			Breathless	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TUMOR THROMBOTIC MICROANGIOPATHY; PULMONARY MICROVASCULAR CYTOLOGY; SUBACUTE COR-PULMONALE; DIAGNOSIS; EMBOLISM		[Levy, Bruce D.] Brigham & Womens Hosp, Harvard Inst Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Levy, BD (corresponding author), Brigham & Womens Hosp, Harvard Inst Med, Dept Med, Bldg HIM855,77 Ave Louis Pasteur, Boston, MA 02115 USA.	blevy@partners.org	Loscalzo, Joseph/ABD-8980-2021					Brill IC, 1937, ARCH INTERN MED, V60, P1043, DOI 10.1001/archinte.1937.00180060096010; Chan C K, 1987, J Thorac Imaging, V2, P4, DOI 10.1097/00005382-198710000-00004; MASSON RG, 1985, CHEST, V88, P908, DOI 10.1378/chest.88.6.908; MASSON RG, 1989, NEW ENGL J MED, V321, P71, DOI 10.1056/NEJM198907133210202; Roberts KE, 2003, AM J MED, V115, P228, DOI 10.1016/S0002-9343(03)00305-X; SATO Y, 1995, PATHOL INT, V45, P436, DOI 10.1111/j.1440-1827.1995.tb03481.x; Schriner KW, 1991, MAYO CLIN P, V66, P439; SCHRINER RW, 1991, MAYO CLIN PROC, V66, P143, DOI 10.1016/S0025-6196(12)60485-6; Shields D J, 1992, Cardiovasc Pathol, V1, P279, DOI 10.1016/1054-8807(92)90038-P; Tashima Y, 2009, CLIN NUCL MED, V34, P175, DOI 10.1097/RLU.0b013e3181966f5c; VONHERBAY A, 1990, CANCER, V66, P587, DOI 10.1002/1097-0142(19900801)66:3<587::AID-CNCR2820660330>3.0.CO;2-J	11	18	19	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 5	2012	366	1					75	81		10.1056/NEJMcps1011918	http://dx.doi.org/10.1056/NEJMcps1011918			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	887XY	22216845				2022-12-28	WOS:000299968800011
J	Lehman, R; Loder, E				Lehman, Richard; Loder, Elizabeth			Missing clinical trial data	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Lehman, Richard] Univ Oxford, Dept Primary Care, Oxford OX1 2ET, England; [Loder, Elizabeth] BMJ, London WC1H 9JR, England	University of Oxford	Lehman, R (corresponding author), Univ Oxford, Dept Primary Care, Oxford OX1 2ET, England.	eloder@bmj.com						Ahmed I, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7762; CHALMERS I, 1990, JAMA-J AM MED ASSOC, V263, P1405, DOI 10.1001/jama.263.10.1405; Chan AW, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8013; Hart B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7202; Jefferson T, 2011, COCHRANE DB SYST REV, V12; Jefferson T, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7258; Krumholz HM, 2011, JAMA-J AM MED ASSOC, V306, P1593, DOI 10.1001/jama.2011.1459; Prayle AP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7373; Ross JS, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7292; Wieland SL, 2012, BRIT MED J, V344, pd7501; Wieseler B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8141	11	38	39	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 3	2012	344								d8158	10.1136/bmj.d8158	http://dx.doi.org/10.1136/bmj.d8158			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	874UE	22214760				2022-12-28	WOS:000298982800011
J	Hayes, JM				Hayes, John M.			Earth's Redox History	SCIENCE			English	Editorial Material									Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Hayes, JM (corresponding author), Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA.	jhayes@whoi.edu						Berner RA, 2009, AM J SCI, V309, P603, DOI 10.2475/07.2009.03; Butterfield NJ, 2011, TRENDS ECOL EVOL, V26, P81, DOI 10.1016/j.tree.2010.11.012; Grotzinger JP, 2011, NAT GEOSCI, V4, P285, DOI [10.1038/ngeo1138, 10.1038/NGEO1138]; Hayes JM, 2006, PHILOS T R SOC B, V361, P931, DOI 10.1098/rstb.2006.1840; Kump LR, 2011, SCIENCE, V334, P1694, DOI 10.1126/science.1213999; LOGAN GA, 1995, NATURE, V376, P53, DOI 10.1038/376053a0	6	4	5	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1654	1655		10.1126/science.1216481	http://dx.doi.org/10.1126/science.1216481			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22194565				2022-12-28	WOS:000298344000053
J	Lawler, A				Lawler, Andrew			Preserving History, One Hill at a Time	SCIENCE			English	News Item																			0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1623	1623		10.1126/science.334.6063.1623	http://dx.doi.org/10.1126/science.334.6063.1623			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22194544				2022-12-28	WOS:000298344000018
J	Ball, P				Ball, Philip			The new history	NATURE			English	Editorial Material												p.ball@btinternet.com						Fukuyama F., 1992, END HIST LAST MAN; HANDY C, 1990, AGE UNREASON; Helbing D., 2008, MANAGING COMPLEXITY; Lammer S, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/04/P04019; National Intelligence Council, 2008, GLOB TRENDS 2025 TRA; Vespignani A, 2010, NATURE, V464, P984, DOI 10.1038/464984a	6	7	7	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2011	480	7378					447	448		10.1038/480447a	http://dx.doi.org/10.1038/480447a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	865NQ	22193083	Bronze			2022-12-28	WOS:000298318000034
J	Grayson, M				Grayson, Michelle			Traditional Asian medicine	NATURE			English	Editorial Material																			0	23	24	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2011	480	7378					S81	S81		10.1038/480S81a	http://dx.doi.org/10.1038/480S81a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865NQ	22190084	Bronze			2022-12-28	WOS:000298318000073
J	Getz, L; Kirkengen, AL; Petursson, H; Sigurdsson, JA				Getz, Linn; Kirkengen, Anna Luise; Petursson, Halfdan; Sigurdsson, Johann A.			CHRISTMAS 2011: ORAL TRADITIONS The royal road to healing: a bit of a saga	BRITISH MEDICAL JOURNAL			English	Editorial Material							BIOMEDICINE; MODEL		[Getz, Linn; Kirkengen, Anna Luise; Petursson, Halfdan] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, Gen Practice Res Unit, N-7491 Trondheim, Norway; [Getz, Linn] Landspitali Univ Hosp, Reykjavik, Iceland; [Kirkengen, Anna Luise] Univ Tromso, Inst Community Med, Tromso, Norway; [Kirkengen, Anna Luise] Akershus Univ Hosp, Ctr Hlth Promot, Lorenskog, Norway; [Sigurdsson, Johann A.] Univ Iceland, Dept Family Med, Reykjavik, Iceland; [Sigurdsson, Johann A.] Primary Hlth Care Capital Area, Ctr Dev, Reykjavik, Iceland	Norwegian University of Science & Technology (NTNU); Landspitali National University Hospital; UiT The Arctic University of Tromso; University of Oslo; University of Iceland	Getz, L (corresponding author), Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, Gen Practice Res Unit, N-7491 Trondheim, Norway.	linn.getz@ntnu.no		Sigurdsson, Johann Agust/0000-0002-5646-6411				Adler RH, 2009, J PSYCHOSOM RES, V67, P607, DOI 10.1016/j.jpsychores.2009.08.008; Andersson Theodore M., 2000, MORKINSKINNA EARLIES; Cassell E.J., 2004, NATURE SUFFERING GOA; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; Frank AW., 2004, RENEWAL GENEROSITY I; Frank AW., 2013, WOUNDED STORYTELLER; GETZ L, 2011, J NORWEGIAN MED ASS, V31, P683; JAKOBSSON A, 2002, THESIS HASKOLAUTGAFA; KIERKEGAARD S, 2008, SICKNESS DEATH PENGU; Kirkengen Anna Luise, 2001, INSCRIBED BODIES; KRISTJANSSON K, 2011, MORKINSKINNA, V1; Lock M, 1988, BIOMEDICINE EXAMINED; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; Vetlesen AJ., 1994, PERCEPTION EMPATHY J; Wakefield, 2007, LOSS SADNESS PSYCHIA; Wolkowitz OM, 2010, DEPRESS ANXIETY, V27, P327, DOI 10.1002/da.20686	16	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 19	2011	343								d7826	10.1136/bmj.d7826	http://dx.doi.org/10.1136/bmj.d7826			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	868QI	22184559				2022-12-28	WOS:000298537800002
J	Caruthers, M; Wells, R				Caruthers, Marvin; Wells, Robert			Har Gobind Khorana (1922-2011)	SCIENCE			English	Biographical-Item									[Caruthers, Marvin] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Wells, Robert] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA	University of Colorado System; University of Colorado Boulder; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Caruthers, M (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.	marvin.caruthers@colorado.edu; bodow1938@comcast.net							0	0	0	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 16	2011	334	6062					1511	1511		10.1126/science.1217138	http://dx.doi.org/10.1126/science.1217138			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	862LE	22174242				2022-12-28	WOS:000298091400041
J	Schiermeier, Q				Schiermeier, Quirin			Race against time for raiders of the lost lake	NATURE			English	News Item																			0	7	7	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 20	2011	469	7330					275	275		10.1038/469275a	http://dx.doi.org/10.1038/469275a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	22180887	Bronze			2022-12-28	WOS:000286385600007
